data_2gfu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gfu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.8 m . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -139.21 94.82 2.84 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 121.071 -1.018 . . . . 0.0 113.725 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.51 126.26 45.56 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 121.25 -0.906 . . . . 0.0 109.113 -174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.4 p -111.09 165.82 11.97 Favored Pre-proline 0 C--N 1.364 1.212 0 C-N-CA 127.671 2.388 . . . . 0.0 114.243 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -56.21 139.66 86.24 Favored 'Trans proline' 0 C--N 1.365 1.425 1 C-N-CA 125.622 4.215 . . . . 0.0 120.867 -167.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.4 -24.54 9.75 Favored Glycine 0 C--N 1.361 1.955 0 C-N-CA 128.287 2.851 . . . . 0.0 110.885 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.43 170.21 12.18 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 119.895 1.847 . . . . 0.0 114.251 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 4.2 mm? -98.28 141.92 30.58 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 103.212 -2.885 . . . . 0.0 103.212 164.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.77 141.46 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 165' ' ' PHE . 28.0 m95 -99.02 129.85 45.32 Favored 'General case' 0 C--O 1.214 -0.787 1 O-C-N 115.97 -4.206 . . . . 0.0 103.455 171.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -114.48 147.33 39.5 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 121.087 1.767 . . . . 0.0 109.494 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -118.71 145.83 45.21 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 37.1 ttm -126.69 154.77 43.64 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 123.233 1.492 . . . . 0.0 111.296 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.73 80.7 0.01 OUTLIER 'General case' 0 C--N 1.355 0.847 0 C-N-CA 131.669 3.988 . . . . 0.0 115.838 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.57 7.09 37.47 Favored Glycine 0 C--N 1.359 1.808 0 C-N-CA 125.504 1.526 . . . . 0.0 113.519 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -114.91 160.32 34.09 Favored Pre-proline 0 C--N 1.356 0.875 0 C-N-CA 125.65 1.58 . . . . 0.0 107.591 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -71.79 166.07 30.61 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.952 3.768 . . . . 0.0 113.422 168.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -49.35 129.49 18.61 Favored 'General case' 0 C--N 1.364 1.203 0 C-N-CA 128.356 2.662 . . . . 0.0 117.147 167.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -134.21 109.0 11.47 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 121.586 3.921 . . . . 0.0 121.586 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.22 110.83 1.11 Allowed 'Trans proline' 0 C--N 1.389 2.679 1 C-N-CA 126.663 4.909 . . . . 0.0 112.743 167.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -123.01 164.98 17.53 Favored 'General case' 0 C--N 1.352 0.677 1 C-N-CA 133.286 4.634 . . . . 0.0 116.022 -170.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp -116.46 132.54 56.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 129.447 3.099 . . . . 0.0 107.254 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -86.16 118.85 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 O-C-N 119.913 -1.742 . . . . 0.0 106.537 174.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -127.36 149.78 49.9 Favored 'General case' 0 C--N 1.368 1.391 0 O-C-N 119.002 -2.311 . . . . 0.0 111.059 -170.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -102.0 113.49 26.77 Favored 'General case' 0 C--N 1.37 1.471 0 CA-C-O 122.489 1.138 . . . . 0.0 111.511 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -79.49 158.81 73.28 Favored Pre-proline 0 C--N 1.353 0.738 0 C-N-CA 129.367 3.067 . . . . 0.0 112.592 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.28 71.4 Cg_exo -47.66 1.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.371 1 C-N-CA 130.356 7.37 . . . . 0.0 121.498 -171.515 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -98.89 31.65 2.9 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 131.588 3.955 . . . . 0.0 106.646 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.289 0.0 OUTLIER -68.7 150.81 47.49 Favored 'General case' 0 C--N 1.373 1.621 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -169.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.69 -20.11 27.59 Favored Glycine 0 C--N 1.365 2.158 0 C-N-CA 126.922 2.201 . . . . 0.0 112.552 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.7 m -130.44 147.0 52.09 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 101.269 -3.604 . . . . 0.0 101.269 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -130.7 -0.73 4.31 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-N 121.111 1.778 . . . . 0.0 114.882 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.7 pt -106.48 148.0 11.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.475 0 CA-C-O 123.904 1.812 . . . . 0.0 113.734 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -119.01 126.58 52.06 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 102.229 -3.248 . . . . 0.0 102.229 172.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -148.16 143.79 27.32 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 120.191 -1.568 . . . . 0.0 110.295 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.54 93.74 4.22 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 127.51 2.324 . . . . 0.0 108.821 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.19 -76.03 0.34 Allowed Glycine 0 C--N 1.365 2.19 0 N-CA-C 119.891 2.716 . . . . 0.0 119.891 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -149.01 60.38 1.05 Allowed 'General case' 0 C--N 1.358 0.959 0 CA-C-O 124.014 1.864 . . . . 0.0 109.055 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.7 m -169.59 133.8 1.34 Allowed 'General case' 0 C--N 1.349 0.566 0 C-N-CA 127.551 2.341 . . . . 0.0 105.48 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.94 146.82 31.07 Favored 'Isoleucine or valine' 0 C--N 1.363 1.186 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -134.35 142.77 47.34 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 129.173 2.989 . . . . 0.0 107.264 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.3 162.21 26.14 Favored 'Isoleucine or valine' 0 C--N 1.368 1.387 0 C-N-CA 127.301 2.24 . . . . 0.0 107.897 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 111' ' ' TYR . 0.4 OUTLIER -94.0 133.4 37.49 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 119.576 -1.953 . . . . 0.0 111.031 175.123 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.91 172.97 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.38 158.09 38.22 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 166.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -113.86 130.75 56.45 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -75.11 71.93 2.19 Favored 'General case' 0 C--N 1.372 1.578 0 C-N-CA 126.759 2.023 . . . . 0.0 109.876 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -95.7 -102.92 0.16 Allowed 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.042 1.337 . . . . 0.0 111.132 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -106.72 -62.69 1.36 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 126.216 1.807 . . . . 0.0 113.867 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 p -85.65 -32.61 0.46 Allowed Pre-proline 0 C--N 1.364 1.204 0 N-CA-C 119.374 3.102 . . . . 0.0 119.374 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -84.86 -176.1 14.16 Favored 'Cis proline' 0 CA--C 1.544 0.989 1 CA-C-N 130.358 4.735 . . . . 0.0 112.727 -0.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.315 4.6 t -97.53 154.86 17.24 Favored 'General case' 0 C--N 1.372 1.57 0 C-N-CA 127.216 2.206 . . . . 0.0 113.051 171.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.79 152.47 41.27 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.946 1.698 . . . . 0.0 106.58 171.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.43 -175.47 39.84 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -93.01 117.87 30.54 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 125.189 1.396 . . . . 0.0 108.059 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.2 161.98 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 C-N-CA 125.603 1.561 . . . . 0.0 113.334 -173.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.6 m -76.68 97.63 4.51 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 126.541 1.936 . . . . 0.0 107.18 171.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.423 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 35.1 tttp -54.62 -29.05 50.89 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 128.283 2.633 . . . . 0.0 115.878 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -70.42 -13.37 62.1 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 127.105 2.162 . . . . 0.0 114.098 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.8 mt -98.12 3.84 49.14 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 126.982 2.113 . . . . 0.0 111.784 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 23.4 mt -89.86 135.01 33.89 Favored 'General case' 0 C--N 1.37 1.47 0 C-N-CA 126.661 1.984 . . . . 0.0 111.221 173.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -114.65 158.75 39.45 Favored Pre-proline 0 C--N 1.346 0.448 0 C-N-CA 127.703 2.401 . . . . 0.0 106.279 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.55 158.23 14.42 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 124.814 3.676 . . . . 0.0 118.563 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -44.09 92.35 0.01 OUTLIER 'General case' 0 C--N 1.357 0.906 1 C-N-CA 132.949 4.5 . . . . 0.0 119.975 171.85 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.4 t -162.28 167.77 23.37 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 102.517 -3.142 . . . . 0.0 102.517 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.74 -157.96 7.58 Favored Glycine 0 C--N 1.365 2.172 0 N-CA-C 119.776 2.67 . . . . 0.0 119.776 -165.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.3 t -45.41 -11.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 1 N-CA-C 122.066 4.099 . . . . 0.0 122.066 -165.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -107.4 -10.01 15.86 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 129.322 3.049 . . . . 0.0 112.709 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 59.8 m -81.88 138.88 34.96 Favored 'General case' 0 C--N 1.376 1.728 0 C-N-CA 127.736 2.415 . . . . 0.0 111.085 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.251 33.1 ttmt -52.22 -33.49 41.43 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -86.71 -0.94 57.25 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 119.318 0.963 . . . . 0.0 112.963 171.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.89 3.25 10.0 Favored 'General case' 0 C--N 1.371 1.53 0 CA-C-N 120.25 1.387 . . . . 0.0 113.444 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -109.9 179.72 4.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.134 2.974 . . . . 0.0 107.331 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -70.74 122.47 19.9 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 120.141 -1.599 . . . . 0.0 113.175 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.37 -5.27 55.1 Favored Glycine 0 C--N 1.363 2.047 0 O-C-N 120.961 -1.087 . . . . 0.0 111.757 -170.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.89 152.22 25.77 Favored Glycine 0 C--N 1.361 1.928 0 C-N-CA 128.648 3.023 . . . . 0.0 114.211 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -62.64 -41.7 99.18 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.42 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-85 -85.48 -7.54 58.85 Favored 'General case' 0 CA--C 1.556 1.174 0 O-C-N 120.269 -1.519 . . . . 0.0 113.57 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -77.92 95.35 4.75 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 128.811 2.844 . . . . 0.0 114.839 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 40.7 t -114.77 128.22 56.18 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 102.461 -3.163 . . . . 0.0 102.461 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -100.76 100.26 10.9 Favored 'General case' 0 C--N 1.362 1.125 0 CA-C-O 125.613 2.625 . . . . 0.0 109.229 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -121.62 138.25 28.16 Favored Pre-proline 0 N--CA 1.421 -1.897 2 C-N-CA 135.988 5.715 . . . . 0.0 98.211 166.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.96 -26.41 66.59 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 125.073 3.848 . . . . 0.0 114.144 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -66.73 -36.65 82.96 Favored 'General case' 0 C--N 1.369 1.428 0 C-N-CA 129.012 2.925 . . . . 0.0 112.633 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 65.3 mt -73.41 -45.99 50.57 Favored 'Isoleucine or valine' 0 C--N 1.374 1.651 0 C-N-CA 126.018 1.727 . . . . 0.0 110.417 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.12 -45.9 89.84 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 125.207 1.403 . . . . 0.0 113.535 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -62.42 -35.53 79.54 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.67 77.25 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 129.673 3.189 . . . . 0.0 110.795 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.71 -38.99 87.85 Favored 'General case' 0 C--N 1.382 2.017 0 C-N-CA 125.197 1.399 . . . . 0.0 111.597 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -74.07 -42.14 60.63 Favored 'General case' 0 C--N 1.374 1.655 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -48.06 64.71 Favored 'General case' 0 C--N 1.371 1.533 0 C-N-CA 130.671 3.589 . . . . 0.0 111.83 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.03 99.08 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 124.592 1.157 . . . . 0.0 113.491 169.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.2 -52.49 63.58 Favored 'General case' 0 C--N 1.375 1.715 0 C-N-CA 126.006 1.722 . . . . 0.0 111.66 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.35 -37.58 67.66 Favored 'General case' 0 C--N 1.372 1.544 0 CA-C-N 121.139 1.79 . . . . 0.0 115.8 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.18 -44.82 36.29 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 116.029 1.862 . . . . 0.0 116.029 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -31.03 67.16 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.21 -10.53 49.52 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 126.535 1.934 . . . . 0.0 110.608 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -123.43 -100.79 0.41 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 125.436 1.494 . . . . 0.0 112.176 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.451 ' HB2' ' HZ2' ' A' ' 189' ' ' LYS . 26.0 m-20 -135.57 158.0 45.47 Favored 'General case' 0 C--N 1.363 1.194 0 O-C-N 120.26 -1.525 . . . . 0.0 113.846 -175.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -50.98 -37.34 44.19 Favored 'General case' 0 C--N 1.369 1.421 1 C-N-CA 132.389 4.276 . . . . 0.0 115.758 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.3 tt -55.23 -33.77 31.41 Favored 'Isoleucine or valine' 0 C--N 1.359 1.012 0 C-N-CA 129.925 3.29 . . . . 0.0 113.238 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.451 ' HZ2' ' HB2' ' A' ' 186' ' ' ASP . 4.1 mptt -71.07 -45.29 64.05 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 125.829 1.651 . . . . 0.0 115.037 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -74.87 -42.45 57.86 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 174.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.292 96.2 mt -73.93 -19.39 60.7 Favored 'General case' 0 C--N 1.371 1.507 0 O-C-N 120.432 -1.417 . . . . 0.0 114.037 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -58.4 -32.06 68.26 Favored 'General case' 0 C--N 1.377 1.803 0 C-N-CA 126.769 2.027 . . . . 0.0 114.155 168.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.28 -51.55 3.95 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 127.053 2.141 . . . . 0.0 108.874 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 42.97 -95.11 0.02 OUTLIER 'General case' 0 C--N 1.38 1.913 0 C-N-CA 130.145 3.378 . . . . 0.0 114.427 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.377 2.5 p . . . . . 0 N--CA 1.443 -0.809 0 N-CA-C 100.811 -3.774 . . . . 0.0 100.811 162.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.427 ' HB2' ' HA ' ' A' ' 146' ' ' ARG 0.412 37.5 m . . . . . 0 C--O 1.222 -0.352 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 66.96 60.15 0.53 Allowed 'General case' 0 C--N 1.359 1.003 0 N-CA-C 120.396 3.48 . . . . 0.0 120.396 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -117.38 125.97 51.88 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 119.878 -1.764 . . . . 0.0 110.16 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.474 28.7 p -111.72 168.43 7.64 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 128.624 2.77 . . . . 0.0 115.55 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.25 151.63 60.69 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 124.434 3.423 . . . . 0.0 118.863 -164.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.77 -7.29 81.64 Favored Glycine 0 C--N 1.37 2.447 0 C-N-CA 128.875 3.131 . . . . 0.0 111.109 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -94.0 164.02 13.25 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 126.246 1.818 . . . . 0.0 110.493 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.74 140.26 37.24 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 119.098 -2.251 . . . . 0.0 107.249 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 m -133.51 153.37 36.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 C-N-CA 125.766 1.626 . . . . 0.0 108.979 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -102.84 116.76 33.19 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 101.422 -3.547 . . . . 0.0 101.422 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -115.12 142.51 46.56 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.727 1.211 . . . . 0.0 113.997 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -116.15 132.93 56.52 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 33.2 ttm -115.98 139.05 50.64 Favored 'General case' 0 CA--C 1.509 -0.629 0 O-C-N 120.099 -1.625 . . . . 0.0 107.267 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.65 100.35 0.1 Allowed 'General case' 0 C--N 1.366 1.324 0 C-N-CA 127.379 2.272 . . . . 0.0 114.07 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.56 -22.15 22.55 Favored Glycine 0 C--N 1.358 1.761 0 C-N-CA 125.367 1.461 . . . . 0.0 113.624 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -97.99 166.81 12.76 Favored Pre-proline 0 C--N 1.361 1.088 0 O-C-N 121.036 -1.273 . . . . 0.0 109.823 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.68 166.18 30.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.803 3.669 . . . . 0.0 113.34 169.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.577 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 5.0 m95 -58.17 135.27 57.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.798 2.839 . . . . 0.0 115.309 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.409 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 24.0 m95 -133.65 114.77 13.3 Favored Pre-proline 0 C--N 1.367 1.354 1 N-CA-C 121.844 4.016 . . . . 0.0 121.844 -174.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -64.91 124.96 13.87 Favored 'Trans proline' 0 C--N 1.391 2.772 1 C-N-CA 125.965 4.444 . . . . 0.0 110.542 160.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 p -147.25 165.15 30.95 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 128.29 2.636 . . . . 0.0 115.017 -156.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 190' ' ' ARG . 3.7 pp -119.45 144.3 47.03 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 125.749 1.619 . . . . 0.0 108.626 173.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.9 t -85.59 116.52 28.92 Favored 'Isoleucine or valine' 0 C--N 1.377 1.796 0 O-C-N 120.174 -1.579 . . . . 0.0 108.059 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -121.56 136.27 54.96 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 116.92 -3.612 . . . . 0.0 114.87 -164.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -75.99 111.36 11.29 Favored 'General case' 0 C--N 1.38 1.908 0 CA-C-O 123.762 1.744 . . . . 0.0 112.654 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.473 ' CG ' ' CD2' ' A' ' 130' ' ' HIS . 10.3 t60 -67.18 161.18 66.04 Favored Pre-proline 0 C--N 1.343 0.285 1 C-N-CA 132.903 4.481 . . . . 0.0 117.641 -170.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.23 -14.05 3.8 Favored 'Trans proline' 0 CA--C 1.554 1.52 1 C-N-CA 125.542 4.161 . . . . 0.0 116.398 174.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -104.69 40.01 1.57 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 129.72 3.208 . . . . 0.0 109.633 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -67.58 151.47 47.27 Favored 'General case' 0 C--N 1.372 1.566 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.74 -11.92 32.51 Favored Glycine 0 C--N 1.358 1.768 0 CA-C-N 112.396 -2.184 . . . . 0.0 110.369 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 t -125.61 166.57 16.47 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 101.855 -3.387 . . . . 0.0 101.855 167.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -154.72 -25.63 0.12 Allowed 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.581 -1.324 . . . . 0.0 114.194 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.0 pt -114.38 154.54 15.73 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 O-C-N 120.491 -1.38 . . . . 0.0 112.086 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -142.92 152.84 42.48 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 128.338 2.655 . . . . 0.0 105.027 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.31 127.99 19.2 Favored 'General case' 0 C--N 1.361 1.089 0 O-C-N 120.793 -1.192 . . . . 0.0 110.424 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -117.94 93.04 3.99 Favored 'General case' 0 C--N 1.363 1.17 0 C-N-CA 127.407 2.283 . . . . 0.0 110.135 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.11 -63.96 0.01 OUTLIER Glycine 0 C--N 1.362 2.006 0 N-CA-C 122.056 3.582 . . . . 0.0 122.056 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -146.62 38.34 1.02 Allowed 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.965 1.306 . . . . 0.0 111.724 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 m -167.63 139.67 3.15 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 119.847 -1.783 . . . . 0.0 106.498 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.66 132.97 70.59 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 CA-C-O 123.505 1.621 . . . . 0.0 109.959 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -106.83 158.94 16.62 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 127.938 2.495 . . . . 0.0 113.481 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.8 m -149.09 164.66 4.09 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 C-N-CA 130.707 3.603 . . . . 0.0 102.755 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.473 ' CD2' ' CG ' ' A' ' 113' ' ' HIS . 6.2 m80 -89.94 141.82 28.29 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 121.19 -0.944 . . . . 0.0 112.248 170.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 m -151.1 169.81 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -133.53 152.91 51.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -109.43 132.26 54.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.518 1.927 . . . . 0.0 108.335 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.534 ' HB3' HH21 ' A' ' 178' ' ' ARG . 29.3 m-85 -68.54 63.77 0.11 Allowed 'General case' 0 C--N 1.371 1.503 0 C-N-CA 127.066 2.147 . . . . 0.0 114.256 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.91 -118.22 0.08 Allowed 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.451 2.3 . . . . 0.0 111.913 -174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -106.85 -58.52 1.92 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.669 1.587 . . . . 0.0 112.807 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.298 27.5 p -77.18 -34.03 1.16 Allowed Pre-proline 0 C--N 1.364 1.209 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.35 -169.5 7.75 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 CA-C-N 127.683 3.779 . . . . 0.0 111.616 -1.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.3 m -95.17 135.08 37.17 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.814 1.246 . . . . 0.0 107.753 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.426 ' HD3' ' HD1' ' A' ' 113' ' ' HIS . 9.9 tmm_? -158.1 167.92 28.52 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.06 -148.74 17.04 Favored Glycine 0 C--N 1.352 1.417 1 N-CA-C 101.239 -4.744 . . . . 0.0 101.239 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -89.58 156.78 18.38 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 167.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.4 -177.68 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 O-C-N 120.636 -1.29 . . . . 0.0 107.712 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.6 t -90.8 120.07 31.54 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 101.864 -3.384 . . . . 0.0 101.864 167.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.492 0.0 OUTLIER -78.53 -10.94 59.91 Favored 'General case' 0 C--N 1.373 1.603 0 CA-C-N 123.113 2.688 . . . . 0.0 115.685 -174.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.427 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 96.2 mtt180 -74.84 -5.53 44.06 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.01 1.324 . . . . 0.0 113.814 172.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.93 2.17 32.16 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 127.102 2.161 . . . . 0.0 112.173 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 43.0 mt -96.89 125.69 41.51 Favored 'General case' 0 C--N 1.368 1.376 0 C-N-CA 127.389 2.276 . . . . 0.0 109.956 174.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -114.7 167.74 9.22 Favored Pre-proline 0 C--N 1.347 0.493 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.0 157.09 15.31 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.306 3.337 . . . . 0.0 113.991 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.64 150.57 20.21 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 123.426 1.584 . . . . 0.0 107.89 170.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.8 t -173.08 -45.58 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.835 1 N-CA-C 97.26 -5.089 . . . . 0.0 97.26 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 128.35 -149.76 18.33 Favored Glycine 0 CA--C 1.474 -2.471 0 C-N-CA 117.892 -2.099 . . . . 0.0 116.865 135.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.9 m -46.5 -18.78 0.07 Allowed 'General case' 0 C--N 1.375 1.68 1 C-N-CA 133.027 4.531 . . . . 0.0 116.67 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 0.94 54.92 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 129.881 3.272 . . . . 0.0 112.582 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.9 m -86.51 142.56 28.26 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 127.529 2.331 . . . . 0.0 111.409 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -61.69 -27.45 68.71 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -79.7 -17.08 54.45 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 124.935 1.294 . . . . 0.0 111.372 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.27 4.21 51.01 Favored 'General case' 0 C--N 1.371 1.515 0 C-N-CA 124.813 1.245 . . . . 0.0 113.017 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -123.74 177.34 5.76 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 120.048 -1.657 . . . . 0.0 111.228 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -57.97 121.84 11.55 Favored 'General case' 0 C--N 1.372 1.576 0 C-N-CA 126.483 1.913 . . . . 0.0 114.598 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.32 -14.52 59.52 Favored Glycine 0 C--N 1.356 1.671 0 C-N-CA 125.174 1.369 . . . . 0.0 112.299 -169.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.6 153.64 40.91 Favored Glycine 0 C--N 1.361 1.941 0 N-CA-C 119.857 2.703 . . . . 0.0 119.857 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -55.86 -42.21 75.51 Favored 'General case' 0 C--N 1.363 1.169 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.577 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.308 0.5 OUTLIER -106.01 -12.16 15.9 Favored 'General case' 0 C--N 1.358 0.951 0 O-C-N 120.638 -1.289 . . . . 0.0 113.619 -179.796 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . 0.301 0.0 OUTLIER -41.68 -27.86 0.12 Allowed 'General case' 0 C--N 1.365 1.248 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.2 m -14.53 90.94 0.01 OUTLIER 'General case' 0 C--N 1.381 1.962 1 C-N-CA 131.901 4.08 . . . . 0.0 116.917 -174.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.35 102.11 13.71 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-O 125.653 2.644 . . . . 0.0 115.045 -163.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -119.96 144.53 37.71 Favored Pre-proline 0 N--CA 1.416 -2.163 3 C-N-CA 134.909 5.284 . . . . 0.0 100.184 170.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -60.31 -28.95 87.85 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 125.014 3.809 . . . . 0.0 115.487 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -65.72 -36.4 83.49 Favored 'General case' 0 C--N 1.365 1.272 0 C-N-CA 128.806 2.842 . . . . 0.0 112.303 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.409 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 20.4 mm -72.39 -37.73 58.74 Favored 'Isoleucine or valine' 0 C--N 1.374 1.631 0 C-N-CA 126.487 1.915 . . . . 0.0 110.237 175.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.73 -49.38 59.23 Favored 'General case' 0 C--N 1.371 1.502 0 O-C-N 120.324 -1.485 . . . . 0.0 113.646 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -58.43 -39.3 79.44 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 127.391 2.276 . . . . 0.0 114.22 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.0 -37.34 84.02 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 131.41 3.884 . . . . 0.0 110.421 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.4 mtt -66.91 -33.03 74.69 Favored 'General case' 0 C--N 1.366 1.284 0 O-C-N 120.609 -1.307 . . . . 0.0 113.024 167.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.43 -46.86 37.22 Favored 'General case' 0 C--N 1.378 1.83 0 C-N-CA 126.527 1.931 . . . . 0.0 112.577 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.534 HH21 ' HB3' ' A' ' 134' ' ' PHE . 22.4 ttp-105 -66.31 -50.56 63.21 Favored 'General case' 0 C--N 1.372 1.57 0 C-N-CA 129.564 3.145 . . . . 0.0 112.322 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.96 69.61 Favored 'General case' 0 C--N 1.375 1.692 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 167.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -68.64 -50.87 47.86 Favored 'General case' 0 C--N 1.371 1.53 0 O-C-N 120.491 -1.381 . . . . 0.0 111.751 173.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -40.36 83.15 Favored 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.363 1.865 . . . . 0.0 115.537 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.06 -27.25 57.18 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.94 -50.17 11.61 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.899 1.679 . . . . 0.0 111.177 173.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.322 0.0 OUTLIER -82.99 -15.71 50.13 Favored 'General case' 0 C--N 1.367 1.355 0 C-N-CA 126.615 1.966 . . . . 0.0 115.176 -169.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -110.64 -98.7 0.4 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.459 ' HB2' ' HZ2' ' A' ' 189' ' ' LYS . 16.3 m-20 -136.28 149.32 48.4 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 124.111 0.964 . . . . 0.0 109.936 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -50.73 -34.64 27.77 Favored 'General case' 0 C--N 1.365 1.27 1 C-N-CA 133.668 4.787 . . . . 0.0 112.282 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 6.4 tt -52.24 -30.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.365 1.278 0 C-N-CA 128.855 2.862 . . . . 0.0 112.758 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.459 ' HZ2' ' HB2' ' A' ' 186' ' ' ASP 0.273 6.5 mptt -68.39 -43.17 77.91 Favored 'General case' 0 C--N 1.376 1.729 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 172.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.45 ' HB2' HD22 ' A' ' 109' ' ' LEU 0.265 1.2 ptm180 -76.51 -43.62 38.67 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 119.043 2.979 . . . . 0.0 119.043 170.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 12.3 tp -71.65 -27.62 63.2 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 127.38 2.272 . . . . 0.0 113.545 -174.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -81.46 -4.46 55.92 Favored 'General case' 0 C--N 1.366 1.298 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 170.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.58 -44.69 5.5 Favored 'General case' 0 C--N 1.366 1.324 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 58.97 -114.34 0.73 Allowed 'General case' 0 C--N 1.372 1.545 0 C-N-CA 127.309 2.243 . . . . 0.0 113.119 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.351 0.644 0 C-N-CA 126.45 1.9 . . . . 0.0 110.448 175.778 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 123.061 1.41 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -118.01 92.79 3.92 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.646 2.379 . . . . 0.0 112.638 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.19 127.25 46.5 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.361 1.464 . . . . 0.0 112.346 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.39 57.8 p -111.72 167.94 8.36 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 119.731 -1.855 . . . . 0.0 113.771 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -57.63 153.07 44.52 Favored 'Trans proline' 0 C--N 1.373 1.84 1 C-N-CA 126.565 4.843 . . . . 0.0 120.821 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.82 -41.87 2.06 Favored Glycine 0 C--N 1.377 2.823 0 C-N-CA 127.483 2.468 . . . . 0.0 107.02 -165.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -73.84 159.57 32.67 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.608 HD11 ' HE ' ' A' ' 190' ' ' ARG . 0.1 OUTLIER -105.51 142.56 35.05 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.7 m -142.82 151.73 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.456 ' CE3' ' HG3' ' A' ' 107' ' ' PRO . 41.0 m95 -99.92 121.1 40.82 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 168.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -102.11 152.27 21.19 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 121.125 1.784 . . . . 0.0 112.345 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -116.9 131.9 56.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 102.398 -3.186 . . . . 0.0 102.398 169.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 34.8 ttm -118.47 138.38 52.53 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.31 101.66 0.45 Allowed 'General case' 0 C--N 1.369 1.424 0 C-N-CA 125.789 1.635 . . . . 0.0 113.816 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.19 -6.0 25.21 Favored Glycine 0 C--N 1.36 1.895 0 C-N-CA 125.667 1.604 . . . . 0.0 113.206 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.24 164.3 15.14 Favored Pre-proline 0 C--N 1.354 0.797 0 C-N-CA 125.779 1.632 . . . . 0.0 109.524 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.05 166.1 30.64 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 124.274 3.316 . . . . 0.0 112.774 162.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -57.84 123.3 15.28 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 129.061 2.944 . . . . 0.0 114.44 171.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -134.15 116.1 13.17 Favored Pre-proline 0 CA--C 1.563 1.476 1 N-CA-C 123.75 4.722 . . . . 0.0 123.75 -168.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HG3' ' CE3' ' A' ' 97' ' ' TRP . 53.8 Cg_exo -54.84 110.38 0.53 Allowed 'Trans proline' 0 C--N 1.396 3.056 1 C-N-CA 127.635 5.556 . . . . 0.0 114.898 164.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.5 p -125.72 164.04 21.5 Favored 'General case' 0 CA--C 1.536 0.431 1 C-N-CA 132.342 4.257 . . . . 0.0 115.901 -169.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp -115.8 138.25 51.32 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 118.65 -2.532 . . . . 0.0 108.257 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.0 118.93 29.65 Favored 'Isoleucine or valine' 0 C--N 1.37 1.476 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -115.8 154.58 29.39 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.03 -1.669 . . . . 0.0 115.36 -163.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -111.67 113.68 26.22 Favored 'General case' 0 C--N 1.372 1.545 0 C-N-CA 125.767 1.627 . . . . 0.0 108.812 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -69.08 160.94 76.26 Favored Pre-proline 0 C--N 1.363 1.188 0 C-N-CA 130.994 3.717 . . . . 0.0 110.191 174.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.67 0.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.5 1 C-N-CA 128.071 5.847 . . . . 0.0 119.226 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -99.57 34.96 2.08 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 130.542 3.537 . . . . 0.0 105.865 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.322 0.0 OUTLIER -61.35 120.86 11.26 Favored 'General case' 0 C--N 1.382 1.993 0 C-N-CA 126.972 2.109 . . . . 0.0 115.542 -166.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.85 -20.49 26.72 Favored Glycine 0 C--N 1.356 1.678 0 C-N-CA 127.302 2.382 . . . . 0.0 111.583 -171.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 p -116.09 119.15 34.92 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 103.979 -2.6 . . . . 0.0 103.979 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.481 ' HB2' ' CE1' ' A' ' 130' ' ' HIS . 16.4 p90 -148.42 -9.65 0.37 Allowed 'General case' 0 C--N 1.363 1.156 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -170.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 pt -109.69 153.18 11.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-N 120.074 1.306 . . . . 0.0 112.473 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -142.28 136.52 29.85 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 104.138 -2.542 . . . . 0.0 104.138 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -150.68 127.24 10.82 Favored 'General case' 0 C--N 1.363 1.166 0 O-C-N 120.044 -1.66 . . . . 0.0 110.986 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -118.41 93.38 4.1 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 125.919 1.688 . . . . 0.0 110.534 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.16 -51.89 0.01 OUTLIER Glycine 0 C--N 1.363 2.033 1 N-CA-C 124.096 4.398 . . . . 0.0 124.096 171.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -137.64 21.58 2.9 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.325 1.45 . . . . 0.0 113.532 -172.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.6 m -163.49 146.39 10.08 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.01 137.72 56.44 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 C-N-CA 123.759 0.824 . . . . 0.0 109.851 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -120.55 130.06 54.06 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 126.829 2.052 . . . . 0.0 107.067 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.29 150.98 21.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.957 1 N-CA-C 98.855 -4.498 . . . . 0.0 98.855 175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.481 ' CE1' ' HB2' ' A' ' 119' ' ' PHE . 12.6 p-80 -81.69 130.04 34.92 Favored 'General case' 0 C--N 1.367 1.336 0 C-N-CA 125.392 1.477 . . . . 0.0 113.16 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.2 m -137.74 151.16 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 N-CA-C 102.651 -3.092 . . . . 0.0 102.651 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -111.83 148.43 33.6 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -106.8 125.27 50.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 127.723 2.409 . . . . 0.0 105.802 -174.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -75.36 76.13 2.45 Favored 'General case' 0 C--N 1.372 1.574 0 C-N-CA 124.726 1.21 . . . . 0.0 109.492 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -102.46 -113.66 0.21 Allowed 'General case' 0 C--N 1.358 0.935 0 O-C-N 120.04 -1.662 . . . . 0.0 110.392 -173.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -106.87 -59.23 1.83 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 126.202 1.801 . . . . 0.0 111.32 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.5 p -86.06 -31.38 0.43 Allowed Pre-proline 0 C--N 1.365 1.245 0 N-CA-C 120.322 3.453 . . . . 0.0 120.322 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.1 -172.65 10.27 Favored 'Cis proline' 0 CA--C 1.541 0.853 1 CA-C-N 129.917 4.578 . . . . 0.0 113.418 0.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.8 m -96.81 155.64 16.69 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 129.429 3.092 . . . . 0.0 108.904 170.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -166.1 171.71 12.11 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.54 -169.87 42.12 Favored Glycine 0 CA--C 1.486 -1.752 1 N-CA-C 101.751 -4.54 . . . . 0.0 101.751 163.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -93.93 99.78 12.06 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 169.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.8 m -84.46 176.49 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 C-N-CA 125.563 1.545 . . . . 0.0 109.052 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.7 m -92.98 121.81 34.7 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 170.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.309 16.3 pttm -76.36 -11.04 59.83 Favored 'General case' 0 C--N 1.372 1.584 0 CA-C-N 121.421 1.919 . . . . 0.0 113.257 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -68.91 -18.85 64.17 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 125.954 1.702 . . . . 0.0 113.487 170.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.1 mt -91.12 0.65 57.49 Favored 'General case' 0 C--N 1.369 1.424 0 C-N-CA 126.184 1.793 . . . . 0.0 114.571 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.47 159.0 15.24 Favored 'General case' 0 C--N 1.364 1.226 0 O-C-N 119.877 -1.764 . . . . 0.0 108.386 176.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.66 159.22 45.0 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -74.51 154.59 45.14 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.671 3.58 . . . . 0.0 114.724 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.274 0.1 OUTLIER -18.56 -107.69 0.0 OUTLIER 'General case' 0 C--N 1.363 1.17 2 N-CA-C 123.486 4.624 . . . . 0.0 123.486 177.19 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.326 4.9 t 50.99 -40.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 1 C-N-CA 132.612 4.365 . . . . 0.0 120.413 177.098 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.82 -144.41 38.23 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 118.812 2.285 . . . . 0.0 118.812 176.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.8 m -53.04 -24.97 11.0 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.487 3.515 . . . . 0.0 119.749 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -84.42 -6.07 59.34 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 126.488 1.915 . . . . 0.0 111.951 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.2 m -83.84 146.47 28.08 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.894 1.678 . . . . 0.0 112.87 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -63.4 -27.5 69.34 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 125.702 1.601 . . . . 0.0 112.419 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.37 -23.82 61.97 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 127.417 2.287 . . . . 0.0 113.163 171.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.4 0.81 48.45 Favored 'General case' 0 C--N 1.371 1.518 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.255 1.1 pp0? -115.47 -175.29 2.68 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 125.284 1.433 . . . . 0.0 110.168 176.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -66.27 122.91 18.55 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 126.692 1.997 . . . . 0.0 112.243 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.46 -10.89 58.04 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 124.848 1.213 . . . . 0.0 111.654 -167.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.64 139.84 23.51 Favored Glycine 0 C--N 1.365 2.154 0 N-CA-C 119.618 2.607 . . . . 0.0 119.618 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -61.01 -16.37 42.6 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 119.324 3.083 . . . . 0.0 119.324 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.85 -0.06 17.03 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.701 -1.249 . . . . 0.0 110.805 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -79.1 142.17 36.68 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 126.166 2.889 . . . . 0.0 118.315 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.6 m -172.86 170.46 4.57 Favored 'General case' 0 C--N 1.348 0.508 2 N-CA-C 98.165 -4.754 . . . . 0.0 98.165 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -138.24 101.59 4.43 Favored 'General case' 0 C--N 1.367 1.366 0 CA-C-N 124.931 3.514 . . . . 0.0 111.223 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -119.88 135.24 24.14 Favored Pre-proline 0 N--CA 1.43 -1.428 0 N-CA-C 100.921 -3.733 . . . . 0.0 100.921 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.7 -26.5 80.04 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 125.196 3.93 . . . . 0.0 114.108 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -63.9 -36.39 83.77 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 127.515 2.326 . . . . 0.0 113.424 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.8 mt -70.97 -42.88 77.05 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 C-N-CA 125.582 1.553 . . . . 0.0 110.923 173.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.46 -43.24 77.46 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 124.766 1.226 . . . . 0.0 113.979 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -58.91 -38.69 79.48 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 128.178 2.591 . . . . 0.0 113.259 175.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.26 -34.54 74.93 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 131.357 3.863 . . . . 0.0 110.887 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.403 ' HG2' ' CH2' ' A' ' 97' ' ' TRP . 31.3 mtt -70.4 -37.59 74.49 Favored 'General case' 0 C--N 1.386 2.156 0 C-N-CA 124.03 0.932 . . . . 0.0 111.339 168.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -68.53 -45.29 72.59 Favored 'General case' 0 C--N 1.378 1.842 0 C-N-CA 126.638 1.975 . . . . 0.0 111.62 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -53.93 47.37 Favored 'General case' 0 C--N 1.37 1.471 0 C-N-CA 131.629 3.971 . . . . 0.0 111.698 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.94 -45.26 82.9 Favored 'General case' 0 C--N 1.373 1.6 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 170.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 184' ' ' ASN 0.318 38.8 t70 -64.19 -24.73 67.78 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 127.339 2.256 . . . . 0.0 112.702 176.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -75.09 -43.89 50.47 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 117.922 -2.986 . . . . 0.0 112.228 168.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.25 -39.62 53.99 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 120.069 3.359 . . . . 0.0 120.069 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.24 -26.85 47.47 Favored 'General case' 0 C--N 1.36 1.051 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.2 OUTLIER -89.78 -30.28 18.1 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.461 2.704 . . . . 0.0 107.93 -173.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -104.98 -98.56 0.32 Allowed 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -136.03 159.7 40.89 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 119.995 -1.691 . . . . 0.0 111.691 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -51.55 -38.56 54.85 Favored 'General case' 0 C--N 1.377 1.78 0 C-N-CA 131.201 3.801 . . . . 0.0 115.142 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.6 tt -55.22 -36.07 38.44 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 129.171 2.988 . . . . 0.0 113.379 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -43.92 72.49 Favored 'General case' 0 C--N 1.372 1.558 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.608 ' HE ' HD11 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -75.25 -43.43 51.54 Favored 'General case' 0 C--N 1.37 1.475 0 CA-C-N 121.241 1.837 . . . . 0.0 114.826 172.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.5 tp -71.32 -19.48 62.3 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 128.672 2.789 . . . . 0.0 113.852 -172.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -59.64 -27.9 66.76 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.883 2.073 . . . . 0.0 113.492 164.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.1 21.66 14.47 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 127.472 2.309 . . . . 0.0 111.95 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.03 44.95 0.0 OUTLIER 'General case' 0 C--N 1.374 1.644 0 C-N-CA 131.502 3.921 . . . . 0.0 118.202 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.363 1.183 1 C-N-CA 133.206 4.602 . . . . 0.0 113.827 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 C--O 1.231 0.106 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.285 1.1 p30 -171.81 87.26 0.09 Allowed 'General case' 0 C--N 1.364 1.215 0 C-N-CA 124.973 1.309 . . . . 0.0 112.814 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.43 ' CE1' ' HB3' ' A' ' 150' ' ' PRO . 51.3 m-85 -124.6 127.65 47.69 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 126.029 1.732 . . . . 0.0 114.814 -171.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.358 98.0 p -110.18 169.62 6.18 Favored Pre-proline 0 CA--C 1.574 1.882 0 C-N-CA 131.025 3.73 . . . . 0.0 114.952 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -66.19 146.89 82.81 Favored 'Trans proline' 0 C--N 1.385 2.474 1 C-N-CA 126.88 5.054 . . . . 0.0 117.281 -168.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.59 -32.35 7.03 Favored Glycine 0 C--N 1.366 2.236 0 C-N-CA 126.403 1.954 . . . . 0.0 109.365 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -83.12 162.38 21.33 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 124.486 2.089 . . . . 0.0 113.485 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.02 135.4 54.26 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 101.609 -3.478 . . . . 0.0 101.609 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.99 159.06 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 126.209 1.804 . . . . 0.0 107.082 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -98.7 118.37 35.27 Favored 'General case' 0 C--N 1.349 0.559 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.39 138.9 50.97 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 126.37 1.868 . . . . 0.0 113.397 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -113.65 145.84 40.68 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 170.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.1 ttp -128.97 152.82 48.17 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 119.85 -1.781 . . . . 0.0 109.162 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -63.42 89.68 0.04 OUTLIER 'General case' 0 C--N 1.364 1.228 0 C-N-CA 127.716 2.406 . . . . 0.0 115.472 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.17 -4.13 25.36 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 125.665 1.602 . . . . 0.0 112.249 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -98.02 162.15 23.13 Favored Pre-proline 0 C--N 1.357 0.916 0 C-N-CA 125.508 1.523 . . . . 0.0 110.223 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.26 167.08 27.24 Favored 'Trans proline' 0 CA--C 1.544 0.983 1 C-N-CA 125.777 4.318 . . . . 0.0 112.941 163.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -68.3 130.68 43.61 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 127.426 2.29 . . . . 0.0 112.267 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.452 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 6.3 m95 -128.7 131.91 24.04 Favored Pre-proline 0 N--CA 1.429 -1.502 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.56 139.24 30.94 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 124.211 3.274 . . . . 0.0 108.1 149.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.1 p -152.37 164.18 38.0 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 126.936 2.094 . . . . 0.0 111.611 -163.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 190' ' ' ARG . 1.3 pp -111.47 149.44 31.31 Favored 'General case' 0 C--N 1.367 1.356 0 O-C-N 119.982 -1.699 . . . . 0.0 109.87 171.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 131' ' ' VAL . 2.4 t -91.45 119.83 39.41 Favored 'Isoleucine or valine' 0 C--N 1.364 1.222 0 O-C-N 120.608 -1.308 . . . . 0.0 107.787 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -114.61 141.85 47.22 Favored 'General case' 0 C--N 1.37 1.5 0 N-CA-C 120.066 3.358 . . . . 0.0 120.066 -162.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -85.77 111.27 20.0 Favored 'General case' 0 C--N 1.377 1.772 0 O-C-N 118.526 -2.608 . . . . 0.0 110.522 172.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.406 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 75.0 t60 -85.04 160.2 55.58 Favored Pre-proline 0 N--CA 1.449 -0.497 1 C-N-CA 132.108 4.163 . . . . 0.0 109.673 -176.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.81 -13.84 6.8 Favored 'Trans proline' 0 CA--C 1.55 1.306 1 C-N-CA 125.97 4.447 . . . . 0.0 117.08 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -107.41 54.11 0.68 Allowed 'General case' 0 C--N 1.365 1.244 0 C-N-CA 127.848 2.459 . . . . 0.0 107.564 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.43 167.77 19.05 Favored 'General case' 0 C--N 1.368 1.406 0 O-C-N 119.563 -1.961 . . . . 0.0 114.787 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.48 -20.04 48.98 Favored Glycine 0 C--N 1.364 2.086 0 C-N-CA 126.053 1.787 . . . . 0.0 113.559 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.7 m -123.47 120.3 32.52 Favored 'General case' 0 C--N 1.346 0.453 1 N-CA-C 99.465 -4.272 . . . . 0.0 99.465 170.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -122.64 -3.49 8.77 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 -168.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.6 pt -122.81 149.74 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 119.618 -1.926 . . . . 0.0 112.948 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -141.49 160.18 40.68 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 129.854 3.262 . . . . 0.0 104.595 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -152.08 127.57 10.03 Favored 'General case' 0 C--N 1.365 1.272 0 O-C-N 118.935 -2.353 . . . . 0.0 111.459 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.37 92.94 4.7 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.266 1.426 . . . . 0.0 108.78 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.5 -84.96 0.19 Allowed Glycine 0 C--N 1.363 2.053 0 C-N-CA 127.309 2.385 . . . . 0.0 114.57 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -116.74 -15.26 10.75 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 126.277 1.831 . . . . 0.0 110.591 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.1 m -88.43 100.91 13.41 Favored 'General case' 0 C--N 1.365 1.257 0 O-C-N 120.423 -1.423 . . . . 0.0 110.625 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 p -86.46 132.41 32.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 127.452 2.301 . . . . 0.0 108.246 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -117.1 141.98 47.57 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 126.19 1.796 . . . . 0.0 112.569 -173.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.9 164.16 35.97 Favored 'Isoleucine or valine' 0 C--N 1.359 0.986 0 C-N-CA 130.057 3.343 . . . . 0.0 106.094 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.406 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 17.2 m80 -88.55 116.68 26.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.98 1.712 . . . . 0.0 112.596 176.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 110' ' ' VAL . 3.3 m -134.24 173.76 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 O-C-N 119.25 -2.156 . . . . 0.0 106.87 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.49 147.91 43.73 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 171.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -99.88 127.2 46.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.111 2.164 . . . . 0.0 107.812 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 109' ' ' LEU . 15.2 m-30 -73.8 62.96 0.85 Allowed 'General case' 0 C--N 1.369 1.429 0 C-N-CA 126.736 2.015 . . . . 0.0 114.153 -176.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -91.35 -108.78 0.1 Allowed 'General case' 0 C--N 1.365 1.248 0 O-C-N 121.392 -0.818 . . . . 0.0 112.561 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.74 -65.34 1.09 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 126.224 1.81 . . . . 0.0 114.097 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.5 p -79.85 -32.6 0.73 Allowed Pre-proline 0 C--N 1.361 1.086 0 N-CA-C 119.464 3.135 . . . . 0.0 119.464 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -92.16 -166.3 2.31 Favored 'Cis proline' 0 CA--C 1.539 0.774 1 CA-C-N 129.988 4.603 . . . . 0.0 110.828 -1.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -97.69 135.48 39.42 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 125.093 1.357 . . . . 0.0 111.678 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.2 tmm_? -136.56 147.34 46.97 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 120.748 1.613 . . . . 0.0 106.915 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.81 -179.87 40.72 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 104.892 -3.283 . . . . 0.0 104.892 170.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -86.55 109.11 18.89 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 127.423 2.289 . . . . 0.0 106.76 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.19 -178.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 125.602 1.561 . . . . 0.0 111.574 -172.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.2 m -100.41 117.29 34.29 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 101.318 -3.586 . . . . 0.0 101.318 169.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.427 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 5.6 ttpp -72.42 -14.04 61.6 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 124.026 1.869 . . . . 0.0 113.063 -171.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -75.07 -12.3 60.29 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.971 1.708 . . . . 0.0 113.961 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.46 3.82 43.26 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 126.742 2.017 . . . . 0.0 110.948 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.427 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 31.5 mt -94.25 130.44 40.51 Favored 'General case' 0 C--N 1.366 1.292 0 C-N-CA 126.623 1.969 . . . . 0.0 109.201 173.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.427 ' HG3' ' CE1' ' A' ' 165' ' ' PHE . 5.1 mmtt -114.88 165.65 13.51 Favored Pre-proline 0 C--N 1.35 0.611 0 N-CA-C 102.947 -2.983 . . . . 0.0 102.947 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.43 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . 98.4 Cg_endo -82.56 155.8 16.16 Favored 'Trans proline' 0 C--N 1.326 -0.656 0 C-N-CA 124.644 3.563 . . . . 0.0 112.561 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.64 124.04 41.89 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 121.643 0.735 . . . . 0.0 112.067 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.0 t -161.52 25.77 0.13 Allowed 'General case' 0 C--N 1.358 0.954 0 C-N-CA 127.493 2.317 . . . . 0.0 105.523 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.64 81.74 0.07 OUTLIER Glycine 0 C--N 1.354 1.575 0 C-N-CA 115.941 -3.028 . . . . 0.0 117.55 -162.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 69.9 m -67.92 -11.45 58.76 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 128.571 2.748 . . . . 0.0 114.068 172.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -122.52 37.97 4.27 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 128.445 2.698 . . . . 0.0 109.788 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.3 m -95.09 147.87 22.96 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.584 2.354 . . . . 0.0 108.027 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -61.78 -24.49 66.87 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -82.23 -19.09 40.41 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 125.586 1.554 . . . . 0.0 112.161 168.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.34 -39.62 10.38 Favored 'General case' 0 C--N 1.368 1.393 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.337 0.0 OUTLIER -83.74 -173.67 4.85 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -178.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.74 121.34 15.74 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.81 -1.806 . . . . 0.0 113.462 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.34 -13.24 51.58 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.075 -166.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.9 158.65 36.95 Favored Glycine 0 C--N 1.369 2.375 0 N-CA-C 120.665 3.026 . . . . 0.0 120.665 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -60.05 -41.76 93.02 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 129.084 2.953 . . . . 0.0 117.561 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.427 ' CE1' ' HG3' ' A' ' 149' ' ' LYS . 1.6 m-85 -92.67 -30.1 15.75 Favored 'General case' 0 C--N 1.37 1.463 0 O-C-N 120.9 -1.125 . . . . 0.0 110.538 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.3 t80 0.4 -91.51 0.0 OUTLIER 'General case' 0 C--N 1.382 1.981 1 C-N-CA 133.59 4.756 . . . . 0.0 117.216 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.1 m 49.17 65.77 1.29 Allowed 'General case' 0 C--N 1.364 1.211 0 C-N-CA 130.756 3.623 . . . . 0.0 116.413 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.5 100.93 11.06 Favored 'General case' 0 C--N 1.369 1.415 0 CA-C-O 124.93 2.3 . . . . 0.0 114.049 -170.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -120.63 146.1 42.52 Favored Pre-proline 0 N--CA 1.429 -1.51 1 C-N-CA 132.009 4.124 . . . . 0.0 105.028 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -50.26 -38.3 51.43 Favored 'Trans proline' 0 CA--C 1.548 1.2 1 C-N-CA 127.403 5.402 . . . . 0.0 117.113 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.75 -35.54 75.05 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 128.943 2.897 . . . . 0.0 113.644 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.255 12.8 mt -76.01 -32.12 22.82 Favored 'Isoleucine or valine' 0 C--N 1.371 1.541 0 C-N-CA 127.119 2.168 . . . . 0.0 110.528 175.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.91 -53.16 58.42 Favored 'General case' 0 C--N 1.383 2.037 0 C-N-CA 126.704 2.002 . . . . 0.0 109.178 168.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -34.47 68.5 Favored 'General case' 0 C--N 1.369 1.449 0 C-N-CA 128.651 2.78 . . . . 0.0 115.066 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.21 -45.81 68.96 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 130.19 3.396 . . . . 0.0 112.116 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 12.8 mtt -67.03 -33.37 75.4 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-N 119.416 1.007 . . . . 0.0 113.515 170.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -70.02 -52.19 26.14 Favored 'General case' 0 C--N 1.381 1.976 0 C-N-CA 126.495 1.918 . . . . 0.0 113.06 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.274 5.4 ptt180 -72.43 -35.94 68.46 Favored 'General case' 0 C--N 1.384 2.067 0 O-C-N 119.184 -2.198 . . . . 0.0 114.48 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.96 89.38 Favored 'General case' 0 C--N 1.37 1.478 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 169.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.1 -35.78 79.74 Favored 'General case' 0 C--N 1.381 1.971 0 O-C-N 120.082 -1.636 . . . . 0.0 112.092 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -65.46 -45.78 82.4 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 119.337 -2.102 . . . . 0.0 113.743 170.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 190' ' ' ARG . . . -71.41 -36.2 71.25 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . 0.291 0.0 OUTLIER -79.74 -28.96 40.44 Favored 'General case' 0 C--N 1.371 1.535 0 O-C-N 119.893 -1.754 . . . . 0.0 114.89 177.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.267 0.0 OUTLIER -89.57 -15.48 32.76 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 124.966 1.306 . . . . 0.0 111.061 -176.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -115.2 -102.23 0.42 Allowed 'General case' 0 C--N 1.357 0.927 0 O-C-N 122.107 -0.37 . . . . 0.0 110.342 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.19 156.94 47.95 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 123.097 1.427 . . . . 0.0 109.952 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -50.97 -36.73 40.57 Favored 'General case' 0 C--N 1.361 1.08 1 C-N-CA 131.994 4.117 . . . . 0.0 114.116 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 8.1 tt -54.98 -28.29 20.29 Favored 'Isoleucine or valine' 0 C--N 1.364 1.236 1 C-N-CA 131.808 4.043 . . . . 0.0 113.514 175.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.281 5.3 mptt -71.98 -29.53 64.33 Favored 'General case' 0 C--N 1.376 1.733 0 C-N-CA 125.932 1.693 . . . . 0.0 113.551 171.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.425 ' HG2' ' HB2' ' A' ' 109' ' ' LEU 0.532 0.0 OUTLIER -74.73 -42.21 58.7 Favored 'General case' 0 C--N 1.375 1.713 0 O-C-N 119.198 -2.189 . . . . 0.0 113.368 170.045 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.5 -19.97 65.92 Favored 'General case' 0 C--N 1.379 1.869 0 C-N-CA 129.099 2.959 . . . . 0.0 114.424 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.88 -29.9 70.87 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 128.419 2.688 . . . . 0.0 112.925 169.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mt -105.07 -50.02 3.34 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 125.252 1.421 . . . . 0.0 108.535 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 34.37 38.31 0.03 OUTLIER 'General case' 0 C--N 1.375 1.706 1 C-N-CA 131.889 4.076 . . . . 0.0 119.229 173.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.273 40.5 t . . . . . 0 C--N 1.354 0.793 0 C-N-CA 128.963 2.905 . . . . 0.0 105.67 -170.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.9 p . . . . . 0 C--O 1.225 -0.207 0 CA-C-O 118.927 -0.559 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -155.85 92.4 1.37 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 124.698 1.199 . . . . 0.0 109.303 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -125.56 127.51 46.49 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.441 56.6 p -111.73 167.39 9.17 Favored Pre-proline 0 CA--C 1.562 1.41 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -59.54 137.66 79.02 Favored 'Trans proline' 0 C--N 1.379 2.165 1 C-N-CA 126.957 5.105 . . . . 0.0 118.531 -169.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.2 -22.65 39.8 Favored Glycine 0 C--N 1.371 2.513 0 C-N-CA 126.028 1.775 . . . . 0.0 111.39 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.34 159.31 27.21 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 120.208 -1.76 . . . . 0.0 112.212 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.74 133.35 48.88 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.533 -1.355 . . . . 0.0 107.522 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.13 152.73 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 C-N-CA 126.565 1.946 . . . . 0.0 107.335 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -101.72 119.88 39.47 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 168.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -110.08 149.59 29.81 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 121.487 1.949 . . . . 0.0 111.873 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -117.14 140.91 48.94 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 174.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.9 ttp -126.54 145.17 50.63 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 119.958 -1.714 . . . . 0.0 107.418 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -49.72 86.27 0.0 OUTLIER 'General case' 0 C--N 1.365 1.245 0 C-N-CA 130.457 3.503 . . . . 0.0 117.188 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.71 -3.47 45.83 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.961 1.267 . . . . 0.0 114.064 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -99.95 165.7 14.1 Favored Pre-proline 0 C--N 1.357 0.906 0 C-N-CA 125.7 1.6 . . . . 0.0 108.315 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.44 165.79 31.37 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.323 3.349 . . . . 0.0 113.56 169.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.419 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.0 m95 -63.68 110.19 1.95 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 130.145 3.378 . . . . 0.0 112.824 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.475 ' CE3' ' HA ' ' A' ' 106' ' ' TRP . 4.9 m95 -109.24 108.55 60.33 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 119.197 3.036 . . . . 0.0 119.197 -172.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.45 123.03 12.62 Favored 'Trans proline' 0 C--N 1.384 2.413 1 C-N-CA 125.908 4.405 . . . . 0.0 111.708 159.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.4 p -148.65 165.72 30.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 124.574 2.13 . . . . 0.0 114.332 -156.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 tp -114.41 138.46 50.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.83 2.452 . . . . 0.0 106.663 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.92 127.88 39.47 Favored 'Isoleucine or valine' 0 C--N 1.364 1.206 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -139.73 153.88 47.31 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 122.712 2.505 . . . . 0.0 112.596 -168.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -104.07 114.62 28.99 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.572 2.349 . . . . 0.0 109.158 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.47 ' H ' ' CE1' ' A' ' 130' ' ' HIS . 14.6 t60 -67.74 161.27 67.8 Favored Pre-proline 0 C--N 1.354 0.774 0 C-N-CA 128.267 2.627 . . . . 0.0 112.496 177.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.04 -1.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.563 1.931 1 C-N-CA 126.494 4.796 . . . . 0.0 118.159 172.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -91.09 34.33 0.93 Allowed 'General case' 0 C--N 1.36 1.04 1 C-N-CA 135.074 5.349 . . . . 0.0 107.32 169.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.329 0.5 OUTLIER -77.92 156.36 30.33 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -173.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.39 -10.45 33.27 Favored Glycine 0 C--N 1.359 1.842 0 CA-C-N 111.826 -2.443 . . . . 0.0 111.776 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 t -146.87 150.66 35.68 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 101.269 -3.604 . . . . 0.0 101.269 172.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -149.83 9.64 0.7 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 119.555 1.071 . . . . 0.0 111.055 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 34.2 pt -117.5 148.81 20.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 CA-C-O 122.302 1.049 . . . . 0.0 110.687 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -137.66 138.89 39.89 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.3 129.78 14.87 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 119.859 -1.776 . . . . 0.0 109.776 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -117.78 93.84 4.3 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.511 2.324 . . . . 0.0 111.157 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.08 -73.07 0.55 Allowed Glycine 0 C--N 1.362 1.98 0 N-CA-C 120.127 2.811 . . . . 0.0 120.127 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -147.21 58.8 1.16 Allowed 'General case' 0 C--N 1.356 0.849 0 CA-C-O 122.601 1.191 . . . . 0.0 110.201 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.1 m -175.56 157.91 2.15 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.47 135.01 35.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 122.598 1.19 . . . . 0.0 109.735 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -115.17 130.37 56.9 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 127.618 2.367 . . . . 0.0 107.164 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 m -125.81 146.43 31.58 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 1 N-CA-C 98.237 -4.727 . . . . 0.0 98.237 172.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.54 ' CD2' ' CZ2' ' A' ' 142' ' ' TRP 0.329 0.1 OUTLIER -81.57 137.32 35.54 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 121.709 0.766 . . . . 0.0 112.449 176.074 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 2.5 m -146.2 165.06 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -173.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -129.17 153.43 47.73 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -110.86 122.69 48.49 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.022 1.329 . . . . 0.0 107.564 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -74.83 60.59 0.96 Allowed 'General case' 0 C--N 1.37 1.493 0 C-N-CA 127.689 2.396 . . . . 0.0 114.475 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.417 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP 0.31 50.8 p-10 -87.66 -99.21 0.08 Allowed 'General case' 0 C--N 1.363 1.19 0 C-N-CA 125.604 1.562 . . . . 0.0 113.377 -177.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -106.84 -65.7 1.07 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.452 1.901 . . . . 0.0 114.57 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.272 10.1 p -77.81 -38.04 1.65 Allowed Pre-proline 0 C--N 1.365 1.251 0 N-CA-C 118.546 2.795 . . . . 0.0 118.546 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -82.43 -174.73 13.76 Favored 'Cis proline' 0 C--N 1.354 0.866 1 CA-C-N 128.707 4.145 . . . . 0.0 113.822 -0.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.274 4.0 t -97.62 154.06 17.8 Favored 'General case' 0 C--N 1.374 1.646 0 C-N-CA 127.613 2.365 . . . . 0.0 111.045 171.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.512 HH22 ' CG ' ' A' ' 130' ' ' HIS . 32.7 ttt-85 -158.44 162.05 37.52 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.26 -163.97 29.64 Favored Glycine 0 CA--C 1.484 -1.87 0 N-CA-C 104.24 -3.544 . . . . 0.0 104.24 166.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.54 ' CZ2' ' CD2' ' A' ' 130' ' ' HIS . 78.7 m95 -96.65 99.95 11.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 171.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.2 m -81.65 178.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 126.973 2.109 . . . . 0.0 108.001 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.5 m -94.92 130.08 41.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -79.53 -9.62 59.65 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 119.891 -1.755 . . . . 0.0 113.993 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.21 -13.75 61.61 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.496 1.118 . . . . 0.0 112.475 174.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.7 mt -96.84 1.11 50.27 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 126.436 1.894 . . . . 0.0 114.074 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.09 141.79 28.31 Favored 'General case' 0 C--N 1.372 1.546 0 CA-C-N 121.1 1.773 . . . . 0.0 109.233 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -115.99 158.57 42.1 Favored Pre-proline 0 C--O 1.224 -0.273 0 O-C-N 119.313 -2.117 . . . . 0.0 105.621 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.98 151.44 21.25 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.395 3.397 . . . . 0.0 112.869 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -121.61 117.42 26.67 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-O 122.056 0.932 . . . . 0.0 112.262 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.3 t -160.89 23.72 0.14 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 126.182 1.793 . . . . 0.0 106.698 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.41 70.42 0.3 Allowed Glycine 0 C--N 1.353 1.514 0 C-N-CA 120.424 -0.894 . . . . 0.0 114.578 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 m -63.7 -10.99 22.17 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 131.221 3.808 . . . . 0.0 116.215 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -126.73 29.95 5.6 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 129.226 3.01 . . . . 0.0 108.065 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 t -96.09 136.58 36.36 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 127.695 2.398 . . . . 0.0 107.243 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -47.91 -38.91 17.52 Favored 'General case' 0 C--N 1.369 1.428 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.12 -18.3 60.27 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.608 -1.307 . . . . 0.0 113.885 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.72 -1.38 46.62 Favored 'General case' 0 C--N 1.371 1.505 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.376 0.6 OUTLIER -119.65 -173.51 2.55 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.409 1.484 . . . . 0.0 112.74 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -71.32 122.38 20.18 Favored 'General case' 0 C--N 1.37 1.468 0 O-C-N 119.506 -1.996 . . . . 0.0 112.355 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.26 -8.0 56.92 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.299 0.952 . . . . 0.0 111.774 -168.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.09 157.31 28.12 Favored Glycine 0 C--N 1.363 2.065 0 N-CA-C 117.437 1.735 . . . . 0.0 117.437 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -58.41 -42.53 87.41 Favored 'General case' 0 C--N 1.366 1.304 0 N-CA-C 119.358 3.096 . . . . 0.0 119.358 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.419 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.391 0.2 OUTLIER -106.32 3.15 27.26 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -175.037 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -101.91 144.13 30.92 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.091 1.757 . . . . 0.0 108.87 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.1 m -166.93 147.16 5.64 Favored 'General case' 0 N--CA 1.445 -0.709 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.37 99.89 9.24 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-O 126.398 2.999 . . . . 0.0 111.693 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -120.84 134.46 24.31 Favored Pre-proline 0 N--CA 1.416 -2.145 3 N-CA-C 98.046 -4.798 . . . . 0.0 98.046 164.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -60.74 -22.78 74.47 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.691 4.26 . . . . 0.0 115.509 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.09 -36.33 74.83 Favored 'General case' 0 C--N 1.36 1.059 0 C-N-CA 128.741 2.816 . . . . 0.0 113.829 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.1 mm -71.73 -40.24 69.72 Favored 'Isoleucine or valine' 0 C--N 1.379 1.877 0 C-N-CA 127.553 2.341 . . . . 0.0 108.472 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.0 mt -66.44 -48.57 69.55 Favored 'General case' 0 C--N 1.369 1.454 0 C-N-CA 125.314 1.446 . . . . 0.0 113.264 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -57.81 -34.16 69.35 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 128.288 2.635 . . . . 0.0 114.881 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.35 -45.88 71.65 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 130.959 3.704 . . . . 0.0 111.599 171.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.35 0.0 OUTLIER -64.25 -32.35 73.9 Favored 'General case' 0 C--N 1.38 1.931 0 CA-C-N 120.321 1.419 . . . . 0.0 113.374 168.187 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -68.96 -48.51 62.99 Favored 'General case' 0 C--N 1.376 1.752 0 C-N-CA 126.059 1.743 . . . . 0.0 113.711 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -60.44 -53.51 56.75 Favored 'General case' 0 C--N 1.379 1.884 0 C-N-CA 128.838 2.855 . . . . 0.0 111.108 173.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -59.86 -45.42 92.52 Favored 'General case' 0 C--N 1.365 1.277 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.45 -37.79 70.77 Favored 'General case' 0 C--N 1.378 1.83 0 C-N-CA 127.668 2.387 . . . . 0.0 112.955 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.99 -39.62 72.34 Favored 'General case' 0 C--N 1.361 1.093 0 O-C-N 119.781 -1.824 . . . . 0.0 115.122 173.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.92 -29.35 55.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 119.417 3.118 . . . . 0.0 119.417 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.83 -50.2 69.83 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 130.298 3.439 . . . . 0.0 113.074 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.274 0.0 OUTLIER -90.93 -16.6 27.83 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 127.577 2.351 . . . . 0.0 111.985 -175.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -120.78 -110.91 0.33 Allowed 'General case' 0 C--N 1.357 0.906 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -135.52 149.55 49.51 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 119.797 -1.814 . . . . 0.0 107.836 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.492 0.0 OUTLIER -51.03 -32.69 22.32 Favored 'General case' 0 CA--C 1.5 -0.957 1 C-N-CA 132.017 4.127 . . . . 0.0 117.711 175.49 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 17.4 tt -49.43 -30.91 5.08 Favored 'Isoleucine or valine' 0 C--N 1.365 1.278 0 C-N-CA 130.12 3.368 . . . . 0.0 113.029 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -60.43 -35.88 76.86 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 128.146 2.578 . . . . 0.0 113.955 169.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -75.3 -44.23 46.7 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 171.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 10.0 mp -67.92 -19.95 65.04 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 129.694 3.197 . . . . 0.0 112.753 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -64.86 -38.64 91.64 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 130.652 3.581 . . . . 0.0 114.344 168.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.34 -51.08 3.44 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.78 2.032 . . . . 0.0 109.667 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 46.67 -134.13 1.0 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 131.303 3.841 . . . . 0.0 117.919 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.318 9.1 p . . . . . 0 C--N 1.368 1.398 0 CA-C-O 124.645 2.164 . . . . 0.0 109.279 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.451 ' HA ' ' CE2' ' A' ' 90' ' ' PHE 0.47 12.1 p . . . . . 0 N--CA 1.464 0.275 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -122.79 102.6 8.13 Favored 'General case' 0 C--N 1.369 1.442 0 O-C-N 120.566 -1.334 . . . . 0.0 110.386 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 8.5 m-85 -126.06 128.6 47.65 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.766 1.626 . . . . 0.0 114.591 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.5 p -110.67 163.73 16.54 Favored Pre-proline 0 C--N 1.365 1.241 0 O-C-N 119.868 -1.77 . . . . 0.0 115.776 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.67 134.97 65.22 Favored 'Trans proline' 0 C--N 1.373 1.839 1 C-N-CA 126.659 4.906 . . . . 0.0 117.097 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.33 -51.19 0.75 Allowed Glycine 0 C--N 1.353 1.522 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 -169.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -65.49 159.36 24.59 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.436 HD22 HH11 ' A' ' 190' ' ' ARG . 3.5 mm? -102.83 141.49 35.54 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.42 159.68 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 C-N-CA 126.639 1.976 . . . . 0.0 106.538 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.508 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 52.2 m95 -108.56 115.76 30.7 Favored 'General case' 0 C--O 1.214 -0.786 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 171.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.25 147.66 26.77 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 122.728 2.513 . . . . 0.0 113.602 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -115.14 130.57 56.96 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 170.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 44.1 ttm -116.04 141.19 48.45 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.26 101.29 0.9 Allowed 'General case' 0 C--N 1.364 1.203 0 C-N-CA 126.062 1.745 . . . . 0.0 113.5 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.42 -10.93 23.97 Favored Glycine 0 C--N 1.358 1.782 0 C-N-CA 125.752 1.644 . . . . 0.0 113.45 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -103.9 164.83 14.57 Favored Pre-proline 0 C--N 1.357 0.913 0 C-N-CA 125.567 1.547 . . . . 0.0 109.719 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -71.41 166.09 30.41 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 125.039 3.826 . . . . 0.0 112.752 164.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.92 126.0 25.83 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 127.776 2.43 . . . . 0.0 114.95 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.443 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 3.3 m95 -134.75 116.57 12.67 Favored Pre-proline 0 CA--C 1.571 1.787 1 N-CA-C 123.893 4.775 . . . . 0.0 123.893 -169.25 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.508 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 27.1 Cg_exo -56.44 113.45 1.46 Allowed 'Trans proline' 0 C--N 1.401 3.325 1 C-N-CA 126.788 4.992 . . . . 0.0 114.145 166.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -127.06 164.29 21.87 Favored 'General case' 0 N--CA 1.449 -0.508 1 C-N-CA 133.199 4.6 . . . . 0.0 116.104 -168.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.16 146.72 41.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.742 2.817 . . . . 0.0 107.165 172.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 t -91.63 130.64 40.46 Favored 'Isoleucine or valine' 0 C--N 1.37 1.467 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 171.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -132.18 152.47 51.27 Favored 'General case' 0 C--N 1.361 1.066 0 O-C-N 118.729 -2.482 . . . . 0.0 115.097 -164.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -92.31 112.82 24.9 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 2.0 m-70 -65.68 160.7 58.96 Favored Pre-proline 0 C--N 1.36 1.061 0 C-N-CA 128.2 2.6 . . . . 0.0 117.417 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.37 -1.41 0.2 Allowed 'Trans proline' 0 CA--C 1.572 2.398 0 C-N-CA 124.933 3.755 . . . . 0.0 116.895 169.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -115.71 33.92 5.22 Favored 'General case' 0 C--N 1.356 0.883 1 C-N-CA 135.638 5.575 . . . . 0.0 107.247 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.318 1.1 p30 -72.64 150.26 43.17 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -172.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.07 2.94 31.68 Favored Glycine 0 C--N 1.359 1.849 0 CA-C-N 111.99 -2.368 . . . . 0.0 110.959 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.4 m -149.74 130.76 14.38 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 102.141 -3.281 . . . . 0.0 102.141 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -149.37 -10.44 0.31 Allowed 'General case' 0 C--N 1.364 1.21 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.9 pt -108.63 145.6 15.37 Favored 'Isoleucine or valine' 0 C--N 1.369 1.446 0 CA-C-N 121.862 2.119 . . . . 0.0 112.196 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -139.1 137.9 36.58 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -143.27 127.42 17.54 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -117.86 94.0 4.36 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 126.926 2.09 . . . . 0.0 110.675 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.12 -71.02 0.32 Allowed Glycine 0 C--N 1.362 2.027 0 N-CA-C 120.205 2.842 . . . . 0.0 120.205 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -150.38 57.59 0.94 Allowed 'General case' 0 C--N 1.353 0.721 0 CA-C-O 122.512 1.149 . . . . 0.0 109.861 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.5 m -176.8 140.15 0.32 Allowed 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.486 1.914 . . . . 0.0 106.293 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.47 136.98 58.64 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 123.13 1.443 . . . . 0.0 112.31 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 -114.89 141.95 47.24 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.456 2.302 . . . . 0.0 107.994 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 145' ' ' LYS . 8.8 m -146.58 156.62 11.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 1 N-CA-C 98.711 -4.551 . . . . 0.0 98.711 174.202 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 2.5 m80 -79.66 138.66 37.45 Favored 'General case' 0 C--N 1.37 1.496 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.5 m -139.91 172.08 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.08 147.65 44.25 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.417 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -114.34 118.59 34.31 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 127.854 2.462 . . . . 0.0 104.951 -177.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.51 53.36 0.02 OUTLIER 'General case' 0 C--N 1.373 1.622 0 C-N-CA 129.478 3.111 . . . . 0.0 114.568 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.443 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 1.6 p30 -100.83 -127.67 0.2 Allowed 'General case' 0 C--N 1.359 1.016 0 O-C-N 118.6 -2.563 . . . . 0.0 113.035 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -96.66 -46.4 6.32 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 124.785 1.234 . . . . 0.0 114.042 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.286 12.3 t -74.12 -51.86 4.54 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 116.797 2.147 . . . . 0.0 116.797 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.3 -173.63 12.96 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 126.012 3.183 . . . . 0.0 112.755 0.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 133' ' ' PHE . 75.0 m -95.72 116.79 29.38 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 174.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -155.34 152.94 29.76 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 120.781 -1.199 . . . . 0.0 109.83 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.93 -149.2 19.86 Favored Glycine 0 CA--C 1.488 -1.611 0 N-CA-C 104.468 -3.453 . . . . 0.0 104.468 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -86.78 111.33 20.62 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 126.166 1.786 . . . . 0.0 110.738 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.1 m -98.37 175.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 126.136 1.774 . . . . 0.0 107.069 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.9 t -94.31 128.56 40.88 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.444 ' HB3' HG23 ' A' ' 129' ' ' VAL 0.293 47.7 pttt -77.6 -7.26 56.1 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-N 121.206 1.821 . . . . 0.0 113.791 -176.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -67.64 -19.32 65.2 Favored 'General case' 0 C--N 1.364 1.223 0 C-N-CA 124.72 1.208 . . . . 0.0 113.307 172.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.9 mt -94.55 -0.23 54.74 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 125.666 1.586 . . . . 0.0 114.272 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.29 157.02 17.1 Favored 'General case' 0 C--N 1.366 1.285 0 CA-C-N 122.025 2.193 . . . . 0.0 108.3 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.483 ' HG3' ' CE1' ' A' ' 165' ' ' PHE . 21.0 mmtt -119.67 168.07 10.94 Favored Pre-proline 0 C--O 1.222 -0.376 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.8 156.24 15.66 Favored 'Trans proline' 0 C--N 1.326 -0.649 1 C-N-CA 125.67 4.247 . . . . 0.0 113.481 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.5 148.95 22.71 Favored 'General case' 0 C--N 1.359 0.994 0 CA-C-O 122.621 1.2 . . . . 0.0 110.109 172.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.5 t -171.38 -37.85 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 101.115 -3.661 . . . . 0.0 101.115 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 119.74 -159.36 14.9 Favored Glycine 0 C--N 1.36 1.886 0 CA-C-N 113.949 -1.478 . . . . 0.0 115.969 140.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.3 m -46.35 -16.74 0.03 OUTLIER 'General case' 0 C--N 1.373 1.609 1 C-N-CA 133.263 4.625 . . . . 0.0 117.629 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -77.69 -23.07 49.64 Favored 'General case' 0 N--CA 1.442 -0.873 1 C-N-CA 135.379 5.471 . . . . 0.0 112.831 176.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 6.8 t -89.17 153.9 20.58 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.209 1.404 . . . . 0.0 114.052 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -61.23 -36.26 79.46 Favored 'General case' 0 C--N 1.369 1.417 0 C-N-CA 126.404 1.881 . . . . 0.0 113.858 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -73.08 -4.57 33.42 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 125.686 1.594 . . . . 0.0 113.197 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -111.75 7.11 20.16 Favored 'General case' 0 C--N 1.372 1.567 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.311 1.5 pp0? -127.98 -172.89 2.79 Favored 'General case' 0 C--N 1.363 1.194 0 O-C-N 119.621 -1.924 . . . . 0.0 111.853 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -63.69 122.38 16.23 Favored 'General case' 0 C--N 1.372 1.584 0 C-N-CA 126.824 2.05 . . . . 0.0 112.897 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.45 -9.04 66.89 Favored Glycine 0 C--N 1.359 1.854 0 C-N-CA 124.38 0.99 . . . . 0.0 112.22 -167.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.55 140.67 20.59 Favored Glycine 0 C--N 1.365 2.157 0 C-N-CA 126.926 2.203 . . . . 0.0 116.705 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -61.47 -21.6 64.33 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 119.453 3.131 . . . . 0.0 119.453 -172.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.483 ' CE1' ' HG3' ' A' ' 149' ' ' LYS . 1.7 m-85 -108.74 -3.6 17.67 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 120.623 -1.298 . . . . 0.0 111.449 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -86.53 165.46 16.22 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 125.566 2.603 . . . . 0.0 117.171 -173.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.4 m 169.95 173.84 0.05 Allowed 'General case' 0 CA--C 1.503 -0.848 2 N-CA-C 98.487 -4.634 . . . . 0.0 98.487 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -121.12 101.49 7.7 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-N 122.299 2.318 . . . . 0.0 107.168 170.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -119.58 123.9 28.35 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 101.173 -3.64 . . . . 0.0 101.173 169.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -55.73 -29.72 72.63 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 125.189 3.926 . . . . 0.0 116.868 -174.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -65.22 -36.11 83.13 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.921 2.889 . . . . 0.0 113.067 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.9 mt -68.36 -41.79 83.78 Favored 'Isoleucine or valine' 0 C--N 1.38 1.895 0 C-N-CA 126.164 1.786 . . . . 0.0 110.612 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.7 mt -68.55 -43.9 75.63 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 125.826 1.651 . . . . 0.0 113.275 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -58.05 -42.97 86.55 Favored 'General case' 0 CA--C 1.486 -1.498 0 C-N-CA 128.581 2.752 . . . . 0.0 113.777 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.59 -34.35 77.7 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 130.41 3.484 . . . . 0.0 110.09 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.255 6.8 mtt -70.09 -33.4 71.84 Favored 'General case' 0 C--N 1.376 1.721 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 165.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -71.31 -45.7 62.41 Favored 'General case' 0 C--N 1.379 1.884 0 C-N-CA 125.961 1.704 . . . . 0.0 110.955 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -67.48 -52.81 34.86 Favored 'General case' 0 C--N 1.375 1.699 0 C-N-CA 127.882 2.473 . . . . 0.0 112.154 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.64 85.55 Favored 'General case' 0 C--N 1.374 1.636 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.28 -40.37 93.78 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-N 121.714 2.052 . . . . 0.0 112.527 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.27 -52.13 63.3 Favored 'General case' 0 C--N 1.367 1.353 0 O-C-N 119.099 -2.251 . . . . 0.0 113.935 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.84 72.8 Favored 'General case' 0 C--N 1.361 1.065 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -50.21 43.54 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 127.084 2.154 . . . . 0.0 112.309 171.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.378 0.0 OUTLIER -81.19 -12.88 59.06 Favored 'General case' 0 C--N 1.363 1.183 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -170.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -107.42 -107.94 0.32 Allowed 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.731 0.812 . . . . 0.0 111.734 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -136.25 176.31 8.81 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 119.839 -1.788 . . . . 0.0 112.053 -175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.698 ' HA ' ' HE ' ' A' ' 190' ' ' ARG . 40.6 mmtm -51.45 -43.83 62.18 Favored 'General case' 0 C--N 1.384 2.065 1 C-N-CA 132.495 4.318 . . . . 0.0 114.207 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.5 tt -59.84 -27.99 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 129.929 3.292 . . . . 0.0 114.148 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -71.95 -45.33 61.51 Favored 'General case' 0 C--N 1.376 1.737 0 C-N-CA 126.288 1.835 . . . . 0.0 112.983 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.698 ' HE ' ' HA ' ' A' ' 187' ' ' LYS . 0.0 OUTLIER -75.13 -41.5 58.29 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 126.91 2.084 . . . . 0.0 114.7 170.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.46 -20.92 62.84 Favored 'General case' 0 C--N 1.369 1.422 0 C-N-CA 127.985 2.514 . . . . 0.0 113.329 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.74 -38.04 88.96 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 128.438 2.695 . . . . 0.0 114.044 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.4 mt -99.21 -46.27 5.61 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 126.777 2.031 . . . . 0.0 108.648 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . 0.256 . . 65.13 -94.16 0.04 OUTLIER 'General case' 0 C--N 1.367 1.351 0 C-N-CA 128.937 2.895 . . . . 0.0 114.39 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.453 -0.276 0 C-N-CA 125.989 1.716 . . . . 0.0 109.673 175.352 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.2 p . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -163.09 62.12 0.19 Allowed 'General case' 0 C--N 1.364 1.236 0 CA-C-N 119.854 1.206 . . . . 0.0 113.409 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -118.04 125.78 51.0 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 120.215 -1.553 . . . . 0.0 110.067 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 87.4 p -111.73 166.22 11.31 Favored Pre-proline 0 C--N 1.36 1.022 0 C-N-CA 126.126 1.77 . . . . 0.0 110.773 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -54.56 149.14 40.66 Favored 'Trans proline' 0 C--N 1.37 1.691 1 C-N-CA 126.107 4.538 . . . . 0.0 119.188 -170.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.45 -39.37 2.89 Favored Glycine 0 C--N 1.356 1.689 0 C-N-CA 126.023 1.773 . . . . 0.0 113.015 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.54 169.04 17.58 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.89 134.46 37.51 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.0 m -136.08 159.22 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-O 123.613 1.673 . . . . 0.0 107.548 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.414 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 70.3 m95 -104.18 116.73 32.72 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 173.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.62 135.08 53.76 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.497 2.319 . . . . 0.0 112.791 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.463 ' HB2' ' CZ2' ' A' ' 105' ' ' TRP . 51.7 tptt -112.93 141.83 46.31 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 173.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.8 ttm -128.82 149.72 50.62 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.018 -1.676 . . . . 0.0 108.615 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -65.16 100.11 0.42 Allowed 'General case' 0 C--N 1.368 1.39 0 C-N-CA 125.788 1.635 . . . . 0.0 114.125 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.97 -4.38 25.67 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 125.873 1.701 . . . . 0.0 112.909 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -112.01 161.26 26.65 Favored Pre-proline 0 C--N 1.358 0.95 0 C-N-CA 125.41 1.484 . . . . 0.0 111.588 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.47 167.53 26.09 Favored 'Trans proline' 0 C--N 1.366 1.479 1 C-N-CA 126.12 4.547 . . . . 0.0 112.682 164.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 99' ' ' LYS . 6.9 m95 -65.34 132.8 49.94 Favored 'General case' 0 C--N 1.363 1.154 0 CA-C-O 124.316 2.008 . . . . 0.0 113.238 171.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.26 10.6 m95 -134.88 134.55 21.98 Favored Pre-proline 0 N--CA 1.413 -2.276 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -169.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.402 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 4.7 Cg_exo -72.2 143.15 39.17 Favored 'Trans proline' 0 C--N 1.38 2.204 1 C-N-CA 126.123 4.549 . . . . 0.0 110.916 156.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -156.77 165.42 36.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.27 3.028 . . . . 0.0 114.39 -161.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.8 tp -119.45 138.49 53.09 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.345 2.258 . . . . 0.0 107.745 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.31 121.89 33.43 Favored 'Isoleucine or valine' 0 C--N 1.378 1.836 0 C-N-CA 126.387 1.875 . . . . 0.0 106.528 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -127.38 152.75 47.09 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 119.626 -1.921 . . . . 0.0 113.172 -167.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.79 113.58 26.92 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 127.472 2.309 . . . . 0.0 106.463 173.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.451 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 3.4 m-70 -62.56 159.98 38.25 Favored Pre-proline 0 C--N 1.358 0.975 0 C-N-CA 130.224 3.41 . . . . 0.0 117.456 -175.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.77 -1.41 0.24 Allowed 'Trans proline' 0 CA--C 1.564 2.021 1 C-N-CA 125.551 4.167 . . . . 0.0 116.951 170.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.72 31.27 5.78 Favored 'General case' 0 C--N 1.356 0.878 1 C-N-CA 134.813 5.245 . . . . 0.0 107.603 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.339 0.1 OUTLIER -69.53 150.29 47.29 Favored 'General case' 0 C--N 1.374 1.636 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -172.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.22 5.51 30.31 Favored Glycine 0 C--N 1.359 1.836 0 CA-C-N 112.174 -2.285 . . . . 0.0 111.556 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.4 m -152.56 135.29 15.39 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 100.813 -3.773 . . . . 0.0 100.813 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.418 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.255 2.2 p90 -155.23 -37.36 0.09 Allowed 'General case' 0 C--N 1.365 1.261 0 CA-C-N 120.423 1.465 . . . . 0.0 113.684 -175.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.5 tt -108.26 140.48 26.6 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-O 122.972 1.368 . . . . 0.0 110.574 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -119.88 121.29 38.72 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 101.091 -3.67 . . . . 0.0 101.091 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.84 179.71 4.19 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.097 0.959 . . . . 0.0 112.794 -171.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -46.3 131.73 10.41 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 120.241 3.423 . . . . 0.0 120.241 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 172.14 -51.38 0.17 Allowed Glycine 0 C--N 1.353 1.527 0 N-CA-C 106.37 -2.692 . . . . 0.0 106.37 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.0 mmmt -103.69 -52.81 2.9 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 126.605 1.962 . . . . 0.0 108.985 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.8 t -171.67 -166.49 0.44 Allowed 'General case' 0 C--N 1.353 0.739 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -129.13 120.68 52.15 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 124.917 1.287 . . . . 0.0 110.423 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -130.18 139.42 50.85 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 126.519 1.928 . . . . 0.0 112.786 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.97 163.25 36.95 Favored 'Isoleucine or valine' 0 C--N 1.367 1.347 0 C-N-CA 126.524 1.929 . . . . 0.0 105.844 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.451 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 1.1 m80 -83.34 140.93 32.15 Favored 'General case' 0 C--N 1.373 1.625 0 CA-C-N 120.654 1.57 . . . . 0.0 113.223 172.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 m -150.96 171.97 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.868 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -136.69 146.77 46.28 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 124.453 1.101 . . . . 0.0 109.104 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.49 124.5 52.42 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 104.713 -2.328 . . . . 0.0 104.713 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.71 60.34 0.07 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 127.42 2.288 . . . . 0.0 113.394 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -98.29 -124.12 0.14 Allowed 'General case' 0 C--N 1.361 1.085 0 O-C-N 119.572 -1.955 . . . . 0.0 111.859 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -106.27 -52.55 2.77 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.731 1.612 . . . . 0.0 111.716 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 m -69.82 -40.35 13.19 Favored Pre-proline 0 C--N 1.364 1.232 0 N-CA-C 118.508 2.781 . . . . 0.0 118.508 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.14 178.0 36.54 Favored 'Cis proline' 0 C--N 1.354 0.852 0 CA-C-N 126.442 3.336 . . . . 0.0 110.479 -4.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.6 m -89.67 115.62 27.18 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 118.743 -2.473 . . . . 0.0 106.849 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.2 ttp85 -149.04 150.97 33.68 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-O 122.6 1.19 . . . . 0.0 109.347 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 165.62 -157.06 29.38 Favored Glycine 0 CA--C 1.491 -1.413 0 N-CA-C 105.973 -2.851 . . . . 0.0 105.973 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -80.22 110.17 15.39 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 126.547 1.939 . . . . 0.0 109.885 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.17 169.25 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 124.636 1.174 . . . . 0.0 110.543 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.5 m -90.23 115.67 27.63 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.47 33.8 pttt -69.25 -5.6 23.91 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -168.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -82.05 -12.78 58.09 Favored 'General case' 0 C--N 1.365 1.256 0 O-C-N 119.242 -2.161 . . . . 0.0 109.714 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.73 -0.63 45.06 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 128.679 2.792 . . . . 0.0 110.145 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER -104.89 125.0 50.46 Favored 'General case' 0 C--N 1.388 2.262 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 173.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -118.97 168.48 9.73 Favored Pre-proline 0 C--O 1.218 -0.563 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -82.47 153.23 15.73 Favored 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 124.433 3.422 . . . . 0.0 112.697 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -127.6 121.2 29.92 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.324 1.059 . . . . 0.0 111.696 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.7 t -162.14 30.67 0.12 Allowed 'General case' 0 C--N 1.359 0.997 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.72 82.12 0.09 OUTLIER Glycine 0 C--N 1.35 1.345 0 C-N-CA 116.499 -2.762 . . . . 0.0 115.228 -166.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . 0.34 89.2 p -68.42 -10.11 53.0 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 121.007 2.404 . . . . 0.0 116.791 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -112.12 32.02 5.83 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 130.166 3.386 . . . . 0.0 108.656 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 19.3 t -103.04 133.4 48.22 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.258 42.7 tttm -55.72 -33.08 63.91 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -174.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -70.89 -19.2 62.64 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 124.704 1.202 . . . . 0.0 113.972 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.49 3.26 54.37 Favored 'General case' 0 C--N 1.371 1.536 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -130.56 -173.07 2.97 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 125.743 1.617 . . . . 0.0 112.042 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -62.79 122.22 15.39 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 126.284 1.834 . . . . 0.0 113.106 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.02 -8.01 64.95 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 124.554 1.073 . . . . 0.0 112.475 -169.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.09 146.2 21.85 Favored Glycine 0 C--N 1.361 1.935 0 C-N-CA 126.565 2.031 . . . . 0.0 115.824 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -60.37 -42.25 95.41 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.4 ' HB2' ' CE3' ' A' ' 97' ' ' TRP 0.322 0.1 OUTLIER -99.84 2.93 44.37 Favored 'General case' 0 C--N 1.363 1.163 0 CA-C-N 120.402 1.455 . . . . 0.0 114.826 -178.217 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -91.77 140.83 29.31 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 126.551 1.94 . . . . 0.0 107.928 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.5 m -166.66 132.4 2.28 Favored 'General case' 0 N--CA 1.446 -0.635 1 N-CA-C 99.797 -4.149 . . . . 0.0 99.797 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.93 100.53 10.83 Favored 'General case' 0 C--N 1.369 1.432 0 CA-C-O 126.281 2.944 . . . . 0.0 112.848 -173.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.426 ' HB2' ' HZ3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -120.57 131.56 24.42 Favored Pre-proline 0 N--CA 1.417 -2.093 3 N-CA-C 98.51 -4.626 . . . . 0.0 98.51 164.704 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.53 -24.7 63.1 Favored 'Trans proline' 0 CA--C 1.543 0.942 1 C-N-CA 125.534 4.156 . . . . 0.0 115.998 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -69.62 -35.88 75.65 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.47 2.708 . . . . 0.0 113.831 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 45.8 mt -74.12 -36.18 43.32 Favored 'Isoleucine or valine' 0 C--N 1.376 1.745 0 C-N-CA 126.369 1.868 . . . . 0.0 109.854 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 20.1 mt -69.0 -45.63 70.05 Favored 'General case' 0 C--N 1.367 1.336 0 C-N-CA 125.298 1.439 . . . . 0.0 112.488 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -58.11 -43.21 87.04 Favored 'General case' 0 CA--C 1.486 -1.519 0 C-N-CA 127.951 2.5 . . . . 0.0 114.596 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.25 -36.88 85.51 Favored 'General case' 0 N--CA 1.428 -1.539 0 C-N-CA 129.449 3.1 . . . . 0.0 111.208 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.1 mtt -65.04 -35.51 81.41 Favored 'General case' 0 C--N 1.379 1.883 0 CA-C-O 115.486 -2.197 . . . . 0.0 112.724 165.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -74.06 -40.2 62.98 Favored 'General case' 0 C--N 1.383 2.026 0 C-N-CA 126.019 1.728 . . . . 0.0 113.731 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.413 HH21 ' HB3' ' A' ' 193' ' ' LEU . 0.2 OUTLIER -73.68 -49.46 25.69 Favored 'General case' 0 C--N 1.374 1.651 0 C-N-CA 131.551 3.941 . . . . 0.0 111.491 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.54 95.72 Favored 'General case' 0 C--N 1.376 1.75 0 C-N-CA 123.836 0.854 . . . . 0.0 113.267 165.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.329 38.5 t70 -57.13 -52.76 64.02 Favored 'General case' 0 C--N 1.387 2.232 0 C-N-CA 126.692 1.997 . . . . 0.0 113.014 172.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -33.44 70.17 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 121.777 2.081 . . . . 0.0 115.702 173.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.26 -44.84 35.48 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.53 -36.86 76.79 Favored 'General case' 0 C--N 1.374 1.65 0 C-N-CA 126.16 1.784 . . . . 0.0 114.221 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.38 -9.78 58.14 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.664 1.586 . . . . 0.0 112.125 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -124.68 -101.27 0.39 Allowed 'General case' 0 C--N 1.356 0.867 0 CA-C-O 120.756 0.312 . . . . 0.0 111.44 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -135.77 152.69 51.37 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.036 -1.04 . . . . 0.0 110.953 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.351 17.2 ttpt -51.51 -35.96 42.63 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 130.839 3.656 . . . . 0.0 116.2 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 14.0 tt -55.03 -30.22 23.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 129.032 2.933 . . . . 0.0 113.035 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -73.22 -37.88 66.27 Favored 'General case' 0 C--N 1.375 1.691 0 O-C-N 119.717 -1.864 . . . . 0.0 113.795 176.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -76.23 -44.35 38.01 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 167.499 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.31 78.4 mt -79.19 -18.96 52.02 Favored 'General case' 0 C--N 1.366 1.292 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -173.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -84.41 -12.95 53.47 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.607 1.163 . . . . 0.0 113.216 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.413 ' HB3' HH21 ' A' ' 178' ' ' ARG . 9.2 mp -105.03 -51.34 3.05 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 126.18 1.792 . . . . 0.0 106.22 176.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 46.48 -113.25 0.44 Allowed 'General case' 0 C--N 1.366 1.287 0 C-N-CA 129.696 3.198 . . . . 0.0 115.787 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--N 1.349 0.548 0 C-N-CA 128.182 2.593 . . . . 0.0 113.221 -178.206 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.405 ' HA ' ' CE1' ' A' ' 90' ' ' PHE . 87.4 p . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.12 109.9 6.38 Favored 'General case' 0 C--N 1.361 1.086 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.405 ' CE1' ' HA ' ' A' ' 88' ' ' SER . 18.2 m-85 -125.71 128.49 47.86 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.952 1.701 . . . . 0.0 113.47 -173.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.318 90.8 p -110.2 162.59 19.84 Favored Pre-proline 0 C--N 1.364 1.235 0 O-C-N 120.249 -1.532 . . . . 0.0 114.855 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.24 136.9 77.75 Favored 'Trans proline' 0 C--N 1.378 2.095 1 C-N-CA 126.449 4.766 . . . . 0.0 119.217 -170.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.63 -20.83 19.97 Favored Glycine 0 C--N 1.364 2.11 0 C-N-CA 125.605 1.574 . . . . 0.0 111.813 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -85.53 169.04 13.95 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 125.697 1.599 . . . . 0.0 114.891 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -110.28 131.68 54.84 Favored 'General case' 0 C--N 1.369 1.447 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 172.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -134.46 161.77 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -106.98 138.31 43.39 Favored 'General case' 0 C--O 1.217 -0.618 1 N-CA-C 99.768 -4.16 . . . . 0.0 99.768 165.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 148' ' ' LEU . . . -128.86 152.58 48.36 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 121.632 2.014 . . . . 0.0 111.976 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -121.46 146.04 47.32 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.9 ttp -128.85 146.43 50.93 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 119.61 -1.931 . . . . 0.0 108.016 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -48.6 91.06 0.0 OUTLIER 'General case' 0 C--N 1.366 1.285 0 C-N-CA 129.475 3.11 . . . . 0.0 117.01 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.06 -9.13 33.7 Favored Glycine 0 C--N 1.36 1.875 0 C-N-CA 125.102 1.334 . . . . 0.0 113.436 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -99.71 162.12 22.2 Favored Pre-proline 0 C--N 1.359 0.983 0 C-N-CA 125.308 1.443 . . . . 0.0 109.231 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.88 167.31 26.27 Favored 'Trans proline' 0 CA--C 1.537 0.674 1 C-N-CA 125.848 4.365 . . . . 0.0 114.736 167.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -60.91 132.0 52.47 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 127.335 2.254 . . . . 0.0 115.04 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.427 ' CE3' ' HA ' ' A' ' 106' ' ' TRP . 10.7 m95 -132.29 108.56 13.61 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 121.729 3.974 . . . . 0.0 121.729 -171.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -58.07 113.58 1.59 Allowed 'Trans proline' 0 C--N 1.388 2.631 1 C-N-CA 126.275 4.65 . . . . 0.0 111.588 165.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.1 m -123.65 166.12 16.05 Favored 'General case' 0 N--CA 1.438 -1.026 1 C-N-CA 132.871 4.468 . . . . 0.0 114.147 -160.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tp -126.12 144.41 50.76 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.16 118.8 37.17 Favored 'Isoleucine or valine' 0 C--N 1.366 1.294 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -113.41 143.59 44.23 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.103 -1.623 . . . . 0.0 111.679 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -79.31 111.31 15.43 Favored 'General case' 0 C--N 1.373 1.612 0 O-C-N 120.379 -1.451 . . . . 0.0 109.597 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.447 ' HB2' ' CG ' ' A' ' 130' ' ' HIS . 9.9 t60 -69.22 160.15 80.09 Favored Pre-proline 0 C--N 1.348 0.522 0 CA-C-O 114.488 -2.672 . . . . 0.0 115.336 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.82 -6.47 2.56 Favored 'Trans proline' 0 CA--C 1.562 1.901 1 CA-C-N 128.814 4.184 . . . . 0.0 116.577 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -108.32 29.72 7.09 Favored 'General case' 0 C--N 1.357 0.922 1 C-N-CA 133.384 4.674 . . . . 0.0 109.642 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -63.45 149.73 45.36 Favored 'General case' 0 C--N 1.365 1.276 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.07 -20.14 50.14 Favored Glycine 0 C--N 1.36 1.889 0 CA-C-N 113.226 -1.806 . . . . 0.0 110.007 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.86 119.1 38.56 Favored 'General case' 0 N--CA 1.446 -0.672 2 N-CA-C 98.646 -4.575 . . . . 0.0 98.646 168.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.585 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.359 0.0 OUTLIER -121.82 -33.41 3.58 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -169.378 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.3 pt -108.33 155.84 9.09 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 120.269 -1.519 . . . . 0.0 110.581 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -141.35 151.16 43.32 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 128.016 2.527 . . . . 0.0 104.208 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.65 130.21 11.48 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 121.0 -1.063 . . . . 0.0 108.249 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -117.4 98.93 6.67 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.952 2.101 . . . . 0.0 108.654 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.43 -89.78 1.02 Allowed Glycine 0 C--N 1.36 1.916 0 N-CA-C 117.869 1.908 . . . . 0.0 117.869 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -142.57 71.34 1.34 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 125.0 1.32 . . . . 0.0 109.391 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.0 m -179.92 170.36 1.21 Allowed 'General case' 0 C--N 1.351 0.667 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.49 145.46 16.22 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -141.32 150.31 42.34 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.498 2.319 . . . . 0.0 110.757 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.2 m -129.0 162.36 36.48 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 129.592 3.157 . . . . 0.0 104.475 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.585 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -82.5 124.8 30.43 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.335 -1.478 . . . . 0.0 110.976 172.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.78 169.48 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.436 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.98 150.84 46.32 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -106.21 127.86 53.53 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.36 1.864 . . . . 0.0 107.376 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -74.95 69.35 1.89 Allowed 'General case' 0 C--N 1.379 1.872 0 CA-C-N 120.258 1.39 . . . . 0.0 111.881 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -88.98 -119.92 0.05 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 127.459 2.304 . . . . 0.0 111.002 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -107.25 -51.99 2.83 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.184 1.794 . . . . 0.0 110.91 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.6 t -69.97 -49.98 18.02 Favored Pre-proline 0 C--N 1.36 1.063 0 C-N-CA 127.975 2.51 . . . . 0.0 117.734 -172.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -81.99 -175.64 15.67 Favored 'Cis proline' 0 C--N 1.347 0.497 0 CA-C-N 126.104 3.216 . . . . 0.0 111.52 -0.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 34.5 m -94.62 141.17 28.92 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.291 1.036 . . . . 0.0 108.319 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -160.23 156.21 26.15 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.16 -159.8 29.21 Favored Glycine 0 CA--C 1.484 -1.904 1 N-CA-C 98.235 -5.946 . . . . 0.0 98.235 174.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -104.85 113.73 27.5 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.5 m -87.83 173.78 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 C-N-CA 128.231 2.612 . . . . 0.0 106.711 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.8 m -94.31 110.88 22.61 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -50.93 -17.8 0.65 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -69.27 -19.47 63.91 Favored 'General case' 0 N--CA 1.439 -1.014 1 C-N-CA 131.784 4.034 . . . . 0.0 112.75 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.4 mt -92.33 -2.23 56.53 Favored 'General case' 0 C--N 1.365 1.278 0 C-N-CA 126.182 1.793 . . . . 0.0 113.935 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -95.35 156.9 16.13 Favored 'General case' 0 C--N 1.369 1.451 0 CA-C-N 122.231 2.287 . . . . 0.0 109.715 174.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.06 159.04 58.43 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 102.567 -3.123 . . . . 0.0 102.567 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.98 151.93 21.51 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 125.035 3.823 . . . . 0.0 111.399 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.365 1.0 OUTLIER -93.31 -116.2 0.09 Allowed 'General case' 0 C--N 1.367 1.335 0 O-C-N 120.649 -1.282 . . . . 0.0 110.737 175.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.426 4.6 t 63.47 -36.87 0.16 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 127.849 2.459 . . . . 0.0 116.149 -174.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.04 88.54 0.53 Allowed Glycine 0 C--N 1.349 1.27 0 C-N-CA 126.448 1.975 . . . . 0.0 116.769 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.2 m -67.66 -10.92 56.6 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 131.473 3.909 . . . . 0.0 115.412 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -121.49 24.58 9.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 128.458 2.703 . . . . 0.0 108.496 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 91.2 p -87.39 139.29 30.7 Favored 'General case' 0 C--N 1.374 1.667 0 C-N-CA 125.598 1.559 . . . . 0.0 107.821 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -56.39 -24.34 43.97 Favored 'General case' 0 C--N 1.372 1.579 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -82.24 -19.86 38.81 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.734 1.614 . . . . 0.0 113.224 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.61 -13.99 22.49 Favored 'General case' 0 C--N 1.37 1.494 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.304 0.4 OUTLIER -107.88 -173.97 2.41 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 125.395 1.478 . . . . 0.0 112.939 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -69.31 122.1 18.2 Favored 'General case' 0 C--N 1.373 1.613 0 O-C-N 120.308 -1.495 . . . . 0.0 112.784 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.22 -9.47 50.06 Favored Glycine 0 C--N 1.354 1.553 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.81 -166.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.87 155.76 46.78 Favored Glycine 0 C--N 1.368 2.339 0 N-CA-C 119.97 2.748 . . . . 0.0 119.97 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.69 -41.54 77.53 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.927 3.691 . . . . 0.0 116.164 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -98.42 -17.74 18.64 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -41.08 -36.58 0.72 Allowed 'General case' 0 C--N 1.356 0.854 2 C-N-CA 132.723 4.409 . . . . 0.0 122.472 -168.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.6 m -14.17 92.86 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 1 C-N-CA 132.032 4.133 . . . . 0.0 117.707 -177.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.99 101.65 13.1 Favored 'General case' 0 C--N 1.368 1.38 0 CA-C-O 126.016 2.817 . . . . 0.0 114.003 -166.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -119.78 135.55 24.28 Favored Pre-proline 0 N--CA 1.423 -1.776 1 C-N-CA 133.803 4.841 . . . . 0.0 102.681 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -55.08 -22.76 32.76 Favored 'Trans proline' 0 CA--C 1.544 1.019 1 C-N-CA 125.973 4.448 . . . . 0.0 117.733 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -70.16 -35.96 74.38 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 131.251 3.82 . . . . 0.0 112.453 173.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.8 mt -76.7 -32.7 20.93 Favored 'Isoleucine or valine' 0 C--N 1.375 1.683 0 C-N-CA 127.582 2.353 . . . . 0.0 109.084 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 26.3 mt -66.46 -51.88 52.15 Favored 'General case' 0 C--N 1.373 1.627 0 C-N-CA 127.063 2.145 . . . . 0.0 111.055 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -57.45 -34.52 69.06 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.127 1.771 . . . . 0.0 114.751 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.33 -50.75 43.59 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 130.484 3.514 . . . . 0.0 113.86 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.415 0.0 OUTLIER -68.16 -33.1 73.85 Favored 'General case' 0 C--N 1.385 2.124 0 CA-C-N 121.525 1.966 . . . . 0.0 113.7 173.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -71.96 -48.89 41.95 Favored 'General case' 0 C--N 1.373 1.596 0 C-N-CA 126.688 1.995 . . . . 0.0 112.751 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -38.51 77.83 Favored 'General case' 0 C--N 1.383 2.042 0 O-C-N 119.022 -2.299 . . . . 0.0 114.986 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.89 -51.09 69.61 Favored 'General case' 0 C--N 1.379 1.864 0 C-N-CA 124.655 1.182 . . . . 0.0 112.19 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.268 38.1 t70 -53.47 -43.2 67.96 Favored 'General case' 0 C--N 1.38 1.897 0 C-N-CA 127.263 2.225 . . . . 0.0 113.98 174.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -33.86 76.57 Favored 'General case' 0 C--N 1.374 1.669 0 O-C-N 118.661 -2.524 . . . . 0.0 114.921 173.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.37 -45.59 31.24 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 tt -53.56 -49.87 66.75 Favored 'General case' 0 CA--C 1.498 -1.024 1 C-N-CA 132.298 4.239 . . . . 0.0 116.455 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.253 0.0 OUTLIER -86.84 -7.91 57.8 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 126.606 1.962 . . . . 0.0 111.417 -174.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -120.1 -100.05 0.43 Allowed 'General case' 0 C--N 1.358 0.961 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.462 ' HB2' ' HZ2' ' A' ' 189' ' ' LYS . 17.1 m-20 -135.26 151.05 50.21 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.783 -1.198 . . . . 0.0 108.998 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.445 ' HZ1' HD23 ' A' ' 191' ' ' LEU 0.256 34.3 tttm -51.39 -36.49 43.63 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 130.979 3.712 . . . . 0.0 115.872 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 12.6 tt -56.0 -28.5 24.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 130.118 3.367 . . . . 0.0 113.211 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.462 ' HZ2' ' HB2' ' A' ' 186' ' ' ASP 0.258 4.6 mptt -71.02 -42.62 69.33 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 119.537 -1.977 . . . . 0.0 113.849 174.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.314 0.0 OUTLIER -76.36 -42.98 42.9 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 169.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.445 HD23 ' HZ1' ' A' ' 187' ' ' LYS . 3.3 tp -70.55 -30.7 67.5 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.627 1.971 . . . . 0.0 114.946 -172.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -84.56 -12.25 54.47 Favored 'General case' 0 C--N 1.365 1.282 0 C-N-CA 125.859 1.664 . . . . 0.0 114.305 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 mp -97.34 -50.05 4.69 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 173.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 62.65 -102.64 0.11 Allowed 'General case' 0 C--N 1.364 1.199 0 C-N-CA 130.371 3.468 . . . . 0.0 115.055 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.447 -0.579 0 C-N-CA 128.397 2.679 . . . . 0.0 108.601 -178.937 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -160.4 62.19 0.33 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-N 119.161 0.892 . . . . 0.0 109.505 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -114.58 124.63 52.34 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 120.294 -1.504 . . . . 0.0 111.558 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.6 p -112.07 164.4 15.31 Favored Pre-proline 0 C--N 1.366 1.292 0 C-N-CA 129.045 2.938 . . . . 0.0 114.438 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -47.08 141.01 13.17 Favored 'Trans proline' 0 C--N 1.376 2.005 1 C-N-CA 127.743 5.628 . . . . 0.0 121.147 -169.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.43 -23.3 32.01 Favored Glycine 0 C--N 1.367 2.267 0 C-N-CA 125.636 1.588 . . . . 0.0 112.838 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.05 169.94 13.45 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 120.814 2.307 . . . . 0.0 112.644 -177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.84 141.38 29.36 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 166.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.5 163.4 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -110.34 128.27 55.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 101.288 -3.597 . . . . 0.0 101.288 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.28 137.74 51.05 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 122.848 1.309 . . . . 0.0 111.698 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -110.57 136.41 49.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 171.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 42.7 ttm -119.8 138.32 53.43 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.32 102.14 0.37 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 125.721 1.608 . . . . 0.0 113.98 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.17 -12.6 24.07 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 125.538 1.542 . . . . 0.0 112.757 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -103.18 164.17 16.04 Favored Pre-proline 0 C--N 1.354 0.792 0 C-N-CA 125.639 1.575 . . . . 0.0 109.418 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -71.64 166.36 29.68 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.371 3.381 . . . . 0.0 113.634 162.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -57.69 122.37 12.64 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 130.683 3.593 . . . . 0.0 114.825 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -126.48 112.17 23.17 Favored Pre-proline 0 N--CA 1.427 -1.602 0 N-CA-C 119.888 3.292 . . . . 0.0 119.888 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -59.03 112.24 1.15 Allowed 'Trans proline' 0 C--N 1.383 2.387 1 C-N-CA 125.813 4.342 . . . . 0.0 110.573 162.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.2 t -122.57 165.5 16.33 Favored 'General case' 0 N--CA 1.445 -0.72 1 C-N-CA 133.475 4.71 . . . . 0.0 111.346 -161.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tt -124.05 132.31 53.66 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.251 3.3 p -81.84 127.28 39.74 Favored 'Isoleucine or valine' 0 C--N 1.377 1.8 0 CA-C-N 121.145 1.793 . . . . 0.0 107.385 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -132.05 152.86 50.93 Favored 'General case' 0 C--N 1.366 1.322 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 -161.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.5 113.46 27.05 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 127.698 2.399 . . . . 0.0 109.525 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 115' ' ' PHE . 34.8 m-70 -71.54 161.72 76.97 Favored Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 129.292 3.037 . . . . 0.0 114.342 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.1 -8.22 0.17 Allowed 'Trans proline' 0 CA--C 1.569 2.241 1 C-N-CA 125.605 4.203 . . . . 0.0 117.593 170.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CZ ' ' CD2' ' A' ' 113' ' ' HIS . 0.6 OUTLIER -104.11 44.69 1.0 Allowed 'General case' 0 C--N 1.365 1.252 0 C-N-CA 131.518 3.927 . . . . 0.0 107.565 167.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.6 149.18 38.32 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 119.207 3.04 . . . . 0.0 119.207 -170.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.75 -19.91 27.69 Favored Glycine 0 C--N 1.362 2.025 0 CA-C-N 112.757 -2.019 . . . . 0.0 109.541 165.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 t -118.03 119.39 34.64 Favored 'General case' 0 N--CA 1.435 -1.224 1 N-CA-C 98.161 -4.755 . . . . 0.0 98.161 168.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.473 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 27.2 p90 -140.31 -0.6 1.6 Allowed 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 120.82 -1.175 . . . . 0.0 111.357 -174.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.0 pt -119.84 147.86 23.24 Favored 'Isoleucine or valine' 0 C--N 1.366 1.321 0 CA-C-O 123.467 1.603 . . . . 0.0 115.133 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.87 118.36 31.35 Favored 'General case' 0 C--N 1.357 0.934 1 N-CA-C 99.13 -4.396 . . . . 0.0 99.13 169.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -105.6 -179.66 4.0 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -165.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -46.78 119.69 2.61 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 128.848 2.859 . . . . 0.0 116.985 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.51 -54.92 0.24 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 105.091 -3.204 . . . . 0.0 105.091 -173.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -109.86 -47.6 3.32 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.459 1.504 . . . . 0.0 109.886 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 m -179.51 169.77 1.37 Allowed 'General case' 0 CA--C 1.472 -2.056 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.4 106.87 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -114.98 130.31 56.9 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 127.811 2.445 . . . . 0.0 110.676 -176.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.7 m -130.36 161.91 39.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.473 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 0.6 OUTLIER -92.64 138.52 31.42 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 123.944 0.898 . . . . 0.0 110.897 174.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 5.2 m -150.58 168.71 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.472 -2.033 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.39 152.55 40.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 123.828 0.851 . . . . 0.0 109.599 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -108.09 125.78 51.98 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -67.47 65.34 0.08 Allowed 'General case' 0 C--N 1.369 1.438 0 C-N-CA 126.615 1.966 . . . . 0.0 115.08 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.37 -119.36 0.08 Allowed 'General case' 0 C--N 1.36 1.025 0 O-C-N 119.397 -2.064 . . . . 0.0 110.045 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -106.71 -49.07 3.38 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.627 1.571 . . . . 0.0 112.597 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.274 11.2 t -70.12 -51.39 14.22 Favored Pre-proline 0 C--N 1.363 1.156 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.06 -179.16 26.15 Favored 'Cis proline' 0 CA--C 1.543 0.952 0 CA-C-N 125.944 3.158 . . . . 0.0 113.722 1.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 54.0 m -95.03 127.17 40.88 Favored 'General case' 0 C--N 1.369 1.424 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 131' ' ' VAL . 24.1 ttp-105 -153.61 157.47 39.72 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 119.976 1.262 . . . . 0.0 109.876 -173.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.14 -159.28 25.5 Favored Glycine 0 CA--C 1.492 -1.401 0 N-CA-C 104.901 -3.28 . . . . 0.0 104.901 171.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -83.15 113.55 20.72 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 126.172 1.789 . . . . 0.0 109.15 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.44 178.36 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 125.118 1.367 . . . . 0.0 110.987 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.2 m -99.82 121.18 40.91 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 100.462 -3.903 . . . . 0.0 100.462 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.419 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 26.7 ttpt -73.34 -10.99 60.33 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -170.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -72.58 -13.42 61.39 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.49 2.316 . . . . 0.0 113.738 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.7 mt -103.0 7.61 39.05 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 126.634 1.974 . . . . 0.0 111.404 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 12.4 mt -96.31 125.41 40.79 Favored 'General case' 0 C--N 1.379 1.874 0 CA-C-N 119.891 1.223 . . . . 0.0 108.431 174.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -114.44 159.13 37.99 Favored Pre-proline 0 C--O 1.221 -0.434 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.03 155.72 14.99 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 CA-C-N 124.904 2.787 . . . . 0.0 114.642 -172.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.362 0.0 OUTLIER -30.91 -95.34 0.0 OUTLIER 'General case' 0 C--N 1.357 0.922 2 C-N-CA 132.273 4.229 . . . . 0.0 122.092 -177.927 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.4 t -0.38 54.95 0.0 OUTLIER 'General case' 0 C--N 1.381 1.942 1 C-N-CA 136.511 5.924 . . . . 0.0 118.194 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.689 ' H ' HD13 ' A' ' 183' ' ' LEU . . . -81.07 -91.75 0.52 Allowed Glycine 0 CA--C 1.485 -1.782 0 N-CA-C 121.603 3.401 . . . . 0.0 121.603 -150.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.6 m -46.1 -23.45 0.32 Allowed 'General case' 0 C--N 1.374 1.669 0 C-N-CA 129.182 2.993 . . . . 0.0 119.003 -172.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -18.17 50.41 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 130.519 3.528 . . . . 0.0 113.039 175.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.0 t -80.5 150.78 29.53 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 127.754 2.422 . . . . 0.0 112.454 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -65.05 -21.39 66.82 Favored 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.985 1.714 . . . . 0.0 111.787 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.422 ' HG2' ' CD2' ' A' ' 164' ' ' HIS . 41.9 mt-10 -72.49 -23.03 60.97 Favored 'General case' 0 C--N 1.373 1.607 0 C-N-CA 126.315 1.846 . . . . 0.0 112.481 170.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -105.93 11.98 31.11 Favored 'General case' 0 C--N 1.361 1.088 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -128.0 -179.53 5.02 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.541 1.537 . . . . 0.0 107.712 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.65 122.69 11.94 Favored 'General case' 0 C--N 1.37 1.49 0 C-N-CA 127.731 2.412 . . . . 0.0 114.628 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.8 -10.04 64.21 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 124.397 0.999 . . . . 0.0 112.4 -168.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.8 146.31 25.53 Favored Glycine 0 C--N 1.365 2.145 0 N-CA-C 118.569 2.187 . . . . 0.0 118.569 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.422 ' CD2' ' HG2' ' A' ' 158' ' ' GLU . 5.7 m-70 -59.81 -22.32 62.06 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 119.71 3.226 . . . . 0.0 119.71 -175.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.55 -3.52 15.93 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.297 -1.502 . . . . 0.0 111.48 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -86.9 91.56 8.71 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 -166.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.2 m -118.86 104.91 10.99 Favored 'General case' 0 CA--C 1.504 -0.81 1 N-CA-C 99.559 -4.238 . . . . 0.0 99.559 167.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.27 101.42 14.13 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-O 125.096 2.379 . . . . 0.0 112.189 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -119.36 144.82 37.25 Favored Pre-proline 0 N--CA 1.432 -1.332 0 C-N-CA 130.241 3.416 . . . . 0.0 103.801 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -51.32 -31.82 39.17 Favored 'Trans proline' 0 CA--C 1.54 0.784 1 C-N-CA 127.166 5.244 . . . . 0.0 116.593 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.9 -36.95 75.81 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 127.997 2.519 . . . . 0.0 112.896 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.0 mt -79.05 -33.65 16.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.482 0 C-N-CA 127.163 2.185 . . . . 0.0 109.878 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . 0.266 28.1 mt -61.98 -53.26 58.16 Favored 'General case' 0 C--N 1.392 2.45 0 C-N-CA 128.356 2.662 . . . . 0.0 110.367 170.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -57.41 -50.77 71.92 Favored 'General case' 0 CA--C 1.478 -1.802 0 C-N-CA 128.969 2.908 . . . . 0.0 112.684 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.62 73.33 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 130.988 3.715 . . . . 0.0 113.077 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 57.1 mtt -69.07 -39.18 79.23 Favored 'General case' 0 C--N 1.375 1.681 0 C-N-CA 125.563 1.545 . . . . 0.0 111.655 168.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -74.2 -42.33 59.98 Favored 'General case' 0 C--N 1.374 1.639 0 CA-C-N 120.756 1.616 . . . . 0.0 113.578 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.19 -53.24 56.36 Favored 'General case' 0 C--N 1.375 1.7 1 C-N-CA 132.819 4.448 . . . . 0.0 110.123 174.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.45 -51.57 68.9 Favored 'General case' 0 C--N 1.38 1.9 0 CA-C-O 116.815 -1.564 . . . . 0.0 112.496 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.05 -51.14 62.72 Favored 'General case' 0 C--N 1.38 1.906 0 C-N-CA 126.419 1.887 . . . . 0.0 114.352 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -55.02 -43.11 73.37 Favored 'General case' 0 C--N 1.37 1.462 0 CA-C-N 121.207 1.821 . . . . 0.0 114.993 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.13 -41.05 51.31 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.689 HD13 ' H ' ' A' ' 153' ' ' GLY 0.25 0.5 OUTLIER -61.65 -45.61 93.32 Favored 'General case' 0 C--N 1.359 1.021 1 C-N-CA 132.923 4.489 . . . . 0.0 114.663 175.247 . . . . . . . . 5 4 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -28.58 29.35 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 126.64 1.976 . . . . 0.0 111.768 -176.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -105.52 -99.82 0.33 Allowed 'General case' 0 C--N 1.359 0.986 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.477 ' HB2' ' HZ1' ' A' ' 189' ' ' LYS . 22.3 m-20 -135.56 154.01 51.5 Favored 'General case' 0 C--N 1.36 1.065 0 O-C-N 120.822 -1.174 . . . . 0.0 112.2 -174.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.395 18.0 ttpt -51.51 -37.16 47.94 Favored 'General case' 0 C--N 1.369 1.45 0 C-N-CA 130.217 3.407 . . . . 0.0 117.24 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.9 tp -57.08 -28.39 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 128.915 2.886 . . . . 0.0 112.906 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.477 ' HZ1' ' HB2' ' A' ' 186' ' ' ASP 0.252 4.1 mptt -70.19 -45.82 65.86 Favored 'General case' 0 C--N 1.372 1.575 0 O-C-N 119.773 -1.829 . . . . 0.0 113.387 174.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.291 0.0 OUTLIER -75.27 -40.19 59.01 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 119.03 -2.294 . . . . 0.0 116.804 171.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.5 tp -80.83 -20.6 42.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -170.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -82.85 -22.79 33.96 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 124.107 0.963 . . . . 0.0 112.477 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.16 23.24 13.97 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 130.132 3.373 . . . . 0.0 109.984 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.82 -103.96 0.0 OUTLIER 'General case' 0 C--N 1.367 1.356 0 C-N-CA 131.268 3.827 . . . . 0.0 117.035 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.301 2.7 m . . . . . 0 C--N 1.35 0.615 0 CA-C-O 124.225 1.964 . . . . 0.0 107.491 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.465 ' HA ' ' CE2' ' A' ' 90' ' ' PHE 0.415 62.9 m . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -136.68 77.88 1.67 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 127.243 2.217 . . . . 0.0 109.38 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 62.1 m-85 -123.49 125.21 44.49 Favored 'General case' 0 C--N 1.355 0.837 0 O-C-N 120.336 -1.477 . . . . 0.0 112.719 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.391 88.6 p -112.01 170.51 5.19 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 131.329 3.852 . . . . 0.0 114.834 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -41.72 129.31 3.88 Favored 'Trans proline' 0 C--N 1.382 2.314 1 C-N-CA 128.177 5.918 . . . . 0.0 119.774 -177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.12 0.12 74.69 Favored Glycine 0 C--N 1.366 2.198 0 C-N-CA 127.797 2.618 . . . . 0.0 114.421 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -94.01 154.71 17.5 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 166.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.39 153.55 24.8 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 175.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.3 m -142.48 170.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 123.686 1.708 . . . . 0.0 107.25 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -114.78 116.03 27.97 Favored 'General case' 0 N--CA 1.438 -1.069 1 N-CA-C 99.924 -4.102 . . . . 0.0 99.924 174.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.0 127.96 53.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 122.32 2.327 . . . . 0.0 111.776 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -96.36 143.18 27.65 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.1 ttt -128.63 151.01 49.98 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 118.596 -2.565 . . . . 0.0 108.218 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -74.41 95.77 2.77 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 126.729 2.011 . . . . 0.0 113.544 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.13 -4.44 25.4 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 124.58 1.086 . . . . 0.0 113.042 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -117.08 164.92 16.92 Favored Pre-proline 0 C--N 1.357 0.898 0 CA-C-N 118.723 1.262 . . . . 0.0 108.364 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -71.58 167.37 26.63 Favored 'Trans proline' 0 C--N 1.353 0.783 1 C-N-CA 125.506 4.137 . . . . 0.0 114.413 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -53.79 115.31 1.93 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 128.086 2.554 . . . . 0.0 115.943 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -116.32 117.83 38.24 Favored Pre-proline 0 N--CA 1.415 -2.214 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -56.82 134.07 62.09 Favored 'Trans proline' 0 CA--C 1.561 1.866 1 C-N-CA 125.888 4.392 . . . . 0.0 111.848 160.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 m -147.69 165.39 30.61 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.125 2.17 . . . . 0.0 111.851 -160.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 6.2 tt -124.03 129.0 50.17 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.658 1.583 . . . . 0.0 113.996 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.02 121.81 44.02 Favored 'Isoleucine or valine' 0 C--N 1.372 1.571 0 O-C-N 120.836 -1.165 . . . . 0.0 110.724 171.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.93 153.9 51.45 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 127.26 2.224 . . . . 0.0 109.052 -170.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 9.2 p-10 -71.13 112.7 7.48 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-N 120.734 1.606 . . . . 0.0 113.533 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 14.4 t60 -77.47 158.38 79.02 Favored Pre-proline 0 C--N 1.346 0.455 0 CA-C-O 114.55 -2.643 . . . . 0.0 110.373 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HD2' ' CD2' ' A' ' 113' ' ' HIS . 91.1 Cg_exo -55.38 -1.1 0.18 Allowed 'Trans proline' 0 CA--C 1.544 1.016 1 C-N-CA 125.884 4.389 . . . . 0.0 120.242 -170.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -95.31 -7.34 39.0 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 128.994 2.918 . . . . 0.0 110.381 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 112' ' ' ASN 0.267 0.0 OUTLIER 9.52 94.87 0.0 OUTLIER 'General case' 0 C--N 1.376 1.753 1 C-N-CA 135.939 5.696 . . . . 0.0 120.213 -178.704 . . . . . . . . 5 4 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 110.27 -17.42 29.01 Favored Glycine 0 C--N 1.36 1.887 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -172.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.4 m -103.78 120.13 40.34 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 100.384 -3.932 . . . . 0.0 100.384 170.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.407 ' HA ' ' HE1' ' A' ' 130' ' ' HIS . 1.4 t80 -142.22 -26.8 0.64 Allowed 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -167.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.5 pt -112.3 155.83 13.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-O 123.029 1.395 . . . . 0.0 111.847 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -141.35 149.8 41.63 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 128.034 2.534 . . . . 0.0 104.296 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -150.43 142.51 24.03 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 120.319 -1.488 . . . . 0.0 111.105 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -118.17 93.64 4.21 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 128.044 2.538 . . . . 0.0 110.418 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.65 -67.63 0.17 Allowed Glycine 0 C--N 1.361 1.949 0 N-CA-C 120.979 3.152 . . . . 0.0 120.979 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -144.38 46.1 1.41 Allowed 'General case' 0 C--N 1.354 0.771 0 CA-C-O 122.232 1.015 . . . . 0.0 112.343 -173.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.5 m -171.5 159.04 5.41 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.24 140.28 40.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 120.933 -1.104 . . . . 0.0 109.88 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -116.77 160.2 21.15 Favored 'General case' 0 C--N 1.366 1.308 0 C-N-CA 128.058 2.543 . . . . 0.0 112.906 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.9 m -148.57 164.77 4.79 Favored 'Isoleucine or valine' 0 C--N 1.37 1.487 0 C-N-CA 128.1 2.56 . . . . 0.0 107.058 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -91.55 116.94 29.27 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 122.395 1.093 . . . . 0.0 111.424 169.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.82 158.78 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 N-CA-C 104.702 -2.332 . . . . 0.0 104.702 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -125.73 138.33 53.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 172.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.96 129.7 40.33 Favored 'General case' 0 C--N 1.36 1.058 0 C-N-CA 128.013 2.525 . . . . 0.0 107.864 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 14.1 m-30 -75.85 63.3 1.67 Allowed 'General case' 0 C--N 1.363 1.172 0 C-N-CA 125.829 1.652 . . . . 0.0 113.723 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.332 50.6 p-10 -98.14 -110.32 0.17 Allowed 'General case' 0 C--N 1.358 0.974 0 O-C-N 120.179 -1.576 . . . . 0.0 113.111 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -106.45 -54.95 2.4 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 125.621 1.568 . . . . 0.0 112.642 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.256 0.9 OUTLIER -64.15 -49.34 74.07 Favored Pre-proline 0 C--N 1.365 1.269 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -174.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.12 171.78 54.0 Favored 'Cis proline' 0 CA--C 1.547 1.167 0 CA-C-N 125.98 3.171 . . . . 0.0 111.543 -5.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.327 7.5 t -95.54 154.63 17.11 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 120.392 -1.443 . . . . 0.0 111.849 -176.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -148.85 152.25 36.14 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 125.133 1.373 . . . . 0.0 109.566 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -178.42 -177.5 47.14 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 107.279 -2.329 . . . . 0.0 107.279 168.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -82.78 106.26 14.47 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.456 1.902 . . . . 0.0 107.415 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.6 m -94.41 159.82 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.442 0 C-N-CA 127.577 2.351 . . . . 0.0 109.063 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.4 m -85.59 110.34 19.18 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.429 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 30.6 ttpt -64.51 -25.57 68.05 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -167.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.62 -12.35 57.62 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 127.285 2.234 . . . . 0.0 114.984 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . 0.31 0.2 OUTLIER -104.82 8.53 34.86 Favored 'General case' 0 C--N 1.37 1.464 0 O-C-N 119.107 -2.246 . . . . 0.0 112.402 174.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.429 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 14.4 mt -95.3 127.75 41.6 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 128.122 2.569 . . . . 0.0 108.339 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -114.19 165.37 13.84 Favored Pre-proline 0 C--N 1.357 0.901 0 O-C-N 118.894 -2.379 . . . . 0.0 105.866 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.43 151.97 13.57 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 124.924 3.75 . . . . 0.0 115.689 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.403 ' CE2' ' HA2' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -93.01 167.68 11.63 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 122.834 1.302 . . . . 0.0 113.373 175.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 178.9 -60.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.936 2 N-CA-C 95.073 -5.899 . . . . 0.0 95.073 -174.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.403 ' HA2' ' CE2' ' A' ' 151' ' ' TYR . . . 127.03 -125.52 5.35 Favored Glycine 0 CA--C 1.474 -2.521 0 O-C-N 121.186 -0.946 . . . . 0.0 113.481 151.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 m -59.15 -15.73 16.18 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -96.47 4.95 51.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 129.709 3.204 . . . . 0.0 111.651 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 18.1 t -89.7 139.94 30.07 Favored 'General case' 0 C--N 1.372 1.567 0 C-N-CA 126.658 1.983 . . . . 0.0 108.597 173.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.65 -27.38 68.63 Favored 'General case' 0 C--N 1.369 1.413 0 C-N-CA 125.827 1.651 . . . . 0.0 113.948 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -78.59 -10.22 59.65 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 119.672 -1.892 . . . . 0.0 112.293 171.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -104.13 17.06 24.88 Favored 'General case' 0 C--N 1.375 1.682 0 C-N-CA 125.343 1.457 . . . . 0.0 114.155 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -132.27 174.54 10.12 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.319 1.447 . . . . 0.0 109.003 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -60.36 122.17 13.89 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 126.164 1.786 . . . . 0.0 113.996 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.08 -12.7 57.44 Favored Glycine 0 C--N 1.358 1.781 0 C-N-CA 124.803 1.192 . . . . 0.0 112.53 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.4 151.18 24.16 Favored Glycine 0 C--N 1.363 2.042 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -63.23 -38.87 92.87 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -87.74 -22.03 24.82 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.182 0.993 . . . . 0.0 112.308 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -75.87 91.65 3.02 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 126.635 1.974 . . . . 0.0 114.367 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 70.7 m -119.21 107.69 13.75 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 100.487 -3.894 . . . . 0.0 100.487 170.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.46 101.44 13.92 Favored 'General case' 0 C--N 1.366 1.293 0 CA-C-O 126.535 3.064 . . . . 0.0 114.312 -167.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -120.31 139.69 28.97 Favored Pre-proline 0 N--CA 1.412 -2.344 1 C-N-CA 133.139 4.575 . . . . 0.0 101.353 169.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.63 -32.19 82.38 Favored 'Trans proline' 0 CA--C 1.545 1.066 1 C-N-CA 126.462 4.775 . . . . 0.0 115.694 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -66.11 -35.91 81.76 Favored 'General case' 0 C--N 1.365 1.268 0 C-N-CA 127.578 2.351 . . . . 0.0 113.125 174.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 19.2 mm -68.25 -39.17 80.69 Favored 'Isoleucine or valine' 0 C--N 1.378 1.827 0 C-N-CA 126.279 1.832 . . . . 0.0 110.909 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 20.2 mt -68.9 -51.35 40.97 Favored 'General case' 0 C--N 1.367 1.355 0 C-N-CA 126.162 1.785 . . . . 0.0 113.163 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -61.02 -35.32 76.55 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 127.191 2.197 . . . . 0.0 114.596 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.36 -34.99 75.41 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 130.717 3.607 . . . . 0.0 109.396 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.5 mtt -69.31 -35.37 75.89 Favored 'General case' 0 C--N 1.38 1.924 0 CA-C-N 120.994 1.725 . . . . 0.0 114.017 163.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -66.74 -47.95 70.69 Favored 'General case' 0 C--N 1.372 1.572 0 C-N-CA 125.76 1.624 . . . . 0.0 111.461 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -68.96 -53.05 22.89 Favored 'General case' 0 C--N 1.37 1.472 0 C-N-CA 127.3 2.24 . . . . 0.0 113.026 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.25 -33.13 74.01 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.46 -44.0 75.8 Favored 'General case' 0 C--N 1.375 1.691 0 C-N-CA 127.067 2.147 . . . . 0.0 109.861 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -36.87 83.37 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -69.43 -35.09 75.35 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -81.41 -36.8 29.05 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 119.943 -1.723 . . . . 0.0 114.63 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -87.17 -25.64 23.97 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 126.833 2.053 . . . . 0.0 112.878 -172.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -100.87 -95.15 0.27 Allowed 'General case' 0 C--N 1.367 1.35 0 O-C-N 121.091 -1.006 . . . . 0.0 109.007 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.0 145.01 45.65 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.047 -1.033 . . . . 0.0 109.399 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.521 ' HB3' HH11 ' A' ' 190' ' ' ARG . 93.5 mttt -51.39 -34.71 35.58 Favored 'General case' 0 C--N 1.365 1.257 1 C-N-CA 132.379 4.271 . . . . 0.0 113.881 173.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.5 tt -50.61 -27.81 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 131.001 3.72 . . . . 0.0 112.593 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.257 2.3 mptp? -73.82 -29.97 62.45 Favored 'General case' 0 C--N 1.377 1.786 0 C-N-CA 126.895 2.078 . . . . 0.0 114.728 169.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.521 HH11 ' HB3' ' A' ' 187' ' ' LYS 0.266 0.0 OUTLIER -75.03 -43.25 54.66 Favored 'General case' 0 C--N 1.371 1.518 0 O-C-N 119.278 -2.139 . . . . 0.0 113.168 171.161 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.288 63.2 mt -75.33 -18.87 59.9 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 126.631 1.972 . . . . 0.0 114.488 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -58.12 -38.92 77.43 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 127.699 2.4 . . . . 0.0 113.063 168.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -94.41 -51.07 4.94 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 126.963 2.105 . . . . 0.0 109.159 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 63.55 -83.38 0.02 OUTLIER 'General case' 0 C--N 1.372 1.585 1 C-N-CA 131.91 4.084 . . . . 0.0 114.353 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.435 -1.203 0 C-N-CA 130.841 3.656 . . . . 0.0 101.414 171.029 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.359 87.0 p . . . . . 0 C--O 1.223 -0.335 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -101.41 108.03 19.52 Favored 'General case' 0 C--N 1.361 1.105 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -123.61 126.99 47.63 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 126.02 1.728 . . . . 0.0 111.387 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.4 p -113.12 168.65 7.41 Favored Pre-proline 0 C--N 1.357 0.924 0 C-N-CA 128.864 2.865 . . . . 0.0 117.504 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -44.11 127.26 6.82 Favored 'Trans proline' 0 C--N 1.395 3.003 1 C-N-CA 127.628 5.552 . . . . 0.0 116.15 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.24 57.44 Favored Glycine 0 CA--C 1.482 -1.994 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.045 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -95.35 161.19 14.19 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 122.867 1.318 . . . . 0.0 108.263 169.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.79 135.46 50.67 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 101.253 -3.61 . . . . 0.0 101.253 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 148' ' ' LEU . 1.3 t -129.07 159.01 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -106.93 120.3 41.68 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 162.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.79 143.93 33.24 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 120.635 1.561 . . . . 0.0 109.37 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -115.51 134.9 54.63 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 118.982 -2.324 . . . . 0.0 105.471 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 ttp -128.91 146.45 50.95 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 119.343 -2.098 . . . . 0.0 109.141 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.59 98.88 0.72 Allowed 'General case' 0 C--N 1.365 1.27 0 C-N-CA 127.072 2.149 . . . . 0.0 113.754 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.23 -9.71 24.64 Favored Glycine 0 C--N 1.359 1.833 0 C-N-CA 125.426 1.488 . . . . 0.0 111.935 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -104.97 158.79 31.27 Favored Pre-proline 0 C--N 1.356 0.879 0 C-N-CA 125.678 1.591 . . . . 0.0 109.019 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.83 166.64 28.9 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.368 3.378 . . . . 0.0 112.034 161.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -56.13 115.02 2.2 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 129.86 3.264 . . . . 0.0 112.408 171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.446 ' CE3' ' HA ' ' A' ' 106' ' ' TRP . 2.1 m95 -114.69 108.18 49.57 Favored Pre-proline 0 N--CA 1.434 -1.244 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -173.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.28 106.21 0.18 Allowed 'Trans proline' 0 C--N 1.397 3.116 1 C-N-CA 125.854 4.37 . . . . 0.0 109.984 161.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 m -114.64 164.11 14.49 Favored 'General case' 0 CA--C 1.492 -1.287 1 C-N-CA 132.313 4.245 . . . . 0.0 113.21 -164.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.798 HD13 ' HE ' ' A' ' 190' ' ' ARG . 5.2 tp -123.87 127.66 48.34 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 111.6 -2.545 . . . . 0.0 105.363 173.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -91.33 118.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 166.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -121.18 152.58 38.61 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 124.498 1.119 . . . . 0.0 112.037 -169.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -89.61 111.34 22.25 Favored 'General case' 0 C--N 1.373 1.621 0 CA-C-O 123.342 1.544 . . . . 0.0 108.29 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -100.81 158.7 31.35 Favored Pre-proline 0 N--CA 1.451 -0.399 0 C-N-CA 129.705 3.202 . . . . 0.0 109.343 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -49.95 -0.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 2 C-N-CA 127.569 5.512 . . . . 0.0 122.845 -164.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.6 -0.13 35.34 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 126.792 2.037 . . . . 0.0 108.533 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.269 0.3 OUTLIER -20.36 119.33 0.03 OUTLIER 'General case' 0 C--N 1.376 1.718 2 C-N-CA 134.634 5.174 . . . . 0.0 122.068 -177.913 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.38 -20.96 27.22 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.5 p -120.72 117.94 28.78 Favored 'General case' 0 C--N 1.352 0.704 1 N-CA-C 98.101 -4.777 . . . . 0.0 98.101 164.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -141.94 2.39 1.54 Allowed 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 120.546 -1.346 . . . . 0.0 112.857 -167.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.9 pt -107.93 163.02 5.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 CA-C-O 122.696 1.236 . . . . 0.0 111.724 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -150.62 147.73 27.76 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 103.309 -2.848 . . . . 0.0 103.309 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -144.22 134.31 24.16 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 120.771 1.623 . . . . 0.0 111.926 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -117.46 93.18 4.07 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.689 2.396 . . . . 0.0 107.434 174.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.57 -92.46 0.08 OUTLIER Glycine 0 C--N 1.361 1.921 0 C-N-CA 126.555 2.026 . . . . 0.0 118.051 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -123.21 20.09 9.81 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 125.812 1.645 . . . . 0.0 109.12 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.6 t -118.41 108.69 15.35 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -111.2 135.1 51.42 Favored 'Isoleucine or valine' 0 C--N 1.357 0.898 0 C-N-CA 124.688 1.195 . . . . 0.0 108.686 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 73.4 mtt-85 -123.16 151.17 42.42 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 126.419 1.888 . . . . 0.0 112.588 -175.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.28 163.01 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 128.227 2.611 . . . . 0.0 107.282 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -93.18 121.75 34.86 Favored 'General case' 0 C--N 1.369 1.449 0 O-C-N 119.731 -1.855 . . . . 0.0 111.579 171.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.97 176.64 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.553 0 C-N-CA 126.585 1.954 . . . . 0.0 108.326 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -134.26 152.43 51.81 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.964 0.888 . . . . 0.0 109.495 166.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -106.74 115.59 30.46 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 126.642 1.977 . . . . 0.0 106.069 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -66.8 55.97 0.04 OUTLIER 'General case' 0 C--N 1.367 1.347 0 C-N-CA 127.847 2.459 . . . . 0.0 116.022 -175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.438 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP 0.303 52.7 p-10 -84.79 -102.16 0.05 Allowed 'General case' 0 C--N 1.367 1.367 0 C-N-CA 127.039 2.136 . . . . 0.0 113.17 -176.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -106.47 -58.3 1.94 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.275 1.83 . . . . 0.0 115.121 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.0 t -75.78 -41.77 3.56 Favored Pre-proline 0 C--N 1.366 1.295 0 CA-C-O 114.037 -2.887 . . . . 0.0 117.951 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.7 -177.94 22.45 Favored 'Cis proline' 0 CA--C 1.55 1.279 0 CA-C-N 127.083 3.566 . . . . 0.0 113.379 -2.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.3 t -95.35 142.37 27.81 Favored 'General case' 0 C--N 1.368 1.389 0 O-C-N 118.762 -2.461 . . . . 0.0 108.764 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -142.01 149.33 39.88 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.5 -170.61 37.89 Favored Glycine 0 CA--C 1.488 -1.649 1 N-CA-C 102.201 -4.36 . . . . 0.0 102.201 172.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -89.75 119.81 30.47 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 125.33 1.452 . . . . 0.0 109.371 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.8 m -99.27 160.38 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 C-N-CA 125.621 1.569 . . . . 0.0 111.152 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 41.0 t -70.92 106.12 3.52 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 127.568 2.347 . . . . 0.0 107.335 168.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.436 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 7.5 ttpp -68.95 -29.33 67.55 Favored 'General case' 0 C--N 1.365 1.258 0 CA-C-O 122.777 1.275 . . . . 0.0 112.306 -175.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -67.48 -14.75 63.21 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.681 1.593 . . . . 0.0 114.646 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.6 mt -100.18 18.38 18.84 Favored 'General case' 0 C--N 1.367 1.337 0 C-N-CA 125.9 1.68 . . . . 0.0 111.485 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.436 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 37.2 mt -102.36 131.08 49.21 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.748 -1.22 . . . . 0.0 110.473 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -115.39 156.73 45.45 Favored Pre-proline 0 C--O 1.222 -0.361 0 CA-C-O 116.711 -1.614 . . . . 0.0 107.259 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.69 150.59 14.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 125.223 3.949 . . . . 0.0 113.425 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -120.29 120.0 34.79 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-O 122.42 1.105 . . . . 0.0 112.822 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.0 t -154.49 22.2 0.47 Allowed 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.672 1.589 . . . . 0.0 106.95 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.59 56.1 0.36 Allowed Glycine 0 C--N 1.36 1.888 0 N-CA-C 120.184 2.834 . . . . 0.0 120.184 -158.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.7 m -65.77 -17.72 64.82 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 130.423 3.489 . . . . 0.0 113.978 171.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -107.04 15.59 25.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 129.466 3.106 . . . . 0.0 110.425 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . 0.337 97.2 p -126.17 153.31 44.8 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 124.186 0.994 . . . . 0.0 113.311 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.535 1.4 pttm -47.06 -16.33 0.04 OUTLIER 'General case' 0 C--N 1.369 1.426 0 N-CA-C 121.348 3.833 . . . . 0.0 121.348 -168.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -96.14 -6.21 38.89 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 117.02 -1.467 . . . . 0.0 114.057 167.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.09 18.78 10.81 Favored 'General case' 0 C--N 1.381 1.953 0 CA-C-N 122.588 2.449 . . . . 0.0 116.621 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.75 -173.04 2.97 Favored 'General case' 0 N--CA 1.45 -0.431 1 C-N-CA 132.006 4.123 . . . . 0.0 109.535 -176.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -70.96 122.59 20.26 Favored 'General case' 0 C--N 1.361 1.1 0 O-C-N 119.588 -1.945 . . . . 0.0 113.014 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 98.91 -5.79 59.85 Favored Glycine 0 C--N 1.363 2.052 0 C-N-CA 126.156 1.836 . . . . 0.0 112.158 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -80.67 148.24 28.86 Favored Glycine 0 C--N 1.364 2.1 0 C-N-CA 129.095 3.236 . . . . 0.0 117.225 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -59.87 -33.61 72.04 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -102.52 -5.76 23.63 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 120.494 1.497 . . . . 0.0 113.068 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -88.87 148.6 23.78 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 -170.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.0 m -163.67 151.42 12.86 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 101.342 -3.577 . . . . 0.0 101.342 172.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -112.09 100.12 8.61 Favored 'General case' 0 C--N 1.372 1.56 0 CA-C-O 126.003 2.811 . . . . 0.0 111.032 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -120.55 141.63 32.54 Favored Pre-proline 0 N--CA 1.424 -1.756 2 C-N-CA 132.921 4.488 . . . . 0.0 99.522 168.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.91 -26.05 67.04 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.228 3.286 . . . . 0.0 114.171 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -69.82 -35.66 74.97 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 129.491 3.117 . . . . 0.0 114.017 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.3 mm -69.88 -43.18 79.83 Favored 'Isoleucine or valine' 0 C--N 1.379 1.874 0 C-N-CA 127.109 2.164 . . . . 0.0 109.175 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.7 mt -68.94 -45.18 71.44 Favored 'General case' 0 C--N 1.373 1.593 0 C-N-CA 124.458 1.103 . . . . 0.0 113.748 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -57.95 -34.58 70.06 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 126.474 1.91 . . . . 0.0 114.88 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.58 -48.5 69.39 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 130.854 3.662 . . . . 0.0 111.086 169.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 10.6 mtt -60.6 -39.6 88.74 Favored 'General case' 0 C--N 1.375 1.708 0 CA-C-N 120.558 1.526 . . . . 0.0 115.002 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.5 -52.14 35.5 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 128.052 2.541 . . . . 0.0 112.743 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -72.54 -34.84 67.81 Favored 'General case' 0 C--N 1.381 1.935 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 178.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.02 84.07 Favored 'General case' 0 C--N 1.371 1.517 0 C-N-CA 124.675 1.19 . . . . 0.0 112.615 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.14 -47.46 86.14 Favored 'General case' 0 C--N 1.378 1.819 0 C-N-CA 125.947 1.699 . . . . 0.0 112.763 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -33.84 76.63 Favored 'General case' 0 C--N 1.369 1.454 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -74.56 -28.77 61.09 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.9 -46.96 19.85 Favored 'General case' 0 CA--C 1.499 -1.01 1 C-N-CA 132.23 4.212 . . . . 0.0 114.105 178.266 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.259 0.0 OUTLIER -89.51 -8.52 52.65 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 125.125 1.37 . . . . 0.0 111.441 -174.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -126.17 -103.63 0.35 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 122.799 0.44 . . . . 0.0 111.342 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -136.27 161.3 36.16 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-O 123.51 1.624 . . . . 0.0 112.581 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -51.07 -36.19 38.7 Favored 'General case' 0 C--N 1.358 0.951 1 C-N-CA 136.319 5.847 . . . . 0.0 113.391 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 7.4 tt -55.04 -30.01 23.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 127.937 2.495 . . . . 0.0 113.215 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -74.6 -40.77 61.38 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.798 ' HE ' HD13 ' A' ' 109' ' ' LEU 0.266 5.2 ptm180 -74.44 -33.23 62.88 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 175.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.2 mt -82.3 -19.5 39.31 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.949 -1.094 . . . . 0.0 112.1 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -53.45 -43.87 68.44 Favored 'General case' 0 C--N 1.37 1.467 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -31.96 11.0 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 126.122 1.769 . . . . 0.0 109.974 175.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 41.03 -119.14 0.39 Allowed 'General case' 0 C--N 1.377 1.769 0 C-N-CA 130.903 3.681 . . . . 0.0 114.784 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.827 0 O-C-N 120.035 -1.666 . . . . 0.0 112.505 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.344 80.4 p . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -154.38 94.18 1.68 Allowed 'General case' 0 C--N 1.361 1.104 0 CA-C-O 122.551 1.167 . . . . 0.0 113.107 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -122.75 125.58 45.79 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.44 1.096 . . . . 0.0 109.293 -174.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.464 82.5 p -111.92 170.31 5.41 Favored Pre-proline 0 CA--C 1.558 1.279 1 C-N-CA 132.066 4.147 . . . . 0.0 114.205 -175.043 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.2 139.49 62.9 Favored 'Trans proline' 0 C--N 1.378 2.117 1 C-N-CA 127.36 5.373 . . . . 0.0 120.054 -162.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.88 -13.82 45.49 Favored Glycine 0 C--N 1.363 2.064 0 CA-C-O 118.668 -1.074 . . . . 0.0 112.321 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.26 169.05 11.15 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 121.084 2.442 . . . . 0.0 112.309 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.636 HD22 ' HE ' ' A' ' 190' ' ' ARG . 4.5 mm? -97.72 138.64 34.8 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 101.832 -3.396 . . . . 0.0 101.832 164.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 m -134.03 165.59 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 103.536 -2.765 . . . . 0.0 103.536 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -121.22 116.65 25.31 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 101.174 -3.639 . . . . 0.0 101.174 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.51 128.71 56.54 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 123.667 1.698 . . . . 0.0 112.455 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -99.24 136.6 38.96 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 169.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.407 ' N ' ' CE1' ' A' ' 103' ' ' TYR . 1.2 tpt -121.62 148.04 45.06 Favored 'General case' 0 CA--C 1.511 -0.519 0 O-C-N 118.957 -2.339 . . . . 0.0 105.707 173.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -56.21 83.96 0.01 OUTLIER 'General case' 0 C--N 1.352 0.717 0 C-N-CA 129.107 2.963 . . . . 0.0 116.691 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.09 1.86 25.12 Favored Glycine 0 C--N 1.357 1.737 0 C-N-CA 124.676 1.131 . . . . 0.0 114.61 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.407 ' CE1' ' N ' ' A' ' 100' ' ' MET 0.262 0.0 OUTLIER -105.36 172.33 4.13 Favored Pre-proline 0 C--N 1.361 1.093 0 CA-C-O 116.991 -1.481 . . . . 0.0 109.609 178.246 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.1 165.76 31.65 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.576 3.517 . . . . 0.0 114.151 170.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.0 116.43 6.41 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.457 1.903 . . . . 0.0 112.62 173.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -114.92 127.63 26.65 Favored Pre-proline 0 N--CA 1.426 -1.641 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 -172.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -59.01 144.36 99.4 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 124.992 3.795 . . . . 0.0 111.343 154.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 m -156.27 164.67 38.04 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.276 1.43 . . . . 0.0 110.532 -161.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 tt -127.0 136.91 52.89 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 119.565 -1.959 . . . . 0.0 106.367 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.81 117.89 36.07 Favored 'Isoleucine or valine' 0 C--N 1.374 1.669 0 O-C-N 119.983 -1.698 . . . . 0.0 108.148 172.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -121.8 147.87 45.41 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.052 1.341 . . . . 0.0 111.416 -168.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.08 120.39 39.4 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.575 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 6.3 m-70 -62.32 159.41 40.39 Favored Pre-proline 0 C--N 1.363 1.175 0 C-N-CA 128.114 2.566 . . . . 0.0 114.459 -175.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.37 -0.65 0.16 Allowed 'Trans proline' 0 CA--C 1.558 1.675 1 C-N-CA 126.895 5.063 . . . . 0.0 117.053 172.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -106.99 37.82 2.26 Favored 'General case' 0 CA--C 1.551 1.002 1 C-N-CA 134.805 5.242 . . . . 0.0 107.041 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.305 0.0 OUTLIER -71.03 148.65 47.36 Favored 'General case' 0 C--N 1.373 1.602 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -170.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.56 -6.61 31.68 Favored Glycine 0 C--N 1.36 1.914 0 C-N-CA 125.498 1.523 . . . . 0.0 112.223 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.1 t -136.62 151.62 49.53 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 128.338 2.655 . . . . 0.0 104.159 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.466 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 2.1 t80 -160.31 -41.72 0.05 OUTLIER 'General case' 0 C--N 1.363 1.17 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -171.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.2 pt -107.94 146.72 13.58 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 O-C-N 119.626 -1.921 . . . . 0.0 115.058 -171.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -129.71 140.46 51.1 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -146.79 135.86 22.5 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.579 -1.326 . . . . 0.0 109.37 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -117.86 93.21 4.06 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 127.662 2.385 . . . . 0.0 106.863 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.83 -96.68 0.16 Allowed Glycine 0 C--N 1.362 2.013 0 C-N-CA 126.516 2.008 . . . . 0.0 117.767 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -113.49 16.45 18.81 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 126.937 2.095 . . . . 0.0 110.527 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 t -123.91 123.6 40.77 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.95 133.89 68.32 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-O 122.92 1.343 . . . . 0.0 110.366 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -118.09 133.08 56.24 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 127.302 2.241 . . . . 0.0 109.717 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.2 m -134.71 164.39 34.14 Favored 'Isoleucine or valine' 0 C--N 1.366 1.322 0 C-N-CA 129.002 2.921 . . . . 0.0 108.281 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.575 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 9.1 m170 -72.21 116.5 12.7 Favored 'General case' 0 C--N 1.372 1.567 0 O-C-N 119.398 -2.064 . . . . 0.0 114.203 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.464 ' HB ' ' CG2' ' A' ' 143' ' ' VAL . 37.3 t -144.07 141.44 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.847 0 O-C-N 119.171 -2.206 . . . . 0.0 105.121 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.86 140.98 48.7 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 112.022 -2.354 . . . . 0.0 106.323 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.54 133.05 52.57 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 126.152 1.781 . . . . 0.0 106.271 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -75.66 79.84 2.63 Favored 'General case' 0 C--N 1.372 1.546 0 C-N-CA 124.944 1.298 . . . . 0.0 108.983 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -103.53 -106.77 0.28 Allowed 'General case' 0 C--N 1.361 1.091 0 O-C-N 120.708 -1.245 . . . . 0.0 110.576 -174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -106.35 -58.08 1.97 Allowed 'General case' 0 C--N 1.353 0.718 0 C-N-CA 125.319 1.448 . . . . 0.0 111.894 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.2 m -82.77 -37.24 0.74 Allowed Pre-proline 0 C--N 1.362 1.141 0 N-CA-C 119.817 3.266 . . . . 0.0 119.817 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.61 178.48 33.36 Favored 'Cis proline' 0 CA--C 1.543 0.93 1 CA-C-N 128.529 4.082 . . . . 0.0 113.578 1.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.4 m -96.0 138.64 33.35 Favored 'General case' 0 C--N 1.366 1.301 0 C-N-CA 124.743 1.217 . . . . 0.0 109.279 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -155.67 158.97 39.16 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.673 -1.892 . . . . 0.0 106.315 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.7 -158.69 19.39 Favored Glycine 0 CA--C 1.487 -1.668 1 N-CA-C 100.32 -5.112 . . . . 0.0 100.32 170.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -90.36 132.48 35.57 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.464 ' CG2' ' HB ' ' A' ' 131' ' ' VAL . 2.3 m -99.98 -178.32 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 O-C-N 119.449 -2.032 . . . . 0.0 109.297 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.9 m -100.92 126.59 47.56 Favored 'General case' 0 C--N 1.365 1.272 0 N-CA-C 101.028 -3.693 . . . . 0.0 101.028 166.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.4 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 36.6 ttpt -72.23 -20.23 61.58 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -72.17 -6.25 41.41 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.73 3.51 42.33 Favored 'General case' 0 C--N 1.367 1.326 0 C-N-CA 124.48 1.112 . . . . 0.0 110.547 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.4 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 24.3 mt -91.8 134.44 34.74 Favored 'General case' 0 C--N 1.368 1.405 0 C-N-CA 125.505 1.522 . . . . 0.0 112.198 176.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -114.74 165.35 14.13 Favored Pre-proline 0 C--N 1.344 0.328 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 170.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.56 155.7 14.0 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.348 3.365 . . . . 0.0 113.714 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.487 ' HB2' ' HB2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -29.04 -78.35 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.964 2 N-CA-C 123.678 4.695 . . . . 0.0 123.678 178.575 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.8 t -33.12 36.34 0.0 OUTLIER 'General case' 0 C--N 1.371 1.523 1 C-N-CA 137.186 6.194 . . . . 0.0 119.318 -175.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -101.49 -48.13 1.45 Allowed Glycine 0 C--N 1.358 1.791 0 C-N-CA 127.884 2.659 . . . . 0.0 118.395 -168.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.9 m -46.48 -11.26 0.02 OUTLIER 'General case' 0 C--N 1.373 1.609 0 N-CA-C 121.182 3.771 . . . . 0.0 121.182 -175.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -122.91 13.46 9.85 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 128.746 2.818 . . . . 0.0 110.434 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.1 t -135.78 162.87 31.57 Favored 'General case' 0 CA--C 1.488 -1.424 0 C-N-CA 124.572 1.149 . . . . 0.0 113.743 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -47.05 -16.75 0.04 OUTLIER 'General case' 0 CA--C 1.489 -1.368 1 C-N-CA 134.586 5.155 . . . . 0.0 119.32 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -95.77 -7.51 36.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 117.182 -1.39 . . . . 0.0 113.081 170.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.89 15.47 3.58 Favored 'General case' 0 C--N 1.386 2.18 0 CA-C-N 122.09 2.223 . . . . 0.0 116.728 -172.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.51 -172.81 2.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 130.158 3.383 . . . . 0.0 105.975 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -71.0 122.11 19.42 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 118.971 -2.33 . . . . 0.0 112.813 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.88 -5.72 47.08 Favored Glycine 0 C--N 1.362 2.001 0 C-N-CA 125.461 1.505 . . . . 0.0 112.105 -170.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.12 154.35 50.67 Favored Glycine 0 C--N 1.371 2.51 1 C-N-CA 130.757 4.027 . . . . 0.0 117.717 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -67.78 -42.31 81.89 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 127.381 2.273 . . . . 0.0 116.179 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.57 -4.62 53.17 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 125.16 1.384 . . . . 0.0 112.196 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -82.81 94.2 7.6 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.0 m -118.73 108.38 14.81 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 100.758 -3.793 . . . . 0.0 100.758 167.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.51 101.1 13.78 Favored 'General case' 0 C--N 1.367 1.339 0 CA-C-O 126.132 2.872 . . . . 0.0 110.764 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -119.73 146.17 41.02 Favored Pre-proline 0 N--CA 1.424 -1.766 0 C-N-CA 131.171 3.788 . . . . 0.0 101.167 171.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.96 -38.81 86.58 Favored 'Trans proline' 0 C--N 1.352 0.725 1 C-N-CA 126.388 4.725 . . . . 0.0 115.307 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.46 -42.48 74.83 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.493 1.517 . . . . 0.0 113.655 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.7 mt -64.64 -46.88 91.1 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 C-N-CA 126.143 1.777 . . . . 0.0 111.901 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.432 ' O ' ' HG2' ' A' ' 177' ' ' GLN 0.304 3.9 pp -68.51 -32.38 72.3 Favored 'General case' 0 C--N 1.368 1.407 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 174.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -69.33 -39.25 78.29 Favored 'General case' 0 C--N 1.372 1.576 0 C-N-CA 128.612 2.765 . . . . 0.0 113.997 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.32 -34.55 74.83 Favored 'General case' 0 N--CA 1.431 -1.397 1 C-N-CA 131.843 4.057 . . . . 0.0 110.818 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 44.8 mtt -69.22 -33.38 73.22 Favored 'General case' 0 C--N 1.372 1.555 0 C-N-CA 127.915 2.486 . . . . 0.0 112.517 163.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 173' ' ' LEU . 57.6 mm-40 -72.57 -45.04 61.12 Favored 'General case' 0 C--N 1.385 2.143 0 C-N-CA 127.272 2.229 . . . . 0.0 112.124 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -66.45 -49.41 66.76 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 130.182 3.393 . . . . 0.0 110.362 173.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.65 83.56 Favored 'General case' 0 C--N 1.379 1.856 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.23 -47.14 69.24 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.98 2.112 . . . . 0.0 113.947 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -49.62 58.0 Favored 'General case' 0 C--N 1.359 1.008 0 O-C-N 120.309 -1.495 . . . . 0.0 114.578 173.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 190' ' ' ARG . . . -69.6 -30.43 68.18 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.4 pp -76.44 -40.02 51.78 Favored 'General case' 0 C--N 1.367 1.352 0 C-N-CA 126.517 1.927 . . . . 0.0 115.196 176.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -11.49 55.63 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.918 1.687 . . . . 0.0 111.204 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -114.14 -107.71 0.37 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -135.68 168.77 18.65 Favored 'General case' 0 C--N 1.364 1.208 0 O-C-N 120.247 -1.533 . . . . 0.0 112.739 -171.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.505 ' HA ' HH11 ' A' ' 190' ' ' ARG . 39.8 mmtm -55.51 -40.82 72.27 Favored 'General case' 0 C--N 1.386 2.196 0 C-N-CA 130.476 3.51 . . . . 0.0 114.163 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.99 -31.95 42.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 129.124 2.97 . . . . 0.0 113.914 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -74.48 -40.87 61.57 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 125.231 1.412 . . . . 0.0 114.405 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.636 ' HE ' HD22 ' A' ' 95' ' ' LEU 0.276 0.1 OUTLIER -74.94 -39.67 61.25 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 119.999 -1.688 . . . . 0.0 114.311 169.558 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.16 -21.16 64.01 Favored 'General case' 0 C--N 1.381 1.956 0 C-N-CA 128.205 2.602 . . . . 0.0 113.606 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -66.52 -32.01 73.09 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 130.124 3.37 . . . . 0.0 114.73 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mt -105.67 -47.04 4.0 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.366 2.266 . . . . 0.0 108.358 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 50.15 -112.81 0.61 Allowed 'General case' 0 C--N 1.368 1.394 0 C-N-CA 129.191 2.997 . . . . 0.0 114.803 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 22.0 m . . . . . 0 C--N 1.342 0.281 0 C-N-CA 126.478 1.911 . . . . 0.0 111.421 178.902 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.41 ' HA ' ' CE2' ' A' ' 90' ' ' PHE . 87.3 p . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -157.99 65.85 0.46 Allowed 'General case' 0 C--N 1.355 0.82 0 C-N-CA 124.078 0.951 . . . . 0.0 108.934 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 48.8 m-85 -118.29 124.68 48.41 Favored 'General case' 0 C--N 1.363 1.192 0 O-C-N 118.987 -2.32 . . . . 0.0 114.202 -172.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.44 17.2 p -112.96 169.45 6.35 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 131.114 3.766 . . . . 0.0 114.602 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -49.37 129.45 22.74 Favored 'Trans proline' 0 C--N 1.376 1.986 1 C-N-CA 128.006 5.804 . . . . 0.0 119.087 -169.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.52 -12.42 21.1 Favored Glycine 0 CA--C 1.482 -1.993 0 C-N-CA 124.438 1.018 . . . . 0.0 111.309 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.03 159.99 14.92 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.206 -1.761 . . . . 0.0 108.247 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.42 140.31 36.87 Favored 'General case' 0 C--N 1.344 0.354 1 N-CA-C 99.998 -4.075 . . . . 0.0 99.998 166.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.37 147.36 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 102.667 -3.086 . . . . 0.0 102.667 -171.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -99.93 119.29 38.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HB3' ' HG ' ' A' ' 108' ' ' SER . . . -108.92 136.34 48.63 Favored 'General case' 0 C--N 1.359 1.012 0 CA-C-N 119.862 1.21 . . . . 0.0 111.559 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -108.97 141.31 41.25 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.0 ttp -129.59 149.84 51.18 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 119.311 -2.118 . . . . 0.0 108.932 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -65.6 89.66 0.11 Allowed 'General case' 0 C--N 1.363 1.193 0 C-N-CA 127.103 2.161 . . . . 0.0 115.032 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.24 -3.07 25.29 Favored Glycine 0 C--N 1.357 1.746 0 C-N-CA 125.873 1.701 . . . . 0.0 112.786 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -100.97 163.33 18.2 Favored Pre-proline 0 C--N 1.354 0.782 0 C-N-CA 126.573 1.949 . . . . 0.0 109.773 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.04 165.9 31.22 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.627 2.885 . . . . 0.0 112.666 164.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.471 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 1.6 m95 -66.36 130.55 43.6 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 128.6 2.76 . . . . 0.0 111.053 170.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -129.83 138.94 34.21 Favored Pre-proline 0 N--CA 1.415 -2.196 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.09 132.12 17.68 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 123.313 2.675 . . . . 0.0 107.896 147.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.449 ' HG ' ' HB3' ' A' ' 98' ' ' ALA . 51.6 m -135.66 166.51 23.07 Favored 'General case' 0 C--N 1.345 0.398 1 C-N-CA 132.121 4.168 . . . . 0.0 110.485 -166.234 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 5.9 tt -123.68 133.01 53.97 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 119.155 -2.216 . . . . 0.0 110.299 177.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.14 118.64 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 CA-C-N 122.271 2.305 . . . . 0.0 110.146 171.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.68 153.44 48.97 Favored 'General case' 0 C--N 1.372 1.583 0 C-N-CA 127.238 2.215 . . . . 0.0 112.484 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -78.64 112.55 15.85 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 129.473 3.109 . . . . 0.0 114.062 170.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -90.75 159.58 40.33 Favored Pre-proline 0 C--N 1.373 1.624 0 CA-C-O 114.301 -2.761 . . . . 0.0 109.181 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.265 53.0 Cg_exo -47.54 0.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.861 2 C-N-CA 129.021 6.481 . . . . 0.0 122.536 -166.519 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -102.48 40.56 1.34 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.164 2.586 . . . . 0.0 104.981 168.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.12 118.9 7.39 Favored 'General case' 0 C--N 1.379 1.862 0 C-N-CA 127.493 2.317 . . . . 0.0 114.275 -170.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.96 -19.9 27.18 Favored Glycine 0 C--N 1.356 1.656 0 C-N-CA 125.424 1.487 . . . . 0.0 110.534 -165.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.8 m -104.8 120.21 40.85 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 172.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.435 ' CE2' ' HB ' ' A' ' 129' ' ' VAL . 4.4 t80 -135.77 -43.15 0.67 Allowed 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 119.547 1.067 . . . . 0.0 113.531 -171.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 pt -100.03 173.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-O 122.345 1.069 . . . . 0.0 113.875 -174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -159.0 148.26 18.72 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -147.36 127.05 13.37 Favored 'General case' 0 C--N 1.363 1.193 0 O-C-N 120.071 -1.643 . . . . 0.0 110.3 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -118.29 93.75 4.24 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.601 1.96 . . . . 0.0 110.526 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.02 -76.79 0.23 Allowed Glycine 0 C--N 1.36 1.893 0 N-CA-C 120.391 2.916 . . . . 0.0 120.391 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -139.27 52.49 1.75 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 125.198 1.399 . . . . 0.0 110.657 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.4 m -174.22 146.08 1.09 Allowed 'General case' 0 C--N 1.356 0.852 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.43 139.86 50.27 Favored 'Isoleucine or valine' 0 C--N 1.362 1.111 0 CA-C-O 122.129 0.966 . . . . 0.0 111.362 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -113.56 161.77 17.0 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 126.889 2.076 . . . . 0.0 113.628 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 119' ' ' PHE . 14.0 m -149.35 163.3 4.29 Favored 'Isoleucine or valine' 0 C--N 1.369 1.431 1 C-N-CA 133.024 4.53 . . . . 0.0 103.749 175.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -97.44 127.64 43.56 Favored 'General case' 0 C--N 1.366 1.293 0 O-C-N 121.001 -1.062 . . . . 0.0 111.204 167.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.412 HG13 HG21 ' A' ' 129' ' ' VAL . 1.6 m -146.02 171.65 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.489 HE21 ' CG2' ' A' ' 195' ' ' VAL . 0.1 OUTLIER -131.93 146.51 52.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.43 1.092 . . . . 0.0 109.063 179.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -93.31 132.26 37.68 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 129.992 3.317 . . . . 0.0 107.534 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 7.4 m-30 -76.03 65.21 2.03 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 124.292 1.996 . . . . 0.0 113.509 -176.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -89.45 -109.49 0.08 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 128.891 2.876 . . . . 0.0 110.146 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.23 -52.12 2.81 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.87 1.668 . . . . 0.0 113.902 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.6 m -80.92 -41.07 1.15 Allowed Pre-proline 0 C--N 1.364 1.205 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -172.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.77 169.59 74.09 Favored 'Cis proline' 0 CA--C 1.543 0.953 0 CA-C-N 126.303 3.287 . . . . 0.0 114.259 -1.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.3 m -85.68 125.44 33.19 Favored 'General case' 0 C--N 1.366 1.302 0 C-N-CA 126.413 1.885 . . . . 0.0 110.539 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.43 ' HG2' ' H ' ' A' ' 141' ' ' GLY . 0.5 OUTLIER -117.87 174.84 5.96 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 125.225 1.41 . . . . 0.0 111.219 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.43 ' H ' ' HG2' ' A' ' 140' ' ' ARG . . . 169.14 -160.19 33.48 Favored Glycine 0 CA--C 1.487 -1.715 1 N-CA-C 97.852 -6.099 . . . . 0.0 97.852 171.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.5 m95 -96.95 155.8 16.62 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.0 m -119.92 173.14 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 C-N-CA 124.246 1.018 . . . . 0.0 108.566 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.0 t -84.19 123.58 30.25 Favored 'General case' 0 C--N 1.369 1.443 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 164.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.412 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 15.8 ttpp -73.38 -25.16 60.45 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 120.904 -1.123 . . . . 0.0 111.995 -175.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -73.22 -9.42 58.69 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 125.246 1.418 . . . . 0.0 114.519 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.3 mt -100.11 6.07 44.91 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 125.448 1.499 . . . . 0.0 111.577 172.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 2.8 mt -100.4 132.23 45.9 Favored 'General case' 0 C--N 1.371 1.538 0 C-N-CA 125.366 1.466 . . . . 0.0 108.403 173.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.71 ' HB2' ' HZ3' ' A' ' 149' ' ' LYS . 4.9 mtmp? -114.74 164.89 15.23 Favored Pre-proline 0 CA--C 1.506 -0.735 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.22 156.31 14.76 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.803 2.335 . . . . 0.0 113.409 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -34.09 -107.67 0.0 OUTLIER 'General case' 0 C--N 1.351 0.631 1 C-N-CA 132.888 4.475 . . . . 0.0 120.606 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.392 4.0 t 53.3 -42.94 0.02 OUTLIER 'General case' 0 C--N 1.371 1.505 1 C-N-CA 131.727 4.011 . . . . 0.0 118.927 174.408 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.59 -150.88 30.25 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 121.916 3.527 . . . . 0.0 121.916 159.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.6 m -45.87 -11.87 0.02 OUTLIER 'General case' 0 C--N 1.374 1.637 1 C-N-CA 134.952 5.301 . . . . 0.0 118.864 -175.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -88.67 -14.0 38.42 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 129.276 3.03 . . . . 0.0 111.747 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.4 t -75.98 153.94 36.19 Favored 'General case' 0 C--N 1.377 1.781 0 C-N-CA 126.102 1.761 . . . . 0.0 112.05 171.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -72.12 -26.93 62.31 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.869 1.668 . . . . 0.0 111.98 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -79.39 -17.4 54.47 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 124.352 1.061 . . . . 0.0 111.902 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.33 4.61 48.65 Favored 'General case' 0 C--N 1.368 1.373 0 C-N-CA 126.172 1.789 . . . . 0.0 114.08 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -122.72 177.51 5.42 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 124.653 1.181 . . . . 0.0 109.135 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.33 122.58 14.89 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 126.968 2.107 . . . . 0.0 113.829 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.68 -14.58 53.41 Favored Glycine 0 C--N 1.357 1.708 0 C-N-CA 124.891 1.234 . . . . 0.0 111.615 -168.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.45 153.73 32.14 Favored Glycine 0 C--N 1.359 1.81 0 N-CA-C 119.266 2.467 . . . . 0.0 119.266 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -63.07 -42.5 99.67 Favored 'General case' 0 C--N 1.365 1.239 0 N-CA-C 118.694 2.85 . . . . 0.0 118.694 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.471 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.286 0.4 OUTLIER -101.99 -0.03 34.38 Favored 'General case' 0 C--N 1.359 1.018 0 O-C-N 120.618 -1.301 . . . . 0.0 112.675 -179.139 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -78.64 141.62 37.84 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 126.846 2.058 . . . . 0.0 111.427 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 50.9 m -171.27 150.91 3.02 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 101.06 -3.681 . . . . 0.0 101.06 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -129.67 102.52 6.38 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-O 125.409 2.528 . . . . 0.0 113.544 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -119.68 140.22 29.12 Favored Pre-proline 0 N--CA 1.43 -1.443 2 C-N-CA 134.02 4.928 . . . . 0.0 100.114 168.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . 0.319 92.0 Cg_endo -64.45 -17.95 61.36 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.766 3.644 . . . . 0.0 117.502 -174.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -69.96 -36.06 74.96 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 129.541 3.137 . . . . 0.0 111.67 170.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 31.4 mt -73.03 -32.73 40.54 Favored 'Isoleucine or valine' 0 C--N 1.372 1.576 0 C-N-CA 127.604 2.361 . . . . 0.0 110.402 175.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 41.0 mt -65.05 -49.81 68.65 Favored 'General case' 0 C--N 1.378 1.823 0 C-N-CA 126.55 1.94 . . . . 0.0 110.307 169.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -57.53 -34.58 69.28 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 125.209 1.404 . . . . 0.0 114.184 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.22 -48.35 62.21 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 129.963 3.305 . . . . 0.0 114.304 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.7 mtt -69.64 -33.3 72.43 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 120.991 1.723 . . . . 0.0 113.383 172.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -70.13 -52.39 23.99 Favored 'General case' 0 C--N 1.377 1.784 0 C-N-CA 127.056 2.142 . . . . 0.0 112.028 174.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.426 ' HG3' ' CE2' ' A' ' 134' ' ' PHE 0.267 6.1 ptt180 -71.29 -36.52 71.7 Favored 'General case' 0 C--N 1.382 1.998 0 O-C-N 119.485 -2.009 . . . . 0.0 113.842 176.01 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.4 -50.03 67.03 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.542 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -55.06 -39.22 68.98 Favored 'General case' 0 C--N 1.386 2.18 0 CA-C-N 121.96 2.164 . . . . 0.0 113.542 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -52.32 24.97 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 119.735 -1.853 . . . . 0.0 114.6 170.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.62 -33.51 74.04 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.56 -35.37 34.44 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 126.615 1.966 . . . . 0.0 115.143 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.352 0.0 OUTLIER -91.1 -21.03 21.41 Favored 'General case' 0 C--N 1.367 1.327 0 O-C-N 121.309 -0.869 . . . . 0.0 110.735 -173.613 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -101.85 -110.94 0.22 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 123.348 0.659 . . . . 0.0 112.048 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -135.36 161.86 34.22 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 119.949 -1.72 . . . . 0.0 110.058 -174.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -51.26 -36.94 44.5 Favored 'General case' 0 C--N 1.373 1.608 0 C-N-CA 131.217 3.807 . . . . 0.0 115.216 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -40.09 34.99 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 C-N-CA 130.639 3.576 . . . . 0.0 112.836 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -32.44 69.3 Favored 'General case' 0 C--N 1.37 1.475 0 C-N-CA 125.483 1.513 . . . . 0.0 113.617 176.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.25 0.0 OUTLIER -74.02 -37.2 64.42 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 174.084 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.265 3.9 mt -78.49 -19.28 53.39 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 126.888 2.075 . . . . 0.0 114.855 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -69.65 -24.46 63.63 Favored 'General case' 0 C--N 1.368 1.388 0 O-C-N 120.961 -1.087 . . . . 0.0 113.079 167.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.86 22.45 15.58 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 131.392 3.877 . . . . 0.0 111.431 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.37 -177.99 2.81 Favored 'General case' 0 C--N 1.374 1.633 0 C-N-CA 128.796 2.838 . . . . 0.0 115.03 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.489 ' CG2' HE21 ' A' ' 132' ' ' GLN . 44.6 t . . . . . 0 C--N 1.363 1.183 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.511 -0.531 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -133.31 89.6 2.62 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.176 1.391 . . . . 0.0 112.762 -171.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 150' ' ' PRO . 43.8 m-85 -123.16 126.65 47.4 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 120.913 -1.117 . . . . 0.0 110.587 -176.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.334 64.4 p -111.59 168.98 6.81 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 129.039 2.936 . . . . 0.0 116.433 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -50.66 137.06 41.98 Favored 'Trans proline' 0 C--N 1.367 1.5 1 C-N-CA 126.854 5.036 . . . . 0.0 122.084 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.63 -12.66 56.61 Favored Glycine 0 C--N 1.37 2.456 0 C-N-CA 128.371 2.891 . . . . 0.0 111.139 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.42 169.87 10.04 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.056 2.542 . . . . 0.0 111.449 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.52 143.73 44.49 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 119.151 -2.218 . . . . 0.0 105.477 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 m -142.88 158.68 18.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -101.75 128.52 48.05 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 100.834 -3.765 . . . . 0.0 100.834 167.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.44 141.38 48.61 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 125.341 1.456 . . . . 0.0 112.234 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -120.76 139.88 52.47 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 120.034 -1.666 . . . . 0.0 106.996 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 42.3 ttm -129.32 151.3 50.12 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 120.049 -1.657 . . . . 0.0 107.76 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -72.05 110.96 6.88 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 125.856 1.662 . . . . 0.0 110.546 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.09 -16.34 22.77 Favored Glycine 0 C--N 1.359 1.859 0 C-N-CA 125.073 1.321 . . . . 0.0 112.12 -174.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -114.36 157.95 41.15 Favored Pre-proline 0 C--N 1.356 0.853 0 C-N-CA 125.287 1.435 . . . . 0.0 108.99 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.34 166.54 29.47 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 124.448 3.432 . . . . 0.0 112.484 163.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.572 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.0 m95 -51.52 114.54 1.27 Allowed 'General case' 0 C--N 1.365 1.268 0 C-N-CA 127.705 2.402 . . . . 0.0 114.625 167.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . 0.42 ' CE3' ' HA ' ' A' ' 106' ' ' TRP . 4.4 m95 -118.7 108.22 41.48 Favored Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 119.176 3.028 . . . . 0.0 119.176 -172.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -54.3 118.46 5.06 Favored 'Trans proline' 0 C--N 1.373 1.846 1 C-N-CA 125.678 4.252 . . . . 0.0 112.498 162.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.2 m -132.91 164.97 25.75 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 127.145 2.178 . . . . 0.0 114.226 -159.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.575 HD23 ' HE ' ' A' ' 190' ' ' ARG . 2.2 pp -116.28 147.49 41.46 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 169.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.55 120.93 42.68 Favored 'Isoleucine or valine' 0 C--N 1.369 1.417 0 O-C-N 120.831 -1.168 . . . . 0.0 109.217 172.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -139.83 152.88 46.86 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 120.103 -1.623 . . . . 0.0 112.24 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -89.6 112.1 23.23 Favored 'General case' 0 C--N 1.369 1.416 0 C-N-CA 129.25 3.02 . . . . 0.0 109.514 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.4 ' CE1' ' HE ' ' A' ' 140' ' ' ARG . 69.3 t60 -73.69 159.34 84.68 Favored Pre-proline 0 C--N 1.36 1.027 0 C-N-CA 127.73 2.412 . . . . 0.0 114.716 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -48.97 -1.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.558 1.697 1 C-N-CA 127.077 5.184 . . . . 0.0 119.079 174.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -104.4 35.11 2.83 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 128.305 2.642 . . . . 0.0 107.444 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -68.62 158.14 34.66 Favored 'General case' 0 C--N 1.367 1.331 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -171.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.6 -20.64 27.11 Favored Glycine 0 C--N 1.359 1.855 0 CA-C-N 112.493 -2.14 . . . . 0.0 109.669 171.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -124.58 119.26 28.56 Favored 'General case' 0 N--CA 1.438 -1.05 1 N-CA-C 99.252 -4.351 . . . . 0.0 99.252 164.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.58 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 20.3 p90 -118.83 -3.4 10.76 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.223 -0.923 . . . . 0.0 108.947 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.3 pt -112.77 166.6 6.6 Favored 'Isoleucine or valine' 0 C--N 1.364 1.201 0 C-N-CA 127.367 2.267 . . . . 0.0 112.036 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.406 ' HE ' ' HD2' ' A' ' 128' ' ' ARG . 45.6 ttp180 -158.57 147.36 18.77 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 103.871 -2.641 . . . . 0.0 103.871 176.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -145.53 126.76 14.79 Favored 'General case' 0 C--N 1.359 1.017 0 O-C-N 119.568 -1.958 . . . . 0.0 109.11 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -117.97 93.6 4.2 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 127.184 2.193 . . . . 0.0 110.241 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.42 -71.16 0.1 OUTLIER Glycine 0 C--N 1.36 1.88 0 N-CA-C 120.97 3.148 . . . . 0.0 120.97 172.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -143.6 51.2 1.35 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-O 122.648 1.213 . . . . 0.0 111.138 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.5 m -177.3 143.26 0.37 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.5 p -117.17 136.28 54.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.058 0 CA-C-O 122.79 1.281 . . . . 0.0 110.127 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.406 ' HD2' ' HE ' ' A' ' 121' ' ' ARG . 14.7 mtt-85 -113.67 144.46 42.89 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.715 2.806 . . . . 0.0 107.075 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 12.0 m -146.66 162.7 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.58 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 3.2 p-80 -96.58 134.71 39.46 Favored 'General case' 0 C--N 1.363 1.153 0 CA-C-O 123.598 1.666 . . . . 0.0 110.05 172.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 p -125.89 163.64 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 101.599 -3.482 . . . . 0.0 101.599 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.72 33.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -86.28 129.36 34.88 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.014 3.325 . . . . 0.0 110.283 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.9 75.79 2.81 Favored 'General case' 0 C--N 1.371 1.506 0 CA-C-N 120.511 1.505 . . . . 0.0 114.114 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.07 -104.38 0.1 Allowed 'General case' 0 C--N 1.368 1.384 0 C-N-CA 124.678 1.191 . . . . 0.0 108.569 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -107.22 -56.18 2.24 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.987 2.115 . . . . 0.0 113.825 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.83 -44.92 2.41 Favored Pre-proline 0 C--N 1.368 1.401 0 N-CA-C 119.575 3.176 . . . . 0.0 119.575 -172.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -82.05 177.77 32.57 Favored 'Cis proline' 0 CA--C 1.546 1.088 0 CA-C-N 126.492 3.354 . . . . 0.0 114.058 3.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.9 m -94.84 134.56 37.34 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 125.189 1.396 . . . . 0.0 110.717 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.4 ' HE ' ' CE1' ' A' ' 113' ' ' HIS . 5.8 tmm_? -117.31 148.11 41.99 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 125.656 1.583 . . . . 0.0 110.401 177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -160.47 167.52 35.71 Favored Glycine 0 CA--C 1.486 -1.734 1 N-CA-C 103.035 -4.026 . . . . 0.0 103.035 169.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -88.13 122.01 31.2 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 124.776 2.226 . . . . 0.0 108.329 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.06 168.01 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 129.089 2.955 . . . . 0.0 108.545 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.5 m -91.46 130.12 37.34 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 102.425 -3.176 . . . . 0.0 102.425 168.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.421 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 32.4 ttpt -74.69 -15.58 60.79 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-O 122.921 1.343 . . . . 0.0 114.108 -170.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -72.64 -2.98 22.14 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.701 1.601 . . . . 0.0 115.136 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.6 mt -107.04 10.31 30.33 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 125.187 1.395 . . . . 0.0 110.468 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 11.4 mt -98.96 124.24 43.8 Favored 'General case' 0 C--N 1.374 1.657 0 C-N-CA 125.588 1.555 . . . . 0.0 107.258 174.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -116.24 151.28 46.58 Favored Pre-proline 0 CA--C 1.501 -0.924 0 O-C-N 119.921 -1.737 . . . . 0.0 108.306 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.417 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . 72.5 Cg_endo -81.13 123.73 4.63 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.845 2.364 . . . . 0.0 112.184 -167.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.34 108.5 19.93 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -171.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.1 t -150.42 26.88 0.76 Allowed 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -167.38 80.7 0.1 Allowed Glycine 0 C--N 1.355 1.61 0 C-N-CA 116.061 -2.971 . . . . 0.0 118.862 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.4 t -68.29 -11.9 60.17 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 126.921 2.088 . . . . 0.0 115.988 170.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -122.75 35.0 4.98 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 127.884 2.474 . . . . 0.0 107.645 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.2 t -104.96 142.44 34.78 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 126.316 1.847 . . . . 0.0 106.422 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.27 27.3 ttpt -52.76 -36.91 58.68 Favored 'General case' 0 C--N 1.369 1.442 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -171.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -18.48 61.97 Favored 'General case' 0 C--N 1.37 1.48 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 169.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.66 5.15 49.74 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.257 1.8 pp0? -129.41 -174.95 3.43 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.635 -1.916 . . . . 0.0 110.352 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.3 122.01 15.13 Favored 'General case' 0 C--N 1.368 1.396 0 O-C-N 120.444 -1.41 . . . . 0.0 113.686 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.37 -9.95 61.17 Favored Glycine 0 C--N 1.359 1.839 0 C-N-CA 124.365 0.983 . . . . 0.0 111.674 -167.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.92 160.3 44.63 Favored Glycine 0 C--N 1.366 2.202 0 C-N-CA 125.985 1.755 . . . . 0.0 116.846 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.53 -42.72 74.28 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -174.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.572 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.267 0.1 OUTLIER -99.42 5.06 46.41 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 120.245 -1.534 . . . . 0.0 114.377 -178.936 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -85.61 92.94 8.69 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.164 2.585 . . . . 0.0 114.284 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.4 m -113.86 110.23 19.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 170.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.97 101.5 14.21 Favored 'General case' 0 C--N 1.359 1.014 0 CA-C-O 126.127 2.87 . . . . 0.0 113.486 -170.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -120.47 150.5 52.17 Favored Pre-proline 0 N--CA 1.422 -1.854 1 C-N-CA 133.93 4.892 . . . . 0.0 102.915 171.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -60.41 -32.38 93.8 Favored 'Trans proline' 0 CA--C 1.554 1.478 1 C-N-CA 126.652 4.901 . . . . 0.0 115.037 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -67.27 -35.16 78.93 Favored 'General case' 0 C--N 1.364 1.202 0 C-N-CA 130.059 3.344 . . . . 0.0 113.256 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.0 mm -72.17 -36.2 55.53 Favored 'Isoleucine or valine' 0 C--N 1.372 1.577 0 C-N-CA 127.235 2.214 . . . . 0.0 110.049 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mt -64.0 -53.83 43.87 Favored 'General case' 0 C--N 1.384 2.066 0 C-N-CA 126.428 1.891 . . . . 0.0 110.882 171.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -57.39 -33.87 68.28 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 129.143 2.977 . . . . 0.0 114.447 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.87 -44.67 72.81 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 130.079 3.352 . . . . 0.0 111.617 172.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 37.9 mtm -65.69 -35.74 81.62 Favored 'General case' 0 C--N 1.37 1.473 0 C-N-CA 125.102 1.361 . . . . 0.0 114.456 167.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -74.49 -48.33 27.91 Favored 'General case' 0 C--N 1.378 1.844 0 C-N-CA 125.518 1.527 . . . . 0.0 112.434 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -65.23 -46.54 80.19 Favored 'General case' 0 C--N 1.371 1.51 0 C-N-CA 129.251 3.02 . . . . 0.0 112.705 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.43 84.32 Favored 'General case' 0 C--N 1.375 1.707 0 O-C-N 120.599 -1.313 . . . . 0.0 112.688 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 184' ' ' ASN 0.333 35.3 t70 -64.55 -31.35 72.53 Favored 'General case' 0 C--N 1.378 1.81 0 C-N-CA 125.969 1.708 . . . . 0.0 111.857 175.059 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -76.45 -33.38 58.76 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 118.362 -2.711 . . . . 0.0 113.79 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.24 -36.83 58.31 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 118.64 2.83 . . . . 0.0 118.64 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.1 pp -79.87 -36.45 36.59 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 119.901 -1.749 . . . . 0.0 114.704 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -85.92 -17.78 34.53 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 127.201 2.201 . . . . 0.0 110.839 -176.103 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -117.51 -105.09 0.4 Allowed 'General case' 0 C--N 1.359 1.014 0 CA-C-O 121.791 0.805 . . . . 0.0 110.781 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -129.12 146.93 50.95 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.618 1.199 . . . . 0.0 108.331 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -50.31 -36.19 30.79 Favored 'General case' 0 C--N 1.357 0.924 1 C-N-CA 134.111 4.965 . . . . 0.0 113.826 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 14.9 tt -51.99 -37.18 21.06 Favored 'Isoleucine or valine' 0 C--N 1.37 1.489 0 C-N-CA 128.918 2.887 . . . . 0.0 112.174 171.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.328 2.8 mptp? -64.1 -31.29 72.43 Favored 'General case' 0 C--N 1.371 1.502 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 176.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.575 ' HE ' HD23 ' A' ' 109' ' ' LEU 0.411 0.0 OUTLIER -75.26 -42.2 55.64 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-N 121.327 1.876 . . . . 0.0 112.283 165.132 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.7 tp -57.39 -22.6 43.9 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 129.031 2.932 . . . . 0.0 117.595 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -73.9 -13.13 60.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.997 2.519 . . . . 0.0 113.953 170.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.13 22.76 15.16 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 130.562 3.545 . . . . 0.0 112.093 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.0 118.28 5.63 Favored 'General case' 0 C--N 1.371 1.535 0 C-N-CA 129.574 3.149 . . . . 0.0 116.141 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.373 1.594 0 C-N-CA 128.637 2.775 . . . . 0.0 113.174 -179.675 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.407 ' HA ' ' CE2' ' A' ' 90' ' ' PHE . 83.1 p . . . . . 0 N--CA 1.461 0.105 0 CA-C-O 121.808 0.813 . . . . 0.0 110.046 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.71 72.15 1.26 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 125.306 1.442 . . . . 0.0 108.967 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 59.9 m-85 -116.71 127.11 54.09 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 120.602 -1.311 . . . . 0.0 112.106 -172.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 p -112.0 167.72 8.7 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 127.82 2.448 . . . . 0.0 117.113 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -54.39 129.11 32.97 Favored 'Trans proline' 0 C--N 1.371 1.725 1 C-N-CA 126.943 5.096 . . . . 0.0 116.779 -176.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.8 -16.17 58.85 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 125.418 1.485 . . . . 0.0 112.68 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -92.71 154.3 18.41 Favored 'General case' 0 C--N 1.367 1.36 0 CA-C-N 119.71 1.755 . . . . 0.0 110.859 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.639 HD11 HH21 ' A' ' 190' ' ' ARG . 3.3 mm? -98.44 144.61 27.61 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 119.303 -2.123 . . . . 0.0 109.047 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.1 m -136.8 158.17 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 C-N-CA 125.333 1.453 . . . . 0.0 109.994 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -105.76 119.82 40.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 101.035 -3.691 . . . . 0.0 101.035 167.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.82 144.47 34.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.337 1.855 . . . . 0.0 113.388 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -120.22 135.81 54.86 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.2 ttp -128.63 144.41 51.15 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 119.526 -1.983 . . . . 0.0 108.833 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -64.7 94.64 0.13 Allowed 'General case' 0 C--N 1.368 1.386 0 C-N-CA 126.445 1.898 . . . . 0.0 115.22 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.57 -5.12 24.64 Favored Glycine 0 C--N 1.359 1.817 0 C-N-CA 126.392 1.949 . . . . 0.0 113.01 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -104.64 159.98 27.52 Favored Pre-proline 0 C--N 1.357 0.913 0 C-N-CA 126.001 1.72 . . . . 0.0 109.967 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.44 166.63 29.25 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 123.682 2.921 . . . . 0.0 112.221 162.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.536 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.6 m95 -59.72 123.92 18.49 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 127.644 2.378 . . . . 0.0 114.799 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -127.27 108.54 21.39 Favored Pre-proline 0 N--CA 1.433 -1.305 1 N-CA-C 122.013 4.079 . . . . 0.0 122.013 -168.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.22 133.49 46.94 Favored 'Trans proline' 0 C--N 1.39 2.741 1 C-N-CA 125.968 4.446 . . . . 0.0 111.366 165.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.5 p -155.81 163.68 39.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 125.011 2.339 . . . . 0.0 115.743 -157.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 5.1 tt -101.06 129.99 47.01 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 129.172 2.989 . . . . 0.0 108.151 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.49 ' H ' HH22 ' A' ' 190' ' ' ARG . 31.2 t -87.49 118.81 34.07 Favored 'Isoleucine or valine' 0 C--N 1.378 1.846 0 CA-C-N 120.722 1.601 . . . . 0.0 107.007 173.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -116.57 154.16 30.95 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -164.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -119.4 112.67 19.7 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -83.44 159.09 62.34 Favored Pre-proline 0 C--N 1.348 0.528 0 C-N-CA 129.879 3.271 . . . . 0.0 110.647 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.32 0.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.799 1 C-N-CA 128.632 6.222 . . . . 0.0 119.973 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -95.21 28.2 2.94 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 131.191 3.796 . . . . 0.0 107.249 166.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.271 0.0 OUTLIER -73.79 161.07 30.59 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 127.185 2.194 . . . . 0.0 115.945 -173.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.95 -20.26 36.41 Favored Glycine 0 C--N 1.362 2.002 0 C-N-CA 126.666 2.079 . . . . 0.0 111.33 -174.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 p -135.87 136.18 40.34 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 130.681 3.592 . . . . 0.0 103.087 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -132.79 -3.75 3.24 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 120.206 1.366 . . . . 0.0 113.293 -175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.3 pt -110.73 150.38 13.23 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 123.073 1.416 . . . . 0.0 111.324 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.91 141.82 36.5 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 128.041 2.536 . . . . 0.0 104.227 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -145.67 126.6 14.51 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 120.939 -1.1 . . . . 0.0 109.013 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -109.42 93.55 4.56 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.33 -63.06 1.41 Allowed Glycine 0 C--N 1.362 2.011 0 C-N-CA 127.829 2.633 . . . . 0.0 115.852 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -144.64 -5.41 0.73 Allowed 'General case' 0 C--N 1.352 0.683 0 C-N-CA 127.736 2.414 . . . . 0.0 110.227 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.0 m -82.34 73.77 9.36 Favored 'General case' 0 C--N 1.372 1.551 0 O-C-N 118.944 -2.348 . . . . 0.0 110.306 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.56 111.15 21.58 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 C-N-CA 129.228 3.011 . . . . 0.0 110.594 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -117.34 146.82 43.13 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 111.287 -2.688 . . . . 0.0 112.874 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.86 162.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 127.74 2.416 . . . . 0.0 106.426 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.02 138.43 32.45 Favored 'General case' 0 C--N 1.379 1.889 0 O-C-N 117.975 -2.953 . . . . 0.0 111.112 171.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 m -151.9 169.91 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.478 -1.807 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -149.09 151.13 33.91 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 122.138 0.97 . . . . 0.0 109.695 170.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -104.14 122.13 44.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 128.972 2.909 . . . . 0.0 107.97 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 51.0 m-85 -71.38 62.29 0.35 Allowed 'General case' 0 C--N 1.378 1.837 0 C-N-CA 127.317 2.247 . . . . 0.0 112.136 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -90.33 -114.2 0.07 Allowed 'General case' 0 C--N 1.362 1.151 0 C-N-CA 129.986 3.314 . . . . 0.0 111.531 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -106.53 -45.1 4.33 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 125.723 1.609 . . . . 0.0 112.031 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -81.6 -40.45 1.02 Allowed Pre-proline 0 C--N 1.36 1.055 0 N-CA-C 118.44 2.756 . . . . 0.0 118.44 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.91 159.57 97.79 Favored 'Cis proline' 0 C--N 1.361 1.189 0 CA-C-N 126.202 3.251 . . . . 0.0 109.864 -3.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.9 p -87.88 119.37 28.16 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 119.009 -2.307 . . . . 0.0 112.046 -175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -109.92 152.93 25.2 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 125.877 1.671 . . . . 0.0 107.623 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.35 177.31 37.72 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 104.084 -3.606 . . . . 0.0 104.084 165.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -92.26 109.06 20.43 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 103.12 -2.918 . . . . 0.0 103.12 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.32 164.6 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 C-N-CA 125.466 1.507 . . . . 0.0 111.511 -171.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 m -77.42 109.85 11.69 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.97 2.108 . . . . 0.0 106.305 172.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.503 0.0 OUTLIER -70.72 -10.27 59.07 Favored 'General case' 0 C--N 1.37 1.496 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -169.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -75.44 -14.68 60.46 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 129.214 3.006 . . . . 0.0 114.193 170.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -100.47 0.82 40.39 Favored 'General case' 0 C--N 1.365 1.281 0 C-N-CA 126.859 2.064 . . . . 0.0 110.263 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 49.1 mt -96.28 124.88 40.44 Favored 'General case' 0 C--N 1.368 1.412 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 172.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -114.6 161.74 27.18 Favored Pre-proline 0 CA--C 1.506 -0.718 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.14 149.78 22.47 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 CA-C-N 125.332 2.94 . . . . 0.0 112.463 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -113.28 153.05 29.07 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.8 t -179.61 -32.39 0.01 OUTLIER 'General case' 0 C--N 1.352 0.684 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.77 113.77 0.89 Allowed Glycine 0 C--N 1.355 1.638 0 O-C-N 121.029 -1.044 . . . . 0.0 115.354 -173.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -11.96 59.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 131.0 3.72 . . . . 0.0 112.271 171.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.78 -8.14 35.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 131.241 3.816 . . . . 0.0 111.794 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.8 m -58.09 136.06 57.12 Favored 'General case' 0 C--N 1.385 2.147 0 C-N-CA 126.172 1.789 . . . . 0.0 112.032 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.303 33.6 tttp -54.59 -31.75 57.48 Favored 'General case' 0 C--N 1.368 1.378 0 CA-C-N 122.445 2.384 . . . . 0.0 117.317 -173.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -74.7 -19.34 60.29 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 126.519 1.927 . . . . 0.0 112.835 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.59 1.68 55.63 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 126.359 1.864 . . . . 0.0 112.801 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -132.15 -176.48 4.08 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 119.898 -1.751 . . . . 0.0 112.908 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -63.66 122.13 15.61 Favored 'General case' 0 C--N 1.371 1.525 0 C-N-CA 126.037 1.735 . . . . 0.0 114.209 -177.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.06 -7.92 60.72 Favored Glycine 0 C--N 1.357 1.748 0 C-N-CA 124.533 1.063 . . . . 0.0 111.615 -167.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.7 145.92 20.4 Favored Glycine 0 C--N 1.364 2.133 0 N-CA-C 120.303 2.881 . . . . 0.0 120.303 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -53.85 -42.05 68.11 Favored 'General case' 0 C--N 1.364 1.198 0 C-N-CA 129.448 3.099 . . . . 0.0 119.04 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.536 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.387 0.6 OUTLIER -102.68 -10.59 19.08 Favored 'General case' 0 C--N 1.366 1.314 0 CA-C-N 119.945 1.248 . . . . 0.0 113.104 179.032 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -73.35 92.98 1.87 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 126.383 1.873 . . . . 0.0 113.457 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 72.6 m -113.84 107.36 15.61 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 101.193 -3.632 . . . . 0.0 101.193 173.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.19 101.28 13.68 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-O 125.616 2.627 . . . . 0.0 115.463 -166.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -121.4 153.15 58.7 Favored Pre-proline 0 N--CA 1.419 -1.992 1 C-N-CA 132.848 4.459 . . . . 0.0 104.946 170.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.89 -42.18 69.68 Favored 'Trans proline' 0 C--N 1.347 0.462 1 C-N-CA 126.154 4.569 . . . . 0.0 115.725 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -59.72 -35.26 74.18 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 129.446 3.098 . . . . 0.0 114.006 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 16.8 mm -72.35 -43.46 64.5 Favored 'Isoleucine or valine' 0 C--N 1.372 1.559 0 C-N-CA 125.792 1.637 . . . . 0.0 110.569 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.72 -47.34 66.6 Favored 'General case' 0 C--N 1.372 1.578 0 O-C-N 120.101 -1.625 . . . . 0.0 113.65 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -58.82 -35.23 72.53 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 126.665 1.986 . . . . 0.0 116.172 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.73 -36.71 76.09 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 127.758 2.423 . . . . 0.0 110.94 173.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.2 mtt -69.32 -35.62 76.12 Favored 'General case' 0 C--N 1.378 1.831 0 CA-C-O 116.707 -1.616 . . . . 0.0 113.729 167.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.06 -48.99 55.58 Favored 'General case' 0 C--N 1.377 1.802 0 C-N-CA 127.335 2.254 . . . . 0.0 111.732 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.62 -47.9 71.19 Favored 'General case' 0 C--N 1.371 1.529 0 C-N-CA 128.6 2.76 . . . . 0.0 112.19 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.27 71.13 Favored 'General case' 0 C--N 1.375 1.676 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 170.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.87 -50.1 70.13 Favored 'General case' 0 C--N 1.375 1.694 0 O-C-N 120.212 -1.555 . . . . 0.0 110.363 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -33.72 71.62 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 173.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -73.42 -38.83 65.41 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.46 -38.58 34.24 Favored 'General case' 0 C--N 1.373 1.618 0 C-N-CA 125.986 1.714 . . . . 0.0 113.501 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.298 0.0 OUTLIER -87.58 -16.67 33.89 Favored 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.848 1.659 . . . . 0.0 110.901 -172.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -117.02 -106.96 0.38 Allowed 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -135.86 156.04 49.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.972 1.368 . . . . 0.0 109.564 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -51.24 -35.33 36.44 Favored 'General case' 0 C--N 1.36 1.053 1 C-N-CA 134.275 5.03 . . . . 0.0 113.932 175.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.7 tp -50.9 -31.17 9.93 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 C-N-CA 129.933 3.293 . . . . 0.0 112.458 172.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -73.04 -37.08 67.01 Favored 'General case' 0 C--N 1.377 1.766 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.639 HH21 HD11 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -75.2 -42.94 54.51 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 172.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.326 54.2 mt -73.36 -19.25 61.05 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 126.48 1.912 . . . . 0.0 113.304 -177.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.31 -37.73 67.76 Favored 'General case' 0 C--N 1.373 1.619 0 C-N-CA 128.654 2.782 . . . . 0.0 114.735 164.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.14 -45.66 5.83 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 128.705 2.802 . . . . 0.0 108.779 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 71.19 -86.07 0.03 OUTLIER 'General case' 0 C--N 1.363 1.187 0 C-N-CA 130.094 3.358 . . . . 0.0 115.782 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 128.93 2.892 . . . . 0.0 107.917 177.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 C--O 1.235 0.307 0 CA-C-O 121.301 0.572 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -150.57 81.45 1.35 Allowed 'General case' 0 C--N 1.361 1.107 0 C-N-CA 124.71 1.204 . . . . 0.0 111.066 -173.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -118.23 126.92 53.16 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.361 -1.462 . . . . 0.0 111.02 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.6 p -112.28 167.14 9.6 Favored Pre-proline 0 C--N 1.366 1.29 0 C-N-CA 127.347 2.259 . . . . 0.0 116.808 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -48.46 127.88 16.73 Favored 'Trans proline' 0 C--N 1.389 2.665 1 C-N-CA 127.151 5.234 . . . . 0.0 116.619 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.438 ' HA2' HH11 ' A' ' 190' ' ' ARG . . . 96.74 1.15 60.24 Favored Glycine 0 C--N 1.357 1.713 0 C-N-CA 124.103 0.858 . . . . 0.0 112.668 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -94.8 169.2 10.32 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 170.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -113.82 147.49 38.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 101.751 -3.426 . . . . 0.0 101.751 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.41 167.15 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -112.26 117.75 33.37 Favored 'General case' 0 N--CA 1.437 -1.105 1 N-CA-C 95.796 -5.631 . . . . 0.0 95.796 166.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.56 131.94 52.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -106.8 136.07 47.26 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 118.221 -2.8 . . . . 0.0 106.014 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 40.9 ttm -123.27 145.02 49.03 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 119.827 -1.796 . . . . 0.0 108.578 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.41 96.43 0.08 Allowed 'General case' 0 C--N 1.367 1.356 0 C-N-CA 127.469 2.307 . . . . 0.0 114.418 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.44 -6.29 24.73 Favored Glycine 0 C--N 1.359 1.851 0 C-N-CA 125.685 1.612 . . . . 0.0 113.257 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -106.67 162.07 20.87 Favored Pre-proline 0 C--N 1.355 0.812 0 C-N-CA 125.713 1.605 . . . . 0.0 109.555 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.88 166.6 29.05 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.129 3.219 . . . . 0.0 112.483 164.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -59.88 121.06 10.81 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 126.589 1.956 . . . . 0.0 114.238 170.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -125.09 116.77 25.77 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -57.42 127.16 24.38 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.865 3.71 . . . . 0.0 110.227 160.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.7 t -138.71 165.73 26.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 130.11 3.364 . . . . 0.0 111.535 -153.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 1.9 tt -130.07 131.63 45.85 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 119.82 -1.8 . . . . 0.0 106.285 176.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.84 119.36 39.09 Favored 'Isoleucine or valine' 0 C--N 1.373 1.63 0 CA-C-N 120.072 1.306 . . . . 0.0 108.942 172.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 153.58 39.81 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -165.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -90.89 113.5 25.71 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.903 2.081 . . . . 0.0 111.04 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.533 ' CD2' ' CG ' ' A' ' 130' ' ' HIS . 5.3 m-70 -67.79 162.22 60.07 Favored Pre-proline 0 C--N 1.36 1.055 0 C-N-CA 129.55 3.14 . . . . 0.0 113.461 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.25 -7.79 0.86 Allowed 'Trans proline' 0 CA--C 1.563 1.932 1 C-N-CA 125.419 4.079 . . . . 0.0 117.044 169.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.83 35.12 3.0 Favored 'General case' 0 C--N 1.358 0.949 1 C-N-CA 132.153 4.181 . . . . 0.0 107.84 173.067 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.54 149.43 43.05 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 -172.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.47 -19.96 50.79 Favored Glycine 0 C--N 1.362 1.99 0 C-N-CA 125.962 1.744 . . . . 0.0 112.011 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.92 119.96 36.42 Favored 'General case' 0 N--CA 1.447 -0.616 1 C-N-CA 132.864 4.466 . . . . 0.0 102.369 174.186 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.485 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 22.2 p90 -151.0 -2.11 0.35 Allowed 'General case' 0 C--N 1.353 0.739 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -174.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.6 pt -106.14 169.16 2.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 O-C-N 119.354 -2.091 . . . . 0.0 113.143 -175.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -159.3 153.58 23.84 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 174.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.87 127.04 8.43 Favored 'General case' 0 C--N 1.368 1.386 0 CA-C-N 123.097 2.68 . . . . 0.0 114.391 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.553 ' HG2' HH12 ' A' ' 128' ' ' ARG . 75.6 mmtt -116.81 93.42 4.19 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 120.493 -1.379 . . . . 0.0 108.223 174.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.21 -78.11 0.23 Allowed Glycine 0 C--N 1.363 2.056 0 C-N-CA 128.027 2.727 . . . . 0.0 116.287 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -118.81 -16.11 9.34 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 128.192 2.597 . . . . 0.0 109.015 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.6 m -84.41 75.24 10.26 Favored 'General case' 0 C--N 1.367 1.342 0 O-C-N 118.326 -2.734 . . . . 0.0 110.649 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 p -89.22 112.89 24.89 Favored 'Isoleucine or valine' 0 C--N 1.363 1.171 0 C-N-CA 127.789 2.435 . . . . 0.0 107.563 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.553 HH12 ' HG2' ' A' ' 123' ' ' LYS . 65.3 mtt85 -104.6 157.2 17.34 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 124.893 1.277 . . . . 0.0 111.952 -171.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.2 m -149.23 164.25 4.1 Favored 'Isoleucine or valine' 0 C--N 1.367 1.369 1 C-N-CA 132.053 4.141 . . . . 0.0 103.848 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.533 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 4.4 m170 -90.3 116.19 28.08 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 118.9 -2.375 . . . . 0.0 114.485 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . 0.276 2.3 m -143.33 156.65 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 O-C-N 119.016 -2.303 . . . . 0.0 111.587 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -112.72 153.96 26.9 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 111.635 -2.53 . . . . 0.0 111.271 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.17 116.11 27.83 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 129.13 2.972 . . . . 0.0 103.012 -174.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 15.0 m-85 -71.85 65.78 0.54 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.859 2.064 . . . . 0.0 113.37 -175.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -92.11 -119.07 0.08 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 126.898 2.079 . . . . 0.0 110.408 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.85 -52.84 2.7 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.188 1.395 . . . . 0.0 112.93 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.4 m -71.07 -44.5 14.12 Favored Pre-proline 0 C--N 1.362 1.127 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.11 -174.71 12.51 Favored 'Cis proline' 0 CA--C 1.541 0.866 0 CA-C-N 126.973 3.526 . . . . 0.0 112.257 -2.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.5 m -95.23 123.78 38.92 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.104 1.362 . . . . 0.0 109.347 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.2 tmm_? -147.47 151.44 36.4 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 120.78 1.627 . . . . 0.0 108.503 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.62 -155.48 12.92 Favored Glycine 0 CA--C 1.489 -1.583 1 N-CA-C 98.502 -5.839 . . . . 0.0 98.502 174.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -89.17 160.33 17.04 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 119.975 1.887 . . . . 0.0 110.479 172.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.53 171.21 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 O-C-N 120.455 -1.403 . . . . 0.0 109.773 174.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.1 m -100.05 116.4 32.0 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.423 11.4 pttt -68.35 -6.41 24.12 Favored 'General case' 0 C--N 1.366 1.29 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 -172.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -70.75 -15.37 62.68 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.474 1.109 . . . . 0.0 113.536 170.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.2 mt -100.41 2.9 42.74 Favored 'General case' 0 C--N 1.37 1.457 0 C-N-CA 126.693 1.997 . . . . 0.0 112.471 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.7 mp -94.92 124.47 38.99 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 128.351 2.661 . . . . 0.0 108.771 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -118.13 154.16 51.59 Favored Pre-proline 0 CA--C 1.497 -1.058 0 C-N-CA 125.932 1.693 . . . . 0.0 107.664 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -78.42 153.52 27.35 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.614 2.209 . . . . 0.0 115.451 -166.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' A' ' 183' ' ' LEU 0.311 0.0 OUTLIER -17.94 -107.29 0.0 OUTLIER 'General case' 0 C--N 1.354 0.804 2 C-N-CA 132.681 4.392 . . . . 0.0 122.551 174.747 . . . . . . . . 5 4 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.326 12.4 t 47.41 -36.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 1 C-N-CA 132.616 4.366 . . . . 0.0 119.86 -179.526 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 67.55 -148.67 49.97 Favored Glycine 0 C--N 1.35 1.351 0 C-N-CA 128.129 2.776 . . . . 0.0 119.773 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 m -46.39 -23.75 0.4 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 130.232 3.413 . . . . 0.0 119.342 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -85.62 -8.45 58.24 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.542 1.937 . . . . 0.0 113.161 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 t -85.31 155.85 21.17 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-O 123.029 1.395 . . . . 0.0 112.597 173.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -68.49 -32.74 72.94 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 127.034 2.134 . . . . 0.0 112.751 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.72 -11.87 60.08 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 125.257 1.423 . . . . 0.0 111.488 171.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.66 3.75 42.7 Favored 'General case' 0 C--N 1.371 1.522 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.257 0.9 OUTLIER -122.94 173.38 7.83 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 125.689 1.596 . . . . 0.0 109.408 174.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -61.53 122.64 15.75 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 126.567 1.947 . . . . 0.0 114.449 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.32 -14.01 51.35 Favored Glycine 0 C--N 1.358 1.757 0 C-N-CA 124.947 1.261 . . . . 0.0 111.076 -167.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.98 155.52 31.72 Favored Glycine 0 C--N 1.36 1.882 0 N-CA-C 117.186 1.634 . . . . 0.0 117.186 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -58.46 -41.59 85.53 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 120.953 3.686 . . . . 0.0 120.953 -174.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . 0.273 0.1 OUTLIER -102.2 23.32 11.83 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 122.266 2.303 . . . . 0.0 111.785 -179.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -93.17 161.32 14.47 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 124.674 2.178 . . . . 0.0 116.671 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 m 170.65 175.99 0.06 Allowed 'General case' 0 C--N 1.354 0.778 1 N-CA-C 98.554 -4.61 . . . . 0.0 98.554 -178.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -137.77 102.25 4.68 Favored 'General case' 0 C--N 1.364 1.219 0 CA-C-N 124.551 3.341 . . . . 0.0 111.286 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -119.88 141.97 32.32 Favored Pre-proline 0 N--CA 1.433 -1.279 0 C-N-CA 130.116 3.366 . . . . 0.0 105.041 173.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -58.37 -31.82 94.78 Favored 'Trans proline' 0 C--N 1.364 1.386 1 C-N-CA 127.678 5.586 . . . . 0.0 115.074 177.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -69.79 -35.97 75.3 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 130.332 3.453 . . . . 0.0 113.393 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.4 mm -70.33 -36.21 66.02 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 C-N-CA 127.17 2.188 . . . . 0.0 109.132 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.1 mt -62.73 -53.67 50.79 Favored 'General case' 0 C--N 1.382 1.982 0 C-N-CA 126.226 1.81 . . . . 0.0 111.045 173.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -57.26 -34.22 68.4 Favored 'General case' 0 C--N 1.373 1.613 0 C-N-CA 128.968 2.907 . . . . 0.0 114.374 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.0 -47.83 73.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 130.225 3.41 . . . . 0.0 111.718 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 36.3 mtt -68.45 -33.38 74.08 Favored 'General case' 0 C--N 1.369 1.423 0 CA-C-O 118.069 -0.967 . . . . 0.0 113.547 170.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -74.32 -43.71 55.61 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 126.366 1.866 . . . . 0.0 112.027 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -68.31 -47.96 66.21 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 129.116 2.966 . . . . 0.0 111.147 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.06 87.42 Favored 'General case' 0 C--N 1.382 2.015 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 170.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.257 23.1 t70 -54.5 -47.44 73.07 Favored 'General case' 0 C--N 1.376 1.753 0 C-N-CA 127.17 2.188 . . . . 0.0 114.161 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -66.0 -43.0 89.01 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-N 120.8 1.636 . . . . 0.0 115.366 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 190' ' ' ARG . . . -76.12 -29.05 57.7 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.5 pp -80.0 -32.58 39.71 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 175.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.277 0.4 OUTLIER -89.68 -34.28 16.31 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 125.393 1.477 . . . . 0.0 111.199 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -100.48 -99.61 0.25 Allowed 'General case' 0 C--N 1.362 1.151 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -135.49 152.22 51.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.223 -1.548 . . . . 0.0 110.27 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.431 16.4 ptpt -50.92 -33.31 23.79 Favored 'General case' 0 C--N 1.358 0.967 1 C-N-CA 133.193 4.597 . . . . 0.0 113.898 172.222 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.497 HG21 ' HZ2' ' A' ' 189' ' ' LYS . 13.5 tt -50.6 -27.97 5.25 Favored 'Isoleucine or valine' 0 C--N 1.368 1.393 0 C-N-CA 127.923 2.489 . . . . 0.0 113.032 172.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.497 ' HZ2' HG21 ' A' ' 188' ' ' ILE . 2.4 mptp? -72.72 -39.27 67.08 Favored 'General case' 0 C--N 1.377 1.764 0 C-N-CA 126.343 1.857 . . . . 0.0 114.75 170.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.438 HH11 ' HA2' ' A' ' 93' ' ' GLY 0.283 0.0 OUTLIER -74.68 -34.41 62.66 Favored 'General case' 0 C--N 1.367 1.362 0 O-C-N 119.286 -2.134 . . . . 0.0 114.859 172.871 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.8 -22.45 56.34 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 126.323 1.849 . . . . 0.0 112.901 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.26 -46.15 86.53 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 126.478 1.911 . . . . 0.0 114.309 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . 0.264 0.2 OUTLIER -105.56 22.14 16.0 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 128.208 2.603 . . . . 0.0 112.922 176.201 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -49.59 141.81 9.05 Favored 'General case' 0 C--N 1.374 1.663 0 C-N-CA 128.991 2.916 . . . . 0.0 118.823 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.368 5.3 p . . . . . 0 C--N 1.374 1.657 0 CA-C-O 125.636 2.636 . . . . 0.0 114.966 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 CA--C 1.511 -0.528 0 CA-C-O 120.722 0.296 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -97.61 99.88 11.27 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -124.42 126.51 46.06 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 124.431 1.093 . . . . 0.0 112.393 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.345 88.8 p -112.12 170.86 4.83 Favored Pre-proline 0 CA--C 1.558 1.279 1 C-N-CA 133.022 4.529 . . . . 0.0 116.524 -177.18 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -41.69 128.55 3.71 Favored 'Trans proline' 0 C--N 1.389 2.691 1 C-N-CA 127.927 5.751 . . . . 0.0 118.879 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.08 4.38 78.25 Favored Glycine 0 CA--C 1.477 -2.314 0 C-N-CA 129.382 3.372 . . . . 0.0 117.223 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -93.59 148.57 21.97 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 168.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.97 126.31 52.96 Favored 'General case' 0 N--CA 1.441 -0.902 1 N-CA-C 99.834 -4.135 . . . . 0.0 99.834 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.3 154.93 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -99.9 122.15 42.4 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 101.832 -3.396 . . . . 0.0 101.832 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.97 131.12 55.36 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 127.831 2.452 . . . . 0.0 110.77 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.87 135.85 49.39 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 174.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.0 ttp -130.08 153.55 48.36 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 119.946 -1.721 . . . . 0.0 112.098 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -63.22 90.25 0.04 OUTLIER 'General case' 0 C--N 1.364 1.224 0 C-N-CA 129.206 3.002 . . . . 0.0 114.734 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.46 -0.77 24.99 Favored Glycine 0 C--N 1.358 1.804 0 C-N-CA 125.786 1.66 . . . . 0.0 113.028 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -108.25 161.39 23.58 Favored Pre-proline 0 C--N 1.357 0.911 0 C-N-CA 125.366 1.466 . . . . 0.0 110.296 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.48 166.49 29.2 Favored 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 124.976 3.784 . . . . 0.0 111.65 164.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.6 121.53 16.62 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 126.454 1.902 . . . . 0.0 109.557 173.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.282 0.8 OUTLIER -128.64 135.16 27.16 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 119.267 3.062 . . . . 0.0 119.267 -167.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.51 149.19 90.75 Favored 'Trans proline' 0 CA--C 1.567 2.154 0 C-N-CA 124.722 3.615 . . . . 0.0 113.763 153.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 p -155.34 161.91 40.95 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 125.554 1.541 . . . . 0.0 112.464 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.455 ' CD2' ' HB2' ' A' ' 190' ' ' ARG . 2.3 pp -115.7 137.16 52.36 Favored 'General case' 0 C--N 1.374 1.66 0 O-C-N 120.386 -1.446 . . . . 0.0 110.594 171.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.436 HG11 HG12 ' A' ' 131' ' ' VAL . 2.2 t -93.86 118.97 40.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 C-N-CA 125.603 1.561 . . . . 0.0 109.141 170.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 109' ' ' LEU 0.288 0.1 OUTLIER -137.81 155.62 48.81 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 128.481 2.713 . . . . 0.0 110.747 -177.746 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -71.42 113.63 8.66 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 125.588 1.555 . . . . 0.0 113.105 170.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -89.59 159.0 44.76 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 113.798 -3.001 . . . . 0.0 106.631 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.288 46.4 Cg_exo -47.99 -0.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 2 C-N-CA 127.361 5.374 . . . . 0.0 122.745 -166.239 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -82.29 -26.17 33.34 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 128.15 2.58 . . . . 0.0 109.926 167.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 27.47 95.11 0.0 OUTLIER 'General case' 0 C--N 1.37 1.466 1 C-N-CA 135.226 5.41 . . . . 0.0 121.2 178.375 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.67 -20.85 26.68 Favored Glycine 0 C--N 1.357 1.699 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 39.9 m -107.67 118.16 36.0 Favored 'General case' 0 C--N 1.357 0.905 1 N-CA-C 98.954 -4.461 . . . . 0.0 98.954 165.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -147.35 0.82 0.71 Allowed 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.996 -1.065 . . . . 0.0 111.442 -171.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.4 pt -109.9 156.97 10.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 CA-C-O 121.97 0.891 . . . . 0.0 110.614 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -149.85 152.19 34.72 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.23 131.39 19.42 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 120.352 -1.468 . . . . 0.0 110.539 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -117.94 93.52 4.17 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.687 1.995 . . . . 0.0 110.558 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.38 -83.24 0.44 Allowed Glycine 0 C--N 1.362 2.002 0 N-CA-C 119.247 2.459 . . . . 0.0 119.247 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -138.32 52.77 1.82 Allowed 'General case' 0 C--N 1.36 1.025 0 C-N-CA 125.616 1.566 . . . . 0.0 110.365 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.1 m -171.96 142.2 1.44 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 p -119.9 136.91 55.49 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 C-N-CA 124.708 1.203 . . . . 0.0 110.871 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -119.62 143.16 47.83 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 127.623 2.369 . . . . 0.0 111.489 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.01 162.86 35.49 Favored 'Isoleucine or valine' 0 C--N 1.37 1.468 0 C-N-CA 130.052 3.341 . . . . 0.0 107.042 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -97.02 119.68 35.94 Favored 'General case' 0 C--N 1.371 1.526 0 O-C-N 119.147 -2.221 . . . . 0.0 112.305 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.436 HG12 HG11 ' A' ' 110' ' ' VAL . 0.9 OUTLIER -145.51 166.22 10.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.353 0 C-N-CA 127.709 2.404 . . . . 0.0 105.543 -177.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.2 147.56 47.93 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.332 1.453 . . . . 0.0 108.423 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -96.15 127.91 42.58 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 128.73 2.812 . . . . 0.0 106.214 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 109' ' ' LEU . 17.0 m-30 -72.61 59.37 0.45 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -174.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -94.93 -119.95 0.1 Allowed 'General case' 0 C--N 1.36 1.036 0 C-N-CA 127.238 2.215 . . . . 0.0 111.643 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -103.04 -52.43 3.04 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 125.129 1.372 . . . . 0.0 113.349 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.0 m -66.63 -43.81 52.17 Favored Pre-proline 0 C--N 1.366 1.323 0 N-CA-C 117.99 2.589 . . . . 0.0 117.99 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -80.12 173.61 52.32 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 CA-C-N 125.693 3.069 . . . . 0.0 110.753 -5.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.5 m -81.62 134.67 35.51 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.196 -1.565 . . . . 0.0 110.191 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.5 ttp-105 -141.96 157.78 44.55 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 121.098 1.772 . . . . 0.0 109.153 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.16 -159.92 28.42 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 103.679 -3.768 . . . . 0.0 103.679 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -97.48 108.45 21.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.523 2.329 . . . . 0.0 107.17 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 m -88.81 160.75 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.182 0 C-N-CA 126.941 2.096 . . . . 0.0 110.52 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.9 m -82.68 114.97 21.41 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.407 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 7.2 ttmt -72.85 -16.76 61.59 Favored 'General case' 0 C--N 1.359 0.985 0 CA-C-O 122.752 1.263 . . . . 0.0 113.962 -169.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -76.03 -5.85 48.31 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.266 -1.522 . . . . 0.0 113.547 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 75.1 mt -105.39 14.8 28.23 Favored 'General case' 0 C--N 1.37 1.461 0 C-N-CA 126.956 2.102 . . . . 0.0 110.844 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 29.2 mt -100.32 125.46 46.55 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 126.453 1.901 . . . . 0.0 107.81 173.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.72 163.14 20.37 Favored Pre-proline 0 C--O 1.226 -0.172 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -79.53 141.1 15.48 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.844 3.029 . . . . 0.0 112.515 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.95 140.06 30.16 Favored 'General case' 0 C--N 1.365 1.263 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 171.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.403 ' HA ' ' CD1' ' A' ' 183' ' ' LEU . 13.5 t -164.24 -15.97 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.39 114.48 0.47 Allowed Glycine 0 C--N 1.352 1.469 0 C-N-CA 116.471 -2.776 . . . . 0.0 114.201 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 50.1 m -65.22 -10.63 33.31 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 127.835 2.454 . . . . 0.0 117.283 176.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.27 27.7 9.41 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 127.55 2.34 . . . . 0.0 109.19 175.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.7 t -99.42 142.84 30.38 Favored 'General case' 0 CA--C 1.48 -1.712 0 C-N-CA 128.278 2.631 . . . . 0.0 107.329 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.4 tptt -47.79 -40.63 21.43 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 127.393 2.277 . . . . 0.0 116.615 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -73.97 -15.6 61.1 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 124.744 1.218 . . . . 0.0 113.822 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.77 -1.52 40.24 Favored 'General case' 0 C--N 1.379 1.857 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -126.94 -173.77 2.97 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.255 1.422 . . . . 0.0 113.667 -176.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -61.93 121.88 14.07 Favored 'General case' 0 C--N 1.38 1.927 0 C-N-CA 125.921 1.688 . . . . 0.0 113.227 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.9 -6.19 73.06 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 124.307 0.956 . . . . 0.0 114.095 -170.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.53 158.45 37.46 Favored Glycine 0 C--N 1.369 2.377 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -59.72 -41.84 91.79 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.86 -30.04 13.38 Favored 'General case' 0 C--N 1.365 1.25 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 3.1 t80 19.53 -101.42 0.01 OUTLIER 'General case' 0 C--N 1.388 2.282 1 C-N-CA 132.971 4.509 . . . . 0.0 114.575 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m 54.26 57.65 5.69 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 129.378 3.071 . . . . 0.0 115.51 170.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.43 101.08 12.32 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 124.941 2.305 . . . . 0.0 113.112 -171.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -120.34 147.03 44.17 Favored Pre-proline 0 N--CA 1.43 -1.464 1 C-N-CA 133.231 4.612 . . . . 0.0 103.42 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -56.76 -33.79 94.9 Favored 'Trans proline' 0 CA--C 1.545 1.058 1 C-N-CA 125.883 4.389 . . . . 0.0 116.741 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.83 -36.28 80.08 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.698 1.999 . . . . 0.0 112.4 173.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.256 6.5 mt -76.0 -32.62 23.55 Favored 'Isoleucine or valine' 0 C--N 1.369 1.425 0 C-N-CA 126.648 1.979 . . . . 0.0 110.566 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . 0.276 35.7 mt -62.57 -53.85 48.55 Favored 'General case' 0 C--N 1.387 2.226 0 C-N-CA 127.391 2.276 . . . . 0.0 110.269 172.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -57.76 -43.23 85.31 Favored 'General case' 0 C--N 1.369 1.418 0 C-N-CA 129.743 3.217 . . . . 0.0 114.197 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.26 -35.5 76.15 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 130.769 3.628 . . . . 0.0 111.454 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.0 mtt -68.09 -40.17 82.69 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.108 1.763 . . . . 0.0 110.384 168.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -66.17 -50.3 64.41 Favored 'General case' 0 C--N 1.374 1.655 0 C-N-CA 126.142 1.777 . . . . 0.0 112.258 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.298 4.7 ptt180 -71.65 -37.53 70.8 Favored 'General case' 0 C--N 1.382 2.001 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 175.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.22 68.77 Favored 'General case' 0 C--N 1.373 1.612 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 169.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 20.6 t0 -70.11 -48.79 56.11 Favored 'General case' 0 C--N 1.372 1.546 0 O-C-N 119.212 -2.18 . . . . 0.0 110.569 168.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -53.37 -47.81 69.13 Favored 'General case' 0 C--N 1.373 1.629 0 C-N-CA 128.88 2.872 . . . . 0.0 114.696 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -68.11 -29.34 68.24 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' A' ' 152' ' ' THR 0.267 0.2 OUTLIER -81.35 -41.85 21.41 Favored 'General case' 0 C--N 1.367 1.365 0 O-C-N 118.552 -2.592 . . . . 0.0 112.811 171.077 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 180' ' ' ASP 0.277 0.0 OUTLIER -70.91 -30.3 66.59 Favored 'General case' 0 C--N 1.379 1.889 0 C-N-CA 129.359 3.064 . . . . 0.0 112.676 -173.402 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -103.99 -100.59 0.31 Allowed 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.374 0.607 . . . . 0.0 109.712 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -136.62 144.03 43.84 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.675 7.1 pttm -51.19 -33.73 28.62 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 129.972 3.309 . . . . 0.0 116.41 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.78 -28.29 3.94 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 C-N-CA 129.096 2.958 . . . . 0.0 112.586 169.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.295 2.4 mptp? -64.79 -30.95 71.98 Favored 'General case' 0 C--N 1.374 1.642 0 C-N-CA 126.861 2.064 . . . . 0.0 115.479 168.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . 0.455 ' HB2' ' CD2' ' A' ' 109' ' ' LEU 0.381 0.0 OUTLIER -75.51 -41.35 55.5 Favored 'General case' 0 C--N 1.38 1.911 0 CA-C-N 123.046 2.657 . . . . 0.0 113.16 167.53 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 43.7 mt -69.38 -19.7 63.83 Favored 'General case' 0 C--N 1.378 1.843 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -64.68 -24.17 67.49 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 129.902 3.281 . . . . 0.0 112.55 170.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.3 mt -105.93 -49.35 3.41 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 55.85 -128.81 2.02 Favored 'General case' 0 C--N 1.375 1.701 0 C-N-CA 128.683 2.793 . . . . 0.0 110.871 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.535 0.394 0 C-N-CA 124.802 1.241 . . . . 0.0 112.076 175.745 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -148.01 105.49 3.67 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 121.078 -1.014 . . . . 0.0 109.631 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -124.61 128.37 48.78 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 126.019 1.728 . . . . 0.0 108.958 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 119' ' ' PHE . 0.7 OUTLIER -110.54 164.55 14.59 Favored Pre-proline 0 C--N 1.355 0.827 0 C-N-CA 125.052 1.341 . . . . 0.0 113.747 -175.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -45.01 135.0 10.8 Favored 'Trans proline' 0 C--N 1.373 1.864 1 C-N-CA 127.828 5.686 . . . . 0.0 119.642 -173.007 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.74 -6.45 54.76 Favored Glycine 0 C--N 1.366 2.211 0 C-N-CA 125.777 1.656 . . . . 0.0 112.11 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -94.3 169.65 10.08 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.265 2.033 . . . . 0.0 112.827 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.18 138.57 38.95 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 102.891 -3.003 . . . . 0.0 102.891 164.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.76 132.5 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.409 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 12.3 m95 -89.49 122.45 32.68 Favored 'General case' 0 N--CA 1.478 0.931 1 O-C-N 116.24 -4.037 . . . . 0.0 106.081 175.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.15 131.62 53.2 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 122.71 1.243 . . . . 0.0 113.124 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -102.33 135.48 43.86 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -122.53 147.65 46.12 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 104.566 -2.383 . . . . 0.0 104.566 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.79 107.93 1.59 Allowed 'General case' 0 C--N 1.354 0.772 0 C-N-CA 126.217 1.807 . . . . 0.0 113.114 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.32 -15.25 46.88 Favored Glycine 0 C--N 1.354 1.57 0 C-N-CA 124.769 1.176 . . . . 0.0 114.599 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . 0.256 0.0 OUTLIER -102.25 168.28 9.19 Favored Pre-proline 0 C--N 1.363 1.159 0 CA-C-N 119.659 1.729 . . . . 0.0 111.94 -178.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.76 158.52 50.23 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 125.196 3.931 . . . . 0.0 113.583 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -54.95 129.38 37.47 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 128.948 2.899 . . . . 0.0 115.351 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -134.04 126.58 18.72 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 119.768 3.247 . . . . 0.0 119.768 -172.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 2.9 Cg_exo -67.21 117.64 4.97 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 124.944 3.763 . . . . 0.0 113.695 164.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.94 164.37 17.71 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 131.257 3.823 . . . . 0.0 114.335 -170.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp -120.99 132.77 55.12 Favored 'General case' 0 C--N 1.345 0.409 0 O-C-N 118.563 -2.586 . . . . 0.0 107.381 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -91.51 129.79 41.67 Favored 'Isoleucine or valine' 0 C--N 1.374 1.638 0 CA-C-N 119.987 1.267 . . . . 0.0 108.216 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.345 0.0 OUTLIER -138.64 153.27 48.59 Favored 'General case' 0 C--N 1.372 1.563 0 O-C-N 117.922 -2.986 . . . . 0.0 117.351 -173.111 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -87.92 112.31 22.4 Favored 'General case' 0 C--N 1.368 1.413 0 CA-C-O 123.386 1.565 . . . . 0.0 109.246 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -97.33 154.99 37.86 Favored Pre-proline 0 N--CA 1.447 -0.599 0 C-N-CA 129.377 3.071 . . . . 0.0 108.115 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -56.68 -0.96 0.28 Allowed 'Trans proline' 0 N--CA 1.487 1.121 1 C-N-CA 126.524 4.816 . . . . 0.0 121.076 -165.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.79 -7.81 58.52 Favored 'General case' 0 C--N 1.363 1.191 0 C-N-CA 129.404 3.082 . . . . 0.0 109.624 170.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -30.18 139.99 0.02 OUTLIER 'General case' 0 C--N 1.375 1.715 1 C-N-CA 134.153 4.981 . . . . 0.0 121.361 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.22 -20.24 28.55 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 113.456 -1.702 . . . . 0.0 109.236 175.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.6 p -125.5 118.78 26.53 Favored 'General case' 0 C--N 1.348 0.514 1 N-CA-C 96.518 -5.364 . . . . 0.0 96.518 164.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 91' ' ' SER . 31.2 p90 -123.87 4.73 8.74 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 119.688 1.131 . . . . 0.0 112.12 -172.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.5 pt -110.12 166.43 5.16 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.746 1.218 . . . . 0.0 110.401 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -151.04 147.36 27.01 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.826 2.45 . . . . 0.0 105.201 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.06 134.67 15.4 Favored 'General case' 0 C--N 1.357 0.935 0 O-C-N 120.546 -1.346 . . . . 0.0 110.702 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 93.55 4.17 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 127.921 2.488 . . . . 0.0 108.834 175.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.32 -74.38 0.14 Allowed Glycine 0 C--N 1.361 1.971 0 N-CA-C 121.212 3.245 . . . . 0.0 121.212 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.32 37.58 3.53 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.775 1.63 . . . . 0.0 111.488 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m -166.22 151.6 8.46 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 119.461 -2.025 . . . . 0.0 107.286 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.47 144.58 32.41 Favored 'Isoleucine or valine' 0 C--N 1.366 1.293 0 C-N-CA 126.023 1.729 . . . . 0.0 111.126 -174.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -135.55 154.76 51.27 Favored 'General case' 0 C--N 1.366 1.298 0 C-N-CA 127.975 2.51 . . . . 0.0 113.931 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.3 m -126.28 162.74 29.57 Favored 'Isoleucine or valine' 0 C--N 1.38 1.904 0 C-N-CA 130.77 3.628 . . . . 0.0 106.144 173.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -86.42 116.42 24.56 Favored 'General case' 0 C--N 1.365 1.275 0 O-C-N 119.695 -1.878 . . . . 0.0 110.815 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.459 ' HB ' HG21 ' A' ' 143' ' ' VAL . 2.3 t -138.67 150.13 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 C-N-CA 125.044 1.338 . . . . 0.0 107.714 -174.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -118.7 144.93 45.91 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 170.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -100.22 131.05 46.39 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.53 72.59 2.52 Favored 'General case' 0 C--N 1.38 1.893 0 C-N-CA 125.098 1.359 . . . . 0.0 111.542 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -97.9 -103.9 0.19 Allowed 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.518 1.127 . . . . 0.0 111.002 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -106.61 -62.44 1.39 Allowed 'General case' 0 C--N 1.354 0.763 0 C-N-CA 126.051 1.74 . . . . 0.0 113.75 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 p -88.27 -29.14 0.37 Allowed Pre-proline 0 C--N 1.364 1.196 0 N-CA-C 118.945 2.943 . . . . 0.0 118.945 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.5 -177.84 18.72 Favored 'Cis proline' 0 C--N 1.357 1.025 1 CA-C-N 129.585 4.459 . . . . 0.0 113.386 -2.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 64.2 m -98.12 113.37 25.24 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 127.889 2.476 . . . . 0.0 113.585 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -113.41 161.53 17.19 Favored 'General case' 0 C--N 1.363 1.155 0 CA-C-N 124.972 3.533 . . . . 0.0 108.086 172.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.58 -170.33 31.34 Favored Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 103.359 -3.896 . . . . 0.0 103.359 168.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -93.93 110.21 21.9 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 172.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.459 HG21 ' HB ' ' A' ' 131' ' ' VAL . 17.6 m -94.6 157.16 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 C-N-CA 125.949 1.7 . . . . 0.0 110.947 -175.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.5 t -79.14 110.98 14.91 Favored 'General case' 0 C--N 1.364 1.222 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.419 0.0 OUTLIER -65.73 -14.89 62.2 Favored 'General case' 0 C--N 1.366 1.295 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -172.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -74.76 -3.87 34.2 Favored 'General case' 0 N--CA 1.434 -1.227 1 C-N-CA 132.798 4.439 . . . . 0.0 112.933 170.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.3 mt -109.73 2.29 19.99 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.391 2.276 . . . . 0.0 110.902 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.8 mt -96.41 153.22 17.95 Favored 'General case' 0 C--N 1.373 1.615 0 O-C-N 120.069 -1.644 . . . . 0.0 113.19 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -119.02 155.21 53.28 Favored Pre-proline 0 C--N 1.351 0.654 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -82.76 155.53 15.61 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 125.403 2.965 . . . . 0.0 113.069 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -35.63 -87.89 0.0 OUTLIER 'General case' 0 C--N 1.348 0.512 2 C-N-CA 132.297 4.239 . . . . 0.0 122.4 -177.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.6 t -31.48 24.94 0.0 OUTLIER 'General case' 0 C--N 1.359 0.988 1 C-N-CA 138.555 6.742 . . . . 0.0 120.643 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.03 0.4 47.9 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 -165.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . 0.256 5.8 p -62.73 -15.53 53.46 Favored 'General case' 0 C--N 1.366 1.289 0 CA-C-N 120.988 2.394 . . . . 0.0 117.287 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -91.47 -6.7 52.25 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 128.808 2.843 . . . . 0.0 111.107 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.0 p -90.85 147.85 22.9 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 127.34 2.256 . . . . 0.0 112.775 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -62.19 -18.47 61.11 Favored 'General case' 0 C--N 1.37 1.475 0 C-N-CA 126.82 2.048 . . . . 0.0 113.517 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -75.87 -26.51 57.13 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 127.452 2.301 . . . . 0.0 112.696 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.63 -12.89 38.38 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -114.91 -178.91 3.48 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 126.177 1.791 . . . . 0.0 111.4 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -57.74 122.75 13.58 Favored 'General case' 0 C--N 1.372 1.55 0 C-N-CA 127.243 2.217 . . . . 0.0 115.134 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.12 -10.95 58.58 Favored Glycine 0 C--N 1.357 1.72 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.81 -167.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -84.33 160.34 36.26 Favored Glycine 0 C--N 1.363 2.058 0 N-CA-C 121.13 3.212 . . . . 0.0 121.13 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -60.38 -30.0 69.29 Favored 'General case' 0 C--N 1.369 1.447 0 C-N-CA 128.915 2.886 . . . . 0.0 118.691 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -105.34 7.9 33.52 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.357 -1.464 . . . . 0.0 110.456 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -87.78 162.64 16.9 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -171.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.5 m 174.91 176.75 0.16 Allowed 'General case' 0 C--N 1.353 0.724 1 N-CA-C 99.097 -4.409 . . . . 0.0 99.097 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -138.71 102.29 4.54 Favored 'General case' 0 C--N 1.364 1.228 0 CA-C-N 124.187 3.176 . . . . 0.0 111.288 173.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -119.74 138.32 26.62 Favored Pre-proline 0 N--CA 1.435 -1.21 0 C-N-CA 130.269 3.428 . . . . 0.0 105.766 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -59.4 -27.44 84.99 Favored 'Trans proline' 0 C--N 1.363 1.334 1 C-N-CA 127.013 5.142 . . . . 0.0 115.086 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -70.02 -36.85 75.38 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 129.465 3.106 . . . . 0.0 113.167 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.2 mt -70.45 -34.89 59.63 Favored 'Isoleucine or valine' 0 C--N 1.381 1.977 0 C-N-CA 126.677 1.991 . . . . 0.0 110.056 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.69 -53.26 60.05 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 125.987 1.715 . . . . 0.0 110.742 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -57.55 -34.6 69.34 Favored 'General case' 0 C--N 1.367 1.356 0 C-N-CA 128.217 2.607 . . . . 0.0 115.403 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.81 -42.83 80.94 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 129.191 2.996 . . . . 0.0 111.662 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 18.1 mtt -69.98 -33.24 71.8 Favored 'General case' 0 C--N 1.372 1.546 0 CA-C-O 117.282 -1.342 . . . . 0.0 113.193 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -74.29 -42.64 59.23 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-N 121.713 2.051 . . . . 0.0 111.109 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -68.54 -49.65 57.91 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 127.348 2.259 . . . . 0.0 111.418 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.57 -41.39 98.9 Favored 'General case' 0 C--N 1.374 1.645 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 173.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.33 -37.26 84.94 Favored 'General case' 0 C--N 1.379 1.876 0 C-N-CA 128.808 2.843 . . . . 0.0 111.353 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -72.03 -44.81 62.79 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 119.828 -1.795 . . . . 0.0 112.481 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -73.0 -38.89 66.46 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.23 -37.28 77.94 Favored 'General case' 0 C--N 1.374 1.645 0 C-N-CA 127.243 2.217 . . . . 0.0 115.056 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.72 -31.95 25.77 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 127.103 2.161 . . . . 0.0 111.451 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -105.13 -98.46 0.33 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -135.63 150.73 49.73 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.819 -1.176 . . . . 0.0 112.347 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.277 24.6 ttpp -51.69 -36.37 46.34 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 131.485 3.914 . . . . 0.0 115.385 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.8 tp -53.24 -27.59 13.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 129.219 3.007 . . . . 0.0 112.409 172.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -75.78 -41.27 53.45 Favored 'General case' 0 C--N 1.372 1.555 0 O-C-N 119.483 -2.011 . . . . 0.0 114.636 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -74.61 -37.06 62.94 Favored 'General case' 0 C--N 1.366 1.295 0 O-C-N 118.832 -2.418 . . . . 0.0 116.466 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.0 tp -79.92 -27.82 39.84 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.919 2.087 . . . . 0.0 113.052 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -77.43 -27.42 52.21 Favored 'General case' 0 C--N 1.371 1.541 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 171.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.83 -2.06 54.04 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 124.618 1.167 . . . . 0.0 111.108 175.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 21.9 -124.76 0.01 OUTLIER 'General case' 0 C--N 1.361 1.068 1 C-N-CA 133.807 4.843 . . . . 0.0 121.752 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.349 0.555 0 O-C-N 119.8 -1.813 . . . . 0.0 110.575 -176.923 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.413 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 47.2 m . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.66 64.05 0.47 Allowed 'General case' 0 C--N 1.366 1.308 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -172.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -116.45 124.15 49.28 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.147 -1.596 . . . . 0.0 108.645 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.9 p -112.33 165.26 13.37 Favored Pre-proline 0 C--N 1.362 1.127 0 C-N-CA 126.999 2.12 . . . . 0.0 114.651 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -52.22 138.22 54.76 Favored 'Trans proline' 0 C--N 1.371 1.747 1 C-N-CA 126.21 4.607 . . . . 0.0 120.483 -170.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.91 -12.43 38.05 Favored Glycine 0 C--N 1.365 2.169 0 C-N-CA 125.019 1.295 . . . . 0.0 110.418 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.66 170.08 9.72 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 120.37 2.085 . . . . 0.0 111.982 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.9 mm? -101.33 145.9 28.29 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 163.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.1 m -143.1 157.26 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.425 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 66.9 m95 -108.39 123.33 48.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 102.064 -3.31 . . . . 0.0 102.064 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.4 136.64 54.19 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.509 1.523 . . . . 0.0 112.932 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -109.51 145.41 36.32 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 tpt -129.18 150.23 50.65 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 118.622 -2.549 . . . . 0.0 110.042 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.26 90.18 0.07 Allowed 'General case' 0 C--N 1.368 1.406 0 C-N-CA 126.307 1.843 . . . . 0.0 115.622 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.19 1.47 25.07 Favored Glycine 0 C--N 1.359 1.841 0 C-N-CA 125.715 1.626 . . . . 0.0 112.983 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -108.82 161.36 23.92 Favored Pre-proline 0 C--N 1.354 0.786 0 C-N-CA 126.201 1.8 . . . . 0.0 109.352 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.76 167.6 26.11 Favored 'Trans proline' 0 CA--C 1.545 1.055 1 C-N-CA 125.323 4.015 . . . . 0.0 113.295 162.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.437 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 1.8 m95 -57.62 121.54 10.59 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 128.066 2.546 . . . . 0.0 115.301 170.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -123.76 111.83 29.21 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 119.252 3.056 . . . . 0.0 119.252 -172.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.425 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 4.6 Cg_exo -58.5 124.21 15.31 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 125.136 3.891 . . . . 0.0 111.227 162.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.8 p -137.82 165.5 26.31 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 128.461 2.704 . . . . 0.0 115.391 -161.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp -119.97 132.67 55.58 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.968 2.107 . . . . 0.0 105.952 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.437 HG22 HG11 ' A' ' 131' ' ' VAL . 2.9 p -83.61 118.98 32.04 Favored 'Isoleucine or valine' 0 C--N 1.381 1.959 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 173.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.71 143.39 49.83 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.036 -1.665 . . . . 0.0 111.794 -164.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 6.8 p-10 -98.0 118.53 34.8 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 119.349 -2.094 . . . . 0.0 112.049 174.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.538 ' H ' ' CE1' ' A' ' 130' ' ' HIS . 2.4 m-70 -71.79 159.78 84.5 Favored Pre-proline 0 C--N 1.358 0.95 0 C-N-CA 128.191 2.596 . . . . 0.0 108.303 169.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.17 -9.06 1.89 Allowed 'Trans proline' 0 CA--C 1.552 1.398 1 C-N-CA 126.563 4.842 . . . . 0.0 116.446 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -63.39 -18.48 63.73 Favored 'General case' 0 C--N 1.36 1.053 1 C-N-CA 134.752 5.221 . . . . 0.0 113.561 166.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 112' ' ' ASN 0.341 0.0 OUTLIER -28.78 136.49 0.02 OUTLIER 'General case' 0 C--N 1.381 1.962 0 N-CA-C 120.926 3.676 . . . . 0.0 120.926 -177.249 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.91 -19.77 27.48 Favored Glycine 0 C--N 1.361 1.936 0 CA-C-O 123.432 1.573 . . . . 0.0 109.633 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.4 m -141.99 119.66 11.8 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 100.269 -3.974 . . . . 0.0 100.269 164.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.4 ' HB2' ' CE1' ' A' ' 130' ' ' HIS . 26.1 p90 -123.98 10.65 8.86 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.764 -1.21 . . . . 0.0 109.154 -176.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.2 pt -121.57 157.12 25.51 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 CA-C-O 123.637 1.684 . . . . 0.0 111.921 -173.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.0 mtp-105 -137.38 149.1 46.72 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 130.467 3.507 . . . . 0.0 102.421 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.1 139.83 24.96 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 120.267 -1.521 . . . . 0.0 109.184 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -118.27 93.69 4.22 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 126.59 1.956 . . . . 0.0 109.622 175.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.63 -76.32 0.21 Allowed Glycine 0 C--N 1.366 2.249 0 N-CA-C 118.635 2.214 . . . . 0.0 118.635 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -141.18 22.7 2.22 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 125.763 1.625 . . . . 0.0 110.073 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.4 t -125.88 128.55 47.77 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 126.493 1.917 . . . . 0.0 108.674 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.21 116.06 49.74 Favored 'Isoleucine or valine' 0 C--N 1.358 0.949 0 C-N-CA 126.625 1.97 . . . . 0.0 112.406 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -113.84 130.68 56.45 Favored 'General case' 0 C--N 1.367 1.329 0 C-N-CA 127.362 2.265 . . . . 0.0 111.256 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 m -125.37 159.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.364 1.217 0 C-N-CA 127.438 2.295 . . . . 0.0 106.578 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.538 ' CE1' ' H ' ' A' ' 113' ' ' HIS . 3.8 p80 -90.46 129.76 36.6 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 125.262 1.425 . . . . 0.0 113.268 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.437 HG11 HG22 ' A' ' 110' ' ' VAL . 3.3 m -146.47 165.3 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 C-N-CA 128.358 2.663 . . . . 0.0 106.612 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -126.05 143.18 51.21 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.092 0.557 . . . . 0.0 109.909 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.55 123.91 39.32 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 129.666 3.186 . . . . 0.0 107.885 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -75.69 70.57 2.5 Favored 'General case' 0 C--N 1.374 1.654 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -90.79 -114.38 0.08 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.203 1.801 . . . . 0.0 110.96 -175.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -107.07 -51.99 2.83 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 126.183 1.793 . . . . 0.0 112.105 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.3 m -73.68 -45.92 7.16 Favored Pre-proline 0 C--N 1.366 1.295 0 N-CA-C 119.396 3.11 . . . . 0.0 119.396 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -85.29 177.31 27.38 Favored 'Cis proline' 0 CA--C 1.548 1.175 0 CA-C-N 127.452 3.697 . . . . 0.0 112.832 -1.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 84.5 m -95.08 119.98 34.52 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 120.058 -1.651 . . . . 0.0 110.83 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -132.19 148.03 52.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 121.351 1.887 . . . . 0.0 108.484 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.34 -166.65 30.47 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.59 111.92 17.47 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 127.233 2.213 . . . . 0.0 109.591 175.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.7 m -98.45 169.7 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 C-N-CA 125.275 1.43 . . . . 0.0 108.302 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.8 m -95.74 124.53 39.8 Favored 'General case' 0 C--N 1.364 1.199 0 N-CA-C 101.157 -3.646 . . . . 0.0 101.157 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -70.46 -9.06 55.48 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 124.359 3.254 . . . . 0.0 117.451 -168.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.413 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 15.8 ptp180 -73.34 -6.26 44.98 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 129.622 3.169 . . . . 0.0 115.291 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . 0.264 0.8 OUTLIER -112.94 11.63 19.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.839 0.856 . . . . 0.0 110.371 176.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 4.8 mt -98.01 125.37 42.93 Favored 'General case' 0 C--N 1.38 1.903 0 C-N-CA 126.381 1.872 . . . . 0.0 107.898 173.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -114.15 161.57 27.48 Favored Pre-proline 0 C--N 1.346 0.426 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.32 153.59 14.06 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 124.959 2.807 . . . . 0.0 113.628 -174.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' A' ' 95' ' ' LEU 0.296 0.1 OUTLIER -29.87 -84.14 0.0 OUTLIER 'General case' 0 C--N 1.353 0.76 2 N-CA-C 123.685 4.698 . . . . 0.0 123.685 -179.943 . . . . . . . . 5 4 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.8 t -34.27 38.34 0.0 OUTLIER 'General case' 0 C--N 1.373 1.616 1 C-N-CA 136.961 6.105 . . . . 0.0 118.154 -176.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.51 -36.86 2.36 Favored Glycine 0 C--N 1.358 1.788 0 C-N-CA 128.802 3.096 . . . . 0.0 117.969 -168.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 38.0 m -48.6 -15.41 0.08 Allowed 'General case' 0 C--N 1.376 1.755 0 N-CA-C 119.493 3.145 . . . . 0.0 119.493 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -111.34 0.12 16.54 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.453 2.301 . . . . 0.0 110.619 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.5 t -103.35 158.45 16.32 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 127.719 2.407 . . . . 0.0 114.691 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -56.54 -18.64 12.36 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.334 2.654 . . . . 0.0 118.09 -171.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -90.25 -10.53 43.93 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 124.814 1.246 . . . . 0.0 112.402 169.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 4.8 10.62 Favored 'General case' 0 C--N 1.375 1.694 0 CA-C-N 120.146 1.339 . . . . 0.0 114.396 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.424 0.0 OUTLIER -113.2 162.01 16.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -50.08 122.41 6.71 Favored 'General case' 0 C--N 1.372 1.587 0 C-N-CA 127.318 2.247 . . . . 0.0 116.569 -172.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.86 -22.82 32.68 Favored Glycine 0 C--N 1.36 1.907 0 C-N-CA 125.01 1.291 . . . . 0.0 111.943 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.32 158.7 44.09 Favored Glycine 0 C--N 1.371 2.516 0 N-CA-C 119.43 2.532 . . . . 0.0 119.43 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -52.19 -42.86 63.83 Favored 'General case' 0 C--N 1.366 1.317 0 N-CA-C 121.751 3.982 . . . . 0.0 121.751 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.437 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.344 0.2 OUTLIER -105.16 12.49 31.95 Favored 'General case' 0 C--N 1.365 1.262 0 O-C-N 120.327 -1.483 . . . . 0.0 112.967 -177.779 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -93.53 90.87 6.84 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 126.096 1.758 . . . . 0.0 112.722 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.6 m -115.01 117.52 30.82 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 101.735 -3.431 . . . . 0.0 101.735 170.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.19 101.7 14.42 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 125.87 2.748 . . . . 0.0 113.581 -168.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -120.36 137.77 26.5 Favored Pre-proline 0 N--CA 1.422 -1.836 1 C-N-CA 133.753 4.821 . . . . 0.0 103.039 170.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.92 -26.07 79.66 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.943 3.762 . . . . 0.0 115.134 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -69.74 -35.97 75.45 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 130.961 3.705 . . . . 0.0 112.985 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.251 56.1 mt -75.15 -34.57 31.85 Favored 'Isoleucine or valine' 0 C--N 1.377 1.77 0 C-N-CA 126.289 1.836 . . . . 0.0 109.569 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.88 -46.53 68.17 Favored 'General case' 0 C--N 1.375 1.698 0 C-N-CA 124.827 1.251 . . . . 0.0 111.765 170.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -57.61 -35.79 70.91 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.751 2.02 . . . . 0.0 114.061 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.17 -40.22 86.59 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 130.788 3.635 . . . . 0.0 112.071 172.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 56.4 mtt -69.67 -33.19 72.22 Favored 'General case' 0 C--N 1.364 1.201 0 CA-C-O 116.786 -1.578 . . . . 0.0 113.633 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -74.14 -48.21 30.94 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 126.769 2.028 . . . . 0.0 111.008 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.463 ' HE ' ' HG ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -69.08 -43.93 73.56 Favored 'General case' 0 C--N 1.369 1.432 0 C-N-CA 129.292 3.037 . . . . 0.0 112.454 177.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.86 93.05 Favored 'General case' 0 C--N 1.377 1.794 0 C-N-CA 125.359 1.463 . . . . 0.0 112.198 169.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.356 4.4 t70 -60.9 -51.38 69.53 Favored 'General case' 0 C--N 1.384 2.096 0 CA-C-N 120.524 1.511 . . . . 0.0 113.016 173.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -35.17 64.84 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 121.938 2.154 . . . . 0.0 116.268 175.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.77 -44.63 32.14 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 168.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -40.95 95.01 Favored 'General case' 0 C--N 1.364 1.203 0 C-N-CA 131.032 3.733 . . . . 0.0 116.032 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.284 0.0 OUTLIER -89.21 -13.82 37.4 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.801 2.04 . . . . 0.0 110.783 -173.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -121.31 -108.78 0.35 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 126.553 1.941 . . . . 0.0 114.525 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -131.97 162.11 31.5 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.53 -1.981 . . . . 0.0 113.7 -172.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -37.65 54.1 Favored 'General case' 0 C--N 1.375 1.678 1 C-N-CA 132.113 4.165 . . . . 0.0 116.262 177.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.446 HG22 ' HZ1' ' A' ' 189' ' ' LYS . 15.3 tt -60.2 -31.89 49.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.501 0 C-N-CA 127.222 2.209 . . . . 0.0 113.74 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.446 ' HZ1' HG22 ' A' ' 188' ' ' ILE . 2.3 mptp? -70.84 -42.79 69.71 Favored 'General case' 0 C--N 1.374 1.635 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -75.44 -44.28 45.23 Favored 'General case' 0 C--N 1.364 1.199 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 170.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.269 7.7 tp -72.52 -19.19 61.56 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 127.234 2.213 . . . . 0.0 114.806 -173.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -63.0 -27.88 69.72 Favored 'General case' 0 C--N 1.368 1.371 0 C-N-CA 127.863 2.465 . . . . 0.0 112.697 166.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.463 ' HG ' ' HE ' ' A' ' 178' ' ' ARG . 2.0 mm? -100.06 22.45 11.29 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 127.965 2.506 . . . . 0.0 112.191 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.61 53.95 0.03 OUTLIER 'General case' 0 C--N 1.374 1.655 0 C-N-CA 127.825 2.45 . . . . 0.0 115.634 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.403 2.9 m . . . . . 0 C--N 1.366 1.283 1 C-N-CA 134.867 5.267 . . . . 0.0 117.024 -179.833 . . . . . . . . 2 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 120.286 0.089 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -138.36 58.29 1.67 Allowed 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -113.82 122.97 48.67 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 119.336 -2.102 . . . . 0.0 114.314 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.297 96.8 p -112.92 167.35 9.36 Favored Pre-proline 0 C--N 1.359 0.992 0 C-N-CA 129.278 3.031 . . . . 0.0 115.42 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -48.58 139.92 22.73 Favored 'Trans proline' 0 C--N 1.379 2.161 1 C-N-CA 127.457 5.438 . . . . 0.0 121.266 -170.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.26 -7.07 66.43 Favored Glycine 0 C--N 1.37 2.418 0 C-N-CA 126.092 1.806 . . . . 0.0 112.585 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.82 169.15 10.52 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 119.971 1.886 . . . . 0.0 111.851 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.7 147.76 26.43 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 167.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.35 159.34 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 -177.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -104.67 119.1 38.2 Favored 'General case' 0 CA--C 1.51 -0.558 1 N-CA-C 98.054 -4.795 . . . . 0.0 98.054 165.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.96 131.53 52.35 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.29 136.99 47.84 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 118.675 -2.516 . . . . 0.0 106.136 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 57.1 ttm -129.69 141.4 50.91 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 119.922 -1.736 . . . . 0.0 110.264 173.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -65.37 107.62 1.7 Allowed 'General case' 0 C--N 1.367 1.353 0 C-N-CA 126.082 1.753 . . . . 0.0 112.878 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.55 -16.61 21.52 Favored Glycine 0 C--N 1.36 1.887 0 C-N-CA 125.438 1.494 . . . . 0.0 112.55 -172.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -112.53 161.63 25.4 Favored Pre-proline 0 C--N 1.359 1.011 0 O-C-N 121.144 -1.21 . . . . 0.0 109.111 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.95 167.06 27.73 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 125.015 3.81 . . . . 0.0 113.342 166.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.498 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -58.36 116.42 3.61 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 127.908 2.483 . . . . 0.0 112.821 171.394 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -127.0 117.9 22.1 Favored Pre-proline 0 N--CA 1.426 -1.633 0 N-CA-C 121.387 3.847 . . . . 0.0 121.387 -169.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -49.08 125.3 13.03 Favored 'Trans proline' 0 C--N 1.387 2.58 1 C-N-CA 127.079 5.186 . . . . 0.0 112.374 162.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 m -146.55 164.19 33.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 124.298 1.999 . . . . 0.0 112.045 -158.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 tt -135.67 135.57 40.23 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 119.564 -1.96 . . . . 0.0 106.61 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.312 3.3 p -92.45 130.97 40.77 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 CA-C-N 121.19 1.814 . . . . 0.0 110.372 175.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -133.37 153.05 51.92 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 125.521 1.528 . . . . 0.0 111.955 -166.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -99.81 112.16 24.43 Favored 'General case' 0 C--N 1.376 1.718 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 171.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -96.73 158.38 33.67 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 130.416 3.486 . . . . 0.0 108.767 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -50.05 -1.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.525 2 C-N-CA 127.565 5.51 . . . . 0.0 122.852 -165.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -99.83 9.1 43.58 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 126.673 1.989 . . . . 0.0 108.981 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.0 143.66 0.08 Allowed 'General case' 0 C--N 1.369 1.437 1 C-N-CA 134.224 5.01 . . . . 0.0 120.884 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.94 -19.68 27.51 Favored Glycine 0 C--N 1.359 1.832 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.5 t -134.12 127.52 32.27 Favored 'General case' 0 N--CA 1.448 -0.571 1 N-CA-C 99.456 -4.276 . . . . 0.0 99.456 163.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -128.24 6.41 5.86 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 120.514 -1.366 . . . . 0.0 109.671 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.5 pt -118.59 150.36 20.86 Favored 'Isoleucine or valine' 0 C--N 1.361 1.105 0 CA-C-O 124.076 1.893 . . . . 0.0 113.678 -173.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.528 ' HE ' ' H ' ' A' ' 122' ' ' GLU . 5.7 tpm_? -140.42 144.23 36.04 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 130.025 3.33 . . . . 0.0 103.715 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.528 ' H ' ' HE ' ' A' ' 121' ' ' ARG . 42.4 tt0 -140.3 126.93 20.34 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 176.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -107.16 93.39 4.53 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.82 1.648 . . . . 0.0 107.175 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.5 -93.55 0.81 Allowed Glycine 0 C--N 1.362 2.014 0 C-N-CA 126.489 1.995 . . . . 0.0 111.729 -174.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.58 -0.78 10.76 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 125.248 1.419 . . . . 0.0 109.204 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.5 t -92.52 97.97 11.16 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 125.298 1.439 . . . . 0.0 111.055 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.18 129.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 128.135 2.574 . . . . 0.0 112.404 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -123.49 140.66 52.78 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 126.998 2.119 . . . . 0.0 109.709 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.8 m -127.2 163.53 29.96 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 127.284 2.233 . . . . 0.0 109.928 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -78.62 123.46 27.14 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 119.195 -2.191 . . . . 0.0 111.819 171.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.441 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 5.5 m -143.96 176.21 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.232 0 CA-C-N 123.278 2.763 . . . . 0.0 104.846 174.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.32 152.36 51.77 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 125.07 1.481 . . . . 0.0 108.442 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.52 120.65 42.82 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 104.141 -2.541 . . . . 0.0 104.141 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -64.86 65.88 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.5 1.92 . . . . 0.0 114.839 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -103.16 -128.62 0.23 Allowed 'General case' 0 C--N 1.36 1.045 0 O-C-N 118.963 -2.336 . . . . 0.0 112.123 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -102.24 -57.53 2.05 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 126.144 1.778 . . . . 0.0 113.001 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.6 p -80.91 -26.6 0.43 Allowed Pre-proline 0 C--N 1.362 1.113 0 N-CA-C 118.356 2.724 . . . . 0.0 118.356 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -85.89 -157.26 1.22 Allowed 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 127.944 3.873 . . . . 0.0 109.977 -2.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.4 m -96.68 127.82 43.03 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 1.1 tmt_? -161.64 154.77 20.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 119.488 -2.008 . . . . 0.0 108.936 -176.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.95 -158.02 19.33 Favored Glycine 0 CA--C 1.485 -1.803 0 N-CA-C 103.74 -3.744 . . . . 0.0 103.74 166.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -91.01 112.61 24.58 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 169.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . 0.304 14.8 p -102.64 161.31 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.988 -163.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 m -78.37 109.69 12.74 Favored 'General case' 0 C--N 1.363 1.188 0 C-N-CA 124.919 1.288 . . . . 0.0 107.836 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.433 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 26.9 tttp -64.4 -19.05 65.26 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -170.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -82.41 -6.33 59.21 Favored 'General case' 0 C--N 1.362 1.146 0 O-C-N 120.237 -1.54 . . . . 0.0 113.742 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.4 mt -100.68 6.85 44.13 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 126.405 1.882 . . . . 0.0 109.695 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.433 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 26.1 mt -96.69 124.42 40.67 Favored 'General case' 0 C--N 1.368 1.397 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -116.65 158.84 42.52 Favored Pre-proline 0 CA--C 1.493 -1.24 0 O-C-N 120.478 -1.389 . . . . 0.0 107.809 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.81 150.73 14.39 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 CA-C-N 122.711 2.004 . . . . 0.0 113.41 -170.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.36 0.0 OUTLIER -28.2 -87.39 0.0 OUTLIER 'General case' 0 C--N 1.355 0.81 2 N-CA-C 123.459 4.615 . . . . 0.0 123.459 -177.997 . . . . . . . . 4 3 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.8 t 2.52 57.23 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 1 C-N-CA 134.656 5.183 . . . . 0.0 118.865 176.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.688 ' H ' HD13 ' A' ' 183' ' ' LEU . . . -79.16 -108.24 0.22 Allowed Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 122.234 3.654 . . . . 0.0 122.234 -154.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.3 m -45.17 -22.44 0.11 Allowed 'General case' 0 C--N 1.371 1.54 0 C-N-CA 130.643 3.577 . . . . 0.0 120.197 -167.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -85.39 -11.5 54.35 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 127.934 2.493 . . . . 0.0 113.051 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 68.8 m -89.81 150.82 22.09 Favored 'General case' 0 C--N 1.367 1.341 0 C-N-CA 126.342 1.857 . . . . 0.0 114.401 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -47.89 -39.84 19.98 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 129.358 3.063 . . . . 0.0 116.694 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.22 -13.18 59.98 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -106.24 8.19 31.81 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 121.111 -0.993 . . . . 0.0 113.519 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -117.27 179.76 3.95 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 126.082 1.753 . . . . 0.0 108.867 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.2 122.77 15.88 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 126.706 2.002 . . . . 0.0 113.8 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.31 -8.25 64.49 Favored Glycine 0 C--N 1.359 1.846 0 C-N-CA 124.909 1.242 . . . . 0.0 111.755 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.69 154.87 34.73 Favored Glycine 0 C--N 1.362 2.019 0 C-N-CA 126.342 1.925 . . . . 0.0 114.944 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -65.97 -42.48 89.82 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 119.57 3.174 . . . . 0.0 119.57 -172.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.498 ' HB3' ' CD2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -101.62 1.72 38.06 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 121.567 1.985 . . . . 0.0 113.41 -178.25 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -81.06 91.88 6.15 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 127.054 2.142 . . . . 0.0 113.337 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 27.6 m -116.48 102.25 9.34 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 100.49 -3.893 . . . . 0.0 100.49 168.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.31 101.94 13.71 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 125.842 2.734 . . . . 0.0 111.661 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -119.45 149.45 47.77 Favored Pre-proline 0 N--CA 1.422 -1.826 1 C-N-CA 132.338 4.255 . . . . 0.0 100.516 171.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.34 -30.14 79.74 Favored 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 126.137 4.558 . . . . 0.0 115.822 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -68.71 -47.49 66.23 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 126.828 2.051 . . . . 0.0 113.258 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.5 mt -67.28 -45.28 86.42 Favored 'Isoleucine or valine' 0 C--N 1.373 1.59 0 C-N-CA 127.363 2.265 . . . . 0.0 111.337 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . 0.424 2.3 pp -68.81 -32.1 71.57 Favored 'General case' 0 C--N 1.372 1.559 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 174.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 52.5 tpt85 -66.5 -42.02 88.0 Favored 'General case' 0 C--N 1.379 1.862 0 C-N-CA 127.903 2.481 . . . . 0.0 113.165 172.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.21 -33.86 76.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 131.593 3.957 . . . . 0.0 111.275 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 41.2 mtp -69.95 -32.7 71.09 Favored 'General case' 0 C--N 1.371 1.504 0 C-N-CA 126.824 2.05 . . . . 0.0 112.424 164.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -72.11 -45.09 61.94 Favored 'General case' 0 C--N 1.383 2.026 0 CA-C-N 121.259 1.845 . . . . 0.0 111.647 174.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -64.78 -50.52 66.44 Favored 'General case' 0 C--N 1.381 1.952 0 C-N-CA 129.443 3.097 . . . . 0.0 111.586 174.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.3 -52.47 61.84 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-O 116.879 -1.534 . . . . 0.0 113.912 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.26 -43.91 71.37 Favored 'General case' 0 C--N 1.383 2.036 0 CA-C-N 121.822 2.101 . . . . 0.0 114.048 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -36.59 84.71 Favored 'General case' 0 C--N 1.366 1.294 0 O-C-N 119.12 -2.238 . . . . 0.0 115.809 172.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -75.52 -44.65 42.55 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.688 HD13 ' H ' ' A' ' 153' ' ' GLY 0.259 1.2 tt -58.93 -42.97 91.03 Favored 'General case' 0 C--N 1.358 0.955 1 C-N-CA 132.174 4.19 . . . . 0.0 116.051 176.851 . . . . . . . . 4 3 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.278 0.0 OUTLIER -91.56 -7.37 50.43 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.342 1.457 . . . . 0.0 111.068 -177.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -119.09 -112.34 0.34 Allowed 'General case' 0 C--N 1.362 1.122 0 O-C-N 121.629 -0.669 . . . . 0.0 111.979 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -127.05 158.27 37.43 Favored 'General case' 0 C--N 1.36 1.059 0 O-C-N 120.337 -1.477 . . . . 0.0 110.667 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.298 24.0 tttm -51.63 -37.01 48.23 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 130.708 3.603 . . . . 0.0 116.774 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.5 tp -53.7 -29.71 17.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 129.273 3.029 . . . . 0.0 113.526 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.263 6.1 mptt -72.05 -47.92 48.1 Favored 'General case' 0 C--N 1.371 1.542 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 175.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -37.43 60.62 Favored 'General case' 0 C--N 1.368 1.384 0 CA-C-N 123.168 2.713 . . . . 0.0 115.335 172.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.46 -25.2 63.97 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 126.426 1.89 . . . . 0.0 114.552 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -60.99 -38.03 84.56 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.612 2.765 . . . . 0.0 113.542 166.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -85.17 -51.04 6.9 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 126.741 2.017 . . . . 0.0 108.68 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 66.52 -72.14 0.09 Allowed 'General case' 0 C--N 1.365 1.252 0 C-N-CA 127.818 2.447 . . . . 0.0 116.027 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.226 -0.132 0 C-N-CA 129.426 3.09 . . . . 0.0 111.642 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.83 40.51 0.53 Allowed 'General case' 0 C--N 1.36 1.062 0 C-N-CA 126.755 2.022 . . . . 0.0 115.427 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -159.14 80.36 0.76 Allowed 'General case' 0 C--N 1.354 0.77 0 C-N-CA 125.018 1.327 . . . . 0.0 108.462 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -82.36 118.92 23.53 Favored 'General case' 0 C--N 1.362 1.144 0 O-C-N 120.063 -1.648 . . . . 0.0 110.746 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.5 tp 68.84 -87.42 0.03 OUTLIER 'General case' 0 C--N 1.366 1.283 0 C-N-CA 128.073 2.549 . . . . 0.0 111.71 -175.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -121.3 5.15 10.24 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.096 1.358 . . . . 0.0 111.13 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.12 18.99 73.52 Favored Glycine 0 C--N 1.369 2.388 0 N-CA-C 119.776 2.67 . . . . 0.0 119.776 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.05 -84.19 0.35 Allowed Glycine 0 C--N 1.356 1.652 0 C-N-CA 126.242 1.877 . . . . 0.0 111.557 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.7 tp -135.72 -113.82 0.19 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.155 0.982 . . . . 0.0 109.099 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.435 HH22 ' HE ' ' A' ' 121' ' ' ARG . 15.5 ptp180 -72.21 -54.33 9.96 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 -176.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -148.17 29.18 0.89 Allowed 'General case' 0 C--N 1.354 0.775 0 O-C-N 119.866 -1.772 . . . . 0.0 107.245 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 62.9 m 67.64 -59.94 0.4 Allowed 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.823 2.849 . . . . 0.0 116.463 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.81 129.3 36.83 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 129.056 2.942 . . . . 0.0 114.879 -172.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.38 166.88 10.08 Favored Pre-proline 0 C--N 1.351 0.662 0 C-N-CA 128.899 2.879 . . . . 0.0 108.396 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.03 -104.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.806 3.004 . . . . 0.0 111.081 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 177.18 -156.49 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.73 115.18 63.66 Favored Pre-proline 0 C--N 1.355 0.824 0 CA-C-O 117.056 -1.45 . . . . 0.0 110.547 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -88.98 161.53 5.94 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.63 2.886 . . . . 0.0 115.385 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 t -146.93 23.46 1.21 Allowed 'General case' 0 C--N 1.356 0.852 0 N-CA-C 104.038 -2.578 . . . . 0.0 104.038 168.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 t -154.3 142.1 20.04 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.8 m 66.52 89.58 0.1 Allowed 'General case' 0 C--N 1.356 0.88 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 172.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -139.21 94.82 2.84 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 121.071 -1.018 . . . . 0.0 113.725 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.51 126.26 45.56 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 121.25 -0.906 . . . . 0.0 109.113 -174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.4 p -111.09 165.82 11.97 Favored Pre-proline 0 C--N 1.364 1.212 0 C-N-CA 127.671 2.388 . . . . 0.0 114.243 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -56.21 139.66 86.24 Favored 'Trans proline' 0 C--N 1.365 1.425 1 C-N-CA 125.622 4.215 . . . . 0.0 120.867 -167.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.4 -24.54 9.75 Favored Glycine 0 C--N 1.361 1.955 0 C-N-CA 128.287 2.851 . . . . 0.0 110.885 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.43 170.21 12.18 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 119.895 1.847 . . . . 0.0 114.251 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 4.2 mm? -98.28 141.92 30.58 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 103.212 -2.885 . . . . 0.0 103.212 164.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.77 141.46 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 165' ' ' PHE . 28.0 m95 -99.02 129.85 45.32 Favored 'General case' 0 C--O 1.214 -0.787 1 O-C-N 115.97 -4.206 . . . . 0.0 103.455 171.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -114.48 147.33 39.5 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 121.087 1.767 . . . . 0.0 109.494 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -118.71 145.83 45.21 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 37.1 ttm -126.69 154.77 43.64 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 123.233 1.492 . . . . 0.0 111.296 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.73 80.7 0.01 OUTLIER 'General case' 0 C--N 1.355 0.847 0 C-N-CA 131.669 3.988 . . . . 0.0 115.838 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.57 7.09 37.47 Favored Glycine 0 C--N 1.359 1.808 0 C-N-CA 125.504 1.526 . . . . 0.0 113.519 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -114.91 160.32 34.09 Favored Pre-proline 0 C--N 1.356 0.875 0 C-N-CA 125.65 1.58 . . . . 0.0 107.591 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -71.79 166.07 30.61 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.952 3.768 . . . . 0.0 113.422 168.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -49.35 129.49 18.61 Favored 'General case' 0 C--N 1.364 1.203 0 C-N-CA 128.356 2.662 . . . . 0.0 117.147 167.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -134.21 109.0 11.47 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 121.586 3.921 . . . . 0.0 121.586 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.22 110.83 1.11 Allowed 'Trans proline' 0 C--N 1.389 2.679 1 C-N-CA 126.663 4.909 . . . . 0.0 112.743 167.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -123.01 164.98 17.53 Favored 'General case' 0 C--N 1.352 0.677 1 C-N-CA 133.286 4.634 . . . . 0.0 116.022 -170.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp -116.46 132.54 56.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 129.447 3.099 . . . . 0.0 107.254 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -86.16 118.85 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 O-C-N 119.913 -1.742 . . . . 0.0 106.537 174.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -127.36 149.78 49.9 Favored 'General case' 0 C--N 1.368 1.391 0 O-C-N 119.002 -2.311 . . . . 0.0 111.059 -170.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -102.0 113.49 26.77 Favored 'General case' 0 C--N 1.37 1.471 0 CA-C-O 122.489 1.138 . . . . 0.0 111.511 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -79.49 158.81 73.28 Favored Pre-proline 0 C--N 1.353 0.738 0 C-N-CA 129.367 3.067 . . . . 0.0 112.592 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.28 71.4 Cg_exo -47.66 1.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.371 1 C-N-CA 130.356 7.37 . . . . 0.0 121.498 -171.515 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -98.89 31.65 2.9 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 131.588 3.955 . . . . 0.0 106.646 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.289 0.0 OUTLIER -68.7 150.81 47.49 Favored 'General case' 0 C--N 1.373 1.621 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -169.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.69 -20.11 27.59 Favored Glycine 0 C--N 1.365 2.158 0 C-N-CA 126.922 2.201 . . . . 0.0 112.552 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.7 m -130.44 147.0 52.09 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 101.269 -3.604 . . . . 0.0 101.269 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -130.7 -0.73 4.31 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-N 121.111 1.778 . . . . 0.0 114.882 -175.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.7 pt -106.48 148.0 11.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.475 0 CA-C-O 123.904 1.812 . . . . 0.0 113.734 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.435 ' HE ' HH22 ' A' ' 77' ' ' ARG . 29.8 tpt180 -119.01 126.58 52.06 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 102.229 -3.248 . . . . 0.0 102.229 172.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -148.16 143.79 27.32 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 120.191 -1.568 . . . . 0.0 110.295 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.54 93.74 4.22 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 127.51 2.324 . . . . 0.0 108.821 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.19 -76.03 0.34 Allowed Glycine 0 C--N 1.365 2.19 0 N-CA-C 119.891 2.716 . . . . 0.0 119.891 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -149.01 60.38 1.05 Allowed 'General case' 0 C--N 1.358 0.959 0 CA-C-O 124.014 1.864 . . . . 0.0 109.055 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.7 m -169.59 133.8 1.34 Allowed 'General case' 0 C--N 1.349 0.566 0 C-N-CA 127.551 2.341 . . . . 0.0 105.48 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.94 146.82 31.07 Favored 'Isoleucine or valine' 0 C--N 1.363 1.186 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -134.35 142.77 47.34 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 129.173 2.989 . . . . 0.0 107.264 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.3 162.21 26.14 Favored 'Isoleucine or valine' 0 C--N 1.368 1.387 0 C-N-CA 127.301 2.24 . . . . 0.0 107.897 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 111' ' ' TYR . 0.4 OUTLIER -94.0 133.4 37.49 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 119.576 -1.953 . . . . 0.0 111.031 175.123 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.91 172.97 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.38 158.09 38.22 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 166.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -113.86 130.75 56.45 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -75.11 71.93 2.19 Favored 'General case' 0 C--N 1.372 1.578 0 C-N-CA 126.759 2.023 . . . . 0.0 109.876 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -95.7 -102.92 0.16 Allowed 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.042 1.337 . . . . 0.0 111.132 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -106.72 -62.69 1.36 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 126.216 1.807 . . . . 0.0 113.867 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 p -85.65 -32.61 0.46 Allowed Pre-proline 0 C--N 1.364 1.204 0 N-CA-C 119.374 3.102 . . . . 0.0 119.374 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -84.86 -176.1 14.16 Favored 'Cis proline' 0 CA--C 1.544 0.989 1 CA-C-N 130.358 4.735 . . . . 0.0 112.727 -0.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.315 4.6 t -97.53 154.86 17.24 Favored 'General case' 0 C--N 1.372 1.57 0 C-N-CA 127.216 2.206 . . . . 0.0 113.051 171.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.79 152.47 41.27 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.946 1.698 . . . . 0.0 106.58 171.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.43 -175.47 39.84 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -93.01 117.87 30.54 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 125.189 1.396 . . . . 0.0 108.059 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.2 161.98 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 C-N-CA 125.603 1.561 . . . . 0.0 113.334 -173.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.6 m -76.68 97.63 4.51 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 126.541 1.936 . . . . 0.0 107.18 171.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.423 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 35.1 tttp -54.62 -29.05 50.89 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 128.283 2.633 . . . . 0.0 115.878 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -70.42 -13.37 62.1 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 127.105 2.162 . . . . 0.0 114.098 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.8 mt -98.12 3.84 49.14 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 126.982 2.113 . . . . 0.0 111.784 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.423 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 23.4 mt -89.86 135.01 33.89 Favored 'General case' 0 C--N 1.37 1.47 0 C-N-CA 126.661 1.984 . . . . 0.0 111.221 173.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -114.65 158.75 39.45 Favored Pre-proline 0 C--N 1.346 0.448 0 C-N-CA 127.703 2.401 . . . . 0.0 106.279 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.55 158.23 14.42 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 124.814 3.676 . . . . 0.0 118.563 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -44.09 92.35 0.01 OUTLIER 'General case' 0 C--N 1.357 0.906 1 C-N-CA 132.949 4.5 . . . . 0.0 119.975 171.85 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.4 t -162.28 167.77 23.37 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 102.517 -3.142 . . . . 0.0 102.517 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.74 -157.96 7.58 Favored Glycine 0 C--N 1.365 2.172 0 N-CA-C 119.776 2.67 . . . . 0.0 119.776 -165.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.3 t -45.41 -11.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 1 N-CA-C 122.066 4.099 . . . . 0.0 122.066 -165.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -107.4 -10.01 15.86 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 129.322 3.049 . . . . 0.0 112.709 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 59.8 m -81.88 138.88 34.96 Favored 'General case' 0 C--N 1.376 1.728 0 C-N-CA 127.736 2.415 . . . . 0.0 111.085 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.251 33.1 ttmt -52.22 -33.49 41.43 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -86.71 -0.94 57.25 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 119.318 0.963 . . . . 0.0 112.963 171.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.89 3.25 10.0 Favored 'General case' 0 C--N 1.371 1.53 0 CA-C-N 120.25 1.387 . . . . 0.0 113.444 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -109.9 179.72 4.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.134 2.974 . . . . 0.0 107.331 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -70.74 122.47 19.9 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 120.141 -1.599 . . . . 0.0 113.175 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.37 -5.27 55.1 Favored Glycine 0 C--N 1.363 2.047 0 O-C-N 120.961 -1.087 . . . . 0.0 111.757 -170.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.89 152.22 25.77 Favored Glycine 0 C--N 1.361 1.928 0 C-N-CA 128.648 3.023 . . . . 0.0 114.211 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -62.64 -41.7 99.18 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.42 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-85 -85.48 -7.54 58.85 Favored 'General case' 0 CA--C 1.556 1.174 0 O-C-N 120.269 -1.519 . . . . 0.0 113.57 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -77.92 95.35 4.75 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 128.811 2.844 . . . . 0.0 114.839 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 40.7 t -114.77 128.22 56.18 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 102.461 -3.163 . . . . 0.0 102.461 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -100.76 100.26 10.9 Favored 'General case' 0 C--N 1.362 1.125 0 CA-C-O 125.613 2.625 . . . . 0.0 109.229 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -121.62 138.25 28.16 Favored Pre-proline 0 N--CA 1.421 -1.897 2 C-N-CA 135.988 5.715 . . . . 0.0 98.211 166.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.96 -26.41 66.59 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 125.073 3.848 . . . . 0.0 114.144 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -66.73 -36.65 82.96 Favored 'General case' 0 C--N 1.369 1.428 0 C-N-CA 129.012 2.925 . . . . 0.0 112.633 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 65.3 mt -73.41 -45.99 50.57 Favored 'Isoleucine or valine' 0 C--N 1.374 1.651 0 C-N-CA 126.018 1.727 . . . . 0.0 110.417 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.12 -45.9 89.84 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 125.207 1.403 . . . . 0.0 113.535 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -62.42 -35.53 79.54 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.67 77.25 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 129.673 3.189 . . . . 0.0 110.795 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.71 -38.99 87.85 Favored 'General case' 0 C--N 1.382 2.017 0 C-N-CA 125.197 1.399 . . . . 0.0 111.597 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -74.07 -42.14 60.63 Favored 'General case' 0 C--N 1.374 1.655 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -48.06 64.71 Favored 'General case' 0 C--N 1.371 1.533 0 C-N-CA 130.671 3.589 . . . . 0.0 111.83 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.03 99.08 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 124.592 1.157 . . . . 0.0 113.491 169.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.2 -52.49 63.58 Favored 'General case' 0 C--N 1.375 1.715 0 C-N-CA 126.006 1.722 . . . . 0.0 111.66 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.35 -37.58 67.66 Favored 'General case' 0 C--N 1.372 1.544 0 CA-C-N 121.139 1.79 . . . . 0.0 115.8 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.18 -44.82 36.29 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 116.029 1.862 . . . . 0.0 116.029 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -31.03 67.16 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.21 -10.53 49.52 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 126.535 1.934 . . . . 0.0 110.608 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -123.43 -100.79 0.41 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 125.436 1.494 . . . . 0.0 112.176 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.451 ' HB2' ' HZ2' ' A' ' 189' ' ' LYS . 26.0 m-20 -135.57 158.0 45.47 Favored 'General case' 0 C--N 1.363 1.194 0 O-C-N 120.26 -1.525 . . . . 0.0 113.846 -175.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -50.98 -37.34 44.19 Favored 'General case' 0 C--N 1.369 1.421 1 C-N-CA 132.389 4.276 . . . . 0.0 115.758 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.3 tt -55.23 -33.77 31.41 Favored 'Isoleucine or valine' 0 C--N 1.359 1.012 0 C-N-CA 129.925 3.29 . . . . 0.0 113.238 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.451 ' HZ2' ' HB2' ' A' ' 186' ' ' ASP . 4.1 mptt -71.07 -45.29 64.05 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 125.829 1.651 . . . . 0.0 115.037 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -74.87 -42.45 57.86 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 174.408 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.292 96.2 mt -73.93 -19.39 60.7 Favored 'General case' 0 C--N 1.371 1.507 0 O-C-N 120.432 -1.417 . . . . 0.0 114.037 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -58.4 -32.06 68.26 Favored 'General case' 0 C--N 1.377 1.803 0 C-N-CA 126.769 2.027 . . . . 0.0 114.155 168.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.28 -51.55 3.95 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 127.053 2.141 . . . . 0.0 108.874 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 42.97 -95.11 0.02 OUTLIER 'General case' 0 C--N 1.38 1.913 0 C-N-CA 130.145 3.378 . . . . 0.0 114.427 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.377 2.5 p -160.74 58.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 100.811 -3.774 . . . . 0.0 100.811 162.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.4 t -99.26 48.71 0.95 Allowed 'General case' 0 C--N 1.367 1.327 0 C-N-CA 127.618 2.367 . . . . 0.0 112.233 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.81 -55.56 5.69 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 126.617 1.967 . . . . 0.0 114.808 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -150.97 140.31 13.67 Favored Pre-proline 0 C--N 1.35 0.593 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.12 65.15 7.87 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 124.212 3.274 . . . . 0.0 113.753 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 15.2 m -98.24 10.65 40.13 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 127.805 2.442 . . . . 0.0 111.154 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.282 10.8 pt-20 . . . . . 0 C--N 1.365 1.242 0 C-N-CA 130.804 3.641 . . . . 0.0 118.715 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt . . . . . 0 N--CA 1.441 -0.886 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.59 -44.0 3.96 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 126.394 1.878 . . . . 0.0 110.437 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -161.71 179.72 7.91 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -103.26 129.93 50.37 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.87 2.468 . . . . 0.0 106.986 171.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -95.91 -35.31 11.5 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 -174.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -104.33 -12.77 16.41 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 119.795 -1.816 . . . . 0.0 114.225 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 -4.23 61.35 Favored Glycine 0 C--N 1.353 1.511 0 C-N-CA 125.668 1.604 . . . . 0.0 115.155 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.36 151.44 20.38 Favored Glycine 0 C--N 1.36 1.881 0 C-N-CA 125.441 1.496 . . . . 0.0 114.405 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.31 21.56 7.93 Favored 'General case' 0 C--N 1.366 1.296 0 CA-C-O 122.736 1.255 . . . . 0.0 113.568 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -72.17 -24.39 61.42 Favored 'General case' 0 C--N 1.363 1.191 0 C-N-CA 127.912 2.485 . . . . 0.0 113.247 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 143.19 -60.13 0.0 OUTLIER 'General case' 0 C--N 1.353 0.724 1 C-N-CA 133.569 4.748 . . . . 0.0 100.865 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.265 76.6 p 83.71 2.74 0.92 Allowed 'General case' 0 C--N 1.362 1.128 0 C-N-CA 129.527 3.131 . . . . 0.0 113.388 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.357 21.2 t 92.53 -11.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.055 0 C-N-CA 129.887 3.275 . . . . 0.0 109.807 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.71 166.74 21.14 Favored Pre-proline 0 C--N 1.362 1.146 0 C-N-CA 126.933 2.093 . . . . 0.0 111.602 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -69.44 112.75 3.11 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 124.411 3.407 . . . . 0.0 115.486 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -114.6 -86.52 0.59 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 127.321 2.248 . . . . 0.0 108.828 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.13 111.77 64.27 Favored Pre-proline 0 C--N 1.361 1.08 0 C-N-CA 124.997 1.319 . . . . 0.0 111.438 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -90.13 37.98 0.36 Allowed 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.656 2.904 . . . . 0.0 112.474 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.3 m -69.59 67.8 0.23 Allowed 'General case' 0 C--N 1.363 1.189 0 C-N-CA 128.901 2.88 . . . . 0.0 114.878 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 m 115.02 29.55 0.0 OUTLIER 'General case' 0 C--N 1.354 0.791 0 C-N-CA 130.878 3.671 . . . . 0.0 108.634 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.427 ' HB2' ' HA ' ' A' ' 146' ' ' ARG 0.412 37.5 m 79.03 -73.43 0.07 Allowed 'General case' 0 C--N 1.362 1.132 0 C-N-CA 128.42 2.688 . . . . 0.0 111.045 -176.557 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 66.96 60.15 0.53 Allowed 'General case' 0 C--N 1.359 1.003 0 N-CA-C 120.396 3.48 . . . . 0.0 120.396 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -117.38 125.97 51.88 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 119.878 -1.764 . . . . 0.0 110.16 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.474 28.7 p -111.72 168.43 7.64 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 128.624 2.77 . . . . 0.0 115.55 -172.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.25 151.63 60.69 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 124.434 3.423 . . . . 0.0 118.863 -164.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.77 -7.29 81.64 Favored Glycine 0 C--N 1.37 2.447 0 C-N-CA 128.875 3.131 . . . . 0.0 111.109 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -94.0 164.02 13.25 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 126.246 1.818 . . . . 0.0 110.493 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.74 140.26 37.24 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 119.098 -2.251 . . . . 0.0 107.249 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 m -133.51 153.37 36.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 C-N-CA 125.766 1.626 . . . . 0.0 108.979 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -102.84 116.76 33.19 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 101.422 -3.547 . . . . 0.0 101.422 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -115.12 142.51 46.56 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.727 1.211 . . . . 0.0 113.997 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -116.15 132.93 56.52 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 33.2 ttm -115.98 139.05 50.64 Favored 'General case' 0 CA--C 1.509 -0.629 0 O-C-N 120.099 -1.625 . . . . 0.0 107.267 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.65 100.35 0.1 Allowed 'General case' 0 C--N 1.366 1.324 0 C-N-CA 127.379 2.272 . . . . 0.0 114.07 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.56 -22.15 22.55 Favored Glycine 0 C--N 1.358 1.761 0 C-N-CA 125.367 1.461 . . . . 0.0 113.624 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -97.99 166.81 12.76 Favored Pre-proline 0 C--N 1.361 1.088 0 O-C-N 121.036 -1.273 . . . . 0.0 109.823 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.68 166.18 30.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.803 3.669 . . . . 0.0 113.34 169.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.577 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 5.0 m95 -58.17 135.27 57.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.798 2.839 . . . . 0.0 115.309 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.409 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 24.0 m95 -133.65 114.77 13.3 Favored Pre-proline 0 C--N 1.367 1.354 1 N-CA-C 121.844 4.016 . . . . 0.0 121.844 -174.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -64.91 124.96 13.87 Favored 'Trans proline' 0 C--N 1.391 2.772 1 C-N-CA 125.965 4.444 . . . . 0.0 110.542 160.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 p -147.25 165.15 30.95 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 128.29 2.636 . . . . 0.0 115.017 -156.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 190' ' ' ARG . 3.7 pp -119.45 144.3 47.03 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 125.749 1.619 . . . . 0.0 108.626 173.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.9 t -85.59 116.52 28.92 Favored 'Isoleucine or valine' 0 C--N 1.377 1.796 0 O-C-N 120.174 -1.579 . . . . 0.0 108.059 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -121.56 136.27 54.96 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 116.92 -3.612 . . . . 0.0 114.87 -164.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -75.99 111.36 11.29 Favored 'General case' 0 C--N 1.38 1.908 0 CA-C-O 123.762 1.744 . . . . 0.0 112.654 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.473 ' CG ' ' CD2' ' A' ' 130' ' ' HIS . 10.3 t60 -67.18 161.18 66.04 Favored Pre-proline 0 C--N 1.343 0.285 1 C-N-CA 132.903 4.481 . . . . 0.0 117.641 -170.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.23 -14.05 3.8 Favored 'Trans proline' 0 CA--C 1.554 1.52 1 C-N-CA 125.542 4.161 . . . . 0.0 116.398 174.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -104.69 40.01 1.57 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 129.72 3.208 . . . . 0.0 109.633 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -67.58 151.47 47.27 Favored 'General case' 0 C--N 1.372 1.566 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.74 -11.92 32.51 Favored Glycine 0 C--N 1.358 1.768 0 CA-C-N 112.396 -2.184 . . . . 0.0 110.369 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 t -125.61 166.57 16.47 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 101.855 -3.387 . . . . 0.0 101.855 167.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -154.72 -25.63 0.12 Allowed 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.581 -1.324 . . . . 0.0 114.194 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.0 pt -114.38 154.54 15.73 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 O-C-N 120.491 -1.38 . . . . 0.0 112.086 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -142.92 152.84 42.48 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 128.338 2.655 . . . . 0.0 105.027 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.31 127.99 19.2 Favored 'General case' 0 C--N 1.361 1.089 0 O-C-N 120.793 -1.192 . . . . 0.0 110.424 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -117.94 93.04 3.99 Favored 'General case' 0 C--N 1.363 1.17 0 C-N-CA 127.407 2.283 . . . . 0.0 110.135 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.11 -63.96 0.01 OUTLIER Glycine 0 C--N 1.362 2.006 0 N-CA-C 122.056 3.582 . . . . 0.0 122.056 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -146.62 38.34 1.02 Allowed 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.965 1.306 . . . . 0.0 111.724 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 m -167.63 139.67 3.15 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 119.847 -1.783 . . . . 0.0 106.498 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.66 132.97 70.59 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 CA-C-O 123.505 1.621 . . . . 0.0 109.959 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -106.83 158.94 16.62 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 127.938 2.495 . . . . 0.0 113.481 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 33.8 m -149.09 164.66 4.09 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 C-N-CA 130.707 3.603 . . . . 0.0 102.755 174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.473 ' CD2' ' CG ' ' A' ' 113' ' ' HIS . 6.2 m80 -89.94 141.82 28.29 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 121.19 -0.944 . . . . 0.0 112.248 170.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 m -151.1 169.81 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -133.53 152.91 51.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -109.43 132.26 54.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.518 1.927 . . . . 0.0 108.335 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.534 ' HB3' HH21 ' A' ' 178' ' ' ARG . 29.3 m-85 -68.54 63.77 0.11 Allowed 'General case' 0 C--N 1.371 1.503 0 C-N-CA 127.066 2.147 . . . . 0.0 114.256 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.91 -118.22 0.08 Allowed 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.451 2.3 . . . . 0.0 111.913 -174.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -106.85 -58.52 1.92 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.669 1.587 . . . . 0.0 112.807 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.298 27.5 p -77.18 -34.03 1.16 Allowed Pre-proline 0 C--N 1.364 1.209 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.35 -169.5 7.75 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 CA-C-N 127.683 3.779 . . . . 0.0 111.616 -1.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.3 m -95.17 135.08 37.17 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.814 1.246 . . . . 0.0 107.753 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.426 ' HD3' ' HD1' ' A' ' 113' ' ' HIS . 9.9 tmm_? -158.1 167.92 28.52 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.06 -148.74 17.04 Favored Glycine 0 C--N 1.352 1.417 1 N-CA-C 101.239 -4.744 . . . . 0.0 101.239 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -89.58 156.78 18.38 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 167.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.4 -177.68 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 O-C-N 120.636 -1.29 . . . . 0.0 107.712 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.6 t -90.8 120.07 31.54 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 101.864 -3.384 . . . . 0.0 101.864 167.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.492 0.0 OUTLIER -78.53 -10.94 59.91 Favored 'General case' 0 C--N 1.373 1.603 0 CA-C-N 123.113 2.688 . . . . 0.0 115.685 -174.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.427 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 96.2 mtt180 -74.84 -5.53 44.06 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.01 1.324 . . . . 0.0 113.814 172.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.93 2.17 32.16 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 127.102 2.161 . . . . 0.0 112.173 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 43.0 mt -96.89 125.69 41.51 Favored 'General case' 0 C--N 1.368 1.376 0 C-N-CA 127.389 2.276 . . . . 0.0 109.956 174.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -114.7 167.74 9.22 Favored Pre-proline 0 C--N 1.347 0.493 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.0 157.09 15.31 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.306 3.337 . . . . 0.0 113.991 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.64 150.57 20.21 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 123.426 1.584 . . . . 0.0 107.89 170.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.8 t -173.08 -45.58 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.835 1 N-CA-C 97.26 -5.089 . . . . 0.0 97.26 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 128.35 -149.76 18.33 Favored Glycine 0 CA--C 1.474 -2.471 0 C-N-CA 117.892 -2.099 . . . . 0.0 116.865 135.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.9 m -46.5 -18.78 0.07 Allowed 'General case' 0 C--N 1.375 1.68 1 C-N-CA 133.027 4.531 . . . . 0.0 116.67 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 0.94 54.92 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 129.881 3.272 . . . . 0.0 112.582 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.9 m -86.51 142.56 28.26 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 127.529 2.331 . . . . 0.0 111.409 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -61.69 -27.45 68.71 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -79.7 -17.08 54.45 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 124.935 1.294 . . . . 0.0 111.372 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.27 4.21 51.01 Favored 'General case' 0 C--N 1.371 1.515 0 C-N-CA 124.813 1.245 . . . . 0.0 113.017 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -123.74 177.34 5.76 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 120.048 -1.657 . . . . 0.0 111.228 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -57.97 121.84 11.55 Favored 'General case' 0 C--N 1.372 1.576 0 C-N-CA 126.483 1.913 . . . . 0.0 114.598 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.32 -14.52 59.52 Favored Glycine 0 C--N 1.356 1.671 0 C-N-CA 125.174 1.369 . . . . 0.0 112.299 -169.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.6 153.64 40.91 Favored Glycine 0 C--N 1.361 1.941 0 N-CA-C 119.857 2.703 . . . . 0.0 119.857 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -55.86 -42.21 75.51 Favored 'General case' 0 C--N 1.363 1.169 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.577 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.308 0.5 OUTLIER -106.01 -12.16 15.9 Favored 'General case' 0 C--N 1.358 0.951 0 O-C-N 120.638 -1.289 . . . . 0.0 113.619 -179.796 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . 0.301 0.0 OUTLIER -41.68 -27.86 0.12 Allowed 'General case' 0 C--N 1.365 1.248 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.2 m -14.53 90.94 0.01 OUTLIER 'General case' 0 C--N 1.381 1.962 1 C-N-CA 131.901 4.08 . . . . 0.0 116.917 -174.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.35 102.11 13.71 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-O 125.653 2.644 . . . . 0.0 115.045 -163.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -119.96 144.53 37.71 Favored Pre-proline 0 N--CA 1.416 -2.163 3 C-N-CA 134.909 5.284 . . . . 0.0 100.184 170.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -60.31 -28.95 87.85 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 125.014 3.809 . . . . 0.0 115.487 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -65.72 -36.4 83.49 Favored 'General case' 0 C--N 1.365 1.272 0 C-N-CA 128.806 2.842 . . . . 0.0 112.303 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.409 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 20.4 mm -72.39 -37.73 58.74 Favored 'Isoleucine or valine' 0 C--N 1.374 1.631 0 C-N-CA 126.487 1.915 . . . . 0.0 110.237 175.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.73 -49.38 59.23 Favored 'General case' 0 C--N 1.371 1.502 0 O-C-N 120.324 -1.485 . . . . 0.0 113.646 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -58.43 -39.3 79.44 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 127.391 2.276 . . . . 0.0 114.22 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.0 -37.34 84.02 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 131.41 3.884 . . . . 0.0 110.421 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.4 mtt -66.91 -33.03 74.69 Favored 'General case' 0 C--N 1.366 1.284 0 O-C-N 120.609 -1.307 . . . . 0.0 113.024 167.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.43 -46.86 37.22 Favored 'General case' 0 C--N 1.378 1.83 0 C-N-CA 126.527 1.931 . . . . 0.0 112.577 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.534 HH21 ' HB3' ' A' ' 134' ' ' PHE . 22.4 ttp-105 -66.31 -50.56 63.21 Favored 'General case' 0 C--N 1.372 1.57 0 C-N-CA 129.564 3.145 . . . . 0.0 112.322 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.96 69.61 Favored 'General case' 0 C--N 1.375 1.692 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 167.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -68.64 -50.87 47.86 Favored 'General case' 0 C--N 1.371 1.53 0 O-C-N 120.491 -1.381 . . . . 0.0 111.751 173.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -40.36 83.15 Favored 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.363 1.865 . . . . 0.0 115.537 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.06 -27.25 57.18 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.94 -50.17 11.61 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.899 1.679 . . . . 0.0 111.177 173.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.322 0.0 OUTLIER -82.99 -15.71 50.13 Favored 'General case' 0 C--N 1.367 1.355 0 C-N-CA 126.615 1.966 . . . . 0.0 115.176 -169.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -110.64 -98.7 0.4 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.459 ' HB2' ' HZ2' ' A' ' 189' ' ' LYS . 16.3 m-20 -136.28 149.32 48.4 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 124.111 0.964 . . . . 0.0 109.936 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -50.73 -34.64 27.77 Favored 'General case' 0 C--N 1.365 1.27 1 C-N-CA 133.668 4.787 . . . . 0.0 112.282 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 6.4 tt -52.24 -30.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.365 1.278 0 C-N-CA 128.855 2.862 . . . . 0.0 112.758 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.459 ' HZ2' ' HB2' ' A' ' 186' ' ' ASP 0.273 6.5 mptt -68.39 -43.17 77.91 Favored 'General case' 0 C--N 1.376 1.729 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 172.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.45 ' HB2' HD22 ' A' ' 109' ' ' LEU 0.265 1.2 ptm180 -76.51 -43.62 38.67 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 119.043 2.979 . . . . 0.0 119.043 170.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 12.3 tp -71.65 -27.62 63.2 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 127.38 2.272 . . . . 0.0 113.545 -174.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -81.46 -4.46 55.92 Favored 'General case' 0 C--N 1.366 1.298 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 170.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.58 -44.69 5.5 Favored 'General case' 0 C--N 1.366 1.324 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 58.97 -114.34 0.73 Allowed 'General case' 0 C--N 1.372 1.545 0 C-N-CA 127.309 2.243 . . . . 0.0 113.119 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.45 27.93 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 126.45 1.9 . . . . 0.0 110.448 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 5.1 t 70.74 8.13 6.45 Favored 'General case' 0 C--N 1.37 1.459 0 C-N-CA 128.219 2.607 . . . . 0.0 115.027 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 10.5 t70 91.23 16.38 0.03 OUTLIER 'General case' 0 C--N 1.359 0.986 0 C-N-CA 130.828 3.651 . . . . 0.0 111.967 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.52 125.09 59.03 Favored Pre-proline 0 C--N 1.37 1.474 0 O-C-N 120.11 -1.618 . . . . 0.0 113.506 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -85.62 144.91 9.02 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.853 3.036 . . . . 0.0 109.45 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 81.6 p -84.4 70.98 10.73 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 125.798 1.639 . . . . 0.0 113.749 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 . . . . . 0 C--N 1.356 0.883 0 C-N-CA 126.177 1.791 . . . . 0.0 110.177 -178.235 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? . . . . . 0 N--CA 1.441 -0.876 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.25 166.36 25.53 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 126.119 1.768 . . . . 0.0 106.988 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -152.22 165.3 35.27 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -103.67 152.69 21.5 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 127.121 2.169 . . . . 0.0 108.697 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.317 15.7 mt 77.51 176.8 0.17 Allowed 'General case' 0 C--N 1.364 1.215 0 C-N-CA 127.653 2.381 . . . . 0.0 116.722 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.0 21.35 17.69 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 126.713 2.005 . . . . 0.0 111.43 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.92 -16.67 58.21 Favored Glycine 0 C--N 1.361 1.948 0 C-N-CA 126.438 1.97 . . . . 0.0 114.423 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.97 11.05 44.28 Favored Glycine 0 C--N 1.356 1.68 0 C-N-CA 126.838 2.161 . . . . 0.0 110.856 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.24 65.77 1.63 Allowed 'General case' 0 C--N 1.356 0.86 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -71.61 -24.16 61.83 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 130.189 3.396 . . . . 0.0 112.365 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.5 tpt85 -92.32 -0.1 57.41 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 128.267 2.627 . . . . 0.0 110.211 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.1 t 66.77 -102.35 0.07 Allowed 'General case' 0 C--N 1.365 1.241 0 C-N-CA 129.665 3.186 . . . . 0.0 114.832 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.8 m -112.95 10.66 8.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 126.175 1.79 . . . . 0.0 110.518 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.11 140.05 20.88 Favored Pre-proline 0 C--N 1.358 0.976 0 O-C-N 120.518 -1.364 . . . . 0.0 110.854 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.7 -69.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 124.236 3.291 . . . . 0.0 110.823 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -147.73 -56.23 0.23 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 124.803 1.241 . . . . 0.0 107.809 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.48 111.78 64.83 Favored Pre-proline 0 C--N 1.361 1.108 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -89.73 53.61 1.5 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.842 3.028 . . . . 0.0 111.52 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.9 m -103.27 127.68 50.53 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 126.204 1.802 . . . . 0.0 109.083 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 m -93.27 53.38 1.92 Allowed 'General case' 0 C--N 1.362 1.114 0 O-C-N 120.046 -1.658 . . . . 0.0 112.226 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.11 72.0 8.33 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 129.629 3.172 . . . . 0.0 110.032 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -118.01 92.79 3.92 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.646 2.379 . . . . 0.0 112.638 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.19 127.25 46.5 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.361 1.464 . . . . 0.0 112.346 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.39 57.8 p -111.72 167.94 8.36 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 119.731 -1.855 . . . . 0.0 113.771 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -57.63 153.07 44.52 Favored 'Trans proline' 0 C--N 1.373 1.84 1 C-N-CA 126.565 4.843 . . . . 0.0 120.821 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.82 -41.87 2.06 Favored Glycine 0 C--N 1.377 2.823 0 C-N-CA 127.483 2.468 . . . . 0.0 107.02 -165.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -73.84 159.57 32.67 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.608 HD11 ' HE ' ' A' ' 190' ' ' ARG . 0.1 OUTLIER -105.51 142.56 35.05 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.7 m -142.82 151.73 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.456 ' CE3' ' HG3' ' A' ' 107' ' ' PRO . 41.0 m95 -99.92 121.1 40.82 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 168.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -102.11 152.27 21.19 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 121.125 1.784 . . . . 0.0 112.345 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -116.9 131.9 56.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 102.398 -3.186 . . . . 0.0 102.398 169.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 34.8 ttm -118.47 138.38 52.53 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.31 101.66 0.45 Allowed 'General case' 0 C--N 1.369 1.424 0 C-N-CA 125.789 1.635 . . . . 0.0 113.816 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.19 -6.0 25.21 Favored Glycine 0 C--N 1.36 1.895 0 C-N-CA 125.667 1.604 . . . . 0.0 113.206 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.24 164.3 15.14 Favored Pre-proline 0 C--N 1.354 0.797 0 C-N-CA 125.779 1.632 . . . . 0.0 109.524 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.05 166.1 30.64 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 124.274 3.316 . . . . 0.0 112.774 162.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -57.84 123.3 15.28 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 129.061 2.944 . . . . 0.0 114.44 171.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -134.15 116.1 13.17 Favored Pre-proline 0 CA--C 1.563 1.476 1 N-CA-C 123.75 4.722 . . . . 0.0 123.75 -168.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HG3' ' CE3' ' A' ' 97' ' ' TRP . 53.8 Cg_exo -54.84 110.38 0.53 Allowed 'Trans proline' 0 C--N 1.396 3.056 1 C-N-CA 127.635 5.556 . . . . 0.0 114.898 164.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.5 p -125.72 164.04 21.5 Favored 'General case' 0 CA--C 1.536 0.431 1 C-N-CA 132.342 4.257 . . . . 0.0 115.901 -169.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp -115.8 138.25 51.32 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 118.65 -2.532 . . . . 0.0 108.257 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.0 118.93 29.65 Favored 'Isoleucine or valine' 0 C--N 1.37 1.476 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -115.8 154.58 29.39 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.03 -1.669 . . . . 0.0 115.36 -163.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -111.67 113.68 26.22 Favored 'General case' 0 C--N 1.372 1.545 0 C-N-CA 125.767 1.627 . . . . 0.0 108.812 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -69.08 160.94 76.26 Favored Pre-proline 0 C--N 1.363 1.188 0 C-N-CA 130.994 3.717 . . . . 0.0 110.191 174.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.67 0.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.5 1 C-N-CA 128.071 5.847 . . . . 0.0 119.226 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -99.57 34.96 2.08 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 130.542 3.537 . . . . 0.0 105.865 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.322 0.0 OUTLIER -61.35 120.86 11.26 Favored 'General case' 0 C--N 1.382 1.993 0 C-N-CA 126.972 2.109 . . . . 0.0 115.542 -166.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.85 -20.49 26.72 Favored Glycine 0 C--N 1.356 1.678 0 C-N-CA 127.302 2.382 . . . . 0.0 111.583 -171.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 p -116.09 119.15 34.92 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 103.979 -2.6 . . . . 0.0 103.979 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.481 ' HB2' ' CE1' ' A' ' 130' ' ' HIS . 16.4 p90 -148.42 -9.65 0.37 Allowed 'General case' 0 C--N 1.363 1.156 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -170.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 pt -109.69 153.18 11.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-N 120.074 1.306 . . . . 0.0 112.473 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -142.28 136.52 29.85 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 104.138 -2.542 . . . . 0.0 104.138 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -150.68 127.24 10.82 Favored 'General case' 0 C--N 1.363 1.166 0 O-C-N 120.044 -1.66 . . . . 0.0 110.986 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -118.41 93.38 4.1 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 125.919 1.688 . . . . 0.0 110.534 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.16 -51.89 0.01 OUTLIER Glycine 0 C--N 1.363 2.033 1 N-CA-C 124.096 4.398 . . . . 0.0 124.096 171.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -137.64 21.58 2.9 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.325 1.45 . . . . 0.0 113.532 -172.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.6 m -163.49 146.39 10.08 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.01 137.72 56.44 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 C-N-CA 123.759 0.824 . . . . 0.0 109.851 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -120.55 130.06 54.06 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 126.829 2.052 . . . . 0.0 107.067 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.29 150.98 21.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.957 1 N-CA-C 98.855 -4.498 . . . . 0.0 98.855 175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.481 ' CE1' ' HB2' ' A' ' 119' ' ' PHE . 12.6 p-80 -81.69 130.04 34.92 Favored 'General case' 0 C--N 1.367 1.336 0 C-N-CA 125.392 1.477 . . . . 0.0 113.16 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.2 m -137.74 151.16 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 N-CA-C 102.651 -3.092 . . . . 0.0 102.651 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -111.83 148.43 33.6 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -106.8 125.27 50.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 127.723 2.409 . . . . 0.0 105.802 -174.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -75.36 76.13 2.45 Favored 'General case' 0 C--N 1.372 1.574 0 C-N-CA 124.726 1.21 . . . . 0.0 109.492 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -102.46 -113.66 0.21 Allowed 'General case' 0 C--N 1.358 0.935 0 O-C-N 120.04 -1.662 . . . . 0.0 110.392 -173.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -106.87 -59.23 1.83 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 126.202 1.801 . . . . 0.0 111.32 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.5 p -86.06 -31.38 0.43 Allowed Pre-proline 0 C--N 1.365 1.245 0 N-CA-C 120.322 3.453 . . . . 0.0 120.322 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.1 -172.65 10.27 Favored 'Cis proline' 0 CA--C 1.541 0.853 1 CA-C-N 129.917 4.578 . . . . 0.0 113.418 0.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.8 m -96.81 155.64 16.69 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 129.429 3.092 . . . . 0.0 108.904 170.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.434 HH12 ' HB2' ' A' ' 197' ' ' ASP . 58.1 ttp180 -166.1 171.71 12.11 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.54 -169.87 42.12 Favored Glycine 0 CA--C 1.486 -1.752 1 N-CA-C 101.751 -4.54 . . . . 0.0 101.751 163.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -93.93 99.78 12.06 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 169.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.8 m -84.46 176.49 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 C-N-CA 125.563 1.545 . . . . 0.0 109.052 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.7 m -92.98 121.81 34.7 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 170.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.309 16.3 pttm -76.36 -11.04 59.83 Favored 'General case' 0 C--N 1.372 1.584 0 CA-C-N 121.421 1.919 . . . . 0.0 113.257 -176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -68.91 -18.85 64.17 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 125.954 1.702 . . . . 0.0 113.487 170.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.1 mt -91.12 0.65 57.49 Favored 'General case' 0 C--N 1.369 1.424 0 C-N-CA 126.184 1.793 . . . . 0.0 114.571 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.47 159.0 15.24 Favored 'General case' 0 C--N 1.364 1.226 0 O-C-N 119.877 -1.764 . . . . 0.0 108.386 176.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.66 159.22 45.0 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -74.51 154.59 45.14 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.671 3.58 . . . . 0.0 114.724 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.274 0.1 OUTLIER -18.56 -107.69 0.0 OUTLIER 'General case' 0 C--N 1.363 1.17 2 N-CA-C 123.486 4.624 . . . . 0.0 123.486 177.19 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.326 4.9 t 50.99 -40.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 1 C-N-CA 132.612 4.365 . . . . 0.0 120.413 177.098 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.82 -144.41 38.23 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 118.812 2.285 . . . . 0.0 118.812 176.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.8 m -53.04 -24.97 11.0 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.487 3.515 . . . . 0.0 119.749 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -84.42 -6.07 59.34 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 126.488 1.915 . . . . 0.0 111.951 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.2 m -83.84 146.47 28.08 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.894 1.678 . . . . 0.0 112.87 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -63.4 -27.5 69.34 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 125.702 1.601 . . . . 0.0 112.419 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.37 -23.82 61.97 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 127.417 2.287 . . . . 0.0 113.163 171.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.4 0.81 48.45 Favored 'General case' 0 C--N 1.371 1.518 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.255 1.1 pp0? -115.47 -175.29 2.68 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 125.284 1.433 . . . . 0.0 110.168 176.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -66.27 122.91 18.55 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 126.692 1.997 . . . . 0.0 112.243 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.46 -10.89 58.04 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 124.848 1.213 . . . . 0.0 111.654 -167.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.64 139.84 23.51 Favored Glycine 0 C--N 1.365 2.154 0 N-CA-C 119.618 2.607 . . . . 0.0 119.618 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -61.01 -16.37 42.6 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 119.324 3.083 . . . . 0.0 119.324 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.85 -0.06 17.03 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.701 -1.249 . . . . 0.0 110.805 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -79.1 142.17 36.68 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 126.166 2.889 . . . . 0.0 118.315 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.6 m -172.86 170.46 4.57 Favored 'General case' 0 C--N 1.348 0.508 2 N-CA-C 98.165 -4.754 . . . . 0.0 98.165 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -138.24 101.59 4.43 Favored 'General case' 0 C--N 1.367 1.366 0 CA-C-N 124.931 3.514 . . . . 0.0 111.223 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -119.88 135.24 24.14 Favored Pre-proline 0 N--CA 1.43 -1.428 0 N-CA-C 100.921 -3.733 . . . . 0.0 100.921 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.7 -26.5 80.04 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 125.196 3.93 . . . . 0.0 114.108 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -63.9 -36.39 83.77 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 127.515 2.326 . . . . 0.0 113.424 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.8 mt -70.97 -42.88 77.05 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 C-N-CA 125.582 1.553 . . . . 0.0 110.923 173.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.46 -43.24 77.46 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 124.766 1.226 . . . . 0.0 113.979 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -58.91 -38.69 79.48 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 128.178 2.591 . . . . 0.0 113.259 175.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.26 -34.54 74.93 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 131.357 3.863 . . . . 0.0 110.887 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.403 ' HG2' ' CH2' ' A' ' 97' ' ' TRP . 31.3 mtt -70.4 -37.59 74.49 Favored 'General case' 0 C--N 1.386 2.156 0 C-N-CA 124.03 0.932 . . . . 0.0 111.339 168.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -68.53 -45.29 72.59 Favored 'General case' 0 C--N 1.378 1.842 0 C-N-CA 126.638 1.975 . . . . 0.0 111.62 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -53.93 47.37 Favored 'General case' 0 C--N 1.37 1.471 0 C-N-CA 131.629 3.971 . . . . 0.0 111.698 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.94 -45.26 82.9 Favored 'General case' 0 C--N 1.373 1.6 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 170.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 184' ' ' ASN 0.318 38.8 t70 -64.19 -24.73 67.78 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 127.339 2.256 . . . . 0.0 112.702 176.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -75.09 -43.89 50.47 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 117.922 -2.986 . . . . 0.0 112.228 168.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.25 -39.62 53.99 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 120.069 3.359 . . . . 0.0 120.069 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.24 -26.85 47.47 Favored 'General case' 0 C--N 1.36 1.051 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.2 OUTLIER -89.78 -30.28 18.1 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.461 2.704 . . . . 0.0 107.93 -173.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -104.98 -98.56 0.32 Allowed 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -136.03 159.7 40.89 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 119.995 -1.691 . . . . 0.0 111.691 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.2 mmtt -51.55 -38.56 54.85 Favored 'General case' 0 C--N 1.377 1.78 0 C-N-CA 131.201 3.801 . . . . 0.0 115.142 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.6 tt -55.22 -36.07 38.44 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 129.171 2.988 . . . . 0.0 113.379 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -43.92 72.49 Favored 'General case' 0 C--N 1.372 1.558 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.608 ' HE ' HD11 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -75.25 -43.43 51.54 Favored 'General case' 0 C--N 1.37 1.475 0 CA-C-N 121.241 1.837 . . . . 0.0 114.826 172.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.5 tp -71.32 -19.48 62.3 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 128.672 2.789 . . . . 0.0 113.852 -172.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -59.64 -27.9 66.76 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.883 2.073 . . . . 0.0 113.492 164.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.1 21.66 14.47 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 127.472 2.309 . . . . 0.0 111.95 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.03 44.95 0.0 OUTLIER 'General case' 0 C--N 1.374 1.644 0 C-N-CA 131.502 3.921 . . . . 0.0 118.202 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.8 t 66.79 -51.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.183 1 C-N-CA 133.206 4.602 . . . . 0.0 113.827 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.9 t 86.79 35.95 0.02 OUTLIER 'General case' 0 C--N 1.361 1.092 0 C-N-CA 130.528 3.531 . . . . 0.0 109.742 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.434 ' HB2' HH12 ' A' ' 140' ' ' ARG . 18.3 t70 -70.51 65.13 0.29 Allowed 'General case' 0 C--N 1.363 1.179 0 C-N-CA 127.686 2.395 . . . . 0.0 116.98 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 70.65 68.76 0.37 Allowed Pre-proline 0 C--N 1.358 0.956 0 C-N-CA 129.695 3.198 . . . . 0.0 114.34 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.28 78.59 3.62 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 124.225 3.283 . . . . 0.0 111.476 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 97.0 p -80.05 69.64 6.48 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 126.156 1.782 . . . . 0.0 114.231 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 . . . . . 0 C--N 1.356 0.863 0 C-N-CA 126.201 1.801 . . . . 0.0 110.192 -178.941 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.27 -109.67 0.01 OUTLIER 'General case' 0 C--N 1.351 0.641 0 C-N-CA 125.352 1.461 . . . . 0.0 108.545 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -148.76 112.81 5.18 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.877 -1.139 . . . . 0.0 109.131 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -85.55 123.2 30.7 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.454 1.501 . . . . 0.0 110.841 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.27 58.9 mt 76.45 73.95 0.08 Allowed 'General case' 0 C--N 1.363 1.156 0 C-N-CA 126.836 2.054 . . . . 0.0 114.188 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -106.66 20.81 18.46 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.678 1.591 . . . . 0.0 110.338 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.95 -21.64 43.89 Favored Glycine 0 C--N 1.358 1.761 0 C-N-CA 128.852 3.12 . . . . 0.0 117.525 168.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.55 -174.38 41.99 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 105.425 -3.07 . . . . 0.0 105.425 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mt -128.68 34.85 4.44 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 118.826 1.313 . . . . 0.0 109.804 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -71.73 -52.74 16.19 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 128.439 2.695 . . . . 0.0 114.519 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -113.88 -6.83 13.21 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.43 1.492 . . . . 0.0 112.15 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 t 84.46 -26.1 0.12 Allowed 'General case' 0 C--N 1.364 1.199 0 C-N-CA 128.493 2.717 . . . . 0.0 114.636 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.288 24.4 t 65.73 -49.97 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.033 0 C-N-CA 129.027 2.931 . . . . 0.0 116.039 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.91 160.79 63.18 Favored Pre-proline 0 N--CA 1.447 -0.623 0 O-C-N 120.516 -1.365 . . . . 0.0 109.135 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.82 78.92 2.98 Favored 'Trans proline' 0 C--N 1.363 1.299 1 C-N-CA 125.314 4.009 . . . . 0.0 109.734 170.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.01 -88.54 0.54 Allowed 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.915 2.086 . . . . 0.0 111.246 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.3 112.75 63.86 Favored Pre-proline 0 C--N 1.359 0.979 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.19 80.12 3.14 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.682 2.921 . . . . 0.0 114.094 -167.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . 0.525 75.5 p 90.74 -3.02 0.25 Allowed 'General case' 0 C--N 1.357 0.895 0 C-N-CA 130.235 3.414 . . . . 0.0 116.338 175.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . 0.276 0.7 OUTLIER 83.62 -50.99 0.14 Allowed 'General case' 0 C--N 1.358 0.947 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 169.031 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.8 p -144.39 85.18 1.78 Allowed 'General case' 0 C--N 1.356 0.872 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.285 1.1 p30 -171.81 87.26 0.09 Allowed 'General case' 0 C--N 1.364 1.215 0 C-N-CA 124.973 1.309 . . . . 0.0 112.814 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.43 ' CE1' ' HB3' ' A' ' 150' ' ' PRO . 51.3 m-85 -124.6 127.65 47.69 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 126.029 1.732 . . . . 0.0 114.814 -171.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.358 98.0 p -110.18 169.62 6.18 Favored Pre-proline 0 CA--C 1.574 1.882 0 C-N-CA 131.025 3.73 . . . . 0.0 114.952 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -66.19 146.89 82.81 Favored 'Trans proline' 0 C--N 1.385 2.474 1 C-N-CA 126.88 5.054 . . . . 0.0 117.281 -168.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.59 -32.35 7.03 Favored Glycine 0 C--N 1.366 2.236 0 C-N-CA 126.403 1.954 . . . . 0.0 109.365 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -83.12 162.38 21.33 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 124.486 2.089 . . . . 0.0 113.485 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.02 135.4 54.26 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 101.609 -3.478 . . . . 0.0 101.609 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.99 159.06 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 126.209 1.804 . . . . 0.0 107.082 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -98.7 118.37 35.27 Favored 'General case' 0 C--N 1.349 0.559 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.39 138.9 50.97 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 126.37 1.868 . . . . 0.0 113.397 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -113.65 145.84 40.68 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 170.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.1 ttp -128.97 152.82 48.17 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 119.85 -1.781 . . . . 0.0 109.162 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -63.42 89.68 0.04 OUTLIER 'General case' 0 C--N 1.364 1.228 0 C-N-CA 127.716 2.406 . . . . 0.0 115.472 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.17 -4.13 25.36 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 125.665 1.602 . . . . 0.0 112.249 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -98.02 162.15 23.13 Favored Pre-proline 0 C--N 1.357 0.916 0 C-N-CA 125.508 1.523 . . . . 0.0 110.223 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.26 167.08 27.24 Favored 'Trans proline' 0 CA--C 1.544 0.983 1 C-N-CA 125.777 4.318 . . . . 0.0 112.941 163.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -68.3 130.68 43.61 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 127.426 2.29 . . . . 0.0 112.267 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.452 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 6.3 m95 -128.7 131.91 24.04 Favored Pre-proline 0 N--CA 1.429 -1.502 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.56 139.24 30.94 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 124.211 3.274 . . . . 0.0 108.1 149.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.1 p -152.37 164.18 38.0 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 126.936 2.094 . . . . 0.0 111.611 -163.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 190' ' ' ARG . 1.3 pp -111.47 149.44 31.31 Favored 'General case' 0 C--N 1.367 1.356 0 O-C-N 119.982 -1.699 . . . . 0.0 109.87 171.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.418 HG12 HG13 ' A' ' 131' ' ' VAL . 2.4 t -91.45 119.83 39.41 Favored 'Isoleucine or valine' 0 C--N 1.364 1.222 0 O-C-N 120.608 -1.308 . . . . 0.0 107.787 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -114.61 141.85 47.22 Favored 'General case' 0 C--N 1.37 1.5 0 N-CA-C 120.066 3.358 . . . . 0.0 120.066 -162.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -85.77 111.27 20.0 Favored 'General case' 0 C--N 1.377 1.772 0 O-C-N 118.526 -2.608 . . . . 0.0 110.522 172.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.406 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 75.0 t60 -85.04 160.2 55.58 Favored Pre-proline 0 N--CA 1.449 -0.497 1 C-N-CA 132.108 4.163 . . . . 0.0 109.673 -176.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.81 -13.84 6.8 Favored 'Trans proline' 0 CA--C 1.55 1.306 1 C-N-CA 125.97 4.447 . . . . 0.0 117.08 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -107.41 54.11 0.68 Allowed 'General case' 0 C--N 1.365 1.244 0 C-N-CA 127.848 2.459 . . . . 0.0 107.564 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.43 167.77 19.05 Favored 'General case' 0 C--N 1.368 1.406 0 O-C-N 119.563 -1.961 . . . . 0.0 114.787 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.48 -20.04 48.98 Favored Glycine 0 C--N 1.364 2.086 0 C-N-CA 126.053 1.787 . . . . 0.0 113.559 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.7 m -123.47 120.3 32.52 Favored 'General case' 0 C--N 1.346 0.453 1 N-CA-C 99.465 -4.272 . . . . 0.0 99.465 170.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -122.64 -3.49 8.77 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 -168.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.6 pt -122.81 149.74 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 119.618 -1.926 . . . . 0.0 112.948 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -141.49 160.18 40.68 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 129.854 3.262 . . . . 0.0 104.595 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -152.08 127.57 10.03 Favored 'General case' 0 C--N 1.365 1.272 0 O-C-N 118.935 -2.353 . . . . 0.0 111.459 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.37 92.94 4.7 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.266 1.426 . . . . 0.0 108.78 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.5 -84.96 0.19 Allowed Glycine 0 C--N 1.363 2.053 0 C-N-CA 127.309 2.385 . . . . 0.0 114.57 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -116.74 -15.26 10.75 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 126.277 1.831 . . . . 0.0 110.591 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.1 m -88.43 100.91 13.41 Favored 'General case' 0 C--N 1.365 1.257 0 O-C-N 120.423 -1.423 . . . . 0.0 110.625 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 p -86.46 132.41 32.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 127.452 2.301 . . . . 0.0 108.246 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -117.1 141.98 47.57 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 126.19 1.796 . . . . 0.0 112.569 -173.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.9 164.16 35.97 Favored 'Isoleucine or valine' 0 C--N 1.359 0.986 0 C-N-CA 130.057 3.343 . . . . 0.0 106.094 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.406 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 17.2 m80 -88.55 116.68 26.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.98 1.712 . . . . 0.0 112.596 176.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.418 HG13 HG12 ' A' ' 110' ' ' VAL . 3.3 m -134.24 173.76 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 O-C-N 119.25 -2.156 . . . . 0.0 106.87 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.49 147.91 43.73 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 171.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -99.88 127.2 46.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.111 2.164 . . . . 0.0 107.812 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 109' ' ' LEU . 15.2 m-30 -73.8 62.96 0.85 Allowed 'General case' 0 C--N 1.369 1.429 0 C-N-CA 126.736 2.015 . . . . 0.0 114.153 -176.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -91.35 -108.78 0.1 Allowed 'General case' 0 C--N 1.365 1.248 0 O-C-N 121.392 -0.818 . . . . 0.0 112.561 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.74 -65.34 1.09 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 126.224 1.81 . . . . 0.0 114.097 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.5 p -79.85 -32.6 0.73 Allowed Pre-proline 0 C--N 1.361 1.086 0 N-CA-C 119.464 3.135 . . . . 0.0 119.464 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -92.16 -166.3 2.31 Favored 'Cis proline' 0 CA--C 1.539 0.774 1 CA-C-N 129.988 4.603 . . . . 0.0 110.828 -1.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -97.69 135.48 39.42 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 125.093 1.357 . . . . 0.0 111.678 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.2 tmm_? -136.56 147.34 46.97 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 120.748 1.613 . . . . 0.0 106.915 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.81 -179.87 40.72 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 104.892 -3.283 . . . . 0.0 104.892 170.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -86.55 109.11 18.89 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 127.423 2.289 . . . . 0.0 106.76 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.19 -178.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 125.602 1.561 . . . . 0.0 111.574 -172.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.2 m -100.41 117.29 34.29 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 101.318 -3.586 . . . . 0.0 101.318 169.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.427 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 5.6 ttpp -72.42 -14.04 61.6 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 124.026 1.869 . . . . 0.0 113.063 -171.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -75.07 -12.3 60.29 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.971 1.708 . . . . 0.0 113.961 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.46 3.82 43.26 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 126.742 2.017 . . . . 0.0 110.948 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.427 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 31.5 mt -94.25 130.44 40.51 Favored 'General case' 0 C--N 1.366 1.292 0 C-N-CA 126.623 1.969 . . . . 0.0 109.201 173.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.427 ' HG3' ' CE1' ' A' ' 165' ' ' PHE . 5.1 mmtt -114.88 165.65 13.51 Favored Pre-proline 0 C--N 1.35 0.611 0 N-CA-C 102.947 -2.983 . . . . 0.0 102.947 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.43 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . 98.4 Cg_endo -82.56 155.8 16.16 Favored 'Trans proline' 0 C--N 1.326 -0.656 0 C-N-CA 124.644 3.563 . . . . 0.0 112.561 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.64 124.04 41.89 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 121.643 0.735 . . . . 0.0 112.067 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.0 t -161.52 25.77 0.13 Allowed 'General case' 0 C--N 1.358 0.954 0 C-N-CA 127.493 2.317 . . . . 0.0 105.523 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.64 81.74 0.07 OUTLIER Glycine 0 C--N 1.354 1.575 0 C-N-CA 115.941 -3.028 . . . . 0.0 117.55 -162.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 69.9 m -67.92 -11.45 58.76 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 128.571 2.748 . . . . 0.0 114.068 172.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -122.52 37.97 4.27 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 128.445 2.698 . . . . 0.0 109.788 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.3 m -95.09 147.87 22.96 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.584 2.354 . . . . 0.0 108.027 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -61.78 -24.49 66.87 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -82.23 -19.09 40.41 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 125.586 1.554 . . . . 0.0 112.161 168.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.34 -39.62 10.38 Favored 'General case' 0 C--N 1.368 1.393 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.337 0.0 OUTLIER -83.74 -173.67 4.85 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -178.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.74 121.34 15.74 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.81 -1.806 . . . . 0.0 113.462 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.34 -13.24 51.58 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.075 -166.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.9 158.65 36.95 Favored Glycine 0 C--N 1.369 2.375 0 N-CA-C 120.665 3.026 . . . . 0.0 120.665 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -60.05 -41.76 93.02 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 129.084 2.953 . . . . 0.0 117.561 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.427 ' CE1' ' HG3' ' A' ' 149' ' ' LYS . 1.6 m-85 -92.67 -30.1 15.75 Favored 'General case' 0 C--N 1.37 1.463 0 O-C-N 120.9 -1.125 . . . . 0.0 110.538 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.3 t80 0.4 -91.51 0.0 OUTLIER 'General case' 0 C--N 1.382 1.981 1 C-N-CA 133.59 4.756 . . . . 0.0 117.216 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.1 m 49.17 65.77 1.29 Allowed 'General case' 0 C--N 1.364 1.211 0 C-N-CA 130.756 3.623 . . . . 0.0 116.413 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.5 100.93 11.06 Favored 'General case' 0 C--N 1.369 1.415 0 CA-C-O 124.93 2.3 . . . . 0.0 114.049 -170.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -120.63 146.1 42.52 Favored Pre-proline 0 N--CA 1.429 -1.51 1 C-N-CA 132.009 4.124 . . . . 0.0 105.028 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -50.26 -38.3 51.43 Favored 'Trans proline' 0 CA--C 1.548 1.2 1 C-N-CA 127.403 5.402 . . . . 0.0 117.113 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.75 -35.54 75.05 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 128.943 2.897 . . . . 0.0 113.644 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.255 12.8 mt -76.01 -32.12 22.82 Favored 'Isoleucine or valine' 0 C--N 1.371 1.541 0 C-N-CA 127.119 2.168 . . . . 0.0 110.528 175.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.3 mt -62.91 -53.16 58.42 Favored 'General case' 0 C--N 1.383 2.037 0 C-N-CA 126.704 2.002 . . . . 0.0 109.178 168.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -34.47 68.5 Favored 'General case' 0 C--N 1.369 1.449 0 C-N-CA 128.651 2.78 . . . . 0.0 115.066 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.21 -45.81 68.96 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 130.19 3.396 . . . . 0.0 112.116 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 12.8 mtt -67.03 -33.37 75.4 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-N 119.416 1.007 . . . . 0.0 113.515 170.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -70.02 -52.19 26.14 Favored 'General case' 0 C--N 1.381 1.976 0 C-N-CA 126.495 1.918 . . . . 0.0 113.06 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.274 5.4 ptt180 -72.43 -35.94 68.46 Favored 'General case' 0 C--N 1.384 2.067 0 O-C-N 119.184 -2.198 . . . . 0.0 114.48 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.96 89.38 Favored 'General case' 0 C--N 1.37 1.478 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 169.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.1 -35.78 79.74 Favored 'General case' 0 C--N 1.381 1.971 0 O-C-N 120.082 -1.636 . . . . 0.0 112.092 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -65.46 -45.78 82.4 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 119.337 -2.102 . . . . 0.0 113.743 170.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 190' ' ' ARG . . . -71.41 -36.2 71.25 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . 0.291 0.0 OUTLIER -79.74 -28.96 40.44 Favored 'General case' 0 C--N 1.371 1.535 0 O-C-N 119.893 -1.754 . . . . 0.0 114.89 177.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.267 0.0 OUTLIER -89.57 -15.48 32.76 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 124.966 1.306 . . . . 0.0 111.061 -176.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -115.2 -102.23 0.42 Allowed 'General case' 0 C--N 1.357 0.927 0 O-C-N 122.107 -0.37 . . . . 0.0 110.342 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -136.19 156.94 47.95 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 123.097 1.427 . . . . 0.0 109.952 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -50.97 -36.73 40.57 Favored 'General case' 0 C--N 1.361 1.08 1 C-N-CA 131.994 4.117 . . . . 0.0 114.116 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 8.1 tt -54.98 -28.29 20.29 Favored 'Isoleucine or valine' 0 C--N 1.364 1.236 1 C-N-CA 131.808 4.043 . . . . 0.0 113.514 175.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.281 5.3 mptt -71.98 -29.53 64.33 Favored 'General case' 0 C--N 1.376 1.733 0 C-N-CA 125.932 1.693 . . . . 0.0 113.551 171.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.425 ' HG2' ' HB2' ' A' ' 109' ' ' LEU 0.532 0.0 OUTLIER -74.73 -42.21 58.7 Favored 'General case' 0 C--N 1.375 1.713 0 O-C-N 119.198 -2.189 . . . . 0.0 113.368 170.045 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.5 -19.97 65.92 Favored 'General case' 0 C--N 1.379 1.869 0 C-N-CA 129.099 2.959 . . . . 0.0 114.424 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.88 -29.9 70.87 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 128.419 2.688 . . . . 0.0 112.925 169.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mt -105.07 -50.02 3.34 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 125.252 1.421 . . . . 0.0 108.535 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 34.37 38.31 0.03 OUTLIER 'General case' 0 C--N 1.375 1.706 1 C-N-CA 131.889 4.076 . . . . 0.0 119.229 173.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.273 40.5 t 88.32 77.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 128.963 2.905 . . . . 0.0 105.67 -170.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 80.4 p -59.53 79.99 0.01 OUTLIER 'General case' 0 C--N 1.361 1.065 0 C-N-CA 129.959 3.304 . . . . 0.0 117.439 -173.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -139.81 -74.04 0.36 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -142.55 80.26 14.59 Favored Pre-proline 0 N--CA 1.445 -0.675 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -82.42 -82.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 124.135 3.223 . . . . 0.0 109.283 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 31.9 m -172.21 -47.9 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 C--N 1.352 0.701 0 C-N-CA 127.352 2.261 . . . . 0.0 111.773 178.528 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? . . . . . 0 N--CA 1.44 -0.94 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.83 72.67 4.19 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 126.267 1.827 . . . . 0.0 110.489 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -101.86 90.89 4.15 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 126.835 2.054 . . . . 0.0 108.263 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -103.0 133.97 47.23 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 125.797 1.639 . . . . 0.0 109.503 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.81 66.94 5.44 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 115.832 1.789 . . . . 0.0 115.832 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -98.65 -17.87 18.37 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.433 1.893 . . . . 0.0 110.729 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.62 0.81 49.7 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 126.603 2.049 . . . . 0.0 113.079 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.87 -116.61 3.41 Favored Glycine 0 C--N 1.359 1.817 0 N-CA-C 106.174 -2.77 . . . . 0.0 106.174 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.1 mt -113.56 45.2 1.46 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 125.944 1.698 . . . . 0.0 107.341 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -71.21 -36.38 71.87 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 129.197 2.999 . . . . 0.0 114.691 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -106.58 13.11 28.66 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.012 1.325 . . . . 0.0 110.229 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.6 t 71.81 -152.09 0.08 Allowed 'General case' 0 C--N 1.364 1.197 0 C-N-CA 128.405 2.682 . . . . 0.0 115.023 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -149.65 146.34 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.02 150.48 41.86 Favored Pre-proline 0 C--N 1.351 0.658 0 C-N-CA 125.326 1.45 . . . . 0.0 110.733 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.38 -36.4 5.39 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 124.712 3.608 . . . . 0.0 112.365 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.92 -107.07 0.09 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 103.077 -2.935 . . . . 0.0 103.077 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.58 136.88 19.19 Favored Pre-proline 0 C--N 1.353 0.739 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -81.12 70.49 7.46 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.839 3.026 . . . . 0.0 111.734 -175.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.9 m -166.57 145.6 5.58 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.5 m -167.82 51.92 0.06 Allowed 'General case' 0 C--N 1.358 0.94 0 C-N-CA 125.126 1.37 . . . . 0.0 108.027 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.9 p -99.05 100.86 12.07 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 125.551 1.54 . . . . 0.0 110.463 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -155.85 92.4 1.37 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 124.698 1.199 . . . . 0.0 109.303 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -125.56 127.51 46.49 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.441 56.6 p -111.73 167.39 9.17 Favored Pre-proline 0 CA--C 1.562 1.41 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -59.54 137.66 79.02 Favored 'Trans proline' 0 C--N 1.379 2.165 1 C-N-CA 126.957 5.105 . . . . 0.0 118.531 -169.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.2 -22.65 39.8 Favored Glycine 0 C--N 1.371 2.513 0 C-N-CA 126.028 1.775 . . . . 0.0 111.39 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.34 159.31 27.21 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 120.208 -1.76 . . . . 0.0 112.212 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.74 133.35 48.88 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.533 -1.355 . . . . 0.0 107.522 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.13 152.73 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 C-N-CA 126.565 1.946 . . . . 0.0 107.335 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -101.72 119.88 39.47 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 168.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -110.08 149.59 29.81 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 121.487 1.949 . . . . 0.0 111.873 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -117.14 140.91 48.94 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 174.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.9 ttp -126.54 145.17 50.63 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 119.958 -1.714 . . . . 0.0 107.418 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -49.72 86.27 0.0 OUTLIER 'General case' 0 C--N 1.365 1.245 0 C-N-CA 130.457 3.503 . . . . 0.0 117.188 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.71 -3.47 45.83 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.961 1.267 . . . . 0.0 114.064 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -99.95 165.7 14.1 Favored Pre-proline 0 C--N 1.357 0.906 0 C-N-CA 125.7 1.6 . . . . 0.0 108.315 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.44 165.79 31.37 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.323 3.349 . . . . 0.0 113.56 169.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.419 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.0 m95 -63.68 110.19 1.95 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 130.145 3.378 . . . . 0.0 112.824 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.475 ' CE3' ' HA ' ' A' ' 106' ' ' TRP . 4.9 m95 -109.24 108.55 60.33 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 119.197 3.036 . . . . 0.0 119.197 -172.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -54.45 123.03 12.62 Favored 'Trans proline' 0 C--N 1.384 2.413 1 C-N-CA 125.908 4.405 . . . . 0.0 111.708 159.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.4 p -148.65 165.72 30.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 124.574 2.13 . . . . 0.0 114.332 -156.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 tp -114.41 138.46 50.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.83 2.452 . . . . 0.0 106.663 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.92 127.88 39.47 Favored 'Isoleucine or valine' 0 C--N 1.364 1.206 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -139.73 153.88 47.31 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 122.712 2.505 . . . . 0.0 112.596 -168.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -104.07 114.62 28.99 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.572 2.349 . . . . 0.0 109.158 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.47 ' H ' ' CE1' ' A' ' 130' ' ' HIS . 14.6 t60 -67.74 161.27 67.8 Favored Pre-proline 0 C--N 1.354 0.774 0 C-N-CA 128.267 2.627 . . . . 0.0 112.496 177.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.04 -1.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.563 1.931 1 C-N-CA 126.494 4.796 . . . . 0.0 118.159 172.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -91.09 34.33 0.93 Allowed 'General case' 0 C--N 1.36 1.04 1 C-N-CA 135.074 5.349 . . . . 0.0 107.32 169.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.329 0.5 OUTLIER -77.92 156.36 30.33 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -173.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.39 -10.45 33.27 Favored Glycine 0 C--N 1.359 1.842 0 CA-C-N 111.826 -2.443 . . . . 0.0 111.776 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 t -146.87 150.66 35.68 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 101.269 -3.604 . . . . 0.0 101.269 172.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -149.83 9.64 0.7 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 119.555 1.071 . . . . 0.0 111.055 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 34.2 pt -117.5 148.81 20.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 CA-C-O 122.302 1.049 . . . . 0.0 110.687 -175.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -137.66 138.89 39.89 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.3 129.78 14.87 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 119.859 -1.776 . . . . 0.0 109.776 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -117.78 93.84 4.3 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.511 2.324 . . . . 0.0 111.157 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.08 -73.07 0.55 Allowed Glycine 0 C--N 1.362 1.98 0 N-CA-C 120.127 2.811 . . . . 0.0 120.127 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -147.21 58.8 1.16 Allowed 'General case' 0 C--N 1.356 0.849 0 CA-C-O 122.601 1.191 . . . . 0.0 110.201 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.1 m -175.56 157.91 2.15 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.47 135.01 35.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 122.598 1.19 . . . . 0.0 109.735 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -115.17 130.37 56.9 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 127.618 2.367 . . . . 0.0 107.164 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 m -125.81 146.43 31.58 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 1 N-CA-C 98.237 -4.727 . . . . 0.0 98.237 172.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.54 ' CD2' ' CZ2' ' A' ' 142' ' ' TRP 0.329 0.1 OUTLIER -81.57 137.32 35.54 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 121.709 0.766 . . . . 0.0 112.449 176.074 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.407 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 2.5 m -146.2 165.06 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -173.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -129.17 153.43 47.73 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -110.86 122.69 48.49 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.022 1.329 . . . . 0.0 107.564 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -74.83 60.59 0.96 Allowed 'General case' 0 C--N 1.37 1.493 0 C-N-CA 127.689 2.396 . . . . 0.0 114.475 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.417 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP 0.31 50.8 p-10 -87.66 -99.21 0.08 Allowed 'General case' 0 C--N 1.363 1.19 0 C-N-CA 125.604 1.562 . . . . 0.0 113.377 -177.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -106.84 -65.7 1.07 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.452 1.901 . . . . 0.0 114.57 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.272 10.1 p -77.81 -38.04 1.65 Allowed Pre-proline 0 C--N 1.365 1.251 0 N-CA-C 118.546 2.795 . . . . 0.0 118.546 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -82.43 -174.73 13.76 Favored 'Cis proline' 0 C--N 1.354 0.866 1 CA-C-N 128.707 4.145 . . . . 0.0 113.822 -0.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.274 4.0 t -97.62 154.06 17.8 Favored 'General case' 0 C--N 1.374 1.646 0 C-N-CA 127.613 2.365 . . . . 0.0 111.045 171.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.512 HH22 ' CG ' ' A' ' 130' ' ' HIS . 32.7 ttt-85 -158.44 162.05 37.52 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.26 -163.97 29.64 Favored Glycine 0 CA--C 1.484 -1.87 0 N-CA-C 104.24 -3.544 . . . . 0.0 104.24 166.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.54 ' CZ2' ' CD2' ' A' ' 130' ' ' HIS . 78.7 m95 -96.65 99.95 11.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 171.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.2 m -81.65 178.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 126.973 2.109 . . . . 0.0 108.001 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.5 m -94.92 130.08 41.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -79.53 -9.62 59.65 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 119.891 -1.755 . . . . 0.0 113.993 -175.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.21 -13.75 61.61 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.496 1.118 . . . . 0.0 112.475 174.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.7 mt -96.84 1.11 50.27 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 126.436 1.894 . . . . 0.0 114.074 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.09 141.79 28.31 Favored 'General case' 0 C--N 1.372 1.546 0 CA-C-N 121.1 1.773 . . . . 0.0 109.233 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -115.99 158.57 42.1 Favored Pre-proline 0 C--O 1.224 -0.273 0 O-C-N 119.313 -2.117 . . . . 0.0 105.621 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.98 151.44 21.25 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.395 3.397 . . . . 0.0 112.869 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -121.61 117.42 26.67 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-O 122.056 0.932 . . . . 0.0 112.262 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.3 t -160.89 23.72 0.14 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 126.182 1.793 . . . . 0.0 106.698 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.41 70.42 0.3 Allowed Glycine 0 C--N 1.353 1.514 0 C-N-CA 120.424 -0.894 . . . . 0.0 114.578 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 m -63.7 -10.99 22.17 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 131.221 3.808 . . . . 0.0 116.215 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -126.73 29.95 5.6 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 129.226 3.01 . . . . 0.0 108.065 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 t -96.09 136.58 36.36 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 127.695 2.398 . . . . 0.0 107.243 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -47.91 -38.91 17.52 Favored 'General case' 0 C--N 1.369 1.428 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.12 -18.3 60.27 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.608 -1.307 . . . . 0.0 113.885 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.72 -1.38 46.62 Favored 'General case' 0 C--N 1.371 1.505 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.376 0.6 OUTLIER -119.65 -173.51 2.55 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.409 1.484 . . . . 0.0 112.74 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -71.32 122.38 20.18 Favored 'General case' 0 C--N 1.37 1.468 0 O-C-N 119.506 -1.996 . . . . 0.0 112.355 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.26 -8.0 56.92 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.299 0.952 . . . . 0.0 111.774 -168.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.09 157.31 28.12 Favored Glycine 0 C--N 1.363 2.065 0 N-CA-C 117.437 1.735 . . . . 0.0 117.437 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -58.41 -42.53 87.41 Favored 'General case' 0 C--N 1.366 1.304 0 N-CA-C 119.358 3.096 . . . . 0.0 119.358 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.419 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.391 0.2 OUTLIER -106.32 3.15 27.26 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -175.037 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -101.91 144.13 30.92 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.091 1.757 . . . . 0.0 108.87 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.1 m -166.93 147.16 5.64 Favored 'General case' 0 N--CA 1.445 -0.709 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.37 99.89 9.24 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-O 126.398 2.999 . . . . 0.0 111.693 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -120.84 134.46 24.31 Favored Pre-proline 0 N--CA 1.416 -2.145 3 N-CA-C 98.046 -4.798 . . . . 0.0 98.046 164.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -60.74 -22.78 74.47 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.691 4.26 . . . . 0.0 115.509 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.09 -36.33 74.83 Favored 'General case' 0 C--N 1.36 1.059 0 C-N-CA 128.741 2.816 . . . . 0.0 113.829 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.1 mm -71.73 -40.24 69.72 Favored 'Isoleucine or valine' 0 C--N 1.379 1.877 0 C-N-CA 127.553 2.341 . . . . 0.0 108.472 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.0 mt -66.44 -48.57 69.55 Favored 'General case' 0 C--N 1.369 1.454 0 C-N-CA 125.314 1.446 . . . . 0.0 113.264 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -57.81 -34.16 69.35 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 128.288 2.635 . . . . 0.0 114.881 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.35 -45.88 71.65 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 130.959 3.704 . . . . 0.0 111.599 171.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.35 0.0 OUTLIER -64.25 -32.35 73.9 Favored 'General case' 0 C--N 1.38 1.931 0 CA-C-N 120.321 1.419 . . . . 0.0 113.374 168.187 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -68.96 -48.51 62.99 Favored 'General case' 0 C--N 1.376 1.752 0 C-N-CA 126.059 1.743 . . . . 0.0 113.711 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -60.44 -53.51 56.75 Favored 'General case' 0 C--N 1.379 1.884 0 C-N-CA 128.838 2.855 . . . . 0.0 111.108 173.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -59.86 -45.42 92.52 Favored 'General case' 0 C--N 1.365 1.277 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.45 -37.79 70.77 Favored 'General case' 0 C--N 1.378 1.83 0 C-N-CA 127.668 2.387 . . . . 0.0 112.955 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.99 -39.62 72.34 Favored 'General case' 0 C--N 1.361 1.093 0 O-C-N 119.781 -1.824 . . . . 0.0 115.122 173.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.92 -29.35 55.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 119.417 3.118 . . . . 0.0 119.417 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.83 -50.2 69.83 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 130.298 3.439 . . . . 0.0 113.074 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.274 0.0 OUTLIER -90.93 -16.6 27.83 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 127.577 2.351 . . . . 0.0 111.985 -175.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -120.78 -110.91 0.33 Allowed 'General case' 0 C--N 1.357 0.906 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -135.52 149.55 49.51 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 119.797 -1.814 . . . . 0.0 107.836 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.492 0.0 OUTLIER -51.03 -32.69 22.32 Favored 'General case' 0 CA--C 1.5 -0.957 1 C-N-CA 132.017 4.127 . . . . 0.0 117.711 175.49 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 17.4 tt -49.43 -30.91 5.08 Favored 'Isoleucine or valine' 0 C--N 1.365 1.278 0 C-N-CA 130.12 3.368 . . . . 0.0 113.029 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -60.43 -35.88 76.86 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 128.146 2.578 . . . . 0.0 113.955 169.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -75.3 -44.23 46.7 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 171.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 10.0 mp -67.92 -19.95 65.04 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 129.694 3.197 . . . . 0.0 112.753 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -64.86 -38.64 91.64 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 130.652 3.581 . . . . 0.0 114.344 168.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.34 -51.08 3.44 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.78 2.032 . . . . 0.0 109.667 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 46.67 -134.13 1.0 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 131.303 3.841 . . . . 0.0 117.919 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.318 9.1 p -109.87 63.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.398 0 CA-C-O 124.645 2.164 . . . . 0.0 109.279 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.6 p -95.16 67.85 3.06 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 127.612 2.365 . . . . 0.0 108.676 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -79.64 65.53 4.84 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.986 1.714 . . . . 0.0 112.83 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -155.93 159.68 31.36 Favored Pre-proline 0 C--N 1.352 0.681 0 C-N-CA 126.856 2.062 . . . . 0.0 105.833 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.93 -176.15 2.88 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.126 3.217 . . . . 0.0 113.927 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 24.6 t -90.7 60.03 4.38 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.999 2.119 . . . . 0.0 112.684 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.365 3.3 pt-20 . . . . . 0 C--N 1.361 1.104 0 C-N-CA 130.83 3.652 . . . . 0.0 112.463 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.14 52.18 2.37 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 119.933 -1.73 . . . . 0.0 114.703 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.26 71.82 1.73 Allowed 'General case' 0 C--N 1.36 1.052 0 C-N-CA 127.633 2.373 . . . . 0.0 114.276 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -97.01 133.36 41.79 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 128.204 2.602 . . . . 0.0 109.573 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.02 63.46 1.78 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 126.216 1.806 . . . . 0.0 115.126 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -100.07 -5.97 27.12 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 126.493 1.917 . . . . 0.0 110.659 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.49 12.26 45.25 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 129.038 3.209 . . . . 0.0 117.506 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.97 7.07 68.69 Favored Glycine 0 C--N 1.358 1.761 0 C-N-CA 125.979 1.752 . . . . 0.0 112.753 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.0 mt -98.44 23.29 8.66 Favored 'General case' 0 C--N 1.367 1.326 0 O-C-N 121.223 -1.163 . . . . 0.0 112.882 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -71.6 -45.18 62.88 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 128.274 2.63 . . . . 0.0 113.017 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -105.83 -49.52 3.38 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 127.437 2.295 . . . . 0.0 107.404 173.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.27 4.5 t 89.0 160.67 0.06 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 128.938 2.895 . . . . 0.0 114.301 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 m -119.69 -5.95 10.72 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 C-N-CA 127.624 2.37 . . . . 0.0 109.886 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -138.04 154.71 74.45 Favored Pre-proline 0 C--N 1.359 0.99 0 C-N-CA 126.849 2.06 . . . . 0.0 107.938 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.97 167.36 23.72 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 125.144 3.896 . . . . 0.0 113.231 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.75 -91.47 0.1 Allowed 'General case' 0 C--N 1.359 1.013 0 O-C-N 121.349 -0.844 . . . . 0.0 109.676 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.6 112.8 64.59 Favored Pre-proline 0 C--N 1.356 0.848 0 C-N-CA 125.799 1.639 . . . . 0.0 107.109 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.22 90.9 0.46 Allowed 'Trans proline' 0 C--N 1.368 1.571 1 C-N-CA 125.52 4.147 . . . . 0.0 110.053 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.0 m -81.37 126.32 31.47 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 128.118 2.567 . . . . 0.0 115.558 -167.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.5 p -63.9 47.16 0.02 OUTLIER 'General case' 0 C--N 1.359 0.996 0 C-N-CA 131.593 3.957 . . . . 0.0 117.909 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.451 ' HA ' ' CE2' ' A' ' 90' ' ' PHE 0.47 12.1 p 152.31 36.47 0.0 OUTLIER 'General case' 0 C--N 1.349 0.572 0 C-N-CA 129.911 3.284 . . . . 0.0 112.994 174.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -122.79 102.6 8.13 Favored 'General case' 0 C--N 1.369 1.442 0 O-C-N 120.566 -1.334 . . . . 0.0 110.386 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 8.5 m-85 -126.06 128.6 47.65 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.766 1.626 . . . . 0.0 114.591 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.5 p -110.67 163.73 16.54 Favored Pre-proline 0 C--N 1.365 1.241 0 O-C-N 119.868 -1.77 . . . . 0.0 115.776 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.67 134.97 65.22 Favored 'Trans proline' 0 C--N 1.373 1.839 1 C-N-CA 126.659 4.906 . . . . 0.0 117.097 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.33 -51.19 0.75 Allowed Glycine 0 C--N 1.353 1.522 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 -169.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -65.49 159.36 24.59 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.436 HD22 HH11 ' A' ' 190' ' ' ARG . 3.5 mm? -102.83 141.49 35.54 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.42 159.68 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 C-N-CA 126.639 1.976 . . . . 0.0 106.538 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.508 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 52.2 m95 -108.56 115.76 30.7 Favored 'General case' 0 C--O 1.214 -0.786 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 171.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.25 147.66 26.77 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 122.728 2.513 . . . . 0.0 113.602 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -115.14 130.57 56.96 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 170.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 44.1 ttm -116.04 141.19 48.45 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.26 101.29 0.9 Allowed 'General case' 0 C--N 1.364 1.203 0 C-N-CA 126.062 1.745 . . . . 0.0 113.5 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.42 -10.93 23.97 Favored Glycine 0 C--N 1.358 1.782 0 C-N-CA 125.752 1.644 . . . . 0.0 113.45 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -103.9 164.83 14.57 Favored Pre-proline 0 C--N 1.357 0.913 0 C-N-CA 125.567 1.547 . . . . 0.0 109.719 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -71.41 166.09 30.41 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 125.039 3.826 . . . . 0.0 112.752 164.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.92 126.0 25.83 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 127.776 2.43 . . . . 0.0 114.95 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.443 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 3.3 m95 -134.75 116.57 12.67 Favored Pre-proline 0 CA--C 1.571 1.787 1 N-CA-C 123.893 4.775 . . . . 0.0 123.893 -169.25 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.508 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 27.1 Cg_exo -56.44 113.45 1.46 Allowed 'Trans proline' 0 C--N 1.401 3.325 1 C-N-CA 126.788 4.992 . . . . 0.0 114.145 166.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -127.06 164.29 21.87 Favored 'General case' 0 N--CA 1.449 -0.508 1 C-N-CA 133.199 4.6 . . . . 0.0 116.104 -168.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.16 146.72 41.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.742 2.817 . . . . 0.0 107.165 172.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 t -91.63 130.64 40.46 Favored 'Isoleucine or valine' 0 C--N 1.37 1.467 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 171.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -132.18 152.47 51.27 Favored 'General case' 0 C--N 1.361 1.066 0 O-C-N 118.729 -2.482 . . . . 0.0 115.097 -164.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -92.31 112.82 24.9 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 2.0 m-70 -65.68 160.7 58.96 Favored Pre-proline 0 C--N 1.36 1.061 0 C-N-CA 128.2 2.6 . . . . 0.0 117.417 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.37 -1.41 0.2 Allowed 'Trans proline' 0 CA--C 1.572 2.398 0 C-N-CA 124.933 3.755 . . . . 0.0 116.895 169.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -115.71 33.92 5.22 Favored 'General case' 0 C--N 1.356 0.883 1 C-N-CA 135.638 5.575 . . . . 0.0 107.247 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.318 1.1 p30 -72.64 150.26 43.17 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -172.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.07 2.94 31.68 Favored Glycine 0 C--N 1.359 1.849 0 CA-C-N 111.99 -2.368 . . . . 0.0 110.959 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.4 m -149.74 130.76 14.38 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 102.141 -3.281 . . . . 0.0 102.141 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -149.37 -10.44 0.31 Allowed 'General case' 0 C--N 1.364 1.21 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.9 pt -108.63 145.6 15.37 Favored 'Isoleucine or valine' 0 C--N 1.369 1.446 0 CA-C-N 121.862 2.119 . . . . 0.0 112.196 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -139.1 137.9 36.58 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -143.27 127.42 17.54 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -117.86 94.0 4.36 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 126.926 2.09 . . . . 0.0 110.675 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.12 -71.02 0.32 Allowed Glycine 0 C--N 1.362 2.027 0 N-CA-C 120.205 2.842 . . . . 0.0 120.205 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -150.38 57.59 0.94 Allowed 'General case' 0 C--N 1.353 0.721 0 CA-C-O 122.512 1.149 . . . . 0.0 109.861 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.5 m -176.8 140.15 0.32 Allowed 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.486 1.914 . . . . 0.0 106.293 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.47 136.98 58.64 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 123.13 1.443 . . . . 0.0 112.31 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 -114.89 141.95 47.24 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.456 2.302 . . . . 0.0 107.994 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 145' ' ' LYS . 8.8 m -146.58 156.62 11.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 1 N-CA-C 98.711 -4.551 . . . . 0.0 98.711 174.202 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 2.5 m80 -79.66 138.66 37.45 Favored 'General case' 0 C--N 1.37 1.496 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.5 m -139.91 172.08 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.08 147.65 44.25 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.417 ' HB2' ' HB ' ' A' ' 139' ' ' THR . 0.1 OUTLIER -114.34 118.59 34.31 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 127.854 2.462 . . . . 0.0 104.951 -177.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.51 53.36 0.02 OUTLIER 'General case' 0 C--N 1.373 1.622 0 C-N-CA 129.478 3.111 . . . . 0.0 114.568 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.443 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 1.6 p30 -100.83 -127.67 0.2 Allowed 'General case' 0 C--N 1.359 1.016 0 O-C-N 118.6 -2.563 . . . . 0.0 113.035 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -96.66 -46.4 6.32 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 124.785 1.234 . . . . 0.0 114.042 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.286 12.3 t -74.12 -51.86 4.54 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 116.797 2.147 . . . . 0.0 116.797 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.3 -173.63 12.96 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 126.012 3.183 . . . . 0.0 112.755 0.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 133' ' ' PHE . 75.0 m -95.72 116.79 29.38 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 174.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -155.34 152.94 29.76 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 120.781 -1.199 . . . . 0.0 109.83 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.93 -149.2 19.86 Favored Glycine 0 CA--C 1.488 -1.611 0 N-CA-C 104.468 -3.453 . . . . 0.0 104.468 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -86.78 111.33 20.62 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 126.166 1.786 . . . . 0.0 110.738 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.1 m -98.37 175.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 126.136 1.774 . . . . 0.0 107.069 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.9 t -94.31 128.56 40.88 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.444 ' HB3' HG23 ' A' ' 129' ' ' VAL 0.293 47.7 pttt -77.6 -7.26 56.1 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-N 121.206 1.821 . . . . 0.0 113.791 -176.407 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -67.64 -19.32 65.2 Favored 'General case' 0 C--N 1.364 1.223 0 C-N-CA 124.72 1.208 . . . . 0.0 113.307 172.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.9 mt -94.55 -0.23 54.74 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 125.666 1.586 . . . . 0.0 114.272 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.29 157.02 17.1 Favored 'General case' 0 C--N 1.366 1.285 0 CA-C-N 122.025 2.193 . . . . 0.0 108.3 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.483 ' HG3' ' CE1' ' A' ' 165' ' ' PHE . 21.0 mmtt -119.67 168.07 10.94 Favored Pre-proline 0 C--O 1.222 -0.376 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.8 156.24 15.66 Favored 'Trans proline' 0 C--N 1.326 -0.649 1 C-N-CA 125.67 4.247 . . . . 0.0 113.481 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.5 148.95 22.71 Favored 'General case' 0 C--N 1.359 0.994 0 CA-C-O 122.621 1.2 . . . . 0.0 110.109 172.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.5 t -171.38 -37.85 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 101.115 -3.661 . . . . 0.0 101.115 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 119.74 -159.36 14.9 Favored Glycine 0 C--N 1.36 1.886 0 CA-C-N 113.949 -1.478 . . . . 0.0 115.969 140.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.3 m -46.35 -16.74 0.03 OUTLIER 'General case' 0 C--N 1.373 1.609 1 C-N-CA 133.263 4.625 . . . . 0.0 117.629 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -77.69 -23.07 49.64 Favored 'General case' 0 N--CA 1.442 -0.873 1 C-N-CA 135.379 5.471 . . . . 0.0 112.831 176.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 6.8 t -89.17 153.9 20.58 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.209 1.404 . . . . 0.0 114.052 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -61.23 -36.26 79.46 Favored 'General case' 0 C--N 1.369 1.417 0 C-N-CA 126.404 1.881 . . . . 0.0 113.858 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -73.08 -4.57 33.42 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 125.686 1.594 . . . . 0.0 113.197 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -111.75 7.11 20.16 Favored 'General case' 0 C--N 1.372 1.567 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.311 1.5 pp0? -127.98 -172.89 2.79 Favored 'General case' 0 C--N 1.363 1.194 0 O-C-N 119.621 -1.924 . . . . 0.0 111.853 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -63.69 122.38 16.23 Favored 'General case' 0 C--N 1.372 1.584 0 C-N-CA 126.824 2.05 . . . . 0.0 112.897 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.45 -9.04 66.89 Favored Glycine 0 C--N 1.359 1.854 0 C-N-CA 124.38 0.99 . . . . 0.0 112.22 -167.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.55 140.67 20.59 Favored Glycine 0 C--N 1.365 2.157 0 C-N-CA 126.926 2.203 . . . . 0.0 116.705 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -61.47 -21.6 64.33 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 119.453 3.131 . . . . 0.0 119.453 -172.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.483 ' CE1' ' HG3' ' A' ' 149' ' ' LYS . 1.7 m-85 -108.74 -3.6 17.67 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 120.623 -1.298 . . . . 0.0 111.449 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -86.53 165.46 16.22 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 125.566 2.603 . . . . 0.0 117.171 -173.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.4 m 169.95 173.84 0.05 Allowed 'General case' 0 CA--C 1.503 -0.848 2 N-CA-C 98.487 -4.634 . . . . 0.0 98.487 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -121.12 101.49 7.7 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-N 122.299 2.318 . . . . 0.0 107.168 170.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -119.58 123.9 28.35 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 101.173 -3.64 . . . . 0.0 101.173 169.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -55.73 -29.72 72.63 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 125.189 3.926 . . . . 0.0 116.868 -174.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -65.22 -36.11 83.13 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.921 2.889 . . . . 0.0 113.067 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.9 mt -68.36 -41.79 83.78 Favored 'Isoleucine or valine' 0 C--N 1.38 1.895 0 C-N-CA 126.164 1.786 . . . . 0.0 110.612 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.7 mt -68.55 -43.9 75.63 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 125.826 1.651 . . . . 0.0 113.275 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -58.05 -42.97 86.55 Favored 'General case' 0 CA--C 1.486 -1.498 0 C-N-CA 128.581 2.752 . . . . 0.0 113.777 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.59 -34.35 77.7 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 130.41 3.484 . . . . 0.0 110.09 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.255 6.8 mtt -70.09 -33.4 71.84 Favored 'General case' 0 C--N 1.376 1.721 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 165.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -71.31 -45.7 62.41 Favored 'General case' 0 C--N 1.379 1.884 0 C-N-CA 125.961 1.704 . . . . 0.0 110.955 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -67.48 -52.81 34.86 Favored 'General case' 0 C--N 1.375 1.699 0 C-N-CA 127.882 2.473 . . . . 0.0 112.154 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.64 85.55 Favored 'General case' 0 C--N 1.374 1.636 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.28 -40.37 93.78 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-N 121.714 2.052 . . . . 0.0 112.527 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.27 -52.13 63.3 Favored 'General case' 0 C--N 1.367 1.353 0 O-C-N 119.099 -2.251 . . . . 0.0 113.935 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.84 72.8 Favored 'General case' 0 C--N 1.361 1.065 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -50.21 43.54 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 127.084 2.154 . . . . 0.0 112.309 171.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.378 0.0 OUTLIER -81.19 -12.88 59.06 Favored 'General case' 0 C--N 1.363 1.183 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -170.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -107.42 -107.94 0.32 Allowed 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.731 0.812 . . . . 0.0 111.734 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -136.25 176.31 8.81 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 119.839 -1.788 . . . . 0.0 112.053 -175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.698 ' HA ' ' HE ' ' A' ' 190' ' ' ARG . 40.6 mmtm -51.45 -43.83 62.18 Favored 'General case' 0 C--N 1.384 2.065 1 C-N-CA 132.495 4.318 . . . . 0.0 114.207 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.5 tt -59.84 -27.99 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 129.929 3.292 . . . . 0.0 114.148 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -71.95 -45.33 61.51 Favored 'General case' 0 C--N 1.376 1.737 0 C-N-CA 126.288 1.835 . . . . 0.0 112.983 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.698 ' HE ' ' HA ' ' A' ' 187' ' ' LYS . 0.0 OUTLIER -75.13 -41.5 58.29 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 126.91 2.084 . . . . 0.0 114.7 170.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.46 -20.92 62.84 Favored 'General case' 0 C--N 1.369 1.422 0 C-N-CA 127.985 2.514 . . . . 0.0 113.329 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.74 -38.04 88.96 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 128.438 2.695 . . . . 0.0 114.044 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.4 mt -99.21 -46.27 5.61 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 126.777 2.031 . . . . 0.0 108.648 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . 0.256 . . 65.13 -94.16 0.04 OUTLIER 'General case' 0 C--N 1.367 1.351 0 C-N-CA 128.937 2.895 . . . . 0.0 114.39 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 8.4 m -117.05 0.82 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.989 1.716 . . . . 0.0 109.673 175.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.1 t 70.81 -52.44 0.67 Allowed 'General case' 0 C--N 1.366 1.322 0 C-N-CA 127.058 2.143 . . . . 0.0 115.465 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -157.23 158.43 36.15 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.52 147.77 18.29 Favored Pre-proline 0 C--N 1.352 0.694 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.9 -104.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 124.229 3.286 . . . . 0.0 112.256 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 41.0 t -105.85 55.68 0.68 Allowed 'General case' 0 C--N 1.358 0.948 0 C-N-CA 125.975 1.71 . . . . 0.0 108.793 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--N 1.36 1.052 0 C-N-CA 128.855 2.862 . . . . 0.0 113.953 179.578 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp . . . . . 0 N--CA 1.438 -1.062 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.07 -72.21 0.7 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 125.655 1.582 . . . . 0.0 110.553 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -119.55 119.02 32.59 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 126.156 1.782 . . . . 0.0 107.262 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -103.46 125.47 50.06 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.205 1.402 . . . . 0.0 109.852 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.2 mt -108.17 -93.36 0.41 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.747 1.219 . . . . 0.0 109.529 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.49 22.91 0.09 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 130.103 3.361 . . . . 0.0 115.163 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.31 4.24 47.19 Favored Glycine 0 C--N 1.354 1.579 0 C-N-CA 127.21 2.338 . . . . 0.0 114.705 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.2 52.96 1.8 Allowed Glycine 0 C--N 1.36 1.913 0 C-N-CA 126.485 1.993 . . . . 0.0 117.121 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.1 tp -91.22 -26.17 19.16 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 129.276 3.03 . . . . 0.0 110.198 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -71.64 -24.49 61.87 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 131.646 3.979 . . . . 0.0 115.962 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 64.9 ttp85 -171.14 -71.36 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t 175.91 -166.37 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 100.813 -3.773 . . . . 0.0 100.813 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.02 53.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 123.634 1.683 . . . . 0.0 109.203 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.13 114.91 65.31 Favored Pre-proline 0 C--N 1.358 0.946 0 C-N-CA 125.289 1.435 . . . . 0.0 110.923 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -84.39 162.85 12.95 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.08 3.187 . . . . 0.0 112.512 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -114.83 -125.93 0.29 Allowed 'General case' 0 C--N 1.351 0.659 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.63 117.08 58.86 Favored Pre-proline 0 C--N 1.358 0.964 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -72.53 -12.74 27.24 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 125.01 3.807 . . . . 0.0 113.594 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 p -84.55 -40.22 17.84 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 128.936 2.894 . . . . 0.0 109.568 172.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.9 m 63.4 -38.1 0.17 Allowed 'General case' 0 C--N 1.366 1.31 0 C-N-CA 130.243 3.417 . . . . 0.0 118.599 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.2 p -141.21 71.35 1.36 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.744 2.017 . . . . 0.0 108.367 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -163.09 62.12 0.19 Allowed 'General case' 0 C--N 1.364 1.236 0 CA-C-N 119.854 1.206 . . . . 0.0 113.409 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -118.04 125.78 51.0 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 120.215 -1.553 . . . . 0.0 110.067 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 87.4 p -111.73 166.22 11.31 Favored Pre-proline 0 C--N 1.36 1.022 0 C-N-CA 126.126 1.77 . . . . 0.0 110.773 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -54.56 149.14 40.66 Favored 'Trans proline' 0 C--N 1.37 1.691 1 C-N-CA 126.107 4.538 . . . . 0.0 119.188 -170.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.45 -39.37 2.89 Favored Glycine 0 C--N 1.356 1.689 0 C-N-CA 126.023 1.773 . . . . 0.0 113.015 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.54 169.04 17.58 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -94.89 134.46 37.51 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 172.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.0 m -136.08 159.22 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-O 123.613 1.673 . . . . 0.0 107.548 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.414 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 70.3 m95 -104.18 116.73 32.72 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 173.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.62 135.08 53.76 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.497 2.319 . . . . 0.0 112.791 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.463 ' HB2' ' CZ2' ' A' ' 105' ' ' TRP . 51.7 tptt -112.93 141.83 46.31 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 173.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.8 ttm -128.82 149.72 50.62 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.018 -1.676 . . . . 0.0 108.615 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -65.16 100.11 0.42 Allowed 'General case' 0 C--N 1.368 1.39 0 C-N-CA 125.788 1.635 . . . . 0.0 114.125 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.97 -4.38 25.67 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 125.873 1.701 . . . . 0.0 112.909 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -112.01 161.26 26.65 Favored Pre-proline 0 C--N 1.358 0.95 0 C-N-CA 125.41 1.484 . . . . 0.0 111.588 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.47 167.53 26.09 Favored 'Trans proline' 0 C--N 1.366 1.479 1 C-N-CA 126.12 4.547 . . . . 0.0 112.682 164.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 99' ' ' LYS . 6.9 m95 -65.34 132.8 49.94 Favored 'General case' 0 C--N 1.363 1.154 0 CA-C-O 124.316 2.008 . . . . 0.0 113.238 171.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.26 10.6 m95 -134.88 134.55 21.98 Favored Pre-proline 0 N--CA 1.413 -2.276 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -169.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.402 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 4.7 Cg_exo -72.2 143.15 39.17 Favored 'Trans proline' 0 C--N 1.38 2.204 1 C-N-CA 126.123 4.549 . . . . 0.0 110.916 156.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -156.77 165.42 36.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.27 3.028 . . . . 0.0 114.39 -161.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 8.8 tp -119.45 138.49 53.09 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.345 2.258 . . . . 0.0 107.745 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.31 121.89 33.43 Favored 'Isoleucine or valine' 0 C--N 1.378 1.836 0 C-N-CA 126.387 1.875 . . . . 0.0 106.528 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -127.38 152.75 47.09 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 119.626 -1.921 . . . . 0.0 113.172 -167.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.79 113.58 26.92 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 127.472 2.309 . . . . 0.0 106.463 173.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.451 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 3.4 m-70 -62.56 159.98 38.25 Favored Pre-proline 0 C--N 1.358 0.975 0 C-N-CA 130.224 3.41 . . . . 0.0 117.456 -175.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.77 -1.41 0.24 Allowed 'Trans proline' 0 CA--C 1.564 2.021 1 C-N-CA 125.551 4.167 . . . . 0.0 116.951 170.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.72 31.27 5.78 Favored 'General case' 0 C--N 1.356 0.878 1 C-N-CA 134.813 5.245 . . . . 0.0 107.603 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.339 0.1 OUTLIER -69.53 150.29 47.29 Favored 'General case' 0 C--N 1.374 1.636 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -172.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.22 5.51 30.31 Favored Glycine 0 C--N 1.359 1.836 0 CA-C-N 112.174 -2.285 . . . . 0.0 111.556 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.4 m -152.56 135.29 15.39 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 100.813 -3.773 . . . . 0.0 100.813 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.418 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.255 2.2 p90 -155.23 -37.36 0.09 Allowed 'General case' 0 C--N 1.365 1.261 0 CA-C-N 120.423 1.465 . . . . 0.0 113.684 -175.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.5 tt -108.26 140.48 26.6 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-O 122.972 1.368 . . . . 0.0 110.574 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -119.88 121.29 38.72 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 101.091 -3.67 . . . . 0.0 101.091 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.84 179.71 4.19 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.097 0.959 . . . . 0.0 112.794 -171.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -46.3 131.73 10.41 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 120.241 3.423 . . . . 0.0 120.241 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 172.14 -51.38 0.17 Allowed Glycine 0 C--N 1.353 1.527 0 N-CA-C 106.37 -2.692 . . . . 0.0 106.37 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.0 mmmt -103.69 -52.81 2.9 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 126.605 1.962 . . . . 0.0 108.985 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.8 t -171.67 -166.49 0.44 Allowed 'General case' 0 C--N 1.353 0.739 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -129.13 120.68 52.15 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 124.917 1.287 . . . . 0.0 110.423 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -130.18 139.42 50.85 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 126.519 1.928 . . . . 0.0 112.786 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.97 163.25 36.95 Favored 'Isoleucine or valine' 0 C--N 1.367 1.347 0 C-N-CA 126.524 1.929 . . . . 0.0 105.844 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.451 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 1.1 m80 -83.34 140.93 32.15 Favored 'General case' 0 C--N 1.373 1.625 0 CA-C-N 120.654 1.57 . . . . 0.0 113.223 172.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 m -150.96 171.97 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.868 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -136.69 146.77 46.28 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 124.453 1.101 . . . . 0.0 109.104 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.49 124.5 52.42 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 104.713 -2.328 . . . . 0.0 104.713 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.71 60.34 0.07 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 127.42 2.288 . . . . 0.0 113.394 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -98.29 -124.12 0.14 Allowed 'General case' 0 C--N 1.361 1.085 0 O-C-N 119.572 -1.955 . . . . 0.0 111.859 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -106.27 -52.55 2.77 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.731 1.612 . . . . 0.0 111.716 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 m -69.82 -40.35 13.19 Favored Pre-proline 0 C--N 1.364 1.232 0 N-CA-C 118.508 2.781 . . . . 0.0 118.508 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.14 178.0 36.54 Favored 'Cis proline' 0 C--N 1.354 0.852 0 CA-C-N 126.442 3.336 . . . . 0.0 110.479 -4.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.6 m -89.67 115.62 27.18 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 118.743 -2.473 . . . . 0.0 106.849 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.2 ttp85 -149.04 150.97 33.68 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-O 122.6 1.19 . . . . 0.0 109.347 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 165.62 -157.06 29.38 Favored Glycine 0 CA--C 1.491 -1.413 0 N-CA-C 105.973 -2.851 . . . . 0.0 105.973 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -80.22 110.17 15.39 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 126.547 1.939 . . . . 0.0 109.885 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.17 169.25 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 124.636 1.174 . . . . 0.0 110.543 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.5 m -90.23 115.67 27.63 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.47 33.8 pttt -69.25 -5.6 23.91 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -168.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -82.05 -12.78 58.09 Favored 'General case' 0 C--N 1.365 1.256 0 O-C-N 119.242 -2.161 . . . . 0.0 109.714 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.73 -0.63 45.06 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 128.679 2.792 . . . . 0.0 110.145 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 97' ' ' TRP . 0.1 OUTLIER -104.89 125.0 50.46 Favored 'General case' 0 C--N 1.388 2.262 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 173.147 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -118.97 168.48 9.73 Favored Pre-proline 0 C--O 1.218 -0.563 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -82.47 153.23 15.73 Favored 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 124.433 3.422 . . . . 0.0 112.697 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -127.6 121.2 29.92 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.324 1.059 . . . . 0.0 111.696 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.7 t -162.14 30.67 0.12 Allowed 'General case' 0 C--N 1.359 0.997 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.72 82.12 0.09 OUTLIER Glycine 0 C--N 1.35 1.345 0 C-N-CA 116.499 -2.762 . . . . 0.0 115.228 -166.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . 0.34 89.2 p -68.42 -10.11 53.0 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 121.007 2.404 . . . . 0.0 116.791 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -112.12 32.02 5.83 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 130.166 3.386 . . . . 0.0 108.656 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 19.3 t -103.04 133.4 48.22 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.258 42.7 tttm -55.72 -33.08 63.91 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -174.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -70.89 -19.2 62.64 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 124.704 1.202 . . . . 0.0 113.972 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.49 3.26 54.37 Favored 'General case' 0 C--N 1.371 1.536 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -130.56 -173.07 2.97 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 125.743 1.617 . . . . 0.0 112.042 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -62.79 122.22 15.39 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 126.284 1.834 . . . . 0.0 113.106 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.02 -8.01 64.95 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 124.554 1.073 . . . . 0.0 112.475 -169.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.09 146.2 21.85 Favored Glycine 0 C--N 1.361 1.935 0 C-N-CA 126.565 2.031 . . . . 0.0 115.824 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -60.37 -42.25 95.41 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.4 ' HB2' ' CE3' ' A' ' 97' ' ' TRP 0.322 0.1 OUTLIER -99.84 2.93 44.37 Favored 'General case' 0 C--N 1.363 1.163 0 CA-C-N 120.402 1.455 . . . . 0.0 114.826 -178.217 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -91.77 140.83 29.31 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 126.551 1.94 . . . . 0.0 107.928 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.5 m -166.66 132.4 2.28 Favored 'General case' 0 N--CA 1.446 -0.635 1 N-CA-C 99.797 -4.149 . . . . 0.0 99.797 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.93 100.53 10.83 Favored 'General case' 0 C--N 1.369 1.432 0 CA-C-O 126.281 2.944 . . . . 0.0 112.848 -173.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.426 ' HB2' ' HZ3' ' A' ' 169' ' ' LYS . 0.0 OUTLIER -120.57 131.56 24.42 Favored Pre-proline 0 N--CA 1.417 -2.093 3 N-CA-C 98.51 -4.626 . . . . 0.0 98.51 164.704 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.53 -24.7 63.1 Favored 'Trans proline' 0 CA--C 1.543 0.942 1 C-N-CA 125.534 4.156 . . . . 0.0 115.998 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -69.62 -35.88 75.65 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.47 2.708 . . . . 0.0 113.831 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 45.8 mt -74.12 -36.18 43.32 Favored 'Isoleucine or valine' 0 C--N 1.376 1.745 0 C-N-CA 126.369 1.868 . . . . 0.0 109.854 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 20.1 mt -69.0 -45.63 70.05 Favored 'General case' 0 C--N 1.367 1.336 0 C-N-CA 125.298 1.439 . . . . 0.0 112.488 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -58.11 -43.21 87.04 Favored 'General case' 0 CA--C 1.486 -1.519 0 C-N-CA 127.951 2.5 . . . . 0.0 114.596 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.25 -36.88 85.51 Favored 'General case' 0 N--CA 1.428 -1.539 0 C-N-CA 129.449 3.1 . . . . 0.0 111.208 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.1 mtt -65.04 -35.51 81.41 Favored 'General case' 0 C--N 1.379 1.883 0 CA-C-O 115.486 -2.197 . . . . 0.0 112.724 165.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -74.06 -40.2 62.98 Favored 'General case' 0 C--N 1.383 2.026 0 C-N-CA 126.019 1.728 . . . . 0.0 113.731 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.413 HH21 ' HB3' ' A' ' 193' ' ' LEU . 0.2 OUTLIER -73.68 -49.46 25.69 Favored 'General case' 0 C--N 1.374 1.651 0 C-N-CA 131.551 3.941 . . . . 0.0 111.491 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.54 95.72 Favored 'General case' 0 C--N 1.376 1.75 0 C-N-CA 123.836 0.854 . . . . 0.0 113.267 165.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.329 38.5 t70 -57.13 -52.76 64.02 Favored 'General case' 0 C--N 1.387 2.232 0 C-N-CA 126.692 1.997 . . . . 0.0 113.014 172.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -33.44 70.17 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 121.777 2.081 . . . . 0.0 115.702 173.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.26 -44.84 35.48 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.53 -36.86 76.79 Favored 'General case' 0 C--N 1.374 1.65 0 C-N-CA 126.16 1.784 . . . . 0.0 114.221 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.38 -9.78 58.14 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.664 1.586 . . . . 0.0 112.125 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -124.68 -101.27 0.39 Allowed 'General case' 0 C--N 1.356 0.867 0 CA-C-O 120.756 0.312 . . . . 0.0 111.44 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -135.77 152.69 51.37 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.036 -1.04 . . . . 0.0 110.953 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.351 17.2 ttpt -51.51 -35.96 42.63 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 130.839 3.656 . . . . 0.0 116.2 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 14.0 tt -55.03 -30.22 23.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 129.032 2.933 . . . . 0.0 113.035 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -73.22 -37.88 66.27 Favored 'General case' 0 C--N 1.375 1.691 0 O-C-N 119.717 -1.864 . . . . 0.0 113.795 176.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.28 0.0 OUTLIER -76.23 -44.35 38.01 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 167.499 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.31 78.4 mt -79.19 -18.96 52.02 Favored 'General case' 0 C--N 1.366 1.292 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -173.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -84.41 -12.95 53.47 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.607 1.163 . . . . 0.0 113.216 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.413 ' HB3' HH21 ' A' ' 178' ' ' ARG . 9.2 mp -105.03 -51.34 3.05 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 126.18 1.792 . . . . 0.0 106.22 176.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 46.48 -113.25 0.44 Allowed 'General case' 0 C--N 1.366 1.287 0 C-N-CA 129.696 3.198 . . . . 0.0 115.787 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.8 m -88.27 12.87 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 128.182 2.593 . . . . 0.0 113.221 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.286 1.5 t 95.11 48.4 0.0 OUTLIER 'General case' 0 C--N 1.359 0.982 0 C-N-CA 129.023 2.929 . . . . 0.0 109.114 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -117.25 63.75 0.73 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 127.535 2.334 . . . . 0.0 106.481 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -59.76 -43.18 94.58 Favored Pre-proline 0 C--N 1.365 1.262 0 C-N-CA 127.907 2.483 . . . . 0.0 116.494 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.42 -42.94 2.37 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 124.074 3.183 . . . . 0.0 111.411 167.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.278 1.9 m 67.37 -48.24 0.49 Allowed 'General case' 0 C--N 1.369 1.423 0 C-N-CA 129.525 3.13 . . . . 0.0 115.838 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 . . . . . 0 C--N 1.351 0.669 0 C-N-CA 127.523 2.329 . . . . 0.0 109.613 178.75 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 mttp . . . . . 0 N--CA 1.443 -0.793 0 CA-C-O 121.836 0.827 . . . . 0.0 108.788 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.06 -179.16 6.02 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -86.74 128.67 35.03 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 124.887 1.275 . . . . 0.0 111.935 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -102.66 120.33 40.38 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.322 1.849 . . . . 0.0 108.561 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.24 -158.46 0.86 Allowed 'General case' 0 C--N 1.362 1.138 0 C-N-CA 126.144 1.777 . . . . 0.0 107.486 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -100.46 20.85 14.16 Favored 'General case' 0 C--N 1.37 1.492 0 O-C-N 120.463 -1.398 . . . . 0.0 113.078 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.78 -12.85 57.9 Favored Glycine 0 C--N 1.363 2.06 0 C-N-CA 125.63 1.586 . . . . 0.0 111.177 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.51 -172.03 45.08 Favored Glycine 0 N--CA 1.441 -1.02 2 N-CA-C 102.629 -4.188 . . . . 0.0 102.629 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 tp -154.47 53.15 0.67 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 53.3 ttp85 -65.44 -38.22 89.23 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.642 2.777 . . . . 0.0 117.79 -173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -94.48 -15.06 24.53 Favored 'General case' 0 C--N 1.362 1.147 0 O-C-N 120.545 -1.347 . . . . 0.0 110.589 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.267 19.7 m 85.45 19.03 0.11 Allowed 'General case' 0 C--N 1.358 0.973 0 C-N-CA 129.744 3.218 . . . . 0.0 114.079 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.9 m -74.92 69.19 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 127.047 2.139 . . . . 0.0 114.527 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.16 115.03 45.63 Favored Pre-proline 0 C--N 1.358 0.937 0 O-C-N 120.205 -1.56 . . . . 0.0 107.67 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.01 -72.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 124.322 3.348 . . . . 0.0 111.017 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -165.7 -64.51 0.03 OUTLIER 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.6 134.98 19.44 Favored Pre-proline 0 C--N 1.355 0.846 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.76 167.84 18.19 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.248 2.632 . . . . 0.0 114.806 -171.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 m -114.15 125.72 54.26 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 125.315 1.446 . . . . 0.0 111.547 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 m -56.47 -39.73 73.69 Favored 'General case' 0 C--N 1.37 1.485 0 C-N-CA 129.375 3.07 . . . . 0.0 117.461 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.405 ' HA ' ' CE1' ' A' ' 90' ' ' PHE . 87.4 p -117.15 49.92 1.14 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 124.378 1.071 . . . . 0.0 112.95 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.12 109.9 6.38 Favored 'General case' 0 C--N 1.361 1.086 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.405 ' CE1' ' HA ' ' A' ' 88' ' ' SER . 18.2 m-85 -125.71 128.49 47.86 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.952 1.701 . . . . 0.0 113.47 -173.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.318 90.8 p -110.2 162.59 19.84 Favored Pre-proline 0 C--N 1.364 1.235 0 O-C-N 120.249 -1.532 . . . . 0.0 114.855 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.24 136.9 77.75 Favored 'Trans proline' 0 C--N 1.378 2.095 1 C-N-CA 126.449 4.766 . . . . 0.0 119.217 -170.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.63 -20.83 19.97 Favored Glycine 0 C--N 1.364 2.11 0 C-N-CA 125.605 1.574 . . . . 0.0 111.813 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -85.53 169.04 13.95 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 125.697 1.599 . . . . 0.0 114.891 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -110.28 131.68 54.84 Favored 'General case' 0 C--N 1.369 1.447 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 172.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -134.46 161.77 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -106.98 138.31 43.39 Favored 'General case' 0 C--O 1.217 -0.618 1 N-CA-C 99.768 -4.16 . . . . 0.0 99.768 165.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 148' ' ' LEU . . . -128.86 152.58 48.36 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 121.632 2.014 . . . . 0.0 111.976 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -121.46 146.04 47.32 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.9 ttp -128.85 146.43 50.93 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 119.61 -1.931 . . . . 0.0 108.016 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -48.6 91.06 0.0 OUTLIER 'General case' 0 C--N 1.366 1.285 0 C-N-CA 129.475 3.11 . . . . 0.0 117.01 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.06 -9.13 33.7 Favored Glycine 0 C--N 1.36 1.875 0 C-N-CA 125.102 1.334 . . . . 0.0 113.436 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -99.71 162.12 22.2 Favored Pre-proline 0 C--N 1.359 0.983 0 C-N-CA 125.308 1.443 . . . . 0.0 109.231 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.88 167.31 26.27 Favored 'Trans proline' 0 CA--C 1.537 0.674 1 C-N-CA 125.848 4.365 . . . . 0.0 114.736 167.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -60.91 132.0 52.47 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 127.335 2.254 . . . . 0.0 115.04 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.427 ' CE3' ' HA ' ' A' ' 106' ' ' TRP . 10.7 m95 -132.29 108.56 13.61 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 121.729 3.974 . . . . 0.0 121.729 -171.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -58.07 113.58 1.59 Allowed 'Trans proline' 0 C--N 1.388 2.631 1 C-N-CA 126.275 4.65 . . . . 0.0 111.588 165.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.1 m -123.65 166.12 16.05 Favored 'General case' 0 N--CA 1.438 -1.026 1 C-N-CA 132.871 4.468 . . . . 0.0 114.147 -160.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tp -126.12 144.41 50.76 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.16 118.8 37.17 Favored 'Isoleucine or valine' 0 C--N 1.366 1.294 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -113.41 143.59 44.23 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.103 -1.623 . . . . 0.0 111.679 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -79.31 111.31 15.43 Favored 'General case' 0 C--N 1.373 1.612 0 O-C-N 120.379 -1.451 . . . . 0.0 109.597 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.447 ' HB2' ' CG ' ' A' ' 130' ' ' HIS . 9.9 t60 -69.22 160.15 80.09 Favored Pre-proline 0 C--N 1.348 0.522 0 CA-C-O 114.488 -2.672 . . . . 0.0 115.336 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.82 -6.47 2.56 Favored 'Trans proline' 0 CA--C 1.562 1.901 1 CA-C-N 128.814 4.184 . . . . 0.0 116.577 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -108.32 29.72 7.09 Favored 'General case' 0 C--N 1.357 0.922 1 C-N-CA 133.384 4.674 . . . . 0.0 109.642 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -63.45 149.73 45.36 Favored 'General case' 0 C--N 1.365 1.276 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.07 -20.14 50.14 Favored Glycine 0 C--N 1.36 1.889 0 CA-C-N 113.226 -1.806 . . . . 0.0 110.007 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.86 119.1 38.56 Favored 'General case' 0 N--CA 1.446 -0.672 2 N-CA-C 98.646 -4.575 . . . . 0.0 98.646 168.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.585 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.359 0.0 OUTLIER -121.82 -33.41 3.58 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -169.378 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.3 pt -108.33 155.84 9.09 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 120.269 -1.519 . . . . 0.0 110.581 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -141.35 151.16 43.32 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 128.016 2.527 . . . . 0.0 104.208 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.65 130.21 11.48 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 121.0 -1.063 . . . . 0.0 108.249 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -117.4 98.93 6.67 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.952 2.101 . . . . 0.0 108.654 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.43 -89.78 1.02 Allowed Glycine 0 C--N 1.36 1.916 0 N-CA-C 117.869 1.908 . . . . 0.0 117.869 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -142.57 71.34 1.34 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 125.0 1.32 . . . . 0.0 109.391 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.0 m -179.92 170.36 1.21 Allowed 'General case' 0 C--N 1.351 0.667 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.49 145.46 16.22 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -141.32 150.31 42.34 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.498 2.319 . . . . 0.0 110.757 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 26.2 m -129.0 162.36 36.48 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 129.592 3.157 . . . . 0.0 104.475 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.585 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -82.5 124.8 30.43 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.335 -1.478 . . . . 0.0 110.976 172.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.78 169.48 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.436 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.98 150.84 46.32 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -106.21 127.86 53.53 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.36 1.864 . . . . 0.0 107.376 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -74.95 69.35 1.89 Allowed 'General case' 0 C--N 1.379 1.872 0 CA-C-N 120.258 1.39 . . . . 0.0 111.881 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -88.98 -119.92 0.05 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 127.459 2.304 . . . . 0.0 111.002 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -107.25 -51.99 2.83 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.184 1.794 . . . . 0.0 110.91 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.6 t -69.97 -49.98 18.02 Favored Pre-proline 0 C--N 1.36 1.063 0 C-N-CA 127.975 2.51 . . . . 0.0 117.734 -172.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -81.99 -175.64 15.67 Favored 'Cis proline' 0 C--N 1.347 0.497 0 CA-C-N 126.104 3.216 . . . . 0.0 111.52 -0.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 34.5 m -94.62 141.17 28.92 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.291 1.036 . . . . 0.0 108.319 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -160.23 156.21 26.15 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.16 -159.8 29.21 Favored Glycine 0 CA--C 1.484 -1.904 1 N-CA-C 98.235 -5.946 . . . . 0.0 98.235 174.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -104.85 113.73 27.5 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.5 m -87.83 173.78 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 C-N-CA 128.231 2.612 . . . . 0.0 106.711 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.8 m -94.31 110.88 22.61 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -50.93 -17.8 0.65 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -69.27 -19.47 63.91 Favored 'General case' 0 N--CA 1.439 -1.014 1 C-N-CA 131.784 4.034 . . . . 0.0 112.75 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.4 mt -92.33 -2.23 56.53 Favored 'General case' 0 C--N 1.365 1.278 0 C-N-CA 126.182 1.793 . . . . 0.0 113.935 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -95.35 156.9 16.13 Favored 'General case' 0 C--N 1.369 1.451 0 CA-C-N 122.231 2.287 . . . . 0.0 109.715 174.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.06 159.04 58.43 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 102.567 -3.123 . . . . 0.0 102.567 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.98 151.93 21.51 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 125.035 3.823 . . . . 0.0 111.399 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.365 1.0 OUTLIER -93.31 -116.2 0.09 Allowed 'General case' 0 C--N 1.367 1.335 0 O-C-N 120.649 -1.282 . . . . 0.0 110.737 175.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.426 4.6 t 63.47 -36.87 0.16 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 127.849 2.459 . . . . 0.0 116.149 -174.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.04 88.54 0.53 Allowed Glycine 0 C--N 1.349 1.27 0 C-N-CA 126.448 1.975 . . . . 0.0 116.769 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.2 m -67.66 -10.92 56.6 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 131.473 3.909 . . . . 0.0 115.412 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -121.49 24.58 9.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 128.458 2.703 . . . . 0.0 108.496 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 91.2 p -87.39 139.29 30.7 Favored 'General case' 0 C--N 1.374 1.667 0 C-N-CA 125.598 1.559 . . . . 0.0 107.821 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -56.39 -24.34 43.97 Favored 'General case' 0 C--N 1.372 1.579 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -82.24 -19.86 38.81 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.734 1.614 . . . . 0.0 113.224 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.61 -13.99 22.49 Favored 'General case' 0 C--N 1.37 1.494 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.304 0.4 OUTLIER -107.88 -173.97 2.41 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 125.395 1.478 . . . . 0.0 112.939 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -69.31 122.1 18.2 Favored 'General case' 0 C--N 1.373 1.613 0 O-C-N 120.308 -1.495 . . . . 0.0 112.784 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.22 -9.47 50.06 Favored Glycine 0 C--N 1.354 1.553 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.81 -166.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.87 155.76 46.78 Favored Glycine 0 C--N 1.368 2.339 0 N-CA-C 119.97 2.748 . . . . 0.0 119.97 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.69 -41.54 77.53 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.927 3.691 . . . . 0.0 116.164 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -98.42 -17.74 18.64 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -41.08 -36.58 0.72 Allowed 'General case' 0 C--N 1.356 0.854 2 C-N-CA 132.723 4.409 . . . . 0.0 122.472 -168.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.6 m -14.17 92.86 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 1 C-N-CA 132.032 4.133 . . . . 0.0 117.707 -177.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.99 101.65 13.1 Favored 'General case' 0 C--N 1.368 1.38 0 CA-C-O 126.016 2.817 . . . . 0.0 114.003 -166.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -119.78 135.55 24.28 Favored Pre-proline 0 N--CA 1.423 -1.776 1 C-N-CA 133.803 4.841 . . . . 0.0 102.681 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -55.08 -22.76 32.76 Favored 'Trans proline' 0 CA--C 1.544 1.019 1 C-N-CA 125.973 4.448 . . . . 0.0 117.733 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -70.16 -35.96 74.38 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 131.251 3.82 . . . . 0.0 112.453 173.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.8 mt -76.7 -32.7 20.93 Favored 'Isoleucine or valine' 0 C--N 1.375 1.683 0 C-N-CA 127.582 2.353 . . . . 0.0 109.084 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 26.3 mt -66.46 -51.88 52.15 Favored 'General case' 0 C--N 1.373 1.627 0 C-N-CA 127.063 2.145 . . . . 0.0 111.055 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -57.45 -34.52 69.06 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.127 1.771 . . . . 0.0 114.751 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.33 -50.75 43.59 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 130.484 3.514 . . . . 0.0 113.86 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.415 0.0 OUTLIER -68.16 -33.1 73.85 Favored 'General case' 0 C--N 1.385 2.124 0 CA-C-N 121.525 1.966 . . . . 0.0 113.7 173.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -71.96 -48.89 41.95 Favored 'General case' 0 C--N 1.373 1.596 0 C-N-CA 126.688 1.995 . . . . 0.0 112.751 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -38.51 77.83 Favored 'General case' 0 C--N 1.383 2.042 0 O-C-N 119.022 -2.299 . . . . 0.0 114.986 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.89 -51.09 69.61 Favored 'General case' 0 C--N 1.379 1.864 0 C-N-CA 124.655 1.182 . . . . 0.0 112.19 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.268 38.1 t70 -53.47 -43.2 67.96 Favored 'General case' 0 C--N 1.38 1.897 0 C-N-CA 127.263 2.225 . . . . 0.0 113.98 174.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -33.86 76.57 Favored 'General case' 0 C--N 1.374 1.669 0 O-C-N 118.661 -2.524 . . . . 0.0 114.921 173.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.37 -45.59 31.24 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 tt -53.56 -49.87 66.75 Favored 'General case' 0 CA--C 1.498 -1.024 1 C-N-CA 132.298 4.239 . . . . 0.0 116.455 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.253 0.0 OUTLIER -86.84 -7.91 57.8 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 126.606 1.962 . . . . 0.0 111.417 -174.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -120.1 -100.05 0.43 Allowed 'General case' 0 C--N 1.358 0.961 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.462 ' HB2' ' HZ2' ' A' ' 189' ' ' LYS . 17.1 m-20 -135.26 151.05 50.21 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.783 -1.198 . . . . 0.0 108.998 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.445 ' HZ1' HD23 ' A' ' 191' ' ' LEU 0.256 34.3 tttm -51.39 -36.49 43.63 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 130.979 3.712 . . . . 0.0 115.872 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 12.6 tt -56.0 -28.5 24.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 130.118 3.367 . . . . 0.0 113.211 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.462 ' HZ2' ' HB2' ' A' ' 186' ' ' ASP 0.258 4.6 mptt -71.02 -42.62 69.33 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 119.537 -1.977 . . . . 0.0 113.849 174.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.314 0.0 OUTLIER -76.36 -42.98 42.9 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 169.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.445 HD23 ' HZ1' ' A' ' 187' ' ' LYS . 3.3 tp -70.55 -30.7 67.5 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.627 1.971 . . . . 0.0 114.946 -172.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -84.56 -12.25 54.47 Favored 'General case' 0 C--N 1.365 1.282 0 C-N-CA 125.859 1.664 . . . . 0.0 114.305 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 mp -97.34 -50.05 4.69 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 173.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 62.65 -102.64 0.11 Allowed 'General case' 0 C--N 1.364 1.199 0 C-N-CA 130.371 3.468 . . . . 0.0 115.055 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 13.9 m -115.63 29.99 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 128.397 2.679 . . . . 0.0 108.601 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.273 4.2 t 82.03 60.81 0.02 OUTLIER 'General case' 0 C--N 1.357 0.921 0 C-N-CA 128.751 2.821 . . . . 0.0 113.944 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -101.84 148.4 25.35 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 124.79 1.236 . . . . 0.0 109.738 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -112.06 89.81 12.47 Favored Pre-proline 0 C--N 1.358 0.972 0 C-N-CA 125.794 1.637 . . . . 0.0 110.627 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.75 60.8 7.35 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 125.07 3.847 . . . . 0.0 113.147 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 51.0 m -99.31 79.73 2.34 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 126.7 2.0 . . . . 0.0 112.125 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--N 1.359 1.016 0 C-N-CA 125.958 1.703 . . . . 0.0 113.356 -179.006 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.5 tttt . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.59 2.59 8.95 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 127.036 2.134 . . . . 0.0 110.027 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.56 158.68 34.42 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -102.98 157.31 17.06 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.178 1.391 . . . . 0.0 112.255 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 18.6 tp -107.42 119.39 39.27 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 125.238 1.415 . . . . 0.0 108.621 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -89.13 20.68 3.56 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 127.344 2.258 . . . . 0.0 116.25 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.13 18.89 73.56 Favored Glycine 0 C--N 1.365 2.151 0 C-N-CA 125.34 1.447 . . . . 0.0 114.982 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.67 142.65 16.1 Favored Glycine 0 C--N 1.356 1.645 0 C-N-CA 125.964 1.745 . . . . 0.0 115.643 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.6 mt -115.48 -69.43 0.86 Allowed 'General case' 0 C--N 1.363 1.159 0 C-N-CA 125.176 1.39 . . . . 0.0 112.686 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -72.13 -52.41 16.8 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 128.948 2.899 . . . . 0.0 113.189 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.3 tpp180 -179.23 35.95 0.0 OUTLIER 'General case' 0 C--N 1.35 0.599 0 C-N-CA 129.399 3.079 . . . . 0.0 104.382 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.7 t 130.95 -152.5 0.0 OUTLIER 'General case' 0 C--N 1.366 1.302 0 C-N-CA 130.098 3.359 . . . . 0.0 103.31 -172.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.7 m -132.43 -47.72 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 128.75 2.82 . . . . 0.0 107.204 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.66 145.52 30.7 Favored Pre-proline 0 C--N 1.36 1.025 0 CA-C-O 116.103 -1.903 . . . . 0.0 106.863 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -63.27 139.95 74.59 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 125.127 3.885 . . . . 0.0 116.801 -172.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.76 -63.05 0.3 Allowed 'General case' 0 C--N 1.359 0.987 0 C-N-CA 124.43 1.092 . . . . 0.0 110.636 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.66 111.66 64.69 Favored Pre-proline 0 C--N 1.359 1.011 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.27 88.82 1.37 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.793 2.995 . . . . 0.0 112.491 -168.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 p -127.57 -75.81 0.57 Allowed 'General case' 0 C--N 1.35 0.622 0 C-N-CA 129.458 3.103 . . . . 0.0 109.07 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.7 p -65.12 96.11 0.2 Allowed 'General case' 0 C--N 1.365 1.274 0 C-N-CA 127.962 2.505 . . . . 0.0 115.285 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.7 p -68.34 116.58 9.09 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 130.048 3.339 . . . . 0.0 116.476 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -160.4 62.19 0.33 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-N 119.161 0.892 . . . . 0.0 109.505 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -114.58 124.63 52.34 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 120.294 -1.504 . . . . 0.0 111.558 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.6 p -112.07 164.4 15.31 Favored Pre-proline 0 C--N 1.366 1.292 0 C-N-CA 129.045 2.938 . . . . 0.0 114.438 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -47.08 141.01 13.17 Favored 'Trans proline' 0 C--N 1.376 2.005 1 C-N-CA 127.743 5.628 . . . . 0.0 121.147 -169.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.43 -23.3 32.01 Favored Glycine 0 C--N 1.367 2.267 0 C-N-CA 125.636 1.588 . . . . 0.0 112.838 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.05 169.94 13.45 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 120.814 2.307 . . . . 0.0 112.644 -177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.84 141.38 29.36 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 166.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.5 163.4 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -110.34 128.27 55.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 101.288 -3.597 . . . . 0.0 101.288 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.28 137.74 51.05 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 122.848 1.309 . . . . 0.0 111.698 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -110.57 136.41 49.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 171.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 42.7 ttm -119.8 138.32 53.43 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.32 102.14 0.37 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 125.721 1.608 . . . . 0.0 113.98 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.17 -12.6 24.07 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 125.538 1.542 . . . . 0.0 112.757 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -103.18 164.17 16.04 Favored Pre-proline 0 C--N 1.354 0.792 0 C-N-CA 125.639 1.575 . . . . 0.0 109.418 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -71.64 166.36 29.68 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.371 3.381 . . . . 0.0 113.634 162.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -57.69 122.37 12.64 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 130.683 3.593 . . . . 0.0 114.825 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -126.48 112.17 23.17 Favored Pre-proline 0 N--CA 1.427 -1.602 0 N-CA-C 119.888 3.292 . . . . 0.0 119.888 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -59.03 112.24 1.15 Allowed 'Trans proline' 0 C--N 1.383 2.387 1 C-N-CA 125.813 4.342 . . . . 0.0 110.573 162.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.2 t -122.57 165.5 16.33 Favored 'General case' 0 N--CA 1.445 -0.72 1 C-N-CA 133.475 4.71 . . . . 0.0 111.346 -161.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tt -124.05 132.31 53.66 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.251 3.3 p -81.84 127.28 39.74 Favored 'Isoleucine or valine' 0 C--N 1.377 1.8 0 CA-C-N 121.145 1.793 . . . . 0.0 107.385 176.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -132.05 152.86 50.93 Favored 'General case' 0 C--N 1.366 1.322 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 -161.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.5 113.46 27.05 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 127.698 2.399 . . . . 0.0 109.525 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 115' ' ' PHE . 34.8 m-70 -71.54 161.72 76.97 Favored Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 129.292 3.037 . . . . 0.0 114.342 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.1 -8.22 0.17 Allowed 'Trans proline' 0 CA--C 1.569 2.241 1 C-N-CA 125.605 4.203 . . . . 0.0 117.593 170.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CZ ' ' CD2' ' A' ' 113' ' ' HIS . 0.6 OUTLIER -104.11 44.69 1.0 Allowed 'General case' 0 C--N 1.365 1.252 0 C-N-CA 131.518 3.927 . . . . 0.0 107.565 167.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.6 149.18 38.32 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 119.207 3.04 . . . . 0.0 119.207 -170.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.75 -19.91 27.69 Favored Glycine 0 C--N 1.362 2.025 0 CA-C-N 112.757 -2.019 . . . . 0.0 109.541 165.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 t -118.03 119.39 34.64 Favored 'General case' 0 N--CA 1.435 -1.224 1 N-CA-C 98.161 -4.755 . . . . 0.0 98.161 168.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.473 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 27.2 p90 -140.31 -0.6 1.6 Allowed 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 120.82 -1.175 . . . . 0.0 111.357 -174.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.0 pt -119.84 147.86 23.24 Favored 'Isoleucine or valine' 0 C--N 1.366 1.321 0 CA-C-O 123.467 1.603 . . . . 0.0 115.133 -174.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.87 118.36 31.35 Favored 'General case' 0 C--N 1.357 0.934 1 N-CA-C 99.13 -4.396 . . . . 0.0 99.13 169.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -105.6 -179.66 4.0 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -165.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -46.78 119.69 2.61 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 128.848 2.859 . . . . 0.0 116.985 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.51 -54.92 0.24 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 105.091 -3.204 . . . . 0.0 105.091 -173.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -109.86 -47.6 3.32 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.459 1.504 . . . . 0.0 109.886 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 m -179.51 169.77 1.37 Allowed 'General case' 0 CA--C 1.472 -2.056 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.4 106.87 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -114.98 130.31 56.9 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 127.811 2.445 . . . . 0.0 110.676 -176.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 13.7 m -130.36 161.91 39.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.473 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 0.6 OUTLIER -92.64 138.52 31.42 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 123.944 0.898 . . . . 0.0 110.897 174.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.423 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 5.2 m -150.58 168.71 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.472 -2.033 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.39 152.55 40.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 123.828 0.851 . . . . 0.0 109.599 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -108.09 125.78 51.98 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -67.47 65.34 0.08 Allowed 'General case' 0 C--N 1.369 1.438 0 C-N-CA 126.615 1.966 . . . . 0.0 115.08 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.37 -119.36 0.08 Allowed 'General case' 0 C--N 1.36 1.025 0 O-C-N 119.397 -2.064 . . . . 0.0 110.045 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -106.71 -49.07 3.38 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.627 1.571 . . . . 0.0 112.597 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.274 11.2 t -70.12 -51.39 14.22 Favored Pre-proline 0 C--N 1.363 1.156 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.06 -179.16 26.15 Favored 'Cis proline' 0 CA--C 1.543 0.952 0 CA-C-N 125.944 3.158 . . . . 0.0 113.722 1.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 54.0 m -95.03 127.17 40.88 Favored 'General case' 0 C--N 1.369 1.424 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 131' ' ' VAL . 24.1 ttp-105 -153.61 157.47 39.72 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 119.976 1.262 . . . . 0.0 109.876 -173.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.14 -159.28 25.5 Favored Glycine 0 CA--C 1.492 -1.401 0 N-CA-C 104.901 -3.28 . . . . 0.0 104.901 171.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -83.15 113.55 20.72 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 126.172 1.789 . . . . 0.0 109.15 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.44 178.36 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 125.118 1.367 . . . . 0.0 110.987 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.2 m -99.82 121.18 40.91 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 100.462 -3.903 . . . . 0.0 100.462 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.419 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 26.7 ttpt -73.34 -10.99 60.33 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -170.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -72.58 -13.42 61.39 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.49 2.316 . . . . 0.0 113.738 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.7 mt -103.0 7.61 39.05 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 126.634 1.974 . . . . 0.0 111.404 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.419 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 12.4 mt -96.31 125.41 40.79 Favored 'General case' 0 C--N 1.379 1.874 0 CA-C-N 119.891 1.223 . . . . 0.0 108.431 174.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -114.44 159.13 37.99 Favored Pre-proline 0 C--O 1.221 -0.434 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.03 155.72 14.99 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 CA-C-N 124.904 2.787 . . . . 0.0 114.642 -172.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.362 0.0 OUTLIER -30.91 -95.34 0.0 OUTLIER 'General case' 0 C--N 1.357 0.922 2 C-N-CA 132.273 4.229 . . . . 0.0 122.092 -177.927 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.4 t -0.38 54.95 0.0 OUTLIER 'General case' 0 C--N 1.381 1.942 1 C-N-CA 136.511 5.924 . . . . 0.0 118.194 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.689 ' H ' HD13 ' A' ' 183' ' ' LEU . . . -81.07 -91.75 0.52 Allowed Glycine 0 CA--C 1.485 -1.782 0 N-CA-C 121.603 3.401 . . . . 0.0 121.603 -150.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.6 m -46.1 -23.45 0.32 Allowed 'General case' 0 C--N 1.374 1.669 0 C-N-CA 129.182 2.993 . . . . 0.0 119.003 -172.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -18.17 50.41 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 130.519 3.528 . . . . 0.0 113.039 175.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.0 t -80.5 150.78 29.53 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 127.754 2.422 . . . . 0.0 112.454 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -65.05 -21.39 66.82 Favored 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.985 1.714 . . . . 0.0 111.787 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.422 ' HG2' ' CD2' ' A' ' 164' ' ' HIS . 41.9 mt-10 -72.49 -23.03 60.97 Favored 'General case' 0 C--N 1.373 1.607 0 C-N-CA 126.315 1.846 . . . . 0.0 112.481 170.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -105.93 11.98 31.11 Favored 'General case' 0 C--N 1.361 1.088 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -128.0 -179.53 5.02 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.541 1.537 . . . . 0.0 107.712 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.65 122.69 11.94 Favored 'General case' 0 C--N 1.37 1.49 0 C-N-CA 127.731 2.412 . . . . 0.0 114.628 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.8 -10.04 64.21 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 124.397 0.999 . . . . 0.0 112.4 -168.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.8 146.31 25.53 Favored Glycine 0 C--N 1.365 2.145 0 N-CA-C 118.569 2.187 . . . . 0.0 118.569 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.422 ' CD2' ' HG2' ' A' ' 158' ' ' GLU . 5.7 m-70 -59.81 -22.32 62.06 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 119.71 3.226 . . . . 0.0 119.71 -175.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.55 -3.52 15.93 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.297 -1.502 . . . . 0.0 111.48 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -86.9 91.56 8.71 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 -166.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.2 m -118.86 104.91 10.99 Favored 'General case' 0 CA--C 1.504 -0.81 1 N-CA-C 99.559 -4.238 . . . . 0.0 99.559 167.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.27 101.42 14.13 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-O 125.096 2.379 . . . . 0.0 112.189 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -119.36 144.82 37.25 Favored Pre-proline 0 N--CA 1.432 -1.332 0 C-N-CA 130.241 3.416 . . . . 0.0 103.801 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -51.32 -31.82 39.17 Favored 'Trans proline' 0 CA--C 1.54 0.784 1 C-N-CA 127.166 5.244 . . . . 0.0 116.593 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.9 -36.95 75.81 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 127.997 2.519 . . . . 0.0 112.896 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.0 mt -79.05 -33.65 16.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.482 0 C-N-CA 127.163 2.185 . . . . 0.0 109.878 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . 0.266 28.1 mt -61.98 -53.26 58.16 Favored 'General case' 0 C--N 1.392 2.45 0 C-N-CA 128.356 2.662 . . . . 0.0 110.367 170.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -57.41 -50.77 71.92 Favored 'General case' 0 CA--C 1.478 -1.802 0 C-N-CA 128.969 2.908 . . . . 0.0 112.684 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.62 73.33 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 130.988 3.715 . . . . 0.0 113.077 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 57.1 mtt -69.07 -39.18 79.23 Favored 'General case' 0 C--N 1.375 1.681 0 C-N-CA 125.563 1.545 . . . . 0.0 111.655 168.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -74.2 -42.33 59.98 Favored 'General case' 0 C--N 1.374 1.639 0 CA-C-N 120.756 1.616 . . . . 0.0 113.578 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.19 -53.24 56.36 Favored 'General case' 0 C--N 1.375 1.7 1 C-N-CA 132.819 4.448 . . . . 0.0 110.123 174.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.45 -51.57 68.9 Favored 'General case' 0 C--N 1.38 1.9 0 CA-C-O 116.815 -1.564 . . . . 0.0 112.496 170.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.05 -51.14 62.72 Favored 'General case' 0 C--N 1.38 1.906 0 C-N-CA 126.419 1.887 . . . . 0.0 114.352 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -55.02 -43.11 73.37 Favored 'General case' 0 C--N 1.37 1.462 0 CA-C-N 121.207 1.821 . . . . 0.0 114.993 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.13 -41.05 51.31 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.689 HD13 ' H ' ' A' ' 153' ' ' GLY 0.25 0.5 OUTLIER -61.65 -45.61 93.32 Favored 'General case' 0 C--N 1.359 1.021 1 C-N-CA 132.923 4.489 . . . . 0.0 114.663 175.247 . . . . . . . . 5 4 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -28.58 29.35 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 126.64 1.976 . . . . 0.0 111.768 -176.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -105.52 -99.82 0.33 Allowed 'General case' 0 C--N 1.359 0.986 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.477 ' HB2' ' HZ1' ' A' ' 189' ' ' LYS . 22.3 m-20 -135.56 154.01 51.5 Favored 'General case' 0 C--N 1.36 1.065 0 O-C-N 120.822 -1.174 . . . . 0.0 112.2 -174.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.395 18.0 ttpt -51.51 -37.16 47.94 Favored 'General case' 0 C--N 1.369 1.45 0 C-N-CA 130.217 3.407 . . . . 0.0 117.24 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.9 tp -57.08 -28.39 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 128.915 2.886 . . . . 0.0 112.906 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.477 ' HZ1' ' HB2' ' A' ' 186' ' ' ASP 0.252 4.1 mptt -70.19 -45.82 65.86 Favored 'General case' 0 C--N 1.372 1.575 0 O-C-N 119.773 -1.829 . . . . 0.0 113.387 174.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.291 0.0 OUTLIER -75.27 -40.19 59.01 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 119.03 -2.294 . . . . 0.0 116.804 171.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.5 tp -80.83 -20.6 42.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -170.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -82.85 -22.79 33.96 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 124.107 0.963 . . . . 0.0 112.477 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.16 23.24 13.97 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 130.132 3.373 . . . . 0.0 109.984 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.82 -103.96 0.0 OUTLIER 'General case' 0 C--N 1.367 1.356 0 C-N-CA 131.268 3.827 . . . . 0.0 117.035 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.301 2.7 m -130.4 89.02 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 124.225 1.964 . . . . 0.0 107.491 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.3 m -89.44 56.91 3.77 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 118.759 -2.463 . . . . 0.0 110.261 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.48 -3.19 50.44 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.855 2.062 . . . . 0.0 114.84 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . 0.264 42.9 tt0 -161.48 -69.18 0.01 OUTLIER Pre-proline 0 C--N 1.35 0.602 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.07 178.66 6.95 Favored 'Trans proline' 0 C--N 1.364 1.353 0 CA-C-N 124.194 2.534 . . . . 0.0 109.449 161.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 16.3 m -89.5 -45.73 9.2 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.051 1.34 . . . . 0.0 111.912 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 C--N 1.361 1.066 0 C-N-CA 126.872 2.069 . . . . 0.0 108.61 176.55 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.0 mttp . . . . . 0 N--CA 1.436 -1.128 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.2 39.26 1.08 Allowed 'General case' 0 C--N 1.363 1.182 0 C-N-CA 126.27 1.828 . . . . 0.0 112.774 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HZ1' ' HB3' ' A' ' 77' ' ' ARG . 22.9 pttp -161.31 164.98 29.78 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -102.41 138.79 38.87 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.9 tp -93.24 106.96 18.86 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.509 1.523 . . . . 0.0 112.061 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -80.05 -30.24 39.37 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 126.101 1.76 . . . . 0.0 114.488 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.31 -19.15 46.58 Favored Glycine 0 C--N 1.364 2.126 0 C-N-CA 125.749 1.642 . . . . 0.0 113.109 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.35 143.76 14.58 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 107.174 -2.37 . . . . 0.0 107.174 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . 0.256 75.6 mt 78.77 -59.42 0.41 Allowed 'General case' 0 C--N 1.366 1.304 0 C-N-CA 126.635 1.974 . . . . 0.0 113.25 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.446 ' HB3' ' HZ1' ' A' ' 70' ' ' LYS . 5.7 mmp_? -70.99 -33.58 70.55 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.676 1.991 . . . . 0.0 114.223 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -96.3 -2.38 46.01 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 127.103 2.161 . . . . 0.0 111.471 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.31 92.6 p 88.65 -123.3 0.01 OUTLIER 'General case' 0 C--N 1.356 0.882 0 C-N-CA 130.393 3.477 . . . . 0.0 110.281 -175.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -134.34 95.42 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.6 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.69 114.81 64.39 Favored Pre-proline 0 C--N 1.354 0.776 0 C-N-CA 125.864 1.665 . . . . 0.0 110.116 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.52 91.18 1.11 Allowed 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 124.116 3.211 . . . . 0.0 111.936 -175.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.82 -105.56 0.2 Allowed 'General case' 0 C--N 1.358 0.959 0 C-N-CA 125.139 1.375 . . . . 0.0 109.831 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.0 111.24 64.5 Favored Pre-proline 0 C--N 1.361 1.07 0 O-C-N 120.749 -1.219 . . . . 0.0 110.201 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -86.38 4.81 6.22 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 123.871 3.048 . . . . 0.0 114.35 -174.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 t -121.71 40.73 3.54 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 126.859 2.064 . . . . 0.0 106.859 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 p -101.23 -13.48 18.08 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 128.547 2.739 . . . . 0.0 111.336 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.465 ' HA ' ' CE2' ' A' ' 90' ' ' PHE 0.415 62.9 m 61.3 76.66 0.36 Allowed 'General case' 0 C--N 1.353 0.742 1 C-N-CA 131.718 4.007 . . . . 0.0 118.156 178.017 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -136.68 77.88 1.67 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 127.243 2.217 . . . . 0.0 109.38 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 62.1 m-85 -123.49 125.21 44.49 Favored 'General case' 0 C--N 1.355 0.837 0 O-C-N 120.336 -1.477 . . . . 0.0 112.719 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.391 88.6 p -112.01 170.51 5.19 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 131.329 3.852 . . . . 0.0 114.834 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -41.72 129.31 3.88 Favored 'Trans proline' 0 C--N 1.382 2.314 1 C-N-CA 128.177 5.918 . . . . 0.0 119.774 -177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.12 0.12 74.69 Favored Glycine 0 C--N 1.366 2.198 0 C-N-CA 127.797 2.618 . . . . 0.0 114.421 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -94.01 154.71 17.5 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 166.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -110.39 153.55 24.8 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 175.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.3 m -142.48 170.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 123.686 1.708 . . . . 0.0 107.25 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -114.78 116.03 27.97 Favored 'General case' 0 N--CA 1.438 -1.069 1 N-CA-C 99.924 -4.102 . . . . 0.0 99.924 174.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.0 127.96 53.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 122.32 2.327 . . . . 0.0 111.776 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -96.36 143.18 27.65 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.1 ttt -128.63 151.01 49.98 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 118.596 -2.565 . . . . 0.0 108.218 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -74.41 95.77 2.77 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 126.729 2.011 . . . . 0.0 113.544 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.13 -4.44 25.4 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 124.58 1.086 . . . . 0.0 113.042 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -117.08 164.92 16.92 Favored Pre-proline 0 C--N 1.357 0.898 0 CA-C-N 118.723 1.262 . . . . 0.0 108.364 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -71.58 167.37 26.63 Favored 'Trans proline' 0 C--N 1.353 0.783 1 C-N-CA 125.506 4.137 . . . . 0.0 114.413 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -53.79 115.31 1.93 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 128.086 2.554 . . . . 0.0 115.943 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -116.32 117.83 38.24 Favored Pre-proline 0 N--CA 1.415 -2.214 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -173.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -56.82 134.07 62.09 Favored 'Trans proline' 0 CA--C 1.561 1.866 1 C-N-CA 125.888 4.392 . . . . 0.0 111.848 160.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 m -147.69 165.39 30.61 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.125 2.17 . . . . 0.0 111.851 -160.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 6.2 tt -124.03 129.0 50.17 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.658 1.583 . . . . 0.0 113.996 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.02 121.81 44.02 Favored 'Isoleucine or valine' 0 C--N 1.372 1.571 0 O-C-N 120.836 -1.165 . . . . 0.0 110.724 171.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.93 153.9 51.45 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 127.26 2.224 . . . . 0.0 109.052 -170.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 9.2 p-10 -71.13 112.7 7.48 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-N 120.734 1.606 . . . . 0.0 113.533 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 14.4 t60 -77.47 158.38 79.02 Favored Pre-proline 0 C--N 1.346 0.455 0 CA-C-O 114.55 -2.643 . . . . 0.0 110.373 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HD2' ' CD2' ' A' ' 113' ' ' HIS . 91.1 Cg_exo -55.38 -1.1 0.18 Allowed 'Trans proline' 0 CA--C 1.544 1.016 1 C-N-CA 125.884 4.389 . . . . 0.0 120.242 -170.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -95.31 -7.34 39.0 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 128.994 2.918 . . . . 0.0 110.381 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 112' ' ' ASN 0.267 0.0 OUTLIER 9.52 94.87 0.0 OUTLIER 'General case' 0 C--N 1.376 1.753 1 C-N-CA 135.939 5.696 . . . . 0.0 120.213 -178.704 . . . . . . . . 5 4 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 110.27 -17.42 29.01 Favored Glycine 0 C--N 1.36 1.887 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -172.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.4 m -103.78 120.13 40.34 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 100.384 -3.932 . . . . 0.0 100.384 170.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.407 ' HA ' ' HE1' ' A' ' 130' ' ' HIS . 1.4 t80 -142.22 -26.8 0.64 Allowed 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -167.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.5 pt -112.3 155.83 13.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-O 123.029 1.395 . . . . 0.0 111.847 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -141.35 149.8 41.63 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 128.034 2.534 . . . . 0.0 104.296 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -150.43 142.51 24.03 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 120.319 -1.488 . . . . 0.0 111.105 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -118.17 93.64 4.21 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 128.044 2.538 . . . . 0.0 110.418 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.65 -67.63 0.17 Allowed Glycine 0 C--N 1.361 1.949 0 N-CA-C 120.979 3.152 . . . . 0.0 120.979 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -144.38 46.1 1.41 Allowed 'General case' 0 C--N 1.354 0.771 0 CA-C-O 122.232 1.015 . . . . 0.0 112.343 -173.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.5 m -171.5 159.04 5.41 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.24 140.28 40.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 120.933 -1.104 . . . . 0.0 109.88 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -116.77 160.2 21.15 Favored 'General case' 0 C--N 1.366 1.308 0 C-N-CA 128.058 2.543 . . . . 0.0 112.906 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 9.9 m -148.57 164.77 4.79 Favored 'Isoleucine or valine' 0 C--N 1.37 1.487 0 C-N-CA 128.1 2.56 . . . . 0.0 107.058 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -91.55 116.94 29.27 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 122.395 1.093 . . . . 0.0 111.424 169.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.82 158.78 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 N-CA-C 104.702 -2.332 . . . . 0.0 104.702 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -125.73 138.33 53.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 172.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.96 129.7 40.33 Favored 'General case' 0 C--N 1.36 1.058 0 C-N-CA 128.013 2.525 . . . . 0.0 107.864 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 14.1 m-30 -75.85 63.3 1.67 Allowed 'General case' 0 C--N 1.363 1.172 0 C-N-CA 125.829 1.652 . . . . 0.0 113.723 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.332 50.6 p-10 -98.14 -110.32 0.17 Allowed 'General case' 0 C--N 1.358 0.974 0 O-C-N 120.179 -1.576 . . . . 0.0 113.111 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -106.45 -54.95 2.4 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 125.621 1.568 . . . . 0.0 112.642 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.256 0.9 OUTLIER -64.15 -49.34 74.07 Favored Pre-proline 0 C--N 1.365 1.269 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -174.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.12 171.78 54.0 Favored 'Cis proline' 0 CA--C 1.547 1.167 0 CA-C-N 125.98 3.171 . . . . 0.0 111.543 -5.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.327 7.5 t -95.54 154.63 17.11 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 120.392 -1.443 . . . . 0.0 111.849 -176.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -148.85 152.25 36.14 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 125.133 1.373 . . . . 0.0 109.566 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -178.42 -177.5 47.14 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 107.279 -2.329 . . . . 0.0 107.279 168.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -82.78 106.26 14.47 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.456 1.902 . . . . 0.0 107.415 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.6 m -94.41 159.82 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.442 0 C-N-CA 127.577 2.351 . . . . 0.0 109.063 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.4 m -85.59 110.34 19.18 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.429 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 30.6 ttpt -64.51 -25.57 68.05 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -167.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.62 -12.35 57.62 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 127.285 2.234 . . . . 0.0 114.984 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . 0.31 0.2 OUTLIER -104.82 8.53 34.86 Favored 'General case' 0 C--N 1.37 1.464 0 O-C-N 119.107 -2.246 . . . . 0.0 112.402 174.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.429 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 14.4 mt -95.3 127.75 41.6 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 128.122 2.569 . . . . 0.0 108.339 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -114.19 165.37 13.84 Favored Pre-proline 0 C--N 1.357 0.901 0 O-C-N 118.894 -2.379 . . . . 0.0 105.866 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.43 151.97 13.57 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 124.924 3.75 . . . . 0.0 115.689 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.403 ' CE2' ' HA2' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -93.01 167.68 11.63 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 122.834 1.302 . . . . 0.0 113.373 175.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 178.9 -60.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.936 2 N-CA-C 95.073 -5.899 . . . . 0.0 95.073 -174.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.403 ' HA2' ' CE2' ' A' ' 151' ' ' TYR . . . 127.03 -125.52 5.35 Favored Glycine 0 CA--C 1.474 -2.521 0 O-C-N 121.186 -0.946 . . . . 0.0 113.481 151.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 m -59.15 -15.73 16.18 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -96.47 4.95 51.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 129.709 3.204 . . . . 0.0 111.651 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 18.1 t -89.7 139.94 30.07 Favored 'General case' 0 C--N 1.372 1.567 0 C-N-CA 126.658 1.983 . . . . 0.0 108.597 173.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.65 -27.38 68.63 Favored 'General case' 0 C--N 1.369 1.413 0 C-N-CA 125.827 1.651 . . . . 0.0 113.948 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -78.59 -10.22 59.65 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 119.672 -1.892 . . . . 0.0 112.293 171.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -104.13 17.06 24.88 Favored 'General case' 0 C--N 1.375 1.682 0 C-N-CA 125.343 1.457 . . . . 0.0 114.155 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -132.27 174.54 10.12 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.319 1.447 . . . . 0.0 109.003 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -60.36 122.17 13.89 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 126.164 1.786 . . . . 0.0 113.996 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.08 -12.7 57.44 Favored Glycine 0 C--N 1.358 1.781 0 C-N-CA 124.803 1.192 . . . . 0.0 112.53 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.4 151.18 24.16 Favored Glycine 0 C--N 1.363 2.042 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -63.23 -38.87 92.87 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -87.74 -22.03 24.82 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.182 0.993 . . . . 0.0 112.308 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -75.87 91.65 3.02 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 126.635 1.974 . . . . 0.0 114.367 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 70.7 m -119.21 107.69 13.75 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 100.487 -3.894 . . . . 0.0 100.487 170.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.46 101.44 13.92 Favored 'General case' 0 C--N 1.366 1.293 0 CA-C-O 126.535 3.064 . . . . 0.0 114.312 -167.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -120.31 139.69 28.97 Favored Pre-proline 0 N--CA 1.412 -2.344 1 C-N-CA 133.139 4.575 . . . . 0.0 101.353 169.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.63 -32.19 82.38 Favored 'Trans proline' 0 CA--C 1.545 1.066 1 C-N-CA 126.462 4.775 . . . . 0.0 115.694 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -66.11 -35.91 81.76 Favored 'General case' 0 C--N 1.365 1.268 0 C-N-CA 127.578 2.351 . . . . 0.0 113.125 174.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 19.2 mm -68.25 -39.17 80.69 Favored 'Isoleucine or valine' 0 C--N 1.378 1.827 0 C-N-CA 126.279 1.832 . . . . 0.0 110.909 174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 20.2 mt -68.9 -51.35 40.97 Favored 'General case' 0 C--N 1.367 1.355 0 C-N-CA 126.162 1.785 . . . . 0.0 113.163 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -61.02 -35.32 76.55 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 127.191 2.197 . . . . 0.0 114.596 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.36 -34.99 75.41 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 130.717 3.607 . . . . 0.0 109.396 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.5 mtt -69.31 -35.37 75.89 Favored 'General case' 0 C--N 1.38 1.924 0 CA-C-N 120.994 1.725 . . . . 0.0 114.017 163.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -66.74 -47.95 70.69 Favored 'General case' 0 C--N 1.372 1.572 0 C-N-CA 125.76 1.624 . . . . 0.0 111.461 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -68.96 -53.05 22.89 Favored 'General case' 0 C--N 1.37 1.472 0 C-N-CA 127.3 2.24 . . . . 0.0 113.026 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.25 -33.13 74.01 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.46 -44.0 75.8 Favored 'General case' 0 C--N 1.375 1.691 0 C-N-CA 127.067 2.147 . . . . 0.0 109.861 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -36.87 83.37 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -69.43 -35.09 75.35 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -81.41 -36.8 29.05 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 119.943 -1.723 . . . . 0.0 114.63 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -87.17 -25.64 23.97 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 126.833 2.053 . . . . 0.0 112.878 -172.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -100.87 -95.15 0.27 Allowed 'General case' 0 C--N 1.367 1.35 0 O-C-N 121.091 -1.006 . . . . 0.0 109.007 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.0 145.01 45.65 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.047 -1.033 . . . . 0.0 109.399 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.521 ' HB3' HH11 ' A' ' 190' ' ' ARG . 93.5 mttt -51.39 -34.71 35.58 Favored 'General case' 0 C--N 1.365 1.257 1 C-N-CA 132.379 4.271 . . . . 0.0 113.881 173.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.5 tt -50.61 -27.81 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 131.001 3.72 . . . . 0.0 112.593 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.257 2.3 mptp? -73.82 -29.97 62.45 Favored 'General case' 0 C--N 1.377 1.786 0 C-N-CA 126.895 2.078 . . . . 0.0 114.728 169.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.521 HH11 ' HB3' ' A' ' 187' ' ' LYS 0.266 0.0 OUTLIER -75.03 -43.25 54.66 Favored 'General case' 0 C--N 1.371 1.518 0 O-C-N 119.278 -2.139 . . . . 0.0 113.168 171.161 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.288 63.2 mt -75.33 -18.87 59.9 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 126.631 1.972 . . . . 0.0 114.488 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -58.12 -38.92 77.43 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 127.699 2.4 . . . . 0.0 113.063 168.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -94.41 -51.07 4.94 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 126.963 2.105 . . . . 0.0 109.159 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 63.55 -83.38 0.02 OUTLIER 'General case' 0 C--N 1.372 1.585 1 C-N-CA 131.91 4.084 . . . . 0.0 114.353 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 11.4 m -146.03 82.59 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 C-N-CA 130.841 3.656 . . . . 0.0 101.414 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.7 m -82.43 62.4 6.09 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 118.748 -2.47 . . . . 0.0 110.503 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -68.78 52.68 0.08 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 131.252 3.821 . . . . 0.0 114.431 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 78.98 90.89 0.05 OUTLIER Pre-proline 0 C--N 1.361 1.074 0 C-N-CA 130.554 3.542 . . . . 0.0 113.276 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.79 72.25 5.79 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 124.51 3.474 . . . . 0.0 110.637 175.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 67.5 m 75.01 -57.8 0.59 Allowed 'General case' 0 C--N 1.361 1.078 0 C-N-CA 129.921 3.289 . . . . 0.0 114.936 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--N 1.351 0.671 0 C-N-CA 125.644 1.578 . . . . 0.0 109.069 -179.002 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.428 ' HZ3' ' HB3' ' A' ' 68' ' ' LYS . 4.5 mmmp? . . . . . 0 N--CA 1.435 -1.189 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 79.26 -61.42 0.33 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 127.998 2.519 . . . . 0.0 115.454 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -116.39 153.88 31.25 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 125.414 1.485 . . . . 0.0 110.347 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -102.67 123.53 46.55 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 125.695 1.598 . . . . 0.0 111.305 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.3 mt -68.9 2.18 2.82 Favored 'General case' 0 C--N 1.371 1.528 1 C-N-CA 131.952 4.101 . . . . 0.0 120.075 -171.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -94.2 -16.07 24.0 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 126.053 1.741 . . . . 0.0 109.431 174.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.84 0.97 49.02 Favored Glycine 0 C--N 1.37 2.423 0 C-N-CA 124.726 1.155 . . . . 0.0 114.734 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.41 -157.24 8.15 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . 0.296 76.9 mt 113.15 -95.62 0.0 OUTLIER 'General case' 0 C--N 1.355 0.837 1 C-N-CA 131.911 4.084 . . . . 0.0 107.369 -178.409 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -72.02 -34.78 69.09 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 126.229 1.812 . . . . 0.0 113.761 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 174.17 -57.04 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.1 39.96 7.35 Favored 'General case' 0 C--N 1.363 1.19 0 C-N-CA 129.148 2.979 . . . . 0.0 113.981 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.421 0.8 OUTLIER 63.99 -48.76 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.103 0 C-N-CA 130.439 3.495 . . . . 0.0 118.288 -178.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.42 158.21 33.01 Favored Pre-proline 0 C--N 1.351 0.64 0 C-N-CA 126.677 1.991 . . . . 0.0 110.579 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.12 -38.5 1.14 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 124.019 3.146 . . . . 0.0 113.563 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -165.65 -64.54 0.03 OUTLIER 'General case' 0 C--N 1.352 0.685 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.45 116.73 59.73 Favored Pre-proline 0 C--N 1.352 0.693 0 C-N-CA 125.574 1.55 . . . . 0.0 109.693 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -84.82 34.18 0.5 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 124.218 3.279 . . . . 0.0 113.134 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.9 t -179.53 -169.0 0.13 Allowed 'General case' 0 C--N 1.355 0.838 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 p -165.01 -91.49 0.02 OUTLIER 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.91 2.084 . . . . 0.0 108.605 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.359 87.0 p 82.27 23.66 0.21 Allowed 'General case' 0 C--N 1.354 0.774 0 C-N-CA 129.972 3.309 . . . . 0.0 114.696 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -101.41 108.03 19.52 Favored 'General case' 0 C--N 1.361 1.105 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -123.61 126.99 47.63 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 126.02 1.728 . . . . 0.0 111.387 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.4 p -113.12 168.65 7.41 Favored Pre-proline 0 C--N 1.357 0.924 0 C-N-CA 128.864 2.865 . . . . 0.0 117.504 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -44.11 127.26 6.82 Favored 'Trans proline' 0 C--N 1.395 3.003 1 C-N-CA 127.628 5.552 . . . . 0.0 116.15 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.24 57.44 Favored Glycine 0 CA--C 1.482 -1.994 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.045 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -95.35 161.19 14.19 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 122.867 1.318 . . . . 0.0 108.263 169.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.79 135.46 50.67 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 101.253 -3.61 . . . . 0.0 101.253 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 148' ' ' LEU . 1.3 t -129.07 159.01 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 -175.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -106.93 120.3 41.68 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 162.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.79 143.93 33.24 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 120.635 1.561 . . . . 0.0 109.37 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -115.51 134.9 54.63 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 118.982 -2.324 . . . . 0.0 105.471 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 ttp -128.91 146.45 50.95 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 119.343 -2.098 . . . . 0.0 109.141 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.59 98.88 0.72 Allowed 'General case' 0 C--N 1.365 1.27 0 C-N-CA 127.072 2.149 . . . . 0.0 113.754 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.23 -9.71 24.64 Favored Glycine 0 C--N 1.359 1.833 0 C-N-CA 125.426 1.488 . . . . 0.0 111.935 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -104.97 158.79 31.27 Favored Pre-proline 0 C--N 1.356 0.879 0 C-N-CA 125.678 1.591 . . . . 0.0 109.019 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.83 166.64 28.9 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.368 3.378 . . . . 0.0 112.034 161.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -56.13 115.02 2.2 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 129.86 3.264 . . . . 0.0 112.408 171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.446 ' CE3' ' HA ' ' A' ' 106' ' ' TRP . 2.1 m95 -114.69 108.18 49.57 Favored Pre-proline 0 N--CA 1.434 -1.244 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -173.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -55.28 106.21 0.18 Allowed 'Trans proline' 0 C--N 1.397 3.116 1 C-N-CA 125.854 4.37 . . . . 0.0 109.984 161.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 m -114.64 164.11 14.49 Favored 'General case' 0 CA--C 1.492 -1.287 1 C-N-CA 132.313 4.245 . . . . 0.0 113.21 -164.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.798 HD13 ' HE ' ' A' ' 190' ' ' ARG . 5.2 tp -123.87 127.66 48.34 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 111.6 -2.545 . . . . 0.0 105.363 173.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -91.33 118.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 166.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -121.18 152.58 38.61 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 124.498 1.119 . . . . 0.0 112.037 -169.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -89.61 111.34 22.25 Favored 'General case' 0 C--N 1.373 1.621 0 CA-C-O 123.342 1.544 . . . . 0.0 108.29 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -100.81 158.7 31.35 Favored Pre-proline 0 N--CA 1.451 -0.399 0 C-N-CA 129.705 3.202 . . . . 0.0 109.343 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -49.95 -0.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 2 C-N-CA 127.569 5.512 . . . . 0.0 122.845 -164.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.6 -0.13 35.34 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 126.792 2.037 . . . . 0.0 108.533 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.269 0.3 OUTLIER -20.36 119.33 0.03 OUTLIER 'General case' 0 C--N 1.376 1.718 2 C-N-CA 134.634 5.174 . . . . 0.0 122.068 -177.913 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.38 -20.96 27.22 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.5 p -120.72 117.94 28.78 Favored 'General case' 0 C--N 1.352 0.704 1 N-CA-C 98.101 -4.777 . . . . 0.0 98.101 164.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -141.94 2.39 1.54 Allowed 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 120.546 -1.346 . . . . 0.0 112.857 -167.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.9 pt -107.93 163.02 5.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 CA-C-O 122.696 1.236 . . . . 0.0 111.724 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -150.62 147.73 27.76 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 103.309 -2.848 . . . . 0.0 103.309 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -144.22 134.31 24.16 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 120.771 1.623 . . . . 0.0 111.926 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -117.46 93.18 4.07 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.689 2.396 . . . . 0.0 107.434 174.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.57 -92.46 0.08 OUTLIER Glycine 0 C--N 1.361 1.921 0 C-N-CA 126.555 2.026 . . . . 0.0 118.051 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -123.21 20.09 9.81 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 125.812 1.645 . . . . 0.0 109.12 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.6 t -118.41 108.69 15.35 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -111.2 135.1 51.42 Favored 'Isoleucine or valine' 0 C--N 1.357 0.898 0 C-N-CA 124.688 1.195 . . . . 0.0 108.686 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 73.4 mtt-85 -123.16 151.17 42.42 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 126.419 1.888 . . . . 0.0 112.588 -175.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.28 163.01 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 128.227 2.611 . . . . 0.0 107.282 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -93.18 121.75 34.86 Favored 'General case' 0 C--N 1.369 1.449 0 O-C-N 119.731 -1.855 . . . . 0.0 111.579 171.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.97 176.64 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.553 0 C-N-CA 126.585 1.954 . . . . 0.0 108.326 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -134.26 152.43 51.81 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.964 0.888 . . . . 0.0 109.495 166.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -106.74 115.59 30.46 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 126.642 1.977 . . . . 0.0 106.069 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -66.8 55.97 0.04 OUTLIER 'General case' 0 C--N 1.367 1.347 0 C-N-CA 127.847 2.459 . . . . 0.0 116.022 -175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.438 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP 0.303 52.7 p-10 -84.79 -102.16 0.05 Allowed 'General case' 0 C--N 1.367 1.367 0 C-N-CA 127.039 2.136 . . . . 0.0 113.17 -176.663 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -106.47 -58.3 1.94 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.275 1.83 . . . . 0.0 115.121 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.0 t -75.78 -41.77 3.56 Favored Pre-proline 0 C--N 1.366 1.295 0 CA-C-O 114.037 -2.887 . . . . 0.0 117.951 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.7 -177.94 22.45 Favored 'Cis proline' 0 CA--C 1.55 1.279 0 CA-C-N 127.083 3.566 . . . . 0.0 113.379 -2.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.3 t -95.35 142.37 27.81 Favored 'General case' 0 C--N 1.368 1.389 0 O-C-N 118.762 -2.461 . . . . 0.0 108.764 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -142.01 149.33 39.88 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.5 -170.61 37.89 Favored Glycine 0 CA--C 1.488 -1.649 1 N-CA-C 102.201 -4.36 . . . . 0.0 102.201 172.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -89.75 119.81 30.47 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 125.33 1.452 . . . . 0.0 109.371 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.8 m -99.27 160.38 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 C-N-CA 125.621 1.569 . . . . 0.0 111.152 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 41.0 t -70.92 106.12 3.52 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 127.568 2.347 . . . . 0.0 107.335 168.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.436 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 7.5 ttpp -68.95 -29.33 67.55 Favored 'General case' 0 C--N 1.365 1.258 0 CA-C-O 122.777 1.275 . . . . 0.0 112.306 -175.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -67.48 -14.75 63.21 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.681 1.593 . . . . 0.0 114.646 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.6 mt -100.18 18.38 18.84 Favored 'General case' 0 C--N 1.367 1.337 0 C-N-CA 125.9 1.68 . . . . 0.0 111.485 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.436 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 37.2 mt -102.36 131.08 49.21 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.748 -1.22 . . . . 0.0 110.473 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -115.39 156.73 45.45 Favored Pre-proline 0 C--O 1.222 -0.361 0 CA-C-O 116.711 -1.614 . . . . 0.0 107.259 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.69 150.59 14.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 125.223 3.949 . . . . 0.0 113.425 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -120.29 120.0 34.79 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-O 122.42 1.105 . . . . 0.0 112.822 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.0 t -154.49 22.2 0.47 Allowed 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.672 1.589 . . . . 0.0 106.95 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.59 56.1 0.36 Allowed Glycine 0 C--N 1.36 1.888 0 N-CA-C 120.184 2.834 . . . . 0.0 120.184 -158.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.7 m -65.77 -17.72 64.82 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 130.423 3.489 . . . . 0.0 113.978 171.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -107.04 15.59 25.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 129.466 3.106 . . . . 0.0 110.425 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . 0.337 97.2 p -126.17 153.31 44.8 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 124.186 0.994 . . . . 0.0 113.311 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.535 1.4 pttm -47.06 -16.33 0.04 OUTLIER 'General case' 0 C--N 1.369 1.426 0 N-CA-C 121.348 3.833 . . . . 0.0 121.348 -168.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -96.14 -6.21 38.89 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 117.02 -1.467 . . . . 0.0 114.057 167.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.09 18.78 10.81 Favored 'General case' 0 C--N 1.381 1.953 0 CA-C-N 122.588 2.449 . . . . 0.0 116.621 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.75 -173.04 2.97 Favored 'General case' 0 N--CA 1.45 -0.431 1 C-N-CA 132.006 4.123 . . . . 0.0 109.535 -176.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -70.96 122.59 20.26 Favored 'General case' 0 C--N 1.361 1.1 0 O-C-N 119.588 -1.945 . . . . 0.0 113.014 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 98.91 -5.79 59.85 Favored Glycine 0 C--N 1.363 2.052 0 C-N-CA 126.156 1.836 . . . . 0.0 112.158 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -80.67 148.24 28.86 Favored Glycine 0 C--N 1.364 2.1 0 C-N-CA 129.095 3.236 . . . . 0.0 117.225 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -59.87 -33.61 72.04 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -102.52 -5.76 23.63 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 120.494 1.497 . . . . 0.0 113.068 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -88.87 148.6 23.78 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 -170.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.0 m -163.67 151.42 12.86 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 101.342 -3.577 . . . . 0.0 101.342 172.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -112.09 100.12 8.61 Favored 'General case' 0 C--N 1.372 1.56 0 CA-C-O 126.003 2.811 . . . . 0.0 111.032 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -120.55 141.63 32.54 Favored Pre-proline 0 N--CA 1.424 -1.756 2 C-N-CA 132.921 4.488 . . . . 0.0 99.522 168.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.91 -26.05 67.04 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.228 3.286 . . . . 0.0 114.171 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -69.82 -35.66 74.97 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 129.491 3.117 . . . . 0.0 114.017 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.3 mm -69.88 -43.18 79.83 Favored 'Isoleucine or valine' 0 C--N 1.379 1.874 0 C-N-CA 127.109 2.164 . . . . 0.0 109.175 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.7 mt -68.94 -45.18 71.44 Favored 'General case' 0 C--N 1.373 1.593 0 C-N-CA 124.458 1.103 . . . . 0.0 113.748 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -57.95 -34.58 70.06 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 126.474 1.91 . . . . 0.0 114.88 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.58 -48.5 69.39 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 130.854 3.662 . . . . 0.0 111.086 169.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 10.6 mtt -60.6 -39.6 88.74 Favored 'General case' 0 C--N 1.375 1.708 0 CA-C-N 120.558 1.526 . . . . 0.0 115.002 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.5 -52.14 35.5 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 128.052 2.541 . . . . 0.0 112.743 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -72.54 -34.84 67.81 Favored 'General case' 0 C--N 1.381 1.935 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 178.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.02 84.07 Favored 'General case' 0 C--N 1.371 1.517 0 C-N-CA 124.675 1.19 . . . . 0.0 112.615 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.14 -47.46 86.14 Favored 'General case' 0 C--N 1.378 1.819 0 C-N-CA 125.947 1.699 . . . . 0.0 112.763 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -33.84 76.63 Favored 'General case' 0 C--N 1.369 1.454 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -74.56 -28.77 61.09 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.9 -46.96 19.85 Favored 'General case' 0 CA--C 1.499 -1.01 1 C-N-CA 132.23 4.212 . . . . 0.0 114.105 178.266 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.259 0.0 OUTLIER -89.51 -8.52 52.65 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 125.125 1.37 . . . . 0.0 111.441 -174.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -126.17 -103.63 0.35 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 122.799 0.44 . . . . 0.0 111.342 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -136.27 161.3 36.16 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-O 123.51 1.624 . . . . 0.0 112.581 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -51.07 -36.19 38.7 Favored 'General case' 0 C--N 1.358 0.951 1 C-N-CA 136.319 5.847 . . . . 0.0 113.391 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 7.4 tt -55.04 -30.01 23.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 127.937 2.495 . . . . 0.0 113.215 176.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -74.6 -40.77 61.38 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.798 ' HE ' HD13 ' A' ' 109' ' ' LEU 0.266 5.2 ptm180 -74.44 -33.23 62.88 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 175.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.2 mt -82.3 -19.5 39.31 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.949 -1.094 . . . . 0.0 112.1 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -53.45 -43.87 68.44 Favored 'General case' 0 C--N 1.37 1.467 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -31.96 11.0 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 126.122 1.769 . . . . 0.0 109.974 175.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 41.03 -119.14 0.39 Allowed 'General case' 0 C--N 1.377 1.769 0 C-N-CA 130.903 3.681 . . . . 0.0 114.784 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.59 -9.56 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 120.035 -1.666 . . . . 0.0 112.505 176.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.307 20.2 m 65.29 -27.85 0.1 Allowed 'General case' 0 C--N 1.364 1.223 0 C-N-CA 130.284 3.434 . . . . 0.0 118.176 174.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -88.68 74.94 8.31 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 127.442 2.297 . . . . 0.0 109.317 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 74.13 68.87 0.26 Allowed Pre-proline 0 C--N 1.361 1.079 0 C-N-CA 129.431 3.093 . . . . 0.0 113.216 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.71 155.43 10.3 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.959 3.106 . . . . 0.0 111.899 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 35.7 p -99.61 87.83 3.68 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 125.884 1.674 . . . . 0.0 110.614 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 . . . . . 0 C--N 1.355 0.826 0 C-N-CA 125.016 1.327 . . . . 0.0 108.543 -179.59 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 73.92 -51.27 0.69 Allowed 'General case' 0 C--N 1.36 1.053 0 C-N-CA 129.268 3.027 . . . . 0.0 115.898 178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -135.52 168.87 18.43 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 125.811 1.644 . . . . 0.0 107.756 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -103.17 136.31 43.2 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.248 1.419 . . . . 0.0 108.476 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.7 tp -171.54 167.14 6.72 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 101.471 -3.529 . . . . 0.0 101.471 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -88.11 -22.25 24.23 Favored 'General case' 0 C--N 1.377 1.778 0 CA-C-N 122.516 2.416 . . . . 0.0 112.76 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.88 11.22 44.04 Favored Glycine 0 C--N 1.365 2.145 0 N-CA-C 118.865 2.306 . . . . 0.0 118.865 171.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.33 -62.36 0.03 OUTLIER Glycine 0 C--N 1.351 1.399 0 N-CA-C 107.53 -2.228 . . . . 0.0 107.53 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.8 mt -79.02 72.92 5.57 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 127.17 2.188 . . . . 0.0 109.308 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -51.48 -38.45 53.93 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 130.998 3.719 . . . . 0.0 116.198 -175.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -109.69 9.24 24.99 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 126.628 1.971 . . . . 0.0 110.059 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.291 96.5 p 70.2 -93.84 0.03 OUTLIER 'General case' 0 C--N 1.365 1.243 0 C-N-CA 128.168 2.587 . . . . 0.0 115.808 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.8 t -88.17 76.51 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.825 0 C-N-CA 126.625 1.97 . . . . 0.0 109.892 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.98 137.0 20.02 Favored Pre-proline 0 C--N 1.359 1.011 0 C-N-CA 126.344 1.858 . . . . 0.0 110.412 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.51 63.75 7.94 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.877 3.718 . . . . 0.0 113.342 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -148.6 -78.3 0.15 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.973 0.909 . . . . 0.0 108.935 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.53 112.73 64.67 Favored Pre-proline 0 C--N 1.354 0.772 0 C-N-CA 124.858 1.263 . . . . 0.0 109.656 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.76 -42.52 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.451 2.767 . . . . 0.0 110.97 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 m -168.94 146.1 3.68 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.7 m -177.76 -168.74 0.19 Allowed 'General case' 0 C--N 1.351 0.64 0 N-CA-C 100.432 -3.914 . . . . 0.0 100.432 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.344 80.4 p 74.9 74.17 0.1 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 126.247 1.819 . . . . 0.0 114.299 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -154.38 94.18 1.68 Allowed 'General case' 0 C--N 1.361 1.104 0 CA-C-O 122.551 1.167 . . . . 0.0 113.107 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -122.75 125.58 45.79 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.44 1.096 . . . . 0.0 109.293 -174.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.464 82.5 p -111.92 170.31 5.41 Favored Pre-proline 0 CA--C 1.558 1.279 1 C-N-CA 132.066 4.147 . . . . 0.0 114.205 -175.043 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.2 139.49 62.9 Favored 'Trans proline' 0 C--N 1.378 2.117 1 C-N-CA 127.36 5.373 . . . . 0.0 120.054 -162.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.88 -13.82 45.49 Favored Glycine 0 C--N 1.363 2.064 0 CA-C-O 118.668 -1.074 . . . . 0.0 112.321 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.26 169.05 11.15 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 121.084 2.442 . . . . 0.0 112.309 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.636 HD22 ' HE ' ' A' ' 190' ' ' ARG . 4.5 mm? -97.72 138.64 34.8 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 101.832 -3.396 . . . . 0.0 101.832 164.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 m -134.03 165.59 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 103.536 -2.765 . . . . 0.0 103.536 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -121.22 116.65 25.31 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 101.174 -3.639 . . . . 0.0 101.174 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.51 128.71 56.54 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 123.667 1.698 . . . . 0.0 112.455 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -99.24 136.6 38.96 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 169.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.407 ' N ' ' CE1' ' A' ' 103' ' ' TYR . 1.2 tpt -121.62 148.04 45.06 Favored 'General case' 0 CA--C 1.511 -0.519 0 O-C-N 118.957 -2.339 . . . . 0.0 105.707 173.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -56.21 83.96 0.01 OUTLIER 'General case' 0 C--N 1.352 0.717 0 C-N-CA 129.107 2.963 . . . . 0.0 116.691 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.09 1.86 25.12 Favored Glycine 0 C--N 1.357 1.737 0 C-N-CA 124.676 1.131 . . . . 0.0 114.61 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.407 ' CE1' ' N ' ' A' ' 100' ' ' MET 0.262 0.0 OUTLIER -105.36 172.33 4.13 Favored Pre-proline 0 C--N 1.361 1.093 0 CA-C-O 116.991 -1.481 . . . . 0.0 109.609 178.246 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.1 165.76 31.65 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.576 3.517 . . . . 0.0 114.151 170.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.0 116.43 6.41 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.457 1.903 . . . . 0.0 112.62 173.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -114.92 127.63 26.65 Favored Pre-proline 0 N--CA 1.426 -1.641 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 -172.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -59.01 144.36 99.4 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 124.992 3.795 . . . . 0.0 111.343 154.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 m -156.27 164.67 38.04 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.276 1.43 . . . . 0.0 110.532 -161.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 tt -127.0 136.91 52.89 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 119.565 -1.959 . . . . 0.0 106.367 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.81 117.89 36.07 Favored 'Isoleucine or valine' 0 C--N 1.374 1.669 0 O-C-N 119.983 -1.698 . . . . 0.0 108.148 172.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -121.8 147.87 45.41 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.052 1.341 . . . . 0.0 111.416 -168.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.08 120.39 39.4 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.575 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 6.3 m-70 -62.32 159.41 40.39 Favored Pre-proline 0 C--N 1.363 1.175 0 C-N-CA 128.114 2.566 . . . . 0.0 114.459 -175.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.37 -0.65 0.16 Allowed 'Trans proline' 0 CA--C 1.558 1.675 1 C-N-CA 126.895 5.063 . . . . 0.0 117.053 172.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -106.99 37.82 2.26 Favored 'General case' 0 CA--C 1.551 1.002 1 C-N-CA 134.805 5.242 . . . . 0.0 107.041 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.305 0.0 OUTLIER -71.03 148.65 47.36 Favored 'General case' 0 C--N 1.373 1.602 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -170.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.56 -6.61 31.68 Favored Glycine 0 C--N 1.36 1.914 0 C-N-CA 125.498 1.523 . . . . 0.0 112.223 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.1 t -136.62 151.62 49.53 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 128.338 2.655 . . . . 0.0 104.159 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.466 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 2.1 t80 -160.31 -41.72 0.05 OUTLIER 'General case' 0 C--N 1.363 1.17 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -171.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.2 pt -107.94 146.72 13.58 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 O-C-N 119.626 -1.921 . . . . 0.0 115.058 -171.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -129.71 140.46 51.1 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -146.79 135.86 22.5 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.579 -1.326 . . . . 0.0 109.37 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -117.86 93.21 4.06 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 127.662 2.385 . . . . 0.0 106.863 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.83 -96.68 0.16 Allowed Glycine 0 C--N 1.362 2.013 0 C-N-CA 126.516 2.008 . . . . 0.0 117.767 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -113.49 16.45 18.81 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 126.937 2.095 . . . . 0.0 110.527 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 t -123.91 123.6 40.77 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.95 133.89 68.32 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-O 122.92 1.343 . . . . 0.0 110.366 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -118.09 133.08 56.24 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 127.302 2.241 . . . . 0.0 109.717 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.2 m -134.71 164.39 34.14 Favored 'Isoleucine or valine' 0 C--N 1.366 1.322 0 C-N-CA 129.002 2.921 . . . . 0.0 108.281 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.575 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 9.1 m170 -72.21 116.5 12.7 Favored 'General case' 0 C--N 1.372 1.567 0 O-C-N 119.398 -2.064 . . . . 0.0 114.203 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.464 ' HB ' ' CG2' ' A' ' 143' ' ' VAL . 37.3 t -144.07 141.44 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.847 0 O-C-N 119.171 -2.206 . . . . 0.0 105.121 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.86 140.98 48.7 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 112.022 -2.354 . . . . 0.0 106.323 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.54 133.05 52.57 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 126.152 1.781 . . . . 0.0 106.271 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -75.66 79.84 2.63 Favored 'General case' 0 C--N 1.372 1.546 0 C-N-CA 124.944 1.298 . . . . 0.0 108.983 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -103.53 -106.77 0.28 Allowed 'General case' 0 C--N 1.361 1.091 0 O-C-N 120.708 -1.245 . . . . 0.0 110.576 -174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -106.35 -58.08 1.97 Allowed 'General case' 0 C--N 1.353 0.718 0 C-N-CA 125.319 1.448 . . . . 0.0 111.894 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.2 m -82.77 -37.24 0.74 Allowed Pre-proline 0 C--N 1.362 1.141 0 N-CA-C 119.817 3.266 . . . . 0.0 119.817 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.61 178.48 33.36 Favored 'Cis proline' 0 CA--C 1.543 0.93 1 CA-C-N 128.529 4.082 . . . . 0.0 113.578 1.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.4 m -96.0 138.64 33.35 Favored 'General case' 0 C--N 1.366 1.301 0 C-N-CA 124.743 1.217 . . . . 0.0 109.279 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -155.67 158.97 39.16 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.673 -1.892 . . . . 0.0 106.315 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.7 -158.69 19.39 Favored Glycine 0 CA--C 1.487 -1.668 1 N-CA-C 100.32 -5.112 . . . . 0.0 100.32 170.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -90.36 132.48 35.57 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.464 ' CG2' ' HB ' ' A' ' 131' ' ' VAL . 2.3 m -99.98 -178.32 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 O-C-N 119.449 -2.032 . . . . 0.0 109.297 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.9 m -100.92 126.59 47.56 Favored 'General case' 0 C--N 1.365 1.272 0 N-CA-C 101.028 -3.693 . . . . 0.0 101.028 166.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.4 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 36.6 ttpt -72.23 -20.23 61.58 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -72.17 -6.25 41.41 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.73 3.51 42.33 Favored 'General case' 0 C--N 1.367 1.326 0 C-N-CA 124.48 1.112 . . . . 0.0 110.547 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.4 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 24.3 mt -91.8 134.44 34.74 Favored 'General case' 0 C--N 1.368 1.405 0 C-N-CA 125.505 1.522 . . . . 0.0 112.198 176.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -114.74 165.35 14.13 Favored Pre-proline 0 C--N 1.344 0.328 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 170.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.56 155.7 14.0 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.348 3.365 . . . . 0.0 113.714 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.487 ' HB2' ' HB2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -29.04 -78.35 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.964 2 N-CA-C 123.678 4.695 . . . . 0.0 123.678 178.575 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.8 t -33.12 36.34 0.0 OUTLIER 'General case' 0 C--N 1.371 1.523 1 C-N-CA 137.186 6.194 . . . . 0.0 119.318 -175.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -101.49 -48.13 1.45 Allowed Glycine 0 C--N 1.358 1.791 0 C-N-CA 127.884 2.659 . . . . 0.0 118.395 -168.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.9 m -46.48 -11.26 0.02 OUTLIER 'General case' 0 C--N 1.373 1.609 0 N-CA-C 121.182 3.771 . . . . 0.0 121.182 -175.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -122.91 13.46 9.85 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 128.746 2.818 . . . . 0.0 110.434 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.1 t -135.78 162.87 31.57 Favored 'General case' 0 CA--C 1.488 -1.424 0 C-N-CA 124.572 1.149 . . . . 0.0 113.743 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -47.05 -16.75 0.04 OUTLIER 'General case' 0 CA--C 1.489 -1.368 1 C-N-CA 134.586 5.155 . . . . 0.0 119.32 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -95.77 -7.51 36.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 117.182 -1.39 . . . . 0.0 113.081 170.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.89 15.47 3.58 Favored 'General case' 0 C--N 1.386 2.18 0 CA-C-N 122.09 2.223 . . . . 0.0 116.728 -172.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.51 -172.81 2.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 130.158 3.383 . . . . 0.0 105.975 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -71.0 122.11 19.42 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 118.971 -2.33 . . . . 0.0 112.813 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.88 -5.72 47.08 Favored Glycine 0 C--N 1.362 2.001 0 C-N-CA 125.461 1.505 . . . . 0.0 112.105 -170.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.12 154.35 50.67 Favored Glycine 0 C--N 1.371 2.51 1 C-N-CA 130.757 4.027 . . . . 0.0 117.717 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -67.78 -42.31 81.89 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 127.381 2.273 . . . . 0.0 116.179 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.57 -4.62 53.17 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 125.16 1.384 . . . . 0.0 112.196 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -82.81 94.2 7.6 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.0 m -118.73 108.38 14.81 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 100.758 -3.793 . . . . 0.0 100.758 167.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.51 101.1 13.78 Favored 'General case' 0 C--N 1.367 1.339 0 CA-C-O 126.132 2.872 . . . . 0.0 110.764 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -119.73 146.17 41.02 Favored Pre-proline 0 N--CA 1.424 -1.766 0 C-N-CA 131.171 3.788 . . . . 0.0 101.167 171.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.96 -38.81 86.58 Favored 'Trans proline' 0 C--N 1.352 0.725 1 C-N-CA 126.388 4.725 . . . . 0.0 115.307 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.46 -42.48 74.83 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.493 1.517 . . . . 0.0 113.655 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.7 mt -64.64 -46.88 91.1 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 C-N-CA 126.143 1.777 . . . . 0.0 111.901 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.432 ' O ' ' HG2' ' A' ' 177' ' ' GLN 0.304 3.9 pp -68.51 -32.38 72.3 Favored 'General case' 0 C--N 1.368 1.407 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 174.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -69.33 -39.25 78.29 Favored 'General case' 0 C--N 1.372 1.576 0 C-N-CA 128.612 2.765 . . . . 0.0 113.997 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.32 -34.55 74.83 Favored 'General case' 0 N--CA 1.431 -1.397 1 C-N-CA 131.843 4.057 . . . . 0.0 110.818 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 44.8 mtt -69.22 -33.38 73.22 Favored 'General case' 0 C--N 1.372 1.555 0 C-N-CA 127.915 2.486 . . . . 0.0 112.517 163.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 173' ' ' LEU . 57.6 mm-40 -72.57 -45.04 61.12 Favored 'General case' 0 C--N 1.385 2.143 0 C-N-CA 127.272 2.229 . . . . 0.0 112.124 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -66.45 -49.41 66.76 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 130.182 3.393 . . . . 0.0 110.362 173.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.65 83.56 Favored 'General case' 0 C--N 1.379 1.856 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.23 -47.14 69.24 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.98 2.112 . . . . 0.0 113.947 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -49.62 58.0 Favored 'General case' 0 C--N 1.359 1.008 0 O-C-N 120.309 -1.495 . . . . 0.0 114.578 173.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 190' ' ' ARG . . . -69.6 -30.43 68.18 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.4 pp -76.44 -40.02 51.78 Favored 'General case' 0 C--N 1.367 1.352 0 C-N-CA 126.517 1.927 . . . . 0.0 115.196 176.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -11.49 55.63 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.918 1.687 . . . . 0.0 111.204 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -114.14 -107.71 0.37 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -135.68 168.77 18.65 Favored 'General case' 0 C--N 1.364 1.208 0 O-C-N 120.247 -1.533 . . . . 0.0 112.739 -171.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.505 ' HA ' HH11 ' A' ' 190' ' ' ARG . 39.8 mmtm -55.51 -40.82 72.27 Favored 'General case' 0 C--N 1.386 2.196 0 C-N-CA 130.476 3.51 . . . . 0.0 114.163 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.99 -31.95 42.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 129.124 2.97 . . . . 0.0 113.914 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -74.48 -40.87 61.57 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 125.231 1.412 . . . . 0.0 114.405 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.636 ' HE ' HD22 ' A' ' 95' ' ' LEU 0.276 0.1 OUTLIER -74.94 -39.67 61.25 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 119.999 -1.688 . . . . 0.0 114.311 169.558 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.16 -21.16 64.01 Favored 'General case' 0 C--N 1.381 1.956 0 C-N-CA 128.205 2.602 . . . . 0.0 113.606 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -66.52 -32.01 73.09 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 130.124 3.37 . . . . 0.0 114.73 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mt -105.67 -47.04 4.0 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.366 2.266 . . . . 0.0 108.358 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 50.15 -112.81 0.61 Allowed 'General case' 0 C--N 1.368 1.394 0 C-N-CA 129.191 2.997 . . . . 0.0 114.803 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 22.0 m -108.98 15.49 8.0 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 126.478 1.911 . . . . 0.0 111.421 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.298 8.3 t 89.7 22.55 0.03 OUTLIER 'General case' 0 C--N 1.358 0.964 0 C-N-CA 128.687 2.795 . . . . 0.0 113.64 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -95.35 87.78 4.91 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 126.653 1.981 . . . . 0.0 108.828 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 69.41 64.11 0.53 Allowed Pre-proline 0 C--N 1.365 1.27 0 C-N-CA 128.243 2.617 . . . . 0.0 112.46 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.18 107.01 2.37 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 124.411 3.407 . . . . 0.0 112.062 -172.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.282 7.4 t 89.16 2.15 0.25 Allowed 'General case' 0 C--N 1.354 0.793 0 C-N-CA 126.767 2.027 . . . . 0.0 109.677 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--N 1.361 1.105 0 C-N-CA 128.55 2.74 . . . . 0.0 114.753 177.915 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 pttp . . . . . 0 N--CA 1.44 -0.949 0 CA-C-O 122.72 1.248 . . . . 0.0 108.543 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.1 44.25 0.56 Allowed 'General case' 0 C--N 1.36 1.025 0 C-N-CA 128.458 2.703 . . . . 0.0 114.318 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -122.79 71.35 1.03 Allowed 'General case' 0 C--N 1.352 0.714 0 C-N-CA 127.35 2.26 . . . . 0.0 105.828 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -80.63 134.05 35.83 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 126.327 1.851 . . . . 0.0 114.552 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.343 82.2 mt 89.31 -128.28 0.0 OUTLIER 'General case' 0 C--N 1.361 1.084 0 C-N-CA 129.245 3.018 . . . . 0.0 110.67 -177.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -81.76 -38.01 26.33 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.24 -21.19 13.28 Favored Glycine 0 C--N 1.359 1.857 0 C-N-CA 124.677 1.132 . . . . 0.0 114.585 -167.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.93 133.12 3.47 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 108.316 -1.913 . . . . 0.0 108.316 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -105.68 -33.05 8.17 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -72.1 -41.87 66.76 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 127.383 2.273 . . . . 0.0 114.423 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -125.89 60.58 1.27 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 128.599 2.76 . . . . 0.0 105.456 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.88 53.57 1.98 Allowed 'General case' 0 C--N 1.365 1.259 0 O-C-N 120.066 -1.646 . . . . 0.0 114.165 -175.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.423 0.3 OUTLIER 66.29 -46.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 129.739 3.215 . . . . 0.0 115.401 -174.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.78 114.8 9.45 Favored Pre-proline 0 C--N 1.357 0.909 0 C-N-CA 125.191 1.396 . . . . 0.0 108.984 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.49 -56.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 123.83 3.02 . . . . 0.0 111.254 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.11 -167.55 0.08 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 100.443 -3.91 . . . . 0.0 100.443 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.63 112.06 65.3 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -85.49 55.21 3.9 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 124.396 3.398 . . . . 0.0 112.395 -170.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.5 m -173.99 63.32 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 101.906 -3.368 . . . . 0.0 101.906 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.1 p -148.58 -99.69 0.08 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.41 ' HA ' ' CE2' ' A' ' 90' ' ' PHE . 87.3 p -141.85 95.43 2.81 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -157.99 65.85 0.46 Allowed 'General case' 0 C--N 1.355 0.82 0 C-N-CA 124.078 0.951 . . . . 0.0 108.934 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 48.8 m-85 -118.29 124.68 48.41 Favored 'General case' 0 C--N 1.363 1.192 0 O-C-N 118.987 -2.32 . . . . 0.0 114.202 -172.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.44 17.2 p -112.96 169.45 6.35 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 131.114 3.766 . . . . 0.0 114.602 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -49.37 129.45 22.74 Favored 'Trans proline' 0 C--N 1.376 1.986 1 C-N-CA 128.006 5.804 . . . . 0.0 119.087 -169.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.52 -12.42 21.1 Favored Glycine 0 CA--C 1.482 -1.993 0 C-N-CA 124.438 1.018 . . . . 0.0 111.309 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.03 159.99 14.92 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.206 -1.761 . . . . 0.0 108.247 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.42 140.31 36.87 Favored 'General case' 0 C--N 1.344 0.354 1 N-CA-C 99.998 -4.075 . . . . 0.0 99.998 166.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.37 147.36 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 102.667 -3.086 . . . . 0.0 102.667 -171.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -99.93 119.29 38.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HB3' ' HG ' ' A' ' 108' ' ' SER . . . -108.92 136.34 48.63 Favored 'General case' 0 C--N 1.359 1.012 0 CA-C-N 119.862 1.21 . . . . 0.0 111.559 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -108.97 141.31 41.25 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.0 ttp -129.59 149.84 51.18 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 119.311 -2.118 . . . . 0.0 108.932 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -65.6 89.66 0.11 Allowed 'General case' 0 C--N 1.363 1.193 0 C-N-CA 127.103 2.161 . . . . 0.0 115.032 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.24 -3.07 25.29 Favored Glycine 0 C--N 1.357 1.746 0 C-N-CA 125.873 1.701 . . . . 0.0 112.786 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -100.97 163.33 18.2 Favored Pre-proline 0 C--N 1.354 0.782 0 C-N-CA 126.573 1.949 . . . . 0.0 109.773 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.04 165.9 31.22 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.627 2.885 . . . . 0.0 112.666 164.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.471 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 1.6 m95 -66.36 130.55 43.6 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 128.6 2.76 . . . . 0.0 111.053 170.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -129.83 138.94 34.21 Favored Pre-proline 0 N--CA 1.415 -2.196 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.09 132.12 17.68 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 123.313 2.675 . . . . 0.0 107.896 147.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.449 ' HG ' ' HB3' ' A' ' 98' ' ' ALA . 51.6 m -135.66 166.51 23.07 Favored 'General case' 0 C--N 1.345 0.398 1 C-N-CA 132.121 4.168 . . . . 0.0 110.485 -166.234 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 5.9 tt -123.68 133.01 53.97 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 119.155 -2.216 . . . . 0.0 110.299 177.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.14 118.64 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 CA-C-N 122.271 2.305 . . . . 0.0 110.146 171.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.68 153.44 48.97 Favored 'General case' 0 C--N 1.372 1.583 0 C-N-CA 127.238 2.215 . . . . 0.0 112.484 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -78.64 112.55 15.85 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 129.473 3.109 . . . . 0.0 114.062 170.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -90.75 159.58 40.33 Favored Pre-proline 0 C--N 1.373 1.624 0 CA-C-O 114.301 -2.761 . . . . 0.0 109.181 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.265 53.0 Cg_exo -47.54 0.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.861 2 C-N-CA 129.021 6.481 . . . . 0.0 122.536 -166.519 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -102.48 40.56 1.34 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.164 2.586 . . . . 0.0 104.981 168.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.12 118.9 7.39 Favored 'General case' 0 C--N 1.379 1.862 0 C-N-CA 127.493 2.317 . . . . 0.0 114.275 -170.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.96 -19.9 27.18 Favored Glycine 0 C--N 1.356 1.656 0 C-N-CA 125.424 1.487 . . . . 0.0 110.534 -165.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.8 m -104.8 120.21 40.85 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 172.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.435 ' CE2' ' HB ' ' A' ' 129' ' ' VAL . 4.4 t80 -135.77 -43.15 0.67 Allowed 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 119.547 1.067 . . . . 0.0 113.531 -171.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 pt -100.03 173.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-O 122.345 1.069 . . . . 0.0 113.875 -174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -159.0 148.26 18.72 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -147.36 127.05 13.37 Favored 'General case' 0 C--N 1.363 1.193 0 O-C-N 120.071 -1.643 . . . . 0.0 110.3 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -118.29 93.75 4.24 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.601 1.96 . . . . 0.0 110.526 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.02 -76.79 0.23 Allowed Glycine 0 C--N 1.36 1.893 0 N-CA-C 120.391 2.916 . . . . 0.0 120.391 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -139.27 52.49 1.75 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 125.198 1.399 . . . . 0.0 110.657 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.4 m -174.22 146.08 1.09 Allowed 'General case' 0 C--N 1.356 0.852 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.43 139.86 50.27 Favored 'Isoleucine or valine' 0 C--N 1.362 1.111 0 CA-C-O 122.129 0.966 . . . . 0.0 111.362 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -113.56 161.77 17.0 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 126.889 2.076 . . . . 0.0 113.628 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 119' ' ' PHE . 14.0 m -149.35 163.3 4.29 Favored 'Isoleucine or valine' 0 C--N 1.369 1.431 1 C-N-CA 133.024 4.53 . . . . 0.0 103.749 175.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -97.44 127.64 43.56 Favored 'General case' 0 C--N 1.366 1.293 0 O-C-N 121.001 -1.062 . . . . 0.0 111.204 167.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.412 HG13 HG21 ' A' ' 129' ' ' VAL . 1.6 m -146.02 171.65 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.489 HE21 ' CG2' ' A' ' 195' ' ' VAL . 0.1 OUTLIER -131.93 146.51 52.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.43 1.092 . . . . 0.0 109.063 179.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -93.31 132.26 37.68 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 129.992 3.317 . . . . 0.0 107.534 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 7.4 m-30 -76.03 65.21 2.03 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 124.292 1.996 . . . . 0.0 113.509 -176.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -89.45 -109.49 0.08 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 128.891 2.876 . . . . 0.0 110.146 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.23 -52.12 2.81 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.87 1.668 . . . . 0.0 113.902 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.6 m -80.92 -41.07 1.15 Allowed Pre-proline 0 C--N 1.364 1.205 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -172.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.77 169.59 74.09 Favored 'Cis proline' 0 CA--C 1.543 0.953 0 CA-C-N 126.303 3.287 . . . . 0.0 114.259 -1.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.3 m -85.68 125.44 33.19 Favored 'General case' 0 C--N 1.366 1.302 0 C-N-CA 126.413 1.885 . . . . 0.0 110.539 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.43 ' HG2' ' H ' ' A' ' 141' ' ' GLY . 0.5 OUTLIER -117.87 174.84 5.96 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 125.225 1.41 . . . . 0.0 111.219 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.43 ' H ' ' HG2' ' A' ' 140' ' ' ARG . . . 169.14 -160.19 33.48 Favored Glycine 0 CA--C 1.487 -1.715 1 N-CA-C 97.852 -6.099 . . . . 0.0 97.852 171.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.5 m95 -96.95 155.8 16.62 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.0 m -119.92 173.14 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 C-N-CA 124.246 1.018 . . . . 0.0 108.566 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.0 t -84.19 123.58 30.25 Favored 'General case' 0 C--N 1.369 1.443 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 164.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.412 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 15.8 ttpp -73.38 -25.16 60.45 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 120.904 -1.123 . . . . 0.0 111.995 -175.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -73.22 -9.42 58.69 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 125.246 1.418 . . . . 0.0 114.519 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.3 mt -100.11 6.07 44.91 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 125.448 1.499 . . . . 0.0 111.577 172.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 2.8 mt -100.4 132.23 45.9 Favored 'General case' 0 C--N 1.371 1.538 0 C-N-CA 125.366 1.466 . . . . 0.0 108.403 173.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.71 ' HB2' ' HZ3' ' A' ' 149' ' ' LYS . 4.9 mtmp? -114.74 164.89 15.23 Favored Pre-proline 0 CA--C 1.506 -0.735 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.22 156.31 14.76 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.803 2.335 . . . . 0.0 113.409 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -34.09 -107.67 0.0 OUTLIER 'General case' 0 C--N 1.351 0.631 1 C-N-CA 132.888 4.475 . . . . 0.0 120.606 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.392 4.0 t 53.3 -42.94 0.02 OUTLIER 'General case' 0 C--N 1.371 1.505 1 C-N-CA 131.727 4.011 . . . . 0.0 118.927 174.408 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.59 -150.88 30.25 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 121.916 3.527 . . . . 0.0 121.916 159.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.6 m -45.87 -11.87 0.02 OUTLIER 'General case' 0 C--N 1.374 1.637 1 C-N-CA 134.952 5.301 . . . . 0.0 118.864 -175.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -88.67 -14.0 38.42 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 129.276 3.03 . . . . 0.0 111.747 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.4 t -75.98 153.94 36.19 Favored 'General case' 0 C--N 1.377 1.781 0 C-N-CA 126.102 1.761 . . . . 0.0 112.05 171.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -72.12 -26.93 62.31 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.869 1.668 . . . . 0.0 111.98 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -79.39 -17.4 54.47 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 124.352 1.061 . . . . 0.0 111.902 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.33 4.61 48.65 Favored 'General case' 0 C--N 1.368 1.373 0 C-N-CA 126.172 1.789 . . . . 0.0 114.08 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -122.72 177.51 5.42 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 124.653 1.181 . . . . 0.0 109.135 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.33 122.58 14.89 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 126.968 2.107 . . . . 0.0 113.829 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.68 -14.58 53.41 Favored Glycine 0 C--N 1.357 1.708 0 C-N-CA 124.891 1.234 . . . . 0.0 111.615 -168.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.45 153.73 32.14 Favored Glycine 0 C--N 1.359 1.81 0 N-CA-C 119.266 2.467 . . . . 0.0 119.266 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -63.07 -42.5 99.67 Favored 'General case' 0 C--N 1.365 1.239 0 N-CA-C 118.694 2.85 . . . . 0.0 118.694 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.471 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.286 0.4 OUTLIER -101.99 -0.03 34.38 Favored 'General case' 0 C--N 1.359 1.018 0 O-C-N 120.618 -1.301 . . . . 0.0 112.675 -179.139 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -78.64 141.62 37.84 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 126.846 2.058 . . . . 0.0 111.427 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 50.9 m -171.27 150.91 3.02 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 101.06 -3.681 . . . . 0.0 101.06 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -129.67 102.52 6.38 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-O 125.409 2.528 . . . . 0.0 113.544 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -119.68 140.22 29.12 Favored Pre-proline 0 N--CA 1.43 -1.443 2 C-N-CA 134.02 4.928 . . . . 0.0 100.114 168.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . 0.319 92.0 Cg_endo -64.45 -17.95 61.36 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.766 3.644 . . . . 0.0 117.502 -174.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -69.96 -36.06 74.96 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 129.541 3.137 . . . . 0.0 111.67 170.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 31.4 mt -73.03 -32.73 40.54 Favored 'Isoleucine or valine' 0 C--N 1.372 1.576 0 C-N-CA 127.604 2.361 . . . . 0.0 110.402 175.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 41.0 mt -65.05 -49.81 68.65 Favored 'General case' 0 C--N 1.378 1.823 0 C-N-CA 126.55 1.94 . . . . 0.0 110.307 169.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -57.53 -34.58 69.28 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 125.209 1.404 . . . . 0.0 114.184 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.22 -48.35 62.21 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 129.963 3.305 . . . . 0.0 114.304 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.7 mtt -69.64 -33.3 72.43 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 120.991 1.723 . . . . 0.0 113.383 172.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -70.13 -52.39 23.99 Favored 'General case' 0 C--N 1.377 1.784 0 C-N-CA 127.056 2.142 . . . . 0.0 112.028 174.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.426 ' HG3' ' CE2' ' A' ' 134' ' ' PHE 0.267 6.1 ptt180 -71.29 -36.52 71.7 Favored 'General case' 0 C--N 1.382 1.998 0 O-C-N 119.485 -2.009 . . . . 0.0 113.842 176.01 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.4 -50.03 67.03 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.542 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -55.06 -39.22 68.98 Favored 'General case' 0 C--N 1.386 2.18 0 CA-C-N 121.96 2.164 . . . . 0.0 113.542 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -52.32 24.97 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 119.735 -1.853 . . . . 0.0 114.6 170.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.62 -33.51 74.04 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.56 -35.37 34.44 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 126.615 1.966 . . . . 0.0 115.143 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.352 0.0 OUTLIER -91.1 -21.03 21.41 Favored 'General case' 0 C--N 1.367 1.327 0 O-C-N 121.309 -0.869 . . . . 0.0 110.735 -173.613 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -101.85 -110.94 0.22 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 123.348 0.659 . . . . 0.0 112.048 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -135.36 161.86 34.22 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 119.949 -1.72 . . . . 0.0 110.058 -174.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -51.26 -36.94 44.5 Favored 'General case' 0 C--N 1.373 1.608 0 C-N-CA 131.217 3.807 . . . . 0.0 115.216 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -40.09 34.99 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 C-N-CA 130.639 3.576 . . . . 0.0 112.836 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -32.44 69.3 Favored 'General case' 0 C--N 1.37 1.475 0 C-N-CA 125.483 1.513 . . . . 0.0 113.617 176.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.25 0.0 OUTLIER -74.02 -37.2 64.42 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 174.084 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.265 3.9 mt -78.49 -19.28 53.39 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 126.888 2.075 . . . . 0.0 114.855 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -69.65 -24.46 63.63 Favored 'General case' 0 C--N 1.368 1.388 0 O-C-N 120.961 -1.087 . . . . 0.0 113.079 167.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.86 22.45 15.58 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 131.392 3.877 . . . . 0.0 111.431 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.37 -177.99 2.81 Favored 'General case' 0 C--N 1.374 1.633 0 C-N-CA 128.796 2.838 . . . . 0.0 115.03 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.489 ' CG2' HE21 ' A' ' 132' ' ' GLN . 44.6 t -100.58 86.74 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.183 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.6 m -79.15 124.21 28.11 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.61 40.52 1.09 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 125.658 1.583 . . . . 0.0 111.093 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -158.02 143.28 12.18 Favored Pre-proline 0 C--N 1.354 0.783 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.34 63.87 7.13 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 124.72 3.613 . . . . 0.0 113.466 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 47.7 t -125.35 41.14 3.58 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.75 2.02 . . . . 0.0 109.7 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--N 1.36 1.041 0 CA-C-O 122.733 1.254 . . . . 0.0 111.425 -176.65 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.1 59.62 1.04 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.483 1.513 . . . . 0.0 108.682 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -131.39 71.45 1.47 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 123.264 1.507 . . . . 0.0 110.252 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -99.77 118.69 36.79 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 120.269 -1.519 . . . . 0.0 112.002 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.12 6.59 8.53 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 124.682 1.193 . . . . 0.0 110.771 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -97.4 -4.06 39.03 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.158 -1.588 . . . . 0.0 113.952 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.2 8.35 61.79 Favored Glycine 0 C--N 1.366 2.246 0 C-N-CA 126.931 2.205 . . . . 0.0 116.815 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.68 1.47 37.06 Favored Glycine 0 C--N 1.359 1.824 0 C-N-CA 125.7 1.619 . . . . 0.0 111.983 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tp -88.31 102.66 15.07 Favored 'General case' 0 C--N 1.363 1.163 0 O-C-N 120.745 -1.444 . . . . 0.0 110.909 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -71.85 -30.07 65.05 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 125.99 1.716 . . . . 0.0 113.879 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -169.15 -87.17 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.9 m 171.73 135.89 0.03 OUTLIER 'General case' 0 C--N 1.353 0.719 0 C-N-CA 128.909 2.884 . . . . 0.0 103.941 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -83.18 1.65 3.8 Favored 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 -175.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.98 152.02 71.26 Favored Pre-proline 0 C--N 1.35 0.592 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -77.83 -25.97 7.2 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 124.654 3.569 . . . . 0.0 113.461 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 76.83 -58.85 0.5 Allowed 'General case' 0 C--N 1.367 1.364 0 C-N-CA 127.934 2.494 . . . . 0.0 113.42 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.69 112.23 64.58 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 172.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.46 69.3 7.43 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.506 2.804 . . . . 0.0 110.976 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.0 p -88.36 68.96 9.01 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 129.16 2.984 . . . . 0.0 112.399 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 93.5 p -82.39 88.74 6.57 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 127.202 2.201 . . . . 0.0 114.095 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -141.93 94.37 2.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -133.31 89.6 2.62 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.176 1.391 . . . . 0.0 112.762 -171.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 150' ' ' PRO . 43.8 m-85 -123.16 126.65 47.4 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 120.913 -1.117 . . . . 0.0 110.587 -176.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.334 64.4 p -111.59 168.98 6.81 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 129.039 2.936 . . . . 0.0 116.433 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -50.66 137.06 41.98 Favored 'Trans proline' 0 C--N 1.367 1.5 1 C-N-CA 126.854 5.036 . . . . 0.0 122.084 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.63 -12.66 56.61 Favored Glycine 0 C--N 1.37 2.456 0 C-N-CA 128.371 2.891 . . . . 0.0 111.139 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.42 169.87 10.04 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.056 2.542 . . . . 0.0 111.449 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.52 143.73 44.49 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 119.151 -2.218 . . . . 0.0 105.477 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 m -142.88 158.68 18.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -101.75 128.52 48.05 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 100.834 -3.765 . . . . 0.0 100.834 167.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.44 141.38 48.61 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 125.341 1.456 . . . . 0.0 112.234 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -120.76 139.88 52.47 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 120.034 -1.666 . . . . 0.0 106.996 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 42.3 ttm -129.32 151.3 50.12 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 120.049 -1.657 . . . . 0.0 107.76 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -72.05 110.96 6.88 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 125.856 1.662 . . . . 0.0 110.546 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.09 -16.34 22.77 Favored Glycine 0 C--N 1.359 1.859 0 C-N-CA 125.073 1.321 . . . . 0.0 112.12 -174.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -114.36 157.95 41.15 Favored Pre-proline 0 C--N 1.356 0.853 0 C-N-CA 125.287 1.435 . . . . 0.0 108.99 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.34 166.54 29.47 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 124.448 3.432 . . . . 0.0 112.484 163.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.572 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.0 m95 -51.52 114.54 1.27 Allowed 'General case' 0 C--N 1.365 1.268 0 C-N-CA 127.705 2.402 . . . . 0.0 114.625 167.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.42 ' CE3' ' HA ' ' A' ' 106' ' ' TRP . 4.4 m95 -118.7 108.22 41.48 Favored Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 119.176 3.028 . . . . 0.0 119.176 -172.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -54.3 118.46 5.06 Favored 'Trans proline' 0 C--N 1.373 1.846 1 C-N-CA 125.678 4.252 . . . . 0.0 112.498 162.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.2 m -132.91 164.97 25.75 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 127.145 2.178 . . . . 0.0 114.226 -159.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.575 HD23 ' HE ' ' A' ' 190' ' ' ARG . 2.2 pp -116.28 147.49 41.46 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 169.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.55 120.93 42.68 Favored 'Isoleucine or valine' 0 C--N 1.369 1.417 0 O-C-N 120.831 -1.168 . . . . 0.0 109.217 172.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -139.83 152.88 46.86 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 120.103 -1.623 . . . . 0.0 112.24 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -89.6 112.1 23.23 Favored 'General case' 0 C--N 1.369 1.416 0 C-N-CA 129.25 3.02 . . . . 0.0 109.514 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.4 ' CE1' ' HE ' ' A' ' 140' ' ' ARG . 69.3 t60 -73.69 159.34 84.68 Favored Pre-proline 0 C--N 1.36 1.027 0 C-N-CA 127.73 2.412 . . . . 0.0 114.716 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -48.97 -1.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.558 1.697 1 C-N-CA 127.077 5.184 . . . . 0.0 119.079 174.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -104.4 35.11 2.83 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 128.305 2.642 . . . . 0.0 107.444 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -68.62 158.14 34.66 Favored 'General case' 0 C--N 1.367 1.331 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -171.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.6 -20.64 27.11 Favored Glycine 0 C--N 1.359 1.855 0 CA-C-N 112.493 -2.14 . . . . 0.0 109.669 171.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -124.58 119.26 28.56 Favored 'General case' 0 N--CA 1.438 -1.05 1 N-CA-C 99.252 -4.351 . . . . 0.0 99.252 164.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.58 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 20.3 p90 -118.83 -3.4 10.76 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.223 -0.923 . . . . 0.0 108.947 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.3 pt -112.77 166.6 6.6 Favored 'Isoleucine or valine' 0 C--N 1.364 1.201 0 C-N-CA 127.367 2.267 . . . . 0.0 112.036 -174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.406 ' HE ' ' HD2' ' A' ' 128' ' ' ARG . 45.6 ttp180 -158.57 147.36 18.77 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 103.871 -2.641 . . . . 0.0 103.871 176.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -145.53 126.76 14.79 Favored 'General case' 0 C--N 1.359 1.017 0 O-C-N 119.568 -1.958 . . . . 0.0 109.11 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -117.97 93.6 4.2 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 127.184 2.193 . . . . 0.0 110.241 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.42 -71.16 0.1 OUTLIER Glycine 0 C--N 1.36 1.88 0 N-CA-C 120.97 3.148 . . . . 0.0 120.97 172.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -143.6 51.2 1.35 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-O 122.648 1.213 . . . . 0.0 111.138 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.5 m -177.3 143.26 0.37 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.5 p -117.17 136.28 54.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.058 0 CA-C-O 122.79 1.281 . . . . 0.0 110.127 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.406 ' HD2' ' HE ' ' A' ' 121' ' ' ARG . 14.7 mtt-85 -113.67 144.46 42.89 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.715 2.806 . . . . 0.0 107.075 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 12.0 m -146.66 162.7 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.58 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 3.2 p-80 -96.58 134.71 39.46 Favored 'General case' 0 C--N 1.363 1.153 0 CA-C-O 123.598 1.666 . . . . 0.0 110.05 172.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 p -125.89 163.64 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 101.599 -3.482 . . . . 0.0 101.599 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.72 33.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -86.28 129.36 34.88 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.014 3.325 . . . . 0.0 110.283 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.9 75.79 2.81 Favored 'General case' 0 C--N 1.371 1.506 0 CA-C-N 120.511 1.505 . . . . 0.0 114.114 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.07 -104.38 0.1 Allowed 'General case' 0 C--N 1.368 1.384 0 C-N-CA 124.678 1.191 . . . . 0.0 108.569 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -107.22 -56.18 2.24 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.987 2.115 . . . . 0.0 113.825 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.83 -44.92 2.41 Favored Pre-proline 0 C--N 1.368 1.401 0 N-CA-C 119.575 3.176 . . . . 0.0 119.575 -172.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -82.05 177.77 32.57 Favored 'Cis proline' 0 CA--C 1.546 1.088 0 CA-C-N 126.492 3.354 . . . . 0.0 114.058 3.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.9 m -94.84 134.56 37.34 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 125.189 1.396 . . . . 0.0 110.717 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.4 ' HE ' ' CE1' ' A' ' 113' ' ' HIS . 5.8 tmm_? -117.31 148.11 41.99 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 125.656 1.583 . . . . 0.0 110.401 177.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -160.47 167.52 35.71 Favored Glycine 0 CA--C 1.486 -1.734 1 N-CA-C 103.035 -4.026 . . . . 0.0 103.035 169.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -88.13 122.01 31.2 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 124.776 2.226 . . . . 0.0 108.329 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.06 168.01 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 129.089 2.955 . . . . 0.0 108.545 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.5 m -91.46 130.12 37.34 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 102.425 -3.176 . . . . 0.0 102.425 168.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.421 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 32.4 ttpt -74.69 -15.58 60.79 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-O 122.921 1.343 . . . . 0.0 114.108 -170.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -72.64 -2.98 22.14 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.701 1.601 . . . . 0.0 115.136 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.6 mt -107.04 10.31 30.33 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 125.187 1.395 . . . . 0.0 110.468 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 11.4 mt -98.96 124.24 43.8 Favored 'General case' 0 C--N 1.374 1.657 0 C-N-CA 125.588 1.555 . . . . 0.0 107.258 174.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -116.24 151.28 46.58 Favored Pre-proline 0 CA--C 1.501 -0.924 0 O-C-N 119.921 -1.737 . . . . 0.0 108.306 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.417 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . 72.5 Cg_endo -81.13 123.73 4.63 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.845 2.364 . . . . 0.0 112.184 -167.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.34 108.5 19.93 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -171.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.1 t -150.42 26.88 0.76 Allowed 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -167.38 80.7 0.1 Allowed Glycine 0 C--N 1.355 1.61 0 C-N-CA 116.061 -2.971 . . . . 0.0 118.862 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.4 t -68.29 -11.9 60.17 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 126.921 2.088 . . . . 0.0 115.988 170.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -122.75 35.0 4.98 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 127.884 2.474 . . . . 0.0 107.645 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.2 t -104.96 142.44 34.78 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 126.316 1.847 . . . . 0.0 106.422 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.27 27.3 ttpt -52.76 -36.91 58.68 Favored 'General case' 0 C--N 1.369 1.442 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -171.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -18.48 61.97 Favored 'General case' 0 C--N 1.37 1.48 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 169.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.66 5.15 49.74 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.257 1.8 pp0? -129.41 -174.95 3.43 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.635 -1.916 . . . . 0.0 110.352 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.3 122.01 15.13 Favored 'General case' 0 C--N 1.368 1.396 0 O-C-N 120.444 -1.41 . . . . 0.0 113.686 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.37 -9.95 61.17 Favored Glycine 0 C--N 1.359 1.839 0 C-N-CA 124.365 0.983 . . . . 0.0 111.674 -167.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.92 160.3 44.63 Favored Glycine 0 C--N 1.366 2.202 0 C-N-CA 125.985 1.755 . . . . 0.0 116.846 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.53 -42.72 74.28 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -174.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.572 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.267 0.1 OUTLIER -99.42 5.06 46.41 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 120.245 -1.534 . . . . 0.0 114.377 -178.936 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -85.61 92.94 8.69 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.164 2.585 . . . . 0.0 114.284 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.4 m -113.86 110.23 19.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 170.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.97 101.5 14.21 Favored 'General case' 0 C--N 1.359 1.014 0 CA-C-O 126.127 2.87 . . . . 0.0 113.486 -170.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -120.47 150.5 52.17 Favored Pre-proline 0 N--CA 1.422 -1.854 1 C-N-CA 133.93 4.892 . . . . 0.0 102.915 171.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -60.41 -32.38 93.8 Favored 'Trans proline' 0 CA--C 1.554 1.478 1 C-N-CA 126.652 4.901 . . . . 0.0 115.037 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -67.27 -35.16 78.93 Favored 'General case' 0 C--N 1.364 1.202 0 C-N-CA 130.059 3.344 . . . . 0.0 113.256 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.0 mm -72.17 -36.2 55.53 Favored 'Isoleucine or valine' 0 C--N 1.372 1.577 0 C-N-CA 127.235 2.214 . . . . 0.0 110.049 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 mt -64.0 -53.83 43.87 Favored 'General case' 0 C--N 1.384 2.066 0 C-N-CA 126.428 1.891 . . . . 0.0 110.882 171.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -57.39 -33.87 68.28 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 129.143 2.977 . . . . 0.0 114.447 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -68.87 -44.67 72.81 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 130.079 3.352 . . . . 0.0 111.617 172.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 37.9 mtm -65.69 -35.74 81.62 Favored 'General case' 0 C--N 1.37 1.473 0 C-N-CA 125.102 1.361 . . . . 0.0 114.456 167.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -74.49 -48.33 27.91 Favored 'General case' 0 C--N 1.378 1.844 0 C-N-CA 125.518 1.527 . . . . 0.0 112.434 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -65.23 -46.54 80.19 Favored 'General case' 0 C--N 1.371 1.51 0 C-N-CA 129.251 3.02 . . . . 0.0 112.705 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.43 84.32 Favored 'General case' 0 C--N 1.375 1.707 0 O-C-N 120.599 -1.313 . . . . 0.0 112.688 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 184' ' ' ASN 0.333 35.3 t70 -64.55 -31.35 72.53 Favored 'General case' 0 C--N 1.378 1.81 0 C-N-CA 125.969 1.708 . . . . 0.0 111.857 175.059 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -76.45 -33.38 58.76 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 118.362 -2.711 . . . . 0.0 113.79 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.24 -36.83 58.31 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 118.64 2.83 . . . . 0.0 118.64 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.1 pp -79.87 -36.45 36.59 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 119.901 -1.749 . . . . 0.0 114.704 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -85.92 -17.78 34.53 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 127.201 2.201 . . . . 0.0 110.839 -176.103 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -117.51 -105.09 0.4 Allowed 'General case' 0 C--N 1.359 1.014 0 CA-C-O 121.791 0.805 . . . . 0.0 110.781 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -129.12 146.93 50.95 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.618 1.199 . . . . 0.0 108.331 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -50.31 -36.19 30.79 Favored 'General case' 0 C--N 1.357 0.924 1 C-N-CA 134.111 4.965 . . . . 0.0 113.826 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 14.9 tt -51.99 -37.18 21.06 Favored 'Isoleucine or valine' 0 C--N 1.37 1.489 0 C-N-CA 128.918 2.887 . . . . 0.0 112.174 171.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.328 2.8 mptp? -64.1 -31.29 72.43 Favored 'General case' 0 C--N 1.371 1.502 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 176.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.575 ' HE ' HD23 ' A' ' 109' ' ' LEU 0.411 0.0 OUTLIER -75.26 -42.2 55.64 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-N 121.327 1.876 . . . . 0.0 112.283 165.132 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.7 tp -57.39 -22.6 43.9 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 129.031 2.932 . . . . 0.0 117.595 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -73.9 -13.13 60.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.997 2.519 . . . . 0.0 113.953 170.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.13 22.76 15.16 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 130.562 3.545 . . . . 0.0 112.093 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.0 118.28 5.63 Favored 'General case' 0 C--N 1.371 1.535 0 C-N-CA 129.574 3.149 . . . . 0.0 116.141 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 10.7 t -72.37 57.08 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.594 0 C-N-CA 128.637 2.775 . . . . 0.0 113.174 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 28.0 p -83.22 -52.01 6.96 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 130.058 3.343 . . . . 0.0 113.94 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . 0.486 1.7 p30 83.28 153.7 0.1 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 130.548 3.539 . . . . 0.0 116.789 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -107.38 147.98 36.28 Favored Pre-proline 0 C--N 1.359 0.985 0 O-C-N 119.839 -1.788 . . . . 0.0 109.188 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.61 98.81 1.24 Allowed 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.993 3.129 . . . . 0.0 112.913 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 91.6 p -79.79 53.54 1.66 Allowed 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.465 1.506 . . . . 0.0 113.491 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 . . . . . 0 C--N 1.356 0.851 0 C-N-CA 126.134 1.774 . . . . 0.0 109.47 -178.293 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 pttt . . . . . 0 N--CA 1.443 -0.783 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.01 -51.34 2.56 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 126.374 1.87 . . . . 0.0 112.511 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -148.98 134.11 18.23 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -102.97 155.66 18.21 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 125.338 1.455 . . . . 0.0 111.279 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.4 tp -106.8 123.73 48.58 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 126.076 1.75 . . . . 0.0 108.576 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.23 -22.06 58.17 Favored 'General case' 0 C--N 1.367 1.369 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.67 -20.79 16.99 Favored Glycine 0 C--N 1.365 2.163 0 C-N-CA 127.633 2.54 . . . . 0.0 115.559 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.13 -128.29 2.56 Favored Glycine 0 CA--C 1.496 -1.095 1 N-CA-C 102.911 -4.076 . . . . 0.0 102.911 -176.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -109.88 121.46 45.28 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 125.099 1.359 . . . . 0.0 109.876 175.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.516 ' HE ' ' H ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -71.51 -24.6 62.0 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 127.574 2.35 . . . . 0.0 115.047 -178.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -169.66 -42.36 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.842 2.057 . . . . 0.0 106.184 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.3 m -175.47 -169.03 0.34 Allowed 'General case' 0 C--N 1.354 0.802 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.353 72.6 t 94.4 112.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.342 0 C-N-CA 128.786 2.834 . . . . 0.0 113.621 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.74 148.99 43.16 Favored Pre-proline 0 C--N 1.358 0.968 0 C-N-CA 126.227 1.811 . . . . 0.0 106.865 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.88 78.87 3.55 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 124.466 3.444 . . . . 0.0 112.856 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.45 -89.93 0.59 Allowed 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.115 0.966 . . . . 0.0 111.213 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.8 112.73 64.39 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.66 90.35 1.28 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.739 2.96 . . . . 0.0 112.058 -171.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -47.01 18.08 0.0 OUTLIER 'General case' 0 C--N 1.363 1.195 1 C-N-CA 133.412 4.685 . . . . 0.0 120.747 -177.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.3 p -148.2 11.22 0.91 Allowed 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.69 -1.256 . . . . 0.0 110.03 176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.407 ' HA ' ' CE2' ' A' ' 90' ' ' PHE . 83.1 p -146.19 71.74 1.27 Allowed 'General case' 0 C--N 1.363 1.181 0 C-N-CA 123.937 0.895 . . . . 0.0 110.046 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.71 72.15 1.26 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 125.306 1.442 . . . . 0.0 108.967 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 59.9 m-85 -116.71 127.11 54.09 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 120.602 -1.311 . . . . 0.0 112.106 -172.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 p -112.0 167.72 8.7 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 127.82 2.448 . . . . 0.0 117.113 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -54.39 129.11 32.97 Favored 'Trans proline' 0 C--N 1.371 1.725 1 C-N-CA 126.943 5.096 . . . . 0.0 116.779 -176.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.8 -16.17 58.85 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 125.418 1.485 . . . . 0.0 112.68 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -92.71 154.3 18.41 Favored 'General case' 0 C--N 1.367 1.36 0 CA-C-N 119.71 1.755 . . . . 0.0 110.859 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.639 HD11 HH21 ' A' ' 190' ' ' ARG . 3.3 mm? -98.44 144.61 27.61 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 119.303 -2.123 . . . . 0.0 109.047 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.1 m -136.8 158.17 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 C-N-CA 125.333 1.453 . . . . 0.0 109.994 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -105.76 119.82 40.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 101.035 -3.691 . . . . 0.0 101.035 167.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.82 144.47 34.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.337 1.855 . . . . 0.0 113.388 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -120.22 135.81 54.86 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.2 ttp -128.63 144.41 51.15 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 119.526 -1.983 . . . . 0.0 108.833 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -64.7 94.64 0.13 Allowed 'General case' 0 C--N 1.368 1.386 0 C-N-CA 126.445 1.898 . . . . 0.0 115.22 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.57 -5.12 24.64 Favored Glycine 0 C--N 1.359 1.817 0 C-N-CA 126.392 1.949 . . . . 0.0 113.01 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -104.64 159.98 27.52 Favored Pre-proline 0 C--N 1.357 0.913 0 C-N-CA 126.001 1.72 . . . . 0.0 109.967 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.44 166.63 29.25 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 123.682 2.921 . . . . 0.0 112.221 162.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.536 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.6 m95 -59.72 123.92 18.49 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 127.644 2.378 . . . . 0.0 114.799 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -127.27 108.54 21.39 Favored Pre-proline 0 N--CA 1.433 -1.305 1 N-CA-C 122.013 4.079 . . . . 0.0 122.013 -168.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.22 133.49 46.94 Favored 'Trans proline' 0 C--N 1.39 2.741 1 C-N-CA 125.968 4.446 . . . . 0.0 111.366 165.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.5 p -155.81 163.68 39.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 125.011 2.339 . . . . 0.0 115.743 -157.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.407 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 5.1 tt -101.06 129.99 47.01 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 129.172 2.989 . . . . 0.0 108.151 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.49 ' H ' HH22 ' A' ' 190' ' ' ARG . 31.2 t -87.49 118.81 34.07 Favored 'Isoleucine or valine' 0 C--N 1.378 1.846 0 CA-C-N 120.722 1.601 . . . . 0.0 107.007 173.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -116.57 154.16 30.95 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -164.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -119.4 112.67 19.7 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -83.44 159.09 62.34 Favored Pre-proline 0 C--N 1.348 0.528 0 C-N-CA 129.879 3.271 . . . . 0.0 110.647 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.32 0.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.799 1 C-N-CA 128.632 6.222 . . . . 0.0 119.973 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -95.21 28.2 2.94 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 131.191 3.796 . . . . 0.0 107.249 166.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.271 0.0 OUTLIER -73.79 161.07 30.59 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 127.185 2.194 . . . . 0.0 115.945 -173.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.95 -20.26 36.41 Favored Glycine 0 C--N 1.362 2.002 0 C-N-CA 126.666 2.079 . . . . 0.0 111.33 -174.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 p -135.87 136.18 40.34 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 130.681 3.592 . . . . 0.0 103.087 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -132.79 -3.75 3.24 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 120.206 1.366 . . . . 0.0 113.293 -175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.3 pt -110.73 150.38 13.23 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 123.073 1.416 . . . . 0.0 111.324 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.91 141.82 36.5 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 128.041 2.536 . . . . 0.0 104.227 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -145.67 126.6 14.51 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 120.939 -1.1 . . . . 0.0 109.013 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -109.42 93.55 4.56 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.33 -63.06 1.41 Allowed Glycine 0 C--N 1.362 2.011 0 C-N-CA 127.829 2.633 . . . . 0.0 115.852 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -144.64 -5.41 0.73 Allowed 'General case' 0 C--N 1.352 0.683 0 C-N-CA 127.736 2.414 . . . . 0.0 110.227 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.0 m -82.34 73.77 9.36 Favored 'General case' 0 C--N 1.372 1.551 0 O-C-N 118.944 -2.348 . . . . 0.0 110.306 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.56 111.15 21.58 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 C-N-CA 129.228 3.011 . . . . 0.0 110.594 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -117.34 146.82 43.13 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 111.287 -2.688 . . . . 0.0 112.874 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.86 162.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 127.74 2.416 . . . . 0.0 106.426 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.02 138.43 32.45 Favored 'General case' 0 C--N 1.379 1.889 0 O-C-N 117.975 -2.953 . . . . 0.0 111.112 171.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 m -151.9 169.91 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.478 -1.807 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -149.09 151.13 33.91 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 122.138 0.97 . . . . 0.0 109.695 170.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -104.14 122.13 44.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 128.972 2.909 . . . . 0.0 107.97 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.407 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 51.0 m-85 -71.38 62.29 0.35 Allowed 'General case' 0 C--N 1.378 1.837 0 C-N-CA 127.317 2.247 . . . . 0.0 112.136 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -90.33 -114.2 0.07 Allowed 'General case' 0 C--N 1.362 1.151 0 C-N-CA 129.986 3.314 . . . . 0.0 111.531 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -106.53 -45.1 4.33 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 125.723 1.609 . . . . 0.0 112.031 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -81.6 -40.45 1.02 Allowed Pre-proline 0 C--N 1.36 1.055 0 N-CA-C 118.44 2.756 . . . . 0.0 118.44 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.91 159.57 97.79 Favored 'Cis proline' 0 C--N 1.361 1.189 0 CA-C-N 126.202 3.251 . . . . 0.0 109.864 -3.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.9 p -87.88 119.37 28.16 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 119.009 -2.307 . . . . 0.0 112.046 -175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -109.92 152.93 25.2 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 125.877 1.671 . . . . 0.0 107.623 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.35 177.31 37.72 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 104.084 -3.606 . . . . 0.0 104.084 165.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -92.26 109.06 20.43 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 103.12 -2.918 . . . . 0.0 103.12 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.5 m -96.32 164.6 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 C-N-CA 125.466 1.507 . . . . 0.0 111.511 -171.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 m -77.42 109.85 11.69 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.97 2.108 . . . . 0.0 106.305 172.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.503 0.0 OUTLIER -70.72 -10.27 59.07 Favored 'General case' 0 C--N 1.37 1.496 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -169.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 31.5 ptt-85 -75.44 -14.68 60.46 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 129.214 3.006 . . . . 0.0 114.193 170.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -100.47 0.82 40.39 Favored 'General case' 0 C--N 1.365 1.281 0 C-N-CA 126.859 2.064 . . . . 0.0 110.263 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 49.1 mt -96.28 124.88 40.44 Favored 'General case' 0 C--N 1.368 1.412 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 172.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -114.6 161.74 27.18 Favored Pre-proline 0 CA--C 1.506 -0.718 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.14 149.78 22.47 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 CA-C-N 125.332 2.94 . . . . 0.0 112.463 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -113.28 153.05 29.07 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.8 t -179.61 -32.39 0.01 OUTLIER 'General case' 0 C--N 1.352 0.684 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.77 113.77 0.89 Allowed Glycine 0 C--N 1.355 1.638 0 O-C-N 121.029 -1.044 . . . . 0.0 115.354 -173.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -11.96 59.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 131.0 3.72 . . . . 0.0 112.271 171.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.78 -8.14 35.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 131.241 3.816 . . . . 0.0 111.794 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.8 m -58.09 136.06 57.12 Favored 'General case' 0 C--N 1.385 2.147 0 C-N-CA 126.172 1.789 . . . . 0.0 112.032 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.303 33.6 tttp -54.59 -31.75 57.48 Favored 'General case' 0 C--N 1.368 1.378 0 CA-C-N 122.445 2.384 . . . . 0.0 117.317 -173.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -74.7 -19.34 60.29 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 126.519 1.927 . . . . 0.0 112.835 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.59 1.68 55.63 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 126.359 1.864 . . . . 0.0 112.801 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -132.15 -176.48 4.08 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 119.898 -1.751 . . . . 0.0 112.908 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -63.66 122.13 15.61 Favored 'General case' 0 C--N 1.371 1.525 0 C-N-CA 126.037 1.735 . . . . 0.0 114.209 -177.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.06 -7.92 60.72 Favored Glycine 0 C--N 1.357 1.748 0 C-N-CA 124.533 1.063 . . . . 0.0 111.615 -167.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.7 145.92 20.4 Favored Glycine 0 C--N 1.364 2.133 0 N-CA-C 120.303 2.881 . . . . 0.0 120.303 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -53.85 -42.05 68.11 Favored 'General case' 0 C--N 1.364 1.198 0 C-N-CA 129.448 3.099 . . . . 0.0 119.04 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.536 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.387 0.6 OUTLIER -102.68 -10.59 19.08 Favored 'General case' 0 C--N 1.366 1.314 0 CA-C-N 119.945 1.248 . . . . 0.0 113.104 179.032 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -73.35 92.98 1.87 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 126.383 1.873 . . . . 0.0 113.457 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 72.6 m -113.84 107.36 15.61 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 101.193 -3.632 . . . . 0.0 101.193 173.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.19 101.28 13.68 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-O 125.616 2.627 . . . . 0.0 115.463 -166.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -121.4 153.15 58.7 Favored Pre-proline 0 N--CA 1.419 -1.992 1 C-N-CA 132.848 4.459 . . . . 0.0 104.946 170.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.89 -42.18 69.68 Favored 'Trans proline' 0 C--N 1.347 0.462 1 C-N-CA 126.154 4.569 . . . . 0.0 115.725 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -59.72 -35.26 74.18 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 129.446 3.098 . . . . 0.0 114.006 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 16.8 mm -72.35 -43.46 64.5 Favored 'Isoleucine or valine' 0 C--N 1.372 1.559 0 C-N-CA 125.792 1.637 . . . . 0.0 110.569 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.72 -47.34 66.6 Favored 'General case' 0 C--N 1.372 1.578 0 O-C-N 120.101 -1.625 . . . . 0.0 113.65 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -58.82 -35.23 72.53 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 126.665 1.986 . . . . 0.0 116.172 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.73 -36.71 76.09 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 127.758 2.423 . . . . 0.0 110.94 173.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.2 mtt -69.32 -35.62 76.12 Favored 'General case' 0 C--N 1.378 1.831 0 CA-C-O 116.707 -1.616 . . . . 0.0 113.729 167.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.06 -48.99 55.58 Favored 'General case' 0 C--N 1.377 1.802 0 C-N-CA 127.335 2.254 . . . . 0.0 111.732 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.62 -47.9 71.19 Favored 'General case' 0 C--N 1.371 1.529 0 C-N-CA 128.6 2.76 . . . . 0.0 112.19 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.27 71.13 Favored 'General case' 0 C--N 1.375 1.676 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 170.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.87 -50.1 70.13 Favored 'General case' 0 C--N 1.375 1.694 0 O-C-N 120.212 -1.555 . . . . 0.0 110.363 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -33.72 71.62 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 173.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -73.42 -38.83 65.41 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.46 -38.58 34.24 Favored 'General case' 0 C--N 1.373 1.618 0 C-N-CA 125.986 1.714 . . . . 0.0 113.501 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.298 0.0 OUTLIER -87.58 -16.67 33.89 Favored 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.848 1.659 . . . . 0.0 110.901 -172.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -117.02 -106.96 0.38 Allowed 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -135.86 156.04 49.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.972 1.368 . . . . 0.0 109.564 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -51.24 -35.33 36.44 Favored 'General case' 0 C--N 1.36 1.053 1 C-N-CA 134.275 5.03 . . . . 0.0 113.932 175.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.7 tp -50.9 -31.17 9.93 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 C-N-CA 129.933 3.293 . . . . 0.0 112.458 172.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -73.04 -37.08 67.01 Favored 'General case' 0 C--N 1.377 1.766 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.639 HH21 HD11 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -75.2 -42.94 54.51 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 172.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.326 54.2 mt -73.36 -19.25 61.05 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 126.48 1.912 . . . . 0.0 113.304 -177.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.31 -37.73 67.76 Favored 'General case' 0 C--N 1.373 1.619 0 C-N-CA 128.654 2.782 . . . . 0.0 114.735 164.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.14 -45.66 5.83 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 128.705 2.802 . . . . 0.0 108.779 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 71.19 -86.07 0.03 OUTLIER 'General case' 0 C--N 1.363 1.187 0 C-N-CA 130.094 3.358 . . . . 0.0 115.782 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.78 11.52 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 128.93 2.892 . . . . 0.0 107.917 177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.328 66.5 m 76.04 66.7 0.06 Allowed 'General case' 0 C--N 1.359 0.994 0 C-N-CA 131.192 3.797 . . . . 0.0 112.417 -176.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -88.81 145.07 25.81 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.632 1.573 . . . . 0.0 111.181 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . 0.298 5.0 mp0 88.48 160.91 0.09 OUTLIER Pre-proline 0 C--N 1.368 1.398 0 C-N-CA 129.484 3.113 . . . . 0.0 111.975 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -68.88 66.28 1.28 Allowed 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 124.699 3.599 . . . . 0.0 117.428 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.377 88.5 p 102.8 -24.99 0.02 OUTLIER 'General case' 0 C--N 1.365 1.243 0 C-N-CA 130.229 3.412 . . . . 0.0 112.816 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 . . . . . 0 C--N 1.359 0.992 0 C-N-CA 126.496 1.919 . . . . 0.0 112.318 179.772 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.422 ' HB3' ' HZ3' ' A' ' 68' ' ' LYS . 9.0 mtpm? . . . . . 0 N--CA 1.443 -0.791 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.69 35.83 2.66 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 125.402 1.481 . . . . 0.0 110.754 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -86.49 71.23 10.46 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 119.813 -1.804 . . . . 0.0 113.632 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.93 119.38 38.75 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.951 1.7 . . . . 0.0 110.041 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.56 142.92 19.43 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 102.464 -3.162 . . . . 0.0 102.464 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -122.75 20.7 10.14 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 119.33 0.968 . . . . 0.0 112.306 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.42 -21.78 43.79 Favored Glycine 0 C--N 1.362 1.994 0 C-N-CA 127.154 2.311 . . . . 0.0 116.648 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -37.46 -78.99 0.04 OUTLIER Glycine 0 C--N 1.368 2.348 0 C-N-CA 130.253 3.787 . . . . 0.0 119.618 -178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.48 -13.1 55.41 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 120.933 -1.334 . . . . 0.0 113.448 174.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -72.39 -52.45 15.93 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.099 2.56 . . . . 0.0 116.418 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -139.46 -28.8 0.76 Allowed 'General case' 0 C--N 1.354 0.787 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.324 97.1 p 105.9 -107.16 0.0 OUTLIER 'General case' 0 C--N 1.364 1.239 0 C-N-CA 129.675 3.19 . . . . 0.0 107.958 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 t -119.68 -64.89 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.896 0 C-N-CA 125.335 1.454 . . . . 0.0 108.129 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.492 ' HB3' ' HZ2' ' A' ' 149' ' ' LYS . . . -135.39 139.57 31.79 Favored Pre-proline 0 C--N 1.354 0.765 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.03 64.98 8.37 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 124.7 3.6 . . . . 0.0 113.475 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.05 -115.71 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.97 117.26 58.08 Favored Pre-proline 0 C--N 1.353 0.76 0 C-N-CA 124.973 1.309 . . . . 0.0 108.957 174.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.37 56.39 5.74 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.278 3.319 . . . . 0.0 111.679 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.1 p -115.96 54.86 0.81 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.703 1.601 . . . . 0.0 112.182 -173.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . 0.265 1.1 t 74.04 -172.0 0.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 119.68 3.215 . . . . 0.0 119.68 175.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.3 p -151.39 79.96 1.29 Allowed 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.491 -1.381 . . . . 0.0 110.584 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -150.57 81.45 1.35 Allowed 'General case' 0 C--N 1.361 1.107 0 C-N-CA 124.71 1.204 . . . . 0.0 111.066 -173.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -118.23 126.92 53.16 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.361 -1.462 . . . . 0.0 111.02 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.6 p -112.28 167.14 9.6 Favored Pre-proline 0 C--N 1.366 1.29 0 C-N-CA 127.347 2.259 . . . . 0.0 116.808 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -48.46 127.88 16.73 Favored 'Trans proline' 0 C--N 1.389 2.665 1 C-N-CA 127.151 5.234 . . . . 0.0 116.619 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.438 ' HA2' HH11 ' A' ' 190' ' ' ARG . . . 96.74 1.15 60.24 Favored Glycine 0 C--N 1.357 1.713 0 C-N-CA 124.103 0.858 . . . . 0.0 112.668 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -94.8 169.2 10.32 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 170.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -113.82 147.49 38.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 101.751 -3.426 . . . . 0.0 101.751 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.41 167.15 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 -174.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -112.26 117.75 33.37 Favored 'General case' 0 N--CA 1.437 -1.105 1 N-CA-C 95.796 -5.631 . . . . 0.0 95.796 166.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.56 131.94 52.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -106.8 136.07 47.26 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 118.221 -2.8 . . . . 0.0 106.014 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 40.9 ttm -123.27 145.02 49.03 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 119.827 -1.796 . . . . 0.0 108.578 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.41 96.43 0.08 Allowed 'General case' 0 C--N 1.367 1.356 0 C-N-CA 127.469 2.307 . . . . 0.0 114.418 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.44 -6.29 24.73 Favored Glycine 0 C--N 1.359 1.851 0 C-N-CA 125.685 1.612 . . . . 0.0 113.257 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -106.67 162.07 20.87 Favored Pre-proline 0 C--N 1.355 0.812 0 C-N-CA 125.713 1.605 . . . . 0.0 109.555 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.88 166.6 29.05 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.129 3.219 . . . . 0.0 112.483 164.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -59.88 121.06 10.81 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 126.589 1.956 . . . . 0.0 114.238 170.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -125.09 116.77 25.77 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 -172.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -57.42 127.16 24.38 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.865 3.71 . . . . 0.0 110.227 160.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.7 t -138.71 165.73 26.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 130.11 3.364 . . . . 0.0 111.535 -153.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 1.9 tt -130.07 131.63 45.85 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 119.82 -1.8 . . . . 0.0 106.285 176.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.84 119.36 39.09 Favored 'Isoleucine or valine' 0 C--N 1.373 1.63 0 CA-C-N 120.072 1.306 . . . . 0.0 108.942 172.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 153.58 39.81 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -165.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -90.89 113.5 25.71 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.903 2.081 . . . . 0.0 111.04 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.533 ' CD2' ' CG ' ' A' ' 130' ' ' HIS . 5.3 m-70 -67.79 162.22 60.07 Favored Pre-proline 0 C--N 1.36 1.055 0 C-N-CA 129.55 3.14 . . . . 0.0 113.461 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.25 -7.79 0.86 Allowed 'Trans proline' 0 CA--C 1.563 1.932 1 C-N-CA 125.419 4.079 . . . . 0.0 117.044 169.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.83 35.12 3.0 Favored 'General case' 0 C--N 1.358 0.949 1 C-N-CA 132.153 4.181 . . . . 0.0 107.84 173.067 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.54 149.43 43.05 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 -172.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.47 -19.96 50.79 Favored Glycine 0 C--N 1.362 1.99 0 C-N-CA 125.962 1.744 . . . . 0.0 112.011 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.92 119.96 36.42 Favored 'General case' 0 N--CA 1.447 -0.616 1 C-N-CA 132.864 4.466 . . . . 0.0 102.369 174.186 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.485 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 22.2 p90 -151.0 -2.11 0.35 Allowed 'General case' 0 C--N 1.353 0.739 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -174.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.6 pt -106.14 169.16 2.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 O-C-N 119.354 -2.091 . . . . 0.0 113.143 -175.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -159.3 153.58 23.84 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 174.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.87 127.04 8.43 Favored 'General case' 0 C--N 1.368 1.386 0 CA-C-N 123.097 2.68 . . . . 0.0 114.391 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.553 ' HG2' HH12 ' A' ' 128' ' ' ARG . 75.6 mmtt -116.81 93.42 4.19 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 120.493 -1.379 . . . . 0.0 108.223 174.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.21 -78.11 0.23 Allowed Glycine 0 C--N 1.363 2.056 0 C-N-CA 128.027 2.727 . . . . 0.0 116.287 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -118.81 -16.11 9.34 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 128.192 2.597 . . . . 0.0 109.015 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.6 m -84.41 75.24 10.26 Favored 'General case' 0 C--N 1.367 1.342 0 O-C-N 118.326 -2.734 . . . . 0.0 110.649 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 p -89.22 112.89 24.89 Favored 'Isoleucine or valine' 0 C--N 1.363 1.171 0 C-N-CA 127.789 2.435 . . . . 0.0 107.563 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.553 HH12 ' HG2' ' A' ' 123' ' ' LYS . 65.3 mtt85 -104.6 157.2 17.34 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 124.893 1.277 . . . . 0.0 111.952 -171.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.2 m -149.23 164.25 4.1 Favored 'Isoleucine or valine' 0 C--N 1.367 1.369 1 C-N-CA 132.053 4.141 . . . . 0.0 103.848 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.533 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 4.4 m170 -90.3 116.19 28.08 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 118.9 -2.375 . . . . 0.0 114.485 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . 0.276 2.3 m -143.33 156.65 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 O-C-N 119.016 -2.303 . . . . 0.0 111.587 177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -112.72 153.96 26.9 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 111.635 -2.53 . . . . 0.0 111.271 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.17 116.11 27.83 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 129.13 2.972 . . . . 0.0 103.012 -174.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 15.0 m-85 -71.85 65.78 0.54 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.859 2.064 . . . . 0.0 113.37 -175.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -92.11 -119.07 0.08 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 126.898 2.079 . . . . 0.0 110.408 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.85 -52.84 2.7 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.188 1.395 . . . . 0.0 112.93 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.4 m -71.07 -44.5 14.12 Favored Pre-proline 0 C--N 1.362 1.127 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.11 -174.71 12.51 Favored 'Cis proline' 0 CA--C 1.541 0.866 0 CA-C-N 126.973 3.526 . . . . 0.0 112.257 -2.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.5 m -95.23 123.78 38.92 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.104 1.362 . . . . 0.0 109.347 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.2 tmm_? -147.47 151.44 36.4 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 120.78 1.627 . . . . 0.0 108.503 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.62 -155.48 12.92 Favored Glycine 0 CA--C 1.489 -1.583 1 N-CA-C 98.502 -5.839 . . . . 0.0 98.502 174.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -89.17 160.33 17.04 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 119.975 1.887 . . . . 0.0 110.479 172.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.53 171.21 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 O-C-N 120.455 -1.403 . . . . 0.0 109.773 174.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.1 m -100.05 116.4 32.0 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.423 11.4 pttt -68.35 -6.41 24.12 Favored 'General case' 0 C--N 1.366 1.29 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 -172.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -70.75 -15.37 62.68 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.474 1.109 . . . . 0.0 113.536 170.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.2 mt -100.41 2.9 42.74 Favored 'General case' 0 C--N 1.37 1.457 0 C-N-CA 126.693 1.997 . . . . 0.0 112.471 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.7 mp -94.92 124.47 38.99 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 128.351 2.661 . . . . 0.0 108.771 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.492 ' HZ2' ' HB3' ' A' ' 81' ' ' ALA . 33.1 mtmt -118.13 154.16 51.59 Favored Pre-proline 0 CA--C 1.497 -1.058 0 C-N-CA 125.932 1.693 . . . . 0.0 107.664 178.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -78.42 153.52 27.35 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.614 2.209 . . . . 0.0 115.451 -166.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' A' ' 183' ' ' LEU 0.311 0.0 OUTLIER -17.94 -107.29 0.0 OUTLIER 'General case' 0 C--N 1.354 0.804 2 C-N-CA 132.681 4.392 . . . . 0.0 122.551 174.747 . . . . . . . . 5 4 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.326 12.4 t 47.41 -36.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 1 C-N-CA 132.616 4.366 . . . . 0.0 119.86 -179.526 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 67.55 -148.67 49.97 Favored Glycine 0 C--N 1.35 1.351 0 C-N-CA 128.129 2.776 . . . . 0.0 119.773 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 m -46.39 -23.75 0.4 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 130.232 3.413 . . . . 0.0 119.342 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -85.62 -8.45 58.24 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.542 1.937 . . . . 0.0 113.161 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 t -85.31 155.85 21.17 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-O 123.029 1.395 . . . . 0.0 112.597 173.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -68.49 -32.74 72.94 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 127.034 2.134 . . . . 0.0 112.751 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.72 -11.87 60.08 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 125.257 1.423 . . . . 0.0 111.488 171.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.66 3.75 42.7 Favored 'General case' 0 C--N 1.371 1.522 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.257 0.9 OUTLIER -122.94 173.38 7.83 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 125.689 1.596 . . . . 0.0 109.408 174.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -61.53 122.64 15.75 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 126.567 1.947 . . . . 0.0 114.449 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.32 -14.01 51.35 Favored Glycine 0 C--N 1.358 1.757 0 C-N-CA 124.947 1.261 . . . . 0.0 111.076 -167.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.98 155.52 31.72 Favored Glycine 0 C--N 1.36 1.882 0 N-CA-C 117.186 1.634 . . . . 0.0 117.186 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -58.46 -41.59 85.53 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 120.953 3.686 . . . . 0.0 120.953 -174.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . 0.273 0.1 OUTLIER -102.2 23.32 11.83 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 122.266 2.303 . . . . 0.0 111.785 -179.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -93.17 161.32 14.47 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 124.674 2.178 . . . . 0.0 116.671 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 m 170.65 175.99 0.06 Allowed 'General case' 0 C--N 1.354 0.778 1 N-CA-C 98.554 -4.61 . . . . 0.0 98.554 -178.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -137.77 102.25 4.68 Favored 'General case' 0 C--N 1.364 1.219 0 CA-C-N 124.551 3.341 . . . . 0.0 111.286 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -119.88 141.97 32.32 Favored Pre-proline 0 N--CA 1.433 -1.279 0 C-N-CA 130.116 3.366 . . . . 0.0 105.041 173.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -58.37 -31.82 94.78 Favored 'Trans proline' 0 C--N 1.364 1.386 1 C-N-CA 127.678 5.586 . . . . 0.0 115.074 177.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -69.79 -35.97 75.3 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 130.332 3.453 . . . . 0.0 113.393 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.4 mm -70.33 -36.21 66.02 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 C-N-CA 127.17 2.188 . . . . 0.0 109.132 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.1 mt -62.73 -53.67 50.79 Favored 'General case' 0 C--N 1.382 1.982 0 C-N-CA 126.226 1.81 . . . . 0.0 111.045 173.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -57.26 -34.22 68.4 Favored 'General case' 0 C--N 1.373 1.613 0 C-N-CA 128.968 2.907 . . . . 0.0 114.374 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.0 -47.83 73.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 130.225 3.41 . . . . 0.0 111.718 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 36.3 mtt -68.45 -33.38 74.08 Favored 'General case' 0 C--N 1.369 1.423 0 CA-C-O 118.069 -0.967 . . . . 0.0 113.547 170.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -74.32 -43.71 55.61 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 126.366 1.866 . . . . 0.0 112.027 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -68.31 -47.96 66.21 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 129.116 2.966 . . . . 0.0 111.147 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.06 87.42 Favored 'General case' 0 C--N 1.382 2.015 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 170.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.257 23.1 t70 -54.5 -47.44 73.07 Favored 'General case' 0 C--N 1.376 1.753 0 C-N-CA 127.17 2.188 . . . . 0.0 114.161 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -66.0 -43.0 89.01 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-N 120.8 1.636 . . . . 0.0 115.366 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 190' ' ' ARG . . . -76.12 -29.05 57.7 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.5 pp -80.0 -32.58 39.71 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 175.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.277 0.4 OUTLIER -89.68 -34.28 16.31 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 125.393 1.477 . . . . 0.0 111.199 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -100.48 -99.61 0.25 Allowed 'General case' 0 C--N 1.362 1.151 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -135.49 152.22 51.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.223 -1.548 . . . . 0.0 110.27 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.431 16.4 ptpt -50.92 -33.31 23.79 Favored 'General case' 0 C--N 1.358 0.967 1 C-N-CA 133.193 4.597 . . . . 0.0 113.898 172.222 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.497 HG21 ' HZ2' ' A' ' 189' ' ' LYS . 13.5 tt -50.6 -27.97 5.25 Favored 'Isoleucine or valine' 0 C--N 1.368 1.393 0 C-N-CA 127.923 2.489 . . . . 0.0 113.032 172.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.497 ' HZ2' HG21 ' A' ' 188' ' ' ILE . 2.4 mptp? -72.72 -39.27 67.08 Favored 'General case' 0 C--N 1.377 1.764 0 C-N-CA 126.343 1.857 . . . . 0.0 114.75 170.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.438 HH11 ' HA2' ' A' ' 93' ' ' GLY 0.283 0.0 OUTLIER -74.68 -34.41 62.66 Favored 'General case' 0 C--N 1.367 1.362 0 O-C-N 119.286 -2.134 . . . . 0.0 114.859 172.871 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.8 -22.45 56.34 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 126.323 1.849 . . . . 0.0 112.901 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.26 -46.15 86.53 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 126.478 1.911 . . . . 0.0 114.309 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . 0.264 0.2 OUTLIER -105.56 22.14 16.0 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 128.208 2.603 . . . . 0.0 112.922 176.201 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -49.59 141.81 9.05 Favored 'General case' 0 C--N 1.374 1.663 0 C-N-CA 128.991 2.916 . . . . 0.0 118.823 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.368 5.3 p -83.96 48.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.657 0 CA-C-O 125.636 2.636 . . . . 0.0 114.966 176.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 31.3 p -115.7 60.97 0.7 Allowed 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.68 2.792 . . . . 0.0 104.692 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -95.61 139.8 31.35 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 127.571 2.349 . . . . 0.0 116.336 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -143.13 157.87 59.62 Favored Pre-proline 0 C--N 1.357 0.918 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.57 66.64 8.52 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 124.701 3.601 . . . . 0.0 112.299 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.0 t -127.69 33.11 4.86 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.958 1.703 . . . . 0.0 109.933 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.353 0.728 0 C-N-CA 123.487 0.715 . . . . 0.0 109.93 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.67 -46.69 3.03 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.499 1.92 . . . . 0.0 111.51 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -151.83 115.13 4.76 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 120.806 -1.184 . . . . 0.0 108.176 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -102.58 120.9 41.35 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 126.512 1.925 . . . . 0.0 106.546 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.38 66.86 0.19 Allowed 'General case' 0 C--N 1.362 1.126 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 -173.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -84.42 -30.8 25.05 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 129.225 3.01 . . . . 0.0 109.425 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.03 4.43 47.97 Favored Glycine 0 C--N 1.361 1.932 0 C-N-CA 126.647 2.07 . . . . 0.0 113.79 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.63 -28.81 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.297 0 O-C-N 121.169 -1.195 . . . . 0.0 111.46 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 tp 69.58 -92.84 0.03 OUTLIER 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.052 3.341 . . . . 0.0 112.421 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -71.96 -23.87 61.51 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 131.548 3.939 . . . . 0.0 112.604 173.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . 0.28 10.0 tpp180 103.62 48.72 0.0 OUTLIER 'General case' 0 C--N 1.36 1.037 0 C-N-CA 131.06 3.744 . . . . 0.0 109.652 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.8 t 77.21 173.6 0.21 Allowed 'General case' 0 C--N 1.369 1.447 0 C-N-CA 128.647 2.779 . . . . 0.0 116.155 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.6 m -123.98 -2.31 6.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 128.382 2.673 . . . . 0.0 108.6 173.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.56 115.13 29.85 Favored Pre-proline 0 C--N 1.362 1.135 0 C-N-CA 126.105 1.762 . . . . 0.0 108.33 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.84 114.3 1.97 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.33 3.353 . . . . 0.0 111.891 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -139.68 -108.26 0.16 Allowed 'General case' 0 C--N 1.352 0.7 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.8 119.46 52.39 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 116.177 -1.868 . . . . 0.0 106.334 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.33 91.53 0.33 Allowed 'Trans proline' 0 C--N 1.367 1.508 1 C-N-CA 125.615 4.21 . . . . 0.0 112.433 -172.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.8 p -139.73 -97.54 0.16 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.654 1.982 . . . . 0.0 110.145 -170.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 t -176.6 -172.62 0.46 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 126.817 2.047 . . . . 0.0 106.988 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.7 m -166.48 36.65 0.04 OUTLIER 'General case' 0 C--N 1.353 0.753 0 O-C-N 120.49 -1.381 . . . . 0.0 110.287 172.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -97.61 99.88 11.27 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -124.42 126.51 46.06 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 124.431 1.093 . . . . 0.0 112.393 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.345 88.8 p -112.12 170.86 4.83 Favored Pre-proline 0 CA--C 1.558 1.279 1 C-N-CA 133.022 4.529 . . . . 0.0 116.524 -177.18 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -41.69 128.55 3.71 Favored 'Trans proline' 0 C--N 1.389 2.691 1 C-N-CA 127.927 5.751 . . . . 0.0 118.879 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.08 4.38 78.25 Favored Glycine 0 CA--C 1.477 -2.314 0 C-N-CA 129.382 3.372 . . . . 0.0 117.223 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -93.59 148.57 21.97 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 168.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.97 126.31 52.96 Favored 'General case' 0 N--CA 1.441 -0.902 1 N-CA-C 99.834 -4.135 . . . . 0.0 99.834 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.3 154.93 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -99.9 122.15 42.4 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 101.832 -3.396 . . . . 0.0 101.832 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.97 131.12 55.36 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 127.831 2.452 . . . . 0.0 110.77 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.87 135.85 49.39 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 174.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.0 ttp -130.08 153.55 48.36 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 119.946 -1.721 . . . . 0.0 112.098 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -63.22 90.25 0.04 OUTLIER 'General case' 0 C--N 1.364 1.224 0 C-N-CA 129.206 3.002 . . . . 0.0 114.734 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.46 -0.77 24.99 Favored Glycine 0 C--N 1.358 1.804 0 C-N-CA 125.786 1.66 . . . . 0.0 113.028 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -108.25 161.39 23.58 Favored Pre-proline 0 C--N 1.357 0.911 0 C-N-CA 125.366 1.466 . . . . 0.0 110.296 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.48 166.49 29.2 Favored 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 124.976 3.784 . . . . 0.0 111.65 164.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.6 121.53 16.62 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 126.454 1.902 . . . . 0.0 109.557 173.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.282 0.8 OUTLIER -128.64 135.16 27.16 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 119.267 3.062 . . . . 0.0 119.267 -167.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.51 149.19 90.75 Favored 'Trans proline' 0 CA--C 1.567 2.154 0 C-N-CA 124.722 3.615 . . . . 0.0 113.763 153.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 p -155.34 161.91 40.95 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 125.554 1.541 . . . . 0.0 112.464 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.455 ' CD2' ' HB2' ' A' ' 190' ' ' ARG . 2.3 pp -115.7 137.16 52.36 Favored 'General case' 0 C--N 1.374 1.66 0 O-C-N 120.386 -1.446 . . . . 0.0 110.594 171.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.436 HG11 HG12 ' A' ' 131' ' ' VAL . 2.2 t -93.86 118.97 40.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 C-N-CA 125.603 1.561 . . . . 0.0 109.141 170.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 109' ' ' LEU 0.288 0.1 OUTLIER -137.81 155.62 48.81 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 128.481 2.713 . . . . 0.0 110.747 -177.746 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -71.42 113.63 8.66 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 125.588 1.555 . . . . 0.0 113.105 170.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -89.59 159.0 44.76 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 113.798 -3.001 . . . . 0.0 106.631 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.288 46.4 Cg_exo -47.99 -0.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 2 C-N-CA 127.361 5.374 . . . . 0.0 122.745 -166.239 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -82.29 -26.17 33.34 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 128.15 2.58 . . . . 0.0 109.926 167.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 27.47 95.11 0.0 OUTLIER 'General case' 0 C--N 1.37 1.466 1 C-N-CA 135.226 5.41 . . . . 0.0 121.2 178.375 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.67 -20.85 26.68 Favored Glycine 0 C--N 1.357 1.699 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 39.9 m -107.67 118.16 36.0 Favored 'General case' 0 C--N 1.357 0.905 1 N-CA-C 98.954 -4.461 . . . . 0.0 98.954 165.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -147.35 0.82 0.71 Allowed 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.996 -1.065 . . . . 0.0 111.442 -171.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 17.4 pt -109.9 156.97 10.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 CA-C-O 121.97 0.891 . . . . 0.0 110.614 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -149.85 152.19 34.72 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.23 131.39 19.42 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 120.352 -1.468 . . . . 0.0 110.539 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -117.94 93.52 4.17 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.687 1.995 . . . . 0.0 110.558 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.38 -83.24 0.44 Allowed Glycine 0 C--N 1.362 2.002 0 N-CA-C 119.247 2.459 . . . . 0.0 119.247 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -138.32 52.77 1.82 Allowed 'General case' 0 C--N 1.36 1.025 0 C-N-CA 125.616 1.566 . . . . 0.0 110.365 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.1 m -171.96 142.2 1.44 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 p -119.9 136.91 55.49 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 C-N-CA 124.708 1.203 . . . . 0.0 110.871 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -119.62 143.16 47.83 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 127.623 2.369 . . . . 0.0 111.489 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.01 162.86 35.49 Favored 'Isoleucine or valine' 0 C--N 1.37 1.468 0 C-N-CA 130.052 3.341 . . . . 0.0 107.042 177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -97.02 119.68 35.94 Favored 'General case' 0 C--N 1.371 1.526 0 O-C-N 119.147 -2.221 . . . . 0.0 112.305 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.436 HG12 HG11 ' A' ' 110' ' ' VAL . 0.9 OUTLIER -145.51 166.22 10.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.353 0 C-N-CA 127.709 2.404 . . . . 0.0 105.543 -177.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.2 147.56 47.93 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.332 1.453 . . . . 0.0 108.423 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -96.15 127.91 42.58 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 128.73 2.812 . . . . 0.0 106.214 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 109' ' ' LEU . 17.0 m-30 -72.61 59.37 0.45 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -174.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -94.93 -119.95 0.1 Allowed 'General case' 0 C--N 1.36 1.036 0 C-N-CA 127.238 2.215 . . . . 0.0 111.643 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -103.04 -52.43 3.04 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 125.129 1.372 . . . . 0.0 113.349 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.0 m -66.63 -43.81 52.17 Favored Pre-proline 0 C--N 1.366 1.323 0 N-CA-C 117.99 2.589 . . . . 0.0 117.99 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -80.12 173.61 52.32 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 CA-C-N 125.693 3.069 . . . . 0.0 110.753 -5.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.5 m -81.62 134.67 35.51 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.196 -1.565 . . . . 0.0 110.191 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.5 ttp-105 -141.96 157.78 44.55 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 121.098 1.772 . . . . 0.0 109.153 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.16 -159.92 28.42 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 103.679 -3.768 . . . . 0.0 103.679 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -97.48 108.45 21.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.523 2.329 . . . . 0.0 107.17 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 m -88.81 160.75 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.182 0 C-N-CA 126.941 2.096 . . . . 0.0 110.52 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.9 m -82.68 114.97 21.41 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.407 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 7.2 ttmt -72.85 -16.76 61.59 Favored 'General case' 0 C--N 1.359 0.985 0 CA-C-O 122.752 1.263 . . . . 0.0 113.962 -169.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -76.03 -5.85 48.31 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.266 -1.522 . . . . 0.0 113.547 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 75.1 mt -105.39 14.8 28.23 Favored 'General case' 0 C--N 1.37 1.461 0 C-N-CA 126.956 2.102 . . . . 0.0 110.844 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 29.2 mt -100.32 125.46 46.55 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 126.453 1.901 . . . . 0.0 107.81 173.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.72 163.14 20.37 Favored Pre-proline 0 C--O 1.226 -0.172 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -79.53 141.1 15.48 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.844 3.029 . . . . 0.0 112.515 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.95 140.06 30.16 Favored 'General case' 0 C--N 1.365 1.263 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 171.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.403 ' HA ' ' CD1' ' A' ' 183' ' ' LEU . 13.5 t -164.24 -15.97 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.39 114.48 0.47 Allowed Glycine 0 C--N 1.352 1.469 0 C-N-CA 116.471 -2.776 . . . . 0.0 114.201 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 50.1 m -65.22 -10.63 33.31 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 127.835 2.454 . . . . 0.0 117.283 176.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.27 27.7 9.41 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 127.55 2.34 . . . . 0.0 109.19 175.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.7 t -99.42 142.84 30.38 Favored 'General case' 0 CA--C 1.48 -1.712 0 C-N-CA 128.278 2.631 . . . . 0.0 107.329 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.4 tptt -47.79 -40.63 21.43 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 127.393 2.277 . . . . 0.0 116.615 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -73.97 -15.6 61.1 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 124.744 1.218 . . . . 0.0 113.822 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.77 -1.52 40.24 Favored 'General case' 0 C--N 1.379 1.857 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -126.94 -173.77 2.97 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.255 1.422 . . . . 0.0 113.667 -176.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -61.93 121.88 14.07 Favored 'General case' 0 C--N 1.38 1.927 0 C-N-CA 125.921 1.688 . . . . 0.0 113.227 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.9 -6.19 73.06 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 124.307 0.956 . . . . 0.0 114.095 -170.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.53 158.45 37.46 Favored Glycine 0 C--N 1.369 2.377 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -59.72 -41.84 91.79 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.86 -30.04 13.38 Favored 'General case' 0 C--N 1.365 1.25 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 3.1 t80 19.53 -101.42 0.01 OUTLIER 'General case' 0 C--N 1.388 2.282 1 C-N-CA 132.971 4.509 . . . . 0.0 114.575 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m 54.26 57.65 5.69 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 129.378 3.071 . . . . 0.0 115.51 170.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.43 101.08 12.32 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 124.941 2.305 . . . . 0.0 113.112 -171.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -120.34 147.03 44.17 Favored Pre-proline 0 N--CA 1.43 -1.464 1 C-N-CA 133.231 4.612 . . . . 0.0 103.42 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -56.76 -33.79 94.9 Favored 'Trans proline' 0 CA--C 1.545 1.058 1 C-N-CA 125.883 4.389 . . . . 0.0 116.741 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.83 -36.28 80.08 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.698 1.999 . . . . 0.0 112.4 173.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.256 6.5 mt -76.0 -32.62 23.55 Favored 'Isoleucine or valine' 0 C--N 1.369 1.425 0 C-N-CA 126.648 1.979 . . . . 0.0 110.566 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . 0.276 35.7 mt -62.57 -53.85 48.55 Favored 'General case' 0 C--N 1.387 2.226 0 C-N-CA 127.391 2.276 . . . . 0.0 110.269 172.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -57.76 -43.23 85.31 Favored 'General case' 0 C--N 1.369 1.418 0 C-N-CA 129.743 3.217 . . . . 0.0 114.197 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.26 -35.5 76.15 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 130.769 3.628 . . . . 0.0 111.454 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.0 mtt -68.09 -40.17 82.69 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.108 1.763 . . . . 0.0 110.384 168.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -66.17 -50.3 64.41 Favored 'General case' 0 C--N 1.374 1.655 0 C-N-CA 126.142 1.777 . . . . 0.0 112.258 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.298 4.7 ptt180 -71.65 -37.53 70.8 Favored 'General case' 0 C--N 1.382 2.001 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 175.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.22 68.77 Favored 'General case' 0 C--N 1.373 1.612 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 169.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 20.6 t0 -70.11 -48.79 56.11 Favored 'General case' 0 C--N 1.372 1.546 0 O-C-N 119.212 -2.18 . . . . 0.0 110.569 168.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -53.37 -47.81 69.13 Favored 'General case' 0 C--N 1.373 1.629 0 C-N-CA 128.88 2.872 . . . . 0.0 114.696 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -68.11 -29.34 68.24 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' A' ' 152' ' ' THR 0.267 0.2 OUTLIER -81.35 -41.85 21.41 Favored 'General case' 0 C--N 1.367 1.365 0 O-C-N 118.552 -2.592 . . . . 0.0 112.811 171.077 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . 0.447 ' HB3' ' O ' ' A' ' 180' ' ' ASP 0.277 0.0 OUTLIER -70.91 -30.3 66.59 Favored 'General case' 0 C--N 1.379 1.889 0 C-N-CA 129.359 3.064 . . . . 0.0 112.676 -173.402 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -103.99 -100.59 0.31 Allowed 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.374 0.607 . . . . 0.0 109.712 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -136.62 144.03 43.84 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.675 7.1 pttm -51.19 -33.73 28.62 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 129.972 3.309 . . . . 0.0 116.41 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.78 -28.29 3.94 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 C-N-CA 129.096 2.958 . . . . 0.0 112.586 169.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.295 2.4 mptp? -64.79 -30.95 71.98 Favored 'General case' 0 C--N 1.374 1.642 0 C-N-CA 126.861 2.064 . . . . 0.0 115.479 168.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . 0.455 ' HB2' ' CD2' ' A' ' 109' ' ' LEU 0.381 0.0 OUTLIER -75.51 -41.35 55.5 Favored 'General case' 0 C--N 1.38 1.911 0 CA-C-N 123.046 2.657 . . . . 0.0 113.16 167.53 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 43.7 mt -69.38 -19.7 63.83 Favored 'General case' 0 C--N 1.378 1.843 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -64.68 -24.17 67.49 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 129.902 3.281 . . . . 0.0 112.55 170.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.3 mt -105.93 -49.35 3.41 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 55.85 -128.81 2.02 Favored 'General case' 0 C--N 1.375 1.701 0 C-N-CA 128.683 2.793 . . . . 0.0 110.871 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.44 14.81 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.802 1.241 . . . . 0.0 112.076 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.4 t 79.12 24.57 0.5 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 128.999 2.92 . . . . 0.0 110.523 -171.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -25.35 31.82 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.163 2 C-N-CA 135.74 5.616 . . . . 0.0 124.42 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -82.12 146.04 54.16 Favored Pre-proline 0 C--N 1.356 0.879 0 C-N-CA 126.918 2.087 . . . . 0.0 114.555 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -84.97 -167.72 0.45 Allowed 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 123.958 3.105 . . . . 0.0 113.547 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.0 m -162.11 53.42 0.23 Allowed 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 120.527 -1.358 . . . . 0.0 107.919 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 C--N 1.353 0.74 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.932 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 tptm . . . . . 0 N--CA 1.443 -0.775 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 74.52 -50.52 0.67 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 129.148 2.979 . . . . 0.0 114.601 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -92.47 175.87 6.67 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 127.441 2.296 . . . . 0.0 111.703 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -103.13 141.49 35.76 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.793 1.237 . . . . 0.0 108.308 174.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.8 mt -64.92 -21.59 66.85 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 128.385 2.674 . . . . 0.0 117.039 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -101.88 1.78 37.35 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.127 1.771 . . . . 0.0 109.199 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.16 -22.29 3.11 Favored Glycine 0 C--N 1.357 1.748 0 C-N-CA 130.684 3.993 . . . . 0.0 115.136 -174.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.83 87.33 1.76 Allowed Glycine 0 C--N 1.357 1.716 0 C-N-CA 127.483 2.468 . . . . 0.0 113.081 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.6 tp 89.9 95.69 0.02 OUTLIER 'General case' 0 C--N 1.368 1.399 0 C-N-CA 128.293 2.637 . . . . 0.0 112.936 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -73.01 -52.14 15.53 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 126.89 2.076 . . . . 0.0 114.762 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -157.49 152.5 25.74 Favored 'General case' 0 N--CA 1.429 -1.494 1 N-CA-C 97.037 -5.171 . . . . 0.0 97.037 177.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.3 p -96.84 70.39 2.48 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 120.511 -1.368 . . . . 0.0 110.767 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.3 p -99.28 102.59 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-O 124.157 1.932 . . . . 0.0 111.586 -175.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.69 150.6 68.56 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.19 69.54 7.88 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 124.688 3.592 . . . . 0.0 112.422 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.8 -160.81 0.91 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.197 0.999 . . . . 0.0 109.744 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.68 112.72 60.05 Favored Pre-proline 0 C--N 1.357 0.897 0 O-C-N 120.445 -1.409 . . . . 0.0 110.905 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -91.84 -161.53 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.559 2.84 . . . . 0.0 112.043 -176.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t -104.26 135.64 45.35 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.049 1.74 . . . . 0.0 107.182 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.5 p -81.82 72.16 8.86 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 129.141 2.976 . . . . 0.0 110.173 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.8 m -119.35 109.07 15.36 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.448 2.699 . . . . 0.0 110.347 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -148.01 105.49 3.67 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 121.078 -1.014 . . . . 0.0 109.631 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -124.61 128.37 48.78 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 126.019 1.728 . . . . 0.0 108.958 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 119' ' ' PHE . 0.7 OUTLIER -110.54 164.55 14.59 Favored Pre-proline 0 C--N 1.355 0.827 0 C-N-CA 125.052 1.341 . . . . 0.0 113.747 -175.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -45.01 135.0 10.8 Favored 'Trans proline' 0 C--N 1.373 1.864 1 C-N-CA 127.828 5.686 . . . . 0.0 119.642 -173.007 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.74 -6.45 54.76 Favored Glycine 0 C--N 1.366 2.211 0 C-N-CA 125.777 1.656 . . . . 0.0 112.11 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -94.3 169.65 10.08 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.265 2.033 . . . . 0.0 112.827 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.18 138.57 38.95 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 102.891 -3.003 . . . . 0.0 102.891 164.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.76 132.5 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.409 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 12.3 m95 -89.49 122.45 32.68 Favored 'General case' 0 N--CA 1.478 0.931 1 O-C-N 116.24 -4.037 . . . . 0.0 106.081 175.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.15 131.62 53.2 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 122.71 1.243 . . . . 0.0 113.124 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -102.33 135.48 43.86 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -122.53 147.65 46.12 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 104.566 -2.383 . . . . 0.0 104.566 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.79 107.93 1.59 Allowed 'General case' 0 C--N 1.354 0.772 0 C-N-CA 126.217 1.807 . . . . 0.0 113.114 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.32 -15.25 46.88 Favored Glycine 0 C--N 1.354 1.57 0 C-N-CA 124.769 1.176 . . . . 0.0 114.599 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . 0.256 0.0 OUTLIER -102.25 168.28 9.19 Favored Pre-proline 0 C--N 1.363 1.159 0 CA-C-N 119.659 1.729 . . . . 0.0 111.94 -178.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.76 158.52 50.23 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 125.196 3.931 . . . . 0.0 113.583 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -54.95 129.38 37.47 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 128.948 2.899 . . . . 0.0 115.351 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -134.04 126.58 18.72 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 119.768 3.247 . . . . 0.0 119.768 -172.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 2.9 Cg_exo -67.21 117.64 4.97 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 124.944 3.763 . . . . 0.0 113.695 164.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.94 164.37 17.71 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 131.257 3.823 . . . . 0.0 114.335 -170.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp -120.99 132.77 55.12 Favored 'General case' 0 C--N 1.345 0.409 0 O-C-N 118.563 -2.586 . . . . 0.0 107.381 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -91.51 129.79 41.67 Favored 'Isoleucine or valine' 0 C--N 1.374 1.638 0 CA-C-N 119.987 1.267 . . . . 0.0 108.216 176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.345 0.0 OUTLIER -138.64 153.27 48.59 Favored 'General case' 0 C--N 1.372 1.563 0 O-C-N 117.922 -2.986 . . . . 0.0 117.351 -173.111 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -87.92 112.31 22.4 Favored 'General case' 0 C--N 1.368 1.413 0 CA-C-O 123.386 1.565 . . . . 0.0 109.246 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -97.33 154.99 37.86 Favored Pre-proline 0 N--CA 1.447 -0.599 0 C-N-CA 129.377 3.071 . . . . 0.0 108.115 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -56.68 -0.96 0.28 Allowed 'Trans proline' 0 N--CA 1.487 1.121 1 C-N-CA 126.524 4.816 . . . . 0.0 121.076 -165.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.79 -7.81 58.52 Favored 'General case' 0 C--N 1.363 1.191 0 C-N-CA 129.404 3.082 . . . . 0.0 109.624 170.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -30.18 139.99 0.02 OUTLIER 'General case' 0 C--N 1.375 1.715 1 C-N-CA 134.153 4.981 . . . . 0.0 121.361 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.22 -20.24 28.55 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 113.456 -1.702 . . . . 0.0 109.236 175.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.6 p -125.5 118.78 26.53 Favored 'General case' 0 C--N 1.348 0.514 1 N-CA-C 96.518 -5.364 . . . . 0.0 96.518 164.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 91' ' ' SER . 31.2 p90 -123.87 4.73 8.74 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 119.688 1.131 . . . . 0.0 112.12 -172.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.5 pt -110.12 166.43 5.16 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.746 1.218 . . . . 0.0 110.401 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -151.04 147.36 27.01 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.826 2.45 . . . . 0.0 105.201 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.06 134.67 15.4 Favored 'General case' 0 C--N 1.357 0.935 0 O-C-N 120.546 -1.346 . . . . 0.0 110.702 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 93.55 4.17 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 127.921 2.488 . . . . 0.0 108.834 175.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.32 -74.38 0.14 Allowed Glycine 0 C--N 1.361 1.971 0 N-CA-C 121.212 3.245 . . . . 0.0 121.212 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.32 37.58 3.53 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.775 1.63 . . . . 0.0 111.488 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m -166.22 151.6 8.46 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 119.461 -2.025 . . . . 0.0 107.286 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.47 144.58 32.41 Favored 'Isoleucine or valine' 0 C--N 1.366 1.293 0 C-N-CA 126.023 1.729 . . . . 0.0 111.126 -174.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -135.55 154.76 51.27 Favored 'General case' 0 C--N 1.366 1.298 0 C-N-CA 127.975 2.51 . . . . 0.0 113.931 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.3 m -126.28 162.74 29.57 Favored 'Isoleucine or valine' 0 C--N 1.38 1.904 0 C-N-CA 130.77 3.628 . . . . 0.0 106.144 173.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -86.42 116.42 24.56 Favored 'General case' 0 C--N 1.365 1.275 0 O-C-N 119.695 -1.878 . . . . 0.0 110.815 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.459 ' HB ' HG21 ' A' ' 143' ' ' VAL . 2.3 t -138.67 150.13 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 C-N-CA 125.044 1.338 . . . . 0.0 107.714 -174.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -118.7 144.93 45.91 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 170.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -100.22 131.05 46.39 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.53 72.59 2.52 Favored 'General case' 0 C--N 1.38 1.893 0 C-N-CA 125.098 1.359 . . . . 0.0 111.542 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -97.9 -103.9 0.19 Allowed 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.518 1.127 . . . . 0.0 111.002 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -106.61 -62.44 1.39 Allowed 'General case' 0 C--N 1.354 0.763 0 C-N-CA 126.051 1.74 . . . . 0.0 113.75 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 p -88.27 -29.14 0.37 Allowed Pre-proline 0 C--N 1.364 1.196 0 N-CA-C 118.945 2.943 . . . . 0.0 118.945 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.5 -177.84 18.72 Favored 'Cis proline' 0 C--N 1.357 1.025 1 CA-C-N 129.585 4.459 . . . . 0.0 113.386 -2.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 64.2 m -98.12 113.37 25.24 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 127.889 2.476 . . . . 0.0 113.585 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -113.41 161.53 17.19 Favored 'General case' 0 C--N 1.363 1.155 0 CA-C-N 124.972 3.533 . . . . 0.0 108.086 172.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.58 -170.33 31.34 Favored Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 103.359 -3.896 . . . . 0.0 103.359 168.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -93.93 110.21 21.9 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 172.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.459 HG21 ' HB ' ' A' ' 131' ' ' VAL . 17.6 m -94.6 157.16 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 C-N-CA 125.949 1.7 . . . . 0.0 110.947 -175.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.5 t -79.14 110.98 14.91 Favored 'General case' 0 C--N 1.364 1.222 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.419 0.0 OUTLIER -65.73 -14.89 62.2 Favored 'General case' 0 C--N 1.366 1.295 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -172.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -74.76 -3.87 34.2 Favored 'General case' 0 N--CA 1.434 -1.227 1 C-N-CA 132.798 4.439 . . . . 0.0 112.933 170.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.3 mt -109.73 2.29 19.99 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.391 2.276 . . . . 0.0 110.902 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.8 mt -96.41 153.22 17.95 Favored 'General case' 0 C--N 1.373 1.615 0 O-C-N 120.069 -1.644 . . . . 0.0 113.19 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -119.02 155.21 53.28 Favored Pre-proline 0 C--N 1.351 0.654 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -82.76 155.53 15.61 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 125.403 2.965 . . . . 0.0 113.069 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -35.63 -87.89 0.0 OUTLIER 'General case' 0 C--N 1.348 0.512 2 C-N-CA 132.297 4.239 . . . . 0.0 122.4 -177.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 4.6 t -31.48 24.94 0.0 OUTLIER 'General case' 0 C--N 1.359 0.988 1 C-N-CA 138.555 6.742 . . . . 0.0 120.643 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.03 0.4 47.9 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 -165.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . 0.256 5.8 p -62.73 -15.53 53.46 Favored 'General case' 0 C--N 1.366 1.289 0 CA-C-N 120.988 2.394 . . . . 0.0 117.287 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -91.47 -6.7 52.25 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 128.808 2.843 . . . . 0.0 111.107 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.0 p -90.85 147.85 22.9 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 127.34 2.256 . . . . 0.0 112.775 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -62.19 -18.47 61.11 Favored 'General case' 0 C--N 1.37 1.475 0 C-N-CA 126.82 2.048 . . . . 0.0 113.517 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -75.87 -26.51 57.13 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 127.452 2.301 . . . . 0.0 112.696 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.63 -12.89 38.38 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -114.91 -178.91 3.48 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 126.177 1.791 . . . . 0.0 111.4 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -57.74 122.75 13.58 Favored 'General case' 0 C--N 1.372 1.55 0 C-N-CA 127.243 2.217 . . . . 0.0 115.134 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.12 -10.95 58.58 Favored Glycine 0 C--N 1.357 1.72 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.81 -167.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -84.33 160.34 36.26 Favored Glycine 0 C--N 1.363 2.058 0 N-CA-C 121.13 3.212 . . . . 0.0 121.13 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -60.38 -30.0 69.29 Favored 'General case' 0 C--N 1.369 1.447 0 C-N-CA 128.915 2.886 . . . . 0.0 118.691 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -105.34 7.9 33.52 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.357 -1.464 . . . . 0.0 110.456 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -87.78 162.64 16.9 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -171.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.5 m 174.91 176.75 0.16 Allowed 'General case' 0 C--N 1.353 0.724 1 N-CA-C 99.097 -4.409 . . . . 0.0 99.097 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -138.71 102.29 4.54 Favored 'General case' 0 C--N 1.364 1.228 0 CA-C-N 124.187 3.176 . . . . 0.0 111.288 173.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -119.74 138.32 26.62 Favored Pre-proline 0 N--CA 1.435 -1.21 0 C-N-CA 130.269 3.428 . . . . 0.0 105.766 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -59.4 -27.44 84.99 Favored 'Trans proline' 0 C--N 1.363 1.334 1 C-N-CA 127.013 5.142 . . . . 0.0 115.086 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -70.02 -36.85 75.38 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 129.465 3.106 . . . . 0.0 113.167 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.2 mt -70.45 -34.89 59.63 Favored 'Isoleucine or valine' 0 C--N 1.381 1.977 0 C-N-CA 126.677 1.991 . . . . 0.0 110.056 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.69 -53.26 60.05 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 125.987 1.715 . . . . 0.0 110.742 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -57.55 -34.6 69.34 Favored 'General case' 0 C--N 1.367 1.356 0 C-N-CA 128.217 2.607 . . . . 0.0 115.403 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.81 -42.83 80.94 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 129.191 2.996 . . . . 0.0 111.662 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 18.1 mtt -69.98 -33.24 71.8 Favored 'General case' 0 C--N 1.372 1.546 0 CA-C-O 117.282 -1.342 . . . . 0.0 113.193 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -74.29 -42.64 59.23 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-N 121.713 2.051 . . . . 0.0 111.109 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -68.54 -49.65 57.91 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 127.348 2.259 . . . . 0.0 111.418 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.57 -41.39 98.9 Favored 'General case' 0 C--N 1.374 1.645 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 173.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -62.33 -37.26 84.94 Favored 'General case' 0 C--N 1.379 1.876 0 C-N-CA 128.808 2.843 . . . . 0.0 111.353 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -72.03 -44.81 62.79 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 119.828 -1.795 . . . . 0.0 112.481 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -73.0 -38.89 66.46 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.23 -37.28 77.94 Favored 'General case' 0 C--N 1.374 1.645 0 C-N-CA 127.243 2.217 . . . . 0.0 115.056 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.72 -31.95 25.77 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 127.103 2.161 . . . . 0.0 111.451 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -105.13 -98.46 0.33 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -135.63 150.73 49.73 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.819 -1.176 . . . . 0.0 112.347 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.277 24.6 ttpp -51.69 -36.37 46.34 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 131.485 3.914 . . . . 0.0 115.385 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.8 tp -53.24 -27.59 13.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 129.219 3.007 . . . . 0.0 112.409 172.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -75.78 -41.27 53.45 Favored 'General case' 0 C--N 1.372 1.555 0 O-C-N 119.483 -2.011 . . . . 0.0 114.636 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -74.61 -37.06 62.94 Favored 'General case' 0 C--N 1.366 1.295 0 O-C-N 118.832 -2.418 . . . . 0.0 116.466 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.0 tp -79.92 -27.82 39.84 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.919 2.087 . . . . 0.0 113.052 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -77.43 -27.42 52.21 Favored 'General case' 0 C--N 1.371 1.541 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 171.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.83 -2.06 54.04 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 124.618 1.167 . . . . 0.0 111.108 175.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 21.9 -124.76 0.01 OUTLIER 'General case' 0 C--N 1.361 1.068 1 C-N-CA 133.807 4.843 . . . . 0.0 121.752 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.6 p -108.38 -20.19 6.32 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 O-C-N 119.8 -1.813 . . . . 0.0 110.575 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.29 5.8 t 59.26 -50.61 0.06 Allowed 'General case' 0 C--N 1.366 1.317 0 C-N-CA 129.844 3.258 . . . . 0.0 116.025 -176.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -84.83 59.41 5.55 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 127.378 2.271 . . . . 0.0 112.055 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -118.13 96.28 49.48 Favored Pre-proline 0 C--N 1.352 0.693 0 C-N-CA 125.492 1.517 . . . . 0.0 108.523 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.89 62.71 6.63 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 124.698 3.598 . . . . 0.0 113.785 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.327 97.9 p 88.05 -77.32 0.01 OUTLIER 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.088 3.355 . . . . 0.0 111.237 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 . . . . . 0 C--N 1.36 1.038 0 C-N-CA 129.054 2.942 . . . . 0.0 116.253 178.067 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.58 50.81 2.13 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 125.923 1.689 . . . . 0.0 109.48 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -134.93 142.4 46.52 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -85.56 130.52 34.55 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.822 2.049 . . . . 0.0 112.224 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -145.97 126.75 14.37 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 120.999 -1.063 . . . . 0.0 109.837 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -118.02 11.81 13.47 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 125.747 1.619 . . . . 0.0 110.468 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.37 -21.27 43.54 Favored Glycine 0 C--N 1.359 1.849 0 C-N-CA 126.807 2.146 . . . . 0.0 117.175 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.61 49.11 0.17 Allowed Glycine 0 C--N 1.354 1.582 0 CA-C-N 118.396 1.098 . . . . 0.0 110.49 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.28 30.35 0.14 Allowed 'General case' 0 C--N 1.361 1.081 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -72.02 -35.94 69.54 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 129.651 3.18 . . . . 0.0 114.645 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -135.94 50.37 2.09 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 126.72 2.008 . . . . 0.0 106.316 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 t -68.23 49.16 0.06 Allowed 'General case' 0 C--N 1.365 1.258 0 C-N-CA 129.287 3.035 . . . . 0.0 116.367 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.9 80.1 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.975 0 C-N-CA 127.308 2.243 . . . . 0.0 110.256 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.91 120.23 60.57 Favored Pre-proline 0 C--N 1.357 0.903 0 C-N-CA 126.096 1.758 . . . . 0.0 110.818 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -83.07 40.3 0.93 Allowed 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 124.232 3.288 . . . . 0.0 113.522 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -175.97 -168.81 0.29 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.2 117.26 67.1 Favored Pre-proline 0 C--N 1.358 0.939 0 C-N-CA 125.2 1.4 . . . . 0.0 107.553 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -82.48 47.5 2.49 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 124.838 3.692 . . . . 0.0 112.897 -172.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.1 p -136.83 54.28 1.87 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 127.526 2.33 . . . . 0.0 107.883 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . 0.272 5.9 t 78.98 -73.94 0.06 Allowed 'General case' 0 C--N 1.361 1.101 0 N-CA-C 118.132 2.641 . . . . 0.0 118.132 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.413 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 47.2 m -100.25 152.09 20.69 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 126.637 1.975 . . . . 0.0 113.686 -175.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.66 64.05 0.47 Allowed 'General case' 0 C--N 1.366 1.308 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -172.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -116.45 124.15 49.28 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.147 -1.596 . . . . 0.0 108.645 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.9 p -112.33 165.26 13.37 Favored Pre-proline 0 C--N 1.362 1.127 0 C-N-CA 126.999 2.12 . . . . 0.0 114.651 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -52.22 138.22 54.76 Favored 'Trans proline' 0 C--N 1.371 1.747 1 C-N-CA 126.21 4.607 . . . . 0.0 120.483 -170.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.91 -12.43 38.05 Favored Glycine 0 C--N 1.365 2.169 0 C-N-CA 125.019 1.295 . . . . 0.0 110.418 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.66 170.08 9.72 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 120.37 2.085 . . . . 0.0 111.982 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.9 mm? -101.33 145.9 28.29 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 163.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.1 m -143.1 157.26 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.425 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 66.9 m95 -108.39 123.33 48.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 102.064 -3.31 . . . . 0.0 102.064 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.4 136.64 54.19 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.509 1.523 . . . . 0.0 112.932 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -109.51 145.41 36.32 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 170.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 tpt -129.18 150.23 50.65 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 118.622 -2.549 . . . . 0.0 110.042 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.26 90.18 0.07 Allowed 'General case' 0 C--N 1.368 1.406 0 C-N-CA 126.307 1.843 . . . . 0.0 115.622 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.19 1.47 25.07 Favored Glycine 0 C--N 1.359 1.841 0 C-N-CA 125.715 1.626 . . . . 0.0 112.983 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -108.82 161.36 23.92 Favored Pre-proline 0 C--N 1.354 0.786 0 C-N-CA 126.201 1.8 . . . . 0.0 109.352 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.76 167.6 26.11 Favored 'Trans proline' 0 CA--C 1.545 1.055 1 C-N-CA 125.323 4.015 . . . . 0.0 113.295 162.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.437 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 1.8 m95 -57.62 121.54 10.59 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 128.066 2.546 . . . . 0.0 115.301 170.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -123.76 111.83 29.21 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 119.252 3.056 . . . . 0.0 119.252 -172.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.425 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 4.6 Cg_exo -58.5 124.21 15.31 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 125.136 3.891 . . . . 0.0 111.227 162.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.8 p -137.82 165.5 26.31 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 128.461 2.704 . . . . 0.0 115.391 -161.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp -119.97 132.67 55.58 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.968 2.107 . . . . 0.0 105.952 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.437 HG22 HG11 ' A' ' 131' ' ' VAL . 2.9 p -83.61 118.98 32.04 Favored 'Isoleucine or valine' 0 C--N 1.381 1.959 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 173.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.71 143.39 49.83 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.036 -1.665 . . . . 0.0 111.794 -164.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 6.8 p-10 -98.0 118.53 34.8 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 119.349 -2.094 . . . . 0.0 112.049 174.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.538 ' H ' ' CE1' ' A' ' 130' ' ' HIS . 2.4 m-70 -71.79 159.78 84.5 Favored Pre-proline 0 C--N 1.358 0.95 0 C-N-CA 128.191 2.596 . . . . 0.0 108.303 169.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.17 -9.06 1.89 Allowed 'Trans proline' 0 CA--C 1.552 1.398 1 C-N-CA 126.563 4.842 . . . . 0.0 116.446 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -63.39 -18.48 63.73 Favored 'General case' 0 C--N 1.36 1.053 1 C-N-CA 134.752 5.221 . . . . 0.0 113.561 166.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 112' ' ' ASN 0.341 0.0 OUTLIER -28.78 136.49 0.02 OUTLIER 'General case' 0 C--N 1.381 1.962 0 N-CA-C 120.926 3.676 . . . . 0.0 120.926 -177.249 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.91 -19.77 27.48 Favored Glycine 0 C--N 1.361 1.936 0 CA-C-O 123.432 1.573 . . . . 0.0 109.633 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.4 m -141.99 119.66 11.8 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 100.269 -3.974 . . . . 0.0 100.269 164.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.4 ' HB2' ' CE1' ' A' ' 130' ' ' HIS . 26.1 p90 -123.98 10.65 8.86 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.764 -1.21 . . . . 0.0 109.154 -176.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 8.2 pt -121.57 157.12 25.51 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 CA-C-O 123.637 1.684 . . . . 0.0 111.921 -173.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.0 mtp-105 -137.38 149.1 46.72 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 130.467 3.507 . . . . 0.0 102.421 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.1 139.83 24.96 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 120.267 -1.521 . . . . 0.0 109.184 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -118.27 93.69 4.22 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 126.59 1.956 . . . . 0.0 109.622 175.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.63 -76.32 0.21 Allowed Glycine 0 C--N 1.366 2.249 0 N-CA-C 118.635 2.214 . . . . 0.0 118.635 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -141.18 22.7 2.22 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 125.763 1.625 . . . . 0.0 110.073 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.4 t -125.88 128.55 47.77 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 126.493 1.917 . . . . 0.0 108.674 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.21 116.06 49.74 Favored 'Isoleucine or valine' 0 C--N 1.358 0.949 0 C-N-CA 126.625 1.97 . . . . 0.0 112.406 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -113.84 130.68 56.45 Favored 'General case' 0 C--N 1.367 1.329 0 C-N-CA 127.362 2.265 . . . . 0.0 111.256 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 10.3 m -125.37 159.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.364 1.217 0 C-N-CA 127.438 2.295 . . . . 0.0 106.578 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.538 ' CE1' ' H ' ' A' ' 113' ' ' HIS . 3.8 p80 -90.46 129.76 36.6 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 125.262 1.425 . . . . 0.0 113.268 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.437 HG11 HG22 ' A' ' 110' ' ' VAL . 3.3 m -146.47 165.3 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 C-N-CA 128.358 2.663 . . . . 0.0 106.612 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -126.05 143.18 51.21 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.092 0.557 . . . . 0.0 109.909 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.55 123.91 39.32 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 129.666 3.186 . . . . 0.0 107.885 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -75.69 70.57 2.5 Favored 'General case' 0 C--N 1.374 1.654 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -90.79 -114.38 0.08 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.203 1.801 . . . . 0.0 110.96 -175.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -107.07 -51.99 2.83 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 126.183 1.793 . . . . 0.0 112.105 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.3 m -73.68 -45.92 7.16 Favored Pre-proline 0 C--N 1.366 1.295 0 N-CA-C 119.396 3.11 . . . . 0.0 119.396 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -85.29 177.31 27.38 Favored 'Cis proline' 0 CA--C 1.548 1.175 0 CA-C-N 127.452 3.697 . . . . 0.0 112.832 -1.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 84.5 m -95.08 119.98 34.52 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 120.058 -1.651 . . . . 0.0 110.83 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -132.19 148.03 52.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 121.351 1.887 . . . . 0.0 108.484 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.34 -166.65 30.47 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.59 111.92 17.47 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 127.233 2.213 . . . . 0.0 109.591 175.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.7 m -98.45 169.7 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 C-N-CA 125.275 1.43 . . . . 0.0 108.302 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.8 m -95.74 124.53 39.8 Favored 'General case' 0 C--N 1.364 1.199 0 N-CA-C 101.157 -3.646 . . . . 0.0 101.157 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -70.46 -9.06 55.48 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 124.359 3.254 . . . . 0.0 117.451 -168.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.413 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 15.8 ptp180 -73.34 -6.26 44.98 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 129.622 3.169 . . . . 0.0 115.291 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . 0.264 0.8 OUTLIER -112.94 11.63 19.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.839 0.856 . . . . 0.0 110.371 176.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 4.8 mt -98.01 125.37 42.93 Favored 'General case' 0 C--N 1.38 1.903 0 C-N-CA 126.381 1.872 . . . . 0.0 107.898 173.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -114.15 161.57 27.48 Favored Pre-proline 0 C--N 1.346 0.426 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.32 153.59 14.06 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 124.959 2.807 . . . . 0.0 113.628 -174.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' A' ' 95' ' ' LEU 0.296 0.1 OUTLIER -29.87 -84.14 0.0 OUTLIER 'General case' 0 C--N 1.353 0.76 2 N-CA-C 123.685 4.698 . . . . 0.0 123.685 -179.943 . . . . . . . . 5 4 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.8 t -34.27 38.34 0.0 OUTLIER 'General case' 0 C--N 1.373 1.616 1 C-N-CA 136.961 6.105 . . . . 0.0 118.154 -176.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.51 -36.86 2.36 Favored Glycine 0 C--N 1.358 1.788 0 C-N-CA 128.802 3.096 . . . . 0.0 117.969 -168.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 38.0 m -48.6 -15.41 0.08 Allowed 'General case' 0 C--N 1.376 1.755 0 N-CA-C 119.493 3.145 . . . . 0.0 119.493 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -111.34 0.12 16.54 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.453 2.301 . . . . 0.0 110.619 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.5 t -103.35 158.45 16.32 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 127.719 2.407 . . . . 0.0 114.691 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -56.54 -18.64 12.36 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.334 2.654 . . . . 0.0 118.09 -171.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -90.25 -10.53 43.93 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 124.814 1.246 . . . . 0.0 112.402 169.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 4.8 10.62 Favored 'General case' 0 C--N 1.375 1.694 0 CA-C-N 120.146 1.339 . . . . 0.0 114.396 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.424 0.0 OUTLIER -113.2 162.01 16.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -50.08 122.41 6.71 Favored 'General case' 0 C--N 1.372 1.587 0 C-N-CA 127.318 2.247 . . . . 0.0 116.569 -172.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.86 -22.82 32.68 Favored Glycine 0 C--N 1.36 1.907 0 C-N-CA 125.01 1.291 . . . . 0.0 111.943 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.32 158.7 44.09 Favored Glycine 0 C--N 1.371 2.516 0 N-CA-C 119.43 2.532 . . . . 0.0 119.43 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -52.19 -42.86 63.83 Favored 'General case' 0 C--N 1.366 1.317 0 N-CA-C 121.751 3.982 . . . . 0.0 121.751 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.437 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.344 0.2 OUTLIER -105.16 12.49 31.95 Favored 'General case' 0 C--N 1.365 1.262 0 O-C-N 120.327 -1.483 . . . . 0.0 112.967 -177.779 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -93.53 90.87 6.84 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 126.096 1.758 . . . . 0.0 112.722 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.6 m -115.01 117.52 30.82 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 101.735 -3.431 . . . . 0.0 101.735 170.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.19 101.7 14.42 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 125.87 2.748 . . . . 0.0 113.581 -168.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -120.36 137.77 26.5 Favored Pre-proline 0 N--CA 1.422 -1.836 1 C-N-CA 133.753 4.821 . . . . 0.0 103.039 170.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.92 -26.07 79.66 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.943 3.762 . . . . 0.0 115.134 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -69.74 -35.97 75.45 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 130.961 3.705 . . . . 0.0 112.985 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.251 56.1 mt -75.15 -34.57 31.85 Favored 'Isoleucine or valine' 0 C--N 1.377 1.77 0 C-N-CA 126.289 1.836 . . . . 0.0 109.569 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.88 -46.53 68.17 Favored 'General case' 0 C--N 1.375 1.698 0 C-N-CA 124.827 1.251 . . . . 0.0 111.765 170.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -57.61 -35.79 70.91 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.751 2.02 . . . . 0.0 114.061 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.17 -40.22 86.59 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 130.788 3.635 . . . . 0.0 112.071 172.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 56.4 mtt -69.67 -33.19 72.22 Favored 'General case' 0 C--N 1.364 1.201 0 CA-C-O 116.786 -1.578 . . . . 0.0 113.633 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -74.14 -48.21 30.94 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 126.769 2.028 . . . . 0.0 111.008 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.463 ' HE ' ' HG ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -69.08 -43.93 73.56 Favored 'General case' 0 C--N 1.369 1.432 0 C-N-CA 129.292 3.037 . . . . 0.0 112.454 177.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.86 93.05 Favored 'General case' 0 C--N 1.377 1.794 0 C-N-CA 125.359 1.463 . . . . 0.0 112.198 169.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.356 4.4 t70 -60.9 -51.38 69.53 Favored 'General case' 0 C--N 1.384 2.096 0 CA-C-N 120.524 1.511 . . . . 0.0 113.016 173.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -35.17 64.84 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 121.938 2.154 . . . . 0.0 116.268 175.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.77 -44.63 32.14 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 168.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -40.95 95.01 Favored 'General case' 0 C--N 1.364 1.203 0 C-N-CA 131.032 3.733 . . . . 0.0 116.032 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.284 0.0 OUTLIER -89.21 -13.82 37.4 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.801 2.04 . . . . 0.0 110.783 -173.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -121.31 -108.78 0.35 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 126.553 1.941 . . . . 0.0 114.525 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -131.97 162.11 31.5 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.53 -1.981 . . . . 0.0 113.7 -172.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -37.65 54.1 Favored 'General case' 0 C--N 1.375 1.678 1 C-N-CA 132.113 4.165 . . . . 0.0 116.262 177.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.446 HG22 ' HZ1' ' A' ' 189' ' ' LYS . 15.3 tt -60.2 -31.89 49.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.501 0 C-N-CA 127.222 2.209 . . . . 0.0 113.74 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.446 ' HZ1' HG22 ' A' ' 188' ' ' ILE . 2.3 mptp? -70.84 -42.79 69.71 Favored 'General case' 0 C--N 1.374 1.635 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -75.44 -44.28 45.23 Favored 'General case' 0 C--N 1.364 1.199 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 170.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.269 7.7 tp -72.52 -19.19 61.56 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 127.234 2.213 . . . . 0.0 114.806 -173.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -63.0 -27.88 69.72 Favored 'General case' 0 C--N 1.368 1.371 0 C-N-CA 127.863 2.465 . . . . 0.0 112.697 166.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.463 ' HG ' ' HE ' ' A' ' 178' ' ' ARG . 2.0 mm? -100.06 22.45 11.29 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 127.965 2.506 . . . . 0.0 112.191 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.61 53.95 0.03 OUTLIER 'General case' 0 C--N 1.374 1.655 0 C-N-CA 127.825 2.45 . . . . 0.0 115.634 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.403 2.9 m 62.0 -41.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.283 1 C-N-CA 134.867 5.267 . . . . 0.0 117.024 -179.833 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.318 87.0 p 77.79 59.34 0.03 OUTLIER 'General case' 0 C--N 1.365 1.246 0 C-N-CA 128.996 2.918 . . . . 0.0 108.83 -173.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.05 62.57 0.01 OUTLIER 'General case' 0 C--N 1.361 1.108 0 C-N-CA 129.265 3.026 . . . . 0.0 117.845 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . 0.394 44.6 mt-10 13.37 -73.44 0.0 OUTLIER Pre-proline 0 C--N 1.364 1.22 1 C-N-CA 133.996 4.919 . . . . 0.0 120.931 178.498 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.37 -9.88 17.52 Favored 'Trans proline' 0 C--N 1.36 1.163 0 CA-C-N 125.383 2.958 . . . . 0.0 114.021 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.282 17.6 m 79.79 -37.81 0.17 Allowed 'General case' 0 C--N 1.364 1.209 0 C-N-CA 128.033 2.533 . . . . 0.0 115.767 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 . . . . . 0 C--N 1.357 0.899 0 C-N-CA 127.064 2.146 . . . . 0.0 112.706 178.825 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.0 tttp . . . . . 0 N--CA 1.441 -0.898 0 CA-C-O 122.269 1.033 . . . . 0.0 108.351 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.22 60.75 4.46 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 127.209 2.204 . . . . 0.0 113.761 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -110.51 122.84 48.71 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 126.825 2.05 . . . . 0.0 108.038 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -102.93 149.18 24.77 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 125.137 1.375 . . . . 0.0 109.206 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.259 2.6 pt? -63.22 -0.17 0.75 Allowed 'General case' 0 C--N 1.36 1.049 0 N-CA-C 120.656 3.576 . . . . 0.0 120.656 -173.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -97.41 -11.56 23.77 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 125.814 1.645 . . . . 0.0 110.294 173.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.1 0.48 3.16 Favored Glycine 0 C--N 1.369 2.413 0 N-CA-C 122.129 3.612 . . . . 0.0 122.129 162.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.67 -24.58 1.49 Allowed Glycine 0 C--N 1.351 1.371 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -174.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.3 mt -85.61 79.1 9.48 Favored 'General case' 0 C--N 1.367 1.346 0 CA-C-O 123.082 1.42 . . . . 0.0 109.219 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -71.24 -25.22 62.39 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 128.565 2.746 . . . . 0.0 114.112 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 178.8 -44.78 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.6 p -156.56 -137.94 0.06 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 125.699 1.6 . . . . 0.0 106.969 175.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.331 10.9 m 47.43 27.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.238 1 C-N-CA 133.301 4.64 . . . . 0.0 120.617 176.457 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.73 142.69 41.45 Favored Pre-proline 0 C--N 1.357 0.923 0 O-C-N 120.081 -1.637 . . . . 0.0 113.375 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.99 69.04 6.4 Favored 'Trans proline' 0 C--N 1.368 1.575 1 C-N-CA 125.885 4.39 . . . . 0.0 111.043 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -154.88 -37.43 0.09 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.719 2.808 . . . . 0.0 106.09 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -104.77 111.65 65.24 Favored Pre-proline 0 C--N 1.364 1.205 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.23 64.9 4.21 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.521 2.814 . . . . 0.0 110.371 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 p -89.99 59.15 4.43 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 130.05 3.34 . . . . 0.0 112.159 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.3 t -86.87 98.2 11.08 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 127.634 2.374 . . . . 0.0 110.185 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 99.5 p -101.13 96.56 7.3 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.573 1.549 . . . . 0.0 110.85 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -138.36 58.29 1.67 Allowed 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -113.82 122.97 48.67 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 119.336 -2.102 . . . . 0.0 114.314 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.297 96.8 p -112.92 167.35 9.36 Favored Pre-proline 0 C--N 1.359 0.992 0 C-N-CA 129.278 3.031 . . . . 0.0 115.42 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -48.58 139.92 22.73 Favored 'Trans proline' 0 C--N 1.379 2.161 1 C-N-CA 127.457 5.438 . . . . 0.0 121.266 -170.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.26 -7.07 66.43 Favored Glycine 0 C--N 1.37 2.418 0 C-N-CA 126.092 1.806 . . . . 0.0 112.585 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.82 169.15 10.52 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 119.971 1.886 . . . . 0.0 111.851 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.7 147.76 26.43 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 167.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.35 159.34 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 -177.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -104.67 119.1 38.2 Favored 'General case' 0 CA--C 1.51 -0.558 1 N-CA-C 98.054 -4.795 . . . . 0.0 98.054 165.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.96 131.53 52.35 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.29 136.99 47.84 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 118.675 -2.516 . . . . 0.0 106.136 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 57.1 ttm -129.69 141.4 50.91 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 119.922 -1.736 . . . . 0.0 110.264 173.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -65.37 107.62 1.7 Allowed 'General case' 0 C--N 1.367 1.353 0 C-N-CA 126.082 1.753 . . . . 0.0 112.878 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.55 -16.61 21.52 Favored Glycine 0 C--N 1.36 1.887 0 C-N-CA 125.438 1.494 . . . . 0.0 112.55 -172.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -112.53 161.63 25.4 Favored Pre-proline 0 C--N 1.359 1.011 0 O-C-N 121.144 -1.21 . . . . 0.0 109.111 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.95 167.06 27.73 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 125.015 3.81 . . . . 0.0 113.342 166.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.498 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -58.36 116.42 3.61 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 127.908 2.483 . . . . 0.0 112.821 171.394 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -127.0 117.9 22.1 Favored Pre-proline 0 N--CA 1.426 -1.633 0 N-CA-C 121.387 3.847 . . . . 0.0 121.387 -169.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -49.08 125.3 13.03 Favored 'Trans proline' 0 C--N 1.387 2.58 1 C-N-CA 127.079 5.186 . . . . 0.0 112.374 162.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 m -146.55 164.19 33.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 124.298 1.999 . . . . 0.0 112.045 -158.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 tt -135.67 135.57 40.23 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 119.564 -1.96 . . . . 0.0 106.61 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.312 3.3 p -92.45 130.97 40.77 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 CA-C-N 121.19 1.814 . . . . 0.0 110.372 175.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -133.37 153.05 51.92 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 125.521 1.528 . . . . 0.0 111.955 -166.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -99.81 112.16 24.43 Favored 'General case' 0 C--N 1.376 1.718 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 171.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -96.73 158.38 33.67 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 130.416 3.486 . . . . 0.0 108.767 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -50.05 -1.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.525 2 C-N-CA 127.565 5.51 . . . . 0.0 122.852 -165.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -99.83 9.1 43.58 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 126.673 1.989 . . . . 0.0 108.981 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.0 143.66 0.08 Allowed 'General case' 0 C--N 1.369 1.437 1 C-N-CA 134.224 5.01 . . . . 0.0 120.884 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.94 -19.68 27.51 Favored Glycine 0 C--N 1.359 1.832 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.5 t -134.12 127.52 32.27 Favored 'General case' 0 N--CA 1.448 -0.571 1 N-CA-C 99.456 -4.276 . . . . 0.0 99.456 163.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -128.24 6.41 5.86 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 120.514 -1.366 . . . . 0.0 109.671 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.5 pt -118.59 150.36 20.86 Favored 'Isoleucine or valine' 0 C--N 1.361 1.105 0 CA-C-O 124.076 1.893 . . . . 0.0 113.678 -173.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.528 ' HE ' ' H ' ' A' ' 122' ' ' GLU . 5.7 tpm_? -140.42 144.23 36.04 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 130.025 3.33 . . . . 0.0 103.715 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.528 ' H ' ' HE ' ' A' ' 121' ' ' ARG . 42.4 tt0 -140.3 126.93 20.34 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 176.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -107.16 93.39 4.53 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.82 1.648 . . . . 0.0 107.175 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.5 -93.55 0.81 Allowed Glycine 0 C--N 1.362 2.014 0 C-N-CA 126.489 1.995 . . . . 0.0 111.729 -174.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.58 -0.78 10.76 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 125.248 1.419 . . . . 0.0 109.204 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.5 t -92.52 97.97 11.16 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 125.298 1.439 . . . . 0.0 111.055 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.18 129.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 128.135 2.574 . . . . 0.0 112.404 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -123.49 140.66 52.78 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 126.998 2.119 . . . . 0.0 109.709 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.8 m -127.2 163.53 29.96 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 127.284 2.233 . . . . 0.0 109.928 -178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -78.62 123.46 27.14 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 119.195 -2.191 . . . . 0.0 111.819 171.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.441 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 5.5 m -143.96 176.21 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.232 0 CA-C-N 123.278 2.763 . . . . 0.0 104.846 174.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.32 152.36 51.77 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 125.07 1.481 . . . . 0.0 108.442 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.52 120.65 42.82 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 104.141 -2.541 . . . . 0.0 104.141 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -64.86 65.88 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.5 1.92 . . . . 0.0 114.839 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -103.16 -128.62 0.23 Allowed 'General case' 0 C--N 1.36 1.045 0 O-C-N 118.963 -2.336 . . . . 0.0 112.123 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -102.24 -57.53 2.05 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 126.144 1.778 . . . . 0.0 113.001 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.6 p -80.91 -26.6 0.43 Allowed Pre-proline 0 C--N 1.362 1.113 0 N-CA-C 118.356 2.724 . . . . 0.0 118.356 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -85.89 -157.26 1.22 Allowed 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 127.944 3.873 . . . . 0.0 109.977 -2.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.4 m -96.68 127.82 43.03 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 1.1 tmt_? -161.64 154.77 20.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 119.488 -2.008 . . . . 0.0 108.936 -176.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.95 -158.02 19.33 Favored Glycine 0 CA--C 1.485 -1.803 0 N-CA-C 103.74 -3.744 . . . . 0.0 103.74 166.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -91.01 112.61 24.58 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 169.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . 0.304 14.8 p -102.64 161.31 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.988 -163.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 m -78.37 109.69 12.74 Favored 'General case' 0 C--N 1.363 1.188 0 C-N-CA 124.919 1.288 . . . . 0.0 107.836 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.433 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 26.9 tttp -64.4 -19.05 65.26 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -170.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -82.41 -6.33 59.21 Favored 'General case' 0 C--N 1.362 1.146 0 O-C-N 120.237 -1.54 . . . . 0.0 113.742 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.4 mt -100.68 6.85 44.13 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 126.405 1.882 . . . . 0.0 109.695 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.433 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 26.1 mt -96.69 124.42 40.67 Favored 'General case' 0 C--N 1.368 1.397 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -116.65 158.84 42.52 Favored Pre-proline 0 CA--C 1.493 -1.24 0 O-C-N 120.478 -1.389 . . . . 0.0 107.809 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.81 150.73 14.39 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 CA-C-N 122.711 2.004 . . . . 0.0 113.41 -170.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.36 0.0 OUTLIER -28.2 -87.39 0.0 OUTLIER 'General case' 0 C--N 1.355 0.81 2 N-CA-C 123.459 4.615 . . . . 0.0 123.459 -177.997 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.8 t 2.52 57.23 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 1 C-N-CA 134.656 5.183 . . . . 0.0 118.865 176.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.688 ' H ' HD13 ' A' ' 183' ' ' LEU . . . -79.16 -108.24 0.22 Allowed Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 122.234 3.654 . . . . 0.0 122.234 -154.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.3 m -45.17 -22.44 0.11 Allowed 'General case' 0 C--N 1.371 1.54 0 C-N-CA 130.643 3.577 . . . . 0.0 120.197 -167.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -85.39 -11.5 54.35 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 127.934 2.493 . . . . 0.0 113.051 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 68.8 m -89.81 150.82 22.09 Favored 'General case' 0 C--N 1.367 1.341 0 C-N-CA 126.342 1.857 . . . . 0.0 114.401 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -47.89 -39.84 19.98 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 129.358 3.063 . . . . 0.0 116.694 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.22 -13.18 59.98 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -106.24 8.19 31.81 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 121.111 -0.993 . . . . 0.0 113.519 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -117.27 179.76 3.95 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 126.082 1.753 . . . . 0.0 108.867 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.2 122.77 15.88 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 126.706 2.002 . . . . 0.0 113.8 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.31 -8.25 64.49 Favored Glycine 0 C--N 1.359 1.846 0 C-N-CA 124.909 1.242 . . . . 0.0 111.755 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.69 154.87 34.73 Favored Glycine 0 C--N 1.362 2.019 0 C-N-CA 126.342 1.925 . . . . 0.0 114.944 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -65.97 -42.48 89.82 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 119.57 3.174 . . . . 0.0 119.57 -172.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.498 ' HB3' ' CD2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -101.62 1.72 38.06 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 121.567 1.985 . . . . 0.0 113.41 -178.25 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -81.06 91.88 6.15 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 127.054 2.142 . . . . 0.0 113.337 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 27.6 m -116.48 102.25 9.34 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 100.49 -3.893 . . . . 0.0 100.49 168.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.31 101.94 13.71 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 125.842 2.734 . . . . 0.0 111.661 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -119.45 149.45 47.77 Favored Pre-proline 0 N--CA 1.422 -1.826 1 C-N-CA 132.338 4.255 . . . . 0.0 100.516 171.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.34 -30.14 79.74 Favored 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 126.137 4.558 . . . . 0.0 115.822 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -68.71 -47.49 66.23 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 126.828 2.051 . . . . 0.0 113.258 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.5 mt -67.28 -45.28 86.42 Favored 'Isoleucine or valine' 0 C--N 1.373 1.59 0 C-N-CA 127.363 2.265 . . . . 0.0 111.337 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . 0.424 2.3 pp -68.81 -32.1 71.57 Favored 'General case' 0 C--N 1.372 1.559 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 174.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 52.5 tpt85 -66.5 -42.02 88.0 Favored 'General case' 0 C--N 1.379 1.862 0 C-N-CA 127.903 2.481 . . . . 0.0 113.165 172.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.21 -33.86 76.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 131.593 3.957 . . . . 0.0 111.275 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 41.2 mtp -69.95 -32.7 71.09 Favored 'General case' 0 C--N 1.371 1.504 0 C-N-CA 126.824 2.05 . . . . 0.0 112.424 164.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -72.11 -45.09 61.94 Favored 'General case' 0 C--N 1.383 2.026 0 CA-C-N 121.259 1.845 . . . . 0.0 111.647 174.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -64.78 -50.52 66.44 Favored 'General case' 0 C--N 1.381 1.952 0 C-N-CA 129.443 3.097 . . . . 0.0 111.586 174.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.3 -52.47 61.84 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-O 116.879 -1.534 . . . . 0.0 113.912 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.26 -43.91 71.37 Favored 'General case' 0 C--N 1.383 2.036 0 CA-C-N 121.822 2.101 . . . . 0.0 114.048 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -36.59 84.71 Favored 'General case' 0 C--N 1.366 1.294 0 O-C-N 119.12 -2.238 . . . . 0.0 115.809 172.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -75.52 -44.65 42.55 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.688 HD13 ' H ' ' A' ' 153' ' ' GLY 0.259 1.2 tt -58.93 -42.97 91.03 Favored 'General case' 0 C--N 1.358 0.955 1 C-N-CA 132.174 4.19 . . . . 0.0 116.051 176.851 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.278 0.0 OUTLIER -91.56 -7.37 50.43 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.342 1.457 . . . . 0.0 111.068 -177.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -119.09 -112.34 0.34 Allowed 'General case' 0 C--N 1.362 1.122 0 O-C-N 121.629 -0.669 . . . . 0.0 111.979 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -127.05 158.27 37.43 Favored 'General case' 0 C--N 1.36 1.059 0 O-C-N 120.337 -1.477 . . . . 0.0 110.667 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.298 24.0 tttm -51.63 -37.01 48.23 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 130.708 3.603 . . . . 0.0 116.774 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.5 tp -53.7 -29.71 17.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 129.273 3.029 . . . . 0.0 113.526 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.263 6.1 mptt -72.05 -47.92 48.1 Favored 'General case' 0 C--N 1.371 1.542 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 175.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.37 -37.43 60.62 Favored 'General case' 0 C--N 1.368 1.384 0 CA-C-N 123.168 2.713 . . . . 0.0 115.335 172.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.46 -25.2 63.97 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 126.426 1.89 . . . . 0.0 114.552 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -60.99 -38.03 84.56 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.612 2.765 . . . . 0.0 113.542 166.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -85.17 -51.04 6.9 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 126.741 2.017 . . . . 0.0 108.68 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 66.52 -72.14 0.09 Allowed 'General case' 0 C--N 1.365 1.252 0 C-N-CA 127.818 2.447 . . . . 0.0 116.027 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.67 -5.96 2.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 C-N-CA 129.426 3.09 . . . . 0.0 111.642 176.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.428 85.1 p 97.43 -98.6 0.0 OUTLIER 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.684 2.794 . . . . 0.0 111.236 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -115.89 113.59 23.54 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 125.399 1.48 . . . . 0.0 109.504 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -158.68 -63.99 0.02 OUTLIER Pre-proline 0 C--N 1.351 0.649 0 CA-C-O 116.819 -1.563 . . . . 0.0 107.627 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.36 64.59 8.89 Favored 'Trans proline' 0 C--N 1.364 1.362 0 CA-C-N 125.295 2.927 . . . . 0.0 111.109 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 20.2 t -107.68 36.04 2.88 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.465 1.506 . . . . 0.0 112.179 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 C--N 1.362 1.122 0 C-N-CA 128.599 2.76 . . . . 0.0 116.738 176.34 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.463 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 36.8 m . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -139.21 94.82 2.84 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 121.071 -1.018 . . . . 0.0 113.725 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.51 126.26 45.56 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 121.25 -0.906 . . . . 0.0 109.113 -174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.4 p -111.09 165.82 11.97 Favored Pre-proline 0 C--N 1.364 1.212 0 C-N-CA 127.671 2.388 . . . . 0.0 114.243 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -56.21 139.66 86.24 Favored 'Trans proline' 0 C--N 1.365 1.425 1 C-N-CA 125.622 4.215 . . . . 0.0 120.867 -167.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.4 -24.54 9.75 Favored Glycine 0 C--N 1.361 1.955 0 C-N-CA 128.287 2.851 . . . . 0.0 110.885 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.43 170.21 12.18 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 119.895 1.847 . . . . 0.0 114.251 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.2 mm? -98.28 141.92 30.58 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 103.212 -2.885 . . . . 0.0 103.212 164.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 149' ' ' LYS . 19.3 m -143.77 141.46 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -175.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.451 ' CZ3' ' HB2' ' A' ' 165' ' ' PHE . 28.0 m95 -99.02 129.85 45.32 Favored 'General case' 0 C--O 1.214 -0.787 1 O-C-N 115.97 -4.206 . . . . 0.0 103.455 171.396 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -114.48 147.33 39.5 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 121.087 1.767 . . . . 0.0 109.494 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -118.71 145.83 45.21 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 37.1 ttm -126.69 154.77 43.64 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 123.233 1.492 . . . . 0.0 111.296 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.73 80.7 0.01 OUTLIER 'General case' 0 C--N 1.355 0.847 0 C-N-CA 131.669 3.988 . . . . 0.0 115.838 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.57 7.09 37.47 Favored Glycine 0 C--N 1.359 1.808 0 C-N-CA 125.504 1.526 . . . . 0.0 113.519 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -114.91 160.32 34.09 Favored Pre-proline 0 C--N 1.356 0.875 0 C-N-CA 125.65 1.58 . . . . 0.0 107.591 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -71.79 166.07 30.61 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.952 3.768 . . . . 0.0 113.422 168.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -49.35 129.49 18.61 Favored 'General case' 0 C--N 1.364 1.203 0 C-N-CA 128.356 2.662 . . . . 0.0 117.147 167.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.463 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 7.4 m95 -134.21 109.0 11.47 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 121.586 3.921 . . . . 0.0 121.586 -173.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 19.2 Cg_endo -62.22 110.83 1.11 Allowed 'Trans proline' 0 C--N 1.389 2.679 1 C-N-CA 126.663 4.909 . . . . 0.0 112.743 167.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -123.01 164.98 17.53 Favored 'General case' 0 C--N 1.352 0.677 1 C-N-CA 133.286 4.634 . . . . 0.0 116.022 -170.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp -116.46 132.54 56.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 129.447 3.099 . . . . 0.0 107.254 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -86.16 118.85 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 O-C-N 119.913 -1.742 . . . . 0.0 106.537 174.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -127.36 149.78 49.9 Favored 'General case' 0 C--N 1.368 1.391 0 O-C-N 119.002 -2.311 . . . . 0.0 111.059 -170.139 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -102.0 113.49 26.77 Favored 'General case' 0 C--N 1.37 1.471 0 CA-C-O 122.489 1.138 . . . . 0.0 111.511 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -79.49 158.81 73.28 Favored Pre-proline 0 C--N 1.353 0.738 0 C-N-CA 129.367 3.067 . . . . 0.0 112.592 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.28 71.4 Cg_exo -47.66 1.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.371 1 C-N-CA 130.356 7.37 . . . . 0.0 121.498 -171.515 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -98.89 31.65 2.9 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 131.588 3.955 . . . . 0.0 106.646 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.289 0.0 OUTLIER -68.7 150.81 47.49 Favored 'General case' 0 C--N 1.373 1.621 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -169.355 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.69 -20.11 27.59 Favored Glycine 0 C--N 1.365 2.158 0 C-N-CA 126.922 2.201 . . . . 0.0 112.552 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.7 m -130.44 147.0 52.09 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 101.269 -3.604 . . . . 0.0 101.269 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.405 ' HB2' ' NE2' ' A' ' 130' ' ' HIS . 7.3 p90 -130.7 -0.73 4.31 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-N 121.111 1.778 . . . . 0.0 114.882 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.7 pt -106.48 148.0 11.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.475 0 CA-C-O 123.904 1.812 . . . . 0.0 113.734 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -119.01 126.58 52.06 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 102.229 -3.248 . . . . 0.0 102.229 172.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -148.16 143.79 27.32 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 120.191 -1.568 . . . . 0.0 110.295 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.54 93.74 4.22 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 127.51 2.324 . . . . 0.0 108.821 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.19 -76.03 0.34 Allowed Glycine 0 C--N 1.365 2.19 0 N-CA-C 119.891 2.716 . . . . 0.0 119.891 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -149.01 60.38 1.05 Allowed 'General case' 0 C--N 1.358 0.959 0 CA-C-O 124.014 1.864 . . . . 0.0 109.055 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.7 m -169.59 133.8 1.34 Allowed 'General case' 0 C--N 1.349 0.566 0 C-N-CA 127.551 2.341 . . . . 0.0 105.48 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.94 146.82 31.07 Favored 'Isoleucine or valine' 0 C--N 1.363 1.186 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -134.35 142.77 47.34 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 129.173 2.989 . . . . 0.0 107.264 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.3 162.21 26.14 Favored 'Isoleucine or valine' 0 C--N 1.368 1.387 0 C-N-CA 127.301 2.24 . . . . 0.0 107.897 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 111' ' ' TYR . 0.4 OUTLIER -94.0 133.4 37.49 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 119.576 -1.953 . . . . 0.0 111.031 175.123 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.91 172.97 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.38 158.09 38.22 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 166.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -113.86 130.75 56.45 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -75.11 71.93 2.19 Favored 'General case' 0 C--N 1.372 1.578 0 C-N-CA 126.759 2.023 . . . . 0.0 109.876 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -95.7 -102.92 0.16 Allowed 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.042 1.337 . . . . 0.0 111.132 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -106.72 -62.69 1.36 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 126.216 1.807 . . . . 0.0 113.867 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 p -85.65 -32.61 0.46 Allowed Pre-proline 0 C--N 1.364 1.204 0 N-CA-C 119.374 3.102 . . . . 0.0 119.374 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -84.86 -176.1 14.16 Favored 'Cis proline' 0 CA--C 1.544 0.989 1 CA-C-N 130.358 4.735 . . . . 0.0 112.727 -0.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.315 4.6 t -97.53 154.86 17.24 Favored 'General case' 0 C--N 1.372 1.57 0 C-N-CA 127.216 2.206 . . . . 0.0 113.051 171.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.79 152.47 41.27 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.946 1.698 . . . . 0.0 106.58 171.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.43 -175.47 39.84 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -93.01 117.87 30.54 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 125.189 1.396 . . . . 0.0 108.059 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.2 161.98 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 C-N-CA 125.603 1.561 . . . . 0.0 113.334 -173.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.6 m -76.68 97.63 4.51 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 126.541 1.936 . . . . 0.0 107.18 171.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.511 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 35.1 tttp -54.62 -29.05 50.89 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 128.283 2.633 . . . . 0.0 115.878 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 60.7 ttt180 -70.42 -13.37 62.1 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 127.105 2.162 . . . . 0.0 114.098 173.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.8 mt -98.12 3.84 49.14 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 126.982 2.113 . . . . 0.0 111.784 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 23.4 mt -89.86 135.01 33.89 Favored 'General case' 0 C--N 1.37 1.47 0 C-N-CA 126.661 1.984 . . . . 0.0 111.221 173.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 71.0 mmtt -114.65 158.75 39.45 Favored Pre-proline 0 C--N 1.346 0.448 0 C-N-CA 127.703 2.401 . . . . 0.0 106.279 -177.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.55 158.23 14.42 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 124.814 3.676 . . . . 0.0 118.563 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -44.09 92.35 0.01 OUTLIER 'General case' 0 C--N 1.357 0.906 1 C-N-CA 132.949 4.5 . . . . 0.0 119.975 171.85 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.4 t -162.28 167.77 23.37 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 102.517 -3.142 . . . . 0.0 102.517 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.74 -157.96 7.58 Favored Glycine 0 C--N 1.365 2.172 0 N-CA-C 119.776 2.67 . . . . 0.0 119.776 -165.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.3 t -45.41 -11.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 1 N-CA-C 122.066 4.099 . . . . 0.0 122.066 -165.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -107.4 -10.01 15.86 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 129.322 3.049 . . . . 0.0 112.709 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 59.8 m -81.88 138.88 34.96 Favored 'General case' 0 C--N 1.376 1.728 0 C-N-CA 127.736 2.415 . . . . 0.0 111.085 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.251 33.1 ttmt -52.22 -33.49 41.43 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -86.71 -0.94 57.25 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 119.318 0.963 . . . . 0.0 112.963 171.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.89 3.25 10.0 Favored 'General case' 0 C--N 1.371 1.53 0 CA-C-N 120.25 1.387 . . . . 0.0 113.444 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.251 7.0 tm0? -109.9 179.72 4.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.134 2.974 . . . . 0.0 107.331 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -70.74 122.47 19.9 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 120.141 -1.599 . . . . 0.0 113.175 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.37 -5.27 55.1 Favored Glycine 0 C--N 1.363 2.047 0 O-C-N 120.961 -1.087 . . . . 0.0 111.757 -170.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.89 152.22 25.77 Favored Glycine 0 C--N 1.361 1.928 0 C-N-CA 128.648 3.023 . . . . 0.0 114.211 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -62.64 -41.7 99.18 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.451 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-85 -85.48 -7.54 58.85 Favored 'General case' 0 CA--C 1.556 1.174 0 O-C-N 120.269 -1.519 . . . . 0.0 113.57 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -77.92 95.35 4.75 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 128.811 2.844 . . . . 0.0 114.839 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 40.7 t -114.77 128.22 56.18 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 102.461 -3.163 . . . . 0.0 102.461 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -100.76 100.26 10.9 Favored 'General case' 0 C--N 1.362 1.125 0 CA-C-O 125.613 2.625 . . . . 0.0 109.229 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -121.62 138.25 28.16 Favored Pre-proline 0 N--CA 1.421 -1.897 2 C-N-CA 135.988 5.715 . . . . 0.0 98.211 166.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.96 -26.41 66.59 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 125.073 3.848 . . . . 0.0 114.144 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -66.73 -36.65 82.96 Favored 'General case' 0 C--N 1.369 1.428 0 C-N-CA 129.012 2.925 . . . . 0.0 112.633 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 65.3 mt -73.41 -45.99 50.57 Favored 'Isoleucine or valine' 0 C--N 1.374 1.651 0 C-N-CA 126.018 1.727 . . . . 0.0 110.417 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.12 -45.9 89.84 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 125.207 1.403 . . . . 0.0 113.535 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -62.42 -35.53 79.54 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.67 77.25 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 129.673 3.189 . . . . 0.0 110.795 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.71 -38.99 87.85 Favored 'General case' 0 C--N 1.382 2.017 0 C-N-CA 125.197 1.399 . . . . 0.0 111.597 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -74.07 -42.14 60.63 Favored 'General case' 0 C--N 1.374 1.655 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -48.06 64.71 Favored 'General case' 0 C--N 1.371 1.533 0 C-N-CA 130.671 3.589 . . . . 0.0 111.83 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.03 99.08 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 124.592 1.157 . . . . 0.0 113.491 169.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.2 -52.49 63.58 Favored 'General case' 0 C--N 1.375 1.715 0 C-N-CA 126.006 1.722 . . . . 0.0 111.66 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.35 -37.58 67.66 Favored 'General case' 0 C--N 1.372 1.544 0 CA-C-N 121.139 1.79 . . . . 0.0 115.8 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.18 -44.82 36.29 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 116.029 1.862 . . . . 0.0 116.029 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -31.03 67.16 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.21 -10.53 49.52 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 126.535 1.934 . . . . 0.0 110.608 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -123.43 -100.79 0.41 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 125.436 1.494 . . . . 0.0 112.176 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -135.57 158.0 45.47 Favored 'General case' 0 C--N 1.363 1.194 0 O-C-N 120.26 -1.525 . . . . 0.0 113.846 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -50.98 -37.34 44.19 Favored 'General case' 0 C--N 1.369 1.421 1 C-N-CA 132.389 4.276 . . . . 0.0 115.758 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.3 tt -55.23 -33.77 31.41 Favored 'Isoleucine or valine' 0 C--N 1.359 1.012 0 C-N-CA 129.925 3.29 . . . . 0.0 113.238 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -71.07 -45.29 64.05 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 125.829 1.651 . . . . 0.0 115.037 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -74.87 -42.45 57.86 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 174.408 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.292 96.2 mt -73.93 -19.39 60.7 Favored 'General case' 0 C--N 1.371 1.507 0 O-C-N 120.432 -1.417 . . . . 0.0 114.037 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -58.4 -32.06 68.26 Favored 'General case' 0 C--N 1.377 1.803 0 C-N-CA 126.769 2.027 . . . . 0.0 114.155 168.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.28 -51.55 3.95 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 127.053 2.141 . . . . 0.0 108.874 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 42.97 -95.11 0.02 OUTLIER 'General case' 0 C--N 1.38 1.913 0 C-N-CA 130.145 3.378 . . . . 0.0 114.427 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.377 2.5 p . . . . . 0 N--CA 1.443 -0.809 0 N-CA-C 100.811 -3.774 . . . . 0.0 100.811 162.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.417 ' HB2' ' HA ' ' A' ' 146' ' ' ARG 0.412 37.5 m . . . . . 0 C--O 1.222 -0.352 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 66.96 60.15 0.53 Allowed 'General case' 0 C--N 1.359 1.003 0 N-CA-C 120.396 3.48 . . . . 0.0 120.396 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -117.38 125.97 51.88 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 119.878 -1.764 . . . . 0.0 110.16 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.474 28.7 p -111.72 168.43 7.64 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 128.624 2.77 . . . . 0.0 115.55 -172.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 73.1 Cg_endo -71.25 151.63 60.69 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 124.434 3.423 . . . . 0.0 118.863 -164.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.77 -7.29 81.64 Favored Glycine 0 C--N 1.37 2.447 0 C-N-CA 128.875 3.131 . . . . 0.0 111.109 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -94.0 164.02 13.25 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 126.246 1.818 . . . . 0.0 110.493 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.74 140.26 37.24 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 119.098 -2.251 . . . . 0.0 107.249 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 m -133.51 153.37 36.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 C-N-CA 125.766 1.626 . . . . 0.0 108.979 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -102.84 116.76 33.19 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 101.422 -3.547 . . . . 0.0 101.422 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -115.12 142.51 46.56 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.727 1.211 . . . . 0.0 113.997 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -116.15 132.93 56.52 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 33.2 ttm -115.98 139.05 50.64 Favored 'General case' 0 CA--C 1.509 -0.629 0 O-C-N 120.099 -1.625 . . . . 0.0 107.267 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.65 100.35 0.1 Allowed 'General case' 0 C--N 1.366 1.324 0 C-N-CA 127.379 2.272 . . . . 0.0 114.07 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.56 -22.15 22.55 Favored Glycine 0 C--N 1.358 1.761 0 C-N-CA 125.367 1.461 . . . . 0.0 113.624 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -97.99 166.81 12.76 Favored Pre-proline 0 C--N 1.361 1.088 0 O-C-N 121.036 -1.273 . . . . 0.0 109.823 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.68 166.18 30.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.803 3.669 . . . . 0.0 113.34 169.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.657 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 5.0 m95 -58.17 135.27 57.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.798 2.839 . . . . 0.0 115.309 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.438 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 24.0 m95 -133.65 114.77 13.3 Favored Pre-proline 0 C--N 1.367 1.354 1 N-CA-C 121.844 4.016 . . . . 0.0 121.844 -174.554 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -64.91 124.96 13.87 Favored 'Trans proline' 0 C--N 1.391 2.772 1 C-N-CA 125.965 4.444 . . . . 0.0 110.542 160.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 p -147.25 165.15 30.95 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 128.29 2.636 . . . . 0.0 115.017 -156.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.613 HD22 ' HB2' ' A' ' 190' ' ' ARG . 3.7 pp -119.45 144.3 47.03 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 125.749 1.619 . . . . 0.0 108.626 173.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.9 t -85.59 116.52 28.92 Favored 'Isoleucine or valine' 0 C--N 1.377 1.796 0 O-C-N 120.174 -1.579 . . . . 0.0 108.059 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -121.56 136.27 54.96 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 116.92 -3.612 . . . . 0.0 114.87 -164.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -75.99 111.36 11.29 Favored 'General case' 0 C--N 1.38 1.908 0 CA-C-O 123.762 1.744 . . . . 0.0 112.654 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.473 ' CG ' ' CD2' ' A' ' 130' ' ' HIS . 10.3 t60 -67.18 161.18 66.04 Favored Pre-proline 0 C--N 1.343 0.285 1 C-N-CA 132.903 4.481 . . . . 0.0 117.641 -170.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.23 -14.05 3.8 Favored 'Trans proline' 0 CA--C 1.554 1.52 1 C-N-CA 125.542 4.161 . . . . 0.0 116.398 174.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -104.69 40.01 1.57 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 129.72 3.208 . . . . 0.0 109.633 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -67.58 151.47 47.27 Favored 'General case' 0 C--N 1.372 1.566 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.74 -11.92 32.51 Favored Glycine 0 C--N 1.358 1.768 0 CA-C-N 112.396 -2.184 . . . . 0.0 110.369 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 t -125.61 166.57 16.47 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 101.855 -3.387 . . . . 0.0 101.855 167.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -154.72 -25.63 0.12 Allowed 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.581 -1.324 . . . . 0.0 114.194 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.0 pt -114.38 154.54 15.73 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 O-C-N 120.491 -1.38 . . . . 0.0 112.086 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -142.92 152.84 42.48 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 128.338 2.655 . . . . 0.0 105.027 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.31 127.99 19.2 Favored 'General case' 0 C--N 1.361 1.089 0 O-C-N 120.793 -1.192 . . . . 0.0 110.424 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -117.94 93.04 3.99 Favored 'General case' 0 C--N 1.363 1.17 0 C-N-CA 127.407 2.283 . . . . 0.0 110.135 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.11 -63.96 0.01 OUTLIER Glycine 0 C--N 1.362 2.006 0 N-CA-C 122.056 3.582 . . . . 0.0 122.056 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -146.62 38.34 1.02 Allowed 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.965 1.306 . . . . 0.0 111.724 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 m -167.63 139.67 3.15 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 119.847 -1.783 . . . . 0.0 106.498 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.66 132.97 70.59 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 CA-C-O 123.505 1.621 . . . . 0.0 109.959 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -106.83 158.94 16.62 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 127.938 2.495 . . . . 0.0 113.481 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 145' ' ' LYS . 33.8 m -149.09 164.66 4.09 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 C-N-CA 130.707 3.603 . . . . 0.0 102.755 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.473 ' CD2' ' CG ' ' A' ' 113' ' ' HIS . 6.2 m80 -89.94 141.82 28.29 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 121.19 -0.944 . . . . 0.0 112.248 170.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 m -151.1 169.81 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -133.53 152.91 51.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -109.43 132.26 54.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.518 1.927 . . . . 0.0 108.335 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.511 ' HB3' HH21 ' A' ' 178' ' ' ARG . 29.3 m-85 -68.54 63.77 0.11 Allowed 'General case' 0 C--N 1.371 1.503 0 C-N-CA 127.066 2.147 . . . . 0.0 114.256 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.91 -118.22 0.08 Allowed 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.451 2.3 . . . . 0.0 111.913 -174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -106.85 -58.52 1.92 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.669 1.587 . . . . 0.0 112.807 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.298 27.5 p -77.18 -34.03 1.16 Allowed Pre-proline 0 C--N 1.364 1.209 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.35 -169.5 7.75 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 CA-C-N 127.683 3.779 . . . . 0.0 111.616 -1.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.3 m -95.17 135.08 37.17 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.814 1.246 . . . . 0.0 107.753 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.9 tmm_? -158.1 167.92 28.52 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.06 -148.74 17.04 Favored Glycine 0 C--N 1.352 1.417 1 N-CA-C 101.239 -4.744 . . . . 0.0 101.239 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -89.58 156.78 18.38 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 167.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.4 -177.68 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 O-C-N 120.636 -1.29 . . . . 0.0 107.712 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.6 t -90.8 120.07 31.54 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 101.864 -3.384 . . . . 0.0 101.864 167.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.69 ' HB2' HG22 ' A' ' 129' ' ' VAL 0.492 0.0 OUTLIER -78.53 -10.94 59.91 Favored 'General case' 0 C--N 1.373 1.603 0 CA-C-N 123.113 2.688 . . . . 0.0 115.685 -174.396 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.417 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 96.2 mtt180 -74.84 -5.53 44.06 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.01 1.324 . . . . 0.0 113.814 172.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.93 2.17 32.16 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 127.102 2.161 . . . . 0.0 112.173 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 43.0 mt -96.89 125.69 41.51 Favored 'General case' 0 C--N 1.368 1.376 0 C-N-CA 127.389 2.276 . . . . 0.0 109.956 174.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -114.7 167.74 9.22 Favored Pre-proline 0 C--N 1.347 0.493 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.0 157.09 15.31 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.306 3.337 . . . . 0.0 113.991 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.64 150.57 20.21 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 123.426 1.584 . . . . 0.0 107.89 170.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.8 t -173.08 -45.58 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.835 1 N-CA-C 97.26 -5.089 . . . . 0.0 97.26 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 128.35 -149.76 18.33 Favored Glycine 0 CA--C 1.474 -2.471 0 C-N-CA 117.892 -2.099 . . . . 0.0 116.865 135.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.9 m -46.5 -18.78 0.07 Allowed 'General case' 0 C--N 1.375 1.68 1 C-N-CA 133.027 4.531 . . . . 0.0 116.67 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 0.94 54.92 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 129.881 3.272 . . . . 0.0 112.582 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.9 m -86.51 142.56 28.26 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 127.529 2.331 . . . . 0.0 111.409 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -61.69 -27.45 68.71 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -79.7 -17.08 54.45 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 124.935 1.294 . . . . 0.0 111.372 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.27 4.21 51.01 Favored 'General case' 0 C--N 1.371 1.515 0 C-N-CA 124.813 1.245 . . . . 0.0 113.017 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -123.74 177.34 5.76 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 120.048 -1.657 . . . . 0.0 111.228 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -57.97 121.84 11.55 Favored 'General case' 0 C--N 1.372 1.576 0 C-N-CA 126.483 1.913 . . . . 0.0 114.598 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.32 -14.52 59.52 Favored Glycine 0 C--N 1.356 1.671 0 C-N-CA 125.174 1.369 . . . . 0.0 112.299 -169.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.6 153.64 40.91 Favored Glycine 0 C--N 1.361 1.941 0 N-CA-C 119.857 2.703 . . . . 0.0 119.857 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -55.86 -42.21 75.51 Favored 'General case' 0 C--N 1.363 1.169 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.657 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.308 0.5 OUTLIER -106.01 -12.16 15.9 Favored 'General case' 0 C--N 1.358 0.951 0 O-C-N 120.638 -1.289 . . . . 0.0 113.619 -179.796 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . 0.301 0.0 OUTLIER -41.68 -27.86 0.12 Allowed 'General case' 0 C--N 1.365 1.248 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.2 m -14.53 90.94 0.01 OUTLIER 'General case' 0 C--N 1.381 1.962 1 C-N-CA 131.901 4.08 . . . . 0.0 116.917 -174.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.35 102.11 13.71 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-O 125.653 2.644 . . . . 0.0 115.045 -163.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -119.96 144.53 37.71 Favored Pre-proline 0 N--CA 1.416 -2.163 3 C-N-CA 134.909 5.284 . . . . 0.0 100.184 170.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -60.31 -28.95 87.85 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 125.014 3.809 . . . . 0.0 115.487 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -65.72 -36.4 83.49 Favored 'General case' 0 C--N 1.365 1.272 0 C-N-CA 128.806 2.842 . . . . 0.0 112.303 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.438 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 20.4 mm -72.39 -37.73 58.74 Favored 'Isoleucine or valine' 0 C--N 1.374 1.631 0 C-N-CA 126.487 1.915 . . . . 0.0 110.237 175.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.73 -49.38 59.23 Favored 'General case' 0 C--N 1.371 1.502 0 O-C-N 120.324 -1.485 . . . . 0.0 113.646 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -58.43 -39.3 79.44 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 127.391 2.276 . . . . 0.0 114.22 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.0 -37.34 84.02 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 131.41 3.884 . . . . 0.0 110.421 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.4 mtt -66.91 -33.03 74.69 Favored 'General case' 0 C--N 1.366 1.284 0 O-C-N 120.609 -1.307 . . . . 0.0 113.024 167.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.43 -46.86 37.22 Favored 'General case' 0 C--N 1.378 1.83 0 C-N-CA 126.527 1.931 . . . . 0.0 112.577 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.511 HH21 ' HB3' ' A' ' 134' ' ' PHE . 22.4 ttp-105 -66.31 -50.56 63.21 Favored 'General case' 0 C--N 1.372 1.57 0 C-N-CA 129.564 3.145 . . . . 0.0 112.322 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.96 69.61 Favored 'General case' 0 C--N 1.375 1.692 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 167.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -68.64 -50.87 47.86 Favored 'General case' 0 C--N 1.371 1.53 0 O-C-N 120.491 -1.381 . . . . 0.0 111.751 173.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -40.36 83.15 Favored 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.363 1.865 . . . . 0.0 115.537 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.589 ' HB1' ' HG2' ' A' ' 190' ' ' ARG . . . -76.06 -27.25 57.18 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.423 HD13 ' N ' ' A' ' 184' ' ' ASN . 0.2 OUTLIER -78.94 -50.17 11.61 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.899 1.679 . . . . 0.0 111.177 173.236 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.423 ' N ' HD13 ' A' ' 183' ' ' LEU 0.322 0.0 OUTLIER -82.99 -15.71 50.13 Favored 'General case' 0 C--N 1.367 1.355 0 C-N-CA 126.615 1.966 . . . . 0.0 115.176 -169.222 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -110.64 -98.7 0.4 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -136.28 149.32 48.4 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 124.111 0.964 . . . . 0.0 109.936 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -50.73 -34.64 27.77 Favored 'General case' 0 C--N 1.365 1.27 1 C-N-CA 133.668 4.787 . . . . 0.0 112.282 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 6.4 tt -52.24 -30.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.365 1.278 0 C-N-CA 128.855 2.862 . . . . 0.0 112.758 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.273 6.5 mptt -68.39 -43.17 77.91 Favored 'General case' 0 C--N 1.376 1.729 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 172.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.613 ' HB2' HD22 ' A' ' 109' ' ' LEU 0.265 1.2 ptm180 -76.51 -43.62 38.67 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 119.043 2.979 . . . . 0.0 119.043 170.369 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.453 HD12 HH21 ' A' ' 190' ' ' ARG . 12.3 tp -71.65 -27.62 63.2 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 127.38 2.272 . . . . 0.0 113.545 -174.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -81.46 -4.46 55.92 Favored 'General case' 0 C--N 1.366 1.298 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 170.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.58 -44.69 5.5 Favored 'General case' 0 C--N 1.366 1.324 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 58.97 -114.34 0.73 Allowed 'General case' 0 C--N 1.372 1.545 0 C-N-CA 127.309 2.243 . . . . 0.0 113.119 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.351 0.644 0 C-N-CA 126.45 1.9 . . . . 0.0 110.448 175.778 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 123.061 1.41 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -118.01 92.79 3.92 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.646 2.379 . . . . 0.0 112.638 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.411 ' H ' ' HD2' ' A' ' 145' ' ' LYS . 5.2 m-85 -125.19 127.25 46.5 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.361 1.464 . . . . 0.0 112.346 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.39 57.8 p -111.72 167.94 8.36 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 119.731 -1.855 . . . . 0.0 113.771 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.4 ' HA ' ' HB ' ' A' ' 110' ' ' VAL . 89.3 Cg_exo -57.63 153.07 44.52 Favored 'Trans proline' 0 C--N 1.373 1.84 1 C-N-CA 126.565 4.843 . . . . 0.0 120.821 -174.131 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.82 -41.87 2.06 Favored Glycine 0 C--N 1.377 2.823 0 C-N-CA 127.483 2.468 . . . . 0.0 107.02 -165.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -73.84 159.57 32.67 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.511 HD13 ' HE ' ' A' ' 190' ' ' ARG . 0.1 OUTLIER -105.51 142.56 35.05 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.155 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.814 HG21 HD13 ' A' ' 148' ' ' LEU . 17.7 m -142.82 151.73 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.452 ' CE3' ' HG3' ' A' ' 107' ' ' PRO . 41.0 m95 -99.92 121.1 40.82 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 168.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.469 ' CB ' HD22 ' A' ' 148' ' ' LEU . . . -102.11 152.27 21.19 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 121.125 1.784 . . . . 0.0 112.345 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -116.9 131.9 56.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 102.398 -3.186 . . . . 0.0 102.398 169.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 34.8 ttm -118.47 138.38 52.53 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.31 101.66 0.45 Allowed 'General case' 0 C--N 1.369 1.424 0 C-N-CA 125.789 1.635 . . . . 0.0 113.816 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.19 -6.0 25.21 Favored Glycine 0 C--N 1.36 1.895 0 C-N-CA 125.667 1.604 . . . . 0.0 113.206 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.24 164.3 15.14 Favored Pre-proline 0 C--N 1.354 0.797 0 C-N-CA 125.779 1.632 . . . . 0.0 109.524 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.05 166.1 30.64 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 124.274 3.316 . . . . 0.0 112.774 162.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -57.84 123.3 15.28 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 129.061 2.944 . . . . 0.0 114.44 171.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -134.15 116.1 13.17 Favored Pre-proline 0 CA--C 1.563 1.476 1 N-CA-C 123.75 4.722 . . . . 0.0 123.75 -168.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HG3' ' CE3' ' A' ' 97' ' ' TRP . 53.8 Cg_exo -54.84 110.38 0.53 Allowed 'Trans proline' 0 C--N 1.396 3.056 1 C-N-CA 127.635 5.556 . . . . 0.0 114.898 164.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.5 p -125.72 164.04 21.5 Favored 'General case' 0 CA--C 1.536 0.431 1 C-N-CA 132.342 4.257 . . . . 0.0 115.901 -169.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.522 HD13 ' HG3' ' A' ' 190' ' ' ARG . 5.7 tp -115.8 138.25 51.32 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 118.65 -2.532 . . . . 0.0 108.257 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 92' ' ' PRO . 2.1 t -81.0 118.93 29.65 Favored 'Isoleucine or valine' 0 C--N 1.37 1.476 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -115.8 154.58 29.39 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.03 -1.669 . . . . 0.0 115.36 -163.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -111.67 113.68 26.22 Favored 'General case' 0 C--N 1.372 1.545 0 C-N-CA 125.767 1.627 . . . . 0.0 108.812 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.418 ' H ' ' CD2' ' A' ' 130' ' ' HIS . 1.5 m-70 -69.08 160.94 76.26 Favored Pre-proline 0 C--N 1.363 1.188 0 C-N-CA 130.994 3.717 . . . . 0.0 110.191 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.67 0.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.5 1 C-N-CA 128.071 5.847 . . . . 0.0 119.226 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -99.57 34.96 2.08 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 130.542 3.537 . . . . 0.0 105.865 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.322 0.0 OUTLIER -61.35 120.86 11.26 Favored 'General case' 0 C--N 1.382 1.993 0 C-N-CA 126.972 2.109 . . . . 0.0 115.542 -166.276 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.85 -20.49 26.72 Favored Glycine 0 C--N 1.356 1.678 0 C-N-CA 127.302 2.382 . . . . 0.0 111.583 -171.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 p -116.09 119.15 34.92 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 103.979 -2.6 . . . . 0.0 103.979 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.494 ' HB2' ' CE1' ' A' ' 130' ' ' HIS . 16.4 p90 -148.42 -9.65 0.37 Allowed 'General case' 0 C--N 1.363 1.156 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -170.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 pt -109.69 153.18 11.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-N 120.074 1.306 . . . . 0.0 112.473 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -142.28 136.52 29.85 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 104.138 -2.542 . . . . 0.0 104.138 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -150.68 127.24 10.82 Favored 'General case' 0 C--N 1.363 1.166 0 O-C-N 120.044 -1.66 . . . . 0.0 110.986 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -118.41 93.38 4.1 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 125.919 1.688 . . . . 0.0 110.534 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.16 -51.89 0.01 OUTLIER Glycine 0 C--N 1.363 2.033 1 N-CA-C 124.096 4.398 . . . . 0.0 124.096 171.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -137.64 21.58 2.9 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.325 1.45 . . . . 0.0 113.532 -172.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.6 m -163.49 146.39 10.08 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.01 137.72 56.44 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 C-N-CA 123.759 0.824 . . . . 0.0 109.851 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -120.55 130.06 54.06 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 126.829 2.052 . . . . 0.0 107.067 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 145' ' ' LYS . 2.2 m -140.29 150.98 21.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.957 1 N-CA-C 98.855 -4.498 . . . . 0.0 98.855 175.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' ' 119' ' ' PHE . 12.6 p-80 -81.69 130.04 34.92 Favored 'General case' 0 C--N 1.367 1.336 0 C-N-CA 125.392 1.477 . . . . 0.0 113.16 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.2 m -137.74 151.16 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 N-CA-C 102.651 -3.092 . . . . 0.0 102.651 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -111.83 148.43 33.6 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -106.8 125.27 50.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 127.723 2.409 . . . . 0.0 105.802 -174.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -75.36 76.13 2.45 Favored 'General case' 0 C--N 1.372 1.574 0 C-N-CA 124.726 1.21 . . . . 0.0 109.492 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -102.46 -113.66 0.21 Allowed 'General case' 0 C--N 1.358 0.935 0 O-C-N 120.04 -1.662 . . . . 0.0 110.392 -173.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -106.87 -59.23 1.83 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 126.202 1.801 . . . . 0.0 111.32 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.5 p -86.06 -31.38 0.43 Allowed Pre-proline 0 C--N 1.365 1.245 0 N-CA-C 120.322 3.453 . . . . 0.0 120.322 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.1 -172.65 10.27 Favored 'Cis proline' 0 CA--C 1.541 0.853 1 CA-C-N 129.917 4.578 . . . . 0.0 113.418 0.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.8 m -96.81 155.64 16.69 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 129.429 3.092 . . . . 0.0 108.904 170.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -166.1 171.71 12.11 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.54 -169.87 42.12 Favored Glycine 0 CA--C 1.486 -1.752 1 N-CA-C 101.751 -4.54 . . . . 0.0 101.751 163.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -93.93 99.78 12.06 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 169.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.8 m -84.46 176.49 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 C-N-CA 125.563 1.545 . . . . 0.0 109.052 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.7 m -92.98 121.81 34.7 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 170.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.411 ' HD2' ' H ' ' A' ' 90' ' ' PHE 0.309 16.3 pttm -76.36 -11.04 59.83 Favored 'General case' 0 C--N 1.372 1.584 0 CA-C-N 121.421 1.919 . . . . 0.0 113.257 -176.65 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -68.91 -18.85 64.17 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 125.954 1.702 . . . . 0.0 113.487 170.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 147' ' ' LEU . 15.1 mt -91.12 0.65 57.49 Favored 'General case' 0 C--N 1.369 1.424 0 C-N-CA 126.184 1.793 . . . . 0.0 114.571 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.814 HD13 HG21 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -98.47 159.0 15.24 Favored 'General case' 0 C--N 1.364 1.226 0 O-C-N 119.877 -1.764 . . . . 0.0 108.386 176.315 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.66 159.22 45.0 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -74.51 154.59 45.14 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.671 3.58 . . . . 0.0 114.724 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.274 0.1 OUTLIER -18.56 -107.69 0.0 OUTLIER 'General case' 0 C--N 1.363 1.17 2 N-CA-C 123.486 4.624 . . . . 0.0 123.486 177.19 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.326 4.9 t 50.99 -40.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 1 C-N-CA 132.612 4.365 . . . . 0.0 120.413 177.098 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.82 -144.41 38.23 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 118.812 2.285 . . . . 0.0 118.812 176.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.8 m -53.04 -24.97 11.0 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.487 3.515 . . . . 0.0 119.749 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -84.42 -6.07 59.34 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 126.488 1.915 . . . . 0.0 111.951 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.2 m -83.84 146.47 28.08 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.894 1.678 . . . . 0.0 112.87 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -63.4 -27.5 69.34 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 125.702 1.601 . . . . 0.0 112.419 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.37 -23.82 61.97 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 127.417 2.287 . . . . 0.0 113.163 171.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.4 0.81 48.45 Favored 'General case' 0 C--N 1.371 1.518 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.255 1.1 pp0? -115.47 -175.29 2.68 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 125.284 1.433 . . . . 0.0 110.168 176.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -66.27 122.91 18.55 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 126.692 1.997 . . . . 0.0 112.243 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.46 -10.89 58.04 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 124.848 1.213 . . . . 0.0 111.654 -167.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.64 139.84 23.51 Favored Glycine 0 C--N 1.365 2.154 0 N-CA-C 119.618 2.607 . . . . 0.0 119.618 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -61.01 -16.37 42.6 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 119.324 3.083 . . . . 0.0 119.324 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.85 -0.06 17.03 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.701 -1.249 . . . . 0.0 110.805 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -79.1 142.17 36.68 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 126.166 2.889 . . . . 0.0 118.315 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.6 m -172.86 170.46 4.57 Favored 'General case' 0 C--N 1.348 0.508 2 N-CA-C 98.165 -4.754 . . . . 0.0 98.165 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -138.24 101.59 4.43 Favored 'General case' 0 C--N 1.367 1.366 0 CA-C-N 124.931 3.514 . . . . 0.0 111.223 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -119.88 135.24 24.14 Favored Pre-proline 0 N--CA 1.43 -1.428 0 N-CA-C 100.921 -3.733 . . . . 0.0 100.921 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.7 -26.5 80.04 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 125.196 3.93 . . . . 0.0 114.108 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -63.9 -36.39 83.77 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 127.515 2.326 . . . . 0.0 113.424 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.8 mt -70.97 -42.88 77.05 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 C-N-CA 125.582 1.553 . . . . 0.0 110.923 173.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.46 -43.24 77.46 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 124.766 1.226 . . . . 0.0 113.979 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -58.91 -38.69 79.48 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 128.178 2.591 . . . . 0.0 113.259 175.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.26 -34.54 74.93 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 131.357 3.863 . . . . 0.0 110.887 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.427 ' HG2' ' CH2' ' A' ' 97' ' ' TRP . 31.3 mtt -70.4 -37.59 74.49 Favored 'General case' 0 C--N 1.386 2.156 0 C-N-CA 124.03 0.932 . . . . 0.0 111.339 168.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -68.53 -45.29 72.59 Favored 'General case' 0 C--N 1.378 1.842 0 C-N-CA 126.638 1.975 . . . . 0.0 111.62 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -53.93 47.37 Favored 'General case' 0 C--N 1.37 1.471 0 C-N-CA 131.629 3.971 . . . . 0.0 111.698 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.94 -45.26 82.9 Favored 'General case' 0 C--N 1.373 1.6 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 170.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 184' ' ' ASN 0.318 38.8 t70 -64.19 -24.73 67.78 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 127.339 2.256 . . . . 0.0 112.702 176.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -75.09 -43.89 50.47 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 117.922 -2.986 . . . . 0.0 112.228 168.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 190' ' ' ARG . . . -76.25 -39.62 53.99 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 120.069 3.359 . . . . 0.0 120.069 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.24 -26.85 47.47 Favored 'General case' 0 C--N 1.36 1.051 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.2 OUTLIER -89.78 -30.28 18.1 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.461 2.704 . . . . 0.0 107.93 -173.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -104.98 -98.56 0.32 Allowed 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -136.03 159.7 40.89 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 119.995 -1.691 . . . . 0.0 111.691 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.514 ' HA ' ' HD3' ' A' ' 190' ' ' ARG . 44.2 mmtt -51.55 -38.56 54.85 Favored 'General case' 0 C--N 1.377 1.78 0 C-N-CA 131.201 3.801 . . . . 0.0 115.142 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.6 tt -55.22 -36.07 38.44 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 129.171 2.988 . . . . 0.0 113.379 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -43.92 72.49 Favored 'General case' 0 C--N 1.372 1.558 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.522 ' HG3' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -75.25 -43.43 51.54 Favored 'General case' 0 C--N 1.37 1.475 0 CA-C-N 121.241 1.837 . . . . 0.0 114.826 172.123 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.5 tp -71.32 -19.48 62.3 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 128.672 2.789 . . . . 0.0 113.852 -172.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -59.64 -27.9 66.76 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.883 2.073 . . . . 0.0 113.492 164.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.1 21.66 14.47 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 127.472 2.309 . . . . 0.0 111.95 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.03 44.95 0.0 OUTLIER 'General case' 0 C--N 1.374 1.644 0 C-N-CA 131.502 3.921 . . . . 0.0 118.202 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.363 1.183 1 C-N-CA 133.206 4.602 . . . . 0.0 113.827 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 C--O 1.231 0.106 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.285 1.1 p30 -171.81 87.26 0.09 Allowed 'General case' 0 C--N 1.364 1.215 0 C-N-CA 124.973 1.309 . . . . 0.0 112.814 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -124.6 127.65 47.69 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 126.029 1.732 . . . . 0.0 114.814 -171.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.358 98.0 p -110.18 169.62 6.18 Favored Pre-proline 0 CA--C 1.574 1.882 0 C-N-CA 131.025 3.73 . . . . 0.0 114.952 -174.564 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 93.4 Cg_endo -66.19 146.89 82.81 Favored 'Trans proline' 0 C--N 1.385 2.474 1 C-N-CA 126.88 5.054 . . . . 0.0 117.281 -168.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.59 -32.35 7.03 Favored Glycine 0 C--N 1.366 2.236 0 C-N-CA 126.403 1.954 . . . . 0.0 109.365 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -83.12 162.38 21.33 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 124.486 2.089 . . . . 0.0 113.485 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.02 135.4 54.26 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 101.609 -3.478 . . . . 0.0 101.609 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.99 159.06 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 126.209 1.804 . . . . 0.0 107.082 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -98.7 118.37 35.27 Favored 'General case' 0 C--N 1.349 0.559 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.39 138.9 50.97 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 126.37 1.868 . . . . 0.0 113.397 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -113.65 145.84 40.68 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 170.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.1 ttp -128.97 152.82 48.17 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 119.85 -1.781 . . . . 0.0 109.162 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -63.42 89.68 0.04 OUTLIER 'General case' 0 C--N 1.364 1.228 0 C-N-CA 127.716 2.406 . . . . 0.0 115.472 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.17 -4.13 25.36 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 125.665 1.602 . . . . 0.0 112.249 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -98.02 162.15 23.13 Favored Pre-proline 0 C--N 1.357 0.916 0 C-N-CA 125.508 1.523 . . . . 0.0 110.223 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.26 167.08 27.24 Favored 'Trans proline' 0 CA--C 1.544 0.983 1 C-N-CA 125.777 4.318 . . . . 0.0 112.941 163.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -68.3 130.68 43.61 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 127.426 2.29 . . . . 0.0 112.267 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.425 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 6.3 m95 -128.7 131.91 24.04 Favored Pre-proline 0 N--CA 1.429 -1.502 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.56 139.24 30.94 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 124.211 3.274 . . . . 0.0 108.1 149.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.1 p -152.37 164.18 38.0 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 126.936 2.094 . . . . 0.0 111.611 -163.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 190' ' ' ARG . 1.3 pp -111.47 149.44 31.31 Favored 'General case' 0 C--N 1.367 1.356 0 O-C-N 119.982 -1.699 . . . . 0.0 109.87 171.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 131' ' ' VAL . 2.4 t -91.45 119.83 39.41 Favored 'Isoleucine or valine' 0 C--N 1.364 1.222 0 O-C-N 120.608 -1.308 . . . . 0.0 107.787 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -114.61 141.85 47.22 Favored 'General case' 0 C--N 1.37 1.5 0 N-CA-C 120.066 3.358 . . . . 0.0 120.066 -162.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -85.77 111.27 20.0 Favored 'General case' 0 C--N 1.377 1.772 0 O-C-N 118.526 -2.608 . . . . 0.0 110.522 172.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -85.04 160.2 55.58 Favored Pre-proline 0 N--CA 1.449 -0.497 1 C-N-CA 132.108 4.163 . . . . 0.0 109.673 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.81 -13.84 6.8 Favored 'Trans proline' 0 CA--C 1.55 1.306 1 C-N-CA 125.97 4.447 . . . . 0.0 117.08 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -107.41 54.11 0.68 Allowed 'General case' 0 C--N 1.365 1.244 0 C-N-CA 127.848 2.459 . . . . 0.0 107.564 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.43 167.77 19.05 Favored 'General case' 0 C--N 1.368 1.406 0 O-C-N 119.563 -1.961 . . . . 0.0 114.787 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.48 -20.04 48.98 Favored Glycine 0 C--N 1.364 2.086 0 C-N-CA 126.053 1.787 . . . . 0.0 113.559 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.7 m -123.47 120.3 32.52 Favored 'General case' 0 C--N 1.346 0.453 1 N-CA-C 99.465 -4.272 . . . . 0.0 99.465 170.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -122.64 -3.49 8.77 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 -168.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.6 pt -122.81 149.74 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 119.618 -1.926 . . . . 0.0 112.948 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -141.49 160.18 40.68 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 129.854 3.262 . . . . 0.0 104.595 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -152.08 127.57 10.03 Favored 'General case' 0 C--N 1.365 1.272 0 O-C-N 118.935 -2.353 . . . . 0.0 111.459 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.37 92.94 4.7 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.266 1.426 . . . . 0.0 108.78 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.5 -84.96 0.19 Allowed Glycine 0 C--N 1.363 2.053 0 C-N-CA 127.309 2.385 . . . . 0.0 114.57 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -116.74 -15.26 10.75 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 126.277 1.831 . . . . 0.0 110.591 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.1 m -88.43 100.91 13.41 Favored 'General case' 0 C--N 1.365 1.257 0 O-C-N 120.423 -1.423 . . . . 0.0 110.625 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 p -86.46 132.41 32.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 127.452 2.301 . . . . 0.0 108.246 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -117.1 141.98 47.57 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 126.19 1.796 . . . . 0.0 112.569 -173.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.9 164.16 35.97 Favored 'Isoleucine or valine' 0 C--N 1.359 0.986 0 C-N-CA 130.057 3.343 . . . . 0.0 106.094 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -88.55 116.68 26.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.98 1.712 . . . . 0.0 112.596 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 110' ' ' VAL . 3.3 m -134.24 173.76 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 O-C-N 119.25 -2.156 . . . . 0.0 106.87 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.49 147.91 43.73 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 171.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -99.88 127.2 46.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.111 2.164 . . . . 0.0 107.812 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -73.8 62.96 0.85 Allowed 'General case' 0 C--N 1.369 1.429 0 C-N-CA 126.736 2.015 . . . . 0.0 114.153 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -91.35 -108.78 0.1 Allowed 'General case' 0 C--N 1.365 1.248 0 O-C-N 121.392 -0.818 . . . . 0.0 112.561 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.74 -65.34 1.09 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 126.224 1.81 . . . . 0.0 114.097 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.5 p -79.85 -32.6 0.73 Allowed Pre-proline 0 C--N 1.361 1.086 0 N-CA-C 119.464 3.135 . . . . 0.0 119.464 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -92.16 -166.3 2.31 Favored 'Cis proline' 0 CA--C 1.539 0.774 1 CA-C-N 129.988 4.603 . . . . 0.0 110.828 -1.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -97.69 135.48 39.42 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 125.093 1.357 . . . . 0.0 111.678 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.2 tmm_? -136.56 147.34 46.97 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 120.748 1.613 . . . . 0.0 106.915 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.81 -179.87 40.72 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 104.892 -3.283 . . . . 0.0 104.892 170.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -86.55 109.11 18.89 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 127.423 2.289 . . . . 0.0 106.76 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.19 -178.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 125.602 1.561 . . . . 0.0 111.574 -172.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.2 m -100.41 117.29 34.29 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 101.318 -3.586 . . . . 0.0 101.318 169.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 5.6 ttpp -72.42 -14.04 61.6 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 124.026 1.869 . . . . 0.0 113.063 -171.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -75.07 -12.3 60.29 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.971 1.708 . . . . 0.0 113.961 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.46 3.82 43.26 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 126.742 2.017 . . . . 0.0 110.948 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.457 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 31.5 mt -94.25 130.44 40.51 Favored 'General case' 0 C--N 1.366 1.292 0 C-N-CA 126.623 1.969 . . . . 0.0 109.201 173.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.403 ' HG3' ' CE1' ' A' ' 165' ' ' PHE . 5.1 mmtt -114.88 165.65 13.51 Favored Pre-proline 0 C--N 1.35 0.611 0 N-CA-C 102.947 -2.983 . . . . 0.0 102.947 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.56 155.8 16.16 Favored 'Trans proline' 0 C--N 1.326 -0.656 0 C-N-CA 124.644 3.563 . . . . 0.0 112.561 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.64 124.04 41.89 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 121.643 0.735 . . . . 0.0 112.067 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.0 t -161.52 25.77 0.13 Allowed 'General case' 0 C--N 1.358 0.954 0 C-N-CA 127.493 2.317 . . . . 0.0 105.523 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.64 81.74 0.07 OUTLIER Glycine 0 C--N 1.354 1.575 0 C-N-CA 115.941 -3.028 . . . . 0.0 117.55 -162.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 69.9 m -67.92 -11.45 58.76 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 128.571 2.748 . . . . 0.0 114.068 172.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -122.52 37.97 4.27 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 128.445 2.698 . . . . 0.0 109.788 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.3 m -95.09 147.87 22.96 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.584 2.354 . . . . 0.0 108.027 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -61.78 -24.49 66.87 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -82.23 -19.09 40.41 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 125.586 1.554 . . . . 0.0 112.161 168.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.34 -39.62 10.38 Favored 'General case' 0 C--N 1.368 1.393 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.337 0.0 OUTLIER -83.74 -173.67 4.85 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -178.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.74 121.34 15.74 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.81 -1.806 . . . . 0.0 113.462 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.34 -13.24 51.58 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.075 -166.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.9 158.65 36.95 Favored Glycine 0 C--N 1.369 2.375 0 N-CA-C 120.665 3.026 . . . . 0.0 120.665 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -60.05 -41.76 93.02 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 129.084 2.953 . . . . 0.0 117.561 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.403 ' CE1' ' HG3' ' A' ' 149' ' ' LYS . 1.6 m-85 -92.67 -30.1 15.75 Favored 'General case' 0 C--N 1.37 1.463 0 O-C-N 120.9 -1.125 . . . . 0.0 110.538 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.3 t80 0.4 -91.51 0.0 OUTLIER 'General case' 0 C--N 1.382 1.981 1 C-N-CA 133.59 4.756 . . . . 0.0 117.216 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.1 m 49.17 65.77 1.29 Allowed 'General case' 0 C--N 1.364 1.211 0 C-N-CA 130.756 3.623 . . . . 0.0 116.413 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.5 100.93 11.06 Favored 'General case' 0 C--N 1.369 1.415 0 CA-C-O 124.93 2.3 . . . . 0.0 114.049 -170.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -120.63 146.1 42.52 Favored Pre-proline 0 N--CA 1.429 -1.51 1 C-N-CA 132.009 4.124 . . . . 0.0 105.028 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -50.26 -38.3 51.43 Favored 'Trans proline' 0 CA--C 1.548 1.2 1 C-N-CA 127.403 5.402 . . . . 0.0 117.113 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.75 -35.54 75.05 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 128.943 2.897 . . . . 0.0 113.644 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.255 12.8 mt -76.01 -32.12 22.82 Favored 'Isoleucine or valine' 0 C--N 1.371 1.541 0 C-N-CA 127.119 2.168 . . . . 0.0 110.528 175.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 177' ' ' GLN . 19.3 mt -62.91 -53.16 58.42 Favored 'General case' 0 C--N 1.383 2.037 0 C-N-CA 126.704 2.002 . . . . 0.0 109.178 168.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -34.47 68.5 Favored 'General case' 0 C--N 1.369 1.449 0 C-N-CA 128.651 2.78 . . . . 0.0 115.066 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.21 -45.81 68.96 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 130.19 3.396 . . . . 0.0 112.116 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 12.8 mtt -67.03 -33.37 75.4 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-N 119.416 1.007 . . . . 0.0 113.515 170.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 8.6 mt-30 -70.02 -52.19 26.14 Favored 'General case' 0 C--N 1.381 1.976 0 C-N-CA 126.495 1.918 . . . . 0.0 113.06 172.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.274 5.4 ptt180 -72.43 -35.94 68.46 Favored 'General case' 0 C--N 1.384 2.067 0 O-C-N 119.184 -2.198 . . . . 0.0 114.48 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.418 ' O ' HD13 ' A' ' 183' ' ' LEU . . . -66.39 -39.96 89.38 Favored 'General case' 0 C--N 1.37 1.478 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 169.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 29.8 t70 -62.1 -35.78 79.74 Favored 'General case' 0 C--N 1.381 1.971 0 O-C-N 120.082 -1.636 . . . . 0.0 112.092 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -65.46 -45.78 82.4 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 119.337 -2.102 . . . . 0.0 113.743 170.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -71.41 -36.2 71.25 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 179' ' ' ALA 0.291 0.0 OUTLIER -79.74 -28.96 40.44 Favored 'General case' 0 C--N 1.371 1.535 0 O-C-N 119.893 -1.754 . . . . 0.0 114.89 177.415 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 180' ' ' ASP 0.267 0.0 OUTLIER -89.57 -15.48 32.76 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 124.966 1.306 . . . . 0.0 111.061 -176.789 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -115.2 -102.23 0.42 Allowed 'General case' 0 C--N 1.357 0.927 0 O-C-N 122.107 -0.37 . . . . 0.0 110.342 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.459 ' HB3' HG22 ' A' ' 188' ' ' ILE . 25.0 t70 -136.19 156.94 47.95 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 123.097 1.427 . . . . 0.0 109.952 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -50.97 -36.73 40.57 Favored 'General case' 0 C--N 1.361 1.08 1 C-N-CA 131.994 4.117 . . . . 0.0 114.116 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.459 HG22 ' HB3' ' A' ' 186' ' ' ASP . 8.1 tt -54.98 -28.29 20.29 Favored 'Isoleucine or valine' 0 C--N 1.364 1.236 1 C-N-CA 131.808 4.043 . . . . 0.0 113.514 175.284 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.281 5.3 mptt -71.98 -29.53 64.33 Favored 'General case' 0 C--N 1.376 1.733 0 C-N-CA 125.932 1.693 . . . . 0.0 113.551 171.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.501 ' HB2' HD22 ' A' ' 109' ' ' LEU 0.532 0.0 OUTLIER -74.73 -42.21 58.7 Favored 'General case' 0 C--N 1.375 1.713 0 O-C-N 119.198 -2.189 . . . . 0.0 113.368 170.045 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.5 -19.97 65.92 Favored 'General case' 0 C--N 1.379 1.869 0 C-N-CA 129.099 2.959 . . . . 0.0 114.424 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.88 -29.9 70.87 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 128.419 2.688 . . . . 0.0 112.925 169.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mt -105.07 -50.02 3.34 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 125.252 1.421 . . . . 0.0 108.535 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 34.37 38.31 0.03 OUTLIER 'General case' 0 C--N 1.375 1.706 1 C-N-CA 131.889 4.076 . . . . 0.0 119.229 173.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.273 40.5 t . . . . . 0 C--N 1.354 0.793 0 C-N-CA 128.963 2.905 . . . . 0.0 105.67 -170.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.9 p . . . . . 0 C--O 1.225 -0.207 0 CA-C-O 118.927 -0.559 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -155.85 92.4 1.37 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 124.698 1.199 . . . . 0.0 109.303 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -125.56 127.51 46.49 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.441 56.6 p -111.73 167.39 9.17 Favored Pre-proline 0 CA--C 1.562 1.41 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -59.54 137.66 79.02 Favored 'Trans proline' 0 C--N 1.379 2.165 1 C-N-CA 126.957 5.105 . . . . 0.0 118.531 -169.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.2 -22.65 39.8 Favored Glycine 0 C--N 1.371 2.513 0 C-N-CA 126.028 1.775 . . . . 0.0 111.39 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.34 159.31 27.21 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 120.208 -1.76 . . . . 0.0 112.212 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.74 133.35 48.88 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.533 -1.355 . . . . 0.0 107.522 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.13 152.73 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 C-N-CA 126.565 1.946 . . . . 0.0 107.335 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -101.72 119.88 39.47 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 168.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -110.08 149.59 29.81 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 121.487 1.949 . . . . 0.0 111.873 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -117.14 140.91 48.94 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 174.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.9 ttp -126.54 145.17 50.63 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 119.958 -1.714 . . . . 0.0 107.418 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -49.72 86.27 0.0 OUTLIER 'General case' 0 C--N 1.365 1.245 0 C-N-CA 130.457 3.503 . . . . 0.0 117.188 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.71 -3.47 45.83 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.961 1.267 . . . . 0.0 114.064 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -99.95 165.7 14.1 Favored Pre-proline 0 C--N 1.357 0.906 0 C-N-CA 125.7 1.6 . . . . 0.0 108.315 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.44 165.79 31.37 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.323 3.349 . . . . 0.0 113.56 169.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.434 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.0 m95 -63.68 110.19 1.95 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 130.145 3.378 . . . . 0.0 112.824 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 4.9 m95 -109.24 108.55 60.33 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 119.197 3.036 . . . . 0.0 119.197 -172.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 20.3 Cg_endo -54.45 123.03 12.62 Favored 'Trans proline' 0 C--N 1.384 2.413 1 C-N-CA 125.908 4.405 . . . . 0.0 111.708 159.599 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.4 p -148.65 165.72 30.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 124.574 2.13 . . . . 0.0 114.332 -156.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 tp -114.41 138.46 50.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.83 2.452 . . . . 0.0 106.663 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.92 127.88 39.47 Favored 'Isoleucine or valine' 0 C--N 1.364 1.206 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.406 ' CE2' HG12 ' A' ' 195' ' ' VAL . 81.2 t80 -139.73 153.88 47.31 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 122.712 2.505 . . . . 0.0 112.596 -168.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -104.07 114.62 28.99 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.572 2.349 . . . . 0.0 109.158 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -67.74 161.27 67.8 Favored Pre-proline 0 C--N 1.354 0.774 0 C-N-CA 128.267 2.627 . . . . 0.0 112.496 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.04 -1.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.563 1.931 1 C-N-CA 126.494 4.796 . . . . 0.0 118.159 172.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -91.09 34.33 0.93 Allowed 'General case' 0 C--N 1.36 1.04 1 C-N-CA 135.074 5.349 . . . . 0.0 107.32 169.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.329 0.5 OUTLIER -77.92 156.36 30.33 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -173.23 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.39 -10.45 33.27 Favored Glycine 0 C--N 1.359 1.842 0 CA-C-N 111.826 -2.443 . . . . 0.0 111.776 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 t -146.87 150.66 35.68 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 101.269 -3.604 . . . . 0.0 101.269 172.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -149.83 9.64 0.7 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 119.555 1.071 . . . . 0.0 111.055 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.424 HG22 HG12 ' A' ' 129' ' ' VAL . 34.2 pt -117.5 148.81 20.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 CA-C-O 122.302 1.049 . . . . 0.0 110.687 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -137.66 138.89 39.89 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.3 129.78 14.87 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 119.859 -1.776 . . . . 0.0 109.776 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -117.78 93.84 4.3 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.511 2.324 . . . . 0.0 111.157 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.08 -73.07 0.55 Allowed Glycine 0 C--N 1.362 1.98 0 N-CA-C 120.127 2.811 . . . . 0.0 120.127 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -147.21 58.8 1.16 Allowed 'General case' 0 C--N 1.356 0.849 0 CA-C-O 122.601 1.191 . . . . 0.0 110.201 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.1 m -175.56 157.91 2.15 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.47 135.01 35.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 122.598 1.19 . . . . 0.0 109.735 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -115.17 130.37 56.9 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 127.618 2.367 . . . . 0.0 107.164 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 145' ' ' LYS . 10.3 m -125.81 146.43 31.58 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 1 N-CA-C 98.237 -4.727 . . . . 0.0 98.237 172.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.52 ' CG ' HH22 ' A' ' 140' ' ' ARG 0.329 0.4 OUTLIER -81.57 137.32 35.54 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 121.709 0.766 . . . . 0.0 112.449 176.074 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -146.2 165.06 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -129.17 153.43 47.73 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -110.86 122.69 48.49 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.022 1.329 . . . . 0.0 107.564 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -74.83 60.59 0.96 Allowed 'General case' 0 C--N 1.37 1.493 0 C-N-CA 127.689 2.396 . . . . 0.0 114.475 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP 0.31 50.8 p-10 -87.66 -99.21 0.08 Allowed 'General case' 0 C--N 1.363 1.19 0 C-N-CA 125.604 1.562 . . . . 0.0 113.377 -177.069 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -106.84 -65.7 1.07 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.452 1.901 . . . . 0.0 114.57 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.272 10.1 p -77.81 -38.04 1.65 Allowed Pre-proline 0 C--N 1.365 1.251 0 N-CA-C 118.546 2.795 . . . . 0.0 118.546 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -82.43 -174.73 13.76 Favored 'Cis proline' 0 C--N 1.354 0.866 1 CA-C-N 128.707 4.145 . . . . 0.0 113.822 -0.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.274 4.0 t -97.62 154.06 17.8 Favored 'General case' 0 C--N 1.374 1.646 0 C-N-CA 127.613 2.365 . . . . 0.0 111.045 171.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.52 HH22 ' CG ' ' A' ' 130' ' ' HIS . 32.7 ttt-85 -158.44 162.05 37.52 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.26 -163.97 29.64 Favored Glycine 0 CA--C 1.484 -1.87 0 N-CA-C 104.24 -3.544 . . . . 0.0 104.24 166.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -96.65 99.95 11.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.2 m -81.65 178.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 126.973 2.109 . . . . 0.0 108.001 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.5 m -94.92 130.08 41.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.522 ' HB3' HG22 ' A' ' 129' ' ' VAL . 4.2 pttp -79.53 -9.62 59.65 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 119.891 -1.755 . . . . 0.0 113.993 -175.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.21 -13.75 61.61 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.496 1.118 . . . . 0.0 112.475 174.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.7 mt -96.84 1.11 50.27 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 126.436 1.894 . . . . 0.0 114.074 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.09 141.79 28.31 Favored 'General case' 0 C--N 1.372 1.546 0 CA-C-N 121.1 1.773 . . . . 0.0 109.233 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -115.99 158.57 42.1 Favored Pre-proline 0 C--O 1.224 -0.273 0 O-C-N 119.313 -2.117 . . . . 0.0 105.621 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.98 151.44 21.25 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.395 3.397 . . . . 0.0 112.869 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -121.61 117.42 26.67 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-O 122.056 0.932 . . . . 0.0 112.262 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.3 t -160.89 23.72 0.14 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 126.182 1.793 . . . . 0.0 106.698 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.41 70.42 0.3 Allowed Glycine 0 C--N 1.353 1.514 0 C-N-CA 120.424 -0.894 . . . . 0.0 114.578 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 m -63.7 -10.99 22.17 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 131.221 3.808 . . . . 0.0 116.215 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -126.73 29.95 5.6 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 129.226 3.01 . . . . 0.0 108.065 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 t -96.09 136.58 36.36 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 127.695 2.398 . . . . 0.0 107.243 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -47.91 -38.91 17.52 Favored 'General case' 0 C--N 1.369 1.428 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.12 -18.3 60.27 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.608 -1.307 . . . . 0.0 113.885 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.72 -1.38 46.62 Favored 'General case' 0 C--N 1.371 1.505 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.376 0.6 OUTLIER -119.65 -173.51 2.55 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.409 1.484 . . . . 0.0 112.74 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -71.32 122.38 20.18 Favored 'General case' 0 C--N 1.37 1.468 0 O-C-N 119.506 -1.996 . . . . 0.0 112.355 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.26 -8.0 56.92 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.299 0.952 . . . . 0.0 111.774 -168.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.09 157.31 28.12 Favored Glycine 0 C--N 1.363 2.065 0 N-CA-C 117.437 1.735 . . . . 0.0 117.437 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -58.41 -42.53 87.41 Favored 'General case' 0 C--N 1.366 1.304 0 N-CA-C 119.358 3.096 . . . . 0.0 119.358 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.434 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.391 0.2 OUTLIER -106.32 3.15 27.26 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -175.037 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -101.91 144.13 30.92 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.091 1.757 . . . . 0.0 108.87 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.1 m -166.93 147.16 5.64 Favored 'General case' 0 N--CA 1.445 -0.709 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.37 99.89 9.24 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-O 126.398 2.999 . . . . 0.0 111.693 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -120.84 134.46 24.31 Favored Pre-proline 0 N--CA 1.416 -2.145 3 N-CA-C 98.046 -4.798 . . . . 0.0 98.046 164.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -60.74 -22.78 74.47 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.691 4.26 . . . . 0.0 115.509 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.09 -36.33 74.83 Favored 'General case' 0 C--N 1.36 1.059 0 C-N-CA 128.741 2.816 . . . . 0.0 113.829 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.1 mm -71.73 -40.24 69.72 Favored 'Isoleucine or valine' 0 C--N 1.379 1.877 0 C-N-CA 127.553 2.341 . . . . 0.0 108.472 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.0 mt -66.44 -48.57 69.55 Favored 'General case' 0 C--N 1.369 1.454 0 C-N-CA 125.314 1.446 . . . . 0.0 113.264 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -57.81 -34.16 69.35 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 128.288 2.635 . . . . 0.0 114.881 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.431 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . . . -68.35 -45.88 71.65 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 130.959 3.704 . . . . 0.0 111.599 171.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.35 0.0 OUTLIER -64.25 -32.35 73.9 Favored 'General case' 0 C--N 1.38 1.931 0 CA-C-N 120.321 1.419 . . . . 0.0 113.374 168.187 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -68.96 -48.51 62.99 Favored 'General case' 0 C--N 1.376 1.752 0 C-N-CA 126.059 1.743 . . . . 0.0 113.711 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -60.44 -53.51 56.75 Favored 'General case' 0 C--N 1.379 1.884 0 C-N-CA 128.838 2.855 . . . . 0.0 111.108 173.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -59.86 -45.42 92.52 Favored 'General case' 0 C--N 1.365 1.277 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.45 -37.79 70.77 Favored 'General case' 0 C--N 1.378 1.83 0 C-N-CA 127.668 2.387 . . . . 0.0 112.955 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.99 -39.62 72.34 Favored 'General case' 0 C--N 1.361 1.093 0 O-C-N 119.781 -1.824 . . . . 0.0 115.122 173.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.92 -29.35 55.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 119.417 3.118 . . . . 0.0 119.417 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.83 -50.2 69.83 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 130.298 3.439 . . . . 0.0 113.074 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.274 0.0 OUTLIER -90.93 -16.6 27.83 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 127.577 2.351 . . . . 0.0 111.985 -175.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -120.78 -110.91 0.33 Allowed 'General case' 0 C--N 1.357 0.906 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -135.52 149.55 49.51 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 119.797 -1.814 . . . . 0.0 107.836 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.492 0.0 OUTLIER -51.03 -32.69 22.32 Favored 'General case' 0 CA--C 1.5 -0.957 1 C-N-CA 132.017 4.127 . . . . 0.0 117.711 175.49 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 17.4 tt -49.43 -30.91 5.08 Favored 'Isoleucine or valine' 0 C--N 1.365 1.278 0 C-N-CA 130.12 3.368 . . . . 0.0 113.029 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -60.43 -35.88 76.86 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 128.146 2.578 . . . . 0.0 113.955 169.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -75.3 -44.23 46.7 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 171.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 10.0 mp -67.92 -19.95 65.04 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 129.694 3.197 . . . . 0.0 112.753 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -64.86 -38.64 91.64 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 130.652 3.581 . . . . 0.0 114.344 168.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.34 -51.08 3.44 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.78 2.032 . . . . 0.0 109.667 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 46.67 -134.13 1.0 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 131.303 3.841 . . . . 0.0 117.919 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.406 HG12 ' CE2' ' A' ' 111' ' ' TYR 0.318 9.1 p . . . . . 0 C--N 1.368 1.398 0 CA-C-O 124.645 2.164 . . . . 0.0 109.279 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.47 12.1 p . . . . . 0 N--CA 1.464 0.275 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -122.79 102.6 8.13 Favored 'General case' 0 C--N 1.369 1.442 0 O-C-N 120.566 -1.334 . . . . 0.0 110.386 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.448 ' H ' ' HD2' ' A' ' 145' ' ' LYS . 8.5 m-85 -126.06 128.6 47.65 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.766 1.626 . . . . 0.0 114.591 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.5 p -110.67 163.73 16.54 Favored Pre-proline 0 C--N 1.365 1.241 0 O-C-N 119.868 -1.77 . . . . 0.0 115.776 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.67 134.97 65.22 Favored 'Trans proline' 0 C--N 1.373 1.839 1 C-N-CA 126.659 4.906 . . . . 0.0 117.097 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.33 -51.19 0.75 Allowed Glycine 0 C--N 1.353 1.522 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 -169.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -65.49 159.36 24.59 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.47 HD23 HH11 ' A' ' 190' ' ' ARG . 3.5 mm? -102.83 141.49 35.54 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 148' ' ' LEU . 13.1 m -132.42 159.68 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 C-N-CA 126.639 1.976 . . . . 0.0 106.538 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.529 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 52.2 m95 -108.56 115.76 30.7 Favored 'General case' 0 C--O 1.214 -0.786 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 171.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.25 147.66 26.77 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 122.728 2.513 . . . . 0.0 113.602 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -115.14 130.57 56.96 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 170.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 44.1 ttm -116.04 141.19 48.45 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.26 101.29 0.9 Allowed 'General case' 0 C--N 1.364 1.203 0 C-N-CA 126.062 1.745 . . . . 0.0 113.5 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.42 -10.93 23.97 Favored Glycine 0 C--N 1.358 1.782 0 C-N-CA 125.752 1.644 . . . . 0.0 113.45 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -103.9 164.83 14.57 Favored Pre-proline 0 C--N 1.357 0.913 0 C-N-CA 125.567 1.547 . . . . 0.0 109.719 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -71.41 166.09 30.41 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 125.039 3.826 . . . . 0.0 112.752 164.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.92 126.0 25.83 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 127.776 2.43 . . . . 0.0 114.95 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 3.3 m95 -134.75 116.57 12.67 Favored Pre-proline 0 CA--C 1.571 1.787 1 N-CA-C 123.893 4.775 . . . . 0.0 123.893 -169.25 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.529 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 27.1 Cg_exo -56.44 113.45 1.46 Allowed 'Trans proline' 0 C--N 1.401 3.325 1 C-N-CA 126.788 4.992 . . . . 0.0 114.145 166.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -127.06 164.29 21.87 Favored 'General case' 0 N--CA 1.449 -0.508 1 C-N-CA 133.199 4.6 . . . . 0.0 116.104 -168.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.16 146.72 41.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.742 2.817 . . . . 0.0 107.165 172.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 t -91.63 130.64 40.46 Favored 'Isoleucine or valine' 0 C--N 1.37 1.467 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 171.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -132.18 152.47 51.27 Favored 'General case' 0 C--N 1.361 1.066 0 O-C-N 118.729 -2.482 . . . . 0.0 115.097 -164.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -92.31 112.82 24.9 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -65.68 160.7 58.96 Favored Pre-proline 0 C--N 1.36 1.061 0 C-N-CA 128.2 2.6 . . . . 0.0 117.417 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.37 -1.41 0.2 Allowed 'Trans proline' 0 CA--C 1.572 2.398 0 C-N-CA 124.933 3.755 . . . . 0.0 116.895 169.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -115.71 33.92 5.22 Favored 'General case' 0 C--N 1.356 0.883 1 C-N-CA 135.638 5.575 . . . . 0.0 107.247 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.318 1.1 p30 -72.64 150.26 43.17 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -172.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.07 2.94 31.68 Favored Glycine 0 C--N 1.359 1.849 0 CA-C-N 111.99 -2.368 . . . . 0.0 110.959 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.4 m -149.74 130.76 14.38 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 102.141 -3.281 . . . . 0.0 102.141 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -149.37 -10.44 0.31 Allowed 'General case' 0 C--N 1.364 1.21 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.9 pt -108.63 145.6 15.37 Favored 'Isoleucine or valine' 0 C--N 1.369 1.446 0 CA-C-N 121.862 2.119 . . . . 0.0 112.196 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -139.1 137.9 36.58 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -143.27 127.42 17.54 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -117.86 94.0 4.36 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 126.926 2.09 . . . . 0.0 110.675 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.12 -71.02 0.32 Allowed Glycine 0 C--N 1.362 2.027 0 N-CA-C 120.205 2.842 . . . . 0.0 120.205 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -150.38 57.59 0.94 Allowed 'General case' 0 C--N 1.353 0.721 0 CA-C-O 122.512 1.149 . . . . 0.0 109.861 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.5 m -176.8 140.15 0.32 Allowed 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.486 1.914 . . . . 0.0 106.293 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.47 136.98 58.64 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 123.13 1.443 . . . . 0.0 112.31 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 -114.89 141.95 47.24 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.456 2.302 . . . . 0.0 107.994 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 145' ' ' LYS . 8.8 m -146.58 156.62 11.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 1 N-CA-C 98.711 -4.551 . . . . 0.0 98.711 174.202 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -79.66 138.66 37.45 Favored 'General case' 0 C--N 1.37 1.496 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.511 HG11 HD13 ' A' ' 148' ' ' LEU . 1.5 m -139.91 172.08 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 173.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.555 ' HB3' ' HG3' ' A' ' 140' ' ' ARG . 1.4 pp0? -138.08 147.65 44.25 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.34 118.59 34.31 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 127.854 2.462 . . . . 0.0 104.951 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.51 53.36 0.02 OUTLIER 'General case' 0 C--N 1.373 1.622 0 C-N-CA 129.478 3.111 . . . . 0.0 114.568 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 1.6 p30 -100.83 -127.67 0.2 Allowed 'General case' 0 C--N 1.359 1.016 0 O-C-N 118.6 -2.563 . . . . 0.0 113.035 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -96.66 -46.4 6.32 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 124.785 1.234 . . . . 0.0 114.042 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.286 12.3 t -74.12 -51.86 4.54 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 116.797 2.147 . . . . 0.0 116.797 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.3 -173.63 12.96 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 126.012 3.183 . . . . 0.0 112.755 0.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 75.0 m -95.72 116.79 29.38 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.555 ' HG3' ' HB3' ' A' ' 132' ' ' GLN . 5.9 tmm_? -155.34 152.94 29.76 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 120.781 -1.199 . . . . 0.0 109.83 -176.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.93 -149.2 19.86 Favored Glycine 0 CA--C 1.488 -1.611 0 N-CA-C 104.468 -3.453 . . . . 0.0 104.468 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -86.78 111.33 20.62 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 126.166 1.786 . . . . 0.0 110.738 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.1 m -98.37 175.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 126.136 1.774 . . . . 0.0 107.069 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.9 t -94.31 128.56 40.88 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.587 ' HB3' HG22 ' A' ' 129' ' ' VAL 0.293 47.7 pttt -77.6 -7.26 56.1 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-N 121.206 1.821 . . . . 0.0 113.791 -176.407 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -67.64 -19.32 65.2 Favored 'General case' 0 C--N 1.364 1.223 0 C-N-CA 124.72 1.208 . . . . 0.0 113.307 172.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.9 mt -94.55 -0.23 54.74 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 125.666 1.586 . . . . 0.0 114.272 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.511 HD13 HG11 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -101.29 157.02 17.1 Favored 'General case' 0 C--N 1.366 1.285 0 CA-C-N 122.025 2.193 . . . . 0.0 108.3 179.378 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.457 ' HG3' ' CE1' ' A' ' 165' ' ' PHE . 21.0 mmtt -119.67 168.07 10.94 Favored Pre-proline 0 C--O 1.222 -0.376 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.8 156.24 15.66 Favored 'Trans proline' 0 C--N 1.326 -0.649 1 C-N-CA 125.67 4.247 . . . . 0.0 113.481 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.429 ' CE2' ' HA2' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -97.5 148.95 22.71 Favored 'General case' 0 C--N 1.359 0.994 0 CA-C-O 122.621 1.2 . . . . 0.0 110.109 172.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.5 t -171.38 -37.85 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 101.115 -3.661 . . . . 0.0 101.115 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 151' ' ' TYR . . . 119.74 -159.36 14.9 Favored Glycine 0 C--N 1.36 1.886 0 CA-C-N 113.949 -1.478 . . . . 0.0 115.969 140.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.3 m -46.35 -16.74 0.03 OUTLIER 'General case' 0 C--N 1.373 1.609 1 C-N-CA 133.263 4.625 . . . . 0.0 117.629 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -77.69 -23.07 49.64 Favored 'General case' 0 N--CA 1.442 -0.873 1 C-N-CA 135.379 5.471 . . . . 0.0 112.831 176.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 6.8 t -89.17 153.9 20.58 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.209 1.404 . . . . 0.0 114.052 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -61.23 -36.26 79.46 Favored 'General case' 0 C--N 1.369 1.417 0 C-N-CA 126.404 1.881 . . . . 0.0 113.858 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -73.08 -4.57 33.42 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 125.686 1.594 . . . . 0.0 113.197 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -111.75 7.11 20.16 Favored 'General case' 0 C--N 1.372 1.567 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.311 1.5 pp0? -127.98 -172.89 2.79 Favored 'General case' 0 C--N 1.363 1.194 0 O-C-N 119.621 -1.924 . . . . 0.0 111.853 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -63.69 122.38 16.23 Favored 'General case' 0 C--N 1.372 1.584 0 C-N-CA 126.824 2.05 . . . . 0.0 112.897 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.45 -9.04 66.89 Favored Glycine 0 C--N 1.359 1.854 0 C-N-CA 124.38 0.99 . . . . 0.0 112.22 -167.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.55 140.67 20.59 Favored Glycine 0 C--N 1.365 2.157 0 C-N-CA 126.926 2.203 . . . . 0.0 116.705 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -61.47 -21.6 64.33 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 119.453 3.131 . . . . 0.0 119.453 -172.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.457 ' CE1' ' HG3' ' A' ' 149' ' ' LYS . 1.7 m-85 -108.74 -3.6 17.67 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 120.623 -1.298 . . . . 0.0 111.449 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -86.53 165.46 16.22 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 125.566 2.603 . . . . 0.0 117.171 -173.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.4 m 169.95 173.84 0.05 Allowed 'General case' 0 CA--C 1.503 -0.848 2 N-CA-C 98.487 -4.634 . . . . 0.0 98.487 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -121.12 101.49 7.7 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-N 122.299 2.318 . . . . 0.0 107.168 170.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -119.58 123.9 28.35 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 101.173 -3.64 . . . . 0.0 101.173 169.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -55.73 -29.72 72.63 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 125.189 3.926 . . . . 0.0 116.868 -174.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -65.22 -36.11 83.13 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.921 2.889 . . . . 0.0 113.067 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.9 mt -68.36 -41.79 83.78 Favored 'Isoleucine or valine' 0 C--N 1.38 1.895 0 C-N-CA 126.164 1.786 . . . . 0.0 110.612 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.7 mt -68.55 -43.9 75.63 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 125.826 1.651 . . . . 0.0 113.275 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -58.05 -42.97 86.55 Favored 'General case' 0 CA--C 1.486 -1.498 0 C-N-CA 128.581 2.752 . . . . 0.0 113.777 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.59 -34.35 77.7 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 130.41 3.484 . . . . 0.0 110.09 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.255 6.8 mtt -70.09 -33.4 71.84 Favored 'General case' 0 C--N 1.376 1.721 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 165.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -71.31 -45.7 62.41 Favored 'General case' 0 C--N 1.379 1.884 0 C-N-CA 125.961 1.704 . . . . 0.0 110.955 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -67.48 -52.81 34.86 Favored 'General case' 0 C--N 1.375 1.699 0 C-N-CA 127.882 2.473 . . . . 0.0 112.154 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.64 85.55 Favored 'General case' 0 C--N 1.374 1.636 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.28 -40.37 93.78 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-N 121.714 2.052 . . . . 0.0 112.527 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.27 -52.13 63.3 Favored 'General case' 0 C--N 1.367 1.353 0 O-C-N 119.099 -2.251 . . . . 0.0 113.935 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.84 72.8 Favored 'General case' 0 C--N 1.361 1.065 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -50.21 43.54 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 127.084 2.154 . . . . 0.0 112.309 171.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.378 0.0 OUTLIER -81.19 -12.88 59.06 Favored 'General case' 0 C--N 1.363 1.183 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -170.528 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -107.42 -107.94 0.32 Allowed 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.731 0.812 . . . . 0.0 111.734 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 188' ' ' ILE . 19.5 t70 -136.25 176.31 8.81 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 119.839 -1.788 . . . . 0.0 112.053 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.537 ' HA ' ' HE ' ' A' ' 190' ' ' ARG . 40.6 mmtm -51.45 -43.83 62.18 Favored 'General case' 0 C--N 1.384 2.065 1 C-N-CA 132.495 4.318 . . . . 0.0 114.207 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.474 HG22 ' HB3' ' A' ' 186' ' ' ASP . 9.5 tt -59.84 -27.99 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 129.929 3.292 . . . . 0.0 114.148 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -71.95 -45.33 61.51 Favored 'General case' 0 C--N 1.376 1.737 0 C-N-CA 126.288 1.835 . . . . 0.0 112.983 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.537 ' HE ' ' HA ' ' A' ' 187' ' ' LYS . 0.0 OUTLIER -75.13 -41.5 58.29 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 126.91 2.084 . . . . 0.0 114.7 170.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.46 -20.92 62.84 Favored 'General case' 0 C--N 1.369 1.422 0 C-N-CA 127.985 2.514 . . . . 0.0 113.329 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.74 -38.04 88.96 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 128.438 2.695 . . . . 0.0 114.044 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.4 mt -99.21 -46.27 5.61 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 126.777 2.031 . . . . 0.0 108.648 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . 0.256 . . 65.13 -94.16 0.04 OUTLIER 'General case' 0 C--N 1.367 1.351 0 C-N-CA 128.937 2.895 . . . . 0.0 114.39 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.453 -0.276 0 C-N-CA 125.989 1.716 . . . . 0.0 109.673 175.352 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.2 p . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -163.09 62.12 0.19 Allowed 'General case' 0 C--N 1.364 1.236 0 CA-C-N 119.854 1.206 . . . . 0.0 113.409 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -118.04 125.78 51.0 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 120.215 -1.553 . . . . 0.0 110.067 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 87.4 p -111.73 166.22 11.31 Favored Pre-proline 0 C--N 1.36 1.022 0 C-N-CA 126.126 1.77 . . . . 0.0 110.773 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -54.56 149.14 40.66 Favored 'Trans proline' 0 C--N 1.37 1.691 1 C-N-CA 126.107 4.538 . . . . 0.0 119.188 -170.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.45 -39.37 2.89 Favored Glycine 0 C--N 1.356 1.689 0 C-N-CA 126.023 1.773 . . . . 0.0 113.015 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.54 169.04 17.58 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.476 HD21 ' HD2' ' A' ' 190' ' ' ARG . 3.3 mm? -94.89 134.46 37.51 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.0 m -136.08 159.22 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-O 123.613 1.673 . . . . 0.0 107.548 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -104.18 116.73 32.72 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.62 135.08 53.76 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.497 2.319 . . . . 0.0 112.791 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.469 ' HB2' ' CZ2' ' A' ' 105' ' ' TRP . 51.7 tptt -112.93 141.83 46.31 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 173.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.8 ttm -128.82 149.72 50.62 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.018 -1.676 . . . . 0.0 108.615 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -65.16 100.11 0.42 Allowed 'General case' 0 C--N 1.368 1.39 0 C-N-CA 125.788 1.635 . . . . 0.0 114.125 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.97 -4.38 25.67 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 125.873 1.701 . . . . 0.0 112.909 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -112.01 161.26 26.65 Favored Pre-proline 0 C--N 1.358 0.95 0 C-N-CA 125.41 1.484 . . . . 0.0 111.588 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.47 167.53 26.09 Favored 'Trans proline' 0 C--N 1.366 1.479 1 C-N-CA 126.12 4.547 . . . . 0.0 112.682 164.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.469 ' CZ2' ' HB2' ' A' ' 99' ' ' LYS . 6.9 m95 -65.34 132.8 49.94 Favored 'General case' 0 C--N 1.363 1.154 0 CA-C-O 124.316 2.008 . . . . 0.0 113.238 171.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.26 10.6 m95 -134.88 134.55 21.98 Favored Pre-proline 0 N--CA 1.413 -2.276 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -169.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.2 143.15 39.17 Favored 'Trans proline' 0 C--N 1.38 2.204 1 C-N-CA 126.123 4.549 . . . . 0.0 110.916 156.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -156.77 165.42 36.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.27 3.028 . . . . 0.0 114.39 -161.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.44 HD23 ' OE1' ' A' ' 132' ' ' GLN . 8.8 tp -119.45 138.49 53.09 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.345 2.258 . . . . 0.0 107.745 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.31 121.89 33.43 Favored 'Isoleucine or valine' 0 C--N 1.378 1.836 0 C-N-CA 126.387 1.875 . . . . 0.0 106.528 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -127.38 152.75 47.09 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 119.626 -1.921 . . . . 0.0 113.172 -167.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.79 113.58 26.92 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 127.472 2.309 . . . . 0.0 106.463 173.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.464 ' CD2' HH11 ' A' ' 140' ' ' ARG . 36.7 m170 -62.56 159.98 38.25 Favored Pre-proline 0 C--N 1.358 0.975 0 C-N-CA 130.224 3.41 . . . . 0.0 117.456 -175.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.77 -1.41 0.24 Allowed 'Trans proline' 0 CA--C 1.564 2.021 1 C-N-CA 125.551 4.167 . . . . 0.0 116.951 170.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.72 31.27 5.78 Favored 'General case' 0 C--N 1.356 0.878 1 C-N-CA 134.813 5.245 . . . . 0.0 107.603 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.339 0.1 OUTLIER -69.53 150.29 47.29 Favored 'General case' 0 C--N 1.374 1.636 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -172.342 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.22 5.51 30.31 Favored Glycine 0 C--N 1.359 1.836 0 CA-C-N 112.174 -2.285 . . . . 0.0 111.556 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.4 m -152.56 135.29 15.39 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 100.813 -3.773 . . . . 0.0 100.813 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.421 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.255 2.2 p90 -155.23 -37.36 0.09 Allowed 'General case' 0 C--N 1.365 1.261 0 CA-C-N 120.423 1.465 . . . . 0.0 113.684 -175.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.5 tt -108.26 140.48 26.6 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-O 122.972 1.368 . . . . 0.0 110.574 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -119.88 121.29 38.72 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 101.091 -3.67 . . . . 0.0 101.091 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.84 179.71 4.19 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.097 0.959 . . . . 0.0 112.794 -171.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -46.3 131.73 10.41 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 120.241 3.423 . . . . 0.0 120.241 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 172.14 -51.38 0.17 Allowed Glycine 0 C--N 1.353 1.527 0 N-CA-C 106.37 -2.692 . . . . 0.0 106.37 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.0 mmmt -103.69 -52.81 2.9 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 126.605 1.962 . . . . 0.0 108.985 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.8 t -171.67 -166.49 0.44 Allowed 'General case' 0 C--N 1.353 0.739 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -129.13 120.68 52.15 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 124.917 1.287 . . . . 0.0 110.423 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -130.18 139.42 50.85 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 126.519 1.928 . . . . 0.0 112.786 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.97 163.25 36.95 Favored 'Isoleucine or valine' 0 C--N 1.367 1.347 0 C-N-CA 126.524 1.929 . . . . 0.0 105.844 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.421 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 1.1 m80 -83.34 140.93 32.15 Favored 'General case' 0 C--N 1.373 1.625 0 CA-C-N 120.654 1.57 . . . . 0.0 113.223 172.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.417 HG11 HD13 ' A' ' 148' ' ' LEU . 3.9 m -150.96 171.97 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.868 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.44 ' OE1' HD23 ' A' ' 109' ' ' LEU . 3.3 pt20 -136.69 146.77 46.28 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 124.453 1.101 . . . . 0.0 109.104 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.49 124.5 52.42 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 104.713 -2.328 . . . . 0.0 104.713 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.71 60.34 0.07 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 127.42 2.288 . . . . 0.0 113.394 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -98.29 -124.12 0.14 Allowed 'General case' 0 C--N 1.361 1.085 0 O-C-N 119.572 -1.955 . . . . 0.0 111.859 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -106.27 -52.55 2.77 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.731 1.612 . . . . 0.0 111.716 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 m -69.82 -40.35 13.19 Favored Pre-proline 0 C--N 1.364 1.232 0 N-CA-C 118.508 2.781 . . . . 0.0 118.508 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.14 178.0 36.54 Favored 'Cis proline' 0 C--N 1.354 0.852 0 CA-C-N 126.442 3.336 . . . . 0.0 110.479 -4.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.6 m -89.67 115.62 27.18 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 118.743 -2.473 . . . . 0.0 106.849 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.464 HH11 ' CD2' ' A' ' 113' ' ' HIS . 39.2 ttp85 -149.04 150.97 33.68 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-O 122.6 1.19 . . . . 0.0 109.347 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 165.62 -157.06 29.38 Favored Glycine 0 CA--C 1.491 -1.413 0 N-CA-C 105.973 -2.851 . . . . 0.0 105.973 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -80.22 110.17 15.39 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 126.547 1.939 . . . . 0.0 109.885 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.17 169.25 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 124.636 1.174 . . . . 0.0 110.543 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.5 m -90.23 115.67 27.63 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.47 33.8 pttt -69.25 -5.6 23.91 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -168.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -82.05 -12.78 58.09 Favored 'General case' 0 C--N 1.365 1.256 0 O-C-N 119.242 -2.161 . . . . 0.0 109.714 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.73 -0.63 45.06 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 128.679 2.792 . . . . 0.0 110.145 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.417 HD13 HG11 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -104.89 125.0 50.46 Favored 'General case' 0 C--N 1.388 2.262 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 173.147 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -118.97 168.48 9.73 Favored Pre-proline 0 C--O 1.218 -0.563 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -82.47 153.23 15.73 Favored 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 124.433 3.422 . . . . 0.0 112.697 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -127.6 121.2 29.92 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.324 1.059 . . . . 0.0 111.696 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.694 ' HA ' HD13 ' A' ' 183' ' ' LEU . 8.7 t -162.14 30.67 0.12 Allowed 'General case' 0 C--N 1.359 0.997 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.72 82.12 0.09 OUTLIER Glycine 0 C--N 1.35 1.345 0 C-N-CA 116.499 -2.762 . . . . 0.0 115.228 -166.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . 0.34 89.2 p -68.42 -10.11 53.0 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 121.007 2.404 . . . . 0.0 116.791 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -112.12 32.02 5.83 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 130.166 3.386 . . . . 0.0 108.656 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 19.3 t -103.04 133.4 48.22 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.258 42.7 tttm -55.72 -33.08 63.91 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -174.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -70.89 -19.2 62.64 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 124.704 1.202 . . . . 0.0 113.972 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.49 3.26 54.37 Favored 'General case' 0 C--N 1.371 1.536 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -130.56 -173.07 2.97 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 125.743 1.617 . . . . 0.0 112.042 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -62.79 122.22 15.39 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 126.284 1.834 . . . . 0.0 113.106 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.02 -8.01 64.95 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 124.554 1.073 . . . . 0.0 112.475 -169.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.09 146.2 21.85 Favored Glycine 0 C--N 1.361 1.935 0 C-N-CA 126.565 2.031 . . . . 0.0 115.824 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -60.37 -42.25 95.41 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . 0.322 0.1 OUTLIER -99.84 2.93 44.37 Favored 'General case' 0 C--N 1.363 1.163 0 CA-C-N 120.402 1.455 . . . . 0.0 114.826 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -91.77 140.83 29.31 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 126.551 1.94 . . . . 0.0 107.928 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.5 m -166.66 132.4 2.28 Favored 'General case' 0 N--CA 1.446 -0.635 1 N-CA-C 99.797 -4.149 . . . . 0.0 99.797 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.93 100.53 10.83 Favored 'General case' 0 C--N 1.369 1.432 0 CA-C-O 126.281 2.944 . . . . 0.0 112.848 -173.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.57 131.56 24.42 Favored Pre-proline 0 N--CA 1.417 -2.093 3 N-CA-C 98.51 -4.626 . . . . 0.0 98.51 164.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.53 -24.7 63.1 Favored 'Trans proline' 0 CA--C 1.543 0.942 1 C-N-CA 125.534 4.156 . . . . 0.0 115.998 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -69.62 -35.88 75.65 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.47 2.708 . . . . 0.0 113.831 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 45.8 mt -74.12 -36.18 43.32 Favored 'Isoleucine or valine' 0 C--N 1.376 1.745 0 C-N-CA 126.369 1.868 . . . . 0.0 109.854 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 177' ' ' GLN . 20.1 mt -69.0 -45.63 70.05 Favored 'General case' 0 C--N 1.367 1.336 0 C-N-CA 125.298 1.439 . . . . 0.0 112.488 172.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -58.11 -43.21 87.04 Favored 'General case' 0 CA--C 1.486 -1.519 0 C-N-CA 127.951 2.5 . . . . 0.0 114.596 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.25 -36.88 85.51 Favored 'General case' 0 N--CA 1.428 -1.539 0 C-N-CA 129.449 3.1 . . . . 0.0 111.208 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.1 mtt -65.04 -35.51 81.41 Favored 'General case' 0 C--N 1.379 1.883 0 CA-C-O 115.486 -2.197 . . . . 0.0 112.724 165.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 13.6 mt-30 -74.06 -40.2 62.98 Favored 'General case' 0 C--N 1.383 2.026 0 C-N-CA 126.019 1.728 . . . . 0.0 113.731 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.401 HH21 ' HB3' ' A' ' 193' ' ' LEU . 0.2 OUTLIER -73.68 -49.46 25.69 Favored 'General case' 0 C--N 1.374 1.651 0 C-N-CA 131.551 3.941 . . . . 0.0 111.491 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.54 95.72 Favored 'General case' 0 C--N 1.376 1.75 0 C-N-CA 123.836 0.854 . . . . 0.0 113.267 165.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.329 38.5 t70 -57.13 -52.76 64.02 Favored 'General case' 0 C--N 1.387 2.232 0 C-N-CA 126.692 1.997 . . . . 0.0 113.014 172.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -33.44 70.17 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 121.777 2.081 . . . . 0.0 115.702 173.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.413 ' HB1' ' CD ' ' A' ' 190' ' ' ARG . . . -76.26 -44.84 35.48 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 172.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.694 HD13 ' HA ' ' A' ' 152' ' ' THR . 3.9 pp -69.53 -36.86 76.79 Favored 'General case' 0 C--N 1.374 1.65 0 C-N-CA 126.16 1.784 . . . . 0.0 114.221 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.38 -9.78 58.14 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.664 1.586 . . . . 0.0 112.125 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -124.68 -101.27 0.39 Allowed 'General case' 0 C--N 1.356 0.867 0 CA-C-O 120.756 0.312 . . . . 0.0 111.44 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -135.77 152.69 51.37 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.036 -1.04 . . . . 0.0 110.953 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.351 17.2 ttpt -51.51 -35.96 42.63 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 130.839 3.656 . . . . 0.0 116.2 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 14.0 tt -55.03 -30.22 23.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 129.032 2.933 . . . . 0.0 113.035 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -73.22 -37.88 66.27 Favored 'General case' 0 C--N 1.375 1.691 0 O-C-N 119.717 -1.864 . . . . 0.0 113.795 176.076 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.476 ' HD2' HD21 ' A' ' 95' ' ' LEU 0.28 0.0 OUTLIER -76.23 -44.35 38.01 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 167.499 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.31 78.4 mt -79.19 -18.96 52.02 Favored 'General case' 0 C--N 1.366 1.292 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -173.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -84.41 -12.95 53.47 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.607 1.163 . . . . 0.0 113.216 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.401 ' HB3' HH21 ' A' ' 178' ' ' ARG . 9.2 mp -105.03 -51.34 3.05 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 126.18 1.792 . . . . 0.0 106.22 176.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 46.48 -113.25 0.44 Allowed 'General case' 0 C--N 1.366 1.287 0 C-N-CA 129.696 3.198 . . . . 0.0 115.787 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--N 1.349 0.548 0 C-N-CA 128.182 2.593 . . . . 0.0 113.221 -178.206 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.12 109.9 6.38 Favored 'General case' 0 C--N 1.361 1.086 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.401 ' CD1' HD12 ' A' ' 148' ' ' LEU . 18.2 m-85 -125.71 128.49 47.86 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.952 1.701 . . . . 0.0 113.47 -173.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.318 90.8 p -110.2 162.59 19.84 Favored Pre-proline 0 C--N 1.364 1.235 0 O-C-N 120.249 -1.532 . . . . 0.0 114.855 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.24 136.9 77.75 Favored 'Trans proline' 0 C--N 1.378 2.095 1 C-N-CA 126.449 4.766 . . . . 0.0 119.217 -170.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.63 -20.83 19.97 Favored Glycine 0 C--N 1.364 2.11 0 C-N-CA 125.605 1.574 . . . . 0.0 111.813 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -85.53 169.04 13.95 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 125.697 1.599 . . . . 0.0 114.891 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.477 HD21 ' HD2' ' A' ' 190' ' ' ARG . 2.8 mm? -110.28 131.68 54.84 Favored 'General case' 0 C--N 1.369 1.447 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 172.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -134.46 161.77 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -106.98 138.31 43.39 Favored 'General case' 0 C--O 1.217 -0.618 1 N-CA-C 99.768 -4.16 . . . . 0.0 99.768 165.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 148' ' ' LEU . . . -128.86 152.58 48.36 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 121.632 2.014 . . . . 0.0 111.976 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -121.46 146.04 47.32 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.9 ttp -128.85 146.43 50.93 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 119.61 -1.931 . . . . 0.0 108.016 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -48.6 91.06 0.0 OUTLIER 'General case' 0 C--N 1.366 1.285 0 C-N-CA 129.475 3.11 . . . . 0.0 117.01 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.06 -9.13 33.7 Favored Glycine 0 C--N 1.36 1.875 0 C-N-CA 125.102 1.334 . . . . 0.0 113.436 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -99.71 162.12 22.2 Favored Pre-proline 0 C--N 1.359 0.983 0 C-N-CA 125.308 1.443 . . . . 0.0 109.231 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.88 167.31 26.27 Favored 'Trans proline' 0 CA--C 1.537 0.674 1 C-N-CA 125.848 4.365 . . . . 0.0 114.736 167.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -60.91 132.0 52.47 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 127.335 2.254 . . . . 0.0 115.04 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -132.29 108.56 13.61 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 121.729 3.974 . . . . 0.0 121.729 -171.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HG2' ' HB3' ' A' ' 175' ' ' ALA . 7.6 Cg_endo -58.07 113.58 1.59 Allowed 'Trans proline' 0 C--N 1.388 2.631 1 C-N-CA 126.275 4.65 . . . . 0.0 111.588 165.36 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.1 m -123.65 166.12 16.05 Favored 'General case' 0 N--CA 1.438 -1.026 1 C-N-CA 132.871 4.468 . . . . 0.0 114.147 -160.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tp -126.12 144.41 50.76 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.16 118.8 37.17 Favored 'Isoleucine or valine' 0 C--N 1.366 1.294 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -113.41 143.59 44.23 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.103 -1.623 . . . . 0.0 111.679 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -79.31 111.31 15.43 Favored 'General case' 0 C--N 1.373 1.612 0 O-C-N 120.379 -1.451 . . . . 0.0 109.597 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.475 ' HB2' ' CG ' ' A' ' 130' ' ' HIS . 9.9 t60 -69.22 160.15 80.09 Favored Pre-proline 0 C--N 1.348 0.522 0 CA-C-O 114.488 -2.672 . . . . 0.0 115.336 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.82 -6.47 2.56 Favored 'Trans proline' 0 CA--C 1.562 1.901 1 CA-C-N 128.814 4.184 . . . . 0.0 116.577 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -108.32 29.72 7.09 Favored 'General case' 0 C--N 1.357 0.922 1 C-N-CA 133.384 4.674 . . . . 0.0 109.642 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -63.45 149.73 45.36 Favored 'General case' 0 C--N 1.365 1.276 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.07 -20.14 50.14 Favored Glycine 0 C--N 1.36 1.889 0 CA-C-N 113.226 -1.806 . . . . 0.0 110.007 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.86 119.1 38.56 Favored 'General case' 0 N--CA 1.446 -0.672 2 N-CA-C 98.646 -4.575 . . . . 0.0 98.646 168.249 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.592 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.359 0.0 OUTLIER -121.82 -33.41 3.58 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -169.378 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 129' ' ' VAL . 10.3 pt -108.33 155.84 9.09 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 120.269 -1.519 . . . . 0.0 110.581 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -141.35 151.16 43.32 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 128.016 2.527 . . . . 0.0 104.208 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.65 130.21 11.48 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 121.0 -1.063 . . . . 0.0 108.249 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -117.4 98.93 6.67 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.952 2.101 . . . . 0.0 108.654 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.43 -89.78 1.02 Allowed Glycine 0 C--N 1.36 1.916 0 N-CA-C 117.869 1.908 . . . . 0.0 117.869 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -142.57 71.34 1.34 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 125.0 1.32 . . . . 0.0 109.391 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.0 m -179.92 170.36 1.21 Allowed 'General case' 0 C--N 1.351 0.667 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.49 145.46 16.22 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -141.32 150.31 42.34 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.498 2.319 . . . . 0.0 110.757 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' A' ' 145' ' ' LYS . 26.2 m -129.0 162.36 36.48 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 129.592 3.157 . . . . 0.0 104.475 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.592 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -82.5 124.8 30.43 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.335 -1.478 . . . . 0.0 110.976 172.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.78 169.48 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.436 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.98 150.84 46.32 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -106.21 127.86 53.53 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.36 1.864 . . . . 0.0 107.376 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -74.95 69.35 1.89 Allowed 'General case' 0 C--N 1.379 1.872 0 CA-C-N 120.258 1.39 . . . . 0.0 111.881 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -88.98 -119.92 0.05 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 127.459 2.304 . . . . 0.0 111.002 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -107.25 -51.99 2.83 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.184 1.794 . . . . 0.0 110.91 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.6 t -69.97 -49.98 18.02 Favored Pre-proline 0 C--N 1.36 1.063 0 C-N-CA 127.975 2.51 . . . . 0.0 117.734 -172.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -81.99 -175.64 15.67 Favored 'Cis proline' 0 C--N 1.347 0.497 0 CA-C-N 126.104 3.216 . . . . 0.0 111.52 -0.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 34.5 m -94.62 141.17 28.92 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.291 1.036 . . . . 0.0 108.319 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -160.23 156.21 26.15 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.16 -159.8 29.21 Favored Glycine 0 CA--C 1.484 -1.904 1 N-CA-C 98.235 -5.946 . . . . 0.0 98.235 174.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -104.85 113.73 27.5 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 143' ' ' VAL . 13.5 m -87.83 173.78 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 C-N-CA 128.231 2.612 . . . . 0.0 106.711 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.8 m -94.31 110.88 22.61 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.494 ' HB3' HG22 ' A' ' 129' ' ' VAL . 16.9 ptmt -50.93 -17.8 0.65 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -173.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -69.27 -19.47 63.91 Favored 'General case' 0 N--CA 1.439 -1.014 1 C-N-CA 131.784 4.034 . . . . 0.0 112.75 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.4 mt -92.33 -2.23 56.53 Favored 'General case' 0 C--N 1.365 1.278 0 C-N-CA 126.182 1.793 . . . . 0.0 113.935 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -95.35 156.9 16.13 Favored 'General case' 0 C--N 1.369 1.451 0 CA-C-N 122.231 2.287 . . . . 0.0 109.715 174.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.06 159.04 58.43 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 102.567 -3.123 . . . . 0.0 102.567 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.98 151.93 21.51 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 125.035 3.823 . . . . 0.0 111.399 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.365 1.0 OUTLIER -93.31 -116.2 0.09 Allowed 'General case' 0 C--N 1.367 1.335 0 O-C-N 120.649 -1.282 . . . . 0.0 110.737 175.48 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.426 4.6 t 63.47 -36.87 0.16 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 127.849 2.459 . . . . 0.0 116.149 -174.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.04 88.54 0.53 Allowed Glycine 0 C--N 1.349 1.27 0 C-N-CA 126.448 1.975 . . . . 0.0 116.769 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.2 m -67.66 -10.92 56.6 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 131.473 3.909 . . . . 0.0 115.412 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -121.49 24.58 9.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 128.458 2.703 . . . . 0.0 108.496 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 91.2 p -87.39 139.29 30.7 Favored 'General case' 0 C--N 1.374 1.667 0 C-N-CA 125.598 1.559 . . . . 0.0 107.821 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -56.39 -24.34 43.97 Favored 'General case' 0 C--N 1.372 1.579 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -82.24 -19.86 38.81 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.734 1.614 . . . . 0.0 113.224 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.61 -13.99 22.49 Favored 'General case' 0 C--N 1.37 1.494 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.304 0.0 OUTLIER -107.88 -173.97 2.41 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 125.395 1.478 . . . . 0.0 112.939 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -69.31 122.1 18.2 Favored 'General case' 0 C--N 1.373 1.613 0 O-C-N 120.308 -1.495 . . . . 0.0 112.784 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.22 -9.47 50.06 Favored Glycine 0 C--N 1.354 1.553 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.81 -166.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.87 155.76 46.78 Favored Glycine 0 C--N 1.368 2.339 0 N-CA-C 119.97 2.748 . . . . 0.0 119.97 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.69 -41.54 77.53 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.927 3.691 . . . . 0.0 116.164 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -98.42 -17.74 18.64 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -41.08 -36.58 0.72 Allowed 'General case' 0 C--N 1.356 0.854 2 C-N-CA 132.723 4.409 . . . . 0.0 122.472 -168.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.6 m -14.17 92.86 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 1 C-N-CA 132.032 4.133 . . . . 0.0 117.707 -177.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.99 101.65 13.1 Favored 'General case' 0 C--N 1.368 1.38 0 CA-C-O 126.016 2.817 . . . . 0.0 114.003 -166.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -119.78 135.55 24.28 Favored Pre-proline 0 N--CA 1.423 -1.776 1 C-N-CA 133.803 4.841 . . . . 0.0 102.681 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -55.08 -22.76 32.76 Favored 'Trans proline' 0 CA--C 1.544 1.019 1 C-N-CA 125.973 4.448 . . . . 0.0 117.733 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -70.16 -35.96 74.38 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 131.251 3.82 . . . . 0.0 112.453 173.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.8 mt -76.7 -32.7 20.93 Favored 'Isoleucine or valine' 0 C--N 1.375 1.683 0 C-N-CA 127.582 2.353 . . . . 0.0 109.084 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 26.3 mt -66.46 -51.88 52.15 Favored 'General case' 0 C--N 1.373 1.627 0 C-N-CA 127.063 2.145 . . . . 0.0 111.055 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -57.45 -34.52 69.06 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.127 1.771 . . . . 0.0 114.751 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.411 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . . . -69.33 -50.75 43.59 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 130.484 3.514 . . . . 0.0 113.86 172.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.415 0.0 OUTLIER -68.16 -33.1 73.85 Favored 'General case' 0 C--N 1.385 2.124 0 CA-C-N 121.525 1.966 . . . . 0.0 113.7 173.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -71.96 -48.89 41.95 Favored 'General case' 0 C--N 1.373 1.596 0 C-N-CA 126.688 1.995 . . . . 0.0 112.751 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -38.51 77.83 Favored 'General case' 0 C--N 1.383 2.042 0 O-C-N 119.022 -2.299 . . . . 0.0 114.986 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.89 -51.09 69.61 Favored 'General case' 0 C--N 1.379 1.864 0 C-N-CA 124.655 1.182 . . . . 0.0 112.19 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.268 38.1 t70 -53.47 -43.2 67.96 Favored 'General case' 0 C--N 1.38 1.897 0 C-N-CA 127.263 2.225 . . . . 0.0 113.98 174.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -33.86 76.57 Favored 'General case' 0 C--N 1.374 1.669 0 O-C-N 118.661 -2.524 . . . . 0.0 114.921 173.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.435 ' HB1' ' CD ' ' A' ' 190' ' ' ARG . . . -76.37 -45.59 31.24 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 tt -53.56 -49.87 66.75 Favored 'General case' 0 CA--C 1.498 -1.024 1 C-N-CA 132.298 4.239 . . . . 0.0 116.455 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.253 0.0 OUTLIER -86.84 -7.91 57.8 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 126.606 1.962 . . . . 0.0 111.417 -174.592 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -120.1 -100.05 0.43 Allowed 'General case' 0 C--N 1.358 0.961 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -135.26 151.05 50.21 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.783 -1.198 . . . . 0.0 108.998 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.256 34.3 tttm -51.39 -36.49 43.63 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 130.979 3.712 . . . . 0.0 115.872 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 12.6 tt -56.0 -28.5 24.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 130.118 3.367 . . . . 0.0 113.211 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.258 4.6 mptt -71.02 -42.62 69.33 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 119.537 -1.977 . . . . 0.0 113.849 174.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.477 ' HD2' HD21 ' A' ' 95' ' ' LEU 0.314 0.0 OUTLIER -76.36 -42.98 42.9 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 169.36 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.55 -30.7 67.5 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.627 1.971 . . . . 0.0 114.946 -172.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -84.56 -12.25 54.47 Favored 'General case' 0 C--N 1.365 1.282 0 C-N-CA 125.859 1.664 . . . . 0.0 114.305 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 mp -97.34 -50.05 4.69 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 173.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 62.65 -102.64 0.11 Allowed 'General case' 0 C--N 1.364 1.199 0 C-N-CA 130.371 3.468 . . . . 0.0 115.055 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.447 -0.579 0 C-N-CA 128.397 2.679 . . . . 0.0 108.601 -178.937 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -160.4 62.19 0.33 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-N 119.161 0.892 . . . . 0.0 109.505 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -114.58 124.63 52.34 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 120.294 -1.504 . . . . 0.0 111.558 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.6 p -112.07 164.4 15.31 Favored Pre-proline 0 C--N 1.366 1.292 0 C-N-CA 129.045 2.938 . . . . 0.0 114.438 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -47.08 141.01 13.17 Favored 'Trans proline' 0 C--N 1.376 2.005 1 C-N-CA 127.743 5.628 . . . . 0.0 121.147 -169.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.43 -23.3 32.01 Favored Glycine 0 C--N 1.367 2.267 0 C-N-CA 125.636 1.588 . . . . 0.0 112.838 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.05 169.94 13.45 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 120.814 2.307 . . . . 0.0 112.644 -177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.84 141.38 29.36 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 166.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.5 163.4 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -110.34 128.27 55.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 101.288 -3.597 . . . . 0.0 101.288 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.28 137.74 51.05 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 122.848 1.309 . . . . 0.0 111.698 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -110.57 136.41 49.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 171.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 42.7 ttm -119.8 138.32 53.43 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.32 102.14 0.37 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 125.721 1.608 . . . . 0.0 113.98 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.17 -12.6 24.07 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 125.538 1.542 . . . . 0.0 112.757 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -103.18 164.17 16.04 Favored Pre-proline 0 C--N 1.354 0.792 0 C-N-CA 125.639 1.575 . . . . 0.0 109.418 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -71.64 166.36 29.68 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.371 3.381 . . . . 0.0 113.634 162.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -57.69 122.37 12.64 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 130.683 3.593 . . . . 0.0 114.825 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -126.48 112.17 23.17 Favored Pre-proline 0 N--CA 1.427 -1.602 0 N-CA-C 119.888 3.292 . . . . 0.0 119.888 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -59.03 112.24 1.15 Allowed 'Trans proline' 0 C--N 1.383 2.387 1 C-N-CA 125.813 4.342 . . . . 0.0 110.573 162.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.2 t -122.57 165.5 16.33 Favored 'General case' 0 N--CA 1.445 -0.72 1 C-N-CA 133.475 4.71 . . . . 0.0 111.346 -161.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tt -124.05 132.31 53.66 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.454 HG23 HG12 ' A' ' 131' ' ' VAL 0.251 3.3 p -81.84 127.28 39.74 Favored 'Isoleucine or valine' 0 C--N 1.377 1.8 0 CA-C-N 121.145 1.793 . . . . 0.0 107.385 176.141 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -132.05 152.86 50.93 Favored 'General case' 0 C--N 1.366 1.322 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 -161.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.5 113.46 27.05 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 127.698 2.399 . . . . 0.0 109.525 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -71.54 161.72 76.97 Favored Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 129.292 3.037 . . . . 0.0 114.342 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.1 -8.22 0.17 Allowed 'Trans proline' 0 CA--C 1.569 2.241 1 C-N-CA 125.605 4.203 . . . . 0.0 117.593 170.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.11 44.69 1.0 Allowed 'General case' 0 C--N 1.365 1.252 0 C-N-CA 131.518 3.927 . . . . 0.0 107.565 167.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.6 149.18 38.32 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 119.207 3.04 . . . . 0.0 119.207 -170.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.75 -19.91 27.69 Favored Glycine 0 C--N 1.362 2.025 0 CA-C-N 112.757 -2.019 . . . . 0.0 109.541 165.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 t -118.03 119.39 34.64 Favored 'General case' 0 N--CA 1.435 -1.224 1 N-CA-C 98.161 -4.755 . . . . 0.0 98.161 168.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.461 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 27.2 p90 -140.31 -0.6 1.6 Allowed 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 120.82 -1.175 . . . . 0.0 111.357 -174.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.713 HG22 HG12 ' A' ' 129' ' ' VAL . 7.0 pt -119.84 147.86 23.24 Favored 'Isoleucine or valine' 0 C--N 1.366 1.321 0 CA-C-O 123.467 1.603 . . . . 0.0 115.133 -174.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.87 118.36 31.35 Favored 'General case' 0 C--N 1.357 0.934 1 N-CA-C 99.13 -4.396 . . . . 0.0 99.13 169.068 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -105.6 -179.66 4.0 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -165.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -46.78 119.69 2.61 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 128.848 2.859 . . . . 0.0 116.985 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.51 -54.92 0.24 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 105.091 -3.204 . . . . 0.0 105.091 -173.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -109.86 -47.6 3.32 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.459 1.504 . . . . 0.0 109.886 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 m -179.51 169.77 1.37 Allowed 'General case' 0 CA--C 1.472 -2.056 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.4 106.87 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -114.98 130.31 56.9 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 127.811 2.445 . . . . 0.0 110.676 -176.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.713 HG12 HG22 ' A' ' 120' ' ' ILE . 13.7 m -130.36 161.91 39.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 0.6 OUTLIER -92.64 138.52 31.42 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 123.944 0.898 . . . . 0.0 110.897 174.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.454 HG12 HG23 ' A' ' 110' ' ' VAL . 5.2 m -150.58 168.71 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.472 -2.033 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.39 152.55 40.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 123.828 0.851 . . . . 0.0 109.599 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -108.09 125.78 51.98 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -67.47 65.34 0.08 Allowed 'General case' 0 C--N 1.369 1.438 0 C-N-CA 126.615 1.966 . . . . 0.0 115.08 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.37 -119.36 0.08 Allowed 'General case' 0 C--N 1.36 1.025 0 O-C-N 119.397 -2.064 . . . . 0.0 110.045 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -106.71 -49.07 3.38 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.627 1.571 . . . . 0.0 112.597 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.274 11.2 t -70.12 -51.39 14.22 Favored Pre-proline 0 C--N 1.363 1.156 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.06 -179.16 26.15 Favored 'Cis proline' 0 CA--C 1.543 0.952 0 CA-C-N 125.944 3.158 . . . . 0.0 113.722 1.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 54.0 m -95.03 127.17 40.88 Favored 'General case' 0 C--N 1.369 1.424 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 24.1 ttp-105 -153.61 157.47 39.72 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 119.976 1.262 . . . . 0.0 109.876 -173.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.14 -159.28 25.5 Favored Glycine 0 CA--C 1.492 -1.401 0 N-CA-C 104.901 -3.28 . . . . 0.0 104.901 171.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -83.15 113.55 20.72 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 126.172 1.789 . . . . 0.0 109.15 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.44 178.36 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 125.118 1.367 . . . . 0.0 110.987 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.2 m -99.82 121.18 40.91 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 100.462 -3.903 . . . . 0.0 100.462 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.446 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 26.7 ttpt -73.34 -10.99 60.33 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -170.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -72.58 -13.42 61.39 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.49 2.316 . . . . 0.0 113.738 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.7 mt -103.0 7.61 39.05 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 126.634 1.974 . . . . 0.0 111.404 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 12.4 mt -96.31 125.41 40.79 Favored 'General case' 0 C--N 1.379 1.874 0 CA-C-N 119.891 1.223 . . . . 0.0 108.431 174.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -114.44 159.13 37.99 Favored Pre-proline 0 C--O 1.221 -0.434 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.03 155.72 14.99 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 CA-C-N 124.904 2.787 . . . . 0.0 114.642 -172.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.362 0.0 OUTLIER -30.91 -95.34 0.0 OUTLIER 'General case' 0 C--N 1.357 0.922 2 C-N-CA 132.273 4.229 . . . . 0.0 122.092 -177.927 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.555 ' HA ' HD21 ' A' ' 183' ' ' LEU . 13.4 t -0.38 54.95 0.0 OUTLIER 'General case' 0 C--N 1.381 1.942 1 C-N-CA 136.511 5.924 . . . . 0.0 118.194 178.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.524 ' H ' HD11 ' A' ' 183' ' ' LEU . . . -81.07 -91.75 0.52 Allowed Glycine 0 CA--C 1.485 -1.782 0 N-CA-C 121.603 3.401 . . . . 0.0 121.603 -150.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.6 m -46.1 -23.45 0.32 Allowed 'General case' 0 C--N 1.374 1.669 0 C-N-CA 129.182 2.993 . . . . 0.0 119.003 -172.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -18.17 50.41 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 130.519 3.528 . . . . 0.0 113.039 175.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.0 t -80.5 150.78 29.53 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 127.754 2.422 . . . . 0.0 112.454 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -65.05 -21.39 66.82 Favored 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.985 1.714 . . . . 0.0 111.787 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -72.49 -23.03 60.97 Favored 'General case' 0 C--N 1.373 1.607 0 C-N-CA 126.315 1.846 . . . . 0.0 112.481 170.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -105.93 11.98 31.11 Favored 'General case' 0 C--N 1.361 1.088 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -128.0 -179.53 5.02 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.541 1.537 . . . . 0.0 107.712 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.65 122.69 11.94 Favored 'General case' 0 C--N 1.37 1.49 0 C-N-CA 127.731 2.412 . . . . 0.0 114.628 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.8 -10.04 64.21 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 124.397 0.999 . . . . 0.0 112.4 -168.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.8 146.31 25.53 Favored Glycine 0 C--N 1.365 2.145 0 N-CA-C 118.569 2.187 . . . . 0.0 118.569 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -59.81 -22.32 62.06 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 119.71 3.226 . . . . 0.0 119.71 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.55 -3.52 15.93 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.297 -1.502 . . . . 0.0 111.48 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -86.9 91.56 8.71 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 -166.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.2 m -118.86 104.91 10.99 Favored 'General case' 0 CA--C 1.504 -0.81 1 N-CA-C 99.559 -4.238 . . . . 0.0 99.559 167.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.27 101.42 14.13 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-O 125.096 2.379 . . . . 0.0 112.189 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -119.36 144.82 37.25 Favored Pre-proline 0 N--CA 1.432 -1.332 0 C-N-CA 130.241 3.416 . . . . 0.0 103.801 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -51.32 -31.82 39.17 Favored 'Trans proline' 0 CA--C 1.54 0.784 1 C-N-CA 127.166 5.244 . . . . 0.0 116.593 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.9 -36.95 75.81 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 127.997 2.519 . . . . 0.0 112.896 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.0 mt -79.05 -33.65 16.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.482 0 C-N-CA 127.163 2.185 . . . . 0.0 109.878 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 177' ' ' GLN 0.266 28.1 mt -61.98 -53.26 58.16 Favored 'General case' 0 C--N 1.392 2.45 0 C-N-CA 128.356 2.662 . . . . 0.0 110.367 170.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -57.41 -50.77 71.92 Favored 'General case' 0 CA--C 1.478 -1.802 0 C-N-CA 128.969 2.908 . . . . 0.0 112.684 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.62 73.33 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 130.988 3.715 . . . . 0.0 113.077 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 57.1 mtt -69.07 -39.18 79.23 Favored 'General case' 0 C--N 1.375 1.681 0 C-N-CA 125.563 1.545 . . . . 0.0 111.655 168.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 6.3 mt-30 -74.2 -42.33 59.98 Favored 'General case' 0 C--N 1.374 1.639 0 CA-C-N 120.756 1.616 . . . . 0.0 113.578 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.433 HH12 ' HA ' ' A' ' 190' ' ' ARG . 0.1 OUTLIER -63.19 -53.24 56.36 Favored 'General case' 0 C--N 1.375 1.7 1 C-N-CA 132.819 4.448 . . . . 0.0 110.123 174.465 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 183' ' ' LEU . . . -60.45 -51.57 68.9 Favored 'General case' 0 C--N 1.38 1.9 0 CA-C-O 116.815 -1.564 . . . . 0.0 112.496 170.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.05 -51.14 62.72 Favored 'General case' 0 C--N 1.38 1.906 0 C-N-CA 126.419 1.887 . . . . 0.0 114.352 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -55.02 -43.11 73.37 Favored 'General case' 0 C--N 1.37 1.462 0 CA-C-N 121.207 1.821 . . . . 0.0 114.993 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.13 -41.05 51.31 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 152' ' ' THR 0.25 0.5 OUTLIER -61.65 -45.61 93.32 Favored 'General case' 0 C--N 1.359 1.021 1 C-N-CA 132.923 4.489 . . . . 0.0 114.663 175.247 . . . . . . . . 5 4 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -28.58 29.35 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 126.64 1.976 . . . . 0.0 111.768 -176.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -105.52 -99.82 0.33 Allowed 'General case' 0 C--N 1.359 0.986 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -135.56 154.01 51.5 Favored 'General case' 0 C--N 1.36 1.065 0 O-C-N 120.822 -1.174 . . . . 0.0 112.2 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 190' ' ' ARG 0.395 18.0 ttpt -51.51 -37.16 47.94 Favored 'General case' 0 C--N 1.369 1.45 0 C-N-CA 130.217 3.407 . . . . 0.0 117.24 177.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.9 tp -57.08 -28.39 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 128.915 2.886 . . . . 0.0 112.906 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.252 4.1 mptt -70.19 -45.82 65.86 Favored 'General case' 0 C--N 1.372 1.575 0 O-C-N 119.773 -1.829 . . . . 0.0 113.387 174.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.433 ' HA ' HH12 ' A' ' 178' ' ' ARG 0.291 0.0 OUTLIER -75.27 -40.19 59.01 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 119.03 -2.294 . . . . 0.0 116.804 171.48 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.5 tp -80.83 -20.6 42.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -170.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -82.85 -22.79 33.96 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 124.107 0.963 . . . . 0.0 112.477 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.16 23.24 13.97 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 130.132 3.373 . . . . 0.0 109.984 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.82 -103.96 0.0 OUTLIER 'General case' 0 C--N 1.367 1.356 0 C-N-CA 131.268 3.827 . . . . 0.0 117.035 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.301 2.7 m . . . . . 0 C--N 1.35 0.615 0 CA-C-O 124.225 1.964 . . . . 0.0 107.491 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.478 ' HA ' ' CE2' ' A' ' 90' ' ' PHE 0.415 62.9 m . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -136.68 77.88 1.67 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 127.243 2.217 . . . . 0.0 109.38 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.478 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 62.1 m-85 -123.49 125.21 44.49 Favored 'General case' 0 C--N 1.355 0.837 0 O-C-N 120.336 -1.477 . . . . 0.0 112.719 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.416 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.391 88.6 p -112.01 170.51 5.19 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 131.329 3.852 . . . . 0.0 114.834 -176.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 37.3 Cg_exo -41.72 129.31 3.88 Favored 'Trans proline' 0 C--N 1.382 2.314 1 C-N-CA 128.177 5.918 . . . . 0.0 119.774 -177.087 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.12 0.12 74.69 Favored Glycine 0 C--N 1.366 2.198 0 C-N-CA 127.797 2.618 . . . . 0.0 114.421 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -94.01 154.71 17.5 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 166.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 109' ' ' LEU . 3.8 mm? -110.39 153.55 24.8 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 175.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.3 m -142.48 170.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 123.686 1.708 . . . . 0.0 107.25 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 96.2 m95 -114.78 116.03 27.97 Favored 'General case' 0 N--CA 1.438 -1.069 1 N-CA-C 99.924 -4.102 . . . . 0.0 99.924 174.664 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.0 127.96 53.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 122.32 2.327 . . . . 0.0 111.776 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -96.36 143.18 27.65 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.1 ttt -128.63 151.01 49.98 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 118.596 -2.565 . . . . 0.0 108.218 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -74.41 95.77 2.77 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 126.729 2.011 . . . . 0.0 113.544 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.13 -4.44 25.4 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 124.58 1.086 . . . . 0.0 113.042 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -117.08 164.92 16.92 Favored Pre-proline 0 C--N 1.357 0.898 0 CA-C-N 118.723 1.262 . . . . 0.0 108.364 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -71.58 167.37 26.63 Favored 'Trans proline' 0 C--N 1.353 0.783 1 C-N-CA 125.506 4.137 . . . . 0.0 114.413 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -53.79 115.31 1.93 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 128.086 2.554 . . . . 0.0 115.943 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.471 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 10.8 m95 -116.32 117.83 38.24 Favored Pre-proline 0 N--CA 1.415 -2.214 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HG2' ' HB3' ' A' ' 175' ' ' ALA . 17.4 Cg_endo -56.82 134.07 62.09 Favored 'Trans proline' 0 CA--C 1.561 1.866 1 C-N-CA 125.888 4.392 . . . . 0.0 111.848 160.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 m -147.69 165.39 30.61 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.125 2.17 . . . . 0.0 111.851 -160.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 6.2 tt -124.03 129.0 50.17 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.658 1.583 . . . . 0.0 113.996 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.02 121.81 44.02 Favored 'Isoleucine or valine' 0 C--N 1.372 1.571 0 O-C-N 120.836 -1.165 . . . . 0.0 110.724 171.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.93 153.9 51.45 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 127.26 2.224 . . . . 0.0 109.052 -170.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -71.13 112.7 7.48 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-N 120.734 1.606 . . . . 0.0 113.533 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.457 ' CG ' ' CD2' ' A' ' 130' ' ' HIS . 6.5 t-80 -77.47 158.38 79.02 Favored Pre-proline 0 C--N 1.346 0.455 0 CA-C-O 114.55 -2.643 . . . . 0.0 110.373 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -55.38 -1.1 0.18 Allowed 'Trans proline' 0 CA--C 1.544 1.016 1 C-N-CA 125.884 4.389 . . . . 0.0 120.242 -170.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -95.31 -7.34 39.0 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 128.994 2.918 . . . . 0.0 110.381 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.267 0.0 OUTLIER 9.52 94.87 0.0 OUTLIER 'General case' 0 C--N 1.376 1.753 1 C-N-CA 135.939 5.696 . . . . 0.0 120.213 -178.704 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 110.27 -17.42 29.01 Favored Glycine 0 C--N 1.36 1.887 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -172.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.4 m -103.78 120.13 40.34 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 100.384 -3.932 . . . . 0.0 100.384 170.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.478 ' HA ' ' HE1' ' A' ' 130' ' ' HIS . 1.4 t80 -142.22 -26.8 0.64 Allowed 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -167.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.5 pt -112.3 155.83 13.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-O 123.029 1.395 . . . . 0.0 111.847 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -141.35 149.8 41.63 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 128.034 2.534 . . . . 0.0 104.296 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -150.43 142.51 24.03 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 120.319 -1.488 . . . . 0.0 111.105 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -118.17 93.64 4.21 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 128.044 2.538 . . . . 0.0 110.418 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.65 -67.63 0.17 Allowed Glycine 0 C--N 1.361 1.949 0 N-CA-C 120.979 3.152 . . . . 0.0 120.979 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -144.38 46.1 1.41 Allowed 'General case' 0 C--N 1.354 0.771 0 CA-C-O 122.232 1.015 . . . . 0.0 112.343 -173.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.5 m -171.5 159.04 5.41 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.24 140.28 40.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 120.933 -1.104 . . . . 0.0 109.88 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -116.77 160.2 21.15 Favored 'General case' 0 C--N 1.366 1.308 0 C-N-CA 128.058 2.543 . . . . 0.0 112.906 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.428 HG13 ' HD3' ' A' ' 145' ' ' LYS . 9.9 m -148.57 164.77 4.79 Favored 'Isoleucine or valine' 0 C--N 1.37 1.487 0 C-N-CA 128.1 2.56 . . . . 0.0 107.058 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.478 ' HE1' ' HA ' ' A' ' 119' ' ' PHE . 0.0 OUTLIER -91.55 116.94 29.27 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 122.395 1.093 . . . . 0.0 111.424 169.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.82 158.78 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 N-CA-C 104.702 -2.332 . . . . 0.0 104.702 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -125.73 138.33 53.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 172.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.96 129.7 40.33 Favored 'General case' 0 C--N 1.36 1.058 0 C-N-CA 128.013 2.525 . . . . 0.0 107.864 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 14.1 m-30 -75.85 63.3 1.67 Allowed 'General case' 0 C--N 1.363 1.172 0 C-N-CA 125.829 1.652 . . . . 0.0 113.723 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.332 50.6 p-10 -98.14 -110.32 0.17 Allowed 'General case' 0 C--N 1.358 0.974 0 O-C-N 120.179 -1.576 . . . . 0.0 113.111 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -106.45 -54.95 2.4 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 125.621 1.568 . . . . 0.0 112.642 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.256 0.9 OUTLIER -64.15 -49.34 74.07 Favored Pre-proline 0 C--N 1.365 1.269 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -174.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.12 171.78 54.0 Favored 'Cis proline' 0 CA--C 1.547 1.167 0 CA-C-N 125.98 3.171 . . . . 0.0 111.543 -5.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.327 7.5 t -95.54 154.63 17.11 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 120.392 -1.443 . . . . 0.0 111.849 -176.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -148.85 152.25 36.14 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 125.133 1.373 . . . . 0.0 109.566 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -178.42 -177.5 47.14 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 107.279 -2.329 . . . . 0.0 107.279 168.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -82.78 106.26 14.47 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.456 1.902 . . . . 0.0 107.415 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.6 m -94.41 159.82 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.442 0 C-N-CA 127.577 2.351 . . . . 0.0 109.063 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.4 m -85.59 110.34 19.18 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.448 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 30.6 ttpt -64.51 -25.57 68.05 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -167.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.62 -12.35 57.62 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 127.285 2.234 . . . . 0.0 114.984 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . 0.31 0.2 OUTLIER -104.82 8.53 34.86 Favored 'General case' 0 C--N 1.37 1.464 0 O-C-N 119.107 -2.246 . . . . 0.0 112.402 174.18 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 14.4 mt -95.3 127.75 41.6 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 128.122 2.569 . . . . 0.0 108.339 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -114.19 165.37 13.84 Favored Pre-proline 0 C--N 1.357 0.901 0 O-C-N 118.894 -2.379 . . . . 0.0 105.866 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.43 151.97 13.57 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 124.924 3.75 . . . . 0.0 115.689 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.518 ' CE2' ' HA2' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -93.01 167.68 11.63 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 122.834 1.302 . . . . 0.0 113.373 175.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 178.9 -60.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.936 2 N-CA-C 95.073 -5.899 . . . . 0.0 95.073 -174.608 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.518 ' HA2' ' CE2' ' A' ' 151' ' ' TYR . . . 127.03 -125.52 5.35 Favored Glycine 0 CA--C 1.474 -2.521 0 O-C-N 121.186 -0.946 . . . . 0.0 113.481 151.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 m -59.15 -15.73 16.18 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -96.47 4.95 51.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 129.709 3.204 . . . . 0.0 111.651 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 18.1 t -89.7 139.94 30.07 Favored 'General case' 0 C--N 1.372 1.567 0 C-N-CA 126.658 1.983 . . . . 0.0 108.597 173.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.65 -27.38 68.63 Favored 'General case' 0 C--N 1.369 1.413 0 C-N-CA 125.827 1.651 . . . . 0.0 113.948 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -78.59 -10.22 59.65 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 119.672 -1.892 . . . . 0.0 112.293 171.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -104.13 17.06 24.88 Favored 'General case' 0 C--N 1.375 1.682 0 C-N-CA 125.343 1.457 . . . . 0.0 114.155 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -132.27 174.54 10.12 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.319 1.447 . . . . 0.0 109.003 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -60.36 122.17 13.89 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 126.164 1.786 . . . . 0.0 113.996 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.08 -12.7 57.44 Favored Glycine 0 C--N 1.358 1.781 0 C-N-CA 124.803 1.192 . . . . 0.0 112.53 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.4 151.18 24.16 Favored Glycine 0 C--N 1.363 2.042 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -63.23 -38.87 92.87 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -87.74 -22.03 24.82 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.182 0.993 . . . . 0.0 112.308 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -75.87 91.65 3.02 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 126.635 1.974 . . . . 0.0 114.367 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 70.7 m -119.21 107.69 13.75 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 100.487 -3.894 . . . . 0.0 100.487 170.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.46 101.44 13.92 Favored 'General case' 0 C--N 1.366 1.293 0 CA-C-O 126.535 3.064 . . . . 0.0 114.312 -167.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -120.31 139.69 28.97 Favored Pre-proline 0 N--CA 1.412 -2.344 1 C-N-CA 133.139 4.575 . . . . 0.0 101.353 169.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.63 -32.19 82.38 Favored 'Trans proline' 0 CA--C 1.545 1.066 1 C-N-CA 126.462 4.775 . . . . 0.0 115.694 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -66.11 -35.91 81.76 Favored 'General case' 0 C--N 1.365 1.268 0 C-N-CA 127.578 2.351 . . . . 0.0 113.125 174.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.471 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 19.2 mm -68.25 -39.17 80.69 Favored 'Isoleucine or valine' 0 C--N 1.378 1.827 0 C-N-CA 126.279 1.832 . . . . 0.0 110.909 174.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 20.2 mt -68.9 -51.35 40.97 Favored 'General case' 0 C--N 1.367 1.355 0 C-N-CA 126.162 1.785 . . . . 0.0 113.163 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -61.02 -35.32 76.55 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 127.191 2.197 . . . . 0.0 114.596 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.443 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . . . -69.36 -34.99 75.41 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 130.717 3.607 . . . . 0.0 109.396 171.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.5 mtt -69.31 -35.37 75.89 Favored 'General case' 0 C--N 1.38 1.924 0 CA-C-N 120.994 1.725 . . . . 0.0 114.017 163.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -66.74 -47.95 70.69 Favored 'General case' 0 C--N 1.372 1.572 0 C-N-CA 125.76 1.624 . . . . 0.0 111.461 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -68.96 -53.05 22.89 Favored 'General case' 0 C--N 1.37 1.472 0 C-N-CA 127.3 2.24 . . . . 0.0 113.026 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.25 -33.13 74.01 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.46 -44.0 75.8 Favored 'General case' 0 C--N 1.375 1.691 0 C-N-CA 127.067 2.147 . . . . 0.0 109.861 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -36.87 83.37 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -69.43 -35.09 75.35 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 151' ' ' TYR . 1.7 pt? -81.41 -36.8 29.05 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 119.943 -1.723 . . . . 0.0 114.63 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -87.17 -25.64 23.97 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 126.833 2.053 . . . . 0.0 112.878 -172.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -100.87 -95.15 0.27 Allowed 'General case' 0 C--N 1.367 1.35 0 O-C-N 121.091 -1.006 . . . . 0.0 109.007 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.0 145.01 45.65 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.047 -1.033 . . . . 0.0 109.399 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.523 ' HB3' HH11 ' A' ' 190' ' ' ARG . 93.5 mttt -51.39 -34.71 35.58 Favored 'General case' 0 C--N 1.365 1.257 1 C-N-CA 132.379 4.271 . . . . 0.0 113.881 173.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.5 tt -50.61 -27.81 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 131.001 3.72 . . . . 0.0 112.593 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.257 2.3 mptp? -73.82 -29.97 62.45 Favored 'General case' 0 C--N 1.377 1.786 0 C-N-CA 126.895 2.078 . . . . 0.0 114.728 169.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.523 HH11 ' HB3' ' A' ' 187' ' ' LYS 0.266 0.0 OUTLIER -75.03 -43.25 54.66 Favored 'General case' 0 C--N 1.371 1.518 0 O-C-N 119.278 -2.139 . . . . 0.0 113.168 171.161 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.288 63.2 mt -75.33 -18.87 59.9 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 126.631 1.972 . . . . 0.0 114.488 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -58.12 -38.92 77.43 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 127.699 2.4 . . . . 0.0 113.063 168.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -94.41 -51.07 4.94 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 126.963 2.105 . . . . 0.0 109.159 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 63.55 -83.38 0.02 OUTLIER 'General case' 0 C--N 1.372 1.585 1 C-N-CA 131.91 4.084 . . . . 0.0 114.353 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.435 -1.203 0 C-N-CA 130.841 3.656 . . . . 0.0 101.414 171.029 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.359 87.0 p . . . . . 0 C--O 1.223 -0.335 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -101.41 108.03 19.52 Favored 'General case' 0 C--N 1.361 1.105 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -123.61 126.99 47.63 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 126.02 1.728 . . . . 0.0 111.387 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 25.4 p -113.12 168.65 7.41 Favored Pre-proline 0 C--N 1.357 0.924 0 C-N-CA 128.864 2.865 . . . . 0.0 117.504 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 12.7 Cg_exo -44.11 127.26 6.82 Favored 'Trans proline' 0 C--N 1.395 3.003 1 C-N-CA 127.628 5.552 . . . . 0.0 116.15 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.24 57.44 Favored Glycine 0 CA--C 1.482 -1.994 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.045 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -95.35 161.19 14.19 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 122.867 1.318 . . . . 0.0 108.263 169.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.79 135.46 50.67 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 101.253 -3.61 . . . . 0.0 101.253 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.07 159.01 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -106.93 120.3 41.68 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 162.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.79 143.93 33.24 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 120.635 1.561 . . . . 0.0 109.37 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -115.51 134.9 54.63 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 118.982 -2.324 . . . . 0.0 105.471 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 ttp -128.91 146.45 50.95 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 119.343 -2.098 . . . . 0.0 109.141 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.59 98.88 0.72 Allowed 'General case' 0 C--N 1.365 1.27 0 C-N-CA 127.072 2.149 . . . . 0.0 113.754 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.23 -9.71 24.64 Favored Glycine 0 C--N 1.359 1.833 0 C-N-CA 125.426 1.488 . . . . 0.0 111.935 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -104.97 158.79 31.27 Favored Pre-proline 0 C--N 1.356 0.879 0 C-N-CA 125.678 1.591 . . . . 0.0 109.019 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.83 166.64 28.9 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.368 3.378 . . . . 0.0 112.034 161.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -56.13 115.02 2.2 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 129.86 3.264 . . . . 0.0 112.408 171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.537 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 2.1 m95 -114.69 108.18 49.57 Favored Pre-proline 0 N--CA 1.434 -1.244 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -173.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 19.0 Cg_endo -55.28 106.21 0.18 Allowed 'Trans proline' 0 C--N 1.397 3.116 1 C-N-CA 125.854 4.37 . . . . 0.0 109.984 161.571 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 m -114.64 164.11 14.49 Favored 'General case' 0 CA--C 1.492 -1.287 1 C-N-CA 132.313 4.245 . . . . 0.0 113.21 -164.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.983 HD11 ' HE ' ' A' ' 190' ' ' ARG . 5.2 tp -123.87 127.66 48.34 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 111.6 -2.545 . . . . 0.0 105.363 173.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 131' ' ' VAL . 2.5 p -91.33 118.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 166.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.402 ' HA ' HH21 ' A' ' 190' ' ' ARG . 0.0 OUTLIER -121.18 152.58 38.61 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 124.498 1.119 . . . . 0.0 112.037 -169.589 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -89.61 111.34 22.25 Favored 'General case' 0 C--N 1.373 1.621 0 CA-C-O 123.342 1.544 . . . . 0.0 108.29 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -100.81 158.7 31.35 Favored Pre-proline 0 N--CA 1.451 -0.399 0 C-N-CA 129.705 3.202 . . . . 0.0 109.343 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -49.95 -0.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 2 C-N-CA 127.569 5.512 . . . . 0.0 122.845 -164.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.6 -0.13 35.34 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 126.792 2.037 . . . . 0.0 108.533 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.269 0.3 OUTLIER -20.36 119.33 0.03 OUTLIER 'General case' 0 C--N 1.376 1.718 2 C-N-CA 134.634 5.174 . . . . 0.0 122.068 -177.913 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.38 -20.96 27.22 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.5 p -120.72 117.94 28.78 Favored 'General case' 0 C--N 1.352 0.704 1 N-CA-C 98.101 -4.777 . . . . 0.0 98.101 164.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -141.94 2.39 1.54 Allowed 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 120.546 -1.346 . . . . 0.0 112.857 -167.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.9 pt -107.93 163.02 5.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 CA-C-O 122.696 1.236 . . . . 0.0 111.724 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -150.62 147.73 27.76 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 103.309 -2.848 . . . . 0.0 103.309 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -144.22 134.31 24.16 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 120.771 1.623 . . . . 0.0 111.926 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -117.46 93.18 4.07 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.689 2.396 . . . . 0.0 107.434 174.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.57 -92.46 0.08 OUTLIER Glycine 0 C--N 1.361 1.921 0 C-N-CA 126.555 2.026 . . . . 0.0 118.051 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -123.21 20.09 9.81 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 125.812 1.645 . . . . 0.0 109.12 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.6 t -118.41 108.69 15.35 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -111.2 135.1 51.42 Favored 'Isoleucine or valine' 0 C--N 1.357 0.898 0 C-N-CA 124.688 1.195 . . . . 0.0 108.686 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 73.4 mtt-85 -123.16 151.17 42.42 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 126.419 1.888 . . . . 0.0 112.588 -175.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.28 163.01 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 128.227 2.611 . . . . 0.0 107.282 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -93.18 121.75 34.86 Favored 'General case' 0 C--N 1.369 1.449 0 O-C-N 119.731 -1.855 . . . . 0.0 111.579 171.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.414 HG12 HG23 ' A' ' 110' ' ' VAL . 4.0 m -135.97 176.64 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.553 0 C-N-CA 126.585 1.954 . . . . 0.0 108.326 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -134.26 152.43 51.81 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.964 0.888 . . . . 0.0 109.495 166.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -106.74 115.59 30.46 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 126.642 1.977 . . . . 0.0 106.069 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 13.4 m-85 -66.8 55.97 0.04 OUTLIER 'General case' 0 C--N 1.367 1.347 0 C-N-CA 127.847 2.459 . . . . 0.0 116.022 -175.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.505 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP 0.303 52.7 p-10 -84.79 -102.16 0.05 Allowed 'General case' 0 C--N 1.367 1.367 0 C-N-CA 127.039 2.136 . . . . 0.0 113.17 -176.663 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -106.47 -58.3 1.94 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.275 1.83 . . . . 0.0 115.121 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.0 t -75.78 -41.77 3.56 Favored Pre-proline 0 C--N 1.366 1.295 0 CA-C-O 114.037 -2.887 . . . . 0.0 117.951 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.7 -177.94 22.45 Favored 'Cis proline' 0 CA--C 1.55 1.279 0 CA-C-N 127.083 3.566 . . . . 0.0 113.379 -2.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.3 t -95.35 142.37 27.81 Favored 'General case' 0 C--N 1.368 1.389 0 O-C-N 118.762 -2.461 . . . . 0.0 108.764 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -142.01 149.33 39.88 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.5 -170.61 37.89 Favored Glycine 0 CA--C 1.488 -1.649 1 N-CA-C 102.201 -4.36 . . . . 0.0 102.201 172.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -89.75 119.81 30.47 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 125.33 1.452 . . . . 0.0 109.371 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 143' ' ' VAL . 1.8 m -99.27 160.38 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 C-N-CA 125.621 1.569 . . . . 0.0 111.152 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 41.0 t -70.92 106.12 3.52 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 127.568 2.347 . . . . 0.0 107.335 168.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 7.5 ttpp -68.95 -29.33 67.55 Favored 'General case' 0 C--N 1.365 1.258 0 CA-C-O 122.777 1.275 . . . . 0.0 112.306 -175.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -67.48 -14.75 63.21 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.681 1.593 . . . . 0.0 114.646 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.6 mt -100.18 18.38 18.84 Favored 'General case' 0 C--N 1.367 1.337 0 C-N-CA 125.9 1.68 . . . . 0.0 111.485 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 37.2 mt -102.36 131.08 49.21 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.748 -1.22 . . . . 0.0 110.473 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -115.39 156.73 45.45 Favored Pre-proline 0 C--O 1.222 -0.361 0 CA-C-O 116.711 -1.614 . . . . 0.0 107.259 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.69 150.59 14.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 125.223 3.949 . . . . 0.0 113.425 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -120.29 120.0 34.79 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-O 122.42 1.105 . . . . 0.0 112.822 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.48 ' HA ' HD21 ' A' ' 183' ' ' LEU . 5.0 t -154.49 22.2 0.47 Allowed 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.672 1.589 . . . . 0.0 106.95 177.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.59 56.1 0.36 Allowed Glycine 0 C--N 1.36 1.888 0 N-CA-C 120.184 2.834 . . . . 0.0 120.184 -158.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.7 m -65.77 -17.72 64.82 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 130.423 3.489 . . . . 0.0 113.978 171.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -107.04 15.59 25.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 129.466 3.106 . . . . 0.0 110.425 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . 0.337 97.2 p -126.17 153.31 44.8 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 124.186 0.994 . . . . 0.0 113.311 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.535 1.4 pttm -47.06 -16.33 0.04 OUTLIER 'General case' 0 C--N 1.369 1.426 0 N-CA-C 121.348 3.833 . . . . 0.0 121.348 -168.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -96.14 -6.21 38.89 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 117.02 -1.467 . . . . 0.0 114.057 167.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.09 18.78 10.81 Favored 'General case' 0 C--N 1.381 1.953 0 CA-C-N 122.588 2.449 . . . . 0.0 116.621 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.75 -173.04 2.97 Favored 'General case' 0 N--CA 1.45 -0.431 1 C-N-CA 132.006 4.123 . . . . 0.0 109.535 -176.287 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -70.96 122.59 20.26 Favored 'General case' 0 C--N 1.361 1.1 0 O-C-N 119.588 -1.945 . . . . 0.0 113.014 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 98.91 -5.79 59.85 Favored Glycine 0 C--N 1.363 2.052 0 C-N-CA 126.156 1.836 . . . . 0.0 112.158 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -80.67 148.24 28.86 Favored Glycine 0 C--N 1.364 2.1 0 C-N-CA 129.095 3.236 . . . . 0.0 117.225 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -59.87 -33.61 72.04 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -102.52 -5.76 23.63 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 120.494 1.497 . . . . 0.0 113.068 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -88.87 148.6 23.78 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 -170.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.0 m -163.67 151.42 12.86 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 101.342 -3.577 . . . . 0.0 101.342 172.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -112.09 100.12 8.61 Favored 'General case' 0 C--N 1.372 1.56 0 CA-C-O 126.003 2.811 . . . . 0.0 111.032 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -120.55 141.63 32.54 Favored Pre-proline 0 N--CA 1.424 -1.756 2 C-N-CA 132.921 4.488 . . . . 0.0 99.522 168.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.91 -26.05 67.04 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.228 3.286 . . . . 0.0 114.171 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -69.82 -35.66 74.97 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 129.491 3.117 . . . . 0.0 114.017 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.537 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 9.3 mm -69.88 -43.18 79.83 Favored 'Isoleucine or valine' 0 C--N 1.379 1.874 0 C-N-CA 127.109 2.164 . . . . 0.0 109.175 175.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.7 mt -68.94 -45.18 71.44 Favored 'General case' 0 C--N 1.373 1.593 0 C-N-CA 124.458 1.103 . . . . 0.0 113.748 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -57.95 -34.58 70.06 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 126.474 1.91 . . . . 0.0 114.88 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.58 -48.5 69.39 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 130.854 3.662 . . . . 0.0 111.086 169.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 10.6 mtt -60.6 -39.6 88.74 Favored 'General case' 0 C--N 1.375 1.708 0 CA-C-N 120.558 1.526 . . . . 0.0 115.002 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.5 -52.14 35.5 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 128.052 2.541 . . . . 0.0 112.743 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -72.54 -34.84 67.81 Favored 'General case' 0 C--N 1.381 1.935 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 178.136 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.02 84.07 Favored 'General case' 0 C--N 1.371 1.517 0 C-N-CA 124.675 1.19 . . . . 0.0 112.615 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.14 -47.46 86.14 Favored 'General case' 0 C--N 1.378 1.819 0 C-N-CA 125.947 1.699 . . . . 0.0 112.763 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -33.84 76.63 Favored 'General case' 0 C--N 1.369 1.454 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -74.56 -28.77 61.09 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.48 HD21 ' HA ' ' A' ' 152' ' ' THR . 0.6 OUTLIER -77.9 -46.96 19.85 Favored 'General case' 0 CA--C 1.499 -1.01 1 C-N-CA 132.23 4.212 . . . . 0.0 114.105 178.266 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.259 0.0 OUTLIER -89.51 -8.52 52.65 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 125.125 1.37 . . . . 0.0 111.441 -174.293 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -126.17 -103.63 0.35 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 122.799 0.44 . . . . 0.0 111.342 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.402 ' HB3' HG22 ' A' ' 188' ' ' ILE . 22.9 t70 -136.27 161.3 36.16 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-O 123.51 1.624 . . . . 0.0 112.581 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -51.07 -36.19 38.7 Favored 'General case' 0 C--N 1.358 0.951 1 C-N-CA 136.319 5.847 . . . . 0.0 113.391 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.402 HG22 ' HB3' ' A' ' 186' ' ' ASP . 7.4 tt -55.04 -30.01 23.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 127.937 2.495 . . . . 0.0 113.215 176.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -74.6 -40.77 61.38 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.983 ' HE ' HD11 ' A' ' 109' ' ' LEU 0.266 5.2 ptm180 -74.44 -33.23 62.88 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 175.007 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.2 mt -82.3 -19.5 39.31 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.949 -1.094 . . . . 0.0 112.1 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -53.45 -43.87 68.44 Favored 'General case' 0 C--N 1.37 1.467 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -31.96 11.0 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 126.122 1.769 . . . . 0.0 109.974 175.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 41.03 -119.14 0.39 Allowed 'General case' 0 C--N 1.377 1.769 0 C-N-CA 130.903 3.681 . . . . 0.0 114.784 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.827 0 O-C-N 120.035 -1.666 . . . . 0.0 112.505 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.344 80.4 p . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -154.38 94.18 1.68 Allowed 'General case' 0 C--N 1.361 1.104 0 CA-C-O 122.551 1.167 . . . . 0.0 113.107 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -122.75 125.58 45.79 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.44 1.096 . . . . 0.0 109.293 -174.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.464 82.5 p -111.92 170.31 5.41 Favored Pre-proline 0 CA--C 1.558 1.279 1 C-N-CA 132.066 4.147 . . . . 0.0 114.205 -175.043 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 10.5 Cg_endo -53.2 139.49 62.9 Favored 'Trans proline' 0 C--N 1.378 2.117 1 C-N-CA 127.36 5.373 . . . . 0.0 120.054 -162.732 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.88 -13.82 45.49 Favored Glycine 0 C--N 1.363 2.064 0 CA-C-O 118.668 -1.074 . . . . 0.0 112.321 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.26 169.05 11.15 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 121.084 2.442 . . . . 0.0 112.309 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.633 ' CD2' ' HE ' ' A' ' 190' ' ' ARG . 4.5 mm? -97.72 138.64 34.8 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 101.832 -3.396 . . . . 0.0 101.832 164.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 m -134.03 165.59 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 103.536 -2.765 . . . . 0.0 103.536 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -121.22 116.65 25.31 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 101.174 -3.639 . . . . 0.0 101.174 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.51 128.71 56.54 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 123.667 1.698 . . . . 0.0 112.455 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -99.24 136.6 38.96 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 169.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.407 ' N ' ' CE1' ' A' ' 103' ' ' TYR . 1.2 tpt -121.62 148.04 45.06 Favored 'General case' 0 CA--C 1.511 -0.519 0 O-C-N 118.957 -2.339 . . . . 0.0 105.707 173.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -56.21 83.96 0.01 OUTLIER 'General case' 0 C--N 1.352 0.717 0 C-N-CA 129.107 2.963 . . . . 0.0 116.691 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.09 1.86 25.12 Favored Glycine 0 C--N 1.357 1.737 0 C-N-CA 124.676 1.131 . . . . 0.0 114.61 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.407 ' CE1' ' N ' ' A' ' 100' ' ' MET 0.262 0.0 OUTLIER -105.36 172.33 4.13 Favored Pre-proline 0 C--N 1.361 1.093 0 CA-C-O 116.991 -1.481 . . . . 0.0 109.609 178.246 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.1 165.76 31.65 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.576 3.517 . . . . 0.0 114.151 170.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.0 116.43 6.41 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.457 1.903 . . . . 0.0 112.62 173.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.446 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 10.2 m95 -114.92 127.63 26.65 Favored Pre-proline 0 N--CA 1.426 -1.641 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 -172.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 55.9 Cg_endo -59.01 144.36 99.4 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 124.992 3.795 . . . . 0.0 111.343 154.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 m -156.27 164.67 38.04 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.276 1.43 . . . . 0.0 110.532 -161.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 tt -127.0 136.91 52.89 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 119.565 -1.959 . . . . 0.0 106.367 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.81 117.89 36.07 Favored 'Isoleucine or valine' 0 C--N 1.374 1.669 0 O-C-N 119.983 -1.698 . . . . 0.0 108.148 172.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -121.8 147.87 45.41 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.052 1.341 . . . . 0.0 111.416 -168.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.08 120.39 39.4 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -62.32 159.41 40.39 Favored Pre-proline 0 C--N 1.363 1.175 0 C-N-CA 128.114 2.566 . . . . 0.0 114.459 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.37 -0.65 0.16 Allowed 'Trans proline' 0 CA--C 1.558 1.675 1 C-N-CA 126.895 5.063 . . . . 0.0 117.053 172.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -106.99 37.82 2.26 Favored 'General case' 0 CA--C 1.551 1.002 1 C-N-CA 134.805 5.242 . . . . 0.0 107.041 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.305 0.0 OUTLIER -71.03 148.65 47.36 Favored 'General case' 0 C--N 1.373 1.602 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -170.703 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.56 -6.61 31.68 Favored Glycine 0 C--N 1.36 1.914 0 C-N-CA 125.498 1.523 . . . . 0.0 112.223 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.1 t -136.62 151.62 49.53 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 128.338 2.655 . . . . 0.0 104.159 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -160.31 -41.72 0.05 OUTLIER 'General case' 0 C--N 1.363 1.17 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.614 HG22 HG12 ' A' ' 129' ' ' VAL . 3.2 pt -107.94 146.72 13.58 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 O-C-N 119.626 -1.921 . . . . 0.0 115.058 -171.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -129.71 140.46 51.1 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -146.79 135.86 22.5 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.579 -1.326 . . . . 0.0 109.37 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -117.86 93.21 4.06 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 127.662 2.385 . . . . 0.0 106.863 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.83 -96.68 0.16 Allowed Glycine 0 C--N 1.362 2.013 0 C-N-CA 126.516 2.008 . . . . 0.0 117.767 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -113.49 16.45 18.81 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 126.937 2.095 . . . . 0.0 110.527 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 t -123.91 123.6 40.77 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.95 133.89 68.32 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-O 122.92 1.343 . . . . 0.0 110.366 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -118.09 133.08 56.24 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 127.302 2.241 . . . . 0.0 109.717 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.641 HG11 ' HD3' ' A' ' 145' ' ' LYS . 23.2 m -134.71 164.39 34.14 Favored 'Isoleucine or valine' 0 C--N 1.366 1.322 0 C-N-CA 129.002 2.921 . . . . 0.0 108.281 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -72.21 116.5 12.7 Favored 'General case' 0 C--N 1.372 1.567 0 O-C-N 119.398 -2.064 . . . . 0.0 114.203 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.49 ' HB ' HG21 ' A' ' 143' ' ' VAL . 37.3 t -144.07 141.44 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.847 0 O-C-N 119.171 -2.206 . . . . 0.0 105.121 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.86 140.98 48.7 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 112.022 -2.354 . . . . 0.0 106.323 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.54 133.05 52.57 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 126.152 1.781 . . . . 0.0 106.271 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . 21.5 m-85 -75.66 79.84 2.63 Favored 'General case' 0 C--N 1.372 1.546 0 C-N-CA 124.944 1.298 . . . . 0.0 108.983 177.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -103.53 -106.77 0.28 Allowed 'General case' 0 C--N 1.361 1.091 0 O-C-N 120.708 -1.245 . . . . 0.0 110.576 -174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -106.35 -58.08 1.97 Allowed 'General case' 0 C--N 1.353 0.718 0 C-N-CA 125.319 1.448 . . . . 0.0 111.894 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.2 m -82.77 -37.24 0.74 Allowed Pre-proline 0 C--N 1.362 1.141 0 N-CA-C 119.817 3.266 . . . . 0.0 119.817 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.61 178.48 33.36 Favored 'Cis proline' 0 CA--C 1.543 0.93 1 CA-C-N 128.529 4.082 . . . . 0.0 113.578 1.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.4 m -96.0 138.64 33.35 Favored 'General case' 0 C--N 1.366 1.301 0 C-N-CA 124.743 1.217 . . . . 0.0 109.279 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -155.67 158.97 39.16 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.673 -1.892 . . . . 0.0 106.315 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.7 -158.69 19.39 Favored Glycine 0 CA--C 1.487 -1.668 1 N-CA-C 100.32 -5.112 . . . . 0.0 100.32 170.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -90.36 132.48 35.57 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.49 HG21 ' HB ' ' A' ' 131' ' ' VAL . 2.3 m -99.98 -178.32 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 O-C-N 119.449 -2.032 . . . . 0.0 109.297 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.9 m -100.92 126.59 47.56 Favored 'General case' 0 C--N 1.365 1.272 0 N-CA-C 101.028 -3.693 . . . . 0.0 101.028 166.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.641 ' HD3' HG11 ' A' ' 129' ' ' VAL . 36.6 ttpt -72.23 -20.23 61.58 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -72.17 -6.25 41.41 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.73 3.51 42.33 Favored 'General case' 0 C--N 1.367 1.326 0 C-N-CA 124.48 1.112 . . . . 0.0 110.547 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.432 HD12 ' HG3' ' A' ' 145' ' ' LYS . 24.3 mt -91.8 134.44 34.74 Favored 'General case' 0 C--N 1.368 1.405 0 C-N-CA 125.505 1.522 . . . . 0.0 112.198 176.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -114.74 165.35 14.13 Favored Pre-proline 0 C--N 1.344 0.328 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 170.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.56 155.7 14.0 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.348 3.365 . . . . 0.0 113.714 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -29.04 -78.35 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.964 2 N-CA-C 123.678 4.695 . . . . 0.0 123.678 178.575 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.8 t -33.12 36.34 0.0 OUTLIER 'General case' 0 C--N 1.371 1.523 1 C-N-CA 137.186 6.194 . . . . 0.0 119.318 -175.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -101.49 -48.13 1.45 Allowed Glycine 0 C--N 1.358 1.791 0 C-N-CA 127.884 2.659 . . . . 0.0 118.395 -168.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.9 m -46.48 -11.26 0.02 OUTLIER 'General case' 0 C--N 1.373 1.609 0 N-CA-C 121.182 3.771 . . . . 0.0 121.182 -175.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -122.91 13.46 9.85 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 128.746 2.818 . . . . 0.0 110.434 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.1 t -135.78 162.87 31.57 Favored 'General case' 0 CA--C 1.488 -1.424 0 C-N-CA 124.572 1.149 . . . . 0.0 113.743 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -47.05 -16.75 0.04 OUTLIER 'General case' 0 CA--C 1.489 -1.368 1 C-N-CA 134.586 5.155 . . . . 0.0 119.32 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -95.77 -7.51 36.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 117.182 -1.39 . . . . 0.0 113.081 170.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.89 15.47 3.58 Favored 'General case' 0 C--N 1.386 2.18 0 CA-C-N 122.09 2.223 . . . . 0.0 116.728 -172.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.51 -172.81 2.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 130.158 3.383 . . . . 0.0 105.975 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -71.0 122.11 19.42 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 118.971 -2.33 . . . . 0.0 112.813 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.88 -5.72 47.08 Favored Glycine 0 C--N 1.362 2.001 0 C-N-CA 125.461 1.505 . . . . 0.0 112.105 -170.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.12 154.35 50.67 Favored Glycine 0 C--N 1.371 2.51 1 C-N-CA 130.757 4.027 . . . . 0.0 117.717 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -67.78 -42.31 81.89 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 127.381 2.273 . . . . 0.0 116.179 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.57 -4.62 53.17 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 125.16 1.384 . . . . 0.0 112.196 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -82.81 94.2 7.6 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.0 m -118.73 108.38 14.81 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 100.758 -3.793 . . . . 0.0 100.758 167.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.51 101.1 13.78 Favored 'General case' 0 C--N 1.367 1.339 0 CA-C-O 126.132 2.872 . . . . 0.0 110.764 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -119.73 146.17 41.02 Favored Pre-proline 0 N--CA 1.424 -1.766 0 C-N-CA 131.171 3.788 . . . . 0.0 101.167 171.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.96 -38.81 86.58 Favored 'Trans proline' 0 C--N 1.352 0.725 1 C-N-CA 126.388 4.725 . . . . 0.0 115.307 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.46 -42.48 74.83 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.493 1.517 . . . . 0.0 113.655 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.7 mt -64.64 -46.88 91.1 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 C-N-CA 126.143 1.777 . . . . 0.0 111.901 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.427 ' O ' ' HG2' ' A' ' 177' ' ' GLN 0.304 3.9 pp -68.51 -32.38 72.3 Favored 'General case' 0 C--N 1.368 1.407 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 174.306 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -69.33 -39.25 78.29 Favored 'General case' 0 C--N 1.372 1.576 0 C-N-CA 128.612 2.765 . . . . 0.0 113.997 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 134' ' ' PHE . . . -69.32 -34.55 74.83 Favored 'General case' 0 N--CA 1.431 -1.397 1 C-N-CA 131.843 4.057 . . . . 0.0 110.818 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 44.8 mtt -69.22 -33.38 73.22 Favored 'General case' 0 C--N 1.372 1.555 0 C-N-CA 127.915 2.486 . . . . 0.0 112.517 163.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 173' ' ' LEU . 57.6 mm-40 -72.57 -45.04 61.12 Favored 'General case' 0 C--N 1.385 2.143 0 C-N-CA 127.272 2.229 . . . . 0.0 112.124 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -66.45 -49.41 66.76 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 130.182 3.393 . . . . 0.0 110.362 173.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.65 83.56 Favored 'General case' 0 C--N 1.379 1.856 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.23 -47.14 69.24 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.98 2.112 . . . . 0.0 113.947 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -49.62 58.0 Favored 'General case' 0 C--N 1.359 1.008 0 O-C-N 120.309 -1.495 . . . . 0.0 114.578 173.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 190' ' ' ARG . . . -69.6 -30.43 68.18 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.4 pp -76.44 -40.02 51.78 Favored 'General case' 0 C--N 1.367 1.352 0 C-N-CA 126.517 1.927 . . . . 0.0 115.196 176.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -11.49 55.63 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.918 1.687 . . . . 0.0 111.204 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -114.14 -107.71 0.37 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -135.68 168.77 18.65 Favored 'General case' 0 C--N 1.364 1.208 0 O-C-N 120.247 -1.533 . . . . 0.0 112.739 -171.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.617 ' HA ' HH11 ' A' ' 190' ' ' ARG . 39.8 mmtm -55.51 -40.82 72.27 Favored 'General case' 0 C--N 1.386 2.196 0 C-N-CA 130.476 3.51 . . . . 0.0 114.163 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.99 -31.95 42.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 129.124 2.97 . . . . 0.0 113.914 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -74.48 -40.87 61.57 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 125.231 1.412 . . . . 0.0 114.405 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.633 ' HE ' ' CD2' ' A' ' 95' ' ' LEU 0.276 0.1 OUTLIER -74.94 -39.67 61.25 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 119.999 -1.688 . . . . 0.0 114.311 169.558 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.16 -21.16 64.01 Favored 'General case' 0 C--N 1.381 1.956 0 C-N-CA 128.205 2.602 . . . . 0.0 113.606 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -66.52 -32.01 73.09 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 130.124 3.37 . . . . 0.0 114.73 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mt -105.67 -47.04 4.0 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.366 2.266 . . . . 0.0 108.358 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 50.15 -112.81 0.61 Allowed 'General case' 0 C--N 1.368 1.394 0 C-N-CA 129.191 2.997 . . . . 0.0 114.803 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 22.0 m . . . . . 0 C--N 1.342 0.281 0 C-N-CA 126.478 1.911 . . . . 0.0 111.421 178.902 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.3 p . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -157.99 65.85 0.46 Allowed 'General case' 0 C--N 1.355 0.82 0 C-N-CA 124.078 0.951 . . . . 0.0 108.934 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -118.29 124.68 48.41 Favored 'General case' 0 C--N 1.363 1.192 0 O-C-N 118.987 -2.32 . . . . 0.0 114.202 -172.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.44 17.2 p -112.96 169.45 6.35 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 131.114 3.766 . . . . 0.0 114.602 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -49.37 129.45 22.74 Favored 'Trans proline' 0 C--N 1.376 1.986 1 C-N-CA 128.006 5.804 . . . . 0.0 119.087 -169.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.52 -12.42 21.1 Favored Glycine 0 CA--C 1.482 -1.993 0 C-N-CA 124.438 1.018 . . . . 0.0 111.309 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.03 159.99 14.92 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.206 -1.761 . . . . 0.0 108.247 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.42 140.31 36.87 Favored 'General case' 0 C--N 1.344 0.354 1 N-CA-C 99.998 -4.075 . . . . 0.0 99.998 166.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.37 147.36 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 102.667 -3.086 . . . . 0.0 102.667 -171.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -99.93 119.29 38.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.92 136.34 48.63 Favored 'General case' 0 C--N 1.359 1.012 0 CA-C-N 119.862 1.21 . . . . 0.0 111.559 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -108.97 141.31 41.25 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.0 ttp -129.59 149.84 51.18 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 119.311 -2.118 . . . . 0.0 108.932 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -65.6 89.66 0.11 Allowed 'General case' 0 C--N 1.363 1.193 0 C-N-CA 127.103 2.161 . . . . 0.0 115.032 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.24 -3.07 25.29 Favored Glycine 0 C--N 1.357 1.746 0 C-N-CA 125.873 1.701 . . . . 0.0 112.786 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -100.97 163.33 18.2 Favored Pre-proline 0 C--N 1.354 0.782 0 C-N-CA 126.573 1.949 . . . . 0.0 109.773 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.04 165.9 31.22 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.627 2.885 . . . . 0.0 112.666 164.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.515 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 1.6 m95 -66.36 130.55 43.6 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 128.6 2.76 . . . . 0.0 111.053 170.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -129.83 138.94 34.21 Favored Pre-proline 0 N--CA 1.415 -2.196 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.09 132.12 17.68 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 123.313 2.675 . . . . 0.0 107.896 147.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.6 m -135.66 166.51 23.07 Favored 'General case' 0 C--N 1.345 0.398 1 C-N-CA 132.121 4.168 . . . . 0.0 110.485 -166.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 5.9 tt -123.68 133.01 53.97 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 119.155 -2.216 . . . . 0.0 110.299 177.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.613 HG23 HG12 ' A' ' 131' ' ' VAL . 7.4 p -92.14 118.64 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 CA-C-N 122.271 2.305 . . . . 0.0 110.146 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.68 153.44 48.97 Favored 'General case' 0 C--N 1.372 1.583 0 C-N-CA 127.238 2.215 . . . . 0.0 112.484 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -78.64 112.55 15.85 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 129.473 3.109 . . . . 0.0 114.062 170.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.446 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 22.5 t60 -90.75 159.58 40.33 Favored Pre-proline 0 C--N 1.373 1.624 0 CA-C-O 114.301 -2.761 . . . . 0.0 109.181 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.446 ' HD2' ' CG ' ' A' ' 113' ' ' HIS 0.265 53.0 Cg_exo -47.54 0.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.861 2 C-N-CA 129.021 6.481 . . . . 0.0 122.536 -166.519 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -102.48 40.56 1.34 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.164 2.586 . . . . 0.0 104.981 168.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.12 118.9 7.39 Favored 'General case' 0 C--N 1.379 1.862 0 C-N-CA 127.493 2.317 . . . . 0.0 114.275 -170.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.96 -19.9 27.18 Favored Glycine 0 C--N 1.356 1.656 0 C-N-CA 125.424 1.487 . . . . 0.0 110.534 -165.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.8 m -104.8 120.21 40.85 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 172.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -135.77 -43.15 0.67 Allowed 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 119.547 1.067 . . . . 0.0 113.531 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 pt -100.03 173.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-O 122.345 1.069 . . . . 0.0 113.875 -174.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -159.0 148.26 18.72 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -147.36 127.05 13.37 Favored 'General case' 0 C--N 1.363 1.193 0 O-C-N 120.071 -1.643 . . . . 0.0 110.3 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -118.29 93.75 4.24 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.601 1.96 . . . . 0.0 110.526 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.02 -76.79 0.23 Allowed Glycine 0 C--N 1.36 1.893 0 N-CA-C 120.391 2.916 . . . . 0.0 120.391 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -139.27 52.49 1.75 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 125.198 1.399 . . . . 0.0 110.657 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.4 m -174.22 146.08 1.09 Allowed 'General case' 0 C--N 1.356 0.852 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.43 139.86 50.27 Favored 'Isoleucine or valine' 0 C--N 1.362 1.111 0 CA-C-O 122.129 0.966 . . . . 0.0 111.362 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -113.56 161.77 17.0 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 126.889 2.076 . . . . 0.0 113.628 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 145' ' ' LYS . 14.0 m -149.35 163.3 4.29 Favored 'Isoleucine or valine' 0 C--N 1.369 1.431 1 C-N-CA 133.024 4.53 . . . . 0.0 103.749 175.495 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -97.44 127.64 43.56 Favored 'General case' 0 C--N 1.366 1.293 0 O-C-N 121.001 -1.062 . . . . 0.0 111.204 167.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.613 HG12 HG23 ' A' ' 110' ' ' VAL . 1.6 m -146.02 171.65 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -131.93 146.51 52.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.43 1.092 . . . . 0.0 109.063 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -93.31 132.26 37.68 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 129.992 3.317 . . . . 0.0 107.534 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 7.4 m-30 -76.03 65.21 2.03 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 124.292 1.996 . . . . 0.0 113.509 -176.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -89.45 -109.49 0.08 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 128.891 2.876 . . . . 0.0 110.146 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.23 -52.12 2.81 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.87 1.668 . . . . 0.0 113.902 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.6 m -80.92 -41.07 1.15 Allowed Pre-proline 0 C--N 1.364 1.205 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -172.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.77 169.59 74.09 Favored 'Cis proline' 0 CA--C 1.543 0.953 0 CA-C-N 126.303 3.287 . . . . 0.0 114.259 -1.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.3 m -85.68 125.44 33.19 Favored 'General case' 0 C--N 1.366 1.302 0 C-N-CA 126.413 1.885 . . . . 0.0 110.539 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.486 ' HG2' ' H ' ' A' ' 141' ' ' GLY . 0.5 OUTLIER -117.87 174.84 5.96 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 125.225 1.41 . . . . 0.0 111.219 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.486 ' H ' ' HG2' ' A' ' 140' ' ' ARG . . . 169.14 -160.19 33.48 Favored Glycine 0 CA--C 1.487 -1.715 1 N-CA-C 97.852 -6.099 . . . . 0.0 97.852 171.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.5 m95 -96.95 155.8 16.62 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.0 m -119.92 173.14 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 C-N-CA 124.246 1.018 . . . . 0.0 108.566 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.0 t -84.19 123.58 30.25 Favored 'General case' 0 C--N 1.369 1.443 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 164.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.438 ' HB2' HG22 ' A' ' 129' ' ' VAL . 15.8 ttpp -73.38 -25.16 60.45 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 120.904 -1.123 . . . . 0.0 111.995 -175.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -73.22 -9.42 58.69 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 125.246 1.418 . . . . 0.0 114.519 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.3 mt -100.11 6.07 44.91 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 125.448 1.499 . . . . 0.0 111.577 172.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.8 mt -100.4 132.23 45.9 Favored 'General case' 0 C--N 1.371 1.538 0 C-N-CA 125.366 1.466 . . . . 0.0 108.403 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 149' ' ' LYS . 4.9 mtmp? -114.74 164.89 15.23 Favored Pre-proline 0 CA--C 1.506 -0.735 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.22 156.31 14.76 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.803 2.335 . . . . 0.0 113.409 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -34.09 -107.67 0.0 OUTLIER 'General case' 0 C--N 1.351 0.631 1 C-N-CA 132.888 4.475 . . . . 0.0 120.606 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.392 4.0 t 53.3 -42.94 0.02 OUTLIER 'General case' 0 C--N 1.371 1.505 1 C-N-CA 131.727 4.011 . . . . 0.0 118.927 174.408 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.59 -150.88 30.25 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 121.916 3.527 . . . . 0.0 121.916 159.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.6 m -45.87 -11.87 0.02 OUTLIER 'General case' 0 C--N 1.374 1.637 1 C-N-CA 134.952 5.301 . . . . 0.0 118.864 -175.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -88.67 -14.0 38.42 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 129.276 3.03 . . . . 0.0 111.747 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.4 t -75.98 153.94 36.19 Favored 'General case' 0 C--N 1.377 1.781 0 C-N-CA 126.102 1.761 . . . . 0.0 112.05 171.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -72.12 -26.93 62.31 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.869 1.668 . . . . 0.0 111.98 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -79.39 -17.4 54.47 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 124.352 1.061 . . . . 0.0 111.902 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.33 4.61 48.65 Favored 'General case' 0 C--N 1.368 1.373 0 C-N-CA 126.172 1.789 . . . . 0.0 114.08 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -122.72 177.51 5.42 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 124.653 1.181 . . . . 0.0 109.135 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.33 122.58 14.89 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 126.968 2.107 . . . . 0.0 113.829 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.68 -14.58 53.41 Favored Glycine 0 C--N 1.357 1.708 0 C-N-CA 124.891 1.234 . . . . 0.0 111.615 -168.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.45 153.73 32.14 Favored Glycine 0 C--N 1.359 1.81 0 N-CA-C 119.266 2.467 . . . . 0.0 119.266 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -63.07 -42.5 99.67 Favored 'General case' 0 C--N 1.365 1.239 0 N-CA-C 118.694 2.85 . . . . 0.0 118.694 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.515 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.286 0.4 OUTLIER -101.99 -0.03 34.38 Favored 'General case' 0 C--N 1.359 1.018 0 O-C-N 120.618 -1.301 . . . . 0.0 112.675 -179.139 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -78.64 141.62 37.84 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 126.846 2.058 . . . . 0.0 111.427 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 50.9 m -171.27 150.91 3.02 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 101.06 -3.681 . . . . 0.0 101.06 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -129.67 102.52 6.38 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-O 125.409 2.528 . . . . 0.0 113.544 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -119.68 140.22 29.12 Favored Pre-proline 0 N--CA 1.43 -1.443 2 C-N-CA 134.02 4.928 . . . . 0.0 100.114 168.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . 0.319 92.0 Cg_endo -64.45 -17.95 61.36 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.766 3.644 . . . . 0.0 117.502 -174.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -69.96 -36.06 74.96 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 129.541 3.137 . . . . 0.0 111.67 170.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 31.4 mt -73.03 -32.73 40.54 Favored 'Isoleucine or valine' 0 C--N 1.372 1.576 0 C-N-CA 127.604 2.361 . . . . 0.0 110.402 175.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 41.0 mt -65.05 -49.81 68.65 Favored 'General case' 0 C--N 1.378 1.823 0 C-N-CA 126.55 1.94 . . . . 0.0 110.307 169.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -57.53 -34.58 69.28 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 125.209 1.404 . . . . 0.0 114.184 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.22 -48.35 62.21 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 129.963 3.305 . . . . 0.0 114.304 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.7 mtt -69.64 -33.3 72.43 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 120.991 1.723 . . . . 0.0 113.383 172.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -70.13 -52.39 23.99 Favored 'General case' 0 C--N 1.377 1.784 0 C-N-CA 127.056 2.142 . . . . 0.0 112.028 174.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.402 ' HG3' ' CE2' ' A' ' 134' ' ' PHE 0.267 6.1 ptt180 -71.29 -36.52 71.7 Favored 'General case' 0 C--N 1.382 1.998 0 O-C-N 119.485 -2.009 . . . . 0.0 113.842 176.01 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.4 -50.03 67.03 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.542 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -55.06 -39.22 68.98 Favored 'General case' 0 C--N 1.386 2.18 0 CA-C-N 121.96 2.164 . . . . 0.0 113.542 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -52.32 24.97 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 119.735 -1.853 . . . . 0.0 114.6 170.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 190' ' ' ARG . . . -61.62 -33.51 74.04 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.56 -35.37 34.44 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 126.615 1.966 . . . . 0.0 115.143 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.352 0.0 OUTLIER -91.1 -21.03 21.41 Favored 'General case' 0 C--N 1.367 1.327 0 O-C-N 121.309 -0.869 . . . . 0.0 110.735 -173.613 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -101.85 -110.94 0.22 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 123.348 0.659 . . . . 0.0 112.048 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -135.36 161.86 34.22 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 119.949 -1.72 . . . . 0.0 110.058 -174.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -51.26 -36.94 44.5 Favored 'General case' 0 C--N 1.373 1.608 0 C-N-CA 131.217 3.807 . . . . 0.0 115.216 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -40.09 34.99 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 C-N-CA 130.639 3.576 . . . . 0.0 112.836 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -32.44 69.3 Favored 'General case' 0 C--N 1.37 1.475 0 C-N-CA 125.483 1.513 . . . . 0.0 113.617 176.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.585 ' HB3' ' HB1' ' A' ' 182' ' ' ALA 0.25 0.0 OUTLIER -74.02 -37.2 64.42 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 174.084 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.265 3.9 mt -78.49 -19.28 53.39 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 126.888 2.075 . . . . 0.0 114.855 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -69.65 -24.46 63.63 Favored 'General case' 0 C--N 1.368 1.388 0 O-C-N 120.961 -1.087 . . . . 0.0 113.079 167.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.86 22.45 15.58 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 131.392 3.877 . . . . 0.0 111.431 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.37 -177.99 2.81 Favored 'General case' 0 C--N 1.374 1.633 0 C-N-CA 128.796 2.838 . . . . 0.0 115.03 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 44.6 t . . . . . 0 C--N 1.363 1.183 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.914 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.511 -0.531 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -133.31 89.6 2.62 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.176 1.391 . . . . 0.0 112.762 -171.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -123.16 126.65 47.4 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 120.913 -1.117 . . . . 0.0 110.587 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.334 64.4 p -111.59 168.98 6.81 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 129.039 2.936 . . . . 0.0 116.433 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -50.66 137.06 41.98 Favored 'Trans proline' 0 C--N 1.367 1.5 1 C-N-CA 126.854 5.036 . . . . 0.0 122.084 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.63 -12.66 56.61 Favored Glycine 0 C--N 1.37 2.456 0 C-N-CA 128.371 2.891 . . . . 0.0 111.139 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.42 169.87 10.04 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.056 2.542 . . . . 0.0 111.449 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.52 143.73 44.49 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 119.151 -2.218 . . . . 0.0 105.477 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 m -142.88 158.68 18.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -101.75 128.52 48.05 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 100.834 -3.765 . . . . 0.0 100.834 167.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.44 141.38 48.61 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 125.341 1.456 . . . . 0.0 112.234 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -120.76 139.88 52.47 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 120.034 -1.666 . . . . 0.0 106.996 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 42.3 ttm -129.32 151.3 50.12 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 120.049 -1.657 . . . . 0.0 107.76 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -72.05 110.96 6.88 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 125.856 1.662 . . . . 0.0 110.546 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.09 -16.34 22.77 Favored Glycine 0 C--N 1.359 1.859 0 C-N-CA 125.073 1.321 . . . . 0.0 112.12 -174.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -114.36 157.95 41.15 Favored Pre-proline 0 C--N 1.356 0.853 0 C-N-CA 125.287 1.435 . . . . 0.0 108.99 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.34 166.54 29.47 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 124.448 3.432 . . . . 0.0 112.484 163.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.585 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.0 m95 -51.52 114.54 1.27 Allowed 'General case' 0 C--N 1.365 1.268 0 C-N-CA 127.705 2.402 . . . . 0.0 114.625 167.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.534 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 4.4 m95 -118.7 108.22 41.48 Favored Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 119.176 3.028 . . . . 0.0 119.176 -172.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 23.5 Cg_endo -54.3 118.46 5.06 Favored 'Trans proline' 0 C--N 1.373 1.846 1 C-N-CA 125.678 4.252 . . . . 0.0 112.498 162.104 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.2 m -132.91 164.97 25.75 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 127.145 2.178 . . . . 0.0 114.226 -159.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.718 HD22 ' HE ' ' A' ' 190' ' ' ARG . 2.2 pp -116.28 147.49 41.46 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 169.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.55 120.93 42.68 Favored 'Isoleucine or valine' 0 C--N 1.369 1.417 0 O-C-N 120.831 -1.168 . . . . 0.0 109.217 172.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -139.83 152.88 46.86 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 120.103 -1.623 . . . . 0.0 112.24 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -89.6 112.1 23.23 Favored 'General case' 0 C--N 1.369 1.416 0 C-N-CA 129.25 3.02 . . . . 0.0 109.514 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 130' ' ' HIS . 69.3 t60 -73.69 159.34 84.68 Favored Pre-proline 0 C--N 1.36 1.027 0 C-N-CA 127.73 2.412 . . . . 0.0 114.716 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 113' ' ' HIS . 10.1 Cg_endo -48.97 -1.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.558 1.697 1 C-N-CA 127.077 5.184 . . . . 0.0 119.079 174.322 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -104.4 35.11 2.83 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 128.305 2.642 . . . . 0.0 107.444 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -68.62 158.14 34.66 Favored 'General case' 0 C--N 1.367 1.331 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -171.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.6 -20.64 27.11 Favored Glycine 0 C--N 1.359 1.855 0 CA-C-N 112.493 -2.14 . . . . 0.0 109.669 171.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -124.58 119.26 28.56 Favored 'General case' 0 N--CA 1.438 -1.05 1 N-CA-C 99.252 -4.351 . . . . 0.0 99.252 164.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.557 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 20.3 p90 -118.83 -3.4 10.76 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.223 -0.923 . . . . 0.0 108.947 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.8 HG22 HG12 ' A' ' 129' ' ' VAL . 7.3 pt -112.77 166.6 6.6 Favored 'Isoleucine or valine' 0 C--N 1.364 1.201 0 C-N-CA 127.367 2.267 . . . . 0.0 112.036 -174.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.4 ' HE ' ' HD2' ' A' ' 128' ' ' ARG . 45.6 ttp180 -158.57 147.36 18.77 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 103.871 -2.641 . . . . 0.0 103.871 176.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -145.53 126.76 14.79 Favored 'General case' 0 C--N 1.359 1.017 0 O-C-N 119.568 -1.958 . . . . 0.0 109.11 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -117.97 93.6 4.2 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 127.184 2.193 . . . . 0.0 110.241 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.42 -71.16 0.1 OUTLIER Glycine 0 C--N 1.36 1.88 0 N-CA-C 120.97 3.148 . . . . 0.0 120.97 172.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -143.6 51.2 1.35 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-O 122.648 1.213 . . . . 0.0 111.138 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.5 m -177.3 143.26 0.37 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.5 p -117.17 136.28 54.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.058 0 CA-C-O 122.79 1.281 . . . . 0.0 110.127 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.4 ' HD2' ' HE ' ' A' ' 121' ' ' ARG . 14.7 mtt-85 -113.67 144.46 42.89 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.715 2.806 . . . . 0.0 107.075 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.8 HG12 HG22 ' A' ' 120' ' ' ILE . 12.0 m -146.66 162.7 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 177.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.557 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 3.2 p-80 -96.58 134.71 39.46 Favored 'General case' 0 C--N 1.363 1.153 0 CA-C-O 123.598 1.666 . . . . 0.0 110.05 172.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 p -125.89 163.64 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 101.599 -3.482 . . . . 0.0 101.599 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.72 33.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -86.28 129.36 34.88 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.014 3.325 . . . . 0.0 110.283 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.9 75.79 2.81 Favored 'General case' 0 C--N 1.371 1.506 0 CA-C-N 120.511 1.505 . . . . 0.0 114.114 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.07 -104.38 0.1 Allowed 'General case' 0 C--N 1.368 1.384 0 C-N-CA 124.678 1.191 . . . . 0.0 108.569 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -107.22 -56.18 2.24 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.987 2.115 . . . . 0.0 113.825 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.83 -44.92 2.41 Favored Pre-proline 0 C--N 1.368 1.401 0 N-CA-C 119.575 3.176 . . . . 0.0 119.575 -172.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -82.05 177.77 32.57 Favored 'Cis proline' 0 CA--C 1.546 1.088 0 CA-C-N 126.492 3.354 . . . . 0.0 114.058 3.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.9 m -94.84 134.56 37.34 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 125.189 1.396 . . . . 0.0 110.717 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.406 ' HE ' ' CE1' ' A' ' 113' ' ' HIS . 5.8 tmm_? -117.31 148.11 41.99 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 125.656 1.583 . . . . 0.0 110.401 177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -160.47 167.52 35.71 Favored Glycine 0 CA--C 1.486 -1.734 1 N-CA-C 103.035 -4.026 . . . . 0.0 103.035 169.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -88.13 122.01 31.2 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 124.776 2.226 . . . . 0.0 108.329 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.06 168.01 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 129.089 2.955 . . . . 0.0 108.545 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.5 m -91.46 130.12 37.34 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 102.425 -3.176 . . . . 0.0 102.425 168.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.588 ' HD3' HG11 ' A' ' 129' ' ' VAL . 32.4 ttpt -74.69 -15.58 60.79 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-O 122.921 1.343 . . . . 0.0 114.108 -170.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -72.64 -2.98 22.14 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.701 1.601 . . . . 0.0 115.136 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.6 mt -107.04 10.31 30.33 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 125.187 1.395 . . . . 0.0 110.468 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.538 HD12 ' HG3' ' A' ' 145' ' ' LYS . 11.4 mt -98.96 124.24 43.8 Favored 'General case' 0 C--N 1.374 1.657 0 C-N-CA 125.588 1.555 . . . . 0.0 107.258 174.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -116.24 151.28 46.58 Favored Pre-proline 0 CA--C 1.501 -0.924 0 O-C-N 119.921 -1.737 . . . . 0.0 108.306 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.13 123.73 4.63 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.845 2.364 . . . . 0.0 112.184 -167.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.34 108.5 19.93 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -171.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.773 ' HA ' HD13 ' A' ' 183' ' ' LEU . 9.1 t -150.42 26.88 0.76 Allowed 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -167.38 80.7 0.1 Allowed Glycine 0 C--N 1.355 1.61 0 C-N-CA 116.061 -2.971 . . . . 0.0 118.862 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.4 t -68.29 -11.9 60.17 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 126.921 2.088 . . . . 0.0 115.988 170.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -122.75 35.0 4.98 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 127.884 2.474 . . . . 0.0 107.645 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.2 t -104.96 142.44 34.78 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 126.316 1.847 . . . . 0.0 106.422 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.27 27.3 ttpt -52.76 -36.91 58.68 Favored 'General case' 0 C--N 1.369 1.442 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -171.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -18.48 61.97 Favored 'General case' 0 C--N 1.37 1.48 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 169.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.66 5.15 49.74 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.257 1.8 pp0? -129.41 -174.95 3.43 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.635 -1.916 . . . . 0.0 110.352 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.3 122.01 15.13 Favored 'General case' 0 C--N 1.368 1.396 0 O-C-N 120.444 -1.41 . . . . 0.0 113.686 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.37 -9.95 61.17 Favored Glycine 0 C--N 1.359 1.839 0 C-N-CA 124.365 0.983 . . . . 0.0 111.674 -167.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.92 160.3 44.63 Favored Glycine 0 C--N 1.366 2.202 0 C-N-CA 125.985 1.755 . . . . 0.0 116.846 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.53 -42.72 74.28 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -174.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.585 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.267 0.1 OUTLIER -99.42 5.06 46.41 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 120.245 -1.534 . . . . 0.0 114.377 -178.936 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -85.61 92.94 8.69 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.164 2.585 . . . . 0.0 114.284 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.4 m -113.86 110.23 19.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 170.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.97 101.5 14.21 Favored 'General case' 0 C--N 1.359 1.014 0 CA-C-O 126.127 2.87 . . . . 0.0 113.486 -170.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -120.47 150.5 52.17 Favored Pre-proline 0 N--CA 1.422 -1.854 1 C-N-CA 133.93 4.892 . . . . 0.0 102.915 171.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.486 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 58.7 Cg_endo -60.41 -32.38 93.8 Favored 'Trans proline' 0 CA--C 1.554 1.478 1 C-N-CA 126.652 4.901 . . . . 0.0 115.037 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -67.27 -35.16 78.93 Favored 'General case' 0 C--N 1.364 1.202 0 C-N-CA 130.059 3.344 . . . . 0.0 113.256 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.534 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 8.0 mm -72.17 -36.2 55.53 Favored 'Isoleucine or valine' 0 C--N 1.372 1.577 0 C-N-CA 127.235 2.214 . . . . 0.0 110.049 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 170' ' ' PRO . 2.9 mt -64.0 -53.83 43.87 Favored 'General case' 0 C--N 1.384 2.066 0 C-N-CA 126.428 1.891 . . . . 0.0 110.882 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -57.39 -33.87 68.28 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 129.143 2.977 . . . . 0.0 114.447 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.409 ' CB ' ' HG2' ' A' ' 107' ' ' PRO . . . -68.87 -44.67 72.81 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 130.079 3.352 . . . . 0.0 111.617 172.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 37.9 mtm -65.69 -35.74 81.62 Favored 'General case' 0 C--N 1.37 1.473 0 C-N-CA 125.102 1.361 . . . . 0.0 114.456 167.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 5.4 mt-30 -74.49 -48.33 27.91 Favored 'General case' 0 C--N 1.378 1.844 0 C-N-CA 125.518 1.527 . . . . 0.0 112.434 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -65.23 -46.54 80.19 Favored 'General case' 0 C--N 1.371 1.51 0 C-N-CA 129.251 3.02 . . . . 0.0 112.705 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.43 84.32 Favored 'General case' 0 C--N 1.375 1.707 0 O-C-N 120.599 -1.313 . . . . 0.0 112.688 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.527 ' O ' ' HB3' ' A' ' 184' ' ' ASN 0.333 35.3 t70 -64.55 -31.35 72.53 Favored 'General case' 0 C--N 1.378 1.81 0 C-N-CA 125.969 1.708 . . . . 0.0 111.857 175.059 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -76.45 -33.38 58.76 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 118.362 -2.711 . . . . 0.0 113.79 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.24 -36.83 58.31 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 118.64 2.83 . . . . 0.0 118.64 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 152' ' ' THR . 4.1 pp -79.87 -36.45 36.59 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 119.901 -1.749 . . . . 0.0 114.704 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -85.92 -17.78 34.53 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 127.201 2.201 . . . . 0.0 110.839 -176.103 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -117.51 -105.09 0.4 Allowed 'General case' 0 C--N 1.359 1.014 0 CA-C-O 121.791 0.805 . . . . 0.0 110.781 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -129.12 146.93 50.95 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.618 1.199 . . . . 0.0 108.331 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -50.31 -36.19 30.79 Favored 'General case' 0 C--N 1.357 0.924 1 C-N-CA 134.111 4.965 . . . . 0.0 113.826 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 14.9 tt -51.99 -37.18 21.06 Favored 'Isoleucine or valine' 0 C--N 1.37 1.489 0 C-N-CA 128.918 2.887 . . . . 0.0 112.174 171.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.328 2.8 mptp? -64.1 -31.29 72.43 Favored 'General case' 0 C--N 1.371 1.502 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 176.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.718 ' HE ' HD22 ' A' ' 109' ' ' LEU 0.411 0.0 OUTLIER -75.26 -42.2 55.64 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-N 121.327 1.876 . . . . 0.0 112.283 165.132 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.7 tp -57.39 -22.6 43.9 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 129.031 2.932 . . . . 0.0 117.595 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -73.9 -13.13 60.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.997 2.519 . . . . 0.0 113.953 170.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.13 22.76 15.16 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 130.562 3.545 . . . . 0.0 112.093 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.0 118.28 5.63 Favored 'General case' 0 C--N 1.371 1.535 0 C-N-CA 129.574 3.149 . . . . 0.0 116.141 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.373 1.594 0 C-N-CA 128.637 2.775 . . . . 0.0 113.174 -179.675 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 83.1 p . . . . . 0 N--CA 1.461 0.105 0 CA-C-O 121.808 0.813 . . . . 0.0 110.046 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.71 72.15 1.26 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 125.306 1.442 . . . . 0.0 108.967 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 59.9 m-85 -116.71 127.11 54.09 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 120.602 -1.311 . . . . 0.0 112.106 -172.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 p -112.0 167.72 8.7 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 127.82 2.448 . . . . 0.0 117.113 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -54.39 129.11 32.97 Favored 'Trans proline' 0 C--N 1.371 1.725 1 C-N-CA 126.943 5.096 . . . . 0.0 116.779 -176.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.8 -16.17 58.85 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 125.418 1.485 . . . . 0.0 112.68 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -92.71 154.3 18.41 Favored 'General case' 0 C--N 1.367 1.36 0 CA-C-N 119.71 1.755 . . . . 0.0 110.859 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.583 HD13 HH21 ' A' ' 190' ' ' ARG . 3.3 mm? -98.44 144.61 27.61 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 119.303 -2.123 . . . . 0.0 109.047 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.1 m -136.8 158.17 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 C-N-CA 125.333 1.453 . . . . 0.0 109.994 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -105.76 119.82 40.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 101.035 -3.691 . . . . 0.0 101.035 167.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.82 144.47 34.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.337 1.855 . . . . 0.0 113.388 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -120.22 135.81 54.86 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.2 ttp -128.63 144.41 51.15 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 119.526 -1.983 . . . . 0.0 108.833 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -64.7 94.64 0.13 Allowed 'General case' 0 C--N 1.368 1.386 0 C-N-CA 126.445 1.898 . . . . 0.0 115.22 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.57 -5.12 24.64 Favored Glycine 0 C--N 1.359 1.817 0 C-N-CA 126.392 1.949 . . . . 0.0 113.01 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -104.64 159.98 27.52 Favored Pre-proline 0 C--N 1.357 0.913 0 C-N-CA 126.001 1.72 . . . . 0.0 109.967 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.44 166.63 29.25 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 123.682 2.921 . . . . 0.0 112.221 162.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.613 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.6 m95 -59.72 123.92 18.49 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 127.644 2.378 . . . . 0.0 114.799 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -127.27 108.54 21.39 Favored Pre-proline 0 N--CA 1.433 -1.305 1 N-CA-C 122.013 4.079 . . . . 0.0 122.013 -168.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.22 133.49 46.94 Favored 'Trans proline' 0 C--N 1.39 2.741 1 C-N-CA 125.968 4.446 . . . . 0.0 111.366 165.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.5 p -155.81 163.68 39.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 125.011 2.339 . . . . 0.0 115.743 -157.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 5.1 tt -101.06 129.99 47.01 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 129.172 2.989 . . . . 0.0 108.151 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.449 ' H ' HH22 ' A' ' 190' ' ' ARG . 31.2 t -87.49 118.81 34.07 Favored 'Isoleucine or valine' 0 C--N 1.378 1.846 0 CA-C-N 120.722 1.601 . . . . 0.0 107.007 173.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -116.57 154.16 30.95 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -164.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -119.4 112.67 19.7 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -83.44 159.09 62.34 Favored Pre-proline 0 C--N 1.348 0.528 0 C-N-CA 129.879 3.271 . . . . 0.0 110.647 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.32 0.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.799 1 C-N-CA 128.632 6.222 . . . . 0.0 119.973 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -95.21 28.2 2.94 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 131.191 3.796 . . . . 0.0 107.249 166.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.271 0.0 OUTLIER -73.79 161.07 30.59 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 127.185 2.194 . . . . 0.0 115.945 -173.586 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.95 -20.26 36.41 Favored Glycine 0 C--N 1.362 2.002 0 C-N-CA 126.666 2.079 . . . . 0.0 111.33 -174.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 p -135.87 136.18 40.34 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 130.681 3.592 . . . . 0.0 103.087 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -132.79 -3.75 3.24 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 120.206 1.366 . . . . 0.0 113.293 -175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.3 pt -110.73 150.38 13.23 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 123.073 1.416 . . . . 0.0 111.324 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.91 141.82 36.5 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 128.041 2.536 . . . . 0.0 104.227 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -145.67 126.6 14.51 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 120.939 -1.1 . . . . 0.0 109.013 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -109.42 93.55 4.56 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.33 -63.06 1.41 Allowed Glycine 0 C--N 1.362 2.011 0 C-N-CA 127.829 2.633 . . . . 0.0 115.852 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -144.64 -5.41 0.73 Allowed 'General case' 0 C--N 1.352 0.683 0 C-N-CA 127.736 2.414 . . . . 0.0 110.227 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.0 m -82.34 73.77 9.36 Favored 'General case' 0 C--N 1.372 1.551 0 O-C-N 118.944 -2.348 . . . . 0.0 110.306 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.56 111.15 21.58 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 C-N-CA 129.228 3.011 . . . . 0.0 110.594 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -117.34 146.82 43.13 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 111.287 -2.688 . . . . 0.0 112.874 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.86 162.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 127.74 2.416 . . . . 0.0 106.426 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.02 138.43 32.45 Favored 'General case' 0 C--N 1.379 1.889 0 O-C-N 117.975 -2.953 . . . . 0.0 111.112 171.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 m -151.9 169.91 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.478 -1.807 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.568 HE22 HG12 ' A' ' 195' ' ' VAL . 9.2 pt20 -149.09 151.13 33.91 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 122.138 0.97 . . . . 0.0 109.695 170.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -104.14 122.13 44.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 128.972 2.909 . . . . 0.0 107.97 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 51.0 m-85 -71.38 62.29 0.35 Allowed 'General case' 0 C--N 1.378 1.837 0 C-N-CA 127.317 2.247 . . . . 0.0 112.136 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -90.33 -114.2 0.07 Allowed 'General case' 0 C--N 1.362 1.151 0 C-N-CA 129.986 3.314 . . . . 0.0 111.531 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -106.53 -45.1 4.33 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 125.723 1.609 . . . . 0.0 112.031 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -81.6 -40.45 1.02 Allowed Pre-proline 0 C--N 1.36 1.055 0 N-CA-C 118.44 2.756 . . . . 0.0 118.44 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.91 159.57 97.79 Favored 'Cis proline' 0 C--N 1.361 1.189 0 CA-C-N 126.202 3.251 . . . . 0.0 109.864 -3.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.9 p -87.88 119.37 28.16 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 119.009 -2.307 . . . . 0.0 112.046 -175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -109.92 152.93 25.2 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 125.877 1.671 . . . . 0.0 107.623 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.35 177.31 37.72 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 104.084 -3.606 . . . . 0.0 104.084 165.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -92.26 109.06 20.43 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 103.12 -2.918 . . . . 0.0 103.12 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 143' ' ' VAL . 1.5 m -96.32 164.6 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 C-N-CA 125.466 1.507 . . . . 0.0 111.511 -171.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 m -77.42 109.85 11.69 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.97 2.108 . . . . 0.0 106.305 172.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.503 0.0 OUTLIER -70.72 -10.27 59.07 Favored 'General case' 0 C--N 1.37 1.496 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -169.652 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.436 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 31.5 ptt-85 -75.44 -14.68 60.46 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 129.214 3.006 . . . . 0.0 114.193 170.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -100.47 0.82 40.39 Favored 'General case' 0 C--N 1.365 1.281 0 C-N-CA 126.859 2.064 . . . . 0.0 110.263 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 49.1 mt -96.28 124.88 40.44 Favored 'General case' 0 C--N 1.368 1.412 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 172.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -114.6 161.74 27.18 Favored Pre-proline 0 CA--C 1.506 -0.718 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.14 149.78 22.47 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 CA-C-N 125.332 2.94 . . . . 0.0 112.463 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -113.28 153.05 29.07 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.584 ' HA ' HD13 ' A' ' 183' ' ' LEU . 8.8 t -179.61 -32.39 0.01 OUTLIER 'General case' 0 C--N 1.352 0.684 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.77 113.77 0.89 Allowed Glycine 0 C--N 1.355 1.638 0 O-C-N 121.029 -1.044 . . . . 0.0 115.354 -173.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -11.96 59.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 131.0 3.72 . . . . 0.0 112.271 171.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.78 -8.14 35.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 131.241 3.816 . . . . 0.0 111.794 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.8 m -58.09 136.06 57.12 Favored 'General case' 0 C--N 1.385 2.147 0 C-N-CA 126.172 1.789 . . . . 0.0 112.032 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.303 33.6 tttp -54.59 -31.75 57.48 Favored 'General case' 0 C--N 1.368 1.378 0 CA-C-N 122.445 2.384 . . . . 0.0 117.317 -173.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -74.7 -19.34 60.29 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 126.519 1.927 . . . . 0.0 112.835 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.59 1.68 55.63 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 126.359 1.864 . . . . 0.0 112.801 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -132.15 -176.48 4.08 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 119.898 -1.751 . . . . 0.0 112.908 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -63.66 122.13 15.61 Favored 'General case' 0 C--N 1.371 1.525 0 C-N-CA 126.037 1.735 . . . . 0.0 114.209 -177.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.06 -7.92 60.72 Favored Glycine 0 C--N 1.357 1.748 0 C-N-CA 124.533 1.063 . . . . 0.0 111.615 -167.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.7 145.92 20.4 Favored Glycine 0 C--N 1.364 2.133 0 N-CA-C 120.303 2.881 . . . . 0.0 120.303 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -53.85 -42.05 68.11 Favored 'General case' 0 C--N 1.364 1.198 0 C-N-CA 129.448 3.099 . . . . 0.0 119.04 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.613 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.387 0.6 OUTLIER -102.68 -10.59 19.08 Favored 'General case' 0 C--N 1.366 1.314 0 CA-C-N 119.945 1.248 . . . . 0.0 113.104 179.032 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -73.35 92.98 1.87 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 126.383 1.873 . . . . 0.0 113.457 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 72.6 m -113.84 107.36 15.61 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 101.193 -3.632 . . . . 0.0 101.193 173.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.19 101.28 13.68 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-O 125.616 2.627 . . . . 0.0 115.463 -166.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -121.4 153.15 58.7 Favored Pre-proline 0 N--CA 1.419 -1.992 1 C-N-CA 132.848 4.459 . . . . 0.0 104.946 170.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.89 -42.18 69.68 Favored 'Trans proline' 0 C--N 1.347 0.462 1 C-N-CA 126.154 4.569 . . . . 0.0 115.725 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -59.72 -35.26 74.18 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 129.446 3.098 . . . . 0.0 114.006 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 16.8 mm -72.35 -43.46 64.5 Favored 'Isoleucine or valine' 0 C--N 1.372 1.559 0 C-N-CA 125.792 1.637 . . . . 0.0 110.569 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.72 -47.34 66.6 Favored 'General case' 0 C--N 1.372 1.578 0 O-C-N 120.101 -1.625 . . . . 0.0 113.65 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -58.82 -35.23 72.53 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 126.665 1.986 . . . . 0.0 116.172 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.73 -36.71 76.09 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 127.758 2.423 . . . . 0.0 110.94 173.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.2 mtt -69.32 -35.62 76.12 Favored 'General case' 0 C--N 1.378 1.831 0 CA-C-O 116.707 -1.616 . . . . 0.0 113.729 167.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.06 -48.99 55.58 Favored 'General case' 0 C--N 1.377 1.802 0 C-N-CA 127.335 2.254 . . . . 0.0 111.732 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.62 -47.9 71.19 Favored 'General case' 0 C--N 1.371 1.529 0 C-N-CA 128.6 2.76 . . . . 0.0 112.19 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.27 71.13 Favored 'General case' 0 C--N 1.375 1.676 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 170.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.87 -50.1 70.13 Favored 'General case' 0 C--N 1.375 1.694 0 O-C-N 120.212 -1.555 . . . . 0.0 110.363 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -33.72 71.62 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 173.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -73.42 -38.83 65.41 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.584 HD13 ' HA ' ' A' ' 152' ' ' THR . 2.7 pp -79.46 -38.58 34.24 Favored 'General case' 0 C--N 1.373 1.618 0 C-N-CA 125.986 1.714 . . . . 0.0 113.501 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.298 0.0 OUTLIER -87.58 -16.67 33.89 Favored 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.848 1.659 . . . . 0.0 110.901 -172.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -117.02 -106.96 0.38 Allowed 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -135.86 156.04 49.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.972 1.368 . . . . 0.0 109.564 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -51.24 -35.33 36.44 Favored 'General case' 0 C--N 1.36 1.053 1 C-N-CA 134.275 5.03 . . . . 0.0 113.932 175.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.7 tp -50.9 -31.17 9.93 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 C-N-CA 129.933 3.293 . . . . 0.0 112.458 172.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -73.04 -37.08 67.01 Favored 'General case' 0 C--N 1.377 1.766 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.583 HH21 HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -75.2 -42.94 54.51 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 172.813 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.326 54.2 mt -73.36 -19.25 61.05 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 126.48 1.912 . . . . 0.0 113.304 -177.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.31 -37.73 67.76 Favored 'General case' 0 C--N 1.373 1.619 0 C-N-CA 128.654 2.782 . . . . 0.0 114.735 164.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.14 -45.66 5.83 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 128.705 2.802 . . . . 0.0 108.779 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 71.19 -86.07 0.03 OUTLIER 'General case' 0 C--N 1.363 1.187 0 C-N-CA 130.094 3.358 . . . . 0.0 115.782 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.568 HG12 HE22 ' A' ' 132' ' ' GLN . 3.4 m . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 128.93 2.892 . . . . 0.0 107.917 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 C--O 1.235 0.307 0 CA-C-O 121.301 0.572 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' A' ' 145' ' ' LYS . 5.5 t70 -150.57 81.45 1.35 Allowed 'General case' 0 C--N 1.361 1.107 0 C-N-CA 124.71 1.204 . . . . 0.0 111.066 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -118.23 126.92 53.16 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.361 -1.462 . . . . 0.0 111.02 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.6 p -112.28 167.14 9.6 Favored Pre-proline 0 C--N 1.366 1.29 0 C-N-CA 127.347 2.259 . . . . 0.0 116.808 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -48.46 127.88 16.73 Favored 'Trans proline' 0 C--N 1.389 2.665 1 C-N-CA 127.151 5.234 . . . . 0.0 116.619 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.444 ' HA2' HH11 ' A' ' 190' ' ' ARG . . . 96.74 1.15 60.24 Favored Glycine 0 C--N 1.357 1.713 0 C-N-CA 124.103 0.858 . . . . 0.0 112.668 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -94.8 169.2 10.32 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 170.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -113.82 147.49 38.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 101.751 -3.426 . . . . 0.0 101.751 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.455 HG11 ' HG ' ' A' ' 148' ' ' LEU . 1.4 p -142.41 167.15 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 -174.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -112.26 117.75 33.37 Favored 'General case' 0 N--CA 1.437 -1.105 1 N-CA-C 95.796 -5.631 . . . . 0.0 95.796 166.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.56 131.94 52.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -106.8 136.07 47.26 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 118.221 -2.8 . . . . 0.0 106.014 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 40.9 ttm -123.27 145.02 49.03 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 119.827 -1.796 . . . . 0.0 108.578 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.41 96.43 0.08 Allowed 'General case' 0 C--N 1.367 1.356 0 C-N-CA 127.469 2.307 . . . . 0.0 114.418 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.44 -6.29 24.73 Favored Glycine 0 C--N 1.359 1.851 0 C-N-CA 125.685 1.612 . . . . 0.0 113.257 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -106.67 162.07 20.87 Favored Pre-proline 0 C--N 1.355 0.812 0 C-N-CA 125.713 1.605 . . . . 0.0 109.555 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.88 166.6 29.05 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.129 3.219 . . . . 0.0 112.483 164.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -59.88 121.06 10.81 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 126.589 1.956 . . . . 0.0 114.238 170.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TRP . . . . . 0.44 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 9.3 m95 -125.09 116.77 25.77 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 -172.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -57.42 127.16 24.38 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.865 3.71 . . . . 0.0 110.227 160.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.7 t -138.71 165.73 26.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 130.11 3.364 . . . . 0.0 111.535 -153.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.583 HD21 ' CZ ' ' A' ' 190' ' ' ARG . 1.9 tt -130.07 131.63 45.85 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 119.82 -1.8 . . . . 0.0 106.285 176.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 131' ' ' VAL . 2.7 p -91.84 119.36 39.09 Favored 'Isoleucine or valine' 0 C--N 1.373 1.63 0 CA-C-N 120.072 1.306 . . . . 0.0 108.942 172.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 153.58 39.81 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -165.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -90.89 113.5 25.71 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.903 2.081 . . . . 0.0 111.04 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -67.79 162.22 60.07 Favored Pre-proline 0 C--N 1.36 1.055 0 C-N-CA 129.55 3.14 . . . . 0.0 113.461 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.25 -7.79 0.86 Allowed 'Trans proline' 0 CA--C 1.563 1.932 1 C-N-CA 125.419 4.079 . . . . 0.0 117.044 169.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.83 35.12 3.0 Favored 'General case' 0 C--N 1.358 0.949 1 C-N-CA 132.153 4.181 . . . . 0.0 107.84 173.067 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.54 149.43 43.05 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 -172.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.47 -19.96 50.79 Favored Glycine 0 C--N 1.362 1.99 0 C-N-CA 125.962 1.744 . . . . 0.0 112.011 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.92 119.96 36.42 Favored 'General case' 0 N--CA 1.447 -0.616 1 C-N-CA 132.864 4.466 . . . . 0.0 102.369 174.186 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.441 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 22.2 p90 -151.0 -2.11 0.35 Allowed 'General case' 0 C--N 1.353 0.739 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -174.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.6 pt -106.14 169.16 2.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 O-C-N 119.354 -2.091 . . . . 0.0 113.143 -175.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -159.3 153.58 23.84 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 174.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.87 127.04 8.43 Favored 'General case' 0 C--N 1.368 1.386 0 CA-C-N 123.097 2.68 . . . . 0.0 114.391 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HG2' HH12 ' A' ' 128' ' ' ARG . 75.6 mmtt -116.81 93.42 4.19 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 120.493 -1.379 . . . . 0.0 108.223 174.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.21 -78.11 0.23 Allowed Glycine 0 C--N 1.363 2.056 0 C-N-CA 128.027 2.727 . . . . 0.0 116.287 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -118.81 -16.11 9.34 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 128.192 2.597 . . . . 0.0 109.015 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.6 m -84.41 75.24 10.26 Favored 'General case' 0 C--N 1.367 1.342 0 O-C-N 118.326 -2.734 . . . . 0.0 110.649 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 p -89.22 112.89 24.89 Favored 'Isoleucine or valine' 0 C--N 1.363 1.171 0 C-N-CA 127.789 2.435 . . . . 0.0 107.563 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.567 HH12 ' HG2' ' A' ' 123' ' ' LYS . 65.3 mtt85 -104.6 157.2 17.34 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 124.893 1.277 . . . . 0.0 111.952 -171.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.401 HG13 ' HD3' ' A' ' 145' ' ' LYS . 21.2 m -149.23 164.25 4.1 Favored 'Isoleucine or valine' 0 C--N 1.367 1.369 1 C-N-CA 132.053 4.141 . . . . 0.0 103.848 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.441 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 4.4 m170 -90.3 116.19 28.08 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 118.9 -2.375 . . . . 0.0 114.485 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 110' ' ' VAL 0.276 2.3 m -143.33 156.65 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 O-C-N 119.016 -2.303 . . . . 0.0 111.587 177.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -112.72 153.96 26.9 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 111.635 -2.53 . . . . 0.0 111.271 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.17 116.11 27.83 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 129.13 2.972 . . . . 0.0 103.012 -174.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 15.0 m-85 -71.85 65.78 0.54 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.859 2.064 . . . . 0.0 113.37 -175.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -92.11 -119.07 0.08 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 126.898 2.079 . . . . 0.0 110.408 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.85 -52.84 2.7 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.188 1.395 . . . . 0.0 112.93 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.4 m -71.07 -44.5 14.12 Favored Pre-proline 0 C--N 1.362 1.127 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.11 -174.71 12.51 Favored 'Cis proline' 0 CA--C 1.541 0.866 0 CA-C-N 126.973 3.526 . . . . 0.0 112.257 -2.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.5 m -95.23 123.78 38.92 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.104 1.362 . . . . 0.0 109.347 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.2 tmm_? -147.47 151.44 36.4 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 120.78 1.627 . . . . 0.0 108.503 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.62 -155.48 12.92 Favored Glycine 0 CA--C 1.489 -1.583 1 N-CA-C 98.502 -5.839 . . . . 0.0 98.502 174.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -89.17 160.33 17.04 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 119.975 1.887 . . . . 0.0 110.479 172.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.42 ' CG2' HG22 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -125.53 171.21 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 O-C-N 120.455 -1.403 . . . . 0.0 109.773 174.678 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.1 m -100.05 116.4 32.0 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.434 ' HB2' HD22 ' A' ' 148' ' ' LEU 0.423 11.4 pttt -68.35 -6.41 24.12 Favored 'General case' 0 C--N 1.366 1.29 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 -172.09 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -70.75 -15.37 62.68 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.474 1.109 . . . . 0.0 113.536 170.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.2 mt -100.41 2.9 42.74 Favored 'General case' 0 C--N 1.37 1.457 0 C-N-CA 126.693 1.997 . . . . 0.0 112.471 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.455 ' HG ' HG11 ' A' ' 96' ' ' VAL . 5.7 mp -94.92 124.47 38.99 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 128.351 2.661 . . . . 0.0 108.771 177.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -118.13 154.16 51.59 Favored Pre-proline 0 CA--C 1.497 -1.058 0 C-N-CA 125.932 1.693 . . . . 0.0 107.664 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -78.42 153.52 27.35 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.614 2.209 . . . . 0.0 115.451 -166.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.418 ' HB2' ' HB2' ' A' ' 183' ' ' LEU 0.311 0.0 OUTLIER -17.94 -107.29 0.0 OUTLIER 'General case' 0 C--N 1.354 0.804 2 C-N-CA 132.681 4.392 . . . . 0.0 122.551 174.747 . . . . . . . . 5 4 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.326 12.4 t 47.41 -36.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 1 C-N-CA 132.616 4.366 . . . . 0.0 119.86 -179.526 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 67.55 -148.67 49.97 Favored Glycine 0 C--N 1.35 1.351 0 C-N-CA 128.129 2.776 . . . . 0.0 119.773 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 m -46.39 -23.75 0.4 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 130.232 3.413 . . . . 0.0 119.342 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -85.62 -8.45 58.24 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.542 1.937 . . . . 0.0 113.161 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 t -85.31 155.85 21.17 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-O 123.029 1.395 . . . . 0.0 112.597 173.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -68.49 -32.74 72.94 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 127.034 2.134 . . . . 0.0 112.751 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.72 -11.87 60.08 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 125.257 1.423 . . . . 0.0 111.488 171.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.66 3.75 42.7 Favored 'General case' 0 C--N 1.371 1.522 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.257 0.9 OUTLIER -122.94 173.38 7.83 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 125.689 1.596 . . . . 0.0 109.408 174.546 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -61.53 122.64 15.75 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 126.567 1.947 . . . . 0.0 114.449 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.32 -14.01 51.35 Favored Glycine 0 C--N 1.358 1.757 0 C-N-CA 124.947 1.261 . . . . 0.0 111.076 -167.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.98 155.52 31.72 Favored Glycine 0 C--N 1.36 1.882 0 N-CA-C 117.186 1.634 . . . . 0.0 117.186 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -58.46 -41.59 85.53 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 120.953 3.686 . . . . 0.0 120.953 -174.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . 0.273 0.1 OUTLIER -102.2 23.32 11.83 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 122.266 2.303 . . . . 0.0 111.785 -179.326 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -93.17 161.32 14.47 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 124.674 2.178 . . . . 0.0 116.671 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 m 170.65 175.99 0.06 Allowed 'General case' 0 C--N 1.354 0.778 1 N-CA-C 98.554 -4.61 . . . . 0.0 98.554 -178.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -137.77 102.25 4.68 Favored 'General case' 0 C--N 1.364 1.219 0 CA-C-N 124.551 3.341 . . . . 0.0 111.286 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -119.88 141.97 32.32 Favored Pre-proline 0 N--CA 1.433 -1.279 0 C-N-CA 130.116 3.366 . . . . 0.0 105.041 173.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.423 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 38.0 Cg_endo -58.37 -31.82 94.78 Favored 'Trans proline' 0 C--N 1.364 1.386 1 C-N-CA 127.678 5.586 . . . . 0.0 115.074 177.305 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -69.79 -35.97 75.3 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 130.332 3.453 . . . . 0.0 113.393 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.44 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 4.4 mm -70.33 -36.21 66.02 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 C-N-CA 127.17 2.188 . . . . 0.0 109.132 174.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 177' ' ' GLN . 6.1 mt -62.73 -53.67 50.79 Favored 'General case' 0 C--N 1.382 1.982 0 C-N-CA 126.226 1.81 . . . . 0.0 111.045 173.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -57.26 -34.22 68.4 Favored 'General case' 0 C--N 1.373 1.613 0 C-N-CA 128.968 2.907 . . . . 0.0 114.374 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.0 -47.83 73.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 130.225 3.41 . . . . 0.0 111.718 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 36.3 mtt -68.45 -33.38 74.08 Favored 'General case' 0 C--N 1.369 1.423 0 CA-C-O 118.069 -0.967 . . . . 0.0 113.547 170.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 13.7 mt-30 -74.32 -43.71 55.61 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 126.366 1.866 . . . . 0.0 112.027 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -68.31 -47.96 66.21 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 129.116 2.966 . . . . 0.0 111.147 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.06 87.42 Favored 'General case' 0 C--N 1.382 2.015 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 170.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.257 23.1 t70 -54.5 -47.44 73.07 Favored 'General case' 0 C--N 1.376 1.753 0 C-N-CA 127.17 2.188 . . . . 0.0 114.161 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -66.0 -43.0 89.01 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-N 120.8 1.636 . . . . 0.0 115.366 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 190' ' ' ARG . . . -76.12 -29.05 57.7 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.5 pp -80.0 -32.58 39.71 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 175.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.277 0.4 OUTLIER -89.68 -34.28 16.31 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 125.393 1.477 . . . . 0.0 111.199 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -100.48 -99.61 0.25 Allowed 'General case' 0 C--N 1.362 1.151 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -135.49 152.22 51.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.223 -1.548 . . . . 0.0 110.27 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 190' ' ' ARG 0.431 16.4 ptpt -50.92 -33.31 23.79 Favored 'General case' 0 C--N 1.358 0.967 1 C-N-CA 133.193 4.597 . . . . 0.0 113.898 172.222 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.5 tt -50.6 -27.97 5.25 Favored 'Isoleucine or valine' 0 C--N 1.368 1.393 0 C-N-CA 127.923 2.489 . . . . 0.0 113.032 172.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -72.72 -39.27 67.08 Favored 'General case' 0 C--N 1.377 1.764 0 C-N-CA 126.343 1.857 . . . . 0.0 114.75 170.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.583 ' CZ ' HD21 ' A' ' 109' ' ' LEU 0.283 0.0 OUTLIER -74.68 -34.41 62.66 Favored 'General case' 0 C--N 1.367 1.362 0 O-C-N 119.286 -2.134 . . . . 0.0 114.859 172.871 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.8 -22.45 56.34 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 126.323 1.849 . . . . 0.0 112.901 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.26 -46.15 86.53 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 126.478 1.911 . . . . 0.0 114.309 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . 0.264 0.2 OUTLIER -105.56 22.14 16.0 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 128.208 2.603 . . . . 0.0 112.922 176.201 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -49.59 141.81 9.05 Favored 'General case' 0 C--N 1.374 1.663 0 C-N-CA 128.991 2.916 . . . . 0.0 118.823 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.368 5.3 p . . . . . 0 C--N 1.374 1.657 0 CA-C-O 125.636 2.636 . . . . 0.0 114.966 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 CA--C 1.511 -0.528 0 CA-C-O 120.722 0.296 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -97.61 99.88 11.27 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -124.42 126.51 46.06 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 124.431 1.093 . . . . 0.0 112.393 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.345 88.8 p -112.12 170.86 4.83 Favored Pre-proline 0 CA--C 1.558 1.279 1 C-N-CA 133.022 4.529 . . . . 0.0 116.524 -177.18 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 12.7 Cg_exo -41.69 128.55 3.71 Favored 'Trans proline' 0 C--N 1.389 2.691 1 C-N-CA 127.927 5.751 . . . . 0.0 118.879 -179.165 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.547 ' HA2' ' CZ ' ' A' ' 190' ' ' ARG . . . 88.08 4.38 78.25 Favored Glycine 0 CA--C 1.477 -2.314 0 C-N-CA 129.382 3.372 . . . . 0.0 117.223 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -93.59 148.57 21.97 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 168.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.97 126.31 52.96 Favored 'General case' 0 N--CA 1.441 -0.902 1 N-CA-C 99.834 -4.135 . . . . 0.0 99.834 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.3 154.93 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -99.9 122.15 42.4 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 101.832 -3.396 . . . . 0.0 101.832 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.97 131.12 55.36 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 127.831 2.452 . . . . 0.0 110.77 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.87 135.85 49.39 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 174.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.0 ttp -130.08 153.55 48.36 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 119.946 -1.721 . . . . 0.0 112.098 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -63.22 90.25 0.04 OUTLIER 'General case' 0 C--N 1.364 1.224 0 C-N-CA 129.206 3.002 . . . . 0.0 114.734 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.46 -0.77 24.99 Favored Glycine 0 C--N 1.358 1.804 0 C-N-CA 125.786 1.66 . . . . 0.0 113.028 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -108.25 161.39 23.58 Favored Pre-proline 0 C--N 1.357 0.911 0 C-N-CA 125.366 1.466 . . . . 0.0 110.296 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.48 166.49 29.2 Favored 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 124.976 3.784 . . . . 0.0 111.65 164.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.6 121.53 16.62 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 126.454 1.902 . . . . 0.0 109.557 173.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.282 0.8 OUTLIER -128.64 135.16 27.16 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 119.267 3.062 . . . . 0.0 119.267 -167.696 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.51 149.19 90.75 Favored 'Trans proline' 0 CA--C 1.567 2.154 0 C-N-CA 124.722 3.615 . . . . 0.0 113.763 153.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 p -155.34 161.91 40.95 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 125.554 1.541 . . . . 0.0 112.464 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.447 HD22 ' HB2' ' A' ' 190' ' ' ARG . 2.3 pp -115.7 137.16 52.36 Favored 'General case' 0 C--N 1.374 1.66 0 O-C-N 120.386 -1.446 . . . . 0.0 110.594 171.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.529 HG13 HG12 ' A' ' 131' ' ' VAL . 2.2 t -93.86 118.97 40.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 C-N-CA 125.603 1.561 . . . . 0.0 109.141 170.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.4 ' HB3' ' CD1' ' A' ' 109' ' ' LEU 0.288 0.1 OUTLIER -137.81 155.62 48.81 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 128.481 2.713 . . . . 0.0 110.747 -177.746 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -71.42 113.63 8.66 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 125.588 1.555 . . . . 0.0 113.105 170.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -89.59 159.0 44.76 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 113.798 -3.001 . . . . 0.0 106.631 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.288 46.4 Cg_exo -47.99 -0.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 2 C-N-CA 127.361 5.374 . . . . 0.0 122.745 -166.239 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -82.29 -26.17 33.34 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 128.15 2.58 . . . . 0.0 109.926 167.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 27.47 95.11 0.0 OUTLIER 'General case' 0 C--N 1.37 1.466 1 C-N-CA 135.226 5.41 . . . . 0.0 121.2 178.375 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.67 -20.85 26.68 Favored Glycine 0 C--N 1.357 1.699 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 39.9 m -107.67 118.16 36.0 Favored 'General case' 0 C--N 1.357 0.905 1 N-CA-C 98.954 -4.461 . . . . 0.0 98.954 165.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.402 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 13.2 p90 -147.35 0.82 0.71 Allowed 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.996 -1.065 . . . . 0.0 111.442 -171.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.45 HG22 HG12 ' A' ' 129' ' ' VAL . 17.4 pt -109.9 156.97 10.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 CA-C-O 121.97 0.891 . . . . 0.0 110.614 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -149.85 152.19 34.72 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.23 131.39 19.42 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 120.352 -1.468 . . . . 0.0 110.539 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -117.94 93.52 4.17 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.687 1.995 . . . . 0.0 110.558 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.38 -83.24 0.44 Allowed Glycine 0 C--N 1.362 2.002 0 N-CA-C 119.247 2.459 . . . . 0.0 119.247 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -138.32 52.77 1.82 Allowed 'General case' 0 C--N 1.36 1.025 0 C-N-CA 125.616 1.566 . . . . 0.0 110.365 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.1 m -171.96 142.2 1.44 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 p -119.9 136.91 55.49 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 C-N-CA 124.708 1.203 . . . . 0.0 110.871 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -119.62 143.16 47.83 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 127.623 2.369 . . . . 0.0 111.489 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.45 HG12 HG22 ' A' ' 120' ' ' ILE . 29.9 m -129.01 162.86 35.49 Favored 'Isoleucine or valine' 0 C--N 1.37 1.468 0 C-N-CA 130.052 3.341 . . . . 0.0 107.042 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.402 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 1.5 p-80 -97.02 119.68 35.94 Favored 'General case' 0 C--N 1.371 1.526 0 O-C-N 119.147 -2.221 . . . . 0.0 112.305 174.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.529 HG12 HG13 ' A' ' 110' ' ' VAL . 0.9 OUTLIER -145.51 166.22 10.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.353 0 C-N-CA 127.709 2.404 . . . . 0.0 105.543 -177.1 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.2 147.56 47.93 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.332 1.453 . . . . 0.0 108.423 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -96.15 127.91 42.58 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 128.73 2.812 . . . . 0.0 106.214 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 109' ' ' LEU . 17.0 m-30 -72.61 59.37 0.45 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -174.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -94.93 -119.95 0.1 Allowed 'General case' 0 C--N 1.36 1.036 0 C-N-CA 127.238 2.215 . . . . 0.0 111.643 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -103.04 -52.43 3.04 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 125.129 1.372 . . . . 0.0 113.349 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.0 m -66.63 -43.81 52.17 Favored Pre-proline 0 C--N 1.366 1.323 0 N-CA-C 117.99 2.589 . . . . 0.0 117.99 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -80.12 173.61 52.32 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 CA-C-N 125.693 3.069 . . . . 0.0 110.753 -5.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.5 m -81.62 134.67 35.51 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.196 -1.565 . . . . 0.0 110.191 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.5 ttp-105 -141.96 157.78 44.55 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 121.098 1.772 . . . . 0.0 109.153 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.16 -159.92 28.42 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 103.679 -3.768 . . . . 0.0 103.679 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -97.48 108.45 21.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.523 2.329 . . . . 0.0 107.17 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 m -88.81 160.75 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.182 0 C-N-CA 126.941 2.096 . . . . 0.0 110.52 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.9 m -82.68 114.97 21.41 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.405 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 7.2 ttmt -72.85 -16.76 61.59 Favored 'General case' 0 C--N 1.359 0.985 0 CA-C-O 122.752 1.263 . . . . 0.0 113.962 -169.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -76.03 -5.85 48.31 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.266 -1.522 . . . . 0.0 113.547 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 75.1 mt -105.39 14.8 28.23 Favored 'General case' 0 C--N 1.37 1.461 0 C-N-CA 126.956 2.102 . . . . 0.0 110.844 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 29.2 mt -100.32 125.46 46.55 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 126.453 1.901 . . . . 0.0 107.81 173.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.72 163.14 20.37 Favored Pre-proline 0 C--O 1.226 -0.172 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -79.53 141.1 15.48 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.844 3.029 . . . . 0.0 112.515 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.95 140.06 30.16 Favored 'General case' 0 C--N 1.365 1.263 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 171.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.661 ' HA ' HD11 ' A' ' 183' ' ' LEU . 13.5 t -164.24 -15.97 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.39 114.48 0.47 Allowed Glycine 0 C--N 1.352 1.469 0 C-N-CA 116.471 -2.776 . . . . 0.0 114.201 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 50.1 m -65.22 -10.63 33.31 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 127.835 2.454 . . . . 0.0 117.283 176.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.27 27.7 9.41 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 127.55 2.34 . . . . 0.0 109.19 175.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.7 t -99.42 142.84 30.38 Favored 'General case' 0 CA--C 1.48 -1.712 0 C-N-CA 128.278 2.631 . . . . 0.0 107.329 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.4 tptt -47.79 -40.63 21.43 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 127.393 2.277 . . . . 0.0 116.615 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -73.97 -15.6 61.1 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 124.744 1.218 . . . . 0.0 113.822 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.77 -1.52 40.24 Favored 'General case' 0 C--N 1.379 1.857 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -126.94 -173.77 2.97 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.255 1.422 . . . . 0.0 113.667 -176.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -61.93 121.88 14.07 Favored 'General case' 0 C--N 1.38 1.927 0 C-N-CA 125.921 1.688 . . . . 0.0 113.227 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.9 -6.19 73.06 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 124.307 0.956 . . . . 0.0 114.095 -170.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.53 158.45 37.46 Favored Glycine 0 C--N 1.369 2.377 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -59.72 -41.84 91.79 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.86 -30.04 13.38 Favored 'General case' 0 C--N 1.365 1.25 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 3.1 t80 19.53 -101.42 0.01 OUTLIER 'General case' 0 C--N 1.388 2.282 1 C-N-CA 132.971 4.509 . . . . 0.0 114.575 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m 54.26 57.65 5.69 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 129.378 3.071 . . . . 0.0 115.51 170.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.43 101.08 12.32 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 124.941 2.305 . . . . 0.0 113.112 -171.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -120.34 147.03 44.17 Favored Pre-proline 0 N--CA 1.43 -1.464 1 C-N-CA 133.231 4.612 . . . . 0.0 103.42 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.535 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 57.3 Cg_endo -56.76 -33.79 94.9 Favored 'Trans proline' 0 CA--C 1.545 1.058 1 C-N-CA 125.883 4.389 . . . . 0.0 116.741 -178.331 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.83 -36.28 80.08 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.698 1.999 . . . . 0.0 112.4 173.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.256 6.5 mt -76.0 -32.62 23.55 Favored 'Isoleucine or valine' 0 C--N 1.369 1.425 0 C-N-CA 126.648 1.979 . . . . 0.0 110.566 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.535 ' HG ' ' HA ' ' A' ' 170' ' ' PRO 0.276 35.7 mt -62.57 -53.85 48.55 Favored 'General case' 0 C--N 1.387 2.226 0 C-N-CA 127.391 2.276 . . . . 0.0 110.269 172.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -57.76 -43.23 85.31 Favored 'General case' 0 C--N 1.369 1.418 0 C-N-CA 129.743 3.217 . . . . 0.0 114.197 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.26 -35.5 76.15 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 130.769 3.628 . . . . 0.0 111.454 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.0 mtt -68.09 -40.17 82.69 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.108 1.763 . . . . 0.0 110.384 168.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 11.7 mt-30 -66.17 -50.3 64.41 Favored 'General case' 0 C--N 1.374 1.655 0 C-N-CA 126.142 1.777 . . . . 0.0 112.258 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.298 4.7 ptt180 -71.65 -37.53 70.8 Favored 'General case' 0 C--N 1.382 2.001 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 175.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.22 68.77 Favored 'General case' 0 C--N 1.373 1.612 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 169.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 20.6 t0 -70.11 -48.79 56.11 Favored 'General case' 0 C--N 1.372 1.546 0 O-C-N 119.212 -2.18 . . . . 0.0 110.569 168.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -53.37 -47.81 69.13 Favored 'General case' 0 C--N 1.373 1.629 0 C-N-CA 128.88 2.872 . . . . 0.0 114.696 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.42 ' CB ' ' HB3' ' A' ' 190' ' ' ARG . . . -68.11 -29.34 68.24 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 176.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.661 HD11 ' HA ' ' A' ' 152' ' ' THR 0.267 0.2 OUTLIER -81.35 -41.85 21.41 Favored 'General case' 0 C--N 1.367 1.365 0 O-C-N 118.552 -2.592 . . . . 0.0 112.811 171.077 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 180' ' ' ASP 0.277 0.0 OUTLIER -70.91 -30.3 66.59 Favored 'General case' 0 C--N 1.379 1.889 0 C-N-CA 129.359 3.064 . . . . 0.0 112.676 -173.402 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -103.99 -100.59 0.31 Allowed 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.374 0.607 . . . . 0.0 109.712 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -136.62 144.03 43.84 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.675 7.1 pttm -51.19 -33.73 28.62 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 129.972 3.309 . . . . 0.0 116.41 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.78 -28.29 3.94 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 C-N-CA 129.096 2.958 . . . . 0.0 112.586 169.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.295 2.4 mptp? -64.79 -30.95 71.98 Favored 'General case' 0 C--N 1.374 1.642 0 C-N-CA 126.861 2.064 . . . . 0.0 115.479 168.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.547 ' CZ ' ' HA2' ' A' ' 93' ' ' GLY 0.381 0.0 OUTLIER -75.51 -41.35 55.5 Favored 'General case' 0 C--N 1.38 1.911 0 CA-C-N 123.046 2.657 . . . . 0.0 113.16 167.53 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 43.7 mt -69.38 -19.7 63.83 Favored 'General case' 0 C--N 1.378 1.843 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -64.68 -24.17 67.49 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 129.902 3.281 . . . . 0.0 112.55 170.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.3 mt -105.93 -49.35 3.41 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 55.85 -128.81 2.02 Favored 'General case' 0 C--N 1.375 1.701 0 C-N-CA 128.683 2.793 . . . . 0.0 110.871 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.535 0.394 0 C-N-CA 124.802 1.241 . . . . 0.0 112.076 175.745 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 30.8 m . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -148.01 105.49 3.67 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 121.078 -1.014 . . . . 0.0 109.631 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -124.61 128.37 48.78 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 126.019 1.728 . . . . 0.0 108.958 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.54 164.55 14.59 Favored Pre-proline 0 C--N 1.355 0.827 0 C-N-CA 125.052 1.341 . . . . 0.0 113.747 -175.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -45.01 135.0 10.8 Favored 'Trans proline' 0 C--N 1.373 1.864 1 C-N-CA 127.828 5.686 . . . . 0.0 119.642 -173.007 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 190' ' ' ARG . . . 101.74 -6.45 54.76 Favored Glycine 0 C--N 1.366 2.211 0 C-N-CA 125.777 1.656 . . . . 0.0 112.11 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -94.3 169.65 10.08 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.265 2.033 . . . . 0.0 112.827 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.18 138.57 38.95 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 102.891 -3.003 . . . . 0.0 102.891 164.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.76 132.5 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -89.49 122.45 32.68 Favored 'General case' 0 N--CA 1.478 0.931 1 O-C-N 116.24 -4.037 . . . . 0.0 106.081 175.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.15 131.62 53.2 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 122.71 1.243 . . . . 0.0 113.124 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -102.33 135.48 43.86 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -122.53 147.65 46.12 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 104.566 -2.383 . . . . 0.0 104.566 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.79 107.93 1.59 Allowed 'General case' 0 C--N 1.354 0.772 0 C-N-CA 126.217 1.807 . . . . 0.0 113.114 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.32 -15.25 46.88 Favored Glycine 0 C--N 1.354 1.57 0 C-N-CA 124.769 1.176 . . . . 0.0 114.599 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . 0.256 0.0 OUTLIER -102.25 168.28 9.19 Favored Pre-proline 0 C--N 1.363 1.159 0 CA-C-N 119.659 1.729 . . . . 0.0 111.94 -178.77 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.76 158.52 50.23 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 125.196 3.931 . . . . 0.0 113.583 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -54.95 129.38 37.47 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 128.948 2.899 . . . . 0.0 115.351 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -134.04 126.58 18.72 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 119.768 3.247 . . . . 0.0 119.768 -172.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -67.21 117.64 4.97 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 124.944 3.763 . . . . 0.0 113.695 164.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.94 164.37 17.71 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 131.257 3.823 . . . . 0.0 114.335 -170.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp -120.99 132.77 55.12 Favored 'General case' 0 C--N 1.345 0.409 0 O-C-N 118.563 -2.586 . . . . 0.0 107.381 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 131' ' ' VAL . 7.6 p -91.51 129.79 41.67 Favored 'Isoleucine or valine' 0 C--N 1.374 1.638 0 CA-C-N 119.987 1.267 . . . . 0.0 108.216 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.345 0.0 OUTLIER -138.64 153.27 48.59 Favored 'General case' 0 C--N 1.372 1.563 0 O-C-N 117.922 -2.986 . . . . 0.0 117.351 -173.111 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -87.92 112.31 22.4 Favored 'General case' 0 C--N 1.368 1.413 0 CA-C-O 123.386 1.565 . . . . 0.0 109.246 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -97.33 154.99 37.86 Favored Pre-proline 0 N--CA 1.447 -0.599 0 C-N-CA 129.377 3.071 . . . . 0.0 108.115 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -56.68 -0.96 0.28 Allowed 'Trans proline' 0 N--CA 1.487 1.121 1 C-N-CA 126.524 4.816 . . . . 0.0 121.076 -165.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.79 -7.81 58.52 Favored 'General case' 0 C--N 1.363 1.191 0 C-N-CA 129.404 3.082 . . . . 0.0 109.624 170.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -30.18 139.99 0.02 OUTLIER 'General case' 0 C--N 1.375 1.715 1 C-N-CA 134.153 4.981 . . . . 0.0 121.361 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.22 -20.24 28.55 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 113.456 -1.702 . . . . 0.0 109.236 175.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.6 p -125.5 118.78 26.53 Favored 'General case' 0 C--N 1.348 0.514 1 N-CA-C 96.518 -5.364 . . . . 0.0 96.518 164.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -123.87 4.73 8.74 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 119.688 1.131 . . . . 0.0 112.12 -172.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.5 pt -110.12 166.43 5.16 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.746 1.218 . . . . 0.0 110.401 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -151.04 147.36 27.01 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.826 2.45 . . . . 0.0 105.201 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.06 134.67 15.4 Favored 'General case' 0 C--N 1.357 0.935 0 O-C-N 120.546 -1.346 . . . . 0.0 110.702 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 93.55 4.17 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 127.921 2.488 . . . . 0.0 108.834 175.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.32 -74.38 0.14 Allowed Glycine 0 C--N 1.361 1.971 0 N-CA-C 121.212 3.245 . . . . 0.0 121.212 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.32 37.58 3.53 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.775 1.63 . . . . 0.0 111.488 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m -166.22 151.6 8.46 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 119.461 -2.025 . . . . 0.0 107.286 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.47 144.58 32.41 Favored 'Isoleucine or valine' 0 C--N 1.366 1.293 0 C-N-CA 126.023 1.729 . . . . 0.0 111.126 -174.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -135.55 154.76 51.27 Favored 'General case' 0 C--N 1.366 1.298 0 C-N-CA 127.975 2.51 . . . . 0.0 113.931 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 145' ' ' LYS . 23.3 m -126.28 162.74 29.57 Favored 'Isoleucine or valine' 0 C--N 1.38 1.904 0 C-N-CA 130.77 3.628 . . . . 0.0 106.144 173.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -86.42 116.42 24.56 Favored 'General case' 0 C--N 1.365 1.275 0 O-C-N 119.695 -1.878 . . . . 0.0 110.815 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 110' ' ' VAL . 2.3 t -138.67 150.13 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 C-N-CA 125.044 1.338 . . . . 0.0 107.714 -174.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -118.7 144.93 45.91 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 170.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -100.22 131.05 46.39 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.53 72.59 2.52 Favored 'General case' 0 C--N 1.38 1.893 0 C-N-CA 125.098 1.359 . . . . 0.0 111.542 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -97.9 -103.9 0.19 Allowed 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.518 1.127 . . . . 0.0 111.002 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -106.61 -62.44 1.39 Allowed 'General case' 0 C--N 1.354 0.763 0 C-N-CA 126.051 1.74 . . . . 0.0 113.75 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 p -88.27 -29.14 0.37 Allowed Pre-proline 0 C--N 1.364 1.196 0 N-CA-C 118.945 2.943 . . . . 0.0 118.945 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.5 -177.84 18.72 Favored 'Cis proline' 0 C--N 1.357 1.025 1 CA-C-N 129.585 4.459 . . . . 0.0 113.386 -2.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 64.2 m -98.12 113.37 25.24 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 127.889 2.476 . . . . 0.0 113.585 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -113.41 161.53 17.19 Favored 'General case' 0 C--N 1.363 1.155 0 CA-C-N 124.972 3.533 . . . . 0.0 108.086 172.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.58 -170.33 31.34 Favored Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 103.359 -3.896 . . . . 0.0 103.359 168.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -93.93 110.21 21.9 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 172.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.6 m -94.6 157.16 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 C-N-CA 125.949 1.7 . . . . 0.0 110.947 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.5 t -79.14 110.98 14.91 Favored 'General case' 0 C--N 1.364 1.222 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HB3' HG22 ' A' ' 129' ' ' VAL 0.419 0.0 OUTLIER -65.73 -14.89 62.2 Favored 'General case' 0 C--N 1.366 1.295 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -172.891 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.418 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 41.0 ttm180 -74.76 -3.87 34.2 Favored 'General case' 0 N--CA 1.434 -1.227 1 C-N-CA 132.798 4.439 . . . . 0.0 112.933 170.849 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 147' ' ' LEU . 8.3 mt -109.73 2.29 19.99 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.391 2.276 . . . . 0.0 110.902 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.8 mt -96.41 153.22 17.95 Favored 'General case' 0 C--N 1.373 1.615 0 O-C-N 120.069 -1.644 . . . . 0.0 113.19 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -119.02 155.21 53.28 Favored Pre-proline 0 C--N 1.351 0.654 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -82.76 155.53 15.61 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 125.403 2.965 . . . . 0.0 113.069 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -35.63 -87.89 0.0 OUTLIER 'General case' 0 C--N 1.348 0.512 2 C-N-CA 132.297 4.239 . . . . 0.0 122.4 -177.551 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.845 ' HA ' HD13 ' A' ' 183' ' ' LEU . 4.6 t -31.48 24.94 0.0 OUTLIER 'General case' 0 C--N 1.359 0.988 1 C-N-CA 138.555 6.742 . . . . 0.0 120.643 -179.246 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.03 0.4 47.9 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 -165.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 159' ' ' ALA 0.256 5.8 p -62.73 -15.53 53.46 Favored 'General case' 0 C--N 1.366 1.289 0 CA-C-N 120.988 2.394 . . . . 0.0 117.287 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -91.47 -6.7 52.25 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 128.808 2.843 . . . . 0.0 111.107 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.0 p -90.85 147.85 22.9 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 127.34 2.256 . . . . 0.0 112.775 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -62.19 -18.47 61.11 Favored 'General case' 0 C--N 1.37 1.475 0 C-N-CA 126.82 2.048 . . . . 0.0 113.517 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -75.87 -26.51 57.13 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 127.452 2.301 . . . . 0.0 112.696 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 154' ' ' SER . . . -89.63 -12.89 38.38 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -114.91 -178.91 3.48 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 126.177 1.791 . . . . 0.0 111.4 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -57.74 122.75 13.58 Favored 'General case' 0 C--N 1.372 1.55 0 C-N-CA 127.243 2.217 . . . . 0.0 115.134 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.12 -10.95 58.58 Favored Glycine 0 C--N 1.357 1.72 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.81 -167.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -84.33 160.34 36.26 Favored Glycine 0 C--N 1.363 2.058 0 N-CA-C 121.13 3.212 . . . . 0.0 121.13 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -60.38 -30.0 69.29 Favored 'General case' 0 C--N 1.369 1.447 0 C-N-CA 128.915 2.886 . . . . 0.0 118.691 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -105.34 7.9 33.52 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.357 -1.464 . . . . 0.0 110.456 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -87.78 162.64 16.9 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -171.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.5 m 174.91 176.75 0.16 Allowed 'General case' 0 C--N 1.353 0.724 1 N-CA-C 99.097 -4.409 . . . . 0.0 99.097 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -138.71 102.29 4.54 Favored 'General case' 0 C--N 1.364 1.228 0 CA-C-N 124.187 3.176 . . . . 0.0 111.288 173.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -119.74 138.32 26.62 Favored Pre-proline 0 N--CA 1.435 -1.21 0 C-N-CA 130.269 3.428 . . . . 0.0 105.766 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.47 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 55.4 Cg_endo -59.4 -27.44 84.99 Favored 'Trans proline' 0 C--N 1.363 1.334 1 C-N-CA 127.013 5.142 . . . . 0.0 115.086 177.372 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -70.02 -36.85 75.38 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 129.465 3.106 . . . . 0.0 113.167 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.2 mt -70.45 -34.89 59.63 Favored 'Isoleucine or valine' 0 C--N 1.381 1.977 0 C-N-CA 126.677 1.991 . . . . 0.0 110.056 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 170' ' ' PRO . 6.8 mt -59.69 -53.26 60.05 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 125.987 1.715 . . . . 0.0 110.742 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -57.55 -34.6 69.34 Favored 'General case' 0 C--N 1.367 1.356 0 C-N-CA 128.217 2.607 . . . . 0.0 115.403 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.81 -42.83 80.94 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 129.191 2.996 . . . . 0.0 111.662 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 18.1 mtt -69.98 -33.24 71.8 Favored 'General case' 0 C--N 1.372 1.546 0 CA-C-O 117.282 -1.342 . . . . 0.0 113.193 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 15.8 mt-30 -74.29 -42.64 59.23 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-N 121.713 2.051 . . . . 0.0 111.109 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -68.54 -49.65 57.91 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 127.348 2.259 . . . . 0.0 111.418 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.57 -41.39 98.9 Favored 'General case' 0 C--N 1.374 1.645 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 173.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 21.1 t70 -62.33 -37.26 84.94 Favored 'General case' 0 C--N 1.379 1.876 0 C-N-CA 128.808 2.843 . . . . 0.0 111.353 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -72.03 -44.81 62.79 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 119.828 -1.795 . . . . 0.0 112.481 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -73.0 -38.89 66.46 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.845 HD13 ' HA ' ' A' ' 152' ' ' THR . 4.4 pp -69.23 -37.28 77.94 Favored 'General case' 0 C--N 1.374 1.645 0 C-N-CA 127.243 2.217 . . . . 0.0 115.056 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -83.72 -31.95 25.77 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 127.103 2.161 . . . . 0.0 111.451 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -105.13 -98.46 0.33 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -135.63 150.73 49.73 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.819 -1.176 . . . . 0.0 112.347 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.277 24.6 ttpp -51.69 -36.37 46.34 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 131.485 3.914 . . . . 0.0 115.385 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.8 tp -53.24 -27.59 13.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 129.219 3.007 . . . . 0.0 112.409 172.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -75.78 -41.27 53.45 Favored 'General case' 0 C--N 1.372 1.555 0 O-C-N 119.483 -2.011 . . . . 0.0 114.636 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 93' ' ' GLY . 7.0 ptp180 -74.61 -37.06 62.94 Favored 'General case' 0 C--N 1.366 1.295 0 O-C-N 118.832 -2.418 . . . . 0.0 116.466 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.0 tp -79.92 -27.82 39.84 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.919 2.087 . . . . 0.0 113.052 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -77.43 -27.42 52.21 Favored 'General case' 0 C--N 1.371 1.541 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 171.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.83 -2.06 54.04 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 124.618 1.167 . . . . 0.0 111.108 175.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 21.9 -124.76 0.01 OUTLIER 'General case' 0 C--N 1.361 1.068 1 C-N-CA 133.807 4.843 . . . . 0.0 121.752 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.349 0.555 0 O-C-N 119.8 -1.813 . . . . 0.0 110.575 -176.923 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 47.2 m . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.66 64.05 0.47 Allowed 'General case' 0 C--N 1.366 1.308 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -172.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -116.45 124.15 49.28 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.147 -1.596 . . . . 0.0 108.645 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.9 p -112.33 165.26 13.37 Favored Pre-proline 0 C--N 1.362 1.127 0 C-N-CA 126.999 2.12 . . . . 0.0 114.651 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -52.22 138.22 54.76 Favored 'Trans proline' 0 C--N 1.371 1.747 1 C-N-CA 126.21 4.607 . . . . 0.0 120.483 -170.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.91 -12.43 38.05 Favored Glycine 0 C--N 1.365 2.169 0 C-N-CA 125.019 1.295 . . . . 0.0 110.418 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.66 170.08 9.72 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 120.37 2.085 . . . . 0.0 111.982 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.33 145.9 28.29 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 163.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.1 m -143.1 157.26 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.403 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 66.9 m95 -108.39 123.33 48.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 102.064 -3.31 . . . . 0.0 102.064 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.4 136.64 54.19 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.509 1.523 . . . . 0.0 112.932 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.516 ' O ' HD13 ' A' ' 147' ' ' LEU . 12.5 tptt -109.51 145.41 36.32 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 170.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 tpt -129.18 150.23 50.65 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 118.622 -2.549 . . . . 0.0 110.042 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.26 90.18 0.07 Allowed 'General case' 0 C--N 1.368 1.406 0 C-N-CA 126.307 1.843 . . . . 0.0 115.622 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.19 1.47 25.07 Favored Glycine 0 C--N 1.359 1.841 0 C-N-CA 125.715 1.626 . . . . 0.0 112.983 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -108.82 161.36 23.92 Favored Pre-proline 0 C--N 1.354 0.786 0 C-N-CA 126.201 1.8 . . . . 0.0 109.352 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.76 167.6 26.11 Favored 'Trans proline' 0 CA--C 1.545 1.055 1 C-N-CA 125.323 4.015 . . . . 0.0 113.295 162.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.488 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 1.8 m95 -57.62 121.54 10.59 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 128.066 2.546 . . . . 0.0 115.301 170.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -123.76 111.83 29.21 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 119.252 3.056 . . . . 0.0 119.252 -172.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.403 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 4.6 Cg_exo -58.5 124.21 15.31 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 125.136 3.891 . . . . 0.0 111.227 162.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.8 p -137.82 165.5 26.31 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 128.461 2.704 . . . . 0.0 115.391 -161.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' A' ' 190' ' ' ARG . 9.2 tp -119.97 132.67 55.58 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.968 2.107 . . . . 0.0 105.952 174.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 131' ' ' VAL . 2.9 p -83.61 118.98 32.04 Favored 'Isoleucine or valine' 0 C--N 1.381 1.959 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 173.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.71 143.39 49.83 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.036 -1.665 . . . . 0.0 111.794 -164.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -98.0 118.53 34.8 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 119.349 -2.094 . . . . 0.0 112.049 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.538 ' H ' ' CE1' ' A' ' 130' ' ' HIS . 2.4 m-70 -71.79 159.78 84.5 Favored Pre-proline 0 C--N 1.358 0.95 0 C-N-CA 128.191 2.596 . . . . 0.0 108.303 169.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.17 -9.06 1.89 Allowed 'Trans proline' 0 CA--C 1.552 1.398 1 C-N-CA 126.563 4.842 . . . . 0.0 116.446 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -63.39 -18.48 63.73 Favored 'General case' 0 C--N 1.36 1.053 1 C-N-CA 134.752 5.221 . . . . 0.0 113.561 166.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.341 0.0 OUTLIER -28.78 136.49 0.02 OUTLIER 'General case' 0 C--N 1.381 1.962 0 N-CA-C 120.926 3.676 . . . . 0.0 120.926 -177.249 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.91 -19.77 27.48 Favored Glycine 0 C--N 1.361 1.936 0 CA-C-O 123.432 1.573 . . . . 0.0 109.633 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.4 m -141.99 119.66 11.8 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 100.269 -3.974 . . . . 0.0 100.269 164.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 130' ' ' HIS . 26.1 p90 -123.98 10.65 8.86 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.764 -1.21 . . . . 0.0 109.154 -176.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.814 HG22 HG12 ' A' ' 129' ' ' VAL . 8.2 pt -121.57 157.12 25.51 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 CA-C-O 123.637 1.684 . . . . 0.0 111.921 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.0 mtp-105 -137.38 149.1 46.72 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 130.467 3.507 . . . . 0.0 102.421 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.1 139.83 24.96 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 120.267 -1.521 . . . . 0.0 109.184 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -118.27 93.69 4.22 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 126.59 1.956 . . . . 0.0 109.622 175.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.63 -76.32 0.21 Allowed Glycine 0 C--N 1.366 2.249 0 N-CA-C 118.635 2.214 . . . . 0.0 118.635 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -141.18 22.7 2.22 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 125.763 1.625 . . . . 0.0 110.073 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.4 t -125.88 128.55 47.77 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 126.493 1.917 . . . . 0.0 108.674 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.21 116.06 49.74 Favored 'Isoleucine or valine' 0 C--N 1.358 0.949 0 C-N-CA 126.625 1.97 . . . . 0.0 112.406 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -113.84 130.68 56.45 Favored 'General case' 0 C--N 1.367 1.329 0 C-N-CA 127.362 2.265 . . . . 0.0 111.256 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.814 HG12 HG22 ' A' ' 120' ' ' ILE . 10.3 m -125.37 159.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.364 1.217 0 C-N-CA 127.438 2.295 . . . . 0.0 106.578 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.538 ' CE1' ' H ' ' A' ' 113' ' ' HIS . 3.8 p80 -90.46 129.76 36.6 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 125.262 1.425 . . . . 0.0 113.268 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.474 HG12 HG23 ' A' ' 110' ' ' VAL . 3.3 m -146.47 165.3 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 C-N-CA 128.358 2.663 . . . . 0.0 106.612 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -126.05 143.18 51.21 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.092 0.557 . . . . 0.0 109.909 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.55 123.91 39.32 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 129.666 3.186 . . . . 0.0 107.885 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -75.69 70.57 2.5 Favored 'General case' 0 C--N 1.374 1.654 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -90.79 -114.38 0.08 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.203 1.801 . . . . 0.0 110.96 -175.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -107.07 -51.99 2.83 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 126.183 1.793 . . . . 0.0 112.105 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.3 m -73.68 -45.92 7.16 Favored Pre-proline 0 C--N 1.366 1.295 0 N-CA-C 119.396 3.11 . . . . 0.0 119.396 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -85.29 177.31 27.38 Favored 'Cis proline' 0 CA--C 1.548 1.175 0 CA-C-N 127.452 3.697 . . . . 0.0 112.832 -1.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 84.5 m -95.08 119.98 34.52 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 120.058 -1.651 . . . . 0.0 110.83 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.491 HH21 HG21 ' A' ' 195' ' ' VAL . 4.6 tmm_? -132.19 148.03 52.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 121.351 1.887 . . . . 0.0 108.484 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.34 -166.65 30.47 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.59 111.92 17.47 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 127.233 2.213 . . . . 0.0 109.591 175.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.7 m -98.45 169.7 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 C-N-CA 125.275 1.43 . . . . 0.0 108.302 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.8 m -95.74 124.53 39.8 Favored 'General case' 0 C--N 1.364 1.199 0 N-CA-C 101.157 -3.646 . . . . 0.0 101.157 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.618 ' HD3' HG11 ' A' ' 129' ' ' VAL . 7.3 ttpm? -70.46 -9.06 55.48 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 124.359 3.254 . . . . 0.0 117.451 -168.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 15.8 ptp180 -73.34 -6.26 44.98 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 129.622 3.169 . . . . 0.0 115.291 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.516 HD13 ' O ' ' A' ' 99' ' ' LYS 0.264 0.8 OUTLIER -112.94 11.63 19.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.839 0.856 . . . . 0.0 110.371 176.545 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.46 HD12 ' HG3' ' A' ' 145' ' ' LYS . 4.8 mt -98.01 125.37 42.93 Favored 'General case' 0 C--N 1.38 1.903 0 C-N-CA 126.381 1.872 . . . . 0.0 107.898 173.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -114.15 161.57 27.48 Favored Pre-proline 0 C--N 1.346 0.426 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.32 153.59 14.06 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 124.959 2.807 . . . . 0.0 113.628 -174.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.296 0.1 OUTLIER -29.87 -84.14 0.0 OUTLIER 'General case' 0 C--N 1.353 0.76 2 N-CA-C 123.685 4.698 . . . . 0.0 123.685 -179.943 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.616 ' HA ' HD21 ' A' ' 183' ' ' LEU . 14.8 t -34.27 38.34 0.0 OUTLIER 'General case' 0 C--N 1.373 1.616 1 C-N-CA 136.961 6.105 . . . . 0.0 118.154 -176.156 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.51 -36.86 2.36 Favored Glycine 0 C--N 1.358 1.788 0 C-N-CA 128.802 3.096 . . . . 0.0 117.969 -168.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 38.0 m -48.6 -15.41 0.08 Allowed 'General case' 0 C--N 1.376 1.755 0 N-CA-C 119.493 3.145 . . . . 0.0 119.493 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -111.34 0.12 16.54 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.453 2.301 . . . . 0.0 110.619 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.5 t -103.35 158.45 16.32 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 127.719 2.407 . . . . 0.0 114.691 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -56.54 -18.64 12.36 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.334 2.654 . . . . 0.0 118.09 -171.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -90.25 -10.53 43.93 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 124.814 1.246 . . . . 0.0 112.402 169.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 4.8 10.62 Favored 'General case' 0 C--N 1.375 1.694 0 CA-C-N 120.146 1.339 . . . . 0.0 114.396 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.424 0.0 OUTLIER -113.2 162.01 16.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.532 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -50.08 122.41 6.71 Favored 'General case' 0 C--N 1.372 1.587 0 C-N-CA 127.318 2.247 . . . . 0.0 116.569 -172.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.86 -22.82 32.68 Favored Glycine 0 C--N 1.36 1.907 0 C-N-CA 125.01 1.291 . . . . 0.0 111.943 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.32 158.7 44.09 Favored Glycine 0 C--N 1.371 2.516 0 N-CA-C 119.43 2.532 . . . . 0.0 119.43 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -52.19 -42.86 63.83 Favored 'General case' 0 C--N 1.366 1.317 0 N-CA-C 121.751 3.982 . . . . 0.0 121.751 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.488 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.344 0.2 OUTLIER -105.16 12.49 31.95 Favored 'General case' 0 C--N 1.365 1.262 0 O-C-N 120.327 -1.483 . . . . 0.0 112.967 -177.779 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -93.53 90.87 6.84 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 126.096 1.758 . . . . 0.0 112.722 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.6 m -115.01 117.52 30.82 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 101.735 -3.431 . . . . 0.0 101.735 170.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.19 101.7 14.42 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 125.87 2.748 . . . . 0.0 113.581 -168.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -120.36 137.77 26.5 Favored Pre-proline 0 N--CA 1.422 -1.836 1 C-N-CA 133.753 4.821 . . . . 0.0 103.039 170.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.92 -26.07 79.66 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.943 3.762 . . . . 0.0 115.134 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -69.74 -35.97 75.45 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 130.961 3.705 . . . . 0.0 112.985 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.251 56.1 mt -75.15 -34.57 31.85 Favored 'Isoleucine or valine' 0 C--N 1.377 1.77 0 C-N-CA 126.289 1.836 . . . . 0.0 109.569 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.88 -46.53 68.17 Favored 'General case' 0 C--N 1.375 1.698 0 C-N-CA 124.827 1.251 . . . . 0.0 111.765 170.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -57.61 -35.79 70.91 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.751 2.02 . . . . 0.0 114.061 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.17 -40.22 86.59 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 130.788 3.635 . . . . 0.0 112.071 172.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 56.4 mtt -69.67 -33.19 72.22 Favored 'General case' 0 C--N 1.364 1.201 0 CA-C-O 116.786 -1.578 . . . . 0.0 113.633 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -74.14 -48.21 30.94 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 126.769 2.028 . . . . 0.0 111.008 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.474 ' HE ' ' HG ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -69.08 -43.93 73.56 Favored 'General case' 0 C--N 1.369 1.432 0 C-N-CA 129.292 3.037 . . . . 0.0 112.454 177.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.86 93.05 Favored 'General case' 0 C--N 1.377 1.794 0 C-N-CA 125.359 1.463 . . . . 0.0 112.198 169.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.441 ' HA ' HD13 ' A' ' 183' ' ' LEU 0.356 4.4 t70 -60.9 -51.38 69.53 Favored 'General case' 0 C--N 1.384 2.096 0 CA-C-N 120.524 1.511 . . . . 0.0 113.016 173.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -35.17 64.84 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 121.938 2.154 . . . . 0.0 116.268 175.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.77 -44.63 32.14 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 168.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' A' ' 152' ' ' THR . 0.3 OUTLIER -60.9 -40.95 95.01 Favored 'General case' 0 C--N 1.364 1.203 0 C-N-CA 131.032 3.733 . . . . 0.0 116.032 178.182 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.284 0.0 OUTLIER -89.21 -13.82 37.4 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.801 2.04 . . . . 0.0 110.783 -173.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -121.31 -108.78 0.35 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 126.553 1.941 . . . . 0.0 114.525 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -131.97 162.11 31.5 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.53 -1.981 . . . . 0.0 113.7 -172.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -37.65 54.1 Favored 'General case' 0 C--N 1.375 1.678 1 C-N-CA 132.113 4.165 . . . . 0.0 116.262 177.198 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.2 -31.89 49.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.501 0 C-N-CA 127.222 2.209 . . . . 0.0 113.74 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -70.84 -42.79 69.71 Favored 'General case' 0 C--N 1.374 1.635 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.449 ' HB2' HD13 ' A' ' 109' ' ' LEU . 7.9 ptt180 -75.44 -44.28 45.23 Favored 'General case' 0 C--N 1.364 1.199 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 170.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.269 7.7 tp -72.52 -19.19 61.56 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 127.234 2.213 . . . . 0.0 114.806 -173.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -63.0 -27.88 69.72 Favored 'General case' 0 C--N 1.368 1.371 0 C-N-CA 127.863 2.465 . . . . 0.0 112.697 166.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.474 ' HG ' ' HE ' ' A' ' 178' ' ' ARG . 2.0 mm? -100.06 22.45 11.29 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 127.965 2.506 . . . . 0.0 112.191 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.61 53.95 0.03 OUTLIER 'General case' 0 C--N 1.374 1.655 0 C-N-CA 127.825 2.45 . . . . 0.0 115.634 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.491 HG21 HH21 ' A' ' 140' ' ' ARG 0.403 2.9 m . . . . . 0 C--N 1.366 1.283 1 C-N-CA 134.867 5.267 . . . . 0.0 117.024 -179.833 . . . . . . . . 3 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 120.286 0.089 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -138.36 58.29 1.67 Allowed 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -113.82 122.97 48.67 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 119.336 -2.102 . . . . 0.0 114.314 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.297 96.8 p -112.92 167.35 9.36 Favored Pre-proline 0 C--N 1.359 0.992 0 C-N-CA 129.278 3.031 . . . . 0.0 115.42 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -48.58 139.92 22.73 Favored 'Trans proline' 0 C--N 1.379 2.161 1 C-N-CA 127.457 5.438 . . . . 0.0 121.266 -170.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.26 -7.07 66.43 Favored Glycine 0 C--N 1.37 2.418 0 C-N-CA 126.092 1.806 . . . . 0.0 112.585 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.82 169.15 10.52 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 119.971 1.886 . . . . 0.0 111.851 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 2.8 mm? -102.7 147.76 26.43 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 167.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.35 159.34 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 -177.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -104.67 119.1 38.2 Favored 'General case' 0 CA--C 1.51 -0.558 1 N-CA-C 98.054 -4.795 . . . . 0.0 98.054 165.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.96 131.53 52.35 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.29 136.99 47.84 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 118.675 -2.516 . . . . 0.0 106.136 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 57.1 ttm -129.69 141.4 50.91 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 119.922 -1.736 . . . . 0.0 110.264 173.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -65.37 107.62 1.7 Allowed 'General case' 0 C--N 1.367 1.353 0 C-N-CA 126.082 1.753 . . . . 0.0 112.878 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.55 -16.61 21.52 Favored Glycine 0 C--N 1.36 1.887 0 C-N-CA 125.438 1.494 . . . . 0.0 112.55 -172.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -112.53 161.63 25.4 Favored Pre-proline 0 C--N 1.359 1.011 0 O-C-N 121.144 -1.21 . . . . 0.0 109.111 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.95 167.06 27.73 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 125.015 3.81 . . . . 0.0 113.342 166.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.49 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -58.36 116.42 3.61 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 127.908 2.483 . . . . 0.0 112.821 171.394 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -127.0 117.9 22.1 Favored Pre-proline 0 N--CA 1.426 -1.633 0 N-CA-C 121.387 3.847 . . . . 0.0 121.387 -169.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -49.08 125.3 13.03 Favored 'Trans proline' 0 C--N 1.387 2.58 1 C-N-CA 127.079 5.186 . . . . 0.0 112.374 162.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 m -146.55 164.19 33.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 124.298 1.999 . . . . 0.0 112.045 -158.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 tt -135.67 135.57 40.23 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 119.564 -1.96 . . . . 0.0 106.61 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.312 3.3 p -92.45 130.97 40.77 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 CA-C-N 121.19 1.814 . . . . 0.0 110.372 175.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -133.37 153.05 51.92 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 125.521 1.528 . . . . 0.0 111.955 -166.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -99.81 112.16 24.43 Favored 'General case' 0 C--N 1.376 1.718 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 171.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -96.73 158.38 33.67 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 130.416 3.486 . . . . 0.0 108.767 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -50.05 -1.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.525 2 C-N-CA 127.565 5.51 . . . . 0.0 122.852 -165.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -99.83 9.1 43.58 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 126.673 1.989 . . . . 0.0 108.981 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.0 143.66 0.08 Allowed 'General case' 0 C--N 1.369 1.437 1 C-N-CA 134.224 5.01 . . . . 0.0 120.884 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.94 -19.68 27.51 Favored Glycine 0 C--N 1.359 1.832 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.5 t -134.12 127.52 32.27 Favored 'General case' 0 N--CA 1.448 -0.571 1 N-CA-C 99.456 -4.276 . . . . 0.0 99.456 163.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -128.24 6.41 5.86 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 120.514 -1.366 . . . . 0.0 109.671 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.549 HG22 HG12 ' A' ' 129' ' ' VAL . 23.5 pt -118.59 150.36 20.86 Favored 'Isoleucine or valine' 0 C--N 1.361 1.105 0 CA-C-O 124.076 1.893 . . . . 0.0 113.678 -173.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.532 ' HE ' ' H ' ' A' ' 122' ' ' GLU . 5.7 tpm_? -140.42 144.23 36.04 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 130.025 3.33 . . . . 0.0 103.715 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.532 ' H ' ' HE ' ' A' ' 121' ' ' ARG . 42.4 tt0 -140.3 126.93 20.34 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 176.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -107.16 93.39 4.53 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.82 1.648 . . . . 0.0 107.175 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.5 -93.55 0.81 Allowed Glycine 0 C--N 1.362 2.014 0 C-N-CA 126.489 1.995 . . . . 0.0 111.729 -174.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.58 -0.78 10.76 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 125.248 1.419 . . . . 0.0 109.204 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.5 t -92.52 97.97 11.16 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 125.298 1.439 . . . . 0.0 111.055 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.18 129.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 128.135 2.574 . . . . 0.0 112.404 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -123.49 140.66 52.78 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 126.998 2.119 . . . . 0.0 109.709 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 120' ' ' ILE . 14.8 m -127.2 163.53 29.96 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 127.284 2.233 . . . . 0.0 109.928 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -78.62 123.46 27.14 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 119.195 -2.191 . . . . 0.0 111.819 171.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.538 HG22 HG11 ' A' ' 143' ' ' VAL . 5.5 m -143.96 176.21 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.232 0 CA-C-N 123.278 2.763 . . . . 0.0 104.846 174.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.32 152.36 51.77 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 125.07 1.481 . . . . 0.0 108.442 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.52 120.65 42.82 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 104.141 -2.541 . . . . 0.0 104.141 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -64.86 65.88 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.5 1.92 . . . . 0.0 114.839 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -103.16 -128.62 0.23 Allowed 'General case' 0 C--N 1.36 1.045 0 O-C-N 118.963 -2.336 . . . . 0.0 112.123 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -102.24 -57.53 2.05 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 126.144 1.778 . . . . 0.0 113.001 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.6 p -80.91 -26.6 0.43 Allowed Pre-proline 0 C--N 1.362 1.113 0 N-CA-C 118.356 2.724 . . . . 0.0 118.356 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -85.89 -157.26 1.22 Allowed 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 127.944 3.873 . . . . 0.0 109.977 -2.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.4 m -96.68 127.82 43.03 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 1.1 tmt_? -161.64 154.77 20.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 119.488 -2.008 . . . . 0.0 108.936 -176.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.95 -158.02 19.33 Favored Glycine 0 CA--C 1.485 -1.803 0 N-CA-C 103.74 -3.744 . . . . 0.0 103.74 166.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -91.01 112.61 24.58 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 169.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.538 HG11 HG22 ' A' ' 131' ' ' VAL 0.304 14.8 p -102.64 161.31 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.988 -163.403 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 m -78.37 109.69 12.74 Favored 'General case' 0 C--N 1.363 1.188 0 C-N-CA 124.919 1.288 . . . . 0.0 107.836 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.505 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 26.9 tttp -64.4 -19.05 65.26 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -170.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -82.41 -6.33 59.21 Favored 'General case' 0 C--N 1.362 1.146 0 O-C-N 120.237 -1.54 . . . . 0.0 113.742 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.4 mt -100.68 6.85 44.13 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 126.405 1.882 . . . . 0.0 109.695 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.505 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 26.1 mt -96.69 124.42 40.67 Favored 'General case' 0 C--N 1.368 1.397 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -116.65 158.84 42.52 Favored Pre-proline 0 CA--C 1.493 -1.24 0 O-C-N 120.478 -1.389 . . . . 0.0 107.809 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.81 150.73 14.39 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 CA-C-N 122.711 2.004 . . . . 0.0 113.41 -170.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 95' ' ' LEU 0.36 0.0 OUTLIER -28.2 -87.39 0.0 OUTLIER 'General case' 0 C--N 1.355 0.81 2 N-CA-C 123.459 4.615 . . . . 0.0 123.459 -177.997 . . . . . . . . 5 4 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.54 ' HA ' HD21 ' A' ' 183' ' ' LEU . 8.8 t 2.52 57.23 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 1 C-N-CA 134.656 5.183 . . . . 0.0 118.865 176.392 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.559 ' H ' HD11 ' A' ' 183' ' ' LEU . . . -79.16 -108.24 0.22 Allowed Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 122.234 3.654 . . . . 0.0 122.234 -154.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.3 m -45.17 -22.44 0.11 Allowed 'General case' 0 C--N 1.371 1.54 0 C-N-CA 130.643 3.577 . . . . 0.0 120.197 -167.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -85.39 -11.5 54.35 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 127.934 2.493 . . . . 0.0 113.051 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 68.8 m -89.81 150.82 22.09 Favored 'General case' 0 C--N 1.367 1.341 0 C-N-CA 126.342 1.857 . . . . 0.0 114.401 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -47.89 -39.84 19.98 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 129.358 3.063 . . . . 0.0 116.694 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.22 -13.18 59.98 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -106.24 8.19 31.81 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 121.111 -0.993 . . . . 0.0 113.519 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -117.27 179.76 3.95 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 126.082 1.753 . . . . 0.0 108.867 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.2 122.77 15.88 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 126.706 2.002 . . . . 0.0 113.8 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.31 -8.25 64.49 Favored Glycine 0 C--N 1.359 1.846 0 C-N-CA 124.909 1.242 . . . . 0.0 111.755 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.69 154.87 34.73 Favored Glycine 0 C--N 1.362 2.019 0 C-N-CA 126.342 1.925 . . . . 0.0 114.944 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -65.97 -42.48 89.82 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 119.57 3.174 . . . . 0.0 119.57 -172.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.49 ' HB3' ' CD2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -101.62 1.72 38.06 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 121.567 1.985 . . . . 0.0 113.41 -178.25 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -81.06 91.88 6.15 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 127.054 2.142 . . . . 0.0 113.337 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 27.6 m -116.48 102.25 9.34 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 100.49 -3.893 . . . . 0.0 100.49 168.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.31 101.94 13.71 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 125.842 2.734 . . . . 0.0 111.661 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -119.45 149.45 47.77 Favored Pre-proline 0 N--CA 1.422 -1.826 1 C-N-CA 132.338 4.255 . . . . 0.0 100.516 171.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.34 -30.14 79.74 Favored 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 126.137 4.558 . . . . 0.0 115.822 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -68.71 -47.49 66.23 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 126.828 2.051 . . . . 0.0 113.258 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.5 mt -67.28 -45.28 86.42 Favored 'Isoleucine or valine' 0 C--N 1.373 1.59 0 C-N-CA 127.363 2.265 . . . . 0.0 111.337 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 177' ' ' GLN 0.424 2.3 pp -68.81 -32.1 71.57 Favored 'General case' 0 C--N 1.372 1.559 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 174.617 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 52.5 tpt85 -66.5 -42.02 88.0 Favored 'General case' 0 C--N 1.379 1.862 0 C-N-CA 127.903 2.481 . . . . 0.0 113.165 172.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.21 -33.86 76.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 131.593 3.957 . . . . 0.0 111.275 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 41.2 mtp -69.95 -32.7 71.09 Favored 'General case' 0 C--N 1.371 1.504 0 C-N-CA 126.824 2.05 . . . . 0.0 112.424 164.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 36.2 mt-30 -72.11 -45.09 61.94 Favored 'General case' 0 C--N 1.383 2.026 0 CA-C-N 121.259 1.845 . . . . 0.0 111.647 174.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -64.78 -50.52 66.44 Favored 'General case' 0 C--N 1.381 1.952 0 C-N-CA 129.443 3.097 . . . . 0.0 111.586 174.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.3 -52.47 61.84 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-O 116.879 -1.534 . . . . 0.0 113.912 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.26 -43.91 71.37 Favored 'General case' 0 C--N 1.383 2.036 0 CA-C-N 121.822 2.101 . . . . 0.0 114.048 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -36.59 84.71 Favored 'General case' 0 C--N 1.366 1.294 0 O-C-N 119.12 -2.238 . . . . 0.0 115.809 172.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 190' ' ' ARG . . . -75.52 -44.65 42.55 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 174.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.559 HD11 ' H ' ' A' ' 153' ' ' GLY 0.259 1.2 tt -58.93 -42.97 91.03 Favored 'General case' 0 C--N 1.358 0.955 1 C-N-CA 132.174 4.19 . . . . 0.0 116.051 176.851 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.278 0.0 OUTLIER -91.56 -7.37 50.43 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.342 1.457 . . . . 0.0 111.068 -177.039 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -119.09 -112.34 0.34 Allowed 'General case' 0 C--N 1.362 1.122 0 O-C-N 121.629 -0.669 . . . . 0.0 111.979 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -127.05 158.27 37.43 Favored 'General case' 0 C--N 1.36 1.059 0 O-C-N 120.337 -1.477 . . . . 0.0 110.667 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 190' ' ' ARG 0.298 24.0 tttm -51.63 -37.01 48.23 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 130.708 3.603 . . . . 0.0 116.774 178.658 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.5 tp -53.7 -29.71 17.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 129.273 3.029 . . . . 0.0 113.526 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.263 6.1 mptt -72.05 -47.92 48.1 Favored 'General case' 0 C--N 1.371 1.542 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 175.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ARG . . . . . 0.442 ' HD2' ' HB1' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -75.37 -37.43 60.62 Favored 'General case' 0 C--N 1.368 1.384 0 CA-C-N 123.168 2.713 . . . . 0.0 115.335 172.433 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.46 -25.2 63.97 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 126.426 1.89 . . . . 0.0 114.552 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -60.99 -38.03 84.56 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.612 2.765 . . . . 0.0 113.542 166.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -85.17 -51.04 6.9 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 126.741 2.017 . . . . 0.0 108.68 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 66.52 -72.14 0.09 Allowed 'General case' 0 C--N 1.365 1.252 0 C-N-CA 127.818 2.447 . . . . 0.0 116.027 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.226 -0.132 0 C-N-CA 129.426 3.09 . . . . 0.0 111.642 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.83 40.51 0.53 Allowed 'General case' 0 C--N 1.36 1.062 0 C-N-CA 126.755 2.022 . . . . 0.0 115.427 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -159.14 80.36 0.76 Allowed 'General case' 0 C--N 1.354 0.77 0 C-N-CA 125.018 1.327 . . . . 0.0 108.462 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -82.36 118.92 23.53 Favored 'General case' 0 C--N 1.362 1.144 0 O-C-N 120.063 -1.648 . . . . 0.0 110.746 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.5 tp 68.84 -87.42 0.03 OUTLIER 'General case' 0 C--N 1.366 1.283 0 C-N-CA 128.073 2.549 . . . . 0.0 111.71 -175.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -121.3 5.15 10.24 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.096 1.358 . . . . 0.0 111.13 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.12 18.99 73.52 Favored Glycine 0 C--N 1.369 2.388 0 N-CA-C 119.776 2.67 . . . . 0.0 119.776 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.05 -84.19 0.35 Allowed Glycine 0 C--N 1.356 1.652 0 C-N-CA 126.242 1.877 . . . . 0.0 111.557 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.7 tp -135.72 -113.82 0.19 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.155 0.982 . . . . 0.0 109.099 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.469 HH22 ' HE ' ' A' ' 121' ' ' ARG . 15.5 ptp180 -72.21 -54.33 9.96 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 -176.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -148.17 29.18 0.89 Allowed 'General case' 0 C--N 1.354 0.775 0 O-C-N 119.866 -1.772 . . . . 0.0 107.245 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 62.9 m 67.64 -59.94 0.4 Allowed 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.823 2.849 . . . . 0.0 116.463 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.81 129.3 36.83 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 129.056 2.942 . . . . 0.0 114.879 -172.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.38 166.88 10.08 Favored Pre-proline 0 C--N 1.351 0.662 0 C-N-CA 128.899 2.879 . . . . 0.0 108.396 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.03 -104.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.806 3.004 . . . . 0.0 111.081 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 177.18 -156.49 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.73 115.18 63.66 Favored Pre-proline 0 C--N 1.355 0.824 0 CA-C-O 117.056 -1.45 . . . . 0.0 110.547 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -88.98 161.53 5.94 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.63 2.886 . . . . 0.0 115.385 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 t -146.93 23.46 1.21 Allowed 'General case' 0 C--N 1.356 0.852 0 N-CA-C 104.038 -2.578 . . . . 0.0 104.038 168.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 t -154.3 142.1 20.04 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.463 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 36.8 m 66.52 89.58 0.1 Allowed 'General case' 0 C--N 1.356 0.88 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -139.21 94.82 2.84 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 121.071 -1.018 . . . . 0.0 113.725 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.51 126.26 45.56 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 121.25 -0.906 . . . . 0.0 109.113 -174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.4 p -111.09 165.82 11.97 Favored Pre-proline 0 C--N 1.364 1.212 0 C-N-CA 127.671 2.388 . . . . 0.0 114.243 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -56.21 139.66 86.24 Favored 'Trans proline' 0 C--N 1.365 1.425 1 C-N-CA 125.622 4.215 . . . . 0.0 120.867 -167.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.4 -24.54 9.75 Favored Glycine 0 C--N 1.361 1.955 0 C-N-CA 128.287 2.851 . . . . 0.0 110.885 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.43 170.21 12.18 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 119.895 1.847 . . . . 0.0 114.251 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.2 mm? -98.28 141.92 30.58 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 103.212 -2.885 . . . . 0.0 103.212 164.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 149' ' ' LYS . 19.3 m -143.77 141.46 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -175.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.451 ' CZ3' ' HB2' ' A' ' 165' ' ' PHE . 28.0 m95 -99.02 129.85 45.32 Favored 'General case' 0 C--O 1.214 -0.787 1 O-C-N 115.97 -4.206 . . . . 0.0 103.455 171.396 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -114.48 147.33 39.5 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 121.087 1.767 . . . . 0.0 109.494 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -118.71 145.83 45.21 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 37.1 ttm -126.69 154.77 43.64 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 123.233 1.492 . . . . 0.0 111.296 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.73 80.7 0.01 OUTLIER 'General case' 0 C--N 1.355 0.847 0 C-N-CA 131.669 3.988 . . . . 0.0 115.838 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.57 7.09 37.47 Favored Glycine 0 C--N 1.359 1.808 0 C-N-CA 125.504 1.526 . . . . 0.0 113.519 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -114.91 160.32 34.09 Favored Pre-proline 0 C--N 1.356 0.875 0 C-N-CA 125.65 1.58 . . . . 0.0 107.591 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -71.79 166.07 30.61 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.952 3.768 . . . . 0.0 113.422 168.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -49.35 129.49 18.61 Favored 'General case' 0 C--N 1.364 1.203 0 C-N-CA 128.356 2.662 . . . . 0.0 117.147 167.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.463 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 7.4 m95 -134.21 109.0 11.47 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 121.586 3.921 . . . . 0.0 121.586 -173.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 19.2 Cg_endo -62.22 110.83 1.11 Allowed 'Trans proline' 0 C--N 1.389 2.679 1 C-N-CA 126.663 4.909 . . . . 0.0 112.743 167.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -123.01 164.98 17.53 Favored 'General case' 0 C--N 1.352 0.677 1 C-N-CA 133.286 4.634 . . . . 0.0 116.022 -170.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp -116.46 132.54 56.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 129.447 3.099 . . . . 0.0 107.254 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -86.16 118.85 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 O-C-N 119.913 -1.742 . . . . 0.0 106.537 174.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -127.36 149.78 49.9 Favored 'General case' 0 C--N 1.368 1.391 0 O-C-N 119.002 -2.311 . . . . 0.0 111.059 -170.139 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -102.0 113.49 26.77 Favored 'General case' 0 C--N 1.37 1.471 0 CA-C-O 122.489 1.138 . . . . 0.0 111.511 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -79.49 158.81 73.28 Favored Pre-proline 0 C--N 1.353 0.738 0 C-N-CA 129.367 3.067 . . . . 0.0 112.592 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.28 71.4 Cg_exo -47.66 1.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.371 1 C-N-CA 130.356 7.37 . . . . 0.0 121.498 -171.515 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -98.89 31.65 2.9 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 131.588 3.955 . . . . 0.0 106.646 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.289 0.0 OUTLIER -68.7 150.81 47.49 Favored 'General case' 0 C--N 1.373 1.621 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -169.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.69 -20.11 27.59 Favored Glycine 0 C--N 1.365 2.158 0 C-N-CA 126.922 2.201 . . . . 0.0 112.552 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.7 m -130.44 147.0 52.09 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 101.269 -3.604 . . . . 0.0 101.269 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.405 ' HB2' ' NE2' ' A' ' 130' ' ' HIS . 7.3 p90 -130.7 -0.73 4.31 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-N 121.111 1.778 . . . . 0.0 114.882 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.7 pt -106.48 148.0 11.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.475 0 CA-C-O 123.904 1.812 . . . . 0.0 113.734 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.469 ' HE ' HH22 ' A' ' 77' ' ' ARG . 29.8 tpt180 -119.01 126.58 52.06 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 102.229 -3.248 . . . . 0.0 102.229 172.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -148.16 143.79 27.32 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 120.191 -1.568 . . . . 0.0 110.295 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.54 93.74 4.22 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 127.51 2.324 . . . . 0.0 108.821 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.19 -76.03 0.34 Allowed Glycine 0 C--N 1.365 2.19 0 N-CA-C 119.891 2.716 . . . . 0.0 119.891 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -149.01 60.38 1.05 Allowed 'General case' 0 C--N 1.358 0.959 0 CA-C-O 124.014 1.864 . . . . 0.0 109.055 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.7 m -169.59 133.8 1.34 Allowed 'General case' 0 C--N 1.349 0.566 0 C-N-CA 127.551 2.341 . . . . 0.0 105.48 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.94 146.82 31.07 Favored 'Isoleucine or valine' 0 C--N 1.363 1.186 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -134.35 142.77 47.34 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 129.173 2.989 . . . . 0.0 107.264 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.3 162.21 26.14 Favored 'Isoleucine or valine' 0 C--N 1.368 1.387 0 C-N-CA 127.301 2.24 . . . . 0.0 107.897 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 111' ' ' TYR . 0.4 OUTLIER -94.0 133.4 37.49 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 119.576 -1.953 . . . . 0.0 111.031 175.123 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.91 172.97 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.38 158.09 38.22 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 166.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -113.86 130.75 56.45 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -75.11 71.93 2.19 Favored 'General case' 0 C--N 1.372 1.578 0 C-N-CA 126.759 2.023 . . . . 0.0 109.876 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -95.7 -102.92 0.16 Allowed 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.042 1.337 . . . . 0.0 111.132 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -106.72 -62.69 1.36 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 126.216 1.807 . . . . 0.0 113.867 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 p -85.65 -32.61 0.46 Allowed Pre-proline 0 C--N 1.364 1.204 0 N-CA-C 119.374 3.102 . . . . 0.0 119.374 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -84.86 -176.1 14.16 Favored 'Cis proline' 0 CA--C 1.544 0.989 1 CA-C-N 130.358 4.735 . . . . 0.0 112.727 -0.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.315 4.6 t -97.53 154.86 17.24 Favored 'General case' 0 C--N 1.372 1.57 0 C-N-CA 127.216 2.206 . . . . 0.0 113.051 171.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.79 152.47 41.27 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.946 1.698 . . . . 0.0 106.58 171.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.43 -175.47 39.84 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -93.01 117.87 30.54 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 125.189 1.396 . . . . 0.0 108.059 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.2 161.98 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 C-N-CA 125.603 1.561 . . . . 0.0 113.334 -173.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.6 m -76.68 97.63 4.51 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 126.541 1.936 . . . . 0.0 107.18 171.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.511 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 35.1 tttp -54.62 -29.05 50.89 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 128.283 2.633 . . . . 0.0 115.878 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 60.7 ttt180 -70.42 -13.37 62.1 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 127.105 2.162 . . . . 0.0 114.098 173.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.8 mt -98.12 3.84 49.14 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 126.982 2.113 . . . . 0.0 111.784 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 23.4 mt -89.86 135.01 33.89 Favored 'General case' 0 C--N 1.37 1.47 0 C-N-CA 126.661 1.984 . . . . 0.0 111.221 173.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 71.0 mmtt -114.65 158.75 39.45 Favored Pre-proline 0 C--N 1.346 0.448 0 C-N-CA 127.703 2.401 . . . . 0.0 106.279 -177.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.55 158.23 14.42 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 124.814 3.676 . . . . 0.0 118.563 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -44.09 92.35 0.01 OUTLIER 'General case' 0 C--N 1.357 0.906 1 C-N-CA 132.949 4.5 . . . . 0.0 119.975 171.85 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.4 t -162.28 167.77 23.37 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 102.517 -3.142 . . . . 0.0 102.517 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.74 -157.96 7.58 Favored Glycine 0 C--N 1.365 2.172 0 N-CA-C 119.776 2.67 . . . . 0.0 119.776 -165.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.3 t -45.41 -11.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 1 N-CA-C 122.066 4.099 . . . . 0.0 122.066 -165.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -107.4 -10.01 15.86 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 129.322 3.049 . . . . 0.0 112.709 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 59.8 m -81.88 138.88 34.96 Favored 'General case' 0 C--N 1.376 1.728 0 C-N-CA 127.736 2.415 . . . . 0.0 111.085 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.251 33.1 ttmt -52.22 -33.49 41.43 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -86.71 -0.94 57.25 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 119.318 0.963 . . . . 0.0 112.963 171.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.89 3.25 10.0 Favored 'General case' 0 C--N 1.371 1.53 0 CA-C-N 120.25 1.387 . . . . 0.0 113.444 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.251 7.0 tm0? -109.9 179.72 4.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.134 2.974 . . . . 0.0 107.331 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -70.74 122.47 19.9 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 120.141 -1.599 . . . . 0.0 113.175 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.37 -5.27 55.1 Favored Glycine 0 C--N 1.363 2.047 0 O-C-N 120.961 -1.087 . . . . 0.0 111.757 -170.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.89 152.22 25.77 Favored Glycine 0 C--N 1.361 1.928 0 C-N-CA 128.648 3.023 . . . . 0.0 114.211 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -62.64 -41.7 99.18 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.451 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-85 -85.48 -7.54 58.85 Favored 'General case' 0 CA--C 1.556 1.174 0 O-C-N 120.269 -1.519 . . . . 0.0 113.57 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -77.92 95.35 4.75 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 128.811 2.844 . . . . 0.0 114.839 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 40.7 t -114.77 128.22 56.18 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 102.461 -3.163 . . . . 0.0 102.461 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -100.76 100.26 10.9 Favored 'General case' 0 C--N 1.362 1.125 0 CA-C-O 125.613 2.625 . . . . 0.0 109.229 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -121.62 138.25 28.16 Favored Pre-proline 0 N--CA 1.421 -1.897 2 C-N-CA 135.988 5.715 . . . . 0.0 98.211 166.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.96 -26.41 66.59 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 125.073 3.848 . . . . 0.0 114.144 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -66.73 -36.65 82.96 Favored 'General case' 0 C--N 1.369 1.428 0 C-N-CA 129.012 2.925 . . . . 0.0 112.633 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 65.3 mt -73.41 -45.99 50.57 Favored 'Isoleucine or valine' 0 C--N 1.374 1.651 0 C-N-CA 126.018 1.727 . . . . 0.0 110.417 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.12 -45.9 89.84 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 125.207 1.403 . . . . 0.0 113.535 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -62.42 -35.53 79.54 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.67 77.25 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 129.673 3.189 . . . . 0.0 110.795 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.71 -38.99 87.85 Favored 'General case' 0 C--N 1.382 2.017 0 C-N-CA 125.197 1.399 . . . . 0.0 111.597 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -74.07 -42.14 60.63 Favored 'General case' 0 C--N 1.374 1.655 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -48.06 64.71 Favored 'General case' 0 C--N 1.371 1.533 0 C-N-CA 130.671 3.589 . . . . 0.0 111.83 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.03 99.08 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 124.592 1.157 . . . . 0.0 113.491 169.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.2 -52.49 63.58 Favored 'General case' 0 C--N 1.375 1.715 0 C-N-CA 126.006 1.722 . . . . 0.0 111.66 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.35 -37.58 67.66 Favored 'General case' 0 C--N 1.372 1.544 0 CA-C-N 121.139 1.79 . . . . 0.0 115.8 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.18 -44.82 36.29 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 116.029 1.862 . . . . 0.0 116.029 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -31.03 67.16 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.21 -10.53 49.52 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 126.535 1.934 . . . . 0.0 110.608 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -123.43 -100.79 0.41 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 125.436 1.494 . . . . 0.0 112.176 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -135.57 158.0 45.47 Favored 'General case' 0 C--N 1.363 1.194 0 O-C-N 120.26 -1.525 . . . . 0.0 113.846 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -50.98 -37.34 44.19 Favored 'General case' 0 C--N 1.369 1.421 1 C-N-CA 132.389 4.276 . . . . 0.0 115.758 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.3 tt -55.23 -33.77 31.41 Favored 'Isoleucine or valine' 0 C--N 1.359 1.012 0 C-N-CA 129.925 3.29 . . . . 0.0 113.238 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -71.07 -45.29 64.05 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 125.829 1.651 . . . . 0.0 115.037 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -74.87 -42.45 57.86 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 174.408 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.292 96.2 mt -73.93 -19.39 60.7 Favored 'General case' 0 C--N 1.371 1.507 0 O-C-N 120.432 -1.417 . . . . 0.0 114.037 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -58.4 -32.06 68.26 Favored 'General case' 0 C--N 1.377 1.803 0 C-N-CA 126.769 2.027 . . . . 0.0 114.155 168.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.28 -51.55 3.95 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 127.053 2.141 . . . . 0.0 108.874 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 42.97 -95.11 0.02 OUTLIER 'General case' 0 C--N 1.38 1.913 0 C-N-CA 130.145 3.378 . . . . 0.0 114.427 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.377 2.5 p -160.74 58.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 100.811 -3.774 . . . . 0.0 100.811 162.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.4 t -99.26 48.71 0.95 Allowed 'General case' 0 C--N 1.367 1.327 0 C-N-CA 127.618 2.367 . . . . 0.0 112.233 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.81 -55.56 5.69 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 126.617 1.967 . . . . 0.0 114.808 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -150.97 140.31 13.67 Favored Pre-proline 0 C--N 1.35 0.593 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.12 65.15 7.87 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 124.212 3.274 . . . . 0.0 113.753 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 15.2 m -98.24 10.65 40.13 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 127.805 2.442 . . . . 0.0 111.154 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.282 10.8 pt-20 . . . . . 0 C--N 1.365 1.242 0 C-N-CA 130.804 3.641 . . . . 0.0 118.715 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt . . . . . 0 N--CA 1.441 -0.886 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.59 -44.0 3.96 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 126.394 1.878 . . . . 0.0 110.437 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -161.71 179.72 7.91 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -103.26 129.93 50.37 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.87 2.468 . . . . 0.0 106.986 171.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.5 pt? -95.91 -35.31 11.5 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 -174.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -104.33 -12.77 16.41 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 119.795 -1.816 . . . . 0.0 114.225 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 -4.23 61.35 Favored Glycine 0 C--N 1.353 1.511 0 C-N-CA 125.668 1.604 . . . . 0.0 115.155 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.36 151.44 20.38 Favored Glycine 0 C--N 1.36 1.881 0 C-N-CA 125.441 1.496 . . . . 0.0 114.405 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.31 21.56 7.93 Favored 'General case' 0 C--N 1.366 1.296 0 CA-C-O 122.736 1.255 . . . . 0.0 113.568 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -72.17 -24.39 61.42 Favored 'General case' 0 C--N 1.363 1.191 0 C-N-CA 127.912 2.485 . . . . 0.0 113.247 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 143.19 -60.13 0.0 OUTLIER 'General case' 0 C--N 1.353 0.724 1 C-N-CA 133.569 4.748 . . . . 0.0 100.865 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.265 76.6 p 83.71 2.74 0.92 Allowed 'General case' 0 C--N 1.362 1.128 0 C-N-CA 129.527 3.131 . . . . 0.0 113.388 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.357 21.2 t 92.53 -11.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.055 0 C-N-CA 129.887 3.275 . . . . 0.0 109.807 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.71 166.74 21.14 Favored Pre-proline 0 C--N 1.362 1.146 0 C-N-CA 126.933 2.093 . . . . 0.0 111.602 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -69.44 112.75 3.11 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 124.411 3.407 . . . . 0.0 115.486 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -114.6 -86.52 0.59 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 127.321 2.248 . . . . 0.0 108.828 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.13 111.77 64.27 Favored Pre-proline 0 C--N 1.361 1.08 0 C-N-CA 124.997 1.319 . . . . 0.0 111.438 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -90.13 37.98 0.36 Allowed 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.656 2.904 . . . . 0.0 112.474 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.3 m -69.59 67.8 0.23 Allowed 'General case' 0 C--N 1.363 1.189 0 C-N-CA 128.901 2.88 . . . . 0.0 114.878 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 m 115.02 29.55 0.0 OUTLIER 'General case' 0 C--N 1.354 0.791 0 C-N-CA 130.878 3.671 . . . . 0.0 108.634 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.417 ' HB2' ' HA ' ' A' ' 146' ' ' ARG 0.412 37.5 m 79.03 -73.43 0.07 Allowed 'General case' 0 C--N 1.362 1.132 0 C-N-CA 128.42 2.688 . . . . 0.0 111.045 -176.557 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 66.96 60.15 0.53 Allowed 'General case' 0 C--N 1.359 1.003 0 N-CA-C 120.396 3.48 . . . . 0.0 120.396 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -117.38 125.97 51.88 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 119.878 -1.764 . . . . 0.0 110.16 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.474 28.7 p -111.72 168.43 7.64 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 128.624 2.77 . . . . 0.0 115.55 -172.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 73.1 Cg_endo -71.25 151.63 60.69 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 124.434 3.423 . . . . 0.0 118.863 -164.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.77 -7.29 81.64 Favored Glycine 0 C--N 1.37 2.447 0 C-N-CA 128.875 3.131 . . . . 0.0 111.109 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -94.0 164.02 13.25 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 126.246 1.818 . . . . 0.0 110.493 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.74 140.26 37.24 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 119.098 -2.251 . . . . 0.0 107.249 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 m -133.51 153.37 36.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 C-N-CA 125.766 1.626 . . . . 0.0 108.979 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -102.84 116.76 33.19 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 101.422 -3.547 . . . . 0.0 101.422 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -115.12 142.51 46.56 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.727 1.211 . . . . 0.0 113.997 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -116.15 132.93 56.52 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 33.2 ttm -115.98 139.05 50.64 Favored 'General case' 0 CA--C 1.509 -0.629 0 O-C-N 120.099 -1.625 . . . . 0.0 107.267 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.65 100.35 0.1 Allowed 'General case' 0 C--N 1.366 1.324 0 C-N-CA 127.379 2.272 . . . . 0.0 114.07 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.56 -22.15 22.55 Favored Glycine 0 C--N 1.358 1.761 0 C-N-CA 125.367 1.461 . . . . 0.0 113.624 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -97.99 166.81 12.76 Favored Pre-proline 0 C--N 1.361 1.088 0 O-C-N 121.036 -1.273 . . . . 0.0 109.823 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.68 166.18 30.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.803 3.669 . . . . 0.0 113.34 169.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.657 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 5.0 m95 -58.17 135.27 57.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.798 2.839 . . . . 0.0 115.309 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.438 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 24.0 m95 -133.65 114.77 13.3 Favored Pre-proline 0 C--N 1.367 1.354 1 N-CA-C 121.844 4.016 . . . . 0.0 121.844 -174.554 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -64.91 124.96 13.87 Favored 'Trans proline' 0 C--N 1.391 2.772 1 C-N-CA 125.965 4.444 . . . . 0.0 110.542 160.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 p -147.25 165.15 30.95 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 128.29 2.636 . . . . 0.0 115.017 -156.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.613 HD22 ' HB2' ' A' ' 190' ' ' ARG . 3.7 pp -119.45 144.3 47.03 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 125.749 1.619 . . . . 0.0 108.626 173.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.9 t -85.59 116.52 28.92 Favored 'Isoleucine or valine' 0 C--N 1.377 1.796 0 O-C-N 120.174 -1.579 . . . . 0.0 108.059 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -121.56 136.27 54.96 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 116.92 -3.612 . . . . 0.0 114.87 -164.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -75.99 111.36 11.29 Favored 'General case' 0 C--N 1.38 1.908 0 CA-C-O 123.762 1.744 . . . . 0.0 112.654 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.473 ' CG ' ' CD2' ' A' ' 130' ' ' HIS . 10.3 t60 -67.18 161.18 66.04 Favored Pre-proline 0 C--N 1.343 0.285 1 C-N-CA 132.903 4.481 . . . . 0.0 117.641 -170.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.23 -14.05 3.8 Favored 'Trans proline' 0 CA--C 1.554 1.52 1 C-N-CA 125.542 4.161 . . . . 0.0 116.398 174.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -104.69 40.01 1.57 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 129.72 3.208 . . . . 0.0 109.633 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -67.58 151.47 47.27 Favored 'General case' 0 C--N 1.372 1.566 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.74 -11.92 32.51 Favored Glycine 0 C--N 1.358 1.768 0 CA-C-N 112.396 -2.184 . . . . 0.0 110.369 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 t -125.61 166.57 16.47 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 101.855 -3.387 . . . . 0.0 101.855 167.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -154.72 -25.63 0.12 Allowed 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.581 -1.324 . . . . 0.0 114.194 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.0 pt -114.38 154.54 15.73 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 O-C-N 120.491 -1.38 . . . . 0.0 112.086 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -142.92 152.84 42.48 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 128.338 2.655 . . . . 0.0 105.027 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.31 127.99 19.2 Favored 'General case' 0 C--N 1.361 1.089 0 O-C-N 120.793 -1.192 . . . . 0.0 110.424 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -117.94 93.04 3.99 Favored 'General case' 0 C--N 1.363 1.17 0 C-N-CA 127.407 2.283 . . . . 0.0 110.135 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.11 -63.96 0.01 OUTLIER Glycine 0 C--N 1.362 2.006 0 N-CA-C 122.056 3.582 . . . . 0.0 122.056 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -146.62 38.34 1.02 Allowed 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.965 1.306 . . . . 0.0 111.724 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 m -167.63 139.67 3.15 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 119.847 -1.783 . . . . 0.0 106.498 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.66 132.97 70.59 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 CA-C-O 123.505 1.621 . . . . 0.0 109.959 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -106.83 158.94 16.62 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 127.938 2.495 . . . . 0.0 113.481 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 145' ' ' LYS . 33.8 m -149.09 164.66 4.09 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 C-N-CA 130.707 3.603 . . . . 0.0 102.755 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.473 ' CD2' ' CG ' ' A' ' 113' ' ' HIS . 6.2 m80 -89.94 141.82 28.29 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 121.19 -0.944 . . . . 0.0 112.248 170.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 m -151.1 169.81 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -133.53 152.91 51.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -109.43 132.26 54.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.518 1.927 . . . . 0.0 108.335 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.511 ' HB3' HH21 ' A' ' 178' ' ' ARG . 29.3 m-85 -68.54 63.77 0.11 Allowed 'General case' 0 C--N 1.371 1.503 0 C-N-CA 127.066 2.147 . . . . 0.0 114.256 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.91 -118.22 0.08 Allowed 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.451 2.3 . . . . 0.0 111.913 -174.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -106.85 -58.52 1.92 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.669 1.587 . . . . 0.0 112.807 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.298 27.5 p -77.18 -34.03 1.16 Allowed Pre-proline 0 C--N 1.364 1.209 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.35 -169.5 7.75 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 CA-C-N 127.683 3.779 . . . . 0.0 111.616 -1.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.3 m -95.17 135.08 37.17 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.814 1.246 . . . . 0.0 107.753 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.9 tmm_? -158.1 167.92 28.52 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.06 -148.74 17.04 Favored Glycine 0 C--N 1.352 1.417 1 N-CA-C 101.239 -4.744 . . . . 0.0 101.239 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -89.58 156.78 18.38 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 167.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.4 -177.68 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 O-C-N 120.636 -1.29 . . . . 0.0 107.712 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.6 t -90.8 120.07 31.54 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 101.864 -3.384 . . . . 0.0 101.864 167.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.69 ' HB2' HG22 ' A' ' 129' ' ' VAL 0.492 0.0 OUTLIER -78.53 -10.94 59.91 Favored 'General case' 0 C--N 1.373 1.603 0 CA-C-N 123.113 2.688 . . . . 0.0 115.685 -174.396 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.417 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 96.2 mtt180 -74.84 -5.53 44.06 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.01 1.324 . . . . 0.0 113.814 172.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.93 2.17 32.16 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 127.102 2.161 . . . . 0.0 112.173 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 43.0 mt -96.89 125.69 41.51 Favored 'General case' 0 C--N 1.368 1.376 0 C-N-CA 127.389 2.276 . . . . 0.0 109.956 174.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -114.7 167.74 9.22 Favored Pre-proline 0 C--N 1.347 0.493 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.0 157.09 15.31 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.306 3.337 . . . . 0.0 113.991 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.64 150.57 20.21 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 123.426 1.584 . . . . 0.0 107.89 170.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.8 t -173.08 -45.58 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.835 1 N-CA-C 97.26 -5.089 . . . . 0.0 97.26 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 128.35 -149.76 18.33 Favored Glycine 0 CA--C 1.474 -2.471 0 C-N-CA 117.892 -2.099 . . . . 0.0 116.865 135.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.9 m -46.5 -18.78 0.07 Allowed 'General case' 0 C--N 1.375 1.68 1 C-N-CA 133.027 4.531 . . . . 0.0 116.67 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 0.94 54.92 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 129.881 3.272 . . . . 0.0 112.582 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.9 m -86.51 142.56 28.26 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 127.529 2.331 . . . . 0.0 111.409 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -61.69 -27.45 68.71 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -79.7 -17.08 54.45 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 124.935 1.294 . . . . 0.0 111.372 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.27 4.21 51.01 Favored 'General case' 0 C--N 1.371 1.515 0 C-N-CA 124.813 1.245 . . . . 0.0 113.017 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -123.74 177.34 5.76 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 120.048 -1.657 . . . . 0.0 111.228 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -57.97 121.84 11.55 Favored 'General case' 0 C--N 1.372 1.576 0 C-N-CA 126.483 1.913 . . . . 0.0 114.598 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.32 -14.52 59.52 Favored Glycine 0 C--N 1.356 1.671 0 C-N-CA 125.174 1.369 . . . . 0.0 112.299 -169.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.6 153.64 40.91 Favored Glycine 0 C--N 1.361 1.941 0 N-CA-C 119.857 2.703 . . . . 0.0 119.857 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -55.86 -42.21 75.51 Favored 'General case' 0 C--N 1.363 1.169 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.657 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.308 0.5 OUTLIER -106.01 -12.16 15.9 Favored 'General case' 0 C--N 1.358 0.951 0 O-C-N 120.638 -1.289 . . . . 0.0 113.619 -179.796 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . 0.301 0.0 OUTLIER -41.68 -27.86 0.12 Allowed 'General case' 0 C--N 1.365 1.248 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.2 m -14.53 90.94 0.01 OUTLIER 'General case' 0 C--N 1.381 1.962 1 C-N-CA 131.901 4.08 . . . . 0.0 116.917 -174.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.35 102.11 13.71 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-O 125.653 2.644 . . . . 0.0 115.045 -163.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -119.96 144.53 37.71 Favored Pre-proline 0 N--CA 1.416 -2.163 3 C-N-CA 134.909 5.284 . . . . 0.0 100.184 170.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -60.31 -28.95 87.85 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 125.014 3.809 . . . . 0.0 115.487 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -65.72 -36.4 83.49 Favored 'General case' 0 C--N 1.365 1.272 0 C-N-CA 128.806 2.842 . . . . 0.0 112.303 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.438 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 20.4 mm -72.39 -37.73 58.74 Favored 'Isoleucine or valine' 0 C--N 1.374 1.631 0 C-N-CA 126.487 1.915 . . . . 0.0 110.237 175.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.73 -49.38 59.23 Favored 'General case' 0 C--N 1.371 1.502 0 O-C-N 120.324 -1.485 . . . . 0.0 113.646 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -58.43 -39.3 79.44 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 127.391 2.276 . . . . 0.0 114.22 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.0 -37.34 84.02 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 131.41 3.884 . . . . 0.0 110.421 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.4 mtt -66.91 -33.03 74.69 Favored 'General case' 0 C--N 1.366 1.284 0 O-C-N 120.609 -1.307 . . . . 0.0 113.024 167.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.43 -46.86 37.22 Favored 'General case' 0 C--N 1.378 1.83 0 C-N-CA 126.527 1.931 . . . . 0.0 112.577 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.511 HH21 ' HB3' ' A' ' 134' ' ' PHE . 22.4 ttp-105 -66.31 -50.56 63.21 Favored 'General case' 0 C--N 1.372 1.57 0 C-N-CA 129.564 3.145 . . . . 0.0 112.322 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.96 69.61 Favored 'General case' 0 C--N 1.375 1.692 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 167.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -68.64 -50.87 47.86 Favored 'General case' 0 C--N 1.371 1.53 0 O-C-N 120.491 -1.381 . . . . 0.0 111.751 173.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -40.36 83.15 Favored 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.363 1.865 . . . . 0.0 115.537 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.589 ' HB1' ' HG2' ' A' ' 190' ' ' ARG . . . -76.06 -27.25 57.18 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.423 HD13 ' N ' ' A' ' 184' ' ' ASN . 0.2 OUTLIER -78.94 -50.17 11.61 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.899 1.679 . . . . 0.0 111.177 173.236 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.423 ' N ' HD13 ' A' ' 183' ' ' LEU 0.322 0.0 OUTLIER -82.99 -15.71 50.13 Favored 'General case' 0 C--N 1.367 1.355 0 C-N-CA 126.615 1.966 . . . . 0.0 115.176 -169.222 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -110.64 -98.7 0.4 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -136.28 149.32 48.4 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 124.111 0.964 . . . . 0.0 109.936 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -50.73 -34.64 27.77 Favored 'General case' 0 C--N 1.365 1.27 1 C-N-CA 133.668 4.787 . . . . 0.0 112.282 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 6.4 tt -52.24 -30.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.365 1.278 0 C-N-CA 128.855 2.862 . . . . 0.0 112.758 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.273 6.5 mptt -68.39 -43.17 77.91 Favored 'General case' 0 C--N 1.376 1.729 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 172.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.613 ' HB2' HD22 ' A' ' 109' ' ' LEU 0.265 1.2 ptm180 -76.51 -43.62 38.67 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 119.043 2.979 . . . . 0.0 119.043 170.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.453 HD12 HH21 ' A' ' 190' ' ' ARG . 12.3 tp -71.65 -27.62 63.2 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 127.38 2.272 . . . . 0.0 113.545 -174.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -81.46 -4.46 55.92 Favored 'General case' 0 C--N 1.366 1.298 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 170.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.58 -44.69 5.5 Favored 'General case' 0 C--N 1.366 1.324 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 58.97 -114.34 0.73 Allowed 'General case' 0 C--N 1.372 1.545 0 C-N-CA 127.309 2.243 . . . . 0.0 113.119 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.45 27.93 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 126.45 1.9 . . . . 0.0 110.448 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 5.1 t 70.74 8.13 6.45 Favored 'General case' 0 C--N 1.37 1.459 0 C-N-CA 128.219 2.607 . . . . 0.0 115.027 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 10.5 t70 91.23 16.38 0.03 OUTLIER 'General case' 0 C--N 1.359 0.986 0 C-N-CA 130.828 3.651 . . . . 0.0 111.967 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.52 125.09 59.03 Favored Pre-proline 0 C--N 1.37 1.474 0 O-C-N 120.11 -1.618 . . . . 0.0 113.506 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -85.62 144.91 9.02 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.853 3.036 . . . . 0.0 109.45 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 81.6 p -84.4 70.98 10.73 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 125.798 1.639 . . . . 0.0 113.749 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 . . . . . 0 C--N 1.356 0.883 0 C-N-CA 126.177 1.791 . . . . 0.0 110.177 -178.235 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? . . . . . 0 N--CA 1.441 -0.876 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.25 166.36 25.53 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 126.119 1.768 . . . . 0.0 106.988 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -152.22 165.3 35.27 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -103.67 152.69 21.5 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 127.121 2.169 . . . . 0.0 108.697 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.317 15.7 mt 77.51 176.8 0.17 Allowed 'General case' 0 C--N 1.364 1.215 0 C-N-CA 127.653 2.381 . . . . 0.0 116.722 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.0 21.35 17.69 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 126.713 2.005 . . . . 0.0 111.43 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.92 -16.67 58.21 Favored Glycine 0 C--N 1.361 1.948 0 C-N-CA 126.438 1.97 . . . . 0.0 114.423 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.97 11.05 44.28 Favored Glycine 0 C--N 1.356 1.68 0 C-N-CA 126.838 2.161 . . . . 0.0 110.856 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.24 65.77 1.63 Allowed 'General case' 0 C--N 1.356 0.86 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -71.61 -24.16 61.83 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 130.189 3.396 . . . . 0.0 112.365 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.5 tpt85 -92.32 -0.1 57.41 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 128.267 2.627 . . . . 0.0 110.211 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.1 t 66.77 -102.35 0.07 Allowed 'General case' 0 C--N 1.365 1.241 0 C-N-CA 129.665 3.186 . . . . 0.0 114.832 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.8 m -112.95 10.66 8.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 126.175 1.79 . . . . 0.0 110.518 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.11 140.05 20.88 Favored Pre-proline 0 C--N 1.358 0.976 0 O-C-N 120.518 -1.364 . . . . 0.0 110.854 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.7 -69.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 124.236 3.291 . . . . 0.0 110.823 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -147.73 -56.23 0.23 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 124.803 1.241 . . . . 0.0 107.809 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.48 111.78 64.83 Favored Pre-proline 0 C--N 1.361 1.108 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -89.73 53.61 1.5 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.842 3.028 . . . . 0.0 111.52 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.9 m -103.27 127.68 50.53 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 126.204 1.802 . . . . 0.0 109.083 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 m -93.27 53.38 1.92 Allowed 'General case' 0 C--N 1.362 1.114 0 O-C-N 120.046 -1.658 . . . . 0.0 112.226 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.11 72.0 8.33 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 129.629 3.172 . . . . 0.0 110.032 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -118.01 92.79 3.92 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.646 2.379 . . . . 0.0 112.638 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.411 ' H ' ' HD2' ' A' ' 145' ' ' LYS . 5.2 m-85 -125.19 127.25 46.5 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.361 1.464 . . . . 0.0 112.346 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.39 57.8 p -111.72 167.94 8.36 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 119.731 -1.855 . . . . 0.0 113.771 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.4 ' HA ' ' HB ' ' A' ' 110' ' ' VAL . 89.3 Cg_exo -57.63 153.07 44.52 Favored 'Trans proline' 0 C--N 1.373 1.84 1 C-N-CA 126.565 4.843 . . . . 0.0 120.821 -174.131 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.82 -41.87 2.06 Favored Glycine 0 C--N 1.377 2.823 0 C-N-CA 127.483 2.468 . . . . 0.0 107.02 -165.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -73.84 159.57 32.67 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.511 HD13 ' HE ' ' A' ' 190' ' ' ARG . 0.1 OUTLIER -105.51 142.56 35.05 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.155 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.814 HG21 HD13 ' A' ' 148' ' ' LEU . 17.7 m -142.82 151.73 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.452 ' CE3' ' HG3' ' A' ' 107' ' ' PRO . 41.0 m95 -99.92 121.1 40.82 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 168.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.469 ' CB ' HD22 ' A' ' 148' ' ' LEU . . . -102.11 152.27 21.19 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 121.125 1.784 . . . . 0.0 112.345 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -116.9 131.9 56.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 102.398 -3.186 . . . . 0.0 102.398 169.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 34.8 ttm -118.47 138.38 52.53 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.31 101.66 0.45 Allowed 'General case' 0 C--N 1.369 1.424 0 C-N-CA 125.789 1.635 . . . . 0.0 113.816 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.19 -6.0 25.21 Favored Glycine 0 C--N 1.36 1.895 0 C-N-CA 125.667 1.604 . . . . 0.0 113.206 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.24 164.3 15.14 Favored Pre-proline 0 C--N 1.354 0.797 0 C-N-CA 125.779 1.632 . . . . 0.0 109.524 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.05 166.1 30.64 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 124.274 3.316 . . . . 0.0 112.774 162.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -57.84 123.3 15.28 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 129.061 2.944 . . . . 0.0 114.44 171.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -134.15 116.1 13.17 Favored Pre-proline 0 CA--C 1.563 1.476 1 N-CA-C 123.75 4.722 . . . . 0.0 123.75 -168.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HG3' ' CE3' ' A' ' 97' ' ' TRP . 53.8 Cg_exo -54.84 110.38 0.53 Allowed 'Trans proline' 0 C--N 1.396 3.056 1 C-N-CA 127.635 5.556 . . . . 0.0 114.898 164.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.5 p -125.72 164.04 21.5 Favored 'General case' 0 CA--C 1.536 0.431 1 C-N-CA 132.342 4.257 . . . . 0.0 115.901 -169.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.522 HD13 ' HG3' ' A' ' 190' ' ' ARG . 5.7 tp -115.8 138.25 51.32 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 118.65 -2.532 . . . . 0.0 108.257 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 92' ' ' PRO . 2.1 t -81.0 118.93 29.65 Favored 'Isoleucine or valine' 0 C--N 1.37 1.476 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -115.8 154.58 29.39 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.03 -1.669 . . . . 0.0 115.36 -163.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -111.67 113.68 26.22 Favored 'General case' 0 C--N 1.372 1.545 0 C-N-CA 125.767 1.627 . . . . 0.0 108.812 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.418 ' H ' ' CD2' ' A' ' 130' ' ' HIS . 1.5 m-70 -69.08 160.94 76.26 Favored Pre-proline 0 C--N 1.363 1.188 0 C-N-CA 130.994 3.717 . . . . 0.0 110.191 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.67 0.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.5 1 C-N-CA 128.071 5.847 . . . . 0.0 119.226 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -99.57 34.96 2.08 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 130.542 3.537 . . . . 0.0 105.865 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.322 0.0 OUTLIER -61.35 120.86 11.26 Favored 'General case' 0 C--N 1.382 1.993 0 C-N-CA 126.972 2.109 . . . . 0.0 115.542 -166.276 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.85 -20.49 26.72 Favored Glycine 0 C--N 1.356 1.678 0 C-N-CA 127.302 2.382 . . . . 0.0 111.583 -171.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 p -116.09 119.15 34.92 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 103.979 -2.6 . . . . 0.0 103.979 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.494 ' HB2' ' CE1' ' A' ' 130' ' ' HIS . 16.4 p90 -148.42 -9.65 0.37 Allowed 'General case' 0 C--N 1.363 1.156 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -170.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 pt -109.69 153.18 11.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-N 120.074 1.306 . . . . 0.0 112.473 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -142.28 136.52 29.85 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 104.138 -2.542 . . . . 0.0 104.138 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -150.68 127.24 10.82 Favored 'General case' 0 C--N 1.363 1.166 0 O-C-N 120.044 -1.66 . . . . 0.0 110.986 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -118.41 93.38 4.1 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 125.919 1.688 . . . . 0.0 110.534 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.16 -51.89 0.01 OUTLIER Glycine 0 C--N 1.363 2.033 1 N-CA-C 124.096 4.398 . . . . 0.0 124.096 171.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -137.64 21.58 2.9 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.325 1.45 . . . . 0.0 113.532 -172.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.6 m -163.49 146.39 10.08 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.01 137.72 56.44 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 C-N-CA 123.759 0.824 . . . . 0.0 109.851 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -120.55 130.06 54.06 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 126.829 2.052 . . . . 0.0 107.067 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 145' ' ' LYS . 2.2 m -140.29 150.98 21.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.957 1 N-CA-C 98.855 -4.498 . . . . 0.0 98.855 175.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' ' 119' ' ' PHE . 12.6 p-80 -81.69 130.04 34.92 Favored 'General case' 0 C--N 1.367 1.336 0 C-N-CA 125.392 1.477 . . . . 0.0 113.16 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.2 m -137.74 151.16 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 N-CA-C 102.651 -3.092 . . . . 0.0 102.651 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -111.83 148.43 33.6 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -106.8 125.27 50.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 127.723 2.409 . . . . 0.0 105.802 -174.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -75.36 76.13 2.45 Favored 'General case' 0 C--N 1.372 1.574 0 C-N-CA 124.726 1.21 . . . . 0.0 109.492 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -102.46 -113.66 0.21 Allowed 'General case' 0 C--N 1.358 0.935 0 O-C-N 120.04 -1.662 . . . . 0.0 110.392 -173.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -106.87 -59.23 1.83 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 126.202 1.801 . . . . 0.0 111.32 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.5 p -86.06 -31.38 0.43 Allowed Pre-proline 0 C--N 1.365 1.245 0 N-CA-C 120.322 3.453 . . . . 0.0 120.322 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.1 -172.65 10.27 Favored 'Cis proline' 0 CA--C 1.541 0.853 1 CA-C-N 129.917 4.578 . . . . 0.0 113.418 0.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.8 m -96.81 155.64 16.69 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 129.429 3.092 . . . . 0.0 108.904 170.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.462 HH12 ' HB2' ' A' ' 197' ' ' ASP . 58.1 ttp180 -166.1 171.71 12.11 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.54 -169.87 42.12 Favored Glycine 0 CA--C 1.486 -1.752 1 N-CA-C 101.751 -4.54 . . . . 0.0 101.751 163.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -93.93 99.78 12.06 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 169.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.8 m -84.46 176.49 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 C-N-CA 125.563 1.545 . . . . 0.0 109.052 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.7 m -92.98 121.81 34.7 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 170.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.411 ' HD2' ' H ' ' A' ' 90' ' ' PHE 0.309 16.3 pttm -76.36 -11.04 59.83 Favored 'General case' 0 C--N 1.372 1.584 0 CA-C-N 121.421 1.919 . . . . 0.0 113.257 -176.65 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -68.91 -18.85 64.17 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 125.954 1.702 . . . . 0.0 113.487 170.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 147' ' ' LEU . 15.1 mt -91.12 0.65 57.49 Favored 'General case' 0 C--N 1.369 1.424 0 C-N-CA 126.184 1.793 . . . . 0.0 114.571 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.814 HD13 HG21 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -98.47 159.0 15.24 Favored 'General case' 0 C--N 1.364 1.226 0 O-C-N 119.877 -1.764 . . . . 0.0 108.386 176.315 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.66 159.22 45.0 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -74.51 154.59 45.14 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.671 3.58 . . . . 0.0 114.724 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.274 0.1 OUTLIER -18.56 -107.69 0.0 OUTLIER 'General case' 0 C--N 1.363 1.17 2 N-CA-C 123.486 4.624 . . . . 0.0 123.486 177.19 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.326 4.9 t 50.99 -40.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 1 C-N-CA 132.612 4.365 . . . . 0.0 120.413 177.098 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.82 -144.41 38.23 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 118.812 2.285 . . . . 0.0 118.812 176.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.8 m -53.04 -24.97 11.0 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.487 3.515 . . . . 0.0 119.749 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -84.42 -6.07 59.34 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 126.488 1.915 . . . . 0.0 111.951 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.2 m -83.84 146.47 28.08 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.894 1.678 . . . . 0.0 112.87 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -63.4 -27.5 69.34 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 125.702 1.601 . . . . 0.0 112.419 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.37 -23.82 61.97 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 127.417 2.287 . . . . 0.0 113.163 171.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.4 0.81 48.45 Favored 'General case' 0 C--N 1.371 1.518 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.255 1.1 pp0? -115.47 -175.29 2.68 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 125.284 1.433 . . . . 0.0 110.168 176.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -66.27 122.91 18.55 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 126.692 1.997 . . . . 0.0 112.243 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.46 -10.89 58.04 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 124.848 1.213 . . . . 0.0 111.654 -167.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.64 139.84 23.51 Favored Glycine 0 C--N 1.365 2.154 0 N-CA-C 119.618 2.607 . . . . 0.0 119.618 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -61.01 -16.37 42.6 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 119.324 3.083 . . . . 0.0 119.324 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.85 -0.06 17.03 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.701 -1.249 . . . . 0.0 110.805 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -79.1 142.17 36.68 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 126.166 2.889 . . . . 0.0 118.315 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.6 m -172.86 170.46 4.57 Favored 'General case' 0 C--N 1.348 0.508 2 N-CA-C 98.165 -4.754 . . . . 0.0 98.165 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -138.24 101.59 4.43 Favored 'General case' 0 C--N 1.367 1.366 0 CA-C-N 124.931 3.514 . . . . 0.0 111.223 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -119.88 135.24 24.14 Favored Pre-proline 0 N--CA 1.43 -1.428 0 N-CA-C 100.921 -3.733 . . . . 0.0 100.921 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.7 -26.5 80.04 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 125.196 3.93 . . . . 0.0 114.108 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -63.9 -36.39 83.77 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 127.515 2.326 . . . . 0.0 113.424 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.8 mt -70.97 -42.88 77.05 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 C-N-CA 125.582 1.553 . . . . 0.0 110.923 173.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.46 -43.24 77.46 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 124.766 1.226 . . . . 0.0 113.979 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -58.91 -38.69 79.48 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 128.178 2.591 . . . . 0.0 113.259 175.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.26 -34.54 74.93 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 131.357 3.863 . . . . 0.0 110.887 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.427 ' HG2' ' CH2' ' A' ' 97' ' ' TRP . 31.3 mtt -70.4 -37.59 74.49 Favored 'General case' 0 C--N 1.386 2.156 0 C-N-CA 124.03 0.932 . . . . 0.0 111.339 168.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -68.53 -45.29 72.59 Favored 'General case' 0 C--N 1.378 1.842 0 C-N-CA 126.638 1.975 . . . . 0.0 111.62 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -53.93 47.37 Favored 'General case' 0 C--N 1.37 1.471 0 C-N-CA 131.629 3.971 . . . . 0.0 111.698 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.94 -45.26 82.9 Favored 'General case' 0 C--N 1.373 1.6 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 170.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 184' ' ' ASN 0.318 38.8 t70 -64.19 -24.73 67.78 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 127.339 2.256 . . . . 0.0 112.702 176.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -75.09 -43.89 50.47 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 117.922 -2.986 . . . . 0.0 112.228 168.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 190' ' ' ARG . . . -76.25 -39.62 53.99 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 120.069 3.359 . . . . 0.0 120.069 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.24 -26.85 47.47 Favored 'General case' 0 C--N 1.36 1.051 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.2 OUTLIER -89.78 -30.28 18.1 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.461 2.704 . . . . 0.0 107.93 -173.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -104.98 -98.56 0.32 Allowed 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -136.03 159.7 40.89 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 119.995 -1.691 . . . . 0.0 111.691 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.514 ' HA ' ' HD3' ' A' ' 190' ' ' ARG . 44.2 mmtt -51.55 -38.56 54.85 Favored 'General case' 0 C--N 1.377 1.78 0 C-N-CA 131.201 3.801 . . . . 0.0 115.142 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.6 tt -55.22 -36.07 38.44 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 129.171 2.988 . . . . 0.0 113.379 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -43.92 72.49 Favored 'General case' 0 C--N 1.372 1.558 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.522 ' HG3' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -75.25 -43.43 51.54 Favored 'General case' 0 C--N 1.37 1.475 0 CA-C-N 121.241 1.837 . . . . 0.0 114.826 172.123 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.5 tp -71.32 -19.48 62.3 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 128.672 2.789 . . . . 0.0 113.852 -172.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -59.64 -27.9 66.76 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.883 2.073 . . . . 0.0 113.492 164.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.1 21.66 14.47 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 127.472 2.309 . . . . 0.0 111.95 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.03 44.95 0.0 OUTLIER 'General case' 0 C--N 1.374 1.644 0 C-N-CA 131.502 3.921 . . . . 0.0 118.202 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.8 t 66.79 -51.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.183 1 C-N-CA 133.206 4.602 . . . . 0.0 113.827 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.9 t 86.79 35.95 0.02 OUTLIER 'General case' 0 C--N 1.361 1.092 0 C-N-CA 130.528 3.531 . . . . 0.0 109.742 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.462 ' HB2' HH12 ' A' ' 140' ' ' ARG . 18.3 t70 -70.51 65.13 0.29 Allowed 'General case' 0 C--N 1.363 1.179 0 C-N-CA 127.686 2.395 . . . . 0.0 116.98 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 70.65 68.76 0.37 Allowed Pre-proline 0 C--N 1.358 0.956 0 C-N-CA 129.695 3.198 . . . . 0.0 114.34 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.28 78.59 3.62 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 124.225 3.283 . . . . 0.0 111.476 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 97.0 p -80.05 69.64 6.48 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 126.156 1.782 . . . . 0.0 114.231 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 . . . . . 0 C--N 1.356 0.863 0 C-N-CA 126.201 1.801 . . . . 0.0 110.192 -178.941 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.27 -109.67 0.01 OUTLIER 'General case' 0 C--N 1.351 0.641 0 C-N-CA 125.352 1.461 . . . . 0.0 108.545 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -148.76 112.81 5.18 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.877 -1.139 . . . . 0.0 109.131 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -85.55 123.2 30.7 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.454 1.501 . . . . 0.0 110.841 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.27 58.9 mt 76.45 73.95 0.08 Allowed 'General case' 0 C--N 1.363 1.156 0 C-N-CA 126.836 2.054 . . . . 0.0 114.188 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -106.66 20.81 18.46 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.678 1.591 . . . . 0.0 110.338 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.95 -21.64 43.89 Favored Glycine 0 C--N 1.358 1.761 0 C-N-CA 128.852 3.12 . . . . 0.0 117.525 168.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.55 -174.38 41.99 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 105.425 -3.07 . . . . 0.0 105.425 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mt -128.68 34.85 4.44 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 118.826 1.313 . . . . 0.0 109.804 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -71.73 -52.74 16.19 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 128.439 2.695 . . . . 0.0 114.519 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -113.88 -6.83 13.21 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.43 1.492 . . . . 0.0 112.15 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 t 84.46 -26.1 0.12 Allowed 'General case' 0 C--N 1.364 1.199 0 C-N-CA 128.493 2.717 . . . . 0.0 114.636 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.288 24.4 t 65.73 -49.97 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.033 0 C-N-CA 129.027 2.931 . . . . 0.0 116.039 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.91 160.79 63.18 Favored Pre-proline 0 N--CA 1.447 -0.623 0 O-C-N 120.516 -1.365 . . . . 0.0 109.135 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.82 78.92 2.98 Favored 'Trans proline' 0 C--N 1.363 1.299 1 C-N-CA 125.314 4.009 . . . . 0.0 109.734 170.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.01 -88.54 0.54 Allowed 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.915 2.086 . . . . 0.0 111.246 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.3 112.75 63.86 Favored Pre-proline 0 C--N 1.359 0.979 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.19 80.12 3.14 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.682 2.921 . . . . 0.0 114.094 -167.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . 0.525 75.5 p 90.74 -3.02 0.25 Allowed 'General case' 0 C--N 1.357 0.895 0 C-N-CA 130.235 3.414 . . . . 0.0 116.338 175.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . 0.276 0.7 OUTLIER 83.62 -50.99 0.14 Allowed 'General case' 0 C--N 1.358 0.947 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 169.031 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.8 p -144.39 85.18 1.78 Allowed 'General case' 0 C--N 1.356 0.872 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.285 1.1 p30 -171.81 87.26 0.09 Allowed 'General case' 0 C--N 1.364 1.215 0 C-N-CA 124.973 1.309 . . . . 0.0 112.814 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -124.6 127.65 47.69 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 126.029 1.732 . . . . 0.0 114.814 -171.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.358 98.0 p -110.18 169.62 6.18 Favored Pre-proline 0 CA--C 1.574 1.882 0 C-N-CA 131.025 3.73 . . . . 0.0 114.952 -174.564 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 93.4 Cg_endo -66.19 146.89 82.81 Favored 'Trans proline' 0 C--N 1.385 2.474 1 C-N-CA 126.88 5.054 . . . . 0.0 117.281 -168.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.59 -32.35 7.03 Favored Glycine 0 C--N 1.366 2.236 0 C-N-CA 126.403 1.954 . . . . 0.0 109.365 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -83.12 162.38 21.33 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 124.486 2.089 . . . . 0.0 113.485 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.02 135.4 54.26 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 101.609 -3.478 . . . . 0.0 101.609 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.99 159.06 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 126.209 1.804 . . . . 0.0 107.082 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -98.7 118.37 35.27 Favored 'General case' 0 C--N 1.349 0.559 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.39 138.9 50.97 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 126.37 1.868 . . . . 0.0 113.397 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -113.65 145.84 40.68 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 170.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.1 ttp -128.97 152.82 48.17 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 119.85 -1.781 . . . . 0.0 109.162 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -63.42 89.68 0.04 OUTLIER 'General case' 0 C--N 1.364 1.228 0 C-N-CA 127.716 2.406 . . . . 0.0 115.472 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.17 -4.13 25.36 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 125.665 1.602 . . . . 0.0 112.249 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -98.02 162.15 23.13 Favored Pre-proline 0 C--N 1.357 0.916 0 C-N-CA 125.508 1.523 . . . . 0.0 110.223 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.26 167.08 27.24 Favored 'Trans proline' 0 CA--C 1.544 0.983 1 C-N-CA 125.777 4.318 . . . . 0.0 112.941 163.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -68.3 130.68 43.61 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 127.426 2.29 . . . . 0.0 112.267 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.425 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 6.3 m95 -128.7 131.91 24.04 Favored Pre-proline 0 N--CA 1.429 -1.502 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.56 139.24 30.94 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 124.211 3.274 . . . . 0.0 108.1 149.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.1 p -152.37 164.18 38.0 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 126.936 2.094 . . . . 0.0 111.611 -163.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 190' ' ' ARG . 1.3 pp -111.47 149.44 31.31 Favored 'General case' 0 C--N 1.367 1.356 0 O-C-N 119.982 -1.699 . . . . 0.0 109.87 171.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 131' ' ' VAL . 2.4 t -91.45 119.83 39.41 Favored 'Isoleucine or valine' 0 C--N 1.364 1.222 0 O-C-N 120.608 -1.308 . . . . 0.0 107.787 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -114.61 141.85 47.22 Favored 'General case' 0 C--N 1.37 1.5 0 N-CA-C 120.066 3.358 . . . . 0.0 120.066 -162.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -85.77 111.27 20.0 Favored 'General case' 0 C--N 1.377 1.772 0 O-C-N 118.526 -2.608 . . . . 0.0 110.522 172.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -85.04 160.2 55.58 Favored Pre-proline 0 N--CA 1.449 -0.497 1 C-N-CA 132.108 4.163 . . . . 0.0 109.673 -176.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.81 -13.84 6.8 Favored 'Trans proline' 0 CA--C 1.55 1.306 1 C-N-CA 125.97 4.447 . . . . 0.0 117.08 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -107.41 54.11 0.68 Allowed 'General case' 0 C--N 1.365 1.244 0 C-N-CA 127.848 2.459 . . . . 0.0 107.564 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.43 167.77 19.05 Favored 'General case' 0 C--N 1.368 1.406 0 O-C-N 119.563 -1.961 . . . . 0.0 114.787 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.48 -20.04 48.98 Favored Glycine 0 C--N 1.364 2.086 0 C-N-CA 126.053 1.787 . . . . 0.0 113.559 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.7 m -123.47 120.3 32.52 Favored 'General case' 0 C--N 1.346 0.453 1 N-CA-C 99.465 -4.272 . . . . 0.0 99.465 170.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -122.64 -3.49 8.77 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 -168.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.6 pt -122.81 149.74 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 119.618 -1.926 . . . . 0.0 112.948 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -141.49 160.18 40.68 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 129.854 3.262 . . . . 0.0 104.595 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -152.08 127.57 10.03 Favored 'General case' 0 C--N 1.365 1.272 0 O-C-N 118.935 -2.353 . . . . 0.0 111.459 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.37 92.94 4.7 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.266 1.426 . . . . 0.0 108.78 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.5 -84.96 0.19 Allowed Glycine 0 C--N 1.363 2.053 0 C-N-CA 127.309 2.385 . . . . 0.0 114.57 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -116.74 -15.26 10.75 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 126.277 1.831 . . . . 0.0 110.591 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.1 m -88.43 100.91 13.41 Favored 'General case' 0 C--N 1.365 1.257 0 O-C-N 120.423 -1.423 . . . . 0.0 110.625 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 p -86.46 132.41 32.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 127.452 2.301 . . . . 0.0 108.246 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -117.1 141.98 47.57 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 126.19 1.796 . . . . 0.0 112.569 -173.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.9 164.16 35.97 Favored 'Isoleucine or valine' 0 C--N 1.359 0.986 0 C-N-CA 130.057 3.343 . . . . 0.0 106.094 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -88.55 116.68 26.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.98 1.712 . . . . 0.0 112.596 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 110' ' ' VAL . 3.3 m -134.24 173.76 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 O-C-N 119.25 -2.156 . . . . 0.0 106.87 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.49 147.91 43.73 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 171.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -99.88 127.2 46.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.111 2.164 . . . . 0.0 107.812 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -73.8 62.96 0.85 Allowed 'General case' 0 C--N 1.369 1.429 0 C-N-CA 126.736 2.015 . . . . 0.0 114.153 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -91.35 -108.78 0.1 Allowed 'General case' 0 C--N 1.365 1.248 0 O-C-N 121.392 -0.818 . . . . 0.0 112.561 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.74 -65.34 1.09 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 126.224 1.81 . . . . 0.0 114.097 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.5 p -79.85 -32.6 0.73 Allowed Pre-proline 0 C--N 1.361 1.086 0 N-CA-C 119.464 3.135 . . . . 0.0 119.464 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -92.16 -166.3 2.31 Favored 'Cis proline' 0 CA--C 1.539 0.774 1 CA-C-N 129.988 4.603 . . . . 0.0 110.828 -1.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -97.69 135.48 39.42 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 125.093 1.357 . . . . 0.0 111.678 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.2 tmm_? -136.56 147.34 46.97 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 120.748 1.613 . . . . 0.0 106.915 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.81 -179.87 40.72 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 104.892 -3.283 . . . . 0.0 104.892 170.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -86.55 109.11 18.89 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 127.423 2.289 . . . . 0.0 106.76 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.19 -178.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 125.602 1.561 . . . . 0.0 111.574 -172.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.2 m -100.41 117.29 34.29 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 101.318 -3.586 . . . . 0.0 101.318 169.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 5.6 ttpp -72.42 -14.04 61.6 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 124.026 1.869 . . . . 0.0 113.063 -171.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -75.07 -12.3 60.29 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.971 1.708 . . . . 0.0 113.961 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.46 3.82 43.26 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 126.742 2.017 . . . . 0.0 110.948 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.457 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 31.5 mt -94.25 130.44 40.51 Favored 'General case' 0 C--N 1.366 1.292 0 C-N-CA 126.623 1.969 . . . . 0.0 109.201 173.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.403 ' HG3' ' CE1' ' A' ' 165' ' ' PHE . 5.1 mmtt -114.88 165.65 13.51 Favored Pre-proline 0 C--N 1.35 0.611 0 N-CA-C 102.947 -2.983 . . . . 0.0 102.947 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.56 155.8 16.16 Favored 'Trans proline' 0 C--N 1.326 -0.656 0 C-N-CA 124.644 3.563 . . . . 0.0 112.561 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.64 124.04 41.89 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 121.643 0.735 . . . . 0.0 112.067 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.0 t -161.52 25.77 0.13 Allowed 'General case' 0 C--N 1.358 0.954 0 C-N-CA 127.493 2.317 . . . . 0.0 105.523 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.64 81.74 0.07 OUTLIER Glycine 0 C--N 1.354 1.575 0 C-N-CA 115.941 -3.028 . . . . 0.0 117.55 -162.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 69.9 m -67.92 -11.45 58.76 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 128.571 2.748 . . . . 0.0 114.068 172.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -122.52 37.97 4.27 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 128.445 2.698 . . . . 0.0 109.788 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.3 m -95.09 147.87 22.96 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.584 2.354 . . . . 0.0 108.027 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -61.78 -24.49 66.87 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -82.23 -19.09 40.41 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 125.586 1.554 . . . . 0.0 112.161 168.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.34 -39.62 10.38 Favored 'General case' 0 C--N 1.368 1.393 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.337 0.0 OUTLIER -83.74 -173.67 4.85 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -178.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.74 121.34 15.74 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.81 -1.806 . . . . 0.0 113.462 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.34 -13.24 51.58 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.075 -166.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.9 158.65 36.95 Favored Glycine 0 C--N 1.369 2.375 0 N-CA-C 120.665 3.026 . . . . 0.0 120.665 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -60.05 -41.76 93.02 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 129.084 2.953 . . . . 0.0 117.561 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.403 ' CE1' ' HG3' ' A' ' 149' ' ' LYS . 1.6 m-85 -92.67 -30.1 15.75 Favored 'General case' 0 C--N 1.37 1.463 0 O-C-N 120.9 -1.125 . . . . 0.0 110.538 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.3 t80 0.4 -91.51 0.0 OUTLIER 'General case' 0 C--N 1.382 1.981 1 C-N-CA 133.59 4.756 . . . . 0.0 117.216 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.1 m 49.17 65.77 1.29 Allowed 'General case' 0 C--N 1.364 1.211 0 C-N-CA 130.756 3.623 . . . . 0.0 116.413 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.5 100.93 11.06 Favored 'General case' 0 C--N 1.369 1.415 0 CA-C-O 124.93 2.3 . . . . 0.0 114.049 -170.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -120.63 146.1 42.52 Favored Pre-proline 0 N--CA 1.429 -1.51 1 C-N-CA 132.009 4.124 . . . . 0.0 105.028 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -50.26 -38.3 51.43 Favored 'Trans proline' 0 CA--C 1.548 1.2 1 C-N-CA 127.403 5.402 . . . . 0.0 117.113 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.75 -35.54 75.05 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 128.943 2.897 . . . . 0.0 113.644 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.255 12.8 mt -76.01 -32.12 22.82 Favored 'Isoleucine or valine' 0 C--N 1.371 1.541 0 C-N-CA 127.119 2.168 . . . . 0.0 110.528 175.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 177' ' ' GLN . 19.3 mt -62.91 -53.16 58.42 Favored 'General case' 0 C--N 1.383 2.037 0 C-N-CA 126.704 2.002 . . . . 0.0 109.178 168.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -34.47 68.5 Favored 'General case' 0 C--N 1.369 1.449 0 C-N-CA 128.651 2.78 . . . . 0.0 115.066 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.21 -45.81 68.96 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 130.19 3.396 . . . . 0.0 112.116 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 12.8 mtt -67.03 -33.37 75.4 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-N 119.416 1.007 . . . . 0.0 113.515 170.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 8.6 mt-30 -70.02 -52.19 26.14 Favored 'General case' 0 C--N 1.381 1.976 0 C-N-CA 126.495 1.918 . . . . 0.0 113.06 172.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.274 5.4 ptt180 -72.43 -35.94 68.46 Favored 'General case' 0 C--N 1.384 2.067 0 O-C-N 119.184 -2.198 . . . . 0.0 114.48 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.418 ' O ' HD13 ' A' ' 183' ' ' LEU . . . -66.39 -39.96 89.38 Favored 'General case' 0 C--N 1.37 1.478 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 169.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 29.8 t70 -62.1 -35.78 79.74 Favored 'General case' 0 C--N 1.381 1.971 0 O-C-N 120.082 -1.636 . . . . 0.0 112.092 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -65.46 -45.78 82.4 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 119.337 -2.102 . . . . 0.0 113.743 170.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -71.41 -36.2 71.25 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 179' ' ' ALA 0.291 0.0 OUTLIER -79.74 -28.96 40.44 Favored 'General case' 0 C--N 1.371 1.535 0 O-C-N 119.893 -1.754 . . . . 0.0 114.89 177.415 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 180' ' ' ASP 0.267 0.0 OUTLIER -89.57 -15.48 32.76 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 124.966 1.306 . . . . 0.0 111.061 -176.789 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -115.2 -102.23 0.42 Allowed 'General case' 0 C--N 1.357 0.927 0 O-C-N 122.107 -0.37 . . . . 0.0 110.342 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.459 ' HB3' HG22 ' A' ' 188' ' ' ILE . 25.0 t70 -136.19 156.94 47.95 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 123.097 1.427 . . . . 0.0 109.952 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -50.97 -36.73 40.57 Favored 'General case' 0 C--N 1.361 1.08 1 C-N-CA 131.994 4.117 . . . . 0.0 114.116 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.459 HG22 ' HB3' ' A' ' 186' ' ' ASP . 8.1 tt -54.98 -28.29 20.29 Favored 'Isoleucine or valine' 0 C--N 1.364 1.236 1 C-N-CA 131.808 4.043 . . . . 0.0 113.514 175.284 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.281 5.3 mptt -71.98 -29.53 64.33 Favored 'General case' 0 C--N 1.376 1.733 0 C-N-CA 125.932 1.693 . . . . 0.0 113.551 171.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.501 ' HB2' HD22 ' A' ' 109' ' ' LEU 0.532 0.0 OUTLIER -74.73 -42.21 58.7 Favored 'General case' 0 C--N 1.375 1.713 0 O-C-N 119.198 -2.189 . . . . 0.0 113.368 170.045 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.5 -19.97 65.92 Favored 'General case' 0 C--N 1.379 1.869 0 C-N-CA 129.099 2.959 . . . . 0.0 114.424 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.88 -29.9 70.87 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 128.419 2.688 . . . . 0.0 112.925 169.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mt -105.07 -50.02 3.34 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 125.252 1.421 . . . . 0.0 108.535 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 34.37 38.31 0.03 OUTLIER 'General case' 0 C--N 1.375 1.706 1 C-N-CA 131.889 4.076 . . . . 0.0 119.229 173.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.273 40.5 t 88.32 77.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 128.963 2.905 . . . . 0.0 105.67 -170.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 80.4 p -59.53 79.99 0.01 OUTLIER 'General case' 0 C--N 1.361 1.065 0 C-N-CA 129.959 3.304 . . . . 0.0 117.439 -173.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -139.81 -74.04 0.36 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -142.55 80.26 14.59 Favored Pre-proline 0 N--CA 1.445 -0.675 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -82.42 -82.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 124.135 3.223 . . . . 0.0 109.283 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 31.9 m -172.21 -47.9 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 C--N 1.352 0.701 0 C-N-CA 127.352 2.261 . . . . 0.0 111.773 178.528 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? . . . . . 0 N--CA 1.44 -0.94 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.83 72.67 4.19 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 126.267 1.827 . . . . 0.0 110.489 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -101.86 90.89 4.15 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 126.835 2.054 . . . . 0.0 108.263 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -103.0 133.97 47.23 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 125.797 1.639 . . . . 0.0 109.503 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.81 66.94 5.44 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 115.832 1.789 . . . . 0.0 115.832 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -98.65 -17.87 18.37 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.433 1.893 . . . . 0.0 110.729 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.62 0.81 49.7 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 126.603 2.049 . . . . 0.0 113.079 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.87 -116.61 3.41 Favored Glycine 0 C--N 1.359 1.817 0 N-CA-C 106.174 -2.77 . . . . 0.0 106.174 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.1 mt -113.56 45.2 1.46 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 125.944 1.698 . . . . 0.0 107.341 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -71.21 -36.38 71.87 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 129.197 2.999 . . . . 0.0 114.691 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -106.58 13.11 28.66 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.012 1.325 . . . . 0.0 110.229 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.6 t 71.81 -152.09 0.08 Allowed 'General case' 0 C--N 1.364 1.197 0 C-N-CA 128.405 2.682 . . . . 0.0 115.023 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -149.65 146.34 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.02 150.48 41.86 Favored Pre-proline 0 C--N 1.351 0.658 0 C-N-CA 125.326 1.45 . . . . 0.0 110.733 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.38 -36.4 5.39 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 124.712 3.608 . . . . 0.0 112.365 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.92 -107.07 0.09 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 103.077 -2.935 . . . . 0.0 103.077 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.58 136.88 19.19 Favored Pre-proline 0 C--N 1.353 0.739 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -81.12 70.49 7.46 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.839 3.026 . . . . 0.0 111.734 -175.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.9 m -166.57 145.6 5.58 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.5 m -167.82 51.92 0.06 Allowed 'General case' 0 C--N 1.358 0.94 0 C-N-CA 125.126 1.37 . . . . 0.0 108.027 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.9 p -99.05 100.86 12.07 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 125.551 1.54 . . . . 0.0 110.463 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -155.85 92.4 1.37 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 124.698 1.199 . . . . 0.0 109.303 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -125.56 127.51 46.49 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.441 56.6 p -111.73 167.39 9.17 Favored Pre-proline 0 CA--C 1.562 1.41 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -59.54 137.66 79.02 Favored 'Trans proline' 0 C--N 1.379 2.165 1 C-N-CA 126.957 5.105 . . . . 0.0 118.531 -169.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.2 -22.65 39.8 Favored Glycine 0 C--N 1.371 2.513 0 C-N-CA 126.028 1.775 . . . . 0.0 111.39 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.34 159.31 27.21 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 120.208 -1.76 . . . . 0.0 112.212 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.74 133.35 48.88 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.533 -1.355 . . . . 0.0 107.522 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.13 152.73 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 C-N-CA 126.565 1.946 . . . . 0.0 107.335 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -101.72 119.88 39.47 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 168.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -110.08 149.59 29.81 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 121.487 1.949 . . . . 0.0 111.873 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -117.14 140.91 48.94 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 174.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.9 ttp -126.54 145.17 50.63 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 119.958 -1.714 . . . . 0.0 107.418 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -49.72 86.27 0.0 OUTLIER 'General case' 0 C--N 1.365 1.245 0 C-N-CA 130.457 3.503 . . . . 0.0 117.188 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.71 -3.47 45.83 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.961 1.267 . . . . 0.0 114.064 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -99.95 165.7 14.1 Favored Pre-proline 0 C--N 1.357 0.906 0 C-N-CA 125.7 1.6 . . . . 0.0 108.315 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.44 165.79 31.37 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.323 3.349 . . . . 0.0 113.56 169.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.434 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.0 m95 -63.68 110.19 1.95 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 130.145 3.378 . . . . 0.0 112.824 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 4.9 m95 -109.24 108.55 60.33 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 119.197 3.036 . . . . 0.0 119.197 -172.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 20.3 Cg_endo -54.45 123.03 12.62 Favored 'Trans proline' 0 C--N 1.384 2.413 1 C-N-CA 125.908 4.405 . . . . 0.0 111.708 159.599 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.4 p -148.65 165.72 30.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 124.574 2.13 . . . . 0.0 114.332 -156.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 tp -114.41 138.46 50.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.83 2.452 . . . . 0.0 106.663 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.92 127.88 39.47 Favored 'Isoleucine or valine' 0 C--N 1.364 1.206 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.406 ' CE2' HG12 ' A' ' 195' ' ' VAL . 81.2 t80 -139.73 153.88 47.31 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 122.712 2.505 . . . . 0.0 112.596 -168.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -104.07 114.62 28.99 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.572 2.349 . . . . 0.0 109.158 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -67.74 161.27 67.8 Favored Pre-proline 0 C--N 1.354 0.774 0 C-N-CA 128.267 2.627 . . . . 0.0 112.496 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.04 -1.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.563 1.931 1 C-N-CA 126.494 4.796 . . . . 0.0 118.159 172.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -91.09 34.33 0.93 Allowed 'General case' 0 C--N 1.36 1.04 1 C-N-CA 135.074 5.349 . . . . 0.0 107.32 169.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.329 0.5 OUTLIER -77.92 156.36 30.33 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -173.23 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.39 -10.45 33.27 Favored Glycine 0 C--N 1.359 1.842 0 CA-C-N 111.826 -2.443 . . . . 0.0 111.776 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 t -146.87 150.66 35.68 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 101.269 -3.604 . . . . 0.0 101.269 172.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -149.83 9.64 0.7 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 119.555 1.071 . . . . 0.0 111.055 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.424 HG22 HG12 ' A' ' 129' ' ' VAL . 34.2 pt -117.5 148.81 20.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 CA-C-O 122.302 1.049 . . . . 0.0 110.687 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -137.66 138.89 39.89 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.3 129.78 14.87 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 119.859 -1.776 . . . . 0.0 109.776 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -117.78 93.84 4.3 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.511 2.324 . . . . 0.0 111.157 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.08 -73.07 0.55 Allowed Glycine 0 C--N 1.362 1.98 0 N-CA-C 120.127 2.811 . . . . 0.0 120.127 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -147.21 58.8 1.16 Allowed 'General case' 0 C--N 1.356 0.849 0 CA-C-O 122.601 1.191 . . . . 0.0 110.201 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.1 m -175.56 157.91 2.15 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.47 135.01 35.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 122.598 1.19 . . . . 0.0 109.735 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -115.17 130.37 56.9 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 127.618 2.367 . . . . 0.0 107.164 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 145' ' ' LYS . 10.3 m -125.81 146.43 31.58 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 1 N-CA-C 98.237 -4.727 . . . . 0.0 98.237 172.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.52 ' CG ' HH22 ' A' ' 140' ' ' ARG 0.329 0.4 OUTLIER -81.57 137.32 35.54 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 121.709 0.766 . . . . 0.0 112.449 176.074 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -146.2 165.06 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -129.17 153.43 47.73 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -110.86 122.69 48.49 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.022 1.329 . . . . 0.0 107.564 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -74.83 60.59 0.96 Allowed 'General case' 0 C--N 1.37 1.493 0 C-N-CA 127.689 2.396 . . . . 0.0 114.475 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP 0.31 50.8 p-10 -87.66 -99.21 0.08 Allowed 'General case' 0 C--N 1.363 1.19 0 C-N-CA 125.604 1.562 . . . . 0.0 113.377 -177.069 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -106.84 -65.7 1.07 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.452 1.901 . . . . 0.0 114.57 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.272 10.1 p -77.81 -38.04 1.65 Allowed Pre-proline 0 C--N 1.365 1.251 0 N-CA-C 118.546 2.795 . . . . 0.0 118.546 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -82.43 -174.73 13.76 Favored 'Cis proline' 0 C--N 1.354 0.866 1 CA-C-N 128.707 4.145 . . . . 0.0 113.822 -0.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.274 4.0 t -97.62 154.06 17.8 Favored 'General case' 0 C--N 1.374 1.646 0 C-N-CA 127.613 2.365 . . . . 0.0 111.045 171.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.52 HH22 ' CG ' ' A' ' 130' ' ' HIS . 32.7 ttt-85 -158.44 162.05 37.52 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.26 -163.97 29.64 Favored Glycine 0 CA--C 1.484 -1.87 0 N-CA-C 104.24 -3.544 . . . . 0.0 104.24 166.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -96.65 99.95 11.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 171.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.2 m -81.65 178.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 126.973 2.109 . . . . 0.0 108.001 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.5 m -94.92 130.08 41.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.522 ' HB3' HG22 ' A' ' 129' ' ' VAL . 4.2 pttp -79.53 -9.62 59.65 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 119.891 -1.755 . . . . 0.0 113.993 -175.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.21 -13.75 61.61 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.496 1.118 . . . . 0.0 112.475 174.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.7 mt -96.84 1.11 50.27 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 126.436 1.894 . . . . 0.0 114.074 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.09 141.79 28.31 Favored 'General case' 0 C--N 1.372 1.546 0 CA-C-N 121.1 1.773 . . . . 0.0 109.233 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -115.99 158.57 42.1 Favored Pre-proline 0 C--O 1.224 -0.273 0 O-C-N 119.313 -2.117 . . . . 0.0 105.621 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.98 151.44 21.25 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.395 3.397 . . . . 0.0 112.869 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -121.61 117.42 26.67 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-O 122.056 0.932 . . . . 0.0 112.262 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.3 t -160.89 23.72 0.14 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 126.182 1.793 . . . . 0.0 106.698 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.41 70.42 0.3 Allowed Glycine 0 C--N 1.353 1.514 0 C-N-CA 120.424 -0.894 . . . . 0.0 114.578 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 m -63.7 -10.99 22.17 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 131.221 3.808 . . . . 0.0 116.215 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -126.73 29.95 5.6 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 129.226 3.01 . . . . 0.0 108.065 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 t -96.09 136.58 36.36 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 127.695 2.398 . . . . 0.0 107.243 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -47.91 -38.91 17.52 Favored 'General case' 0 C--N 1.369 1.428 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.12 -18.3 60.27 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.608 -1.307 . . . . 0.0 113.885 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.72 -1.38 46.62 Favored 'General case' 0 C--N 1.371 1.505 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.376 0.6 OUTLIER -119.65 -173.51 2.55 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.409 1.484 . . . . 0.0 112.74 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -71.32 122.38 20.18 Favored 'General case' 0 C--N 1.37 1.468 0 O-C-N 119.506 -1.996 . . . . 0.0 112.355 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.26 -8.0 56.92 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.299 0.952 . . . . 0.0 111.774 -168.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.09 157.31 28.12 Favored Glycine 0 C--N 1.363 2.065 0 N-CA-C 117.437 1.735 . . . . 0.0 117.437 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -58.41 -42.53 87.41 Favored 'General case' 0 C--N 1.366 1.304 0 N-CA-C 119.358 3.096 . . . . 0.0 119.358 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.434 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.391 0.2 OUTLIER -106.32 3.15 27.26 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -175.037 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -101.91 144.13 30.92 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.091 1.757 . . . . 0.0 108.87 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.1 m -166.93 147.16 5.64 Favored 'General case' 0 N--CA 1.445 -0.709 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.37 99.89 9.24 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-O 126.398 2.999 . . . . 0.0 111.693 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -120.84 134.46 24.31 Favored Pre-proline 0 N--CA 1.416 -2.145 3 N-CA-C 98.046 -4.798 . . . . 0.0 98.046 164.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -60.74 -22.78 74.47 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.691 4.26 . . . . 0.0 115.509 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.09 -36.33 74.83 Favored 'General case' 0 C--N 1.36 1.059 0 C-N-CA 128.741 2.816 . . . . 0.0 113.829 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.1 mm -71.73 -40.24 69.72 Favored 'Isoleucine or valine' 0 C--N 1.379 1.877 0 C-N-CA 127.553 2.341 . . . . 0.0 108.472 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.0 mt -66.44 -48.57 69.55 Favored 'General case' 0 C--N 1.369 1.454 0 C-N-CA 125.314 1.446 . . . . 0.0 113.264 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -57.81 -34.16 69.35 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 128.288 2.635 . . . . 0.0 114.881 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.431 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . . . -68.35 -45.88 71.65 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 130.959 3.704 . . . . 0.0 111.599 171.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.35 0.0 OUTLIER -64.25 -32.35 73.9 Favored 'General case' 0 C--N 1.38 1.931 0 CA-C-N 120.321 1.419 . . . . 0.0 113.374 168.187 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -68.96 -48.51 62.99 Favored 'General case' 0 C--N 1.376 1.752 0 C-N-CA 126.059 1.743 . . . . 0.0 113.711 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -60.44 -53.51 56.75 Favored 'General case' 0 C--N 1.379 1.884 0 C-N-CA 128.838 2.855 . . . . 0.0 111.108 173.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -59.86 -45.42 92.52 Favored 'General case' 0 C--N 1.365 1.277 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.45 -37.79 70.77 Favored 'General case' 0 C--N 1.378 1.83 0 C-N-CA 127.668 2.387 . . . . 0.0 112.955 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.99 -39.62 72.34 Favored 'General case' 0 C--N 1.361 1.093 0 O-C-N 119.781 -1.824 . . . . 0.0 115.122 173.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.92 -29.35 55.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 119.417 3.118 . . . . 0.0 119.417 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.83 -50.2 69.83 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 130.298 3.439 . . . . 0.0 113.074 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.274 0.0 OUTLIER -90.93 -16.6 27.83 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 127.577 2.351 . . . . 0.0 111.985 -175.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -120.78 -110.91 0.33 Allowed 'General case' 0 C--N 1.357 0.906 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -135.52 149.55 49.51 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 119.797 -1.814 . . . . 0.0 107.836 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.492 0.0 OUTLIER -51.03 -32.69 22.32 Favored 'General case' 0 CA--C 1.5 -0.957 1 C-N-CA 132.017 4.127 . . . . 0.0 117.711 175.49 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 17.4 tt -49.43 -30.91 5.08 Favored 'Isoleucine or valine' 0 C--N 1.365 1.278 0 C-N-CA 130.12 3.368 . . . . 0.0 113.029 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -60.43 -35.88 76.86 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 128.146 2.578 . . . . 0.0 113.955 169.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -75.3 -44.23 46.7 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 171.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 10.0 mp -67.92 -19.95 65.04 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 129.694 3.197 . . . . 0.0 112.753 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -64.86 -38.64 91.64 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 130.652 3.581 . . . . 0.0 114.344 168.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.34 -51.08 3.44 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.78 2.032 . . . . 0.0 109.667 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 46.67 -134.13 1.0 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 131.303 3.841 . . . . 0.0 117.919 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.406 HG12 ' CE2' ' A' ' 111' ' ' TYR 0.318 9.1 p -109.87 63.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.398 0 CA-C-O 124.645 2.164 . . . . 0.0 109.279 176.223 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.6 p -95.16 67.85 3.06 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 127.612 2.365 . . . . 0.0 108.676 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -79.64 65.53 4.84 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.986 1.714 . . . . 0.0 112.83 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -155.93 159.68 31.36 Favored Pre-proline 0 C--N 1.352 0.681 0 C-N-CA 126.856 2.062 . . . . 0.0 105.833 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.93 -176.15 2.88 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.126 3.217 . . . . 0.0 113.927 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 24.6 t -90.7 60.03 4.38 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.999 2.119 . . . . 0.0 112.684 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.365 3.3 pt-20 . . . . . 0 C--N 1.361 1.104 0 C-N-CA 130.83 3.652 . . . . 0.0 112.463 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.14 52.18 2.37 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 119.933 -1.73 . . . . 0.0 114.703 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.26 71.82 1.73 Allowed 'General case' 0 C--N 1.36 1.052 0 C-N-CA 127.633 2.373 . . . . 0.0 114.276 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -97.01 133.36 41.79 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 128.204 2.602 . . . . 0.0 109.573 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.02 63.46 1.78 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 126.216 1.806 . . . . 0.0 115.126 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -100.07 -5.97 27.12 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 126.493 1.917 . . . . 0.0 110.659 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.49 12.26 45.25 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 129.038 3.209 . . . . 0.0 117.506 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.97 7.07 68.69 Favored Glycine 0 C--N 1.358 1.761 0 C-N-CA 125.979 1.752 . . . . 0.0 112.753 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.0 mt -98.44 23.29 8.66 Favored 'General case' 0 C--N 1.367 1.326 0 O-C-N 121.223 -1.163 . . . . 0.0 112.882 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -71.6 -45.18 62.88 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 128.274 2.63 . . . . 0.0 113.017 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -105.83 -49.52 3.38 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 127.437 2.295 . . . . 0.0 107.404 173.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.27 4.5 t 89.0 160.67 0.06 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 128.938 2.895 . . . . 0.0 114.301 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 m -119.69 -5.95 10.72 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 C-N-CA 127.624 2.37 . . . . 0.0 109.886 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -138.04 154.71 74.45 Favored Pre-proline 0 C--N 1.359 0.99 0 C-N-CA 126.849 2.06 . . . . 0.0 107.938 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.97 167.36 23.72 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 125.144 3.896 . . . . 0.0 113.231 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.75 -91.47 0.1 Allowed 'General case' 0 C--N 1.359 1.013 0 O-C-N 121.349 -0.844 . . . . 0.0 109.676 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.6 112.8 64.59 Favored Pre-proline 0 C--N 1.356 0.848 0 C-N-CA 125.799 1.639 . . . . 0.0 107.109 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.22 90.9 0.46 Allowed 'Trans proline' 0 C--N 1.368 1.571 1 C-N-CA 125.52 4.147 . . . . 0.0 110.053 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.0 m -81.37 126.32 31.47 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 128.118 2.567 . . . . 0.0 115.558 -167.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.5 p -63.9 47.16 0.02 OUTLIER 'General case' 0 C--N 1.359 0.996 0 C-N-CA 131.593 3.957 . . . . 0.0 117.909 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.47 12.1 p 152.31 36.47 0.0 OUTLIER 'General case' 0 C--N 1.349 0.572 0 C-N-CA 129.911 3.284 . . . . 0.0 112.994 174.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -122.79 102.6 8.13 Favored 'General case' 0 C--N 1.369 1.442 0 O-C-N 120.566 -1.334 . . . . 0.0 110.386 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.448 ' H ' ' HD2' ' A' ' 145' ' ' LYS . 8.5 m-85 -126.06 128.6 47.65 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.766 1.626 . . . . 0.0 114.591 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.5 p -110.67 163.73 16.54 Favored Pre-proline 0 C--N 1.365 1.241 0 O-C-N 119.868 -1.77 . . . . 0.0 115.776 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.67 134.97 65.22 Favored 'Trans proline' 0 C--N 1.373 1.839 1 C-N-CA 126.659 4.906 . . . . 0.0 117.097 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.33 -51.19 0.75 Allowed Glycine 0 C--N 1.353 1.522 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 -169.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -65.49 159.36 24.59 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.47 HD23 HH11 ' A' ' 190' ' ' ARG . 3.5 mm? -102.83 141.49 35.54 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 148' ' ' LEU . 13.1 m -132.42 159.68 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 C-N-CA 126.639 1.976 . . . . 0.0 106.538 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.529 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 52.2 m95 -108.56 115.76 30.7 Favored 'General case' 0 C--O 1.214 -0.786 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 171.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.25 147.66 26.77 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 122.728 2.513 . . . . 0.0 113.602 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -115.14 130.57 56.96 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 170.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 44.1 ttm -116.04 141.19 48.45 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.26 101.29 0.9 Allowed 'General case' 0 C--N 1.364 1.203 0 C-N-CA 126.062 1.745 . . . . 0.0 113.5 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.42 -10.93 23.97 Favored Glycine 0 C--N 1.358 1.782 0 C-N-CA 125.752 1.644 . . . . 0.0 113.45 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -103.9 164.83 14.57 Favored Pre-proline 0 C--N 1.357 0.913 0 C-N-CA 125.567 1.547 . . . . 0.0 109.719 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -71.41 166.09 30.41 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 125.039 3.826 . . . . 0.0 112.752 164.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.92 126.0 25.83 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 127.776 2.43 . . . . 0.0 114.95 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 3.3 m95 -134.75 116.57 12.67 Favored Pre-proline 0 CA--C 1.571 1.787 1 N-CA-C 123.893 4.775 . . . . 0.0 123.893 -169.25 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.529 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 27.1 Cg_exo -56.44 113.45 1.46 Allowed 'Trans proline' 0 C--N 1.401 3.325 1 C-N-CA 126.788 4.992 . . . . 0.0 114.145 166.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -127.06 164.29 21.87 Favored 'General case' 0 N--CA 1.449 -0.508 1 C-N-CA 133.199 4.6 . . . . 0.0 116.104 -168.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.16 146.72 41.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.742 2.817 . . . . 0.0 107.165 172.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 t -91.63 130.64 40.46 Favored 'Isoleucine or valine' 0 C--N 1.37 1.467 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 171.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -132.18 152.47 51.27 Favored 'General case' 0 C--N 1.361 1.066 0 O-C-N 118.729 -2.482 . . . . 0.0 115.097 -164.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -92.31 112.82 24.9 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 22.3 m170 -65.68 160.7 58.96 Favored Pre-proline 0 C--N 1.36 1.061 0 C-N-CA 128.2 2.6 . . . . 0.0 117.417 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.37 -1.41 0.2 Allowed 'Trans proline' 0 CA--C 1.572 2.398 0 C-N-CA 124.933 3.755 . . . . 0.0 116.895 169.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -115.71 33.92 5.22 Favored 'General case' 0 C--N 1.356 0.883 1 C-N-CA 135.638 5.575 . . . . 0.0 107.247 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.318 1.1 p30 -72.64 150.26 43.17 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -172.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.07 2.94 31.68 Favored Glycine 0 C--N 1.359 1.849 0 CA-C-N 111.99 -2.368 . . . . 0.0 110.959 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.4 m -149.74 130.76 14.38 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 102.141 -3.281 . . . . 0.0 102.141 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -149.37 -10.44 0.31 Allowed 'General case' 0 C--N 1.364 1.21 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.9 pt -108.63 145.6 15.37 Favored 'Isoleucine or valine' 0 C--N 1.369 1.446 0 CA-C-N 121.862 2.119 . . . . 0.0 112.196 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -139.1 137.9 36.58 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -143.27 127.42 17.54 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -117.86 94.0 4.36 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 126.926 2.09 . . . . 0.0 110.675 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.12 -71.02 0.32 Allowed Glycine 0 C--N 1.362 2.027 0 N-CA-C 120.205 2.842 . . . . 0.0 120.205 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -150.38 57.59 0.94 Allowed 'General case' 0 C--N 1.353 0.721 0 CA-C-O 122.512 1.149 . . . . 0.0 109.861 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.5 m -176.8 140.15 0.32 Allowed 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.486 1.914 . . . . 0.0 106.293 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.47 136.98 58.64 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 123.13 1.443 . . . . 0.0 112.31 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 -114.89 141.95 47.24 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.456 2.302 . . . . 0.0 107.994 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 145' ' ' LYS . 8.8 m -146.58 156.62 11.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 1 N-CA-C 98.711 -4.551 . . . . 0.0 98.711 174.202 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -79.66 138.66 37.45 Favored 'General case' 0 C--N 1.37 1.496 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 176.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.511 HG11 HD13 ' A' ' 148' ' ' LEU . 1.5 m -139.91 172.08 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 173.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.555 ' HB3' ' HG3' ' A' ' 140' ' ' ARG . 1.4 pp0? -138.08 147.65 44.25 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.34 118.59 34.31 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 127.854 2.462 . . . . 0.0 104.951 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.51 53.36 0.02 OUTLIER 'General case' 0 C--N 1.373 1.622 0 C-N-CA 129.478 3.111 . . . . 0.0 114.568 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 1.6 p30 -100.83 -127.67 0.2 Allowed 'General case' 0 C--N 1.359 1.016 0 O-C-N 118.6 -2.563 . . . . 0.0 113.035 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -96.66 -46.4 6.32 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 124.785 1.234 . . . . 0.0 114.042 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.286 12.3 t -74.12 -51.86 4.54 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 116.797 2.147 . . . . 0.0 116.797 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.3 -173.63 12.96 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 126.012 3.183 . . . . 0.0 112.755 0.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 75.0 m -95.72 116.79 29.38 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.555 ' HG3' ' HB3' ' A' ' 132' ' ' GLN . 5.9 tmm_? -155.34 152.94 29.76 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 120.781 -1.199 . . . . 0.0 109.83 -176.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.93 -149.2 19.86 Favored Glycine 0 CA--C 1.488 -1.611 0 N-CA-C 104.468 -3.453 . . . . 0.0 104.468 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -86.78 111.33 20.62 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 126.166 1.786 . . . . 0.0 110.738 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.1 m -98.37 175.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 126.136 1.774 . . . . 0.0 107.069 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.9 t -94.31 128.56 40.88 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.587 ' HB3' HG22 ' A' ' 129' ' ' VAL 0.293 47.7 pttt -77.6 -7.26 56.1 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-N 121.206 1.821 . . . . 0.0 113.791 -176.407 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -67.64 -19.32 65.2 Favored 'General case' 0 C--N 1.364 1.223 0 C-N-CA 124.72 1.208 . . . . 0.0 113.307 172.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.9 mt -94.55 -0.23 54.74 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 125.666 1.586 . . . . 0.0 114.272 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.511 HD13 HG11 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -101.29 157.02 17.1 Favored 'General case' 0 C--N 1.366 1.285 0 CA-C-N 122.025 2.193 . . . . 0.0 108.3 179.378 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.457 ' HG3' ' CE1' ' A' ' 165' ' ' PHE . 21.0 mmtt -119.67 168.07 10.94 Favored Pre-proline 0 C--O 1.222 -0.376 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.8 156.24 15.66 Favored 'Trans proline' 0 C--N 1.326 -0.649 1 C-N-CA 125.67 4.247 . . . . 0.0 113.481 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.429 ' CE2' ' HA2' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -97.5 148.95 22.71 Favored 'General case' 0 C--N 1.359 0.994 0 CA-C-O 122.621 1.2 . . . . 0.0 110.109 172.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.5 t -171.38 -37.85 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 101.115 -3.661 . . . . 0.0 101.115 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 151' ' ' TYR . . . 119.74 -159.36 14.9 Favored Glycine 0 C--N 1.36 1.886 0 CA-C-N 113.949 -1.478 . . . . 0.0 115.969 140.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.3 m -46.35 -16.74 0.03 OUTLIER 'General case' 0 C--N 1.373 1.609 1 C-N-CA 133.263 4.625 . . . . 0.0 117.629 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -77.69 -23.07 49.64 Favored 'General case' 0 N--CA 1.442 -0.873 1 C-N-CA 135.379 5.471 . . . . 0.0 112.831 176.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 6.8 t -89.17 153.9 20.58 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.209 1.404 . . . . 0.0 114.052 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -61.23 -36.26 79.46 Favored 'General case' 0 C--N 1.369 1.417 0 C-N-CA 126.404 1.881 . . . . 0.0 113.858 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -73.08 -4.57 33.42 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 125.686 1.594 . . . . 0.0 113.197 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -111.75 7.11 20.16 Favored 'General case' 0 C--N 1.372 1.567 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.311 1.5 pp0? -127.98 -172.89 2.79 Favored 'General case' 0 C--N 1.363 1.194 0 O-C-N 119.621 -1.924 . . . . 0.0 111.853 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -63.69 122.38 16.23 Favored 'General case' 0 C--N 1.372 1.584 0 C-N-CA 126.824 2.05 . . . . 0.0 112.897 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.45 -9.04 66.89 Favored Glycine 0 C--N 1.359 1.854 0 C-N-CA 124.38 0.99 . . . . 0.0 112.22 -167.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.55 140.67 20.59 Favored Glycine 0 C--N 1.365 2.157 0 C-N-CA 126.926 2.203 . . . . 0.0 116.705 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -61.47 -21.6 64.33 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 119.453 3.131 . . . . 0.0 119.453 -172.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.457 ' CE1' ' HG3' ' A' ' 149' ' ' LYS . 1.7 m-85 -108.74 -3.6 17.67 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 120.623 -1.298 . . . . 0.0 111.449 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -86.53 165.46 16.22 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 125.566 2.603 . . . . 0.0 117.171 -173.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.4 m 169.95 173.84 0.05 Allowed 'General case' 0 CA--C 1.503 -0.848 2 N-CA-C 98.487 -4.634 . . . . 0.0 98.487 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -121.12 101.49 7.7 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-N 122.299 2.318 . . . . 0.0 107.168 170.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -119.58 123.9 28.35 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 101.173 -3.64 . . . . 0.0 101.173 169.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -55.73 -29.72 72.63 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 125.189 3.926 . . . . 0.0 116.868 -174.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -65.22 -36.11 83.13 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.921 2.889 . . . . 0.0 113.067 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.9 mt -68.36 -41.79 83.78 Favored 'Isoleucine or valine' 0 C--N 1.38 1.895 0 C-N-CA 126.164 1.786 . . . . 0.0 110.612 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.7 mt -68.55 -43.9 75.63 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 125.826 1.651 . . . . 0.0 113.275 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -58.05 -42.97 86.55 Favored 'General case' 0 CA--C 1.486 -1.498 0 C-N-CA 128.581 2.752 . . . . 0.0 113.777 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.59 -34.35 77.7 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 130.41 3.484 . . . . 0.0 110.09 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.255 6.8 mtt -70.09 -33.4 71.84 Favored 'General case' 0 C--N 1.376 1.721 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 165.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -71.31 -45.7 62.41 Favored 'General case' 0 C--N 1.379 1.884 0 C-N-CA 125.961 1.704 . . . . 0.0 110.955 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -67.48 -52.81 34.86 Favored 'General case' 0 C--N 1.375 1.699 0 C-N-CA 127.882 2.473 . . . . 0.0 112.154 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.64 85.55 Favored 'General case' 0 C--N 1.374 1.636 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.28 -40.37 93.78 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-N 121.714 2.052 . . . . 0.0 112.527 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.27 -52.13 63.3 Favored 'General case' 0 C--N 1.367 1.353 0 O-C-N 119.099 -2.251 . . . . 0.0 113.935 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.84 72.8 Favored 'General case' 0 C--N 1.361 1.065 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -50.21 43.54 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 127.084 2.154 . . . . 0.0 112.309 171.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.378 0.0 OUTLIER -81.19 -12.88 59.06 Favored 'General case' 0 C--N 1.363 1.183 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -170.528 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -107.42 -107.94 0.32 Allowed 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.731 0.812 . . . . 0.0 111.734 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 188' ' ' ILE . 19.5 t70 -136.25 176.31 8.81 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 119.839 -1.788 . . . . 0.0 112.053 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.537 ' HA ' ' HE ' ' A' ' 190' ' ' ARG . 40.6 mmtm -51.45 -43.83 62.18 Favored 'General case' 0 C--N 1.384 2.065 1 C-N-CA 132.495 4.318 . . . . 0.0 114.207 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.474 HG22 ' HB3' ' A' ' 186' ' ' ASP . 9.5 tt -59.84 -27.99 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 129.929 3.292 . . . . 0.0 114.148 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -71.95 -45.33 61.51 Favored 'General case' 0 C--N 1.376 1.737 0 C-N-CA 126.288 1.835 . . . . 0.0 112.983 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.537 ' HE ' ' HA ' ' A' ' 187' ' ' LYS . 0.0 OUTLIER -75.13 -41.5 58.29 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 126.91 2.084 . . . . 0.0 114.7 170.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.46 -20.92 62.84 Favored 'General case' 0 C--N 1.369 1.422 0 C-N-CA 127.985 2.514 . . . . 0.0 113.329 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.74 -38.04 88.96 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 128.438 2.695 . . . . 0.0 114.044 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.4 mt -99.21 -46.27 5.61 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 126.777 2.031 . . . . 0.0 108.648 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . 0.256 . . 65.13 -94.16 0.04 OUTLIER 'General case' 0 C--N 1.367 1.351 0 C-N-CA 128.937 2.895 . . . . 0.0 114.39 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 8.4 m -117.05 0.82 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.989 1.716 . . . . 0.0 109.673 175.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.1 t 70.81 -52.44 0.67 Allowed 'General case' 0 C--N 1.366 1.322 0 C-N-CA 127.058 2.143 . . . . 0.0 115.465 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -157.23 158.43 36.15 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.52 147.77 18.29 Favored Pre-proline 0 C--N 1.352 0.694 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.9 -104.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 124.229 3.286 . . . . 0.0 112.256 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 41.0 t -105.85 55.68 0.68 Allowed 'General case' 0 C--N 1.358 0.948 0 C-N-CA 125.975 1.71 . . . . 0.0 108.793 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--N 1.36 1.052 0 C-N-CA 128.855 2.862 . . . . 0.0 113.953 179.578 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp . . . . . 0 N--CA 1.438 -1.062 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.07 -72.21 0.7 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 125.655 1.582 . . . . 0.0 110.553 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -119.55 119.02 32.59 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 126.156 1.782 . . . . 0.0 107.262 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -103.46 125.47 50.06 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.205 1.402 . . . . 0.0 109.852 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.2 mt -108.17 -93.36 0.41 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.747 1.219 . . . . 0.0 109.529 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.49 22.91 0.09 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 130.103 3.361 . . . . 0.0 115.163 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.31 4.24 47.19 Favored Glycine 0 C--N 1.354 1.579 0 C-N-CA 127.21 2.338 . . . . 0.0 114.705 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.2 52.96 1.8 Allowed Glycine 0 C--N 1.36 1.913 0 C-N-CA 126.485 1.993 . . . . 0.0 117.121 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.1 tp -91.22 -26.17 19.16 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 129.276 3.03 . . . . 0.0 110.198 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -71.64 -24.49 61.87 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 131.646 3.979 . . . . 0.0 115.962 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 64.9 ttp85 -171.14 -71.36 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t 175.91 -166.37 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 100.813 -3.773 . . . . 0.0 100.813 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.02 53.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 123.634 1.683 . . . . 0.0 109.203 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.13 114.91 65.31 Favored Pre-proline 0 C--N 1.358 0.946 0 C-N-CA 125.289 1.435 . . . . 0.0 110.923 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -84.39 162.85 12.95 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.08 3.187 . . . . 0.0 112.512 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -114.83 -125.93 0.29 Allowed 'General case' 0 C--N 1.351 0.659 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.63 117.08 58.86 Favored Pre-proline 0 C--N 1.358 0.964 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -72.53 -12.74 27.24 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 125.01 3.807 . . . . 0.0 113.594 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 p -84.55 -40.22 17.84 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 128.936 2.894 . . . . 0.0 109.568 172.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.9 m 63.4 -38.1 0.17 Allowed 'General case' 0 C--N 1.366 1.31 0 C-N-CA 130.243 3.417 . . . . 0.0 118.599 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.2 p -141.21 71.35 1.36 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.744 2.017 . . . . 0.0 108.367 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -163.09 62.12 0.19 Allowed 'General case' 0 C--N 1.364 1.236 0 CA-C-N 119.854 1.206 . . . . 0.0 113.409 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -118.04 125.78 51.0 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 120.215 -1.553 . . . . 0.0 110.067 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 87.4 p -111.73 166.22 11.31 Favored Pre-proline 0 C--N 1.36 1.022 0 C-N-CA 126.126 1.77 . . . . 0.0 110.773 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -54.56 149.14 40.66 Favored 'Trans proline' 0 C--N 1.37 1.691 1 C-N-CA 126.107 4.538 . . . . 0.0 119.188 -170.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.45 -39.37 2.89 Favored Glycine 0 C--N 1.356 1.689 0 C-N-CA 126.023 1.773 . . . . 0.0 113.015 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.54 169.04 17.58 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.476 HD21 ' HD2' ' A' ' 190' ' ' ARG . 3.3 mm? -94.89 134.46 37.51 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.0 m -136.08 159.22 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-O 123.613 1.673 . . . . 0.0 107.548 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -104.18 116.73 32.72 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.62 135.08 53.76 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.497 2.319 . . . . 0.0 112.791 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.469 ' HB2' ' CZ2' ' A' ' 105' ' ' TRP . 51.7 tptt -112.93 141.83 46.31 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 173.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.8 ttm -128.82 149.72 50.62 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.018 -1.676 . . . . 0.0 108.615 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -65.16 100.11 0.42 Allowed 'General case' 0 C--N 1.368 1.39 0 C-N-CA 125.788 1.635 . . . . 0.0 114.125 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.97 -4.38 25.67 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 125.873 1.701 . . . . 0.0 112.909 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -112.01 161.26 26.65 Favored Pre-proline 0 C--N 1.358 0.95 0 C-N-CA 125.41 1.484 . . . . 0.0 111.588 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.47 167.53 26.09 Favored 'Trans proline' 0 C--N 1.366 1.479 1 C-N-CA 126.12 4.547 . . . . 0.0 112.682 164.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.469 ' CZ2' ' HB2' ' A' ' 99' ' ' LYS . 6.9 m95 -65.34 132.8 49.94 Favored 'General case' 0 C--N 1.363 1.154 0 CA-C-O 124.316 2.008 . . . . 0.0 113.238 171.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.26 10.6 m95 -134.88 134.55 21.98 Favored Pre-proline 0 N--CA 1.413 -2.276 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -169.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.2 143.15 39.17 Favored 'Trans proline' 0 C--N 1.38 2.204 1 C-N-CA 126.123 4.549 . . . . 0.0 110.916 156.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -156.77 165.42 36.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.27 3.028 . . . . 0.0 114.39 -161.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.44 HD23 ' OE1' ' A' ' 132' ' ' GLN . 8.8 tp -119.45 138.49 53.09 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.345 2.258 . . . . 0.0 107.745 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.31 121.89 33.43 Favored 'Isoleucine or valine' 0 C--N 1.378 1.836 0 C-N-CA 126.387 1.875 . . . . 0.0 106.528 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -127.38 152.75 47.09 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 119.626 -1.921 . . . . 0.0 113.172 -167.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.79 113.58 26.92 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 127.472 2.309 . . . . 0.0 106.463 173.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.464 ' CD2' HH11 ' A' ' 140' ' ' ARG . 36.7 m170 -62.56 159.98 38.25 Favored Pre-proline 0 C--N 1.358 0.975 0 C-N-CA 130.224 3.41 . . . . 0.0 117.456 -175.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.77 -1.41 0.24 Allowed 'Trans proline' 0 CA--C 1.564 2.021 1 C-N-CA 125.551 4.167 . . . . 0.0 116.951 170.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.72 31.27 5.78 Favored 'General case' 0 C--N 1.356 0.878 1 C-N-CA 134.813 5.245 . . . . 0.0 107.603 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.339 0.1 OUTLIER -69.53 150.29 47.29 Favored 'General case' 0 C--N 1.374 1.636 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -172.342 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.22 5.51 30.31 Favored Glycine 0 C--N 1.359 1.836 0 CA-C-N 112.174 -2.285 . . . . 0.0 111.556 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.4 m -152.56 135.29 15.39 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 100.813 -3.773 . . . . 0.0 100.813 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.421 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.255 2.2 p90 -155.23 -37.36 0.09 Allowed 'General case' 0 C--N 1.365 1.261 0 CA-C-N 120.423 1.465 . . . . 0.0 113.684 -175.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.5 tt -108.26 140.48 26.6 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-O 122.972 1.368 . . . . 0.0 110.574 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -119.88 121.29 38.72 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 101.091 -3.67 . . . . 0.0 101.091 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.84 179.71 4.19 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.097 0.959 . . . . 0.0 112.794 -171.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -46.3 131.73 10.41 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 120.241 3.423 . . . . 0.0 120.241 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 172.14 -51.38 0.17 Allowed Glycine 0 C--N 1.353 1.527 0 N-CA-C 106.37 -2.692 . . . . 0.0 106.37 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.0 mmmt -103.69 -52.81 2.9 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 126.605 1.962 . . . . 0.0 108.985 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.8 t -171.67 -166.49 0.44 Allowed 'General case' 0 C--N 1.353 0.739 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -129.13 120.68 52.15 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 124.917 1.287 . . . . 0.0 110.423 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -130.18 139.42 50.85 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 126.519 1.928 . . . . 0.0 112.786 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.97 163.25 36.95 Favored 'Isoleucine or valine' 0 C--N 1.367 1.347 0 C-N-CA 126.524 1.929 . . . . 0.0 105.844 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.421 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 1.1 m80 -83.34 140.93 32.15 Favored 'General case' 0 C--N 1.373 1.625 0 CA-C-N 120.654 1.57 . . . . 0.0 113.223 172.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.417 HG11 HD13 ' A' ' 148' ' ' LEU . 3.9 m -150.96 171.97 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.868 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.44 ' OE1' HD23 ' A' ' 109' ' ' LEU . 3.3 pt20 -136.69 146.77 46.28 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 124.453 1.101 . . . . 0.0 109.104 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.49 124.5 52.42 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 104.713 -2.328 . . . . 0.0 104.713 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.71 60.34 0.07 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 127.42 2.288 . . . . 0.0 113.394 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -98.29 -124.12 0.14 Allowed 'General case' 0 C--N 1.361 1.085 0 O-C-N 119.572 -1.955 . . . . 0.0 111.859 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -106.27 -52.55 2.77 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.731 1.612 . . . . 0.0 111.716 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 m -69.82 -40.35 13.19 Favored Pre-proline 0 C--N 1.364 1.232 0 N-CA-C 118.508 2.781 . . . . 0.0 118.508 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.14 178.0 36.54 Favored 'Cis proline' 0 C--N 1.354 0.852 0 CA-C-N 126.442 3.336 . . . . 0.0 110.479 -4.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.6 m -89.67 115.62 27.18 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 118.743 -2.473 . . . . 0.0 106.849 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.464 HH11 ' CD2' ' A' ' 113' ' ' HIS . 39.2 ttp85 -149.04 150.97 33.68 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-O 122.6 1.19 . . . . 0.0 109.347 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 165.62 -157.06 29.38 Favored Glycine 0 CA--C 1.491 -1.413 0 N-CA-C 105.973 -2.851 . . . . 0.0 105.973 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -80.22 110.17 15.39 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 126.547 1.939 . . . . 0.0 109.885 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.17 169.25 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 124.636 1.174 . . . . 0.0 110.543 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.5 m -90.23 115.67 27.63 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.47 33.8 pttt -69.25 -5.6 23.91 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -168.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -82.05 -12.78 58.09 Favored 'General case' 0 C--N 1.365 1.256 0 O-C-N 119.242 -2.161 . . . . 0.0 109.714 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.73 -0.63 45.06 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 128.679 2.792 . . . . 0.0 110.145 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.417 HD13 HG11 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -104.89 125.0 50.46 Favored 'General case' 0 C--N 1.388 2.262 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 173.147 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -118.97 168.48 9.73 Favored Pre-proline 0 C--O 1.218 -0.563 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -82.47 153.23 15.73 Favored 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 124.433 3.422 . . . . 0.0 112.697 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -127.6 121.2 29.92 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.324 1.059 . . . . 0.0 111.696 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.694 ' HA ' HD13 ' A' ' 183' ' ' LEU . 8.7 t -162.14 30.67 0.12 Allowed 'General case' 0 C--N 1.359 0.997 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.72 82.12 0.09 OUTLIER Glycine 0 C--N 1.35 1.345 0 C-N-CA 116.499 -2.762 . . . . 0.0 115.228 -166.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . 0.34 89.2 p -68.42 -10.11 53.0 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 121.007 2.404 . . . . 0.0 116.791 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -112.12 32.02 5.83 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 130.166 3.386 . . . . 0.0 108.656 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 19.3 t -103.04 133.4 48.22 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.258 42.7 tttm -55.72 -33.08 63.91 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -174.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -70.89 -19.2 62.64 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 124.704 1.202 . . . . 0.0 113.972 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.49 3.26 54.37 Favored 'General case' 0 C--N 1.371 1.536 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -130.56 -173.07 2.97 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 125.743 1.617 . . . . 0.0 112.042 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -62.79 122.22 15.39 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 126.284 1.834 . . . . 0.0 113.106 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.02 -8.01 64.95 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 124.554 1.073 . . . . 0.0 112.475 -169.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.09 146.2 21.85 Favored Glycine 0 C--N 1.361 1.935 0 C-N-CA 126.565 2.031 . . . . 0.0 115.824 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -60.37 -42.25 95.41 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . 0.322 0.1 OUTLIER -99.84 2.93 44.37 Favored 'General case' 0 C--N 1.363 1.163 0 CA-C-N 120.402 1.455 . . . . 0.0 114.826 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -91.77 140.83 29.31 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 126.551 1.94 . . . . 0.0 107.928 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.5 m -166.66 132.4 2.28 Favored 'General case' 0 N--CA 1.446 -0.635 1 N-CA-C 99.797 -4.149 . . . . 0.0 99.797 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.93 100.53 10.83 Favored 'General case' 0 C--N 1.369 1.432 0 CA-C-O 126.281 2.944 . . . . 0.0 112.848 -173.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.57 131.56 24.42 Favored Pre-proline 0 N--CA 1.417 -2.093 3 N-CA-C 98.51 -4.626 . . . . 0.0 98.51 164.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.53 -24.7 63.1 Favored 'Trans proline' 0 CA--C 1.543 0.942 1 C-N-CA 125.534 4.156 . . . . 0.0 115.998 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -69.62 -35.88 75.65 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.47 2.708 . . . . 0.0 113.831 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 45.8 mt -74.12 -36.18 43.32 Favored 'Isoleucine or valine' 0 C--N 1.376 1.745 0 C-N-CA 126.369 1.868 . . . . 0.0 109.854 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 177' ' ' GLN . 20.1 mt -69.0 -45.63 70.05 Favored 'General case' 0 C--N 1.367 1.336 0 C-N-CA 125.298 1.439 . . . . 0.0 112.488 172.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -58.11 -43.21 87.04 Favored 'General case' 0 CA--C 1.486 -1.519 0 C-N-CA 127.951 2.5 . . . . 0.0 114.596 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.25 -36.88 85.51 Favored 'General case' 0 N--CA 1.428 -1.539 0 C-N-CA 129.449 3.1 . . . . 0.0 111.208 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.1 mtt -65.04 -35.51 81.41 Favored 'General case' 0 C--N 1.379 1.883 0 CA-C-O 115.486 -2.197 . . . . 0.0 112.724 165.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 13.6 mt-30 -74.06 -40.2 62.98 Favored 'General case' 0 C--N 1.383 2.026 0 C-N-CA 126.019 1.728 . . . . 0.0 113.731 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.401 HH21 ' HB3' ' A' ' 193' ' ' LEU . 0.2 OUTLIER -73.68 -49.46 25.69 Favored 'General case' 0 C--N 1.374 1.651 0 C-N-CA 131.551 3.941 . . . . 0.0 111.491 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.54 95.72 Favored 'General case' 0 C--N 1.376 1.75 0 C-N-CA 123.836 0.854 . . . . 0.0 113.267 165.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.329 38.5 t70 -57.13 -52.76 64.02 Favored 'General case' 0 C--N 1.387 2.232 0 C-N-CA 126.692 1.997 . . . . 0.0 113.014 172.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -33.44 70.17 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 121.777 2.081 . . . . 0.0 115.702 173.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.413 ' HB1' ' CD ' ' A' ' 190' ' ' ARG . . . -76.26 -44.84 35.48 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 172.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.694 HD13 ' HA ' ' A' ' 152' ' ' THR . 3.9 pp -69.53 -36.86 76.79 Favored 'General case' 0 C--N 1.374 1.65 0 C-N-CA 126.16 1.784 . . . . 0.0 114.221 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.38 -9.78 58.14 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.664 1.586 . . . . 0.0 112.125 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -124.68 -101.27 0.39 Allowed 'General case' 0 C--N 1.356 0.867 0 CA-C-O 120.756 0.312 . . . . 0.0 111.44 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -135.77 152.69 51.37 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.036 -1.04 . . . . 0.0 110.953 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.351 17.2 ttpt -51.51 -35.96 42.63 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 130.839 3.656 . . . . 0.0 116.2 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 14.0 tt -55.03 -30.22 23.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 129.032 2.933 . . . . 0.0 113.035 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -73.22 -37.88 66.27 Favored 'General case' 0 C--N 1.375 1.691 0 O-C-N 119.717 -1.864 . . . . 0.0 113.795 176.076 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.476 ' HD2' HD21 ' A' ' 95' ' ' LEU 0.28 0.0 OUTLIER -76.23 -44.35 38.01 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 167.499 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.31 78.4 mt -79.19 -18.96 52.02 Favored 'General case' 0 C--N 1.366 1.292 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -173.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -84.41 -12.95 53.47 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.607 1.163 . . . . 0.0 113.216 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.401 ' HB3' HH21 ' A' ' 178' ' ' ARG . 9.2 mp -105.03 -51.34 3.05 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 126.18 1.792 . . . . 0.0 106.22 176.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 46.48 -113.25 0.44 Allowed 'General case' 0 C--N 1.366 1.287 0 C-N-CA 129.696 3.198 . . . . 0.0 115.787 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.8 m -88.27 12.87 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 128.182 2.593 . . . . 0.0 113.221 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.286 1.5 t 95.11 48.4 0.0 OUTLIER 'General case' 0 C--N 1.359 0.982 0 C-N-CA 129.023 2.929 . . . . 0.0 109.114 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -117.25 63.75 0.73 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 127.535 2.334 . . . . 0.0 106.481 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -59.76 -43.18 94.58 Favored Pre-proline 0 C--N 1.365 1.262 0 C-N-CA 127.907 2.483 . . . . 0.0 116.494 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.42 -42.94 2.37 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 124.074 3.183 . . . . 0.0 111.411 167.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.278 1.9 m 67.37 -48.24 0.49 Allowed 'General case' 0 C--N 1.369 1.423 0 C-N-CA 129.525 3.13 . . . . 0.0 115.838 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 . . . . . 0 C--N 1.351 0.669 0 C-N-CA 127.523 2.329 . . . . 0.0 109.613 178.75 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 mttp . . . . . 0 N--CA 1.443 -0.793 0 CA-C-O 121.836 0.827 . . . . 0.0 108.788 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.06 -179.16 6.02 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -86.74 128.67 35.03 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 124.887 1.275 . . . . 0.0 111.935 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -102.66 120.33 40.38 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.322 1.849 . . . . 0.0 108.561 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.24 -158.46 0.86 Allowed 'General case' 0 C--N 1.362 1.138 0 C-N-CA 126.144 1.777 . . . . 0.0 107.486 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -100.46 20.85 14.16 Favored 'General case' 0 C--N 1.37 1.492 0 O-C-N 120.463 -1.398 . . . . 0.0 113.078 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.78 -12.85 57.9 Favored Glycine 0 C--N 1.363 2.06 0 C-N-CA 125.63 1.586 . . . . 0.0 111.177 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.51 -172.03 45.08 Favored Glycine 0 N--CA 1.441 -1.02 2 N-CA-C 102.629 -4.188 . . . . 0.0 102.629 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 tp -154.47 53.15 0.67 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 53.3 ttp85 -65.44 -38.22 89.23 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.642 2.777 . . . . 0.0 117.79 -173.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -94.48 -15.06 24.53 Favored 'General case' 0 C--N 1.362 1.147 0 O-C-N 120.545 -1.347 . . . . 0.0 110.589 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.267 19.7 m 85.45 19.03 0.11 Allowed 'General case' 0 C--N 1.358 0.973 0 C-N-CA 129.744 3.218 . . . . 0.0 114.079 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.9 m -74.92 69.19 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 127.047 2.139 . . . . 0.0 114.527 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.16 115.03 45.63 Favored Pre-proline 0 C--N 1.358 0.937 0 O-C-N 120.205 -1.56 . . . . 0.0 107.67 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.01 -72.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 124.322 3.348 . . . . 0.0 111.017 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -165.7 -64.51 0.03 OUTLIER 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.6 134.98 19.44 Favored Pre-proline 0 C--N 1.355 0.846 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.76 167.84 18.19 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.248 2.632 . . . . 0.0 114.806 -171.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 m -114.15 125.72 54.26 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 125.315 1.446 . . . . 0.0 111.547 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 m -56.47 -39.73 73.69 Favored 'General case' 0 C--N 1.37 1.485 0 C-N-CA 129.375 3.07 . . . . 0.0 117.461 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.4 p -117.15 49.92 1.14 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 124.378 1.071 . . . . 0.0 112.95 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.12 109.9 6.38 Favored 'General case' 0 C--N 1.361 1.086 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.401 ' CD1' HD12 ' A' ' 148' ' ' LEU . 18.2 m-85 -125.71 128.49 47.86 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.952 1.701 . . . . 0.0 113.47 -173.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.318 90.8 p -110.2 162.59 19.84 Favored Pre-proline 0 C--N 1.364 1.235 0 O-C-N 120.249 -1.532 . . . . 0.0 114.855 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.24 136.9 77.75 Favored 'Trans proline' 0 C--N 1.378 2.095 1 C-N-CA 126.449 4.766 . . . . 0.0 119.217 -170.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.63 -20.83 19.97 Favored Glycine 0 C--N 1.364 2.11 0 C-N-CA 125.605 1.574 . . . . 0.0 111.813 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -85.53 169.04 13.95 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 125.697 1.599 . . . . 0.0 114.891 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.477 HD21 ' HD2' ' A' ' 190' ' ' ARG . 2.8 mm? -110.28 131.68 54.84 Favored 'General case' 0 C--N 1.369 1.447 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 172.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -134.46 161.77 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -106.98 138.31 43.39 Favored 'General case' 0 C--O 1.217 -0.618 1 N-CA-C 99.768 -4.16 . . . . 0.0 99.768 165.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 148' ' ' LEU . . . -128.86 152.58 48.36 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 121.632 2.014 . . . . 0.0 111.976 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -121.46 146.04 47.32 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.9 ttp -128.85 146.43 50.93 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 119.61 -1.931 . . . . 0.0 108.016 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -48.6 91.06 0.0 OUTLIER 'General case' 0 C--N 1.366 1.285 0 C-N-CA 129.475 3.11 . . . . 0.0 117.01 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.06 -9.13 33.7 Favored Glycine 0 C--N 1.36 1.875 0 C-N-CA 125.102 1.334 . . . . 0.0 113.436 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -99.71 162.12 22.2 Favored Pre-proline 0 C--N 1.359 0.983 0 C-N-CA 125.308 1.443 . . . . 0.0 109.231 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.88 167.31 26.27 Favored 'Trans proline' 0 CA--C 1.537 0.674 1 C-N-CA 125.848 4.365 . . . . 0.0 114.736 167.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -60.91 132.0 52.47 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 127.335 2.254 . . . . 0.0 115.04 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -132.29 108.56 13.61 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 121.729 3.974 . . . . 0.0 121.729 -171.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HG2' ' HB3' ' A' ' 175' ' ' ALA . 7.6 Cg_endo -58.07 113.58 1.59 Allowed 'Trans proline' 0 C--N 1.388 2.631 1 C-N-CA 126.275 4.65 . . . . 0.0 111.588 165.36 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.1 m -123.65 166.12 16.05 Favored 'General case' 0 N--CA 1.438 -1.026 1 C-N-CA 132.871 4.468 . . . . 0.0 114.147 -160.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tp -126.12 144.41 50.76 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.16 118.8 37.17 Favored 'Isoleucine or valine' 0 C--N 1.366 1.294 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -113.41 143.59 44.23 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.103 -1.623 . . . . 0.0 111.679 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -79.31 111.31 15.43 Favored 'General case' 0 C--N 1.373 1.612 0 O-C-N 120.379 -1.451 . . . . 0.0 109.597 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.475 ' HB2' ' CG ' ' A' ' 130' ' ' HIS . 9.9 t60 -69.22 160.15 80.09 Favored Pre-proline 0 C--N 1.348 0.522 0 CA-C-O 114.488 -2.672 . . . . 0.0 115.336 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.82 -6.47 2.56 Favored 'Trans proline' 0 CA--C 1.562 1.901 1 CA-C-N 128.814 4.184 . . . . 0.0 116.577 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -108.32 29.72 7.09 Favored 'General case' 0 C--N 1.357 0.922 1 C-N-CA 133.384 4.674 . . . . 0.0 109.642 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -63.45 149.73 45.36 Favored 'General case' 0 C--N 1.365 1.276 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.07 -20.14 50.14 Favored Glycine 0 C--N 1.36 1.889 0 CA-C-N 113.226 -1.806 . . . . 0.0 110.007 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.86 119.1 38.56 Favored 'General case' 0 N--CA 1.446 -0.672 2 N-CA-C 98.646 -4.575 . . . . 0.0 98.646 168.249 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.592 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.359 0.0 OUTLIER -121.82 -33.41 3.58 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -169.378 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 129' ' ' VAL . 10.3 pt -108.33 155.84 9.09 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 120.269 -1.519 . . . . 0.0 110.581 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -141.35 151.16 43.32 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 128.016 2.527 . . . . 0.0 104.208 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.65 130.21 11.48 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 121.0 -1.063 . . . . 0.0 108.249 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -117.4 98.93 6.67 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.952 2.101 . . . . 0.0 108.654 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.43 -89.78 1.02 Allowed Glycine 0 C--N 1.36 1.916 0 N-CA-C 117.869 1.908 . . . . 0.0 117.869 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -142.57 71.34 1.34 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 125.0 1.32 . . . . 0.0 109.391 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.0 m -179.92 170.36 1.21 Allowed 'General case' 0 C--N 1.351 0.667 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.49 145.46 16.22 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -141.32 150.31 42.34 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.498 2.319 . . . . 0.0 110.757 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' A' ' 145' ' ' LYS . 26.2 m -129.0 162.36 36.48 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 129.592 3.157 . . . . 0.0 104.475 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.592 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -82.5 124.8 30.43 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.335 -1.478 . . . . 0.0 110.976 172.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.78 169.48 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.436 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.98 150.84 46.32 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -106.21 127.86 53.53 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.36 1.864 . . . . 0.0 107.376 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -74.95 69.35 1.89 Allowed 'General case' 0 C--N 1.379 1.872 0 CA-C-N 120.258 1.39 . . . . 0.0 111.881 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -88.98 -119.92 0.05 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 127.459 2.304 . . . . 0.0 111.002 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -107.25 -51.99 2.83 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.184 1.794 . . . . 0.0 110.91 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.6 t -69.97 -49.98 18.02 Favored Pre-proline 0 C--N 1.36 1.063 0 C-N-CA 127.975 2.51 . . . . 0.0 117.734 -172.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -81.99 -175.64 15.67 Favored 'Cis proline' 0 C--N 1.347 0.497 0 CA-C-N 126.104 3.216 . . . . 0.0 111.52 -0.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 34.5 m -94.62 141.17 28.92 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.291 1.036 . . . . 0.0 108.319 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -160.23 156.21 26.15 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.16 -159.8 29.21 Favored Glycine 0 CA--C 1.484 -1.904 1 N-CA-C 98.235 -5.946 . . . . 0.0 98.235 174.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -104.85 113.73 27.5 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 143' ' ' VAL . 13.5 m -87.83 173.78 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 C-N-CA 128.231 2.612 . . . . 0.0 106.711 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.8 m -94.31 110.88 22.61 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.494 ' HB3' HG22 ' A' ' 129' ' ' VAL . 16.9 ptmt -50.93 -17.8 0.65 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -173.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -69.27 -19.47 63.91 Favored 'General case' 0 N--CA 1.439 -1.014 1 C-N-CA 131.784 4.034 . . . . 0.0 112.75 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.4 mt -92.33 -2.23 56.53 Favored 'General case' 0 C--N 1.365 1.278 0 C-N-CA 126.182 1.793 . . . . 0.0 113.935 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -95.35 156.9 16.13 Favored 'General case' 0 C--N 1.369 1.451 0 CA-C-N 122.231 2.287 . . . . 0.0 109.715 174.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.06 159.04 58.43 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 102.567 -3.123 . . . . 0.0 102.567 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.98 151.93 21.51 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 125.035 3.823 . . . . 0.0 111.399 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.365 1.0 OUTLIER -93.31 -116.2 0.09 Allowed 'General case' 0 C--N 1.367 1.335 0 O-C-N 120.649 -1.282 . . . . 0.0 110.737 175.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.426 4.6 t 63.47 -36.87 0.16 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 127.849 2.459 . . . . 0.0 116.149 -174.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.04 88.54 0.53 Allowed Glycine 0 C--N 1.349 1.27 0 C-N-CA 126.448 1.975 . . . . 0.0 116.769 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.2 m -67.66 -10.92 56.6 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 131.473 3.909 . . . . 0.0 115.412 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -121.49 24.58 9.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 128.458 2.703 . . . . 0.0 108.496 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 91.2 p -87.39 139.29 30.7 Favored 'General case' 0 C--N 1.374 1.667 0 C-N-CA 125.598 1.559 . . . . 0.0 107.821 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -56.39 -24.34 43.97 Favored 'General case' 0 C--N 1.372 1.579 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -82.24 -19.86 38.81 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.734 1.614 . . . . 0.0 113.224 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.61 -13.99 22.49 Favored 'General case' 0 C--N 1.37 1.494 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.304 0.0 OUTLIER -107.88 -173.97 2.41 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 125.395 1.478 . . . . 0.0 112.939 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -69.31 122.1 18.2 Favored 'General case' 0 C--N 1.373 1.613 0 O-C-N 120.308 -1.495 . . . . 0.0 112.784 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.22 -9.47 50.06 Favored Glycine 0 C--N 1.354 1.553 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.81 -166.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.87 155.76 46.78 Favored Glycine 0 C--N 1.368 2.339 0 N-CA-C 119.97 2.748 . . . . 0.0 119.97 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.69 -41.54 77.53 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.927 3.691 . . . . 0.0 116.164 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -98.42 -17.74 18.64 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -41.08 -36.58 0.72 Allowed 'General case' 0 C--N 1.356 0.854 2 C-N-CA 132.723 4.409 . . . . 0.0 122.472 -168.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.6 m -14.17 92.86 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 1 C-N-CA 132.032 4.133 . . . . 0.0 117.707 -177.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.99 101.65 13.1 Favored 'General case' 0 C--N 1.368 1.38 0 CA-C-O 126.016 2.817 . . . . 0.0 114.003 -166.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -119.78 135.55 24.28 Favored Pre-proline 0 N--CA 1.423 -1.776 1 C-N-CA 133.803 4.841 . . . . 0.0 102.681 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -55.08 -22.76 32.76 Favored 'Trans proline' 0 CA--C 1.544 1.019 1 C-N-CA 125.973 4.448 . . . . 0.0 117.733 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -70.16 -35.96 74.38 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 131.251 3.82 . . . . 0.0 112.453 173.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.8 mt -76.7 -32.7 20.93 Favored 'Isoleucine or valine' 0 C--N 1.375 1.683 0 C-N-CA 127.582 2.353 . . . . 0.0 109.084 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 26.3 mt -66.46 -51.88 52.15 Favored 'General case' 0 C--N 1.373 1.627 0 C-N-CA 127.063 2.145 . . . . 0.0 111.055 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -57.45 -34.52 69.06 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.127 1.771 . . . . 0.0 114.751 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.411 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . . . -69.33 -50.75 43.59 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 130.484 3.514 . . . . 0.0 113.86 172.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.415 0.0 OUTLIER -68.16 -33.1 73.85 Favored 'General case' 0 C--N 1.385 2.124 0 CA-C-N 121.525 1.966 . . . . 0.0 113.7 173.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -71.96 -48.89 41.95 Favored 'General case' 0 C--N 1.373 1.596 0 C-N-CA 126.688 1.995 . . . . 0.0 112.751 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -38.51 77.83 Favored 'General case' 0 C--N 1.383 2.042 0 O-C-N 119.022 -2.299 . . . . 0.0 114.986 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.89 -51.09 69.61 Favored 'General case' 0 C--N 1.379 1.864 0 C-N-CA 124.655 1.182 . . . . 0.0 112.19 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.268 38.1 t70 -53.47 -43.2 67.96 Favored 'General case' 0 C--N 1.38 1.897 0 C-N-CA 127.263 2.225 . . . . 0.0 113.98 174.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -33.86 76.57 Favored 'General case' 0 C--N 1.374 1.669 0 O-C-N 118.661 -2.524 . . . . 0.0 114.921 173.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.435 ' HB1' ' CD ' ' A' ' 190' ' ' ARG . . . -76.37 -45.59 31.24 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 tt -53.56 -49.87 66.75 Favored 'General case' 0 CA--C 1.498 -1.024 1 C-N-CA 132.298 4.239 . . . . 0.0 116.455 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.253 0.0 OUTLIER -86.84 -7.91 57.8 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 126.606 1.962 . . . . 0.0 111.417 -174.592 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -120.1 -100.05 0.43 Allowed 'General case' 0 C--N 1.358 0.961 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -135.26 151.05 50.21 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.783 -1.198 . . . . 0.0 108.998 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.256 34.3 tttm -51.39 -36.49 43.63 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 130.979 3.712 . . . . 0.0 115.872 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 12.6 tt -56.0 -28.5 24.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 130.118 3.367 . . . . 0.0 113.211 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.258 4.6 mptt -71.02 -42.62 69.33 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 119.537 -1.977 . . . . 0.0 113.849 174.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.477 ' HD2' HD21 ' A' ' 95' ' ' LEU 0.314 0.0 OUTLIER -76.36 -42.98 42.9 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 169.36 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.55 -30.7 67.5 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.627 1.971 . . . . 0.0 114.946 -172.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -84.56 -12.25 54.47 Favored 'General case' 0 C--N 1.365 1.282 0 C-N-CA 125.859 1.664 . . . . 0.0 114.305 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 mp -97.34 -50.05 4.69 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 173.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 62.65 -102.64 0.11 Allowed 'General case' 0 C--N 1.364 1.199 0 C-N-CA 130.371 3.468 . . . . 0.0 115.055 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 13.9 m -115.63 29.99 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 128.397 2.679 . . . . 0.0 108.601 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.273 4.2 t 82.03 60.81 0.02 OUTLIER 'General case' 0 C--N 1.357 0.921 0 C-N-CA 128.751 2.821 . . . . 0.0 113.944 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -101.84 148.4 25.35 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 124.79 1.236 . . . . 0.0 109.738 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -112.06 89.81 12.47 Favored Pre-proline 0 C--N 1.358 0.972 0 C-N-CA 125.794 1.637 . . . . 0.0 110.627 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.75 60.8 7.35 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 125.07 3.847 . . . . 0.0 113.147 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 51.0 m -99.31 79.73 2.34 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 126.7 2.0 . . . . 0.0 112.125 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--N 1.359 1.016 0 C-N-CA 125.958 1.703 . . . . 0.0 113.356 -179.006 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.5 tttt . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.59 2.59 8.95 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 127.036 2.134 . . . . 0.0 110.027 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.56 158.68 34.42 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -102.98 157.31 17.06 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.178 1.391 . . . . 0.0 112.255 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 18.6 tp -107.42 119.39 39.27 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 125.238 1.415 . . . . 0.0 108.621 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -89.13 20.68 3.56 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 127.344 2.258 . . . . 0.0 116.25 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.13 18.89 73.56 Favored Glycine 0 C--N 1.365 2.151 0 C-N-CA 125.34 1.447 . . . . 0.0 114.982 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.67 142.65 16.1 Favored Glycine 0 C--N 1.356 1.645 0 C-N-CA 125.964 1.745 . . . . 0.0 115.643 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.6 mt -115.48 -69.43 0.86 Allowed 'General case' 0 C--N 1.363 1.159 0 C-N-CA 125.176 1.39 . . . . 0.0 112.686 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -72.13 -52.41 16.8 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 128.948 2.899 . . . . 0.0 113.189 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.3 tpp180 -179.23 35.95 0.0 OUTLIER 'General case' 0 C--N 1.35 0.599 0 C-N-CA 129.399 3.079 . . . . 0.0 104.382 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.7 t 130.95 -152.5 0.0 OUTLIER 'General case' 0 C--N 1.366 1.302 0 C-N-CA 130.098 3.359 . . . . 0.0 103.31 -172.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.7 m -132.43 -47.72 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 128.75 2.82 . . . . 0.0 107.204 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.66 145.52 30.7 Favored Pre-proline 0 C--N 1.36 1.025 0 CA-C-O 116.103 -1.903 . . . . 0.0 106.863 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -63.27 139.95 74.59 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 125.127 3.885 . . . . 0.0 116.801 -172.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.76 -63.05 0.3 Allowed 'General case' 0 C--N 1.359 0.987 0 C-N-CA 124.43 1.092 . . . . 0.0 110.636 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.66 111.66 64.69 Favored Pre-proline 0 C--N 1.359 1.011 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.27 88.82 1.37 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.793 2.995 . . . . 0.0 112.491 -168.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 p -127.57 -75.81 0.57 Allowed 'General case' 0 C--N 1.35 0.622 0 C-N-CA 129.458 3.103 . . . . 0.0 109.07 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.7 p -65.12 96.11 0.2 Allowed 'General case' 0 C--N 1.365 1.274 0 C-N-CA 127.962 2.505 . . . . 0.0 115.285 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.7 p -68.34 116.58 9.09 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 130.048 3.339 . . . . 0.0 116.476 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -160.4 62.19 0.33 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-N 119.161 0.892 . . . . 0.0 109.505 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -114.58 124.63 52.34 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 120.294 -1.504 . . . . 0.0 111.558 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.6 p -112.07 164.4 15.31 Favored Pre-proline 0 C--N 1.366 1.292 0 C-N-CA 129.045 2.938 . . . . 0.0 114.438 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -47.08 141.01 13.17 Favored 'Trans proline' 0 C--N 1.376 2.005 1 C-N-CA 127.743 5.628 . . . . 0.0 121.147 -169.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.43 -23.3 32.01 Favored Glycine 0 C--N 1.367 2.267 0 C-N-CA 125.636 1.588 . . . . 0.0 112.838 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.05 169.94 13.45 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 120.814 2.307 . . . . 0.0 112.644 -177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.84 141.38 29.36 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 166.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.5 163.4 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -110.34 128.27 55.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 101.288 -3.597 . . . . 0.0 101.288 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.28 137.74 51.05 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 122.848 1.309 . . . . 0.0 111.698 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -110.57 136.41 49.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 171.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 42.7 ttm -119.8 138.32 53.43 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.32 102.14 0.37 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 125.721 1.608 . . . . 0.0 113.98 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.17 -12.6 24.07 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 125.538 1.542 . . . . 0.0 112.757 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -103.18 164.17 16.04 Favored Pre-proline 0 C--N 1.354 0.792 0 C-N-CA 125.639 1.575 . . . . 0.0 109.418 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -71.64 166.36 29.68 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.371 3.381 . . . . 0.0 113.634 162.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -57.69 122.37 12.64 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 130.683 3.593 . . . . 0.0 114.825 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -126.48 112.17 23.17 Favored Pre-proline 0 N--CA 1.427 -1.602 0 N-CA-C 119.888 3.292 . . . . 0.0 119.888 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -59.03 112.24 1.15 Allowed 'Trans proline' 0 C--N 1.383 2.387 1 C-N-CA 125.813 4.342 . . . . 0.0 110.573 162.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.2 t -122.57 165.5 16.33 Favored 'General case' 0 N--CA 1.445 -0.72 1 C-N-CA 133.475 4.71 . . . . 0.0 111.346 -161.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tt -124.05 132.31 53.66 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.454 HG23 HG12 ' A' ' 131' ' ' VAL 0.251 3.3 p -81.84 127.28 39.74 Favored 'Isoleucine or valine' 0 C--N 1.377 1.8 0 CA-C-N 121.145 1.793 . . . . 0.0 107.385 176.141 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -132.05 152.86 50.93 Favored 'General case' 0 C--N 1.366 1.322 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 -161.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.5 113.46 27.05 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 127.698 2.399 . . . . 0.0 109.525 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -71.54 161.72 76.97 Favored Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 129.292 3.037 . . . . 0.0 114.342 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.1 -8.22 0.17 Allowed 'Trans proline' 0 CA--C 1.569 2.241 1 C-N-CA 125.605 4.203 . . . . 0.0 117.593 170.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -104.11 44.69 1.0 Allowed 'General case' 0 C--N 1.365 1.252 0 C-N-CA 131.518 3.927 . . . . 0.0 107.565 167.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.6 149.18 38.32 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 119.207 3.04 . . . . 0.0 119.207 -170.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.75 -19.91 27.69 Favored Glycine 0 C--N 1.362 2.025 0 CA-C-N 112.757 -2.019 . . . . 0.0 109.541 165.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 t -118.03 119.39 34.64 Favored 'General case' 0 N--CA 1.435 -1.224 1 N-CA-C 98.161 -4.755 . . . . 0.0 98.161 168.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.461 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 27.2 p90 -140.31 -0.6 1.6 Allowed 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 120.82 -1.175 . . . . 0.0 111.357 -174.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.713 HG22 HG12 ' A' ' 129' ' ' VAL . 7.0 pt -119.84 147.86 23.24 Favored 'Isoleucine or valine' 0 C--N 1.366 1.321 0 CA-C-O 123.467 1.603 . . . . 0.0 115.133 -174.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.87 118.36 31.35 Favored 'General case' 0 C--N 1.357 0.934 1 N-CA-C 99.13 -4.396 . . . . 0.0 99.13 169.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -105.6 -179.66 4.0 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -165.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -46.78 119.69 2.61 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 128.848 2.859 . . . . 0.0 116.985 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.51 -54.92 0.24 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 105.091 -3.204 . . . . 0.0 105.091 -173.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -109.86 -47.6 3.32 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.459 1.504 . . . . 0.0 109.886 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 m -179.51 169.77 1.37 Allowed 'General case' 0 CA--C 1.472 -2.056 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.4 106.87 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -114.98 130.31 56.9 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 127.811 2.445 . . . . 0.0 110.676 -176.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.713 HG12 HG22 ' A' ' 120' ' ' ILE . 13.7 m -130.36 161.91 39.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 0.6 OUTLIER -92.64 138.52 31.42 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 123.944 0.898 . . . . 0.0 110.897 174.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.454 HG12 HG23 ' A' ' 110' ' ' VAL . 5.2 m -150.58 168.71 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.472 -2.033 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.39 152.55 40.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 123.828 0.851 . . . . 0.0 109.599 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -108.09 125.78 51.98 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -67.47 65.34 0.08 Allowed 'General case' 0 C--N 1.369 1.438 0 C-N-CA 126.615 1.966 . . . . 0.0 115.08 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.37 -119.36 0.08 Allowed 'General case' 0 C--N 1.36 1.025 0 O-C-N 119.397 -2.064 . . . . 0.0 110.045 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -106.71 -49.07 3.38 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.627 1.571 . . . . 0.0 112.597 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.274 11.2 t -70.12 -51.39 14.22 Favored Pre-proline 0 C--N 1.363 1.156 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.06 -179.16 26.15 Favored 'Cis proline' 0 CA--C 1.543 0.952 0 CA-C-N 125.944 3.158 . . . . 0.0 113.722 1.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 54.0 m -95.03 127.17 40.88 Favored 'General case' 0 C--N 1.369 1.424 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 24.1 ttp-105 -153.61 157.47 39.72 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 119.976 1.262 . . . . 0.0 109.876 -173.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.14 -159.28 25.5 Favored Glycine 0 CA--C 1.492 -1.401 0 N-CA-C 104.901 -3.28 . . . . 0.0 104.901 171.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -83.15 113.55 20.72 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 126.172 1.789 . . . . 0.0 109.15 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.44 178.36 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 125.118 1.367 . . . . 0.0 110.987 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.2 m -99.82 121.18 40.91 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 100.462 -3.903 . . . . 0.0 100.462 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.446 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 26.7 ttpt -73.34 -10.99 60.33 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -170.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -72.58 -13.42 61.39 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.49 2.316 . . . . 0.0 113.738 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.7 mt -103.0 7.61 39.05 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 126.634 1.974 . . . . 0.0 111.404 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 12.4 mt -96.31 125.41 40.79 Favored 'General case' 0 C--N 1.379 1.874 0 CA-C-N 119.891 1.223 . . . . 0.0 108.431 174.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -114.44 159.13 37.99 Favored Pre-proline 0 C--O 1.221 -0.434 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.03 155.72 14.99 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 CA-C-N 124.904 2.787 . . . . 0.0 114.642 -172.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.362 0.0 OUTLIER -30.91 -95.34 0.0 OUTLIER 'General case' 0 C--N 1.357 0.922 2 C-N-CA 132.273 4.229 . . . . 0.0 122.092 -177.927 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.555 ' HA ' HD21 ' A' ' 183' ' ' LEU . 13.4 t -0.38 54.95 0.0 OUTLIER 'General case' 0 C--N 1.381 1.942 1 C-N-CA 136.511 5.924 . . . . 0.0 118.194 178.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.524 ' H ' HD11 ' A' ' 183' ' ' LEU . . . -81.07 -91.75 0.52 Allowed Glycine 0 CA--C 1.485 -1.782 0 N-CA-C 121.603 3.401 . . . . 0.0 121.603 -150.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.6 m -46.1 -23.45 0.32 Allowed 'General case' 0 C--N 1.374 1.669 0 C-N-CA 129.182 2.993 . . . . 0.0 119.003 -172.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -18.17 50.41 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 130.519 3.528 . . . . 0.0 113.039 175.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.0 t -80.5 150.78 29.53 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 127.754 2.422 . . . . 0.0 112.454 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -65.05 -21.39 66.82 Favored 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.985 1.714 . . . . 0.0 111.787 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -72.49 -23.03 60.97 Favored 'General case' 0 C--N 1.373 1.607 0 C-N-CA 126.315 1.846 . . . . 0.0 112.481 170.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -105.93 11.98 31.11 Favored 'General case' 0 C--N 1.361 1.088 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -128.0 -179.53 5.02 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.541 1.537 . . . . 0.0 107.712 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.65 122.69 11.94 Favored 'General case' 0 C--N 1.37 1.49 0 C-N-CA 127.731 2.412 . . . . 0.0 114.628 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.8 -10.04 64.21 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 124.397 0.999 . . . . 0.0 112.4 -168.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.8 146.31 25.53 Favored Glycine 0 C--N 1.365 2.145 0 N-CA-C 118.569 2.187 . . . . 0.0 118.569 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 5.9 m170 -59.81 -22.32 62.06 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 119.71 3.226 . . . . 0.0 119.71 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.55 -3.52 15.93 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.297 -1.502 . . . . 0.0 111.48 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -86.9 91.56 8.71 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 -166.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.2 m -118.86 104.91 10.99 Favored 'General case' 0 CA--C 1.504 -0.81 1 N-CA-C 99.559 -4.238 . . . . 0.0 99.559 167.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.27 101.42 14.13 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-O 125.096 2.379 . . . . 0.0 112.189 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -119.36 144.82 37.25 Favored Pre-proline 0 N--CA 1.432 -1.332 0 C-N-CA 130.241 3.416 . . . . 0.0 103.801 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -51.32 -31.82 39.17 Favored 'Trans proline' 0 CA--C 1.54 0.784 1 C-N-CA 127.166 5.244 . . . . 0.0 116.593 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.9 -36.95 75.81 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 127.997 2.519 . . . . 0.0 112.896 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.0 mt -79.05 -33.65 16.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.482 0 C-N-CA 127.163 2.185 . . . . 0.0 109.878 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 177' ' ' GLN 0.266 28.1 mt -61.98 -53.26 58.16 Favored 'General case' 0 C--N 1.392 2.45 0 C-N-CA 128.356 2.662 . . . . 0.0 110.367 170.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -57.41 -50.77 71.92 Favored 'General case' 0 CA--C 1.478 -1.802 0 C-N-CA 128.969 2.908 . . . . 0.0 112.684 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.62 73.33 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 130.988 3.715 . . . . 0.0 113.077 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 57.1 mtt -69.07 -39.18 79.23 Favored 'General case' 0 C--N 1.375 1.681 0 C-N-CA 125.563 1.545 . . . . 0.0 111.655 168.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 6.3 mt-30 -74.2 -42.33 59.98 Favored 'General case' 0 C--N 1.374 1.639 0 CA-C-N 120.756 1.616 . . . . 0.0 113.578 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.433 HH12 ' HA ' ' A' ' 190' ' ' ARG . 0.1 OUTLIER -63.19 -53.24 56.36 Favored 'General case' 0 C--N 1.375 1.7 1 C-N-CA 132.819 4.448 . . . . 0.0 110.123 174.465 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 183' ' ' LEU . . . -60.45 -51.57 68.9 Favored 'General case' 0 C--N 1.38 1.9 0 CA-C-O 116.815 -1.564 . . . . 0.0 112.496 170.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.05 -51.14 62.72 Favored 'General case' 0 C--N 1.38 1.906 0 C-N-CA 126.419 1.887 . . . . 0.0 114.352 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -55.02 -43.11 73.37 Favored 'General case' 0 C--N 1.37 1.462 0 CA-C-N 121.207 1.821 . . . . 0.0 114.993 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.13 -41.05 51.31 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 152' ' ' THR 0.25 0.5 OUTLIER -61.65 -45.61 93.32 Favored 'General case' 0 C--N 1.359 1.021 1 C-N-CA 132.923 4.489 . . . . 0.0 114.663 175.247 . . . . . . . . 5 4 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -28.58 29.35 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 126.64 1.976 . . . . 0.0 111.768 -176.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -105.52 -99.82 0.33 Allowed 'General case' 0 C--N 1.359 0.986 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -135.56 154.01 51.5 Favored 'General case' 0 C--N 1.36 1.065 0 O-C-N 120.822 -1.174 . . . . 0.0 112.2 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 190' ' ' ARG 0.395 18.0 ttpt -51.51 -37.16 47.94 Favored 'General case' 0 C--N 1.369 1.45 0 C-N-CA 130.217 3.407 . . . . 0.0 117.24 177.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.9 tp -57.08 -28.39 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 128.915 2.886 . . . . 0.0 112.906 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.252 4.1 mptt -70.19 -45.82 65.86 Favored 'General case' 0 C--N 1.372 1.575 0 O-C-N 119.773 -1.829 . . . . 0.0 113.387 174.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.433 ' HA ' HH12 ' A' ' 178' ' ' ARG 0.291 0.0 OUTLIER -75.27 -40.19 59.01 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 119.03 -2.294 . . . . 0.0 116.804 171.48 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.5 tp -80.83 -20.6 42.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -170.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -82.85 -22.79 33.96 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 124.107 0.963 . . . . 0.0 112.477 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.16 23.24 13.97 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 130.132 3.373 . . . . 0.0 109.984 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.82 -103.96 0.0 OUTLIER 'General case' 0 C--N 1.367 1.356 0 C-N-CA 131.268 3.827 . . . . 0.0 117.035 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.301 2.7 m -130.4 89.02 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 124.225 1.964 . . . . 0.0 107.491 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.3 m -89.44 56.91 3.77 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 118.759 -2.463 . . . . 0.0 110.261 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.48 -3.19 50.44 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.855 2.062 . . . . 0.0 114.84 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . 0.264 42.9 tt0 -161.48 -69.18 0.01 OUTLIER Pre-proline 0 C--N 1.35 0.602 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.07 178.66 6.95 Favored 'Trans proline' 0 C--N 1.364 1.353 0 CA-C-N 124.194 2.534 . . . . 0.0 109.449 161.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 16.3 m -89.5 -45.73 9.2 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.051 1.34 . . . . 0.0 111.912 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 C--N 1.361 1.066 0 C-N-CA 126.872 2.069 . . . . 0.0 108.61 176.55 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.0 mttp . . . . . 0 N--CA 1.436 -1.128 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.2 39.26 1.08 Allowed 'General case' 0 C--N 1.363 1.182 0 C-N-CA 126.27 1.828 . . . . 0.0 112.774 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -161.31 164.98 29.78 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -102.41 138.79 38.87 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.9 tp -93.24 106.96 18.86 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.509 1.523 . . . . 0.0 112.061 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -80.05 -30.24 39.37 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 126.101 1.76 . . . . 0.0 114.488 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.31 -19.15 46.58 Favored Glycine 0 C--N 1.364 2.126 0 C-N-CA 125.749 1.642 . . . . 0.0 113.109 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.35 143.76 14.58 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 107.174 -2.37 . . . . 0.0 107.174 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . 0.256 75.6 mt 78.77 -59.42 0.41 Allowed 'General case' 0 C--N 1.366 1.304 0 C-N-CA 126.635 1.974 . . . . 0.0 113.25 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -70.99 -33.58 70.55 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.676 1.991 . . . . 0.0 114.223 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -96.3 -2.38 46.01 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 127.103 2.161 . . . . 0.0 111.471 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.31 92.6 p 88.65 -123.3 0.01 OUTLIER 'General case' 0 C--N 1.356 0.882 0 C-N-CA 130.393 3.477 . . . . 0.0 110.281 -175.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -134.34 95.42 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.6 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.69 114.81 64.39 Favored Pre-proline 0 C--N 1.354 0.776 0 C-N-CA 125.864 1.665 . . . . 0.0 110.116 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.52 91.18 1.11 Allowed 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 124.116 3.211 . . . . 0.0 111.936 -175.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.82 -105.56 0.2 Allowed 'General case' 0 C--N 1.358 0.959 0 C-N-CA 125.139 1.375 . . . . 0.0 109.831 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.0 111.24 64.5 Favored Pre-proline 0 C--N 1.361 1.07 0 O-C-N 120.749 -1.219 . . . . 0.0 110.201 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -86.38 4.81 6.22 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 123.871 3.048 . . . . 0.0 114.35 -174.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 t -121.71 40.73 3.54 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 126.859 2.064 . . . . 0.0 106.859 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 p -101.23 -13.48 18.08 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 128.547 2.739 . . . . 0.0 111.336 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.478 ' HA ' ' CE2' ' A' ' 90' ' ' PHE 0.415 62.9 m 61.3 76.66 0.36 Allowed 'General case' 0 C--N 1.353 0.742 1 C-N-CA 131.718 4.007 . . . . 0.0 118.156 178.017 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -136.68 77.88 1.67 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 127.243 2.217 . . . . 0.0 109.38 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.478 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 62.1 m-85 -123.49 125.21 44.49 Favored 'General case' 0 C--N 1.355 0.837 0 O-C-N 120.336 -1.477 . . . . 0.0 112.719 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.416 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.391 88.6 p -112.01 170.51 5.19 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 131.329 3.852 . . . . 0.0 114.834 -176.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 37.3 Cg_exo -41.72 129.31 3.88 Favored 'Trans proline' 0 C--N 1.382 2.314 1 C-N-CA 128.177 5.918 . . . . 0.0 119.774 -177.087 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.12 0.12 74.69 Favored Glycine 0 C--N 1.366 2.198 0 C-N-CA 127.797 2.618 . . . . 0.0 114.421 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -94.01 154.71 17.5 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 166.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 109' ' ' LEU . 3.8 mm? -110.39 153.55 24.8 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 175.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.3 m -142.48 170.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 123.686 1.708 . . . . 0.0 107.25 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 96.2 m95 -114.78 116.03 27.97 Favored 'General case' 0 N--CA 1.438 -1.069 1 N-CA-C 99.924 -4.102 . . . . 0.0 99.924 174.664 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.0 127.96 53.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 122.32 2.327 . . . . 0.0 111.776 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -96.36 143.18 27.65 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.1 ttt -128.63 151.01 49.98 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 118.596 -2.565 . . . . 0.0 108.218 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -74.41 95.77 2.77 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 126.729 2.011 . . . . 0.0 113.544 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.13 -4.44 25.4 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 124.58 1.086 . . . . 0.0 113.042 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -117.08 164.92 16.92 Favored Pre-proline 0 C--N 1.357 0.898 0 CA-C-N 118.723 1.262 . . . . 0.0 108.364 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -71.58 167.37 26.63 Favored 'Trans proline' 0 C--N 1.353 0.783 1 C-N-CA 125.506 4.137 . . . . 0.0 114.413 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -53.79 115.31 1.93 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 128.086 2.554 . . . . 0.0 115.943 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.471 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 10.8 m95 -116.32 117.83 38.24 Favored Pre-proline 0 N--CA 1.415 -2.214 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HG2' ' HB3' ' A' ' 175' ' ' ALA . 17.4 Cg_endo -56.82 134.07 62.09 Favored 'Trans proline' 0 CA--C 1.561 1.866 1 C-N-CA 125.888 4.392 . . . . 0.0 111.848 160.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 m -147.69 165.39 30.61 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.125 2.17 . . . . 0.0 111.851 -160.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 6.2 tt -124.03 129.0 50.17 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.658 1.583 . . . . 0.0 113.996 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.02 121.81 44.02 Favored 'Isoleucine or valine' 0 C--N 1.372 1.571 0 O-C-N 120.836 -1.165 . . . . 0.0 110.724 171.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.93 153.9 51.45 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 127.26 2.224 . . . . 0.0 109.052 -170.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -71.13 112.7 7.48 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-N 120.734 1.606 . . . . 0.0 113.533 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.457 ' CG ' ' CD2' ' A' ' 130' ' ' HIS . 6.5 t-80 -77.47 158.38 79.02 Favored Pre-proline 0 C--N 1.346 0.455 0 CA-C-O 114.55 -2.643 . . . . 0.0 110.373 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -55.38 -1.1 0.18 Allowed 'Trans proline' 0 CA--C 1.544 1.016 1 C-N-CA 125.884 4.389 . . . . 0.0 120.242 -170.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -95.31 -7.34 39.0 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 128.994 2.918 . . . . 0.0 110.381 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.267 0.0 OUTLIER 9.52 94.87 0.0 OUTLIER 'General case' 0 C--N 1.376 1.753 1 C-N-CA 135.939 5.696 . . . . 0.0 120.213 -178.704 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 110.27 -17.42 29.01 Favored Glycine 0 C--N 1.36 1.887 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -172.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.4 m -103.78 120.13 40.34 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 100.384 -3.932 . . . . 0.0 100.384 170.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.478 ' HA ' ' HE1' ' A' ' 130' ' ' HIS . 1.4 t80 -142.22 -26.8 0.64 Allowed 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -167.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.5 pt -112.3 155.83 13.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-O 123.029 1.395 . . . . 0.0 111.847 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -141.35 149.8 41.63 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 128.034 2.534 . . . . 0.0 104.296 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -150.43 142.51 24.03 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 120.319 -1.488 . . . . 0.0 111.105 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -118.17 93.64 4.21 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 128.044 2.538 . . . . 0.0 110.418 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.65 -67.63 0.17 Allowed Glycine 0 C--N 1.361 1.949 0 N-CA-C 120.979 3.152 . . . . 0.0 120.979 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -144.38 46.1 1.41 Allowed 'General case' 0 C--N 1.354 0.771 0 CA-C-O 122.232 1.015 . . . . 0.0 112.343 -173.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.5 m -171.5 159.04 5.41 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.24 140.28 40.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 120.933 -1.104 . . . . 0.0 109.88 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -116.77 160.2 21.15 Favored 'General case' 0 C--N 1.366 1.308 0 C-N-CA 128.058 2.543 . . . . 0.0 112.906 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.428 HG13 ' HD3' ' A' ' 145' ' ' LYS . 9.9 m -148.57 164.77 4.79 Favored 'Isoleucine or valine' 0 C--N 1.37 1.487 0 C-N-CA 128.1 2.56 . . . . 0.0 107.058 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.478 ' HE1' ' HA ' ' A' ' 119' ' ' PHE . 0.0 OUTLIER -91.55 116.94 29.27 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 122.395 1.093 . . . . 0.0 111.424 169.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.82 158.78 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 N-CA-C 104.702 -2.332 . . . . 0.0 104.702 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -125.73 138.33 53.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 172.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.96 129.7 40.33 Favored 'General case' 0 C--N 1.36 1.058 0 C-N-CA 128.013 2.525 . . . . 0.0 107.864 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 14.1 m-30 -75.85 63.3 1.67 Allowed 'General case' 0 C--N 1.363 1.172 0 C-N-CA 125.829 1.652 . . . . 0.0 113.723 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.332 50.6 p-10 -98.14 -110.32 0.17 Allowed 'General case' 0 C--N 1.358 0.974 0 O-C-N 120.179 -1.576 . . . . 0.0 113.111 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -106.45 -54.95 2.4 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 125.621 1.568 . . . . 0.0 112.642 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.256 0.9 OUTLIER -64.15 -49.34 74.07 Favored Pre-proline 0 C--N 1.365 1.269 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -174.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.12 171.78 54.0 Favored 'Cis proline' 0 CA--C 1.547 1.167 0 CA-C-N 125.98 3.171 . . . . 0.0 111.543 -5.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.327 7.5 t -95.54 154.63 17.11 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 120.392 -1.443 . . . . 0.0 111.849 -176.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -148.85 152.25 36.14 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 125.133 1.373 . . . . 0.0 109.566 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -178.42 -177.5 47.14 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 107.279 -2.329 . . . . 0.0 107.279 168.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -82.78 106.26 14.47 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.456 1.902 . . . . 0.0 107.415 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.6 m -94.41 159.82 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.442 0 C-N-CA 127.577 2.351 . . . . 0.0 109.063 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.4 m -85.59 110.34 19.18 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.448 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 30.6 ttpt -64.51 -25.57 68.05 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -167.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.62 -12.35 57.62 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 127.285 2.234 . . . . 0.0 114.984 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . 0.31 0.2 OUTLIER -104.82 8.53 34.86 Favored 'General case' 0 C--N 1.37 1.464 0 O-C-N 119.107 -2.246 . . . . 0.0 112.402 174.18 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 14.4 mt -95.3 127.75 41.6 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 128.122 2.569 . . . . 0.0 108.339 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -114.19 165.37 13.84 Favored Pre-proline 0 C--N 1.357 0.901 0 O-C-N 118.894 -2.379 . . . . 0.0 105.866 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.43 151.97 13.57 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 124.924 3.75 . . . . 0.0 115.689 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.518 ' CE2' ' HA2' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -93.01 167.68 11.63 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 122.834 1.302 . . . . 0.0 113.373 175.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 178.9 -60.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.936 2 N-CA-C 95.073 -5.899 . . . . 0.0 95.073 -174.608 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.518 ' HA2' ' CE2' ' A' ' 151' ' ' TYR . . . 127.03 -125.52 5.35 Favored Glycine 0 CA--C 1.474 -2.521 0 O-C-N 121.186 -0.946 . . . . 0.0 113.481 151.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 m -59.15 -15.73 16.18 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -96.47 4.95 51.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 129.709 3.204 . . . . 0.0 111.651 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 18.1 t -89.7 139.94 30.07 Favored 'General case' 0 C--N 1.372 1.567 0 C-N-CA 126.658 1.983 . . . . 0.0 108.597 173.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.65 -27.38 68.63 Favored 'General case' 0 C--N 1.369 1.413 0 C-N-CA 125.827 1.651 . . . . 0.0 113.948 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -78.59 -10.22 59.65 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 119.672 -1.892 . . . . 0.0 112.293 171.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -104.13 17.06 24.88 Favored 'General case' 0 C--N 1.375 1.682 0 C-N-CA 125.343 1.457 . . . . 0.0 114.155 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -132.27 174.54 10.12 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.319 1.447 . . . . 0.0 109.003 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -60.36 122.17 13.89 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 126.164 1.786 . . . . 0.0 113.996 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.08 -12.7 57.44 Favored Glycine 0 C--N 1.358 1.781 0 C-N-CA 124.803 1.192 . . . . 0.0 112.53 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.4 151.18 24.16 Favored Glycine 0 C--N 1.363 2.042 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -63.23 -38.87 92.87 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -87.74 -22.03 24.82 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.182 0.993 . . . . 0.0 112.308 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -75.87 91.65 3.02 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 126.635 1.974 . . . . 0.0 114.367 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 70.7 m -119.21 107.69 13.75 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 100.487 -3.894 . . . . 0.0 100.487 170.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.46 101.44 13.92 Favored 'General case' 0 C--N 1.366 1.293 0 CA-C-O 126.535 3.064 . . . . 0.0 114.312 -167.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -120.31 139.69 28.97 Favored Pre-proline 0 N--CA 1.412 -2.344 1 C-N-CA 133.139 4.575 . . . . 0.0 101.353 169.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.63 -32.19 82.38 Favored 'Trans proline' 0 CA--C 1.545 1.066 1 C-N-CA 126.462 4.775 . . . . 0.0 115.694 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -66.11 -35.91 81.76 Favored 'General case' 0 C--N 1.365 1.268 0 C-N-CA 127.578 2.351 . . . . 0.0 113.125 174.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.471 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 19.2 mm -68.25 -39.17 80.69 Favored 'Isoleucine or valine' 0 C--N 1.378 1.827 0 C-N-CA 126.279 1.832 . . . . 0.0 110.909 174.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 20.2 mt -68.9 -51.35 40.97 Favored 'General case' 0 C--N 1.367 1.355 0 C-N-CA 126.162 1.785 . . . . 0.0 113.163 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -61.02 -35.32 76.55 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 127.191 2.197 . . . . 0.0 114.596 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.443 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . . . -69.36 -34.99 75.41 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 130.717 3.607 . . . . 0.0 109.396 171.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.5 mtt -69.31 -35.37 75.89 Favored 'General case' 0 C--N 1.38 1.924 0 CA-C-N 120.994 1.725 . . . . 0.0 114.017 163.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -66.74 -47.95 70.69 Favored 'General case' 0 C--N 1.372 1.572 0 C-N-CA 125.76 1.624 . . . . 0.0 111.461 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -68.96 -53.05 22.89 Favored 'General case' 0 C--N 1.37 1.472 0 C-N-CA 127.3 2.24 . . . . 0.0 113.026 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.25 -33.13 74.01 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.46 -44.0 75.8 Favored 'General case' 0 C--N 1.375 1.691 0 C-N-CA 127.067 2.147 . . . . 0.0 109.861 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -36.87 83.37 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -69.43 -35.09 75.35 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 151' ' ' TYR . 1.7 pt? -81.41 -36.8 29.05 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 119.943 -1.723 . . . . 0.0 114.63 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -87.17 -25.64 23.97 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 126.833 2.053 . . . . 0.0 112.878 -172.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -100.87 -95.15 0.27 Allowed 'General case' 0 C--N 1.367 1.35 0 O-C-N 121.091 -1.006 . . . . 0.0 109.007 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.0 145.01 45.65 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.047 -1.033 . . . . 0.0 109.399 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.523 ' HB3' HH11 ' A' ' 190' ' ' ARG . 93.5 mttt -51.39 -34.71 35.58 Favored 'General case' 0 C--N 1.365 1.257 1 C-N-CA 132.379 4.271 . . . . 0.0 113.881 173.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.5 tt -50.61 -27.81 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 131.001 3.72 . . . . 0.0 112.593 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.257 2.3 mptp? -73.82 -29.97 62.45 Favored 'General case' 0 C--N 1.377 1.786 0 C-N-CA 126.895 2.078 . . . . 0.0 114.728 169.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.523 HH11 ' HB3' ' A' ' 187' ' ' LYS 0.266 0.0 OUTLIER -75.03 -43.25 54.66 Favored 'General case' 0 C--N 1.371 1.518 0 O-C-N 119.278 -2.139 . . . . 0.0 113.168 171.161 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.288 63.2 mt -75.33 -18.87 59.9 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 126.631 1.972 . . . . 0.0 114.488 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -58.12 -38.92 77.43 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 127.699 2.4 . . . . 0.0 113.063 168.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -94.41 -51.07 4.94 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 126.963 2.105 . . . . 0.0 109.159 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 63.55 -83.38 0.02 OUTLIER 'General case' 0 C--N 1.372 1.585 1 C-N-CA 131.91 4.084 . . . . 0.0 114.353 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 11.4 m -146.03 82.59 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 C-N-CA 130.841 3.656 . . . . 0.0 101.414 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.7 m -82.43 62.4 6.09 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 118.748 -2.47 . . . . 0.0 110.503 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -68.78 52.68 0.08 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 131.252 3.821 . . . . 0.0 114.431 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 78.98 90.89 0.05 OUTLIER Pre-proline 0 C--N 1.361 1.074 0 C-N-CA 130.554 3.542 . . . . 0.0 113.276 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.79 72.25 5.79 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 124.51 3.474 . . . . 0.0 110.637 175.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 67.5 m 75.01 -57.8 0.59 Allowed 'General case' 0 C--N 1.361 1.078 0 C-N-CA 129.921 3.289 . . . . 0.0 114.936 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--N 1.351 0.671 0 C-N-CA 125.644 1.578 . . . . 0.0 109.069 -179.002 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? . . . . . 0 N--CA 1.435 -1.189 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 79.26 -61.42 0.33 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 127.998 2.519 . . . . 0.0 115.454 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -116.39 153.88 31.25 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 125.414 1.485 . . . . 0.0 110.347 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -102.67 123.53 46.55 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 125.695 1.598 . . . . 0.0 111.305 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.3 mt -68.9 2.18 2.82 Favored 'General case' 0 C--N 1.371 1.528 1 C-N-CA 131.952 4.101 . . . . 0.0 120.075 -171.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -94.2 -16.07 24.0 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 126.053 1.741 . . . . 0.0 109.431 174.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.84 0.97 49.02 Favored Glycine 0 C--N 1.37 2.423 0 C-N-CA 124.726 1.155 . . . . 0.0 114.734 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.41 -157.24 8.15 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . 0.296 76.9 mt 113.15 -95.62 0.0 OUTLIER 'General case' 0 C--N 1.355 0.837 1 C-N-CA 131.911 4.084 . . . . 0.0 107.369 -178.409 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -72.02 -34.78 69.09 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 126.229 1.812 . . . . 0.0 113.761 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 174.17 -57.04 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.1 39.96 7.35 Favored 'General case' 0 C--N 1.363 1.19 0 C-N-CA 129.148 2.979 . . . . 0.0 113.981 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.421 0.8 OUTLIER 63.99 -48.76 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.103 0 C-N-CA 130.439 3.495 . . . . 0.0 118.288 -178.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.42 158.21 33.01 Favored Pre-proline 0 C--N 1.351 0.64 0 C-N-CA 126.677 1.991 . . . . 0.0 110.579 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.12 -38.5 1.14 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 124.019 3.146 . . . . 0.0 113.563 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -165.65 -64.54 0.03 OUTLIER 'General case' 0 C--N 1.352 0.685 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.45 116.73 59.73 Favored Pre-proline 0 C--N 1.352 0.693 0 C-N-CA 125.574 1.55 . . . . 0.0 109.693 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -84.82 34.18 0.5 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 124.218 3.279 . . . . 0.0 113.134 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.9 t -179.53 -169.0 0.13 Allowed 'General case' 0 C--N 1.355 0.838 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 p -165.01 -91.49 0.02 OUTLIER 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.91 2.084 . . . . 0.0 108.605 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.359 87.0 p 82.27 23.66 0.21 Allowed 'General case' 0 C--N 1.354 0.774 0 C-N-CA 129.972 3.309 . . . . 0.0 114.696 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -101.41 108.03 19.52 Favored 'General case' 0 C--N 1.361 1.105 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -123.61 126.99 47.63 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 126.02 1.728 . . . . 0.0 111.387 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 25.4 p -113.12 168.65 7.41 Favored Pre-proline 0 C--N 1.357 0.924 0 C-N-CA 128.864 2.865 . . . . 0.0 117.504 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 12.7 Cg_exo -44.11 127.26 6.82 Favored 'Trans proline' 0 C--N 1.395 3.003 1 C-N-CA 127.628 5.552 . . . . 0.0 116.15 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.24 57.44 Favored Glycine 0 CA--C 1.482 -1.994 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.045 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -95.35 161.19 14.19 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 122.867 1.318 . . . . 0.0 108.263 169.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.79 135.46 50.67 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 101.253 -3.61 . . . . 0.0 101.253 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.07 159.01 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -106.93 120.3 41.68 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 162.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.79 143.93 33.24 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 120.635 1.561 . . . . 0.0 109.37 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -115.51 134.9 54.63 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 118.982 -2.324 . . . . 0.0 105.471 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 ttp -128.91 146.45 50.95 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 119.343 -2.098 . . . . 0.0 109.141 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.59 98.88 0.72 Allowed 'General case' 0 C--N 1.365 1.27 0 C-N-CA 127.072 2.149 . . . . 0.0 113.754 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.23 -9.71 24.64 Favored Glycine 0 C--N 1.359 1.833 0 C-N-CA 125.426 1.488 . . . . 0.0 111.935 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -104.97 158.79 31.27 Favored Pre-proline 0 C--N 1.356 0.879 0 C-N-CA 125.678 1.591 . . . . 0.0 109.019 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.83 166.64 28.9 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.368 3.378 . . . . 0.0 112.034 161.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -56.13 115.02 2.2 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 129.86 3.264 . . . . 0.0 112.408 171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.537 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 2.1 m95 -114.69 108.18 49.57 Favored Pre-proline 0 N--CA 1.434 -1.244 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -173.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 19.0 Cg_endo -55.28 106.21 0.18 Allowed 'Trans proline' 0 C--N 1.397 3.116 1 C-N-CA 125.854 4.37 . . . . 0.0 109.984 161.571 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 m -114.64 164.11 14.49 Favored 'General case' 0 CA--C 1.492 -1.287 1 C-N-CA 132.313 4.245 . . . . 0.0 113.21 -164.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.983 HD11 ' HE ' ' A' ' 190' ' ' ARG . 5.2 tp -123.87 127.66 48.34 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 111.6 -2.545 . . . . 0.0 105.363 173.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 131' ' ' VAL . 2.5 p -91.33 118.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 166.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.402 ' HA ' HH21 ' A' ' 190' ' ' ARG . 0.0 OUTLIER -121.18 152.58 38.61 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 124.498 1.119 . . . . 0.0 112.037 -169.589 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -89.61 111.34 22.25 Favored 'General case' 0 C--N 1.373 1.621 0 CA-C-O 123.342 1.544 . . . . 0.0 108.29 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -100.81 158.7 31.35 Favored Pre-proline 0 N--CA 1.451 -0.399 0 C-N-CA 129.705 3.202 . . . . 0.0 109.343 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -49.95 -0.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 2 C-N-CA 127.569 5.512 . . . . 0.0 122.845 -164.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.6 -0.13 35.34 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 126.792 2.037 . . . . 0.0 108.533 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.269 0.3 OUTLIER -20.36 119.33 0.03 OUTLIER 'General case' 0 C--N 1.376 1.718 2 C-N-CA 134.634 5.174 . . . . 0.0 122.068 -177.913 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.38 -20.96 27.22 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.5 p -120.72 117.94 28.78 Favored 'General case' 0 C--N 1.352 0.704 1 N-CA-C 98.101 -4.777 . . . . 0.0 98.101 164.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -141.94 2.39 1.54 Allowed 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 120.546 -1.346 . . . . 0.0 112.857 -167.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.9 pt -107.93 163.02 5.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 CA-C-O 122.696 1.236 . . . . 0.0 111.724 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -150.62 147.73 27.76 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 103.309 -2.848 . . . . 0.0 103.309 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -144.22 134.31 24.16 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 120.771 1.623 . . . . 0.0 111.926 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -117.46 93.18 4.07 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.689 2.396 . . . . 0.0 107.434 174.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.57 -92.46 0.08 OUTLIER Glycine 0 C--N 1.361 1.921 0 C-N-CA 126.555 2.026 . . . . 0.0 118.051 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -123.21 20.09 9.81 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 125.812 1.645 . . . . 0.0 109.12 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.6 t -118.41 108.69 15.35 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -111.2 135.1 51.42 Favored 'Isoleucine or valine' 0 C--N 1.357 0.898 0 C-N-CA 124.688 1.195 . . . . 0.0 108.686 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 73.4 mtt-85 -123.16 151.17 42.42 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 126.419 1.888 . . . . 0.0 112.588 -175.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.28 163.01 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 128.227 2.611 . . . . 0.0 107.282 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -93.18 121.75 34.86 Favored 'General case' 0 C--N 1.369 1.449 0 O-C-N 119.731 -1.855 . . . . 0.0 111.579 171.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.414 HG12 HG23 ' A' ' 110' ' ' VAL . 4.0 m -135.97 176.64 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.553 0 C-N-CA 126.585 1.954 . . . . 0.0 108.326 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -134.26 152.43 51.81 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.964 0.888 . . . . 0.0 109.495 166.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -106.74 115.59 30.46 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 126.642 1.977 . . . . 0.0 106.069 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 13.4 m-85 -66.8 55.97 0.04 OUTLIER 'General case' 0 C--N 1.367 1.347 0 C-N-CA 127.847 2.459 . . . . 0.0 116.022 -175.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.505 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP 0.303 52.7 p-10 -84.79 -102.16 0.05 Allowed 'General case' 0 C--N 1.367 1.367 0 C-N-CA 127.039 2.136 . . . . 0.0 113.17 -176.663 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -106.47 -58.3 1.94 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.275 1.83 . . . . 0.0 115.121 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.0 t -75.78 -41.77 3.56 Favored Pre-proline 0 C--N 1.366 1.295 0 CA-C-O 114.037 -2.887 . . . . 0.0 117.951 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.7 -177.94 22.45 Favored 'Cis proline' 0 CA--C 1.55 1.279 0 CA-C-N 127.083 3.566 . . . . 0.0 113.379 -2.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.3 t -95.35 142.37 27.81 Favored 'General case' 0 C--N 1.368 1.389 0 O-C-N 118.762 -2.461 . . . . 0.0 108.764 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -142.01 149.33 39.88 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.5 -170.61 37.89 Favored Glycine 0 CA--C 1.488 -1.649 1 N-CA-C 102.201 -4.36 . . . . 0.0 102.201 172.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -89.75 119.81 30.47 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 125.33 1.452 . . . . 0.0 109.371 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 143' ' ' VAL . 1.8 m -99.27 160.38 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 C-N-CA 125.621 1.569 . . . . 0.0 111.152 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 41.0 t -70.92 106.12 3.52 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 127.568 2.347 . . . . 0.0 107.335 168.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 7.5 ttpp -68.95 -29.33 67.55 Favored 'General case' 0 C--N 1.365 1.258 0 CA-C-O 122.777 1.275 . . . . 0.0 112.306 -175.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -67.48 -14.75 63.21 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.681 1.593 . . . . 0.0 114.646 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.6 mt -100.18 18.38 18.84 Favored 'General case' 0 C--N 1.367 1.337 0 C-N-CA 125.9 1.68 . . . . 0.0 111.485 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 37.2 mt -102.36 131.08 49.21 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.748 -1.22 . . . . 0.0 110.473 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -115.39 156.73 45.45 Favored Pre-proline 0 C--O 1.222 -0.361 0 CA-C-O 116.711 -1.614 . . . . 0.0 107.259 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.69 150.59 14.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 125.223 3.949 . . . . 0.0 113.425 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -120.29 120.0 34.79 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-O 122.42 1.105 . . . . 0.0 112.822 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.48 ' HA ' HD21 ' A' ' 183' ' ' LEU . 5.0 t -154.49 22.2 0.47 Allowed 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.672 1.589 . . . . 0.0 106.95 177.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.59 56.1 0.36 Allowed Glycine 0 C--N 1.36 1.888 0 N-CA-C 120.184 2.834 . . . . 0.0 120.184 -158.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.7 m -65.77 -17.72 64.82 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 130.423 3.489 . . . . 0.0 113.978 171.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -107.04 15.59 25.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 129.466 3.106 . . . . 0.0 110.425 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . 0.337 97.2 p -126.17 153.31 44.8 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 124.186 0.994 . . . . 0.0 113.311 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.535 1.4 pttm -47.06 -16.33 0.04 OUTLIER 'General case' 0 C--N 1.369 1.426 0 N-CA-C 121.348 3.833 . . . . 0.0 121.348 -168.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -96.14 -6.21 38.89 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 117.02 -1.467 . . . . 0.0 114.057 167.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.09 18.78 10.81 Favored 'General case' 0 C--N 1.381 1.953 0 CA-C-N 122.588 2.449 . . . . 0.0 116.621 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.75 -173.04 2.97 Favored 'General case' 0 N--CA 1.45 -0.431 1 C-N-CA 132.006 4.123 . . . . 0.0 109.535 -176.287 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -70.96 122.59 20.26 Favored 'General case' 0 C--N 1.361 1.1 0 O-C-N 119.588 -1.945 . . . . 0.0 113.014 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 98.91 -5.79 59.85 Favored Glycine 0 C--N 1.363 2.052 0 C-N-CA 126.156 1.836 . . . . 0.0 112.158 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -80.67 148.24 28.86 Favored Glycine 0 C--N 1.364 2.1 0 C-N-CA 129.095 3.236 . . . . 0.0 117.225 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -59.87 -33.61 72.04 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -102.52 -5.76 23.63 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 120.494 1.497 . . . . 0.0 113.068 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -88.87 148.6 23.78 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 -170.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.0 m -163.67 151.42 12.86 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 101.342 -3.577 . . . . 0.0 101.342 172.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -112.09 100.12 8.61 Favored 'General case' 0 C--N 1.372 1.56 0 CA-C-O 126.003 2.811 . . . . 0.0 111.032 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -120.55 141.63 32.54 Favored Pre-proline 0 N--CA 1.424 -1.756 2 C-N-CA 132.921 4.488 . . . . 0.0 99.522 168.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.91 -26.05 67.04 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.228 3.286 . . . . 0.0 114.171 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -69.82 -35.66 74.97 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 129.491 3.117 . . . . 0.0 114.017 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.537 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 9.3 mm -69.88 -43.18 79.83 Favored 'Isoleucine or valine' 0 C--N 1.379 1.874 0 C-N-CA 127.109 2.164 . . . . 0.0 109.175 175.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.7 mt -68.94 -45.18 71.44 Favored 'General case' 0 C--N 1.373 1.593 0 C-N-CA 124.458 1.103 . . . . 0.0 113.748 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -57.95 -34.58 70.06 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 126.474 1.91 . . . . 0.0 114.88 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.58 -48.5 69.39 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 130.854 3.662 . . . . 0.0 111.086 169.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 10.6 mtt -60.6 -39.6 88.74 Favored 'General case' 0 C--N 1.375 1.708 0 CA-C-N 120.558 1.526 . . . . 0.0 115.002 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.5 -52.14 35.5 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 128.052 2.541 . . . . 0.0 112.743 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -72.54 -34.84 67.81 Favored 'General case' 0 C--N 1.381 1.935 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 178.136 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.02 84.07 Favored 'General case' 0 C--N 1.371 1.517 0 C-N-CA 124.675 1.19 . . . . 0.0 112.615 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.14 -47.46 86.14 Favored 'General case' 0 C--N 1.378 1.819 0 C-N-CA 125.947 1.699 . . . . 0.0 112.763 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -33.84 76.63 Favored 'General case' 0 C--N 1.369 1.454 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -74.56 -28.77 61.09 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.48 HD21 ' HA ' ' A' ' 152' ' ' THR . 0.6 OUTLIER -77.9 -46.96 19.85 Favored 'General case' 0 CA--C 1.499 -1.01 1 C-N-CA 132.23 4.212 . . . . 0.0 114.105 178.266 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.259 0.0 OUTLIER -89.51 -8.52 52.65 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 125.125 1.37 . . . . 0.0 111.441 -174.293 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -126.17 -103.63 0.35 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 122.799 0.44 . . . . 0.0 111.342 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.402 ' HB3' HG22 ' A' ' 188' ' ' ILE . 22.9 t70 -136.27 161.3 36.16 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-O 123.51 1.624 . . . . 0.0 112.581 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -51.07 -36.19 38.7 Favored 'General case' 0 C--N 1.358 0.951 1 C-N-CA 136.319 5.847 . . . . 0.0 113.391 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.402 HG22 ' HB3' ' A' ' 186' ' ' ASP . 7.4 tt -55.04 -30.01 23.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 127.937 2.495 . . . . 0.0 113.215 176.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -74.6 -40.77 61.38 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.983 ' HE ' HD11 ' A' ' 109' ' ' LEU 0.266 5.2 ptm180 -74.44 -33.23 62.88 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 175.007 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.2 mt -82.3 -19.5 39.31 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.949 -1.094 . . . . 0.0 112.1 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -53.45 -43.87 68.44 Favored 'General case' 0 C--N 1.37 1.467 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -31.96 11.0 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 126.122 1.769 . . . . 0.0 109.974 175.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 41.03 -119.14 0.39 Allowed 'General case' 0 C--N 1.377 1.769 0 C-N-CA 130.903 3.681 . . . . 0.0 114.784 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.59 -9.56 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 120.035 -1.666 . . . . 0.0 112.505 176.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.307 20.2 m 65.29 -27.85 0.1 Allowed 'General case' 0 C--N 1.364 1.223 0 C-N-CA 130.284 3.434 . . . . 0.0 118.176 174.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -88.68 74.94 8.31 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 127.442 2.297 . . . . 0.0 109.317 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 74.13 68.87 0.26 Allowed Pre-proline 0 C--N 1.361 1.079 0 C-N-CA 129.431 3.093 . . . . 0.0 113.216 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.71 155.43 10.3 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.959 3.106 . . . . 0.0 111.899 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 35.7 p -99.61 87.83 3.68 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 125.884 1.674 . . . . 0.0 110.614 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 . . . . . 0 C--N 1.355 0.826 0 C-N-CA 125.016 1.327 . . . . 0.0 108.543 -179.59 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 73.92 -51.27 0.69 Allowed 'General case' 0 C--N 1.36 1.053 0 C-N-CA 129.268 3.027 . . . . 0.0 115.898 178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -135.52 168.87 18.43 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 125.811 1.644 . . . . 0.0 107.756 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -103.17 136.31 43.2 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.248 1.419 . . . . 0.0 108.476 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.7 tp -171.54 167.14 6.72 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 101.471 -3.529 . . . . 0.0 101.471 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -88.11 -22.25 24.23 Favored 'General case' 0 C--N 1.377 1.778 0 CA-C-N 122.516 2.416 . . . . 0.0 112.76 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.88 11.22 44.04 Favored Glycine 0 C--N 1.365 2.145 0 N-CA-C 118.865 2.306 . . . . 0.0 118.865 171.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.33 -62.36 0.03 OUTLIER Glycine 0 C--N 1.351 1.399 0 N-CA-C 107.53 -2.228 . . . . 0.0 107.53 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.412 HD12 HH22 ' A' ' 146' ' ' ARG . 26.8 mt -79.02 72.92 5.57 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 127.17 2.188 . . . . 0.0 109.308 175.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -51.48 -38.45 53.93 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 130.998 3.719 . . . . 0.0 116.198 -175.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -109.69 9.24 24.99 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 126.628 1.971 . . . . 0.0 110.059 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.291 96.5 p 70.2 -93.84 0.03 OUTLIER 'General case' 0 C--N 1.365 1.243 0 C-N-CA 128.168 2.587 . . . . 0.0 115.808 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.8 t -88.17 76.51 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.825 0 C-N-CA 126.625 1.97 . . . . 0.0 109.892 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.98 137.0 20.02 Favored Pre-proline 0 C--N 1.359 1.011 0 C-N-CA 126.344 1.858 . . . . 0.0 110.412 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.51 63.75 7.94 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.877 3.718 . . . . 0.0 113.342 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -148.6 -78.3 0.15 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.973 0.909 . . . . 0.0 108.935 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.53 112.73 64.67 Favored Pre-proline 0 C--N 1.354 0.772 0 C-N-CA 124.858 1.263 . . . . 0.0 109.656 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.76 -42.52 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.451 2.767 . . . . 0.0 110.97 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 m -168.94 146.1 3.68 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.7 m -177.76 -168.74 0.19 Allowed 'General case' 0 C--N 1.351 0.64 0 N-CA-C 100.432 -3.914 . . . . 0.0 100.432 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.344 80.4 p 74.9 74.17 0.1 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 126.247 1.819 . . . . 0.0 114.299 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -154.38 94.18 1.68 Allowed 'General case' 0 C--N 1.361 1.104 0 CA-C-O 122.551 1.167 . . . . 0.0 113.107 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -122.75 125.58 45.79 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.44 1.096 . . . . 0.0 109.293 -174.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.464 82.5 p -111.92 170.31 5.41 Favored Pre-proline 0 CA--C 1.558 1.279 1 C-N-CA 132.066 4.147 . . . . 0.0 114.205 -175.043 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 10.5 Cg_endo -53.2 139.49 62.9 Favored 'Trans proline' 0 C--N 1.378 2.117 1 C-N-CA 127.36 5.373 . . . . 0.0 120.054 -162.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.88 -13.82 45.49 Favored Glycine 0 C--N 1.363 2.064 0 CA-C-O 118.668 -1.074 . . . . 0.0 112.321 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.26 169.05 11.15 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 121.084 2.442 . . . . 0.0 112.309 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.633 ' CD2' ' HE ' ' A' ' 190' ' ' ARG . 4.5 mm? -97.72 138.64 34.8 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 101.832 -3.396 . . . . 0.0 101.832 164.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 m -134.03 165.59 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 103.536 -2.765 . . . . 0.0 103.536 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -121.22 116.65 25.31 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 101.174 -3.639 . . . . 0.0 101.174 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.51 128.71 56.54 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 123.667 1.698 . . . . 0.0 112.455 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -99.24 136.6 38.96 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 169.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.407 ' N ' ' CE1' ' A' ' 103' ' ' TYR . 1.2 tpt -121.62 148.04 45.06 Favored 'General case' 0 CA--C 1.511 -0.519 0 O-C-N 118.957 -2.339 . . . . 0.0 105.707 173.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -56.21 83.96 0.01 OUTLIER 'General case' 0 C--N 1.352 0.717 0 C-N-CA 129.107 2.963 . . . . 0.0 116.691 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.09 1.86 25.12 Favored Glycine 0 C--N 1.357 1.737 0 C-N-CA 124.676 1.131 . . . . 0.0 114.61 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.407 ' CE1' ' N ' ' A' ' 100' ' ' MET 0.262 0.0 OUTLIER -105.36 172.33 4.13 Favored Pre-proline 0 C--N 1.361 1.093 0 CA-C-O 116.991 -1.481 . . . . 0.0 109.609 178.246 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.1 165.76 31.65 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.576 3.517 . . . . 0.0 114.151 170.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.0 116.43 6.41 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.457 1.903 . . . . 0.0 112.62 173.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.446 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 10.2 m95 -114.92 127.63 26.65 Favored Pre-proline 0 N--CA 1.426 -1.641 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 -172.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 55.9 Cg_endo -59.01 144.36 99.4 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 124.992 3.795 . . . . 0.0 111.343 154.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 m -156.27 164.67 38.04 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.276 1.43 . . . . 0.0 110.532 -161.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 tt -127.0 136.91 52.89 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 119.565 -1.959 . . . . 0.0 106.367 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.81 117.89 36.07 Favored 'Isoleucine or valine' 0 C--N 1.374 1.669 0 O-C-N 119.983 -1.698 . . . . 0.0 108.148 172.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -121.8 147.87 45.41 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.052 1.341 . . . . 0.0 111.416 -168.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.08 120.39 39.4 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 39.5 m170 -62.32 159.41 40.39 Favored Pre-proline 0 C--N 1.363 1.175 0 C-N-CA 128.114 2.566 . . . . 0.0 114.459 -175.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.37 -0.65 0.16 Allowed 'Trans proline' 0 CA--C 1.558 1.675 1 C-N-CA 126.895 5.063 . . . . 0.0 117.053 172.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -106.99 37.82 2.26 Favored 'General case' 0 CA--C 1.551 1.002 1 C-N-CA 134.805 5.242 . . . . 0.0 107.041 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.305 0.0 OUTLIER -71.03 148.65 47.36 Favored 'General case' 0 C--N 1.373 1.602 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -170.703 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.56 -6.61 31.68 Favored Glycine 0 C--N 1.36 1.914 0 C-N-CA 125.498 1.523 . . . . 0.0 112.223 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.1 t -136.62 151.62 49.53 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 128.338 2.655 . . . . 0.0 104.159 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -160.31 -41.72 0.05 OUTLIER 'General case' 0 C--N 1.363 1.17 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.614 HG22 HG12 ' A' ' 129' ' ' VAL . 3.2 pt -107.94 146.72 13.58 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 O-C-N 119.626 -1.921 . . . . 0.0 115.058 -171.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -129.71 140.46 51.1 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -146.79 135.86 22.5 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.579 -1.326 . . . . 0.0 109.37 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -117.86 93.21 4.06 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 127.662 2.385 . . . . 0.0 106.863 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.83 -96.68 0.16 Allowed Glycine 0 C--N 1.362 2.013 0 C-N-CA 126.516 2.008 . . . . 0.0 117.767 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -113.49 16.45 18.81 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 126.937 2.095 . . . . 0.0 110.527 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 t -123.91 123.6 40.77 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.95 133.89 68.32 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-O 122.92 1.343 . . . . 0.0 110.366 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -118.09 133.08 56.24 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 127.302 2.241 . . . . 0.0 109.717 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.641 HG11 ' HD3' ' A' ' 145' ' ' LYS . 23.2 m -134.71 164.39 34.14 Favored 'Isoleucine or valine' 0 C--N 1.366 1.322 0 C-N-CA 129.002 2.921 . . . . 0.0 108.281 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -72.21 116.5 12.7 Favored 'General case' 0 C--N 1.372 1.567 0 O-C-N 119.398 -2.064 . . . . 0.0 114.203 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.49 ' HB ' HG21 ' A' ' 143' ' ' VAL . 37.3 t -144.07 141.44 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.847 0 O-C-N 119.171 -2.206 . . . . 0.0 105.121 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.86 140.98 48.7 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 112.022 -2.354 . . . . 0.0 106.323 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.54 133.05 52.57 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 126.152 1.781 . . . . 0.0 106.271 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . 21.5 m-85 -75.66 79.84 2.63 Favored 'General case' 0 C--N 1.372 1.546 0 C-N-CA 124.944 1.298 . . . . 0.0 108.983 177.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -103.53 -106.77 0.28 Allowed 'General case' 0 C--N 1.361 1.091 0 O-C-N 120.708 -1.245 . . . . 0.0 110.576 -174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -106.35 -58.08 1.97 Allowed 'General case' 0 C--N 1.353 0.718 0 C-N-CA 125.319 1.448 . . . . 0.0 111.894 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.2 m -82.77 -37.24 0.74 Allowed Pre-proline 0 C--N 1.362 1.141 0 N-CA-C 119.817 3.266 . . . . 0.0 119.817 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.61 178.48 33.36 Favored 'Cis proline' 0 CA--C 1.543 0.93 1 CA-C-N 128.529 4.082 . . . . 0.0 113.578 1.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.4 m -96.0 138.64 33.35 Favored 'General case' 0 C--N 1.366 1.301 0 C-N-CA 124.743 1.217 . . . . 0.0 109.279 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -155.67 158.97 39.16 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.673 -1.892 . . . . 0.0 106.315 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.7 -158.69 19.39 Favored Glycine 0 CA--C 1.487 -1.668 1 N-CA-C 100.32 -5.112 . . . . 0.0 100.32 170.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -90.36 132.48 35.57 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.49 HG21 ' HB ' ' A' ' 131' ' ' VAL . 2.3 m -99.98 -178.32 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 O-C-N 119.449 -2.032 . . . . 0.0 109.297 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.9 m -100.92 126.59 47.56 Favored 'General case' 0 C--N 1.365 1.272 0 N-CA-C 101.028 -3.693 . . . . 0.0 101.028 166.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.641 ' HD3' HG11 ' A' ' 129' ' ' VAL . 36.6 ttpt -72.23 -20.23 61.58 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.412 HH22 HD12 ' A' ' 76' ' ' LEU . 6.6 ptp180 -72.17 -6.25 41.41 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.73 3.51 42.33 Favored 'General case' 0 C--N 1.367 1.326 0 C-N-CA 124.48 1.112 . . . . 0.0 110.547 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.432 HD12 ' HG3' ' A' ' 145' ' ' LYS . 24.3 mt -91.8 134.44 34.74 Favored 'General case' 0 C--N 1.368 1.405 0 C-N-CA 125.505 1.522 . . . . 0.0 112.198 176.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -114.74 165.35 14.13 Favored Pre-proline 0 C--N 1.344 0.328 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 170.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.56 155.7 14.0 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.348 3.365 . . . . 0.0 113.714 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -29.04 -78.35 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.964 2 N-CA-C 123.678 4.695 . . . . 0.0 123.678 178.575 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.8 t -33.12 36.34 0.0 OUTLIER 'General case' 0 C--N 1.371 1.523 1 C-N-CA 137.186 6.194 . . . . 0.0 119.318 -175.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -101.49 -48.13 1.45 Allowed Glycine 0 C--N 1.358 1.791 0 C-N-CA 127.884 2.659 . . . . 0.0 118.395 -168.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.9 m -46.48 -11.26 0.02 OUTLIER 'General case' 0 C--N 1.373 1.609 0 N-CA-C 121.182 3.771 . . . . 0.0 121.182 -175.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -122.91 13.46 9.85 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 128.746 2.818 . . . . 0.0 110.434 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.1 t -135.78 162.87 31.57 Favored 'General case' 0 CA--C 1.488 -1.424 0 C-N-CA 124.572 1.149 . . . . 0.0 113.743 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -47.05 -16.75 0.04 OUTLIER 'General case' 0 CA--C 1.489 -1.368 1 C-N-CA 134.586 5.155 . . . . 0.0 119.32 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -95.77 -7.51 36.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 117.182 -1.39 . . . . 0.0 113.081 170.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.89 15.47 3.58 Favored 'General case' 0 C--N 1.386 2.18 0 CA-C-N 122.09 2.223 . . . . 0.0 116.728 -172.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.51 -172.81 2.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 130.158 3.383 . . . . 0.0 105.975 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -71.0 122.11 19.42 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 118.971 -2.33 . . . . 0.0 112.813 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.88 -5.72 47.08 Favored Glycine 0 C--N 1.362 2.001 0 C-N-CA 125.461 1.505 . . . . 0.0 112.105 -170.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.12 154.35 50.67 Favored Glycine 0 C--N 1.371 2.51 1 C-N-CA 130.757 4.027 . . . . 0.0 117.717 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -67.78 -42.31 81.89 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 127.381 2.273 . . . . 0.0 116.179 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.57 -4.62 53.17 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 125.16 1.384 . . . . 0.0 112.196 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -82.81 94.2 7.6 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.0 m -118.73 108.38 14.81 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 100.758 -3.793 . . . . 0.0 100.758 167.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.51 101.1 13.78 Favored 'General case' 0 C--N 1.367 1.339 0 CA-C-O 126.132 2.872 . . . . 0.0 110.764 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -119.73 146.17 41.02 Favored Pre-proline 0 N--CA 1.424 -1.766 0 C-N-CA 131.171 3.788 . . . . 0.0 101.167 171.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.96 -38.81 86.58 Favored 'Trans proline' 0 C--N 1.352 0.725 1 C-N-CA 126.388 4.725 . . . . 0.0 115.307 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.46 -42.48 74.83 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.493 1.517 . . . . 0.0 113.655 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.7 mt -64.64 -46.88 91.1 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 C-N-CA 126.143 1.777 . . . . 0.0 111.901 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.427 ' O ' ' HG2' ' A' ' 177' ' ' GLN 0.304 3.9 pp -68.51 -32.38 72.3 Favored 'General case' 0 C--N 1.368 1.407 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 174.306 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -69.33 -39.25 78.29 Favored 'General case' 0 C--N 1.372 1.576 0 C-N-CA 128.612 2.765 . . . . 0.0 113.997 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 134' ' ' PHE . . . -69.32 -34.55 74.83 Favored 'General case' 0 N--CA 1.431 -1.397 1 C-N-CA 131.843 4.057 . . . . 0.0 110.818 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 44.8 mtt -69.22 -33.38 73.22 Favored 'General case' 0 C--N 1.372 1.555 0 C-N-CA 127.915 2.486 . . . . 0.0 112.517 163.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 173' ' ' LEU . 57.6 mm-40 -72.57 -45.04 61.12 Favored 'General case' 0 C--N 1.385 2.143 0 C-N-CA 127.272 2.229 . . . . 0.0 112.124 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -66.45 -49.41 66.76 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 130.182 3.393 . . . . 0.0 110.362 173.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.65 83.56 Favored 'General case' 0 C--N 1.379 1.856 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.23 -47.14 69.24 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.98 2.112 . . . . 0.0 113.947 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -49.62 58.0 Favored 'General case' 0 C--N 1.359 1.008 0 O-C-N 120.309 -1.495 . . . . 0.0 114.578 173.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 190' ' ' ARG . . . -69.6 -30.43 68.18 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.4 pp -76.44 -40.02 51.78 Favored 'General case' 0 C--N 1.367 1.352 0 C-N-CA 126.517 1.927 . . . . 0.0 115.196 176.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -11.49 55.63 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.918 1.687 . . . . 0.0 111.204 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -114.14 -107.71 0.37 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -135.68 168.77 18.65 Favored 'General case' 0 C--N 1.364 1.208 0 O-C-N 120.247 -1.533 . . . . 0.0 112.739 -171.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.617 ' HA ' HH11 ' A' ' 190' ' ' ARG . 39.8 mmtm -55.51 -40.82 72.27 Favored 'General case' 0 C--N 1.386 2.196 0 C-N-CA 130.476 3.51 . . . . 0.0 114.163 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.99 -31.95 42.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 129.124 2.97 . . . . 0.0 113.914 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -74.48 -40.87 61.57 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 125.231 1.412 . . . . 0.0 114.405 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.633 ' HE ' ' CD2' ' A' ' 95' ' ' LEU 0.276 0.1 OUTLIER -74.94 -39.67 61.25 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 119.999 -1.688 . . . . 0.0 114.311 169.558 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.16 -21.16 64.01 Favored 'General case' 0 C--N 1.381 1.956 0 C-N-CA 128.205 2.602 . . . . 0.0 113.606 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -66.52 -32.01 73.09 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 130.124 3.37 . . . . 0.0 114.73 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mt -105.67 -47.04 4.0 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.366 2.266 . . . . 0.0 108.358 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 50.15 -112.81 0.61 Allowed 'General case' 0 C--N 1.368 1.394 0 C-N-CA 129.191 2.997 . . . . 0.0 114.803 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 22.0 m -108.98 15.49 8.0 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 126.478 1.911 . . . . 0.0 111.421 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.298 8.3 t 89.7 22.55 0.03 OUTLIER 'General case' 0 C--N 1.358 0.964 0 C-N-CA 128.687 2.795 . . . . 0.0 113.64 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -95.35 87.78 4.91 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 126.653 1.981 . . . . 0.0 108.828 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 69.41 64.11 0.53 Allowed Pre-proline 0 C--N 1.365 1.27 0 C-N-CA 128.243 2.617 . . . . 0.0 112.46 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.18 107.01 2.37 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 124.411 3.407 . . . . 0.0 112.062 -172.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.282 7.4 t 89.16 2.15 0.25 Allowed 'General case' 0 C--N 1.354 0.793 0 C-N-CA 126.767 2.027 . . . . 0.0 109.677 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--N 1.361 1.105 0 C-N-CA 128.55 2.74 . . . . 0.0 114.753 177.915 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 pttp . . . . . 0 N--CA 1.44 -0.949 0 CA-C-O 122.72 1.248 . . . . 0.0 108.543 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.1 44.25 0.56 Allowed 'General case' 0 C--N 1.36 1.025 0 C-N-CA 128.458 2.703 . . . . 0.0 114.318 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -122.79 71.35 1.03 Allowed 'General case' 0 C--N 1.352 0.714 0 C-N-CA 127.35 2.26 . . . . 0.0 105.828 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -80.63 134.05 35.83 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 126.327 1.851 . . . . 0.0 114.552 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.343 82.2 mt 89.31 -128.28 0.0 OUTLIER 'General case' 0 C--N 1.361 1.084 0 C-N-CA 129.245 3.018 . . . . 0.0 110.67 -177.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -81.76 -38.01 26.33 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.24 -21.19 13.28 Favored Glycine 0 C--N 1.359 1.857 0 C-N-CA 124.677 1.132 . . . . 0.0 114.585 -167.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.93 133.12 3.47 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 108.316 -1.913 . . . . 0.0 108.316 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.3 pt? -105.68 -33.05 8.17 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -72.1 -41.87 66.76 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 127.383 2.273 . . . . 0.0 114.423 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -125.89 60.58 1.27 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 128.599 2.76 . . . . 0.0 105.456 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.88 53.57 1.98 Allowed 'General case' 0 C--N 1.365 1.259 0 O-C-N 120.066 -1.646 . . . . 0.0 114.165 -175.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.423 0.3 OUTLIER 66.29 -46.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 129.739 3.215 . . . . 0.0 115.401 -174.439 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.78 114.8 9.45 Favored Pre-proline 0 C--N 1.357 0.909 0 C-N-CA 125.191 1.396 . . . . 0.0 108.984 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.49 -56.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 123.83 3.02 . . . . 0.0 111.254 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.11 -167.55 0.08 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 100.443 -3.91 . . . . 0.0 100.443 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.63 112.06 65.3 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -85.49 55.21 3.9 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 124.396 3.398 . . . . 0.0 112.395 -170.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.5 m -173.99 63.32 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 101.906 -3.368 . . . . 0.0 101.906 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.1 p -148.58 -99.69 0.08 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.3 p -141.85 95.43 2.81 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -157.99 65.85 0.46 Allowed 'General case' 0 C--N 1.355 0.82 0 C-N-CA 124.078 0.951 . . . . 0.0 108.934 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -118.29 124.68 48.41 Favored 'General case' 0 C--N 1.363 1.192 0 O-C-N 118.987 -2.32 . . . . 0.0 114.202 -172.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.44 17.2 p -112.96 169.45 6.35 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 131.114 3.766 . . . . 0.0 114.602 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -49.37 129.45 22.74 Favored 'Trans proline' 0 C--N 1.376 1.986 1 C-N-CA 128.006 5.804 . . . . 0.0 119.087 -169.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.52 -12.42 21.1 Favored Glycine 0 CA--C 1.482 -1.993 0 C-N-CA 124.438 1.018 . . . . 0.0 111.309 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.03 159.99 14.92 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.206 -1.761 . . . . 0.0 108.247 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.42 140.31 36.87 Favored 'General case' 0 C--N 1.344 0.354 1 N-CA-C 99.998 -4.075 . . . . 0.0 99.998 166.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.37 147.36 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 102.667 -3.086 . . . . 0.0 102.667 -171.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -99.93 119.29 38.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.92 136.34 48.63 Favored 'General case' 0 C--N 1.359 1.012 0 CA-C-N 119.862 1.21 . . . . 0.0 111.559 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -108.97 141.31 41.25 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.0 ttp -129.59 149.84 51.18 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 119.311 -2.118 . . . . 0.0 108.932 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -65.6 89.66 0.11 Allowed 'General case' 0 C--N 1.363 1.193 0 C-N-CA 127.103 2.161 . . . . 0.0 115.032 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.24 -3.07 25.29 Favored Glycine 0 C--N 1.357 1.746 0 C-N-CA 125.873 1.701 . . . . 0.0 112.786 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -100.97 163.33 18.2 Favored Pre-proline 0 C--N 1.354 0.782 0 C-N-CA 126.573 1.949 . . . . 0.0 109.773 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.04 165.9 31.22 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.627 2.885 . . . . 0.0 112.666 164.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.515 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 1.6 m95 -66.36 130.55 43.6 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 128.6 2.76 . . . . 0.0 111.053 170.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -129.83 138.94 34.21 Favored Pre-proline 0 N--CA 1.415 -2.196 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.09 132.12 17.68 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 123.313 2.675 . . . . 0.0 107.896 147.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.6 m -135.66 166.51 23.07 Favored 'General case' 0 C--N 1.345 0.398 1 C-N-CA 132.121 4.168 . . . . 0.0 110.485 -166.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 5.9 tt -123.68 133.01 53.97 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 119.155 -2.216 . . . . 0.0 110.299 177.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.613 HG23 HG12 ' A' ' 131' ' ' VAL . 7.4 p -92.14 118.64 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 CA-C-N 122.271 2.305 . . . . 0.0 110.146 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.68 153.44 48.97 Favored 'General case' 0 C--N 1.372 1.583 0 C-N-CA 127.238 2.215 . . . . 0.0 112.484 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -78.64 112.55 15.85 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 129.473 3.109 . . . . 0.0 114.062 170.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.446 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 22.5 t60 -90.75 159.58 40.33 Favored Pre-proline 0 C--N 1.373 1.624 0 CA-C-O 114.301 -2.761 . . . . 0.0 109.181 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.446 ' HD2' ' CG ' ' A' ' 113' ' ' HIS 0.265 53.0 Cg_exo -47.54 0.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.861 2 C-N-CA 129.021 6.481 . . . . 0.0 122.536 -166.519 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -102.48 40.56 1.34 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.164 2.586 . . . . 0.0 104.981 168.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.12 118.9 7.39 Favored 'General case' 0 C--N 1.379 1.862 0 C-N-CA 127.493 2.317 . . . . 0.0 114.275 -170.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.96 -19.9 27.18 Favored Glycine 0 C--N 1.356 1.656 0 C-N-CA 125.424 1.487 . . . . 0.0 110.534 -165.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.8 m -104.8 120.21 40.85 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 172.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -135.77 -43.15 0.67 Allowed 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 119.547 1.067 . . . . 0.0 113.531 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 pt -100.03 173.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-O 122.345 1.069 . . . . 0.0 113.875 -174.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -159.0 148.26 18.72 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -147.36 127.05 13.37 Favored 'General case' 0 C--N 1.363 1.193 0 O-C-N 120.071 -1.643 . . . . 0.0 110.3 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -118.29 93.75 4.24 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.601 1.96 . . . . 0.0 110.526 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.02 -76.79 0.23 Allowed Glycine 0 C--N 1.36 1.893 0 N-CA-C 120.391 2.916 . . . . 0.0 120.391 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -139.27 52.49 1.75 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 125.198 1.399 . . . . 0.0 110.657 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.4 m -174.22 146.08 1.09 Allowed 'General case' 0 C--N 1.356 0.852 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.43 139.86 50.27 Favored 'Isoleucine or valine' 0 C--N 1.362 1.111 0 CA-C-O 122.129 0.966 . . . . 0.0 111.362 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -113.56 161.77 17.0 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 126.889 2.076 . . . . 0.0 113.628 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 145' ' ' LYS . 14.0 m -149.35 163.3 4.29 Favored 'Isoleucine or valine' 0 C--N 1.369 1.431 1 C-N-CA 133.024 4.53 . . . . 0.0 103.749 175.495 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -97.44 127.64 43.56 Favored 'General case' 0 C--N 1.366 1.293 0 O-C-N 121.001 -1.062 . . . . 0.0 111.204 167.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.613 HG12 HG23 ' A' ' 110' ' ' VAL . 1.6 m -146.02 171.65 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -131.93 146.51 52.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.43 1.092 . . . . 0.0 109.063 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -93.31 132.26 37.68 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 129.992 3.317 . . . . 0.0 107.534 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 7.4 m-30 -76.03 65.21 2.03 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 124.292 1.996 . . . . 0.0 113.509 -176.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -89.45 -109.49 0.08 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 128.891 2.876 . . . . 0.0 110.146 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.23 -52.12 2.81 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.87 1.668 . . . . 0.0 113.902 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.6 m -80.92 -41.07 1.15 Allowed Pre-proline 0 C--N 1.364 1.205 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -172.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.77 169.59 74.09 Favored 'Cis proline' 0 CA--C 1.543 0.953 0 CA-C-N 126.303 3.287 . . . . 0.0 114.259 -1.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.3 m -85.68 125.44 33.19 Favored 'General case' 0 C--N 1.366 1.302 0 C-N-CA 126.413 1.885 . . . . 0.0 110.539 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.486 ' HG2' ' H ' ' A' ' 141' ' ' GLY . 0.5 OUTLIER -117.87 174.84 5.96 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 125.225 1.41 . . . . 0.0 111.219 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.486 ' H ' ' HG2' ' A' ' 140' ' ' ARG . . . 169.14 -160.19 33.48 Favored Glycine 0 CA--C 1.487 -1.715 1 N-CA-C 97.852 -6.099 . . . . 0.0 97.852 171.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.5 m95 -96.95 155.8 16.62 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.0 m -119.92 173.14 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 C-N-CA 124.246 1.018 . . . . 0.0 108.566 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.0 t -84.19 123.58 30.25 Favored 'General case' 0 C--N 1.369 1.443 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 164.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.438 ' HB2' HG22 ' A' ' 129' ' ' VAL . 15.8 ttpp -73.38 -25.16 60.45 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 120.904 -1.123 . . . . 0.0 111.995 -175.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -73.22 -9.42 58.69 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 125.246 1.418 . . . . 0.0 114.519 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.3 mt -100.11 6.07 44.91 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 125.448 1.499 . . . . 0.0 111.577 172.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.8 mt -100.4 132.23 45.9 Favored 'General case' 0 C--N 1.371 1.538 0 C-N-CA 125.366 1.466 . . . . 0.0 108.403 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 149' ' ' LYS . 4.9 mtmp? -114.74 164.89 15.23 Favored Pre-proline 0 CA--C 1.506 -0.735 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.22 156.31 14.76 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.803 2.335 . . . . 0.0 113.409 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -34.09 -107.67 0.0 OUTLIER 'General case' 0 C--N 1.351 0.631 1 C-N-CA 132.888 4.475 . . . . 0.0 120.606 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.392 4.0 t 53.3 -42.94 0.02 OUTLIER 'General case' 0 C--N 1.371 1.505 1 C-N-CA 131.727 4.011 . . . . 0.0 118.927 174.408 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.59 -150.88 30.25 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 121.916 3.527 . . . . 0.0 121.916 159.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.6 m -45.87 -11.87 0.02 OUTLIER 'General case' 0 C--N 1.374 1.637 1 C-N-CA 134.952 5.301 . . . . 0.0 118.864 -175.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -88.67 -14.0 38.42 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 129.276 3.03 . . . . 0.0 111.747 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.4 t -75.98 153.94 36.19 Favored 'General case' 0 C--N 1.377 1.781 0 C-N-CA 126.102 1.761 . . . . 0.0 112.05 171.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -72.12 -26.93 62.31 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.869 1.668 . . . . 0.0 111.98 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -79.39 -17.4 54.47 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 124.352 1.061 . . . . 0.0 111.902 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.33 4.61 48.65 Favored 'General case' 0 C--N 1.368 1.373 0 C-N-CA 126.172 1.789 . . . . 0.0 114.08 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -122.72 177.51 5.42 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 124.653 1.181 . . . . 0.0 109.135 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.33 122.58 14.89 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 126.968 2.107 . . . . 0.0 113.829 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.68 -14.58 53.41 Favored Glycine 0 C--N 1.357 1.708 0 C-N-CA 124.891 1.234 . . . . 0.0 111.615 -168.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.45 153.73 32.14 Favored Glycine 0 C--N 1.359 1.81 0 N-CA-C 119.266 2.467 . . . . 0.0 119.266 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -63.07 -42.5 99.67 Favored 'General case' 0 C--N 1.365 1.239 0 N-CA-C 118.694 2.85 . . . . 0.0 118.694 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.515 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.286 0.4 OUTLIER -101.99 -0.03 34.38 Favored 'General case' 0 C--N 1.359 1.018 0 O-C-N 120.618 -1.301 . . . . 0.0 112.675 -179.139 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -78.64 141.62 37.84 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 126.846 2.058 . . . . 0.0 111.427 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 50.9 m -171.27 150.91 3.02 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 101.06 -3.681 . . . . 0.0 101.06 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -129.67 102.52 6.38 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-O 125.409 2.528 . . . . 0.0 113.544 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -119.68 140.22 29.12 Favored Pre-proline 0 N--CA 1.43 -1.443 2 C-N-CA 134.02 4.928 . . . . 0.0 100.114 168.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . 0.319 92.0 Cg_endo -64.45 -17.95 61.36 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.766 3.644 . . . . 0.0 117.502 -174.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -69.96 -36.06 74.96 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 129.541 3.137 . . . . 0.0 111.67 170.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 31.4 mt -73.03 -32.73 40.54 Favored 'Isoleucine or valine' 0 C--N 1.372 1.576 0 C-N-CA 127.604 2.361 . . . . 0.0 110.402 175.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 41.0 mt -65.05 -49.81 68.65 Favored 'General case' 0 C--N 1.378 1.823 0 C-N-CA 126.55 1.94 . . . . 0.0 110.307 169.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -57.53 -34.58 69.28 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 125.209 1.404 . . . . 0.0 114.184 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.22 -48.35 62.21 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 129.963 3.305 . . . . 0.0 114.304 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.7 mtt -69.64 -33.3 72.43 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 120.991 1.723 . . . . 0.0 113.383 172.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -70.13 -52.39 23.99 Favored 'General case' 0 C--N 1.377 1.784 0 C-N-CA 127.056 2.142 . . . . 0.0 112.028 174.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.402 ' HG3' ' CE2' ' A' ' 134' ' ' PHE 0.267 6.1 ptt180 -71.29 -36.52 71.7 Favored 'General case' 0 C--N 1.382 1.998 0 O-C-N 119.485 -2.009 . . . . 0.0 113.842 176.01 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.4 -50.03 67.03 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.542 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -55.06 -39.22 68.98 Favored 'General case' 0 C--N 1.386 2.18 0 CA-C-N 121.96 2.164 . . . . 0.0 113.542 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -52.32 24.97 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 119.735 -1.853 . . . . 0.0 114.6 170.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 190' ' ' ARG . . . -61.62 -33.51 74.04 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.56 -35.37 34.44 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 126.615 1.966 . . . . 0.0 115.143 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.352 0.0 OUTLIER -91.1 -21.03 21.41 Favored 'General case' 0 C--N 1.367 1.327 0 O-C-N 121.309 -0.869 . . . . 0.0 110.735 -173.613 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -101.85 -110.94 0.22 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 123.348 0.659 . . . . 0.0 112.048 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -135.36 161.86 34.22 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 119.949 -1.72 . . . . 0.0 110.058 -174.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -51.26 -36.94 44.5 Favored 'General case' 0 C--N 1.373 1.608 0 C-N-CA 131.217 3.807 . . . . 0.0 115.216 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -40.09 34.99 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 C-N-CA 130.639 3.576 . . . . 0.0 112.836 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -32.44 69.3 Favored 'General case' 0 C--N 1.37 1.475 0 C-N-CA 125.483 1.513 . . . . 0.0 113.617 176.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.585 ' HB3' ' HB1' ' A' ' 182' ' ' ALA 0.25 0.0 OUTLIER -74.02 -37.2 64.42 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 174.084 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.265 3.9 mt -78.49 -19.28 53.39 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 126.888 2.075 . . . . 0.0 114.855 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -69.65 -24.46 63.63 Favored 'General case' 0 C--N 1.368 1.388 0 O-C-N 120.961 -1.087 . . . . 0.0 113.079 167.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.86 22.45 15.58 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 131.392 3.877 . . . . 0.0 111.431 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.37 -177.99 2.81 Favored 'General case' 0 C--N 1.374 1.633 0 C-N-CA 128.796 2.838 . . . . 0.0 115.03 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 44.6 t -100.58 86.74 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.183 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.6 m -79.15 124.21 28.11 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.61 40.52 1.09 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 125.658 1.583 . . . . 0.0 111.093 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -158.02 143.28 12.18 Favored Pre-proline 0 C--N 1.354 0.783 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.34 63.87 7.13 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 124.72 3.613 . . . . 0.0 113.466 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 47.7 t -125.35 41.14 3.58 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.75 2.02 . . . . 0.0 109.7 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--N 1.36 1.041 0 CA-C-O 122.733 1.254 . . . . 0.0 111.425 -176.65 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.1 59.62 1.04 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.483 1.513 . . . . 0.0 108.682 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -131.39 71.45 1.47 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 123.264 1.507 . . . . 0.0 110.252 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -99.77 118.69 36.79 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 120.269 -1.519 . . . . 0.0 112.002 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.12 6.59 8.53 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 124.682 1.193 . . . . 0.0 110.771 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -97.4 -4.06 39.03 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.158 -1.588 . . . . 0.0 113.952 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.2 8.35 61.79 Favored Glycine 0 C--N 1.366 2.246 0 C-N-CA 126.931 2.205 . . . . 0.0 116.815 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.68 1.47 37.06 Favored Glycine 0 C--N 1.359 1.824 0 C-N-CA 125.7 1.619 . . . . 0.0 111.983 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tp -88.31 102.66 15.07 Favored 'General case' 0 C--N 1.363 1.163 0 O-C-N 120.745 -1.444 . . . . 0.0 110.909 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -71.85 -30.07 65.05 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 125.99 1.716 . . . . 0.0 113.879 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -169.15 -87.17 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.9 m 171.73 135.89 0.03 OUTLIER 'General case' 0 C--N 1.353 0.719 0 C-N-CA 128.909 2.884 . . . . 0.0 103.941 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -83.18 1.65 3.8 Favored 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 -175.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.98 152.02 71.26 Favored Pre-proline 0 C--N 1.35 0.592 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -77.83 -25.97 7.2 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 124.654 3.569 . . . . 0.0 113.461 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 76.83 -58.85 0.5 Allowed 'General case' 0 C--N 1.367 1.364 0 C-N-CA 127.934 2.494 . . . . 0.0 113.42 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.69 112.23 64.58 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 172.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.46 69.3 7.43 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.506 2.804 . . . . 0.0 110.976 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.0 p -88.36 68.96 9.01 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 129.16 2.984 . . . . 0.0 112.399 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 93.5 p -82.39 88.74 6.57 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 127.202 2.201 . . . . 0.0 114.095 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -141.93 94.37 2.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -133.31 89.6 2.62 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.176 1.391 . . . . 0.0 112.762 -171.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -123.16 126.65 47.4 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 120.913 -1.117 . . . . 0.0 110.587 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.334 64.4 p -111.59 168.98 6.81 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 129.039 2.936 . . . . 0.0 116.433 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -50.66 137.06 41.98 Favored 'Trans proline' 0 C--N 1.367 1.5 1 C-N-CA 126.854 5.036 . . . . 0.0 122.084 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.63 -12.66 56.61 Favored Glycine 0 C--N 1.37 2.456 0 C-N-CA 128.371 2.891 . . . . 0.0 111.139 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.42 169.87 10.04 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.056 2.542 . . . . 0.0 111.449 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.52 143.73 44.49 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 119.151 -2.218 . . . . 0.0 105.477 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 m -142.88 158.68 18.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -101.75 128.52 48.05 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 100.834 -3.765 . . . . 0.0 100.834 167.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.44 141.38 48.61 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 125.341 1.456 . . . . 0.0 112.234 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -120.76 139.88 52.47 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 120.034 -1.666 . . . . 0.0 106.996 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 42.3 ttm -129.32 151.3 50.12 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 120.049 -1.657 . . . . 0.0 107.76 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -72.05 110.96 6.88 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 125.856 1.662 . . . . 0.0 110.546 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.09 -16.34 22.77 Favored Glycine 0 C--N 1.359 1.859 0 C-N-CA 125.073 1.321 . . . . 0.0 112.12 -174.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -114.36 157.95 41.15 Favored Pre-proline 0 C--N 1.356 0.853 0 C-N-CA 125.287 1.435 . . . . 0.0 108.99 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.34 166.54 29.47 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 124.448 3.432 . . . . 0.0 112.484 163.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.585 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.0 m95 -51.52 114.54 1.27 Allowed 'General case' 0 C--N 1.365 1.268 0 C-N-CA 127.705 2.402 . . . . 0.0 114.625 167.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.534 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 4.4 m95 -118.7 108.22 41.48 Favored Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 119.176 3.028 . . . . 0.0 119.176 -172.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 23.5 Cg_endo -54.3 118.46 5.06 Favored 'Trans proline' 0 C--N 1.373 1.846 1 C-N-CA 125.678 4.252 . . . . 0.0 112.498 162.104 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.2 m -132.91 164.97 25.75 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 127.145 2.178 . . . . 0.0 114.226 -159.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.718 HD22 ' HE ' ' A' ' 190' ' ' ARG . 2.2 pp -116.28 147.49 41.46 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 169.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.55 120.93 42.68 Favored 'Isoleucine or valine' 0 C--N 1.369 1.417 0 O-C-N 120.831 -1.168 . . . . 0.0 109.217 172.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -139.83 152.88 46.86 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 120.103 -1.623 . . . . 0.0 112.24 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -89.6 112.1 23.23 Favored 'General case' 0 C--N 1.369 1.416 0 C-N-CA 129.25 3.02 . . . . 0.0 109.514 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 130' ' ' HIS . 69.3 t60 -73.69 159.34 84.68 Favored Pre-proline 0 C--N 1.36 1.027 0 C-N-CA 127.73 2.412 . . . . 0.0 114.716 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 113' ' ' HIS . 10.1 Cg_endo -48.97 -1.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.558 1.697 1 C-N-CA 127.077 5.184 . . . . 0.0 119.079 174.322 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -104.4 35.11 2.83 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 128.305 2.642 . . . . 0.0 107.444 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -68.62 158.14 34.66 Favored 'General case' 0 C--N 1.367 1.331 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -171.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.6 -20.64 27.11 Favored Glycine 0 C--N 1.359 1.855 0 CA-C-N 112.493 -2.14 . . . . 0.0 109.669 171.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -124.58 119.26 28.56 Favored 'General case' 0 N--CA 1.438 -1.05 1 N-CA-C 99.252 -4.351 . . . . 0.0 99.252 164.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.557 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 20.3 p90 -118.83 -3.4 10.76 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.223 -0.923 . . . . 0.0 108.947 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.8 HG22 HG12 ' A' ' 129' ' ' VAL . 7.3 pt -112.77 166.6 6.6 Favored 'Isoleucine or valine' 0 C--N 1.364 1.201 0 C-N-CA 127.367 2.267 . . . . 0.0 112.036 -174.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.4 ' HE ' ' HD2' ' A' ' 128' ' ' ARG . 45.6 ttp180 -158.57 147.36 18.77 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 103.871 -2.641 . . . . 0.0 103.871 176.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -145.53 126.76 14.79 Favored 'General case' 0 C--N 1.359 1.017 0 O-C-N 119.568 -1.958 . . . . 0.0 109.11 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -117.97 93.6 4.2 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 127.184 2.193 . . . . 0.0 110.241 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.42 -71.16 0.1 OUTLIER Glycine 0 C--N 1.36 1.88 0 N-CA-C 120.97 3.148 . . . . 0.0 120.97 172.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -143.6 51.2 1.35 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-O 122.648 1.213 . . . . 0.0 111.138 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.5 m -177.3 143.26 0.37 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.5 p -117.17 136.28 54.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.058 0 CA-C-O 122.79 1.281 . . . . 0.0 110.127 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.4 ' HD2' ' HE ' ' A' ' 121' ' ' ARG . 14.7 mtt-85 -113.67 144.46 42.89 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.715 2.806 . . . . 0.0 107.075 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.8 HG12 HG22 ' A' ' 120' ' ' ILE . 12.0 m -146.66 162.7 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 177.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.557 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 3.2 p-80 -96.58 134.71 39.46 Favored 'General case' 0 C--N 1.363 1.153 0 CA-C-O 123.598 1.666 . . . . 0.0 110.05 172.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 p -125.89 163.64 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 101.599 -3.482 . . . . 0.0 101.599 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.72 33.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -86.28 129.36 34.88 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.014 3.325 . . . . 0.0 110.283 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.9 75.79 2.81 Favored 'General case' 0 C--N 1.371 1.506 0 CA-C-N 120.511 1.505 . . . . 0.0 114.114 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.07 -104.38 0.1 Allowed 'General case' 0 C--N 1.368 1.384 0 C-N-CA 124.678 1.191 . . . . 0.0 108.569 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -107.22 -56.18 2.24 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.987 2.115 . . . . 0.0 113.825 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.83 -44.92 2.41 Favored Pre-proline 0 C--N 1.368 1.401 0 N-CA-C 119.575 3.176 . . . . 0.0 119.575 -172.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -82.05 177.77 32.57 Favored 'Cis proline' 0 CA--C 1.546 1.088 0 CA-C-N 126.492 3.354 . . . . 0.0 114.058 3.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.9 m -94.84 134.56 37.34 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 125.189 1.396 . . . . 0.0 110.717 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.406 ' HE ' ' CE1' ' A' ' 113' ' ' HIS . 5.8 tmm_? -117.31 148.11 41.99 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 125.656 1.583 . . . . 0.0 110.401 177.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -160.47 167.52 35.71 Favored Glycine 0 CA--C 1.486 -1.734 1 N-CA-C 103.035 -4.026 . . . . 0.0 103.035 169.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -88.13 122.01 31.2 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 124.776 2.226 . . . . 0.0 108.329 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.06 168.01 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 129.089 2.955 . . . . 0.0 108.545 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.5 m -91.46 130.12 37.34 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 102.425 -3.176 . . . . 0.0 102.425 168.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.588 ' HD3' HG11 ' A' ' 129' ' ' VAL . 32.4 ttpt -74.69 -15.58 60.79 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-O 122.921 1.343 . . . . 0.0 114.108 -170.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -72.64 -2.98 22.14 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.701 1.601 . . . . 0.0 115.136 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.6 mt -107.04 10.31 30.33 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 125.187 1.395 . . . . 0.0 110.468 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.538 HD12 ' HG3' ' A' ' 145' ' ' LYS . 11.4 mt -98.96 124.24 43.8 Favored 'General case' 0 C--N 1.374 1.657 0 C-N-CA 125.588 1.555 . . . . 0.0 107.258 174.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -116.24 151.28 46.58 Favored Pre-proline 0 CA--C 1.501 -0.924 0 O-C-N 119.921 -1.737 . . . . 0.0 108.306 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.13 123.73 4.63 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.845 2.364 . . . . 0.0 112.184 -167.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.34 108.5 19.93 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -171.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.773 ' HA ' HD13 ' A' ' 183' ' ' LEU . 9.1 t -150.42 26.88 0.76 Allowed 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -167.38 80.7 0.1 Allowed Glycine 0 C--N 1.355 1.61 0 C-N-CA 116.061 -2.971 . . . . 0.0 118.862 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.4 t -68.29 -11.9 60.17 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 126.921 2.088 . . . . 0.0 115.988 170.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -122.75 35.0 4.98 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 127.884 2.474 . . . . 0.0 107.645 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.2 t -104.96 142.44 34.78 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 126.316 1.847 . . . . 0.0 106.422 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.27 27.3 ttpt -52.76 -36.91 58.68 Favored 'General case' 0 C--N 1.369 1.442 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -171.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -18.48 61.97 Favored 'General case' 0 C--N 1.37 1.48 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 169.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.66 5.15 49.74 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.257 1.8 pp0? -129.41 -174.95 3.43 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.635 -1.916 . . . . 0.0 110.352 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.3 122.01 15.13 Favored 'General case' 0 C--N 1.368 1.396 0 O-C-N 120.444 -1.41 . . . . 0.0 113.686 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.37 -9.95 61.17 Favored Glycine 0 C--N 1.359 1.839 0 C-N-CA 124.365 0.983 . . . . 0.0 111.674 -167.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.92 160.3 44.63 Favored Glycine 0 C--N 1.366 2.202 0 C-N-CA 125.985 1.755 . . . . 0.0 116.846 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.53 -42.72 74.28 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -174.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.585 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.267 0.1 OUTLIER -99.42 5.06 46.41 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 120.245 -1.534 . . . . 0.0 114.377 -178.936 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -85.61 92.94 8.69 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.164 2.585 . . . . 0.0 114.284 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.4 m -113.86 110.23 19.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 170.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.97 101.5 14.21 Favored 'General case' 0 C--N 1.359 1.014 0 CA-C-O 126.127 2.87 . . . . 0.0 113.486 -170.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -120.47 150.5 52.17 Favored Pre-proline 0 N--CA 1.422 -1.854 1 C-N-CA 133.93 4.892 . . . . 0.0 102.915 171.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.486 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 58.7 Cg_endo -60.41 -32.38 93.8 Favored 'Trans proline' 0 CA--C 1.554 1.478 1 C-N-CA 126.652 4.901 . . . . 0.0 115.037 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -67.27 -35.16 78.93 Favored 'General case' 0 C--N 1.364 1.202 0 C-N-CA 130.059 3.344 . . . . 0.0 113.256 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.534 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 8.0 mm -72.17 -36.2 55.53 Favored 'Isoleucine or valine' 0 C--N 1.372 1.577 0 C-N-CA 127.235 2.214 . . . . 0.0 110.049 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 170' ' ' PRO . 2.9 mt -64.0 -53.83 43.87 Favored 'General case' 0 C--N 1.384 2.066 0 C-N-CA 126.428 1.891 . . . . 0.0 110.882 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -57.39 -33.87 68.28 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 129.143 2.977 . . . . 0.0 114.447 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.409 ' CB ' ' HG2' ' A' ' 107' ' ' PRO . . . -68.87 -44.67 72.81 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 130.079 3.352 . . . . 0.0 111.617 172.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 37.9 mtm -65.69 -35.74 81.62 Favored 'General case' 0 C--N 1.37 1.473 0 C-N-CA 125.102 1.361 . . . . 0.0 114.456 167.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 5.4 mt-30 -74.49 -48.33 27.91 Favored 'General case' 0 C--N 1.378 1.844 0 C-N-CA 125.518 1.527 . . . . 0.0 112.434 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -65.23 -46.54 80.19 Favored 'General case' 0 C--N 1.371 1.51 0 C-N-CA 129.251 3.02 . . . . 0.0 112.705 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.43 84.32 Favored 'General case' 0 C--N 1.375 1.707 0 O-C-N 120.599 -1.313 . . . . 0.0 112.688 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.527 ' O ' ' HB3' ' A' ' 184' ' ' ASN 0.333 35.3 t70 -64.55 -31.35 72.53 Favored 'General case' 0 C--N 1.378 1.81 0 C-N-CA 125.969 1.708 . . . . 0.0 111.857 175.059 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -76.45 -33.38 58.76 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 118.362 -2.711 . . . . 0.0 113.79 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.24 -36.83 58.31 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 118.64 2.83 . . . . 0.0 118.64 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 152' ' ' THR . 4.1 pp -79.87 -36.45 36.59 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 119.901 -1.749 . . . . 0.0 114.704 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -85.92 -17.78 34.53 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 127.201 2.201 . . . . 0.0 110.839 -176.103 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -117.51 -105.09 0.4 Allowed 'General case' 0 C--N 1.359 1.014 0 CA-C-O 121.791 0.805 . . . . 0.0 110.781 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -129.12 146.93 50.95 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.618 1.199 . . . . 0.0 108.331 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -50.31 -36.19 30.79 Favored 'General case' 0 C--N 1.357 0.924 1 C-N-CA 134.111 4.965 . . . . 0.0 113.826 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 14.9 tt -51.99 -37.18 21.06 Favored 'Isoleucine or valine' 0 C--N 1.37 1.489 0 C-N-CA 128.918 2.887 . . . . 0.0 112.174 171.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.328 2.8 mptp? -64.1 -31.29 72.43 Favored 'General case' 0 C--N 1.371 1.502 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 176.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.718 ' HE ' HD22 ' A' ' 109' ' ' LEU 0.411 0.0 OUTLIER -75.26 -42.2 55.64 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-N 121.327 1.876 . . . . 0.0 112.283 165.132 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.7 tp -57.39 -22.6 43.9 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 129.031 2.932 . . . . 0.0 117.595 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -73.9 -13.13 60.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.997 2.519 . . . . 0.0 113.953 170.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.13 22.76 15.16 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 130.562 3.545 . . . . 0.0 112.093 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.0 118.28 5.63 Favored 'General case' 0 C--N 1.371 1.535 0 C-N-CA 129.574 3.149 . . . . 0.0 116.141 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 10.7 t -72.37 57.08 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.594 0 C-N-CA 128.637 2.775 . . . . 0.0 113.174 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 28.0 p -83.22 -52.01 6.96 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 130.058 3.343 . . . . 0.0 113.94 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . 0.486 1.7 p30 83.28 153.7 0.1 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 130.548 3.539 . . . . 0.0 116.789 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -107.38 147.98 36.28 Favored Pre-proline 0 C--N 1.359 0.985 0 O-C-N 119.839 -1.788 . . . . 0.0 109.188 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.61 98.81 1.24 Allowed 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.993 3.129 . . . . 0.0 112.913 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 91.6 p -79.79 53.54 1.66 Allowed 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.465 1.506 . . . . 0.0 113.491 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 . . . . . 0 C--N 1.356 0.851 0 C-N-CA 126.134 1.774 . . . . 0.0 109.47 -178.293 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 pttt . . . . . 0 N--CA 1.443 -0.783 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.01 -51.34 2.56 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 126.374 1.87 . . . . 0.0 112.511 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -148.98 134.11 18.23 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -102.97 155.66 18.21 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 125.338 1.455 . . . . 0.0 111.279 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.4 tp -106.8 123.73 48.58 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 126.076 1.75 . . . . 0.0 108.576 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.23 -22.06 58.17 Favored 'General case' 0 C--N 1.367 1.369 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.67 -20.79 16.99 Favored Glycine 0 C--N 1.365 2.163 0 C-N-CA 127.633 2.54 . . . . 0.0 115.559 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.13 -128.29 2.56 Favored Glycine 0 CA--C 1.496 -1.095 1 N-CA-C 102.911 -4.076 . . . . 0.0 102.911 -176.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.7 pt? -109.88 121.46 45.28 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 125.099 1.359 . . . . 0.0 109.876 175.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.549 ' H ' ' HE ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -71.51 -24.6 62.0 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 127.574 2.35 . . . . 0.0 115.047 -178.539 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -169.66 -42.36 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.842 2.057 . . . . 0.0 106.184 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.3 m -175.47 -169.03 0.34 Allowed 'General case' 0 C--N 1.354 0.802 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.353 72.6 t 94.4 112.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.342 0 C-N-CA 128.786 2.834 . . . . 0.0 113.621 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.74 148.99 43.16 Favored Pre-proline 0 C--N 1.358 0.968 0 C-N-CA 126.227 1.811 . . . . 0.0 106.865 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.88 78.87 3.55 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 124.466 3.444 . . . . 0.0 112.856 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.45 -89.93 0.59 Allowed 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.115 0.966 . . . . 0.0 111.213 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.8 112.73 64.39 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.66 90.35 1.28 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.739 2.96 . . . . 0.0 112.058 -171.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -47.01 18.08 0.0 OUTLIER 'General case' 0 C--N 1.363 1.195 1 C-N-CA 133.412 4.685 . . . . 0.0 120.747 -177.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.3 p -148.2 11.22 0.91 Allowed 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.69 -1.256 . . . . 0.0 110.03 176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 83.1 p -146.19 71.74 1.27 Allowed 'General case' 0 C--N 1.363 1.181 0 C-N-CA 123.937 0.895 . . . . 0.0 110.046 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.71 72.15 1.26 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 125.306 1.442 . . . . 0.0 108.967 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 59.9 m-85 -116.71 127.11 54.09 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 120.602 -1.311 . . . . 0.0 112.106 -172.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 p -112.0 167.72 8.7 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 127.82 2.448 . . . . 0.0 117.113 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -54.39 129.11 32.97 Favored 'Trans proline' 0 C--N 1.371 1.725 1 C-N-CA 126.943 5.096 . . . . 0.0 116.779 -176.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.8 -16.17 58.85 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 125.418 1.485 . . . . 0.0 112.68 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -92.71 154.3 18.41 Favored 'General case' 0 C--N 1.367 1.36 0 CA-C-N 119.71 1.755 . . . . 0.0 110.859 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.583 HD13 HH21 ' A' ' 190' ' ' ARG . 3.3 mm? -98.44 144.61 27.61 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 119.303 -2.123 . . . . 0.0 109.047 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.1 m -136.8 158.17 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 C-N-CA 125.333 1.453 . . . . 0.0 109.994 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -105.76 119.82 40.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 101.035 -3.691 . . . . 0.0 101.035 167.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.82 144.47 34.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.337 1.855 . . . . 0.0 113.388 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -120.22 135.81 54.86 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.2 ttp -128.63 144.41 51.15 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 119.526 -1.983 . . . . 0.0 108.833 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -64.7 94.64 0.13 Allowed 'General case' 0 C--N 1.368 1.386 0 C-N-CA 126.445 1.898 . . . . 0.0 115.22 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.57 -5.12 24.64 Favored Glycine 0 C--N 1.359 1.817 0 C-N-CA 126.392 1.949 . . . . 0.0 113.01 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -104.64 159.98 27.52 Favored Pre-proline 0 C--N 1.357 0.913 0 C-N-CA 126.001 1.72 . . . . 0.0 109.967 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.44 166.63 29.25 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 123.682 2.921 . . . . 0.0 112.221 162.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.613 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.6 m95 -59.72 123.92 18.49 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 127.644 2.378 . . . . 0.0 114.799 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -127.27 108.54 21.39 Favored Pre-proline 0 N--CA 1.433 -1.305 1 N-CA-C 122.013 4.079 . . . . 0.0 122.013 -168.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.22 133.49 46.94 Favored 'Trans proline' 0 C--N 1.39 2.741 1 C-N-CA 125.968 4.446 . . . . 0.0 111.366 165.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.5 p -155.81 163.68 39.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 125.011 2.339 . . . . 0.0 115.743 -157.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 5.1 tt -101.06 129.99 47.01 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 129.172 2.989 . . . . 0.0 108.151 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.449 ' H ' HH22 ' A' ' 190' ' ' ARG . 31.2 t -87.49 118.81 34.07 Favored 'Isoleucine or valine' 0 C--N 1.378 1.846 0 CA-C-N 120.722 1.601 . . . . 0.0 107.007 173.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -116.57 154.16 30.95 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -164.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -119.4 112.67 19.7 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -83.44 159.09 62.34 Favored Pre-proline 0 C--N 1.348 0.528 0 C-N-CA 129.879 3.271 . . . . 0.0 110.647 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.32 0.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.799 1 C-N-CA 128.632 6.222 . . . . 0.0 119.973 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -95.21 28.2 2.94 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 131.191 3.796 . . . . 0.0 107.249 166.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.271 0.0 OUTLIER -73.79 161.07 30.59 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 127.185 2.194 . . . . 0.0 115.945 -173.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.95 -20.26 36.41 Favored Glycine 0 C--N 1.362 2.002 0 C-N-CA 126.666 2.079 . . . . 0.0 111.33 -174.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 p -135.87 136.18 40.34 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 130.681 3.592 . . . . 0.0 103.087 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -132.79 -3.75 3.24 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 120.206 1.366 . . . . 0.0 113.293 -175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.3 pt -110.73 150.38 13.23 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 123.073 1.416 . . . . 0.0 111.324 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.91 141.82 36.5 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 128.041 2.536 . . . . 0.0 104.227 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -145.67 126.6 14.51 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 120.939 -1.1 . . . . 0.0 109.013 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -109.42 93.55 4.56 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.33 -63.06 1.41 Allowed Glycine 0 C--N 1.362 2.011 0 C-N-CA 127.829 2.633 . . . . 0.0 115.852 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -144.64 -5.41 0.73 Allowed 'General case' 0 C--N 1.352 0.683 0 C-N-CA 127.736 2.414 . . . . 0.0 110.227 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.0 m -82.34 73.77 9.36 Favored 'General case' 0 C--N 1.372 1.551 0 O-C-N 118.944 -2.348 . . . . 0.0 110.306 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.56 111.15 21.58 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 C-N-CA 129.228 3.011 . . . . 0.0 110.594 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -117.34 146.82 43.13 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 111.287 -2.688 . . . . 0.0 112.874 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.86 162.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 127.74 2.416 . . . . 0.0 106.426 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.02 138.43 32.45 Favored 'General case' 0 C--N 1.379 1.889 0 O-C-N 117.975 -2.953 . . . . 0.0 111.112 171.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 m -151.9 169.91 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.478 -1.807 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.568 HE22 HG12 ' A' ' 195' ' ' VAL . 9.2 pt20 -149.09 151.13 33.91 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 122.138 0.97 . . . . 0.0 109.695 170.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -104.14 122.13 44.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 128.972 2.909 . . . . 0.0 107.97 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 51.0 m-85 -71.38 62.29 0.35 Allowed 'General case' 0 C--N 1.378 1.837 0 C-N-CA 127.317 2.247 . . . . 0.0 112.136 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -90.33 -114.2 0.07 Allowed 'General case' 0 C--N 1.362 1.151 0 C-N-CA 129.986 3.314 . . . . 0.0 111.531 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -106.53 -45.1 4.33 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 125.723 1.609 . . . . 0.0 112.031 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -81.6 -40.45 1.02 Allowed Pre-proline 0 C--N 1.36 1.055 0 N-CA-C 118.44 2.756 . . . . 0.0 118.44 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.91 159.57 97.79 Favored 'Cis proline' 0 C--N 1.361 1.189 0 CA-C-N 126.202 3.251 . . . . 0.0 109.864 -3.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.9 p -87.88 119.37 28.16 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 119.009 -2.307 . . . . 0.0 112.046 -175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -109.92 152.93 25.2 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 125.877 1.671 . . . . 0.0 107.623 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.35 177.31 37.72 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 104.084 -3.606 . . . . 0.0 104.084 165.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -92.26 109.06 20.43 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 103.12 -2.918 . . . . 0.0 103.12 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 143' ' ' VAL . 1.5 m -96.32 164.6 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 C-N-CA 125.466 1.507 . . . . 0.0 111.511 -171.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 m -77.42 109.85 11.69 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.97 2.108 . . . . 0.0 106.305 172.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.503 0.0 OUTLIER -70.72 -10.27 59.07 Favored 'General case' 0 C--N 1.37 1.496 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -169.652 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.436 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 31.5 ptt-85 -75.44 -14.68 60.46 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 129.214 3.006 . . . . 0.0 114.193 170.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -100.47 0.82 40.39 Favored 'General case' 0 C--N 1.365 1.281 0 C-N-CA 126.859 2.064 . . . . 0.0 110.263 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 49.1 mt -96.28 124.88 40.44 Favored 'General case' 0 C--N 1.368 1.412 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 172.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -114.6 161.74 27.18 Favored Pre-proline 0 CA--C 1.506 -0.718 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.14 149.78 22.47 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 CA-C-N 125.332 2.94 . . . . 0.0 112.463 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -113.28 153.05 29.07 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.584 ' HA ' HD13 ' A' ' 183' ' ' LEU . 8.8 t -179.61 -32.39 0.01 OUTLIER 'General case' 0 C--N 1.352 0.684 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.77 113.77 0.89 Allowed Glycine 0 C--N 1.355 1.638 0 O-C-N 121.029 -1.044 . . . . 0.0 115.354 -173.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -11.96 59.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 131.0 3.72 . . . . 0.0 112.271 171.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.78 -8.14 35.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 131.241 3.816 . . . . 0.0 111.794 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.8 m -58.09 136.06 57.12 Favored 'General case' 0 C--N 1.385 2.147 0 C-N-CA 126.172 1.789 . . . . 0.0 112.032 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.303 33.6 tttp -54.59 -31.75 57.48 Favored 'General case' 0 C--N 1.368 1.378 0 CA-C-N 122.445 2.384 . . . . 0.0 117.317 -173.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -74.7 -19.34 60.29 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 126.519 1.927 . . . . 0.0 112.835 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.59 1.68 55.63 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 126.359 1.864 . . . . 0.0 112.801 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -132.15 -176.48 4.08 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 119.898 -1.751 . . . . 0.0 112.908 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -63.66 122.13 15.61 Favored 'General case' 0 C--N 1.371 1.525 0 C-N-CA 126.037 1.735 . . . . 0.0 114.209 -177.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.06 -7.92 60.72 Favored Glycine 0 C--N 1.357 1.748 0 C-N-CA 124.533 1.063 . . . . 0.0 111.615 -167.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.7 145.92 20.4 Favored Glycine 0 C--N 1.364 2.133 0 N-CA-C 120.303 2.881 . . . . 0.0 120.303 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -53.85 -42.05 68.11 Favored 'General case' 0 C--N 1.364 1.198 0 C-N-CA 129.448 3.099 . . . . 0.0 119.04 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.613 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.387 0.6 OUTLIER -102.68 -10.59 19.08 Favored 'General case' 0 C--N 1.366 1.314 0 CA-C-N 119.945 1.248 . . . . 0.0 113.104 179.032 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -73.35 92.98 1.87 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 126.383 1.873 . . . . 0.0 113.457 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 72.6 m -113.84 107.36 15.61 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 101.193 -3.632 . . . . 0.0 101.193 173.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.19 101.28 13.68 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-O 125.616 2.627 . . . . 0.0 115.463 -166.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -121.4 153.15 58.7 Favored Pre-proline 0 N--CA 1.419 -1.992 1 C-N-CA 132.848 4.459 . . . . 0.0 104.946 170.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.89 -42.18 69.68 Favored 'Trans proline' 0 C--N 1.347 0.462 1 C-N-CA 126.154 4.569 . . . . 0.0 115.725 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -59.72 -35.26 74.18 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 129.446 3.098 . . . . 0.0 114.006 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 16.8 mm -72.35 -43.46 64.5 Favored 'Isoleucine or valine' 0 C--N 1.372 1.559 0 C-N-CA 125.792 1.637 . . . . 0.0 110.569 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.72 -47.34 66.6 Favored 'General case' 0 C--N 1.372 1.578 0 O-C-N 120.101 -1.625 . . . . 0.0 113.65 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -58.82 -35.23 72.53 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 126.665 1.986 . . . . 0.0 116.172 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.73 -36.71 76.09 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 127.758 2.423 . . . . 0.0 110.94 173.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.2 mtt -69.32 -35.62 76.12 Favored 'General case' 0 C--N 1.378 1.831 0 CA-C-O 116.707 -1.616 . . . . 0.0 113.729 167.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.06 -48.99 55.58 Favored 'General case' 0 C--N 1.377 1.802 0 C-N-CA 127.335 2.254 . . . . 0.0 111.732 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.62 -47.9 71.19 Favored 'General case' 0 C--N 1.371 1.529 0 C-N-CA 128.6 2.76 . . . . 0.0 112.19 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.27 71.13 Favored 'General case' 0 C--N 1.375 1.676 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 170.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.87 -50.1 70.13 Favored 'General case' 0 C--N 1.375 1.694 0 O-C-N 120.212 -1.555 . . . . 0.0 110.363 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -33.72 71.62 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 173.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -73.42 -38.83 65.41 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.584 HD13 ' HA ' ' A' ' 152' ' ' THR . 2.7 pp -79.46 -38.58 34.24 Favored 'General case' 0 C--N 1.373 1.618 0 C-N-CA 125.986 1.714 . . . . 0.0 113.501 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.298 0.0 OUTLIER -87.58 -16.67 33.89 Favored 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.848 1.659 . . . . 0.0 110.901 -172.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -117.02 -106.96 0.38 Allowed 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -135.86 156.04 49.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.972 1.368 . . . . 0.0 109.564 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -51.24 -35.33 36.44 Favored 'General case' 0 C--N 1.36 1.053 1 C-N-CA 134.275 5.03 . . . . 0.0 113.932 175.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.7 tp -50.9 -31.17 9.93 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 C-N-CA 129.933 3.293 . . . . 0.0 112.458 172.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -73.04 -37.08 67.01 Favored 'General case' 0 C--N 1.377 1.766 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.583 HH21 HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -75.2 -42.94 54.51 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 172.813 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.326 54.2 mt -73.36 -19.25 61.05 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 126.48 1.912 . . . . 0.0 113.304 -177.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.31 -37.73 67.76 Favored 'General case' 0 C--N 1.373 1.619 0 C-N-CA 128.654 2.782 . . . . 0.0 114.735 164.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.14 -45.66 5.83 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 128.705 2.802 . . . . 0.0 108.779 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 71.19 -86.07 0.03 OUTLIER 'General case' 0 C--N 1.363 1.187 0 C-N-CA 130.094 3.358 . . . . 0.0 115.782 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.568 HG12 HE22 ' A' ' 132' ' ' GLN . 3.4 m -116.78 11.52 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 128.93 2.892 . . . . 0.0 107.917 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.328 66.5 m 76.04 66.7 0.06 Allowed 'General case' 0 C--N 1.359 0.994 0 C-N-CA 131.192 3.797 . . . . 0.0 112.417 -176.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -88.81 145.07 25.81 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.632 1.573 . . . . 0.0 111.181 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . 0.298 5.0 mp0 88.48 160.91 0.09 OUTLIER Pre-proline 0 C--N 1.368 1.398 0 C-N-CA 129.484 3.113 . . . . 0.0 111.975 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -68.88 66.28 1.28 Allowed 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 124.699 3.599 . . . . 0.0 117.428 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.377 88.5 p 102.8 -24.99 0.02 OUTLIER 'General case' 0 C--N 1.365 1.243 0 C-N-CA 130.229 3.412 . . . . 0.0 112.816 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 . . . . . 0 C--N 1.359 0.992 0 C-N-CA 126.496 1.919 . . . . 0.0 112.318 179.772 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? . . . . . 0 N--CA 1.443 -0.791 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.69 35.83 2.66 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 125.402 1.481 . . . . 0.0 110.754 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -86.49 71.23 10.46 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 119.813 -1.804 . . . . 0.0 113.632 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.93 119.38 38.75 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.951 1.7 . . . . 0.0 110.041 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.56 142.92 19.43 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 102.464 -3.162 . . . . 0.0 102.464 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -122.75 20.7 10.14 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 119.33 0.968 . . . . 0.0 112.306 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.42 -21.78 43.79 Favored Glycine 0 C--N 1.362 1.994 0 C-N-CA 127.154 2.311 . . . . 0.0 116.648 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -37.46 -78.99 0.04 OUTLIER Glycine 0 C--N 1.368 2.348 0 C-N-CA 130.253 3.787 . . . . 0.0 119.618 -178.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.48 -13.1 55.41 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 120.933 -1.334 . . . . 0.0 113.448 174.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -72.39 -52.45 15.93 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.099 2.56 . . . . 0.0 116.418 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -139.46 -28.8 0.76 Allowed 'General case' 0 C--N 1.354 0.787 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.324 97.1 p 105.9 -107.16 0.0 OUTLIER 'General case' 0 C--N 1.364 1.239 0 C-N-CA 129.675 3.19 . . . . 0.0 107.958 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 t -119.68 -64.89 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.896 0 C-N-CA 125.335 1.454 . . . . 0.0 108.129 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.39 139.57 31.79 Favored Pre-proline 0 C--N 1.354 0.765 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.03 64.98 8.37 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 124.7 3.6 . . . . 0.0 113.475 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.05 -115.71 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.97 117.26 58.08 Favored Pre-proline 0 C--N 1.353 0.76 0 C-N-CA 124.973 1.309 . . . . 0.0 108.957 174.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.37 56.39 5.74 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.278 3.319 . . . . 0.0 111.679 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.1 p -115.96 54.86 0.81 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.703 1.601 . . . . 0.0 112.182 -173.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . 0.265 1.1 t 74.04 -172.0 0.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 119.68 3.215 . . . . 0.0 119.68 175.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.3 p -151.39 79.96 1.29 Allowed 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.491 -1.381 . . . . 0.0 110.584 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' A' ' 145' ' ' LYS . 5.5 t70 -150.57 81.45 1.35 Allowed 'General case' 0 C--N 1.361 1.107 0 C-N-CA 124.71 1.204 . . . . 0.0 111.066 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -118.23 126.92 53.16 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.361 -1.462 . . . . 0.0 111.02 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.6 p -112.28 167.14 9.6 Favored Pre-proline 0 C--N 1.366 1.29 0 C-N-CA 127.347 2.259 . . . . 0.0 116.808 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -48.46 127.88 16.73 Favored 'Trans proline' 0 C--N 1.389 2.665 1 C-N-CA 127.151 5.234 . . . . 0.0 116.619 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.444 ' HA2' HH11 ' A' ' 190' ' ' ARG . . . 96.74 1.15 60.24 Favored Glycine 0 C--N 1.357 1.713 0 C-N-CA 124.103 0.858 . . . . 0.0 112.668 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -94.8 169.2 10.32 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 170.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -113.82 147.49 38.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 101.751 -3.426 . . . . 0.0 101.751 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.455 HG11 ' HG ' ' A' ' 148' ' ' LEU . 1.4 p -142.41 167.15 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 -174.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -112.26 117.75 33.37 Favored 'General case' 0 N--CA 1.437 -1.105 1 N-CA-C 95.796 -5.631 . . . . 0.0 95.796 166.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.56 131.94 52.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -106.8 136.07 47.26 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 118.221 -2.8 . . . . 0.0 106.014 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 40.9 ttm -123.27 145.02 49.03 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 119.827 -1.796 . . . . 0.0 108.578 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.41 96.43 0.08 Allowed 'General case' 0 C--N 1.367 1.356 0 C-N-CA 127.469 2.307 . . . . 0.0 114.418 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.44 -6.29 24.73 Favored Glycine 0 C--N 1.359 1.851 0 C-N-CA 125.685 1.612 . . . . 0.0 113.257 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -106.67 162.07 20.87 Favored Pre-proline 0 C--N 1.355 0.812 0 C-N-CA 125.713 1.605 . . . . 0.0 109.555 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.88 166.6 29.05 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.129 3.219 . . . . 0.0 112.483 164.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -59.88 121.06 10.81 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 126.589 1.956 . . . . 0.0 114.238 170.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.44 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 9.3 m95 -125.09 116.77 25.77 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 -172.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -57.42 127.16 24.38 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.865 3.71 . . . . 0.0 110.227 160.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.7 t -138.71 165.73 26.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 130.11 3.364 . . . . 0.0 111.535 -153.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.583 HD21 ' CZ ' ' A' ' 190' ' ' ARG . 1.9 tt -130.07 131.63 45.85 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 119.82 -1.8 . . . . 0.0 106.285 176.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 131' ' ' VAL . 2.7 p -91.84 119.36 39.09 Favored 'Isoleucine or valine' 0 C--N 1.373 1.63 0 CA-C-N 120.072 1.306 . . . . 0.0 108.942 172.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 153.58 39.81 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -165.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -90.89 113.5 25.71 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.903 2.081 . . . . 0.0 111.04 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -67.79 162.22 60.07 Favored Pre-proline 0 C--N 1.36 1.055 0 C-N-CA 129.55 3.14 . . . . 0.0 113.461 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.25 -7.79 0.86 Allowed 'Trans proline' 0 CA--C 1.563 1.932 1 C-N-CA 125.419 4.079 . . . . 0.0 117.044 169.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.83 35.12 3.0 Favored 'General case' 0 C--N 1.358 0.949 1 C-N-CA 132.153 4.181 . . . . 0.0 107.84 173.067 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.54 149.43 43.05 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 -172.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.47 -19.96 50.79 Favored Glycine 0 C--N 1.362 1.99 0 C-N-CA 125.962 1.744 . . . . 0.0 112.011 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.92 119.96 36.42 Favored 'General case' 0 N--CA 1.447 -0.616 1 C-N-CA 132.864 4.466 . . . . 0.0 102.369 174.186 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.441 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 22.2 p90 -151.0 -2.11 0.35 Allowed 'General case' 0 C--N 1.353 0.739 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -174.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.6 pt -106.14 169.16 2.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 O-C-N 119.354 -2.091 . . . . 0.0 113.143 -175.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -159.3 153.58 23.84 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 174.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.87 127.04 8.43 Favored 'General case' 0 C--N 1.368 1.386 0 CA-C-N 123.097 2.68 . . . . 0.0 114.391 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HG2' HH12 ' A' ' 128' ' ' ARG . 75.6 mmtt -116.81 93.42 4.19 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 120.493 -1.379 . . . . 0.0 108.223 174.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.21 -78.11 0.23 Allowed Glycine 0 C--N 1.363 2.056 0 C-N-CA 128.027 2.727 . . . . 0.0 116.287 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -118.81 -16.11 9.34 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 128.192 2.597 . . . . 0.0 109.015 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.6 m -84.41 75.24 10.26 Favored 'General case' 0 C--N 1.367 1.342 0 O-C-N 118.326 -2.734 . . . . 0.0 110.649 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 p -89.22 112.89 24.89 Favored 'Isoleucine or valine' 0 C--N 1.363 1.171 0 C-N-CA 127.789 2.435 . . . . 0.0 107.563 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.567 HH12 ' HG2' ' A' ' 123' ' ' LYS . 65.3 mtt85 -104.6 157.2 17.34 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 124.893 1.277 . . . . 0.0 111.952 -171.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.401 HG13 ' HD3' ' A' ' 145' ' ' LYS . 21.2 m -149.23 164.25 4.1 Favored 'Isoleucine or valine' 0 C--N 1.367 1.369 1 C-N-CA 132.053 4.141 . . . . 0.0 103.848 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.441 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 4.4 m170 -90.3 116.19 28.08 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 118.9 -2.375 . . . . 0.0 114.485 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 110' ' ' VAL 0.276 2.3 m -143.33 156.65 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 O-C-N 119.016 -2.303 . . . . 0.0 111.587 177.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -112.72 153.96 26.9 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 111.635 -2.53 . . . . 0.0 111.271 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.17 116.11 27.83 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 129.13 2.972 . . . . 0.0 103.012 -174.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 15.0 m-85 -71.85 65.78 0.54 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.859 2.064 . . . . 0.0 113.37 -175.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -92.11 -119.07 0.08 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 126.898 2.079 . . . . 0.0 110.408 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.85 -52.84 2.7 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.188 1.395 . . . . 0.0 112.93 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.4 m -71.07 -44.5 14.12 Favored Pre-proline 0 C--N 1.362 1.127 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.11 -174.71 12.51 Favored 'Cis proline' 0 CA--C 1.541 0.866 0 CA-C-N 126.973 3.526 . . . . 0.0 112.257 -2.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.5 m -95.23 123.78 38.92 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.104 1.362 . . . . 0.0 109.347 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.2 tmm_? -147.47 151.44 36.4 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 120.78 1.627 . . . . 0.0 108.503 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.62 -155.48 12.92 Favored Glycine 0 CA--C 1.489 -1.583 1 N-CA-C 98.502 -5.839 . . . . 0.0 98.502 174.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -89.17 160.33 17.04 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 119.975 1.887 . . . . 0.0 110.479 172.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.42 ' CG2' HG22 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -125.53 171.21 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 O-C-N 120.455 -1.403 . . . . 0.0 109.773 174.678 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.1 m -100.05 116.4 32.0 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.434 ' HB2' HD22 ' A' ' 148' ' ' LEU 0.423 11.4 pttt -68.35 -6.41 24.12 Favored 'General case' 0 C--N 1.366 1.29 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 -172.09 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -70.75 -15.37 62.68 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.474 1.109 . . . . 0.0 113.536 170.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.2 mt -100.41 2.9 42.74 Favored 'General case' 0 C--N 1.37 1.457 0 C-N-CA 126.693 1.997 . . . . 0.0 112.471 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.455 ' HG ' HG11 ' A' ' 96' ' ' VAL . 5.7 mp -94.92 124.47 38.99 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 128.351 2.661 . . . . 0.0 108.771 177.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -118.13 154.16 51.59 Favored Pre-proline 0 CA--C 1.497 -1.058 0 C-N-CA 125.932 1.693 . . . . 0.0 107.664 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -78.42 153.52 27.35 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.614 2.209 . . . . 0.0 115.451 -166.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.418 ' HB2' ' HB2' ' A' ' 183' ' ' LEU 0.311 0.0 OUTLIER -17.94 -107.29 0.0 OUTLIER 'General case' 0 C--N 1.354 0.804 2 C-N-CA 132.681 4.392 . . . . 0.0 122.551 174.747 . . . . . . . . 5 4 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.326 12.4 t 47.41 -36.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 1 C-N-CA 132.616 4.366 . . . . 0.0 119.86 -179.526 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 67.55 -148.67 49.97 Favored Glycine 0 C--N 1.35 1.351 0 C-N-CA 128.129 2.776 . . . . 0.0 119.773 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 m -46.39 -23.75 0.4 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 130.232 3.413 . . . . 0.0 119.342 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -85.62 -8.45 58.24 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.542 1.937 . . . . 0.0 113.161 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 t -85.31 155.85 21.17 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-O 123.029 1.395 . . . . 0.0 112.597 173.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -68.49 -32.74 72.94 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 127.034 2.134 . . . . 0.0 112.751 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.72 -11.87 60.08 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 125.257 1.423 . . . . 0.0 111.488 171.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.66 3.75 42.7 Favored 'General case' 0 C--N 1.371 1.522 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.257 0.9 OUTLIER -122.94 173.38 7.83 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 125.689 1.596 . . . . 0.0 109.408 174.546 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -61.53 122.64 15.75 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 126.567 1.947 . . . . 0.0 114.449 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.32 -14.01 51.35 Favored Glycine 0 C--N 1.358 1.757 0 C-N-CA 124.947 1.261 . . . . 0.0 111.076 -167.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.98 155.52 31.72 Favored Glycine 0 C--N 1.36 1.882 0 N-CA-C 117.186 1.634 . . . . 0.0 117.186 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -58.46 -41.59 85.53 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 120.953 3.686 . . . . 0.0 120.953 -174.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . 0.273 0.1 OUTLIER -102.2 23.32 11.83 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 122.266 2.303 . . . . 0.0 111.785 -179.326 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -93.17 161.32 14.47 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 124.674 2.178 . . . . 0.0 116.671 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 m 170.65 175.99 0.06 Allowed 'General case' 0 C--N 1.354 0.778 1 N-CA-C 98.554 -4.61 . . . . 0.0 98.554 -178.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -137.77 102.25 4.68 Favored 'General case' 0 C--N 1.364 1.219 0 CA-C-N 124.551 3.341 . . . . 0.0 111.286 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -119.88 141.97 32.32 Favored Pre-proline 0 N--CA 1.433 -1.279 0 C-N-CA 130.116 3.366 . . . . 0.0 105.041 173.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.423 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 38.0 Cg_endo -58.37 -31.82 94.78 Favored 'Trans proline' 0 C--N 1.364 1.386 1 C-N-CA 127.678 5.586 . . . . 0.0 115.074 177.305 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -69.79 -35.97 75.3 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 130.332 3.453 . . . . 0.0 113.393 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.44 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 4.4 mm -70.33 -36.21 66.02 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 C-N-CA 127.17 2.188 . . . . 0.0 109.132 174.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 177' ' ' GLN . 6.1 mt -62.73 -53.67 50.79 Favored 'General case' 0 C--N 1.382 1.982 0 C-N-CA 126.226 1.81 . . . . 0.0 111.045 173.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -57.26 -34.22 68.4 Favored 'General case' 0 C--N 1.373 1.613 0 C-N-CA 128.968 2.907 . . . . 0.0 114.374 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.0 -47.83 73.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 130.225 3.41 . . . . 0.0 111.718 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 36.3 mtt -68.45 -33.38 74.08 Favored 'General case' 0 C--N 1.369 1.423 0 CA-C-O 118.069 -0.967 . . . . 0.0 113.547 170.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 13.7 mt-30 -74.32 -43.71 55.61 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 126.366 1.866 . . . . 0.0 112.027 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -68.31 -47.96 66.21 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 129.116 2.966 . . . . 0.0 111.147 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.06 87.42 Favored 'General case' 0 C--N 1.382 2.015 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 170.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.257 23.1 t70 -54.5 -47.44 73.07 Favored 'General case' 0 C--N 1.376 1.753 0 C-N-CA 127.17 2.188 . . . . 0.0 114.161 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -66.0 -43.0 89.01 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-N 120.8 1.636 . . . . 0.0 115.366 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 190' ' ' ARG . . . -76.12 -29.05 57.7 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.5 pp -80.0 -32.58 39.71 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 175.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.277 0.4 OUTLIER -89.68 -34.28 16.31 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 125.393 1.477 . . . . 0.0 111.199 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -100.48 -99.61 0.25 Allowed 'General case' 0 C--N 1.362 1.151 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -135.49 152.22 51.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.223 -1.548 . . . . 0.0 110.27 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 190' ' ' ARG 0.431 16.4 ptpt -50.92 -33.31 23.79 Favored 'General case' 0 C--N 1.358 0.967 1 C-N-CA 133.193 4.597 . . . . 0.0 113.898 172.222 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.5 tt -50.6 -27.97 5.25 Favored 'Isoleucine or valine' 0 C--N 1.368 1.393 0 C-N-CA 127.923 2.489 . . . . 0.0 113.032 172.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -72.72 -39.27 67.08 Favored 'General case' 0 C--N 1.377 1.764 0 C-N-CA 126.343 1.857 . . . . 0.0 114.75 170.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.583 ' CZ ' HD21 ' A' ' 109' ' ' LEU 0.283 0.0 OUTLIER -74.68 -34.41 62.66 Favored 'General case' 0 C--N 1.367 1.362 0 O-C-N 119.286 -2.134 . . . . 0.0 114.859 172.871 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.8 -22.45 56.34 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 126.323 1.849 . . . . 0.0 112.901 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.26 -46.15 86.53 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 126.478 1.911 . . . . 0.0 114.309 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . 0.264 0.2 OUTLIER -105.56 22.14 16.0 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 128.208 2.603 . . . . 0.0 112.922 176.201 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -49.59 141.81 9.05 Favored 'General case' 0 C--N 1.374 1.663 0 C-N-CA 128.991 2.916 . . . . 0.0 118.823 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.368 5.3 p -83.96 48.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.657 0 CA-C-O 125.636 2.636 . . . . 0.0 114.966 176.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 31.3 p -115.7 60.97 0.7 Allowed 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.68 2.792 . . . . 0.0 104.692 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -95.61 139.8 31.35 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 127.571 2.349 . . . . 0.0 116.336 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -143.13 157.87 59.62 Favored Pre-proline 0 C--N 1.357 0.918 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.57 66.64 8.52 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 124.701 3.601 . . . . 0.0 112.299 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.0 t -127.69 33.11 4.86 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.958 1.703 . . . . 0.0 109.933 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.353 0.728 0 C-N-CA 123.487 0.715 . . . . 0.0 109.93 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.67 -46.69 3.03 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.499 1.92 . . . . 0.0 111.51 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -151.83 115.13 4.76 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 120.806 -1.184 . . . . 0.0 108.176 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -102.58 120.9 41.35 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 126.512 1.925 . . . . 0.0 106.546 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.38 66.86 0.19 Allowed 'General case' 0 C--N 1.362 1.126 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 -173.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -84.42 -30.8 25.05 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 129.225 3.01 . . . . 0.0 109.425 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.03 4.43 47.97 Favored Glycine 0 C--N 1.361 1.932 0 C-N-CA 126.647 2.07 . . . . 0.0 113.79 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.63 -28.81 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.297 0 O-C-N 121.169 -1.195 . . . . 0.0 111.46 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 tp 69.58 -92.84 0.03 OUTLIER 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.052 3.341 . . . . 0.0 112.421 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -71.96 -23.87 61.51 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 131.548 3.939 . . . . 0.0 112.604 173.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . 0.28 10.0 tpp180 103.62 48.72 0.0 OUTLIER 'General case' 0 C--N 1.36 1.037 0 C-N-CA 131.06 3.744 . . . . 0.0 109.652 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.8 t 77.21 173.6 0.21 Allowed 'General case' 0 C--N 1.369 1.447 0 C-N-CA 128.647 2.779 . . . . 0.0 116.155 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.6 m -123.98 -2.31 6.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 128.382 2.673 . . . . 0.0 108.6 173.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.56 115.13 29.85 Favored Pre-proline 0 C--N 1.362 1.135 0 C-N-CA 126.105 1.762 . . . . 0.0 108.33 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.84 114.3 1.97 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.33 3.353 . . . . 0.0 111.891 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -139.68 -108.26 0.16 Allowed 'General case' 0 C--N 1.352 0.7 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.8 119.46 52.39 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 116.177 -1.868 . . . . 0.0 106.334 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.33 91.53 0.33 Allowed 'Trans proline' 0 C--N 1.367 1.508 1 C-N-CA 125.615 4.21 . . . . 0.0 112.433 -172.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.8 p -139.73 -97.54 0.16 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.654 1.982 . . . . 0.0 110.145 -170.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 t -176.6 -172.62 0.46 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 126.817 2.047 . . . . 0.0 106.988 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.7 m -166.48 36.65 0.04 OUTLIER 'General case' 0 C--N 1.353 0.753 0 O-C-N 120.49 -1.381 . . . . 0.0 110.287 172.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -97.61 99.88 11.27 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -124.42 126.51 46.06 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 124.431 1.093 . . . . 0.0 112.393 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.345 88.8 p -112.12 170.86 4.83 Favored Pre-proline 0 CA--C 1.558 1.279 1 C-N-CA 133.022 4.529 . . . . 0.0 116.524 -177.18 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 12.7 Cg_exo -41.69 128.55 3.71 Favored 'Trans proline' 0 C--N 1.389 2.691 1 C-N-CA 127.927 5.751 . . . . 0.0 118.879 -179.165 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.547 ' HA2' ' CZ ' ' A' ' 190' ' ' ARG . . . 88.08 4.38 78.25 Favored Glycine 0 CA--C 1.477 -2.314 0 C-N-CA 129.382 3.372 . . . . 0.0 117.223 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -93.59 148.57 21.97 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 168.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.97 126.31 52.96 Favored 'General case' 0 N--CA 1.441 -0.902 1 N-CA-C 99.834 -4.135 . . . . 0.0 99.834 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.3 154.93 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -99.9 122.15 42.4 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 101.832 -3.396 . . . . 0.0 101.832 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.97 131.12 55.36 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 127.831 2.452 . . . . 0.0 110.77 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.87 135.85 49.39 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 174.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.0 ttp -130.08 153.55 48.36 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 119.946 -1.721 . . . . 0.0 112.098 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -63.22 90.25 0.04 OUTLIER 'General case' 0 C--N 1.364 1.224 0 C-N-CA 129.206 3.002 . . . . 0.0 114.734 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.46 -0.77 24.99 Favored Glycine 0 C--N 1.358 1.804 0 C-N-CA 125.786 1.66 . . . . 0.0 113.028 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -108.25 161.39 23.58 Favored Pre-proline 0 C--N 1.357 0.911 0 C-N-CA 125.366 1.466 . . . . 0.0 110.296 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.48 166.49 29.2 Favored 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 124.976 3.784 . . . . 0.0 111.65 164.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.6 121.53 16.62 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 126.454 1.902 . . . . 0.0 109.557 173.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.282 0.8 OUTLIER -128.64 135.16 27.16 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 119.267 3.062 . . . . 0.0 119.267 -167.696 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.51 149.19 90.75 Favored 'Trans proline' 0 CA--C 1.567 2.154 0 C-N-CA 124.722 3.615 . . . . 0.0 113.763 153.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 p -155.34 161.91 40.95 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 125.554 1.541 . . . . 0.0 112.464 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.447 HD22 ' HB2' ' A' ' 190' ' ' ARG . 2.3 pp -115.7 137.16 52.36 Favored 'General case' 0 C--N 1.374 1.66 0 O-C-N 120.386 -1.446 . . . . 0.0 110.594 171.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.529 HG13 HG12 ' A' ' 131' ' ' VAL . 2.2 t -93.86 118.97 40.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 C-N-CA 125.603 1.561 . . . . 0.0 109.141 170.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.4 ' HB3' ' CD1' ' A' ' 109' ' ' LEU 0.288 0.1 OUTLIER -137.81 155.62 48.81 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 128.481 2.713 . . . . 0.0 110.747 -177.746 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -71.42 113.63 8.66 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 125.588 1.555 . . . . 0.0 113.105 170.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -89.59 159.0 44.76 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 113.798 -3.001 . . . . 0.0 106.631 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.288 46.4 Cg_exo -47.99 -0.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 2 C-N-CA 127.361 5.374 . . . . 0.0 122.745 -166.239 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -82.29 -26.17 33.34 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 128.15 2.58 . . . . 0.0 109.926 167.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 27.47 95.11 0.0 OUTLIER 'General case' 0 C--N 1.37 1.466 1 C-N-CA 135.226 5.41 . . . . 0.0 121.2 178.375 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.67 -20.85 26.68 Favored Glycine 0 C--N 1.357 1.699 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 39.9 m -107.67 118.16 36.0 Favored 'General case' 0 C--N 1.357 0.905 1 N-CA-C 98.954 -4.461 . . . . 0.0 98.954 165.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.402 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 13.2 p90 -147.35 0.82 0.71 Allowed 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.996 -1.065 . . . . 0.0 111.442 -171.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.45 HG22 HG12 ' A' ' 129' ' ' VAL . 17.4 pt -109.9 156.97 10.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 CA-C-O 121.97 0.891 . . . . 0.0 110.614 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -149.85 152.19 34.72 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.23 131.39 19.42 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 120.352 -1.468 . . . . 0.0 110.539 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -117.94 93.52 4.17 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.687 1.995 . . . . 0.0 110.558 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.38 -83.24 0.44 Allowed Glycine 0 C--N 1.362 2.002 0 N-CA-C 119.247 2.459 . . . . 0.0 119.247 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -138.32 52.77 1.82 Allowed 'General case' 0 C--N 1.36 1.025 0 C-N-CA 125.616 1.566 . . . . 0.0 110.365 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.1 m -171.96 142.2 1.44 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 p -119.9 136.91 55.49 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 C-N-CA 124.708 1.203 . . . . 0.0 110.871 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -119.62 143.16 47.83 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 127.623 2.369 . . . . 0.0 111.489 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.45 HG12 HG22 ' A' ' 120' ' ' ILE . 29.9 m -129.01 162.86 35.49 Favored 'Isoleucine or valine' 0 C--N 1.37 1.468 0 C-N-CA 130.052 3.341 . . . . 0.0 107.042 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.402 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 1.5 p-80 -97.02 119.68 35.94 Favored 'General case' 0 C--N 1.371 1.526 0 O-C-N 119.147 -2.221 . . . . 0.0 112.305 174.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.529 HG12 HG13 ' A' ' 110' ' ' VAL . 0.9 OUTLIER -145.51 166.22 10.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.353 0 C-N-CA 127.709 2.404 . . . . 0.0 105.543 -177.1 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.2 147.56 47.93 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.332 1.453 . . . . 0.0 108.423 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -96.15 127.91 42.58 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 128.73 2.812 . . . . 0.0 106.214 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 109' ' ' LEU . 17.0 m-30 -72.61 59.37 0.45 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -174.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -94.93 -119.95 0.1 Allowed 'General case' 0 C--N 1.36 1.036 0 C-N-CA 127.238 2.215 . . . . 0.0 111.643 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -103.04 -52.43 3.04 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 125.129 1.372 . . . . 0.0 113.349 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.0 m -66.63 -43.81 52.17 Favored Pre-proline 0 C--N 1.366 1.323 0 N-CA-C 117.99 2.589 . . . . 0.0 117.99 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -80.12 173.61 52.32 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 CA-C-N 125.693 3.069 . . . . 0.0 110.753 -5.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.5 m -81.62 134.67 35.51 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.196 -1.565 . . . . 0.0 110.191 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.5 ttp-105 -141.96 157.78 44.55 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 121.098 1.772 . . . . 0.0 109.153 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.16 -159.92 28.42 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 103.679 -3.768 . . . . 0.0 103.679 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -97.48 108.45 21.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.523 2.329 . . . . 0.0 107.17 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 m -88.81 160.75 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.182 0 C-N-CA 126.941 2.096 . . . . 0.0 110.52 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.9 m -82.68 114.97 21.41 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.405 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 7.2 ttmt -72.85 -16.76 61.59 Favored 'General case' 0 C--N 1.359 0.985 0 CA-C-O 122.752 1.263 . . . . 0.0 113.962 -169.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -76.03 -5.85 48.31 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.266 -1.522 . . . . 0.0 113.547 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 75.1 mt -105.39 14.8 28.23 Favored 'General case' 0 C--N 1.37 1.461 0 C-N-CA 126.956 2.102 . . . . 0.0 110.844 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 29.2 mt -100.32 125.46 46.55 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 126.453 1.901 . . . . 0.0 107.81 173.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.72 163.14 20.37 Favored Pre-proline 0 C--O 1.226 -0.172 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -79.53 141.1 15.48 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.844 3.029 . . . . 0.0 112.515 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.95 140.06 30.16 Favored 'General case' 0 C--N 1.365 1.263 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 171.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.661 ' HA ' HD11 ' A' ' 183' ' ' LEU . 13.5 t -164.24 -15.97 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.39 114.48 0.47 Allowed Glycine 0 C--N 1.352 1.469 0 C-N-CA 116.471 -2.776 . . . . 0.0 114.201 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 50.1 m -65.22 -10.63 33.31 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 127.835 2.454 . . . . 0.0 117.283 176.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.27 27.7 9.41 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 127.55 2.34 . . . . 0.0 109.19 175.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.7 t -99.42 142.84 30.38 Favored 'General case' 0 CA--C 1.48 -1.712 0 C-N-CA 128.278 2.631 . . . . 0.0 107.329 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.4 tptt -47.79 -40.63 21.43 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 127.393 2.277 . . . . 0.0 116.615 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -73.97 -15.6 61.1 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 124.744 1.218 . . . . 0.0 113.822 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.77 -1.52 40.24 Favored 'General case' 0 C--N 1.379 1.857 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -126.94 -173.77 2.97 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.255 1.422 . . . . 0.0 113.667 -176.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -61.93 121.88 14.07 Favored 'General case' 0 C--N 1.38 1.927 0 C-N-CA 125.921 1.688 . . . . 0.0 113.227 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.9 -6.19 73.06 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 124.307 0.956 . . . . 0.0 114.095 -170.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.53 158.45 37.46 Favored Glycine 0 C--N 1.369 2.377 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -59.72 -41.84 91.79 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.86 -30.04 13.38 Favored 'General case' 0 C--N 1.365 1.25 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 3.1 t80 19.53 -101.42 0.01 OUTLIER 'General case' 0 C--N 1.388 2.282 1 C-N-CA 132.971 4.509 . . . . 0.0 114.575 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m 54.26 57.65 5.69 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 129.378 3.071 . . . . 0.0 115.51 170.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.43 101.08 12.32 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 124.941 2.305 . . . . 0.0 113.112 -171.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -120.34 147.03 44.17 Favored Pre-proline 0 N--CA 1.43 -1.464 1 C-N-CA 133.231 4.612 . . . . 0.0 103.42 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.535 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 57.3 Cg_endo -56.76 -33.79 94.9 Favored 'Trans proline' 0 CA--C 1.545 1.058 1 C-N-CA 125.883 4.389 . . . . 0.0 116.741 -178.331 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.83 -36.28 80.08 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.698 1.999 . . . . 0.0 112.4 173.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.256 6.5 mt -76.0 -32.62 23.55 Favored 'Isoleucine or valine' 0 C--N 1.369 1.425 0 C-N-CA 126.648 1.979 . . . . 0.0 110.566 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.535 ' HG ' ' HA ' ' A' ' 170' ' ' PRO 0.276 35.7 mt -62.57 -53.85 48.55 Favored 'General case' 0 C--N 1.387 2.226 0 C-N-CA 127.391 2.276 . . . . 0.0 110.269 172.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -57.76 -43.23 85.31 Favored 'General case' 0 C--N 1.369 1.418 0 C-N-CA 129.743 3.217 . . . . 0.0 114.197 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.26 -35.5 76.15 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 130.769 3.628 . . . . 0.0 111.454 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.0 mtt -68.09 -40.17 82.69 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.108 1.763 . . . . 0.0 110.384 168.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 11.7 mt-30 -66.17 -50.3 64.41 Favored 'General case' 0 C--N 1.374 1.655 0 C-N-CA 126.142 1.777 . . . . 0.0 112.258 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.298 4.7 ptt180 -71.65 -37.53 70.8 Favored 'General case' 0 C--N 1.382 2.001 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 175.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.22 68.77 Favored 'General case' 0 C--N 1.373 1.612 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 169.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 20.6 t0 -70.11 -48.79 56.11 Favored 'General case' 0 C--N 1.372 1.546 0 O-C-N 119.212 -2.18 . . . . 0.0 110.569 168.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -53.37 -47.81 69.13 Favored 'General case' 0 C--N 1.373 1.629 0 C-N-CA 128.88 2.872 . . . . 0.0 114.696 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.42 ' CB ' ' HB3' ' A' ' 190' ' ' ARG . . . -68.11 -29.34 68.24 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 176.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.661 HD11 ' HA ' ' A' ' 152' ' ' THR 0.267 0.2 OUTLIER -81.35 -41.85 21.41 Favored 'General case' 0 C--N 1.367 1.365 0 O-C-N 118.552 -2.592 . . . . 0.0 112.811 171.077 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 180' ' ' ASP 0.277 0.0 OUTLIER -70.91 -30.3 66.59 Favored 'General case' 0 C--N 1.379 1.889 0 C-N-CA 129.359 3.064 . . . . 0.0 112.676 -173.402 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -103.99 -100.59 0.31 Allowed 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.374 0.607 . . . . 0.0 109.712 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -136.62 144.03 43.84 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.675 7.1 pttm -51.19 -33.73 28.62 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 129.972 3.309 . . . . 0.0 116.41 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.78 -28.29 3.94 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 C-N-CA 129.096 2.958 . . . . 0.0 112.586 169.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.295 2.4 mptp? -64.79 -30.95 71.98 Favored 'General case' 0 C--N 1.374 1.642 0 C-N-CA 126.861 2.064 . . . . 0.0 115.479 168.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.547 ' CZ ' ' HA2' ' A' ' 93' ' ' GLY 0.381 0.0 OUTLIER -75.51 -41.35 55.5 Favored 'General case' 0 C--N 1.38 1.911 0 CA-C-N 123.046 2.657 . . . . 0.0 113.16 167.53 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 43.7 mt -69.38 -19.7 63.83 Favored 'General case' 0 C--N 1.378 1.843 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -64.68 -24.17 67.49 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 129.902 3.281 . . . . 0.0 112.55 170.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.3 mt -105.93 -49.35 3.41 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 55.85 -128.81 2.02 Favored 'General case' 0 C--N 1.375 1.701 0 C-N-CA 128.683 2.793 . . . . 0.0 110.871 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.44 14.81 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.802 1.241 . . . . 0.0 112.076 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.4 t 79.12 24.57 0.5 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 128.999 2.92 . . . . 0.0 110.523 -171.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -25.35 31.82 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.163 2 C-N-CA 135.74 5.616 . . . . 0.0 124.42 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -82.12 146.04 54.16 Favored Pre-proline 0 C--N 1.356 0.879 0 C-N-CA 126.918 2.087 . . . . 0.0 114.555 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -84.97 -167.72 0.45 Allowed 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 123.958 3.105 . . . . 0.0 113.547 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.0 m -162.11 53.42 0.23 Allowed 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 120.527 -1.358 . . . . 0.0 107.919 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 C--N 1.353 0.74 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.932 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 tptm . . . . . 0 N--CA 1.443 -0.775 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 74.52 -50.52 0.67 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 129.148 2.979 . . . . 0.0 114.601 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -92.47 175.87 6.67 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 127.441 2.296 . . . . 0.0 111.703 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -103.13 141.49 35.76 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.793 1.237 . . . . 0.0 108.308 174.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.8 mt -64.92 -21.59 66.85 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 128.385 2.674 . . . . 0.0 117.039 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -101.88 1.78 37.35 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.127 1.771 . . . . 0.0 109.199 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.16 -22.29 3.11 Favored Glycine 0 C--N 1.357 1.748 0 C-N-CA 130.684 3.993 . . . . 0.0 115.136 -174.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.83 87.33 1.76 Allowed Glycine 0 C--N 1.357 1.716 0 C-N-CA 127.483 2.468 . . . . 0.0 113.081 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.6 tp 89.9 95.69 0.02 OUTLIER 'General case' 0 C--N 1.368 1.399 0 C-N-CA 128.293 2.637 . . . . 0.0 112.936 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -73.01 -52.14 15.53 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 126.89 2.076 . . . . 0.0 114.762 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.429 ' HE ' HH22 ' A' ' 128' ' ' ARG . 20.4 tpp180 -157.49 152.5 25.74 Favored 'General case' 0 N--CA 1.429 -1.494 1 N-CA-C 97.037 -5.171 . . . . 0.0 97.037 177.655 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.3 p -96.84 70.39 2.48 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 120.511 -1.368 . . . . 0.0 110.767 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.3 p -99.28 102.59 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-O 124.157 1.932 . . . . 0.0 111.586 -175.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.69 150.6 68.56 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.19 69.54 7.88 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 124.688 3.592 . . . . 0.0 112.422 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.8 -160.81 0.91 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.197 0.999 . . . . 0.0 109.744 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.68 112.72 60.05 Favored Pre-proline 0 C--N 1.357 0.897 0 O-C-N 120.445 -1.409 . . . . 0.0 110.905 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -91.84 -161.53 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.559 2.84 . . . . 0.0 112.043 -176.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t -104.26 135.64 45.35 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.049 1.74 . . . . 0.0 107.182 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.5 p -81.82 72.16 8.86 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 129.141 2.976 . . . . 0.0 110.173 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 30.8 m -119.35 109.07 15.36 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.448 2.699 . . . . 0.0 110.347 -169.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -148.01 105.49 3.67 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 121.078 -1.014 . . . . 0.0 109.631 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -124.61 128.37 48.78 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 126.019 1.728 . . . . 0.0 108.958 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.54 164.55 14.59 Favored Pre-proline 0 C--N 1.355 0.827 0 C-N-CA 125.052 1.341 . . . . 0.0 113.747 -175.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -45.01 135.0 10.8 Favored 'Trans proline' 0 C--N 1.373 1.864 1 C-N-CA 127.828 5.686 . . . . 0.0 119.642 -173.007 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 190' ' ' ARG . . . 101.74 -6.45 54.76 Favored Glycine 0 C--N 1.366 2.211 0 C-N-CA 125.777 1.656 . . . . 0.0 112.11 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -94.3 169.65 10.08 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.265 2.033 . . . . 0.0 112.827 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.18 138.57 38.95 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 102.891 -3.003 . . . . 0.0 102.891 164.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.76 132.5 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -89.49 122.45 32.68 Favored 'General case' 0 N--CA 1.478 0.931 1 O-C-N 116.24 -4.037 . . . . 0.0 106.081 175.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.15 131.62 53.2 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 122.71 1.243 . . . . 0.0 113.124 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -102.33 135.48 43.86 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -122.53 147.65 46.12 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 104.566 -2.383 . . . . 0.0 104.566 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.79 107.93 1.59 Allowed 'General case' 0 C--N 1.354 0.772 0 C-N-CA 126.217 1.807 . . . . 0.0 113.114 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.32 -15.25 46.88 Favored Glycine 0 C--N 1.354 1.57 0 C-N-CA 124.769 1.176 . . . . 0.0 114.599 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . 0.256 0.0 OUTLIER -102.25 168.28 9.19 Favored Pre-proline 0 C--N 1.363 1.159 0 CA-C-N 119.659 1.729 . . . . 0.0 111.94 -178.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.76 158.52 50.23 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 125.196 3.931 . . . . 0.0 113.583 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -54.95 129.38 37.47 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 128.948 2.899 . . . . 0.0 115.351 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -134.04 126.58 18.72 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 119.768 3.247 . . . . 0.0 119.768 -172.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -67.21 117.64 4.97 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 124.944 3.763 . . . . 0.0 113.695 164.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.94 164.37 17.71 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 131.257 3.823 . . . . 0.0 114.335 -170.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp -120.99 132.77 55.12 Favored 'General case' 0 C--N 1.345 0.409 0 O-C-N 118.563 -2.586 . . . . 0.0 107.381 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 131' ' ' VAL . 7.6 p -91.51 129.79 41.67 Favored 'Isoleucine or valine' 0 C--N 1.374 1.638 0 CA-C-N 119.987 1.267 . . . . 0.0 108.216 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.345 0.0 OUTLIER -138.64 153.27 48.59 Favored 'General case' 0 C--N 1.372 1.563 0 O-C-N 117.922 -2.986 . . . . 0.0 117.351 -173.111 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -87.92 112.31 22.4 Favored 'General case' 0 C--N 1.368 1.413 0 CA-C-O 123.386 1.565 . . . . 0.0 109.246 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -97.33 154.99 37.86 Favored Pre-proline 0 N--CA 1.447 -0.599 0 C-N-CA 129.377 3.071 . . . . 0.0 108.115 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -56.68 -0.96 0.28 Allowed 'Trans proline' 0 N--CA 1.487 1.121 1 C-N-CA 126.524 4.816 . . . . 0.0 121.076 -165.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.79 -7.81 58.52 Favored 'General case' 0 C--N 1.363 1.191 0 C-N-CA 129.404 3.082 . . . . 0.0 109.624 170.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -30.18 139.99 0.02 OUTLIER 'General case' 0 C--N 1.375 1.715 1 C-N-CA 134.153 4.981 . . . . 0.0 121.361 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.22 -20.24 28.55 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 113.456 -1.702 . . . . 0.0 109.236 175.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.6 p -125.5 118.78 26.53 Favored 'General case' 0 C--N 1.348 0.514 1 N-CA-C 96.518 -5.364 . . . . 0.0 96.518 164.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -123.87 4.73 8.74 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 119.688 1.131 . . . . 0.0 112.12 -172.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.5 pt -110.12 166.43 5.16 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.746 1.218 . . . . 0.0 110.401 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -151.04 147.36 27.01 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.826 2.45 . . . . 0.0 105.201 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.06 134.67 15.4 Favored 'General case' 0 C--N 1.357 0.935 0 O-C-N 120.546 -1.346 . . . . 0.0 110.702 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 93.55 4.17 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 127.921 2.488 . . . . 0.0 108.834 175.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.32 -74.38 0.14 Allowed Glycine 0 C--N 1.361 1.971 0 N-CA-C 121.212 3.245 . . . . 0.0 121.212 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.32 37.58 3.53 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.775 1.63 . . . . 0.0 111.488 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m -166.22 151.6 8.46 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 119.461 -2.025 . . . . 0.0 107.286 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.47 144.58 32.41 Favored 'Isoleucine or valine' 0 C--N 1.366 1.293 0 C-N-CA 126.023 1.729 . . . . 0.0 111.126 -174.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.429 HH22 ' HE ' ' A' ' 78' ' ' ARG . 90.3 mtt-85 -135.55 154.76 51.27 Favored 'General case' 0 C--N 1.366 1.298 0 C-N-CA 127.975 2.51 . . . . 0.0 113.931 -175.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 145' ' ' LYS . 23.3 m -126.28 162.74 29.57 Favored 'Isoleucine or valine' 0 C--N 1.38 1.904 0 C-N-CA 130.77 3.628 . . . . 0.0 106.144 173.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -86.42 116.42 24.56 Favored 'General case' 0 C--N 1.365 1.275 0 O-C-N 119.695 -1.878 . . . . 0.0 110.815 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 110' ' ' VAL . 2.3 t -138.67 150.13 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 C-N-CA 125.044 1.338 . . . . 0.0 107.714 -174.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -118.7 144.93 45.91 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 170.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -100.22 131.05 46.39 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.53 72.59 2.52 Favored 'General case' 0 C--N 1.38 1.893 0 C-N-CA 125.098 1.359 . . . . 0.0 111.542 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -97.9 -103.9 0.19 Allowed 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.518 1.127 . . . . 0.0 111.002 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -106.61 -62.44 1.39 Allowed 'General case' 0 C--N 1.354 0.763 0 C-N-CA 126.051 1.74 . . . . 0.0 113.75 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 p -88.27 -29.14 0.37 Allowed Pre-proline 0 C--N 1.364 1.196 0 N-CA-C 118.945 2.943 . . . . 0.0 118.945 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.5 -177.84 18.72 Favored 'Cis proline' 0 C--N 1.357 1.025 1 CA-C-N 129.585 4.459 . . . . 0.0 113.386 -2.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 64.2 m -98.12 113.37 25.24 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 127.889 2.476 . . . . 0.0 113.585 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -113.41 161.53 17.19 Favored 'General case' 0 C--N 1.363 1.155 0 CA-C-N 124.972 3.533 . . . . 0.0 108.086 172.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.58 -170.33 31.34 Favored Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 103.359 -3.896 . . . . 0.0 103.359 168.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -93.93 110.21 21.9 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 172.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.6 m -94.6 157.16 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 C-N-CA 125.949 1.7 . . . . 0.0 110.947 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.5 t -79.14 110.98 14.91 Favored 'General case' 0 C--N 1.364 1.222 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HB3' HG22 ' A' ' 129' ' ' VAL 0.419 0.0 OUTLIER -65.73 -14.89 62.2 Favored 'General case' 0 C--N 1.366 1.295 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -172.891 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.418 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 41.0 ttm180 -74.76 -3.87 34.2 Favored 'General case' 0 N--CA 1.434 -1.227 1 C-N-CA 132.798 4.439 . . . . 0.0 112.933 170.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 147' ' ' LEU . 8.3 mt -109.73 2.29 19.99 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.391 2.276 . . . . 0.0 110.902 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.8 mt -96.41 153.22 17.95 Favored 'General case' 0 C--N 1.373 1.615 0 O-C-N 120.069 -1.644 . . . . 0.0 113.19 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -119.02 155.21 53.28 Favored Pre-proline 0 C--N 1.351 0.654 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -82.76 155.53 15.61 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 125.403 2.965 . . . . 0.0 113.069 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -35.63 -87.89 0.0 OUTLIER 'General case' 0 C--N 1.348 0.512 2 C-N-CA 132.297 4.239 . . . . 0.0 122.4 -177.551 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.845 ' HA ' HD13 ' A' ' 183' ' ' LEU . 4.6 t -31.48 24.94 0.0 OUTLIER 'General case' 0 C--N 1.359 0.988 1 C-N-CA 138.555 6.742 . . . . 0.0 120.643 -179.246 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.03 0.4 47.9 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 -165.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 159' ' ' ALA 0.256 5.8 p -62.73 -15.53 53.46 Favored 'General case' 0 C--N 1.366 1.289 0 CA-C-N 120.988 2.394 . . . . 0.0 117.287 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -91.47 -6.7 52.25 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 128.808 2.843 . . . . 0.0 111.107 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.0 p -90.85 147.85 22.9 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 127.34 2.256 . . . . 0.0 112.775 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -62.19 -18.47 61.11 Favored 'General case' 0 C--N 1.37 1.475 0 C-N-CA 126.82 2.048 . . . . 0.0 113.517 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -75.87 -26.51 57.13 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 127.452 2.301 . . . . 0.0 112.696 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 154' ' ' SER . . . -89.63 -12.89 38.38 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -114.91 -178.91 3.48 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 126.177 1.791 . . . . 0.0 111.4 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -57.74 122.75 13.58 Favored 'General case' 0 C--N 1.372 1.55 0 C-N-CA 127.243 2.217 . . . . 0.0 115.134 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.12 -10.95 58.58 Favored Glycine 0 C--N 1.357 1.72 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.81 -167.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -84.33 160.34 36.26 Favored Glycine 0 C--N 1.363 2.058 0 N-CA-C 121.13 3.212 . . . . 0.0 121.13 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -60.38 -30.0 69.29 Favored 'General case' 0 C--N 1.369 1.447 0 C-N-CA 128.915 2.886 . . . . 0.0 118.691 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -105.34 7.9 33.52 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.357 -1.464 . . . . 0.0 110.456 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -87.78 162.64 16.9 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -171.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.5 m 174.91 176.75 0.16 Allowed 'General case' 0 C--N 1.353 0.724 1 N-CA-C 99.097 -4.409 . . . . 0.0 99.097 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -138.71 102.29 4.54 Favored 'General case' 0 C--N 1.364 1.228 0 CA-C-N 124.187 3.176 . . . . 0.0 111.288 173.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -119.74 138.32 26.62 Favored Pre-proline 0 N--CA 1.435 -1.21 0 C-N-CA 130.269 3.428 . . . . 0.0 105.766 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.47 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 55.4 Cg_endo -59.4 -27.44 84.99 Favored 'Trans proline' 0 C--N 1.363 1.334 1 C-N-CA 127.013 5.142 . . . . 0.0 115.086 177.372 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -70.02 -36.85 75.38 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 129.465 3.106 . . . . 0.0 113.167 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.2 mt -70.45 -34.89 59.63 Favored 'Isoleucine or valine' 0 C--N 1.381 1.977 0 C-N-CA 126.677 1.991 . . . . 0.0 110.056 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 170' ' ' PRO . 6.8 mt -59.69 -53.26 60.05 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 125.987 1.715 . . . . 0.0 110.742 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -57.55 -34.6 69.34 Favored 'General case' 0 C--N 1.367 1.356 0 C-N-CA 128.217 2.607 . . . . 0.0 115.403 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.81 -42.83 80.94 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 129.191 2.996 . . . . 0.0 111.662 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 18.1 mtt -69.98 -33.24 71.8 Favored 'General case' 0 C--N 1.372 1.546 0 CA-C-O 117.282 -1.342 . . . . 0.0 113.193 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 15.8 mt-30 -74.29 -42.64 59.23 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-N 121.713 2.051 . . . . 0.0 111.109 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -68.54 -49.65 57.91 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 127.348 2.259 . . . . 0.0 111.418 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.57 -41.39 98.9 Favored 'General case' 0 C--N 1.374 1.645 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 173.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 21.1 t70 -62.33 -37.26 84.94 Favored 'General case' 0 C--N 1.379 1.876 0 C-N-CA 128.808 2.843 . . . . 0.0 111.353 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -72.03 -44.81 62.79 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 119.828 -1.795 . . . . 0.0 112.481 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -73.0 -38.89 66.46 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.845 HD13 ' HA ' ' A' ' 152' ' ' THR . 4.4 pp -69.23 -37.28 77.94 Favored 'General case' 0 C--N 1.374 1.645 0 C-N-CA 127.243 2.217 . . . . 0.0 115.056 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -83.72 -31.95 25.77 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 127.103 2.161 . . . . 0.0 111.451 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -105.13 -98.46 0.33 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -135.63 150.73 49.73 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.819 -1.176 . . . . 0.0 112.347 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.277 24.6 ttpp -51.69 -36.37 46.34 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 131.485 3.914 . . . . 0.0 115.385 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.8 tp -53.24 -27.59 13.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 129.219 3.007 . . . . 0.0 112.409 172.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -75.78 -41.27 53.45 Favored 'General case' 0 C--N 1.372 1.555 0 O-C-N 119.483 -2.011 . . . . 0.0 114.636 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 93' ' ' GLY . 7.0 ptp180 -74.61 -37.06 62.94 Favored 'General case' 0 C--N 1.366 1.295 0 O-C-N 118.832 -2.418 . . . . 0.0 116.466 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.0 tp -79.92 -27.82 39.84 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.919 2.087 . . . . 0.0 113.052 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -77.43 -27.42 52.21 Favored 'General case' 0 C--N 1.371 1.541 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 171.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.83 -2.06 54.04 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 124.618 1.167 . . . . 0.0 111.108 175.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 21.9 -124.76 0.01 OUTLIER 'General case' 0 C--N 1.361 1.068 1 C-N-CA 133.807 4.843 . . . . 0.0 121.752 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.6 p -108.38 -20.19 6.32 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 O-C-N 119.8 -1.813 . . . . 0.0 110.575 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.29 5.8 t 59.26 -50.61 0.06 Allowed 'General case' 0 C--N 1.366 1.317 0 C-N-CA 129.844 3.258 . . . . 0.0 116.025 -176.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -84.83 59.41 5.55 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 127.378 2.271 . . . . 0.0 112.055 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -118.13 96.28 49.48 Favored Pre-proline 0 C--N 1.352 0.693 0 C-N-CA 125.492 1.517 . . . . 0.0 108.523 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.89 62.71 6.63 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 124.698 3.598 . . . . 0.0 113.785 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.327 97.9 p 88.05 -77.32 0.01 OUTLIER 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.088 3.355 . . . . 0.0 111.237 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 . . . . . 0 C--N 1.36 1.038 0 C-N-CA 129.054 2.942 . . . . 0.0 116.253 178.067 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.58 50.81 2.13 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 125.923 1.689 . . . . 0.0 109.48 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -134.93 142.4 46.52 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -85.56 130.52 34.55 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.822 2.049 . . . . 0.0 112.224 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -145.97 126.75 14.37 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 120.999 -1.063 . . . . 0.0 109.837 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -118.02 11.81 13.47 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 125.747 1.619 . . . . 0.0 110.468 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.37 -21.27 43.54 Favored Glycine 0 C--N 1.359 1.849 0 C-N-CA 126.807 2.146 . . . . 0.0 117.175 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.61 49.11 0.17 Allowed Glycine 0 C--N 1.354 1.582 0 CA-C-N 118.396 1.098 . . . . 0.0 110.49 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.28 30.35 0.14 Allowed 'General case' 0 C--N 1.361 1.081 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -72.02 -35.94 69.54 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 129.651 3.18 . . . . 0.0 114.645 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -135.94 50.37 2.09 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 126.72 2.008 . . . . 0.0 106.316 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 t -68.23 49.16 0.06 Allowed 'General case' 0 C--N 1.365 1.258 0 C-N-CA 129.287 3.035 . . . . 0.0 116.367 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.9 80.1 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.975 0 C-N-CA 127.308 2.243 . . . . 0.0 110.256 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.91 120.23 60.57 Favored Pre-proline 0 C--N 1.357 0.903 0 C-N-CA 126.096 1.758 . . . . 0.0 110.818 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -83.07 40.3 0.93 Allowed 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 124.232 3.288 . . . . 0.0 113.522 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -175.97 -168.81 0.29 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.2 117.26 67.1 Favored Pre-proline 0 C--N 1.358 0.939 0 C-N-CA 125.2 1.4 . . . . 0.0 107.553 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -82.48 47.5 2.49 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 124.838 3.692 . . . . 0.0 112.897 -172.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.1 p -136.83 54.28 1.87 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 127.526 2.33 . . . . 0.0 107.883 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . 0.272 5.9 t 78.98 -73.94 0.06 Allowed 'General case' 0 C--N 1.361 1.101 0 N-CA-C 118.132 2.641 . . . . 0.0 118.132 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 47.2 m -100.25 152.09 20.69 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 126.637 1.975 . . . . 0.0 113.686 -175.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.66 64.05 0.47 Allowed 'General case' 0 C--N 1.366 1.308 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -172.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -116.45 124.15 49.28 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.147 -1.596 . . . . 0.0 108.645 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.9 p -112.33 165.26 13.37 Favored Pre-proline 0 C--N 1.362 1.127 0 C-N-CA 126.999 2.12 . . . . 0.0 114.651 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -52.22 138.22 54.76 Favored 'Trans proline' 0 C--N 1.371 1.747 1 C-N-CA 126.21 4.607 . . . . 0.0 120.483 -170.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.91 -12.43 38.05 Favored Glycine 0 C--N 1.365 2.169 0 C-N-CA 125.019 1.295 . . . . 0.0 110.418 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.66 170.08 9.72 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 120.37 2.085 . . . . 0.0 111.982 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.33 145.9 28.29 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 163.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.1 m -143.1 157.26 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.403 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 66.9 m95 -108.39 123.33 48.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 102.064 -3.31 . . . . 0.0 102.064 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.4 136.64 54.19 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.509 1.523 . . . . 0.0 112.932 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.516 ' O ' HD13 ' A' ' 147' ' ' LEU . 12.5 tptt -109.51 145.41 36.32 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 170.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 tpt -129.18 150.23 50.65 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 118.622 -2.549 . . . . 0.0 110.042 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.26 90.18 0.07 Allowed 'General case' 0 C--N 1.368 1.406 0 C-N-CA 126.307 1.843 . . . . 0.0 115.622 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.19 1.47 25.07 Favored Glycine 0 C--N 1.359 1.841 0 C-N-CA 125.715 1.626 . . . . 0.0 112.983 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -108.82 161.36 23.92 Favored Pre-proline 0 C--N 1.354 0.786 0 C-N-CA 126.201 1.8 . . . . 0.0 109.352 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.76 167.6 26.11 Favored 'Trans proline' 0 CA--C 1.545 1.055 1 C-N-CA 125.323 4.015 . . . . 0.0 113.295 162.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.488 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 1.8 m95 -57.62 121.54 10.59 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 128.066 2.546 . . . . 0.0 115.301 170.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -123.76 111.83 29.21 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 119.252 3.056 . . . . 0.0 119.252 -172.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.403 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 4.6 Cg_exo -58.5 124.21 15.31 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 125.136 3.891 . . . . 0.0 111.227 162.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.8 p -137.82 165.5 26.31 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 128.461 2.704 . . . . 0.0 115.391 -161.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' A' ' 190' ' ' ARG . 9.2 tp -119.97 132.67 55.58 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.968 2.107 . . . . 0.0 105.952 174.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 131' ' ' VAL . 2.9 p -83.61 118.98 32.04 Favored 'Isoleucine or valine' 0 C--N 1.381 1.959 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 173.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.71 143.39 49.83 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.036 -1.665 . . . . 0.0 111.794 -164.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -98.0 118.53 34.8 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 119.349 -2.094 . . . . 0.0 112.049 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.538 ' H ' ' CE1' ' A' ' 130' ' ' HIS . 2.4 m-70 -71.79 159.78 84.5 Favored Pre-proline 0 C--N 1.358 0.95 0 C-N-CA 128.191 2.596 . . . . 0.0 108.303 169.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.17 -9.06 1.89 Allowed 'Trans proline' 0 CA--C 1.552 1.398 1 C-N-CA 126.563 4.842 . . . . 0.0 116.446 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -63.39 -18.48 63.73 Favored 'General case' 0 C--N 1.36 1.053 1 C-N-CA 134.752 5.221 . . . . 0.0 113.561 166.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.341 0.0 OUTLIER -28.78 136.49 0.02 OUTLIER 'General case' 0 C--N 1.381 1.962 0 N-CA-C 120.926 3.676 . . . . 0.0 120.926 -177.249 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.91 -19.77 27.48 Favored Glycine 0 C--N 1.361 1.936 0 CA-C-O 123.432 1.573 . . . . 0.0 109.633 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.4 m -141.99 119.66 11.8 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 100.269 -3.974 . . . . 0.0 100.269 164.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 130' ' ' HIS . 26.1 p90 -123.98 10.65 8.86 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.764 -1.21 . . . . 0.0 109.154 -176.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.814 HG22 HG12 ' A' ' 129' ' ' VAL . 8.2 pt -121.57 157.12 25.51 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 CA-C-O 123.637 1.684 . . . . 0.0 111.921 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.0 mtp-105 -137.38 149.1 46.72 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 130.467 3.507 . . . . 0.0 102.421 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.1 139.83 24.96 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 120.267 -1.521 . . . . 0.0 109.184 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -118.27 93.69 4.22 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 126.59 1.956 . . . . 0.0 109.622 175.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.63 -76.32 0.21 Allowed Glycine 0 C--N 1.366 2.249 0 N-CA-C 118.635 2.214 . . . . 0.0 118.635 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -141.18 22.7 2.22 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 125.763 1.625 . . . . 0.0 110.073 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.4 t -125.88 128.55 47.77 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 126.493 1.917 . . . . 0.0 108.674 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.21 116.06 49.74 Favored 'Isoleucine or valine' 0 C--N 1.358 0.949 0 C-N-CA 126.625 1.97 . . . . 0.0 112.406 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -113.84 130.68 56.45 Favored 'General case' 0 C--N 1.367 1.329 0 C-N-CA 127.362 2.265 . . . . 0.0 111.256 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.814 HG12 HG22 ' A' ' 120' ' ' ILE . 10.3 m -125.37 159.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.364 1.217 0 C-N-CA 127.438 2.295 . . . . 0.0 106.578 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.538 ' CE1' ' H ' ' A' ' 113' ' ' HIS . 3.8 p80 -90.46 129.76 36.6 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 125.262 1.425 . . . . 0.0 113.268 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.474 HG12 HG23 ' A' ' 110' ' ' VAL . 3.3 m -146.47 165.3 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 C-N-CA 128.358 2.663 . . . . 0.0 106.612 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -126.05 143.18 51.21 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.092 0.557 . . . . 0.0 109.909 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.55 123.91 39.32 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 129.666 3.186 . . . . 0.0 107.885 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -75.69 70.57 2.5 Favored 'General case' 0 C--N 1.374 1.654 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -90.79 -114.38 0.08 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.203 1.801 . . . . 0.0 110.96 -175.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -107.07 -51.99 2.83 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 126.183 1.793 . . . . 0.0 112.105 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.3 m -73.68 -45.92 7.16 Favored Pre-proline 0 C--N 1.366 1.295 0 N-CA-C 119.396 3.11 . . . . 0.0 119.396 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -85.29 177.31 27.38 Favored 'Cis proline' 0 CA--C 1.548 1.175 0 CA-C-N 127.452 3.697 . . . . 0.0 112.832 -1.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 84.5 m -95.08 119.98 34.52 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 120.058 -1.651 . . . . 0.0 110.83 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.491 HH21 HG21 ' A' ' 195' ' ' VAL . 4.6 tmm_? -132.19 148.03 52.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 121.351 1.887 . . . . 0.0 108.484 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.34 -166.65 30.47 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.59 111.92 17.47 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 127.233 2.213 . . . . 0.0 109.591 175.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.7 m -98.45 169.7 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 C-N-CA 125.275 1.43 . . . . 0.0 108.302 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.8 m -95.74 124.53 39.8 Favored 'General case' 0 C--N 1.364 1.199 0 N-CA-C 101.157 -3.646 . . . . 0.0 101.157 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.618 ' HD3' HG11 ' A' ' 129' ' ' VAL . 7.3 ttpm? -70.46 -9.06 55.48 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 124.359 3.254 . . . . 0.0 117.451 -168.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 15.8 ptp180 -73.34 -6.26 44.98 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 129.622 3.169 . . . . 0.0 115.291 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.516 HD13 ' O ' ' A' ' 99' ' ' LYS 0.264 0.8 OUTLIER -112.94 11.63 19.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.839 0.856 . . . . 0.0 110.371 176.545 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.46 HD12 ' HG3' ' A' ' 145' ' ' LYS . 4.8 mt -98.01 125.37 42.93 Favored 'General case' 0 C--N 1.38 1.903 0 C-N-CA 126.381 1.872 . . . . 0.0 107.898 173.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -114.15 161.57 27.48 Favored Pre-proline 0 C--N 1.346 0.426 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.32 153.59 14.06 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 124.959 2.807 . . . . 0.0 113.628 -174.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.296 0.1 OUTLIER -29.87 -84.14 0.0 OUTLIER 'General case' 0 C--N 1.353 0.76 2 N-CA-C 123.685 4.698 . . . . 0.0 123.685 -179.943 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.616 ' HA ' HD21 ' A' ' 183' ' ' LEU . 14.8 t -34.27 38.34 0.0 OUTLIER 'General case' 0 C--N 1.373 1.616 1 C-N-CA 136.961 6.105 . . . . 0.0 118.154 -176.156 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.51 -36.86 2.36 Favored Glycine 0 C--N 1.358 1.788 0 C-N-CA 128.802 3.096 . . . . 0.0 117.969 -168.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 38.0 m -48.6 -15.41 0.08 Allowed 'General case' 0 C--N 1.376 1.755 0 N-CA-C 119.493 3.145 . . . . 0.0 119.493 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -111.34 0.12 16.54 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.453 2.301 . . . . 0.0 110.619 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.5 t -103.35 158.45 16.32 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 127.719 2.407 . . . . 0.0 114.691 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -56.54 -18.64 12.36 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.334 2.654 . . . . 0.0 118.09 -171.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -90.25 -10.53 43.93 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 124.814 1.246 . . . . 0.0 112.402 169.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 4.8 10.62 Favored 'General case' 0 C--N 1.375 1.694 0 CA-C-N 120.146 1.339 . . . . 0.0 114.396 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.424 0.0 OUTLIER -113.2 162.01 16.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.532 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -50.08 122.41 6.71 Favored 'General case' 0 C--N 1.372 1.587 0 C-N-CA 127.318 2.247 . . . . 0.0 116.569 -172.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.86 -22.82 32.68 Favored Glycine 0 C--N 1.36 1.907 0 C-N-CA 125.01 1.291 . . . . 0.0 111.943 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.32 158.7 44.09 Favored Glycine 0 C--N 1.371 2.516 0 N-CA-C 119.43 2.532 . . . . 0.0 119.43 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -52.19 -42.86 63.83 Favored 'General case' 0 C--N 1.366 1.317 0 N-CA-C 121.751 3.982 . . . . 0.0 121.751 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.488 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.344 0.2 OUTLIER -105.16 12.49 31.95 Favored 'General case' 0 C--N 1.365 1.262 0 O-C-N 120.327 -1.483 . . . . 0.0 112.967 -177.779 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -93.53 90.87 6.84 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 126.096 1.758 . . . . 0.0 112.722 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.6 m -115.01 117.52 30.82 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 101.735 -3.431 . . . . 0.0 101.735 170.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.19 101.7 14.42 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 125.87 2.748 . . . . 0.0 113.581 -168.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -120.36 137.77 26.5 Favored Pre-proline 0 N--CA 1.422 -1.836 1 C-N-CA 133.753 4.821 . . . . 0.0 103.039 170.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.92 -26.07 79.66 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.943 3.762 . . . . 0.0 115.134 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -69.74 -35.97 75.45 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 130.961 3.705 . . . . 0.0 112.985 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.251 56.1 mt -75.15 -34.57 31.85 Favored 'Isoleucine or valine' 0 C--N 1.377 1.77 0 C-N-CA 126.289 1.836 . . . . 0.0 109.569 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.88 -46.53 68.17 Favored 'General case' 0 C--N 1.375 1.698 0 C-N-CA 124.827 1.251 . . . . 0.0 111.765 170.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -57.61 -35.79 70.91 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.751 2.02 . . . . 0.0 114.061 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.17 -40.22 86.59 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 130.788 3.635 . . . . 0.0 112.071 172.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 56.4 mtt -69.67 -33.19 72.22 Favored 'General case' 0 C--N 1.364 1.201 0 CA-C-O 116.786 -1.578 . . . . 0.0 113.633 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -74.14 -48.21 30.94 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 126.769 2.028 . . . . 0.0 111.008 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.474 ' HE ' ' HG ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -69.08 -43.93 73.56 Favored 'General case' 0 C--N 1.369 1.432 0 C-N-CA 129.292 3.037 . . . . 0.0 112.454 177.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.86 93.05 Favored 'General case' 0 C--N 1.377 1.794 0 C-N-CA 125.359 1.463 . . . . 0.0 112.198 169.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.441 ' HA ' HD13 ' A' ' 183' ' ' LEU 0.356 4.4 t70 -60.9 -51.38 69.53 Favored 'General case' 0 C--N 1.384 2.096 0 CA-C-N 120.524 1.511 . . . . 0.0 113.016 173.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -35.17 64.84 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 121.938 2.154 . . . . 0.0 116.268 175.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.77 -44.63 32.14 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 168.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' A' ' 152' ' ' THR . 0.3 OUTLIER -60.9 -40.95 95.01 Favored 'General case' 0 C--N 1.364 1.203 0 C-N-CA 131.032 3.733 . . . . 0.0 116.032 178.182 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.284 0.0 OUTLIER -89.21 -13.82 37.4 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.801 2.04 . . . . 0.0 110.783 -173.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -121.31 -108.78 0.35 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 126.553 1.941 . . . . 0.0 114.525 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -131.97 162.11 31.5 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.53 -1.981 . . . . 0.0 113.7 -172.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -37.65 54.1 Favored 'General case' 0 C--N 1.375 1.678 1 C-N-CA 132.113 4.165 . . . . 0.0 116.262 177.198 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.2 -31.89 49.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.501 0 C-N-CA 127.222 2.209 . . . . 0.0 113.74 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -70.84 -42.79 69.71 Favored 'General case' 0 C--N 1.374 1.635 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.449 ' HB2' HD13 ' A' ' 109' ' ' LEU . 7.9 ptt180 -75.44 -44.28 45.23 Favored 'General case' 0 C--N 1.364 1.199 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 170.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.269 7.7 tp -72.52 -19.19 61.56 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 127.234 2.213 . . . . 0.0 114.806 -173.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -63.0 -27.88 69.72 Favored 'General case' 0 C--N 1.368 1.371 0 C-N-CA 127.863 2.465 . . . . 0.0 112.697 166.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.474 ' HG ' ' HE ' ' A' ' 178' ' ' ARG . 2.0 mm? -100.06 22.45 11.29 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 127.965 2.506 . . . . 0.0 112.191 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.61 53.95 0.03 OUTLIER 'General case' 0 C--N 1.374 1.655 0 C-N-CA 127.825 2.45 . . . . 0.0 115.634 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.491 HG21 HH21 ' A' ' 140' ' ' ARG 0.403 2.9 m 62.0 -41.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.283 1 C-N-CA 134.867 5.267 . . . . 0.0 117.024 -179.833 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.318 87.0 p 77.79 59.34 0.03 OUTLIER 'General case' 0 C--N 1.365 1.246 0 C-N-CA 128.996 2.918 . . . . 0.0 108.83 -173.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.05 62.57 0.01 OUTLIER 'General case' 0 C--N 1.361 1.108 0 C-N-CA 129.265 3.026 . . . . 0.0 117.845 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . 0.394 44.6 mt-10 13.37 -73.44 0.0 OUTLIER Pre-proline 0 C--N 1.364 1.22 1 C-N-CA 133.996 4.919 . . . . 0.0 120.931 178.498 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.37 -9.88 17.52 Favored 'Trans proline' 0 C--N 1.36 1.163 0 CA-C-N 125.383 2.958 . . . . 0.0 114.021 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.282 17.6 m 79.79 -37.81 0.17 Allowed 'General case' 0 C--N 1.364 1.209 0 C-N-CA 128.033 2.533 . . . . 0.0 115.767 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 . . . . . 0 C--N 1.357 0.899 0 C-N-CA 127.064 2.146 . . . . 0.0 112.706 178.825 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.0 tttp . . . . . 0 N--CA 1.441 -0.898 0 CA-C-O 122.269 1.033 . . . . 0.0 108.351 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.22 60.75 4.46 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 127.209 2.204 . . . . 0.0 113.761 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -110.51 122.84 48.71 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 126.825 2.05 . . . . 0.0 108.038 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -102.93 149.18 24.77 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 125.137 1.375 . . . . 0.0 109.206 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.474 ' H ' HD23 ' A' ' 72' ' ' LEU 0.259 2.6 pt? -63.22 -0.17 0.75 Allowed 'General case' 0 C--N 1.36 1.049 0 N-CA-C 120.656 3.576 . . . . 0.0 120.656 -173.28 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -97.41 -11.56 23.77 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 125.814 1.645 . . . . 0.0 110.294 173.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.1 0.48 3.16 Favored Glycine 0 C--N 1.369 2.413 0 N-CA-C 122.129 3.612 . . . . 0.0 122.129 162.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.67 -24.58 1.49 Allowed Glycine 0 C--N 1.351 1.371 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -174.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.3 mt -85.61 79.1 9.48 Favored 'General case' 0 C--N 1.367 1.346 0 CA-C-O 123.082 1.42 . . . . 0.0 109.219 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -71.24 -25.22 62.39 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 128.565 2.746 . . . . 0.0 114.112 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 178.8 -44.78 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.6 p -156.56 -137.94 0.06 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 125.699 1.6 . . . . 0.0 106.969 175.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.331 10.9 m 47.43 27.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.238 1 C-N-CA 133.301 4.64 . . . . 0.0 120.617 176.457 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.73 142.69 41.45 Favored Pre-proline 0 C--N 1.357 0.923 0 O-C-N 120.081 -1.637 . . . . 0.0 113.375 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.99 69.04 6.4 Favored 'Trans proline' 0 C--N 1.368 1.575 1 C-N-CA 125.885 4.39 . . . . 0.0 111.043 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -154.88 -37.43 0.09 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.719 2.808 . . . . 0.0 106.09 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -104.77 111.65 65.24 Favored Pre-proline 0 C--N 1.364 1.205 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.23 64.9 4.21 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.521 2.814 . . . . 0.0 110.371 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 p -89.99 59.15 4.43 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 130.05 3.34 . . . . 0.0 112.159 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.3 t -86.87 98.2 11.08 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 127.634 2.374 . . . . 0.0 110.185 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 99.5 p -101.13 96.56 7.3 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.573 1.549 . . . . 0.0 110.85 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -138.36 58.29 1.67 Allowed 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -113.82 122.97 48.67 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 119.336 -2.102 . . . . 0.0 114.314 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.297 96.8 p -112.92 167.35 9.36 Favored Pre-proline 0 C--N 1.359 0.992 0 C-N-CA 129.278 3.031 . . . . 0.0 115.42 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -48.58 139.92 22.73 Favored 'Trans proline' 0 C--N 1.379 2.161 1 C-N-CA 127.457 5.438 . . . . 0.0 121.266 -170.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.26 -7.07 66.43 Favored Glycine 0 C--N 1.37 2.418 0 C-N-CA 126.092 1.806 . . . . 0.0 112.585 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.82 169.15 10.52 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 119.971 1.886 . . . . 0.0 111.851 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 2.8 mm? -102.7 147.76 26.43 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 167.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.35 159.34 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 -177.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -104.67 119.1 38.2 Favored 'General case' 0 CA--C 1.51 -0.558 1 N-CA-C 98.054 -4.795 . . . . 0.0 98.054 165.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.96 131.53 52.35 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.29 136.99 47.84 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 118.675 -2.516 . . . . 0.0 106.136 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 57.1 ttm -129.69 141.4 50.91 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 119.922 -1.736 . . . . 0.0 110.264 173.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -65.37 107.62 1.7 Allowed 'General case' 0 C--N 1.367 1.353 0 C-N-CA 126.082 1.753 . . . . 0.0 112.878 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.55 -16.61 21.52 Favored Glycine 0 C--N 1.36 1.887 0 C-N-CA 125.438 1.494 . . . . 0.0 112.55 -172.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -112.53 161.63 25.4 Favored Pre-proline 0 C--N 1.359 1.011 0 O-C-N 121.144 -1.21 . . . . 0.0 109.111 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.95 167.06 27.73 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 125.015 3.81 . . . . 0.0 113.342 166.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.49 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -58.36 116.42 3.61 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 127.908 2.483 . . . . 0.0 112.821 171.394 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -127.0 117.9 22.1 Favored Pre-proline 0 N--CA 1.426 -1.633 0 N-CA-C 121.387 3.847 . . . . 0.0 121.387 -169.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -49.08 125.3 13.03 Favored 'Trans proline' 0 C--N 1.387 2.58 1 C-N-CA 127.079 5.186 . . . . 0.0 112.374 162.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 m -146.55 164.19 33.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 124.298 1.999 . . . . 0.0 112.045 -158.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 tt -135.67 135.57 40.23 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 119.564 -1.96 . . . . 0.0 106.61 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.312 3.3 p -92.45 130.97 40.77 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 CA-C-N 121.19 1.814 . . . . 0.0 110.372 175.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -133.37 153.05 51.92 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 125.521 1.528 . . . . 0.0 111.955 -166.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -99.81 112.16 24.43 Favored 'General case' 0 C--N 1.376 1.718 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 171.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -96.73 158.38 33.67 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 130.416 3.486 . . . . 0.0 108.767 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -50.05 -1.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.525 2 C-N-CA 127.565 5.51 . . . . 0.0 122.852 -165.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -99.83 9.1 43.58 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 126.673 1.989 . . . . 0.0 108.981 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.0 143.66 0.08 Allowed 'General case' 0 C--N 1.369 1.437 1 C-N-CA 134.224 5.01 . . . . 0.0 120.884 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.94 -19.68 27.51 Favored Glycine 0 C--N 1.359 1.832 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.5 t -134.12 127.52 32.27 Favored 'General case' 0 N--CA 1.448 -0.571 1 N-CA-C 99.456 -4.276 . . . . 0.0 99.456 163.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -128.24 6.41 5.86 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 120.514 -1.366 . . . . 0.0 109.671 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.549 HG22 HG12 ' A' ' 129' ' ' VAL . 23.5 pt -118.59 150.36 20.86 Favored 'Isoleucine or valine' 0 C--N 1.361 1.105 0 CA-C-O 124.076 1.893 . . . . 0.0 113.678 -173.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.532 ' HE ' ' H ' ' A' ' 122' ' ' GLU . 5.7 tpm_? -140.42 144.23 36.04 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 130.025 3.33 . . . . 0.0 103.715 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.532 ' H ' ' HE ' ' A' ' 121' ' ' ARG . 42.4 tt0 -140.3 126.93 20.34 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 176.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -107.16 93.39 4.53 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.82 1.648 . . . . 0.0 107.175 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.5 -93.55 0.81 Allowed Glycine 0 C--N 1.362 2.014 0 C-N-CA 126.489 1.995 . . . . 0.0 111.729 -174.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.58 -0.78 10.76 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 125.248 1.419 . . . . 0.0 109.204 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.5 t -92.52 97.97 11.16 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 125.298 1.439 . . . . 0.0 111.055 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.18 129.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 128.135 2.574 . . . . 0.0 112.404 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -123.49 140.66 52.78 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 126.998 2.119 . . . . 0.0 109.709 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 120' ' ' ILE . 14.8 m -127.2 163.53 29.96 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 127.284 2.233 . . . . 0.0 109.928 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -78.62 123.46 27.14 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 119.195 -2.191 . . . . 0.0 111.819 171.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.538 HG22 HG11 ' A' ' 143' ' ' VAL . 5.5 m -143.96 176.21 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.232 0 CA-C-N 123.278 2.763 . . . . 0.0 104.846 174.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.32 152.36 51.77 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 125.07 1.481 . . . . 0.0 108.442 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.52 120.65 42.82 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 104.141 -2.541 . . . . 0.0 104.141 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -64.86 65.88 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.5 1.92 . . . . 0.0 114.839 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -103.16 -128.62 0.23 Allowed 'General case' 0 C--N 1.36 1.045 0 O-C-N 118.963 -2.336 . . . . 0.0 112.123 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -102.24 -57.53 2.05 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 126.144 1.778 . . . . 0.0 113.001 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.6 p -80.91 -26.6 0.43 Allowed Pre-proline 0 C--N 1.362 1.113 0 N-CA-C 118.356 2.724 . . . . 0.0 118.356 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -85.89 -157.26 1.22 Allowed 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 127.944 3.873 . . . . 0.0 109.977 -2.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.4 m -96.68 127.82 43.03 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 1.1 tmt_? -161.64 154.77 20.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 119.488 -2.008 . . . . 0.0 108.936 -176.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.95 -158.02 19.33 Favored Glycine 0 CA--C 1.485 -1.803 0 N-CA-C 103.74 -3.744 . . . . 0.0 103.74 166.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -91.01 112.61 24.58 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 169.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.538 HG11 HG22 ' A' ' 131' ' ' VAL 0.304 14.8 p -102.64 161.31 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.988 -163.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 m -78.37 109.69 12.74 Favored 'General case' 0 C--N 1.363 1.188 0 C-N-CA 124.919 1.288 . . . . 0.0 107.836 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.505 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 26.9 tttp -64.4 -19.05 65.26 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -170.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -82.41 -6.33 59.21 Favored 'General case' 0 C--N 1.362 1.146 0 O-C-N 120.237 -1.54 . . . . 0.0 113.742 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.4 mt -100.68 6.85 44.13 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 126.405 1.882 . . . . 0.0 109.695 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.505 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 26.1 mt -96.69 124.42 40.67 Favored 'General case' 0 C--N 1.368 1.397 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -116.65 158.84 42.52 Favored Pre-proline 0 CA--C 1.493 -1.24 0 O-C-N 120.478 -1.389 . . . . 0.0 107.809 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.81 150.73 14.39 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 CA-C-N 122.711 2.004 . . . . 0.0 113.41 -170.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 95' ' ' LEU 0.36 0.0 OUTLIER -28.2 -87.39 0.0 OUTLIER 'General case' 0 C--N 1.355 0.81 2 N-CA-C 123.459 4.615 . . . . 0.0 123.459 -177.997 . . . . . . . . 5 4 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.54 ' HA ' HD21 ' A' ' 183' ' ' LEU . 8.8 t 2.52 57.23 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 1 C-N-CA 134.656 5.183 . . . . 0.0 118.865 176.392 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.559 ' H ' HD11 ' A' ' 183' ' ' LEU . . . -79.16 -108.24 0.22 Allowed Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 122.234 3.654 . . . . 0.0 122.234 -154.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.3 m -45.17 -22.44 0.11 Allowed 'General case' 0 C--N 1.371 1.54 0 C-N-CA 130.643 3.577 . . . . 0.0 120.197 -167.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -85.39 -11.5 54.35 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 127.934 2.493 . . . . 0.0 113.051 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 68.8 m -89.81 150.82 22.09 Favored 'General case' 0 C--N 1.367 1.341 0 C-N-CA 126.342 1.857 . . . . 0.0 114.401 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -47.89 -39.84 19.98 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 129.358 3.063 . . . . 0.0 116.694 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.22 -13.18 59.98 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -106.24 8.19 31.81 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 121.111 -0.993 . . . . 0.0 113.519 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -117.27 179.76 3.95 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 126.082 1.753 . . . . 0.0 108.867 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.2 122.77 15.88 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 126.706 2.002 . . . . 0.0 113.8 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.31 -8.25 64.49 Favored Glycine 0 C--N 1.359 1.846 0 C-N-CA 124.909 1.242 . . . . 0.0 111.755 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.69 154.87 34.73 Favored Glycine 0 C--N 1.362 2.019 0 C-N-CA 126.342 1.925 . . . . 0.0 114.944 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -65.97 -42.48 89.82 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 119.57 3.174 . . . . 0.0 119.57 -172.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.49 ' HB3' ' CD2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -101.62 1.72 38.06 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 121.567 1.985 . . . . 0.0 113.41 -178.25 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -81.06 91.88 6.15 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 127.054 2.142 . . . . 0.0 113.337 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 27.6 m -116.48 102.25 9.34 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 100.49 -3.893 . . . . 0.0 100.49 168.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.31 101.94 13.71 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 125.842 2.734 . . . . 0.0 111.661 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -119.45 149.45 47.77 Favored Pre-proline 0 N--CA 1.422 -1.826 1 C-N-CA 132.338 4.255 . . . . 0.0 100.516 171.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.34 -30.14 79.74 Favored 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 126.137 4.558 . . . . 0.0 115.822 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -68.71 -47.49 66.23 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 126.828 2.051 . . . . 0.0 113.258 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.5 mt -67.28 -45.28 86.42 Favored 'Isoleucine or valine' 0 C--N 1.373 1.59 0 C-N-CA 127.363 2.265 . . . . 0.0 111.337 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 177' ' ' GLN 0.424 2.3 pp -68.81 -32.1 71.57 Favored 'General case' 0 C--N 1.372 1.559 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 174.617 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 52.5 tpt85 -66.5 -42.02 88.0 Favored 'General case' 0 C--N 1.379 1.862 0 C-N-CA 127.903 2.481 . . . . 0.0 113.165 172.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.21 -33.86 76.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 131.593 3.957 . . . . 0.0 111.275 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 41.2 mtp -69.95 -32.7 71.09 Favored 'General case' 0 C--N 1.371 1.504 0 C-N-CA 126.824 2.05 . . . . 0.0 112.424 164.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 36.2 mt-30 -72.11 -45.09 61.94 Favored 'General case' 0 C--N 1.383 2.026 0 CA-C-N 121.259 1.845 . . . . 0.0 111.647 174.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -64.78 -50.52 66.44 Favored 'General case' 0 C--N 1.381 1.952 0 C-N-CA 129.443 3.097 . . . . 0.0 111.586 174.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.3 -52.47 61.84 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-O 116.879 -1.534 . . . . 0.0 113.912 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.26 -43.91 71.37 Favored 'General case' 0 C--N 1.383 2.036 0 CA-C-N 121.822 2.101 . . . . 0.0 114.048 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -36.59 84.71 Favored 'General case' 0 C--N 1.366 1.294 0 O-C-N 119.12 -2.238 . . . . 0.0 115.809 172.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 190' ' ' ARG . . . -75.52 -44.65 42.55 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 174.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.559 HD11 ' H ' ' A' ' 153' ' ' GLY 0.259 1.2 tt -58.93 -42.97 91.03 Favored 'General case' 0 C--N 1.358 0.955 1 C-N-CA 132.174 4.19 . . . . 0.0 116.051 176.851 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.278 0.0 OUTLIER -91.56 -7.37 50.43 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.342 1.457 . . . . 0.0 111.068 -177.039 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -119.09 -112.34 0.34 Allowed 'General case' 0 C--N 1.362 1.122 0 O-C-N 121.629 -0.669 . . . . 0.0 111.979 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -127.05 158.27 37.43 Favored 'General case' 0 C--N 1.36 1.059 0 O-C-N 120.337 -1.477 . . . . 0.0 110.667 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 190' ' ' ARG 0.298 24.0 tttm -51.63 -37.01 48.23 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 130.708 3.603 . . . . 0.0 116.774 178.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.5 tp -53.7 -29.71 17.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 129.273 3.029 . . . . 0.0 113.526 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.263 6.1 mptt -72.05 -47.92 48.1 Favored 'General case' 0 C--N 1.371 1.542 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 175.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ARG . . . . . 0.442 ' HD2' ' HB1' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -75.37 -37.43 60.62 Favored 'General case' 0 C--N 1.368 1.384 0 CA-C-N 123.168 2.713 . . . . 0.0 115.335 172.433 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.46 -25.2 63.97 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 126.426 1.89 . . . . 0.0 114.552 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -60.99 -38.03 84.56 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.612 2.765 . . . . 0.0 113.542 166.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -85.17 -51.04 6.9 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 126.741 2.017 . . . . 0.0 108.68 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 66.52 -72.14 0.09 Allowed 'General case' 0 C--N 1.365 1.252 0 C-N-CA 127.818 2.447 . . . . 0.0 116.027 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.67 -5.96 2.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 C-N-CA 129.426 3.09 . . . . 0.0 111.642 176.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.428 85.1 p 97.43 -98.6 0.0 OUTLIER 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.684 2.794 . . . . 0.0 111.236 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -115.89 113.59 23.54 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 125.399 1.48 . . . . 0.0 109.504 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -158.68 -63.99 0.02 OUTLIER Pre-proline 0 C--N 1.351 0.649 0 CA-C-O 116.819 -1.563 . . . . 0.0 107.627 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.36 64.59 8.89 Favored 'Trans proline' 0 C--N 1.364 1.362 0 CA-C-N 125.295 2.927 . . . . 0.0 111.109 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 20.2 t -107.68 36.04 2.88 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.465 1.506 . . . . 0.0 112.179 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 C--N 1.362 1.122 0 C-N-CA 128.599 2.76 . . . . 0.0 116.738 176.34 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.463 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 36.8 m . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -139.21 94.82 2.84 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 121.071 -1.018 . . . . 0.0 113.725 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.51 126.26 45.56 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 121.25 -0.906 . . . . 0.0 109.113 -174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.4 p -111.09 165.82 11.97 Favored Pre-proline 0 C--N 1.364 1.212 0 C-N-CA 127.671 2.388 . . . . 0.0 114.243 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -56.21 139.66 86.24 Favored 'Trans proline' 0 C--N 1.365 1.425 1 C-N-CA 125.622 4.215 . . . . 0.0 120.867 -167.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.4 -24.54 9.75 Favored Glycine 0 C--N 1.361 1.955 0 C-N-CA 128.287 2.851 . . . . 0.0 110.885 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.43 170.21 12.18 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 119.895 1.847 . . . . 0.0 114.251 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.2 mm? -98.28 141.92 30.58 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 103.212 -2.885 . . . . 0.0 103.212 164.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 149' ' ' LYS . 19.3 m -143.77 141.46 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -175.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.451 ' CZ3' ' HB2' ' A' ' 165' ' ' PHE . 28.0 m95 -99.02 129.85 45.32 Favored 'General case' 0 C--O 1.214 -0.787 1 O-C-N 115.97 -4.206 . . . . 0.0 103.455 171.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -114.48 147.33 39.5 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 121.087 1.767 . . . . 0.0 109.494 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -118.71 145.83 45.21 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 37.1 ttm -126.69 154.77 43.64 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 123.233 1.492 . . . . 0.0 111.296 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.73 80.7 0.01 OUTLIER 'General case' 0 C--N 1.355 0.847 0 C-N-CA 131.669 3.988 . . . . 0.0 115.838 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.57 7.09 37.47 Favored Glycine 0 C--N 1.359 1.808 0 C-N-CA 125.504 1.526 . . . . 0.0 113.519 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -114.91 160.32 34.09 Favored Pre-proline 0 C--N 1.356 0.875 0 C-N-CA 125.65 1.58 . . . . 0.0 107.591 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -71.79 166.07 30.61 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.952 3.768 . . . . 0.0 113.422 168.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -49.35 129.49 18.61 Favored 'General case' 0 C--N 1.364 1.203 0 C-N-CA 128.356 2.662 . . . . 0.0 117.147 167.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.463 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 7.4 m95 -134.21 109.0 11.47 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 121.586 3.921 . . . . 0.0 121.586 -173.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 19.2 Cg_endo -62.22 110.83 1.11 Allowed 'Trans proline' 0 C--N 1.389 2.679 1 C-N-CA 126.663 4.909 . . . . 0.0 112.743 167.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -123.01 164.98 17.53 Favored 'General case' 0 C--N 1.352 0.677 1 C-N-CA 133.286 4.634 . . . . 0.0 116.022 -170.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp -116.46 132.54 56.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 129.447 3.099 . . . . 0.0 107.254 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -86.16 118.85 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 O-C-N 119.913 -1.742 . . . . 0.0 106.537 174.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -127.36 149.78 49.9 Favored 'General case' 0 C--N 1.368 1.391 0 O-C-N 119.002 -2.311 . . . . 0.0 111.059 -170.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -102.0 113.49 26.77 Favored 'General case' 0 C--N 1.37 1.471 0 CA-C-O 122.489 1.138 . . . . 0.0 111.511 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -79.49 158.81 73.28 Favored Pre-proline 0 C--N 1.353 0.738 0 C-N-CA 129.367 3.067 . . . . 0.0 112.592 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.28 71.4 Cg_exo -47.66 1.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.371 1 C-N-CA 130.356 7.37 . . . . 0.0 121.498 -171.515 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -98.89 31.65 2.9 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 131.588 3.955 . . . . 0.0 106.646 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.289 0.0 OUTLIER -68.7 150.81 47.49 Favored 'General case' 0 C--N 1.373 1.621 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -169.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.69 -20.11 27.59 Favored Glycine 0 C--N 1.365 2.158 0 C-N-CA 126.922 2.201 . . . . 0.0 112.552 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.7 m -130.44 147.0 52.09 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 101.269 -3.604 . . . . 0.0 101.269 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.405 ' HB2' ' NE2' ' A' ' 130' ' ' HIS . 7.3 p90 -130.7 -0.73 4.31 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-N 121.111 1.778 . . . . 0.0 114.882 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.7 pt -106.48 148.0 11.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.475 0 CA-C-O 123.904 1.812 . . . . 0.0 113.734 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -119.01 126.58 52.06 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 102.229 -3.248 . . . . 0.0 102.229 172.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -148.16 143.79 27.32 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 120.191 -1.568 . . . . 0.0 110.295 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.54 93.74 4.22 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 127.51 2.324 . . . . 0.0 108.821 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.19 -76.03 0.34 Allowed Glycine 0 C--N 1.365 2.19 0 N-CA-C 119.891 2.716 . . . . 0.0 119.891 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -149.01 60.38 1.05 Allowed 'General case' 0 C--N 1.358 0.959 0 CA-C-O 124.014 1.864 . . . . 0.0 109.055 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.7 m -169.59 133.8 1.34 Allowed 'General case' 0 C--N 1.349 0.566 0 C-N-CA 127.551 2.341 . . . . 0.0 105.48 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.94 146.82 31.07 Favored 'Isoleucine or valine' 0 C--N 1.363 1.186 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -134.35 142.77 47.34 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 129.173 2.989 . . . . 0.0 107.264 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.3 162.21 26.14 Favored 'Isoleucine or valine' 0 C--N 1.368 1.387 0 C-N-CA 127.301 2.24 . . . . 0.0 107.897 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 111' ' ' TYR . 0.4 OUTLIER -94.0 133.4 37.49 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 119.576 -1.953 . . . . 0.0 111.031 175.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.91 172.97 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.38 158.09 38.22 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 166.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -113.86 130.75 56.45 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -75.11 71.93 2.19 Favored 'General case' 0 C--N 1.372 1.578 0 C-N-CA 126.759 2.023 . . . . 0.0 109.876 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -95.7 -102.92 0.16 Allowed 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.042 1.337 . . . . 0.0 111.132 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -106.72 -62.69 1.36 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 126.216 1.807 . . . . 0.0 113.867 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 p -85.65 -32.61 0.46 Allowed Pre-proline 0 C--N 1.364 1.204 0 N-CA-C 119.374 3.102 . . . . 0.0 119.374 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -84.86 -176.1 14.16 Favored 'Cis proline' 0 CA--C 1.544 0.989 1 CA-C-N 130.358 4.735 . . . . 0.0 112.727 -0.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.315 4.6 t -97.53 154.86 17.24 Favored 'General case' 0 C--N 1.372 1.57 0 C-N-CA 127.216 2.206 . . . . 0.0 113.051 171.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.79 152.47 41.27 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.946 1.698 . . . . 0.0 106.58 171.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.43 -175.47 39.84 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -93.01 117.87 30.54 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 125.189 1.396 . . . . 0.0 108.059 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.2 161.98 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 C-N-CA 125.603 1.561 . . . . 0.0 113.334 -173.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.6 m -76.68 97.63 4.51 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 126.541 1.936 . . . . 0.0 107.18 171.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.511 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 35.1 tttp -54.62 -29.05 50.89 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 128.283 2.633 . . . . 0.0 115.878 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 60.7 ttt180 -70.42 -13.37 62.1 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 127.105 2.162 . . . . 0.0 114.098 173.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.8 mt -98.12 3.84 49.14 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 126.982 2.113 . . . . 0.0 111.784 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 23.4 mt -89.86 135.01 33.89 Favored 'General case' 0 C--N 1.37 1.47 0 C-N-CA 126.661 1.984 . . . . 0.0 111.221 173.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 71.0 mmtt -114.65 158.75 39.45 Favored Pre-proline 0 C--N 1.346 0.448 0 C-N-CA 127.703 2.401 . . . . 0.0 106.279 -177.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.55 158.23 14.42 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 124.814 3.676 . . . . 0.0 118.563 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -44.09 92.35 0.01 OUTLIER 'General case' 0 C--N 1.357 0.906 1 C-N-CA 132.949 4.5 . . . . 0.0 119.975 171.85 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.4 t -162.28 167.77 23.37 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 102.517 -3.142 . . . . 0.0 102.517 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.74 -157.96 7.58 Favored Glycine 0 C--N 1.365 2.172 0 N-CA-C 119.776 2.67 . . . . 0.0 119.776 -165.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.3 t -45.41 -11.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 1 N-CA-C 122.066 4.099 . . . . 0.0 122.066 -165.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -107.4 -10.01 15.86 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 129.322 3.049 . . . . 0.0 112.709 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 59.8 m -81.88 138.88 34.96 Favored 'General case' 0 C--N 1.376 1.728 0 C-N-CA 127.736 2.415 . . . . 0.0 111.085 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.251 33.1 ttmt -52.22 -33.49 41.43 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -86.71 -0.94 57.25 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 119.318 0.963 . . . . 0.0 112.963 171.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.89 3.25 10.0 Favored 'General case' 0 C--N 1.371 1.53 0 CA-C-N 120.25 1.387 . . . . 0.0 113.444 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.448 HE21 ' HB3' ' A' ' 160' ' ' GLN 0.251 0.0 OUTLIER -109.9 179.72 4.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.134 2.974 . . . . 0.0 107.331 -178.901 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -70.74 122.47 19.9 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 120.141 -1.599 . . . . 0.0 113.175 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.37 -5.27 55.1 Favored Glycine 0 C--N 1.363 2.047 0 O-C-N 120.961 -1.087 . . . . 0.0 111.757 -170.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.89 152.22 25.77 Favored Glycine 0 C--N 1.361 1.928 0 C-N-CA 128.648 3.023 . . . . 0.0 114.211 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -62.64 -41.7 99.18 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.451 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-85 -85.48 -7.54 58.85 Favored 'General case' 0 CA--C 1.556 1.174 0 O-C-N 120.269 -1.519 . . . . 0.0 113.57 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -77.92 95.35 4.75 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 128.811 2.844 . . . . 0.0 114.839 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 40.7 t -114.77 128.22 56.18 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 102.461 -3.163 . . . . 0.0 102.461 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -100.76 100.26 10.9 Favored 'General case' 0 C--N 1.362 1.125 0 CA-C-O 125.613 2.625 . . . . 0.0 109.229 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -121.62 138.25 28.16 Favored Pre-proline 0 N--CA 1.421 -1.897 2 C-N-CA 135.988 5.715 . . . . 0.0 98.211 166.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.96 -26.41 66.59 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 125.073 3.848 . . . . 0.0 114.144 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -66.73 -36.65 82.96 Favored 'General case' 0 C--N 1.369 1.428 0 C-N-CA 129.012 2.925 . . . . 0.0 112.633 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 65.3 mt -73.41 -45.99 50.57 Favored 'Isoleucine or valine' 0 C--N 1.374 1.651 0 C-N-CA 126.018 1.727 . . . . 0.0 110.417 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.12 -45.9 89.84 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 125.207 1.403 . . . . 0.0 113.535 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -62.42 -35.53 79.54 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.67 77.25 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 129.673 3.189 . . . . 0.0 110.795 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.71 -38.99 87.85 Favored 'General case' 0 C--N 1.382 2.017 0 C-N-CA 125.197 1.399 . . . . 0.0 111.597 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -74.07 -42.14 60.63 Favored 'General case' 0 C--N 1.374 1.655 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -48.06 64.71 Favored 'General case' 0 C--N 1.371 1.533 0 C-N-CA 130.671 3.589 . . . . 0.0 111.83 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.03 99.08 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 124.592 1.157 . . . . 0.0 113.491 169.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.2 -52.49 63.58 Favored 'General case' 0 C--N 1.375 1.715 0 C-N-CA 126.006 1.722 . . . . 0.0 111.66 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.35 -37.58 67.66 Favored 'General case' 0 C--N 1.372 1.544 0 CA-C-N 121.139 1.79 . . . . 0.0 115.8 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.18 -44.82 36.29 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 116.029 1.862 . . . . 0.0 116.029 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -31.03 67.16 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.21 -10.53 49.52 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 126.535 1.934 . . . . 0.0 110.608 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -123.43 -100.79 0.41 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 125.436 1.494 . . . . 0.0 112.176 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -135.57 158.0 45.47 Favored 'General case' 0 C--N 1.363 1.194 0 O-C-N 120.26 -1.525 . . . . 0.0 113.846 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -50.98 -37.34 44.19 Favored 'General case' 0 C--N 1.369 1.421 1 C-N-CA 132.389 4.276 . . . . 0.0 115.758 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.3 tt -55.23 -33.77 31.41 Favored 'Isoleucine or valine' 0 C--N 1.359 1.012 0 C-N-CA 129.925 3.29 . . . . 0.0 113.238 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -71.07 -45.29 64.05 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 125.829 1.651 . . . . 0.0 115.037 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -74.87 -42.45 57.86 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 174.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.292 96.2 mt -73.93 -19.39 60.7 Favored 'General case' 0 C--N 1.371 1.507 0 O-C-N 120.432 -1.417 . . . . 0.0 114.037 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -58.4 -32.06 68.26 Favored 'General case' 0 C--N 1.377 1.803 0 C-N-CA 126.769 2.027 . . . . 0.0 114.155 168.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.28 -51.55 3.95 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 127.053 2.141 . . . . 0.0 108.874 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 42.97 -95.11 0.02 OUTLIER 'General case' 0 C--N 1.38 1.913 0 C-N-CA 130.145 3.378 . . . . 0.0 114.427 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.377 2.5 p . . . . . 0 N--CA 1.443 -0.809 0 N-CA-C 100.811 -3.774 . . . . 0.0 100.811 162.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.417 ' HB2' ' HA ' ' A' ' 146' ' ' ARG 0.412 37.5 m . . . . . 0 C--O 1.222 -0.352 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 66.96 60.15 0.53 Allowed 'General case' 0 C--N 1.359 1.003 0 N-CA-C 120.396 3.48 . . . . 0.0 120.396 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -117.38 125.97 51.88 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 119.878 -1.764 . . . . 0.0 110.16 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.474 28.7 p -111.72 168.43 7.64 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 128.624 2.77 . . . . 0.0 115.55 -172.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 73.1 Cg_endo -71.25 151.63 60.69 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 124.434 3.423 . . . . 0.0 118.863 -164.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.77 -7.29 81.64 Favored Glycine 0 C--N 1.37 2.447 0 C-N-CA 128.875 3.131 . . . . 0.0 111.109 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -94.0 164.02 13.25 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 126.246 1.818 . . . . 0.0 110.493 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.74 140.26 37.24 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 119.098 -2.251 . . . . 0.0 107.249 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 m -133.51 153.37 36.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 C-N-CA 125.766 1.626 . . . . 0.0 108.979 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -102.84 116.76 33.19 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 101.422 -3.547 . . . . 0.0 101.422 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -115.12 142.51 46.56 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.727 1.211 . . . . 0.0 113.997 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -116.15 132.93 56.52 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 33.2 ttm -115.98 139.05 50.64 Favored 'General case' 0 CA--C 1.509 -0.629 0 O-C-N 120.099 -1.625 . . . . 0.0 107.267 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.65 100.35 0.1 Allowed 'General case' 0 C--N 1.366 1.324 0 C-N-CA 127.379 2.272 . . . . 0.0 114.07 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.56 -22.15 22.55 Favored Glycine 0 C--N 1.358 1.761 0 C-N-CA 125.367 1.461 . . . . 0.0 113.624 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -97.99 166.81 12.76 Favored Pre-proline 0 C--N 1.361 1.088 0 O-C-N 121.036 -1.273 . . . . 0.0 109.823 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.68 166.18 30.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.803 3.669 . . . . 0.0 113.34 169.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.657 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 5.0 m95 -58.17 135.27 57.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.798 2.839 . . . . 0.0 115.309 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.438 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 24.0 m95 -133.65 114.77 13.3 Favored Pre-proline 0 C--N 1.367 1.354 1 N-CA-C 121.844 4.016 . . . . 0.0 121.844 -174.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -64.91 124.96 13.87 Favored 'Trans proline' 0 C--N 1.391 2.772 1 C-N-CA 125.965 4.444 . . . . 0.0 110.542 160.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 p -147.25 165.15 30.95 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 128.29 2.636 . . . . 0.0 115.017 -156.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.613 HD22 ' HB2' ' A' ' 190' ' ' ARG . 3.7 pp -119.45 144.3 47.03 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 125.749 1.619 . . . . 0.0 108.626 173.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.9 t -85.59 116.52 28.92 Favored 'Isoleucine or valine' 0 C--N 1.377 1.796 0 O-C-N 120.174 -1.579 . . . . 0.0 108.059 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -121.56 136.27 54.96 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 116.92 -3.612 . . . . 0.0 114.87 -164.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -75.99 111.36 11.29 Favored 'General case' 0 C--N 1.38 1.908 0 CA-C-O 123.762 1.744 . . . . 0.0 112.654 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.473 ' CG ' ' CD2' ' A' ' 130' ' ' HIS . 10.3 t60 -67.18 161.18 66.04 Favored Pre-proline 0 C--N 1.343 0.285 1 C-N-CA 132.903 4.481 . . . . 0.0 117.641 -170.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.23 -14.05 3.8 Favored 'Trans proline' 0 CA--C 1.554 1.52 1 C-N-CA 125.542 4.161 . . . . 0.0 116.398 174.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -104.69 40.01 1.57 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 129.72 3.208 . . . . 0.0 109.633 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -67.58 151.47 47.27 Favored 'General case' 0 C--N 1.372 1.566 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.74 -11.92 32.51 Favored Glycine 0 C--N 1.358 1.768 0 CA-C-N 112.396 -2.184 . . . . 0.0 110.369 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 t -125.61 166.57 16.47 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 101.855 -3.387 . . . . 0.0 101.855 167.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -154.72 -25.63 0.12 Allowed 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.581 -1.324 . . . . 0.0 114.194 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.0 pt -114.38 154.54 15.73 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 O-C-N 120.491 -1.38 . . . . 0.0 112.086 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -142.92 152.84 42.48 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 128.338 2.655 . . . . 0.0 105.027 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.31 127.99 19.2 Favored 'General case' 0 C--N 1.361 1.089 0 O-C-N 120.793 -1.192 . . . . 0.0 110.424 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -117.94 93.04 3.99 Favored 'General case' 0 C--N 1.363 1.17 0 C-N-CA 127.407 2.283 . . . . 0.0 110.135 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.11 -63.96 0.01 OUTLIER Glycine 0 C--N 1.362 2.006 0 N-CA-C 122.056 3.582 . . . . 0.0 122.056 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -146.62 38.34 1.02 Allowed 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.965 1.306 . . . . 0.0 111.724 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 m -167.63 139.67 3.15 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 119.847 -1.783 . . . . 0.0 106.498 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.66 132.97 70.59 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 CA-C-O 123.505 1.621 . . . . 0.0 109.959 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -106.83 158.94 16.62 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 127.938 2.495 . . . . 0.0 113.481 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 145' ' ' LYS . 33.8 m -149.09 164.66 4.09 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 C-N-CA 130.707 3.603 . . . . 0.0 102.755 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.473 ' CD2' ' CG ' ' A' ' 113' ' ' HIS . 6.2 m80 -89.94 141.82 28.29 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 121.19 -0.944 . . . . 0.0 112.248 170.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 m -151.1 169.81 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -133.53 152.91 51.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -109.43 132.26 54.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.518 1.927 . . . . 0.0 108.335 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.511 ' HB3' HH21 ' A' ' 178' ' ' ARG . 29.3 m-85 -68.54 63.77 0.11 Allowed 'General case' 0 C--N 1.371 1.503 0 C-N-CA 127.066 2.147 . . . . 0.0 114.256 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.91 -118.22 0.08 Allowed 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.451 2.3 . . . . 0.0 111.913 -174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -106.85 -58.52 1.92 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.669 1.587 . . . . 0.0 112.807 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.298 27.5 p -77.18 -34.03 1.16 Allowed Pre-proline 0 C--N 1.364 1.209 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.35 -169.5 7.75 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 CA-C-N 127.683 3.779 . . . . 0.0 111.616 -1.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.3 m -95.17 135.08 37.17 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.814 1.246 . . . . 0.0 107.753 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.9 tmm_? -158.1 167.92 28.52 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.06 -148.74 17.04 Favored Glycine 0 C--N 1.352 1.417 1 N-CA-C 101.239 -4.744 . . . . 0.0 101.239 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -89.58 156.78 18.38 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 167.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.4 -177.68 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 O-C-N 120.636 -1.29 . . . . 0.0 107.712 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.6 t -90.8 120.07 31.54 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 101.864 -3.384 . . . . 0.0 101.864 167.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.69 ' HB2' HG22 ' A' ' 129' ' ' VAL 0.492 0.0 OUTLIER -78.53 -10.94 59.91 Favored 'General case' 0 C--N 1.373 1.603 0 CA-C-N 123.113 2.688 . . . . 0.0 115.685 -174.396 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.417 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 96.2 mtt180 -74.84 -5.53 44.06 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.01 1.324 . . . . 0.0 113.814 172.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.93 2.17 32.16 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 127.102 2.161 . . . . 0.0 112.173 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 43.0 mt -96.89 125.69 41.51 Favored 'General case' 0 C--N 1.368 1.376 0 C-N-CA 127.389 2.276 . . . . 0.0 109.956 174.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -114.7 167.74 9.22 Favored Pre-proline 0 C--N 1.347 0.493 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.0 157.09 15.31 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.306 3.337 . . . . 0.0 113.991 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.64 150.57 20.21 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 123.426 1.584 . . . . 0.0 107.89 170.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.8 t -173.08 -45.58 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.835 1 N-CA-C 97.26 -5.089 . . . . 0.0 97.26 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 128.35 -149.76 18.33 Favored Glycine 0 CA--C 1.474 -2.471 0 C-N-CA 117.892 -2.099 . . . . 0.0 116.865 135.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.9 m -46.5 -18.78 0.07 Allowed 'General case' 0 C--N 1.375 1.68 1 C-N-CA 133.027 4.531 . . . . 0.0 116.67 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 0.94 54.92 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 129.881 3.272 . . . . 0.0 112.582 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.9 m -86.51 142.56 28.26 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 127.529 2.331 . . . . 0.0 111.409 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -61.69 -27.45 68.71 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -79.7 -17.08 54.45 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 124.935 1.294 . . . . 0.0 111.372 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.27 4.21 51.01 Favored 'General case' 0 C--N 1.371 1.515 0 C-N-CA 124.813 1.245 . . . . 0.0 113.017 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -123.74 177.34 5.76 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 120.048 -1.657 . . . . 0.0 111.228 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -57.97 121.84 11.55 Favored 'General case' 0 C--N 1.372 1.576 0 C-N-CA 126.483 1.913 . . . . 0.0 114.598 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.32 -14.52 59.52 Favored Glycine 0 C--N 1.356 1.671 0 C-N-CA 125.174 1.369 . . . . 0.0 112.299 -169.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.6 153.64 40.91 Favored Glycine 0 C--N 1.361 1.941 0 N-CA-C 119.857 2.703 . . . . 0.0 119.857 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -55.86 -42.21 75.51 Favored 'General case' 0 C--N 1.363 1.169 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.657 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.308 0.5 OUTLIER -106.01 -12.16 15.9 Favored 'General case' 0 C--N 1.358 0.951 0 O-C-N 120.638 -1.289 . . . . 0.0 113.619 -179.796 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . 0.301 0.0 OUTLIER -41.68 -27.86 0.12 Allowed 'General case' 0 C--N 1.365 1.248 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.2 m -14.53 90.94 0.01 OUTLIER 'General case' 0 C--N 1.381 1.962 1 C-N-CA 131.901 4.08 . . . . 0.0 116.917 -174.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.35 102.11 13.71 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-O 125.653 2.644 . . . . 0.0 115.045 -163.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -119.96 144.53 37.71 Favored Pre-proline 0 N--CA 1.416 -2.163 3 C-N-CA 134.909 5.284 . . . . 0.0 100.184 170.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -60.31 -28.95 87.85 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 125.014 3.809 . . . . 0.0 115.487 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -65.72 -36.4 83.49 Favored 'General case' 0 C--N 1.365 1.272 0 C-N-CA 128.806 2.842 . . . . 0.0 112.303 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.438 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 20.4 mm -72.39 -37.73 58.74 Favored 'Isoleucine or valine' 0 C--N 1.374 1.631 0 C-N-CA 126.487 1.915 . . . . 0.0 110.237 175.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.73 -49.38 59.23 Favored 'General case' 0 C--N 1.371 1.502 0 O-C-N 120.324 -1.485 . . . . 0.0 113.646 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -58.43 -39.3 79.44 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 127.391 2.276 . . . . 0.0 114.22 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.0 -37.34 84.02 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 131.41 3.884 . . . . 0.0 110.421 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.4 mtt -66.91 -33.03 74.69 Favored 'General case' 0 C--N 1.366 1.284 0 O-C-N 120.609 -1.307 . . . . 0.0 113.024 167.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.43 -46.86 37.22 Favored 'General case' 0 C--N 1.378 1.83 0 C-N-CA 126.527 1.931 . . . . 0.0 112.577 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.511 HH21 ' HB3' ' A' ' 134' ' ' PHE . 22.4 ttp-105 -66.31 -50.56 63.21 Favored 'General case' 0 C--N 1.372 1.57 0 C-N-CA 129.564 3.145 . . . . 0.0 112.322 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.96 69.61 Favored 'General case' 0 C--N 1.375 1.692 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 167.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -68.64 -50.87 47.86 Favored 'General case' 0 C--N 1.371 1.53 0 O-C-N 120.491 -1.381 . . . . 0.0 111.751 173.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -40.36 83.15 Favored 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.363 1.865 . . . . 0.0 115.537 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.589 ' HB1' ' HG2' ' A' ' 190' ' ' ARG . . . -76.06 -27.25 57.18 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.423 HD13 ' N ' ' A' ' 184' ' ' ASN . 0.2 OUTLIER -78.94 -50.17 11.61 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.899 1.679 . . . . 0.0 111.177 173.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.423 ' N ' HD13 ' A' ' 183' ' ' LEU 0.322 0.0 OUTLIER -82.99 -15.71 50.13 Favored 'General case' 0 C--N 1.367 1.355 0 C-N-CA 126.615 1.966 . . . . 0.0 115.176 -169.222 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -110.64 -98.7 0.4 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -136.28 149.32 48.4 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 124.111 0.964 . . . . 0.0 109.936 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -50.73 -34.64 27.77 Favored 'General case' 0 C--N 1.365 1.27 1 C-N-CA 133.668 4.787 . . . . 0.0 112.282 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 6.4 tt -52.24 -30.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.365 1.278 0 C-N-CA 128.855 2.862 . . . . 0.0 112.758 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.273 6.5 mptt -68.39 -43.17 77.91 Favored 'General case' 0 C--N 1.376 1.729 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 172.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.613 ' HB2' HD22 ' A' ' 109' ' ' LEU 0.265 1.2 ptm180 -76.51 -43.62 38.67 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 119.043 2.979 . . . . 0.0 119.043 170.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.453 HD12 HH21 ' A' ' 190' ' ' ARG . 12.3 tp -71.65 -27.62 63.2 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 127.38 2.272 . . . . 0.0 113.545 -174.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -81.46 -4.46 55.92 Favored 'General case' 0 C--N 1.366 1.298 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 170.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.58 -44.69 5.5 Favored 'General case' 0 C--N 1.366 1.324 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 58.97 -114.34 0.73 Allowed 'General case' 0 C--N 1.372 1.545 0 C-N-CA 127.309 2.243 . . . . 0.0 113.119 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.351 0.644 0 C-N-CA 126.45 1.9 . . . . 0.0 110.448 175.778 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 123.061 1.41 . . . . 0.0 110.032 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -118.01 92.79 3.92 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.646 2.379 . . . . 0.0 112.638 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.411 ' H ' ' HD2' ' A' ' 145' ' ' LYS . 5.2 m-85 -125.19 127.25 46.5 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.361 1.464 . . . . 0.0 112.346 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.39 57.8 p -111.72 167.94 8.36 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 119.731 -1.855 . . . . 0.0 113.771 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.4 ' HA ' ' HB ' ' A' ' 110' ' ' VAL . 89.3 Cg_exo -57.63 153.07 44.52 Favored 'Trans proline' 0 C--N 1.373 1.84 1 C-N-CA 126.565 4.843 . . . . 0.0 120.821 -174.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.82 -41.87 2.06 Favored Glycine 0 C--N 1.377 2.823 0 C-N-CA 127.483 2.468 . . . . 0.0 107.02 -165.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -73.84 159.57 32.67 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.511 HD13 ' HE ' ' A' ' 190' ' ' ARG . 0.1 OUTLIER -105.51 142.56 35.05 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.814 HG21 HD13 ' A' ' 148' ' ' LEU . 17.7 m -142.82 151.73 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.452 ' CE3' ' HG3' ' A' ' 107' ' ' PRO . 41.0 m95 -99.92 121.1 40.82 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 168.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.469 ' CB ' HD22 ' A' ' 148' ' ' LEU . . . -102.11 152.27 21.19 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 121.125 1.784 . . . . 0.0 112.345 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -116.9 131.9 56.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 102.398 -3.186 . . . . 0.0 102.398 169.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 34.8 ttm -118.47 138.38 52.53 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.31 101.66 0.45 Allowed 'General case' 0 C--N 1.369 1.424 0 C-N-CA 125.789 1.635 . . . . 0.0 113.816 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.19 -6.0 25.21 Favored Glycine 0 C--N 1.36 1.895 0 C-N-CA 125.667 1.604 . . . . 0.0 113.206 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.24 164.3 15.14 Favored Pre-proline 0 C--N 1.354 0.797 0 C-N-CA 125.779 1.632 . . . . 0.0 109.524 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.05 166.1 30.64 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 124.274 3.316 . . . . 0.0 112.774 162.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -57.84 123.3 15.28 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 129.061 2.944 . . . . 0.0 114.44 171.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -134.15 116.1 13.17 Favored Pre-proline 0 CA--C 1.563 1.476 1 N-CA-C 123.75 4.722 . . . . 0.0 123.75 -168.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HG3' ' CE3' ' A' ' 97' ' ' TRP . 53.8 Cg_exo -54.84 110.38 0.53 Allowed 'Trans proline' 0 C--N 1.396 3.056 1 C-N-CA 127.635 5.556 . . . . 0.0 114.898 164.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.5 p -125.72 164.04 21.5 Favored 'General case' 0 CA--C 1.536 0.431 1 C-N-CA 132.342 4.257 . . . . 0.0 115.901 -169.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.522 HD13 ' HG3' ' A' ' 190' ' ' ARG . 5.7 tp -115.8 138.25 51.32 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 118.65 -2.532 . . . . 0.0 108.257 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 92' ' ' PRO . 2.1 t -81.0 118.93 29.65 Favored 'Isoleucine or valine' 0 C--N 1.37 1.476 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -115.8 154.58 29.39 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.03 -1.669 . . . . 0.0 115.36 -163.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -111.67 113.68 26.22 Favored 'General case' 0 C--N 1.372 1.545 0 C-N-CA 125.767 1.627 . . . . 0.0 108.812 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.418 ' H ' ' CD2' ' A' ' 130' ' ' HIS . 1.5 m-70 -69.08 160.94 76.26 Favored Pre-proline 0 C--N 1.363 1.188 0 C-N-CA 130.994 3.717 . . . . 0.0 110.191 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.67 0.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.5 1 C-N-CA 128.071 5.847 . . . . 0.0 119.226 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -99.57 34.96 2.08 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 130.542 3.537 . . . . 0.0 105.865 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.322 0.0 OUTLIER -61.35 120.86 11.26 Favored 'General case' 0 C--N 1.382 1.993 0 C-N-CA 126.972 2.109 . . . . 0.0 115.542 -166.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.85 -20.49 26.72 Favored Glycine 0 C--N 1.356 1.678 0 C-N-CA 127.302 2.382 . . . . 0.0 111.583 -171.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 p -116.09 119.15 34.92 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 103.979 -2.6 . . . . 0.0 103.979 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.494 ' HB2' ' CE1' ' A' ' 130' ' ' HIS . 16.4 p90 -148.42 -9.65 0.37 Allowed 'General case' 0 C--N 1.363 1.156 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -170.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 pt -109.69 153.18 11.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-N 120.074 1.306 . . . . 0.0 112.473 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -142.28 136.52 29.85 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 104.138 -2.542 . . . . 0.0 104.138 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -150.68 127.24 10.82 Favored 'General case' 0 C--N 1.363 1.166 0 O-C-N 120.044 -1.66 . . . . 0.0 110.986 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -118.41 93.38 4.1 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 125.919 1.688 . . . . 0.0 110.534 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.16 -51.89 0.01 OUTLIER Glycine 0 C--N 1.363 2.033 1 N-CA-C 124.096 4.398 . . . . 0.0 124.096 171.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -137.64 21.58 2.9 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.325 1.45 . . . . 0.0 113.532 -172.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.6 m -163.49 146.39 10.08 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.01 137.72 56.44 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 C-N-CA 123.759 0.824 . . . . 0.0 109.851 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -120.55 130.06 54.06 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 126.829 2.052 . . . . 0.0 107.067 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 145' ' ' LYS . 2.2 m -140.29 150.98 21.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.957 1 N-CA-C 98.855 -4.498 . . . . 0.0 98.855 175.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' ' 119' ' ' PHE . 12.6 p-80 -81.69 130.04 34.92 Favored 'General case' 0 C--N 1.367 1.336 0 C-N-CA 125.392 1.477 . . . . 0.0 113.16 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.2 m -137.74 151.16 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 N-CA-C 102.651 -3.092 . . . . 0.0 102.651 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -111.83 148.43 33.6 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -106.8 125.27 50.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 127.723 2.409 . . . . 0.0 105.802 -174.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -75.36 76.13 2.45 Favored 'General case' 0 C--N 1.372 1.574 0 C-N-CA 124.726 1.21 . . . . 0.0 109.492 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -102.46 -113.66 0.21 Allowed 'General case' 0 C--N 1.358 0.935 0 O-C-N 120.04 -1.662 . . . . 0.0 110.392 -173.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -106.87 -59.23 1.83 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 126.202 1.801 . . . . 0.0 111.32 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.5 p -86.06 -31.38 0.43 Allowed Pre-proline 0 C--N 1.365 1.245 0 N-CA-C 120.322 3.453 . . . . 0.0 120.322 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.1 -172.65 10.27 Favored 'Cis proline' 0 CA--C 1.541 0.853 1 CA-C-N 129.917 4.578 . . . . 0.0 113.418 0.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.8 m -96.81 155.64 16.69 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 129.429 3.092 . . . . 0.0 108.904 170.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -166.1 171.71 12.11 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.54 -169.87 42.12 Favored Glycine 0 CA--C 1.486 -1.752 1 N-CA-C 101.751 -4.54 . . . . 0.0 101.751 163.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -93.93 99.78 12.06 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 169.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.8 m -84.46 176.49 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 C-N-CA 125.563 1.545 . . . . 0.0 109.052 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.7 m -92.98 121.81 34.7 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 170.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.411 ' HD2' ' H ' ' A' ' 90' ' ' PHE 0.309 16.3 pttm -76.36 -11.04 59.83 Favored 'General case' 0 C--N 1.372 1.584 0 CA-C-N 121.421 1.919 . . . . 0.0 113.257 -176.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -68.91 -18.85 64.17 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 125.954 1.702 . . . . 0.0 113.487 170.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 147' ' ' LEU . 15.1 mt -91.12 0.65 57.49 Favored 'General case' 0 C--N 1.369 1.424 0 C-N-CA 126.184 1.793 . . . . 0.0 114.571 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.814 HD13 HG21 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -98.47 159.0 15.24 Favored 'General case' 0 C--N 1.364 1.226 0 O-C-N 119.877 -1.764 . . . . 0.0 108.386 176.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.66 159.22 45.0 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -74.51 154.59 45.14 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.671 3.58 . . . . 0.0 114.724 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.274 0.1 OUTLIER -18.56 -107.69 0.0 OUTLIER 'General case' 0 C--N 1.363 1.17 2 N-CA-C 123.486 4.624 . . . . 0.0 123.486 177.19 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.326 4.9 t 50.99 -40.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 1 C-N-CA 132.612 4.365 . . . . 0.0 120.413 177.098 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.82 -144.41 38.23 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 118.812 2.285 . . . . 0.0 118.812 176.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.8 m -53.04 -24.97 11.0 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.487 3.515 . . . . 0.0 119.749 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -84.42 -6.07 59.34 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 126.488 1.915 . . . . 0.0 111.951 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.2 m -83.84 146.47 28.08 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.894 1.678 . . . . 0.0 112.87 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -63.4 -27.5 69.34 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 125.702 1.601 . . . . 0.0 112.419 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.37 -23.82 61.97 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 127.417 2.287 . . . . 0.0 113.163 171.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.4 0.81 48.45 Favored 'General case' 0 C--N 1.371 1.518 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.255 1.1 pp0? -115.47 -175.29 2.68 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 125.284 1.433 . . . . 0.0 110.168 176.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -66.27 122.91 18.55 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 126.692 1.997 . . . . 0.0 112.243 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.46 -10.89 58.04 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 124.848 1.213 . . . . 0.0 111.654 -167.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.64 139.84 23.51 Favored Glycine 0 C--N 1.365 2.154 0 N-CA-C 119.618 2.607 . . . . 0.0 119.618 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -61.01 -16.37 42.6 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 119.324 3.083 . . . . 0.0 119.324 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.85 -0.06 17.03 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.701 -1.249 . . . . 0.0 110.805 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -79.1 142.17 36.68 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 126.166 2.889 . . . . 0.0 118.315 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.6 m -172.86 170.46 4.57 Favored 'General case' 0 C--N 1.348 0.508 2 N-CA-C 98.165 -4.754 . . . . 0.0 98.165 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -138.24 101.59 4.43 Favored 'General case' 0 C--N 1.367 1.366 0 CA-C-N 124.931 3.514 . . . . 0.0 111.223 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -119.88 135.24 24.14 Favored Pre-proline 0 N--CA 1.43 -1.428 0 N-CA-C 100.921 -3.733 . . . . 0.0 100.921 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.7 -26.5 80.04 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 125.196 3.93 . . . . 0.0 114.108 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -63.9 -36.39 83.77 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 127.515 2.326 . . . . 0.0 113.424 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.8 mt -70.97 -42.88 77.05 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 C-N-CA 125.582 1.553 . . . . 0.0 110.923 173.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.46 -43.24 77.46 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 124.766 1.226 . . . . 0.0 113.979 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -58.91 -38.69 79.48 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 128.178 2.591 . . . . 0.0 113.259 175.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.26 -34.54 74.93 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 131.357 3.863 . . . . 0.0 110.887 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.427 ' HG2' ' CH2' ' A' ' 97' ' ' TRP . 31.3 mtt -70.4 -37.59 74.49 Favored 'General case' 0 C--N 1.386 2.156 0 C-N-CA 124.03 0.932 . . . . 0.0 111.339 168.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -68.53 -45.29 72.59 Favored 'General case' 0 C--N 1.378 1.842 0 C-N-CA 126.638 1.975 . . . . 0.0 111.62 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -53.93 47.37 Favored 'General case' 0 C--N 1.37 1.471 0 C-N-CA 131.629 3.971 . . . . 0.0 111.698 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.94 -45.26 82.9 Favored 'General case' 0 C--N 1.373 1.6 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 170.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 184' ' ' ASN 0.318 38.8 t70 -64.19 -24.73 67.78 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 127.339 2.256 . . . . 0.0 112.702 176.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -75.09 -43.89 50.47 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 117.922 -2.986 . . . . 0.0 112.228 168.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 190' ' ' ARG . . . -76.25 -39.62 53.99 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 120.069 3.359 . . . . 0.0 120.069 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.24 -26.85 47.47 Favored 'General case' 0 C--N 1.36 1.051 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.2 OUTLIER -89.78 -30.28 18.1 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.461 2.704 . . . . 0.0 107.93 -173.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -104.98 -98.56 0.32 Allowed 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -136.03 159.7 40.89 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 119.995 -1.691 . . . . 0.0 111.691 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.514 ' HA ' ' HD3' ' A' ' 190' ' ' ARG . 44.2 mmtt -51.55 -38.56 54.85 Favored 'General case' 0 C--N 1.377 1.78 0 C-N-CA 131.201 3.801 . . . . 0.0 115.142 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.6 tt -55.22 -36.07 38.44 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 129.171 2.988 . . . . 0.0 113.379 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -43.92 72.49 Favored 'General case' 0 C--N 1.372 1.558 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.522 ' HG3' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -75.25 -43.43 51.54 Favored 'General case' 0 C--N 1.37 1.475 0 CA-C-N 121.241 1.837 . . . . 0.0 114.826 172.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.5 tp -71.32 -19.48 62.3 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 128.672 2.789 . . . . 0.0 113.852 -172.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -59.64 -27.9 66.76 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.883 2.073 . . . . 0.0 113.492 164.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.1 21.66 14.47 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 127.472 2.309 . . . . 0.0 111.95 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.03 44.95 0.0 OUTLIER 'General case' 0 C--N 1.374 1.644 0 C-N-CA 131.502 3.921 . . . . 0.0 118.202 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.363 1.183 1 C-N-CA 133.206 4.602 . . . . 0.0 113.827 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 C--O 1.231 0.106 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.285 1.1 p30 -171.81 87.26 0.09 Allowed 'General case' 0 C--N 1.364 1.215 0 C-N-CA 124.973 1.309 . . . . 0.0 112.814 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -124.6 127.65 47.69 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 126.029 1.732 . . . . 0.0 114.814 -171.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.358 98.0 p -110.18 169.62 6.18 Favored Pre-proline 0 CA--C 1.574 1.882 0 C-N-CA 131.025 3.73 . . . . 0.0 114.952 -174.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 93.4 Cg_endo -66.19 146.89 82.81 Favored 'Trans proline' 0 C--N 1.385 2.474 1 C-N-CA 126.88 5.054 . . . . 0.0 117.281 -168.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.59 -32.35 7.03 Favored Glycine 0 C--N 1.366 2.236 0 C-N-CA 126.403 1.954 . . . . 0.0 109.365 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -83.12 162.38 21.33 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 124.486 2.089 . . . . 0.0 113.485 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.02 135.4 54.26 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 101.609 -3.478 . . . . 0.0 101.609 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.99 159.06 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 126.209 1.804 . . . . 0.0 107.082 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -98.7 118.37 35.27 Favored 'General case' 0 C--N 1.349 0.559 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.39 138.9 50.97 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 126.37 1.868 . . . . 0.0 113.397 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -113.65 145.84 40.68 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 170.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.1 ttp -128.97 152.82 48.17 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 119.85 -1.781 . . . . 0.0 109.162 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -63.42 89.68 0.04 OUTLIER 'General case' 0 C--N 1.364 1.228 0 C-N-CA 127.716 2.406 . . . . 0.0 115.472 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.17 -4.13 25.36 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 125.665 1.602 . . . . 0.0 112.249 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -98.02 162.15 23.13 Favored Pre-proline 0 C--N 1.357 0.916 0 C-N-CA 125.508 1.523 . . . . 0.0 110.223 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.26 167.08 27.24 Favored 'Trans proline' 0 CA--C 1.544 0.983 1 C-N-CA 125.777 4.318 . . . . 0.0 112.941 163.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -68.3 130.68 43.61 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 127.426 2.29 . . . . 0.0 112.267 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.425 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 6.3 m95 -128.7 131.91 24.04 Favored Pre-proline 0 N--CA 1.429 -1.502 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.56 139.24 30.94 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 124.211 3.274 . . . . 0.0 108.1 149.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.1 p -152.37 164.18 38.0 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 126.936 2.094 . . . . 0.0 111.611 -163.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 190' ' ' ARG . 1.3 pp -111.47 149.44 31.31 Favored 'General case' 0 C--N 1.367 1.356 0 O-C-N 119.982 -1.699 . . . . 0.0 109.87 171.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 131' ' ' VAL . 2.4 t -91.45 119.83 39.41 Favored 'Isoleucine or valine' 0 C--N 1.364 1.222 0 O-C-N 120.608 -1.308 . . . . 0.0 107.787 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -114.61 141.85 47.22 Favored 'General case' 0 C--N 1.37 1.5 0 N-CA-C 120.066 3.358 . . . . 0.0 120.066 -162.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -85.77 111.27 20.0 Favored 'General case' 0 C--N 1.377 1.772 0 O-C-N 118.526 -2.608 . . . . 0.0 110.522 172.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.406 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 75.0 t60 -85.04 160.2 55.58 Favored Pre-proline 0 N--CA 1.449 -0.497 1 C-N-CA 132.108 4.163 . . . . 0.0 109.673 -176.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.81 -13.84 6.8 Favored 'Trans proline' 0 CA--C 1.55 1.306 1 C-N-CA 125.97 4.447 . . . . 0.0 117.08 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -107.41 54.11 0.68 Allowed 'General case' 0 C--N 1.365 1.244 0 C-N-CA 127.848 2.459 . . . . 0.0 107.564 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.43 167.77 19.05 Favored 'General case' 0 C--N 1.368 1.406 0 O-C-N 119.563 -1.961 . . . . 0.0 114.787 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.48 -20.04 48.98 Favored Glycine 0 C--N 1.364 2.086 0 C-N-CA 126.053 1.787 . . . . 0.0 113.559 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.7 m -123.47 120.3 32.52 Favored 'General case' 0 C--N 1.346 0.453 1 N-CA-C 99.465 -4.272 . . . . 0.0 99.465 170.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -122.64 -3.49 8.77 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 -168.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.6 pt -122.81 149.74 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 119.618 -1.926 . . . . 0.0 112.948 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -141.49 160.18 40.68 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 129.854 3.262 . . . . 0.0 104.595 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -152.08 127.57 10.03 Favored 'General case' 0 C--N 1.365 1.272 0 O-C-N 118.935 -2.353 . . . . 0.0 111.459 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.37 92.94 4.7 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.266 1.426 . . . . 0.0 108.78 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.5 -84.96 0.19 Allowed Glycine 0 C--N 1.363 2.053 0 C-N-CA 127.309 2.385 . . . . 0.0 114.57 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -116.74 -15.26 10.75 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 126.277 1.831 . . . . 0.0 110.591 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.1 m -88.43 100.91 13.41 Favored 'General case' 0 C--N 1.365 1.257 0 O-C-N 120.423 -1.423 . . . . 0.0 110.625 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 p -86.46 132.41 32.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 127.452 2.301 . . . . 0.0 108.246 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -117.1 141.98 47.57 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 126.19 1.796 . . . . 0.0 112.569 -173.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.9 164.16 35.97 Favored 'Isoleucine or valine' 0 C--N 1.359 0.986 0 C-N-CA 130.057 3.343 . . . . 0.0 106.094 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.406 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 17.2 m80 -88.55 116.68 26.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.98 1.712 . . . . 0.0 112.596 176.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 110' ' ' VAL . 3.3 m -134.24 173.76 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 O-C-N 119.25 -2.156 . . . . 0.0 106.87 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.49 147.91 43.73 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 171.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -99.88 127.2 46.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.111 2.164 . . . . 0.0 107.812 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -73.8 62.96 0.85 Allowed 'General case' 0 C--N 1.369 1.429 0 C-N-CA 126.736 2.015 . . . . 0.0 114.153 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -91.35 -108.78 0.1 Allowed 'General case' 0 C--N 1.365 1.248 0 O-C-N 121.392 -0.818 . . . . 0.0 112.561 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.74 -65.34 1.09 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 126.224 1.81 . . . . 0.0 114.097 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.5 p -79.85 -32.6 0.73 Allowed Pre-proline 0 C--N 1.361 1.086 0 N-CA-C 119.464 3.135 . . . . 0.0 119.464 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -92.16 -166.3 2.31 Favored 'Cis proline' 0 CA--C 1.539 0.774 1 CA-C-N 129.988 4.603 . . . . 0.0 110.828 -1.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -97.69 135.48 39.42 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 125.093 1.357 . . . . 0.0 111.678 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.2 tmm_? -136.56 147.34 46.97 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 120.748 1.613 . . . . 0.0 106.915 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.81 -179.87 40.72 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 104.892 -3.283 . . . . 0.0 104.892 170.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -86.55 109.11 18.89 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 127.423 2.289 . . . . 0.0 106.76 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.19 -178.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 125.602 1.561 . . . . 0.0 111.574 -172.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.2 m -100.41 117.29 34.29 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 101.318 -3.586 . . . . 0.0 101.318 169.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 5.6 ttpp -72.42 -14.04 61.6 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 124.026 1.869 . . . . 0.0 113.063 -171.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -75.07 -12.3 60.29 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.971 1.708 . . . . 0.0 113.961 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.46 3.82 43.26 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 126.742 2.017 . . . . 0.0 110.948 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.457 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 31.5 mt -94.25 130.44 40.51 Favored 'General case' 0 C--N 1.366 1.292 0 C-N-CA 126.623 1.969 . . . . 0.0 109.201 173.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.403 ' HG3' ' CE1' ' A' ' 165' ' ' PHE . 5.1 mmtt -114.88 165.65 13.51 Favored Pre-proline 0 C--N 1.35 0.611 0 N-CA-C 102.947 -2.983 . . . . 0.0 102.947 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.56 155.8 16.16 Favored 'Trans proline' 0 C--N 1.326 -0.656 0 C-N-CA 124.644 3.563 . . . . 0.0 112.561 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.64 124.04 41.89 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 121.643 0.735 . . . . 0.0 112.067 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.0 t -161.52 25.77 0.13 Allowed 'General case' 0 C--N 1.358 0.954 0 C-N-CA 127.493 2.317 . . . . 0.0 105.523 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.64 81.74 0.07 OUTLIER Glycine 0 C--N 1.354 1.575 0 C-N-CA 115.941 -3.028 . . . . 0.0 117.55 -162.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 69.9 m -67.92 -11.45 58.76 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 128.571 2.748 . . . . 0.0 114.068 172.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -122.52 37.97 4.27 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 128.445 2.698 . . . . 0.0 109.788 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.3 m -95.09 147.87 22.96 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.584 2.354 . . . . 0.0 108.027 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -61.78 -24.49 66.87 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -82.23 -19.09 40.41 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 125.586 1.554 . . . . 0.0 112.161 168.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.34 -39.62 10.38 Favored 'General case' 0 C--N 1.368 1.393 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.337 0.0 OUTLIER -83.74 -173.67 4.85 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -178.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.74 121.34 15.74 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.81 -1.806 . . . . 0.0 113.462 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.34 -13.24 51.58 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.075 -166.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.9 158.65 36.95 Favored Glycine 0 C--N 1.369 2.375 0 N-CA-C 120.665 3.026 . . . . 0.0 120.665 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -60.05 -41.76 93.02 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 129.084 2.953 . . . . 0.0 117.561 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.403 ' CE1' ' HG3' ' A' ' 149' ' ' LYS . 1.6 m-85 -92.67 -30.1 15.75 Favored 'General case' 0 C--N 1.37 1.463 0 O-C-N 120.9 -1.125 . . . . 0.0 110.538 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.3 t80 0.4 -91.51 0.0 OUTLIER 'General case' 0 C--N 1.382 1.981 1 C-N-CA 133.59 4.756 . . . . 0.0 117.216 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.1 m 49.17 65.77 1.29 Allowed 'General case' 0 C--N 1.364 1.211 0 C-N-CA 130.756 3.623 . . . . 0.0 116.413 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.5 100.93 11.06 Favored 'General case' 0 C--N 1.369 1.415 0 CA-C-O 124.93 2.3 . . . . 0.0 114.049 -170.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -120.63 146.1 42.52 Favored Pre-proline 0 N--CA 1.429 -1.51 1 C-N-CA 132.009 4.124 . . . . 0.0 105.028 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -50.26 -38.3 51.43 Favored 'Trans proline' 0 CA--C 1.548 1.2 1 C-N-CA 127.403 5.402 . . . . 0.0 117.113 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.75 -35.54 75.05 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 128.943 2.897 . . . . 0.0 113.644 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.255 12.8 mt -76.01 -32.12 22.82 Favored 'Isoleucine or valine' 0 C--N 1.371 1.541 0 C-N-CA 127.119 2.168 . . . . 0.0 110.528 175.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 177' ' ' GLN . 19.3 mt -62.91 -53.16 58.42 Favored 'General case' 0 C--N 1.383 2.037 0 C-N-CA 126.704 2.002 . . . . 0.0 109.178 168.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -34.47 68.5 Favored 'General case' 0 C--N 1.369 1.449 0 C-N-CA 128.651 2.78 . . . . 0.0 115.066 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.21 -45.81 68.96 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 130.19 3.396 . . . . 0.0 112.116 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 12.8 mtt -67.03 -33.37 75.4 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-N 119.416 1.007 . . . . 0.0 113.515 170.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 8.6 mt-30 -70.02 -52.19 26.14 Favored 'General case' 0 C--N 1.381 1.976 0 C-N-CA 126.495 1.918 . . . . 0.0 113.06 172.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.274 5.4 ptt180 -72.43 -35.94 68.46 Favored 'General case' 0 C--N 1.384 2.067 0 O-C-N 119.184 -2.198 . . . . 0.0 114.48 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.418 ' O ' HD13 ' A' ' 183' ' ' LEU . . . -66.39 -39.96 89.38 Favored 'General case' 0 C--N 1.37 1.478 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 169.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 29.8 t70 -62.1 -35.78 79.74 Favored 'General case' 0 C--N 1.381 1.971 0 O-C-N 120.082 -1.636 . . . . 0.0 112.092 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -65.46 -45.78 82.4 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 119.337 -2.102 . . . . 0.0 113.743 170.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -71.41 -36.2 71.25 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 179' ' ' ALA 0.291 0.0 OUTLIER -79.74 -28.96 40.44 Favored 'General case' 0 C--N 1.371 1.535 0 O-C-N 119.893 -1.754 . . . . 0.0 114.89 177.415 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 180' ' ' ASP 0.267 0.0 OUTLIER -89.57 -15.48 32.76 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 124.966 1.306 . . . . 0.0 111.061 -176.789 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -115.2 -102.23 0.42 Allowed 'General case' 0 C--N 1.357 0.927 0 O-C-N 122.107 -0.37 . . . . 0.0 110.342 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.459 ' HB3' HG22 ' A' ' 188' ' ' ILE . 25.0 t70 -136.19 156.94 47.95 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 123.097 1.427 . . . . 0.0 109.952 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -50.97 -36.73 40.57 Favored 'General case' 0 C--N 1.361 1.08 1 C-N-CA 131.994 4.117 . . . . 0.0 114.116 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.459 HG22 ' HB3' ' A' ' 186' ' ' ASP . 8.1 tt -54.98 -28.29 20.29 Favored 'Isoleucine or valine' 0 C--N 1.364 1.236 1 C-N-CA 131.808 4.043 . . . . 0.0 113.514 175.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.281 5.3 mptt -71.98 -29.53 64.33 Favored 'General case' 0 C--N 1.376 1.733 0 C-N-CA 125.932 1.693 . . . . 0.0 113.551 171.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.501 ' HB2' HD22 ' A' ' 109' ' ' LEU 0.532 0.0 OUTLIER -74.73 -42.21 58.7 Favored 'General case' 0 C--N 1.375 1.713 0 O-C-N 119.198 -2.189 . . . . 0.0 113.368 170.045 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.5 -19.97 65.92 Favored 'General case' 0 C--N 1.379 1.869 0 C-N-CA 129.099 2.959 . . . . 0.0 114.424 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.88 -29.9 70.87 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 128.419 2.688 . . . . 0.0 112.925 169.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mt -105.07 -50.02 3.34 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 125.252 1.421 . . . . 0.0 108.535 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 34.37 38.31 0.03 OUTLIER 'General case' 0 C--N 1.375 1.706 1 C-N-CA 131.889 4.076 . . . . 0.0 119.229 173.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.273 40.5 t . . . . . 0 C--N 1.354 0.793 0 C-N-CA 128.963 2.905 . . . . 0.0 105.67 -170.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.9 p . . . . . 0 C--O 1.225 -0.207 0 CA-C-O 118.927 -0.559 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -155.85 92.4 1.37 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 124.698 1.199 . . . . 0.0 109.303 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -125.56 127.51 46.49 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.441 56.6 p -111.73 167.39 9.17 Favored Pre-proline 0 CA--C 1.562 1.41 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -59.54 137.66 79.02 Favored 'Trans proline' 0 C--N 1.379 2.165 1 C-N-CA 126.957 5.105 . . . . 0.0 118.531 -169.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.2 -22.65 39.8 Favored Glycine 0 C--N 1.371 2.513 0 C-N-CA 126.028 1.775 . . . . 0.0 111.39 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.34 159.31 27.21 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 120.208 -1.76 . . . . 0.0 112.212 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.74 133.35 48.88 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.533 -1.355 . . . . 0.0 107.522 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.13 152.73 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 C-N-CA 126.565 1.946 . . . . 0.0 107.335 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -101.72 119.88 39.47 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 168.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -110.08 149.59 29.81 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 121.487 1.949 . . . . 0.0 111.873 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -117.14 140.91 48.94 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 174.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.9 ttp -126.54 145.17 50.63 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 119.958 -1.714 . . . . 0.0 107.418 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -49.72 86.27 0.0 OUTLIER 'General case' 0 C--N 1.365 1.245 0 C-N-CA 130.457 3.503 . . . . 0.0 117.188 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.71 -3.47 45.83 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.961 1.267 . . . . 0.0 114.064 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -99.95 165.7 14.1 Favored Pre-proline 0 C--N 1.357 0.906 0 C-N-CA 125.7 1.6 . . . . 0.0 108.315 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.44 165.79 31.37 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.323 3.349 . . . . 0.0 113.56 169.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.434 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.0 m95 -63.68 110.19 1.95 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 130.145 3.378 . . . . 0.0 112.824 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 4.9 m95 -109.24 108.55 60.33 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 119.197 3.036 . . . . 0.0 119.197 -172.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 20.3 Cg_endo -54.45 123.03 12.62 Favored 'Trans proline' 0 C--N 1.384 2.413 1 C-N-CA 125.908 4.405 . . . . 0.0 111.708 159.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.4 p -148.65 165.72 30.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 124.574 2.13 . . . . 0.0 114.332 -156.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 tp -114.41 138.46 50.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.83 2.452 . . . . 0.0 106.663 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.92 127.88 39.47 Favored 'Isoleucine or valine' 0 C--N 1.364 1.206 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.406 ' CE2' HG12 ' A' ' 195' ' ' VAL . 81.2 t80 -139.73 153.88 47.31 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 122.712 2.505 . . . . 0.0 112.596 -168.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -104.07 114.62 28.99 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.572 2.349 . . . . 0.0 109.158 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.484 ' H ' ' CE1' ' A' ' 130' ' ' HIS . 14.6 t60 -67.74 161.27 67.8 Favored Pre-proline 0 C--N 1.354 0.774 0 C-N-CA 128.267 2.627 . . . . 0.0 112.496 177.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.04 -1.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.563 1.931 1 C-N-CA 126.494 4.796 . . . . 0.0 118.159 172.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -91.09 34.33 0.93 Allowed 'General case' 0 C--N 1.36 1.04 1 C-N-CA 135.074 5.349 . . . . 0.0 107.32 169.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.329 0.5 OUTLIER -77.92 156.36 30.33 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -173.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.39 -10.45 33.27 Favored Glycine 0 C--N 1.359 1.842 0 CA-C-N 111.826 -2.443 . . . . 0.0 111.776 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 t -146.87 150.66 35.68 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 101.269 -3.604 . . . . 0.0 101.269 172.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -149.83 9.64 0.7 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 119.555 1.071 . . . . 0.0 111.055 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.424 HG22 HG12 ' A' ' 129' ' ' VAL . 34.2 pt -117.5 148.81 20.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 CA-C-O 122.302 1.049 . . . . 0.0 110.687 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -137.66 138.89 39.89 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.3 129.78 14.87 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 119.859 -1.776 . . . . 0.0 109.776 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -117.78 93.84 4.3 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.511 2.324 . . . . 0.0 111.157 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.08 -73.07 0.55 Allowed Glycine 0 C--N 1.362 1.98 0 N-CA-C 120.127 2.811 . . . . 0.0 120.127 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -147.21 58.8 1.16 Allowed 'General case' 0 C--N 1.356 0.849 0 CA-C-O 122.601 1.191 . . . . 0.0 110.201 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.1 m -175.56 157.91 2.15 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.47 135.01 35.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 122.598 1.19 . . . . 0.0 109.735 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -115.17 130.37 56.9 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 127.618 2.367 . . . . 0.0 107.164 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 145' ' ' LYS . 10.3 m -125.81 146.43 31.58 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 1 N-CA-C 98.237 -4.727 . . . . 0.0 98.237 172.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.54 ' CD2' ' CZ2' ' A' ' 142' ' ' TRP 0.329 0.1 OUTLIER -81.57 137.32 35.54 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 121.709 0.766 . . . . 0.0 112.449 176.074 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -146.2 165.06 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -129.17 153.43 47.73 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -110.86 122.69 48.49 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.022 1.329 . . . . 0.0 107.564 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -74.83 60.59 0.96 Allowed 'General case' 0 C--N 1.37 1.493 0 C-N-CA 127.689 2.396 . . . . 0.0 114.475 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP 0.31 50.8 p-10 -87.66 -99.21 0.08 Allowed 'General case' 0 C--N 1.363 1.19 0 C-N-CA 125.604 1.562 . . . . 0.0 113.377 -177.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -106.84 -65.7 1.07 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.452 1.901 . . . . 0.0 114.57 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.272 10.1 p -77.81 -38.04 1.65 Allowed Pre-proline 0 C--N 1.365 1.251 0 N-CA-C 118.546 2.795 . . . . 0.0 118.546 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -82.43 -174.73 13.76 Favored 'Cis proline' 0 C--N 1.354 0.866 1 CA-C-N 128.707 4.145 . . . . 0.0 113.822 -0.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.274 4.0 t -97.62 154.06 17.8 Favored 'General case' 0 C--N 1.374 1.646 0 C-N-CA 127.613 2.365 . . . . 0.0 111.045 171.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.52 HH22 ' CG ' ' A' ' 130' ' ' HIS . 32.7 ttt-85 -158.44 162.05 37.52 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.26 -163.97 29.64 Favored Glycine 0 CA--C 1.484 -1.87 0 N-CA-C 104.24 -3.544 . . . . 0.0 104.24 166.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.54 ' CZ2' ' CD2' ' A' ' 130' ' ' HIS . 78.7 m95 -96.65 99.95 11.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 171.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.2 m -81.65 178.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 126.973 2.109 . . . . 0.0 108.001 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.5 m -94.92 130.08 41.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.522 ' HB3' HG22 ' A' ' 129' ' ' VAL . 4.2 pttp -79.53 -9.62 59.65 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 119.891 -1.755 . . . . 0.0 113.993 -175.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.21 -13.75 61.61 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.496 1.118 . . . . 0.0 112.475 174.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.7 mt -96.84 1.11 50.27 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 126.436 1.894 . . . . 0.0 114.074 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.09 141.79 28.31 Favored 'General case' 0 C--N 1.372 1.546 0 CA-C-N 121.1 1.773 . . . . 0.0 109.233 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -115.99 158.57 42.1 Favored Pre-proline 0 C--O 1.224 -0.273 0 O-C-N 119.313 -2.117 . . . . 0.0 105.621 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.98 151.44 21.25 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.395 3.397 . . . . 0.0 112.869 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -121.61 117.42 26.67 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-O 122.056 0.932 . . . . 0.0 112.262 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.3 t -160.89 23.72 0.14 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 126.182 1.793 . . . . 0.0 106.698 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.41 70.42 0.3 Allowed Glycine 0 C--N 1.353 1.514 0 C-N-CA 120.424 -0.894 . . . . 0.0 114.578 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 m -63.7 -10.99 22.17 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 131.221 3.808 . . . . 0.0 116.215 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -126.73 29.95 5.6 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 129.226 3.01 . . . . 0.0 108.065 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 t -96.09 136.58 36.36 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 127.695 2.398 . . . . 0.0 107.243 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -47.91 -38.91 17.52 Favored 'General case' 0 C--N 1.369 1.428 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.12 -18.3 60.27 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.608 -1.307 . . . . 0.0 113.885 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.72 -1.38 46.62 Favored 'General case' 0 C--N 1.371 1.505 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.376 0.6 OUTLIER -119.65 -173.51 2.55 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.409 1.484 . . . . 0.0 112.74 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -71.32 122.38 20.18 Favored 'General case' 0 C--N 1.37 1.468 0 O-C-N 119.506 -1.996 . . . . 0.0 112.355 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.26 -8.0 56.92 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.299 0.952 . . . . 0.0 111.774 -168.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.09 157.31 28.12 Favored Glycine 0 C--N 1.363 2.065 0 N-CA-C 117.437 1.735 . . . . 0.0 117.437 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -58.41 -42.53 87.41 Favored 'General case' 0 C--N 1.366 1.304 0 N-CA-C 119.358 3.096 . . . . 0.0 119.358 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.434 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.391 0.2 OUTLIER -106.32 3.15 27.26 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -175.037 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -101.91 144.13 30.92 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.091 1.757 . . . . 0.0 108.87 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.1 m -166.93 147.16 5.64 Favored 'General case' 0 N--CA 1.445 -0.709 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.37 99.89 9.24 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-O 126.398 2.999 . . . . 0.0 111.693 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -120.84 134.46 24.31 Favored Pre-proline 0 N--CA 1.416 -2.145 3 N-CA-C 98.046 -4.798 . . . . 0.0 98.046 164.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -60.74 -22.78 74.47 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.691 4.26 . . . . 0.0 115.509 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.09 -36.33 74.83 Favored 'General case' 0 C--N 1.36 1.059 0 C-N-CA 128.741 2.816 . . . . 0.0 113.829 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.1 mm -71.73 -40.24 69.72 Favored 'Isoleucine or valine' 0 C--N 1.379 1.877 0 C-N-CA 127.553 2.341 . . . . 0.0 108.472 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.0 mt -66.44 -48.57 69.55 Favored 'General case' 0 C--N 1.369 1.454 0 C-N-CA 125.314 1.446 . . . . 0.0 113.264 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -57.81 -34.16 69.35 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 128.288 2.635 . . . . 0.0 114.881 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.431 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . . . -68.35 -45.88 71.65 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 130.959 3.704 . . . . 0.0 111.599 171.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.35 0.0 OUTLIER -64.25 -32.35 73.9 Favored 'General case' 0 C--N 1.38 1.931 0 CA-C-N 120.321 1.419 . . . . 0.0 113.374 168.187 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -68.96 -48.51 62.99 Favored 'General case' 0 C--N 1.376 1.752 0 C-N-CA 126.059 1.743 . . . . 0.0 113.711 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -60.44 -53.51 56.75 Favored 'General case' 0 C--N 1.379 1.884 0 C-N-CA 128.838 2.855 . . . . 0.0 111.108 173.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -59.86 -45.42 92.52 Favored 'General case' 0 C--N 1.365 1.277 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.45 -37.79 70.77 Favored 'General case' 0 C--N 1.378 1.83 0 C-N-CA 127.668 2.387 . . . . 0.0 112.955 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.99 -39.62 72.34 Favored 'General case' 0 C--N 1.361 1.093 0 O-C-N 119.781 -1.824 . . . . 0.0 115.122 173.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.92 -29.35 55.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 119.417 3.118 . . . . 0.0 119.417 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.83 -50.2 69.83 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 130.298 3.439 . . . . 0.0 113.074 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.274 0.0 OUTLIER -90.93 -16.6 27.83 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 127.577 2.351 . . . . 0.0 111.985 -175.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -120.78 -110.91 0.33 Allowed 'General case' 0 C--N 1.357 0.906 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -135.52 149.55 49.51 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 119.797 -1.814 . . . . 0.0 107.836 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.492 0.0 OUTLIER -51.03 -32.69 22.32 Favored 'General case' 0 CA--C 1.5 -0.957 1 C-N-CA 132.017 4.127 . . . . 0.0 117.711 175.49 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 17.4 tt -49.43 -30.91 5.08 Favored 'Isoleucine or valine' 0 C--N 1.365 1.278 0 C-N-CA 130.12 3.368 . . . . 0.0 113.029 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -60.43 -35.88 76.86 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 128.146 2.578 . . . . 0.0 113.955 169.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -75.3 -44.23 46.7 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 171.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 10.0 mp -67.92 -19.95 65.04 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 129.694 3.197 . . . . 0.0 112.753 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -64.86 -38.64 91.64 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 130.652 3.581 . . . . 0.0 114.344 168.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.34 -51.08 3.44 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.78 2.032 . . . . 0.0 109.667 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 46.67 -134.13 1.0 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 131.303 3.841 . . . . 0.0 117.919 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.406 HG12 ' CE2' ' A' ' 111' ' ' TYR 0.318 9.1 p . . . . . 0 C--N 1.368 1.398 0 CA-C-O 124.645 2.164 . . . . 0.0 109.279 176.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.47 12.1 p . . . . . 0 N--CA 1.464 0.275 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -122.79 102.6 8.13 Favored 'General case' 0 C--N 1.369 1.442 0 O-C-N 120.566 -1.334 . . . . 0.0 110.386 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.448 ' H ' ' HD2' ' A' ' 145' ' ' LYS . 8.5 m-85 -126.06 128.6 47.65 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.766 1.626 . . . . 0.0 114.591 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.5 p -110.67 163.73 16.54 Favored Pre-proline 0 C--N 1.365 1.241 0 O-C-N 119.868 -1.77 . . . . 0.0 115.776 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.67 134.97 65.22 Favored 'Trans proline' 0 C--N 1.373 1.839 1 C-N-CA 126.659 4.906 . . . . 0.0 117.097 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.33 -51.19 0.75 Allowed Glycine 0 C--N 1.353 1.522 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 -169.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -65.49 159.36 24.59 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.47 HD23 HH11 ' A' ' 190' ' ' ARG . 3.5 mm? -102.83 141.49 35.54 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 148' ' ' LEU . 13.1 m -132.42 159.68 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 C-N-CA 126.639 1.976 . . . . 0.0 106.538 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.529 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 52.2 m95 -108.56 115.76 30.7 Favored 'General case' 0 C--O 1.214 -0.786 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 171.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.25 147.66 26.77 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 122.728 2.513 . . . . 0.0 113.602 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -115.14 130.57 56.96 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 170.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 44.1 ttm -116.04 141.19 48.45 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.26 101.29 0.9 Allowed 'General case' 0 C--N 1.364 1.203 0 C-N-CA 126.062 1.745 . . . . 0.0 113.5 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.42 -10.93 23.97 Favored Glycine 0 C--N 1.358 1.782 0 C-N-CA 125.752 1.644 . . . . 0.0 113.45 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -103.9 164.83 14.57 Favored Pre-proline 0 C--N 1.357 0.913 0 C-N-CA 125.567 1.547 . . . . 0.0 109.719 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -71.41 166.09 30.41 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 125.039 3.826 . . . . 0.0 112.752 164.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.92 126.0 25.83 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 127.776 2.43 . . . . 0.0 114.95 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 3.3 m95 -134.75 116.57 12.67 Favored Pre-proline 0 CA--C 1.571 1.787 1 N-CA-C 123.893 4.775 . . . . 0.0 123.893 -169.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.529 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 27.1 Cg_exo -56.44 113.45 1.46 Allowed 'Trans proline' 0 C--N 1.401 3.325 1 C-N-CA 126.788 4.992 . . . . 0.0 114.145 166.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -127.06 164.29 21.87 Favored 'General case' 0 N--CA 1.449 -0.508 1 C-N-CA 133.199 4.6 . . . . 0.0 116.104 -168.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.16 146.72 41.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.742 2.817 . . . . 0.0 107.165 172.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 t -91.63 130.64 40.46 Favored 'Isoleucine or valine' 0 C--N 1.37 1.467 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 171.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -132.18 152.47 51.27 Favored 'General case' 0 C--N 1.361 1.066 0 O-C-N 118.729 -2.482 . . . . 0.0 115.097 -164.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -92.31 112.82 24.9 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.46 ' CE1' ' HD3' ' A' ' 140' ' ' ARG . 2.0 m-70 -65.68 160.7 58.96 Favored Pre-proline 0 C--N 1.36 1.061 0 C-N-CA 128.2 2.6 . . . . 0.0 117.417 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.37 -1.41 0.2 Allowed 'Trans proline' 0 CA--C 1.572 2.398 0 C-N-CA 124.933 3.755 . . . . 0.0 116.895 169.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -115.71 33.92 5.22 Favored 'General case' 0 C--N 1.356 0.883 1 C-N-CA 135.638 5.575 . . . . 0.0 107.247 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.318 1.1 p30 -72.64 150.26 43.17 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -172.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.07 2.94 31.68 Favored Glycine 0 C--N 1.359 1.849 0 CA-C-N 111.99 -2.368 . . . . 0.0 110.959 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.4 m -149.74 130.76 14.38 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 102.141 -3.281 . . . . 0.0 102.141 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -149.37 -10.44 0.31 Allowed 'General case' 0 C--N 1.364 1.21 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.9 pt -108.63 145.6 15.37 Favored 'Isoleucine or valine' 0 C--N 1.369 1.446 0 CA-C-N 121.862 2.119 . . . . 0.0 112.196 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -139.1 137.9 36.58 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -143.27 127.42 17.54 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -117.86 94.0 4.36 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 126.926 2.09 . . . . 0.0 110.675 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.12 -71.02 0.32 Allowed Glycine 0 C--N 1.362 2.027 0 N-CA-C 120.205 2.842 . . . . 0.0 120.205 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -150.38 57.59 0.94 Allowed 'General case' 0 C--N 1.353 0.721 0 CA-C-O 122.512 1.149 . . . . 0.0 109.861 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.5 m -176.8 140.15 0.32 Allowed 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.486 1.914 . . . . 0.0 106.293 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.47 136.98 58.64 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 123.13 1.443 . . . . 0.0 112.31 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 -114.89 141.95 47.24 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.456 2.302 . . . . 0.0 107.994 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 145' ' ' LYS . 8.8 m -146.58 156.62 11.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 1 N-CA-C 98.711 -4.551 . . . . 0.0 98.711 174.202 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 2.5 m80 -79.66 138.66 37.45 Favored 'General case' 0 C--N 1.37 1.496 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.511 HG11 HD13 ' A' ' 148' ' ' LEU . 1.5 m -139.91 172.08 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 173.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.555 ' HB3' ' HG3' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -138.08 147.65 44.25 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 176.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.34 118.59 34.31 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 127.854 2.462 . . . . 0.0 104.951 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.51 53.36 0.02 OUTLIER 'General case' 0 C--N 1.373 1.622 0 C-N-CA 129.478 3.111 . . . . 0.0 114.568 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 1.6 p30 -100.83 -127.67 0.2 Allowed 'General case' 0 C--N 1.359 1.016 0 O-C-N 118.6 -2.563 . . . . 0.0 113.035 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -96.66 -46.4 6.32 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 124.785 1.234 . . . . 0.0 114.042 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.286 12.3 t -74.12 -51.86 4.54 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 116.797 2.147 . . . . 0.0 116.797 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.3 -173.63 12.96 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 126.012 3.183 . . . . 0.0 112.755 0.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 75.0 m -95.72 116.79 29.38 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.555 ' HG3' ' HB3' ' A' ' 132' ' ' GLN . 5.9 tmm_? -155.34 152.94 29.76 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 120.781 -1.199 . . . . 0.0 109.83 -176.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.93 -149.2 19.86 Favored Glycine 0 CA--C 1.488 -1.611 0 N-CA-C 104.468 -3.453 . . . . 0.0 104.468 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -86.78 111.33 20.62 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 126.166 1.786 . . . . 0.0 110.738 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.1 m -98.37 175.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 126.136 1.774 . . . . 0.0 107.069 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.9 t -94.31 128.56 40.88 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.587 ' HB3' HG22 ' A' ' 129' ' ' VAL 0.293 47.7 pttt -77.6 -7.26 56.1 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-N 121.206 1.821 . . . . 0.0 113.791 -176.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -67.64 -19.32 65.2 Favored 'General case' 0 C--N 1.364 1.223 0 C-N-CA 124.72 1.208 . . . . 0.0 113.307 172.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.9 mt -94.55 -0.23 54.74 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 125.666 1.586 . . . . 0.0 114.272 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.511 HD13 HG11 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -101.29 157.02 17.1 Favored 'General case' 0 C--N 1.366 1.285 0 CA-C-N 122.025 2.193 . . . . 0.0 108.3 179.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.457 ' HG3' ' CE1' ' A' ' 165' ' ' PHE . 21.0 mmtt -119.67 168.07 10.94 Favored Pre-proline 0 C--O 1.222 -0.376 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.8 156.24 15.66 Favored 'Trans proline' 0 C--N 1.326 -0.649 1 C-N-CA 125.67 4.247 . . . . 0.0 113.481 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.429 ' CE2' ' HA2' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -97.5 148.95 22.71 Favored 'General case' 0 C--N 1.359 0.994 0 CA-C-O 122.621 1.2 . . . . 0.0 110.109 172.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.5 t -171.38 -37.85 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 101.115 -3.661 . . . . 0.0 101.115 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 151' ' ' TYR . . . 119.74 -159.36 14.9 Favored Glycine 0 C--N 1.36 1.886 0 CA-C-N 113.949 -1.478 . . . . 0.0 115.969 140.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.3 m -46.35 -16.74 0.03 OUTLIER 'General case' 0 C--N 1.373 1.609 1 C-N-CA 133.263 4.625 . . . . 0.0 117.629 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -77.69 -23.07 49.64 Favored 'General case' 0 N--CA 1.442 -0.873 1 C-N-CA 135.379 5.471 . . . . 0.0 112.831 176.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 6.8 t -89.17 153.9 20.58 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.209 1.404 . . . . 0.0 114.052 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -61.23 -36.26 79.46 Favored 'General case' 0 C--N 1.369 1.417 0 C-N-CA 126.404 1.881 . . . . 0.0 113.858 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -73.08 -4.57 33.42 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 125.686 1.594 . . . . 0.0 113.197 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -111.75 7.11 20.16 Favored 'General case' 0 C--N 1.372 1.567 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.311 1.5 pp0? -127.98 -172.89 2.79 Favored 'General case' 0 C--N 1.363 1.194 0 O-C-N 119.621 -1.924 . . . . 0.0 111.853 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -63.69 122.38 16.23 Favored 'General case' 0 C--N 1.372 1.584 0 C-N-CA 126.824 2.05 . . . . 0.0 112.897 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.45 -9.04 66.89 Favored Glycine 0 C--N 1.359 1.854 0 C-N-CA 124.38 0.99 . . . . 0.0 112.22 -167.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.55 140.67 20.59 Favored Glycine 0 C--N 1.365 2.157 0 C-N-CA 126.926 2.203 . . . . 0.0 116.705 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -61.47 -21.6 64.33 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 119.453 3.131 . . . . 0.0 119.453 -172.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.457 ' CE1' ' HG3' ' A' ' 149' ' ' LYS . 1.7 m-85 -108.74 -3.6 17.67 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 120.623 -1.298 . . . . 0.0 111.449 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -86.53 165.46 16.22 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 125.566 2.603 . . . . 0.0 117.171 -173.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.4 m 169.95 173.84 0.05 Allowed 'General case' 0 CA--C 1.503 -0.848 2 N-CA-C 98.487 -4.634 . . . . 0.0 98.487 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -121.12 101.49 7.7 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-N 122.299 2.318 . . . . 0.0 107.168 170.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -119.58 123.9 28.35 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 101.173 -3.64 . . . . 0.0 101.173 169.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -55.73 -29.72 72.63 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 125.189 3.926 . . . . 0.0 116.868 -174.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -65.22 -36.11 83.13 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.921 2.889 . . . . 0.0 113.067 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.9 mt -68.36 -41.79 83.78 Favored 'Isoleucine or valine' 0 C--N 1.38 1.895 0 C-N-CA 126.164 1.786 . . . . 0.0 110.612 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.7 mt -68.55 -43.9 75.63 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 125.826 1.651 . . . . 0.0 113.275 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -58.05 -42.97 86.55 Favored 'General case' 0 CA--C 1.486 -1.498 0 C-N-CA 128.581 2.752 . . . . 0.0 113.777 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.59 -34.35 77.7 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 130.41 3.484 . . . . 0.0 110.09 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.255 6.8 mtt -70.09 -33.4 71.84 Favored 'General case' 0 C--N 1.376 1.721 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 165.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -71.31 -45.7 62.41 Favored 'General case' 0 C--N 1.379 1.884 0 C-N-CA 125.961 1.704 . . . . 0.0 110.955 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -67.48 -52.81 34.86 Favored 'General case' 0 C--N 1.375 1.699 0 C-N-CA 127.882 2.473 . . . . 0.0 112.154 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.64 85.55 Favored 'General case' 0 C--N 1.374 1.636 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.28 -40.37 93.78 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-N 121.714 2.052 . . . . 0.0 112.527 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.27 -52.13 63.3 Favored 'General case' 0 C--N 1.367 1.353 0 O-C-N 119.099 -2.251 . . . . 0.0 113.935 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.84 72.8 Favored 'General case' 0 C--N 1.361 1.065 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -50.21 43.54 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 127.084 2.154 . . . . 0.0 112.309 171.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.378 0.0 OUTLIER -81.19 -12.88 59.06 Favored 'General case' 0 C--N 1.363 1.183 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -170.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -107.42 -107.94 0.32 Allowed 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.731 0.812 . . . . 0.0 111.734 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 188' ' ' ILE . 19.5 t70 -136.25 176.31 8.81 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 119.839 -1.788 . . . . 0.0 112.053 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.537 ' HA ' ' HE ' ' A' ' 190' ' ' ARG . 40.6 mmtm -51.45 -43.83 62.18 Favored 'General case' 0 C--N 1.384 2.065 1 C-N-CA 132.495 4.318 . . . . 0.0 114.207 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.474 HG22 ' HB3' ' A' ' 186' ' ' ASP . 9.5 tt -59.84 -27.99 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 129.929 3.292 . . . . 0.0 114.148 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -71.95 -45.33 61.51 Favored 'General case' 0 C--N 1.376 1.737 0 C-N-CA 126.288 1.835 . . . . 0.0 112.983 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.537 ' HE ' ' HA ' ' A' ' 187' ' ' LYS . 0.0 OUTLIER -75.13 -41.5 58.29 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 126.91 2.084 . . . . 0.0 114.7 170.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.46 -20.92 62.84 Favored 'General case' 0 C--N 1.369 1.422 0 C-N-CA 127.985 2.514 . . . . 0.0 113.329 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.74 -38.04 88.96 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 128.438 2.695 . . . . 0.0 114.044 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.4 mt -99.21 -46.27 5.61 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 126.777 2.031 . . . . 0.0 108.648 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . 0.256 . . 65.13 -94.16 0.04 OUTLIER 'General case' 0 C--N 1.367 1.351 0 C-N-CA 128.937 2.895 . . . . 0.0 114.39 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.453 -0.276 0 C-N-CA 125.989 1.716 . . . . 0.0 109.673 175.352 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.2 p . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -163.09 62.12 0.19 Allowed 'General case' 0 C--N 1.364 1.236 0 CA-C-N 119.854 1.206 . . . . 0.0 113.409 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -118.04 125.78 51.0 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 120.215 -1.553 . . . . 0.0 110.067 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 87.4 p -111.73 166.22 11.31 Favored Pre-proline 0 C--N 1.36 1.022 0 C-N-CA 126.126 1.77 . . . . 0.0 110.773 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -54.56 149.14 40.66 Favored 'Trans proline' 0 C--N 1.37 1.691 1 C-N-CA 126.107 4.538 . . . . 0.0 119.188 -170.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.45 -39.37 2.89 Favored Glycine 0 C--N 1.356 1.689 0 C-N-CA 126.023 1.773 . . . . 0.0 113.015 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.54 169.04 17.58 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.476 HD21 ' HD2' ' A' ' 190' ' ' ARG . 3.3 mm? -94.89 134.46 37.51 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.0 m -136.08 159.22 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-O 123.613 1.673 . . . . 0.0 107.548 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -104.18 116.73 32.72 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.62 135.08 53.76 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.497 2.319 . . . . 0.0 112.791 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.469 ' HB2' ' CZ2' ' A' ' 105' ' ' TRP . 51.7 tptt -112.93 141.83 46.31 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 173.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.8 ttm -128.82 149.72 50.62 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.018 -1.676 . . . . 0.0 108.615 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -65.16 100.11 0.42 Allowed 'General case' 0 C--N 1.368 1.39 0 C-N-CA 125.788 1.635 . . . . 0.0 114.125 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.97 -4.38 25.67 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 125.873 1.701 . . . . 0.0 112.909 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -112.01 161.26 26.65 Favored Pre-proline 0 C--N 1.358 0.95 0 C-N-CA 125.41 1.484 . . . . 0.0 111.588 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.47 167.53 26.09 Favored 'Trans proline' 0 C--N 1.366 1.479 1 C-N-CA 126.12 4.547 . . . . 0.0 112.682 164.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.469 ' CZ2' ' HB2' ' A' ' 99' ' ' LYS . 6.9 m95 -65.34 132.8 49.94 Favored 'General case' 0 C--N 1.363 1.154 0 CA-C-O 124.316 2.008 . . . . 0.0 113.238 171.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.26 10.6 m95 -134.88 134.55 21.98 Favored Pre-proline 0 N--CA 1.413 -2.276 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -169.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.2 143.15 39.17 Favored 'Trans proline' 0 C--N 1.38 2.204 1 C-N-CA 126.123 4.549 . . . . 0.0 110.916 156.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -156.77 165.42 36.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.27 3.028 . . . . 0.0 114.39 -161.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.44 HD23 ' OE1' ' A' ' 132' ' ' GLN . 8.8 tp -119.45 138.49 53.09 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.345 2.258 . . . . 0.0 107.745 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.31 121.89 33.43 Favored 'Isoleucine or valine' 0 C--N 1.378 1.836 0 C-N-CA 126.387 1.875 . . . . 0.0 106.528 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -127.38 152.75 47.09 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 119.626 -1.921 . . . . 0.0 113.172 -167.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.79 113.58 26.92 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 127.472 2.309 . . . . 0.0 106.463 173.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.451 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 3.4 m-70 -62.56 159.98 38.25 Favored Pre-proline 0 C--N 1.358 0.975 0 C-N-CA 130.224 3.41 . . . . 0.0 117.456 -175.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.77 -1.41 0.24 Allowed 'Trans proline' 0 CA--C 1.564 2.021 1 C-N-CA 125.551 4.167 . . . . 0.0 116.951 170.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.72 31.27 5.78 Favored 'General case' 0 C--N 1.356 0.878 1 C-N-CA 134.813 5.245 . . . . 0.0 107.603 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.339 0.1 OUTLIER -69.53 150.29 47.29 Favored 'General case' 0 C--N 1.374 1.636 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -172.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.22 5.51 30.31 Favored Glycine 0 C--N 1.359 1.836 0 CA-C-N 112.174 -2.285 . . . . 0.0 111.556 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.4 m -152.56 135.29 15.39 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 100.813 -3.773 . . . . 0.0 100.813 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.421 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.255 2.2 p90 -155.23 -37.36 0.09 Allowed 'General case' 0 C--N 1.365 1.261 0 CA-C-N 120.423 1.465 . . . . 0.0 113.684 -175.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.5 tt -108.26 140.48 26.6 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-O 122.972 1.368 . . . . 0.0 110.574 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -119.88 121.29 38.72 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 101.091 -3.67 . . . . 0.0 101.091 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.84 179.71 4.19 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.097 0.959 . . . . 0.0 112.794 -171.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -46.3 131.73 10.41 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 120.241 3.423 . . . . 0.0 120.241 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 172.14 -51.38 0.17 Allowed Glycine 0 C--N 1.353 1.527 0 N-CA-C 106.37 -2.692 . . . . 0.0 106.37 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.0 mmmt -103.69 -52.81 2.9 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 126.605 1.962 . . . . 0.0 108.985 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.8 t -171.67 -166.49 0.44 Allowed 'General case' 0 C--N 1.353 0.739 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -129.13 120.68 52.15 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 124.917 1.287 . . . . 0.0 110.423 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -130.18 139.42 50.85 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 126.519 1.928 . . . . 0.0 112.786 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.97 163.25 36.95 Favored 'Isoleucine or valine' 0 C--N 1.367 1.347 0 C-N-CA 126.524 1.929 . . . . 0.0 105.844 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.451 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 1.1 m80 -83.34 140.93 32.15 Favored 'General case' 0 C--N 1.373 1.625 0 CA-C-N 120.654 1.57 . . . . 0.0 113.223 172.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.417 HG11 HD13 ' A' ' 148' ' ' LEU . 3.9 m -150.96 171.97 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.868 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.44 ' OE1' HD23 ' A' ' 109' ' ' LEU . 3.3 pt20 -136.69 146.77 46.28 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 124.453 1.101 . . . . 0.0 109.104 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.49 124.5 52.42 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 104.713 -2.328 . . . . 0.0 104.713 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.71 60.34 0.07 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 127.42 2.288 . . . . 0.0 113.394 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -98.29 -124.12 0.14 Allowed 'General case' 0 C--N 1.361 1.085 0 O-C-N 119.572 -1.955 . . . . 0.0 111.859 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -106.27 -52.55 2.77 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.731 1.612 . . . . 0.0 111.716 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 m -69.82 -40.35 13.19 Favored Pre-proline 0 C--N 1.364 1.232 0 N-CA-C 118.508 2.781 . . . . 0.0 118.508 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.14 178.0 36.54 Favored 'Cis proline' 0 C--N 1.354 0.852 0 CA-C-N 126.442 3.336 . . . . 0.0 110.479 -4.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.6 m -89.67 115.62 27.18 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 118.743 -2.473 . . . . 0.0 106.849 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.414 ' HD3' ' HB3' ' A' ' 132' ' ' GLN . 39.2 ttp85 -149.04 150.97 33.68 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-O 122.6 1.19 . . . . 0.0 109.347 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 165.62 -157.06 29.38 Favored Glycine 0 CA--C 1.491 -1.413 0 N-CA-C 105.973 -2.851 . . . . 0.0 105.973 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -80.22 110.17 15.39 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 126.547 1.939 . . . . 0.0 109.885 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.17 169.25 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 124.636 1.174 . . . . 0.0 110.543 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.5 m -90.23 115.67 27.63 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.47 33.8 pttt -69.25 -5.6 23.91 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -168.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -82.05 -12.78 58.09 Favored 'General case' 0 C--N 1.365 1.256 0 O-C-N 119.242 -2.161 . . . . 0.0 109.714 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.73 -0.63 45.06 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 128.679 2.792 . . . . 0.0 110.145 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.417 HD13 HG11 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -104.89 125.0 50.46 Favored 'General case' 0 C--N 1.388 2.262 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 173.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -118.97 168.48 9.73 Favored Pre-proline 0 C--O 1.218 -0.563 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -82.47 153.23 15.73 Favored 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 124.433 3.422 . . . . 0.0 112.697 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -127.6 121.2 29.92 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.324 1.059 . . . . 0.0 111.696 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.694 ' HA ' HD13 ' A' ' 183' ' ' LEU . 8.7 t -162.14 30.67 0.12 Allowed 'General case' 0 C--N 1.359 0.997 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.72 82.12 0.09 OUTLIER Glycine 0 C--N 1.35 1.345 0 C-N-CA 116.499 -2.762 . . . . 0.0 115.228 -166.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . 0.34 89.2 p -68.42 -10.11 53.0 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 121.007 2.404 . . . . 0.0 116.791 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -112.12 32.02 5.83 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 130.166 3.386 . . . . 0.0 108.656 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 19.3 t -103.04 133.4 48.22 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.258 42.7 tttm -55.72 -33.08 63.91 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -174.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -70.89 -19.2 62.64 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 124.704 1.202 . . . . 0.0 113.972 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.49 3.26 54.37 Favored 'General case' 0 C--N 1.371 1.536 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -130.56 -173.07 2.97 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 125.743 1.617 . . . . 0.0 112.042 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -62.79 122.22 15.39 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 126.284 1.834 . . . . 0.0 113.106 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.02 -8.01 64.95 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 124.554 1.073 . . . . 0.0 112.475 -169.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.09 146.2 21.85 Favored Glycine 0 C--N 1.361 1.935 0 C-N-CA 126.565 2.031 . . . . 0.0 115.824 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -60.37 -42.25 95.41 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . 0.322 0.1 OUTLIER -99.84 2.93 44.37 Favored 'General case' 0 C--N 1.363 1.163 0 CA-C-N 120.402 1.455 . . . . 0.0 114.826 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -91.77 140.83 29.31 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 126.551 1.94 . . . . 0.0 107.928 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.5 m -166.66 132.4 2.28 Favored 'General case' 0 N--CA 1.446 -0.635 1 N-CA-C 99.797 -4.149 . . . . 0.0 99.797 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.93 100.53 10.83 Favored 'General case' 0 C--N 1.369 1.432 0 CA-C-O 126.281 2.944 . . . . 0.0 112.848 -173.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.57 131.56 24.42 Favored Pre-proline 0 N--CA 1.417 -2.093 3 N-CA-C 98.51 -4.626 . . . . 0.0 98.51 164.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.53 -24.7 63.1 Favored 'Trans proline' 0 CA--C 1.543 0.942 1 C-N-CA 125.534 4.156 . . . . 0.0 115.998 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -69.62 -35.88 75.65 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.47 2.708 . . . . 0.0 113.831 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 45.8 mt -74.12 -36.18 43.32 Favored 'Isoleucine or valine' 0 C--N 1.376 1.745 0 C-N-CA 126.369 1.868 . . . . 0.0 109.854 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 177' ' ' GLN . 20.1 mt -69.0 -45.63 70.05 Favored 'General case' 0 C--N 1.367 1.336 0 C-N-CA 125.298 1.439 . . . . 0.0 112.488 172.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -58.11 -43.21 87.04 Favored 'General case' 0 CA--C 1.486 -1.519 0 C-N-CA 127.951 2.5 . . . . 0.0 114.596 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.25 -36.88 85.51 Favored 'General case' 0 N--CA 1.428 -1.539 0 C-N-CA 129.449 3.1 . . . . 0.0 111.208 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.1 mtt -65.04 -35.51 81.41 Favored 'General case' 0 C--N 1.379 1.883 0 CA-C-O 115.486 -2.197 . . . . 0.0 112.724 165.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 13.6 mt-30 -74.06 -40.2 62.98 Favored 'General case' 0 C--N 1.383 2.026 0 C-N-CA 126.019 1.728 . . . . 0.0 113.731 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.401 HH21 ' HB3' ' A' ' 193' ' ' LEU . 0.2 OUTLIER -73.68 -49.46 25.69 Favored 'General case' 0 C--N 1.374 1.651 0 C-N-CA 131.551 3.941 . . . . 0.0 111.491 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.54 95.72 Favored 'General case' 0 C--N 1.376 1.75 0 C-N-CA 123.836 0.854 . . . . 0.0 113.267 165.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.329 38.5 t70 -57.13 -52.76 64.02 Favored 'General case' 0 C--N 1.387 2.232 0 C-N-CA 126.692 1.997 . . . . 0.0 113.014 172.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -33.44 70.17 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 121.777 2.081 . . . . 0.0 115.702 173.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.413 ' HB1' ' CD ' ' A' ' 190' ' ' ARG . . . -76.26 -44.84 35.48 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 172.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.694 HD13 ' HA ' ' A' ' 152' ' ' THR . 3.9 pp -69.53 -36.86 76.79 Favored 'General case' 0 C--N 1.374 1.65 0 C-N-CA 126.16 1.784 . . . . 0.0 114.221 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.38 -9.78 58.14 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.664 1.586 . . . . 0.0 112.125 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -124.68 -101.27 0.39 Allowed 'General case' 0 C--N 1.356 0.867 0 CA-C-O 120.756 0.312 . . . . 0.0 111.44 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -135.77 152.69 51.37 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.036 -1.04 . . . . 0.0 110.953 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.351 17.2 ttpt -51.51 -35.96 42.63 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 130.839 3.656 . . . . 0.0 116.2 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 14.0 tt -55.03 -30.22 23.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 129.032 2.933 . . . . 0.0 113.035 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -73.22 -37.88 66.27 Favored 'General case' 0 C--N 1.375 1.691 0 O-C-N 119.717 -1.864 . . . . 0.0 113.795 176.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.476 ' HD2' HD21 ' A' ' 95' ' ' LEU 0.28 0.0 OUTLIER -76.23 -44.35 38.01 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 167.499 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.31 78.4 mt -79.19 -18.96 52.02 Favored 'General case' 0 C--N 1.366 1.292 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -173.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -84.41 -12.95 53.47 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.607 1.163 . . . . 0.0 113.216 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.401 ' HB3' HH21 ' A' ' 178' ' ' ARG . 9.2 mp -105.03 -51.34 3.05 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 126.18 1.792 . . . . 0.0 106.22 176.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 46.48 -113.25 0.44 Allowed 'General case' 0 C--N 1.366 1.287 0 C-N-CA 129.696 3.198 . . . . 0.0 115.787 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--N 1.349 0.548 0 C-N-CA 128.182 2.593 . . . . 0.0 113.221 -178.206 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.4 p . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.12 109.9 6.38 Favored 'General case' 0 C--N 1.361 1.086 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.401 ' CD1' HD12 ' A' ' 148' ' ' LEU . 18.2 m-85 -125.71 128.49 47.86 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.952 1.701 . . . . 0.0 113.47 -173.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.318 90.8 p -110.2 162.59 19.84 Favored Pre-proline 0 C--N 1.364 1.235 0 O-C-N 120.249 -1.532 . . . . 0.0 114.855 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.24 136.9 77.75 Favored 'Trans proline' 0 C--N 1.378 2.095 1 C-N-CA 126.449 4.766 . . . . 0.0 119.217 -170.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.63 -20.83 19.97 Favored Glycine 0 C--N 1.364 2.11 0 C-N-CA 125.605 1.574 . . . . 0.0 111.813 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -85.53 169.04 13.95 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 125.697 1.599 . . . . 0.0 114.891 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.477 HD21 ' HD2' ' A' ' 190' ' ' ARG . 2.8 mm? -110.28 131.68 54.84 Favored 'General case' 0 C--N 1.369 1.447 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 172.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -134.46 161.77 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -106.98 138.31 43.39 Favored 'General case' 0 C--O 1.217 -0.618 1 N-CA-C 99.768 -4.16 . . . . 0.0 99.768 165.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 148' ' ' LEU . . . -128.86 152.58 48.36 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 121.632 2.014 . . . . 0.0 111.976 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -121.46 146.04 47.32 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.9 ttp -128.85 146.43 50.93 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 119.61 -1.931 . . . . 0.0 108.016 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -48.6 91.06 0.0 OUTLIER 'General case' 0 C--N 1.366 1.285 0 C-N-CA 129.475 3.11 . . . . 0.0 117.01 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.06 -9.13 33.7 Favored Glycine 0 C--N 1.36 1.875 0 C-N-CA 125.102 1.334 . . . . 0.0 113.436 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -99.71 162.12 22.2 Favored Pre-proline 0 C--N 1.359 0.983 0 C-N-CA 125.308 1.443 . . . . 0.0 109.231 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.88 167.31 26.27 Favored 'Trans proline' 0 CA--C 1.537 0.674 1 C-N-CA 125.848 4.365 . . . . 0.0 114.736 167.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -60.91 132.0 52.47 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 127.335 2.254 . . . . 0.0 115.04 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -132.29 108.56 13.61 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 121.729 3.974 . . . . 0.0 121.729 -171.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HG2' ' HB3' ' A' ' 175' ' ' ALA . 7.6 Cg_endo -58.07 113.58 1.59 Allowed 'Trans proline' 0 C--N 1.388 2.631 1 C-N-CA 126.275 4.65 . . . . 0.0 111.588 165.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.1 m -123.65 166.12 16.05 Favored 'General case' 0 N--CA 1.438 -1.026 1 C-N-CA 132.871 4.468 . . . . 0.0 114.147 -160.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tp -126.12 144.41 50.76 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.16 118.8 37.17 Favored 'Isoleucine or valine' 0 C--N 1.366 1.294 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -113.41 143.59 44.23 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.103 -1.623 . . . . 0.0 111.679 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -79.31 111.31 15.43 Favored 'General case' 0 C--N 1.373 1.612 0 O-C-N 120.379 -1.451 . . . . 0.0 109.597 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.475 ' HB2' ' CG ' ' A' ' 130' ' ' HIS . 9.9 t60 -69.22 160.15 80.09 Favored Pre-proline 0 C--N 1.348 0.522 0 CA-C-O 114.488 -2.672 . . . . 0.0 115.336 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.82 -6.47 2.56 Favored 'Trans proline' 0 CA--C 1.562 1.901 1 CA-C-N 128.814 4.184 . . . . 0.0 116.577 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -108.32 29.72 7.09 Favored 'General case' 0 C--N 1.357 0.922 1 C-N-CA 133.384 4.674 . . . . 0.0 109.642 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -63.45 149.73 45.36 Favored 'General case' 0 C--N 1.365 1.276 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.07 -20.14 50.14 Favored Glycine 0 C--N 1.36 1.889 0 CA-C-N 113.226 -1.806 . . . . 0.0 110.007 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.86 119.1 38.56 Favored 'General case' 0 N--CA 1.446 -0.672 2 N-CA-C 98.646 -4.575 . . . . 0.0 98.646 168.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.592 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.359 0.0 OUTLIER -121.82 -33.41 3.58 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -169.378 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 129' ' ' VAL . 10.3 pt -108.33 155.84 9.09 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 120.269 -1.519 . . . . 0.0 110.581 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -141.35 151.16 43.32 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 128.016 2.527 . . . . 0.0 104.208 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.65 130.21 11.48 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 121.0 -1.063 . . . . 0.0 108.249 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -117.4 98.93 6.67 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.952 2.101 . . . . 0.0 108.654 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.43 -89.78 1.02 Allowed Glycine 0 C--N 1.36 1.916 0 N-CA-C 117.869 1.908 . . . . 0.0 117.869 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -142.57 71.34 1.34 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 125.0 1.32 . . . . 0.0 109.391 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.0 m -179.92 170.36 1.21 Allowed 'General case' 0 C--N 1.351 0.667 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.49 145.46 16.22 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -141.32 150.31 42.34 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.498 2.319 . . . . 0.0 110.757 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' A' ' 145' ' ' LYS . 26.2 m -129.0 162.36 36.48 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 129.592 3.157 . . . . 0.0 104.475 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.592 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -82.5 124.8 30.43 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.335 -1.478 . . . . 0.0 110.976 172.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.78 169.48 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.436 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.98 150.84 46.32 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -106.21 127.86 53.53 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.36 1.864 . . . . 0.0 107.376 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -74.95 69.35 1.89 Allowed 'General case' 0 C--N 1.379 1.872 0 CA-C-N 120.258 1.39 . . . . 0.0 111.881 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -88.98 -119.92 0.05 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 127.459 2.304 . . . . 0.0 111.002 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -107.25 -51.99 2.83 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.184 1.794 . . . . 0.0 110.91 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.6 t -69.97 -49.98 18.02 Favored Pre-proline 0 C--N 1.36 1.063 0 C-N-CA 127.975 2.51 . . . . 0.0 117.734 -172.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -81.99 -175.64 15.67 Favored 'Cis proline' 0 C--N 1.347 0.497 0 CA-C-N 126.104 3.216 . . . . 0.0 111.52 -0.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 34.5 m -94.62 141.17 28.92 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.291 1.036 . . . . 0.0 108.319 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -160.23 156.21 26.15 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.16 -159.8 29.21 Favored Glycine 0 CA--C 1.484 -1.904 1 N-CA-C 98.235 -5.946 . . . . 0.0 98.235 174.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -104.85 113.73 27.5 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 143' ' ' VAL . 13.5 m -87.83 173.78 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 C-N-CA 128.231 2.612 . . . . 0.0 106.711 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.8 m -94.31 110.88 22.61 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.494 ' HB3' HG22 ' A' ' 129' ' ' VAL . 16.9 ptmt -50.93 -17.8 0.65 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -173.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -69.27 -19.47 63.91 Favored 'General case' 0 N--CA 1.439 -1.014 1 C-N-CA 131.784 4.034 . . . . 0.0 112.75 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.4 mt -92.33 -2.23 56.53 Favored 'General case' 0 C--N 1.365 1.278 0 C-N-CA 126.182 1.793 . . . . 0.0 113.935 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -95.35 156.9 16.13 Favored 'General case' 0 C--N 1.369 1.451 0 CA-C-N 122.231 2.287 . . . . 0.0 109.715 174.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.06 159.04 58.43 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 102.567 -3.123 . . . . 0.0 102.567 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.98 151.93 21.51 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 125.035 3.823 . . . . 0.0 111.399 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.365 1.0 OUTLIER -93.31 -116.2 0.09 Allowed 'General case' 0 C--N 1.367 1.335 0 O-C-N 120.649 -1.282 . . . . 0.0 110.737 175.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.426 4.6 t 63.47 -36.87 0.16 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 127.849 2.459 . . . . 0.0 116.149 -174.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.04 88.54 0.53 Allowed Glycine 0 C--N 1.349 1.27 0 C-N-CA 126.448 1.975 . . . . 0.0 116.769 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.2 m -67.66 -10.92 56.6 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 131.473 3.909 . . . . 0.0 115.412 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -121.49 24.58 9.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 128.458 2.703 . . . . 0.0 108.496 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 91.2 p -87.39 139.29 30.7 Favored 'General case' 0 C--N 1.374 1.667 0 C-N-CA 125.598 1.559 . . . . 0.0 107.821 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -56.39 -24.34 43.97 Favored 'General case' 0 C--N 1.372 1.579 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -82.24 -19.86 38.81 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.734 1.614 . . . . 0.0 113.224 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.61 -13.99 22.49 Favored 'General case' 0 C--N 1.37 1.494 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.304 0.4 OUTLIER -107.88 -173.97 2.41 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 125.395 1.478 . . . . 0.0 112.939 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -69.31 122.1 18.2 Favored 'General case' 0 C--N 1.373 1.613 0 O-C-N 120.308 -1.495 . . . . 0.0 112.784 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.22 -9.47 50.06 Favored Glycine 0 C--N 1.354 1.553 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.81 -166.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.87 155.76 46.78 Favored Glycine 0 C--N 1.368 2.339 0 N-CA-C 119.97 2.748 . . . . 0.0 119.97 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.69 -41.54 77.53 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.927 3.691 . . . . 0.0 116.164 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -98.42 -17.74 18.64 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -41.08 -36.58 0.72 Allowed 'General case' 0 C--N 1.356 0.854 2 C-N-CA 132.723 4.409 . . . . 0.0 122.472 -168.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.6 m -14.17 92.86 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 1 C-N-CA 132.032 4.133 . . . . 0.0 117.707 -177.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.99 101.65 13.1 Favored 'General case' 0 C--N 1.368 1.38 0 CA-C-O 126.016 2.817 . . . . 0.0 114.003 -166.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -119.78 135.55 24.28 Favored Pre-proline 0 N--CA 1.423 -1.776 1 C-N-CA 133.803 4.841 . . . . 0.0 102.681 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -55.08 -22.76 32.76 Favored 'Trans proline' 0 CA--C 1.544 1.019 1 C-N-CA 125.973 4.448 . . . . 0.0 117.733 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -70.16 -35.96 74.38 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 131.251 3.82 . . . . 0.0 112.453 173.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.8 mt -76.7 -32.7 20.93 Favored 'Isoleucine or valine' 0 C--N 1.375 1.683 0 C-N-CA 127.582 2.353 . . . . 0.0 109.084 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 26.3 mt -66.46 -51.88 52.15 Favored 'General case' 0 C--N 1.373 1.627 0 C-N-CA 127.063 2.145 . . . . 0.0 111.055 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -57.45 -34.52 69.06 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.127 1.771 . . . . 0.0 114.751 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.411 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . . . -69.33 -50.75 43.59 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 130.484 3.514 . . . . 0.0 113.86 172.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.415 0.0 OUTLIER -68.16 -33.1 73.85 Favored 'General case' 0 C--N 1.385 2.124 0 CA-C-N 121.525 1.966 . . . . 0.0 113.7 173.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -71.96 -48.89 41.95 Favored 'General case' 0 C--N 1.373 1.596 0 C-N-CA 126.688 1.995 . . . . 0.0 112.751 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -38.51 77.83 Favored 'General case' 0 C--N 1.383 2.042 0 O-C-N 119.022 -2.299 . . . . 0.0 114.986 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.89 -51.09 69.61 Favored 'General case' 0 C--N 1.379 1.864 0 C-N-CA 124.655 1.182 . . . . 0.0 112.19 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.268 38.1 t70 -53.47 -43.2 67.96 Favored 'General case' 0 C--N 1.38 1.897 0 C-N-CA 127.263 2.225 . . . . 0.0 113.98 174.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -33.86 76.57 Favored 'General case' 0 C--N 1.374 1.669 0 O-C-N 118.661 -2.524 . . . . 0.0 114.921 173.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.435 ' HB1' ' CD ' ' A' ' 190' ' ' ARG . . . -76.37 -45.59 31.24 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 tt -53.56 -49.87 66.75 Favored 'General case' 0 CA--C 1.498 -1.024 1 C-N-CA 132.298 4.239 . . . . 0.0 116.455 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.253 0.0 OUTLIER -86.84 -7.91 57.8 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 126.606 1.962 . . . . 0.0 111.417 -174.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -120.1 -100.05 0.43 Allowed 'General case' 0 C--N 1.358 0.961 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -135.26 151.05 50.21 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.783 -1.198 . . . . 0.0 108.998 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.256 34.3 tttm -51.39 -36.49 43.63 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 130.979 3.712 . . . . 0.0 115.872 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 12.6 tt -56.0 -28.5 24.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 130.118 3.367 . . . . 0.0 113.211 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.258 4.6 mptt -71.02 -42.62 69.33 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 119.537 -1.977 . . . . 0.0 113.849 174.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.477 ' HD2' HD21 ' A' ' 95' ' ' LEU 0.314 0.0 OUTLIER -76.36 -42.98 42.9 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 169.36 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.55 -30.7 67.5 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.627 1.971 . . . . 0.0 114.946 -172.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -84.56 -12.25 54.47 Favored 'General case' 0 C--N 1.365 1.282 0 C-N-CA 125.859 1.664 . . . . 0.0 114.305 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 mp -97.34 -50.05 4.69 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 173.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 62.65 -102.64 0.11 Allowed 'General case' 0 C--N 1.364 1.199 0 C-N-CA 130.371 3.468 . . . . 0.0 115.055 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.447 -0.579 0 C-N-CA 128.397 2.679 . . . . 0.0 108.601 -178.937 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -160.4 62.19 0.33 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-N 119.161 0.892 . . . . 0.0 109.505 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -114.58 124.63 52.34 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 120.294 -1.504 . . . . 0.0 111.558 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.6 p -112.07 164.4 15.31 Favored Pre-proline 0 C--N 1.366 1.292 0 C-N-CA 129.045 2.938 . . . . 0.0 114.438 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -47.08 141.01 13.17 Favored 'Trans proline' 0 C--N 1.376 2.005 1 C-N-CA 127.743 5.628 . . . . 0.0 121.147 -169.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.43 -23.3 32.01 Favored Glycine 0 C--N 1.367 2.267 0 C-N-CA 125.636 1.588 . . . . 0.0 112.838 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.05 169.94 13.45 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 120.814 2.307 . . . . 0.0 112.644 -177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.84 141.38 29.36 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 166.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.5 163.4 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -110.34 128.27 55.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 101.288 -3.597 . . . . 0.0 101.288 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.28 137.74 51.05 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 122.848 1.309 . . . . 0.0 111.698 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -110.57 136.41 49.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 171.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 42.7 ttm -119.8 138.32 53.43 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.32 102.14 0.37 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 125.721 1.608 . . . . 0.0 113.98 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.17 -12.6 24.07 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 125.538 1.542 . . . . 0.0 112.757 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -103.18 164.17 16.04 Favored Pre-proline 0 C--N 1.354 0.792 0 C-N-CA 125.639 1.575 . . . . 0.0 109.418 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -71.64 166.36 29.68 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.371 3.381 . . . . 0.0 113.634 162.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -57.69 122.37 12.64 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 130.683 3.593 . . . . 0.0 114.825 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -126.48 112.17 23.17 Favored Pre-proline 0 N--CA 1.427 -1.602 0 N-CA-C 119.888 3.292 . . . . 0.0 119.888 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -59.03 112.24 1.15 Allowed 'Trans proline' 0 C--N 1.383 2.387 1 C-N-CA 125.813 4.342 . . . . 0.0 110.573 162.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.2 t -122.57 165.5 16.33 Favored 'General case' 0 N--CA 1.445 -0.72 1 C-N-CA 133.475 4.71 . . . . 0.0 111.346 -161.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tt -124.05 132.31 53.66 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.454 HG23 HG12 ' A' ' 131' ' ' VAL 0.251 3.3 p -81.84 127.28 39.74 Favored 'Isoleucine or valine' 0 C--N 1.377 1.8 0 CA-C-N 121.145 1.793 . . . . 0.0 107.385 176.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -132.05 152.86 50.93 Favored 'General case' 0 C--N 1.366 1.322 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 -161.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.5 113.46 27.05 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 127.698 2.399 . . . . 0.0 109.525 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 115' ' ' PHE . 34.8 m-70 -71.54 161.72 76.97 Favored Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 129.292 3.037 . . . . 0.0 114.342 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.1 -8.22 0.17 Allowed 'Trans proline' 0 CA--C 1.569 2.241 1 C-N-CA 125.605 4.203 . . . . 0.0 117.593 170.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CZ ' ' CD2' ' A' ' 113' ' ' HIS . 0.6 OUTLIER -104.11 44.69 1.0 Allowed 'General case' 0 C--N 1.365 1.252 0 C-N-CA 131.518 3.927 . . . . 0.0 107.565 167.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.6 149.18 38.32 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 119.207 3.04 . . . . 0.0 119.207 -170.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.75 -19.91 27.69 Favored Glycine 0 C--N 1.362 2.025 0 CA-C-N 112.757 -2.019 . . . . 0.0 109.541 165.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 t -118.03 119.39 34.64 Favored 'General case' 0 N--CA 1.435 -1.224 1 N-CA-C 98.161 -4.755 . . . . 0.0 98.161 168.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.461 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 27.2 p90 -140.31 -0.6 1.6 Allowed 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 120.82 -1.175 . . . . 0.0 111.357 -174.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.713 HG22 HG12 ' A' ' 129' ' ' VAL . 7.0 pt -119.84 147.86 23.24 Favored 'Isoleucine or valine' 0 C--N 1.366 1.321 0 CA-C-O 123.467 1.603 . . . . 0.0 115.133 -174.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.87 118.36 31.35 Favored 'General case' 0 C--N 1.357 0.934 1 N-CA-C 99.13 -4.396 . . . . 0.0 99.13 169.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -105.6 -179.66 4.0 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -165.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -46.78 119.69 2.61 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 128.848 2.859 . . . . 0.0 116.985 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.51 -54.92 0.24 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 105.091 -3.204 . . . . 0.0 105.091 -173.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -109.86 -47.6 3.32 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.459 1.504 . . . . 0.0 109.886 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 m -179.51 169.77 1.37 Allowed 'General case' 0 CA--C 1.472 -2.056 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.4 106.87 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -114.98 130.31 56.9 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 127.811 2.445 . . . . 0.0 110.676 -176.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.713 HG12 HG22 ' A' ' 120' ' ' ILE . 13.7 m -130.36 161.91 39.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 0.6 OUTLIER -92.64 138.52 31.42 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 123.944 0.898 . . . . 0.0 110.897 174.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.454 HG12 HG23 ' A' ' 110' ' ' VAL . 5.2 m -150.58 168.71 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.472 -2.033 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.39 152.55 40.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 123.828 0.851 . . . . 0.0 109.599 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -108.09 125.78 51.98 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -67.47 65.34 0.08 Allowed 'General case' 0 C--N 1.369 1.438 0 C-N-CA 126.615 1.966 . . . . 0.0 115.08 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.37 -119.36 0.08 Allowed 'General case' 0 C--N 1.36 1.025 0 O-C-N 119.397 -2.064 . . . . 0.0 110.045 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -106.71 -49.07 3.38 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.627 1.571 . . . . 0.0 112.597 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.274 11.2 t -70.12 -51.39 14.22 Favored Pre-proline 0 C--N 1.363 1.156 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.06 -179.16 26.15 Favored 'Cis proline' 0 CA--C 1.543 0.952 0 CA-C-N 125.944 3.158 . . . . 0.0 113.722 1.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 54.0 m -95.03 127.17 40.88 Favored 'General case' 0 C--N 1.369 1.424 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 24.1 ttp-105 -153.61 157.47 39.72 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 119.976 1.262 . . . . 0.0 109.876 -173.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.14 -159.28 25.5 Favored Glycine 0 CA--C 1.492 -1.401 0 N-CA-C 104.901 -3.28 . . . . 0.0 104.901 171.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -83.15 113.55 20.72 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 126.172 1.789 . . . . 0.0 109.15 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.44 178.36 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 125.118 1.367 . . . . 0.0 110.987 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.2 m -99.82 121.18 40.91 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 100.462 -3.903 . . . . 0.0 100.462 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.446 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 26.7 ttpt -73.34 -10.99 60.33 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -170.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -72.58 -13.42 61.39 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.49 2.316 . . . . 0.0 113.738 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.7 mt -103.0 7.61 39.05 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 126.634 1.974 . . . . 0.0 111.404 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 12.4 mt -96.31 125.41 40.79 Favored 'General case' 0 C--N 1.379 1.874 0 CA-C-N 119.891 1.223 . . . . 0.0 108.431 174.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -114.44 159.13 37.99 Favored Pre-proline 0 C--O 1.221 -0.434 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.03 155.72 14.99 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 CA-C-N 124.904 2.787 . . . . 0.0 114.642 -172.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.362 0.0 OUTLIER -30.91 -95.34 0.0 OUTLIER 'General case' 0 C--N 1.357 0.922 2 C-N-CA 132.273 4.229 . . . . 0.0 122.092 -177.927 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.555 ' HA ' HD21 ' A' ' 183' ' ' LEU . 13.4 t -0.38 54.95 0.0 OUTLIER 'General case' 0 C--N 1.381 1.942 1 C-N-CA 136.511 5.924 . . . . 0.0 118.194 178.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.524 ' H ' HD11 ' A' ' 183' ' ' LEU . . . -81.07 -91.75 0.52 Allowed Glycine 0 CA--C 1.485 -1.782 0 N-CA-C 121.603 3.401 . . . . 0.0 121.603 -150.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.6 m -46.1 -23.45 0.32 Allowed 'General case' 0 C--N 1.374 1.669 0 C-N-CA 129.182 2.993 . . . . 0.0 119.003 -172.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -18.17 50.41 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 130.519 3.528 . . . . 0.0 113.039 175.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.0 t -80.5 150.78 29.53 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 127.754 2.422 . . . . 0.0 112.454 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -65.05 -21.39 66.82 Favored 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.985 1.714 . . . . 0.0 111.787 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.409 ' HG2' ' CD2' ' A' ' 164' ' ' HIS . 41.9 mt-10 -72.49 -23.03 60.97 Favored 'General case' 0 C--N 1.373 1.607 0 C-N-CA 126.315 1.846 . . . . 0.0 112.481 170.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -105.93 11.98 31.11 Favored 'General case' 0 C--N 1.361 1.088 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -128.0 -179.53 5.02 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.541 1.537 . . . . 0.0 107.712 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.65 122.69 11.94 Favored 'General case' 0 C--N 1.37 1.49 0 C-N-CA 127.731 2.412 . . . . 0.0 114.628 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.8 -10.04 64.21 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 124.397 0.999 . . . . 0.0 112.4 -168.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.8 146.31 25.53 Favored Glycine 0 C--N 1.365 2.145 0 N-CA-C 118.569 2.187 . . . . 0.0 118.569 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.409 ' CD2' ' HG2' ' A' ' 158' ' ' GLU . 5.7 m-70 -59.81 -22.32 62.06 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 119.71 3.226 . . . . 0.0 119.71 -175.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.55 -3.52 15.93 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.297 -1.502 . . . . 0.0 111.48 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -86.9 91.56 8.71 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 -166.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.2 m -118.86 104.91 10.99 Favored 'General case' 0 CA--C 1.504 -0.81 1 N-CA-C 99.559 -4.238 . . . . 0.0 99.559 167.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.27 101.42 14.13 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-O 125.096 2.379 . . . . 0.0 112.189 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -119.36 144.82 37.25 Favored Pre-proline 0 N--CA 1.432 -1.332 0 C-N-CA 130.241 3.416 . . . . 0.0 103.801 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -51.32 -31.82 39.17 Favored 'Trans proline' 0 CA--C 1.54 0.784 1 C-N-CA 127.166 5.244 . . . . 0.0 116.593 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.9 -36.95 75.81 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 127.997 2.519 . . . . 0.0 112.896 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.0 mt -79.05 -33.65 16.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.482 0 C-N-CA 127.163 2.185 . . . . 0.0 109.878 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 177' ' ' GLN 0.266 28.1 mt -61.98 -53.26 58.16 Favored 'General case' 0 C--N 1.392 2.45 0 C-N-CA 128.356 2.662 . . . . 0.0 110.367 170.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -57.41 -50.77 71.92 Favored 'General case' 0 CA--C 1.478 -1.802 0 C-N-CA 128.969 2.908 . . . . 0.0 112.684 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.62 73.33 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 130.988 3.715 . . . . 0.0 113.077 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 57.1 mtt -69.07 -39.18 79.23 Favored 'General case' 0 C--N 1.375 1.681 0 C-N-CA 125.563 1.545 . . . . 0.0 111.655 168.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 6.3 mt-30 -74.2 -42.33 59.98 Favored 'General case' 0 C--N 1.374 1.639 0 CA-C-N 120.756 1.616 . . . . 0.0 113.578 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.433 HH12 ' HA ' ' A' ' 190' ' ' ARG . 0.1 OUTLIER -63.19 -53.24 56.36 Favored 'General case' 0 C--N 1.375 1.7 1 C-N-CA 132.819 4.448 . . . . 0.0 110.123 174.465 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 183' ' ' LEU . . . -60.45 -51.57 68.9 Favored 'General case' 0 C--N 1.38 1.9 0 CA-C-O 116.815 -1.564 . . . . 0.0 112.496 170.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.05 -51.14 62.72 Favored 'General case' 0 C--N 1.38 1.906 0 C-N-CA 126.419 1.887 . . . . 0.0 114.352 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -55.02 -43.11 73.37 Favored 'General case' 0 C--N 1.37 1.462 0 CA-C-N 121.207 1.821 . . . . 0.0 114.993 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.13 -41.05 51.31 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 152' ' ' THR 0.25 0.5 OUTLIER -61.65 -45.61 93.32 Favored 'General case' 0 C--N 1.359 1.021 1 C-N-CA 132.923 4.489 . . . . 0.0 114.663 175.247 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -28.58 29.35 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 126.64 1.976 . . . . 0.0 111.768 -176.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -105.52 -99.82 0.33 Allowed 'General case' 0 C--N 1.359 0.986 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -135.56 154.01 51.5 Favored 'General case' 0 C--N 1.36 1.065 0 O-C-N 120.822 -1.174 . . . . 0.0 112.2 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 190' ' ' ARG 0.395 18.0 ttpt -51.51 -37.16 47.94 Favored 'General case' 0 C--N 1.369 1.45 0 C-N-CA 130.217 3.407 . . . . 0.0 117.24 177.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.9 tp -57.08 -28.39 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 128.915 2.886 . . . . 0.0 112.906 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.252 4.1 mptt -70.19 -45.82 65.86 Favored 'General case' 0 C--N 1.372 1.575 0 O-C-N 119.773 -1.829 . . . . 0.0 113.387 174.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.433 ' HA ' HH12 ' A' ' 178' ' ' ARG 0.291 0.0 OUTLIER -75.27 -40.19 59.01 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 119.03 -2.294 . . . . 0.0 116.804 171.48 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.5 tp -80.83 -20.6 42.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -170.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -82.85 -22.79 33.96 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 124.107 0.963 . . . . 0.0 112.477 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.16 23.24 13.97 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 130.132 3.373 . . . . 0.0 109.984 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.82 -103.96 0.0 OUTLIER 'General case' 0 C--N 1.367 1.356 0 C-N-CA 131.268 3.827 . . . . 0.0 117.035 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.301 2.7 m . . . . . 0 C--N 1.35 0.615 0 CA-C-O 124.225 1.964 . . . . 0.0 107.491 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.478 ' HA ' ' CE2' ' A' ' 90' ' ' PHE 0.415 62.9 m . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 118.156 2.65 . . . . 0.0 118.156 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -136.68 77.88 1.67 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 127.243 2.217 . . . . 0.0 109.38 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.478 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 62.1 m-85 -123.49 125.21 44.49 Favored 'General case' 0 C--N 1.355 0.837 0 O-C-N 120.336 -1.477 . . . . 0.0 112.719 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.416 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.391 88.6 p -112.01 170.51 5.19 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 131.329 3.852 . . . . 0.0 114.834 -176.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 37.3 Cg_exo -41.72 129.31 3.88 Favored 'Trans proline' 0 C--N 1.382 2.314 1 C-N-CA 128.177 5.918 . . . . 0.0 119.774 -177.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.12 0.12 74.69 Favored Glycine 0 C--N 1.366 2.198 0 C-N-CA 127.797 2.618 . . . . 0.0 114.421 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -94.01 154.71 17.5 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 166.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 109' ' ' LEU . 3.8 mm? -110.39 153.55 24.8 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 175.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.3 m -142.48 170.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 123.686 1.708 . . . . 0.0 107.25 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 96.2 m95 -114.78 116.03 27.97 Favored 'General case' 0 N--CA 1.438 -1.069 1 N-CA-C 99.924 -4.102 . . . . 0.0 99.924 174.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.0 127.96 53.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 122.32 2.327 . . . . 0.0 111.776 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -96.36 143.18 27.65 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.1 ttt -128.63 151.01 49.98 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 118.596 -2.565 . . . . 0.0 108.218 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -74.41 95.77 2.77 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 126.729 2.011 . . . . 0.0 113.544 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.13 -4.44 25.4 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 124.58 1.086 . . . . 0.0 113.042 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -117.08 164.92 16.92 Favored Pre-proline 0 C--N 1.357 0.898 0 CA-C-N 118.723 1.262 . . . . 0.0 108.364 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -71.58 167.37 26.63 Favored 'Trans proline' 0 C--N 1.353 0.783 1 C-N-CA 125.506 4.137 . . . . 0.0 114.413 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -53.79 115.31 1.93 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 128.086 2.554 . . . . 0.0 115.943 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.471 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 10.8 m95 -116.32 117.83 38.24 Favored Pre-proline 0 N--CA 1.415 -2.214 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HG2' ' HB3' ' A' ' 175' ' ' ALA . 17.4 Cg_endo -56.82 134.07 62.09 Favored 'Trans proline' 0 CA--C 1.561 1.866 1 C-N-CA 125.888 4.392 . . . . 0.0 111.848 160.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 m -147.69 165.39 30.61 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.125 2.17 . . . . 0.0 111.851 -160.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 6.2 tt -124.03 129.0 50.17 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.658 1.583 . . . . 0.0 113.996 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.02 121.81 44.02 Favored 'Isoleucine or valine' 0 C--N 1.372 1.571 0 O-C-N 120.836 -1.165 . . . . 0.0 110.724 171.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.93 153.9 51.45 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 127.26 2.224 . . . . 0.0 109.052 -170.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -71.13 112.7 7.48 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-N 120.734 1.606 . . . . 0.0 113.533 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 14.4 t60 -77.47 158.38 79.02 Favored Pre-proline 0 C--N 1.346 0.455 0 CA-C-O 114.55 -2.643 . . . . 0.0 110.373 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.457 ' HD2' ' CD2' ' A' ' 113' ' ' HIS . 91.1 Cg_exo -55.38 -1.1 0.18 Allowed 'Trans proline' 0 CA--C 1.544 1.016 1 C-N-CA 125.884 4.389 . . . . 0.0 120.242 -170.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -95.31 -7.34 39.0 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 128.994 2.918 . . . . 0.0 110.381 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.267 0.0 OUTLIER 9.52 94.87 0.0 OUTLIER 'General case' 0 C--N 1.376 1.753 1 C-N-CA 135.939 5.696 . . . . 0.0 120.213 -178.704 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 110.27 -17.42 29.01 Favored Glycine 0 C--N 1.36 1.887 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -172.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.4 m -103.78 120.13 40.34 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 100.384 -3.932 . . . . 0.0 100.384 170.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.478 ' HA ' ' HE1' ' A' ' 130' ' ' HIS . 1.4 t80 -142.22 -26.8 0.64 Allowed 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -167.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.5 pt -112.3 155.83 13.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-O 123.029 1.395 . . . . 0.0 111.847 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -141.35 149.8 41.63 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 128.034 2.534 . . . . 0.0 104.296 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -150.43 142.51 24.03 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 120.319 -1.488 . . . . 0.0 111.105 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -118.17 93.64 4.21 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 128.044 2.538 . . . . 0.0 110.418 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.65 -67.63 0.17 Allowed Glycine 0 C--N 1.361 1.949 0 N-CA-C 120.979 3.152 . . . . 0.0 120.979 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -144.38 46.1 1.41 Allowed 'General case' 0 C--N 1.354 0.771 0 CA-C-O 122.232 1.015 . . . . 0.0 112.343 -173.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.5 m -171.5 159.04 5.41 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.24 140.28 40.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 120.933 -1.104 . . . . 0.0 109.88 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -116.77 160.2 21.15 Favored 'General case' 0 C--N 1.366 1.308 0 C-N-CA 128.058 2.543 . . . . 0.0 112.906 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.428 HG13 ' HD3' ' A' ' 145' ' ' LYS . 9.9 m -148.57 164.77 4.79 Favored 'Isoleucine or valine' 0 C--N 1.37 1.487 0 C-N-CA 128.1 2.56 . . . . 0.0 107.058 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -91.55 116.94 29.27 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 122.395 1.093 . . . . 0.0 111.424 169.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.82 158.78 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 N-CA-C 104.702 -2.332 . . . . 0.0 104.702 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -125.73 138.33 53.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 172.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.96 129.7 40.33 Favored 'General case' 0 C--N 1.36 1.058 0 C-N-CA 128.013 2.525 . . . . 0.0 107.864 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 14.1 m-30 -75.85 63.3 1.67 Allowed 'General case' 0 C--N 1.363 1.172 0 C-N-CA 125.829 1.652 . . . . 0.0 113.723 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.332 50.6 p-10 -98.14 -110.32 0.17 Allowed 'General case' 0 C--N 1.358 0.974 0 O-C-N 120.179 -1.576 . . . . 0.0 113.111 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -106.45 -54.95 2.4 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 125.621 1.568 . . . . 0.0 112.642 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.256 0.9 OUTLIER -64.15 -49.34 74.07 Favored Pre-proline 0 C--N 1.365 1.269 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -174.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.12 171.78 54.0 Favored 'Cis proline' 0 CA--C 1.547 1.167 0 CA-C-N 125.98 3.171 . . . . 0.0 111.543 -5.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.327 7.5 t -95.54 154.63 17.11 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 120.392 -1.443 . . . . 0.0 111.849 -176.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -148.85 152.25 36.14 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 125.133 1.373 . . . . 0.0 109.566 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -178.42 -177.5 47.14 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 107.279 -2.329 . . . . 0.0 107.279 168.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -82.78 106.26 14.47 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.456 1.902 . . . . 0.0 107.415 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.6 m -94.41 159.82 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.442 0 C-N-CA 127.577 2.351 . . . . 0.0 109.063 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.4 m -85.59 110.34 19.18 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.448 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 30.6 ttpt -64.51 -25.57 68.05 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -167.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.62 -12.35 57.62 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 127.285 2.234 . . . . 0.0 114.984 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . 0.31 0.2 OUTLIER -104.82 8.53 34.86 Favored 'General case' 0 C--N 1.37 1.464 0 O-C-N 119.107 -2.246 . . . . 0.0 112.402 174.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 14.4 mt -95.3 127.75 41.6 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 128.122 2.569 . . . . 0.0 108.339 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -114.19 165.37 13.84 Favored Pre-proline 0 C--N 1.357 0.901 0 O-C-N 118.894 -2.379 . . . . 0.0 105.866 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.43 151.97 13.57 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 124.924 3.75 . . . . 0.0 115.689 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.518 ' CE2' ' HA2' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -93.01 167.68 11.63 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 122.834 1.302 . . . . 0.0 113.373 175.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 178.9 -60.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.936 2 N-CA-C 95.073 -5.899 . . . . 0.0 95.073 -174.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.518 ' HA2' ' CE2' ' A' ' 151' ' ' TYR . . . 127.03 -125.52 5.35 Favored Glycine 0 CA--C 1.474 -2.521 0 O-C-N 121.186 -0.946 . . . . 0.0 113.481 151.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 m -59.15 -15.73 16.18 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -96.47 4.95 51.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 129.709 3.204 . . . . 0.0 111.651 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 18.1 t -89.7 139.94 30.07 Favored 'General case' 0 C--N 1.372 1.567 0 C-N-CA 126.658 1.983 . . . . 0.0 108.597 173.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.65 -27.38 68.63 Favored 'General case' 0 C--N 1.369 1.413 0 C-N-CA 125.827 1.651 . . . . 0.0 113.948 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -78.59 -10.22 59.65 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 119.672 -1.892 . . . . 0.0 112.293 171.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -104.13 17.06 24.88 Favored 'General case' 0 C--N 1.375 1.682 0 C-N-CA 125.343 1.457 . . . . 0.0 114.155 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -132.27 174.54 10.12 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.319 1.447 . . . . 0.0 109.003 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -60.36 122.17 13.89 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 126.164 1.786 . . . . 0.0 113.996 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.08 -12.7 57.44 Favored Glycine 0 C--N 1.358 1.781 0 C-N-CA 124.803 1.192 . . . . 0.0 112.53 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.4 151.18 24.16 Favored Glycine 0 C--N 1.363 2.042 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -63.23 -38.87 92.87 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -87.74 -22.03 24.82 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.182 0.993 . . . . 0.0 112.308 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -75.87 91.65 3.02 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 126.635 1.974 . . . . 0.0 114.367 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 70.7 m -119.21 107.69 13.75 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 100.487 -3.894 . . . . 0.0 100.487 170.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.46 101.44 13.92 Favored 'General case' 0 C--N 1.366 1.293 0 CA-C-O 126.535 3.064 . . . . 0.0 114.312 -167.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -120.31 139.69 28.97 Favored Pre-proline 0 N--CA 1.412 -2.344 1 C-N-CA 133.139 4.575 . . . . 0.0 101.353 169.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.63 -32.19 82.38 Favored 'Trans proline' 0 CA--C 1.545 1.066 1 C-N-CA 126.462 4.775 . . . . 0.0 115.694 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -66.11 -35.91 81.76 Favored 'General case' 0 C--N 1.365 1.268 0 C-N-CA 127.578 2.351 . . . . 0.0 113.125 174.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.471 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 19.2 mm -68.25 -39.17 80.69 Favored 'Isoleucine or valine' 0 C--N 1.378 1.827 0 C-N-CA 126.279 1.832 . . . . 0.0 110.909 174.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 20.2 mt -68.9 -51.35 40.97 Favored 'General case' 0 C--N 1.367 1.355 0 C-N-CA 126.162 1.785 . . . . 0.0 113.163 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -61.02 -35.32 76.55 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 127.191 2.197 . . . . 0.0 114.596 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.443 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . . . -69.36 -34.99 75.41 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 130.717 3.607 . . . . 0.0 109.396 171.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.5 mtt -69.31 -35.37 75.89 Favored 'General case' 0 C--N 1.38 1.924 0 CA-C-N 120.994 1.725 . . . . 0.0 114.017 163.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -66.74 -47.95 70.69 Favored 'General case' 0 C--N 1.372 1.572 0 C-N-CA 125.76 1.624 . . . . 0.0 111.461 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -68.96 -53.05 22.89 Favored 'General case' 0 C--N 1.37 1.472 0 C-N-CA 127.3 2.24 . . . . 0.0 113.026 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.25 -33.13 74.01 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.46 -44.0 75.8 Favored 'General case' 0 C--N 1.375 1.691 0 C-N-CA 127.067 2.147 . . . . 0.0 109.861 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -36.87 83.37 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -69.43 -35.09 75.35 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 151' ' ' TYR . 1.7 pt? -81.41 -36.8 29.05 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 119.943 -1.723 . . . . 0.0 114.63 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -87.17 -25.64 23.97 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 126.833 2.053 . . . . 0.0 112.878 -172.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -100.87 -95.15 0.27 Allowed 'General case' 0 C--N 1.367 1.35 0 O-C-N 121.091 -1.006 . . . . 0.0 109.007 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.0 145.01 45.65 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.047 -1.033 . . . . 0.0 109.399 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.523 ' HB3' HH11 ' A' ' 190' ' ' ARG . 93.5 mttt -51.39 -34.71 35.58 Favored 'General case' 0 C--N 1.365 1.257 1 C-N-CA 132.379 4.271 . . . . 0.0 113.881 173.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.5 tt -50.61 -27.81 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 131.001 3.72 . . . . 0.0 112.593 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.257 2.3 mptp? -73.82 -29.97 62.45 Favored 'General case' 0 C--N 1.377 1.786 0 C-N-CA 126.895 2.078 . . . . 0.0 114.728 169.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.523 HH11 ' HB3' ' A' ' 187' ' ' LYS 0.266 0.0 OUTLIER -75.03 -43.25 54.66 Favored 'General case' 0 C--N 1.371 1.518 0 O-C-N 119.278 -2.139 . . . . 0.0 113.168 171.161 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.288 63.2 mt -75.33 -18.87 59.9 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 126.631 1.972 . . . . 0.0 114.488 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -58.12 -38.92 77.43 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 127.699 2.4 . . . . 0.0 113.063 168.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -94.41 -51.07 4.94 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 126.963 2.105 . . . . 0.0 109.159 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 63.55 -83.38 0.02 OUTLIER 'General case' 0 C--N 1.372 1.585 1 C-N-CA 131.91 4.084 . . . . 0.0 114.353 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.435 -1.203 0 C-N-CA 130.841 3.656 . . . . 0.0 101.414 171.029 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.359 87.0 p . . . . . 0 C--O 1.223 -0.335 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -101.41 108.03 19.52 Favored 'General case' 0 C--N 1.361 1.105 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -123.61 126.99 47.63 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 126.02 1.728 . . . . 0.0 111.387 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 25.4 p -113.12 168.65 7.41 Favored Pre-proline 0 C--N 1.357 0.924 0 C-N-CA 128.864 2.865 . . . . 0.0 117.504 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 12.7 Cg_exo -44.11 127.26 6.82 Favored 'Trans proline' 0 C--N 1.395 3.003 1 C-N-CA 127.628 5.552 . . . . 0.0 116.15 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.24 57.44 Favored Glycine 0 CA--C 1.482 -1.994 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.045 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -95.35 161.19 14.19 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 122.867 1.318 . . . . 0.0 108.263 169.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.79 135.46 50.67 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 101.253 -3.61 . . . . 0.0 101.253 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.07 159.01 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -106.93 120.3 41.68 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 162.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.79 143.93 33.24 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 120.635 1.561 . . . . 0.0 109.37 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -115.51 134.9 54.63 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 118.982 -2.324 . . . . 0.0 105.471 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 ttp -128.91 146.45 50.95 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 119.343 -2.098 . . . . 0.0 109.141 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.59 98.88 0.72 Allowed 'General case' 0 C--N 1.365 1.27 0 C-N-CA 127.072 2.149 . . . . 0.0 113.754 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.23 -9.71 24.64 Favored Glycine 0 C--N 1.359 1.833 0 C-N-CA 125.426 1.488 . . . . 0.0 111.935 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -104.97 158.79 31.27 Favored Pre-proline 0 C--N 1.356 0.879 0 C-N-CA 125.678 1.591 . . . . 0.0 109.019 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.83 166.64 28.9 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.368 3.378 . . . . 0.0 112.034 161.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -56.13 115.02 2.2 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 129.86 3.264 . . . . 0.0 112.408 171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.537 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 2.1 m95 -114.69 108.18 49.57 Favored Pre-proline 0 N--CA 1.434 -1.244 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -173.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 19.0 Cg_endo -55.28 106.21 0.18 Allowed 'Trans proline' 0 C--N 1.397 3.116 1 C-N-CA 125.854 4.37 . . . . 0.0 109.984 161.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 m -114.64 164.11 14.49 Favored 'General case' 0 CA--C 1.492 -1.287 1 C-N-CA 132.313 4.245 . . . . 0.0 113.21 -164.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.983 HD11 ' HE ' ' A' ' 190' ' ' ARG . 5.2 tp -123.87 127.66 48.34 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 111.6 -2.545 . . . . 0.0 105.363 173.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 131' ' ' VAL . 2.5 p -91.33 118.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 166.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.402 ' HA ' HH21 ' A' ' 190' ' ' ARG . 0.0 OUTLIER -121.18 152.58 38.61 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 124.498 1.119 . . . . 0.0 112.037 -169.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -89.61 111.34 22.25 Favored 'General case' 0 C--N 1.373 1.621 0 CA-C-O 123.342 1.544 . . . . 0.0 108.29 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -100.81 158.7 31.35 Favored Pre-proline 0 N--CA 1.451 -0.399 0 C-N-CA 129.705 3.202 . . . . 0.0 109.343 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -49.95 -0.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 2 C-N-CA 127.569 5.512 . . . . 0.0 122.845 -164.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.6 -0.13 35.34 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 126.792 2.037 . . . . 0.0 108.533 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.269 0.3 OUTLIER -20.36 119.33 0.03 OUTLIER 'General case' 0 C--N 1.376 1.718 2 C-N-CA 134.634 5.174 . . . . 0.0 122.068 -177.913 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.38 -20.96 27.22 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.5 p -120.72 117.94 28.78 Favored 'General case' 0 C--N 1.352 0.704 1 N-CA-C 98.101 -4.777 . . . . 0.0 98.101 164.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -141.94 2.39 1.54 Allowed 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 120.546 -1.346 . . . . 0.0 112.857 -167.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.9 pt -107.93 163.02 5.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 CA-C-O 122.696 1.236 . . . . 0.0 111.724 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -150.62 147.73 27.76 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 103.309 -2.848 . . . . 0.0 103.309 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -144.22 134.31 24.16 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 120.771 1.623 . . . . 0.0 111.926 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -117.46 93.18 4.07 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.689 2.396 . . . . 0.0 107.434 174.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.57 -92.46 0.08 OUTLIER Glycine 0 C--N 1.361 1.921 0 C-N-CA 126.555 2.026 . . . . 0.0 118.051 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -123.21 20.09 9.81 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 125.812 1.645 . . . . 0.0 109.12 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.6 t -118.41 108.69 15.35 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -111.2 135.1 51.42 Favored 'Isoleucine or valine' 0 C--N 1.357 0.898 0 C-N-CA 124.688 1.195 . . . . 0.0 108.686 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 73.4 mtt-85 -123.16 151.17 42.42 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 126.419 1.888 . . . . 0.0 112.588 -175.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.28 163.01 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 128.227 2.611 . . . . 0.0 107.282 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -93.18 121.75 34.86 Favored 'General case' 0 C--N 1.369 1.449 0 O-C-N 119.731 -1.855 . . . . 0.0 111.579 171.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.414 HG12 HG23 ' A' ' 110' ' ' VAL . 4.0 m -135.97 176.64 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.553 0 C-N-CA 126.585 1.954 . . . . 0.0 108.326 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.405 HE22 ' C ' ' A' ' 194' ' ' ALA . 6.2 pt20 -134.26 152.43 51.81 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.964 0.888 . . . . 0.0 109.495 166.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -106.74 115.59 30.46 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 126.642 1.977 . . . . 0.0 106.069 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 13.4 m-85 -66.8 55.97 0.04 OUTLIER 'General case' 0 C--N 1.367 1.347 0 C-N-CA 127.847 2.459 . . . . 0.0 116.022 -175.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.505 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP 0.303 52.7 p-10 -84.79 -102.16 0.05 Allowed 'General case' 0 C--N 1.367 1.367 0 C-N-CA 127.039 2.136 . . . . 0.0 113.17 -176.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -106.47 -58.3 1.94 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.275 1.83 . . . . 0.0 115.121 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.0 t -75.78 -41.77 3.56 Favored Pre-proline 0 C--N 1.366 1.295 0 CA-C-O 114.037 -2.887 . . . . 0.0 117.951 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.7 -177.94 22.45 Favored 'Cis proline' 0 CA--C 1.55 1.279 0 CA-C-N 127.083 3.566 . . . . 0.0 113.379 -2.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.3 t -95.35 142.37 27.81 Favored 'General case' 0 C--N 1.368 1.389 0 O-C-N 118.762 -2.461 . . . . 0.0 108.764 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -142.01 149.33 39.88 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.5 -170.61 37.89 Favored Glycine 0 CA--C 1.488 -1.649 1 N-CA-C 102.201 -4.36 . . . . 0.0 102.201 172.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -89.75 119.81 30.47 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 125.33 1.452 . . . . 0.0 109.371 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 143' ' ' VAL . 1.8 m -99.27 160.38 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 C-N-CA 125.621 1.569 . . . . 0.0 111.152 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 41.0 t -70.92 106.12 3.52 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 127.568 2.347 . . . . 0.0 107.335 168.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 7.5 ttpp -68.95 -29.33 67.55 Favored 'General case' 0 C--N 1.365 1.258 0 CA-C-O 122.777 1.275 . . . . 0.0 112.306 -175.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -67.48 -14.75 63.21 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.681 1.593 . . . . 0.0 114.646 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.6 mt -100.18 18.38 18.84 Favored 'General case' 0 C--N 1.367 1.337 0 C-N-CA 125.9 1.68 . . . . 0.0 111.485 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 37.2 mt -102.36 131.08 49.21 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.748 -1.22 . . . . 0.0 110.473 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -115.39 156.73 45.45 Favored Pre-proline 0 C--O 1.222 -0.361 0 CA-C-O 116.711 -1.614 . . . . 0.0 107.259 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.69 150.59 14.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 125.223 3.949 . . . . 0.0 113.425 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -120.29 120.0 34.79 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-O 122.42 1.105 . . . . 0.0 112.822 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.48 ' HA ' HD21 ' A' ' 183' ' ' LEU . 5.0 t -154.49 22.2 0.47 Allowed 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.672 1.589 . . . . 0.0 106.95 177.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.59 56.1 0.36 Allowed Glycine 0 C--N 1.36 1.888 0 N-CA-C 120.184 2.834 . . . . 0.0 120.184 -158.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.7 m -65.77 -17.72 64.82 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 130.423 3.489 . . . . 0.0 113.978 171.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -107.04 15.59 25.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 129.466 3.106 . . . . 0.0 110.425 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . 0.337 97.2 p -126.17 153.31 44.8 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 124.186 0.994 . . . . 0.0 113.311 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.535 1.4 pttm -47.06 -16.33 0.04 OUTLIER 'General case' 0 C--N 1.369 1.426 0 N-CA-C 121.348 3.833 . . . . 0.0 121.348 -168.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -96.14 -6.21 38.89 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 117.02 -1.467 . . . . 0.0 114.057 167.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.09 18.78 10.81 Favored 'General case' 0 C--N 1.381 1.953 0 CA-C-N 122.588 2.449 . . . . 0.0 116.621 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.75 -173.04 2.97 Favored 'General case' 0 N--CA 1.45 -0.431 1 C-N-CA 132.006 4.123 . . . . 0.0 109.535 -176.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -70.96 122.59 20.26 Favored 'General case' 0 C--N 1.361 1.1 0 O-C-N 119.588 -1.945 . . . . 0.0 113.014 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 98.91 -5.79 59.85 Favored Glycine 0 C--N 1.363 2.052 0 C-N-CA 126.156 1.836 . . . . 0.0 112.158 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -80.67 148.24 28.86 Favored Glycine 0 C--N 1.364 2.1 0 C-N-CA 129.095 3.236 . . . . 0.0 117.225 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -59.87 -33.61 72.04 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -102.52 -5.76 23.63 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 120.494 1.497 . . . . 0.0 113.068 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -88.87 148.6 23.78 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 -170.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.0 m -163.67 151.42 12.86 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 101.342 -3.577 . . . . 0.0 101.342 172.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -112.09 100.12 8.61 Favored 'General case' 0 C--N 1.372 1.56 0 CA-C-O 126.003 2.811 . . . . 0.0 111.032 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -120.55 141.63 32.54 Favored Pre-proline 0 N--CA 1.424 -1.756 2 C-N-CA 132.921 4.488 . . . . 0.0 99.522 168.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.91 -26.05 67.04 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.228 3.286 . . . . 0.0 114.171 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -69.82 -35.66 74.97 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 129.491 3.117 . . . . 0.0 114.017 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.537 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 9.3 mm -69.88 -43.18 79.83 Favored 'Isoleucine or valine' 0 C--N 1.379 1.874 0 C-N-CA 127.109 2.164 . . . . 0.0 109.175 175.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.7 mt -68.94 -45.18 71.44 Favored 'General case' 0 C--N 1.373 1.593 0 C-N-CA 124.458 1.103 . . . . 0.0 113.748 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -57.95 -34.58 70.06 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 126.474 1.91 . . . . 0.0 114.88 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.58 -48.5 69.39 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 130.854 3.662 . . . . 0.0 111.086 169.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 10.6 mtt -60.6 -39.6 88.74 Favored 'General case' 0 C--N 1.375 1.708 0 CA-C-N 120.558 1.526 . . . . 0.0 115.002 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.5 -52.14 35.5 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 128.052 2.541 . . . . 0.0 112.743 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -72.54 -34.84 67.81 Favored 'General case' 0 C--N 1.381 1.935 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 178.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.02 84.07 Favored 'General case' 0 C--N 1.371 1.517 0 C-N-CA 124.675 1.19 . . . . 0.0 112.615 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.14 -47.46 86.14 Favored 'General case' 0 C--N 1.378 1.819 0 C-N-CA 125.947 1.699 . . . . 0.0 112.763 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -33.84 76.63 Favored 'General case' 0 C--N 1.369 1.454 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -74.56 -28.77 61.09 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.48 HD21 ' HA ' ' A' ' 152' ' ' THR . 0.6 OUTLIER -77.9 -46.96 19.85 Favored 'General case' 0 CA--C 1.499 -1.01 1 C-N-CA 132.23 4.212 . . . . 0.0 114.105 178.266 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.259 0.0 OUTLIER -89.51 -8.52 52.65 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 125.125 1.37 . . . . 0.0 111.441 -174.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -126.17 -103.63 0.35 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 122.799 0.44 . . . . 0.0 111.342 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.402 ' HB3' HG22 ' A' ' 188' ' ' ILE . 22.9 t70 -136.27 161.3 36.16 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-O 123.51 1.624 . . . . 0.0 112.581 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -51.07 -36.19 38.7 Favored 'General case' 0 C--N 1.358 0.951 1 C-N-CA 136.319 5.847 . . . . 0.0 113.391 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.402 HG22 ' HB3' ' A' ' 186' ' ' ASP . 7.4 tt -55.04 -30.01 23.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 127.937 2.495 . . . . 0.0 113.215 176.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -74.6 -40.77 61.38 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.983 ' HE ' HD11 ' A' ' 109' ' ' LEU 0.266 5.2 ptm180 -74.44 -33.23 62.88 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 175.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.2 mt -82.3 -19.5 39.31 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.949 -1.094 . . . . 0.0 112.1 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -53.45 -43.87 68.44 Favored 'General case' 0 C--N 1.37 1.467 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -31.96 11.0 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 126.122 1.769 . . . . 0.0 109.974 175.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.405 ' C ' HE22 ' A' ' 132' ' ' GLN . . . 41.03 -119.14 0.39 Allowed 'General case' 0 C--N 1.377 1.769 0 C-N-CA 130.903 3.681 . . . . 0.0 114.784 -176.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.827 0 O-C-N 120.035 -1.666 . . . . 0.0 112.505 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.344 80.4 p . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -154.38 94.18 1.68 Allowed 'General case' 0 C--N 1.361 1.104 0 CA-C-O 122.551 1.167 . . . . 0.0 113.107 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -122.75 125.58 45.79 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.44 1.096 . . . . 0.0 109.293 -174.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.464 82.5 p -111.92 170.31 5.41 Favored Pre-proline 0 CA--C 1.558 1.279 1 C-N-CA 132.066 4.147 . . . . 0.0 114.205 -175.043 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 10.5 Cg_endo -53.2 139.49 62.9 Favored 'Trans proline' 0 C--N 1.378 2.117 1 C-N-CA 127.36 5.373 . . . . 0.0 120.054 -162.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.88 -13.82 45.49 Favored Glycine 0 C--N 1.363 2.064 0 CA-C-O 118.668 -1.074 . . . . 0.0 112.321 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.26 169.05 11.15 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 121.084 2.442 . . . . 0.0 112.309 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.633 ' CD2' ' HE ' ' A' ' 190' ' ' ARG . 4.5 mm? -97.72 138.64 34.8 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 101.832 -3.396 . . . . 0.0 101.832 164.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 m -134.03 165.59 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 103.536 -2.765 . . . . 0.0 103.536 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -121.22 116.65 25.31 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 101.174 -3.639 . . . . 0.0 101.174 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.51 128.71 56.54 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 123.667 1.698 . . . . 0.0 112.455 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -99.24 136.6 38.96 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 169.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.407 ' N ' ' CE1' ' A' ' 103' ' ' TYR . 1.2 tpt -121.62 148.04 45.06 Favored 'General case' 0 CA--C 1.511 -0.519 0 O-C-N 118.957 -2.339 . . . . 0.0 105.707 173.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -56.21 83.96 0.01 OUTLIER 'General case' 0 C--N 1.352 0.717 0 C-N-CA 129.107 2.963 . . . . 0.0 116.691 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.09 1.86 25.12 Favored Glycine 0 C--N 1.357 1.737 0 C-N-CA 124.676 1.131 . . . . 0.0 114.61 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.407 ' CE1' ' N ' ' A' ' 100' ' ' MET 0.262 0.0 OUTLIER -105.36 172.33 4.13 Favored Pre-proline 0 C--N 1.361 1.093 0 CA-C-O 116.991 -1.481 . . . . 0.0 109.609 178.246 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.1 165.76 31.65 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.576 3.517 . . . . 0.0 114.151 170.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.0 116.43 6.41 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.457 1.903 . . . . 0.0 112.62 173.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.446 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 10.2 m95 -114.92 127.63 26.65 Favored Pre-proline 0 N--CA 1.426 -1.641 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 -172.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 55.9 Cg_endo -59.01 144.36 99.4 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 124.992 3.795 . . . . 0.0 111.343 154.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 m -156.27 164.67 38.04 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.276 1.43 . . . . 0.0 110.532 -161.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 tt -127.0 136.91 52.89 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 119.565 -1.959 . . . . 0.0 106.367 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.81 117.89 36.07 Favored 'Isoleucine or valine' 0 C--N 1.374 1.669 0 O-C-N 119.983 -1.698 . . . . 0.0 108.148 172.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -121.8 147.87 45.41 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.052 1.341 . . . . 0.0 111.416 -168.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.08 120.39 39.4 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.575 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 6.3 m-70 -62.32 159.41 40.39 Favored Pre-proline 0 C--N 1.363 1.175 0 C-N-CA 128.114 2.566 . . . . 0.0 114.459 -175.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.37 -0.65 0.16 Allowed 'Trans proline' 0 CA--C 1.558 1.675 1 C-N-CA 126.895 5.063 . . . . 0.0 117.053 172.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -106.99 37.82 2.26 Favored 'General case' 0 CA--C 1.551 1.002 1 C-N-CA 134.805 5.242 . . . . 0.0 107.041 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.305 0.0 OUTLIER -71.03 148.65 47.36 Favored 'General case' 0 C--N 1.373 1.602 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -170.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.56 -6.61 31.68 Favored Glycine 0 C--N 1.36 1.914 0 C-N-CA 125.498 1.523 . . . . 0.0 112.223 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.1 t -136.62 151.62 49.53 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 128.338 2.655 . . . . 0.0 104.159 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.467 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 2.1 t80 -160.31 -41.72 0.05 OUTLIER 'General case' 0 C--N 1.363 1.17 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -171.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.614 HG22 HG12 ' A' ' 129' ' ' VAL . 3.2 pt -107.94 146.72 13.58 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 O-C-N 119.626 -1.921 . . . . 0.0 115.058 -171.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -129.71 140.46 51.1 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -146.79 135.86 22.5 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.579 -1.326 . . . . 0.0 109.37 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -117.86 93.21 4.06 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 127.662 2.385 . . . . 0.0 106.863 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.83 -96.68 0.16 Allowed Glycine 0 C--N 1.362 2.013 0 C-N-CA 126.516 2.008 . . . . 0.0 117.767 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -113.49 16.45 18.81 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 126.937 2.095 . . . . 0.0 110.527 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 t -123.91 123.6 40.77 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.95 133.89 68.32 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-O 122.92 1.343 . . . . 0.0 110.366 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -118.09 133.08 56.24 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 127.302 2.241 . . . . 0.0 109.717 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.641 HG11 ' HD3' ' A' ' 145' ' ' LYS . 23.2 m -134.71 164.39 34.14 Favored 'Isoleucine or valine' 0 C--N 1.366 1.322 0 C-N-CA 129.002 2.921 . . . . 0.0 108.281 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.575 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 9.1 m170 -72.21 116.5 12.7 Favored 'General case' 0 C--N 1.372 1.567 0 O-C-N 119.398 -2.064 . . . . 0.0 114.203 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.49 ' HB ' HG21 ' A' ' 143' ' ' VAL . 37.3 t -144.07 141.44 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.847 0 O-C-N 119.171 -2.206 . . . . 0.0 105.121 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.86 140.98 48.7 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 112.022 -2.354 . . . . 0.0 106.323 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.54 133.05 52.57 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 126.152 1.781 . . . . 0.0 106.271 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . 21.5 m-85 -75.66 79.84 2.63 Favored 'General case' 0 C--N 1.372 1.546 0 C-N-CA 124.944 1.298 . . . . 0.0 108.983 177.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -103.53 -106.77 0.28 Allowed 'General case' 0 C--N 1.361 1.091 0 O-C-N 120.708 -1.245 . . . . 0.0 110.576 -174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -106.35 -58.08 1.97 Allowed 'General case' 0 C--N 1.353 0.718 0 C-N-CA 125.319 1.448 . . . . 0.0 111.894 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.2 m -82.77 -37.24 0.74 Allowed Pre-proline 0 C--N 1.362 1.141 0 N-CA-C 119.817 3.266 . . . . 0.0 119.817 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.61 178.48 33.36 Favored 'Cis proline' 0 CA--C 1.543 0.93 1 CA-C-N 128.529 4.082 . . . . 0.0 113.578 1.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.4 m -96.0 138.64 33.35 Favored 'General case' 0 C--N 1.366 1.301 0 C-N-CA 124.743 1.217 . . . . 0.0 109.279 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -155.67 158.97 39.16 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.673 -1.892 . . . . 0.0 106.315 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.7 -158.69 19.39 Favored Glycine 0 CA--C 1.487 -1.668 1 N-CA-C 100.32 -5.112 . . . . 0.0 100.32 170.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -90.36 132.48 35.57 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.49 HG21 ' HB ' ' A' ' 131' ' ' VAL . 2.3 m -99.98 -178.32 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 O-C-N 119.449 -2.032 . . . . 0.0 109.297 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.9 m -100.92 126.59 47.56 Favored 'General case' 0 C--N 1.365 1.272 0 N-CA-C 101.028 -3.693 . . . . 0.0 101.028 166.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.641 ' HD3' HG11 ' A' ' 129' ' ' VAL . 36.6 ttpt -72.23 -20.23 61.58 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -72.17 -6.25 41.41 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.73 3.51 42.33 Favored 'General case' 0 C--N 1.367 1.326 0 C-N-CA 124.48 1.112 . . . . 0.0 110.547 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.432 HD12 ' HG3' ' A' ' 145' ' ' LYS . 24.3 mt -91.8 134.44 34.74 Favored 'General case' 0 C--N 1.368 1.405 0 C-N-CA 125.505 1.522 . . . . 0.0 112.198 176.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -114.74 165.35 14.13 Favored Pre-proline 0 C--N 1.344 0.328 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 170.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.56 155.7 14.0 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.348 3.365 . . . . 0.0 113.714 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -29.04 -78.35 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.964 2 N-CA-C 123.678 4.695 . . . . 0.0 123.678 178.575 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.8 t -33.12 36.34 0.0 OUTLIER 'General case' 0 C--N 1.371 1.523 1 C-N-CA 137.186 6.194 . . . . 0.0 119.318 -175.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -101.49 -48.13 1.45 Allowed Glycine 0 C--N 1.358 1.791 0 C-N-CA 127.884 2.659 . . . . 0.0 118.395 -168.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.9 m -46.48 -11.26 0.02 OUTLIER 'General case' 0 C--N 1.373 1.609 0 N-CA-C 121.182 3.771 . . . . 0.0 121.182 -175.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -122.91 13.46 9.85 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 128.746 2.818 . . . . 0.0 110.434 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.1 t -135.78 162.87 31.57 Favored 'General case' 0 CA--C 1.488 -1.424 0 C-N-CA 124.572 1.149 . . . . 0.0 113.743 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -47.05 -16.75 0.04 OUTLIER 'General case' 0 CA--C 1.489 -1.368 1 C-N-CA 134.586 5.155 . . . . 0.0 119.32 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -95.77 -7.51 36.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 117.182 -1.39 . . . . 0.0 113.081 170.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.89 15.47 3.58 Favored 'General case' 0 C--N 1.386 2.18 0 CA-C-N 122.09 2.223 . . . . 0.0 116.728 -172.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.51 -172.81 2.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 130.158 3.383 . . . . 0.0 105.975 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -71.0 122.11 19.42 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 118.971 -2.33 . . . . 0.0 112.813 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.88 -5.72 47.08 Favored Glycine 0 C--N 1.362 2.001 0 C-N-CA 125.461 1.505 . . . . 0.0 112.105 -170.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.12 154.35 50.67 Favored Glycine 0 C--N 1.371 2.51 1 C-N-CA 130.757 4.027 . . . . 0.0 117.717 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -67.78 -42.31 81.89 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 127.381 2.273 . . . . 0.0 116.179 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.57 -4.62 53.17 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 125.16 1.384 . . . . 0.0 112.196 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -82.81 94.2 7.6 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.0 m -118.73 108.38 14.81 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 100.758 -3.793 . . . . 0.0 100.758 167.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.51 101.1 13.78 Favored 'General case' 0 C--N 1.367 1.339 0 CA-C-O 126.132 2.872 . . . . 0.0 110.764 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -119.73 146.17 41.02 Favored Pre-proline 0 N--CA 1.424 -1.766 0 C-N-CA 131.171 3.788 . . . . 0.0 101.167 171.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.96 -38.81 86.58 Favored 'Trans proline' 0 C--N 1.352 0.725 1 C-N-CA 126.388 4.725 . . . . 0.0 115.307 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.46 -42.48 74.83 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.493 1.517 . . . . 0.0 113.655 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.7 mt -64.64 -46.88 91.1 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 C-N-CA 126.143 1.777 . . . . 0.0 111.901 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.427 ' O ' ' HG2' ' A' ' 177' ' ' GLN 0.304 3.9 pp -68.51 -32.38 72.3 Favored 'General case' 0 C--N 1.368 1.407 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 174.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -69.33 -39.25 78.29 Favored 'General case' 0 C--N 1.372 1.576 0 C-N-CA 128.612 2.765 . . . . 0.0 113.997 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 134' ' ' PHE . . . -69.32 -34.55 74.83 Favored 'General case' 0 N--CA 1.431 -1.397 1 C-N-CA 131.843 4.057 . . . . 0.0 110.818 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 44.8 mtt -69.22 -33.38 73.22 Favored 'General case' 0 C--N 1.372 1.555 0 C-N-CA 127.915 2.486 . . . . 0.0 112.517 163.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 173' ' ' LEU . 57.6 mm-40 -72.57 -45.04 61.12 Favored 'General case' 0 C--N 1.385 2.143 0 C-N-CA 127.272 2.229 . . . . 0.0 112.124 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -66.45 -49.41 66.76 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 130.182 3.393 . . . . 0.0 110.362 173.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.65 83.56 Favored 'General case' 0 C--N 1.379 1.856 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.23 -47.14 69.24 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.98 2.112 . . . . 0.0 113.947 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -49.62 58.0 Favored 'General case' 0 C--N 1.359 1.008 0 O-C-N 120.309 -1.495 . . . . 0.0 114.578 173.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 190' ' ' ARG . . . -69.6 -30.43 68.18 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.4 pp -76.44 -40.02 51.78 Favored 'General case' 0 C--N 1.367 1.352 0 C-N-CA 126.517 1.927 . . . . 0.0 115.196 176.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -11.49 55.63 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.918 1.687 . . . . 0.0 111.204 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -114.14 -107.71 0.37 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -135.68 168.77 18.65 Favored 'General case' 0 C--N 1.364 1.208 0 O-C-N 120.247 -1.533 . . . . 0.0 112.739 -171.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.617 ' HA ' HH11 ' A' ' 190' ' ' ARG . 39.8 mmtm -55.51 -40.82 72.27 Favored 'General case' 0 C--N 1.386 2.196 0 C-N-CA 130.476 3.51 . . . . 0.0 114.163 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.99 -31.95 42.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 129.124 2.97 . . . . 0.0 113.914 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -74.48 -40.87 61.57 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 125.231 1.412 . . . . 0.0 114.405 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.633 ' HE ' ' CD2' ' A' ' 95' ' ' LEU 0.276 0.1 OUTLIER -74.94 -39.67 61.25 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 119.999 -1.688 . . . . 0.0 114.311 169.558 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.16 -21.16 64.01 Favored 'General case' 0 C--N 1.381 1.956 0 C-N-CA 128.205 2.602 . . . . 0.0 113.606 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -66.52 -32.01 73.09 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 130.124 3.37 . . . . 0.0 114.73 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mt -105.67 -47.04 4.0 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.366 2.266 . . . . 0.0 108.358 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 50.15 -112.81 0.61 Allowed 'General case' 0 C--N 1.368 1.394 0 C-N-CA 129.191 2.997 . . . . 0.0 114.803 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 22.0 m . . . . . 0 C--N 1.342 0.281 0 C-N-CA 126.478 1.911 . . . . 0.0 111.421 178.902 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.3 p . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -157.99 65.85 0.46 Allowed 'General case' 0 C--N 1.355 0.82 0 C-N-CA 124.078 0.951 . . . . 0.0 108.934 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -118.29 124.68 48.41 Favored 'General case' 0 C--N 1.363 1.192 0 O-C-N 118.987 -2.32 . . . . 0.0 114.202 -172.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.44 17.2 p -112.96 169.45 6.35 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 131.114 3.766 . . . . 0.0 114.602 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -49.37 129.45 22.74 Favored 'Trans proline' 0 C--N 1.376 1.986 1 C-N-CA 128.006 5.804 . . . . 0.0 119.087 -169.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.52 -12.42 21.1 Favored Glycine 0 CA--C 1.482 -1.993 0 C-N-CA 124.438 1.018 . . . . 0.0 111.309 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.03 159.99 14.92 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.206 -1.761 . . . . 0.0 108.247 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.42 140.31 36.87 Favored 'General case' 0 C--N 1.344 0.354 1 N-CA-C 99.998 -4.075 . . . . 0.0 99.998 166.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.37 147.36 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 102.667 -3.086 . . . . 0.0 102.667 -171.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -99.93 119.29 38.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.92 136.34 48.63 Favored 'General case' 0 C--N 1.359 1.012 0 CA-C-N 119.862 1.21 . . . . 0.0 111.559 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -108.97 141.31 41.25 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.0 ttp -129.59 149.84 51.18 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 119.311 -2.118 . . . . 0.0 108.932 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -65.6 89.66 0.11 Allowed 'General case' 0 C--N 1.363 1.193 0 C-N-CA 127.103 2.161 . . . . 0.0 115.032 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.24 -3.07 25.29 Favored Glycine 0 C--N 1.357 1.746 0 C-N-CA 125.873 1.701 . . . . 0.0 112.786 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -100.97 163.33 18.2 Favored Pre-proline 0 C--N 1.354 0.782 0 C-N-CA 126.573 1.949 . . . . 0.0 109.773 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.04 165.9 31.22 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.627 2.885 . . . . 0.0 112.666 164.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.515 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 1.6 m95 -66.36 130.55 43.6 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 128.6 2.76 . . . . 0.0 111.053 170.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -129.83 138.94 34.21 Favored Pre-proline 0 N--CA 1.415 -2.196 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.09 132.12 17.68 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 123.313 2.675 . . . . 0.0 107.896 147.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.6 m -135.66 166.51 23.07 Favored 'General case' 0 C--N 1.345 0.398 1 C-N-CA 132.121 4.168 . . . . 0.0 110.485 -166.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 5.9 tt -123.68 133.01 53.97 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 119.155 -2.216 . . . . 0.0 110.299 177.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.613 HG23 HG12 ' A' ' 131' ' ' VAL . 7.4 p -92.14 118.64 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 CA-C-N 122.271 2.305 . . . . 0.0 110.146 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.68 153.44 48.97 Favored 'General case' 0 C--N 1.372 1.583 0 C-N-CA 127.238 2.215 . . . . 0.0 112.484 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -78.64 112.55 15.85 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 129.473 3.109 . . . . 0.0 114.062 170.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.446 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 22.5 t60 -90.75 159.58 40.33 Favored Pre-proline 0 C--N 1.373 1.624 0 CA-C-O 114.301 -2.761 . . . . 0.0 109.181 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.446 ' HD2' ' CG ' ' A' ' 113' ' ' HIS 0.265 53.0 Cg_exo -47.54 0.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.861 2 C-N-CA 129.021 6.481 . . . . 0.0 122.536 -166.519 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -102.48 40.56 1.34 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.164 2.586 . . . . 0.0 104.981 168.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.12 118.9 7.39 Favored 'General case' 0 C--N 1.379 1.862 0 C-N-CA 127.493 2.317 . . . . 0.0 114.275 -170.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.96 -19.9 27.18 Favored Glycine 0 C--N 1.356 1.656 0 C-N-CA 125.424 1.487 . . . . 0.0 110.534 -165.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.8 m -104.8 120.21 40.85 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 172.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -135.77 -43.15 0.67 Allowed 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 119.547 1.067 . . . . 0.0 113.531 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 pt -100.03 173.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-O 122.345 1.069 . . . . 0.0 113.875 -174.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -159.0 148.26 18.72 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -147.36 127.05 13.37 Favored 'General case' 0 C--N 1.363 1.193 0 O-C-N 120.071 -1.643 . . . . 0.0 110.3 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -118.29 93.75 4.24 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.601 1.96 . . . . 0.0 110.526 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.02 -76.79 0.23 Allowed Glycine 0 C--N 1.36 1.893 0 N-CA-C 120.391 2.916 . . . . 0.0 120.391 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -139.27 52.49 1.75 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 125.198 1.399 . . . . 0.0 110.657 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.4 m -174.22 146.08 1.09 Allowed 'General case' 0 C--N 1.356 0.852 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.43 139.86 50.27 Favored 'Isoleucine or valine' 0 C--N 1.362 1.111 0 CA-C-O 122.129 0.966 . . . . 0.0 111.362 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -113.56 161.77 17.0 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 126.889 2.076 . . . . 0.0 113.628 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 145' ' ' LYS . 14.0 m -149.35 163.3 4.29 Favored 'Isoleucine or valine' 0 C--N 1.369 1.431 1 C-N-CA 133.024 4.53 . . . . 0.0 103.749 175.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -97.44 127.64 43.56 Favored 'General case' 0 C--N 1.366 1.293 0 O-C-N 121.001 -1.062 . . . . 0.0 111.204 167.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.613 HG12 HG23 ' A' ' 110' ' ' VAL . 1.6 m -146.02 171.65 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.503 HE21 ' CG2' ' A' ' 195' ' ' VAL . 0.1 OUTLIER -131.93 146.51 52.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.43 1.092 . . . . 0.0 109.063 179.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -93.31 132.26 37.68 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 129.992 3.317 . . . . 0.0 107.534 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 7.4 m-30 -76.03 65.21 2.03 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 124.292 1.996 . . . . 0.0 113.509 -176.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -89.45 -109.49 0.08 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 128.891 2.876 . . . . 0.0 110.146 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.23 -52.12 2.81 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.87 1.668 . . . . 0.0 113.902 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.6 m -80.92 -41.07 1.15 Allowed Pre-proline 0 C--N 1.364 1.205 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -172.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.77 169.59 74.09 Favored 'Cis proline' 0 CA--C 1.543 0.953 0 CA-C-N 126.303 3.287 . . . . 0.0 114.259 -1.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.3 m -85.68 125.44 33.19 Favored 'General case' 0 C--N 1.366 1.302 0 C-N-CA 126.413 1.885 . . . . 0.0 110.539 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.486 ' HG2' ' H ' ' A' ' 141' ' ' GLY . 0.5 OUTLIER -117.87 174.84 5.96 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 125.225 1.41 . . . . 0.0 111.219 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.486 ' H ' ' HG2' ' A' ' 140' ' ' ARG . . . 169.14 -160.19 33.48 Favored Glycine 0 CA--C 1.487 -1.715 1 N-CA-C 97.852 -6.099 . . . . 0.0 97.852 171.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.5 m95 -96.95 155.8 16.62 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.0 m -119.92 173.14 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 C-N-CA 124.246 1.018 . . . . 0.0 108.566 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.0 t -84.19 123.58 30.25 Favored 'General case' 0 C--N 1.369 1.443 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 164.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.438 ' HB2' HG22 ' A' ' 129' ' ' VAL . 15.8 ttpp -73.38 -25.16 60.45 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 120.904 -1.123 . . . . 0.0 111.995 -175.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -73.22 -9.42 58.69 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 125.246 1.418 . . . . 0.0 114.519 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.3 mt -100.11 6.07 44.91 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 125.448 1.499 . . . . 0.0 111.577 172.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.8 mt -100.4 132.23 45.9 Favored 'General case' 0 C--N 1.371 1.538 0 C-N-CA 125.366 1.466 . . . . 0.0 108.403 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 149' ' ' LYS . 4.9 mtmp? -114.74 164.89 15.23 Favored Pre-proline 0 CA--C 1.506 -0.735 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.22 156.31 14.76 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.803 2.335 . . . . 0.0 113.409 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -34.09 -107.67 0.0 OUTLIER 'General case' 0 C--N 1.351 0.631 1 C-N-CA 132.888 4.475 . . . . 0.0 120.606 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.392 4.0 t 53.3 -42.94 0.02 OUTLIER 'General case' 0 C--N 1.371 1.505 1 C-N-CA 131.727 4.011 . . . . 0.0 118.927 174.408 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.59 -150.88 30.25 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 121.916 3.527 . . . . 0.0 121.916 159.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.6 m -45.87 -11.87 0.02 OUTLIER 'General case' 0 C--N 1.374 1.637 1 C-N-CA 134.952 5.301 . . . . 0.0 118.864 -175.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -88.67 -14.0 38.42 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 129.276 3.03 . . . . 0.0 111.747 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.4 t -75.98 153.94 36.19 Favored 'General case' 0 C--N 1.377 1.781 0 C-N-CA 126.102 1.761 . . . . 0.0 112.05 171.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -72.12 -26.93 62.31 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.869 1.668 . . . . 0.0 111.98 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -79.39 -17.4 54.47 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 124.352 1.061 . . . . 0.0 111.902 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.33 4.61 48.65 Favored 'General case' 0 C--N 1.368 1.373 0 C-N-CA 126.172 1.789 . . . . 0.0 114.08 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -122.72 177.51 5.42 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 124.653 1.181 . . . . 0.0 109.135 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.33 122.58 14.89 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 126.968 2.107 . . . . 0.0 113.829 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.68 -14.58 53.41 Favored Glycine 0 C--N 1.357 1.708 0 C-N-CA 124.891 1.234 . . . . 0.0 111.615 -168.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.45 153.73 32.14 Favored Glycine 0 C--N 1.359 1.81 0 N-CA-C 119.266 2.467 . . . . 0.0 119.266 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -63.07 -42.5 99.67 Favored 'General case' 0 C--N 1.365 1.239 0 N-CA-C 118.694 2.85 . . . . 0.0 118.694 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.515 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.286 0.4 OUTLIER -101.99 -0.03 34.38 Favored 'General case' 0 C--N 1.359 1.018 0 O-C-N 120.618 -1.301 . . . . 0.0 112.675 -179.139 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -78.64 141.62 37.84 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 126.846 2.058 . . . . 0.0 111.427 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 50.9 m -171.27 150.91 3.02 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 101.06 -3.681 . . . . 0.0 101.06 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -129.67 102.52 6.38 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-O 125.409 2.528 . . . . 0.0 113.544 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -119.68 140.22 29.12 Favored Pre-proline 0 N--CA 1.43 -1.443 2 C-N-CA 134.02 4.928 . . . . 0.0 100.114 168.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . 0.319 92.0 Cg_endo -64.45 -17.95 61.36 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.766 3.644 . . . . 0.0 117.502 -174.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -69.96 -36.06 74.96 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 129.541 3.137 . . . . 0.0 111.67 170.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 31.4 mt -73.03 -32.73 40.54 Favored 'Isoleucine or valine' 0 C--N 1.372 1.576 0 C-N-CA 127.604 2.361 . . . . 0.0 110.402 175.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 41.0 mt -65.05 -49.81 68.65 Favored 'General case' 0 C--N 1.378 1.823 0 C-N-CA 126.55 1.94 . . . . 0.0 110.307 169.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -57.53 -34.58 69.28 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 125.209 1.404 . . . . 0.0 114.184 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.22 -48.35 62.21 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 129.963 3.305 . . . . 0.0 114.304 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.7 mtt -69.64 -33.3 72.43 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 120.991 1.723 . . . . 0.0 113.383 172.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -70.13 -52.39 23.99 Favored 'General case' 0 C--N 1.377 1.784 0 C-N-CA 127.056 2.142 . . . . 0.0 112.028 174.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.402 ' HG3' ' CE2' ' A' ' 134' ' ' PHE 0.267 6.1 ptt180 -71.29 -36.52 71.7 Favored 'General case' 0 C--N 1.382 1.998 0 O-C-N 119.485 -2.009 . . . . 0.0 113.842 176.01 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.4 -50.03 67.03 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.542 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -55.06 -39.22 68.98 Favored 'General case' 0 C--N 1.386 2.18 0 CA-C-N 121.96 2.164 . . . . 0.0 113.542 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -52.32 24.97 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 119.735 -1.853 . . . . 0.0 114.6 170.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 190' ' ' ARG . . . -61.62 -33.51 74.04 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.56 -35.37 34.44 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 126.615 1.966 . . . . 0.0 115.143 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.352 0.0 OUTLIER -91.1 -21.03 21.41 Favored 'General case' 0 C--N 1.367 1.327 0 O-C-N 121.309 -0.869 . . . . 0.0 110.735 -173.613 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -101.85 -110.94 0.22 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 123.348 0.659 . . . . 0.0 112.048 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -135.36 161.86 34.22 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 119.949 -1.72 . . . . 0.0 110.058 -174.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -51.26 -36.94 44.5 Favored 'General case' 0 C--N 1.373 1.608 0 C-N-CA 131.217 3.807 . . . . 0.0 115.216 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -40.09 34.99 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 C-N-CA 130.639 3.576 . . . . 0.0 112.836 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -32.44 69.3 Favored 'General case' 0 C--N 1.37 1.475 0 C-N-CA 125.483 1.513 . . . . 0.0 113.617 176.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.585 ' HB3' ' HB1' ' A' ' 182' ' ' ALA 0.25 0.0 OUTLIER -74.02 -37.2 64.42 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 174.084 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.265 3.9 mt -78.49 -19.28 53.39 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 126.888 2.075 . . . . 0.0 114.855 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -69.65 -24.46 63.63 Favored 'General case' 0 C--N 1.368 1.388 0 O-C-N 120.961 -1.087 . . . . 0.0 113.079 167.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.86 22.45 15.58 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 131.392 3.877 . . . . 0.0 111.431 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.37 -177.99 2.81 Favored 'General case' 0 C--N 1.374 1.633 0 C-N-CA 128.796 2.838 . . . . 0.0 115.03 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.503 ' CG2' HE21 ' A' ' 132' ' ' GLN . 44.6 t . . . . . 0 C--N 1.363 1.183 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.511 -0.531 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -133.31 89.6 2.62 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.176 1.391 . . . . 0.0 112.762 -171.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -123.16 126.65 47.4 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 120.913 -1.117 . . . . 0.0 110.587 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.334 64.4 p -111.59 168.98 6.81 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 129.039 2.936 . . . . 0.0 116.433 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -50.66 137.06 41.98 Favored 'Trans proline' 0 C--N 1.367 1.5 1 C-N-CA 126.854 5.036 . . . . 0.0 122.084 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.63 -12.66 56.61 Favored Glycine 0 C--N 1.37 2.456 0 C-N-CA 128.371 2.891 . . . . 0.0 111.139 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.42 169.87 10.04 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.056 2.542 . . . . 0.0 111.449 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.52 143.73 44.49 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 119.151 -2.218 . . . . 0.0 105.477 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 m -142.88 158.68 18.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -101.75 128.52 48.05 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 100.834 -3.765 . . . . 0.0 100.834 167.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.44 141.38 48.61 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 125.341 1.456 . . . . 0.0 112.234 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -120.76 139.88 52.47 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 120.034 -1.666 . . . . 0.0 106.996 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 42.3 ttm -129.32 151.3 50.12 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 120.049 -1.657 . . . . 0.0 107.76 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -72.05 110.96 6.88 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 125.856 1.662 . . . . 0.0 110.546 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.09 -16.34 22.77 Favored Glycine 0 C--N 1.359 1.859 0 C-N-CA 125.073 1.321 . . . . 0.0 112.12 -174.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -114.36 157.95 41.15 Favored Pre-proline 0 C--N 1.356 0.853 0 C-N-CA 125.287 1.435 . . . . 0.0 108.99 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.34 166.54 29.47 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 124.448 3.432 . . . . 0.0 112.484 163.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.585 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.0 m95 -51.52 114.54 1.27 Allowed 'General case' 0 C--N 1.365 1.268 0 C-N-CA 127.705 2.402 . . . . 0.0 114.625 167.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.534 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 4.4 m95 -118.7 108.22 41.48 Favored Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 119.176 3.028 . . . . 0.0 119.176 -172.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 23.5 Cg_endo -54.3 118.46 5.06 Favored 'Trans proline' 0 C--N 1.373 1.846 1 C-N-CA 125.678 4.252 . . . . 0.0 112.498 162.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.2 m -132.91 164.97 25.75 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 127.145 2.178 . . . . 0.0 114.226 -159.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.718 HD22 ' HE ' ' A' ' 190' ' ' ARG . 2.2 pp -116.28 147.49 41.46 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 169.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.55 120.93 42.68 Favored 'Isoleucine or valine' 0 C--N 1.369 1.417 0 O-C-N 120.831 -1.168 . . . . 0.0 109.217 172.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -139.83 152.88 46.86 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 120.103 -1.623 . . . . 0.0 112.24 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -89.6 112.1 23.23 Favored 'General case' 0 C--N 1.369 1.416 0 C-N-CA 129.25 3.02 . . . . 0.0 109.514 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 130' ' ' HIS . 69.3 t60 -73.69 159.34 84.68 Favored Pre-proline 0 C--N 1.36 1.027 0 C-N-CA 127.73 2.412 . . . . 0.0 114.716 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 113' ' ' HIS . 10.1 Cg_endo -48.97 -1.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.558 1.697 1 C-N-CA 127.077 5.184 . . . . 0.0 119.079 174.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -104.4 35.11 2.83 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 128.305 2.642 . . . . 0.0 107.444 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -68.62 158.14 34.66 Favored 'General case' 0 C--N 1.367 1.331 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -171.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.6 -20.64 27.11 Favored Glycine 0 C--N 1.359 1.855 0 CA-C-N 112.493 -2.14 . . . . 0.0 109.669 171.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -124.58 119.26 28.56 Favored 'General case' 0 N--CA 1.438 -1.05 1 N-CA-C 99.252 -4.351 . . . . 0.0 99.252 164.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.557 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 20.3 p90 -118.83 -3.4 10.76 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.223 -0.923 . . . . 0.0 108.947 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.8 HG22 HG12 ' A' ' 129' ' ' VAL . 7.3 pt -112.77 166.6 6.6 Favored 'Isoleucine or valine' 0 C--N 1.364 1.201 0 C-N-CA 127.367 2.267 . . . . 0.0 112.036 -174.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.4 ' HE ' ' HD2' ' A' ' 128' ' ' ARG . 45.6 ttp180 -158.57 147.36 18.77 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 103.871 -2.641 . . . . 0.0 103.871 176.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -145.53 126.76 14.79 Favored 'General case' 0 C--N 1.359 1.017 0 O-C-N 119.568 -1.958 . . . . 0.0 109.11 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -117.97 93.6 4.2 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 127.184 2.193 . . . . 0.0 110.241 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.42 -71.16 0.1 OUTLIER Glycine 0 C--N 1.36 1.88 0 N-CA-C 120.97 3.148 . . . . 0.0 120.97 172.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -143.6 51.2 1.35 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-O 122.648 1.213 . . . . 0.0 111.138 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.5 m -177.3 143.26 0.37 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.5 p -117.17 136.28 54.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.058 0 CA-C-O 122.79 1.281 . . . . 0.0 110.127 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.4 ' HD2' ' HE ' ' A' ' 121' ' ' ARG . 14.7 mtt-85 -113.67 144.46 42.89 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.715 2.806 . . . . 0.0 107.075 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.8 HG12 HG22 ' A' ' 120' ' ' ILE . 12.0 m -146.66 162.7 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 177.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.557 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 3.2 p-80 -96.58 134.71 39.46 Favored 'General case' 0 C--N 1.363 1.153 0 CA-C-O 123.598 1.666 . . . . 0.0 110.05 172.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 p -125.89 163.64 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 101.599 -3.482 . . . . 0.0 101.599 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.72 33.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -86.28 129.36 34.88 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.014 3.325 . . . . 0.0 110.283 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.9 75.79 2.81 Favored 'General case' 0 C--N 1.371 1.506 0 CA-C-N 120.511 1.505 . . . . 0.0 114.114 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.07 -104.38 0.1 Allowed 'General case' 0 C--N 1.368 1.384 0 C-N-CA 124.678 1.191 . . . . 0.0 108.569 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -107.22 -56.18 2.24 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.987 2.115 . . . . 0.0 113.825 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.83 -44.92 2.41 Favored Pre-proline 0 C--N 1.368 1.401 0 N-CA-C 119.575 3.176 . . . . 0.0 119.575 -172.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -82.05 177.77 32.57 Favored 'Cis proline' 0 CA--C 1.546 1.088 0 CA-C-N 126.492 3.354 . . . . 0.0 114.058 3.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.9 m -94.84 134.56 37.34 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 125.189 1.396 . . . . 0.0 110.717 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.406 ' HE ' ' CE1' ' A' ' 113' ' ' HIS . 5.8 tmm_? -117.31 148.11 41.99 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 125.656 1.583 . . . . 0.0 110.401 177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -160.47 167.52 35.71 Favored Glycine 0 CA--C 1.486 -1.734 1 N-CA-C 103.035 -4.026 . . . . 0.0 103.035 169.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -88.13 122.01 31.2 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 124.776 2.226 . . . . 0.0 108.329 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.06 168.01 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 129.089 2.955 . . . . 0.0 108.545 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.5 m -91.46 130.12 37.34 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 102.425 -3.176 . . . . 0.0 102.425 168.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.588 ' HD3' HG11 ' A' ' 129' ' ' VAL . 32.4 ttpt -74.69 -15.58 60.79 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-O 122.921 1.343 . . . . 0.0 114.108 -170.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -72.64 -2.98 22.14 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.701 1.601 . . . . 0.0 115.136 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.6 mt -107.04 10.31 30.33 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 125.187 1.395 . . . . 0.0 110.468 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.538 HD12 ' HG3' ' A' ' 145' ' ' LYS . 11.4 mt -98.96 124.24 43.8 Favored 'General case' 0 C--N 1.374 1.657 0 C-N-CA 125.588 1.555 . . . . 0.0 107.258 174.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -116.24 151.28 46.58 Favored Pre-proline 0 CA--C 1.501 -0.924 0 O-C-N 119.921 -1.737 . . . . 0.0 108.306 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.13 123.73 4.63 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.845 2.364 . . . . 0.0 112.184 -167.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.34 108.5 19.93 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -171.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.773 ' HA ' HD13 ' A' ' 183' ' ' LEU . 9.1 t -150.42 26.88 0.76 Allowed 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -167.38 80.7 0.1 Allowed Glycine 0 C--N 1.355 1.61 0 C-N-CA 116.061 -2.971 . . . . 0.0 118.862 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.4 t -68.29 -11.9 60.17 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 126.921 2.088 . . . . 0.0 115.988 170.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -122.75 35.0 4.98 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 127.884 2.474 . . . . 0.0 107.645 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.2 t -104.96 142.44 34.78 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 126.316 1.847 . . . . 0.0 106.422 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.27 27.3 ttpt -52.76 -36.91 58.68 Favored 'General case' 0 C--N 1.369 1.442 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -171.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -18.48 61.97 Favored 'General case' 0 C--N 1.37 1.48 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 169.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.66 5.15 49.74 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.257 1.8 pp0? -129.41 -174.95 3.43 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.635 -1.916 . . . . 0.0 110.352 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.3 122.01 15.13 Favored 'General case' 0 C--N 1.368 1.396 0 O-C-N 120.444 -1.41 . . . . 0.0 113.686 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.37 -9.95 61.17 Favored Glycine 0 C--N 1.359 1.839 0 C-N-CA 124.365 0.983 . . . . 0.0 111.674 -167.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.92 160.3 44.63 Favored Glycine 0 C--N 1.366 2.202 0 C-N-CA 125.985 1.755 . . . . 0.0 116.846 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.53 -42.72 74.28 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -174.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.585 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.267 0.1 OUTLIER -99.42 5.06 46.41 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 120.245 -1.534 . . . . 0.0 114.377 -178.936 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -85.61 92.94 8.69 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.164 2.585 . . . . 0.0 114.284 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.4 m -113.86 110.23 19.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 170.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.97 101.5 14.21 Favored 'General case' 0 C--N 1.359 1.014 0 CA-C-O 126.127 2.87 . . . . 0.0 113.486 -170.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -120.47 150.5 52.17 Favored Pre-proline 0 N--CA 1.422 -1.854 1 C-N-CA 133.93 4.892 . . . . 0.0 102.915 171.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.486 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 58.7 Cg_endo -60.41 -32.38 93.8 Favored 'Trans proline' 0 CA--C 1.554 1.478 1 C-N-CA 126.652 4.901 . . . . 0.0 115.037 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -67.27 -35.16 78.93 Favored 'General case' 0 C--N 1.364 1.202 0 C-N-CA 130.059 3.344 . . . . 0.0 113.256 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.534 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 8.0 mm -72.17 -36.2 55.53 Favored 'Isoleucine or valine' 0 C--N 1.372 1.577 0 C-N-CA 127.235 2.214 . . . . 0.0 110.049 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 170' ' ' PRO . 2.9 mt -64.0 -53.83 43.87 Favored 'General case' 0 C--N 1.384 2.066 0 C-N-CA 126.428 1.891 . . . . 0.0 110.882 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -57.39 -33.87 68.28 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 129.143 2.977 . . . . 0.0 114.447 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.409 ' CB ' ' HG2' ' A' ' 107' ' ' PRO . . . -68.87 -44.67 72.81 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 130.079 3.352 . . . . 0.0 111.617 172.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 37.9 mtm -65.69 -35.74 81.62 Favored 'General case' 0 C--N 1.37 1.473 0 C-N-CA 125.102 1.361 . . . . 0.0 114.456 167.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 5.4 mt-30 -74.49 -48.33 27.91 Favored 'General case' 0 C--N 1.378 1.844 0 C-N-CA 125.518 1.527 . . . . 0.0 112.434 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -65.23 -46.54 80.19 Favored 'General case' 0 C--N 1.371 1.51 0 C-N-CA 129.251 3.02 . . . . 0.0 112.705 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.43 84.32 Favored 'General case' 0 C--N 1.375 1.707 0 O-C-N 120.599 -1.313 . . . . 0.0 112.688 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.527 ' O ' ' HB3' ' A' ' 184' ' ' ASN 0.333 35.3 t70 -64.55 -31.35 72.53 Favored 'General case' 0 C--N 1.378 1.81 0 C-N-CA 125.969 1.708 . . . . 0.0 111.857 175.059 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -76.45 -33.38 58.76 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 118.362 -2.711 . . . . 0.0 113.79 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.24 -36.83 58.31 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 118.64 2.83 . . . . 0.0 118.64 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 152' ' ' THR . 4.1 pp -79.87 -36.45 36.59 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 119.901 -1.749 . . . . 0.0 114.704 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -85.92 -17.78 34.53 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 127.201 2.201 . . . . 0.0 110.839 -176.103 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -117.51 -105.09 0.4 Allowed 'General case' 0 C--N 1.359 1.014 0 CA-C-O 121.791 0.805 . . . . 0.0 110.781 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -129.12 146.93 50.95 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.618 1.199 . . . . 0.0 108.331 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -50.31 -36.19 30.79 Favored 'General case' 0 C--N 1.357 0.924 1 C-N-CA 134.111 4.965 . . . . 0.0 113.826 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 14.9 tt -51.99 -37.18 21.06 Favored 'Isoleucine or valine' 0 C--N 1.37 1.489 0 C-N-CA 128.918 2.887 . . . . 0.0 112.174 171.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.328 2.8 mptp? -64.1 -31.29 72.43 Favored 'General case' 0 C--N 1.371 1.502 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 176.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.718 ' HE ' HD22 ' A' ' 109' ' ' LEU 0.411 0.0 OUTLIER -75.26 -42.2 55.64 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-N 121.327 1.876 . . . . 0.0 112.283 165.132 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.7 tp -57.39 -22.6 43.9 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 129.031 2.932 . . . . 0.0 117.595 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -73.9 -13.13 60.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.997 2.519 . . . . 0.0 113.953 170.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.13 22.76 15.16 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 130.562 3.545 . . . . 0.0 112.093 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.0 118.28 5.63 Favored 'General case' 0 C--N 1.371 1.535 0 C-N-CA 129.574 3.149 . . . . 0.0 116.141 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.373 1.594 0 C-N-CA 128.637 2.775 . . . . 0.0 113.174 -179.675 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 83.1 p . . . . . 0 N--CA 1.461 0.105 0 CA-C-O 121.808 0.813 . . . . 0.0 110.046 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.71 72.15 1.26 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 125.306 1.442 . . . . 0.0 108.967 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 59.9 m-85 -116.71 127.11 54.09 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 120.602 -1.311 . . . . 0.0 112.106 -172.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 p -112.0 167.72 8.7 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 127.82 2.448 . . . . 0.0 117.113 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -54.39 129.11 32.97 Favored 'Trans proline' 0 C--N 1.371 1.725 1 C-N-CA 126.943 5.096 . . . . 0.0 116.779 -176.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.8 -16.17 58.85 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 125.418 1.485 . . . . 0.0 112.68 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -92.71 154.3 18.41 Favored 'General case' 0 C--N 1.367 1.36 0 CA-C-N 119.71 1.755 . . . . 0.0 110.859 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.583 HD13 HH21 ' A' ' 190' ' ' ARG . 3.3 mm? -98.44 144.61 27.61 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 119.303 -2.123 . . . . 0.0 109.047 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.1 m -136.8 158.17 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 C-N-CA 125.333 1.453 . . . . 0.0 109.994 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -105.76 119.82 40.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 101.035 -3.691 . . . . 0.0 101.035 167.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.82 144.47 34.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.337 1.855 . . . . 0.0 113.388 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -120.22 135.81 54.86 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.2 ttp -128.63 144.41 51.15 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 119.526 -1.983 . . . . 0.0 108.833 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -64.7 94.64 0.13 Allowed 'General case' 0 C--N 1.368 1.386 0 C-N-CA 126.445 1.898 . . . . 0.0 115.22 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.57 -5.12 24.64 Favored Glycine 0 C--N 1.359 1.817 0 C-N-CA 126.392 1.949 . . . . 0.0 113.01 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -104.64 159.98 27.52 Favored Pre-proline 0 C--N 1.357 0.913 0 C-N-CA 126.001 1.72 . . . . 0.0 109.967 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.44 166.63 29.25 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 123.682 2.921 . . . . 0.0 112.221 162.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.613 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.6 m95 -59.72 123.92 18.49 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 127.644 2.378 . . . . 0.0 114.799 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -127.27 108.54 21.39 Favored Pre-proline 0 N--CA 1.433 -1.305 1 N-CA-C 122.013 4.079 . . . . 0.0 122.013 -168.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.22 133.49 46.94 Favored 'Trans proline' 0 C--N 1.39 2.741 1 C-N-CA 125.968 4.446 . . . . 0.0 111.366 165.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.5 p -155.81 163.68 39.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 125.011 2.339 . . . . 0.0 115.743 -157.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 5.1 tt -101.06 129.99 47.01 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 129.172 2.989 . . . . 0.0 108.151 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.449 ' H ' HH22 ' A' ' 190' ' ' ARG . 31.2 t -87.49 118.81 34.07 Favored 'Isoleucine or valine' 0 C--N 1.378 1.846 0 CA-C-N 120.722 1.601 . . . . 0.0 107.007 173.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -116.57 154.16 30.95 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -164.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -119.4 112.67 19.7 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -83.44 159.09 62.34 Favored Pre-proline 0 C--N 1.348 0.528 0 C-N-CA 129.879 3.271 . . . . 0.0 110.647 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.32 0.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.799 1 C-N-CA 128.632 6.222 . . . . 0.0 119.973 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -95.21 28.2 2.94 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 131.191 3.796 . . . . 0.0 107.249 166.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.271 0.0 OUTLIER -73.79 161.07 30.59 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 127.185 2.194 . . . . 0.0 115.945 -173.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.95 -20.26 36.41 Favored Glycine 0 C--N 1.362 2.002 0 C-N-CA 126.666 2.079 . . . . 0.0 111.33 -174.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 p -135.87 136.18 40.34 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 130.681 3.592 . . . . 0.0 103.087 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -132.79 -3.75 3.24 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 120.206 1.366 . . . . 0.0 113.293 -175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.3 pt -110.73 150.38 13.23 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 123.073 1.416 . . . . 0.0 111.324 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.91 141.82 36.5 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 128.041 2.536 . . . . 0.0 104.227 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -145.67 126.6 14.51 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 120.939 -1.1 . . . . 0.0 109.013 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -109.42 93.55 4.56 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.33 -63.06 1.41 Allowed Glycine 0 C--N 1.362 2.011 0 C-N-CA 127.829 2.633 . . . . 0.0 115.852 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -144.64 -5.41 0.73 Allowed 'General case' 0 C--N 1.352 0.683 0 C-N-CA 127.736 2.414 . . . . 0.0 110.227 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.0 m -82.34 73.77 9.36 Favored 'General case' 0 C--N 1.372 1.551 0 O-C-N 118.944 -2.348 . . . . 0.0 110.306 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.56 111.15 21.58 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 C-N-CA 129.228 3.011 . . . . 0.0 110.594 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -117.34 146.82 43.13 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 111.287 -2.688 . . . . 0.0 112.874 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.86 162.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 127.74 2.416 . . . . 0.0 106.426 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.02 138.43 32.45 Favored 'General case' 0 C--N 1.379 1.889 0 O-C-N 117.975 -2.953 . . . . 0.0 111.112 171.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 m -151.9 169.91 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.478 -1.807 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.568 HE22 HG12 ' A' ' 195' ' ' VAL . 9.2 pt20 -149.09 151.13 33.91 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 122.138 0.97 . . . . 0.0 109.695 170.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -104.14 122.13 44.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 128.972 2.909 . . . . 0.0 107.97 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 51.0 m-85 -71.38 62.29 0.35 Allowed 'General case' 0 C--N 1.378 1.837 0 C-N-CA 127.317 2.247 . . . . 0.0 112.136 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -90.33 -114.2 0.07 Allowed 'General case' 0 C--N 1.362 1.151 0 C-N-CA 129.986 3.314 . . . . 0.0 111.531 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -106.53 -45.1 4.33 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 125.723 1.609 . . . . 0.0 112.031 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -81.6 -40.45 1.02 Allowed Pre-proline 0 C--N 1.36 1.055 0 N-CA-C 118.44 2.756 . . . . 0.0 118.44 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.91 159.57 97.79 Favored 'Cis proline' 0 C--N 1.361 1.189 0 CA-C-N 126.202 3.251 . . . . 0.0 109.864 -3.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.9 p -87.88 119.37 28.16 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 119.009 -2.307 . . . . 0.0 112.046 -175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -109.92 152.93 25.2 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 125.877 1.671 . . . . 0.0 107.623 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.35 177.31 37.72 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 104.084 -3.606 . . . . 0.0 104.084 165.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -92.26 109.06 20.43 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 103.12 -2.918 . . . . 0.0 103.12 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 143' ' ' VAL . 1.5 m -96.32 164.6 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 C-N-CA 125.466 1.507 . . . . 0.0 111.511 -171.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 m -77.42 109.85 11.69 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.97 2.108 . . . . 0.0 106.305 172.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.503 0.0 OUTLIER -70.72 -10.27 59.07 Favored 'General case' 0 C--N 1.37 1.496 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -169.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.436 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 31.5 ptt-85 -75.44 -14.68 60.46 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 129.214 3.006 . . . . 0.0 114.193 170.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -100.47 0.82 40.39 Favored 'General case' 0 C--N 1.365 1.281 0 C-N-CA 126.859 2.064 . . . . 0.0 110.263 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 49.1 mt -96.28 124.88 40.44 Favored 'General case' 0 C--N 1.368 1.412 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 172.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -114.6 161.74 27.18 Favored Pre-proline 0 CA--C 1.506 -0.718 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.14 149.78 22.47 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 CA-C-N 125.332 2.94 . . . . 0.0 112.463 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -113.28 153.05 29.07 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.584 ' HA ' HD13 ' A' ' 183' ' ' LEU . 8.8 t -179.61 -32.39 0.01 OUTLIER 'General case' 0 C--N 1.352 0.684 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.77 113.77 0.89 Allowed Glycine 0 C--N 1.355 1.638 0 O-C-N 121.029 -1.044 . . . . 0.0 115.354 -173.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -11.96 59.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 131.0 3.72 . . . . 0.0 112.271 171.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.78 -8.14 35.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 131.241 3.816 . . . . 0.0 111.794 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.8 m -58.09 136.06 57.12 Favored 'General case' 0 C--N 1.385 2.147 0 C-N-CA 126.172 1.789 . . . . 0.0 112.032 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.303 33.6 tttp -54.59 -31.75 57.48 Favored 'General case' 0 C--N 1.368 1.378 0 CA-C-N 122.445 2.384 . . . . 0.0 117.317 -173.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -74.7 -19.34 60.29 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 126.519 1.927 . . . . 0.0 112.835 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.59 1.68 55.63 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 126.359 1.864 . . . . 0.0 112.801 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -132.15 -176.48 4.08 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 119.898 -1.751 . . . . 0.0 112.908 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -63.66 122.13 15.61 Favored 'General case' 0 C--N 1.371 1.525 0 C-N-CA 126.037 1.735 . . . . 0.0 114.209 -177.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.06 -7.92 60.72 Favored Glycine 0 C--N 1.357 1.748 0 C-N-CA 124.533 1.063 . . . . 0.0 111.615 -167.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.7 145.92 20.4 Favored Glycine 0 C--N 1.364 2.133 0 N-CA-C 120.303 2.881 . . . . 0.0 120.303 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -53.85 -42.05 68.11 Favored 'General case' 0 C--N 1.364 1.198 0 C-N-CA 129.448 3.099 . . . . 0.0 119.04 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.613 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.387 0.6 OUTLIER -102.68 -10.59 19.08 Favored 'General case' 0 C--N 1.366 1.314 0 CA-C-N 119.945 1.248 . . . . 0.0 113.104 179.032 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -73.35 92.98 1.87 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 126.383 1.873 . . . . 0.0 113.457 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 72.6 m -113.84 107.36 15.61 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 101.193 -3.632 . . . . 0.0 101.193 173.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.19 101.28 13.68 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-O 125.616 2.627 . . . . 0.0 115.463 -166.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -121.4 153.15 58.7 Favored Pre-proline 0 N--CA 1.419 -1.992 1 C-N-CA 132.848 4.459 . . . . 0.0 104.946 170.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.89 -42.18 69.68 Favored 'Trans proline' 0 C--N 1.347 0.462 1 C-N-CA 126.154 4.569 . . . . 0.0 115.725 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -59.72 -35.26 74.18 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 129.446 3.098 . . . . 0.0 114.006 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 16.8 mm -72.35 -43.46 64.5 Favored 'Isoleucine or valine' 0 C--N 1.372 1.559 0 C-N-CA 125.792 1.637 . . . . 0.0 110.569 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.72 -47.34 66.6 Favored 'General case' 0 C--N 1.372 1.578 0 O-C-N 120.101 -1.625 . . . . 0.0 113.65 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -58.82 -35.23 72.53 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 126.665 1.986 . . . . 0.0 116.172 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.73 -36.71 76.09 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 127.758 2.423 . . . . 0.0 110.94 173.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.2 mtt -69.32 -35.62 76.12 Favored 'General case' 0 C--N 1.378 1.831 0 CA-C-O 116.707 -1.616 . . . . 0.0 113.729 167.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.06 -48.99 55.58 Favored 'General case' 0 C--N 1.377 1.802 0 C-N-CA 127.335 2.254 . . . . 0.0 111.732 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.62 -47.9 71.19 Favored 'General case' 0 C--N 1.371 1.529 0 C-N-CA 128.6 2.76 . . . . 0.0 112.19 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.27 71.13 Favored 'General case' 0 C--N 1.375 1.676 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 170.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.87 -50.1 70.13 Favored 'General case' 0 C--N 1.375 1.694 0 O-C-N 120.212 -1.555 . . . . 0.0 110.363 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -33.72 71.62 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 173.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -73.42 -38.83 65.41 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.584 HD13 ' HA ' ' A' ' 152' ' ' THR . 2.7 pp -79.46 -38.58 34.24 Favored 'General case' 0 C--N 1.373 1.618 0 C-N-CA 125.986 1.714 . . . . 0.0 113.501 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.298 0.0 OUTLIER -87.58 -16.67 33.89 Favored 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.848 1.659 . . . . 0.0 110.901 -172.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -117.02 -106.96 0.38 Allowed 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -135.86 156.04 49.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.972 1.368 . . . . 0.0 109.564 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -51.24 -35.33 36.44 Favored 'General case' 0 C--N 1.36 1.053 1 C-N-CA 134.275 5.03 . . . . 0.0 113.932 175.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.7 tp -50.9 -31.17 9.93 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 C-N-CA 129.933 3.293 . . . . 0.0 112.458 172.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -73.04 -37.08 67.01 Favored 'General case' 0 C--N 1.377 1.766 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.583 HH21 HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -75.2 -42.94 54.51 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 172.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.326 54.2 mt -73.36 -19.25 61.05 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 126.48 1.912 . . . . 0.0 113.304 -177.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.31 -37.73 67.76 Favored 'General case' 0 C--N 1.373 1.619 0 C-N-CA 128.654 2.782 . . . . 0.0 114.735 164.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.14 -45.66 5.83 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 128.705 2.802 . . . . 0.0 108.779 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 71.19 -86.07 0.03 OUTLIER 'General case' 0 C--N 1.363 1.187 0 C-N-CA 130.094 3.358 . . . . 0.0 115.782 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.568 HG12 HE22 ' A' ' 132' ' ' GLN . 3.4 m . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 128.93 2.892 . . . . 0.0 107.917 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 C--O 1.235 0.307 0 CA-C-O 121.301 0.572 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' A' ' 145' ' ' LYS . 5.5 t70 -150.57 81.45 1.35 Allowed 'General case' 0 C--N 1.361 1.107 0 C-N-CA 124.71 1.204 . . . . 0.0 111.066 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -118.23 126.92 53.16 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.361 -1.462 . . . . 0.0 111.02 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.6 p -112.28 167.14 9.6 Favored Pre-proline 0 C--N 1.366 1.29 0 C-N-CA 127.347 2.259 . . . . 0.0 116.808 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -48.46 127.88 16.73 Favored 'Trans proline' 0 C--N 1.389 2.665 1 C-N-CA 127.151 5.234 . . . . 0.0 116.619 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.444 ' HA2' HH11 ' A' ' 190' ' ' ARG . . . 96.74 1.15 60.24 Favored Glycine 0 C--N 1.357 1.713 0 C-N-CA 124.103 0.858 . . . . 0.0 112.668 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -94.8 169.2 10.32 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 170.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -113.82 147.49 38.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 101.751 -3.426 . . . . 0.0 101.751 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.455 HG11 ' HG ' ' A' ' 148' ' ' LEU . 1.4 p -142.41 167.15 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 -174.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -112.26 117.75 33.37 Favored 'General case' 0 N--CA 1.437 -1.105 1 N-CA-C 95.796 -5.631 . . . . 0.0 95.796 166.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.56 131.94 52.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -106.8 136.07 47.26 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 118.221 -2.8 . . . . 0.0 106.014 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 40.9 ttm -123.27 145.02 49.03 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 119.827 -1.796 . . . . 0.0 108.578 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.41 96.43 0.08 Allowed 'General case' 0 C--N 1.367 1.356 0 C-N-CA 127.469 2.307 . . . . 0.0 114.418 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.44 -6.29 24.73 Favored Glycine 0 C--N 1.359 1.851 0 C-N-CA 125.685 1.612 . . . . 0.0 113.257 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -106.67 162.07 20.87 Favored Pre-proline 0 C--N 1.355 0.812 0 C-N-CA 125.713 1.605 . . . . 0.0 109.555 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.88 166.6 29.05 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.129 3.219 . . . . 0.0 112.483 164.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -59.88 121.06 10.81 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 126.589 1.956 . . . . 0.0 114.238 170.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . 0.44 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 9.3 m95 -125.09 116.77 25.77 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 -172.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -57.42 127.16 24.38 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.865 3.71 . . . . 0.0 110.227 160.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.7 t -138.71 165.73 26.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 130.11 3.364 . . . . 0.0 111.535 -153.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.583 HD21 ' CZ ' ' A' ' 190' ' ' ARG . 1.9 tt -130.07 131.63 45.85 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 119.82 -1.8 . . . . 0.0 106.285 176.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 131' ' ' VAL . 2.7 p -91.84 119.36 39.09 Favored 'Isoleucine or valine' 0 C--N 1.373 1.63 0 CA-C-N 120.072 1.306 . . . . 0.0 108.942 172.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 153.58 39.81 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -165.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -90.89 113.5 25.71 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.903 2.081 . . . . 0.0 111.04 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.533 ' CD2' ' CG ' ' A' ' 130' ' ' HIS . 5.3 m-70 -67.79 162.22 60.07 Favored Pre-proline 0 C--N 1.36 1.055 0 C-N-CA 129.55 3.14 . . . . 0.0 113.461 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.25 -7.79 0.86 Allowed 'Trans proline' 0 CA--C 1.563 1.932 1 C-N-CA 125.419 4.079 . . . . 0.0 117.044 169.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.83 35.12 3.0 Favored 'General case' 0 C--N 1.358 0.949 1 C-N-CA 132.153 4.181 . . . . 0.0 107.84 173.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.54 149.43 43.05 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 -172.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.47 -19.96 50.79 Favored Glycine 0 C--N 1.362 1.99 0 C-N-CA 125.962 1.744 . . . . 0.0 112.011 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.92 119.96 36.42 Favored 'General case' 0 N--CA 1.447 -0.616 1 C-N-CA 132.864 4.466 . . . . 0.0 102.369 174.186 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.441 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 22.2 p90 -151.0 -2.11 0.35 Allowed 'General case' 0 C--N 1.353 0.739 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -174.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.6 pt -106.14 169.16 2.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 O-C-N 119.354 -2.091 . . . . 0.0 113.143 -175.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -159.3 153.58 23.84 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 174.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.87 127.04 8.43 Favored 'General case' 0 C--N 1.368 1.386 0 CA-C-N 123.097 2.68 . . . . 0.0 114.391 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HG2' HH12 ' A' ' 128' ' ' ARG . 75.6 mmtt -116.81 93.42 4.19 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 120.493 -1.379 . . . . 0.0 108.223 174.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.21 -78.11 0.23 Allowed Glycine 0 C--N 1.363 2.056 0 C-N-CA 128.027 2.727 . . . . 0.0 116.287 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -118.81 -16.11 9.34 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 128.192 2.597 . . . . 0.0 109.015 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.6 m -84.41 75.24 10.26 Favored 'General case' 0 C--N 1.367 1.342 0 O-C-N 118.326 -2.734 . . . . 0.0 110.649 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 p -89.22 112.89 24.89 Favored 'Isoleucine or valine' 0 C--N 1.363 1.171 0 C-N-CA 127.789 2.435 . . . . 0.0 107.563 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.567 HH12 ' HG2' ' A' ' 123' ' ' LYS . 65.3 mtt85 -104.6 157.2 17.34 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 124.893 1.277 . . . . 0.0 111.952 -171.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.401 HG13 ' HD3' ' A' ' 145' ' ' LYS . 21.2 m -149.23 164.25 4.1 Favored 'Isoleucine or valine' 0 C--N 1.367 1.369 1 C-N-CA 132.053 4.141 . . . . 0.0 103.848 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.533 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 4.4 m170 -90.3 116.19 28.08 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 118.9 -2.375 . . . . 0.0 114.485 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 110' ' ' VAL 0.276 2.3 m -143.33 156.65 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 O-C-N 119.016 -2.303 . . . . 0.0 111.587 177.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -112.72 153.96 26.9 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 111.635 -2.53 . . . . 0.0 111.271 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.17 116.11 27.83 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 129.13 2.972 . . . . 0.0 103.012 -174.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 15.0 m-85 -71.85 65.78 0.54 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.859 2.064 . . . . 0.0 113.37 -175.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -92.11 -119.07 0.08 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 126.898 2.079 . . . . 0.0 110.408 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.85 -52.84 2.7 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.188 1.395 . . . . 0.0 112.93 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.4 m -71.07 -44.5 14.12 Favored Pre-proline 0 C--N 1.362 1.127 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.11 -174.71 12.51 Favored 'Cis proline' 0 CA--C 1.541 0.866 0 CA-C-N 126.973 3.526 . . . . 0.0 112.257 -2.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.5 m -95.23 123.78 38.92 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.104 1.362 . . . . 0.0 109.347 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.409 ' HD3' ' HE1' ' A' ' 113' ' ' HIS . 9.2 tmm_? -147.47 151.44 36.4 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 120.78 1.627 . . . . 0.0 108.503 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.62 -155.48 12.92 Favored Glycine 0 CA--C 1.489 -1.583 1 N-CA-C 98.502 -5.839 . . . . 0.0 98.502 174.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -89.17 160.33 17.04 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 119.975 1.887 . . . . 0.0 110.479 172.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.42 ' CG2' HG22 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -125.53 171.21 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 O-C-N 120.455 -1.403 . . . . 0.0 109.773 174.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.1 m -100.05 116.4 32.0 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.434 ' HB2' HD22 ' A' ' 148' ' ' LEU 0.423 11.4 pttt -68.35 -6.41 24.12 Favored 'General case' 0 C--N 1.366 1.29 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 -172.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -70.75 -15.37 62.68 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.474 1.109 . . . . 0.0 113.536 170.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.2 mt -100.41 2.9 42.74 Favored 'General case' 0 C--N 1.37 1.457 0 C-N-CA 126.693 1.997 . . . . 0.0 112.471 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.455 ' HG ' HG11 ' A' ' 96' ' ' VAL . 5.7 mp -94.92 124.47 38.99 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 128.351 2.661 . . . . 0.0 108.771 177.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -118.13 154.16 51.59 Favored Pre-proline 0 CA--C 1.497 -1.058 0 C-N-CA 125.932 1.693 . . . . 0.0 107.664 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -78.42 153.52 27.35 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.614 2.209 . . . . 0.0 115.451 -166.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.418 ' HB2' ' HB2' ' A' ' 183' ' ' LEU 0.311 0.0 OUTLIER -17.94 -107.29 0.0 OUTLIER 'General case' 0 C--N 1.354 0.804 2 C-N-CA 132.681 4.392 . . . . 0.0 122.551 174.747 . . . . . . . . 5 4 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.326 12.4 t 47.41 -36.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 1 C-N-CA 132.616 4.366 . . . . 0.0 119.86 -179.526 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 67.55 -148.67 49.97 Favored Glycine 0 C--N 1.35 1.351 0 C-N-CA 128.129 2.776 . . . . 0.0 119.773 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 m -46.39 -23.75 0.4 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 130.232 3.413 . . . . 0.0 119.342 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -85.62 -8.45 58.24 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.542 1.937 . . . . 0.0 113.161 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 t -85.31 155.85 21.17 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-O 123.029 1.395 . . . . 0.0 112.597 173.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -68.49 -32.74 72.94 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 127.034 2.134 . . . . 0.0 112.751 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.72 -11.87 60.08 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 125.257 1.423 . . . . 0.0 111.488 171.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.66 3.75 42.7 Favored 'General case' 0 C--N 1.371 1.522 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.257 0.9 OUTLIER -122.94 173.38 7.83 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 125.689 1.596 . . . . 0.0 109.408 174.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -61.53 122.64 15.75 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 126.567 1.947 . . . . 0.0 114.449 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.32 -14.01 51.35 Favored Glycine 0 C--N 1.358 1.757 0 C-N-CA 124.947 1.261 . . . . 0.0 111.076 -167.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.98 155.52 31.72 Favored Glycine 0 C--N 1.36 1.882 0 N-CA-C 117.186 1.634 . . . . 0.0 117.186 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -58.46 -41.59 85.53 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 120.953 3.686 . . . . 0.0 120.953 -174.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . 0.273 0.1 OUTLIER -102.2 23.32 11.83 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 122.266 2.303 . . . . 0.0 111.785 -179.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -93.17 161.32 14.47 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 124.674 2.178 . . . . 0.0 116.671 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 m 170.65 175.99 0.06 Allowed 'General case' 0 C--N 1.354 0.778 1 N-CA-C 98.554 -4.61 . . . . 0.0 98.554 -178.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -137.77 102.25 4.68 Favored 'General case' 0 C--N 1.364 1.219 0 CA-C-N 124.551 3.341 . . . . 0.0 111.286 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -119.88 141.97 32.32 Favored Pre-proline 0 N--CA 1.433 -1.279 0 C-N-CA 130.116 3.366 . . . . 0.0 105.041 173.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.423 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 38.0 Cg_endo -58.37 -31.82 94.78 Favored 'Trans proline' 0 C--N 1.364 1.386 1 C-N-CA 127.678 5.586 . . . . 0.0 115.074 177.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -69.79 -35.97 75.3 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 130.332 3.453 . . . . 0.0 113.393 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.44 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 4.4 mm -70.33 -36.21 66.02 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 C-N-CA 127.17 2.188 . . . . 0.0 109.132 174.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 177' ' ' GLN . 6.1 mt -62.73 -53.67 50.79 Favored 'General case' 0 C--N 1.382 1.982 0 C-N-CA 126.226 1.81 . . . . 0.0 111.045 173.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -57.26 -34.22 68.4 Favored 'General case' 0 C--N 1.373 1.613 0 C-N-CA 128.968 2.907 . . . . 0.0 114.374 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.0 -47.83 73.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 130.225 3.41 . . . . 0.0 111.718 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 36.3 mtt -68.45 -33.38 74.08 Favored 'General case' 0 C--N 1.369 1.423 0 CA-C-O 118.069 -0.967 . . . . 0.0 113.547 170.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 13.7 mt-30 -74.32 -43.71 55.61 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 126.366 1.866 . . . . 0.0 112.027 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -68.31 -47.96 66.21 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 129.116 2.966 . . . . 0.0 111.147 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.06 87.42 Favored 'General case' 0 C--N 1.382 2.015 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 170.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.257 23.1 t70 -54.5 -47.44 73.07 Favored 'General case' 0 C--N 1.376 1.753 0 C-N-CA 127.17 2.188 . . . . 0.0 114.161 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -66.0 -43.0 89.01 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-N 120.8 1.636 . . . . 0.0 115.366 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 190' ' ' ARG . . . -76.12 -29.05 57.7 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.5 pp -80.0 -32.58 39.71 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 175.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.277 0.4 OUTLIER -89.68 -34.28 16.31 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 125.393 1.477 . . . . 0.0 111.199 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -100.48 -99.61 0.25 Allowed 'General case' 0 C--N 1.362 1.151 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -135.49 152.22 51.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.223 -1.548 . . . . 0.0 110.27 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 190' ' ' ARG 0.431 16.4 ptpt -50.92 -33.31 23.79 Favored 'General case' 0 C--N 1.358 0.967 1 C-N-CA 133.193 4.597 . . . . 0.0 113.898 172.222 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.5 tt -50.6 -27.97 5.25 Favored 'Isoleucine or valine' 0 C--N 1.368 1.393 0 C-N-CA 127.923 2.489 . . . . 0.0 113.032 172.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -72.72 -39.27 67.08 Favored 'General case' 0 C--N 1.377 1.764 0 C-N-CA 126.343 1.857 . . . . 0.0 114.75 170.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.583 ' CZ ' HD21 ' A' ' 109' ' ' LEU 0.283 0.0 OUTLIER -74.68 -34.41 62.66 Favored 'General case' 0 C--N 1.367 1.362 0 O-C-N 119.286 -2.134 . . . . 0.0 114.859 172.871 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.8 -22.45 56.34 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 126.323 1.849 . . . . 0.0 112.901 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.26 -46.15 86.53 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 126.478 1.911 . . . . 0.0 114.309 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . 0.264 0.2 OUTLIER -105.56 22.14 16.0 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 128.208 2.603 . . . . 0.0 112.922 176.201 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -49.59 141.81 9.05 Favored 'General case' 0 C--N 1.374 1.663 0 C-N-CA 128.991 2.916 . . . . 0.0 118.823 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.368 5.3 p . . . . . 0 C--N 1.374 1.657 0 CA-C-O 125.636 2.636 . . . . 0.0 114.966 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 CA--C 1.511 -0.528 0 CA-C-O 120.722 0.296 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -97.61 99.88 11.27 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -124.42 126.51 46.06 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 124.431 1.093 . . . . 0.0 112.393 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.345 88.8 p -112.12 170.86 4.83 Favored Pre-proline 0 CA--C 1.558 1.279 1 C-N-CA 133.022 4.529 . . . . 0.0 116.524 -177.18 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 12.7 Cg_exo -41.69 128.55 3.71 Favored 'Trans proline' 0 C--N 1.389 2.691 1 C-N-CA 127.927 5.751 . . . . 0.0 118.879 -179.165 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.547 ' HA2' ' CZ ' ' A' ' 190' ' ' ARG . . . 88.08 4.38 78.25 Favored Glycine 0 CA--C 1.477 -2.314 0 C-N-CA 129.382 3.372 . . . . 0.0 117.223 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -93.59 148.57 21.97 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 168.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.97 126.31 52.96 Favored 'General case' 0 N--CA 1.441 -0.902 1 N-CA-C 99.834 -4.135 . . . . 0.0 99.834 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.3 154.93 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -99.9 122.15 42.4 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 101.832 -3.396 . . . . 0.0 101.832 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.97 131.12 55.36 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 127.831 2.452 . . . . 0.0 110.77 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.87 135.85 49.39 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 174.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.0 ttp -130.08 153.55 48.36 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 119.946 -1.721 . . . . 0.0 112.098 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -63.22 90.25 0.04 OUTLIER 'General case' 0 C--N 1.364 1.224 0 C-N-CA 129.206 3.002 . . . . 0.0 114.734 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.46 -0.77 24.99 Favored Glycine 0 C--N 1.358 1.804 0 C-N-CA 125.786 1.66 . . . . 0.0 113.028 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -108.25 161.39 23.58 Favored Pre-proline 0 C--N 1.357 0.911 0 C-N-CA 125.366 1.466 . . . . 0.0 110.296 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.48 166.49 29.2 Favored 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 124.976 3.784 . . . . 0.0 111.65 164.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.6 121.53 16.62 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 126.454 1.902 . . . . 0.0 109.557 173.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.282 0.8 OUTLIER -128.64 135.16 27.16 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 119.267 3.062 . . . . 0.0 119.267 -167.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.51 149.19 90.75 Favored 'Trans proline' 0 CA--C 1.567 2.154 0 C-N-CA 124.722 3.615 . . . . 0.0 113.763 153.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 p -155.34 161.91 40.95 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 125.554 1.541 . . . . 0.0 112.464 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.447 HD22 ' HB2' ' A' ' 190' ' ' ARG . 2.3 pp -115.7 137.16 52.36 Favored 'General case' 0 C--N 1.374 1.66 0 O-C-N 120.386 -1.446 . . . . 0.0 110.594 171.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.529 HG13 HG12 ' A' ' 131' ' ' VAL . 2.2 t -93.86 118.97 40.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 C-N-CA 125.603 1.561 . . . . 0.0 109.141 170.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.4 ' HB3' ' CD1' ' A' ' 109' ' ' LEU 0.288 0.1 OUTLIER -137.81 155.62 48.81 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 128.481 2.713 . . . . 0.0 110.747 -177.746 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -71.42 113.63 8.66 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 125.588 1.555 . . . . 0.0 113.105 170.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -89.59 159.0 44.76 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 113.798 -3.001 . . . . 0.0 106.631 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.288 46.4 Cg_exo -47.99 -0.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 2 C-N-CA 127.361 5.374 . . . . 0.0 122.745 -166.239 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -82.29 -26.17 33.34 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 128.15 2.58 . . . . 0.0 109.926 167.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 27.47 95.11 0.0 OUTLIER 'General case' 0 C--N 1.37 1.466 1 C-N-CA 135.226 5.41 . . . . 0.0 121.2 178.375 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.67 -20.85 26.68 Favored Glycine 0 C--N 1.357 1.699 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 39.9 m -107.67 118.16 36.0 Favored 'General case' 0 C--N 1.357 0.905 1 N-CA-C 98.954 -4.461 . . . . 0.0 98.954 165.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.402 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 13.2 p90 -147.35 0.82 0.71 Allowed 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.996 -1.065 . . . . 0.0 111.442 -171.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.45 HG22 HG12 ' A' ' 129' ' ' VAL . 17.4 pt -109.9 156.97 10.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 CA-C-O 121.97 0.891 . . . . 0.0 110.614 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -149.85 152.19 34.72 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.23 131.39 19.42 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 120.352 -1.468 . . . . 0.0 110.539 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -117.94 93.52 4.17 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.687 1.995 . . . . 0.0 110.558 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.38 -83.24 0.44 Allowed Glycine 0 C--N 1.362 2.002 0 N-CA-C 119.247 2.459 . . . . 0.0 119.247 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -138.32 52.77 1.82 Allowed 'General case' 0 C--N 1.36 1.025 0 C-N-CA 125.616 1.566 . . . . 0.0 110.365 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.1 m -171.96 142.2 1.44 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 p -119.9 136.91 55.49 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 C-N-CA 124.708 1.203 . . . . 0.0 110.871 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -119.62 143.16 47.83 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 127.623 2.369 . . . . 0.0 111.489 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.45 HG12 HG22 ' A' ' 120' ' ' ILE . 29.9 m -129.01 162.86 35.49 Favored 'Isoleucine or valine' 0 C--N 1.37 1.468 0 C-N-CA 130.052 3.341 . . . . 0.0 107.042 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.402 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 1.5 p-80 -97.02 119.68 35.94 Favored 'General case' 0 C--N 1.371 1.526 0 O-C-N 119.147 -2.221 . . . . 0.0 112.305 174.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.529 HG12 HG13 ' A' ' 110' ' ' VAL . 0.9 OUTLIER -145.51 166.22 10.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.353 0 C-N-CA 127.709 2.404 . . . . 0.0 105.543 -177.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.2 147.56 47.93 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.332 1.453 . . . . 0.0 108.423 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -96.15 127.91 42.58 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 128.73 2.812 . . . . 0.0 106.214 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 109' ' ' LEU . 17.0 m-30 -72.61 59.37 0.45 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -174.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -94.93 -119.95 0.1 Allowed 'General case' 0 C--N 1.36 1.036 0 C-N-CA 127.238 2.215 . . . . 0.0 111.643 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -103.04 -52.43 3.04 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 125.129 1.372 . . . . 0.0 113.349 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.0 m -66.63 -43.81 52.17 Favored Pre-proline 0 C--N 1.366 1.323 0 N-CA-C 117.99 2.589 . . . . 0.0 117.99 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -80.12 173.61 52.32 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 CA-C-N 125.693 3.069 . . . . 0.0 110.753 -5.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.5 m -81.62 134.67 35.51 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.196 -1.565 . . . . 0.0 110.191 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.5 ttp-105 -141.96 157.78 44.55 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 121.098 1.772 . . . . 0.0 109.153 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.16 -159.92 28.42 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 103.679 -3.768 . . . . 0.0 103.679 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -97.48 108.45 21.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.523 2.329 . . . . 0.0 107.17 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 m -88.81 160.75 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.182 0 C-N-CA 126.941 2.096 . . . . 0.0 110.52 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.9 m -82.68 114.97 21.41 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.405 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 7.2 ttmt -72.85 -16.76 61.59 Favored 'General case' 0 C--N 1.359 0.985 0 CA-C-O 122.752 1.263 . . . . 0.0 113.962 -169.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -76.03 -5.85 48.31 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.266 -1.522 . . . . 0.0 113.547 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 75.1 mt -105.39 14.8 28.23 Favored 'General case' 0 C--N 1.37 1.461 0 C-N-CA 126.956 2.102 . . . . 0.0 110.844 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 29.2 mt -100.32 125.46 46.55 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 126.453 1.901 . . . . 0.0 107.81 173.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.72 163.14 20.37 Favored Pre-proline 0 C--O 1.226 -0.172 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -79.53 141.1 15.48 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.844 3.029 . . . . 0.0 112.515 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.95 140.06 30.16 Favored 'General case' 0 C--N 1.365 1.263 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 171.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.661 ' HA ' HD11 ' A' ' 183' ' ' LEU . 13.5 t -164.24 -15.97 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.39 114.48 0.47 Allowed Glycine 0 C--N 1.352 1.469 0 C-N-CA 116.471 -2.776 . . . . 0.0 114.201 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 50.1 m -65.22 -10.63 33.31 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 127.835 2.454 . . . . 0.0 117.283 176.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.27 27.7 9.41 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 127.55 2.34 . . . . 0.0 109.19 175.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.7 t -99.42 142.84 30.38 Favored 'General case' 0 CA--C 1.48 -1.712 0 C-N-CA 128.278 2.631 . . . . 0.0 107.329 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.4 tptt -47.79 -40.63 21.43 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 127.393 2.277 . . . . 0.0 116.615 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -73.97 -15.6 61.1 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 124.744 1.218 . . . . 0.0 113.822 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.77 -1.52 40.24 Favored 'General case' 0 C--N 1.379 1.857 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -126.94 -173.77 2.97 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.255 1.422 . . . . 0.0 113.667 -176.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -61.93 121.88 14.07 Favored 'General case' 0 C--N 1.38 1.927 0 C-N-CA 125.921 1.688 . . . . 0.0 113.227 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.9 -6.19 73.06 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 124.307 0.956 . . . . 0.0 114.095 -170.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.53 158.45 37.46 Favored Glycine 0 C--N 1.369 2.377 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -59.72 -41.84 91.79 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.86 -30.04 13.38 Favored 'General case' 0 C--N 1.365 1.25 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 3.1 t80 19.53 -101.42 0.01 OUTLIER 'General case' 0 C--N 1.388 2.282 1 C-N-CA 132.971 4.509 . . . . 0.0 114.575 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m 54.26 57.65 5.69 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 129.378 3.071 . . . . 0.0 115.51 170.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.43 101.08 12.32 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 124.941 2.305 . . . . 0.0 113.112 -171.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -120.34 147.03 44.17 Favored Pre-proline 0 N--CA 1.43 -1.464 1 C-N-CA 133.231 4.612 . . . . 0.0 103.42 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.535 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 57.3 Cg_endo -56.76 -33.79 94.9 Favored 'Trans proline' 0 CA--C 1.545 1.058 1 C-N-CA 125.883 4.389 . . . . 0.0 116.741 -178.331 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.83 -36.28 80.08 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.698 1.999 . . . . 0.0 112.4 173.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.256 6.5 mt -76.0 -32.62 23.55 Favored 'Isoleucine or valine' 0 C--N 1.369 1.425 0 C-N-CA 126.648 1.979 . . . . 0.0 110.566 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.535 ' HG ' ' HA ' ' A' ' 170' ' ' PRO 0.276 35.7 mt -62.57 -53.85 48.55 Favored 'General case' 0 C--N 1.387 2.226 0 C-N-CA 127.391 2.276 . . . . 0.0 110.269 172.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -57.76 -43.23 85.31 Favored 'General case' 0 C--N 1.369 1.418 0 C-N-CA 129.743 3.217 . . . . 0.0 114.197 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.26 -35.5 76.15 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 130.769 3.628 . . . . 0.0 111.454 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.0 mtt -68.09 -40.17 82.69 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.108 1.763 . . . . 0.0 110.384 168.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 11.7 mt-30 -66.17 -50.3 64.41 Favored 'General case' 0 C--N 1.374 1.655 0 C-N-CA 126.142 1.777 . . . . 0.0 112.258 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.298 4.7 ptt180 -71.65 -37.53 70.8 Favored 'General case' 0 C--N 1.382 2.001 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 175.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.22 68.77 Favored 'General case' 0 C--N 1.373 1.612 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 169.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 20.6 t0 -70.11 -48.79 56.11 Favored 'General case' 0 C--N 1.372 1.546 0 O-C-N 119.212 -2.18 . . . . 0.0 110.569 168.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -53.37 -47.81 69.13 Favored 'General case' 0 C--N 1.373 1.629 0 C-N-CA 128.88 2.872 . . . . 0.0 114.696 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.42 ' CB ' ' HB3' ' A' ' 190' ' ' ARG . . . -68.11 -29.34 68.24 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 176.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.661 HD11 ' HA ' ' A' ' 152' ' ' THR 0.267 0.2 OUTLIER -81.35 -41.85 21.41 Favored 'General case' 0 C--N 1.367 1.365 0 O-C-N 118.552 -2.592 . . . . 0.0 112.811 171.077 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 180' ' ' ASP 0.277 0.0 OUTLIER -70.91 -30.3 66.59 Favored 'General case' 0 C--N 1.379 1.889 0 C-N-CA 129.359 3.064 . . . . 0.0 112.676 -173.402 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -103.99 -100.59 0.31 Allowed 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.374 0.607 . . . . 0.0 109.712 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -136.62 144.03 43.84 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.675 7.1 pttm -51.19 -33.73 28.62 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 129.972 3.309 . . . . 0.0 116.41 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.78 -28.29 3.94 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 C-N-CA 129.096 2.958 . . . . 0.0 112.586 169.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.295 2.4 mptp? -64.79 -30.95 71.98 Favored 'General case' 0 C--N 1.374 1.642 0 C-N-CA 126.861 2.064 . . . . 0.0 115.479 168.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.547 ' CZ ' ' HA2' ' A' ' 93' ' ' GLY 0.381 0.0 OUTLIER -75.51 -41.35 55.5 Favored 'General case' 0 C--N 1.38 1.911 0 CA-C-N 123.046 2.657 . . . . 0.0 113.16 167.53 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 43.7 mt -69.38 -19.7 63.83 Favored 'General case' 0 C--N 1.378 1.843 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -64.68 -24.17 67.49 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 129.902 3.281 . . . . 0.0 112.55 170.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.3 mt -105.93 -49.35 3.41 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 55.85 -128.81 2.02 Favored 'General case' 0 C--N 1.375 1.701 0 C-N-CA 128.683 2.793 . . . . 0.0 110.871 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.535 0.394 0 C-N-CA 124.802 1.241 . . . . 0.0 112.076 175.745 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 30.8 m . . . . . 0 N--CA 1.442 -0.852 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -148.01 105.49 3.67 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 121.078 -1.014 . . . . 0.0 109.631 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -124.61 128.37 48.78 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 126.019 1.728 . . . . 0.0 108.958 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.54 164.55 14.59 Favored Pre-proline 0 C--N 1.355 0.827 0 C-N-CA 125.052 1.341 . . . . 0.0 113.747 -175.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -45.01 135.0 10.8 Favored 'Trans proline' 0 C--N 1.373 1.864 1 C-N-CA 127.828 5.686 . . . . 0.0 119.642 -173.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 190' ' ' ARG . . . 101.74 -6.45 54.76 Favored Glycine 0 C--N 1.366 2.211 0 C-N-CA 125.777 1.656 . . . . 0.0 112.11 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -94.3 169.65 10.08 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.265 2.033 . . . . 0.0 112.827 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.18 138.57 38.95 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 102.891 -3.003 . . . . 0.0 102.891 164.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.76 132.5 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -89.49 122.45 32.68 Favored 'General case' 0 N--CA 1.478 0.931 1 O-C-N 116.24 -4.037 . . . . 0.0 106.081 175.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.15 131.62 53.2 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 122.71 1.243 . . . . 0.0 113.124 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -102.33 135.48 43.86 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -122.53 147.65 46.12 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 104.566 -2.383 . . . . 0.0 104.566 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.79 107.93 1.59 Allowed 'General case' 0 C--N 1.354 0.772 0 C-N-CA 126.217 1.807 . . . . 0.0 113.114 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.32 -15.25 46.88 Favored Glycine 0 C--N 1.354 1.57 0 C-N-CA 124.769 1.176 . . . . 0.0 114.599 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . 0.256 0.0 OUTLIER -102.25 168.28 9.19 Favored Pre-proline 0 C--N 1.363 1.159 0 CA-C-N 119.659 1.729 . . . . 0.0 111.94 -178.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.76 158.52 50.23 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 125.196 3.931 . . . . 0.0 113.583 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -54.95 129.38 37.47 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 128.948 2.899 . . . . 0.0 115.351 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -134.04 126.58 18.72 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 119.768 3.247 . . . . 0.0 119.768 -172.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -67.21 117.64 4.97 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 124.944 3.763 . . . . 0.0 113.695 164.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.94 164.37 17.71 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 131.257 3.823 . . . . 0.0 114.335 -170.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp -120.99 132.77 55.12 Favored 'General case' 0 C--N 1.345 0.409 0 O-C-N 118.563 -2.586 . . . . 0.0 107.381 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 131' ' ' VAL . 7.6 p -91.51 129.79 41.67 Favored 'Isoleucine or valine' 0 C--N 1.374 1.638 0 CA-C-N 119.987 1.267 . . . . 0.0 108.216 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.345 0.0 OUTLIER -138.64 153.27 48.59 Favored 'General case' 0 C--N 1.372 1.563 0 O-C-N 117.922 -2.986 . . . . 0.0 117.351 -173.111 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -87.92 112.31 22.4 Favored 'General case' 0 C--N 1.368 1.413 0 CA-C-O 123.386 1.565 . . . . 0.0 109.246 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -97.33 154.99 37.86 Favored Pre-proline 0 N--CA 1.447 -0.599 0 C-N-CA 129.377 3.071 . . . . 0.0 108.115 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -56.68 -0.96 0.28 Allowed 'Trans proline' 0 N--CA 1.487 1.121 1 C-N-CA 126.524 4.816 . . . . 0.0 121.076 -165.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.79 -7.81 58.52 Favored 'General case' 0 C--N 1.363 1.191 0 C-N-CA 129.404 3.082 . . . . 0.0 109.624 170.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -30.18 139.99 0.02 OUTLIER 'General case' 0 C--N 1.375 1.715 1 C-N-CA 134.153 4.981 . . . . 0.0 121.361 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.22 -20.24 28.55 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 113.456 -1.702 . . . . 0.0 109.236 175.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.6 p -125.5 118.78 26.53 Favored 'General case' 0 C--N 1.348 0.514 1 N-CA-C 96.518 -5.364 . . . . 0.0 96.518 164.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -123.87 4.73 8.74 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 119.688 1.131 . . . . 0.0 112.12 -172.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.5 pt -110.12 166.43 5.16 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.746 1.218 . . . . 0.0 110.401 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -151.04 147.36 27.01 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.826 2.45 . . . . 0.0 105.201 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.06 134.67 15.4 Favored 'General case' 0 C--N 1.357 0.935 0 O-C-N 120.546 -1.346 . . . . 0.0 110.702 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 93.55 4.17 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 127.921 2.488 . . . . 0.0 108.834 175.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.32 -74.38 0.14 Allowed Glycine 0 C--N 1.361 1.971 0 N-CA-C 121.212 3.245 . . . . 0.0 121.212 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.32 37.58 3.53 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.775 1.63 . . . . 0.0 111.488 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m -166.22 151.6 8.46 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 119.461 -2.025 . . . . 0.0 107.286 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.47 144.58 32.41 Favored 'Isoleucine or valine' 0 C--N 1.366 1.293 0 C-N-CA 126.023 1.729 . . . . 0.0 111.126 -174.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -135.55 154.76 51.27 Favored 'General case' 0 C--N 1.366 1.298 0 C-N-CA 127.975 2.51 . . . . 0.0 113.931 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 145' ' ' LYS . 23.3 m -126.28 162.74 29.57 Favored 'Isoleucine or valine' 0 C--N 1.38 1.904 0 C-N-CA 130.77 3.628 . . . . 0.0 106.144 173.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -86.42 116.42 24.56 Favored 'General case' 0 C--N 1.365 1.275 0 O-C-N 119.695 -1.878 . . . . 0.0 110.815 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 110' ' ' VAL . 2.3 t -138.67 150.13 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 C-N-CA 125.044 1.338 . . . . 0.0 107.714 -174.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -118.7 144.93 45.91 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 170.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -100.22 131.05 46.39 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.53 72.59 2.52 Favored 'General case' 0 C--N 1.38 1.893 0 C-N-CA 125.098 1.359 . . . . 0.0 111.542 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -97.9 -103.9 0.19 Allowed 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.518 1.127 . . . . 0.0 111.002 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -106.61 -62.44 1.39 Allowed 'General case' 0 C--N 1.354 0.763 0 C-N-CA 126.051 1.74 . . . . 0.0 113.75 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 p -88.27 -29.14 0.37 Allowed Pre-proline 0 C--N 1.364 1.196 0 N-CA-C 118.945 2.943 . . . . 0.0 118.945 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.5 -177.84 18.72 Favored 'Cis proline' 0 C--N 1.357 1.025 1 CA-C-N 129.585 4.459 . . . . 0.0 113.386 -2.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 64.2 m -98.12 113.37 25.24 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 127.889 2.476 . . . . 0.0 113.585 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -113.41 161.53 17.19 Favored 'General case' 0 C--N 1.363 1.155 0 CA-C-N 124.972 3.533 . . . . 0.0 108.086 172.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.58 -170.33 31.34 Favored Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 103.359 -3.896 . . . . 0.0 103.359 168.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -93.93 110.21 21.9 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 172.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.6 m -94.6 157.16 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 C-N-CA 125.949 1.7 . . . . 0.0 110.947 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.5 t -79.14 110.98 14.91 Favored 'General case' 0 C--N 1.364 1.222 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HB3' HG22 ' A' ' 129' ' ' VAL 0.419 0.0 OUTLIER -65.73 -14.89 62.2 Favored 'General case' 0 C--N 1.366 1.295 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -172.891 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.418 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 41.0 ttm180 -74.76 -3.87 34.2 Favored 'General case' 0 N--CA 1.434 -1.227 1 C-N-CA 132.798 4.439 . . . . 0.0 112.933 170.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 147' ' ' LEU . 8.3 mt -109.73 2.29 19.99 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.391 2.276 . . . . 0.0 110.902 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.8 mt -96.41 153.22 17.95 Favored 'General case' 0 C--N 1.373 1.615 0 O-C-N 120.069 -1.644 . . . . 0.0 113.19 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -119.02 155.21 53.28 Favored Pre-proline 0 C--N 1.351 0.654 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -82.76 155.53 15.61 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 125.403 2.965 . . . . 0.0 113.069 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -35.63 -87.89 0.0 OUTLIER 'General case' 0 C--N 1.348 0.512 2 C-N-CA 132.297 4.239 . . . . 0.0 122.4 -177.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.845 ' HA ' HD13 ' A' ' 183' ' ' LEU . 4.6 t -31.48 24.94 0.0 OUTLIER 'General case' 0 C--N 1.359 0.988 1 C-N-CA 138.555 6.742 . . . . 0.0 120.643 -179.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.03 0.4 47.9 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 -165.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 159' ' ' ALA 0.256 5.8 p -62.73 -15.53 53.46 Favored 'General case' 0 C--N 1.366 1.289 0 CA-C-N 120.988 2.394 . . . . 0.0 117.287 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -91.47 -6.7 52.25 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 128.808 2.843 . . . . 0.0 111.107 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.0 p -90.85 147.85 22.9 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 127.34 2.256 . . . . 0.0 112.775 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -62.19 -18.47 61.11 Favored 'General case' 0 C--N 1.37 1.475 0 C-N-CA 126.82 2.048 . . . . 0.0 113.517 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -75.87 -26.51 57.13 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 127.452 2.301 . . . . 0.0 112.696 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 154' ' ' SER . . . -89.63 -12.89 38.38 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -114.91 -178.91 3.48 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 126.177 1.791 . . . . 0.0 111.4 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -57.74 122.75 13.58 Favored 'General case' 0 C--N 1.372 1.55 0 C-N-CA 127.243 2.217 . . . . 0.0 115.134 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.12 -10.95 58.58 Favored Glycine 0 C--N 1.357 1.72 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.81 -167.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -84.33 160.34 36.26 Favored Glycine 0 C--N 1.363 2.058 0 N-CA-C 121.13 3.212 . . . . 0.0 121.13 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -60.38 -30.0 69.29 Favored 'General case' 0 C--N 1.369 1.447 0 C-N-CA 128.915 2.886 . . . . 0.0 118.691 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -105.34 7.9 33.52 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.357 -1.464 . . . . 0.0 110.456 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -87.78 162.64 16.9 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -171.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.5 m 174.91 176.75 0.16 Allowed 'General case' 0 C--N 1.353 0.724 1 N-CA-C 99.097 -4.409 . . . . 0.0 99.097 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -138.71 102.29 4.54 Favored 'General case' 0 C--N 1.364 1.228 0 CA-C-N 124.187 3.176 . . . . 0.0 111.288 173.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -119.74 138.32 26.62 Favored Pre-proline 0 N--CA 1.435 -1.21 0 C-N-CA 130.269 3.428 . . . . 0.0 105.766 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.47 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 55.4 Cg_endo -59.4 -27.44 84.99 Favored 'Trans proline' 0 C--N 1.363 1.334 1 C-N-CA 127.013 5.142 . . . . 0.0 115.086 177.372 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -70.02 -36.85 75.38 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 129.465 3.106 . . . . 0.0 113.167 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.2 mt -70.45 -34.89 59.63 Favored 'Isoleucine or valine' 0 C--N 1.381 1.977 0 C-N-CA 126.677 1.991 . . . . 0.0 110.056 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 170' ' ' PRO . 6.8 mt -59.69 -53.26 60.05 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 125.987 1.715 . . . . 0.0 110.742 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -57.55 -34.6 69.34 Favored 'General case' 0 C--N 1.367 1.356 0 C-N-CA 128.217 2.607 . . . . 0.0 115.403 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.81 -42.83 80.94 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 129.191 2.996 . . . . 0.0 111.662 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 18.1 mtt -69.98 -33.24 71.8 Favored 'General case' 0 C--N 1.372 1.546 0 CA-C-O 117.282 -1.342 . . . . 0.0 113.193 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 15.8 mt-30 -74.29 -42.64 59.23 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-N 121.713 2.051 . . . . 0.0 111.109 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -68.54 -49.65 57.91 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 127.348 2.259 . . . . 0.0 111.418 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.57 -41.39 98.9 Favored 'General case' 0 C--N 1.374 1.645 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 173.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 21.1 t70 -62.33 -37.26 84.94 Favored 'General case' 0 C--N 1.379 1.876 0 C-N-CA 128.808 2.843 . . . . 0.0 111.353 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -72.03 -44.81 62.79 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 119.828 -1.795 . . . . 0.0 112.481 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -73.0 -38.89 66.46 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.845 HD13 ' HA ' ' A' ' 152' ' ' THR . 4.4 pp -69.23 -37.28 77.94 Favored 'General case' 0 C--N 1.374 1.645 0 C-N-CA 127.243 2.217 . . . . 0.0 115.056 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -83.72 -31.95 25.77 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 127.103 2.161 . . . . 0.0 111.451 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -105.13 -98.46 0.33 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -135.63 150.73 49.73 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.819 -1.176 . . . . 0.0 112.347 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.277 24.6 ttpp -51.69 -36.37 46.34 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 131.485 3.914 . . . . 0.0 115.385 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.8 tp -53.24 -27.59 13.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 129.219 3.007 . . . . 0.0 112.409 172.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -75.78 -41.27 53.45 Favored 'General case' 0 C--N 1.372 1.555 0 O-C-N 119.483 -2.011 . . . . 0.0 114.636 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 93' ' ' GLY . 7.0 ptp180 -74.61 -37.06 62.94 Favored 'General case' 0 C--N 1.366 1.295 0 O-C-N 118.832 -2.418 . . . . 0.0 116.466 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.0 tp -79.92 -27.82 39.84 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.919 2.087 . . . . 0.0 113.052 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -77.43 -27.42 52.21 Favored 'General case' 0 C--N 1.371 1.541 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 171.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.83 -2.06 54.04 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 124.618 1.167 . . . . 0.0 111.108 175.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 21.9 -124.76 0.01 OUTLIER 'General case' 0 C--N 1.361 1.068 1 C-N-CA 133.807 4.843 . . . . 0.0 121.752 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--N 1.349 0.555 0 O-C-N 119.8 -1.813 . . . . 0.0 110.575 -176.923 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 47.2 m . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.66 64.05 0.47 Allowed 'General case' 0 C--N 1.366 1.308 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -172.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -116.45 124.15 49.28 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.147 -1.596 . . . . 0.0 108.645 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.9 p -112.33 165.26 13.37 Favored Pre-proline 0 C--N 1.362 1.127 0 C-N-CA 126.999 2.12 . . . . 0.0 114.651 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -52.22 138.22 54.76 Favored 'Trans proline' 0 C--N 1.371 1.747 1 C-N-CA 126.21 4.607 . . . . 0.0 120.483 -170.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.91 -12.43 38.05 Favored Glycine 0 C--N 1.365 2.169 0 C-N-CA 125.019 1.295 . . . . 0.0 110.418 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.66 170.08 9.72 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 120.37 2.085 . . . . 0.0 111.982 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.33 145.9 28.29 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 163.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.1 m -143.1 157.26 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.403 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 66.9 m95 -108.39 123.33 48.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 102.064 -3.31 . . . . 0.0 102.064 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.4 136.64 54.19 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.509 1.523 . . . . 0.0 112.932 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.516 ' O ' HD13 ' A' ' 147' ' ' LEU . 12.5 tptt -109.51 145.41 36.32 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 170.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 tpt -129.18 150.23 50.65 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 118.622 -2.549 . . . . 0.0 110.042 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.26 90.18 0.07 Allowed 'General case' 0 C--N 1.368 1.406 0 C-N-CA 126.307 1.843 . . . . 0.0 115.622 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.19 1.47 25.07 Favored Glycine 0 C--N 1.359 1.841 0 C-N-CA 125.715 1.626 . . . . 0.0 112.983 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -108.82 161.36 23.92 Favored Pre-proline 0 C--N 1.354 0.786 0 C-N-CA 126.201 1.8 . . . . 0.0 109.352 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.76 167.6 26.11 Favored 'Trans proline' 0 CA--C 1.545 1.055 1 C-N-CA 125.323 4.015 . . . . 0.0 113.295 162.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.488 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 1.8 m95 -57.62 121.54 10.59 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 128.066 2.546 . . . . 0.0 115.301 170.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -123.76 111.83 29.21 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 119.252 3.056 . . . . 0.0 119.252 -172.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.403 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 4.6 Cg_exo -58.5 124.21 15.31 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 125.136 3.891 . . . . 0.0 111.227 162.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.8 p -137.82 165.5 26.31 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 128.461 2.704 . . . . 0.0 115.391 -161.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' A' ' 190' ' ' ARG . 9.2 tp -119.97 132.67 55.58 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.968 2.107 . . . . 0.0 105.952 174.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 131' ' ' VAL . 2.9 p -83.61 118.98 32.04 Favored 'Isoleucine or valine' 0 C--N 1.381 1.959 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 173.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.71 143.39 49.83 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.036 -1.665 . . . . 0.0 111.794 -164.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -98.0 118.53 34.8 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 119.349 -2.094 . . . . 0.0 112.049 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.538 ' H ' ' CE1' ' A' ' 130' ' ' HIS . 2.4 m-70 -71.79 159.78 84.5 Favored Pre-proline 0 C--N 1.358 0.95 0 C-N-CA 128.191 2.596 . . . . 0.0 108.303 169.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.17 -9.06 1.89 Allowed 'Trans proline' 0 CA--C 1.552 1.398 1 C-N-CA 126.563 4.842 . . . . 0.0 116.446 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -63.39 -18.48 63.73 Favored 'General case' 0 C--N 1.36 1.053 1 C-N-CA 134.752 5.221 . . . . 0.0 113.561 166.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.341 0.0 OUTLIER -28.78 136.49 0.02 OUTLIER 'General case' 0 C--N 1.381 1.962 0 N-CA-C 120.926 3.676 . . . . 0.0 120.926 -177.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.91 -19.77 27.48 Favored Glycine 0 C--N 1.361 1.936 0 CA-C-O 123.432 1.573 . . . . 0.0 109.633 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.4 m -141.99 119.66 11.8 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 100.269 -3.974 . . . . 0.0 100.269 164.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 130' ' ' HIS . 26.1 p90 -123.98 10.65 8.86 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.764 -1.21 . . . . 0.0 109.154 -176.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.814 HG22 HG12 ' A' ' 129' ' ' VAL . 8.2 pt -121.57 157.12 25.51 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 CA-C-O 123.637 1.684 . . . . 0.0 111.921 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.0 mtp-105 -137.38 149.1 46.72 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 130.467 3.507 . . . . 0.0 102.421 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.1 139.83 24.96 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 120.267 -1.521 . . . . 0.0 109.184 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -118.27 93.69 4.22 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 126.59 1.956 . . . . 0.0 109.622 175.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.63 -76.32 0.21 Allowed Glycine 0 C--N 1.366 2.249 0 N-CA-C 118.635 2.214 . . . . 0.0 118.635 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -141.18 22.7 2.22 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 125.763 1.625 . . . . 0.0 110.073 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.4 t -125.88 128.55 47.77 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 126.493 1.917 . . . . 0.0 108.674 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.21 116.06 49.74 Favored 'Isoleucine or valine' 0 C--N 1.358 0.949 0 C-N-CA 126.625 1.97 . . . . 0.0 112.406 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -113.84 130.68 56.45 Favored 'General case' 0 C--N 1.367 1.329 0 C-N-CA 127.362 2.265 . . . . 0.0 111.256 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.814 HG12 HG22 ' A' ' 120' ' ' ILE . 10.3 m -125.37 159.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.364 1.217 0 C-N-CA 127.438 2.295 . . . . 0.0 106.578 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.538 ' CE1' ' H ' ' A' ' 113' ' ' HIS . 3.8 p80 -90.46 129.76 36.6 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 125.262 1.425 . . . . 0.0 113.268 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.474 HG12 HG23 ' A' ' 110' ' ' VAL . 3.3 m -146.47 165.3 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 C-N-CA 128.358 2.663 . . . . 0.0 106.612 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -126.05 143.18 51.21 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.092 0.557 . . . . 0.0 109.909 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.55 123.91 39.32 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 129.666 3.186 . . . . 0.0 107.885 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -75.69 70.57 2.5 Favored 'General case' 0 C--N 1.374 1.654 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -90.79 -114.38 0.08 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.203 1.801 . . . . 0.0 110.96 -175.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -107.07 -51.99 2.83 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 126.183 1.793 . . . . 0.0 112.105 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.3 m -73.68 -45.92 7.16 Favored Pre-proline 0 C--N 1.366 1.295 0 N-CA-C 119.396 3.11 . . . . 0.0 119.396 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -85.29 177.31 27.38 Favored 'Cis proline' 0 CA--C 1.548 1.175 0 CA-C-N 127.452 3.697 . . . . 0.0 112.832 -1.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 84.5 m -95.08 119.98 34.52 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 120.058 -1.651 . . . . 0.0 110.83 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.491 HH21 HG21 ' A' ' 195' ' ' VAL . 4.6 tmm_? -132.19 148.03 52.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 121.351 1.887 . . . . 0.0 108.484 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.34 -166.65 30.47 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.59 111.92 17.47 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 127.233 2.213 . . . . 0.0 109.591 175.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.7 m -98.45 169.7 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 C-N-CA 125.275 1.43 . . . . 0.0 108.302 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.8 m -95.74 124.53 39.8 Favored 'General case' 0 C--N 1.364 1.199 0 N-CA-C 101.157 -3.646 . . . . 0.0 101.157 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.618 ' HD3' HG11 ' A' ' 129' ' ' VAL . 7.3 ttpm? -70.46 -9.06 55.48 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 124.359 3.254 . . . . 0.0 117.451 -168.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 15.8 ptp180 -73.34 -6.26 44.98 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 129.622 3.169 . . . . 0.0 115.291 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.516 HD13 ' O ' ' A' ' 99' ' ' LYS 0.264 0.8 OUTLIER -112.94 11.63 19.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.839 0.856 . . . . 0.0 110.371 176.545 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.46 HD12 ' HG3' ' A' ' 145' ' ' LYS . 4.8 mt -98.01 125.37 42.93 Favored 'General case' 0 C--N 1.38 1.903 0 C-N-CA 126.381 1.872 . . . . 0.0 107.898 173.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -114.15 161.57 27.48 Favored Pre-proline 0 C--N 1.346 0.426 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.32 153.59 14.06 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 124.959 2.807 . . . . 0.0 113.628 -174.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.296 0.1 OUTLIER -29.87 -84.14 0.0 OUTLIER 'General case' 0 C--N 1.353 0.76 2 N-CA-C 123.685 4.698 . . . . 0.0 123.685 -179.943 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.616 ' HA ' HD21 ' A' ' 183' ' ' LEU . 14.8 t -34.27 38.34 0.0 OUTLIER 'General case' 0 C--N 1.373 1.616 1 C-N-CA 136.961 6.105 . . . . 0.0 118.154 -176.156 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.51 -36.86 2.36 Favored Glycine 0 C--N 1.358 1.788 0 C-N-CA 128.802 3.096 . . . . 0.0 117.969 -168.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 38.0 m -48.6 -15.41 0.08 Allowed 'General case' 0 C--N 1.376 1.755 0 N-CA-C 119.493 3.145 . . . . 0.0 119.493 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -111.34 0.12 16.54 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.453 2.301 . . . . 0.0 110.619 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.5 t -103.35 158.45 16.32 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 127.719 2.407 . . . . 0.0 114.691 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -56.54 -18.64 12.36 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.334 2.654 . . . . 0.0 118.09 -171.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -90.25 -10.53 43.93 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 124.814 1.246 . . . . 0.0 112.402 169.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 4.8 10.62 Favored 'General case' 0 C--N 1.375 1.694 0 CA-C-N 120.146 1.339 . . . . 0.0 114.396 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.424 0.0 OUTLIER -113.2 162.01 16.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -50.08 122.41 6.71 Favored 'General case' 0 C--N 1.372 1.587 0 C-N-CA 127.318 2.247 . . . . 0.0 116.569 -172.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.86 -22.82 32.68 Favored Glycine 0 C--N 1.36 1.907 0 C-N-CA 125.01 1.291 . . . . 0.0 111.943 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.32 158.7 44.09 Favored Glycine 0 C--N 1.371 2.516 0 N-CA-C 119.43 2.532 . . . . 0.0 119.43 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -52.19 -42.86 63.83 Favored 'General case' 0 C--N 1.366 1.317 0 N-CA-C 121.751 3.982 . . . . 0.0 121.751 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.488 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.344 0.2 OUTLIER -105.16 12.49 31.95 Favored 'General case' 0 C--N 1.365 1.262 0 O-C-N 120.327 -1.483 . . . . 0.0 112.967 -177.779 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -93.53 90.87 6.84 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 126.096 1.758 . . . . 0.0 112.722 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.6 m -115.01 117.52 30.82 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 101.735 -3.431 . . . . 0.0 101.735 170.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.19 101.7 14.42 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 125.87 2.748 . . . . 0.0 113.581 -168.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -120.36 137.77 26.5 Favored Pre-proline 0 N--CA 1.422 -1.836 1 C-N-CA 133.753 4.821 . . . . 0.0 103.039 170.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.92 -26.07 79.66 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.943 3.762 . . . . 0.0 115.134 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -69.74 -35.97 75.45 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 130.961 3.705 . . . . 0.0 112.985 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.251 56.1 mt -75.15 -34.57 31.85 Favored 'Isoleucine or valine' 0 C--N 1.377 1.77 0 C-N-CA 126.289 1.836 . . . . 0.0 109.569 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.88 -46.53 68.17 Favored 'General case' 0 C--N 1.375 1.698 0 C-N-CA 124.827 1.251 . . . . 0.0 111.765 170.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -57.61 -35.79 70.91 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.751 2.02 . . . . 0.0 114.061 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.17 -40.22 86.59 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 130.788 3.635 . . . . 0.0 112.071 172.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 56.4 mtt -69.67 -33.19 72.22 Favored 'General case' 0 C--N 1.364 1.201 0 CA-C-O 116.786 -1.578 . . . . 0.0 113.633 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -74.14 -48.21 30.94 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 126.769 2.028 . . . . 0.0 111.008 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.474 ' HE ' ' HG ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -69.08 -43.93 73.56 Favored 'General case' 0 C--N 1.369 1.432 0 C-N-CA 129.292 3.037 . . . . 0.0 112.454 177.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.86 93.05 Favored 'General case' 0 C--N 1.377 1.794 0 C-N-CA 125.359 1.463 . . . . 0.0 112.198 169.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.441 ' HA ' HD13 ' A' ' 183' ' ' LEU 0.356 4.4 t70 -60.9 -51.38 69.53 Favored 'General case' 0 C--N 1.384 2.096 0 CA-C-N 120.524 1.511 . . . . 0.0 113.016 173.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -35.17 64.84 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 121.938 2.154 . . . . 0.0 116.268 175.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.77 -44.63 32.14 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 168.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' A' ' 152' ' ' THR . 0.3 OUTLIER -60.9 -40.95 95.01 Favored 'General case' 0 C--N 1.364 1.203 0 C-N-CA 131.032 3.733 . . . . 0.0 116.032 178.182 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.284 0.0 OUTLIER -89.21 -13.82 37.4 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.801 2.04 . . . . 0.0 110.783 -173.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -121.31 -108.78 0.35 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 126.553 1.941 . . . . 0.0 114.525 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -131.97 162.11 31.5 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.53 -1.981 . . . . 0.0 113.7 -172.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -37.65 54.1 Favored 'General case' 0 C--N 1.375 1.678 1 C-N-CA 132.113 4.165 . . . . 0.0 116.262 177.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.2 -31.89 49.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.501 0 C-N-CA 127.222 2.209 . . . . 0.0 113.74 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -70.84 -42.79 69.71 Favored 'General case' 0 C--N 1.374 1.635 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.449 ' HB2' HD13 ' A' ' 109' ' ' LEU . 7.9 ptt180 -75.44 -44.28 45.23 Favored 'General case' 0 C--N 1.364 1.199 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 170.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.269 7.7 tp -72.52 -19.19 61.56 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 127.234 2.213 . . . . 0.0 114.806 -173.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -63.0 -27.88 69.72 Favored 'General case' 0 C--N 1.368 1.371 0 C-N-CA 127.863 2.465 . . . . 0.0 112.697 166.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.474 ' HG ' ' HE ' ' A' ' 178' ' ' ARG . 2.0 mm? -100.06 22.45 11.29 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 127.965 2.506 . . . . 0.0 112.191 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.61 53.95 0.03 OUTLIER 'General case' 0 C--N 1.374 1.655 0 C-N-CA 127.825 2.45 . . . . 0.0 115.634 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.491 HG21 HH21 ' A' ' 140' ' ' ARG 0.403 2.9 m . . . . . 0 C--N 1.366 1.283 1 C-N-CA 134.867 5.267 . . . . 0.0 117.024 -179.833 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 99.5 p . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 120.286 0.089 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -138.36 58.29 1.67 Allowed 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -113.82 122.97 48.67 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 119.336 -2.102 . . . . 0.0 114.314 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.297 96.8 p -112.92 167.35 9.36 Favored Pre-proline 0 C--N 1.359 0.992 0 C-N-CA 129.278 3.031 . . . . 0.0 115.42 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -48.58 139.92 22.73 Favored 'Trans proline' 0 C--N 1.379 2.161 1 C-N-CA 127.457 5.438 . . . . 0.0 121.266 -170.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.26 -7.07 66.43 Favored Glycine 0 C--N 1.37 2.418 0 C-N-CA 126.092 1.806 . . . . 0.0 112.585 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.82 169.15 10.52 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 119.971 1.886 . . . . 0.0 111.851 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 2.8 mm? -102.7 147.76 26.43 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 167.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.35 159.34 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 -177.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -104.67 119.1 38.2 Favored 'General case' 0 CA--C 1.51 -0.558 1 N-CA-C 98.054 -4.795 . . . . 0.0 98.054 165.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.96 131.53 52.35 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.29 136.99 47.84 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 118.675 -2.516 . . . . 0.0 106.136 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 57.1 ttm -129.69 141.4 50.91 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 119.922 -1.736 . . . . 0.0 110.264 173.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -65.37 107.62 1.7 Allowed 'General case' 0 C--N 1.367 1.353 0 C-N-CA 126.082 1.753 . . . . 0.0 112.878 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.55 -16.61 21.52 Favored Glycine 0 C--N 1.36 1.887 0 C-N-CA 125.438 1.494 . . . . 0.0 112.55 -172.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -112.53 161.63 25.4 Favored Pre-proline 0 C--N 1.359 1.011 0 O-C-N 121.144 -1.21 . . . . 0.0 109.111 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.95 167.06 27.73 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 125.015 3.81 . . . . 0.0 113.342 166.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.49 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -58.36 116.42 3.61 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 127.908 2.483 . . . . 0.0 112.821 171.394 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -127.0 117.9 22.1 Favored Pre-proline 0 N--CA 1.426 -1.633 0 N-CA-C 121.387 3.847 . . . . 0.0 121.387 -169.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -49.08 125.3 13.03 Favored 'Trans proline' 0 C--N 1.387 2.58 1 C-N-CA 127.079 5.186 . . . . 0.0 112.374 162.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 m -146.55 164.19 33.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 124.298 1.999 . . . . 0.0 112.045 -158.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 tt -135.67 135.57 40.23 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 119.564 -1.96 . . . . 0.0 106.61 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.312 3.3 p -92.45 130.97 40.77 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 CA-C-N 121.19 1.814 . . . . 0.0 110.372 175.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -133.37 153.05 51.92 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 125.521 1.528 . . . . 0.0 111.955 -166.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -99.81 112.16 24.43 Favored 'General case' 0 C--N 1.376 1.718 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 171.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -96.73 158.38 33.67 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 130.416 3.486 . . . . 0.0 108.767 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -50.05 -1.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.525 2 C-N-CA 127.565 5.51 . . . . 0.0 122.852 -165.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -99.83 9.1 43.58 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 126.673 1.989 . . . . 0.0 108.981 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.0 143.66 0.08 Allowed 'General case' 0 C--N 1.369 1.437 1 C-N-CA 134.224 5.01 . . . . 0.0 120.884 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.94 -19.68 27.51 Favored Glycine 0 C--N 1.359 1.832 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.5 t -134.12 127.52 32.27 Favored 'General case' 0 N--CA 1.448 -0.571 1 N-CA-C 99.456 -4.276 . . . . 0.0 99.456 163.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -128.24 6.41 5.86 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 120.514 -1.366 . . . . 0.0 109.671 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.549 HG22 HG12 ' A' ' 129' ' ' VAL . 23.5 pt -118.59 150.36 20.86 Favored 'Isoleucine or valine' 0 C--N 1.361 1.105 0 CA-C-O 124.076 1.893 . . . . 0.0 113.678 -173.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.532 ' HE ' ' H ' ' A' ' 122' ' ' GLU . 5.7 tpm_? -140.42 144.23 36.04 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 130.025 3.33 . . . . 0.0 103.715 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.532 ' H ' ' HE ' ' A' ' 121' ' ' ARG . 42.4 tt0 -140.3 126.93 20.34 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 176.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -107.16 93.39 4.53 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.82 1.648 . . . . 0.0 107.175 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.5 -93.55 0.81 Allowed Glycine 0 C--N 1.362 2.014 0 C-N-CA 126.489 1.995 . . . . 0.0 111.729 -174.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.58 -0.78 10.76 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 125.248 1.419 . . . . 0.0 109.204 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.5 t -92.52 97.97 11.16 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 125.298 1.439 . . . . 0.0 111.055 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.18 129.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 128.135 2.574 . . . . 0.0 112.404 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -123.49 140.66 52.78 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 126.998 2.119 . . . . 0.0 109.709 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 120' ' ' ILE . 14.8 m -127.2 163.53 29.96 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 127.284 2.233 . . . . 0.0 109.928 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -78.62 123.46 27.14 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 119.195 -2.191 . . . . 0.0 111.819 171.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.538 HG22 HG11 ' A' ' 143' ' ' VAL . 5.5 m -143.96 176.21 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.232 0 CA-C-N 123.278 2.763 . . . . 0.0 104.846 174.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.32 152.36 51.77 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 125.07 1.481 . . . . 0.0 108.442 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.52 120.65 42.82 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 104.141 -2.541 . . . . 0.0 104.141 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -64.86 65.88 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.5 1.92 . . . . 0.0 114.839 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -103.16 -128.62 0.23 Allowed 'General case' 0 C--N 1.36 1.045 0 O-C-N 118.963 -2.336 . . . . 0.0 112.123 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -102.24 -57.53 2.05 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 126.144 1.778 . . . . 0.0 113.001 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.6 p -80.91 -26.6 0.43 Allowed Pre-proline 0 C--N 1.362 1.113 0 N-CA-C 118.356 2.724 . . . . 0.0 118.356 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -85.89 -157.26 1.22 Allowed 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 127.944 3.873 . . . . 0.0 109.977 -2.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.4 m -96.68 127.82 43.03 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 1.1 tmt_? -161.64 154.77 20.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 119.488 -2.008 . . . . 0.0 108.936 -176.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.95 -158.02 19.33 Favored Glycine 0 CA--C 1.485 -1.803 0 N-CA-C 103.74 -3.744 . . . . 0.0 103.74 166.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -91.01 112.61 24.58 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 169.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.538 HG11 HG22 ' A' ' 131' ' ' VAL 0.304 14.8 p -102.64 161.31 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.988 -163.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 m -78.37 109.69 12.74 Favored 'General case' 0 C--N 1.363 1.188 0 C-N-CA 124.919 1.288 . . . . 0.0 107.836 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.505 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 26.9 tttp -64.4 -19.05 65.26 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -170.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -82.41 -6.33 59.21 Favored 'General case' 0 C--N 1.362 1.146 0 O-C-N 120.237 -1.54 . . . . 0.0 113.742 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.4 mt -100.68 6.85 44.13 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 126.405 1.882 . . . . 0.0 109.695 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.505 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 26.1 mt -96.69 124.42 40.67 Favored 'General case' 0 C--N 1.368 1.397 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -116.65 158.84 42.52 Favored Pre-proline 0 CA--C 1.493 -1.24 0 O-C-N 120.478 -1.389 . . . . 0.0 107.809 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.81 150.73 14.39 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 CA-C-N 122.711 2.004 . . . . 0.0 113.41 -170.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 95' ' ' LEU 0.36 0.0 OUTLIER -28.2 -87.39 0.0 OUTLIER 'General case' 0 C--N 1.355 0.81 2 N-CA-C 123.459 4.615 . . . . 0.0 123.459 -177.997 . . . . . . . . 5 4 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.54 ' HA ' HD21 ' A' ' 183' ' ' LEU . 8.8 t 2.52 57.23 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 1 C-N-CA 134.656 5.183 . . . . 0.0 118.865 176.392 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.559 ' H ' HD11 ' A' ' 183' ' ' LEU . . . -79.16 -108.24 0.22 Allowed Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 122.234 3.654 . . . . 0.0 122.234 -154.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.3 m -45.17 -22.44 0.11 Allowed 'General case' 0 C--N 1.371 1.54 0 C-N-CA 130.643 3.577 . . . . 0.0 120.197 -167.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -85.39 -11.5 54.35 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 127.934 2.493 . . . . 0.0 113.051 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 68.8 m -89.81 150.82 22.09 Favored 'General case' 0 C--N 1.367 1.341 0 C-N-CA 126.342 1.857 . . . . 0.0 114.401 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -47.89 -39.84 19.98 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 129.358 3.063 . . . . 0.0 116.694 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.22 -13.18 59.98 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -106.24 8.19 31.81 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 121.111 -0.993 . . . . 0.0 113.519 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -117.27 179.76 3.95 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 126.082 1.753 . . . . 0.0 108.867 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.2 122.77 15.88 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 126.706 2.002 . . . . 0.0 113.8 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.31 -8.25 64.49 Favored Glycine 0 C--N 1.359 1.846 0 C-N-CA 124.909 1.242 . . . . 0.0 111.755 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.69 154.87 34.73 Favored Glycine 0 C--N 1.362 2.019 0 C-N-CA 126.342 1.925 . . . . 0.0 114.944 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -65.97 -42.48 89.82 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 119.57 3.174 . . . . 0.0 119.57 -172.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.49 ' HB3' ' CD2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -101.62 1.72 38.06 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 121.567 1.985 . . . . 0.0 113.41 -178.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -81.06 91.88 6.15 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 127.054 2.142 . . . . 0.0 113.337 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 27.6 m -116.48 102.25 9.34 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 100.49 -3.893 . . . . 0.0 100.49 168.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.31 101.94 13.71 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 125.842 2.734 . . . . 0.0 111.661 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -119.45 149.45 47.77 Favored Pre-proline 0 N--CA 1.422 -1.826 1 C-N-CA 132.338 4.255 . . . . 0.0 100.516 171.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.34 -30.14 79.74 Favored 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 126.137 4.558 . . . . 0.0 115.822 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -68.71 -47.49 66.23 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 126.828 2.051 . . . . 0.0 113.258 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.5 mt -67.28 -45.28 86.42 Favored 'Isoleucine or valine' 0 C--N 1.373 1.59 0 C-N-CA 127.363 2.265 . . . . 0.0 111.337 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 177' ' ' GLN 0.424 2.3 pp -68.81 -32.1 71.57 Favored 'General case' 0 C--N 1.372 1.559 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 174.617 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 52.5 tpt85 -66.5 -42.02 88.0 Favored 'General case' 0 C--N 1.379 1.862 0 C-N-CA 127.903 2.481 . . . . 0.0 113.165 172.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.21 -33.86 76.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 131.593 3.957 . . . . 0.0 111.275 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 41.2 mtp -69.95 -32.7 71.09 Favored 'General case' 0 C--N 1.371 1.504 0 C-N-CA 126.824 2.05 . . . . 0.0 112.424 164.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 36.2 mt-30 -72.11 -45.09 61.94 Favored 'General case' 0 C--N 1.383 2.026 0 CA-C-N 121.259 1.845 . . . . 0.0 111.647 174.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -64.78 -50.52 66.44 Favored 'General case' 0 C--N 1.381 1.952 0 C-N-CA 129.443 3.097 . . . . 0.0 111.586 174.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.3 -52.47 61.84 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-O 116.879 -1.534 . . . . 0.0 113.912 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.26 -43.91 71.37 Favored 'General case' 0 C--N 1.383 2.036 0 CA-C-N 121.822 2.101 . . . . 0.0 114.048 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -36.59 84.71 Favored 'General case' 0 C--N 1.366 1.294 0 O-C-N 119.12 -2.238 . . . . 0.0 115.809 172.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 190' ' ' ARG . . . -75.52 -44.65 42.55 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 174.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.559 HD11 ' H ' ' A' ' 153' ' ' GLY 0.259 1.2 tt -58.93 -42.97 91.03 Favored 'General case' 0 C--N 1.358 0.955 1 C-N-CA 132.174 4.19 . . . . 0.0 116.051 176.851 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.278 0.0 OUTLIER -91.56 -7.37 50.43 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.342 1.457 . . . . 0.0 111.068 -177.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -119.09 -112.34 0.34 Allowed 'General case' 0 C--N 1.362 1.122 0 O-C-N 121.629 -0.669 . . . . 0.0 111.979 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -127.05 158.27 37.43 Favored 'General case' 0 C--N 1.36 1.059 0 O-C-N 120.337 -1.477 . . . . 0.0 110.667 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 190' ' ' ARG 0.298 24.0 tttm -51.63 -37.01 48.23 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 130.708 3.603 . . . . 0.0 116.774 178.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.5 tp -53.7 -29.71 17.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 129.273 3.029 . . . . 0.0 113.526 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.263 6.1 mptt -72.05 -47.92 48.1 Favored 'General case' 0 C--N 1.371 1.542 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 175.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ARG . . . . . 0.442 ' HD2' ' HB1' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -75.37 -37.43 60.62 Favored 'General case' 0 C--N 1.368 1.384 0 CA-C-N 123.168 2.713 . . . . 0.0 115.335 172.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.46 -25.2 63.97 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 126.426 1.89 . . . . 0.0 114.552 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -60.99 -38.03 84.56 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.612 2.765 . . . . 0.0 113.542 166.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -85.17 -51.04 6.9 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 126.741 2.017 . . . . 0.0 108.68 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 66.52 -72.14 0.09 Allowed 'General case' 0 C--N 1.365 1.252 0 C-N-CA 127.818 2.447 . . . . 0.0 116.027 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.226 -0.132 0 C-N-CA 129.426 3.09 . . . . 0.0 111.642 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.5 tptm . . . . . 0 N--CA 1.439 -1.018 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.83 40.51 0.53 Allowed 'General case' 0 C--N 1.36 1.062 0 C-N-CA 126.755 2.022 . . . . 0.0 115.427 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -159.14 80.36 0.76 Allowed 'General case' 0 C--N 1.354 0.77 0 C-N-CA 125.018 1.327 . . . . 0.0 108.462 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -82.36 118.92 23.53 Favored 'General case' 0 C--N 1.362 1.144 0 O-C-N 120.063 -1.648 . . . . 0.0 110.746 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.5 tp 68.84 -87.42 0.03 OUTLIER 'General case' 0 C--N 1.366 1.283 0 C-N-CA 128.073 2.549 . . . . 0.0 111.71 -175.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -121.3 5.15 10.24 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.096 1.358 . . . . 0.0 111.13 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.12 18.99 73.52 Favored Glycine 0 C--N 1.369 2.388 0 N-CA-C 119.776 2.67 . . . . 0.0 119.776 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.05 -84.19 0.35 Allowed Glycine 0 C--N 1.356 1.652 0 C-N-CA 126.242 1.877 . . . . 0.0 111.557 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.7 tp -135.72 -113.82 0.19 Allowed 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.155 0.982 . . . . 0.0 109.099 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.469 HH22 ' HE ' ' A' ' 121' ' ' ARG . 15.5 ptp180 -72.21 -54.33 9.96 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 -176.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -148.17 29.18 0.89 Allowed 'General case' 0 C--N 1.354 0.775 0 O-C-N 119.866 -1.772 . . . . 0.0 107.245 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 62.9 m 67.64 -59.94 0.4 Allowed 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.823 2.849 . . . . 0.0 116.463 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -74.81 129.3 36.83 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 129.056 2.942 . . . . 0.0 114.879 -172.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.38 166.88 10.08 Favored Pre-proline 0 C--N 1.351 0.662 0 C-N-CA 128.899 2.879 . . . . 0.0 108.396 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -82.03 -104.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.806 3.004 . . . . 0.0 111.081 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 177.18 -156.49 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.73 115.18 63.66 Favored Pre-proline 0 C--N 1.355 0.824 0 CA-C-O 117.056 -1.45 . . . . 0.0 110.547 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -88.98 161.53 5.94 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.63 2.886 . . . . 0.0 115.385 -177.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 t -146.93 23.46 1.21 Allowed 'General case' 0 C--N 1.356 0.852 0 N-CA-C 104.038 -2.578 . . . . 0.0 104.038 168.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.4 t -154.3 142.1 20.04 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 -173.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.463 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 36.8 m 66.52 89.58 0.1 Allowed 'General case' 0 C--N 1.356 0.88 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.3 p30 -139.21 94.82 2.84 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 121.071 -1.018 . . . . 0.0 113.725 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -124.51 126.26 45.56 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 121.25 -0.906 . . . . 0.0 109.113 -174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 56.4 p -111.09 165.82 11.97 Favored Pre-proline 0 C--N 1.364 1.212 0 C-N-CA 127.671 2.388 . . . . 0.0 114.243 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -56.21 139.66 86.24 Favored 'Trans proline' 0 C--N 1.365 1.425 1 C-N-CA 125.622 4.215 . . . . 0.0 120.867 -167.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 116.4 -24.54 9.75 Favored Glycine 0 C--N 1.361 1.955 0 C-N-CA 128.287 2.851 . . . . 0.0 110.885 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.43 170.21 12.18 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 119.895 1.847 . . . . 0.0 114.251 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 151' ' ' TYR . 4.2 mm? -98.28 141.92 30.58 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 103.212 -2.885 . . . . 0.0 103.212 164.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 149' ' ' LYS . 19.3 m -143.77 141.46 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 -175.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.451 ' CZ3' ' HB2' ' A' ' 165' ' ' PHE . 28.0 m95 -99.02 129.85 45.32 Favored 'General case' 0 C--O 1.214 -0.787 1 O-C-N 115.97 -4.206 . . . . 0.0 103.455 171.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -114.48 147.33 39.5 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 121.087 1.767 . . . . 0.0 109.494 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.2 tttp -118.71 145.83 45.21 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 170.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 37.1 ttm -126.69 154.77 43.64 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 123.233 1.492 . . . . 0.0 111.296 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -59.73 80.7 0.01 OUTLIER 'General case' 0 C--N 1.355 0.847 0 C-N-CA 131.669 3.988 . . . . 0.0 115.838 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.57 7.09 37.47 Favored Glycine 0 C--N 1.359 1.808 0 C-N-CA 125.504 1.526 . . . . 0.0 113.519 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -114.91 160.32 34.09 Favored Pre-proline 0 C--N 1.356 0.875 0 C-N-CA 125.65 1.58 . . . . 0.0 107.591 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -71.79 166.07 30.61 Favored 'Trans proline' 0 CA--C 1.548 1.215 0 C-N-CA 124.952 3.768 . . . . 0.0 113.422 168.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -49.35 129.49 18.61 Favored 'General case' 0 C--N 1.364 1.203 0 C-N-CA 128.356 2.662 . . . . 0.0 117.147 167.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.463 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 7.4 m95 -134.21 109.0 11.47 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 121.586 3.921 . . . . 0.0 121.586 -173.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 19.2 Cg_endo -62.22 110.83 1.11 Allowed 'Trans proline' 0 C--N 1.389 2.679 1 C-N-CA 126.663 4.909 . . . . 0.0 112.743 167.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -123.01 164.98 17.53 Favored 'General case' 0 C--N 1.352 0.677 1 C-N-CA 133.286 4.634 . . . . 0.0 116.022 -170.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.2 tp -116.46 132.54 56.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 129.447 3.099 . . . . 0.0 107.254 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.9 p -86.16 118.85 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.806 0 O-C-N 119.913 -1.742 . . . . 0.0 106.537 174.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -127.36 149.78 49.9 Favored 'General case' 0 C--N 1.368 1.391 0 O-C-N 119.002 -2.311 . . . . 0.0 111.059 -170.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -102.0 113.49 26.77 Favored 'General case' 0 C--N 1.37 1.471 0 CA-C-O 122.489 1.138 . . . . 0.0 111.511 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -79.49 158.81 73.28 Favored Pre-proline 0 C--N 1.353 0.738 0 C-N-CA 129.367 3.067 . . . . 0.0 112.592 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.28 71.4 Cg_exo -47.66 1.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.383 2.371 1 C-N-CA 130.356 7.37 . . . . 0.0 121.498 -171.515 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -98.89 31.65 2.9 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 131.588 3.955 . . . . 0.0 106.646 169.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.289 0.0 OUTLIER -68.7 150.81 47.49 Favored 'General case' 0 C--N 1.373 1.621 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 -169.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.69 -20.11 27.59 Favored Glycine 0 C--N 1.365 2.158 0 C-N-CA 126.922 2.201 . . . . 0.0 112.552 -175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.7 m -130.44 147.0 52.09 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 101.269 -3.604 . . . . 0.0 101.269 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.405 ' HB2' ' NE2' ' A' ' 130' ' ' HIS . 7.3 p90 -130.7 -0.73 4.31 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-N 121.111 1.778 . . . . 0.0 114.882 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.7 pt -106.48 148.0 11.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.475 0 CA-C-O 123.904 1.812 . . . . 0.0 113.734 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.469 ' HE ' HH22 ' A' ' 77' ' ' ARG . 29.8 tpt180 -119.01 126.58 52.06 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 102.229 -3.248 . . . . 0.0 102.229 172.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -148.16 143.79 27.32 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 120.191 -1.568 . . . . 0.0 110.295 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.54 93.74 4.22 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 127.51 2.324 . . . . 0.0 108.821 172.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.19 -76.03 0.34 Allowed Glycine 0 C--N 1.365 2.19 0 N-CA-C 119.891 2.716 . . . . 0.0 119.891 175.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -149.01 60.38 1.05 Allowed 'General case' 0 C--N 1.358 0.959 0 CA-C-O 124.014 1.864 . . . . 0.0 109.055 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.7 m -169.59 133.8 1.34 Allowed 'General case' 0 C--N 1.349 0.566 0 C-N-CA 127.551 2.341 . . . . 0.0 105.48 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.94 146.82 31.07 Favored 'Isoleucine or valine' 0 C--N 1.363 1.186 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 58.6 mtp85 -134.35 142.77 47.34 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 129.173 2.989 . . . . 0.0 107.264 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.3 162.21 26.14 Favored 'Isoleucine or valine' 0 C--N 1.368 1.387 0 C-N-CA 127.301 2.24 . . . . 0.0 107.897 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 111' ' ' TYR . 0.4 OUTLIER -94.0 133.4 37.49 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 119.576 -1.953 . . . . 0.0 111.031 175.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.3 m -145.91 172.97 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.769 0 N-CA-C 104.03 -2.581 . . . . 0.0 104.03 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.38 158.09 38.22 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 166.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -113.86 130.75 56.45 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -75.11 71.93 2.19 Favored 'General case' 0 C--N 1.372 1.578 0 C-N-CA 126.759 2.023 . . . . 0.0 109.876 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -95.7 -102.92 0.16 Allowed 'General case' 0 C--N 1.361 1.085 0 C-N-CA 125.042 1.337 . . . . 0.0 111.132 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -106.72 -62.69 1.36 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 126.216 1.807 . . . . 0.0 113.867 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 23.3 p -85.65 -32.61 0.46 Allowed Pre-proline 0 C--N 1.364 1.204 0 N-CA-C 119.374 3.102 . . . . 0.0 119.374 -174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -84.86 -176.1 14.16 Favored 'Cis proline' 0 CA--C 1.544 0.989 1 CA-C-N 130.358 4.735 . . . . 0.0 112.727 -0.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.315 4.6 t -97.53 154.86 17.24 Favored 'General case' 0 C--N 1.372 1.57 0 C-N-CA 127.216 2.206 . . . . 0.0 113.051 171.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.79 152.47 41.27 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.946 1.698 . . . . 0.0 106.58 171.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.43 -175.47 39.84 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 172.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -93.01 117.87 30.54 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 125.189 1.396 . . . . 0.0 108.059 174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 m -102.2 161.98 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 C-N-CA 125.603 1.561 . . . . 0.0 113.334 -173.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.6 m -76.68 97.63 4.51 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 126.541 1.936 . . . . 0.0 107.18 171.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.511 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 35.1 tttp -54.62 -29.05 50.89 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 128.283 2.633 . . . . 0.0 115.878 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 60.7 ttt180 -70.42 -13.37 62.1 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 127.105 2.162 . . . . 0.0 114.098 173.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.8 mt -98.12 3.84 49.14 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 126.982 2.113 . . . . 0.0 111.784 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 23.4 mt -89.86 135.01 33.89 Favored 'General case' 0 C--N 1.37 1.47 0 C-N-CA 126.661 1.984 . . . . 0.0 111.221 173.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 71.0 mmtt -114.65 158.75 39.45 Favored Pre-proline 0 C--N 1.346 0.448 0 C-N-CA 127.703 2.401 . . . . 0.0 106.279 -177.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.55 158.23 14.42 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 C-N-CA 124.814 3.676 . . . . 0.0 118.563 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -44.09 92.35 0.01 OUTLIER 'General case' 0 C--N 1.357 0.906 1 C-N-CA 132.949 4.5 . . . . 0.0 119.975 171.85 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.4 t -162.28 167.77 23.37 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 102.517 -3.142 . . . . 0.0 102.517 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.74 -157.96 7.58 Favored Glycine 0 C--N 1.365 2.172 0 N-CA-C 119.776 2.67 . . . . 0.0 119.776 -165.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.3 t -45.41 -11.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 1 N-CA-C 122.066 4.099 . . . . 0.0 122.066 -165.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -107.4 -10.01 15.86 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 129.322 3.049 . . . . 0.0 112.709 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 59.8 m -81.88 138.88 34.96 Favored 'General case' 0 C--N 1.376 1.728 0 C-N-CA 127.736 2.415 . . . . 0.0 111.085 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.251 33.1 ttmt -52.22 -33.49 41.43 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 117.835 2.531 . . . . 0.0 117.835 -174.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -86.71 -0.94 57.25 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 119.318 0.963 . . . . 0.0 112.963 171.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.89 3.25 10.0 Favored 'General case' 0 C--N 1.371 1.53 0 CA-C-N 120.25 1.387 . . . . 0.0 113.444 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.448 HE21 ' HB3' ' A' ' 160' ' ' GLN 0.251 0.0 OUTLIER -109.9 179.72 4.04 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.134 2.974 . . . . 0.0 107.331 -178.901 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -70.74 122.47 19.9 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 120.141 -1.599 . . . . 0.0 113.175 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.37 -5.27 55.1 Favored Glycine 0 C--N 1.363 2.047 0 O-C-N 120.961 -1.087 . . . . 0.0 111.757 -170.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.89 152.22 25.77 Favored Glycine 0 C--N 1.361 1.928 0 C-N-CA 128.648 3.023 . . . . 0.0 114.211 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -62.64 -41.7 99.18 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 117.846 2.536 . . . . 0.0 117.846 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.451 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 1.1 m-85 -85.48 -7.54 58.85 Favored 'General case' 0 CA--C 1.556 1.174 0 O-C-N 120.269 -1.519 . . . . 0.0 113.57 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -77.92 95.35 4.75 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 128.811 2.844 . . . . 0.0 114.839 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 40.7 t -114.77 128.22 56.18 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 102.461 -3.163 . . . . 0.0 102.461 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -100.76 100.26 10.9 Favored 'General case' 0 C--N 1.362 1.125 0 CA-C-O 125.613 2.625 . . . . 0.0 109.229 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -121.62 138.25 28.16 Favored Pre-proline 0 N--CA 1.421 -1.897 2 C-N-CA 135.988 5.715 . . . . 0.0 98.211 166.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.96 -26.41 66.59 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 125.073 3.848 . . . . 0.0 114.144 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -66.73 -36.65 82.96 Favored 'General case' 0 C--N 1.369 1.428 0 C-N-CA 129.012 2.925 . . . . 0.0 112.633 173.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 65.3 mt -73.41 -45.99 50.57 Favored 'Isoleucine or valine' 0 C--N 1.374 1.651 0 C-N-CA 126.018 1.727 . . . . 0.0 110.417 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.4 mt -63.12 -45.9 89.84 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 125.207 1.403 . . . . 0.0 113.535 175.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -62.42 -35.53 79.54 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.77 -34.67 77.25 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 129.673 3.189 . . . . 0.0 110.795 174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 46.0 mtt -66.71 -38.99 87.85 Favored 'General case' 0 C--N 1.382 2.017 0 C-N-CA 125.197 1.399 . . . . 0.0 111.597 168.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -74.07 -42.14 60.63 Favored 'General case' 0 C--N 1.374 1.655 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -48.06 64.71 Favored 'General case' 0 C--N 1.371 1.533 0 C-N-CA 130.671 3.589 . . . . 0.0 111.83 176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.03 99.08 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 124.592 1.157 . . . . 0.0 113.491 169.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.2 -52.49 63.58 Favored 'General case' 0 C--N 1.375 1.715 0 C-N-CA 126.006 1.722 . . . . 0.0 111.66 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.35 -37.58 67.66 Favored 'General case' 0 C--N 1.372 1.544 0 CA-C-N 121.139 1.79 . . . . 0.0 115.8 175.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.18 -44.82 36.29 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 116.029 1.862 . . . . 0.0 116.029 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.17 -31.03 67.16 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -88.21 -10.53 49.52 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 126.535 1.934 . . . . 0.0 110.608 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -123.43 -100.79 0.41 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 125.436 1.494 . . . . 0.0 112.176 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -135.57 158.0 45.47 Favored 'General case' 0 C--N 1.363 1.194 0 O-C-N 120.26 -1.525 . . . . 0.0 113.846 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -50.98 -37.34 44.19 Favored 'General case' 0 C--N 1.369 1.421 1 C-N-CA 132.389 4.276 . . . . 0.0 115.758 175.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.3 tt -55.23 -33.77 31.41 Favored 'Isoleucine or valine' 0 C--N 1.359 1.012 0 C-N-CA 129.925 3.29 . . . . 0.0 113.238 176.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -71.07 -45.29 64.05 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 125.829 1.651 . . . . 0.0 115.037 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . 0.296 0.0 OUTLIER -74.87 -42.45 57.86 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 174.408 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.292 96.2 mt -73.93 -19.39 60.7 Favored 'General case' 0 C--N 1.371 1.507 0 O-C-N 120.432 -1.417 . . . . 0.0 114.037 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -58.4 -32.06 68.26 Favored 'General case' 0 C--N 1.377 1.803 0 C-N-CA 126.769 2.027 . . . . 0.0 114.155 168.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 mt -98.28 -51.55 3.95 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 127.053 2.141 . . . . 0.0 108.874 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 42.97 -95.11 0.02 OUTLIER 'General case' 0 C--N 1.38 1.913 0 C-N-CA 130.145 3.378 . . . . 0.0 114.427 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.377 2.5 p -160.74 58.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 100.811 -3.774 . . . . 0.0 100.811 162.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 22.4 t -99.26 48.71 0.95 Allowed 'General case' 0 C--N 1.367 1.327 0 C-N-CA 127.618 2.367 . . . . 0.0 112.233 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.81 -55.56 5.69 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 126.617 1.967 . . . . 0.0 114.808 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -150.97 140.31 13.67 Favored Pre-proline 0 C--N 1.35 0.593 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.12 65.15 7.87 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 124.212 3.274 . . . . 0.0 113.753 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 15.2 m -98.24 10.65 40.13 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 127.805 2.442 . . . . 0.0 111.154 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.282 10.8 pt-20 . . . . . 0 C--N 1.365 1.242 0 C-N-CA 130.804 3.641 . . . . 0.0 118.715 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt . . . . . 0 N--CA 1.441 -0.886 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.59 -44.0 3.96 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 126.394 1.878 . . . . 0.0 110.437 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -161.71 179.72 7.91 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -103.26 129.93 50.37 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.87 2.468 . . . . 0.0 106.986 171.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.5 pt? -95.91 -35.31 11.5 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 -174.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -104.33 -12.77 16.41 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 119.795 -1.816 . . . . 0.0 114.225 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.73 -4.23 61.35 Favored Glycine 0 C--N 1.353 1.511 0 C-N-CA 125.668 1.604 . . . . 0.0 115.155 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.36 151.44 20.38 Favored Glycine 0 C--N 1.36 1.881 0 C-N-CA 125.441 1.496 . . . . 0.0 114.405 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 tp -125.31 21.56 7.93 Favored 'General case' 0 C--N 1.366 1.296 0 CA-C-O 122.736 1.255 . . . . 0.0 113.568 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -72.17 -24.39 61.42 Favored 'General case' 0 C--N 1.363 1.191 0 C-N-CA 127.912 2.485 . . . . 0.0 113.247 173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 143.19 -60.13 0.0 OUTLIER 'General case' 0 C--N 1.353 0.724 1 C-N-CA 133.569 4.748 . . . . 0.0 100.865 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.265 76.6 p 83.71 2.74 0.92 Allowed 'General case' 0 C--N 1.362 1.128 0 C-N-CA 129.527 3.131 . . . . 0.0 113.388 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.357 21.2 t 92.53 -11.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.055 0 C-N-CA 129.887 3.275 . . . . 0.0 109.807 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.71 166.74 21.14 Favored Pre-proline 0 C--N 1.362 1.146 0 C-N-CA 126.933 2.093 . . . . 0.0 111.602 176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -69.44 112.75 3.11 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 124.411 3.407 . . . . 0.0 115.486 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -114.6 -86.52 0.59 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 127.321 2.248 . . . . 0.0 108.828 175.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.13 111.77 64.27 Favored Pre-proline 0 C--N 1.361 1.08 0 C-N-CA 124.997 1.319 . . . . 0.0 111.438 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -90.13 37.98 0.36 Allowed 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.656 2.904 . . . . 0.0 112.474 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.3 m -69.59 67.8 0.23 Allowed 'General case' 0 C--N 1.363 1.189 0 C-N-CA 128.901 2.88 . . . . 0.0 114.878 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 m 115.02 29.55 0.0 OUTLIER 'General case' 0 C--N 1.354 0.791 0 C-N-CA 130.878 3.671 . . . . 0.0 108.634 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.417 ' HB2' ' HA ' ' A' ' 146' ' ' ARG 0.412 37.5 m 79.03 -73.43 0.07 Allowed 'General case' 0 C--N 1.362 1.132 0 C-N-CA 128.42 2.688 . . . . 0.0 111.045 -176.557 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 66.96 60.15 0.53 Allowed 'General case' 0 C--N 1.359 1.003 0 N-CA-C 120.396 3.48 . . . . 0.0 120.396 172.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -117.38 125.97 51.88 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 119.878 -1.764 . . . . 0.0 110.16 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.446 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.474 28.7 p -111.72 168.43 7.64 Favored Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 128.624 2.77 . . . . 0.0 115.55 -172.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 73.1 Cg_endo -71.25 151.63 60.69 Favored 'Trans proline' 0 C--N 1.365 1.418 0 C-N-CA 124.434 3.423 . . . . 0.0 118.863 -164.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 87.77 -7.29 81.64 Favored Glycine 0 C--N 1.37 2.447 0 C-N-CA 128.875 3.131 . . . . 0.0 111.109 -172.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -94.0 164.02 13.25 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 126.246 1.818 . . . . 0.0 110.493 176.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.74 140.26 37.24 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 119.098 -2.251 . . . . 0.0 107.249 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 m -133.51 153.37 36.85 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 C-N-CA 125.766 1.626 . . . . 0.0 108.979 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -102.84 116.76 33.19 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 101.422 -3.547 . . . . 0.0 101.422 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -115.12 142.51 46.56 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.727 1.211 . . . . 0.0 113.997 -176.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.7 tmtm? -116.15 132.93 56.52 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 33.2 ttm -115.98 139.05 50.64 Favored 'General case' 0 CA--C 1.509 -0.629 0 O-C-N 120.099 -1.625 . . . . 0.0 107.267 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.65 100.35 0.1 Allowed 'General case' 0 C--N 1.366 1.324 0 C-N-CA 127.379 2.272 . . . . 0.0 114.07 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.56 -22.15 22.55 Favored Glycine 0 C--N 1.358 1.761 0 C-N-CA 125.367 1.461 . . . . 0.0 113.624 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -97.99 166.81 12.76 Favored Pre-proline 0 C--N 1.361 1.088 0 O-C-N 121.036 -1.273 . . . . 0.0 109.823 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.68 166.18 30.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.803 3.669 . . . . 0.0 113.34 169.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.657 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 5.0 m95 -58.17 135.27 57.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 128.798 2.839 . . . . 0.0 115.309 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.438 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 24.0 m95 -133.65 114.77 13.3 Favored Pre-proline 0 C--N 1.367 1.354 1 N-CA-C 121.844 4.016 . . . . 0.0 121.844 -174.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -64.91 124.96 13.87 Favored 'Trans proline' 0 C--N 1.391 2.772 1 C-N-CA 125.965 4.444 . . . . 0.0 110.542 160.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 p -147.25 165.15 30.95 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 128.29 2.636 . . . . 0.0 115.017 -156.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.613 HD22 ' HB2' ' A' ' 190' ' ' ARG . 3.7 pp -119.45 144.3 47.03 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 125.749 1.619 . . . . 0.0 108.626 173.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.9 t -85.59 116.52 28.92 Favored 'Isoleucine or valine' 0 C--N 1.377 1.796 0 O-C-N 120.174 -1.579 . . . . 0.0 108.059 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -121.56 136.27 54.96 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 116.92 -3.612 . . . . 0.0 114.87 -164.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -75.99 111.36 11.29 Favored 'General case' 0 C--N 1.38 1.908 0 CA-C-O 123.762 1.744 . . . . 0.0 112.654 176.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.473 ' CG ' ' CD2' ' A' ' 130' ' ' HIS . 10.3 t60 -67.18 161.18 66.04 Favored Pre-proline 0 C--N 1.343 0.285 1 C-N-CA 132.903 4.481 . . . . 0.0 117.641 -170.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.23 -14.05 3.8 Favored 'Trans proline' 0 CA--C 1.554 1.52 1 C-N-CA 125.542 4.161 . . . . 0.0 116.398 174.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -104.69 40.01 1.57 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 129.72 3.208 . . . . 0.0 109.633 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -67.58 151.47 47.27 Favored 'General case' 0 C--N 1.372 1.566 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.74 -11.92 32.51 Favored Glycine 0 C--N 1.358 1.768 0 CA-C-N 112.396 -2.184 . . . . 0.0 110.369 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 t -125.61 166.57 16.47 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 101.855 -3.387 . . . . 0.0 101.855 167.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -154.72 -25.63 0.12 Allowed 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.581 -1.324 . . . . 0.0 114.194 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.0 pt -114.38 154.54 15.73 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 O-C-N 120.491 -1.38 . . . . 0.0 112.086 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -142.92 152.84 42.48 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 128.338 2.655 . . . . 0.0 105.027 174.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.31 127.99 19.2 Favored 'General case' 0 C--N 1.361 1.089 0 O-C-N 120.793 -1.192 . . . . 0.0 110.424 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -117.94 93.04 3.99 Favored 'General case' 0 C--N 1.363 1.17 0 C-N-CA 127.407 2.283 . . . . 0.0 110.135 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 61.11 -63.96 0.01 OUTLIER Glycine 0 C--N 1.362 2.006 0 N-CA-C 122.056 3.582 . . . . 0.0 122.056 172.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -146.62 38.34 1.02 Allowed 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.965 1.306 . . . . 0.0 111.724 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 m -167.63 139.67 3.15 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 119.847 -1.783 . . . . 0.0 106.498 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -124.66 132.97 70.59 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 CA-C-O 123.505 1.621 . . . . 0.0 109.959 -178.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -106.83 158.94 16.62 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 127.938 2.495 . . . . 0.0 113.481 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.69 HG22 ' HB2' ' A' ' 145' ' ' LYS . 33.8 m -149.09 164.66 4.09 Favored 'Isoleucine or valine' 0 C--N 1.364 1.212 0 C-N-CA 130.707 3.603 . . . . 0.0 102.755 174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.473 ' CD2' ' CG ' ' A' ' 113' ' ' HIS . 6.2 m80 -89.94 141.82 28.29 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 121.19 -0.944 . . . . 0.0 112.248 170.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 m -151.1 169.81 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 N-CA-C 104.675 -2.343 . . . . 0.0 104.675 174.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -133.53 152.91 51.98 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 171.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -109.43 132.26 54.3 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.518 1.927 . . . . 0.0 108.335 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.511 ' HB3' HH21 ' A' ' 178' ' ' ARG . 29.3 m-85 -68.54 63.77 0.11 Allowed 'General case' 0 C--N 1.371 1.503 0 C-N-CA 127.066 2.147 . . . . 0.0 114.256 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -91.91 -118.22 0.08 Allowed 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.451 2.3 . . . . 0.0 111.913 -174.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -106.85 -58.52 1.92 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.669 1.587 . . . . 0.0 112.807 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.298 27.5 p -77.18 -34.03 1.16 Allowed Pre-proline 0 C--N 1.364 1.209 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.35 -169.5 7.75 Favored 'Cis proline' 0 CA--C 1.537 0.649 0 CA-C-N 127.683 3.779 . . . . 0.0 111.616 -1.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.3 m -95.17 135.08 37.17 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.814 1.246 . . . . 0.0 107.753 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.9 tmm_? -158.1 167.92 28.52 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 161.06 -148.74 17.04 Favored Glycine 0 C--N 1.352 1.417 1 N-CA-C 101.239 -4.744 . . . . 0.0 101.239 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -89.58 156.78 18.38 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 167.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.4 -177.68 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 O-C-N 120.636 -1.29 . . . . 0.0 107.712 173.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.6 t -90.8 120.07 31.54 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 101.864 -3.384 . . . . 0.0 101.864 167.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.69 ' HB2' HG22 ' A' ' 129' ' ' VAL 0.492 0.0 OUTLIER -78.53 -10.94 59.91 Favored 'General case' 0 C--N 1.373 1.603 0 CA-C-N 123.113 2.688 . . . . 0.0 115.685 -174.396 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.417 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 96.2 mtt180 -74.84 -5.53 44.06 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.01 1.324 . . . . 0.0 113.814 172.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.1 mt -103.93 2.17 32.16 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 127.102 2.161 . . . . 0.0 112.173 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 43.0 mt -96.89 125.69 41.51 Favored 'General case' 0 C--N 1.368 1.376 0 C-N-CA 127.389 2.276 . . . . 0.0 109.956 174.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -114.7 167.74 9.22 Favored Pre-proline 0 C--N 1.347 0.493 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -83.0 157.09 15.31 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.306 3.337 . . . . 0.0 113.991 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -95.64 150.57 20.21 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-O 123.426 1.584 . . . . 0.0 107.89 170.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.8 t -173.08 -45.58 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.835 1 N-CA-C 97.26 -5.089 . . . . 0.0 97.26 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 128.35 -149.76 18.33 Favored Glycine 0 CA--C 1.474 -2.471 0 C-N-CA 117.892 -2.099 . . . . 0.0 116.865 135.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.9 m -46.5 -18.78 0.07 Allowed 'General case' 0 C--N 1.375 1.68 1 C-N-CA 133.027 4.531 . . . . 0.0 116.67 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.59 0.94 54.92 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 129.881 3.272 . . . . 0.0 112.582 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.9 m -86.51 142.56 28.26 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 127.529 2.331 . . . . 0.0 111.409 173.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -61.69 -27.45 68.71 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -79.7 -17.08 54.45 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 124.935 1.294 . . . . 0.0 111.372 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.27 4.21 51.01 Favored 'General case' 0 C--N 1.371 1.515 0 C-N-CA 124.813 1.245 . . . . 0.0 113.017 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -123.74 177.34 5.76 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 120.048 -1.657 . . . . 0.0 111.228 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -57.97 121.84 11.55 Favored 'General case' 0 C--N 1.372 1.576 0 C-N-CA 126.483 1.913 . . . . 0.0 114.598 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.32 -14.52 59.52 Favored Glycine 0 C--N 1.356 1.671 0 C-N-CA 125.174 1.369 . . . . 0.0 112.299 -169.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.6 153.64 40.91 Favored Glycine 0 C--N 1.361 1.941 0 N-CA-C 119.857 2.703 . . . . 0.0 119.857 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -55.86 -42.21 75.51 Favored 'General case' 0 C--N 1.363 1.169 0 N-CA-C 119.127 3.01 . . . . 0.0 119.127 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.657 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.308 0.5 OUTLIER -106.01 -12.16 15.9 Favored 'General case' 0 C--N 1.358 0.951 0 O-C-N 120.638 -1.289 . . . . 0.0 113.619 -179.796 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . 0.301 0.0 OUTLIER -41.68 -27.86 0.12 Allowed 'General case' 0 C--N 1.365 1.248 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 48.2 m -14.53 90.94 0.01 OUTLIER 'General case' 0 C--N 1.381 1.962 1 C-N-CA 131.901 4.08 . . . . 0.0 116.917 -174.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -86.35 102.11 13.71 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-O 125.653 2.644 . . . . 0.0 115.045 -163.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -119.96 144.53 37.71 Favored Pre-proline 0 N--CA 1.416 -2.163 3 C-N-CA 134.909 5.284 . . . . 0.0 100.184 170.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -60.31 -28.95 87.85 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 125.014 3.809 . . . . 0.0 115.487 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -65.72 -36.4 83.49 Favored 'General case' 0 C--N 1.365 1.272 0 C-N-CA 128.806 2.842 . . . . 0.0 112.303 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.438 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 20.4 mm -72.39 -37.73 58.74 Favored 'Isoleucine or valine' 0 C--N 1.374 1.631 0 C-N-CA 126.487 1.915 . . . . 0.0 110.237 175.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.5 mt -68.73 -49.38 59.23 Favored 'General case' 0 C--N 1.371 1.502 0 O-C-N 120.324 -1.485 . . . . 0.0 113.646 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -58.43 -39.3 79.44 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 127.391 2.276 . . . . 0.0 114.22 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.0 -37.34 84.02 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 131.41 3.884 . . . . 0.0 110.421 171.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.4 mtt -66.91 -33.03 74.69 Favored 'General case' 0 C--N 1.366 1.284 0 O-C-N 120.609 -1.307 . . . . 0.0 113.024 167.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -74.43 -46.86 37.22 Favored 'General case' 0 C--N 1.378 1.83 0 C-N-CA 126.527 1.931 . . . . 0.0 112.577 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.511 HH21 ' HB3' ' A' ' 134' ' ' PHE . 22.4 ttp-105 -66.31 -50.56 63.21 Favored 'General case' 0 C--N 1.372 1.57 0 C-N-CA 129.564 3.145 . . . . 0.0 112.322 174.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.07 -33.96 69.61 Favored 'General case' 0 C--N 1.375 1.692 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 167.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -68.64 -50.87 47.86 Favored 'General case' 0 C--N 1.371 1.53 0 O-C-N 120.491 -1.381 . . . . 0.0 111.751 173.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -40.36 83.15 Favored 'General case' 0 C--N 1.369 1.427 0 C-N-CA 126.363 1.865 . . . . 0.0 115.537 175.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.589 ' HB1' ' HG2' ' A' ' 190' ' ' ARG . . . -76.06 -27.25 57.18 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.423 HD13 ' N ' ' A' ' 184' ' ' ASN . 0.2 OUTLIER -78.94 -50.17 11.61 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.899 1.679 . . . . 0.0 111.177 173.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.423 ' N ' HD13 ' A' ' 183' ' ' LEU 0.322 0.0 OUTLIER -82.99 -15.71 50.13 Favored 'General case' 0 C--N 1.367 1.355 0 C-N-CA 126.615 1.966 . . . . 0.0 115.176 -169.222 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -110.64 -98.7 0.4 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 175.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -136.28 149.32 48.4 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 124.111 0.964 . . . . 0.0 109.936 177.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.8 ttpp -50.73 -34.64 27.77 Favored 'General case' 0 C--N 1.365 1.27 1 C-N-CA 133.668 4.787 . . . . 0.0 112.282 170.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 6.4 tt -52.24 -30.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.365 1.278 0 C-N-CA 128.855 2.862 . . . . 0.0 112.758 173.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.273 6.5 mptt -68.39 -43.17 77.91 Favored 'General case' 0 C--N 1.376 1.729 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 172.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.613 ' HB2' HD22 ' A' ' 109' ' ' LEU 0.265 1.2 ptm180 -76.51 -43.62 38.67 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 119.043 2.979 . . . . 0.0 119.043 170.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.453 HD12 HH21 ' A' ' 190' ' ' ARG . 12.3 tp -71.65 -27.62 63.2 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 127.38 2.272 . . . . 0.0 113.545 -174.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -81.46 -4.46 55.92 Favored 'General case' 0 C--N 1.366 1.298 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 170.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.58 -44.69 5.5 Favored 'General case' 0 C--N 1.366 1.324 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 58.97 -114.34 0.73 Allowed 'General case' 0 C--N 1.372 1.545 0 C-N-CA 127.309 2.243 . . . . 0.0 113.119 176.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.45 27.93 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 126.45 1.9 . . . . 0.0 110.448 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 5.1 t 70.74 8.13 6.45 Favored 'General case' 0 C--N 1.37 1.459 0 C-N-CA 128.219 2.607 . . . . 0.0 115.027 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 10.5 t70 91.23 16.38 0.03 OUTLIER 'General case' 0 C--N 1.359 0.986 0 C-N-CA 130.828 3.651 . . . . 0.0 111.967 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.52 125.09 59.03 Favored Pre-proline 0 C--N 1.37 1.474 0 O-C-N 120.11 -1.618 . . . . 0.0 113.506 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -85.62 144.91 9.02 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.853 3.036 . . . . 0.0 109.45 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 81.6 p -84.4 70.98 10.73 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 125.798 1.639 . . . . 0.0 113.749 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 . . . . . 0 C--N 1.356 0.883 0 C-N-CA 126.177 1.791 . . . . 0.0 110.177 -178.235 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? . . . . . 0 N--CA 1.441 -0.876 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.25 166.36 25.53 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 126.119 1.768 . . . . 0.0 106.988 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -152.22 165.3 35.27 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -103.67 152.69 21.5 Favored 'General case' 0 C--N 1.36 1.063 0 C-N-CA 127.121 2.169 . . . . 0.0 108.697 174.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.317 15.7 mt 77.51 176.8 0.17 Allowed 'General case' 0 C--N 1.364 1.215 0 C-N-CA 127.653 2.381 . . . . 0.0 116.722 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.0 21.35 17.69 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 126.713 2.005 . . . . 0.0 111.43 -176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.92 -16.67 58.21 Favored Glycine 0 C--N 1.361 1.948 0 C-N-CA 126.438 1.97 . . . . 0.0 114.423 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.97 11.05 44.28 Favored Glycine 0 C--N 1.356 1.68 0 C-N-CA 126.838 2.161 . . . . 0.0 110.856 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.24 65.77 1.63 Allowed 'General case' 0 C--N 1.356 0.86 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -71.61 -24.16 61.83 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 130.189 3.396 . . . . 0.0 112.365 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.5 tpt85 -92.32 -0.1 57.41 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 128.267 2.627 . . . . 0.0 110.211 176.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 22.1 t 66.77 -102.35 0.07 Allowed 'General case' 0 C--N 1.365 1.241 0 C-N-CA 129.665 3.186 . . . . 0.0 114.832 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.8 m -112.95 10.66 8.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 126.175 1.79 . . . . 0.0 110.518 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.11 140.05 20.88 Favored Pre-proline 0 C--N 1.358 0.976 0 O-C-N 120.518 -1.364 . . . . 0.0 110.854 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.7 -69.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 124.236 3.291 . . . . 0.0 110.823 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -147.73 -56.23 0.23 Allowed 'General case' 0 C--N 1.354 0.777 0 C-N-CA 124.803 1.241 . . . . 0.0 107.809 175.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.48 111.78 64.83 Favored Pre-proline 0 C--N 1.361 1.108 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -89.73 53.61 1.5 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.842 3.028 . . . . 0.0 111.52 -172.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.9 m -103.27 127.68 50.53 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 126.204 1.802 . . . . 0.0 109.083 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 m -93.27 53.38 1.92 Allowed 'General case' 0 C--N 1.362 1.114 0 O-C-N 120.046 -1.658 . . . . 0.0 112.226 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.11 72.0 8.33 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 129.629 3.172 . . . . 0.0 110.032 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -118.01 92.79 3.92 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.646 2.379 . . . . 0.0 112.638 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.411 ' H ' ' HD2' ' A' ' 145' ' ' LYS . 5.2 m-85 -125.19 127.25 46.5 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.361 1.464 . . . . 0.0 112.346 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.39 57.8 p -111.72 167.94 8.36 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 119.731 -1.855 . . . . 0.0 113.771 174.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.4 ' HA ' ' HB ' ' A' ' 110' ' ' VAL . 89.3 Cg_exo -57.63 153.07 44.52 Favored 'Trans proline' 0 C--N 1.373 1.84 1 C-N-CA 126.565 4.843 . . . . 0.0 120.821 -174.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.82 -41.87 2.06 Favored Glycine 0 C--N 1.377 2.823 0 C-N-CA 127.483 2.468 . . . . 0.0 107.02 -165.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -73.84 159.57 32.67 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 116.754 2.131 . . . . 0.0 116.754 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.511 HD13 ' HE ' ' A' ' 190' ' ' ARG . 0.1 OUTLIER -105.51 142.56 35.05 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 174.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.814 HG21 HD13 ' A' ' 148' ' ' LEU . 17.7 m -142.82 151.73 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.452 ' CE3' ' HG3' ' A' ' 107' ' ' PRO . 41.0 m95 -99.92 121.1 40.82 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 168.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.469 ' CB ' HD22 ' A' ' 148' ' ' LEU . . . -102.11 152.27 21.19 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 121.125 1.784 . . . . 0.0 112.345 -177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -116.9 131.9 56.84 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 102.398 -3.186 . . . . 0.0 102.398 169.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 34.8 ttm -118.47 138.38 52.53 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 176.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -64.31 101.66 0.45 Allowed 'General case' 0 C--N 1.369 1.424 0 C-N-CA 125.789 1.635 . . . . 0.0 113.816 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.19 -6.0 25.21 Favored Glycine 0 C--N 1.36 1.895 0 C-N-CA 125.667 1.604 . . . . 0.0 113.206 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -110.24 164.3 15.14 Favored Pre-proline 0 C--N 1.354 0.797 0 C-N-CA 125.779 1.632 . . . . 0.0 109.524 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.05 166.1 30.64 Favored 'Trans proline' 0 CA--C 1.548 1.186 0 C-N-CA 124.274 3.316 . . . . 0.0 112.774 162.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -57.84 123.3 15.28 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 129.061 2.944 . . . . 0.0 114.44 171.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -134.15 116.1 13.17 Favored Pre-proline 0 CA--C 1.563 1.476 1 N-CA-C 123.75 4.722 . . . . 0.0 123.75 -168.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HG3' ' CE3' ' A' ' 97' ' ' TRP . 53.8 Cg_exo -54.84 110.38 0.53 Allowed 'Trans proline' 0 C--N 1.396 3.056 1 C-N-CA 127.635 5.556 . . . . 0.0 114.898 164.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.5 p -125.72 164.04 21.5 Favored 'General case' 0 CA--C 1.536 0.431 1 C-N-CA 132.342 4.257 . . . . 0.0 115.901 -169.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.522 HD13 ' HG3' ' A' ' 190' ' ' ARG . 5.7 tp -115.8 138.25 51.32 Favored 'General case' 0 CA--C 1.52 -0.186 0 O-C-N 118.65 -2.532 . . . . 0.0 108.257 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 92' ' ' PRO . 2.1 t -81.0 118.93 29.65 Favored 'Isoleucine or valine' 0 C--N 1.37 1.476 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 175.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -115.8 154.58 29.39 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.03 -1.669 . . . . 0.0 115.36 -163.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -111.67 113.68 26.22 Favored 'General case' 0 C--N 1.372 1.545 0 C-N-CA 125.767 1.627 . . . . 0.0 108.812 166.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.418 ' H ' ' CD2' ' A' ' 130' ' ' HIS . 1.5 m-70 -69.08 160.94 76.26 Favored Pre-proline 0 C--N 1.363 1.188 0 C-N-CA 130.994 3.717 . . . . 0.0 110.191 174.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.67 0.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.554 1.5 1 C-N-CA 128.071 5.847 . . . . 0.0 119.226 174.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -99.57 34.96 2.08 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 130.542 3.537 . . . . 0.0 105.865 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.322 0.0 OUTLIER -61.35 120.86 11.26 Favored 'General case' 0 C--N 1.382 1.993 0 C-N-CA 126.972 2.109 . . . . 0.0 115.542 -166.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.85 -20.49 26.72 Favored Glycine 0 C--N 1.356 1.678 0 C-N-CA 127.302 2.382 . . . . 0.0 111.583 -171.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 p -116.09 119.15 34.92 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 103.979 -2.6 . . . . 0.0 103.979 172.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.494 ' HB2' ' CE1' ' A' ' 130' ' ' HIS . 16.4 p90 -148.42 -9.65 0.37 Allowed 'General case' 0 C--N 1.363 1.156 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 -170.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 10.0 pt -109.69 153.18 11.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-N 120.074 1.306 . . . . 0.0 112.473 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -142.28 136.52 29.85 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 104.138 -2.542 . . . . 0.0 104.138 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -150.68 127.24 10.82 Favored 'General case' 0 C--N 1.363 1.166 0 O-C-N 120.044 -1.66 . . . . 0.0 110.986 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -118.41 93.38 4.1 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 125.919 1.688 . . . . 0.0 110.534 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.16 -51.89 0.01 OUTLIER Glycine 0 C--N 1.363 2.033 1 N-CA-C 124.096 4.398 . . . . 0.0 124.096 171.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -137.64 21.58 2.9 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.325 1.45 . . . . 0.0 113.532 -172.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.6 m -163.49 146.39 10.08 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.01 137.72 56.44 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 C-N-CA 123.759 0.824 . . . . 0.0 109.851 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -120.55 130.06 54.06 Favored 'General case' 0 C--N 1.364 1.228 0 C-N-CA 126.829 2.052 . . . . 0.0 107.067 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' A' ' 145' ' ' LYS . 2.2 m -140.29 150.98 21.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.957 1 N-CA-C 98.855 -4.498 . . . . 0.0 98.855 175.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' ' 119' ' ' PHE . 12.6 p-80 -81.69 130.04 34.92 Favored 'General case' 0 C--N 1.367 1.336 0 C-N-CA 125.392 1.477 . . . . 0.0 113.16 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.2 m -137.74 151.16 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 N-CA-C 102.651 -3.092 . . . . 0.0 102.651 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -111.83 148.43 33.6 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -106.8 125.27 50.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 127.723 2.409 . . . . 0.0 105.802 -174.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -75.36 76.13 2.45 Favored 'General case' 0 C--N 1.372 1.574 0 C-N-CA 124.726 1.21 . . . . 0.0 109.492 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -102.46 -113.66 0.21 Allowed 'General case' 0 C--N 1.358 0.935 0 O-C-N 120.04 -1.662 . . . . 0.0 110.392 -173.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -106.87 -59.23 1.83 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 126.202 1.801 . . . . 0.0 111.32 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.5 p -86.06 -31.38 0.43 Allowed Pre-proline 0 C--N 1.365 1.245 0 N-CA-C 120.322 3.453 . . . . 0.0 120.322 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.1 -172.65 10.27 Favored 'Cis proline' 0 CA--C 1.541 0.853 1 CA-C-N 129.917 4.578 . . . . 0.0 113.418 0.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.8 m -96.81 155.64 16.69 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 129.429 3.092 . . . . 0.0 108.904 170.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.462 HH12 ' HB2' ' A' ' 197' ' ' ASP . 58.1 ttp180 -166.1 171.71 12.11 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.54 -169.87 42.12 Favored Glycine 0 CA--C 1.486 -1.752 1 N-CA-C 101.751 -4.54 . . . . 0.0 101.751 163.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -93.93 99.78 12.06 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 169.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.8 m -84.46 176.49 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 C-N-CA 125.563 1.545 . . . . 0.0 109.052 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.7 m -92.98 121.81 34.7 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.235 -2.876 . . . . 0.0 103.235 170.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.411 ' HD2' ' H ' ' A' ' 90' ' ' PHE 0.309 16.3 pttm -76.36 -11.04 59.83 Favored 'General case' 0 C--N 1.372 1.584 0 CA-C-N 121.421 1.919 . . . . 0.0 113.257 -176.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -68.91 -18.85 64.17 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 125.954 1.702 . . . . 0.0 113.487 170.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 147' ' ' LEU . 15.1 mt -91.12 0.65 57.49 Favored 'General case' 0 C--N 1.369 1.424 0 C-N-CA 126.184 1.793 . . . . 0.0 114.571 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.814 HD13 HG21 ' A' ' 96' ' ' VAL . 0.1 OUTLIER -98.47 159.0 15.24 Favored 'General case' 0 C--N 1.364 1.226 0 O-C-N 119.877 -1.764 . . . . 0.0 108.386 176.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.66 159.22 45.0 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 104.443 -2.428 . . . . 0.0 104.443 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -74.51 154.59 45.14 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 124.671 3.58 . . . . 0.0 114.724 -176.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.274 0.1 OUTLIER -18.56 -107.69 0.0 OUTLIER 'General case' 0 C--N 1.363 1.17 2 N-CA-C 123.486 4.624 . . . . 0.0 123.486 177.19 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.326 4.9 t 50.99 -40.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 1 C-N-CA 132.612 4.365 . . . . 0.0 120.413 177.098 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 70.82 -144.41 38.23 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 118.812 2.285 . . . . 0.0 118.812 176.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.8 m -53.04 -24.97 11.0 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.487 3.515 . . . . 0.0 119.749 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -84.42 -6.07 59.34 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 126.488 1.915 . . . . 0.0 111.951 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.2 m -83.84 146.47 28.08 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.894 1.678 . . . . 0.0 112.87 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -63.4 -27.5 69.34 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 125.702 1.601 . . . . 0.0 112.419 175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.37 -23.82 61.97 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 127.417 2.287 . . . . 0.0 113.163 171.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.4 0.81 48.45 Favored 'General case' 0 C--N 1.371 1.518 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.255 1.1 pp0? -115.47 -175.29 2.68 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 125.284 1.433 . . . . 0.0 110.168 176.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -66.27 122.91 18.55 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 126.692 1.997 . . . . 0.0 112.243 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.46 -10.89 58.04 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 124.848 1.213 . . . . 0.0 111.654 -167.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -77.64 139.84 23.51 Favored Glycine 0 C--N 1.365 2.154 0 N-CA-C 119.618 2.607 . . . . 0.0 119.618 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -61.01 -16.37 42.6 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 119.324 3.083 . . . . 0.0 119.324 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -110.85 -0.06 17.03 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.701 -1.249 . . . . 0.0 110.805 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -79.1 142.17 36.68 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 126.166 2.889 . . . . 0.0 118.315 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 19.6 m -172.86 170.46 4.57 Favored 'General case' 0 C--N 1.348 0.508 2 N-CA-C 98.165 -4.754 . . . . 0.0 98.165 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -138.24 101.59 4.43 Favored 'General case' 0 C--N 1.367 1.366 0 CA-C-N 124.931 3.514 . . . . 0.0 111.223 174.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -119.88 135.24 24.14 Favored Pre-proline 0 N--CA 1.43 -1.428 0 N-CA-C 100.921 -3.733 . . . . 0.0 100.921 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.7 -26.5 80.04 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 125.196 3.93 . . . . 0.0 114.108 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -63.9 -36.39 83.77 Favored 'General case' 0 C--N 1.367 1.353 0 C-N-CA 127.515 2.326 . . . . 0.0 113.424 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.8 mt -70.97 -42.88 77.05 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 C-N-CA 125.582 1.553 . . . . 0.0 110.923 173.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.46 -43.24 77.46 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 124.766 1.226 . . . . 0.0 113.979 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.4 ttm-85 -58.91 -38.69 79.48 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 128.178 2.591 . . . . 0.0 113.259 175.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.26 -34.54 74.93 Favored 'General case' 0 N--CA 1.419 -1.992 0 C-N-CA 131.357 3.863 . . . . 0.0 110.887 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.427 ' HG2' ' CH2' ' A' ' 97' ' ' TRP . 31.3 mtt -70.4 -37.59 74.49 Favored 'General case' 0 C--N 1.386 2.156 0 C-N-CA 124.03 0.932 . . . . 0.0 111.339 168.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -68.53 -45.29 72.59 Favored 'General case' 0 C--N 1.378 1.842 0 C-N-CA 126.638 1.975 . . . . 0.0 111.62 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -53.93 47.37 Favored 'General case' 0 C--N 1.37 1.471 0 C-N-CA 131.629 3.971 . . . . 0.0 111.698 172.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.94 -45.26 82.9 Favored 'General case' 0 C--N 1.373 1.6 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 170.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 184' ' ' ASN 0.318 38.8 t70 -64.19 -24.73 67.78 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 127.339 2.256 . . . . 0.0 112.702 176.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -75.09 -43.89 50.47 Favored 'General case' 0 C--N 1.352 0.7 0 O-C-N 117.922 -2.986 . . . . 0.0 112.228 168.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 190' ' ' ARG . . . -76.25 -39.62 53.99 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 120.069 3.359 . . . . 0.0 120.069 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.24 -26.85 47.47 Favored 'General case' 0 C--N 1.36 1.051 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.2 OUTLIER -89.78 -30.28 18.1 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 128.461 2.704 . . . . 0.0 107.93 -173.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -104.98 -98.56 0.32 Allowed 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -136.03 159.7 40.89 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 119.995 -1.691 . . . . 0.0 111.691 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.514 ' HA ' ' HD3' ' A' ' 190' ' ' ARG . 44.2 mmtt -51.55 -38.56 54.85 Favored 'General case' 0 C--N 1.377 1.78 0 C-N-CA 131.201 3.801 . . . . 0.0 115.142 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.6 tt -55.22 -36.07 38.44 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 129.171 2.988 . . . . 0.0 113.379 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -43.92 72.49 Favored 'General case' 0 C--N 1.372 1.558 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.522 ' HG3' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -75.25 -43.43 51.54 Favored 'General case' 0 C--N 1.37 1.475 0 CA-C-N 121.241 1.837 . . . . 0.0 114.826 172.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.5 tp -71.32 -19.48 62.3 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 128.672 2.789 . . . . 0.0 113.852 -172.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -59.64 -27.9 66.76 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.883 2.073 . . . . 0.0 113.492 164.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.3 mp -102.1 21.66 14.47 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 127.472 2.309 . . . . 0.0 111.95 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.03 44.95 0.0 OUTLIER 'General case' 0 C--N 1.374 1.644 0 C-N-CA 131.502 3.921 . . . . 0.0 118.202 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 2.8 t 66.79 -51.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.183 1 C-N-CA 133.206 4.602 . . . . 0.0 113.827 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.9 t 86.79 35.95 0.02 OUTLIER 'General case' 0 C--N 1.361 1.092 0 C-N-CA 130.528 3.531 . . . . 0.0 109.742 -175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.462 ' HB2' HH12 ' A' ' 140' ' ' ARG . 18.3 t70 -70.51 65.13 0.29 Allowed 'General case' 0 C--N 1.363 1.179 0 C-N-CA 127.686 2.395 . . . . 0.0 116.98 -175.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 70.65 68.76 0.37 Allowed Pre-proline 0 C--N 1.358 0.956 0 C-N-CA 129.695 3.198 . . . . 0.0 114.34 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.28 78.59 3.62 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 124.225 3.283 . . . . 0.0 111.476 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 97.0 p -80.05 69.64 6.48 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 126.156 1.782 . . . . 0.0 114.231 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 . . . . . 0 C--N 1.356 0.863 0 C-N-CA 126.201 1.801 . . . . 0.0 110.192 -178.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp . . . . . 0 N--CA 1.441 -0.881 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.27 -109.67 0.01 OUTLIER 'General case' 0 C--N 1.351 0.641 0 C-N-CA 125.352 1.461 . . . . 0.0 108.545 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -148.76 112.81 5.18 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 120.877 -1.139 . . . . 0.0 109.131 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -85.55 123.2 30.7 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.454 1.501 . . . . 0.0 110.841 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.27 58.9 mt 76.45 73.95 0.08 Allowed 'General case' 0 C--N 1.363 1.156 0 C-N-CA 126.836 2.054 . . . . 0.0 114.188 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -106.66 20.81 18.46 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.678 1.591 . . . . 0.0 110.338 177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.95 -21.64 43.89 Favored Glycine 0 C--N 1.358 1.761 0 C-N-CA 128.852 3.12 . . . . 0.0 117.525 168.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.55 -174.38 41.99 Favored Glycine 0 C--N 1.35 1.328 0 N-CA-C 105.425 -3.07 . . . . 0.0 105.425 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mt -128.68 34.85 4.44 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 118.826 1.313 . . . . 0.0 109.804 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -71.73 -52.74 16.19 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 128.439 2.695 . . . . 0.0 114.519 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.8 mtt85 -113.88 -6.83 13.21 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.43 1.492 . . . . 0.0 112.15 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 t 84.46 -26.1 0.12 Allowed 'General case' 0 C--N 1.364 1.199 0 C-N-CA 128.493 2.717 . . . . 0.0 114.636 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.288 24.4 t 65.73 -49.97 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.033 0 C-N-CA 129.027 2.931 . . . . 0.0 116.039 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.91 160.79 63.18 Favored Pre-proline 0 N--CA 1.447 -0.623 0 O-C-N 120.516 -1.365 . . . . 0.0 109.135 178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.82 78.92 2.98 Favored 'Trans proline' 0 C--N 1.363 1.299 1 C-N-CA 125.314 4.009 . . . . 0.0 109.734 170.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.01 -88.54 0.54 Allowed 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.915 2.086 . . . . 0.0 111.246 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.3 112.75 63.86 Favored Pre-proline 0 C--N 1.359 0.979 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.19 80.12 3.14 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.682 2.921 . . . . 0.0 114.094 -167.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . 0.525 75.5 p 90.74 -3.02 0.25 Allowed 'General case' 0 C--N 1.357 0.895 0 C-N-CA 130.235 3.414 . . . . 0.0 116.338 175.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . 0.276 0.7 OUTLIER 83.62 -50.99 0.14 Allowed 'General case' 0 C--N 1.358 0.947 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 169.031 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 77.8 p -144.39 85.18 1.78 Allowed 'General case' 0 C--N 1.356 0.872 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . 0.285 1.1 p30 -171.81 87.26 0.09 Allowed 'General case' 0 C--N 1.364 1.215 0 C-N-CA 124.973 1.309 . . . . 0.0 112.814 175.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -124.6 127.65 47.69 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 126.029 1.732 . . . . 0.0 114.814 -171.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.525 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.358 98.0 p -110.18 169.62 6.18 Favored Pre-proline 0 CA--C 1.574 1.882 0 C-N-CA 131.025 3.73 . . . . 0.0 114.952 -174.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 93.4 Cg_endo -66.19 146.89 82.81 Favored 'Trans proline' 0 C--N 1.385 2.474 1 C-N-CA 126.88 5.054 . . . . 0.0 117.281 -168.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.59 -32.35 7.03 Favored Glycine 0 C--N 1.366 2.236 0 C-N-CA 126.403 1.954 . . . . 0.0 109.365 -171.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -83.12 162.38 21.33 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-O 124.486 2.089 . . . . 0.0 113.485 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.02 135.4 54.26 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 101.609 -3.478 . . . . 0.0 101.609 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.99 159.06 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 C-N-CA 126.209 1.804 . . . . 0.0 107.082 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -98.7 118.37 35.27 Favored 'General case' 0 C--N 1.349 0.559 0 N-CA-C 102.804 -3.036 . . . . 0.0 102.804 169.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -116.39 138.9 50.97 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 126.37 1.868 . . . . 0.0 113.397 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -113.65 145.84 40.68 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 170.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.1 ttp -128.97 152.82 48.17 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 119.85 -1.781 . . . . 0.0 109.162 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -63.42 89.68 0.04 OUTLIER 'General case' 0 C--N 1.364 1.228 0 C-N-CA 127.716 2.406 . . . . 0.0 115.472 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.17 -4.13 25.36 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 125.665 1.602 . . . . 0.0 112.249 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -98.02 162.15 23.13 Favored Pre-proline 0 C--N 1.357 0.916 0 C-N-CA 125.508 1.523 . . . . 0.0 110.223 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -71.26 167.08 27.24 Favored 'Trans proline' 0 CA--C 1.544 0.983 1 C-N-CA 125.777 4.318 . . . . 0.0 112.941 163.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -68.3 130.68 43.61 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 127.426 2.29 . . . . 0.0 112.267 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.425 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 6.3 m95 -128.7 131.91 24.04 Favored Pre-proline 0 N--CA 1.429 -1.502 0 N-CA-C 117.848 2.536 . . . . 0.0 117.848 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -72.56 139.24 30.94 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 124.211 3.274 . . . . 0.0 108.1 149.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.1 p -152.37 164.18 38.0 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 126.936 2.094 . . . . 0.0 111.611 -163.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 190' ' ' ARG . 1.3 pp -111.47 149.44 31.31 Favored 'General case' 0 C--N 1.367 1.356 0 O-C-N 119.982 -1.699 . . . . 0.0 109.87 171.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 131' ' ' VAL . 2.4 t -91.45 119.83 39.41 Favored 'Isoleucine or valine' 0 C--N 1.364 1.222 0 O-C-N 120.608 -1.308 . . . . 0.0 107.787 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -114.61 141.85 47.22 Favored 'General case' 0 C--N 1.37 1.5 0 N-CA-C 120.066 3.358 . . . . 0.0 120.066 -162.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -85.77 111.27 20.0 Favored 'General case' 0 C--N 1.377 1.772 0 O-C-N 118.526 -2.608 . . . . 0.0 110.522 172.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.406 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 75.0 t60 -85.04 160.2 55.58 Favored Pre-proline 0 N--CA 1.449 -0.497 1 C-N-CA 132.108 4.163 . . . . 0.0 109.673 -176.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.81 -13.84 6.8 Favored 'Trans proline' 0 CA--C 1.55 1.306 1 C-N-CA 125.97 4.447 . . . . 0.0 117.08 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -107.41 54.11 0.68 Allowed 'General case' 0 C--N 1.365 1.244 0 C-N-CA 127.848 2.459 . . . . 0.0 107.564 172.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.43 167.77 19.05 Favored 'General case' 0 C--N 1.368 1.406 0 O-C-N 119.563 -1.961 . . . . 0.0 114.787 -178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.48 -20.04 48.98 Favored Glycine 0 C--N 1.364 2.086 0 C-N-CA 126.053 1.787 . . . . 0.0 113.559 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 32.7 m -123.47 120.3 32.52 Favored 'General case' 0 C--N 1.346 0.453 1 N-CA-C 99.465 -4.272 . . . . 0.0 99.465 170.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -122.64 -3.49 8.77 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 -168.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.6 pt -122.81 149.74 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 O-C-N 119.618 -1.926 . . . . 0.0 112.948 -173.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -141.49 160.18 40.68 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 129.854 3.262 . . . . 0.0 104.595 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -152.08 127.57 10.03 Favored 'General case' 0 C--N 1.365 1.272 0 O-C-N 118.935 -2.353 . . . . 0.0 111.459 -176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -103.37 92.94 4.7 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.266 1.426 . . . . 0.0 108.78 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.5 -84.96 0.19 Allowed Glycine 0 C--N 1.363 2.053 0 C-N-CA 127.309 2.385 . . . . 0.0 114.57 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -116.74 -15.26 10.75 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 126.277 1.831 . . . . 0.0 110.591 174.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.1 m -88.43 100.91 13.41 Favored 'General case' 0 C--N 1.365 1.257 0 O-C-N 120.423 -1.423 . . . . 0.0 110.625 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 p -86.46 132.41 32.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 127.452 2.301 . . . . 0.0 108.246 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 33.4 mtm180 -117.1 141.98 47.57 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 126.19 1.796 . . . . 0.0 112.569 -173.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.9 164.16 35.97 Favored 'Isoleucine or valine' 0 C--N 1.359 0.986 0 C-N-CA 130.057 3.343 . . . . 0.0 106.094 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.406 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 17.2 m80 -88.55 116.68 26.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.98 1.712 . . . . 0.0 112.596 176.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.554 HG12 HG13 ' A' ' 110' ' ' VAL . 3.3 m -134.24 173.76 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 O-C-N 119.25 -2.156 . . . . 0.0 106.87 177.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -138.49 147.91 43.73 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 171.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -99.88 127.2 46.07 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.111 2.164 . . . . 0.0 107.812 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -73.8 62.96 0.85 Allowed 'General case' 0 C--N 1.369 1.429 0 C-N-CA 126.736 2.015 . . . . 0.0 114.153 -176.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.425 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 0.9 OUTLIER -91.35 -108.78 0.1 Allowed 'General case' 0 C--N 1.365 1.248 0 O-C-N 121.392 -0.818 . . . . 0.0 112.561 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.74 -65.34 1.09 Allowed 'General case' 0 C--N 1.35 0.628 0 C-N-CA 126.224 1.81 . . . . 0.0 114.097 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 25.5 p -79.85 -32.6 0.73 Allowed Pre-proline 0 C--N 1.361 1.086 0 N-CA-C 119.464 3.135 . . . . 0.0 119.464 -173.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -92.16 -166.3 2.31 Favored 'Cis proline' 0 CA--C 1.539 0.774 1 CA-C-N 129.988 4.603 . . . . 0.0 110.828 -1.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.5 m -97.69 135.48 39.42 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 125.093 1.357 . . . . 0.0 111.678 172.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.2 tmm_? -136.56 147.34 46.97 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 120.748 1.613 . . . . 0.0 106.915 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -167.81 -179.87 40.72 Favored Glycine 0 CA--C 1.489 -1.535 0 N-CA-C 104.892 -3.283 . . . . 0.0 104.892 170.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -86.55 109.11 18.89 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 127.423 2.289 . . . . 0.0 106.76 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.19 -178.2 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 125.602 1.561 . . . . 0.0 111.574 -172.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.2 m -100.41 117.29 34.29 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 101.318 -3.586 . . . . 0.0 101.318 169.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.457 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 5.6 ttpp -72.42 -14.04 61.6 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 124.026 1.869 . . . . 0.0 113.063 -171.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -75.07 -12.3 60.29 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.971 1.708 . . . . 0.0 113.961 174.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.4 mt -100.46 3.82 43.26 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 126.742 2.017 . . . . 0.0 110.948 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.457 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 31.5 mt -94.25 130.44 40.51 Favored 'General case' 0 C--N 1.366 1.292 0 C-N-CA 126.623 1.969 . . . . 0.0 109.201 173.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.403 ' HG3' ' CE1' ' A' ' 165' ' ' PHE . 5.1 mmtt -114.88 165.65 13.51 Favored Pre-proline 0 C--N 1.35 0.611 0 N-CA-C 102.947 -2.983 . . . . 0.0 102.947 174.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.56 155.8 16.16 Favored 'Trans proline' 0 C--N 1.326 -0.656 0 C-N-CA 124.644 3.563 . . . . 0.0 112.561 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.64 124.04 41.89 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 121.643 0.735 . . . . 0.0 112.067 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.0 t -161.52 25.77 0.13 Allowed 'General case' 0 C--N 1.358 0.954 0 C-N-CA 127.493 2.317 . . . . 0.0 105.523 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -175.64 81.74 0.07 OUTLIER Glycine 0 C--N 1.354 1.575 0 C-N-CA 115.941 -3.028 . . . . 0.0 117.55 -162.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 69.9 m -67.92 -11.45 58.76 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 128.571 2.748 . . . . 0.0 114.068 172.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -122.52 37.97 4.27 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 128.445 2.698 . . . . 0.0 109.788 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 15.3 m -95.09 147.87 22.96 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.584 2.354 . . . . 0.0 108.027 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -61.78 -24.49 66.87 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 117.061 2.245 . . . . 0.0 117.061 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -82.23 -19.09 40.41 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 125.586 1.554 . . . . 0.0 112.161 168.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.34 -39.62 10.38 Favored 'General case' 0 C--N 1.368 1.393 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.337 0.0 OUTLIER -83.74 -173.67 4.85 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 116.594 2.072 . . . . 0.0 116.594 -178.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -67.74 121.34 15.74 Favored 'General case' 0 C--N 1.376 1.745 0 O-C-N 119.81 -1.806 . . . . 0.0 113.462 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.34 -13.24 51.58 Favored Glycine 0 C--N 1.355 1.614 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.075 -166.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.9 158.65 36.95 Favored Glycine 0 C--N 1.369 2.375 0 N-CA-C 120.665 3.026 . . . . 0.0 120.665 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -60.05 -41.76 93.02 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 129.084 2.953 . . . . 0.0 117.561 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.403 ' CE1' ' HG3' ' A' ' 149' ' ' LYS . 1.6 m-85 -92.67 -30.1 15.75 Favored 'General case' 0 C--N 1.37 1.463 0 O-C-N 120.9 -1.125 . . . . 0.0 110.538 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.3 t80 0.4 -91.51 0.0 OUTLIER 'General case' 0 C--N 1.382 1.981 1 C-N-CA 133.59 4.756 . . . . 0.0 117.216 -177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.1 m 49.17 65.77 1.29 Allowed 'General case' 0 C--N 1.364 1.211 0 C-N-CA 130.756 3.623 . . . . 0.0 116.413 169.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.5 100.93 11.06 Favored 'General case' 0 C--N 1.369 1.415 0 CA-C-O 124.93 2.3 . . . . 0.0 114.049 -170.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -120.63 146.1 42.52 Favored Pre-proline 0 N--CA 1.429 -1.51 1 C-N-CA 132.009 4.124 . . . . 0.0 105.028 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -50.26 -38.3 51.43 Favored 'Trans proline' 0 CA--C 1.548 1.2 1 C-N-CA 127.403 5.402 . . . . 0.0 117.113 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -69.75 -35.54 75.05 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 128.943 2.897 . . . . 0.0 113.644 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.255 12.8 mt -76.01 -32.12 22.82 Favored 'Isoleucine or valine' 0 C--N 1.371 1.541 0 C-N-CA 127.119 2.168 . . . . 0.0 110.528 175.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.427 ' O ' ' HG3' ' A' ' 177' ' ' GLN . 19.3 mt -62.91 -53.16 58.42 Favored 'General case' 0 C--N 1.383 2.037 0 C-N-CA 126.704 2.002 . . . . 0.0 109.178 168.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.18 -34.47 68.5 Favored 'General case' 0 C--N 1.369 1.449 0 C-N-CA 128.651 2.78 . . . . 0.0 115.066 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.21 -45.81 68.96 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 130.19 3.396 . . . . 0.0 112.116 172.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 12.8 mtt -67.03 -33.37 75.4 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-N 119.416 1.007 . . . . 0.0 113.515 170.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 8.6 mt-30 -70.02 -52.19 26.14 Favored 'General case' 0 C--N 1.381 1.976 0 C-N-CA 126.495 1.918 . . . . 0.0 113.06 172.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.274 5.4 ptt180 -72.43 -35.94 68.46 Favored 'General case' 0 C--N 1.384 2.067 0 O-C-N 119.184 -2.198 . . . . 0.0 114.48 178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.418 ' O ' HD13 ' A' ' 183' ' ' LEU . . . -66.39 -39.96 89.38 Favored 'General case' 0 C--N 1.37 1.478 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 169.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 29.8 t70 -62.1 -35.78 79.74 Favored 'General case' 0 C--N 1.381 1.971 0 O-C-N 120.082 -1.636 . . . . 0.0 112.092 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -65.46 -45.78 82.4 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 119.337 -2.102 . . . . 0.0 113.743 170.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -71.41 -36.2 71.25 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 179' ' ' ALA 0.291 0.0 OUTLIER -79.74 -28.96 40.44 Favored 'General case' 0 C--N 1.371 1.535 0 O-C-N 119.893 -1.754 . . . . 0.0 114.89 177.415 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 180' ' ' ASP 0.267 0.0 OUTLIER -89.57 -15.48 32.76 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 124.966 1.306 . . . . 0.0 111.061 -176.789 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -115.2 -102.23 0.42 Allowed 'General case' 0 C--N 1.357 0.927 0 O-C-N 122.107 -0.37 . . . . 0.0 110.342 176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.459 ' HB3' HG22 ' A' ' 188' ' ' ILE . 25.0 t70 -136.19 156.94 47.95 Favored 'General case' 0 C--N 1.355 0.828 0 CA-C-O 123.097 1.427 . . . . 0.0 109.952 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 54.3 mmtt -50.97 -36.73 40.57 Favored 'General case' 0 C--N 1.361 1.08 1 C-N-CA 131.994 4.117 . . . . 0.0 114.116 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.459 HG22 ' HB3' ' A' ' 186' ' ' ASP . 8.1 tt -54.98 -28.29 20.29 Favored 'Isoleucine or valine' 0 C--N 1.364 1.236 1 C-N-CA 131.808 4.043 . . . . 0.0 113.514 175.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.281 5.3 mptt -71.98 -29.53 64.33 Favored 'General case' 0 C--N 1.376 1.733 0 C-N-CA 125.932 1.693 . . . . 0.0 113.551 171.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.501 ' HB2' HD22 ' A' ' 109' ' ' LEU 0.532 0.0 OUTLIER -74.73 -42.21 58.7 Favored 'General case' 0 C--N 1.375 1.713 0 O-C-N 119.198 -2.189 . . . . 0.0 113.368 170.045 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.6 mt -66.5 -19.97 65.92 Favored 'General case' 0 C--N 1.379 1.869 0 C-N-CA 129.099 2.959 . . . . 0.0 114.424 177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -64.88 -29.9 70.87 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 128.419 2.688 . . . . 0.0 112.925 169.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mt -105.07 -50.02 3.34 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 125.252 1.421 . . . . 0.0 108.535 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 34.37 38.31 0.03 OUTLIER 'General case' 0 C--N 1.375 1.706 1 C-N-CA 131.889 4.076 . . . . 0.0 119.229 173.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.273 40.5 t 88.32 77.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.793 0 C-N-CA 128.963 2.905 . . . . 0.0 105.67 -170.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 80.4 p -59.53 79.99 0.01 OUTLIER 'General case' 0 C--N 1.361 1.065 0 C-N-CA 129.959 3.304 . . . . 0.0 117.439 -173.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -139.81 -74.04 0.36 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -142.55 80.26 14.59 Favored Pre-proline 0 N--CA 1.445 -0.675 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -82.42 -82.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.158 0 C-N-CA 124.135 3.223 . . . . 0.0 109.283 177.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 31.9 m -172.21 -47.9 0.02 OUTLIER 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 C--N 1.352 0.701 0 C-N-CA 127.352 2.261 . . . . 0.0 111.773 178.528 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? . . . . . 0 N--CA 1.44 -0.94 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.83 72.67 4.19 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 126.267 1.827 . . . . 0.0 110.489 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -101.86 90.89 4.15 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 126.835 2.054 . . . . 0.0 108.263 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -103.0 133.97 47.23 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 125.797 1.639 . . . . 0.0 109.503 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.81 66.94 5.44 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 115.832 1.789 . . . . 0.0 115.832 -176.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -98.65 -17.87 18.37 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.433 1.893 . . . . 0.0 110.729 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.62 0.81 49.7 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 126.603 2.049 . . . . 0.0 113.079 -174.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.87 -116.61 3.41 Favored Glycine 0 C--N 1.359 1.817 0 N-CA-C 106.174 -2.77 . . . . 0.0 106.174 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 60.1 mt -113.56 45.2 1.46 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 125.944 1.698 . . . . 0.0 107.341 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -71.21 -36.38 71.87 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 129.197 2.999 . . . . 0.0 114.691 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -106.58 13.11 28.66 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.012 1.325 . . . . 0.0 110.229 177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.6 t 71.81 -152.09 0.08 Allowed 'General case' 0 C--N 1.364 1.197 0 C-N-CA 128.405 2.682 . . . . 0.0 115.023 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -149.65 146.34 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.02 150.48 41.86 Favored Pre-proline 0 C--N 1.351 0.658 0 C-N-CA 125.326 1.45 . . . . 0.0 110.733 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.38 -36.4 5.39 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 124.712 3.608 . . . . 0.0 112.365 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.92 -107.07 0.09 Allowed 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 103.077 -2.935 . . . . 0.0 103.077 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.58 136.88 19.19 Favored Pre-proline 0 C--N 1.353 0.739 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 173.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -81.12 70.49 7.46 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.839 3.026 . . . . 0.0 111.734 -175.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 90.9 m -166.57 145.6 5.58 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.5 m -167.82 51.92 0.06 Allowed 'General case' 0 C--N 1.358 0.94 0 C-N-CA 125.126 1.37 . . . . 0.0 108.027 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.9 p -99.05 100.86 12.07 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 125.551 1.54 . . . . 0.0 110.463 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -155.85 92.4 1.37 Allowed 'General case' 0 C--N 1.357 0.898 0 C-N-CA 124.698 1.199 . . . . 0.0 109.303 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -125.56 127.51 46.49 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.441 56.6 p -111.73 167.39 9.17 Favored Pre-proline 0 CA--C 1.562 1.41 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -59.54 137.66 79.02 Favored 'Trans proline' 0 C--N 1.379 2.165 1 C-N-CA 126.957 5.105 . . . . 0.0 118.531 -169.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.2 -22.65 39.8 Favored Glycine 0 C--N 1.371 2.513 0 C-N-CA 126.028 1.775 . . . . 0.0 111.39 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -79.34 159.31 27.21 Favored 'General case' 0 C--N 1.357 0.921 0 O-C-N 120.208 -1.76 . . . . 0.0 112.212 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.74 133.35 48.88 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.533 -1.355 . . . . 0.0 107.522 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.13 152.73 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.299 0 C-N-CA 126.565 1.946 . . . . 0.0 107.335 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -101.72 119.88 39.47 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 168.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -110.08 149.59 29.81 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 121.487 1.949 . . . . 0.0 111.873 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.1 tptp -117.14 140.91 48.94 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 174.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.9 ttp -126.54 145.17 50.63 Favored 'General case' 0 C--N 1.357 0.925 0 O-C-N 119.958 -1.714 . . . . 0.0 107.418 174.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -49.72 86.27 0.0 OUTLIER 'General case' 0 C--N 1.365 1.245 0 C-N-CA 130.457 3.503 . . . . 0.0 117.188 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.71 -3.47 45.83 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.961 1.267 . . . . 0.0 114.064 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -99.95 165.7 14.1 Favored Pre-proline 0 C--N 1.357 0.906 0 C-N-CA 125.7 1.6 . . . . 0.0 108.315 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.44 165.79 31.37 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.323 3.349 . . . . 0.0 113.56 169.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.434 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.0 m95 -63.68 110.19 1.95 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 130.145 3.378 . . . . 0.0 112.824 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 4.9 m95 -109.24 108.55 60.33 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 119.197 3.036 . . . . 0.0 119.197 -172.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.461 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 20.3 Cg_endo -54.45 123.03 12.62 Favored 'Trans proline' 0 C--N 1.384 2.413 1 C-N-CA 125.908 4.405 . . . . 0.0 111.708 159.599 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.4 p -148.65 165.72 30.48 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 124.574 2.13 . . . . 0.0 114.332 -156.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 21.7 tp -114.41 138.46 50.54 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.83 2.452 . . . . 0.0 106.663 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.9 t -84.92 127.88 39.47 Favored 'Isoleucine or valine' 0 C--N 1.364 1.206 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 171.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.406 ' CE2' HG12 ' A' ' 195' ' ' VAL . 81.2 t80 -139.73 153.88 47.31 Favored 'General case' 0 C--N 1.358 0.962 0 CA-C-N 122.712 2.505 . . . . 0.0 112.596 -168.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -104.07 114.62 28.99 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.572 2.349 . . . . 0.0 109.158 175.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.484 ' H ' ' CE1' ' A' ' 130' ' ' HIS . 14.6 t60 -67.74 161.27 67.8 Favored Pre-proline 0 C--N 1.354 0.774 0 C-N-CA 128.267 2.627 . . . . 0.0 112.496 177.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.04 -1.16 0.04 OUTLIER 'Trans proline' 0 CA--C 1.563 1.931 1 C-N-CA 126.494 4.796 . . . . 0.0 118.159 172.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -91.09 34.33 0.93 Allowed 'General case' 0 C--N 1.36 1.04 1 C-N-CA 135.074 5.349 . . . . 0.0 107.32 169.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.329 0.5 OUTLIER -77.92 156.36 30.33 Favored 'General case' 0 C--N 1.369 1.43 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -173.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.39 -10.45 33.27 Favored Glycine 0 C--N 1.359 1.842 0 CA-C-N 111.826 -2.443 . . . . 0.0 111.776 -178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 t -146.87 150.66 35.68 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 101.269 -3.604 . . . . 0.0 101.269 172.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -149.83 9.64 0.7 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-N 119.555 1.071 . . . . 0.0 111.055 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.424 HG22 HG12 ' A' ' 129' ' ' VAL . 34.2 pt -117.5 148.81 20.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 CA-C-O 122.302 1.049 . . . . 0.0 110.687 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 90.0 mmt-85 -137.66 138.89 39.89 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 103.213 -2.884 . . . . 0.0 103.213 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.3 129.78 14.87 Favored 'General case' 0 C--N 1.359 0.994 0 O-C-N 119.859 -1.776 . . . . 0.0 109.776 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -117.78 93.84 4.3 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.511 2.324 . . . . 0.0 111.157 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.08 -73.07 0.55 Allowed Glycine 0 C--N 1.362 1.98 0 N-CA-C 120.127 2.811 . . . . 0.0 120.127 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -147.21 58.8 1.16 Allowed 'General case' 0 C--N 1.356 0.849 0 CA-C-O 122.601 1.191 . . . . 0.0 110.201 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.1 m -175.56 157.91 2.15 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.47 135.01 35.22 Favored 'Isoleucine or valine' 0 C--N 1.351 0.666 0 CA-C-O 122.598 1.19 . . . . 0.0 109.735 -178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -115.17 130.37 56.9 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 127.618 2.367 . . . . 0.0 107.164 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 145' ' ' LYS . 10.3 m -125.81 146.43 31.58 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 1 N-CA-C 98.237 -4.727 . . . . 0.0 98.237 172.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.54 ' CD2' ' CZ2' ' A' ' 142' ' ' TRP 0.329 0.1 OUTLIER -81.57 137.32 35.54 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 121.709 0.766 . . . . 0.0 112.449 176.074 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -146.2 165.06 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 -173.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -129.17 153.43 47.73 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -110.86 122.69 48.49 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 125.022 1.329 . . . . 0.0 107.564 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -74.83 60.59 0.96 Allowed 'General case' 0 C--N 1.37 1.493 0 C-N-CA 127.689 2.396 . . . . 0.0 114.475 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP 0.31 50.8 p-10 -87.66 -99.21 0.08 Allowed 'General case' 0 C--N 1.363 1.19 0 C-N-CA 125.604 1.562 . . . . 0.0 113.377 -177.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -106.84 -65.7 1.07 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.452 1.901 . . . . 0.0 114.57 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.272 10.1 p -77.81 -38.04 1.65 Allowed Pre-proline 0 C--N 1.365 1.251 0 N-CA-C 118.546 2.795 . . . . 0.0 118.546 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -82.43 -174.73 13.76 Favored 'Cis proline' 0 C--N 1.354 0.866 1 CA-C-N 128.707 4.145 . . . . 0.0 113.822 -0.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.274 4.0 t -97.62 154.06 17.8 Favored 'General case' 0 C--N 1.374 1.646 0 C-N-CA 127.613 2.365 . . . . 0.0 111.045 171.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.52 HH22 ' CG ' ' A' ' 130' ' ' HIS . 32.7 ttt-85 -158.44 162.05 37.52 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.26 -163.97 29.64 Favored Glycine 0 CA--C 1.484 -1.87 0 N-CA-C 104.24 -3.544 . . . . 0.0 104.24 166.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.54 ' CZ2' ' CD2' ' A' ' 130' ' ' HIS . 78.7 m95 -96.65 99.95 11.53 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 171.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.2 m -81.65 178.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.983 0 C-N-CA 126.973 2.109 . . . . 0.0 108.001 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.5 m -94.92 130.08 41.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 168.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.522 ' HB3' HG22 ' A' ' 129' ' ' VAL . 4.2 pttp -79.53 -9.62 59.65 Favored 'General case' 0 C--N 1.365 1.264 0 O-C-N 119.891 -1.755 . . . . 0.0 113.993 -175.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.21 -13.75 61.61 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 124.496 1.118 . . . . 0.0 112.475 174.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.7 mt -96.84 1.11 50.27 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 126.436 1.894 . . . . 0.0 114.074 175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.09 141.79 28.31 Favored 'General case' 0 C--N 1.372 1.546 0 CA-C-N 121.1 1.773 . . . . 0.0 109.233 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -115.99 158.57 42.1 Favored Pre-proline 0 C--O 1.224 -0.273 0 O-C-N 119.313 -2.117 . . . . 0.0 105.621 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.98 151.44 21.25 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 124.395 3.397 . . . . 0.0 112.869 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -121.61 117.42 26.67 Favored 'General case' 0 C--N 1.363 1.17 0 CA-C-O 122.056 0.932 . . . . 0.0 112.262 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.3 t -160.89 23.72 0.14 Allowed 'General case' 0 C--N 1.362 1.121 0 C-N-CA 126.182 1.793 . . . . 0.0 106.698 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.41 70.42 0.3 Allowed Glycine 0 C--N 1.353 1.514 0 C-N-CA 120.424 -0.894 . . . . 0.0 114.578 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 m -63.7 -10.99 22.17 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 131.221 3.808 . . . . 0.0 116.215 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -126.73 29.95 5.6 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 129.226 3.01 . . . . 0.0 108.065 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 t -96.09 136.58 36.36 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 127.695 2.398 . . . . 0.0 107.243 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -47.91 -38.91 17.52 Favored 'General case' 0 C--N 1.369 1.428 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -75.12 -18.3 60.27 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.608 -1.307 . . . . 0.0 113.885 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.72 -1.38 46.62 Favored 'General case' 0 C--N 1.371 1.505 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.376 0.6 OUTLIER -119.65 -173.51 2.55 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.409 1.484 . . . . 0.0 112.74 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -71.32 122.38 20.18 Favored 'General case' 0 C--N 1.37 1.468 0 O-C-N 119.506 -1.996 . . . . 0.0 112.355 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.26 -8.0 56.92 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.299 0.952 . . . . 0.0 111.774 -168.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.09 157.31 28.12 Favored Glycine 0 C--N 1.363 2.065 0 N-CA-C 117.437 1.735 . . . . 0.0 117.437 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -58.41 -42.53 87.41 Favored 'General case' 0 C--N 1.366 1.304 0 N-CA-C 119.358 3.096 . . . . 0.0 119.358 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.434 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.391 0.2 OUTLIER -106.32 3.15 27.26 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -175.037 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -101.91 144.13 30.92 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.091 1.757 . . . . 0.0 108.87 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 26.1 m -166.93 147.16 5.64 Favored 'General case' 0 N--CA 1.445 -0.709 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.37 99.89 9.24 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-O 126.398 2.999 . . . . 0.0 111.693 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -120.84 134.46 24.31 Favored Pre-proline 0 N--CA 1.416 -2.145 3 N-CA-C 98.046 -4.798 . . . . 0.0 98.046 164.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -60.74 -22.78 74.47 Favored 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.691 4.26 . . . . 0.0 115.509 -174.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -70.09 -36.33 74.83 Favored 'General case' 0 C--N 1.36 1.059 0 C-N-CA 128.741 2.816 . . . . 0.0 113.829 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.1 mm -71.73 -40.24 69.72 Favored 'Isoleucine or valine' 0 C--N 1.379 1.877 0 C-N-CA 127.553 2.341 . . . . 0.0 108.472 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.0 mt -66.44 -48.57 69.55 Favored 'General case' 0 C--N 1.369 1.454 0 C-N-CA 125.314 1.446 . . . . 0.0 113.264 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -57.81 -34.16 69.35 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 128.288 2.635 . . . . 0.0 114.881 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.431 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . . . -68.35 -45.88 71.65 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 130.959 3.704 . . . . 0.0 111.599 171.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.35 0.0 OUTLIER -64.25 -32.35 73.9 Favored 'General case' 0 C--N 1.38 1.931 0 CA-C-N 120.321 1.419 . . . . 0.0 113.374 168.187 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -68.96 -48.51 62.99 Favored 'General case' 0 C--N 1.376 1.752 0 C-N-CA 126.059 1.743 . . . . 0.0 113.711 174.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -60.44 -53.51 56.75 Favored 'General case' 0 C--N 1.379 1.884 0 C-N-CA 128.838 2.855 . . . . 0.0 111.108 173.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -59.86 -45.42 92.52 Favored 'General case' 0 C--N 1.365 1.277 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -56.45 -37.79 70.77 Favored 'General case' 0 C--N 1.378 1.83 0 C-N-CA 127.668 2.387 . . . . 0.0 112.955 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.99 -39.62 72.34 Favored 'General case' 0 C--N 1.361 1.093 0 O-C-N 119.781 -1.824 . . . . 0.0 115.122 173.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.92 -29.35 55.63 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 119.417 3.118 . . . . 0.0 119.417 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.4 tt -63.83 -50.2 69.83 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 130.298 3.439 . . . . 0.0 113.074 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.274 0.0 OUTLIER -90.93 -16.6 27.83 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 127.577 2.351 . . . . 0.0 111.985 -175.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -120.78 -110.91 0.33 Allowed 'General case' 0 C--N 1.357 0.906 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -135.52 149.55 49.51 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 119.797 -1.814 . . . . 0.0 107.836 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.492 0.0 OUTLIER -51.03 -32.69 22.32 Favored 'General case' 0 CA--C 1.5 -0.957 1 C-N-CA 132.017 4.127 . . . . 0.0 117.711 175.49 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 17.4 tt -49.43 -30.91 5.08 Favored 'Isoleucine or valine' 0 C--N 1.365 1.278 0 C-N-CA 130.12 3.368 . . . . 0.0 113.029 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -60.43 -35.88 76.86 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 128.146 2.578 . . . . 0.0 113.955 169.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -75.3 -44.23 46.7 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 171.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 10.0 mp -67.92 -19.95 65.04 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 129.694 3.197 . . . . 0.0 112.753 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -64.86 -38.64 91.64 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 130.652 3.581 . . . . 0.0 114.344 168.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.34 -51.08 3.44 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.78 2.032 . . . . 0.0 109.667 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 46.67 -134.13 1.0 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 131.303 3.841 . . . . 0.0 117.919 175.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.406 HG12 ' CE2' ' A' ' 111' ' ' TYR 0.318 9.1 p -109.87 63.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.398 0 CA-C-O 124.645 2.164 . . . . 0.0 109.279 176.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.6 p -95.16 67.85 3.06 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 127.612 2.365 . . . . 0.0 108.676 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -79.64 65.53 4.84 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.986 1.714 . . . . 0.0 112.83 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -155.93 159.68 31.36 Favored Pre-proline 0 C--N 1.352 0.681 0 C-N-CA 126.856 2.062 . . . . 0.0 105.833 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.93 -176.15 2.88 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.126 3.217 . . . . 0.0 113.927 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 24.6 t -90.7 60.03 4.38 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.999 2.119 . . . . 0.0 112.684 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.365 3.3 pt-20 . . . . . 0 C--N 1.361 1.104 0 C-N-CA 130.83 3.652 . . . . 0.0 112.463 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.14 52.18 2.37 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 119.933 -1.73 . . . . 0.0 114.703 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -74.26 71.82 1.73 Allowed 'General case' 0 C--N 1.36 1.052 0 C-N-CA 127.633 2.373 . . . . 0.0 114.276 -178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -97.01 133.36 41.79 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 128.204 2.602 . . . . 0.0 109.573 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.02 63.46 1.78 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 126.216 1.806 . . . . 0.0 115.126 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -100.07 -5.97 27.12 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 126.493 1.917 . . . . 0.0 110.659 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.49 12.26 45.25 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 129.038 3.209 . . . . 0.0 117.506 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.97 7.07 68.69 Favored Glycine 0 C--N 1.358 1.761 0 C-N-CA 125.979 1.752 . . . . 0.0 112.753 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.0 mt -98.44 23.29 8.66 Favored 'General case' 0 C--N 1.367 1.326 0 O-C-N 121.223 -1.163 . . . . 0.0 112.882 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -71.6 -45.18 62.88 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 128.274 2.63 . . . . 0.0 113.017 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -105.83 -49.52 3.38 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 127.437 2.295 . . . . 0.0 107.404 173.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.27 4.5 t 89.0 160.67 0.06 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 128.938 2.895 . . . . 0.0 114.301 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 m -119.69 -5.95 10.72 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 C-N-CA 127.624 2.37 . . . . 0.0 109.886 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -138.04 154.71 74.45 Favored Pre-proline 0 C--N 1.359 0.99 0 C-N-CA 126.849 2.06 . . . . 0.0 107.938 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.97 167.36 23.72 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 125.144 3.896 . . . . 0.0 113.231 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.75 -91.47 0.1 Allowed 'General case' 0 C--N 1.359 1.013 0 O-C-N 121.349 -0.844 . . . . 0.0 109.676 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.6 112.8 64.59 Favored Pre-proline 0 C--N 1.356 0.848 0 C-N-CA 125.799 1.639 . . . . 0.0 107.109 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.22 90.9 0.46 Allowed 'Trans proline' 0 C--N 1.368 1.571 1 C-N-CA 125.52 4.147 . . . . 0.0 110.053 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 63.0 m -81.37 126.32 31.47 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 128.118 2.567 . . . . 0.0 115.558 -167.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 25.5 p -63.9 47.16 0.02 OUTLIER 'General case' 0 C--N 1.359 0.996 0 C-N-CA 131.593 3.957 . . . . 0.0 117.909 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.47 12.1 p 152.31 36.47 0.0 OUTLIER 'General case' 0 C--N 1.349 0.572 0 C-N-CA 129.911 3.284 . . . . 0.0 112.994 174.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -122.79 102.6 8.13 Favored 'General case' 0 C--N 1.369 1.442 0 O-C-N 120.566 -1.334 . . . . 0.0 110.386 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.448 ' H ' ' HD2' ' A' ' 145' ' ' LYS . 8.5 m-85 -126.06 128.6 47.65 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.766 1.626 . . . . 0.0 114.591 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 58.5 p -110.67 163.73 16.54 Favored Pre-proline 0 C--N 1.365 1.241 0 O-C-N 119.868 -1.77 . . . . 0.0 115.776 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -54.67 134.97 65.22 Favored 'Trans proline' 0 C--N 1.373 1.839 1 C-N-CA 126.659 4.906 . . . . 0.0 117.097 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.33 -51.19 0.75 Allowed Glycine 0 C--N 1.353 1.522 0 N-CA-C 106.062 -2.815 . . . . 0.0 106.062 -169.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -65.49 159.36 24.59 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.47 HD23 HH11 ' A' ' 190' ' ' ARG . 3.5 mm? -102.83 141.49 35.54 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 171.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 148' ' ' LEU . 13.1 m -132.42 159.68 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 C-N-CA 126.639 1.976 . . . . 0.0 106.538 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.529 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 52.2 m95 -108.56 115.76 30.7 Favored 'General case' 0 C--O 1.214 -0.786 1 N-CA-C 99.462 -4.273 . . . . 0.0 99.462 171.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -103.25 147.66 26.77 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 122.728 2.513 . . . . 0.0 113.602 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -115.14 130.57 56.96 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 170.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 44.1 ttm -116.04 141.19 48.45 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.26 101.29 0.9 Allowed 'General case' 0 C--N 1.364 1.203 0 C-N-CA 126.062 1.745 . . . . 0.0 113.5 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.42 -10.93 23.97 Favored Glycine 0 C--N 1.358 1.782 0 C-N-CA 125.752 1.644 . . . . 0.0 113.45 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -103.9 164.83 14.57 Favored Pre-proline 0 C--N 1.357 0.913 0 C-N-CA 125.567 1.547 . . . . 0.0 109.719 178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -71.41 166.09 30.41 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 125.039 3.826 . . . . 0.0 112.752 164.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.92 126.0 25.83 Favored 'General case' 0 C--N 1.36 1.023 0 C-N-CA 127.776 2.43 . . . . 0.0 114.95 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' A' ' 135' ' ' ASP . 3.3 m95 -134.75 116.57 12.67 Favored Pre-proline 0 CA--C 1.571 1.787 1 N-CA-C 123.893 4.775 . . . . 0.0 123.893 -169.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.529 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 27.1 Cg_exo -56.44 113.45 1.46 Allowed 'Trans proline' 0 C--N 1.401 3.325 1 C-N-CA 126.788 4.992 . . . . 0.0 114.145 166.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.8 p -127.06 164.29 21.87 Favored 'General case' 0 N--CA 1.449 -0.508 1 C-N-CA 133.199 4.6 . . . . 0.0 116.104 -168.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.16 146.72 41.1 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.742 2.817 . . . . 0.0 107.165 172.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 t -91.63 130.64 40.46 Favored 'Isoleucine or valine' 0 C--N 1.37 1.467 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 171.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -132.18 152.47 51.27 Favored 'General case' 0 C--N 1.361 1.066 0 O-C-N 118.729 -2.482 . . . . 0.0 115.097 -164.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -92.31 112.82 24.9 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.46 ' CE1' ' HD3' ' A' ' 140' ' ' ARG . 2.0 m-70 -65.68 160.7 58.96 Favored Pre-proline 0 C--N 1.36 1.061 0 C-N-CA 128.2 2.6 . . . . 0.0 117.417 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.37 -1.41 0.2 Allowed 'Trans proline' 0 CA--C 1.572 2.398 0 C-N-CA 124.933 3.755 . . . . 0.0 116.895 169.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -115.71 33.92 5.22 Favored 'General case' 0 C--N 1.356 0.883 1 C-N-CA 135.638 5.575 . . . . 0.0 107.247 177.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.318 1.1 p30 -72.64 150.26 43.17 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -172.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.07 2.94 31.68 Favored Glycine 0 C--N 1.359 1.849 0 CA-C-N 111.99 -2.368 . . . . 0.0 110.959 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.4 m -149.74 130.76 14.38 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 102.141 -3.281 . . . . 0.0 102.141 176.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -149.37 -10.44 0.31 Allowed 'General case' 0 C--N 1.364 1.21 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.9 pt -108.63 145.6 15.37 Favored 'Isoleucine or valine' 0 C--N 1.369 1.446 0 CA-C-N 121.862 2.119 . . . . 0.0 112.196 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -139.1 137.9 36.58 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -143.27 127.42 17.54 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -117.86 94.0 4.36 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 126.926 2.09 . . . . 0.0 110.675 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.12 -71.02 0.32 Allowed Glycine 0 C--N 1.362 2.027 0 N-CA-C 120.205 2.842 . . . . 0.0 120.205 173.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -150.38 57.59 0.94 Allowed 'General case' 0 C--N 1.353 0.721 0 CA-C-O 122.512 1.149 . . . . 0.0 109.861 -176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.5 m -176.8 140.15 0.32 Allowed 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.486 1.914 . . . . 0.0 106.293 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.5 p -128.47 136.98 58.64 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 123.13 1.443 . . . . 0.0 112.31 -176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.1 mtt85 -114.89 141.95 47.24 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.456 2.302 . . . . 0.0 107.994 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 145' ' ' LYS . 8.8 m -146.58 156.62 11.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 1 N-CA-C 98.711 -4.551 . . . . 0.0 98.711 174.202 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.453 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 2.5 m80 -79.66 138.66 37.45 Favored 'General case' 0 C--N 1.37 1.496 0 N-CA-C 115.675 1.732 . . . . 0.0 115.675 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.511 HG11 HD13 ' A' ' 148' ' ' LEU . 1.5 m -139.91 172.08 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.292 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 173.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.555 ' HB3' ' HG3' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -138.08 147.65 44.25 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 176.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.34 118.59 34.31 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 127.854 2.462 . . . . 0.0 104.951 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -63.51 53.36 0.02 OUTLIER 'General case' 0 C--N 1.373 1.622 0 C-N-CA 129.478 3.111 . . . . 0.0 114.568 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP . 1.6 p30 -100.83 -127.67 0.2 Allowed 'General case' 0 C--N 1.359 1.016 0 O-C-N 118.6 -2.563 . . . . 0.0 113.035 -177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -96.66 -46.4 6.32 Favored 'General case' 0 C--N 1.355 0.817 0 C-N-CA 124.785 1.234 . . . . 0.0 114.042 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.286 12.3 t -74.12 -51.86 4.54 Favored Pre-proline 0 CA--C 1.552 1.023 0 N-CA-C 116.797 2.147 . . . . 0.0 116.797 -175.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.3 -173.63 12.96 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 126.012 3.183 . . . . 0.0 112.755 0.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 75.0 m -95.72 116.79 29.38 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.555 ' HG3' ' HB3' ' A' ' 132' ' ' GLN . 5.9 tmm_? -155.34 152.94 29.76 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 120.781 -1.199 . . . . 0.0 109.83 -176.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 156.93 -149.2 19.86 Favored Glycine 0 CA--C 1.488 -1.611 0 N-CA-C 104.468 -3.453 . . . . 0.0 104.468 174.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -86.78 111.33 20.62 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 126.166 1.786 . . . . 0.0 110.738 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.1 m -98.37 175.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.863 0 C-N-CA 126.136 1.774 . . . . 0.0 107.069 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.9 t -94.31 128.56 40.88 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 101.726 -3.435 . . . . 0.0 101.726 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.587 ' HB3' HG22 ' A' ' 129' ' ' VAL 0.293 47.7 pttt -77.6 -7.26 56.1 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-N 121.206 1.821 . . . . 0.0 113.791 -176.407 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -67.64 -19.32 65.2 Favored 'General case' 0 C--N 1.364 1.223 0 C-N-CA 124.72 1.208 . . . . 0.0 113.307 172.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.9 mt -94.55 -0.23 54.74 Favored 'General case' 0 C--N 1.367 1.35 0 C-N-CA 125.666 1.586 . . . . 0.0 114.272 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.511 HD13 HG11 ' A' ' 131' ' ' VAL . 0.0 OUTLIER -101.29 157.02 17.1 Favored 'General case' 0 C--N 1.366 1.285 0 CA-C-N 122.025 2.193 . . . . 0.0 108.3 179.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.457 ' HG3' ' CE1' ' A' ' 165' ' ' PHE . 21.0 mmtt -119.67 168.07 10.94 Favored Pre-proline 0 C--O 1.222 -0.376 0 N-CA-C 105.143 -2.169 . . . . 0.0 105.143 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -82.8 156.24 15.66 Favored 'Trans proline' 0 C--N 1.326 -0.649 1 C-N-CA 125.67 4.247 . . . . 0.0 113.481 178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.429 ' CE2' ' HA2' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -97.5 148.95 22.71 Favored 'General case' 0 C--N 1.359 0.994 0 CA-C-O 122.621 1.2 . . . . 0.0 110.109 172.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.5 t -171.38 -37.85 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 101.115 -3.661 . . . . 0.0 101.115 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.429 ' HA2' ' CE2' ' A' ' 151' ' ' TYR . . . 119.74 -159.36 14.9 Favored Glycine 0 C--N 1.36 1.886 0 CA-C-N 113.949 -1.478 . . . . 0.0 115.969 140.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.3 m -46.35 -16.74 0.03 OUTLIER 'General case' 0 C--N 1.373 1.609 1 C-N-CA 133.263 4.625 . . . . 0.0 117.629 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -77.69 -23.07 49.64 Favored 'General case' 0 N--CA 1.442 -0.873 1 C-N-CA 135.379 5.471 . . . . 0.0 112.831 176.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 6.8 t -89.17 153.9 20.58 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 125.209 1.404 . . . . 0.0 114.052 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -61.23 -36.26 79.46 Favored 'General case' 0 C--N 1.369 1.417 0 C-N-CA 126.404 1.881 . . . . 0.0 113.858 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -73.08 -4.57 33.42 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 125.686 1.594 . . . . 0.0 113.197 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -111.75 7.11 20.16 Favored 'General case' 0 C--N 1.372 1.567 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.311 1.5 pp0? -127.98 -172.89 2.79 Favored 'General case' 0 C--N 1.363 1.194 0 O-C-N 119.621 -1.924 . . . . 0.0 111.853 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -63.69 122.38 16.23 Favored 'General case' 0 C--N 1.372 1.584 0 C-N-CA 126.824 2.05 . . . . 0.0 112.897 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.45 -9.04 66.89 Favored Glycine 0 C--N 1.359 1.854 0 C-N-CA 124.38 0.99 . . . . 0.0 112.22 -167.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.55 140.67 20.59 Favored Glycine 0 C--N 1.365 2.157 0 C-N-CA 126.926 2.203 . . . . 0.0 116.705 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -61.47 -21.6 64.33 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 119.453 3.131 . . . . 0.0 119.453 -172.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.457 ' CE1' ' HG3' ' A' ' 149' ' ' LYS . 1.7 m-85 -108.74 -3.6 17.67 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 120.623 -1.298 . . . . 0.0 111.449 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -86.53 165.46 16.22 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 125.566 2.603 . . . . 0.0 117.171 -173.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.4 m 169.95 173.84 0.05 Allowed 'General case' 0 CA--C 1.503 -0.848 2 N-CA-C 98.487 -4.634 . . . . 0.0 98.487 -178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -121.12 101.49 7.7 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-N 122.299 2.318 . . . . 0.0 107.168 170.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -119.58 123.9 28.35 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 101.173 -3.64 . . . . 0.0 101.173 169.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -55.73 -29.72 72.63 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 125.189 3.926 . . . . 0.0 116.868 -174.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -65.22 -36.11 83.13 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 128.921 2.889 . . . . 0.0 113.067 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 8.9 mt -68.36 -41.79 83.78 Favored 'Isoleucine or valine' 0 C--N 1.38 1.895 0 C-N-CA 126.164 1.786 . . . . 0.0 110.612 172.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.7 mt -68.55 -43.9 75.63 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 125.826 1.651 . . . . 0.0 113.275 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 33.1 ttp85 -58.05 -42.97 86.55 Favored 'General case' 0 CA--C 1.486 -1.498 0 C-N-CA 128.581 2.752 . . . . 0.0 113.777 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.59 -34.35 77.7 Favored 'General case' 0 N--CA 1.428 -1.546 0 C-N-CA 130.41 3.484 . . . . 0.0 110.09 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.255 6.8 mtt -70.09 -33.4 71.84 Favored 'General case' 0 C--N 1.376 1.721 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 165.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -71.31 -45.7 62.41 Favored 'General case' 0 C--N 1.379 1.884 0 C-N-CA 125.961 1.704 . . . . 0.0 110.955 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -67.48 -52.81 34.86 Favored 'General case' 0 C--N 1.375 1.699 0 C-N-CA 127.882 2.473 . . . . 0.0 112.154 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.64 85.55 Favored 'General case' 0 C--N 1.374 1.636 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 173.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.28 -40.37 93.78 Favored 'General case' 0 C--N 1.368 1.396 0 CA-C-N 121.714 2.052 . . . . 0.0 112.527 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.27 -52.13 63.3 Favored 'General case' 0 C--N 1.367 1.353 0 O-C-N 119.099 -2.251 . . . . 0.0 113.935 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -66.58 -31.84 72.8 Favored 'General case' 0 C--N 1.361 1.065 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -50.21 43.54 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 127.084 2.154 . . . . 0.0 112.309 171.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.378 0.0 OUTLIER -81.19 -12.88 59.06 Favored 'General case' 0 C--N 1.363 1.183 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -170.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -107.42 -107.94 0.32 Allowed 'General case' 0 C--N 1.356 0.885 0 C-N-CA 123.731 0.812 . . . . 0.0 111.734 174.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 188' ' ' ILE . 19.5 t70 -136.25 176.31 8.81 Favored 'General case' 0 C--N 1.365 1.274 0 O-C-N 119.839 -1.788 . . . . 0.0 112.053 -175.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.537 ' HA ' ' HE ' ' A' ' 190' ' ' ARG . 40.6 mmtm -51.45 -43.83 62.18 Favored 'General case' 0 C--N 1.384 2.065 1 C-N-CA 132.495 4.318 . . . . 0.0 114.207 177.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.474 HG22 ' HB3' ' A' ' 186' ' ' ASP . 9.5 tt -59.84 -27.99 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 C-N-CA 129.929 3.292 . . . . 0.0 114.148 -178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -71.95 -45.33 61.51 Favored 'General case' 0 C--N 1.376 1.737 0 C-N-CA 126.288 1.835 . . . . 0.0 112.983 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.537 ' HE ' ' HA ' ' A' ' 187' ' ' LYS . 0.0 OUTLIER -75.13 -41.5 58.29 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 126.91 2.084 . . . . 0.0 114.7 170.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.46 -20.92 62.84 Favored 'General case' 0 C--N 1.369 1.422 0 C-N-CA 127.985 2.514 . . . . 0.0 113.329 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.74 -38.04 88.96 Favored 'General case' 0 C--N 1.368 1.377 0 C-N-CA 128.438 2.695 . . . . 0.0 114.044 171.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.4 mt -99.21 -46.27 5.61 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 126.777 2.031 . . . . 0.0 108.648 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . 0.256 . . 65.13 -94.16 0.04 OUTLIER 'General case' 0 C--N 1.367 1.351 0 C-N-CA 128.937 2.895 . . . . 0.0 114.39 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 8.4 m -117.05 0.82 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 125.989 1.716 . . . . 0.0 109.673 175.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.1 t 70.81 -52.44 0.67 Allowed 'General case' 0 C--N 1.366 1.322 0 C-N-CA 127.058 2.143 . . . . 0.0 115.465 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -157.23 158.43 36.15 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.52 147.77 18.29 Favored Pre-proline 0 C--N 1.352 0.694 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.9 -104.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 124.229 3.286 . . . . 0.0 112.256 -176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 41.0 t -105.85 55.68 0.68 Allowed 'General case' 0 C--N 1.358 0.948 0 C-N-CA 125.975 1.71 . . . . 0.0 108.793 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--N 1.36 1.052 0 C-N-CA 128.855 2.862 . . . . 0.0 113.953 179.578 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp . . . . . 0 N--CA 1.438 -1.062 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -116.07 -72.21 0.7 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 125.655 1.582 . . . . 0.0 110.553 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -119.55 119.02 32.59 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 126.156 1.782 . . . . 0.0 107.262 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -103.46 125.47 50.06 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.205 1.402 . . . . 0.0 109.852 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.2 mt -108.17 -93.36 0.41 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.747 1.219 . . . . 0.0 109.529 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -74.49 22.91 0.09 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 130.103 3.361 . . . . 0.0 115.163 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.31 4.24 47.19 Favored Glycine 0 C--N 1.354 1.579 0 C-N-CA 127.21 2.338 . . . . 0.0 114.705 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.2 52.96 1.8 Allowed Glycine 0 C--N 1.36 1.913 0 C-N-CA 126.485 1.993 . . . . 0.0 117.121 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.1 tp -91.22 -26.17 19.16 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 129.276 3.03 . . . . 0.0 110.198 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -71.64 -24.49 61.87 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 131.646 3.979 . . . . 0.0 115.962 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 64.9 ttp85 -171.14 -71.36 0.02 OUTLIER 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 104.434 -2.432 . . . . 0.0 104.434 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t 175.91 -166.37 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 100.813 -3.773 . . . . 0.0 100.813 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.02 53.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 123.634 1.683 . . . . 0.0 109.203 -174.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.13 114.91 65.31 Favored Pre-proline 0 C--N 1.358 0.946 0 C-N-CA 125.289 1.435 . . . . 0.0 110.923 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -84.39 162.85 12.95 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.08 3.187 . . . . 0.0 112.512 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -114.83 -125.93 0.29 Allowed 'General case' 0 C--N 1.351 0.659 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.63 117.08 58.86 Favored Pre-proline 0 C--N 1.358 0.964 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -72.53 -12.74 27.24 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 125.01 3.807 . . . . 0.0 113.594 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 p -84.55 -40.22 17.84 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 128.936 2.894 . . . . 0.0 109.568 172.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.9 m 63.4 -38.1 0.17 Allowed 'General case' 0 C--N 1.366 1.31 0 C-N-CA 130.243 3.417 . . . . 0.0 118.599 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.2 p -141.21 71.35 1.36 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.744 2.017 . . . . 0.0 108.367 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -163.09 62.12 0.19 Allowed 'General case' 0 C--N 1.364 1.236 0 CA-C-N 119.854 1.206 . . . . 0.0 113.409 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -118.04 125.78 51.0 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 120.215 -1.553 . . . . 0.0 110.067 -176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 87.4 p -111.73 166.22 11.31 Favored Pre-proline 0 C--N 1.36 1.022 0 C-N-CA 126.126 1.77 . . . . 0.0 110.773 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -54.56 149.14 40.66 Favored 'Trans proline' 0 C--N 1.37 1.691 1 C-N-CA 126.107 4.538 . . . . 0.0 119.188 -170.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.45 -39.37 2.89 Favored Glycine 0 C--N 1.356 1.689 0 C-N-CA 126.023 1.773 . . . . 0.0 113.015 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.54 169.04 17.58 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -173.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.476 HD21 ' HD2' ' A' ' 190' ' ' ARG . 3.3 mm? -94.89 134.46 37.51 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 172.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.0 m -136.08 159.22 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-O 123.613 1.673 . . . . 0.0 107.548 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -104.18 116.73 32.72 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 173.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.62 135.08 53.76 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 127.497 2.319 . . . . 0.0 112.791 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.469 ' HB2' ' CZ2' ' A' ' 105' ' ' TRP . 51.7 tptt -112.93 141.83 46.31 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 173.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 35.8 ttm -128.82 149.72 50.62 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 120.018 -1.676 . . . . 0.0 108.615 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -65.16 100.11 0.42 Allowed 'General case' 0 C--N 1.368 1.39 0 C-N-CA 125.788 1.635 . . . . 0.0 114.125 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.97 -4.38 25.67 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 125.873 1.701 . . . . 0.0 112.909 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -112.01 161.26 26.65 Favored Pre-proline 0 C--N 1.358 0.95 0 C-N-CA 125.41 1.484 . . . . 0.0 111.588 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.47 167.53 26.09 Favored 'Trans proline' 0 C--N 1.366 1.479 1 C-N-CA 126.12 4.547 . . . . 0.0 112.682 164.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.469 ' CZ2' ' HB2' ' A' ' 99' ' ' LYS . 6.9 m95 -65.34 132.8 49.94 Favored 'General case' 0 C--N 1.363 1.154 0 CA-C-O 124.316 2.008 . . . . 0.0 113.238 171.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.26 10.6 m95 -134.88 134.55 21.98 Favored Pre-proline 0 N--CA 1.413 -2.276 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 -169.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -72.2 143.15 39.17 Favored 'Trans proline' 0 C--N 1.38 2.204 1 C-N-CA 126.123 4.549 . . . . 0.0 110.916 156.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.3 p -156.77 165.42 36.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.27 3.028 . . . . 0.0 114.39 -161.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.44 HD23 ' OE1' ' A' ' 132' ' ' GLN . 8.8 tp -119.45 138.49 53.09 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.345 2.258 . . . . 0.0 107.745 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.31 121.89 33.43 Favored 'Isoleucine or valine' 0 C--N 1.378 1.836 0 C-N-CA 126.387 1.875 . . . . 0.0 106.528 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -127.38 152.75 47.09 Favored 'General case' 0 C--N 1.358 0.969 0 O-C-N 119.626 -1.921 . . . . 0.0 113.172 -167.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.79 113.58 26.92 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 127.472 2.309 . . . . 0.0 106.463 173.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.451 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 3.4 m-70 -62.56 159.98 38.25 Favored Pre-proline 0 C--N 1.358 0.975 0 C-N-CA 130.224 3.41 . . . . 0.0 117.456 -175.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.77 -1.41 0.24 Allowed 'Trans proline' 0 CA--C 1.564 2.021 1 C-N-CA 125.551 4.167 . . . . 0.0 116.951 170.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -108.72 31.27 5.78 Favored 'General case' 0 C--N 1.356 0.878 1 C-N-CA 134.813 5.245 . . . . 0.0 107.603 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.339 0.1 OUTLIER -69.53 150.29 47.29 Favored 'General case' 0 C--N 1.374 1.636 0 N-CA-C 117.125 2.269 . . . . 0.0 117.125 -172.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.22 5.51 30.31 Favored Glycine 0 C--N 1.359 1.836 0 CA-C-N 112.174 -2.285 . . . . 0.0 111.556 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 49.4 m -152.56 135.29 15.39 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 100.813 -3.773 . . . . 0.0 100.813 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.421 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.255 2.2 p90 -155.23 -37.36 0.09 Allowed 'General case' 0 C--N 1.365 1.261 0 CA-C-N 120.423 1.465 . . . . 0.0 113.684 -175.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 7.5 tt -108.26 140.48 26.6 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-O 122.972 1.368 . . . . 0.0 110.574 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -119.88 121.29 38.72 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 101.091 -3.67 . . . . 0.0 101.091 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -105.84 179.71 4.19 Favored 'General case' 0 C--N 1.349 0.587 0 C-N-CA 124.097 0.959 . . . . 0.0 112.794 -171.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -46.3 131.73 10.41 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 120.241 3.423 . . . . 0.0 120.241 -169.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 172.14 -51.38 0.17 Allowed Glycine 0 C--N 1.353 1.527 0 N-CA-C 106.37 -2.692 . . . . 0.0 106.37 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 33.0 mmmt -103.69 -52.81 2.9 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 126.605 1.962 . . . . 0.0 108.985 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.8 t -171.67 -166.49 0.44 Allowed 'General case' 0 C--N 1.353 0.739 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -129.13 120.68 52.15 Favored 'Isoleucine or valine' 0 C--N 1.349 0.569 0 C-N-CA 124.917 1.287 . . . . 0.0 110.423 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -130.18 139.42 50.85 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 126.519 1.928 . . . . 0.0 112.786 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.97 163.25 36.95 Favored 'Isoleucine or valine' 0 C--N 1.367 1.347 0 C-N-CA 126.524 1.929 . . . . 0.0 105.844 174.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.451 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 1.1 m80 -83.34 140.93 32.15 Favored 'General case' 0 C--N 1.373 1.625 0 CA-C-N 120.654 1.57 . . . . 0.0 113.223 172.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.417 HG11 HD13 ' A' ' 148' ' ' LEU . 3.9 m -150.96 171.97 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.476 -1.868 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.44 ' OE1' HD23 ' A' ' 109' ' ' LEU . 3.3 pt20 -136.69 146.77 46.28 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 124.453 1.101 . . . . 0.0 109.104 174.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.49 124.5 52.42 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 104.713 -2.328 . . . . 0.0 104.713 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -67.71 60.34 0.07 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 127.42 2.288 . . . . 0.0 113.394 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -98.29 -124.12 0.14 Allowed 'General case' 0 C--N 1.361 1.085 0 O-C-N 119.572 -1.955 . . . . 0.0 111.859 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -106.27 -52.55 2.77 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 125.731 1.612 . . . . 0.0 111.716 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.0 m -69.82 -40.35 13.19 Favored Pre-proline 0 C--N 1.364 1.232 0 N-CA-C 118.508 2.781 . . . . 0.0 118.508 -175.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.14 178.0 36.54 Favored 'Cis proline' 0 C--N 1.354 0.852 0 CA-C-N 126.442 3.336 . . . . 0.0 110.479 -4.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 17.6 m -89.67 115.62 27.18 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 118.743 -2.473 . . . . 0.0 106.849 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.414 ' HD3' ' HB3' ' A' ' 132' ' ' GLN . 39.2 ttp85 -149.04 150.97 33.68 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-O 122.6 1.19 . . . . 0.0 109.347 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 165.62 -157.06 29.38 Favored Glycine 0 CA--C 1.491 -1.413 0 N-CA-C 105.973 -2.851 . . . . 0.0 105.973 173.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -80.22 110.17 15.39 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 126.547 1.939 . . . . 0.0 109.885 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.17 169.25 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 124.636 1.174 . . . . 0.0 110.543 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.5 m -90.23 115.67 27.63 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.47 33.8 pttt -69.25 -5.6 23.91 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 119.848 3.277 . . . . 0.0 119.848 -168.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -82.05 -12.78 58.09 Favored 'General case' 0 C--N 1.365 1.256 0 O-C-N 119.242 -2.161 . . . . 0.0 109.714 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.6 mp -97.73 -0.63 45.06 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 128.679 2.792 . . . . 0.0 110.145 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.417 HD13 HG11 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -104.89 125.0 50.46 Favored 'General case' 0 C--N 1.388 2.262 0 N-CA-C 104.531 -2.396 . . . . 0.0 104.531 173.147 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -118.97 168.48 9.73 Favored Pre-proline 0 C--O 1.218 -0.563 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -82.47 153.23 15.73 Favored 'Trans proline' 0 C--N 1.328 -0.542 0 C-N-CA 124.433 3.422 . . . . 0.0 112.697 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -127.6 121.2 29.92 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.324 1.059 . . . . 0.0 111.696 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.694 ' HA ' HD13 ' A' ' 183' ' ' LEU . 8.7 t -162.14 30.67 0.12 Allowed 'General case' 0 C--N 1.359 0.997 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.72 82.12 0.09 OUTLIER Glycine 0 C--N 1.35 1.345 0 C-N-CA 116.499 -2.762 . . . . 0.0 115.228 -166.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . 0.34 89.2 p -68.42 -10.11 53.0 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 121.007 2.404 . . . . 0.0 116.791 175.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -112.12 32.02 5.83 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 130.166 3.386 . . . . 0.0 108.656 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 19.3 t -103.04 133.4 48.22 Favored 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 174.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.258 42.7 tttm -55.72 -33.08 63.91 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 -174.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -70.89 -19.2 62.64 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 124.704 1.202 . . . . 0.0 113.972 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.49 3.26 54.37 Favored 'General case' 0 C--N 1.371 1.536 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -130.56 -173.07 2.97 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 125.743 1.617 . . . . 0.0 112.042 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -62.79 122.22 15.39 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 126.284 1.834 . . . . 0.0 113.106 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.02 -8.01 64.95 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 124.554 1.073 . . . . 0.0 112.475 -169.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -85.09 146.2 21.85 Favored Glycine 0 C--N 1.361 1.935 0 C-N-CA 126.565 2.031 . . . . 0.0 115.824 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -60.37 -42.25 95.41 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . 0.322 0.1 OUTLIER -99.84 2.93 44.37 Favored 'General case' 0 C--N 1.363 1.163 0 CA-C-N 120.402 1.455 . . . . 0.0 114.826 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -91.77 140.83 29.31 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 126.551 1.94 . . . . 0.0 107.928 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 54.5 m -166.66 132.4 2.28 Favored 'General case' 0 N--CA 1.446 -0.635 1 N-CA-C 99.797 -4.149 . . . . 0.0 99.797 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.93 100.53 10.83 Favored 'General case' 0 C--N 1.369 1.432 0 CA-C-O 126.281 2.944 . . . . 0.0 112.848 -173.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.57 131.56 24.42 Favored Pre-proline 0 N--CA 1.417 -2.093 3 N-CA-C 98.51 -4.626 . . . . 0.0 98.51 164.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.53 -24.7 63.1 Favored 'Trans proline' 0 CA--C 1.543 0.942 1 C-N-CA 125.534 4.156 . . . . 0.0 115.998 -176.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -69.62 -35.88 75.65 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.47 2.708 . . . . 0.0 113.831 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 45.8 mt -74.12 -36.18 43.32 Favored 'Isoleucine or valine' 0 C--N 1.376 1.745 0 C-N-CA 126.369 1.868 . . . . 0.0 109.854 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.419 ' O ' ' HG3' ' A' ' 177' ' ' GLN . 20.1 mt -69.0 -45.63 70.05 Favored 'General case' 0 C--N 1.367 1.336 0 C-N-CA 125.298 1.439 . . . . 0.0 112.488 172.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -58.11 -43.21 87.04 Favored 'General case' 0 CA--C 1.486 -1.519 0 C-N-CA 127.951 2.5 . . . . 0.0 114.596 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.25 -36.88 85.51 Favored 'General case' 0 N--CA 1.428 -1.539 0 C-N-CA 129.449 3.1 . . . . 0.0 111.208 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 15.1 mtt -65.04 -35.51 81.41 Favored 'General case' 0 C--N 1.379 1.883 0 CA-C-O 115.486 -2.197 . . . . 0.0 112.724 165.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 13.6 mt-30 -74.06 -40.2 62.98 Favored 'General case' 0 C--N 1.383 2.026 0 C-N-CA 126.019 1.728 . . . . 0.0 113.731 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.401 HH21 ' HB3' ' A' ' 193' ' ' LEU . 0.2 OUTLIER -73.68 -49.46 25.69 Favored 'General case' 0 C--N 1.374 1.651 0 C-N-CA 131.551 3.941 . . . . 0.0 111.491 179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.54 95.72 Favored 'General case' 0 C--N 1.376 1.75 0 C-N-CA 123.836 0.854 . . . . 0.0 113.267 165.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.329 38.5 t70 -57.13 -52.76 64.02 Favored 'General case' 0 C--N 1.387 2.232 0 C-N-CA 126.692 1.997 . . . . 0.0 113.014 172.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -33.44 70.17 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 121.777 2.081 . . . . 0.0 115.702 173.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.413 ' HB1' ' CD ' ' A' ' 190' ' ' ARG . . . -76.26 -44.84 35.48 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 117.143 2.275 . . . . 0.0 117.143 172.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.694 HD13 ' HA ' ' A' ' 152' ' ' THR . 3.9 pp -69.53 -36.86 76.79 Favored 'General case' 0 C--N 1.374 1.65 0 C-N-CA 126.16 1.784 . . . . 0.0 114.221 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.38 -9.78 58.14 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.664 1.586 . . . . 0.0 112.125 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.1 mtmt -124.68 -101.27 0.39 Allowed 'General case' 0 C--N 1.356 0.867 0 CA-C-O 120.756 0.312 . . . . 0.0 111.44 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -135.77 152.69 51.37 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 121.036 -1.04 . . . . 0.0 110.953 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.351 17.2 ttpt -51.51 -35.96 42.63 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 130.839 3.656 . . . . 0.0 116.2 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 14.0 tt -55.03 -30.22 23.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 C-N-CA 129.032 2.933 . . . . 0.0 113.035 171.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -73.22 -37.88 66.27 Favored 'General case' 0 C--N 1.375 1.691 0 O-C-N 119.717 -1.864 . . . . 0.0 113.795 176.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.476 ' HD2' HD21 ' A' ' 95' ' ' LEU 0.28 0.0 OUTLIER -76.23 -44.35 38.01 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 117.363 2.357 . . . . 0.0 117.363 167.499 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.31 78.4 mt -79.19 -18.96 52.02 Favored 'General case' 0 C--N 1.366 1.292 0 N-CA-C 116.395 1.998 . . . . 0.0 116.395 -173.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -84.41 -12.95 53.47 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.607 1.163 . . . . 0.0 113.216 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.401 ' HB3' HH21 ' A' ' 178' ' ' ARG . 9.2 mp -105.03 -51.34 3.05 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 126.18 1.792 . . . . 0.0 106.22 176.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 46.48 -113.25 0.44 Allowed 'General case' 0 C--N 1.366 1.287 0 C-N-CA 129.696 3.198 . . . . 0.0 115.787 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 18.8 m -88.27 12.87 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 128.182 2.593 . . . . 0.0 113.221 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.286 1.5 t 95.11 48.4 0.0 OUTLIER 'General case' 0 C--N 1.359 0.982 0 C-N-CA 129.023 2.929 . . . . 0.0 109.114 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -117.25 63.75 0.73 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 127.535 2.334 . . . . 0.0 106.481 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -59.76 -43.18 94.58 Favored Pre-proline 0 C--N 1.365 1.262 0 C-N-CA 127.907 2.483 . . . . 0.0 116.494 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -70.42 -42.94 2.37 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 124.074 3.183 . . . . 0.0 111.411 167.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.278 1.9 m 67.37 -48.24 0.49 Allowed 'General case' 0 C--N 1.369 1.423 0 C-N-CA 129.525 3.13 . . . . 0.0 115.838 178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 . . . . . 0 C--N 1.351 0.669 0 C-N-CA 127.523 2.329 . . . . 0.0 109.613 178.75 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.4 mttp . . . . . 0 N--CA 1.443 -0.793 0 CA-C-O 121.836 0.827 . . . . 0.0 108.788 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -164.06 -179.16 6.02 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.1 mtmm -86.74 128.67 35.03 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 124.887 1.275 . . . . 0.0 111.935 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -102.66 120.33 40.38 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 126.322 1.849 . . . . 0.0 108.561 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.3 mt -141.24 -158.46 0.86 Allowed 'General case' 0 C--N 1.362 1.138 0 C-N-CA 126.144 1.777 . . . . 0.0 107.486 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -100.46 20.85 14.16 Favored 'General case' 0 C--N 1.37 1.492 0 O-C-N 120.463 -1.398 . . . . 0.0 113.078 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.78 -12.85 57.9 Favored Glycine 0 C--N 1.363 2.06 0 C-N-CA 125.63 1.586 . . . . 0.0 111.177 -173.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.51 -172.03 45.08 Favored Glycine 0 N--CA 1.441 -1.02 2 N-CA-C 102.629 -4.188 . . . . 0.0 102.629 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 tp -154.47 53.15 0.67 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 53.3 ttp85 -65.44 -38.22 89.23 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.642 2.777 . . . . 0.0 117.79 -173.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -94.48 -15.06 24.53 Favored 'General case' 0 C--N 1.362 1.147 0 O-C-N 120.545 -1.347 . . . . 0.0 110.589 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.267 19.7 m 85.45 19.03 0.11 Allowed 'General case' 0 C--N 1.358 0.973 0 C-N-CA 129.744 3.218 . . . . 0.0 114.079 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.9 m -74.92 69.19 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 127.047 2.139 . . . . 0.0 114.527 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.16 115.03 45.63 Favored Pre-proline 0 C--N 1.358 0.937 0 O-C-N 120.205 -1.56 . . . . 0.0 107.67 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.01 -72.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 124.322 3.348 . . . . 0.0 111.017 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -165.7 -64.51 0.03 OUTLIER 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.6 134.98 19.44 Favored Pre-proline 0 C--N 1.355 0.846 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.76 167.84 18.19 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.248 2.632 . . . . 0.0 114.806 -171.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 m -114.15 125.72 54.26 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 125.315 1.446 . . . . 0.0 111.547 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.6 m -56.47 -39.73 73.69 Favored 'General case' 0 C--N 1.37 1.485 0 C-N-CA 129.375 3.07 . . . . 0.0 117.461 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.4 p -117.15 49.92 1.14 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 124.378 1.071 . . . . 0.0 112.95 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.12 109.9 6.38 Favored 'General case' 0 C--N 1.361 1.086 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.401 ' CD1' HD12 ' A' ' 148' ' ' LEU . 18.2 m-85 -125.71 128.49 47.86 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 125.952 1.701 . . . . 0.0 113.47 -173.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.318 90.8 p -110.2 162.59 19.84 Favored Pre-proline 0 C--N 1.364 1.235 0 O-C-N 120.249 -1.532 . . . . 0.0 114.855 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -56.24 136.9 77.75 Favored 'Trans proline' 0 C--N 1.378 2.095 1 C-N-CA 126.449 4.766 . . . . 0.0 119.217 -170.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.63 -20.83 19.97 Favored Glycine 0 C--N 1.364 2.11 0 C-N-CA 125.605 1.574 . . . . 0.0 111.813 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -85.53 169.04 13.95 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 125.697 1.599 . . . . 0.0 114.891 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.477 HD21 ' HD2' ' A' ' 190' ' ' ARG . 2.8 mm? -110.28 131.68 54.84 Favored 'General case' 0 C--N 1.369 1.447 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 172.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.5 m -134.46 161.77 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -175.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -106.98 138.31 43.39 Favored 'General case' 0 C--O 1.217 -0.618 1 N-CA-C 99.768 -4.16 . . . . 0.0 99.768 165.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 148' ' ' LEU . . . -128.86 152.58 48.36 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 121.632 2.014 . . . . 0.0 111.976 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -121.46 146.04 47.32 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.9 ttp -128.85 146.43 50.93 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 119.61 -1.931 . . . . 0.0 108.016 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -48.6 91.06 0.0 OUTLIER 'General case' 0 C--N 1.366 1.285 0 C-N-CA 129.475 3.11 . . . . 0.0 117.01 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.06 -9.13 33.7 Favored Glycine 0 C--N 1.36 1.875 0 C-N-CA 125.102 1.334 . . . . 0.0 113.436 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -99.71 162.12 22.2 Favored Pre-proline 0 C--N 1.359 0.983 0 C-N-CA 125.308 1.443 . . . . 0.0 109.231 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.88 167.31 26.27 Favored 'Trans proline' 0 CA--C 1.537 0.674 1 C-N-CA 125.848 4.365 . . . . 0.0 114.736 167.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -60.91 132.0 52.47 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 127.335 2.254 . . . . 0.0 115.04 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -132.29 108.56 13.61 Favored Pre-proline 0 N--CA 1.431 -1.386 0 N-CA-C 121.729 3.974 . . . . 0.0 121.729 -171.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HG2' ' HB3' ' A' ' 175' ' ' ALA . 7.6 Cg_endo -58.07 113.58 1.59 Allowed 'Trans proline' 0 C--N 1.388 2.631 1 C-N-CA 126.275 4.65 . . . . 0.0 111.588 165.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.1 m -123.65 166.12 16.05 Favored 'General case' 0 N--CA 1.438 -1.026 1 C-N-CA 132.871 4.468 . . . . 0.0 114.147 -160.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.3 tp -126.12 144.41 50.76 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 174.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.16 118.8 37.17 Favored 'Isoleucine or valine' 0 C--N 1.366 1.294 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 172.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -113.41 143.59 44.23 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.103 -1.623 . . . . 0.0 111.679 -170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -79.31 111.31 15.43 Favored 'General case' 0 C--N 1.373 1.612 0 O-C-N 120.379 -1.451 . . . . 0.0 109.597 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.475 ' HB2' ' CG ' ' A' ' 130' ' ' HIS . 9.9 t60 -69.22 160.15 80.09 Favored Pre-proline 0 C--N 1.348 0.522 0 CA-C-O 114.488 -2.672 . . . . 0.0 115.336 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.82 -6.47 2.56 Favored 'Trans proline' 0 CA--C 1.562 1.901 1 CA-C-N 128.814 4.184 . . . . 0.0 116.577 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -108.32 29.72 7.09 Favored 'General case' 0 C--N 1.357 0.922 1 C-N-CA 133.384 4.674 . . . . 0.0 109.642 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -63.45 149.73 45.36 Favored 'General case' 0 C--N 1.365 1.276 0 N-CA-C 118.54 2.793 . . . . 0.0 118.54 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 100.07 -20.14 50.14 Favored Glycine 0 C--N 1.36 1.889 0 CA-C-N 113.226 -1.806 . . . . 0.0 110.007 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.86 119.1 38.56 Favored 'General case' 0 N--CA 1.446 -0.672 2 N-CA-C 98.646 -4.575 . . . . 0.0 98.646 168.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.592 ' HA ' ' CE1' ' A' ' 130' ' ' HIS 0.359 0.0 OUTLIER -121.82 -33.41 3.58 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -169.378 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.42 HG22 HG12 ' A' ' 129' ' ' VAL . 10.3 pt -108.33 155.84 9.09 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 O-C-N 120.269 -1.519 . . . . 0.0 110.581 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -141.35 151.16 43.32 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 128.016 2.527 . . . . 0.0 104.208 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.65 130.21 11.48 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 121.0 -1.063 . . . . 0.0 108.249 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -117.4 98.93 6.67 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.952 2.101 . . . . 0.0 108.654 177.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.43 -89.78 1.02 Allowed Glycine 0 C--N 1.36 1.916 0 N-CA-C 117.869 1.908 . . . . 0.0 117.869 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -142.57 71.34 1.34 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 125.0 1.32 . . . . 0.0 109.391 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.0 m -179.92 170.36 1.21 Allowed 'General case' 0 C--N 1.351 0.667 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.2 p -151.49 145.46 16.22 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -141.32 150.31 42.34 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.498 2.319 . . . . 0.0 110.757 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' A' ' 145' ' ' LYS . 26.2 m -129.0 162.36 36.48 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 129.592 3.157 . . . . 0.0 104.475 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.592 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 0.1 OUTLIER -82.5 124.8 30.43 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 120.335 -1.478 . . . . 0.0 110.976 172.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.78 169.48 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.436 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -138.98 150.84 46.32 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -106.21 127.86 53.53 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.36 1.864 . . . . 0.0 107.376 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -74.95 69.35 1.89 Allowed 'General case' 0 C--N 1.379 1.872 0 CA-C-N 120.258 1.39 . . . . 0.0 111.881 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -88.98 -119.92 0.05 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 127.459 2.304 . . . . 0.0 111.002 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -107.25 -51.99 2.83 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.184 1.794 . . . . 0.0 110.91 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 46.6 t -69.97 -49.98 18.02 Favored Pre-proline 0 C--N 1.36 1.063 0 C-N-CA 127.975 2.51 . . . . 0.0 117.734 -172.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -81.99 -175.64 15.67 Favored 'Cis proline' 0 C--N 1.347 0.497 0 CA-C-N 126.104 3.216 . . . . 0.0 111.52 -0.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 34.5 m -94.62 141.17 28.92 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.291 1.036 . . . . 0.0 108.319 178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -160.23 156.21 26.15 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.16 -159.8 29.21 Favored Glycine 0 CA--C 1.484 -1.904 1 N-CA-C 98.235 -5.946 . . . . 0.0 98.235 174.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -104.85 113.73 27.5 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 143' ' ' VAL . 13.5 m -87.83 173.78 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 C-N-CA 128.231 2.612 . . . . 0.0 106.711 176.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 60.8 m -94.31 110.88 22.61 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 172.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.494 ' HB3' HG22 ' A' ' 129' ' ' VAL . 16.9 ptmt -50.93 -17.8 0.65 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -173.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -69.27 -19.47 63.91 Favored 'General case' 0 N--CA 1.439 -1.014 1 C-N-CA 131.784 4.034 . . . . 0.0 112.75 174.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.4 mt -92.33 -2.23 56.53 Favored 'General case' 0 C--N 1.365 1.278 0 C-N-CA 126.182 1.793 . . . . 0.0 113.935 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -95.35 156.9 16.13 Favored 'General case' 0 C--N 1.369 1.451 0 CA-C-N 122.231 2.287 . . . . 0.0 109.715 174.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.06 159.04 58.43 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 102.567 -3.123 . . . . 0.0 102.567 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.98 151.93 21.51 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 125.035 3.823 . . . . 0.0 111.399 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.365 1.0 OUTLIER -93.31 -116.2 0.09 Allowed 'General case' 0 C--N 1.367 1.335 0 O-C-N 120.649 -1.282 . . . . 0.0 110.737 175.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.426 4.6 t 63.47 -36.87 0.16 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 127.849 2.459 . . . . 0.0 116.149 -174.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -108.04 88.54 0.53 Allowed Glycine 0 C--N 1.349 1.27 0 C-N-CA 126.448 1.975 . . . . 0.0 116.769 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.2 m -67.66 -10.92 56.6 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 131.473 3.909 . . . . 0.0 115.412 173.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -121.49 24.58 9.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 128.458 2.703 . . . . 0.0 108.496 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 91.2 p -87.39 139.29 30.7 Favored 'General case' 0 C--N 1.374 1.667 0 C-N-CA 125.598 1.559 . . . . 0.0 107.821 174.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -56.39 -24.34 43.97 Favored 'General case' 0 C--N 1.372 1.579 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -82.24 -19.86 38.81 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.734 1.614 . . . . 0.0 113.224 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.61 -13.99 22.49 Favored 'General case' 0 C--N 1.37 1.494 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.304 0.4 OUTLIER -107.88 -173.97 2.41 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 125.395 1.478 . . . . 0.0 112.939 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -69.31 122.1 18.2 Favored 'General case' 0 C--N 1.373 1.613 0 O-C-N 120.308 -1.495 . . . . 0.0 112.784 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.22 -9.47 50.06 Favored Glycine 0 C--N 1.354 1.553 0 CA-C-N 114.069 -1.423 . . . . 0.0 111.81 -166.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -75.87 155.76 46.78 Favored Glycine 0 C--N 1.368 2.339 0 N-CA-C 119.97 2.748 . . . . 0.0 119.97 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.69 -41.54 77.53 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.927 3.691 . . . . 0.0 116.164 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -98.42 -17.74 18.64 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -41.08 -36.58 0.72 Allowed 'General case' 0 C--N 1.356 0.854 2 C-N-CA 132.723 4.409 . . . . 0.0 122.472 -168.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.6 m -14.17 92.86 0.01 OUTLIER 'General case' 0 C--N 1.371 1.507 1 C-N-CA 132.032 4.133 . . . . 0.0 117.707 -177.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.99 101.65 13.1 Favored 'General case' 0 C--N 1.368 1.38 0 CA-C-O 126.016 2.817 . . . . 0.0 114.003 -166.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -119.78 135.55 24.28 Favored Pre-proline 0 N--CA 1.423 -1.776 1 C-N-CA 133.803 4.841 . . . . 0.0 102.681 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -55.08 -22.76 32.76 Favored 'Trans proline' 0 CA--C 1.544 1.019 1 C-N-CA 125.973 4.448 . . . . 0.0 117.733 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -70.16 -35.96 74.38 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 131.251 3.82 . . . . 0.0 112.453 173.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 18.8 mt -76.7 -32.7 20.93 Favored 'Isoleucine or valine' 0 C--N 1.375 1.683 0 C-N-CA 127.582 2.353 . . . . 0.0 109.084 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 26.3 mt -66.46 -51.88 52.15 Favored 'General case' 0 C--N 1.373 1.627 0 C-N-CA 127.063 2.145 . . . . 0.0 111.055 170.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -57.45 -34.52 69.06 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 126.127 1.771 . . . . 0.0 114.751 177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.411 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . . . -69.33 -50.75 43.59 Favored 'General case' 0 N--CA 1.429 -1.521 0 C-N-CA 130.484 3.514 . . . . 0.0 113.86 172.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . 0.415 0.0 OUTLIER -68.16 -33.1 73.85 Favored 'General case' 0 C--N 1.385 2.124 0 CA-C-N 121.525 1.966 . . . . 0.0 113.7 173.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -71.96 -48.89 41.95 Favored 'General case' 0 C--N 1.373 1.596 0 C-N-CA 126.688 1.995 . . . . 0.0 112.751 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.45 -38.51 77.83 Favored 'General case' 0 C--N 1.383 2.042 0 O-C-N 119.022 -2.299 . . . . 0.0 114.986 174.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.89 -51.09 69.61 Favored 'General case' 0 C--N 1.379 1.864 0 C-N-CA 124.655 1.182 . . . . 0.0 112.19 169.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.268 38.1 t70 -53.47 -43.2 67.96 Favored 'General case' 0 C--N 1.38 1.897 0 C-N-CA 127.263 2.225 . . . . 0.0 113.98 174.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -33.86 76.57 Favored 'General case' 0 C--N 1.374 1.669 0 O-C-N 118.661 -2.524 . . . . 0.0 114.921 173.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.435 ' HB1' ' CD ' ' A' ' 190' ' ' ARG . . . -76.37 -45.59 31.24 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 tt -53.56 -49.87 66.75 Favored 'General case' 0 CA--C 1.498 -1.024 1 C-N-CA 132.298 4.239 . . . . 0.0 116.455 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.253 0.0 OUTLIER -86.84 -7.91 57.8 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 126.606 1.962 . . . . 0.0 111.417 -174.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -120.1 -100.05 0.43 Allowed 'General case' 0 C--N 1.358 0.961 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -135.26 151.05 50.21 Favored 'General case' 0 CA--C 1.501 -0.907 0 O-C-N 120.783 -1.198 . . . . 0.0 108.998 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.256 34.3 tttm -51.39 -36.49 43.63 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 130.979 3.712 . . . . 0.0 115.872 177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 12.6 tt -56.0 -28.5 24.86 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 130.118 3.367 . . . . 0.0 113.211 174.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.258 4.6 mptt -71.02 -42.62 69.33 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 119.537 -1.977 . . . . 0.0 113.849 174.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.477 ' HD2' HD21 ' A' ' 95' ' ' LEU 0.314 0.0 OUTLIER -76.36 -42.98 42.9 Favored 'General case' 0 C--N 1.367 1.34 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 169.36 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.55 -30.7 67.5 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 126.627 1.971 . . . . 0.0 114.946 -172.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -84.56 -12.25 54.47 Favored 'General case' 0 C--N 1.365 1.282 0 C-N-CA 125.859 1.664 . . . . 0.0 114.305 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 8.3 mp -97.34 -50.05 4.69 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 173.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 62.65 -102.64 0.11 Allowed 'General case' 0 C--N 1.364 1.199 0 C-N-CA 130.371 3.468 . . . . 0.0 115.055 174.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 13.9 m -115.63 29.99 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 128.397 2.679 . . . . 0.0 108.601 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.273 4.2 t 82.03 60.81 0.02 OUTLIER 'General case' 0 C--N 1.357 0.921 0 C-N-CA 128.751 2.821 . . . . 0.0 113.944 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -101.84 148.4 25.35 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 124.79 1.236 . . . . 0.0 109.738 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -112.06 89.81 12.47 Favored Pre-proline 0 C--N 1.358 0.972 0 C-N-CA 125.794 1.637 . . . . 0.0 110.627 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.75 60.8 7.35 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 125.07 3.847 . . . . 0.0 113.147 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 51.0 m -99.31 79.73 2.34 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 126.7 2.0 . . . . 0.0 112.125 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--N 1.359 1.016 0 C-N-CA 125.958 1.703 . . . . 0.0 113.356 -179.006 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.5 tttt . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -123.59 2.59 8.95 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 127.036 2.134 . . . . 0.0 110.027 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.56 158.68 34.42 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -102.98 157.31 17.06 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 125.178 1.391 . . . . 0.0 112.255 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 18.6 tp -107.42 119.39 39.27 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 125.238 1.415 . . . . 0.0 108.621 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -89.13 20.68 3.56 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 127.344 2.258 . . . . 0.0 116.25 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.13 18.89 73.56 Favored Glycine 0 C--N 1.365 2.151 0 C-N-CA 125.34 1.447 . . . . 0.0 114.982 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.67 142.65 16.1 Favored Glycine 0 C--N 1.356 1.645 0 C-N-CA 125.964 1.745 . . . . 0.0 115.643 -175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.6 mt -115.48 -69.43 0.86 Allowed 'General case' 0 C--N 1.363 1.159 0 C-N-CA 125.176 1.39 . . . . 0.0 112.686 -177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -72.13 -52.41 16.8 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 128.948 2.899 . . . . 0.0 113.189 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.3 tpp180 -179.23 35.95 0.0 OUTLIER 'General case' 0 C--N 1.35 0.599 0 C-N-CA 129.399 3.079 . . . . 0.0 104.382 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 30.7 t 130.95 -152.5 0.0 OUTLIER 'General case' 0 C--N 1.366 1.302 0 C-N-CA 130.098 3.359 . . . . 0.0 103.31 -172.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.7 m -132.43 -47.72 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 128.75 2.82 . . . . 0.0 107.204 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.66 145.52 30.7 Favored Pre-proline 0 C--N 1.36 1.025 0 CA-C-O 116.103 -1.903 . . . . 0.0 106.863 176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -63.27 139.95 74.59 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 125.127 3.885 . . . . 0.0 116.801 -172.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.76 -63.05 0.3 Allowed 'General case' 0 C--N 1.359 0.987 0 C-N-CA 124.43 1.092 . . . . 0.0 110.636 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.66 111.66 64.69 Favored Pre-proline 0 C--N 1.359 1.011 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.27 88.82 1.37 Allowed 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.793 2.995 . . . . 0.0 112.491 -168.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 p -127.57 -75.81 0.57 Allowed 'General case' 0 C--N 1.35 0.622 0 C-N-CA 129.458 3.103 . . . . 0.0 109.07 -174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 52.7 p -65.12 96.11 0.2 Allowed 'General case' 0 C--N 1.365 1.274 0 C-N-CA 127.962 2.505 . . . . 0.0 115.285 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 57.7 p -68.34 116.58 9.09 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 130.048 3.339 . . . . 0.0 116.476 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -160.4 62.19 0.33 Allowed 'General case' 0 C--N 1.358 0.945 0 CA-C-N 119.161 0.892 . . . . 0.0 109.505 -176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -114.58 124.63 52.34 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 120.294 -1.504 . . . . 0.0 111.558 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.6 p -112.07 164.4 15.31 Favored Pre-proline 0 C--N 1.366 1.292 0 C-N-CA 129.045 2.938 . . . . 0.0 114.438 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -47.08 141.01 13.17 Favored 'Trans proline' 0 C--N 1.376 2.005 1 C-N-CA 127.743 5.628 . . . . 0.0 121.147 -169.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.43 -23.3 32.01 Favored Glycine 0 C--N 1.367 2.267 0 C-N-CA 125.636 1.588 . . . . 0.0 112.838 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.05 169.94 13.45 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 120.814 2.307 . . . . 0.0 112.644 -177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -95.84 141.38 29.36 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 166.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.5 163.4 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -110.34 128.27 55.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 101.288 -3.597 . . . . 0.0 101.288 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.28 137.74 51.05 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 122.848 1.309 . . . . 0.0 111.698 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -110.57 136.41 49.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 171.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 42.7 ttm -119.8 138.32 53.43 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.32 102.14 0.37 Allowed 'General case' 0 C--N 1.367 1.354 0 C-N-CA 125.721 1.608 . . . . 0.0 113.98 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.17 -12.6 24.07 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 125.538 1.542 . . . . 0.0 112.757 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -103.18 164.17 16.04 Favored Pre-proline 0 C--N 1.354 0.792 0 C-N-CA 125.639 1.575 . . . . 0.0 109.418 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -71.64 166.36 29.68 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.371 3.381 . . . . 0.0 113.634 162.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -57.69 122.37 12.64 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 130.683 3.593 . . . . 0.0 114.825 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -126.48 112.17 23.17 Favored Pre-proline 0 N--CA 1.427 -1.602 0 N-CA-C 119.888 3.292 . . . . 0.0 119.888 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -59.03 112.24 1.15 Allowed 'Trans proline' 0 C--N 1.383 2.387 1 C-N-CA 125.813 4.342 . . . . 0.0 110.573 162.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.2 t -122.57 165.5 16.33 Favored 'General case' 0 N--CA 1.445 -0.72 1 C-N-CA 133.475 4.71 . . . . 0.0 111.346 -161.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tt -124.05 132.31 53.66 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 103.424 -2.806 . . . . 0.0 103.424 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.454 HG23 HG12 ' A' ' 131' ' ' VAL 0.251 3.3 p -81.84 127.28 39.74 Favored 'Isoleucine or valine' 0 C--N 1.377 1.8 0 CA-C-N 121.145 1.793 . . . . 0.0 107.385 176.141 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -132.05 152.86 50.93 Favored 'General case' 0 C--N 1.366 1.322 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 -161.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.5 113.46 27.05 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 127.698 2.399 . . . . 0.0 109.525 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 115' ' ' PHE . 34.8 m-70 -71.54 161.72 76.97 Favored Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 129.292 3.037 . . . . 0.0 114.342 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.1 -8.22 0.17 Allowed 'Trans proline' 0 CA--C 1.569 2.241 1 C-N-CA 125.605 4.203 . . . . 0.0 117.593 170.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.414 ' CZ ' ' CD2' ' A' ' 113' ' ' HIS . 0.6 OUTLIER -104.11 44.69 1.0 Allowed 'General case' 0 C--N 1.365 1.252 0 C-N-CA 131.518 3.927 . . . . 0.0 107.565 167.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -75.6 149.18 38.32 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 119.207 3.04 . . . . 0.0 119.207 -170.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.75 -19.91 27.69 Favored Glycine 0 C--N 1.362 2.025 0 CA-C-N 112.757 -2.019 . . . . 0.0 109.541 165.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 t -118.03 119.39 34.64 Favored 'General case' 0 N--CA 1.435 -1.224 1 N-CA-C 98.161 -4.755 . . . . 0.0 98.161 168.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.461 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 27.2 p90 -140.31 -0.6 1.6 Allowed 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 120.82 -1.175 . . . . 0.0 111.357 -174.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.713 HG22 HG12 ' A' ' 129' ' ' VAL . 7.0 pt -119.84 147.86 23.24 Favored 'Isoleucine or valine' 0 C--N 1.366 1.321 0 CA-C-O 123.467 1.603 . . . . 0.0 115.133 -174.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.87 118.36 31.35 Favored 'General case' 0 C--N 1.357 0.934 1 N-CA-C 99.13 -4.396 . . . . 0.0 99.13 169.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -105.6 -179.66 4.0 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -165.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -46.78 119.69 2.61 Favored 'General case' 0 C--N 1.371 1.528 0 C-N-CA 128.848 2.859 . . . . 0.0 116.985 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.51 -54.92 0.24 Allowed Glycine 0 C--N 1.348 1.244 0 N-CA-C 105.091 -3.204 . . . . 0.0 105.091 -173.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -109.86 -47.6 3.32 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.459 1.504 . . . . 0.0 109.886 175.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 m -179.51 169.77 1.37 Allowed 'General case' 0 CA--C 1.472 -2.056 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.4 106.87 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -114.98 130.31 56.9 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 127.811 2.445 . . . . 0.0 110.676 -176.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.713 HG12 HG22 ' A' ' 120' ' ' ILE . 13.7 m -130.36 161.91 39.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 103.393 -2.817 . . . . 0.0 103.393 177.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 0.6 OUTLIER -92.64 138.52 31.42 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 123.944 0.898 . . . . 0.0 110.897 174.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.454 HG12 HG23 ' A' ' 110' ' ' VAL . 5.2 m -150.58 168.71 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.472 -2.033 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.39 152.55 40.09 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 123.828 0.851 . . . . 0.0 109.599 172.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -108.09 125.78 51.98 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -67.47 65.34 0.08 Allowed 'General case' 0 C--N 1.369 1.438 0 C-N-CA 126.615 1.966 . . . . 0.0 115.08 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.37 -119.36 0.08 Allowed 'General case' 0 C--N 1.36 1.025 0 O-C-N 119.397 -2.064 . . . . 0.0 110.045 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -106.71 -49.07 3.38 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.627 1.571 . . . . 0.0 112.597 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.274 11.2 t -70.12 -51.39 14.22 Favored Pre-proline 0 C--N 1.363 1.156 0 N-CA-C 117.253 2.316 . . . . 0.0 117.253 -175.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.06 -179.16 26.15 Favored 'Cis proline' 0 CA--C 1.543 0.952 0 CA-C-N 125.944 3.158 . . . . 0.0 113.722 1.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 54.0 m -95.03 127.17 40.88 Favored 'General case' 0 C--N 1.369 1.424 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 24.1 ttp-105 -153.61 157.47 39.72 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 119.976 1.262 . . . . 0.0 109.876 -173.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 177.14 -159.28 25.5 Favored Glycine 0 CA--C 1.492 -1.401 0 N-CA-C 104.901 -3.28 . . . . 0.0 104.901 171.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -83.15 113.55 20.72 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 126.172 1.789 . . . . 0.0 109.15 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.44 178.36 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 125.118 1.367 . . . . 0.0 110.987 -178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.2 m -99.82 121.18 40.91 Favored 'General case' 0 CA--C 1.492 -1.263 0 N-CA-C 100.462 -3.903 . . . . 0.0 100.462 170.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.446 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 26.7 ttpt -73.34 -10.99 60.33 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -170.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -72.58 -13.42 61.39 Favored 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.49 2.316 . . . . 0.0 113.738 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.7 mt -103.0 7.61 39.05 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 126.634 1.974 . . . . 0.0 111.404 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 12.4 mt -96.31 125.41 40.79 Favored 'General case' 0 C--N 1.379 1.874 0 CA-C-N 119.891 1.223 . . . . 0.0 108.431 174.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt -114.44 159.13 37.99 Favored Pre-proline 0 C--O 1.221 -0.434 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -83.03 155.72 14.99 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 CA-C-N 124.904 2.787 . . . . 0.0 114.642 -172.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.362 0.0 OUTLIER -30.91 -95.34 0.0 OUTLIER 'General case' 0 C--N 1.357 0.922 2 C-N-CA 132.273 4.229 . . . . 0.0 122.092 -177.927 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.555 ' HA ' HD21 ' A' ' 183' ' ' LEU . 13.4 t -0.38 54.95 0.0 OUTLIER 'General case' 0 C--N 1.381 1.942 1 C-N-CA 136.511 5.924 . . . . 0.0 118.194 178.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.524 ' H ' HD11 ' A' ' 183' ' ' LEU . . . -81.07 -91.75 0.52 Allowed Glycine 0 CA--C 1.485 -1.782 0 N-CA-C 121.603 3.401 . . . . 0.0 121.603 -150.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.6 m -46.1 -23.45 0.32 Allowed 'General case' 0 C--N 1.374 1.669 0 C-N-CA 129.182 2.993 . . . . 0.0 119.003 -172.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.18 -18.17 50.41 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 130.519 3.528 . . . . 0.0 113.039 175.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.0 t -80.5 150.78 29.53 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 127.754 2.422 . . . . 0.0 112.454 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -65.05 -21.39 66.82 Favored 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.985 1.714 . . . . 0.0 111.787 172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.409 ' HG2' ' CD2' ' A' ' 164' ' ' HIS . 41.9 mt-10 -72.49 -23.03 60.97 Favored 'General case' 0 C--N 1.373 1.607 0 C-N-CA 126.315 1.846 . . . . 0.0 112.481 170.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -105.93 11.98 31.11 Favored 'General case' 0 C--N 1.361 1.088 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -128.0 -179.53 5.02 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.541 1.537 . . . . 0.0 107.712 173.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.65 122.69 11.94 Favored 'General case' 0 C--N 1.37 1.49 0 C-N-CA 127.731 2.412 . . . . 0.0 114.628 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.8 -10.04 64.21 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 124.397 0.999 . . . . 0.0 112.4 -168.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.8 146.31 25.53 Favored Glycine 0 C--N 1.365 2.145 0 N-CA-C 118.569 2.187 . . . . 0.0 118.569 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.409 ' CD2' ' HG2' ' A' ' 158' ' ' GLU . 5.7 m-70 -59.81 -22.32 62.06 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 119.71 3.226 . . . . 0.0 119.71 -175.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.55 -3.52 15.93 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 120.297 -1.502 . . . . 0.0 111.48 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -86.9 91.56 8.71 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 118.603 2.816 . . . . 0.0 118.603 -166.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.2 m -118.86 104.91 10.99 Favored 'General case' 0 CA--C 1.504 -0.81 1 N-CA-C 99.559 -4.238 . . . . 0.0 99.559 167.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.27 101.42 14.13 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-O 125.096 2.379 . . . . 0.0 112.189 -172.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -119.36 144.82 37.25 Favored Pre-proline 0 N--CA 1.432 -1.332 0 C-N-CA 130.241 3.416 . . . . 0.0 103.801 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -51.32 -31.82 39.17 Favored 'Trans proline' 0 CA--C 1.54 0.784 1 C-N-CA 127.166 5.244 . . . . 0.0 116.593 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.9 -36.95 75.81 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 127.997 2.519 . . . . 0.0 112.896 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 9.0 mt -79.05 -33.65 16.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.482 0 C-N-CA 127.163 2.185 . . . . 0.0 109.878 176.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 177' ' ' GLN 0.266 28.1 mt -61.98 -53.26 58.16 Favored 'General case' 0 C--N 1.392 2.45 0 C-N-CA 128.356 2.662 . . . . 0.0 110.367 170.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -57.41 -50.77 71.92 Favored 'General case' 0 CA--C 1.478 -1.802 0 C-N-CA 128.969 2.908 . . . . 0.0 112.684 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.83 -34.62 73.33 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 130.988 3.715 . . . . 0.0 113.077 177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 57.1 mtt -69.07 -39.18 79.23 Favored 'General case' 0 C--N 1.375 1.681 0 C-N-CA 125.563 1.545 . . . . 0.0 111.655 168.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 6.3 mt-30 -74.2 -42.33 59.98 Favored 'General case' 0 C--N 1.374 1.639 0 CA-C-N 120.756 1.616 . . . . 0.0 113.578 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.433 HH12 ' HA ' ' A' ' 190' ' ' ARG . 0.1 OUTLIER -63.19 -53.24 56.36 Favored 'General case' 0 C--N 1.375 1.7 1 C-N-CA 132.819 4.448 . . . . 0.0 110.123 174.465 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 183' ' ' LEU . . . -60.45 -51.57 68.9 Favored 'General case' 0 C--N 1.38 1.9 0 CA-C-O 116.815 -1.564 . . . . 0.0 112.496 170.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.05 -51.14 62.72 Favored 'General case' 0 C--N 1.38 1.906 0 C-N-CA 126.419 1.887 . . . . 0.0 114.352 175.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -55.02 -43.11 73.37 Favored 'General case' 0 C--N 1.37 1.462 0 CA-C-N 121.207 1.821 . . . . 0.0 114.993 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.13 -41.05 51.31 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 152' ' ' THR 0.25 0.5 OUTLIER -61.65 -45.61 93.32 Favored 'General case' 0 C--N 1.359 1.021 1 C-N-CA 132.923 4.489 . . . . 0.0 114.663 175.247 . . . . . . . . 5 4 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -28.58 29.35 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 126.64 1.976 . . . . 0.0 111.768 -176.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -105.52 -99.82 0.33 Allowed 'General case' 0 C--N 1.359 0.986 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -135.56 154.01 51.5 Favored 'General case' 0 C--N 1.36 1.065 0 O-C-N 120.822 -1.174 . . . . 0.0 112.2 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 190' ' ' ARG 0.395 18.0 ttpt -51.51 -37.16 47.94 Favored 'General case' 0 C--N 1.369 1.45 0 C-N-CA 130.217 3.407 . . . . 0.0 117.24 177.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.9 tp -57.08 -28.39 29.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 128.915 2.886 . . . . 0.0 112.906 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.252 4.1 mptt -70.19 -45.82 65.86 Favored 'General case' 0 C--N 1.372 1.575 0 O-C-N 119.773 -1.829 . . . . 0.0 113.387 174.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.433 ' HA ' HH12 ' A' ' 178' ' ' ARG 0.291 0.0 OUTLIER -75.27 -40.19 59.01 Favored 'General case' 0 C--N 1.363 1.156 0 O-C-N 119.03 -2.294 . . . . 0.0 116.804 171.48 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.5 tp -80.83 -20.6 42.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -170.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -82.85 -22.79 33.96 Favored 'General case' 0 C--N 1.366 1.307 0 C-N-CA 124.107 0.963 . . . . 0.0 112.477 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.16 23.24 13.97 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 130.132 3.373 . . . . 0.0 109.984 177.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.82 -103.96 0.0 OUTLIER 'General case' 0 C--N 1.367 1.356 0 C-N-CA 131.268 3.827 . . . . 0.0 117.035 -176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.301 2.7 m -130.4 89.02 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 124.225 1.964 . . . . 0.0 107.491 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.3 m -89.44 56.91 3.77 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 118.759 -2.463 . . . . 0.0 110.261 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.48 -3.19 50.44 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 126.855 2.062 . . . . 0.0 114.84 -172.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . 0.264 42.9 tt0 -161.48 -69.18 0.01 OUTLIER Pre-proline 0 C--N 1.35 0.602 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -80.07 178.66 6.95 Favored 'Trans proline' 0 C--N 1.364 1.353 0 CA-C-N 124.194 2.534 . . . . 0.0 109.449 161.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 16.3 m -89.5 -45.73 9.2 Favored 'General case' 0 C--N 1.35 0.607 0 C-N-CA 125.051 1.34 . . . . 0.0 111.912 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 . . . . . 0 C--N 1.361 1.066 0 C-N-CA 126.872 2.069 . . . . 0.0 108.61 176.55 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.0 mttp . . . . . 0 N--CA 1.436 -1.128 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.2 39.26 1.08 Allowed 'General case' 0 C--N 1.363 1.182 0 C-N-CA 126.27 1.828 . . . . 0.0 112.774 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -161.31 164.98 29.78 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -102.41 138.79 38.87 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.9 tp -93.24 106.96 18.86 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 125.509 1.523 . . . . 0.0 112.061 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -80.05 -30.24 39.37 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 126.101 1.76 . . . . 0.0 114.488 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.31 -19.15 46.58 Favored Glycine 0 C--N 1.364 2.126 0 C-N-CA 125.749 1.642 . . . . 0.0 113.109 -175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.35 143.76 14.58 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 107.174 -2.37 . . . . 0.0 107.174 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . 0.256 75.6 mt 78.77 -59.42 0.41 Allowed 'General case' 0 C--N 1.366 1.304 0 C-N-CA 126.635 1.974 . . . . 0.0 113.25 -176.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -70.99 -33.58 70.55 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 126.676 1.991 . . . . 0.0 114.223 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -96.3 -2.38 46.01 Favored 'General case' 0 C--N 1.363 1.179 0 C-N-CA 127.103 2.161 . . . . 0.0 111.471 176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.31 92.6 p 88.65 -123.3 0.01 OUTLIER 'General case' 0 C--N 1.356 0.882 0 C-N-CA 130.393 3.477 . . . . 0.0 110.281 -175.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -134.34 95.42 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.6 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.69 114.81 64.39 Favored Pre-proline 0 C--N 1.354 0.776 0 C-N-CA 125.864 1.665 . . . . 0.0 110.116 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.52 91.18 1.11 Allowed 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 124.116 3.211 . . . . 0.0 111.936 -175.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.82 -105.56 0.2 Allowed 'General case' 0 C--N 1.358 0.959 0 C-N-CA 125.139 1.375 . . . . 0.0 109.831 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.0 111.24 64.5 Favored Pre-proline 0 C--N 1.361 1.07 0 O-C-N 120.749 -1.219 . . . . 0.0 110.201 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -86.38 4.81 6.22 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 123.871 3.048 . . . . 0.0 114.35 -174.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 t -121.71 40.73 3.54 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 126.859 2.064 . . . . 0.0 106.859 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.7 p -101.23 -13.48 18.08 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 128.547 2.739 . . . . 0.0 111.336 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.478 ' HA ' ' CE2' ' A' ' 90' ' ' PHE 0.415 62.9 m 61.3 76.66 0.36 Allowed 'General case' 0 C--N 1.353 0.742 1 C-N-CA 131.718 4.007 . . . . 0.0 118.156 178.017 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -136.68 77.88 1.67 Allowed 'General case' 0 C--N 1.355 0.827 0 C-N-CA 127.243 2.217 . . . . 0.0 109.38 -176.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.478 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 62.1 m-85 -123.49 125.21 44.49 Favored 'General case' 0 C--N 1.355 0.837 0 O-C-N 120.336 -1.477 . . . . 0.0 112.719 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.416 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.391 88.6 p -112.01 170.51 5.19 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 131.329 3.852 . . . . 0.0 114.834 -176.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 37.3 Cg_exo -41.72 129.31 3.88 Favored 'Trans proline' 0 C--N 1.382 2.314 1 C-N-CA 128.177 5.918 . . . . 0.0 119.774 -177.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 91.12 0.12 74.69 Favored Glycine 0 C--N 1.366 2.198 0 C-N-CA 127.797 2.618 . . . . 0.0 114.421 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -94.01 154.71 17.5 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 166.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 109' ' ' LEU . 3.8 mm? -110.39 153.55 24.8 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 175.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.3 m -142.48 170.01 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-O 123.686 1.708 . . . . 0.0 107.25 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 96.2 m95 -114.78 116.03 27.97 Favored 'General case' 0 N--CA 1.438 -1.069 1 N-CA-C 99.924 -4.102 . . . . 0.0 99.924 174.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.0 127.96 53.09 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 122.32 2.327 . . . . 0.0 111.776 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -96.36 143.18 27.65 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.1 ttt -128.63 151.01 49.98 Favored 'General case' 0 CA--C 1.514 -0.431 0 O-C-N 118.596 -2.565 . . . . 0.0 108.218 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -74.41 95.77 2.77 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 126.729 2.011 . . . . 0.0 113.544 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.13 -4.44 25.4 Favored Glycine 0 C--N 1.357 1.721 0 C-N-CA 124.58 1.086 . . . . 0.0 113.042 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -117.08 164.92 16.92 Favored Pre-proline 0 C--N 1.357 0.898 0 CA-C-N 118.723 1.262 . . . . 0.0 108.364 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -71.58 167.37 26.63 Favored 'Trans proline' 0 C--N 1.353 0.783 1 C-N-CA 125.506 4.137 . . . . 0.0 114.413 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -53.79 115.31 1.93 Allowed 'General case' 0 C--N 1.355 0.841 0 C-N-CA 128.086 2.554 . . . . 0.0 115.943 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.471 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 10.8 m95 -116.32 117.83 38.24 Favored Pre-proline 0 N--CA 1.415 -2.214 0 N-CA-C 119.298 3.073 . . . . 0.0 119.298 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HG2' ' HB3' ' A' ' 175' ' ' ALA . 17.4 Cg_endo -56.82 134.07 62.09 Favored 'Trans proline' 0 CA--C 1.561 1.866 1 C-N-CA 125.888 4.392 . . . . 0.0 111.848 160.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.0 m -147.69 165.39 30.61 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 127.125 2.17 . . . . 0.0 111.851 -160.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 6.2 tt -124.03 129.0 50.17 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.658 1.583 . . . . 0.0 113.996 -177.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -93.02 121.81 44.02 Favored 'Isoleucine or valine' 0 C--N 1.372 1.571 0 O-C-N 120.836 -1.165 . . . . 0.0 110.724 171.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.93 153.9 51.45 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 127.26 2.224 . . . . 0.0 109.052 -170.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -71.13 112.7 7.48 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-N 120.734 1.606 . . . . 0.0 113.533 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 14.4 t60 -77.47 158.38 79.02 Favored Pre-proline 0 C--N 1.346 0.455 0 CA-C-O 114.55 -2.643 . . . . 0.0 110.373 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.457 ' HD2' ' CD2' ' A' ' 113' ' ' HIS . 91.1 Cg_exo -55.38 -1.1 0.18 Allowed 'Trans proline' 0 CA--C 1.544 1.016 1 C-N-CA 125.884 4.389 . . . . 0.0 120.242 -170.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -95.31 -7.34 39.0 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 128.994 2.918 . . . . 0.0 110.381 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.267 0.0 OUTLIER 9.52 94.87 0.0 OUTLIER 'General case' 0 C--N 1.376 1.753 1 C-N-CA 135.939 5.696 . . . . 0.0 120.213 -178.704 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 110.27 -17.42 29.01 Favored Glycine 0 C--N 1.36 1.887 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -172.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.4 m -103.78 120.13 40.34 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 100.384 -3.932 . . . . 0.0 100.384 170.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.478 ' HA ' ' HE1' ' A' ' 130' ' ' HIS . 1.4 t80 -142.22 -26.8 0.64 Allowed 'General case' 0 CA--C 1.499 -1.004 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 -167.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 40.5 pt -112.3 155.83 13.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 CA-C-O 123.029 1.395 . . . . 0.0 111.847 -175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -141.35 149.8 41.63 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 128.034 2.534 . . . . 0.0 104.296 174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -150.43 142.51 24.03 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 120.319 -1.488 . . . . 0.0 111.105 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -118.17 93.64 4.21 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 128.044 2.538 . . . . 0.0 110.418 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.65 -67.63 0.17 Allowed Glycine 0 C--N 1.361 1.949 0 N-CA-C 120.979 3.152 . . . . 0.0 120.979 172.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -144.38 46.1 1.41 Allowed 'General case' 0 C--N 1.354 0.771 0 CA-C-O 122.232 1.015 . . . . 0.0 112.343 -173.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 17.5 m -171.5 159.04 5.41 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.5 p -138.24 140.28 40.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 O-C-N 120.933 -1.104 . . . . 0.0 109.88 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.1 mtt-85 -116.77 160.2 21.15 Favored 'General case' 0 C--N 1.366 1.308 0 C-N-CA 128.058 2.543 . . . . 0.0 112.906 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.428 HG13 ' HD3' ' A' ' 145' ' ' LYS . 9.9 m -148.57 164.77 4.79 Favored 'Isoleucine or valine' 0 C--N 1.37 1.487 0 C-N-CA 128.1 2.56 . . . . 0.0 107.058 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.549 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 0.0 OUTLIER -91.55 116.94 29.27 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 122.395 1.093 . . . . 0.0 111.424 169.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.82 158.78 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.261 0 N-CA-C 104.702 -2.332 . . . . 0.0 104.702 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -125.73 138.33 53.86 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 172.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.96 129.7 40.33 Favored 'General case' 0 C--N 1.36 1.058 0 C-N-CA 128.013 2.525 . . . . 0.0 107.864 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 14.1 m-30 -75.85 63.3 1.67 Allowed 'General case' 0 C--N 1.363 1.172 0 C-N-CA 125.829 1.652 . . . . 0.0 113.723 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . 0.332 50.6 p-10 -98.14 -110.32 0.17 Allowed 'General case' 0 C--N 1.358 0.974 0 O-C-N 120.179 -1.576 . . . . 0.0 113.111 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -106.45 -54.95 2.4 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 125.621 1.568 . . . . 0.0 112.642 -178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . 0.256 0.9 OUTLIER -64.15 -49.34 74.07 Favored Pre-proline 0 C--N 1.365 1.269 0 N-CA-C 118.002 2.593 . . . . 0.0 118.002 -174.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -82.12 171.78 54.0 Favored 'Cis proline' 0 CA--C 1.547 1.167 0 CA-C-N 125.98 3.171 . . . . 0.0 111.543 -5.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . 0.327 7.5 t -95.54 154.63 17.11 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 120.392 -1.443 . . . . 0.0 111.849 -176.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -148.85 152.25 36.14 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 125.133 1.373 . . . . 0.0 109.566 177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -178.42 -177.5 47.14 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 107.279 -2.329 . . . . 0.0 107.279 168.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -82.78 106.26 14.47 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 126.456 1.902 . . . . 0.0 107.415 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.6 m -94.41 159.82 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.442 0 C-N-CA 127.577 2.351 . . . . 0.0 109.063 -174.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.4 m -85.59 110.34 19.18 Favored 'General case' 0 C--N 1.366 1.306 0 N-CA-C 104.092 -2.558 . . . . 0.0 104.092 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.448 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 30.6 ttpt -64.51 -25.57 68.05 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -167.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.62 -12.35 57.62 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 127.285 2.234 . . . . 0.0 114.984 170.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . 0.31 0.2 OUTLIER -104.82 8.53 34.86 Favored 'General case' 0 C--N 1.37 1.464 0 O-C-N 119.107 -2.246 . . . . 0.0 112.402 174.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 14.4 mt -95.3 127.75 41.6 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 128.122 2.569 . . . . 0.0 108.339 173.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -114.19 165.37 13.84 Favored Pre-proline 0 C--N 1.357 0.901 0 O-C-N 118.894 -2.379 . . . . 0.0 105.866 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -83.43 151.97 13.57 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 124.924 3.75 . . . . 0.0 115.689 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.518 ' CE2' ' HA2' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -93.01 167.68 11.63 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-O 122.834 1.302 . . . . 0.0 113.373 175.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 178.9 -60.28 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.936 2 N-CA-C 95.073 -5.899 . . . . 0.0 95.073 -174.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.518 ' HA2' ' CE2' ' A' ' 151' ' ' TYR . . . 127.03 -125.52 5.35 Favored Glycine 0 CA--C 1.474 -2.521 0 O-C-N 121.186 -0.946 . . . . 0.0 113.481 151.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 m -59.15 -15.73 16.18 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.914 2.561 . . . . 0.0 117.914 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 44.5 pttt -96.47 4.95 51.78 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 129.709 3.204 . . . . 0.0 111.651 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 18.1 t -89.7 139.94 30.07 Favored 'General case' 0 C--N 1.372 1.567 0 C-N-CA 126.658 1.983 . . . . 0.0 108.597 173.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -61.65 -27.38 68.63 Favored 'General case' 0 C--N 1.369 1.413 0 C-N-CA 125.827 1.651 . . . . 0.0 113.948 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -78.59 -10.22 59.65 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 119.672 -1.892 . . . . 0.0 112.293 171.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -104.13 17.06 24.88 Favored 'General case' 0 C--N 1.375 1.682 0 C-N-CA 125.343 1.457 . . . . 0.0 114.155 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -132.27 174.54 10.12 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.319 1.447 . . . . 0.0 109.003 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -60.36 122.17 13.89 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 126.164 1.786 . . . . 0.0 113.996 -178.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.08 -12.7 57.44 Favored Glycine 0 C--N 1.358 1.781 0 C-N-CA 124.803 1.192 . . . . 0.0 112.53 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.4 151.18 24.16 Favored Glycine 0 C--N 1.363 2.042 0 N-CA-C 116.951 1.54 . . . . 0.0 116.951 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -63.23 -38.87 92.87 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -87.74 -22.03 24.82 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.182 0.993 . . . . 0.0 112.308 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -75.87 91.65 3.02 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 126.635 1.974 . . . . 0.0 114.367 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 70.7 m -119.21 107.69 13.75 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 100.487 -3.894 . . . . 0.0 100.487 170.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.46 101.44 13.92 Favored 'General case' 0 C--N 1.366 1.293 0 CA-C-O 126.535 3.064 . . . . 0.0 114.312 -167.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -120.31 139.69 28.97 Favored Pre-proline 0 N--CA 1.412 -2.344 1 C-N-CA 133.139 4.575 . . . . 0.0 101.353 169.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -55.63 -32.19 82.38 Favored 'Trans proline' 0 CA--C 1.545 1.066 1 C-N-CA 126.462 4.775 . . . . 0.0 115.694 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -66.11 -35.91 81.76 Favored 'General case' 0 C--N 1.365 1.268 0 C-N-CA 127.578 2.351 . . . . 0.0 113.125 174.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.471 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 19.2 mm -68.25 -39.17 80.69 Favored 'Isoleucine or valine' 0 C--N 1.378 1.827 0 C-N-CA 126.279 1.832 . . . . 0.0 110.909 174.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 20.2 mt -68.9 -51.35 40.97 Favored 'General case' 0 C--N 1.367 1.355 0 C-N-CA 126.162 1.785 . . . . 0.0 113.163 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -61.02 -35.32 76.55 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 127.191 2.197 . . . . 0.0 114.596 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.443 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . . . -69.36 -34.99 75.41 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 130.717 3.607 . . . . 0.0 109.396 171.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 5.5 mtt -69.31 -35.37 75.89 Favored 'General case' 0 C--N 1.38 1.924 0 CA-C-N 120.994 1.725 . . . . 0.0 114.017 163.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -66.74 -47.95 70.69 Favored 'General case' 0 C--N 1.372 1.572 0 C-N-CA 125.76 1.624 . . . . 0.0 111.461 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -68.96 -53.05 22.89 Favored 'General case' 0 C--N 1.37 1.472 0 C-N-CA 127.3 2.24 . . . . 0.0 113.026 174.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.25 -33.13 74.01 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.46 -44.0 75.8 Favored 'General case' 0 C--N 1.375 1.691 0 C-N-CA 127.067 2.147 . . . . 0.0 109.861 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.82 -36.87 83.37 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 116.836 2.161 . . . . 0.0 116.836 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -69.43 -35.09 75.35 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 151' ' ' TYR . 1.7 pt? -81.41 -36.8 29.05 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 119.943 -1.723 . . . . 0.0 114.63 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -87.17 -25.64 23.97 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 126.833 2.053 . . . . 0.0 112.878 -172.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -100.87 -95.15 0.27 Allowed 'General case' 0 C--N 1.367 1.35 0 O-C-N 121.091 -1.006 . . . . 0.0 109.007 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.0 145.01 45.65 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.047 -1.033 . . . . 0.0 109.399 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.523 ' HB3' HH11 ' A' ' 190' ' ' ARG . 93.5 mttt -51.39 -34.71 35.58 Favored 'General case' 0 C--N 1.365 1.257 1 C-N-CA 132.379 4.271 . . . . 0.0 113.881 173.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 4.5 tt -50.61 -27.81 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 131.001 3.72 . . . . 0.0 112.593 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.257 2.3 mptp? -73.82 -29.97 62.45 Favored 'General case' 0 C--N 1.377 1.786 0 C-N-CA 126.895 2.078 . . . . 0.0 114.728 169.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.523 HH11 ' HB3' ' A' ' 187' ' ' LYS 0.266 0.0 OUTLIER -75.03 -43.25 54.66 Favored 'General case' 0 C--N 1.371 1.518 0 O-C-N 119.278 -2.139 . . . . 0.0 113.168 171.161 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.288 63.2 mt -75.33 -18.87 59.9 Favored 'General case' 0 C--N 1.367 1.328 0 C-N-CA 126.631 1.972 . . . . 0.0 114.488 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -58.12 -38.92 77.43 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 127.699 2.4 . . . . 0.0 113.063 168.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -94.41 -51.07 4.94 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 126.963 2.105 . . . . 0.0 109.159 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 63.55 -83.38 0.02 OUTLIER 'General case' 0 C--N 1.372 1.585 1 C-N-CA 131.91 4.084 . . . . 0.0 114.353 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 11.4 m -146.03 82.59 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 C-N-CA 130.841 3.656 . . . . 0.0 101.414 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 3.7 m -82.43 62.4 6.09 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 118.748 -2.47 . . . . 0.0 110.503 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -68.78 52.68 0.08 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 131.252 3.821 . . . . 0.0 114.431 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 78.98 90.89 0.05 OUTLIER Pre-proline 0 C--N 1.361 1.074 0 C-N-CA 130.554 3.542 . . . . 0.0 113.276 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -76.79 72.25 5.79 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 124.51 3.474 . . . . 0.0 110.637 175.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 67.5 m 75.01 -57.8 0.59 Allowed 'General case' 0 C--N 1.361 1.078 0 C-N-CA 129.921 3.289 . . . . 0.0 114.936 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--N 1.351 0.671 0 C-N-CA 125.644 1.578 . . . . 0.0 109.069 -179.002 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.5 mmmp? . . . . . 0 N--CA 1.435 -1.189 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 79.26 -61.42 0.33 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 127.998 2.519 . . . . 0.0 115.454 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -116.39 153.88 31.25 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 125.414 1.485 . . . . 0.0 110.347 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -102.67 123.53 46.55 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 125.695 1.598 . . . . 0.0 111.305 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.3 mt -68.9 2.18 2.82 Favored 'General case' 0 C--N 1.371 1.528 1 C-N-CA 131.952 4.101 . . . . 0.0 120.075 -171.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -94.2 -16.07 24.0 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 126.053 1.741 . . . . 0.0 109.431 174.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.84 0.97 49.02 Favored Glycine 0 C--N 1.37 2.423 0 C-N-CA 124.726 1.155 . . . . 0.0 114.734 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.41 -157.24 8.15 Favored Glycine 0 C--N 1.352 1.441 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . 0.296 76.9 mt 113.15 -95.62 0.0 OUTLIER 'General case' 0 C--N 1.355 0.837 1 C-N-CA 131.911 4.084 . . . . 0.0 107.369 -178.409 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -72.02 -34.78 69.09 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 126.229 1.812 . . . . 0.0 113.761 -178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 45.1 ttt-85 174.17 -57.04 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 N-CA-C 103.03 -2.952 . . . . 0.0 103.03 177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.1 39.96 7.35 Favored 'General case' 0 C--N 1.363 1.19 0 C-N-CA 129.148 2.979 . . . . 0.0 113.981 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.421 0.8 OUTLIER 63.99 -48.76 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.103 0 C-N-CA 130.439 3.495 . . . . 0.0 118.288 -178.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.42 158.21 33.01 Favored Pre-proline 0 C--N 1.351 0.64 0 C-N-CA 126.677 1.991 . . . . 0.0 110.579 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.12 -38.5 1.14 Allowed 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 124.019 3.146 . . . . 0.0 113.563 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -165.65 -64.54 0.03 OUTLIER 'General case' 0 C--N 1.352 0.685 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.45 116.73 59.73 Favored Pre-proline 0 C--N 1.352 0.693 0 C-N-CA 125.574 1.55 . . . . 0.0 109.693 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -84.82 34.18 0.5 Allowed 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 124.218 3.279 . . . . 0.0 113.134 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.9 t -179.53 -169.0 0.13 Allowed 'General case' 0 C--N 1.355 0.838 0 N-CA-C 104.485 -2.413 . . . . 0.0 104.485 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 36.7 p -165.01 -91.49 0.02 OUTLIER 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.91 2.084 . . . . 0.0 108.605 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.359 87.0 p 82.27 23.66 0.21 Allowed 'General case' 0 C--N 1.354 0.774 0 C-N-CA 129.972 3.309 . . . . 0.0 114.696 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -101.41 108.03 19.52 Favored 'General case' 0 C--N 1.361 1.105 0 N-CA-C 117.828 2.529 . . . . 0.0 117.828 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -123.61 126.99 47.63 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 126.02 1.728 . . . . 0.0 111.387 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 25.4 p -113.12 168.65 7.41 Favored Pre-proline 0 C--N 1.357 0.924 0 C-N-CA 128.864 2.865 . . . . 0.0 117.504 -178.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 12.7 Cg_exo -44.11 127.26 6.82 Favored 'Trans proline' 0 C--N 1.395 3.003 1 C-N-CA 127.628 5.552 . . . . 0.0 116.15 179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.94 0.24 57.44 Favored Glycine 0 CA--C 1.482 -1.994 0 CA-C-N 115.369 -0.832 . . . . 0.0 113.045 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -95.35 161.19 14.19 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 122.867 1.318 . . . . 0.0 108.263 169.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.79 135.46 50.67 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 101.253 -3.61 . . . . 0.0 101.253 167.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.07 159.01 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 -175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -106.93 120.3 41.68 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 162.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.79 143.93 33.24 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 120.635 1.561 . . . . 0.0 109.37 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -115.51 134.9 54.63 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 118.982 -2.324 . . . . 0.0 105.471 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 ttp -128.91 146.45 50.95 Favored 'General case' 0 C--N 1.353 0.723 0 O-C-N 119.343 -2.098 . . . . 0.0 109.141 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.59 98.88 0.72 Allowed 'General case' 0 C--N 1.365 1.27 0 C-N-CA 127.072 2.149 . . . . 0.0 113.754 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.23 -9.71 24.64 Favored Glycine 0 C--N 1.359 1.833 0 C-N-CA 125.426 1.488 . . . . 0.0 111.935 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -104.97 158.79 31.27 Favored Pre-proline 0 C--N 1.356 0.879 0 C-N-CA 125.678 1.591 . . . . 0.0 109.019 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -71.83 166.64 28.9 Favored 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.368 3.378 . . . . 0.0 112.034 161.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -56.13 115.02 2.2 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 129.86 3.264 . . . . 0.0 112.408 171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.537 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 2.1 m95 -114.69 108.18 49.57 Favored Pre-proline 0 N--CA 1.434 -1.244 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -173.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 19.0 Cg_endo -55.28 106.21 0.18 Allowed 'Trans proline' 0 C--N 1.397 3.116 1 C-N-CA 125.854 4.37 . . . . 0.0 109.984 161.571 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.2 m -114.64 164.11 14.49 Favored 'General case' 0 CA--C 1.492 -1.287 1 C-N-CA 132.313 4.245 . . . . 0.0 113.21 -164.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.983 HD11 ' HE ' ' A' ' 190' ' ' ARG . 5.2 tp -123.87 127.66 48.34 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 111.6 -2.545 . . . . 0.0 105.363 173.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 131' ' ' VAL . 2.5 p -91.33 118.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.365 1.245 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 166.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.402 ' HA ' HH21 ' A' ' 190' ' ' ARG . 0.0 OUTLIER -121.18 152.58 38.61 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 124.498 1.119 . . . . 0.0 112.037 -169.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -89.61 111.34 22.25 Favored 'General case' 0 C--N 1.373 1.621 0 CA-C-O 123.342 1.544 . . . . 0.0 108.29 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -100.81 158.7 31.35 Favored Pre-proline 0 N--CA 1.451 -0.399 0 C-N-CA 129.705 3.202 . . . . 0.0 109.343 -173.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -49.95 -0.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.417 2 C-N-CA 127.569 5.512 . . . . 0.0 122.845 -164.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -101.6 -0.13 35.34 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 126.792 2.037 . . . . 0.0 108.533 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.269 0.3 OUTLIER -20.36 119.33 0.03 OUTLIER 'General case' 0 C--N 1.376 1.718 2 C-N-CA 134.634 5.174 . . . . 0.0 122.068 -177.913 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.38 -20.96 27.22 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 174.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.5 p -120.72 117.94 28.78 Favored 'General case' 0 C--N 1.352 0.704 1 N-CA-C 98.101 -4.777 . . . . 0.0 98.101 164.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -141.94 2.39 1.54 Allowed 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 120.546 -1.346 . . . . 0.0 112.857 -167.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.9 pt -107.93 163.02 5.83 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 CA-C-O 122.696 1.236 . . . . 0.0 111.724 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -150.62 147.73 27.76 Favored 'General case' 0 C--N 1.351 0.668 0 N-CA-C 103.309 -2.848 . . . . 0.0 103.309 178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -144.22 134.31 24.16 Favored 'General case' 0 C--N 1.362 1.151 0 CA-C-N 120.771 1.623 . . . . 0.0 111.926 -178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -117.46 93.18 4.07 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.689 2.396 . . . . 0.0 107.434 174.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.57 -92.46 0.08 OUTLIER Glycine 0 C--N 1.361 1.921 0 C-N-CA 126.555 2.026 . . . . 0.0 118.051 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -123.21 20.09 9.81 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 125.812 1.645 . . . . 0.0 109.12 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.6 t -118.41 108.69 15.35 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -111.2 135.1 51.42 Favored 'Isoleucine or valine' 0 C--N 1.357 0.898 0 C-N-CA 124.688 1.195 . . . . 0.0 108.686 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 73.4 mtt-85 -123.16 151.17 42.42 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 126.419 1.888 . . . . 0.0 112.588 -175.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.28 163.01 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 128.227 2.611 . . . . 0.0 107.282 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -93.18 121.75 34.86 Favored 'General case' 0 C--N 1.369 1.449 0 O-C-N 119.731 -1.855 . . . . 0.0 111.579 171.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.414 HG12 HG23 ' A' ' 110' ' ' VAL . 4.0 m -135.97 176.64 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.553 0 C-N-CA 126.585 1.954 . . . . 0.0 108.326 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.405 HE22 ' C ' ' A' ' 194' ' ' ALA . 6.2 pt20 -134.26 152.43 51.81 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.964 0.888 . . . . 0.0 109.495 166.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 15.6 m-30 -106.74 115.59 30.46 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 126.642 1.977 . . . . 0.0 106.069 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 13.4 m-85 -66.8 55.97 0.04 OUTLIER 'General case' 0 C--N 1.367 1.347 0 C-N-CA 127.847 2.459 . . . . 0.0 116.022 -175.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.505 ' HB3' ' CZ2' ' A' ' 106' ' ' TRP 0.303 52.7 p-10 -84.79 -102.16 0.05 Allowed 'General case' 0 C--N 1.367 1.367 0 C-N-CA 127.039 2.136 . . . . 0.0 113.17 -176.663 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -106.47 -58.3 1.94 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.275 1.83 . . . . 0.0 115.121 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.0 t -75.78 -41.77 3.56 Favored Pre-proline 0 C--N 1.366 1.295 0 CA-C-O 114.037 -2.887 . . . . 0.0 117.951 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.7 -177.94 22.45 Favored 'Cis proline' 0 CA--C 1.55 1.279 0 CA-C-N 127.083 3.566 . . . . 0.0 113.379 -2.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.3 t -95.35 142.37 27.81 Favored 'General case' 0 C--N 1.368 1.389 0 O-C-N 118.762 -2.461 . . . . 0.0 108.764 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -142.01 149.33 39.88 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.5 -170.61 37.89 Favored Glycine 0 CA--C 1.488 -1.649 1 N-CA-C 102.201 -4.36 . . . . 0.0 102.201 172.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -89.75 119.81 30.47 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 125.33 1.452 . . . . 0.0 109.371 174.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 143' ' ' VAL . 1.8 m -99.27 160.38 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.074 0 C-N-CA 125.621 1.569 . . . . 0.0 111.152 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 41.0 t -70.92 106.12 3.52 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 127.568 2.347 . . . . 0.0 107.335 168.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 7.5 ttpp -68.95 -29.33 67.55 Favored 'General case' 0 C--N 1.365 1.258 0 CA-C-O 122.777 1.275 . . . . 0.0 112.306 -175.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -67.48 -14.75 63.21 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.681 1.593 . . . . 0.0 114.646 171.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.6 mt -100.18 18.38 18.84 Favored 'General case' 0 C--N 1.367 1.337 0 C-N-CA 125.9 1.68 . . . . 0.0 111.485 171.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 37.2 mt -102.36 131.08 49.21 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.748 -1.22 . . . . 0.0 110.473 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -115.39 156.73 45.45 Favored Pre-proline 0 C--O 1.222 -0.361 0 CA-C-O 116.711 -1.614 . . . . 0.0 107.259 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.69 150.59 14.6 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 125.223 3.949 . . . . 0.0 113.425 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -120.29 120.0 34.79 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-O 122.42 1.105 . . . . 0.0 112.822 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.48 ' HA ' HD21 ' A' ' 183' ' ' LEU . 5.0 t -154.49 22.2 0.47 Allowed 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.672 1.589 . . . . 0.0 106.95 177.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.59 56.1 0.36 Allowed Glycine 0 C--N 1.36 1.888 0 N-CA-C 120.184 2.834 . . . . 0.0 120.184 -158.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.7 m -65.77 -17.72 64.82 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 130.423 3.489 . . . . 0.0 113.978 171.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -107.04 15.59 25.11 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 129.466 3.106 . . . . 0.0 110.425 -178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . 0.337 97.2 p -126.17 153.31 44.8 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 124.186 0.994 . . . . 0.0 113.311 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.535 1.4 pttm -47.06 -16.33 0.04 OUTLIER 'General case' 0 C--N 1.369 1.426 0 N-CA-C 121.348 3.833 . . . . 0.0 121.348 -168.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -96.14 -6.21 38.89 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 117.02 -1.467 . . . . 0.0 114.057 167.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.09 18.78 10.81 Favored 'General case' 0 C--N 1.381 1.953 0 CA-C-N 122.588 2.449 . . . . 0.0 116.621 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.75 -173.04 2.97 Favored 'General case' 0 N--CA 1.45 -0.431 1 C-N-CA 132.006 4.123 . . . . 0.0 109.535 -176.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -70.96 122.59 20.26 Favored 'General case' 0 C--N 1.361 1.1 0 O-C-N 119.588 -1.945 . . . . 0.0 113.014 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 98.91 -5.79 59.85 Favored Glycine 0 C--N 1.363 2.052 0 C-N-CA 126.156 1.836 . . . . 0.0 112.158 -170.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -80.67 148.24 28.86 Favored Glycine 0 C--N 1.364 2.1 0 C-N-CA 129.095 3.236 . . . . 0.0 117.225 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -59.87 -33.61 72.04 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -102.52 -5.76 23.63 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 120.494 1.497 . . . . 0.0 113.068 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -88.87 148.6 23.78 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 118.109 2.633 . . . . 0.0 118.109 -170.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 13.0 m -163.67 151.42 12.86 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 101.342 -3.577 . . . . 0.0 101.342 172.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -112.09 100.12 8.61 Favored 'General case' 0 C--N 1.372 1.56 0 CA-C-O 126.003 2.811 . . . . 0.0 111.032 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -120.55 141.63 32.54 Favored Pre-proline 0 N--CA 1.424 -1.756 2 C-N-CA 132.921 4.488 . . . . 0.0 99.522 168.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -63.91 -26.05 67.04 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 124.228 3.286 . . . . 0.0 114.171 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -69.82 -35.66 74.97 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 129.491 3.117 . . . . 0.0 114.017 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.537 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 9.3 mm -69.88 -43.18 79.83 Favored 'Isoleucine or valine' 0 C--N 1.379 1.874 0 C-N-CA 127.109 2.164 . . . . 0.0 109.175 175.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.7 mt -68.94 -45.18 71.44 Favored 'General case' 0 C--N 1.373 1.593 0 C-N-CA 124.458 1.103 . . . . 0.0 113.748 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -57.95 -34.58 70.06 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 126.474 1.91 . . . . 0.0 114.88 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.58 -48.5 69.39 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 130.854 3.662 . . . . 0.0 111.086 169.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 10.6 mtt -60.6 -39.6 88.74 Favored 'General case' 0 C--N 1.375 1.708 0 CA-C-N 120.558 1.526 . . . . 0.0 115.002 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -68.5 -52.14 35.5 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 128.052 2.541 . . . . 0.0 112.743 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -72.54 -34.84 67.81 Favored 'General case' 0 C--N 1.381 1.935 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 178.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.02 84.07 Favored 'General case' 0 C--N 1.371 1.517 0 C-N-CA 124.675 1.19 . . . . 0.0 112.615 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.14 -47.46 86.14 Favored 'General case' 0 C--N 1.378 1.819 0 C-N-CA 125.947 1.699 . . . . 0.0 112.763 174.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -33.84 76.63 Favored 'General case' 0 C--N 1.369 1.454 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -74.56 -28.77 61.09 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 173.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.48 HD21 ' HA ' ' A' ' 152' ' ' THR . 0.6 OUTLIER -77.9 -46.96 19.85 Favored 'General case' 0 CA--C 1.499 -1.01 1 C-N-CA 132.23 4.212 . . . . 0.0 114.105 178.266 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.259 0.0 OUTLIER -89.51 -8.52 52.65 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 125.125 1.37 . . . . 0.0 111.441 -174.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -126.17 -103.63 0.35 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 122.799 0.44 . . . . 0.0 111.342 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.402 ' HB3' HG22 ' A' ' 188' ' ' ILE . 22.9 t70 -136.27 161.3 36.16 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-O 123.51 1.624 . . . . 0.0 112.581 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -51.07 -36.19 38.7 Favored 'General case' 0 C--N 1.358 0.951 1 C-N-CA 136.319 5.847 . . . . 0.0 113.391 174.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.402 HG22 ' HB3' ' A' ' 186' ' ' ASP . 7.4 tt -55.04 -30.01 23.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 127.937 2.495 . . . . 0.0 113.215 176.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -74.6 -40.77 61.38 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 114.541 1.312 . . . . 0.0 114.541 174.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.983 ' HE ' HD11 ' A' ' 109' ' ' LEU 0.266 5.2 ptm180 -74.44 -33.23 62.88 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 115.537 1.681 . . . . 0.0 115.537 175.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.2 mt -82.3 -19.5 39.31 Favored 'General case' 0 C--N 1.366 1.319 0 O-C-N 120.949 -1.094 . . . . 0.0 112.1 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -53.45 -43.87 68.44 Favored 'General case' 0 C--N 1.37 1.467 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 175.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.56 -31.96 11.0 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 126.122 1.769 . . . . 0.0 109.974 175.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.405 ' C ' HE22 ' A' ' 132' ' ' GLN . . . 41.03 -119.14 0.39 Allowed 'General case' 0 C--N 1.377 1.769 0 C-N-CA 130.903 3.681 . . . . 0.0 114.784 -176.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.59 -9.56 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 120.035 -1.666 . . . . 0.0 112.505 176.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.307 20.2 m 65.29 -27.85 0.1 Allowed 'General case' 0 C--N 1.364 1.223 0 C-N-CA 130.284 3.434 . . . . 0.0 118.176 174.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -88.68 74.94 8.31 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 127.442 2.297 . . . . 0.0 109.317 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 74.13 68.87 0.26 Allowed Pre-proline 0 C--N 1.361 1.079 0 C-N-CA 129.431 3.093 . . . . 0.0 113.216 -177.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.71 155.43 10.3 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.959 3.106 . . . . 0.0 111.899 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 35.7 p -99.61 87.83 3.68 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 125.884 1.674 . . . . 0.0 110.614 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 . . . . . 0 C--N 1.355 0.826 0 C-N-CA 125.016 1.327 . . . . 0.0 108.543 -179.59 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 73.92 -51.27 0.69 Allowed 'General case' 0 C--N 1.36 1.053 0 C-N-CA 129.268 3.027 . . . . 0.0 115.898 178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -135.52 168.87 18.43 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 125.811 1.644 . . . . 0.0 107.756 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -103.17 136.31 43.2 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.248 1.419 . . . . 0.0 108.476 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.7 tp -171.54 167.14 6.72 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 101.471 -3.529 . . . . 0.0 101.471 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -88.11 -22.25 24.23 Favored 'General case' 0 C--N 1.377 1.778 0 CA-C-N 122.516 2.416 . . . . 0.0 112.76 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.88 11.22 44.04 Favored Glycine 0 C--N 1.365 2.145 0 N-CA-C 118.865 2.306 . . . . 0.0 118.865 171.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.33 -62.36 0.03 OUTLIER Glycine 0 C--N 1.351 1.399 0 N-CA-C 107.53 -2.228 . . . . 0.0 107.53 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.412 HD12 HH22 ' A' ' 146' ' ' ARG . 26.8 mt -79.02 72.92 5.57 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 127.17 2.188 . . . . 0.0 109.308 175.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -51.48 -38.45 53.93 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 130.998 3.719 . . . . 0.0 116.198 -175.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -109.69 9.24 24.99 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 126.628 1.971 . . . . 0.0 110.059 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.291 96.5 p 70.2 -93.84 0.03 OUTLIER 'General case' 0 C--N 1.365 1.243 0 C-N-CA 128.168 2.587 . . . . 0.0 115.808 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.8 t -88.17 76.51 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.825 0 C-N-CA 126.625 1.97 . . . . 0.0 109.892 177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.98 137.0 20.02 Favored Pre-proline 0 C--N 1.359 1.011 0 C-N-CA 126.344 1.858 . . . . 0.0 110.412 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.51 63.75 7.94 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.877 3.718 . . . . 0.0 113.342 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -148.6 -78.3 0.15 Allowed 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.973 0.909 . . . . 0.0 108.935 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.53 112.73 64.67 Favored Pre-proline 0 C--N 1.354 0.772 0 C-N-CA 124.858 1.263 . . . . 0.0 109.656 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.76 -42.52 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.451 2.767 . . . . 0.0 110.97 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 m -168.94 146.1 3.68 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 175.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.7 m -177.76 -168.74 0.19 Allowed 'General case' 0 C--N 1.351 0.64 0 N-CA-C 100.432 -3.914 . . . . 0.0 100.432 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.344 80.4 p 74.9 74.17 0.1 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 126.247 1.819 . . . . 0.0 114.299 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -154.38 94.18 1.68 Allowed 'General case' 0 C--N 1.361 1.104 0 CA-C-O 122.551 1.167 . . . . 0.0 113.107 -174.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -122.75 125.58 45.79 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.44 1.096 . . . . 0.0 109.293 -174.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.464 82.5 p -111.92 170.31 5.41 Favored Pre-proline 0 CA--C 1.558 1.279 1 C-N-CA 132.066 4.147 . . . . 0.0 114.205 -175.043 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 10.5 Cg_endo -53.2 139.49 62.9 Favored 'Trans proline' 0 C--N 1.378 2.117 1 C-N-CA 127.36 5.373 . . . . 0.0 120.054 -162.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 105.88 -13.82 45.49 Favored Glycine 0 C--N 1.363 2.064 0 CA-C-O 118.668 -1.074 . . . . 0.0 112.321 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.26 169.05 11.15 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-N 121.084 2.442 . . . . 0.0 112.309 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.633 ' CD2' ' HE ' ' A' ' 190' ' ' ARG . 4.5 mm? -97.72 138.64 34.8 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 101.832 -3.396 . . . . 0.0 101.832 164.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.1 m -134.03 165.59 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 103.536 -2.765 . . . . 0.0 103.536 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -121.22 116.65 25.31 Favored 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 101.174 -3.639 . . . . 0.0 101.174 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.51 128.71 56.54 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 123.667 1.698 . . . . 0.0 112.455 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -99.24 136.6 38.96 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 169.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.407 ' N ' ' CE1' ' A' ' 103' ' ' TYR . 1.2 tpt -121.62 148.04 45.06 Favored 'General case' 0 CA--C 1.511 -0.519 0 O-C-N 118.957 -2.339 . . . . 0.0 105.707 173.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -56.21 83.96 0.01 OUTLIER 'General case' 0 C--N 1.352 0.717 0 C-N-CA 129.107 2.963 . . . . 0.0 116.691 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.09 1.86 25.12 Favored Glycine 0 C--N 1.357 1.737 0 C-N-CA 124.676 1.131 . . . . 0.0 114.61 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.407 ' CE1' ' N ' ' A' ' 100' ' ' MET 0.262 0.0 OUTLIER -105.36 172.33 4.13 Favored Pre-proline 0 C--N 1.361 1.093 0 CA-C-O 116.991 -1.481 . . . . 0.0 109.609 178.246 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.1 165.76 31.65 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 C-N-CA 124.576 3.517 . . . . 0.0 114.151 170.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.0 116.43 6.41 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 126.457 1.903 . . . . 0.0 112.62 173.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.446 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 10.2 m95 -114.92 127.63 26.65 Favored Pre-proline 0 N--CA 1.426 -1.641 0 N-CA-C 118.005 2.595 . . . . 0.0 118.005 -172.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 55.9 Cg_endo -59.01 144.36 99.4 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 124.992 3.795 . . . . 0.0 111.343 154.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.8 m -156.27 164.67 38.04 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.276 1.43 . . . . 0.0 110.532 -161.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.1 tt -127.0 136.91 52.89 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 119.565 -1.959 . . . . 0.0 106.367 178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.81 117.89 36.07 Favored 'Isoleucine or valine' 0 C--N 1.374 1.669 0 O-C-N 119.983 -1.698 . . . . 0.0 108.148 172.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -121.8 147.87 45.41 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.052 1.341 . . . . 0.0 111.416 -168.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -99.08 120.39 39.4 Favored 'General case' 0 C--N 1.37 1.483 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.575 ' CD2' ' CD2' ' A' ' 130' ' ' HIS . 6.3 m-70 -62.32 159.41 40.39 Favored Pre-proline 0 C--N 1.363 1.175 0 C-N-CA 128.114 2.566 . . . . 0.0 114.459 -175.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.37 -0.65 0.16 Allowed 'Trans proline' 0 CA--C 1.558 1.675 1 C-N-CA 126.895 5.063 . . . . 0.0 117.053 172.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -106.99 37.82 2.26 Favored 'General case' 0 CA--C 1.551 1.002 1 C-N-CA 134.805 5.242 . . . . 0.0 107.041 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.305 0.0 OUTLIER -71.03 148.65 47.36 Favored 'General case' 0 C--N 1.373 1.602 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -170.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.56 -6.61 31.68 Favored Glycine 0 C--N 1.36 1.914 0 C-N-CA 125.498 1.523 . . . . 0.0 112.223 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.1 t -136.62 151.62 49.53 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 128.338 2.655 . . . . 0.0 104.159 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.467 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 2.1 t80 -160.31 -41.72 0.05 OUTLIER 'General case' 0 C--N 1.363 1.17 0 N-CA-C 116.122 1.897 . . . . 0.0 116.122 -171.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.614 HG22 HG12 ' A' ' 129' ' ' VAL . 3.2 pt -107.94 146.72 13.58 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 O-C-N 119.626 -1.921 . . . . 0.0 115.058 -171.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 27.5 tpt180 -129.71 140.46 51.1 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 103.596 -2.742 . . . . 0.0 103.596 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -146.79 135.86 22.5 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 120.579 -1.326 . . . . 0.0 109.37 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -117.86 93.21 4.06 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 127.662 2.385 . . . . 0.0 106.863 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.83 -96.68 0.16 Allowed Glycine 0 C--N 1.362 2.013 0 C-N-CA 126.516 2.008 . . . . 0.0 117.767 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -113.49 16.45 18.81 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 126.937 2.095 . . . . 0.0 110.527 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.2 t -123.91 123.6 40.77 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.95 133.89 68.32 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-O 122.92 1.343 . . . . 0.0 110.366 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -118.09 133.08 56.24 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 127.302 2.241 . . . . 0.0 109.717 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.641 HG11 ' HD3' ' A' ' 145' ' ' LYS . 23.2 m -134.71 164.39 34.14 Favored 'Isoleucine or valine' 0 C--N 1.366 1.322 0 C-N-CA 129.002 2.921 . . . . 0.0 108.281 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.575 ' CD2' ' CD2' ' A' ' 113' ' ' HIS . 9.1 m170 -72.21 116.5 12.7 Favored 'General case' 0 C--N 1.372 1.567 0 O-C-N 119.398 -2.064 . . . . 0.0 114.203 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.49 ' HB ' HG21 ' A' ' 143' ' ' VAL . 37.3 t -144.07 141.44 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.847 0 O-C-N 119.171 -2.206 . . . . 0.0 105.121 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.86 140.98 48.7 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 112.022 -2.354 . . . . 0.0 106.323 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.54 133.05 52.57 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 126.152 1.781 . . . . 0.0 106.271 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' HB2' ' HB1' ' A' ' 175' ' ' ALA . 21.5 m-85 -75.66 79.84 2.63 Favored 'General case' 0 C--N 1.372 1.546 0 C-N-CA 124.944 1.298 . . . . 0.0 108.983 177.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -103.53 -106.77 0.28 Allowed 'General case' 0 C--N 1.361 1.091 0 O-C-N 120.708 -1.245 . . . . 0.0 110.576 -174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -106.35 -58.08 1.97 Allowed 'General case' 0 C--N 1.353 0.718 0 C-N-CA 125.319 1.448 . . . . 0.0 111.894 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.2 m -82.77 -37.24 0.74 Allowed Pre-proline 0 C--N 1.362 1.141 0 N-CA-C 119.817 3.266 . . . . 0.0 119.817 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.61 178.48 33.36 Favored 'Cis proline' 0 CA--C 1.543 0.93 1 CA-C-N 128.529 4.082 . . . . 0.0 113.578 1.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.4 m -96.0 138.64 33.35 Favored 'General case' 0 C--N 1.366 1.301 0 C-N-CA 124.743 1.217 . . . . 0.0 109.279 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 50.0 ttp180 -155.67 158.97 39.16 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.673 -1.892 . . . . 0.0 106.315 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -174.7 -158.69 19.39 Favored Glycine 0 CA--C 1.487 -1.668 1 N-CA-C 100.32 -5.112 . . . . 0.0 100.32 170.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -90.36 132.48 35.57 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.49 HG21 ' HB ' ' A' ' 131' ' ' VAL . 2.3 m -99.98 -178.32 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.771 0 O-C-N 119.449 -2.032 . . . . 0.0 109.297 -178.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 73.9 m -100.92 126.59 47.56 Favored 'General case' 0 C--N 1.365 1.272 0 N-CA-C 101.028 -3.693 . . . . 0.0 101.028 166.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.641 ' HD3' HG11 ' A' ' 129' ' ' VAL . 36.6 ttpt -72.23 -20.23 61.58 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -172.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.412 HH22 HD12 ' A' ' 76' ' ' LEU . 6.6 ptp180 -72.17 -6.25 41.41 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 172.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.73 3.51 42.33 Favored 'General case' 0 C--N 1.367 1.326 0 C-N-CA 124.48 1.112 . . . . 0.0 110.547 173.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.432 HD12 ' HG3' ' A' ' 145' ' ' LYS . 24.3 mt -91.8 134.44 34.74 Favored 'General case' 0 C--N 1.368 1.405 0 C-N-CA 125.505 1.522 . . . . 0.0 112.198 176.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -114.74 165.35 14.13 Favored Pre-proline 0 C--N 1.344 0.328 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 170.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -83.56 155.7 14.0 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.348 3.365 . . . . 0.0 113.714 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -29.04 -78.35 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.964 2 N-CA-C 123.678 4.695 . . . . 0.0 123.678 178.575 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 13.8 t -33.12 36.34 0.0 OUTLIER 'General case' 0 C--N 1.371 1.523 1 C-N-CA 137.186 6.194 . . . . 0.0 119.318 -175.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -101.49 -48.13 1.45 Allowed Glycine 0 C--N 1.358 1.791 0 C-N-CA 127.884 2.659 . . . . 0.0 118.395 -168.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.9 m -46.48 -11.26 0.02 OUTLIER 'General case' 0 C--N 1.373 1.609 0 N-CA-C 121.182 3.771 . . . . 0.0 121.182 -175.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -122.91 13.46 9.85 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 128.746 2.818 . . . . 0.0 110.434 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.1 t -135.78 162.87 31.57 Favored 'General case' 0 CA--C 1.488 -1.424 0 C-N-CA 124.572 1.149 . . . . 0.0 113.743 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -47.05 -16.75 0.04 OUTLIER 'General case' 0 CA--C 1.489 -1.368 1 C-N-CA 134.586 5.155 . . . . 0.0 119.32 -168.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -95.77 -7.51 36.96 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-O 117.182 -1.39 . . . . 0.0 113.081 170.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.89 15.47 3.58 Favored 'General case' 0 C--N 1.386 2.18 0 CA-C-N 122.09 2.223 . . . . 0.0 116.728 -172.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.51 -172.81 2.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 130.158 3.383 . . . . 0.0 105.975 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -71.0 122.11 19.42 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 118.971 -2.33 . . . . 0.0 112.813 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.88 -5.72 47.08 Favored Glycine 0 C--N 1.362 2.001 0 C-N-CA 125.461 1.505 . . . . 0.0 112.105 -170.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -72.12 154.35 50.67 Favored Glycine 0 C--N 1.371 2.51 1 C-N-CA 130.757 4.027 . . . . 0.0 117.717 -177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -67.78 -42.31 81.89 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 127.381 2.273 . . . . 0.0 116.179 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.57 -4.62 53.17 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 125.16 1.384 . . . . 0.0 112.196 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -82.81 94.2 7.6 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 117.137 2.273 . . . . 0.0 117.137 -171.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.0 m -118.73 108.38 14.81 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 100.758 -3.793 . . . . 0.0 100.758 167.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.51 101.1 13.78 Favored 'General case' 0 C--N 1.367 1.339 0 CA-C-O 126.132 2.872 . . . . 0.0 110.764 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -119.73 146.17 41.02 Favored Pre-proline 0 N--CA 1.424 -1.766 0 C-N-CA 131.171 3.788 . . . . 0.0 101.167 171.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.96 -38.81 86.58 Favored 'Trans proline' 0 C--N 1.352 0.725 1 C-N-CA 126.388 4.725 . . . . 0.0 115.307 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -69.46 -42.48 74.83 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.493 1.517 . . . . 0.0 113.655 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.7 mt -64.64 -46.88 91.1 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 C-N-CA 126.143 1.777 . . . . 0.0 111.901 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.427 ' O ' ' HG2' ' A' ' 177' ' ' GLN 0.304 3.9 pp -68.51 -32.38 72.3 Favored 'General case' 0 C--N 1.368 1.407 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 174.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -69.33 -39.25 78.29 Favored 'General case' 0 C--N 1.372 1.576 0 C-N-CA 128.612 2.765 . . . . 0.0 113.997 176.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 134' ' ' PHE . . . -69.32 -34.55 74.83 Favored 'General case' 0 N--CA 1.431 -1.397 1 C-N-CA 131.843 4.057 . . . . 0.0 110.818 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 44.8 mtt -69.22 -33.38 73.22 Favored 'General case' 0 C--N 1.372 1.555 0 C-N-CA 127.915 2.486 . . . . 0.0 112.517 163.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 173' ' ' LEU . 57.6 mm-40 -72.57 -45.04 61.12 Favored 'General case' 0 C--N 1.385 2.143 0 C-N-CA 127.272 2.229 . . . . 0.0 112.124 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -66.45 -49.41 66.76 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 130.182 3.393 . . . . 0.0 110.362 173.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.65 83.56 Favored 'General case' 0 C--N 1.379 1.856 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 170.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.23 -47.14 69.24 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.98 2.112 . . . . 0.0 113.947 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -49.62 58.0 Favored 'General case' 0 C--N 1.359 1.008 0 O-C-N 120.309 -1.495 . . . . 0.0 114.578 173.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 190' ' ' ARG . . . -69.6 -30.43 68.18 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.4 pp -76.44 -40.02 51.78 Favored 'General case' 0 C--N 1.367 1.352 0 C-N-CA 126.517 1.927 . . . . 0.0 115.196 176.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -11.49 55.63 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.918 1.687 . . . . 0.0 111.204 -175.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -114.14 -107.71 0.37 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -135.68 168.77 18.65 Favored 'General case' 0 C--N 1.364 1.208 0 O-C-N 120.247 -1.533 . . . . 0.0 112.739 -171.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.617 ' HA ' HH11 ' A' ' 190' ' ' ARG . 39.8 mmtm -55.51 -40.82 72.27 Favored 'General case' 0 C--N 1.386 2.196 0 C-N-CA 130.476 3.51 . . . . 0.0 114.163 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 15.6 tt -57.99 -31.95 42.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.443 0 C-N-CA 129.124 2.97 . . . . 0.0 113.914 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -74.48 -40.87 61.57 Favored 'General case' 0 C--N 1.37 1.462 0 C-N-CA 125.231 1.412 . . . . 0.0 114.405 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.633 ' HE ' ' CD2' ' A' ' 95' ' ' LEU 0.276 0.1 OUTLIER -74.94 -39.67 61.25 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 119.999 -1.688 . . . . 0.0 114.311 169.558 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.16 -21.16 64.01 Favored 'General case' 0 C--N 1.381 1.956 0 C-N-CA 128.205 2.602 . . . . 0.0 113.606 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -66.52 -32.01 73.09 Favored 'General case' 0 C--N 1.36 1.04 0 C-N-CA 130.124 3.37 . . . . 0.0 114.73 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mt -105.67 -47.04 4.0 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.366 2.266 . . . . 0.0 108.358 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 50.15 -112.81 0.61 Allowed 'General case' 0 C--N 1.368 1.394 0 C-N-CA 129.191 2.997 . . . . 0.0 114.803 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 22.0 m -108.98 15.49 8.0 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 126.478 1.911 . . . . 0.0 111.421 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.298 8.3 t 89.7 22.55 0.03 OUTLIER 'General case' 0 C--N 1.358 0.964 0 C-N-CA 128.687 2.795 . . . . 0.0 113.64 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -95.35 87.78 4.91 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 126.653 1.981 . . . . 0.0 108.828 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 69.41 64.11 0.53 Allowed Pre-proline 0 C--N 1.365 1.27 0 C-N-CA 128.243 2.617 . . . . 0.0 112.46 -173.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.18 107.01 2.37 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 124.411 3.407 . . . . 0.0 112.062 -172.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.282 7.4 t 89.16 2.15 0.25 Allowed 'General case' 0 C--N 1.354 0.793 0 C-N-CA 126.767 2.027 . . . . 0.0 109.677 -174.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--N 1.361 1.105 0 C-N-CA 128.55 2.74 . . . . 0.0 114.753 177.915 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 pttp . . . . . 0 N--CA 1.44 -0.949 0 CA-C-O 122.72 1.248 . . . . 0.0 108.543 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.1 44.25 0.56 Allowed 'General case' 0 C--N 1.36 1.025 0 C-N-CA 128.458 2.703 . . . . 0.0 114.318 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -122.79 71.35 1.03 Allowed 'General case' 0 C--N 1.352 0.714 0 C-N-CA 127.35 2.26 . . . . 0.0 105.828 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -80.63 134.05 35.83 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 126.327 1.851 . . . . 0.0 114.552 -176.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.343 82.2 mt 89.31 -128.28 0.0 OUTLIER 'General case' 0 C--N 1.361 1.084 0 C-N-CA 129.245 3.018 . . . . 0.0 110.67 -177.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -81.76 -38.01 26.33 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.24 -21.19 13.28 Favored Glycine 0 C--N 1.359 1.857 0 C-N-CA 124.677 1.132 . . . . 0.0 114.585 -167.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.93 133.12 3.47 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 108.316 -1.913 . . . . 0.0 108.316 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 76' ' ' LEU . 2.3 pt? -105.68 -33.05 8.17 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -176.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -72.1 -41.87 66.76 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 127.383 2.273 . . . . 0.0 114.423 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -125.89 60.58 1.27 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 128.599 2.76 . . . . 0.0 105.456 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.88 53.57 1.98 Allowed 'General case' 0 C--N 1.365 1.259 0 O-C-N 120.066 -1.646 . . . . 0.0 114.165 -175.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.423 0.3 OUTLIER 66.29 -46.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 129.739 3.215 . . . . 0.0 115.401 -174.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.78 114.8 9.45 Favored Pre-proline 0 C--N 1.357 0.909 0 C-N-CA 125.191 1.396 . . . . 0.0 108.984 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.49 -56.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.364 1.374 0 C-N-CA 123.83 3.02 . . . . 0.0 111.254 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 179.11 -167.55 0.08 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 100.443 -3.91 . . . . 0.0 100.443 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.63 112.06 65.3 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -85.49 55.21 3.9 Favored 'Trans proline' 0 C--N 1.36 1.138 0 C-N-CA 124.396 3.398 . . . . 0.0 112.395 -170.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.5 m -173.99 63.32 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 101.906 -3.368 . . . . 0.0 101.906 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.1 p -148.58 -99.69 0.08 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.3 p -141.85 95.43 2.81 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -157.99 65.85 0.46 Allowed 'General case' 0 C--N 1.355 0.82 0 C-N-CA 124.078 0.951 . . . . 0.0 108.934 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -118.29 124.68 48.41 Favored 'General case' 0 C--N 1.363 1.192 0 O-C-N 118.987 -2.32 . . . . 0.0 114.202 -172.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.44 17.2 p -112.96 169.45 6.35 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 131.114 3.766 . . . . 0.0 114.602 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -49.37 129.45 22.74 Favored 'Trans proline' 0 C--N 1.376 1.986 1 C-N-CA 128.006 5.804 . . . . 0.0 119.087 -169.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 114.52 -12.42 21.1 Favored Glycine 0 CA--C 1.482 -1.993 0 C-N-CA 124.438 1.018 . . . . 0.0 111.309 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.03 159.99 14.92 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 120.206 -1.761 . . . . 0.0 108.247 176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.42 140.31 36.87 Favored 'General case' 0 C--N 1.344 0.354 1 N-CA-C 99.998 -4.075 . . . . 0.0 99.998 166.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.37 147.36 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 102.667 -3.086 . . . . 0.0 102.667 -171.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -99.93 119.29 38.0 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.92 136.34 48.63 Favored 'General case' 0 C--N 1.359 1.012 0 CA-C-N 119.862 1.21 . . . . 0.0 111.559 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -108.97 141.31 41.25 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.0 ttp -129.59 149.84 51.18 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 119.311 -2.118 . . . . 0.0 108.932 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -65.6 89.66 0.11 Allowed 'General case' 0 C--N 1.363 1.193 0 C-N-CA 127.103 2.161 . . . . 0.0 115.032 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.24 -3.07 25.29 Favored Glycine 0 C--N 1.357 1.746 0 C-N-CA 125.873 1.701 . . . . 0.0 112.786 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -100.97 163.33 18.2 Favored Pre-proline 0 C--N 1.354 0.782 0 C-N-CA 126.573 1.949 . . . . 0.0 109.773 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.04 165.9 31.22 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.627 2.885 . . . . 0.0 112.666 164.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.515 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 1.6 m95 -66.36 130.55 43.6 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 128.6 2.76 . . . . 0.0 111.053 170.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 10.3 m95 -129.83 138.94 34.21 Favored Pre-proline 0 N--CA 1.415 -2.196 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -73.09 132.12 17.68 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 123.313 2.675 . . . . 0.0 107.896 147.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.6 m -135.66 166.51 23.07 Favored 'General case' 0 C--N 1.345 0.398 1 C-N-CA 132.121 4.168 . . . . 0.0 110.485 -166.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 5.9 tt -123.68 133.01 53.97 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 119.155 -2.216 . . . . 0.0 110.299 177.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.613 HG23 HG12 ' A' ' 131' ' ' VAL . 7.4 p -92.14 118.64 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 CA-C-N 122.271 2.305 . . . . 0.0 110.146 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.68 153.44 48.97 Favored 'General case' 0 C--N 1.372 1.583 0 C-N-CA 127.238 2.215 . . . . 0.0 112.484 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -78.64 112.55 15.85 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 129.473 3.109 . . . . 0.0 114.062 170.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.446 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 22.5 t60 -90.75 159.58 40.33 Favored Pre-proline 0 C--N 1.373 1.624 0 CA-C-O 114.301 -2.761 . . . . 0.0 109.181 -178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.446 ' HD2' ' CG ' ' A' ' 113' ' ' HIS 0.265 53.0 Cg_exo -47.54 0.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.861 2 C-N-CA 129.021 6.481 . . . . 0.0 122.536 -166.519 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -102.48 40.56 1.34 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.164 2.586 . . . . 0.0 104.981 168.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.12 118.9 7.39 Favored 'General case' 0 C--N 1.379 1.862 0 C-N-CA 127.493 2.317 . . . . 0.0 114.275 -170.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.96 -19.9 27.18 Favored Glycine 0 C--N 1.356 1.656 0 C-N-CA 125.424 1.487 . . . . 0.0 110.534 -165.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.8 m -104.8 120.21 40.85 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 172.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -135.77 -43.15 0.67 Allowed 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 119.547 1.067 . . . . 0.0 113.531 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 pt -100.03 173.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-O 122.345 1.069 . . . . 0.0 113.875 -174.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -159.0 148.26 18.72 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -147.36 127.05 13.37 Favored 'General case' 0 C--N 1.363 1.193 0 O-C-N 120.071 -1.643 . . . . 0.0 110.3 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -118.29 93.75 4.24 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.601 1.96 . . . . 0.0 110.526 175.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.02 -76.79 0.23 Allowed Glycine 0 C--N 1.36 1.893 0 N-CA-C 120.391 2.916 . . . . 0.0 120.391 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -139.27 52.49 1.75 Allowed 'General case' 0 C--N 1.357 0.924 0 C-N-CA 125.198 1.399 . . . . 0.0 110.657 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.4 m -174.22 146.08 1.09 Allowed 'General case' 0 C--N 1.356 0.852 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.3 p -130.43 139.86 50.27 Favored 'Isoleucine or valine' 0 C--N 1.362 1.111 0 CA-C-O 122.129 0.966 . . . . 0.0 111.362 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.8 mtp180 -113.56 161.77 17.0 Favored 'General case' 0 C--N 1.365 1.265 0 C-N-CA 126.889 2.076 . . . . 0.0 113.628 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 145' ' ' LYS . 14.0 m -149.35 163.3 4.29 Favored 'Isoleucine or valine' 0 C--N 1.369 1.431 1 C-N-CA 133.024 4.53 . . . . 0.0 103.749 175.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -97.44 127.64 43.56 Favored 'General case' 0 C--N 1.366 1.293 0 O-C-N 121.001 -1.062 . . . . 0.0 111.204 167.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.613 HG12 HG23 ' A' ' 110' ' ' VAL . 1.6 m -146.02 171.65 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.503 HE21 ' CG2' ' A' ' 195' ' ' VAL . 0.1 OUTLIER -131.93 146.51 52.14 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.43 1.092 . . . . 0.0 109.063 179.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -93.31 132.26 37.68 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 129.992 3.317 . . . . 0.0 107.534 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 7.4 m-30 -76.03 65.21 2.03 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 124.292 1.996 . . . . 0.0 113.509 -176.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -89.45 -109.49 0.08 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 128.891 2.876 . . . . 0.0 110.146 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -107.23 -52.12 2.81 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.87 1.668 . . . . 0.0 113.902 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.6 m -80.92 -41.07 1.15 Allowed Pre-proline 0 C--N 1.364 1.205 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -172.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.77 169.59 74.09 Favored 'Cis proline' 0 CA--C 1.543 0.953 0 CA-C-N 126.303 3.287 . . . . 0.0 114.259 -1.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.3 m -85.68 125.44 33.19 Favored 'General case' 0 C--N 1.366 1.302 0 C-N-CA 126.413 1.885 . . . . 0.0 110.539 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.486 ' HG2' ' H ' ' A' ' 141' ' ' GLY . 0.5 OUTLIER -117.87 174.84 5.96 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 125.225 1.41 . . . . 0.0 111.219 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.486 ' H ' ' HG2' ' A' ' 140' ' ' ARG . . . 169.14 -160.19 33.48 Favored Glycine 0 CA--C 1.487 -1.715 1 N-CA-C 97.852 -6.099 . . . . 0.0 97.852 171.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 15.5 m95 -96.95 155.8 16.62 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 168.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.0 m -119.92 173.14 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 C-N-CA 124.246 1.018 . . . . 0.0 108.566 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.0 t -84.19 123.58 30.25 Favored 'General case' 0 C--N 1.369 1.443 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 164.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.438 ' HB2' HG22 ' A' ' 129' ' ' VAL . 15.8 ttpp -73.38 -25.16 60.45 Favored 'General case' 0 C--N 1.363 1.182 0 O-C-N 120.904 -1.123 . . . . 0.0 111.995 -175.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -73.22 -9.42 58.69 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 125.246 1.418 . . . . 0.0 114.519 175.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.3 mt -100.11 6.07 44.91 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 125.448 1.499 . . . . 0.0 111.577 172.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.8 mt -100.4 132.23 45.9 Favored 'General case' 0 C--N 1.371 1.538 0 C-N-CA 125.366 1.466 . . . . 0.0 108.403 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.464 ' HB2' ' HZ2' ' A' ' 149' ' ' LYS . 4.9 mtmp? -114.74 164.89 15.23 Favored Pre-proline 0 CA--C 1.506 -0.735 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -83.22 156.31 14.76 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.803 2.335 . . . . 0.0 113.409 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -34.09 -107.67 0.0 OUTLIER 'General case' 0 C--N 1.351 0.631 1 C-N-CA 132.888 4.475 . . . . 0.0 120.606 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.392 4.0 t 53.3 -42.94 0.02 OUTLIER 'General case' 0 C--N 1.371 1.505 1 C-N-CA 131.727 4.011 . . . . 0.0 118.927 174.408 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 81.59 -150.88 30.25 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 121.916 3.527 . . . . 0.0 121.916 159.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 3.6 m -45.87 -11.87 0.02 OUTLIER 'General case' 0 C--N 1.374 1.637 1 C-N-CA 134.952 5.301 . . . . 0.0 118.864 -175.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -88.67 -14.0 38.42 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 129.276 3.03 . . . . 0.0 111.747 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.4 t -75.98 153.94 36.19 Favored 'General case' 0 C--N 1.377 1.781 0 C-N-CA 126.102 1.761 . . . . 0.0 112.05 171.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -72.12 -26.93 62.31 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.869 1.668 . . . . 0.0 111.98 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -79.39 -17.4 54.47 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 124.352 1.061 . . . . 0.0 111.902 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.33 4.61 48.65 Favored 'General case' 0 C--N 1.368 1.373 0 C-N-CA 126.172 1.789 . . . . 0.0 114.08 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -122.72 177.51 5.42 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 124.653 1.181 . . . . 0.0 109.135 172.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.33 122.58 14.89 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 126.968 2.107 . . . . 0.0 113.829 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 103.68 -14.58 53.41 Favored Glycine 0 C--N 1.357 1.708 0 C-N-CA 124.891 1.234 . . . . 0.0 111.615 -168.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.45 153.73 32.14 Favored Glycine 0 C--N 1.359 1.81 0 N-CA-C 119.266 2.467 . . . . 0.0 119.266 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -63.07 -42.5 99.67 Favored 'General case' 0 C--N 1.365 1.239 0 N-CA-C 118.694 2.85 . . . . 0.0 118.694 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.515 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.286 0.4 OUTLIER -101.99 -0.03 34.38 Favored 'General case' 0 C--N 1.359 1.018 0 O-C-N 120.618 -1.301 . . . . 0.0 112.675 -179.139 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -78.64 141.62 37.84 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 126.846 2.058 . . . . 0.0 111.427 173.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 50.9 m -171.27 150.91 3.02 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 101.06 -3.681 . . . . 0.0 101.06 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -129.67 102.52 6.38 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-O 125.409 2.528 . . . . 0.0 113.544 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -119.68 140.22 29.12 Favored Pre-proline 0 N--CA 1.43 -1.443 2 C-N-CA 134.02 4.928 . . . . 0.0 100.114 168.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . 0.319 92.0 Cg_endo -64.45 -17.95 61.36 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.766 3.644 . . . . 0.0 117.502 -174.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -69.96 -36.06 74.96 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 129.541 3.137 . . . . 0.0 111.67 170.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 31.4 mt -73.03 -32.73 40.54 Favored 'Isoleucine or valine' 0 C--N 1.372 1.576 0 C-N-CA 127.604 2.361 . . . . 0.0 110.402 175.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 41.0 mt -65.05 -49.81 68.65 Favored 'General case' 0 C--N 1.378 1.823 0 C-N-CA 126.55 1.94 . . . . 0.0 110.307 169.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -57.53 -34.58 69.28 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 125.209 1.404 . . . . 0.0 114.184 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.22 -48.35 62.21 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 129.963 3.305 . . . . 0.0 114.304 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 25.7 mtt -69.64 -33.3 72.43 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 120.991 1.723 . . . . 0.0 113.383 172.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -70.13 -52.39 23.99 Favored 'General case' 0 C--N 1.377 1.784 0 C-N-CA 127.056 2.142 . . . . 0.0 112.028 174.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.402 ' HG3' ' CE2' ' A' ' 134' ' ' PHE 0.267 6.1 ptt180 -71.29 -36.52 71.7 Favored 'General case' 0 C--N 1.382 1.998 0 O-C-N 119.485 -2.009 . . . . 0.0 113.842 176.01 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.4 -50.03 67.03 Favored 'General case' 0 C--N 1.374 1.638 0 CA-C-O 117.446 -1.264 . . . . 0.0 113.542 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -55.06 -39.22 68.98 Favored 'General case' 0 C--N 1.386 2.18 0 CA-C-N 121.96 2.164 . . . . 0.0 113.542 174.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -52.32 24.97 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 119.735 -1.853 . . . . 0.0 114.6 170.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.585 ' HB1' ' HB3' ' A' ' 190' ' ' ARG . . . -61.62 -33.51 74.04 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 117.285 2.328 . . . . 0.0 117.285 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.6 pp -80.56 -35.37 34.44 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 126.615 1.966 . . . . 0.0 115.143 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.352 0.0 OUTLIER -91.1 -21.03 21.41 Favored 'General case' 0 C--N 1.367 1.327 0 O-C-N 121.309 -0.869 . . . . 0.0 110.735 -173.613 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -101.85 -110.94 0.22 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 123.348 0.659 . . . . 0.0 112.048 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -135.36 161.86 34.22 Favored 'General case' 0 C--N 1.359 1.003 0 O-C-N 119.949 -1.72 . . . . 0.0 110.058 -174.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -51.26 -36.94 44.5 Favored 'General case' 0 C--N 1.373 1.608 0 C-N-CA 131.217 3.807 . . . . 0.0 115.216 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.93 -40.09 34.99 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 C-N-CA 130.639 3.576 . . . . 0.0 112.836 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.96 -32.44 69.3 Favored 'General case' 0 C--N 1.37 1.475 0 C-N-CA 125.483 1.513 . . . . 0.0 113.617 176.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.585 ' HB3' ' HB1' ' A' ' 182' ' ' ALA 0.25 0.0 OUTLIER -74.02 -37.2 64.42 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 174.084 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.265 3.9 mt -78.49 -19.28 53.39 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 126.888 2.075 . . . . 0.0 114.855 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -69.65 -24.46 63.63 Favored 'General case' 0 C--N 1.368 1.388 0 O-C-N 120.961 -1.087 . . . . 0.0 113.079 167.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.86 22.45 15.58 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 131.392 3.877 . . . . 0.0 111.431 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -73.37 -177.99 2.81 Favored 'General case' 0 C--N 1.374 1.633 0 C-N-CA 128.796 2.838 . . . . 0.0 115.03 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.503 ' CG2' HE21 ' A' ' 132' ' ' GLN . 44.6 t -100.58 86.74 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.183 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 169.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.6 m -79.15 124.21 28.11 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.61 40.52 1.09 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 125.658 1.583 . . . . 0.0 111.093 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -158.02 143.28 12.18 Favored Pre-proline 0 C--N 1.354 0.783 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -76.34 63.87 7.13 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 124.72 3.613 . . . . 0.0 113.466 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 47.7 t -125.35 41.14 3.58 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.75 2.02 . . . . 0.0 109.7 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 . . . . . 0 C--N 1.36 1.041 0 CA-C-O 122.733 1.254 . . . . 0.0 111.425 -176.65 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.1 59.62 1.04 Allowed 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.483 1.513 . . . . 0.0 108.682 178.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -131.39 71.45 1.47 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-O 123.264 1.507 . . . . 0.0 110.252 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -99.77 118.69 36.79 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 120.269 -1.519 . . . . 0.0 112.002 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -124.12 6.59 8.53 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 124.682 1.193 . . . . 0.0 110.771 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -97.4 -4.06 39.03 Favored 'General case' 0 C--N 1.356 0.854 0 O-C-N 120.158 -1.588 . . . . 0.0 113.952 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.2 8.35 61.79 Favored Glycine 0 C--N 1.366 2.246 0 C-N-CA 126.931 2.205 . . . . 0.0 116.815 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.68 1.47 37.06 Favored Glycine 0 C--N 1.359 1.824 0 C-N-CA 125.7 1.619 . . . . 0.0 111.983 -175.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tp -88.31 102.66 15.07 Favored 'General case' 0 C--N 1.363 1.163 0 O-C-N 120.745 -1.444 . . . . 0.0 110.909 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -71.85 -30.07 65.05 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 125.99 1.716 . . . . 0.0 113.879 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -169.15 -87.17 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 104.224 -2.51 . . . . 0.0 104.224 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.9 m 171.73 135.89 0.03 OUTLIER 'General case' 0 C--N 1.353 0.719 0 C-N-CA 128.909 2.884 . . . . 0.0 103.941 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.1 m -83.18 1.65 3.8 Favored 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 -175.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.98 152.02 71.26 Favored Pre-proline 0 C--N 1.35 0.592 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -77.83 -25.97 7.2 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 124.654 3.569 . . . . 0.0 113.461 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 76.83 -58.85 0.5 Allowed 'General case' 0 C--N 1.367 1.364 0 C-N-CA 127.934 2.494 . . . . 0.0 113.42 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.69 112.23 64.58 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 172.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.46 69.3 7.43 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.506 2.804 . . . . 0.0 110.976 -175.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.0 p -88.36 68.96 9.01 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 129.16 2.984 . . . . 0.0 112.399 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 93.5 p -82.39 88.74 6.57 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 127.202 2.201 . . . . 0.0 114.095 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -141.93 94.37 2.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -133.31 89.6 2.62 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.176 1.391 . . . . 0.0 112.762 -171.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -123.16 126.65 47.4 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 120.913 -1.117 . . . . 0.0 110.587 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.334 64.4 p -111.59 168.98 6.81 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 129.039 2.936 . . . . 0.0 116.433 -174.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -50.66 137.06 41.98 Favored 'Trans proline' 0 C--N 1.367 1.5 1 C-N-CA 126.854 5.036 . . . . 0.0 122.084 -174.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 102.63 -12.66 56.61 Favored Glycine 0 C--N 1.37 2.456 0 C-N-CA 128.371 2.891 . . . . 0.0 111.139 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.42 169.87 10.04 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 128.056 2.542 . . . . 0.0 111.449 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.52 143.73 44.49 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 119.151 -2.218 . . . . 0.0 105.477 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.9 m -142.88 158.68 18.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -101.75 128.52 48.05 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 100.834 -3.765 . . . . 0.0 100.834 167.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -118.44 141.38 48.61 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 125.341 1.456 . . . . 0.0 112.234 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.1 tttt -120.76 139.88 52.47 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 120.034 -1.666 . . . . 0.0 106.996 172.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 42.3 ttm -129.32 151.3 50.12 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 120.049 -1.657 . . . . 0.0 107.76 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -72.05 110.96 6.88 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 125.856 1.662 . . . . 0.0 110.546 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.09 -16.34 22.77 Favored Glycine 0 C--N 1.359 1.859 0 C-N-CA 125.073 1.321 . . . . 0.0 112.12 -174.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -114.36 157.95 41.15 Favored Pre-proline 0 C--N 1.356 0.853 0 C-N-CA 125.287 1.435 . . . . 0.0 108.99 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.34 166.54 29.47 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 124.448 3.432 . . . . 0.0 112.484 163.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.585 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.0 m95 -51.52 114.54 1.27 Allowed 'General case' 0 C--N 1.365 1.268 0 C-N-CA 127.705 2.402 . . . . 0.0 114.625 167.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.534 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 4.4 m95 -118.7 108.22 41.48 Favored Pre-proline 0 N--CA 1.426 -1.643 0 N-CA-C 119.176 3.028 . . . . 0.0 119.176 -172.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 106' ' ' TRP . 23.5 Cg_endo -54.3 118.46 5.06 Favored 'Trans proline' 0 C--N 1.373 1.846 1 C-N-CA 125.678 4.252 . . . . 0.0 112.498 162.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.2 m -132.91 164.97 25.75 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 127.145 2.178 . . . . 0.0 114.226 -159.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.718 HD22 ' HE ' ' A' ' 190' ' ' ARG . 2.2 pp -116.28 147.49 41.46 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 169.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.55 120.93 42.68 Favored 'Isoleucine or valine' 0 C--N 1.369 1.417 0 O-C-N 120.831 -1.168 . . . . 0.0 109.217 172.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -139.83 152.88 46.86 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 120.103 -1.623 . . . . 0.0 112.24 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -89.6 112.1 23.23 Favored 'General case' 0 C--N 1.369 1.416 0 C-N-CA 129.25 3.02 . . . . 0.0 109.514 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.418 ' HB2' ' CD2' ' A' ' 130' ' ' HIS . 69.3 t60 -73.69 159.34 84.68 Favored Pre-proline 0 C--N 1.36 1.027 0 C-N-CA 127.73 2.412 . . . . 0.0 114.716 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 113' ' ' HIS . 10.1 Cg_endo -48.97 -1.17 0.03 OUTLIER 'Trans proline' 0 CA--C 1.558 1.697 1 C-N-CA 127.077 5.184 . . . . 0.0 119.079 174.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -104.4 35.11 2.83 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 128.305 2.642 . . . . 0.0 107.444 167.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -68.62 158.14 34.66 Favored 'General case' 0 C--N 1.367 1.331 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -171.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.6 -20.64 27.11 Favored Glycine 0 C--N 1.359 1.855 0 CA-C-N 112.493 -2.14 . . . . 0.0 109.669 171.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.3 p -124.58 119.26 28.56 Favored 'General case' 0 N--CA 1.438 -1.05 1 N-CA-C 99.252 -4.351 . . . . 0.0 99.252 164.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.557 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 20.3 p90 -118.83 -3.4 10.76 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.223 -0.923 . . . . 0.0 108.947 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.8 HG22 HG12 ' A' ' 129' ' ' VAL . 7.3 pt -112.77 166.6 6.6 Favored 'Isoleucine or valine' 0 C--N 1.364 1.201 0 C-N-CA 127.367 2.267 . . . . 0.0 112.036 -174.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.4 ' HE ' ' HD2' ' A' ' 128' ' ' ARG . 45.6 ttp180 -158.57 147.36 18.77 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 103.871 -2.641 . . . . 0.0 103.871 176.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -145.53 126.76 14.79 Favored 'General case' 0 C--N 1.359 1.017 0 O-C-N 119.568 -1.958 . . . . 0.0 109.11 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -117.97 93.6 4.2 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 127.184 2.193 . . . . 0.0 110.241 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 65.42 -71.16 0.1 OUTLIER Glycine 0 C--N 1.36 1.88 0 N-CA-C 120.97 3.148 . . . . 0.0 120.97 172.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -143.6 51.2 1.35 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-O 122.648 1.213 . . . . 0.0 111.138 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.5 m -177.3 143.26 0.37 Allowed 'General case' 0 C--N 1.355 0.814 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.5 p -117.17 136.28 54.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.058 0 CA-C-O 122.79 1.281 . . . . 0.0 110.127 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.4 ' HD2' ' HE ' ' A' ' 121' ' ' ARG . 14.7 mtt-85 -113.67 144.46 42.89 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.715 2.806 . . . . 0.0 107.075 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.8 HG12 HG22 ' A' ' 120' ' ' ILE . 12.0 m -146.66 162.7 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 101.497 -3.52 . . . . 0.0 101.497 177.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.557 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 3.2 p-80 -96.58 134.71 39.46 Favored 'General case' 0 C--N 1.363 1.153 0 CA-C-O 123.598 1.666 . . . . 0.0 110.05 172.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.7 p -125.89 163.64 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 N-CA-C 101.599 -3.482 . . . . 0.0 101.599 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 129.72 33.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 103.525 -2.768 . . . . 0.0 103.525 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -86.28 129.36 34.88 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.014 3.325 . . . . 0.0 110.283 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.9 75.79 2.81 Favored 'General case' 0 C--N 1.371 1.506 0 CA-C-N 120.511 1.505 . . . . 0.0 114.114 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.07 -104.38 0.1 Allowed 'General case' 0 C--N 1.368 1.384 0 C-N-CA 124.678 1.191 . . . . 0.0 108.569 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -107.22 -56.18 2.24 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.987 2.115 . . . . 0.0 113.825 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.83 -44.92 2.41 Favored Pre-proline 0 C--N 1.368 1.401 0 N-CA-C 119.575 3.176 . . . . 0.0 119.575 -172.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -82.05 177.77 32.57 Favored 'Cis proline' 0 CA--C 1.546 1.088 0 CA-C-N 126.492 3.354 . . . . 0.0 114.058 3.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 11.9 m -94.84 134.56 37.34 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 125.189 1.396 . . . . 0.0 110.717 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.406 ' HE ' ' CE1' ' A' ' 113' ' ' HIS . 5.8 tmm_? -117.31 148.11 41.99 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 125.656 1.583 . . . . 0.0 110.401 177.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -160.47 167.52 35.71 Favored Glycine 0 CA--C 1.486 -1.734 1 N-CA-C 103.035 -4.026 . . . . 0.0 103.035 169.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 29.5 m95 -88.13 122.01 31.2 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 124.776 2.226 . . . . 0.0 108.329 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.7 m -103.06 168.01 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 129.089 2.955 . . . . 0.0 108.545 -174.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.5 m -91.46 130.12 37.34 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 102.425 -3.176 . . . . 0.0 102.425 168.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.588 ' HD3' HG11 ' A' ' 129' ' ' VAL . 32.4 ttpt -74.69 -15.58 60.79 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-O 122.921 1.343 . . . . 0.0 114.108 -170.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -72.64 -2.98 22.14 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.701 1.601 . . . . 0.0 115.136 171.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.6 mt -107.04 10.31 30.33 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 125.187 1.395 . . . . 0.0 110.468 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.538 HD12 ' HG3' ' A' ' 145' ' ' LYS . 11.4 mt -98.96 124.24 43.8 Favored 'General case' 0 C--N 1.374 1.657 0 C-N-CA 125.588 1.555 . . . . 0.0 107.258 174.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -116.24 151.28 46.58 Favored Pre-proline 0 CA--C 1.501 -0.924 0 O-C-N 119.921 -1.737 . . . . 0.0 108.306 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.13 123.73 4.63 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.845 2.364 . . . . 0.0 112.184 -167.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.34 108.5 19.93 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -171.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.773 ' HA ' HD13 ' A' ' 183' ' ' LEU . 9.1 t -150.42 26.88 0.76 Allowed 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -167.38 80.7 0.1 Allowed Glycine 0 C--N 1.355 1.61 0 C-N-CA 116.061 -2.971 . . . . 0.0 118.862 -168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.4 t -68.29 -11.9 60.17 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 126.921 2.088 . . . . 0.0 115.988 170.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -122.75 35.0 4.98 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 127.884 2.474 . . . . 0.0 107.645 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.2 t -104.96 142.44 34.78 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 126.316 1.847 . . . . 0.0 106.422 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.27 27.3 ttpt -52.76 -36.91 58.68 Favored 'General case' 0 C--N 1.369 1.442 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -171.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -18.48 61.97 Favored 'General case' 0 C--N 1.37 1.48 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 169.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.66 5.15 49.74 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.257 1.8 pp0? -129.41 -174.95 3.43 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.635 -1.916 . . . . 0.0 110.352 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.3 122.01 15.13 Favored 'General case' 0 C--N 1.368 1.396 0 O-C-N 120.444 -1.41 . . . . 0.0 113.686 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.37 -9.95 61.17 Favored Glycine 0 C--N 1.359 1.839 0 C-N-CA 124.365 0.983 . . . . 0.0 111.674 -167.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.92 160.3 44.63 Favored Glycine 0 C--N 1.366 2.202 0 C-N-CA 125.985 1.755 . . . . 0.0 116.846 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -69.53 -42.72 74.28 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 118.096 2.628 . . . . 0.0 118.096 -174.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.585 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.267 0.1 OUTLIER -99.42 5.06 46.41 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 120.245 -1.534 . . . . 0.0 114.377 -178.936 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -85.61 92.94 8.69 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.164 2.585 . . . . 0.0 114.284 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.4 m -113.86 110.23 19.79 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 102.621 -3.103 . . . . 0.0 102.621 170.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.97 101.5 14.21 Favored 'General case' 0 C--N 1.359 1.014 0 CA-C-O 126.127 2.87 . . . . 0.0 113.486 -170.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.1 ttmt -120.47 150.5 52.17 Favored Pre-proline 0 N--CA 1.422 -1.854 1 C-N-CA 133.93 4.892 . . . . 0.0 102.915 171.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.486 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 58.7 Cg_endo -60.41 -32.38 93.8 Favored 'Trans proline' 0 CA--C 1.554 1.478 1 C-N-CA 126.652 4.901 . . . . 0.0 115.037 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -67.27 -35.16 78.93 Favored 'General case' 0 C--N 1.364 1.202 0 C-N-CA 130.059 3.344 . . . . 0.0 113.256 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.534 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 8.0 mm -72.17 -36.2 55.53 Favored 'Isoleucine or valine' 0 C--N 1.372 1.577 0 C-N-CA 127.235 2.214 . . . . 0.0 110.049 175.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.486 ' HG ' ' HA ' ' A' ' 170' ' ' PRO . 2.9 mt -64.0 -53.83 43.87 Favored 'General case' 0 C--N 1.384 2.066 0 C-N-CA 126.428 1.891 . . . . 0.0 110.882 171.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -57.39 -33.87 68.28 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 129.143 2.977 . . . . 0.0 114.447 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.409 ' CB ' ' HG2' ' A' ' 107' ' ' PRO . . . -68.87 -44.67 72.81 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 130.079 3.352 . . . . 0.0 111.617 172.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 37.9 mtm -65.69 -35.74 81.62 Favored 'General case' 0 C--N 1.37 1.473 0 C-N-CA 125.102 1.361 . . . . 0.0 114.456 167.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 5.4 mt-30 -74.49 -48.33 27.91 Favored 'General case' 0 C--N 1.378 1.844 0 C-N-CA 125.518 1.527 . . . . 0.0 112.434 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -65.23 -46.54 80.19 Favored 'General case' 0 C--N 1.371 1.51 0 C-N-CA 129.251 3.02 . . . . 0.0 112.705 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.43 84.32 Favored 'General case' 0 C--N 1.375 1.707 0 O-C-N 120.599 -1.313 . . . . 0.0 112.688 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.527 ' O ' ' HB3' ' A' ' 184' ' ' ASN 0.333 35.3 t70 -64.55 -31.35 72.53 Favored 'General case' 0 C--N 1.378 1.81 0 C-N-CA 125.969 1.708 . . . . 0.0 111.857 175.059 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -76.45 -33.38 58.76 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 118.362 -2.711 . . . . 0.0 113.79 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.24 -36.83 58.31 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 118.64 2.83 . . . . 0.0 118.64 171.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 152' ' ' THR . 4.1 pp -79.87 -36.45 36.59 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 119.901 -1.749 . . . . 0.0 114.704 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -85.92 -17.78 34.53 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 127.201 2.201 . . . . 0.0 110.839 -176.103 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -117.51 -105.09 0.4 Allowed 'General case' 0 C--N 1.359 1.014 0 CA-C-O 121.791 0.805 . . . . 0.0 110.781 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -129.12 146.93 50.95 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-O 122.618 1.199 . . . . 0.0 108.331 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 8.2 ttpt -50.31 -36.19 30.79 Favored 'General case' 0 C--N 1.357 0.924 1 C-N-CA 134.111 4.965 . . . . 0.0 113.826 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 14.9 tt -51.99 -37.18 21.06 Favored 'Isoleucine or valine' 0 C--N 1.37 1.489 0 C-N-CA 128.918 2.887 . . . . 0.0 112.174 171.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.328 2.8 mptp? -64.1 -31.29 72.43 Favored 'General case' 0 C--N 1.371 1.502 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 176.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.718 ' HE ' HD22 ' A' ' 109' ' ' LEU 0.411 0.0 OUTLIER -75.26 -42.2 55.64 Favored 'General case' 0 C--N 1.382 1.985 0 CA-C-N 121.327 1.876 . . . . 0.0 112.283 165.132 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.7 tp -57.39 -22.6 43.9 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 129.031 2.932 . . . . 0.0 117.595 -173.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -73.9 -13.13 60.86 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.997 2.519 . . . . 0.0 113.953 170.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.13 22.76 15.16 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 130.562 3.545 . . . . 0.0 112.093 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.0 118.28 5.63 Favored 'General case' 0 C--N 1.371 1.535 0 C-N-CA 129.574 3.149 . . . . 0.0 116.141 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 10.7 t -72.37 57.08 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.594 0 C-N-CA 128.637 2.775 . . . . 0.0 113.174 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 28.0 p -83.22 -52.01 6.96 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 130.058 3.343 . . . . 0.0 113.94 -176.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . 0.486 1.7 p30 83.28 153.7 0.1 Allowed 'General case' 0 C--N 1.356 0.86 0 C-N-CA 130.548 3.539 . . . . 0.0 116.789 178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -107.38 147.98 36.28 Favored Pre-proline 0 C--N 1.359 0.985 0 O-C-N 119.839 -1.788 . . . . 0.0 109.188 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.61 98.81 1.24 Allowed 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.993 3.129 . . . . 0.0 112.913 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 91.6 p -79.79 53.54 1.66 Allowed 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.465 1.506 . . . . 0.0 113.491 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 . . . . . 0 C--N 1.356 0.851 0 C-N-CA 126.134 1.774 . . . . 0.0 109.47 -178.293 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.5 pttt . . . . . 0 N--CA 1.443 -0.783 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.01 -51.34 2.56 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 126.374 1.87 . . . . 0.0 112.511 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -148.98 134.11 18.23 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -102.97 155.66 18.21 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 125.338 1.455 . . . . 0.0 111.279 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.4 tp -106.8 123.73 48.58 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 126.076 1.75 . . . . 0.0 108.576 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -75.23 -22.06 58.17 Favored 'General case' 0 C--N 1.367 1.369 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 85.67 -20.79 16.99 Favored Glycine 0 C--N 1.365 2.163 0 C-N-CA 127.633 2.54 . . . . 0.0 115.559 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.13 -128.29 2.56 Favored Glycine 0 CA--C 1.496 -1.095 1 N-CA-C 102.911 -4.076 . . . . 0.0 102.911 -176.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 76' ' ' LEU . 1.7 pt? -109.88 121.46 45.28 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 125.099 1.359 . . . . 0.0 109.876 175.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.549 ' H ' ' HE ' ' A' ' 77' ' ' ARG . 0.7 OUTLIER -71.51 -24.6 62.0 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 127.574 2.35 . . . . 0.0 115.047 -178.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -169.66 -42.36 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.842 2.057 . . . . 0.0 106.184 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.3 m -175.47 -169.03 0.34 Allowed 'General case' 0 C--N 1.354 0.802 0 N-CA-C 103.047 -2.946 . . . . 0.0 103.047 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.353 72.6 t 94.4 112.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.342 0 C-N-CA 128.786 2.834 . . . . 0.0 113.621 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.74 148.99 43.16 Favored Pre-proline 0 C--N 1.358 0.968 0 C-N-CA 126.227 1.811 . . . . 0.0 106.865 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.88 78.87 3.55 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 124.466 3.444 . . . . 0.0 112.856 -176.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.45 -89.93 0.59 Allowed 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.115 0.966 . . . . 0.0 111.213 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.8 112.73 64.39 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.66 90.35 1.28 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.739 2.96 . . . . 0.0 112.058 -171.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -47.01 18.08 0.0 OUTLIER 'General case' 0 C--N 1.363 1.195 1 C-N-CA 133.412 4.685 . . . . 0.0 120.747 -177.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.3 p -148.2 11.22 0.91 Allowed 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.69 -1.256 . . . . 0.0 110.03 176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 83.1 p -146.19 71.74 1.27 Allowed 'General case' 0 C--N 1.363 1.181 0 C-N-CA 123.937 0.895 . . . . 0.0 110.046 179.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -146.71 72.15 1.26 Allowed 'General case' 0 C--N 1.349 0.571 0 C-N-CA 125.306 1.442 . . . . 0.0 108.967 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 88' ' ' SER . 59.9 m-85 -116.71 127.11 54.09 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 120.602 -1.311 . . . . 0.0 112.106 -172.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.4 p -112.0 167.72 8.7 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 127.82 2.448 . . . . 0.0 117.113 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -54.39 129.11 32.97 Favored 'Trans proline' 0 C--N 1.371 1.725 1 C-N-CA 126.943 5.096 . . . . 0.0 116.779 -176.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.8 -16.17 58.85 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 125.418 1.485 . . . . 0.0 112.68 -176.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -92.71 154.3 18.41 Favored 'General case' 0 C--N 1.367 1.36 0 CA-C-N 119.71 1.755 . . . . 0.0 110.859 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.583 HD13 HH21 ' A' ' 190' ' ' ARG . 3.3 mm? -98.44 144.61 27.61 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 119.303 -2.123 . . . . 0.0 109.047 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.1 m -136.8 158.17 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 C-N-CA 125.333 1.453 . . . . 0.0 109.994 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -105.76 119.82 40.13 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 101.035 -3.691 . . . . 0.0 101.035 167.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -107.82 144.47 34.96 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.337 1.855 . . . . 0.0 113.388 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -120.22 135.81 54.86 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.2 ttp -128.63 144.41 51.15 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 119.526 -1.983 . . . . 0.0 108.833 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -64.7 94.64 0.13 Allowed 'General case' 0 C--N 1.368 1.386 0 C-N-CA 126.445 1.898 . . . . 0.0 115.22 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.57 -5.12 24.64 Favored Glycine 0 C--N 1.359 1.817 0 C-N-CA 126.392 1.949 . . . . 0.0 113.01 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -104.64 159.98 27.52 Favored Pre-proline 0 C--N 1.357 0.913 0 C-N-CA 126.001 1.72 . . . . 0.0 109.967 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.44 166.63 29.25 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 123.682 2.921 . . . . 0.0 112.221 162.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.613 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 2.6 m95 -59.72 123.92 18.49 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 127.644 2.378 . . . . 0.0 114.799 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -127.27 108.54 21.39 Favored Pre-proline 0 N--CA 1.433 -1.305 1 N-CA-C 122.013 4.079 . . . . 0.0 122.013 -168.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -61.22 133.49 46.94 Favored 'Trans proline' 0 C--N 1.39 2.741 1 C-N-CA 125.968 4.446 . . . . 0.0 111.366 165.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.5 p -155.81 163.68 39.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 125.011 2.339 . . . . 0.0 115.743 -157.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 134' ' ' PHE . 5.1 tt -101.06 129.99 47.01 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 129.172 2.989 . . . . 0.0 108.151 176.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.449 ' H ' HH22 ' A' ' 190' ' ' ARG . 31.2 t -87.49 118.81 34.07 Favored 'Isoleucine or valine' 0 C--N 1.378 1.846 0 CA-C-N 120.722 1.601 . . . . 0.0 107.007 173.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -116.57 154.16 30.95 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 -164.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -119.4 112.67 19.7 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 168.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -83.44 159.09 62.34 Favored Pre-proline 0 C--N 1.348 0.528 0 C-N-CA 129.879 3.271 . . . . 0.0 110.647 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.32 0.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.799 1 C-N-CA 128.632 6.222 . . . . 0.0 119.973 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -95.21 28.2 2.94 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 131.191 3.796 . . . . 0.0 107.249 166.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.271 0.0 OUTLIER -73.79 161.07 30.59 Favored 'General case' 0 C--N 1.368 1.412 0 C-N-CA 127.185 2.194 . . . . 0.0 115.945 -173.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 105.95 -20.26 36.41 Favored Glycine 0 C--N 1.362 2.002 0 C-N-CA 126.666 2.079 . . . . 0.0 111.33 -174.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.1 p -135.87 136.18 40.34 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 130.681 3.592 . . . . 0.0 103.087 173.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -132.79 -3.75 3.24 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 120.206 1.366 . . . . 0.0 113.293 -175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.3 pt -110.73 150.38 13.23 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 123.073 1.416 . . . . 0.0 111.324 -175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.91 141.82 36.5 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 128.041 2.536 . . . . 0.0 104.227 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -145.67 126.6 14.51 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 120.939 -1.1 . . . . 0.0 109.013 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -109.42 93.55 4.56 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 172.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.33 -63.06 1.41 Allowed Glycine 0 C--N 1.362 2.011 0 C-N-CA 127.829 2.633 . . . . 0.0 115.852 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -144.64 -5.41 0.73 Allowed 'General case' 0 C--N 1.352 0.683 0 C-N-CA 127.736 2.414 . . . . 0.0 110.227 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 70.0 m -82.34 73.77 9.36 Favored 'General case' 0 C--N 1.372 1.551 0 O-C-N 118.944 -2.348 . . . . 0.0 110.306 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.56 111.15 21.58 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 C-N-CA 129.228 3.011 . . . . 0.0 110.594 -175.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -117.34 146.82 43.13 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 111.287 -2.688 . . . . 0.0 112.874 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.86 162.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 127.74 2.416 . . . . 0.0 106.426 175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.02 138.43 32.45 Favored 'General case' 0 C--N 1.379 1.889 0 O-C-N 117.975 -2.953 . . . . 0.0 111.112 171.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 m -151.9 169.91 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.478 -1.807 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.568 HE22 HG12 ' A' ' 195' ' ' VAL . 9.2 pt20 -149.09 151.13 33.91 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 122.138 0.97 . . . . 0.0 109.695 170.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -104.14 122.13 44.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 128.972 2.909 . . . . 0.0 107.97 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 51.0 m-85 -71.38 62.29 0.35 Allowed 'General case' 0 C--N 1.378 1.837 0 C-N-CA 127.317 2.247 . . . . 0.0 112.136 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -90.33 -114.2 0.07 Allowed 'General case' 0 C--N 1.362 1.151 0 C-N-CA 129.986 3.314 . . . . 0.0 111.531 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -106.53 -45.1 4.33 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 125.723 1.609 . . . . 0.0 112.031 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -81.6 -40.45 1.02 Allowed Pre-proline 0 C--N 1.36 1.055 0 N-CA-C 118.44 2.756 . . . . 0.0 118.44 -174.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.91 159.57 97.79 Favored 'Cis proline' 0 C--N 1.361 1.189 0 CA-C-N 126.202 3.251 . . . . 0.0 109.864 -3.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 39.9 p -87.88 119.37 28.16 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 119.009 -2.307 . . . . 0.0 112.046 -175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -109.92 152.93 25.2 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 125.877 1.671 . . . . 0.0 107.623 174.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -161.35 177.31 37.72 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 104.084 -3.606 . . . . 0.0 104.084 165.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -92.26 109.06 20.43 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 103.12 -2.918 . . . . 0.0 103.12 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.439 HG22 ' H ' ' A' ' 143' ' ' VAL . 1.5 m -96.32 164.6 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.152 0 C-N-CA 125.466 1.507 . . . . 0.0 111.511 -171.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 m -77.42 109.85 11.69 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.97 2.108 . . . . 0.0 106.305 172.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . 0.503 0.0 OUTLIER -70.72 -10.27 59.07 Favored 'General case' 0 C--N 1.37 1.496 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 -169.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.436 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 31.5 ptt-85 -75.44 -14.68 60.46 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 129.214 3.006 . . . . 0.0 114.193 170.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.0 mt -100.47 0.82 40.39 Favored 'General case' 0 C--N 1.365 1.281 0 C-N-CA 126.859 2.064 . . . . 0.0 110.263 174.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 49.1 mt -96.28 124.88 40.44 Favored 'General case' 0 C--N 1.368 1.412 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 172.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -114.6 161.74 27.18 Favored Pre-proline 0 CA--C 1.506 -0.718 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.14 149.78 22.47 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 CA-C-N 125.332 2.94 . . . . 0.0 112.463 -176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -113.28 153.05 29.07 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 173.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.584 ' HA ' HD13 ' A' ' 183' ' ' LEU . 8.8 t -179.61 -32.39 0.01 OUTLIER 'General case' 0 C--N 1.352 0.684 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.77 113.77 0.89 Allowed Glycine 0 C--N 1.355 1.638 0 O-C-N 121.029 -1.044 . . . . 0.0 115.354 -173.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -11.96 59.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 131.0 3.72 . . . . 0.0 112.271 171.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.78 -8.14 35.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 131.241 3.816 . . . . 0.0 111.794 177.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.8 m -58.09 136.06 57.12 Favored 'General case' 0 C--N 1.385 2.147 0 C-N-CA 126.172 1.789 . . . . 0.0 112.032 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . 0.303 33.6 tttp -54.59 -31.75 57.48 Favored 'General case' 0 C--N 1.368 1.378 0 CA-C-N 122.445 2.384 . . . . 0.0 117.317 -173.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -74.7 -19.34 60.29 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 126.519 1.927 . . . . 0.0 112.835 170.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.59 1.68 55.63 Favored 'General case' 0 C--N 1.369 1.425 0 C-N-CA 126.359 1.864 . . . . 0.0 112.801 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -132.15 -176.48 4.08 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 119.898 -1.751 . . . . 0.0 112.908 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -63.66 122.13 15.61 Favored 'General case' 0 C--N 1.371 1.525 0 C-N-CA 126.037 1.735 . . . . 0.0 114.209 -177.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.06 -7.92 60.72 Favored Glycine 0 C--N 1.357 1.748 0 C-N-CA 124.533 1.063 . . . . 0.0 111.615 -167.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -86.7 145.92 20.4 Favored Glycine 0 C--N 1.364 2.133 0 N-CA-C 120.303 2.881 . . . . 0.0 120.303 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -53.85 -42.05 68.11 Favored 'General case' 0 C--N 1.364 1.198 0 C-N-CA 129.448 3.099 . . . . 0.0 119.04 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.613 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.387 0.6 OUTLIER -102.68 -10.59 19.08 Favored 'General case' 0 C--N 1.366 1.314 0 CA-C-N 119.945 1.248 . . . . 0.0 113.104 179.032 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -73.35 92.98 1.87 Allowed 'General case' 0 C--N 1.362 1.148 0 C-N-CA 126.383 1.873 . . . . 0.0 113.457 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 72.6 m -113.84 107.36 15.61 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 101.193 -3.632 . . . . 0.0 101.193 173.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -88.19 101.28 13.68 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-O 125.616 2.627 . . . . 0.0 115.463 -166.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -121.4 153.15 58.7 Favored Pre-proline 0 N--CA 1.419 -1.992 1 C-N-CA 132.848 4.459 . . . . 0.0 104.946 170.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.89 -42.18 69.68 Favored 'Trans proline' 0 C--N 1.347 0.462 1 C-N-CA 126.154 4.569 . . . . 0.0 115.725 175.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -59.72 -35.26 74.18 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 129.446 3.098 . . . . 0.0 114.006 176.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 16.8 mm -72.35 -43.46 64.5 Favored 'Isoleucine or valine' 0 C--N 1.372 1.559 0 C-N-CA 125.792 1.637 . . . . 0.0 110.569 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.72 -47.34 66.6 Favored 'General case' 0 C--N 1.372 1.578 0 O-C-N 120.101 -1.625 . . . . 0.0 113.65 174.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -58.82 -35.23 72.53 Favored 'General case' 0 CA--C 1.497 -1.094 0 C-N-CA 126.665 1.986 . . . . 0.0 116.172 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.73 -36.71 76.09 Favored 'General case' 0 N--CA 1.428 -1.547 0 C-N-CA 127.758 2.423 . . . . 0.0 110.94 173.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.2 mtt -69.32 -35.62 76.12 Favored 'General case' 0 C--N 1.378 1.831 0 CA-C-O 116.707 -1.616 . . . . 0.0 113.729 167.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -70.06 -48.99 55.58 Favored 'General case' 0 C--N 1.377 1.802 0 C-N-CA 127.335 2.254 . . . . 0.0 111.732 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -66.62 -47.9 71.19 Favored 'General case' 0 C--N 1.371 1.529 0 C-N-CA 128.6 2.76 . . . . 0.0 112.19 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.27 71.13 Favored 'General case' 0 C--N 1.375 1.676 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 170.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.87 -50.1 70.13 Favored 'General case' 0 C--N 1.375 1.694 0 O-C-N 120.212 -1.555 . . . . 0.0 110.363 174.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -33.72 71.62 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 173.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -73.42 -38.83 65.41 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.584 HD13 ' HA ' ' A' ' 152' ' ' THR . 2.7 pp -79.46 -38.58 34.24 Favored 'General case' 0 C--N 1.373 1.618 0 C-N-CA 125.986 1.714 . . . . 0.0 113.501 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.298 0.0 OUTLIER -87.58 -16.67 33.89 Favored 'General case' 0 C--N 1.367 1.33 0 C-N-CA 125.848 1.659 . . . . 0.0 110.901 -172.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -117.02 -106.96 0.38 Allowed 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -135.86 156.04 49.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.972 1.368 . . . . 0.0 109.564 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -51.24 -35.33 36.44 Favored 'General case' 0 C--N 1.36 1.053 1 C-N-CA 134.275 5.03 . . . . 0.0 113.932 175.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.7 tp -50.9 -31.17 9.93 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 C-N-CA 129.933 3.293 . . . . 0.0 112.458 172.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -73.04 -37.08 67.01 Favored 'General case' 0 C--N 1.377 1.766 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 173.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.583 HH21 HD13 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -75.2 -42.94 54.51 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 172.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.326 54.2 mt -73.36 -19.25 61.05 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 126.48 1.912 . . . . 0.0 113.304 -177.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -55.31 -37.73 67.76 Favored 'General case' 0 C--N 1.373 1.619 0 C-N-CA 128.654 2.782 . . . . 0.0 114.735 164.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.14 -45.66 5.83 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 128.705 2.802 . . . . 0.0 108.779 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 71.19 -86.07 0.03 OUTLIER 'General case' 0 C--N 1.363 1.187 0 C-N-CA 130.094 3.358 . . . . 0.0 115.782 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.568 HG12 HE22 ' A' ' 132' ' ' GLN . 3.4 m -116.78 11.52 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 128.93 2.892 . . . . 0.0 107.917 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.328 66.5 m 76.04 66.7 0.06 Allowed 'General case' 0 C--N 1.359 0.994 0 C-N-CA 131.192 3.797 . . . . 0.0 112.417 -176.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -88.81 145.07 25.81 Favored 'General case' 0 C--N 1.361 1.07 0 C-N-CA 125.632 1.573 . . . . 0.0 111.181 176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . 0.298 5.0 mp0 88.48 160.91 0.09 OUTLIER Pre-proline 0 C--N 1.368 1.398 0 C-N-CA 129.484 3.113 . . . . 0.0 111.975 -176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -68.88 66.28 1.28 Allowed 'Trans proline' 0 CA--C 1.551 1.34 0 C-N-CA 124.699 3.599 . . . . 0.0 117.428 -174.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.377 88.5 p 102.8 -24.99 0.02 OUTLIER 'General case' 0 C--N 1.365 1.243 0 C-N-CA 130.229 3.412 . . . . 0.0 112.816 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 . . . . . 0 C--N 1.359 0.992 0 C-N-CA 126.496 1.919 . . . . 0.0 112.318 179.772 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? . . . . . 0 N--CA 1.443 -0.791 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.69 35.83 2.66 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 125.402 1.481 . . . . 0.0 110.754 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -86.49 71.23 10.46 Favored 'General case' 0 C--N 1.361 1.069 0 O-C-N 119.813 -1.804 . . . . 0.0 113.632 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -102.93 119.38 38.75 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.951 1.7 . . . . 0.0 110.041 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.56 142.92 19.43 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 102.464 -3.162 . . . . 0.0 102.464 176.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -122.75 20.7 10.14 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 119.33 0.968 . . . . 0.0 112.306 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 99.42 -21.78 43.79 Favored Glycine 0 C--N 1.362 1.994 0 C-N-CA 127.154 2.311 . . . . 0.0 116.648 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -37.46 -78.99 0.04 OUTLIER Glycine 0 C--N 1.368 2.348 0 C-N-CA 130.253 3.787 . . . . 0.0 119.618 -178.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.48 -13.1 55.41 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 120.933 -1.334 . . . . 0.0 113.448 174.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -72.39 -52.45 15.93 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 128.099 2.56 . . . . 0.0 116.418 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -139.46 -28.8 0.76 Allowed 'General case' 0 C--N 1.354 0.787 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -176.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . 0.324 97.1 p 105.9 -107.16 0.0 OUTLIER 'General case' 0 C--N 1.364 1.239 0 C-N-CA 129.675 3.19 . . . . 0.0 107.958 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.1 t -119.68 -64.89 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.896 0 C-N-CA 125.335 1.454 . . . . 0.0 108.129 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.39 139.57 31.79 Favored Pre-proline 0 C--N 1.354 0.765 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.03 64.98 8.37 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 124.7 3.6 . . . . 0.0 113.475 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.05 -115.71 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.97 117.26 58.08 Favored Pre-proline 0 C--N 1.353 0.76 0 C-N-CA 124.973 1.309 . . . . 0.0 108.957 174.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.37 56.39 5.74 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.278 3.319 . . . . 0.0 111.679 177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.1 p -115.96 54.86 0.81 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 125.703 1.601 . . . . 0.0 112.182 -173.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . 0.265 1.1 t 74.04 -172.0 0.12 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 119.68 3.215 . . . . 0.0 119.68 175.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.3 p -151.39 79.96 1.29 Allowed 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.491 -1.381 . . . . 0.0 110.584 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.41 ' HA ' ' HE3' ' A' ' 145' ' ' LYS . 5.5 t70 -150.57 81.45 1.35 Allowed 'General case' 0 C--N 1.361 1.107 0 C-N-CA 124.71 1.204 . . . . 0.0 111.066 -173.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -118.23 126.92 53.16 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.361 -1.462 . . . . 0.0 111.02 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.6 p -112.28 167.14 9.6 Favored Pre-proline 0 C--N 1.366 1.29 0 C-N-CA 127.347 2.259 . . . . 0.0 116.808 -177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -48.46 127.88 16.73 Favored 'Trans proline' 0 C--N 1.389 2.665 1 C-N-CA 127.151 5.234 . . . . 0.0 116.619 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.444 ' HA2' HH11 ' A' ' 190' ' ' ARG . . . 96.74 1.15 60.24 Favored Glycine 0 C--N 1.357 1.713 0 C-N-CA 124.103 0.858 . . . . 0.0 112.668 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -94.8 169.2 10.32 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 170.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -113.82 147.49 38.28 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 101.751 -3.426 . . . . 0.0 101.751 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.455 HG11 ' HG ' ' A' ' 148' ' ' LEU . 1.4 p -142.41 167.15 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.109 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 -174.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.5 m95 -112.26 117.75 33.37 Favored 'General case' 0 N--CA 1.437 -1.105 1 N-CA-C 95.796 -5.631 . . . . 0.0 95.796 166.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -105.56 131.94 52.33 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -106.8 136.07 47.26 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 118.221 -2.8 . . . . 0.0 106.014 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 40.9 ttm -123.27 145.02 49.03 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 119.827 -1.796 . . . . 0.0 108.578 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -62.41 96.43 0.08 Allowed 'General case' 0 C--N 1.367 1.356 0 C-N-CA 127.469 2.307 . . . . 0.0 114.418 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.44 -6.29 24.73 Favored Glycine 0 C--N 1.359 1.851 0 C-N-CA 125.685 1.612 . . . . 0.0 113.257 -177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -106.67 162.07 20.87 Favored Pre-proline 0 C--N 1.355 0.812 0 C-N-CA 125.713 1.605 . . . . 0.0 109.555 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.88 166.6 29.05 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.129 3.219 . . . . 0.0 112.483 164.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -59.88 121.06 10.81 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 126.589 1.956 . . . . 0.0 114.238 170.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.44 ' CZ3' HD13 ' A' ' 172' ' ' ILE . 9.3 m95 -125.09 116.77 25.77 Favored Pre-proline 0 N--CA 1.428 -1.558 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 -172.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -57.42 127.16 24.38 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 124.865 3.71 . . . . 0.0 110.227 160.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.7 t -138.71 165.73 26.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 130.11 3.364 . . . . 0.0 111.535 -153.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.583 HD21 ' CZ ' ' A' ' 190' ' ' ARG . 1.9 tt -130.07 131.63 45.85 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 119.82 -1.8 . . . . 0.0 106.285 176.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 131' ' ' VAL . 2.7 p -91.84 119.36 39.09 Favored 'Isoleucine or valine' 0 C--N 1.373 1.63 0 CA-C-N 120.072 1.306 . . . . 0.0 108.942 172.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 153.58 39.81 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -165.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -90.89 113.5 25.71 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.903 2.081 . . . . 0.0 111.04 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.533 ' CD2' ' CG ' ' A' ' 130' ' ' HIS . 5.3 m-70 -67.79 162.22 60.07 Favored Pre-proline 0 C--N 1.36 1.055 0 C-N-CA 129.55 3.14 . . . . 0.0 113.461 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -54.25 -7.79 0.86 Allowed 'Trans proline' 0 CA--C 1.563 1.932 1 C-N-CA 125.419 4.079 . . . . 0.0 117.044 169.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.83 35.12 3.0 Favored 'General case' 0 C--N 1.358 0.949 1 C-N-CA 132.153 4.181 . . . . 0.0 107.84 173.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.54 149.43 43.05 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 -172.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.47 -19.96 50.79 Favored Glycine 0 C--N 1.362 1.99 0 C-N-CA 125.962 1.744 . . . . 0.0 112.011 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.92 119.96 36.42 Favored 'General case' 0 N--CA 1.447 -0.616 1 C-N-CA 132.864 4.466 . . . . 0.0 102.369 174.186 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.441 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 22.2 p90 -151.0 -2.11 0.35 Allowed 'General case' 0 C--N 1.353 0.739 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -174.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 37.6 pt -106.14 169.16 2.62 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 O-C-N 119.354 -2.091 . . . . 0.0 113.143 -175.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -159.3 153.58 23.84 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 102.971 -2.974 . . . . 0.0 102.971 174.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.87 127.04 8.43 Favored 'General case' 0 C--N 1.368 1.386 0 CA-C-N 123.097 2.68 . . . . 0.0 114.391 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.567 ' HG2' HH12 ' A' ' 128' ' ' ARG . 75.6 mmtt -116.81 93.42 4.19 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 120.493 -1.379 . . . . 0.0 108.223 174.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.21 -78.11 0.23 Allowed Glycine 0 C--N 1.363 2.056 0 C-N-CA 128.027 2.727 . . . . 0.0 116.287 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -118.81 -16.11 9.34 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 128.192 2.597 . . . . 0.0 109.015 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.6 m -84.41 75.24 10.26 Favored 'General case' 0 C--N 1.367 1.342 0 O-C-N 118.326 -2.734 . . . . 0.0 110.649 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.9 p -89.22 112.89 24.89 Favored 'Isoleucine or valine' 0 C--N 1.363 1.171 0 C-N-CA 127.789 2.435 . . . . 0.0 107.563 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.567 HH12 ' HG2' ' A' ' 123' ' ' LYS . 65.3 mtt85 -104.6 157.2 17.34 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 124.893 1.277 . . . . 0.0 111.952 -171.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.401 HG13 ' HD3' ' A' ' 145' ' ' LYS . 21.2 m -149.23 164.25 4.1 Favored 'Isoleucine or valine' 0 C--N 1.367 1.369 1 C-N-CA 132.053 4.141 . . . . 0.0 103.848 -178.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.533 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 4.4 m170 -90.3 116.19 28.08 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 118.9 -2.375 . . . . 0.0 114.485 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 110' ' ' VAL 0.276 2.3 m -143.33 156.65 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 O-C-N 119.016 -2.303 . . . . 0.0 111.587 177.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -112.72 153.96 26.9 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 111.635 -2.53 . . . . 0.0 111.271 177.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.17 116.11 27.83 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 129.13 2.972 . . . . 0.0 103.012 -174.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 109' ' ' LEU . 15.0 m-85 -71.85 65.78 0.54 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 126.859 2.064 . . . . 0.0 113.37 -175.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -92.11 -119.07 0.08 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 126.898 2.079 . . . . 0.0 110.408 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.85 -52.84 2.7 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 125.188 1.395 . . . . 0.0 112.93 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.4 m -71.07 -44.5 14.12 Favored Pre-proline 0 C--N 1.362 1.127 0 N-CA-C 118.74 2.867 . . . . 0.0 118.74 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.11 -174.71 12.51 Favored 'Cis proline' 0 CA--C 1.541 0.866 0 CA-C-N 126.973 3.526 . . . . 0.0 112.257 -2.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.5 m -95.23 123.78 38.92 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 125.104 1.362 . . . . 0.0 109.347 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.409 ' HD3' ' HE1' ' A' ' 113' ' ' HIS . 9.2 tmm_? -147.47 151.44 36.4 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 120.78 1.627 . . . . 0.0 108.503 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -175.62 -155.48 12.92 Favored Glycine 0 CA--C 1.489 -1.583 1 N-CA-C 98.502 -5.839 . . . . 0.0 98.502 174.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -89.17 160.33 17.04 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 119.975 1.887 . . . . 0.0 110.479 172.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.42 ' CG2' HG22 ' A' ' 131' ' ' VAL . 0.7 OUTLIER -125.53 171.21 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 O-C-N 120.455 -1.403 . . . . 0.0 109.773 174.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.1 m -100.05 116.4 32.0 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.434 ' HB2' HD22 ' A' ' 148' ' ' LEU 0.423 11.4 pttt -68.35 -6.41 24.12 Favored 'General case' 0 C--N 1.366 1.29 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 -172.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -70.75 -15.37 62.68 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 124.474 1.109 . . . . 0.0 113.536 170.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.2 mt -100.41 2.9 42.74 Favored 'General case' 0 C--N 1.37 1.457 0 C-N-CA 126.693 1.997 . . . . 0.0 112.471 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.455 ' HG ' HG11 ' A' ' 96' ' ' VAL . 5.7 mp -94.92 124.47 38.99 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 128.351 2.661 . . . . 0.0 108.771 177.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -118.13 154.16 51.59 Favored Pre-proline 0 CA--C 1.497 -1.058 0 C-N-CA 125.932 1.693 . . . . 0.0 107.664 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -78.42 153.52 27.35 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.614 2.209 . . . . 0.0 115.451 -166.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.418 ' HB2' ' HB2' ' A' ' 183' ' ' LEU 0.311 0.0 OUTLIER -17.94 -107.29 0.0 OUTLIER 'General case' 0 C--N 1.354 0.804 2 C-N-CA 132.681 4.392 . . . . 0.0 122.551 174.747 . . . . . . . . 5 4 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.326 12.4 t 47.41 -36.55 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 1 C-N-CA 132.616 4.366 . . . . 0.0 119.86 -179.526 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 67.55 -148.67 49.97 Favored Glycine 0 C--N 1.35 1.351 0 C-N-CA 128.129 2.776 . . . . 0.0 119.773 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 m -46.39 -23.75 0.4 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 130.232 3.413 . . . . 0.0 119.342 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 47.0 pttt -85.62 -8.45 58.24 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 126.542 1.937 . . . . 0.0 113.161 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 7.2 t -85.31 155.85 21.17 Favored 'General case' 0 C--N 1.374 1.667 0 CA-C-O 123.029 1.395 . . . . 0.0 112.597 173.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -68.49 -32.74 72.94 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 127.034 2.134 . . . . 0.0 112.751 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.72 -11.87 60.08 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 125.257 1.423 . . . . 0.0 111.488 171.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.66 3.75 42.7 Favored 'General case' 0 C--N 1.371 1.522 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 175.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.257 0.9 OUTLIER -122.94 173.38 7.83 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 125.689 1.596 . . . . 0.0 109.408 174.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -61.53 122.64 15.75 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 126.567 1.947 . . . . 0.0 114.449 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.32 -14.01 51.35 Favored Glycine 0 C--N 1.358 1.757 0 C-N-CA 124.947 1.261 . . . . 0.0 111.076 -167.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -83.98 155.52 31.72 Favored Glycine 0 C--N 1.36 1.882 0 N-CA-C 117.186 1.634 . . . . 0.0 117.186 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -58.46 -41.59 85.53 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 120.953 3.686 . . . . 0.0 120.953 -174.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . 0.273 0.1 OUTLIER -102.2 23.32 11.83 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 122.266 2.303 . . . . 0.0 111.785 -179.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -93.17 161.32 14.47 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-O 124.674 2.178 . . . . 0.0 116.671 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.8 m 170.65 175.99 0.06 Allowed 'General case' 0 C--N 1.354 0.778 1 N-CA-C 98.554 -4.61 . . . . 0.0 98.554 -178.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -137.77 102.25 4.68 Favored 'General case' 0 C--N 1.364 1.219 0 CA-C-N 124.551 3.341 . . . . 0.0 111.286 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -119.88 141.97 32.32 Favored Pre-proline 0 N--CA 1.433 -1.279 0 C-N-CA 130.116 3.366 . . . . 0.0 105.041 173.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.423 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 38.0 Cg_endo -58.37 -31.82 94.78 Favored 'Trans proline' 0 C--N 1.364 1.386 1 C-N-CA 127.678 5.586 . . . . 0.0 115.074 177.305 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -69.79 -35.97 75.3 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 130.332 3.453 . . . . 0.0 113.393 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.44 HD13 ' CZ3' ' A' ' 106' ' ' TRP . 4.4 mm -70.33 -36.21 66.02 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 C-N-CA 127.17 2.188 . . . . 0.0 109.132 174.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.441 ' O ' ' HG3' ' A' ' 177' ' ' GLN . 6.1 mt -62.73 -53.67 50.79 Favored 'General case' 0 C--N 1.382 1.982 0 C-N-CA 126.226 1.81 . . . . 0.0 111.045 173.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -57.26 -34.22 68.4 Favored 'General case' 0 C--N 1.373 1.613 0 C-N-CA 128.968 2.907 . . . . 0.0 114.374 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.0 -47.83 73.19 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 130.225 3.41 . . . . 0.0 111.718 172.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 36.3 mtt -68.45 -33.38 74.08 Favored 'General case' 0 C--N 1.369 1.423 0 CA-C-O 118.069 -0.967 . . . . 0.0 113.547 170.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 13.7 mt-30 -74.32 -43.71 55.61 Favored 'General case' 0 C--N 1.383 2.063 0 C-N-CA 126.366 1.866 . . . . 0.0 112.027 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -68.31 -47.96 66.21 Favored 'General case' 0 C--N 1.372 1.577 0 C-N-CA 129.116 2.966 . . . . 0.0 111.147 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.06 87.42 Favored 'General case' 0 C--N 1.382 2.015 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 170.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . 0.257 23.1 t70 -54.5 -47.44 73.07 Favored 'General case' 0 C--N 1.376 1.753 0 C-N-CA 127.17 2.188 . . . . 0.0 114.161 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -66.0 -43.0 89.01 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-N 120.8 1.636 . . . . 0.0 115.366 174.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.455 ' CB ' ' HB3' ' A' ' 190' ' ' ARG . . . -76.12 -29.05 57.7 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 178.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 151' ' ' TYR . 2.5 pp -80.0 -32.58 39.71 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 175.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.277 0.4 OUTLIER -89.68 -34.28 16.31 Favored 'General case' 0 C--N 1.366 1.309 0 C-N-CA 125.393 1.477 . . . . 0.0 111.199 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -100.48 -99.61 0.25 Allowed 'General case' 0 C--N 1.362 1.151 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 175.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -135.49 152.22 51.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.223 -1.548 . . . . 0.0 110.27 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 190' ' ' ARG 0.431 16.4 ptpt -50.92 -33.31 23.79 Favored 'General case' 0 C--N 1.358 0.967 1 C-N-CA 133.193 4.597 . . . . 0.0 113.898 172.222 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 13.5 tt -50.6 -27.97 5.25 Favored 'Isoleucine or valine' 0 C--N 1.368 1.393 0 C-N-CA 127.923 2.489 . . . . 0.0 113.032 172.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -72.72 -39.27 67.08 Favored 'General case' 0 C--N 1.377 1.764 0 C-N-CA 126.343 1.857 . . . . 0.0 114.75 170.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.583 ' CZ ' HD21 ' A' ' 109' ' ' LEU 0.283 0.0 OUTLIER -74.68 -34.41 62.66 Favored 'General case' 0 C--N 1.367 1.362 0 O-C-N 119.286 -2.134 . . . . 0.0 114.859 172.871 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 6.6 mt -75.8 -22.45 56.34 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 126.323 1.849 . . . . 0.0 112.901 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -58.26 -46.15 86.53 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 126.478 1.911 . . . . 0.0 114.309 170.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . 0.264 0.2 OUTLIER -105.56 22.14 16.0 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 128.208 2.603 . . . . 0.0 112.922 176.201 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -49.59 141.81 9.05 Favored 'General case' 0 C--N 1.374 1.663 0 C-N-CA 128.991 2.916 . . . . 0.0 118.823 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . 0.368 5.3 p -83.96 48.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.657 0 CA-C-O 125.636 2.636 . . . . 0.0 114.966 176.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 31.3 p -115.7 60.97 0.7 Allowed 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.68 2.792 . . . . 0.0 104.692 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -95.61 139.8 31.35 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 127.571 2.349 . . . . 0.0 116.336 -172.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -143.13 157.87 59.62 Favored Pre-proline 0 C--N 1.357 0.918 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.57 66.64 8.52 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 124.701 3.601 . . . . 0.0 112.299 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 33.0 t -127.69 33.11 4.86 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.958 1.703 . . . . 0.0 109.933 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.353 0.728 0 C-N-CA 123.487 0.715 . . . . 0.0 109.93 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.444 -0.741 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.67 -46.69 3.03 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.499 1.92 . . . . 0.0 111.51 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -151.83 115.13 4.76 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 120.806 -1.184 . . . . 0.0 108.176 177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -102.58 120.9 41.35 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 126.512 1.925 . . . . 0.0 106.546 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.38 66.86 0.19 Allowed 'General case' 0 C--N 1.362 1.126 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 -173.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -84.42 -30.8 25.05 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 129.225 3.01 . . . . 0.0 109.425 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.03 4.43 47.97 Favored Glycine 0 C--N 1.361 1.932 0 C-N-CA 126.647 2.07 . . . . 0.0 113.79 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.63 -28.81 0.05 OUTLIER Glycine 0 CA--C 1.493 -1.297 0 O-C-N 121.169 -1.195 . . . . 0.0 111.46 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 tp 69.58 -92.84 0.03 OUTLIER 'General case' 0 C--N 1.37 1.474 0 C-N-CA 130.052 3.341 . . . . 0.0 112.421 177.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -71.96 -23.87 61.51 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 131.548 3.939 . . . . 0.0 112.604 173.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . 0.28 10.0 tpp180 103.62 48.72 0.0 OUTLIER 'General case' 0 C--N 1.36 1.037 0 C-N-CA 131.06 3.744 . . . . 0.0 109.652 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 6.8 t 77.21 173.6 0.21 Allowed 'General case' 0 C--N 1.369 1.447 0 C-N-CA 128.647 2.779 . . . . 0.0 116.155 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.6 m -123.98 -2.31 6.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 128.382 2.673 . . . . 0.0 108.6 173.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.56 115.13 29.85 Favored Pre-proline 0 C--N 1.362 1.135 0 C-N-CA 126.105 1.762 . . . . 0.0 108.33 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.84 114.3 1.97 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.33 3.353 . . . . 0.0 111.891 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -139.68 -108.26 0.16 Allowed 'General case' 0 C--N 1.352 0.7 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -105.8 119.46 52.39 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 116.177 -1.868 . . . . 0.0 106.334 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -67.33 91.53 0.33 Allowed 'Trans proline' 0 C--N 1.367 1.508 1 C-N-CA 125.615 4.21 . . . . 0.0 112.433 -172.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.8 p -139.73 -97.54 0.16 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.654 1.982 . . . . 0.0 110.145 -170.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 t -176.6 -172.62 0.46 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 126.817 2.047 . . . . 0.0 106.988 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.7 m -166.48 36.65 0.04 OUTLIER 'General case' 0 C--N 1.353 0.753 0 O-C-N 120.49 -1.381 . . . . 0.0 110.287 172.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -97.61 99.88 11.27 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -124.42 126.51 46.06 Favored 'General case' 0 C--N 1.366 1.319 0 C-N-CA 124.431 1.093 . . . . 0.0 112.393 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 92' ' ' PRO 0.345 88.8 p -112.12 170.86 4.83 Favored Pre-proline 0 CA--C 1.558 1.279 1 C-N-CA 133.022 4.529 . . . . 0.0 116.524 -177.18 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 91' ' ' SER . 12.7 Cg_exo -41.69 128.55 3.71 Favored 'Trans proline' 0 C--N 1.389 2.691 1 C-N-CA 127.927 5.751 . . . . 0.0 118.879 -179.165 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.547 ' HA2' ' CZ ' ' A' ' 190' ' ' ARG . . . 88.08 4.38 78.25 Favored Glycine 0 CA--C 1.477 -2.314 0 C-N-CA 129.382 3.372 . . . . 0.0 117.223 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -93.59 148.57 21.97 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 168.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.97 126.31 52.96 Favored 'General case' 0 N--CA 1.441 -0.902 1 N-CA-C 99.834 -4.135 . . . . 0.0 99.834 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.3 m -129.3 154.93 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 -169.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -99.9 122.15 42.4 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 101.832 -3.396 . . . . 0.0 101.832 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -108.97 131.12 55.36 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 127.831 2.452 . . . . 0.0 110.77 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.87 135.85 49.39 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 174.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.0 ttp -130.08 153.55 48.36 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 119.946 -1.721 . . . . 0.0 112.098 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -63.22 90.25 0.04 OUTLIER 'General case' 0 C--N 1.364 1.224 0 C-N-CA 129.206 3.002 . . . . 0.0 114.734 177.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.46 -0.77 24.99 Favored Glycine 0 C--N 1.358 1.804 0 C-N-CA 125.786 1.66 . . . . 0.0 113.028 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -108.25 161.39 23.58 Favored Pre-proline 0 C--N 1.357 0.911 0 C-N-CA 125.366 1.466 . . . . 0.0 110.296 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.48 166.49 29.2 Favored 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 124.976 3.784 . . . . 0.0 111.65 164.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.6 121.53 16.62 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 126.454 1.902 . . . . 0.0 109.557 173.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . 0.282 0.8 OUTLIER -128.64 135.16 27.16 Favored Pre-proline 0 N--CA 1.428 -1.532 0 N-CA-C 119.267 3.062 . . . . 0.0 119.267 -167.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.51 149.19 90.75 Favored 'Trans proline' 0 CA--C 1.567 2.154 0 C-N-CA 124.722 3.615 . . . . 0.0 113.763 153.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.7 p -155.34 161.91 40.95 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 125.554 1.541 . . . . 0.0 112.464 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.447 HD22 ' HB2' ' A' ' 190' ' ' ARG . 2.3 pp -115.7 137.16 52.36 Favored 'General case' 0 C--N 1.374 1.66 0 O-C-N 120.386 -1.446 . . . . 0.0 110.594 171.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.529 HG13 HG12 ' A' ' 131' ' ' VAL . 2.2 t -93.86 118.97 40.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 C-N-CA 125.603 1.561 . . . . 0.0 109.141 170.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.4 ' HB3' ' CD1' ' A' ' 109' ' ' LEU 0.288 0.1 OUTLIER -137.81 155.62 48.81 Favored 'General case' 0 C--N 1.36 1.054 0 C-N-CA 128.481 2.713 . . . . 0.0 110.747 -177.746 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -71.42 113.63 8.66 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 125.588 1.555 . . . . 0.0 113.105 170.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -89.59 159.0 44.76 Favored Pre-proline 0 C--N 1.358 0.95 0 CA-C-O 113.798 -3.001 . . . . 0.0 106.631 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.288 46.4 Cg_exo -47.99 -0.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.308 2 C-N-CA 127.361 5.374 . . . . 0.0 122.745 -166.239 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -82.29 -26.17 33.34 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 128.15 2.58 . . . . 0.0 109.926 167.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 27.47 95.11 0.0 OUTLIER 'General case' 0 C--N 1.37 1.466 1 C-N-CA 135.226 5.41 . . . . 0.0 121.2 178.375 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.67 -20.85 26.68 Favored Glycine 0 C--N 1.357 1.699 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 39.9 m -107.67 118.16 36.0 Favored 'General case' 0 C--N 1.357 0.905 1 N-CA-C 98.954 -4.461 . . . . 0.0 98.954 165.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.402 ' HA ' ' CE1' ' A' ' 130' ' ' HIS . 13.2 p90 -147.35 0.82 0.71 Allowed 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 120.996 -1.065 . . . . 0.0 111.442 -171.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.45 HG22 HG12 ' A' ' 129' ' ' VAL . 17.4 pt -109.9 156.97 10.6 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 CA-C-O 121.97 0.891 . . . . 0.0 110.614 -178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 -149.85 152.19 34.72 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 103.52 -2.77 . . . . 0.0 103.52 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -145.23 131.39 19.42 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 120.352 -1.468 . . . . 0.0 110.539 -176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -117.94 93.52 4.17 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 126.687 1.995 . . . . 0.0 110.558 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.38 -83.24 0.44 Allowed Glycine 0 C--N 1.362 2.002 0 N-CA-C 119.247 2.459 . . . . 0.0 119.247 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -138.32 52.77 1.82 Allowed 'General case' 0 C--N 1.36 1.025 0 C-N-CA 125.616 1.566 . . . . 0.0 110.365 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 19.1 m -171.96 142.2 1.44 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 p -119.9 136.91 55.49 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 C-N-CA 124.708 1.203 . . . . 0.0 110.871 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -119.62 143.16 47.83 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 127.623 2.369 . . . . 0.0 111.489 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.45 HG12 HG22 ' A' ' 120' ' ' ILE . 29.9 m -129.01 162.86 35.49 Favored 'Isoleucine or valine' 0 C--N 1.37 1.468 0 C-N-CA 130.052 3.341 . . . . 0.0 107.042 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.402 ' CE1' ' HA ' ' A' ' 119' ' ' PHE . 1.5 p-80 -97.02 119.68 35.94 Favored 'General case' 0 C--N 1.371 1.526 0 O-C-N 119.147 -2.221 . . . . 0.0 112.305 174.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.529 HG12 HG13 ' A' ' 110' ' ' VAL . 0.9 OUTLIER -145.51 166.22 10.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.353 0 C-N-CA 127.709 2.404 . . . . 0.0 105.543 -177.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -124.2 147.56 47.93 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.332 1.453 . . . . 0.0 108.423 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -96.15 127.91 42.58 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 128.73 2.812 . . . . 0.0 106.214 176.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.411 ' CZ ' ' HB3' ' A' ' 109' ' ' LEU . 17.0 m-30 -72.61 59.37 0.45 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -174.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -94.93 -119.95 0.1 Allowed 'General case' 0 C--N 1.36 1.036 0 C-N-CA 127.238 2.215 . . . . 0.0 111.643 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -103.04 -52.43 3.04 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 125.129 1.372 . . . . 0.0 113.349 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.0 m -66.63 -43.81 52.17 Favored Pre-proline 0 C--N 1.366 1.323 0 N-CA-C 117.99 2.589 . . . . 0.0 117.99 -176.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -80.12 173.61 52.32 Favored 'Cis proline' 0 CA--C 1.537 0.661 0 CA-C-N 125.693 3.069 . . . . 0.0 110.753 -5.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.5 m -81.62 134.67 35.51 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 120.196 -1.565 . . . . 0.0 110.191 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 18.5 ttp-105 -141.96 157.78 44.55 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-N 121.098 1.772 . . . . 0.0 109.153 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 175.16 -159.92 28.42 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 103.679 -3.768 . . . . 0.0 103.679 173.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -97.48 108.45 21.18 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.523 2.329 . . . . 0.0 107.17 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 m -88.81 160.75 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.182 0 C-N-CA 126.941 2.096 . . . . 0.0 110.52 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.9 m -82.68 114.97 21.41 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.405 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 7.2 ttmt -72.85 -16.76 61.59 Favored 'General case' 0 C--N 1.359 0.985 0 CA-C-O 122.752 1.263 . . . . 0.0 113.962 -169.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -76.03 -5.85 48.31 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 120.266 -1.522 . . . . 0.0 113.547 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 75.1 mt -105.39 14.8 28.23 Favored 'General case' 0 C--N 1.37 1.461 0 C-N-CA 126.956 2.102 . . . . 0.0 110.844 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 29.2 mt -100.32 125.46 46.55 Favored 'General case' 0 C--N 1.365 1.248 0 C-N-CA 126.453 1.901 . . . . 0.0 107.81 173.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.72 163.14 20.37 Favored Pre-proline 0 C--O 1.226 -0.172 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 176.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -79.53 141.1 15.48 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.844 3.029 . . . . 0.0 112.515 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -93.95 140.06 30.16 Favored 'General case' 0 C--N 1.365 1.263 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 171.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.661 ' HA ' HD11 ' A' ' 183' ' ' LEU . 13.5 t -164.24 -15.97 0.03 OUTLIER 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.39 114.48 0.47 Allowed Glycine 0 C--N 1.352 1.469 0 C-N-CA 116.471 -2.776 . . . . 0.0 114.201 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 50.1 m -65.22 -10.63 33.31 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 127.835 2.454 . . . . 0.0 117.283 176.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.27 27.7 9.41 Favored 'General case' 0 C--N 1.355 0.822 0 C-N-CA 127.55 2.34 . . . . 0.0 109.19 175.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 22.7 t -99.42 142.84 30.38 Favored 'General case' 0 CA--C 1.48 -1.712 0 C-N-CA 128.278 2.631 . . . . 0.0 107.329 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 32.4 tptt -47.79 -40.63 21.43 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 127.393 2.277 . . . . 0.0 116.615 -173.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -73.97 -15.6 61.1 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 124.744 1.218 . . . . 0.0 113.822 173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.77 -1.52 40.24 Favored 'General case' 0 C--N 1.379 1.857 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -126.94 -173.77 2.97 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 125.255 1.422 . . . . 0.0 113.667 -176.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -61.93 121.88 14.07 Favored 'General case' 0 C--N 1.38 1.927 0 C-N-CA 125.921 1.688 . . . . 0.0 113.227 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 93.9 -6.19 73.06 Favored Glycine 0 C--N 1.356 1.674 0 C-N-CA 124.307 0.956 . . . . 0.0 114.095 -170.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -82.53 158.45 37.46 Favored Glycine 0 C--N 1.369 2.377 0 N-CA-C 118.345 2.098 . . . . 0.0 118.345 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -59.72 -41.84 91.79 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.86 -30.04 13.38 Favored 'General case' 0 C--N 1.365 1.25 0 O-C-N 121.228 -0.92 . . . . 0.0 110.197 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 3.1 t80 19.53 -101.42 0.01 OUTLIER 'General case' 0 C--N 1.388 2.282 1 C-N-CA 132.971 4.509 . . . . 0.0 114.575 -178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 15.6 m 54.26 57.65 5.69 Favored 'General case' 0 C--N 1.362 1.145 0 C-N-CA 129.378 3.071 . . . . 0.0 115.51 170.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.43 101.08 12.32 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-O 124.941 2.305 . . . . 0.0 113.112 -171.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 16.5 ttpp -120.34 147.03 44.17 Favored Pre-proline 0 N--CA 1.43 -1.464 1 C-N-CA 133.231 4.612 . . . . 0.0 103.42 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.535 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 57.3 Cg_endo -56.76 -33.79 94.9 Favored 'Trans proline' 0 CA--C 1.545 1.058 1 C-N-CA 125.883 4.389 . . . . 0.0 116.741 -178.331 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.83 -36.28 80.08 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 126.698 1.999 . . . . 0.0 112.4 173.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.256 6.5 mt -76.0 -32.62 23.55 Favored 'Isoleucine or valine' 0 C--N 1.369 1.425 0 C-N-CA 126.648 1.979 . . . . 0.0 110.566 174.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.535 ' HG ' ' HA ' ' A' ' 170' ' ' PRO 0.276 35.7 mt -62.57 -53.85 48.55 Favored 'General case' 0 C--N 1.387 2.226 0 C-N-CA 127.391 2.276 . . . . 0.0 110.269 172.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -57.76 -43.23 85.31 Favored 'General case' 0 C--N 1.369 1.418 0 C-N-CA 129.743 3.217 . . . . 0.0 114.197 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.26 -35.5 76.15 Favored 'General case' 0 N--CA 1.419 -1.98 0 C-N-CA 130.769 3.628 . . . . 0.0 111.454 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 14.0 mtt -68.09 -40.17 82.69 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.108 1.763 . . . . 0.0 110.384 168.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.469 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 11.7 mt-30 -66.17 -50.3 64.41 Favored 'General case' 0 C--N 1.374 1.655 0 C-N-CA 126.142 1.777 . . . . 0.0 112.258 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . 0.298 4.7 ptt180 -71.65 -37.53 70.8 Favored 'General case' 0 C--N 1.382 2.001 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 175.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.22 68.77 Favored 'General case' 0 C--N 1.373 1.612 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 169.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 20.6 t0 -70.11 -48.79 56.11 Favored 'General case' 0 C--N 1.372 1.546 0 O-C-N 119.212 -2.18 . . . . 0.0 110.569 168.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -53.37 -47.81 69.13 Favored 'General case' 0 C--N 1.373 1.629 0 C-N-CA 128.88 2.872 . . . . 0.0 114.696 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.42 ' CB ' ' HB3' ' A' ' 190' ' ' ARG . . . -68.11 -29.34 68.24 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 176.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.661 HD11 ' HA ' ' A' ' 152' ' ' THR 0.267 0.2 OUTLIER -81.35 -41.85 21.41 Favored 'General case' 0 C--N 1.367 1.365 0 O-C-N 118.552 -2.592 . . . . 0.0 112.811 171.077 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 180' ' ' ASP 0.277 0.0 OUTLIER -70.91 -30.3 66.59 Favored 'General case' 0 C--N 1.379 1.889 0 C-N-CA 129.359 3.064 . . . . 0.0 112.676 -173.402 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt -103.99 -100.59 0.31 Allowed 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.374 0.607 . . . . 0.0 109.712 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -136.62 144.03 43.84 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.675 7.1 pttm -51.19 -33.73 28.62 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 129.972 3.309 . . . . 0.0 116.41 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -49.78 -28.29 3.94 Favored 'Isoleucine or valine' 0 C--N 1.364 1.219 0 C-N-CA 129.096 2.958 . . . . 0.0 112.586 169.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.295 2.4 mptp? -64.79 -30.95 71.98 Favored 'General case' 0 C--N 1.374 1.642 0 C-N-CA 126.861 2.064 . . . . 0.0 115.479 168.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.547 ' CZ ' ' HA2' ' A' ' 93' ' ' GLY 0.381 0.0 OUTLIER -75.51 -41.35 55.5 Favored 'General case' 0 C--N 1.38 1.911 0 CA-C-N 123.046 2.657 . . . . 0.0 113.16 167.53 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 43.7 mt -69.38 -19.7 63.83 Favored 'General case' 0 C--N 1.378 1.843 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -64.68 -24.17 67.49 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 129.902 3.281 . . . . 0.0 112.55 170.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.3 mt -105.93 -49.35 3.41 Favored 'General case' 0 C--N 1.37 1.457 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 55.85 -128.81 2.02 Favored 'General case' 0 C--N 1.375 1.701 0 C-N-CA 128.683 2.793 . . . . 0.0 110.871 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.44 14.81 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.802 1.241 . . . . 0.0 112.076 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 9.4 t 79.12 24.57 0.5 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 128.999 2.92 . . . . 0.0 110.523 -171.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -25.35 31.82 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.163 2 C-N-CA 135.74 5.616 . . . . 0.0 124.42 -177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -82.12 146.04 54.16 Favored Pre-proline 0 C--N 1.356 0.879 0 C-N-CA 126.918 2.087 . . . . 0.0 114.555 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -84.97 -167.72 0.45 Allowed 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 123.958 3.105 . . . . 0.0 113.547 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 58.0 m -162.11 53.42 0.23 Allowed 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 120.527 -1.358 . . . . 0.0 107.919 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 C--N 1.353 0.74 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 179.932 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 tptm . . . . . 0 N--CA 1.443 -0.775 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 74.52 -50.52 0.67 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 129.148 2.979 . . . . 0.0 114.601 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -92.47 175.87 6.67 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 127.441 2.296 . . . . 0.0 111.703 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -103.13 141.49 35.76 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.793 1.237 . . . . 0.0 108.308 174.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.8 mt -64.92 -21.59 66.85 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 128.385 2.674 . . . . 0.0 117.039 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -101.88 1.78 37.35 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.127 1.771 . . . . 0.0 109.199 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.16 -22.29 3.11 Favored Glycine 0 C--N 1.357 1.748 0 C-N-CA 130.684 3.993 . . . . 0.0 115.136 -174.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.83 87.33 1.76 Allowed Glycine 0 C--N 1.357 1.716 0 C-N-CA 127.483 2.468 . . . . 0.0 113.081 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.6 tp 89.9 95.69 0.02 OUTLIER 'General case' 0 C--N 1.368 1.399 0 C-N-CA 128.293 2.637 . . . . 0.0 112.936 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -73.01 -52.14 15.53 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 126.89 2.076 . . . . 0.0 114.762 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.429 ' HE ' HH22 ' A' ' 128' ' ' ARG . 20.4 tpp180 -157.49 152.5 25.74 Favored 'General case' 0 N--CA 1.429 -1.494 1 N-CA-C 97.037 -5.171 . . . . 0.0 97.037 177.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 65.3 p -96.84 70.39 2.48 Favored 'General case' 0 CA--C 1.51 -0.59 0 O-C-N 120.511 -1.368 . . . . 0.0 110.767 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.3 p -99.28 102.59 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 CA-C-O 124.157 1.932 . . . . 0.0 111.586 -175.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.69 150.6 68.56 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.19 69.54 7.88 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 124.688 3.592 . . . . 0.0 112.422 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -122.8 -160.81 0.91 Allowed 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.197 0.999 . . . . 0.0 109.744 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.68 112.72 60.05 Favored Pre-proline 0 C--N 1.357 0.897 0 O-C-N 120.445 -1.409 . . . . 0.0 110.905 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -91.84 -161.53 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.559 2.84 . . . . 0.0 112.043 -176.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t -104.26 135.64 45.35 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.049 1.74 . . . . 0.0 107.182 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.5 p -81.82 72.16 8.86 Favored 'General case' 0 C--N 1.36 1.056 0 C-N-CA 129.141 2.976 . . . . 0.0 110.173 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 30.8 m -119.35 109.07 15.36 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 128.448 2.699 . . . . 0.0 110.347 -169.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -148.01 105.49 3.67 Favored 'General case' 0 C--N 1.358 0.968 0 O-C-N 121.078 -1.014 . . . . 0.0 109.631 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -124.61 128.37 48.78 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 126.019 1.728 . . . . 0.0 108.958 -171.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.54 164.55 14.59 Favored Pre-proline 0 C--N 1.355 0.827 0 C-N-CA 125.052 1.341 . . . . 0.0 113.747 -175.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -45.01 135.0 10.8 Favored 'Trans proline' 0 C--N 1.373 1.864 1 C-N-CA 127.828 5.686 . . . . 0.0 119.642 -173.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 190' ' ' ARG . . . 101.74 -6.45 54.76 Favored Glycine 0 C--N 1.366 2.211 0 C-N-CA 125.777 1.656 . . . . 0.0 112.11 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -94.3 169.65 10.08 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.265 2.033 . . . . 0.0 112.827 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -102.18 138.57 38.95 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 102.891 -3.003 . . . . 0.0 102.891 164.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.76 132.5 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.3 m95 -89.49 122.45 32.68 Favored 'General case' 0 N--CA 1.478 0.931 1 O-C-N 116.24 -4.037 . . . . 0.0 106.081 175.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -106.15 131.62 53.2 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-O 122.71 1.243 . . . . 0.0 113.124 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -102.33 135.48 43.86 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -122.53 147.65 46.12 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 104.566 -2.383 . . . . 0.0 104.566 175.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -64.79 107.93 1.59 Allowed 'General case' 0 C--N 1.354 0.772 0 C-N-CA 126.217 1.807 . . . . 0.0 113.114 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.32 -15.25 46.88 Favored Glycine 0 C--N 1.354 1.57 0 C-N-CA 124.769 1.176 . . . . 0.0 114.599 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . 0.256 0.0 OUTLIER -102.25 168.28 9.19 Favored Pre-proline 0 C--N 1.363 1.159 0 CA-C-N 119.659 1.729 . . . . 0.0 111.94 -178.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -72.76 158.52 50.23 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 125.196 3.931 . . . . 0.0 113.583 167.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -54.95 129.38 37.47 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 128.948 2.899 . . . . 0.0 115.351 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -134.04 126.58 18.72 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 119.768 3.247 . . . . 0.0 119.768 -172.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -67.21 117.64 4.97 Favored 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 124.944 3.763 . . . . 0.0 113.695 164.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -121.94 164.37 17.71 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 131.257 3.823 . . . . 0.0 114.335 -170.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.7 tp -120.99 132.77 55.12 Favored 'General case' 0 C--N 1.345 0.409 0 O-C-N 118.563 -2.586 . . . . 0.0 107.381 178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 131' ' ' VAL . 7.6 p -91.51 129.79 41.67 Favored 'Isoleucine or valine' 0 C--N 1.374 1.638 0 CA-C-N 119.987 1.267 . . . . 0.0 108.216 176.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . 0.345 0.0 OUTLIER -138.64 153.27 48.59 Favored 'General case' 0 C--N 1.372 1.563 0 O-C-N 117.922 -2.986 . . . . 0.0 117.351 -173.111 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -87.92 112.31 22.4 Favored 'General case' 0 C--N 1.368 1.413 0 CA-C-O 123.386 1.565 . . . . 0.0 109.246 174.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -97.33 154.99 37.86 Favored Pre-proline 0 N--CA 1.447 -0.599 0 C-N-CA 129.377 3.071 . . . . 0.0 108.115 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -56.68 -0.96 0.28 Allowed 'Trans proline' 0 N--CA 1.487 1.121 1 C-N-CA 126.524 4.816 . . . . 0.0 121.076 -165.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.79 -7.81 58.52 Favored 'General case' 0 C--N 1.363 1.191 0 C-N-CA 129.404 3.082 . . . . 0.0 109.624 170.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -30.18 139.99 0.02 OUTLIER 'General case' 0 C--N 1.375 1.715 1 C-N-CA 134.153 4.981 . . . . 0.0 121.361 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.22 -20.24 28.55 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 113.456 -1.702 . . . . 0.0 109.236 175.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.6 p -125.5 118.78 26.53 Favored 'General case' 0 C--N 1.348 0.514 1 N-CA-C 96.518 -5.364 . . . . 0.0 96.518 164.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -123.87 4.73 8.74 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 119.688 1.131 . . . . 0.0 112.12 -172.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.5 pt -110.12 166.43 5.16 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.746 1.218 . . . . 0.0 110.401 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -151.04 147.36 27.01 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.826 2.45 . . . . 0.0 105.201 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.06 134.67 15.4 Favored 'General case' 0 C--N 1.357 0.935 0 O-C-N 120.546 -1.346 . . . . 0.0 110.702 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.24 93.55 4.17 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 127.921 2.488 . . . . 0.0 108.834 175.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.32 -74.38 0.14 Allowed Glycine 0 C--N 1.361 1.971 0 N-CA-C 121.212 3.245 . . . . 0.0 121.212 172.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.32 37.58 3.53 Favored 'General case' 0 C--N 1.36 1.029 0 C-N-CA 125.775 1.63 . . . . 0.0 111.488 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m -166.22 151.6 8.46 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 119.461 -2.025 . . . . 0.0 107.286 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -136.47 144.58 32.41 Favored 'Isoleucine or valine' 0 C--N 1.366 1.293 0 C-N-CA 126.023 1.729 . . . . 0.0 111.126 -174.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.429 HH22 ' HE ' ' A' ' 78' ' ' ARG . 90.3 mtt-85 -135.55 154.76 51.27 Favored 'General case' 0 C--N 1.366 1.298 0 C-N-CA 127.975 2.51 . . . . 0.0 113.931 -175.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.431 HG22 ' HB3' ' A' ' 145' ' ' LYS . 23.3 m -126.28 162.74 29.57 Favored 'Isoleucine or valine' 0 C--N 1.38 1.904 0 C-N-CA 130.77 3.628 . . . . 0.0 106.144 173.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -86.42 116.42 24.56 Favored 'General case' 0 C--N 1.365 1.275 0 O-C-N 119.695 -1.878 . . . . 0.0 110.815 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 110' ' ' VAL . 2.3 t -138.67 150.13 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.542 0 C-N-CA 125.044 1.338 . . . . 0.0 107.714 -174.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.3 pm0 -118.7 144.93 45.91 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 170.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -100.22 131.05 46.39 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -75.53 72.59 2.52 Favored 'General case' 0 C--N 1.38 1.893 0 C-N-CA 125.098 1.359 . . . . 0.0 111.542 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -97.9 -103.9 0.19 Allowed 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.518 1.127 . . . . 0.0 111.002 -174.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -106.61 -62.44 1.39 Allowed 'General case' 0 C--N 1.354 0.763 0 C-N-CA 126.051 1.74 . . . . 0.0 113.75 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 p -88.27 -29.14 0.37 Allowed Pre-proline 0 C--N 1.364 1.196 0 N-CA-C 118.945 2.943 . . . . 0.0 118.945 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.5 -177.84 18.72 Favored 'Cis proline' 0 C--N 1.357 1.025 1 CA-C-N 129.585 4.459 . . . . 0.0 113.386 -2.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 64.2 m -98.12 113.37 25.24 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 127.889 2.476 . . . . 0.0 113.585 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -113.41 161.53 17.19 Favored 'General case' 0 C--N 1.363 1.155 0 CA-C-N 124.972 3.533 . . . . 0.0 108.086 172.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -166.58 -170.33 31.34 Favored Glycine 0 CA--C 1.492 -1.397 0 N-CA-C 103.359 -3.896 . . . . 0.0 103.359 168.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -93.93 110.21 21.9 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 172.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 17.6 m -94.6 157.16 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.232 0 C-N-CA 125.949 1.7 . . . . 0.0 110.947 -175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.5 t -79.14 110.98 14.91 Favored 'General case' 0 C--N 1.364 1.222 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 172.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.431 ' HB3' HG22 ' A' ' 129' ' ' VAL 0.419 0.0 OUTLIER -65.73 -14.89 62.2 Favored 'General case' 0 C--N 1.366 1.295 0 N-CA-C 117.273 2.323 . . . . 0.0 117.273 -172.891 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.418 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 41.0 ttm180 -74.76 -3.87 34.2 Favored 'General case' 0 N--CA 1.434 -1.227 1 C-N-CA 132.798 4.439 . . . . 0.0 112.933 170.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 147' ' ' LEU . 8.3 mt -109.73 2.29 19.99 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 127.391 2.276 . . . . 0.0 110.902 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.8 mt -96.41 153.22 17.95 Favored 'General case' 0 C--N 1.373 1.615 0 O-C-N 120.069 -1.644 . . . . 0.0 113.19 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -119.02 155.21 53.28 Favored Pre-proline 0 C--N 1.351 0.654 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -82.76 155.53 15.61 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 CA-C-N 125.403 2.965 . . . . 0.0 113.069 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -35.63 -87.89 0.0 OUTLIER 'General case' 0 C--N 1.348 0.512 2 C-N-CA 132.297 4.239 . . . . 0.0 122.4 -177.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.845 ' HA ' HD13 ' A' ' 183' ' ' LEU . 4.6 t -31.48 24.94 0.0 OUTLIER 'General case' 0 C--N 1.359 0.988 1 C-N-CA 138.555 6.742 . . . . 0.0 120.643 -179.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.03 0.4 47.9 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 118.445 2.138 . . . . 0.0 118.445 -165.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 159' ' ' ALA 0.256 5.8 p -62.73 -15.53 53.46 Favored 'General case' 0 C--N 1.366 1.289 0 CA-C-N 120.988 2.394 . . . . 0.0 117.287 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -91.47 -6.7 52.25 Favored 'General case' 0 C--N 1.348 0.509 0 C-N-CA 128.808 2.843 . . . . 0.0 111.107 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 10.0 p -90.85 147.85 22.9 Favored 'General case' 0 C--N 1.366 1.318 0 C-N-CA 127.34 2.256 . . . . 0.0 112.775 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -62.19 -18.47 61.11 Favored 'General case' 0 C--N 1.37 1.475 0 C-N-CA 126.82 2.048 . . . . 0.0 113.517 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -75.87 -26.51 57.13 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 127.452 2.301 . . . . 0.0 112.696 172.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.409 ' CB ' ' HA ' ' A' ' 154' ' ' SER . . . -89.63 -12.89 38.38 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -114.91 -178.91 3.48 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 126.177 1.791 . . . . 0.0 111.4 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -57.74 122.75 13.58 Favored 'General case' 0 C--N 1.372 1.55 0 C-N-CA 127.243 2.217 . . . . 0.0 115.134 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.12 -10.95 58.58 Favored Glycine 0 C--N 1.357 1.72 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.81 -167.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -84.33 160.34 36.26 Favored Glycine 0 C--N 1.363 2.058 0 N-CA-C 121.13 3.212 . . . . 0.0 121.13 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -60.38 -30.0 69.29 Favored 'General case' 0 C--N 1.369 1.447 0 C-N-CA 128.915 2.886 . . . . 0.0 118.691 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -105.34 7.9 33.52 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.357 -1.464 . . . . 0.0 110.456 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -87.78 162.64 16.9 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -171.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 25.5 m 174.91 176.75 0.16 Allowed 'General case' 0 C--N 1.353 0.724 1 N-CA-C 99.097 -4.409 . . . . 0.0 99.097 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -138.71 102.29 4.54 Favored 'General case' 0 C--N 1.364 1.228 0 CA-C-N 124.187 3.176 . . . . 0.0 111.288 173.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -119.74 138.32 26.62 Favored Pre-proline 0 N--CA 1.435 -1.21 0 C-N-CA 130.269 3.428 . . . . 0.0 105.766 172.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.47 ' HA ' ' HG ' ' A' ' 173' ' ' LEU . 55.4 Cg_endo -59.4 -27.44 84.99 Favored 'Trans proline' 0 C--N 1.363 1.334 1 C-N-CA 127.013 5.142 . . . . 0.0 115.086 177.372 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -70.02 -36.85 75.38 Favored 'General case' 0 C--N 1.364 1.217 0 C-N-CA 129.465 3.106 . . . . 0.0 113.167 173.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.2 mt -70.45 -34.89 59.63 Favored 'Isoleucine or valine' 0 C--N 1.381 1.977 0 C-N-CA 126.677 1.991 . . . . 0.0 110.056 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 170' ' ' PRO . 6.8 mt -59.69 -53.26 60.05 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 125.987 1.715 . . . . 0.0 110.742 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -57.55 -34.6 69.34 Favored 'General case' 0 C--N 1.367 1.356 0 C-N-CA 128.217 2.607 . . . . 0.0 115.403 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.81 -42.83 80.94 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 129.191 2.996 . . . . 0.0 111.662 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 18.1 mtt -69.98 -33.24 71.8 Favored 'General case' 0 C--N 1.372 1.546 0 CA-C-O 117.282 -1.342 . . . . 0.0 113.193 169.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 15.8 mt-30 -74.29 -42.64 59.23 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-N 121.713 2.051 . . . . 0.0 111.109 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -68.54 -49.65 57.91 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 127.348 2.259 . . . . 0.0 111.418 173.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.57 -41.39 98.9 Favored 'General case' 0 C--N 1.374 1.645 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 173.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 184' ' ' ASN . 21.1 t70 -62.33 -37.26 84.94 Favored 'General case' 0 C--N 1.379 1.876 0 C-N-CA 128.808 2.843 . . . . 0.0 111.353 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -72.03 -44.81 62.79 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 119.828 -1.795 . . . . 0.0 112.481 171.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -73.0 -38.89 66.46 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 118.442 2.756 . . . . 0.0 118.442 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.845 HD13 ' HA ' ' A' ' 152' ' ' THR . 4.4 pp -69.23 -37.28 77.94 Favored 'General case' 0 C--N 1.374 1.645 0 C-N-CA 127.243 2.217 . . . . 0.0 115.056 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 180' ' ' ASP . 0.0 OUTLIER -83.72 -31.95 25.77 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 127.103 2.161 . . . . 0.0 111.451 -177.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -105.13 -98.46 0.33 Allowed 'General case' 0 C--N 1.352 0.711 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -135.63 150.73 49.73 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.819 -1.176 . . . . 0.0 112.347 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.277 24.6 ttpp -51.69 -36.37 46.34 Favored 'General case' 0 C--N 1.37 1.466 0 C-N-CA 131.485 3.914 . . . . 0.0 115.385 174.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.8 tp -53.24 -27.59 13.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 C-N-CA 129.219 3.007 . . . . 0.0 112.409 172.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -75.78 -41.27 53.45 Favored 'General case' 0 C--N 1.372 1.555 0 O-C-N 119.483 -2.011 . . . . 0.0 114.636 173.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 93' ' ' GLY . 7.0 ptp180 -74.61 -37.06 62.94 Favored 'General case' 0 C--N 1.366 1.295 0 O-C-N 118.832 -2.418 . . . . 0.0 116.466 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.0 tp -79.92 -27.82 39.84 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.919 2.087 . . . . 0.0 113.052 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -77.43 -27.42 52.21 Favored 'General case' 0 C--N 1.371 1.541 0 N-CA-C 114.549 1.315 . . . . 0.0 114.549 171.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.83 -2.06 54.04 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 124.618 1.167 . . . . 0.0 111.108 175.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 21.9 -124.76 0.01 OUTLIER 'General case' 0 C--N 1.361 1.068 1 C-N-CA 133.807 4.843 . . . . 0.0 121.752 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.6 p -108.38 -20.19 6.32 Favored 'Isoleucine or valine' 0 C--N 1.349 0.555 0 O-C-N 119.8 -1.813 . . . . 0.0 110.575 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.29 5.8 t 59.26 -50.61 0.06 Allowed 'General case' 0 C--N 1.366 1.317 0 C-N-CA 129.844 3.258 . . . . 0.0 116.025 -176.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -84.83 59.41 5.55 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 127.378 2.271 . . . . 0.0 112.055 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -118.13 96.28 49.48 Favored Pre-proline 0 C--N 1.352 0.693 0 C-N-CA 125.492 1.517 . . . . 0.0 108.523 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.89 62.71 6.63 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 124.698 3.598 . . . . 0.0 113.785 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.327 97.9 p 88.05 -77.32 0.01 OUTLIER 'General case' 0 C--N 1.359 1.018 0 C-N-CA 130.088 3.355 . . . . 0.0 111.237 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 . . . . . 0 C--N 1.36 1.038 0 C-N-CA 129.054 2.942 . . . . 0.0 116.253 178.067 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt . . . . . 0 N--CA 1.441 -0.916 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -129.58 50.81 2.13 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 125.923 1.689 . . . . 0.0 109.48 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -134.93 142.4 46.52 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -85.56 130.52 34.55 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.822 2.049 . . . . 0.0 112.224 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -145.97 126.75 14.37 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 120.999 -1.063 . . . . 0.0 109.837 -176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -118.02 11.81 13.47 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 125.747 1.619 . . . . 0.0 110.468 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.37 -21.27 43.54 Favored Glycine 0 C--N 1.359 1.849 0 C-N-CA 126.807 2.146 . . . . 0.0 117.175 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -172.61 49.11 0.17 Allowed Glycine 0 C--N 1.354 1.582 0 CA-C-N 118.396 1.098 . . . . 0.0 110.49 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.28 30.35 0.14 Allowed 'General case' 0 C--N 1.361 1.081 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -72.02 -35.94 69.54 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 129.651 3.18 . . . . 0.0 114.645 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -135.94 50.37 2.09 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 126.72 2.008 . . . . 0.0 106.316 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.3 t -68.23 49.16 0.06 Allowed 'General case' 0 C--N 1.365 1.258 0 C-N-CA 129.287 3.035 . . . . 0.0 116.367 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.9 80.1 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.975 0 C-N-CA 127.308 2.243 . . . . 0.0 110.256 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.91 120.23 60.57 Favored Pre-proline 0 C--N 1.357 0.903 0 C-N-CA 126.096 1.758 . . . . 0.0 110.818 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -83.07 40.3 0.93 Allowed 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 124.232 3.288 . . . . 0.0 113.522 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -175.97 -168.81 0.29 Allowed 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.2 117.26 67.1 Favored Pre-proline 0 C--N 1.358 0.939 0 C-N-CA 125.2 1.4 . . . . 0.0 107.553 174.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -82.48 47.5 2.49 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 124.838 3.692 . . . . 0.0 112.897 -172.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.1 p -136.83 54.28 1.87 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 127.526 2.33 . . . . 0.0 107.883 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . 0.272 5.9 t 78.98 -73.94 0.06 Allowed 'General case' 0 C--N 1.361 1.101 0 N-CA-C 118.132 2.641 . . . . 0.0 118.132 175.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 146' ' ' ARG . 47.2 m -100.25 152.09 20.69 Favored 'General case' 0 C--N 1.364 1.235 0 C-N-CA 126.637 1.975 . . . . 0.0 113.686 -175.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.66 64.05 0.47 Allowed 'General case' 0 C--N 1.366 1.308 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -172.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -116.45 124.15 49.28 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.147 -1.596 . . . . 0.0 108.645 -175.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.9 p -112.33 165.26 13.37 Favored Pre-proline 0 C--N 1.362 1.127 0 C-N-CA 126.999 2.12 . . . . 0.0 114.651 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -52.22 138.22 54.76 Favored 'Trans proline' 0 C--N 1.371 1.747 1 C-N-CA 126.21 4.607 . . . . 0.0 120.483 -170.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.91 -12.43 38.05 Favored Glycine 0 C--N 1.365 2.169 0 C-N-CA 125.019 1.295 . . . . 0.0 110.418 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.66 170.08 9.72 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 120.37 2.085 . . . . 0.0 111.982 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.33 145.9 28.29 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 103.275 -2.861 . . . . 0.0 103.275 163.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.1 m -143.1 157.26 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 104.32 -2.474 . . . . 0.0 104.32 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.403 ' CZ3' ' HG3' ' A' ' 107' ' ' PRO . 66.9 m95 -108.39 123.33 48.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 102.064 -3.31 . . . . 0.0 102.064 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.4 136.64 54.19 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.509 1.523 . . . . 0.0 112.932 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.516 ' O ' HD13 ' A' ' 147' ' ' LEU . 12.5 tptt -109.51 145.41 36.32 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 170.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 tpt -129.18 150.23 50.65 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 118.622 -2.549 . . . . 0.0 110.042 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.26 90.18 0.07 Allowed 'General case' 0 C--N 1.368 1.406 0 C-N-CA 126.307 1.843 . . . . 0.0 115.622 -178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.19 1.47 25.07 Favored Glycine 0 C--N 1.359 1.841 0 C-N-CA 125.715 1.626 . . . . 0.0 112.983 -179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -108.82 161.36 23.92 Favored Pre-proline 0 C--N 1.354 0.786 0 C-N-CA 126.201 1.8 . . . . 0.0 109.352 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.76 167.6 26.11 Favored 'Trans proline' 0 CA--C 1.545 1.055 1 C-N-CA 125.323 4.015 . . . . 0.0 113.295 162.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.488 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 1.8 m95 -57.62 121.54 10.59 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 128.066 2.546 . . . . 0.0 115.301 170.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -123.76 111.83 29.21 Favored Pre-proline 0 N--CA 1.434 -1.259 0 N-CA-C 119.252 3.056 . . . . 0.0 119.252 -172.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.403 ' HG3' ' CZ3' ' A' ' 97' ' ' TRP . 4.6 Cg_exo -58.5 124.21 15.31 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 125.136 3.891 . . . . 0.0 111.227 162.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 17.8 p -137.82 165.5 26.31 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 128.461 2.704 . . . . 0.0 115.391 -161.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' A' ' 190' ' ' ARG . 9.2 tp -119.97 132.67 55.58 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.968 2.107 . . . . 0.0 105.952 174.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.474 HG23 HG12 ' A' ' 131' ' ' VAL . 2.9 p -83.61 118.98 32.04 Favored 'Isoleucine or valine' 0 C--N 1.381 1.959 0 N-CA-C 104.278 -2.49 . . . . 0.0 104.278 173.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -122.71 143.39 49.83 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.036 -1.665 . . . . 0.0 111.794 -164.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -98.0 118.53 34.8 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 119.349 -2.094 . . . . 0.0 112.049 174.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.538 ' H ' ' CE1' ' A' ' 130' ' ' HIS . 2.4 m-70 -71.79 159.78 84.5 Favored Pre-proline 0 C--N 1.358 0.95 0 C-N-CA 128.191 2.596 . . . . 0.0 108.303 169.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.17 -9.06 1.89 Allowed 'Trans proline' 0 CA--C 1.552 1.398 1 C-N-CA 126.563 4.842 . . . . 0.0 116.446 -178.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -63.39 -18.48 63.73 Favored 'General case' 0 C--N 1.36 1.053 1 C-N-CA 134.752 5.221 . . . . 0.0 113.561 166.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.341 0.0 OUTLIER -28.78 136.49 0.02 OUTLIER 'General case' 0 C--N 1.381 1.962 0 N-CA-C 120.926 3.676 . . . . 0.0 120.926 -177.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.91 -19.77 27.48 Favored Glycine 0 C--N 1.361 1.936 0 CA-C-O 123.432 1.573 . . . . 0.0 109.633 -175.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.4 m -141.99 119.66 11.8 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 100.269 -3.974 . . . . 0.0 100.269 164.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 130' ' ' HIS . 26.1 p90 -123.98 10.65 8.86 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 120.764 -1.21 . . . . 0.0 109.154 -176.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.814 HG22 HG12 ' A' ' 129' ' ' VAL . 8.2 pt -121.57 157.12 25.51 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 CA-C-O 123.637 1.684 . . . . 0.0 111.921 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.0 mtp-105 -137.38 149.1 46.72 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 130.467 3.507 . . . . 0.0 102.421 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.1 139.83 24.96 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 120.267 -1.521 . . . . 0.0 109.184 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -118.27 93.69 4.22 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 126.59 1.956 . . . . 0.0 109.622 175.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.63 -76.32 0.21 Allowed Glycine 0 C--N 1.366 2.249 0 N-CA-C 118.635 2.214 . . . . 0.0 118.635 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -141.18 22.7 2.22 Favored 'General case' 0 C--N 1.352 0.686 0 C-N-CA 125.763 1.625 . . . . 0.0 110.073 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 11.4 t -125.88 128.55 47.77 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 126.493 1.917 . . . . 0.0 108.674 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.7 m -119.21 116.06 49.74 Favored 'Isoleucine or valine' 0 C--N 1.358 0.949 0 C-N-CA 126.625 1.97 . . . . 0.0 112.406 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -113.84 130.68 56.45 Favored 'General case' 0 C--N 1.367 1.329 0 C-N-CA 127.362 2.265 . . . . 0.0 111.256 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.814 HG12 HG22 ' A' ' 120' ' ' ILE . 10.3 m -125.37 159.75 32.29 Favored 'Isoleucine or valine' 0 C--N 1.364 1.217 0 C-N-CA 127.438 2.295 . . . . 0.0 106.578 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.538 ' CE1' ' H ' ' A' ' 113' ' ' HIS . 3.8 p80 -90.46 129.76 36.6 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 125.262 1.425 . . . . 0.0 113.268 178.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.474 HG12 HG23 ' A' ' 110' ' ' VAL . 3.3 m -146.47 165.3 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 C-N-CA 128.358 2.663 . . . . 0.0 106.612 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -126.05 143.18 51.21 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 123.092 0.557 . . . . 0.0 109.909 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.55 123.91 39.32 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 129.666 3.186 . . . . 0.0 107.885 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -75.69 70.57 2.5 Favored 'General case' 0 C--N 1.374 1.654 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -90.79 -114.38 0.08 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 126.203 1.801 . . . . 0.0 110.96 -175.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -107.07 -51.99 2.83 Favored 'General case' 0 C--N 1.352 0.696 0 C-N-CA 126.183 1.793 . . . . 0.0 112.105 177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 16.3 m -73.68 -45.92 7.16 Favored Pre-proline 0 C--N 1.366 1.295 0 N-CA-C 119.396 3.11 . . . . 0.0 119.396 -173.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -85.29 177.31 27.38 Favored 'Cis proline' 0 CA--C 1.548 1.175 0 CA-C-N 127.452 3.697 . . . . 0.0 112.832 -1.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 84.5 m -95.08 119.98 34.52 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 120.058 -1.651 . . . . 0.0 110.83 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.491 HH21 HG21 ' A' ' 195' ' ' VAL . 4.6 tmm_? -132.19 148.03 52.45 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 121.351 1.887 . . . . 0.0 108.484 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -171.34 -166.65 30.47 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 107.527 -2.229 . . . . 0.0 107.527 169.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.59 111.92 17.47 Favored 'General case' 0 C--N 1.362 1.112 0 C-N-CA 127.233 2.213 . . . . 0.0 109.591 175.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.7 m -98.45 169.7 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 C-N-CA 125.275 1.43 . . . . 0.0 108.302 -176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.8 m -95.74 124.53 39.8 Favored 'General case' 0 C--N 1.364 1.199 0 N-CA-C 101.157 -3.646 . . . . 0.0 101.157 174.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.618 ' HD3' HG11 ' A' ' 129' ' ' VAL . 7.3 ttpm? -70.46 -9.06 55.48 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 124.359 3.254 . . . . 0.0 117.451 -168.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.419 ' HA ' ' HB2' ' A' ' 88' ' ' SER . 15.8 ptp180 -73.34 -6.26 44.98 Favored 'General case' 0 C--N 1.347 0.482 0 C-N-CA 129.622 3.169 . . . . 0.0 115.291 175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.516 HD13 ' O ' ' A' ' 99' ' ' LYS 0.264 0.8 OUTLIER -112.94 11.63 19.16 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.839 0.856 . . . . 0.0 110.371 176.545 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.46 HD12 ' HG3' ' A' ' 145' ' ' LYS . 4.8 mt -98.01 125.37 42.93 Favored 'General case' 0 C--N 1.38 1.903 0 C-N-CA 126.381 1.872 . . . . 0.0 107.898 173.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -114.15 161.57 27.48 Favored Pre-proline 0 C--N 1.346 0.426 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.32 153.59 14.06 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 124.959 2.807 . . . . 0.0 113.628 -174.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . 0.296 0.1 OUTLIER -29.87 -84.14 0.0 OUTLIER 'General case' 0 C--N 1.353 0.76 2 N-CA-C 123.685 4.698 . . . . 0.0 123.685 -179.943 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.616 ' HA ' HD21 ' A' ' 183' ' ' LEU . 14.8 t -34.27 38.34 0.0 OUTLIER 'General case' 0 C--N 1.373 1.616 1 C-N-CA 136.961 6.105 . . . . 0.0 118.154 -176.156 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.51 -36.86 2.36 Favored Glycine 0 C--N 1.358 1.788 0 C-N-CA 128.802 3.096 . . . . 0.0 117.969 -168.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 38.0 m -48.6 -15.41 0.08 Allowed 'General case' 0 C--N 1.376 1.755 0 N-CA-C 119.493 3.145 . . . . 0.0 119.493 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -111.34 0.12 16.54 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 127.453 2.301 . . . . 0.0 110.619 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.5 t -103.35 158.45 16.32 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 127.719 2.407 . . . . 0.0 114.691 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -56.54 -18.64 12.36 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.334 2.654 . . . . 0.0 118.09 -171.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -90.25 -10.53 43.93 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 124.814 1.246 . . . . 0.0 112.402 169.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.58 4.8 10.62 Favored 'General case' 0 C--N 1.375 1.694 0 CA-C-N 120.146 1.339 . . . . 0.0 114.396 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . 0.424 0.0 OUTLIER -113.2 162.01 16.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 171.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -50.08 122.41 6.71 Favored 'General case' 0 C--N 1.372 1.587 0 C-N-CA 127.318 2.247 . . . . 0.0 116.569 -172.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.86 -22.82 32.68 Favored Glycine 0 C--N 1.36 1.907 0 C-N-CA 125.01 1.291 . . . . 0.0 111.943 -167.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -79.32 158.7 44.09 Favored Glycine 0 C--N 1.371 2.516 0 N-CA-C 119.43 2.532 . . . . 0.0 119.43 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -52.19 -42.86 63.83 Favored 'General case' 0 C--N 1.366 1.317 0 N-CA-C 121.751 3.982 . . . . 0.0 121.751 -174.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.488 ' HB3' ' CD2' ' A' ' 105' ' ' TRP 0.344 0.2 OUTLIER -105.16 12.49 31.95 Favored 'General case' 0 C--N 1.365 1.262 0 O-C-N 120.327 -1.483 . . . . 0.0 112.967 -177.779 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -93.53 90.87 6.84 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 126.096 1.758 . . . . 0.0 112.722 178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 35.6 m -115.01 117.52 30.82 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 101.735 -3.431 . . . . 0.0 101.735 170.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.19 101.7 14.42 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 125.87 2.748 . . . . 0.0 113.581 -168.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -120.36 137.77 26.5 Favored Pre-proline 0 N--CA 1.422 -1.836 1 C-N-CA 133.753 4.821 . . . . 0.0 103.039 170.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.92 -26.07 79.66 Favored 'Trans proline' 0 CA--C 1.547 1.141 0 C-N-CA 124.943 3.762 . . . . 0.0 115.134 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -69.74 -35.97 75.45 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 130.961 3.705 . . . . 0.0 112.985 173.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.251 56.1 mt -75.15 -34.57 31.85 Favored 'Isoleucine or valine' 0 C--N 1.377 1.77 0 C-N-CA 126.289 1.836 . . . . 0.0 109.569 176.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.88 -46.53 68.17 Favored 'General case' 0 C--N 1.375 1.698 0 C-N-CA 124.827 1.251 . . . . 0.0 111.765 170.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -57.61 -35.79 70.91 Favored 'General case' 0 C--N 1.365 1.249 0 C-N-CA 126.751 2.02 . . . . 0.0 114.061 176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.17 -40.22 86.59 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 130.788 3.635 . . . . 0.0 112.071 172.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 56.4 mtt -69.67 -33.19 72.22 Favored 'General case' 0 C--N 1.364 1.201 0 CA-C-O 116.786 -1.578 . . . . 0.0 113.633 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -74.14 -48.21 30.94 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 126.769 2.028 . . . . 0.0 111.008 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.474 ' HE ' ' HG ' ' A' ' 193' ' ' LEU . 0.0 OUTLIER -69.08 -43.93 73.56 Favored 'General case' 0 C--N 1.369 1.432 0 C-N-CA 129.292 3.037 . . . . 0.0 112.454 177.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.86 93.05 Favored 'General case' 0 C--N 1.377 1.794 0 C-N-CA 125.359 1.463 . . . . 0.0 112.198 169.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.441 ' HA ' HD13 ' A' ' 183' ' ' LEU 0.356 4.4 t70 -60.9 -51.38 69.53 Favored 'General case' 0 C--N 1.384 2.096 0 CA-C-N 120.524 1.511 . . . . 0.0 113.016 173.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.31 -35.17 64.84 Favored 'General case' 0 C--N 1.368 1.412 0 CA-C-N 121.938 2.154 . . . . 0.0 116.268 175.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -76.77 -44.63 32.14 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 116.906 2.188 . . . . 0.0 116.906 168.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' A' ' 152' ' ' THR . 0.3 OUTLIER -60.9 -40.95 95.01 Favored 'General case' 0 C--N 1.364 1.203 0 C-N-CA 131.032 3.733 . . . . 0.0 116.032 178.182 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.284 0.0 OUTLIER -89.21 -13.82 37.4 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.801 2.04 . . . . 0.0 110.783 -173.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -121.31 -108.78 0.35 Allowed 'General case' 0 C--N 1.362 1.143 0 C-N-CA 126.553 1.941 . . . . 0.0 114.525 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -131.97 162.11 31.5 Favored 'General case' 0 C--N 1.37 1.49 0 O-C-N 119.53 -1.981 . . . . 0.0 113.7 -172.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -37.65 54.1 Favored 'General case' 0 C--N 1.375 1.678 1 C-N-CA 132.113 4.165 . . . . 0.0 116.262 177.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 15.3 tt -60.2 -31.89 49.29 Favored 'Isoleucine or valine' 0 C--N 1.348 0.501 0 C-N-CA 127.222 2.209 . . . . 0.0 113.74 177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -70.84 -42.79 69.71 Favored 'General case' 0 C--N 1.374 1.635 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 176.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.449 ' HB2' HD13 ' A' ' 109' ' ' LEU . 7.9 ptt180 -75.44 -44.28 45.23 Favored 'General case' 0 C--N 1.364 1.199 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 170.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . 0.269 7.7 tp -72.52 -19.19 61.56 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 127.234 2.213 . . . . 0.0 114.806 -173.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -63.0 -27.88 69.72 Favored 'General case' 0 C--N 1.368 1.371 0 C-N-CA 127.863 2.465 . . . . 0.0 112.697 166.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.474 ' HG ' ' HE ' ' A' ' 178' ' ' ARG . 2.0 mm? -100.06 22.45 11.29 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 127.965 2.506 . . . . 0.0 112.191 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.61 53.95 0.03 OUTLIER 'General case' 0 C--N 1.374 1.655 0 C-N-CA 127.825 2.45 . . . . 0.0 115.634 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.491 HG21 HH21 ' A' ' 140' ' ' ARG 0.403 2.9 m 62.0 -41.11 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.283 1 C-N-CA 134.867 5.267 . . . . 0.0 117.024 -179.833 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.318 87.0 p 77.79 59.34 0.03 OUTLIER 'General case' 0 C--N 1.365 1.246 0 C-N-CA 128.996 2.918 . . . . 0.0 108.83 -173.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.05 62.57 0.01 OUTLIER 'General case' 0 C--N 1.361 1.108 0 C-N-CA 129.265 3.026 . . . . 0.0 117.845 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . 0.394 44.6 mt-10 13.37 -73.44 0.0 OUTLIER Pre-proline 0 C--N 1.364 1.22 1 C-N-CA 133.996 4.919 . . . . 0.0 120.931 178.498 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -77.37 -9.88 17.52 Favored 'Trans proline' 0 C--N 1.36 1.163 0 CA-C-N 125.383 2.958 . . . . 0.0 114.021 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . 0.282 17.6 m 79.79 -37.81 0.17 Allowed 'General case' 0 C--N 1.364 1.209 0 C-N-CA 128.033 2.533 . . . . 0.0 115.767 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 . . . . . 0 C--N 1.357 0.899 0 C-N-CA 127.064 2.146 . . . . 0.0 112.706 178.825 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.0 tttp . . . . . 0 N--CA 1.441 -0.898 0 CA-C-O 122.269 1.033 . . . . 0.0 108.351 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.22 60.75 4.46 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 127.209 2.204 . . . . 0.0 113.761 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -110.51 122.84 48.71 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 126.825 2.05 . . . . 0.0 108.038 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -102.93 149.18 24.77 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 125.137 1.375 . . . . 0.0 109.206 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.474 ' H ' HD23 ' A' ' 72' ' ' LEU 0.259 2.6 pt? -63.22 -0.17 0.75 Allowed 'General case' 0 C--N 1.36 1.049 0 N-CA-C 120.656 3.576 . . . . 0.0 120.656 -173.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -97.41 -11.56 23.77 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 125.814 1.645 . . . . 0.0 110.294 173.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.1 0.48 3.16 Favored Glycine 0 C--N 1.369 2.413 0 N-CA-C 122.129 3.612 . . . . 0.0 122.129 162.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.67 -24.58 1.49 Allowed Glycine 0 C--N 1.351 1.371 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -174.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.3 mt -85.61 79.1 9.48 Favored 'General case' 0 C--N 1.367 1.346 0 CA-C-O 123.082 1.42 . . . . 0.0 109.219 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -71.24 -25.22 62.39 Favored 'General case' 0 C--N 1.363 1.173 0 C-N-CA 128.565 2.746 . . . . 0.0 114.112 -178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 52.8 tpt85 178.8 -44.78 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 87.6 p -156.56 -137.94 0.06 Allowed 'General case' 0 C--N 1.357 0.917 0 C-N-CA 125.699 1.6 . . . . 0.0 106.969 175.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . 0.331 10.9 m 47.43 27.41 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.238 1 C-N-CA 133.301 4.64 . . . . 0.0 120.617 176.457 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -124.73 142.69 41.45 Favored Pre-proline 0 C--N 1.357 0.923 0 O-C-N 120.081 -1.637 . . . . 0.0 113.375 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.99 69.04 6.4 Favored 'Trans proline' 0 C--N 1.368 1.575 1 C-N-CA 125.885 4.39 . . . . 0.0 111.043 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -154.88 -37.43 0.09 Allowed 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.719 2.808 . . . . 0.0 106.09 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -104.77 111.65 65.24 Favored Pre-proline 0 C--N 1.364 1.205 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 171.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.23 64.9 4.21 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.521 2.814 . . . . 0.0 110.371 -173.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.6 p -89.99 59.15 4.43 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 130.05 3.34 . . . . 0.0 112.159 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.3 t -86.87 98.2 11.08 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 127.634 2.374 . . . . 0.0 110.185 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 99.5 p -101.13 96.56 7.3 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.573 1.549 . . . . 0.0 110.85 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -138.36 58.29 1.67 Allowed 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -113.82 122.97 48.67 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 119.336 -2.102 . . . . 0.0 114.314 -174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . 0.297 96.8 p -112.92 167.35 9.36 Favored Pre-proline 0 C--N 1.359 0.992 0 C-N-CA 129.278 3.031 . . . . 0.0 115.42 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -48.58 139.92 22.73 Favored 'Trans proline' 0 C--N 1.379 2.161 1 C-N-CA 127.457 5.438 . . . . 0.0 121.266 -170.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.26 -7.07 66.43 Favored Glycine 0 C--N 1.37 2.418 0 C-N-CA 126.092 1.806 . . . . 0.0 112.585 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -93.82 169.15 10.52 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 119.971 1.886 . . . . 0.0 111.851 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 151' ' ' TYR . 2.8 mm? -102.7 147.76 26.43 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 167.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.35 159.34 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 -177.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -104.67 119.1 38.2 Favored 'General case' 0 CA--C 1.51 -0.558 1 N-CA-C 98.054 -4.795 . . . . 0.0 98.054 165.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -104.96 131.53 52.35 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.29 136.99 47.84 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 118.675 -2.516 . . . . 0.0 106.136 175.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 57.1 ttm -129.69 141.4 50.91 Favored 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 119.922 -1.736 . . . . 0.0 110.264 173.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -65.37 107.62 1.7 Allowed 'General case' 0 C--N 1.367 1.353 0 C-N-CA 126.082 1.753 . . . . 0.0 112.878 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.55 -16.61 21.52 Favored Glycine 0 C--N 1.36 1.887 0 C-N-CA 125.438 1.494 . . . . 0.0 112.55 -172.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -112.53 161.63 25.4 Favored Pre-proline 0 C--N 1.359 1.011 0 O-C-N 121.144 -1.21 . . . . 0.0 109.111 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.95 167.06 27.73 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 125.015 3.81 . . . . 0.0 113.342 166.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.49 ' CD2' ' HB3' ' A' ' 165' ' ' PHE . 0.3 OUTLIER -58.36 116.42 3.61 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 127.908 2.483 . . . . 0.0 112.821 171.394 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -127.0 117.9 22.1 Favored Pre-proline 0 N--CA 1.426 -1.633 0 N-CA-C 121.387 3.847 . . . . 0.0 121.387 -169.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -49.08 125.3 13.03 Favored 'Trans proline' 0 C--N 1.387 2.58 1 C-N-CA 127.079 5.186 . . . . 0.0 112.374 162.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 m -146.55 164.19 33.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 124.298 1.999 . . . . 0.0 112.045 -158.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.0 tt -135.67 135.57 40.23 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 119.564 -1.96 . . . . 0.0 106.61 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.312 3.3 p -92.45 130.97 40.77 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 CA-C-N 121.19 1.814 . . . . 0.0 110.372 175.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -133.37 153.05 51.92 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 125.521 1.528 . . . . 0.0 111.955 -166.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -99.81 112.16 24.43 Favored 'General case' 0 C--N 1.376 1.718 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 171.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -96.73 158.38 33.67 Favored Pre-proline 0 N--CA 1.449 -0.483 0 C-N-CA 130.416 3.486 . . . . 0.0 108.767 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -50.05 -1.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.367 1.525 2 C-N-CA 127.565 5.51 . . . . 0.0 122.852 -165.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -99.83 9.1 43.58 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 126.673 1.989 . . . . 0.0 108.981 172.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.0 143.66 0.08 Allowed 'General case' 0 C--N 1.369 1.437 1 C-N-CA 134.224 5.01 . . . . 0.0 120.884 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 109.94 -19.68 27.51 Favored Glycine 0 C--N 1.359 1.832 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.5 t -134.12 127.52 32.27 Favored 'General case' 0 N--CA 1.448 -0.571 1 N-CA-C 99.456 -4.276 . . . . 0.0 99.456 163.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -128.24 6.41 5.86 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 120.514 -1.366 . . . . 0.0 109.671 -176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.549 HG22 HG12 ' A' ' 129' ' ' VAL . 23.5 pt -118.59 150.36 20.86 Favored 'Isoleucine or valine' 0 C--N 1.361 1.105 0 CA-C-O 124.076 1.893 . . . . 0.0 113.678 -173.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.532 ' HE ' ' H ' ' A' ' 122' ' ' GLU . 5.7 tpm_? -140.42 144.23 36.04 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 130.025 3.33 . . . . 0.0 103.715 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.532 ' H ' ' HE ' ' A' ' 121' ' ' ARG . 42.4 tt0 -140.3 126.93 20.34 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 176.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -107.16 93.39 4.53 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.82 1.648 . . . . 0.0 107.175 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.5 -93.55 0.81 Allowed Glycine 0 C--N 1.362 2.014 0 C-N-CA 126.489 1.995 . . . . 0.0 111.729 -174.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -119.58 -0.78 10.76 Favored 'General case' 0 C--N 1.351 0.656 0 C-N-CA 125.248 1.419 . . . . 0.0 109.204 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 18.5 t -92.52 97.97 11.16 Favored 'General case' 0 C--N 1.365 1.24 0 C-N-CA 125.298 1.439 . . . . 0.0 111.055 -178.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.18 129.33 38.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 128.135 2.574 . . . . 0.0 112.404 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -123.49 140.66 52.78 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 126.998 2.119 . . . . 0.0 109.709 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.549 HG12 HG22 ' A' ' 120' ' ' ILE . 14.8 m -127.2 163.53 29.96 Favored 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 127.284 2.233 . . . . 0.0 109.928 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -78.62 123.46 27.14 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 119.195 -2.191 . . . . 0.0 111.819 171.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.538 HG22 HG11 ' A' ' 143' ' ' VAL . 5.5 m -143.96 176.21 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.232 0 CA-C-N 123.278 2.763 . . . . 0.0 104.846 174.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.32 152.36 51.77 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 125.07 1.481 . . . . 0.0 108.442 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.52 120.65 42.82 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 104.141 -2.541 . . . . 0.0 104.141 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -64.86 65.88 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.5 1.92 . . . . 0.0 114.839 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -103.16 -128.62 0.23 Allowed 'General case' 0 C--N 1.36 1.045 0 O-C-N 118.963 -2.336 . . . . 0.0 112.123 -175.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -102.24 -57.53 2.05 Favored 'General case' 0 C--N 1.362 1.124 0 C-N-CA 126.144 1.778 . . . . 0.0 113.001 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 12.6 p -80.91 -26.6 0.43 Allowed Pre-proline 0 C--N 1.362 1.113 0 N-CA-C 118.356 2.724 . . . . 0.0 118.356 -178.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -85.89 -157.26 1.22 Allowed 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 127.944 3.873 . . . . 0.0 109.977 -2.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.4 m -96.68 127.82 43.03 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 1.1 tmt_? -161.64 154.77 20.89 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 119.488 -2.008 . . . . 0.0 108.936 -176.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.95 -158.02 19.33 Favored Glycine 0 CA--C 1.485 -1.803 0 N-CA-C 103.74 -3.744 . . . . 0.0 103.74 166.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -91.01 112.61 24.58 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 169.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.538 HG11 HG22 ' A' ' 131' ' ' VAL 0.304 14.8 p -102.64 161.31 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-N 113.186 -1.825 . . . . 0.0 110.988 -163.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 4.5 m -78.37 109.69 12.74 Favored 'General case' 0 C--N 1.363 1.188 0 C-N-CA 124.919 1.288 . . . . 0.0 107.836 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.505 ' HA ' ' HG ' ' A' ' 148' ' ' LEU . 26.9 tttp -64.4 -19.05 65.26 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 116.843 2.164 . . . . 0.0 116.843 -170.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.5 ttt85 -82.41 -6.33 59.21 Favored 'General case' 0 C--N 1.362 1.146 0 O-C-N 120.237 -1.54 . . . . 0.0 113.742 176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.4 mt -100.68 6.85 44.13 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 126.405 1.882 . . . . 0.0 109.695 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.505 ' HG ' ' HA ' ' A' ' 145' ' ' LYS . 26.1 mt -96.69 124.42 40.67 Favored 'General case' 0 C--N 1.368 1.397 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 173.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -116.65 158.84 42.52 Favored Pre-proline 0 CA--C 1.493 -1.24 0 O-C-N 120.478 -1.389 . . . . 0.0 107.809 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.81 150.73 14.39 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 CA-C-N 122.711 2.004 . . . . 0.0 113.41 -170.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.406 ' HB3' ' HB2' ' A' ' 95' ' ' LEU 0.36 0.0 OUTLIER -28.2 -87.39 0.0 OUTLIER 'General case' 0 C--N 1.355 0.81 2 N-CA-C 123.459 4.615 . . . . 0.0 123.459 -177.997 . . . . . . . . 5 4 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.54 ' HA ' HD21 ' A' ' 183' ' ' LEU . 8.8 t 2.52 57.23 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 1 C-N-CA 134.656 5.183 . . . . 0.0 118.865 176.392 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.559 ' H ' HD11 ' A' ' 183' ' ' LEU . . . -79.16 -108.24 0.22 Allowed Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 122.234 3.654 . . . . 0.0 122.234 -154.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 8.3 m -45.17 -22.44 0.11 Allowed 'General case' 0 C--N 1.371 1.54 0 C-N-CA 130.643 3.577 . . . . 0.0 120.197 -167.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -85.39 -11.5 54.35 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 127.934 2.493 . . . . 0.0 113.051 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 68.8 m -89.81 150.82 22.09 Favored 'General case' 0 C--N 1.367 1.341 0 C-N-CA 126.342 1.857 . . . . 0.0 114.401 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -47.89 -39.84 19.98 Favored 'General case' 0 C--N 1.368 1.387 0 C-N-CA 129.358 3.063 . . . . 0.0 116.694 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -77.22 -13.18 59.98 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -106.24 8.19 31.81 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 121.111 -0.993 . . . . 0.0 113.519 -177.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -117.27 179.76 3.95 Favored 'General case' 0 C--N 1.349 0.545 0 C-N-CA 126.082 1.753 . . . . 0.0 108.867 174.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -61.2 122.77 15.88 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 126.706 2.002 . . . . 0.0 113.8 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 97.31 -8.25 64.49 Favored Glycine 0 C--N 1.359 1.846 0 C-N-CA 124.909 1.242 . . . . 0.0 111.755 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.69 154.87 34.73 Favored Glycine 0 C--N 1.362 2.019 0 C-N-CA 126.342 1.925 . . . . 0.0 114.944 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -65.97 -42.48 89.82 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 119.57 3.174 . . . . 0.0 119.57 -172.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.49 ' HB3' ' CD2' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -101.62 1.72 38.06 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-N 121.567 1.985 . . . . 0.0 113.41 -178.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -81.06 91.88 6.15 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 127.054 2.142 . . . . 0.0 113.337 179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 27.6 m -116.48 102.25 9.34 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 100.49 -3.893 . . . . 0.0 100.49 168.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -95.31 101.94 13.71 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 125.842 2.734 . . . . 0.0 111.661 -171.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -119.45 149.45 47.77 Favored Pre-proline 0 N--CA 1.422 -1.826 1 C-N-CA 132.338 4.255 . . . . 0.0 100.516 171.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.34 -30.14 79.74 Favored 'Trans proline' 0 C--N 1.351 0.71 1 C-N-CA 126.137 4.558 . . . . 0.0 115.822 -177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -68.71 -47.49 66.23 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 126.828 2.051 . . . . 0.0 113.258 175.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 10.5 mt -67.28 -45.28 86.42 Favored 'Isoleucine or valine' 0 C--N 1.373 1.59 0 C-N-CA 127.363 2.265 . . . . 0.0 111.337 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.439 ' O ' ' HG3' ' A' ' 177' ' ' GLN 0.424 2.3 pp -68.81 -32.1 71.57 Favored 'General case' 0 C--N 1.372 1.559 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 174.617 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 52.5 tpt85 -66.5 -42.02 88.0 Favored 'General case' 0 C--N 1.379 1.862 0 C-N-CA 127.903 2.481 . . . . 0.0 113.165 172.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.21 -33.86 76.78 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 131.593 3.957 . . . . 0.0 111.275 175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . . . . . . . . . 41.2 mtp -69.95 -32.7 71.09 Favored 'General case' 0 C--N 1.371 1.504 0 C-N-CA 126.824 2.05 . . . . 0.0 112.424 164.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 173' ' ' LEU . 36.2 mt-30 -72.11 -45.09 61.94 Favored 'General case' 0 C--N 1.383 2.026 0 CA-C-N 121.259 1.845 . . . . 0.0 111.647 174.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -64.78 -50.52 66.44 Favored 'General case' 0 C--N 1.381 1.952 0 C-N-CA 129.443 3.097 . . . . 0.0 111.586 174.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.3 -52.47 61.84 Favored 'General case' 0 C--N 1.377 1.775 0 CA-C-O 116.879 -1.534 . . . . 0.0 113.912 173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -54.26 -43.91 71.37 Favored 'General case' 0 C--N 1.383 2.036 0 CA-C-N 121.822 2.101 . . . . 0.0 114.048 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -36.59 84.71 Favored 'General case' 0 C--N 1.366 1.294 0 O-C-N 119.12 -2.238 . . . . 0.0 115.809 172.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.442 ' HB1' ' HD2' ' A' ' 190' ' ' ARG . . . -75.52 -44.65 42.55 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 174.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.559 HD11 ' H ' ' A' ' 153' ' ' GLY 0.259 1.2 tt -58.93 -42.97 91.03 Favored 'General case' 0 C--N 1.358 0.955 1 C-N-CA 132.174 4.19 . . . . 0.0 116.051 176.851 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASN . . . . . . . . . . . . 0.278 0.0 OUTLIER -91.56 -7.37 50.43 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.342 1.457 . . . . 0.0 111.068 -177.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -119.09 -112.34 0.34 Allowed 'General case' 0 C--N 1.362 1.122 0 O-C-N 121.629 -0.669 . . . . 0.0 111.979 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -127.05 158.27 37.43 Favored 'General case' 0 C--N 1.36 1.059 0 O-C-N 120.337 -1.477 . . . . 0.0 110.667 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 190' ' ' ARG 0.298 24.0 tttm -51.63 -37.01 48.23 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 130.708 3.603 . . . . 0.0 116.774 178.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 5.5 tp -53.7 -29.71 17.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 129.273 3.029 . . . . 0.0 113.526 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . 0.263 6.1 mptt -72.05 -47.92 48.1 Favored 'General case' 0 C--N 1.371 1.542 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 175.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ARG . . . . . 0.442 ' HD2' ' HB1' ' A' ' 182' ' ' ALA . 0.0 OUTLIER -75.37 -37.43 60.62 Favored 'General case' 0 C--N 1.368 1.384 0 CA-C-N 123.168 2.713 . . . . 0.0 115.335 172.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.46 -25.2 63.97 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 126.426 1.89 . . . . 0.0 114.552 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -60.99 -38.03 84.56 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.612 2.765 . . . . 0.0 113.542 166.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -85.17 -51.04 6.9 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 126.741 2.017 . . . . 0.0 108.68 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 66.52 -72.14 0.09 Allowed 'General case' 0 C--N 1.365 1.252 0 C-N-CA 127.818 2.447 . . . . 0.0 116.027 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -130.67 -5.96 2.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 C-N-CA 129.426 3.09 . . . . 0.0 111.642 176.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . 0.428 85.1 p 97.43 -98.6 0.0 OUTLIER 'General case' 0 C--N 1.361 1.068 0 C-N-CA 128.684 2.794 . . . . 0.0 111.236 -178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -115.89 113.59 23.54 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 125.399 1.48 . . . . 0.0 109.504 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -158.68 -63.99 0.02 OUTLIER Pre-proline 0 C--N 1.351 0.649 0 CA-C-O 116.819 -1.563 . . . . 0.0 107.627 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -80.36 64.59 8.89 Favored 'Trans proline' 0 C--N 1.364 1.362 0 CA-C-N 125.295 2.927 . . . . 0.0 111.109 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 20.2 t -107.68 36.04 2.88 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.465 1.506 . . . . 0.0 112.179 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 C--N 1.362 1.122 0 C-N-CA 128.599 2.76 . . . . 0.0 116.738 176.34 . . . . . . . . 0 0 . 1 stop_ save_